Citrus Sinensis ID: 008239

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570---
Protein Sequence
MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNPNGSEISSVGTPSTSNSK
Secondary Structure (PSIPRED)
cccccccccccccEEEEcccccccEEEEEEccccccHHHHHHHHHHHHHHHHHHcccccccccEEEEEccEEEEEccccccccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHHHccccEEEEEEcccccccEEEEEEEccccccHHHHHHHHHHHHHHHHHHccccccEEEcccEEEEEccccccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHccccccccccccccccccEEEcccccEEEEEEccccccHHHHHHHHHHHHHHcccccccccEEccccccccEEEEEEEccccccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccccccccccccccccEEEEEcccccHHHHcccccccccccccccEEEEEEEccccccccccccccHHHHHHHHcccccccccccccccccccccHHHHHHHHEEEcccccccccccHHHHHHHHcccccccccccccEEccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccEEccccccccEEEEEEEEcccccHHHHHHHHHHHHHHHHHHcccccccEEEEEEEccEEEEEccccHcccccccccEEEEccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEEccccccccEEEEEEEEcccccHHHHHHHHHHHHHHcHHHccccccEEEcccEEEEEEEEcccccccccccccccccccEEEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccEEcHHHHHHHHccccHHccccccccccEEccEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHHHEEEcccccEEEEEEEcccccccEEEEcHHHcccccHHHHHHHHHHHHHHHHHHHHccHcccccccccHHHEEEcccccEEEcccccccccHHHHccccccEEEcHHHccHHHHHHccccHHHHHHHHHHHHHHHEEcccccccccccccHHHHHHHHHHccccHEEccHcccccccHHHHHHHHHHHHHHccccccccccHHHHHHEccccccccccccccEEEcccccccccccccccccc
Coil and Loop (DISEMBL)
MDIVTPLIARQRYAAVVNGTGTASVYAFgecmkdlspndcnlcfaqcktqvlkclpfqlatrggrvfydgcylryddydffneslssqdrtvcgskdfggnntvfGANAIELVRNLSVqavkndgfFVGSVTfskgnvsvhgLAQCWEfvngsaceNCLENAVSRIASCtqkeegrvlnagCYLRYstqrfynnsgpdpvpgnggdnKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNyfhesnklgqggsgsvykgtlpggeaVAVKRLFYNTTQWVDHFFNEvnlisginhKNLVKLLgcsitgpesllvyefvpnqslldnlfvrqdveplswEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAdfglvrlfpedITHISATLAgtlgymapeyvvrgkltekadvYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKgrlheavdpalagnfqegkpsrLLQIGLLCVQASAELRPSMSIVVKMLTgnheilqptqppflnpngseissvgtpstsnsk
Flexible Loop (DISEMBL)
mdivtpliarqryaavVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASctqkeegrvlNAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRerkqlgalqvavnksklnFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINlftqnscsILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPtqppflnpngseissvgtpstsnsk
Low Complexity Region (SEG)
MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYnnsgpdpvpgnggdnKlavilatsavalllvfslvaffvrrkllqkrrerkqlGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNPNGSEISSVGTPSTSNSK
Disordered region (IsUnstruct)
**IVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYNN***********DNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLG*GGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEI****************************
Disordered Region (DISOPRED)
******LIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFY*******************ILATSAVALLLVFSLVAFFVRR***********************LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPP*********************
Disordered Region (DISEMBL)
MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNPNGS**************
Disordered Region (DISPRO)
********ARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYNNSGP********DNKLAVILATSAVALLLVFSLVAFFVRRKLLQK***************KSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNPN****************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNPNGSEISSVGTPSTSNSK
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	573	2.2.26 [Sep-21-2011]
Q9CAL2	646	Cysteine-rich receptor-li	yes	no	0.993	0.880	0.650	0.0
Q9FNE1	651	Cysteine-rich receptor-li	no	no	0.897	0.789	0.506	1e-148
Q9LMB9	615	Cysteine-rich receptor-li	no	no	0.937	0.873	0.448	1e-131
Q9CAL3	649	Cysteine-rich receptor-li	no	no	0.972	0.858	0.422	1e-120
Q9M0G5	625	Putative cysteine-rich re	no	no	0.944	0.865	0.372	1e-102
Q9T0J1	665	Cysteine-rich receptor-li	no	no	0.921	0.793	0.358	2e-84
Q9M0X5	675	Cysteine-rich receptor-li	no	no	0.883	0.749	0.353	1e-82
Q8S9L6	679	Cysteine-rich receptor-li	no	no	0.937	0.790	0.339	1e-80
O65479	666	Putative cysteine-rich re	no	no	0.904	0.777	0.354	6e-80
Q8GWJ7	645	Cysteine-rich receptor-li	no	no	0.888	0.789	0.352	1e-79

>sp|Q9CAL2|CRK3_ARATH Cysteine-rich receptor-like protein kinase 3 OS=Arabidopsis thaliana GN=CRK3 PE=2 SV=1

 Score =  770 bits (1989), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/578 (65%), Positives = 453/578 (78%), Gaps = 9/578 (1%)

Query: 1   MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
           MD V+PL+  + Y  VVNGTG  +VYA+GEC+KDL   DC+LCFAQ K +V +CLPFQ  
Sbjct: 52  MDAVSPLVEAKGYGQVVNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQKG 111

Query: 61  TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGG-NNTVFGANAIELVRNLSVQ 119
           TRGG+VF DGCY+RYDDY+F+NE+LS QDRTVC  K+  G N TVF  NA ELV+N+SV+
Sbjct: 112 TRGGQVFSDGCYIRYDDYNFYNETLSLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSVE 171

Query: 120 AVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLN 179
           AV+N GF+ G V   + NV+VHGLAQCWE +N S C  CL  A  RI SC   EEGRVL+
Sbjct: 172 AVRNGGFYAGFV--DRHNVTVHGLAQCWETLNRSGCVECLSKASVRIGSCLVNEEGRVLS 229

Query: 180 AGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQ 237
           AGCY+R+STQ+FYNNSG     GNGG N L VILA  +S VA +L+ S   F ++++  +
Sbjct: 230 AGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHAK 289

Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVA 297
           K+RE+KQLG+L +  NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L  G+ VA
Sbjct: 290 KQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVA 349

Query: 298 VKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF 357
           VKRLF+NT QWVDHFFNEVNLIS ++HKNLVKLLGCSITGPESLLVYE++ NQSL D LF
Sbjct: 350 VKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLF 409

Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
           VR+DV+PL+W  R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFGL
Sbjct: 410 VRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGL 469

Query: 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477
            RLFPED THIS  +AGTLGYMAPEYVVRGKLTEKADVYSFGV++IEV+  KR N F Q+
Sbjct: 470 ARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQD 529

Query: 478 SCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK 537
           + SILQ+VW LY    + EAVDP L  NF + + SRLLQIGLLCVQA+ + RP+MS+VVK
Sbjct: 530 AGSILQSVWSLYRTSNVEEAVDPILGDNFNKIEASRLLQIGLLCVQAAFDQRPAMSVVVK 589

Query: 538 MLTGNHEILQPTQPPFLNPNGSEI---SSVGTPSTSNS 572
           M+ G+ EI  PTQPPFLNP GS +     + TP+T+ S
Sbjct: 590 MMKGSLEIHTPTQPPFLNP-GSVVEMRKMMMTPTTNQS 626

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q9FNE1|CRK42_ARATH Cysteine-rich receptor-like protein kinase 42 OS=Arabidopsis thaliana GN=CRK42 PE=2 SV=1

 Score =  526 bits (1355), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 275/543 (50%), Positives = 351/543 (64%), Gaps = 29/543 (5%)

Query: 22  TASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFF 81
           T S+YA  +C  DLSP+DC LC+A  +T++ +CLP    +   R+F DGC+LRY+ Y+F+
Sbjct: 81  TTSIYALIQCHDDLSPSDCQLCYAIARTRIPRCLP----SSSARIFLDGCFLRYETYEFY 136

Query: 82  NESLS-SQDRTVCGSKDFGGNNTVFGAN-AIELVRNLSVQAVKNDGFFVGSVTFSKGNVS 139
           +ES+S + D   C       N+TV       ++    +  AV+  GF V       G   
Sbjct: 137 DESVSDASDSFSCS------NDTVLDPRFGFQVSETAARVAVRKGGFGVA------GENG 184

Query: 140 VHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYNNSGPDP 199
           VH LAQCWE +    C  CLE AV  +  C  + EGR +N GCYLRYS  +FYN  G   
Sbjct: 185 VHALAQCWESLGKEDCRVCLEKAVKEVKRCVSRREGRAMNTGCYLRYSDHKFYNGDGHHK 244

Query: 200 --VPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERKQLGALQVAVNKSKL 257
             V  N G   +A++L TSA  +L++  L  + +  K+ + ++E++ LG +    N SK 
Sbjct: 245 FHVLFNKG-VIVAIVLTTSAFVMLIL--LATYVIMTKVSKTKQEKRNLGLVSRKFNNSKT 301

Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVN 317
            F YETLEKAT+YF     LGQGG+G+V+ G LP G+ VAVKRL +NT  WV+ FFNEVN
Sbjct: 302 KFKYETLEKATDYFSHKKMLGQGGNGTVFLGILPNGKNVAVKRLVFNTRDWVEEFFNEVN 361

Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
           LISGI HKNLVKLLGCSI GPESLLVYE+VPN+SL   LF     + L+W  R  IIL T
Sbjct: 362 LISGIQHKNLVKLLGCSIEGPESLLVYEYVPNKSLDQFLFDESQSKVLNWSQRLNIILGT 421

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           AEGLAYLH  S +RIIHRDIK SN+LLD++   KIADFGL R F  D TH+S  +AGTLG
Sbjct: 422 AEGLAYLHGGSPVRIIHRDIKTSNVLLDDQLNPKIADFGLARCFGLDKTHLSTGIAGTLG 481

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA 497
           YMAPEYVVRG+LTEKADVYSFGV+V+E+ C  RIN F   +  +LQ VW+LY   RL EA
Sbjct: 482 YMAPEYVVRGQLTEKADVYSFGVLVLEIACGTRINAFVPETGHLLQRVWNLYTLNRLVEA 541

Query: 498 VDPALAGNF-----QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG-NHEILQPTQP 551
           +DP L   F      E +  ++L++GLLC QAS  LRPSM  V++MLT  ++ I  PT P
Sbjct: 542 LDPCLKDEFLQVQGSEAEACKVLRVGLLCTQASPSLRPSMEEVIRMLTERDYPIPSPTSP 601

Query: 552 PFL 554
           PFL
Sbjct: 602 PFL 604

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMB9|CRK1_ARATH Cysteine-rich receptor-like protein kinase 1 OS=Arabidopsis thaliana GN=CRK1 PE=2 SV=2

 Score =  469 bits (1208), Expect = e-131,   Method: Compositional matrix adjust.
 Identities = 256/571 (44%), Positives = 359/571 (62%), Gaps = 34/571 (5%)

Query: 1   MDIVTPLIARQRYAAVVNGTGTAS-VYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQL 59
           M  V   I   +   V + T  +  +Y F +C +DLS +DC  CF + + ++ +    + 
Sbjct: 55  MSSVNDFITNDKLWVVSSITDVSPPIYVFLQCREDLSVSDCRHCFNESRLELER----KC 110

Query: 60  ATRGGRVFYDGCYLRYDDYDFFNESLSSQ-DRTVCGSKDFGGNNTVFGANAIELVRNLSV 118
           +  GGR+  D C+LR+DD DF  E +    D+  C  ++ G     F     E + N+++
Sbjct: 111 SGSGGRIHSDRCFLRFDDRDFSEEFVDPTFDKANC--EETGTGFGEFWRFLDEALVNVTL 168

Query: 119 QAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVL 178
           +AVKN GF   SV  ++   +V+ LAQCW+ ++ + C  CL NA S + +C    E R  
Sbjct: 169 KAVKNGGFGAASVIKTE---AVYALAQCWQTLDENTCRECLVNARSSLRAC-DGHEARAF 224

Query: 179 NAGCYLRYSTQRFYNNSG---PDPVPGN--------GGDNKLAVILATSAVALLLVFSLV 227
             GCYL+YST +F++++    PD    N           ++    LA +A++L ++ SL 
Sbjct: 225 FTGCYLKYSTHKFFDDAAEHKPDADQRNFIRSSFFPHLSDRDVTRLAIAAISLSILTSLG 284

Query: 228 AFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYK 287
           AF   R++ +KR+          A   S +NF YE LEKAT  FH+S KLGQGG+GSVYK
Sbjct: 285 AFISYRRVSRKRK----------AQVPSCVNFKYEMLEKATESFHDSMKLGQGGAGSVYK 334

Query: 288 GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347
           G LP G  VAVK+LF+NT +W D FFNEVNLISG+ HKNLV+LLGCSI GP+SLLVYE+V
Sbjct: 335 GILPDGRIVAVKKLFFNTREWADQFFNEVNLISGVQHKNLVRLLGCSIEGPKSLLVYEYV 394

Query: 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE 407
            N+SL   LF++  V  LSW+ R+ II+  +EGL YLH  S+++IIHRDIK SNILLD  
Sbjct: 395 HNRSLDQILFMKNTVHILSWKQRFNIIIGISEGLEYLHRGSEVKIIHRDIKTSNILLDRN 454

Query: 408 FTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            + KIADFGL+R    D T  +  +AGTLGY+APEY+++G+LTEKADVY+FGV++IE+V 
Sbjct: 455 LSPKIADFGLIRSMGTDKTQTNTGIAGTLGYLAPEYLIKGQLTEKADVYAFGVLIIEIVT 514

Query: 468 RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAE 527
            K+ N FTQ + S+L +VW+ +    L  ++DP L G+F E +  ++LQIGLLCVQ+S E
Sbjct: 515 GKKNNAFTQGTSSVLYSVWEHFKANTLDRSIDPRLKGSFVEEEALKVLQIGLLCVQSSVE 574

Query: 528 LRPSMSIVVKMLTGNHEILQ-PTQPPFLNPN 557
           LRPSMS +V ML       + P QPPFL+ +
Sbjct: 575 LRPSMSEIVFMLQNKDSKFEYPKQPPFLSAS 605

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9CAL3|CRK2_ARATH Cysteine-rich receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=CRK2 PE=2 SV=1

 Score =  433 bits (1113), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 249/590 (42%), Positives = 346/590 (58%), Gaps = 33/590 (5%)

Query: 1   MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
           M+ ++  +    +   + GTG  + Y   +C  DL  NDC LC+A+ +T + +C P    
Sbjct: 59  MEKISTQVQTSGFGVALTGTGPDANYGLAQCYGDLPLNDCVLCYAEARTMLPQCYP---- 114

Query: 61  TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
             GGR+F DGC++R ++Y F+NE    +D  VCG+      N  FG    + +RN   +A
Sbjct: 115 QNGGRIFLDGCFMRAENYSFYNEYKGPEDSIVCGNTT--RKNKTFGDAVRQGLRNAVTEA 172

Query: 121 VKNDGFFVGSVTFSKG-NVSVHGLAQCWEFVNGSACENCLENA-VSRIASCTQKEEGRVL 178
               G+   S    +  + S   LA CW  ++  +C+ CLENA  S +  C    EGR L
Sbjct: 173 SGTGGYARASAKAGESESESAFVLANCWRTLSPDSCKQCLENASASVVKGCLPWSEGRAL 232

Query: 179 NAGCYLRYSTQRFYNNSGPDPVPGNG---GDNKLAVILATSAVALLLVFSLVAFFV--RR 233
           + GC+LRYS Q F N      +P NG   G   + V+   S+V + ++   V+ ++  RR
Sbjct: 233 HTGCFLRYSDQDFLNK-----IPRNGRSRGSVVVIVVSVLSSVVVFMIGVAVSVYICKRR 287

Query: 234 KLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGG 293
            + +KRR  K +  +   +  S LNF Y TLEKAT  F  +NKLGQGG G+VYKG LP G
Sbjct: 288 TIKRKRRGSKDVEKMAKTLKDSSLNFKYSTLEKATGSFDNANKLGQGGFGTVYKGVLPDG 347

Query: 294 EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL 353
             +AVKRLF+N       F+NEVN+IS + HKNLV+LLGCS +GPESLLVYE++ N+SL 
Sbjct: 348 RDIAVKRLFFNNRHRATDFYNEVNMISTVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLD 407

Query: 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
             +F     + L W+ RY II+ TAEGL YLHE+S ++IIHRDIK SNILLD +  AKIA
Sbjct: 408 RFIFDVNRGKTLDWQRRYTIIVGTAEGLVYLHEQSSVKIIHRDIKASNILLDSKLQAKIA 467

Query: 414 DFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR--I 471
           DFGL R F +D +HIS  +AGTLGYMAPEY+  G+LTE  DVYSFGV+V+E+V  K+   
Sbjct: 468 DFGLARSFQDDKSHISTAIAGTLGYMAPEYLAHGQLTEMVDVYSFGVLVLEIVTGKQNTK 527

Query: 472 NLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ------EGKPSRLLQIGLLCVQAS 525
           +  +  S S++   W  +  G L +  DP L    Q      + + +R++QIGLLC Q  
Sbjct: 528 SKMSDYSDSLITEAWKHFQSGELEKIYDPNLDWKSQYDSHIIKKEIARVVQIGLLCTQEI 587

Query: 526 AELRPSMSIVVKMLTGNHEILQ-PTQPPFLNP------NGSEISSVGTPS 568
             LRP MS ++ ML    E+L  P+ PPF++       +GS+  S G  S
Sbjct: 588 PSLRPPMSKLLHMLKNKEEVLPLPSNPPFMDERVMELRDGSDGDSAGCAS 637

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0G5|CRK43_ARATH Putative cysteine-rich receptor-like protein kinase 43 OS=Arabidopsis thaliana GN=CRK43 PE=3 SV=1

 Score =  372 bits (955), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 217/582 (37%), Positives = 318/582 (54%), Gaps = 41/582 (7%)

Query: 1   MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
           +D +   +   ++    +G     +Y   +C+ DLS ++C+LC+++    + +C P    
Sbjct: 55  LDAIRGDMRHVKFGTHEHGDPPERMYVLSQCVSDLSSDECSLCWSRATDLLSQCFP---- 110

Query: 61  TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
             GG    DGC++R D+Y F+ E +S QD  +C S      +  F     E+ +++   A
Sbjct: 111 ATGGWFHLDGCFVRADNYSFYQEPVSHQDTKICASDK--EKSAEFKGLVKEVTKSIVEAA 168

Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
             + GF V  +     +++V+GL  CW  +N   C+ CL +    + SC   +EG  LNA
Sbjct: 169 PYSRGFSVAKMGIR--DLTVYGLGVCWRTLNDELCKLCLADGALSVTSCLPSKEGFALNA 226

Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLV----FSLVAFFVRRK-- 234
           GCYLRYS   FYN  G   +  +     L  I   S V +L +    +    F++R    
Sbjct: 227 GCYLRYSNYTFYNERGL--LAMSFTKENLTYIFVISMVGVLAIAAGFWCGKCFYMRTSPK 284

Query: 235 ------------LLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGS 282
                       L    R  K+  +  +      ++F Y TL+KATN F+ES KLG GG 
Sbjct: 285 KKIKGTKTKKFHLFGHLRIEKE--SESICTESHLMSFEYSTLKKATNNFNESCKLGVGGY 342

Query: 283 GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL 342
           G V+KGTL  G  +A+KRL  +  +  D   NE+++IS   HKNLV+LLGC  T   S +
Sbjct: 343 GEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEIDVISRCQHKNLVRLLGCCFTNMNSFI 402

Query: 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402
           VYEF+ N SL   LF  +  + L W+ R  IIL TAEGL YLHE  K  IIHRDIK SNI
Sbjct: 403 VYEFLANTSLDHILFNPEKKKELDWKKRRTIILGTAEGLEYLHETCK--IIHRDIKASNI 460

Query: 403 LLDEEFTAKIADFGLVRLFPEDITHISA------TLAGTLGYMAPEYVVRGKLTEKADVY 456
           LLD ++  KI+DFGL + +PE    I A      ++AGTLGYMAPEY+ +G+L+ K D Y
Sbjct: 461 LLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPSSIAGTLGYMAPEYISKGRLSNKIDAY 520

Query: 457 SFGVVVIEVVCRKRINLF-TQNSCSILQT-VWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           SFGV+V+E+    R N F + NS   L T VW  +   ++ E +D  +  +  + +  R+
Sbjct: 521 SFGVLVLEITSGFRNNKFRSDNSLETLVTQVWKCFASNKMEEMIDKDMGEDTDKQEMKRV 580

Query: 515 LQIGLLCVQASAELRPSMSIVVKMLTGNHEIL-QPTQPPFLN 555
           +QIGLLC Q S +LRP+MS V++M++    +L  PT+PPFL+
Sbjct: 581 MQIGLLCTQESPQLRPTMSKVIQMVSSTDIVLPTPTKPPFLH 622

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T0J1|CRK26_ARATH Cysteine-rich receptor-like protein kinase 26 OS=Arabidopsis thaliana GN=CRK26 PE=2 SV=1

 Score =  313 bits (803), Expect = 2e-84,   Method: Compositional matrix adjust.
 Identities = 206/574 (35%), Positives = 299/574 (52%), Gaps = 46/574 (8%)

Query: 19  GTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDY 78
           G     V +  +C  D+    C  C A    +++   P Q   +   ++YD C  RY + 
Sbjct: 71  GDSDEKVNSISQCRGDVKLEVCINCIAMAGKRLVTLCPVQ---KEAIIWYDKCTFRYSNR 127

Query: 79  DFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNL----SVQAVKNDGFFVGSVTFS 134
             FN    S   ++ G+++F G+   +  +   L+  L    SV       F VG  T  
Sbjct: 128 TIFNRLEISPHTSITGTRNFTGDRDSWEKSLRGLLEGLKNRASVIGRSKKNFVVGE-TSG 186

Query: 135 KGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGR-VLNAGCYLRYSTQRFYN 193
               ++ GL QC   ++   C  CL   +++I SC   + G  V++  C L Y+  RFY+
Sbjct: 187 PSFQTLFGLVQCTPDISEEDCSYCLSQGIAKIPSCCDMKMGSYVMSPSCMLAYAPWRFYD 246

Query: 194 ---NSGPDPVPG--------------NGGDNK---LAVILATSAVALLLVFSLVAFF--- 230
                 P  VP                G  N+    A+I A+++VA++++F ++      
Sbjct: 247 PVDTDDPSSVPATPSRPPKNETRSVTQGDKNRGVPKALIFASASVAIVVLFIVLLVVFLK 306

Query: 231 VRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL 290
           +RRK   +  E K        ++   + F +  L+ AT++F   NKLG+GG G+VYKG L
Sbjct: 307 LRRKENIRNSENKHENE---NISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVL 363

Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
             G+ +AVKRL  N  Q    F NE  L++ + H+NLVKLLG SI G E LLVYEF+P+ 
Sbjct: 364 SDGQKIAVKRLSKNAQQGETEFKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHT 423

Query: 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
           SL   +F       L WE+RYKII   A GL YLH++S+LRIIHRD+K SNILLDEE T 
Sbjct: 424 SLDKFIFDPIQGNELEWEIRYKIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTP 483

Query: 411 KIADFGLVRLFPEDITHISAT----LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           KIADFG+ RLF  DI H +      + GT GYMAPEYV+ G+ + K DVYSFGV+V+E++
Sbjct: 484 KIADFGMARLF--DIDHTTQRYTNRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEII 541

Query: 467 CRKRINLFTQNSC--SILQTVWDLYVKGRLHEAVDPALA--GNFQEGKPSRLLQIGLLCV 522
             K+ + F+       ++   W  + +G     VD  L    ++      R + IGLLCV
Sbjct: 542 SGKKNSGFSSEDSMGDLISFAWRNWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCV 601

Query: 523 QASAELRPSMSIVVKMLTGNHEIL-QPTQPPFLN 555
           Q     RPSM+ VV ML G+   L +P++P F +
Sbjct: 602 QEKVAERPSMASVVLMLDGHTIALSEPSKPAFFS 635

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M0X5|CRK25_ARATH Cysteine-rich receptor-like protein kinase 25 OS=Arabidopsis thaliana GN=CRK25 PE=2 SV=1

 Score =  307 bits (787), Expect = 1e-82,   Method: Compositional matrix adjust.
 Identities = 193/546 (35%), Positives = 285/546 (52%), Gaps = 40/546 (7%)

Query: 25  VYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNES 84
           VY    C  D+S   C  C A    + L+  P +   +   ++YD C +RY      N+S
Sbjct: 82  VYGVFLCRGDVSAEICRDCVAFAANETLQRCPRE---KVAVIWYDECMVRYS-----NQS 133

Query: 85  LSSQDRTVCG----SKDFGGNNTV--FGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNV 138
           +  Q R   G    +K     N V  F  +   L+ +++V+A  +   F           
Sbjct: 134 IVGQMRIRPGVFLTNKQNITENQVSRFNESLPALLIDVAVKAALSSRKFATEKANFTVFQ 193

Query: 139 SVHGLAQCWEFVNGSACENCLENAVSRIASCTQKE-EGRVLNAGCYLRYSTQRFYNNS-- 195
           +++ L QC   +    CE+CL   ++ +  C  +   GRV+   C  RY    FYN +  
Sbjct: 194 TIYSLVQCTPDLTNQDCESCLRQVINYLPRCCDRSVGGRVIAPSCSFRYELYPFYNETIA 253

Query: 196 --------------GPDPVPGNGGDNKLAVILATS-----AVALLLVFSLVAFFVRRKLL 236
                          P  +P   G  K   ++ T+     +V +LL+ ++     RR+  
Sbjct: 254 AAPMAPPPSSTVTAPPLNIPSEKGKGKNLTVIVTAIAVPVSVCVLLLGAMCWLLARRRNN 313

Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAV 296
           +   E + L    +   ++ L F +  +E ATN F ESNKLG GG G VYKG L  GE V
Sbjct: 314 KLSAETEDLDEDGITSTET-LQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETV 372

Query: 297 AVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
           A+KRL   +TQ  + F NEV++++ + H+NL KLLG  + G E +LVYEFVPN+SL   L
Sbjct: 373 AIKRLSQGSTQGAEEFKNEVDVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFL 432

Query: 357 FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
           F  +    L W+ RYKII   A G+ YLH +S+L IIHRD+K SNILLD +   KI+DFG
Sbjct: 433 FDNEKRRVLDWQRRYKIIEGIARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFG 492

Query: 417 LVRLFPEDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475
           + R+F  D T   +  + GT GYM+PEY + GK + K+DVYSFGV+V+E++  K+ + F 
Sbjct: 493 MARIFGVDQTQANTKRIVGTYGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFY 552

Query: 476 QNS--CSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
           +      ++  VW L+V+    E VD A+ GNFQ  +  R + I LLCVQ  +  RPSM 
Sbjct: 553 EEDGLGDLVTYVWKLWVENSPLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMD 612

Query: 534 IVVKML 539
            ++ M+
Sbjct: 613 DILVMM 618

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8S9L6|CRK29_ARATH Cysteine-rich receptor-like protein kinase 29 OS=Arabidopsis thaliana GN=CRK29 PE=2 SV=1

 Score =  301 bits (770), Expect = 1e-80,   Method: Compositional matrix adjust.
 Identities = 200/589 (33%), Positives = 294/589 (49%), Gaps = 52/589 (8%)

Query: 25  VYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFFNES 84
            YA G C +++  +DC  C       + K  P    T+   V+Y  C  RY +   +   
Sbjct: 82  AYAIGLCRREVKRDDCVSCIQTAARNLTKQCPL---TKQAVVWYTHCMFRYSNRTIYGRK 138

Query: 85  LSSQDRTVCGSKDFGGNNTVF---GANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVH 141
            ++  +     ++   N   F       ++ ++ ++     N  +  G+ + S G    +
Sbjct: 139 ETNPTKAFIAGEEISANRDDFERLQRGLLDRLKGIAAAGGPNRKYAQGNGSASAGYRRFY 198

Query: 142 GLAQCWEFVNGSACENCLENAVSRIASCTQKEEG-RVLNAGCYLRYSTQRFYNNSG---P 197
           G  QC   ++   C +CL      I SC   E G R  +  C  R+ T RFY       P
Sbjct: 199 GTVQCTPDLSEQDCNDCLVFGFENIPSCCDAEIGLRWFSPSCNFRFETWRFYEFDADLEP 258

Query: 198 DPVP------------------GNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKR 239
           DP                    G GG   +  I+    +  LL   L      RK  +  
Sbjct: 259 DPPAIQPADSPQSAARTERTGKGKGGSKVIIAIVIPILLVALLAICLCLVLKWRKN-KSG 317

Query: 240 RERKQLGALQVAVNKSKLNFS--------YETLEKATNYFHESNKLGQGGSGSVYKGTLP 291
            + K LG   ++ + ++  FS        +ETL+ AT+ F   N+LG+GG GSVYKG  P
Sbjct: 318 YKNKVLGKSPLSGSIAEDEFSNTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFP 377

Query: 292 GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS 351
            G+ +AVKRL  N+ Q  + F NE+ L++ + H+NLV+L+G  I G E LLVYEF+ N S
Sbjct: 378 QGQEIAVKRLSGNSGQGDNEFKNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNAS 437

Query: 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411
           L   +F  +  + L W VRYK+I   A GL YLHE+S+ RIIHRD+K SNILLD+E   K
Sbjct: 438 LDQFIFDTEKRQLLDWVVRYKMIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPK 497

Query: 412 IADFGLVRLFP--EDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR 468
           IADFGL +LF   + +TH  ++ +AGT GYMAPEY + G+ + K DV+SFGV+VIE++  
Sbjct: 498 IADFGLAKLFDSGQTMTHRFTSRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITG 557

Query: 469 KRINLFTQN----SCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQA 524
           KR N    N    +  +L  VW  + +  +   +DP+L       +  R + IGLLCVQ 
Sbjct: 558 KRNNNGGSNGDEDAEDLLSWVWRSWREDTILSVIDPSLTAG-SRNEILRCIHIGLLCVQE 616

Query: 525 SAELRPSMSIVVKMLTG-NHEILQPTQPPFLNPNGSEISSVGTPSTSNS 572
           SA  RP+M+ V  ML   +  +  P +P F+      + SV  PS  +S
Sbjct: 617 SAATRPTMATVSLMLNSYSFTLPTPLRPAFV------LESVVIPSNVSS 659

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65479|CRK20_ARATH Putative cysteine-rich receptor-like protein kinase 20 OS=Arabidopsis thaliana GN=CRK20 PE=2 SV=2

 Score =  298 bits (764), Expect = 6e-80,   Method: Compositional matrix adjust.
 Identities = 209/590 (35%), Positives = 291/590 (49%), Gaps = 72/590 (12%)

Query: 31  CMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDFF--------- 81
           C  ++SP  C  C A    + L   P +   R    +Y+ C LRY + +           
Sbjct: 85  CRGNVSPEVCRSCIALSVNESLSRCPNE---REAVFYYEQCMLRYSNRNILSTLNTDGGV 141

Query: 82  ------NESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSK 135
                 N     QDR     +D   N     A  IE  R++   AV    F + ++    
Sbjct: 142 FMQNARNPISVKQDRF----RDLVLNPMNLAA--IEAARSIKRFAVTK--FDLNALQ--- 190

Query: 136 GNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYN-- 193
              S++G+ QC   +    C +CL+ +++++     K  GR     C  RY    FYN  
Sbjct: 191 ---SLYGMVQCTPDLTEQDCLDCLQQSINQVT--YDKIGGRTFLPSCTSRYDNYEFYNEF 245

Query: 194 NSG----PDPVPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERKQLGALQ 249
           N G      P PG GG++ + VI     + +L +  +  F VRR      + +K +GA+ 
Sbjct: 246 NVGTPQDSSPRPGKGGNSSVIVIAVVVPITVLFLLFVAFFSVRRA-----KRKKTIGAIP 300

Query: 250 VAVNKSK----------------------LNFSYETLEKATNYFHESNKLGQGGSGSVYK 287
           +   K K                      L F ++ +  AT+ F   NKLGQGG G VYK
Sbjct: 301 LFKVKRKETEVTEPPAETTDGDDITTAGSLQFDFKAIVAATDIFLPINKLGQGGFGEVYK 360

Query: 288 GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV 347
           GT P G  VAVKRL  N+ Q    F NEV +++ + H+NLVKLLG  + G E +LVYEFV
Sbjct: 361 GTFPSGVQVAVKRLSKNSGQGEKEFENEVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFV 420

Query: 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE 407
           PN+SL   LF       L W  RYKII   A G+ YLH++S+L IIHRD+K  NILLD +
Sbjct: 421 PNKSLDYFLFDPTMQGQLDWSRRYKIIGGIARGILYLHQDSRLTIIHRDLKAGNILLDAD 480

Query: 408 FTAKIADFGLVRLFPEDITHISA-TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
              K+ADFG+ R+F  D T  +   + GT GYMAPEY + GK + K+DVYSFGV+V+E+V
Sbjct: 481 MNPKVADFGMARIFGMDQTEANTRRVVGTYGYMAPEYAMYGKFSMKSDVYSFGVLVLEIV 540

Query: 467 CRKRINLFTQNSCSILQTV---WDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQ 523
              + +   Q   SI   V   W L+  G   E VDP+   N+Q  + +R + I LLCVQ
Sbjct: 541 SGMKNSSLDQMDGSISNLVTYTWRLWSNGSPSELVDPSFGDNYQTSEITRCIHIALLCVQ 600

Query: 524 ASAELRPSMSIVVKMLTGNHEILQPTQPP-FLNPNGSEISSVGTPSTSNS 572
             A  RP+MS +V+MLT +   L   +PP F   +  E +    PS   S
Sbjct: 601 EDANDRPTMSAIVQMLTTSSIALAVPRPPGFFLRSKQEQAERACPSMDTS 650

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GWJ7|CRK19_ARATH Cysteine-rich receptor-like protein kinase 19 OS=Arabidopsis thaliana GN=CRK19 PE=2 SV=2

 Score =  298 bits (762), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 191/542 (35%), Positives = 283/542 (52%), Gaps = 33/542 (6%)

Query: 31  CMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDYDF---FNES--- 84
           C  D+S   C  C      + L   P     + G  +Y+ C LRY + +     N     
Sbjct: 83  CRVDVSSEVCRSCVTFAVNETLTRCP---KDKEGVFYYEQCLLRYSNRNIVATLNTDGGM 139

Query: 85  -LSSQDRTVCGSKDFGGNNTVFGAN--AIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVH 141
            + S    +   +D   +  +   N  A+E  R+    AV+              + S++
Sbjct: 140 FMQSARNPLSVKQDQFRDLVLTPMNLAAVEAARSFKKWAVRKIDL--------NASQSLY 191

Query: 142 GLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNAGCYLRYSTQRFYNNSG----- 196
           G+ +C   +    C +CL+  ++++     K  GR+L   C  RY    FYN S      
Sbjct: 192 GMVRCTPDLREQDCLDCLKIGINQVT--YDKIGGRILLPSCASRYDNYAFYNESNVGTPQ 249

Query: 197 -PDPVPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKLLQKRRERKQLGALQVAVNKS 255
              P PG GG++ + +I     + +L +  +  F VR K  +   E++ +      +  +
Sbjct: 250 DSSPRPGKGGNSSVIIIAVVVPITVLFLLLVAVFSVRAKNKRTLNEKEPVAEDGNDITTA 309

Query: 256 -KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFN 314
             L F ++ +E ATN F   NKLGQGG G VYKGTL  G  VAVKRL   + Q    F N
Sbjct: 310 GSLQFDFKAIEAATNCFLPINKLGQGGFGEVYKGTLSSGLQVAVKRLSKTSGQGEKEFEN 369

Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV +++ + H+NLVKLLG  + G E +LVYEFVPN+SL   LF       L W  RYKII
Sbjct: 370 EVVVVAKLQHRNLVKLLGYCLEGEEKILVYEFVPNKSLDHFLFDSTMKMKLDWTRRYKII 429

Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLA 433
              A G+ YLH++S+L IIHRD+K  NILLD++   KIADFG+ R+F  D T  ++  + 
Sbjct: 430 GGIARGILYLHQDSRLTIIHRDLKAGNILLDDDMNPKIADFGMARIFGMDQTEAMTRRVV 489

Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSC--SILQTVWDLYV 490
           GT GYM+PEY + G+ + K+DVYSFGV+V+E++   K  +L+  +    +++   W L+ 
Sbjct: 490 GTYGYMSPEYAMYGQFSMKSDVYSFGVLVLEIISGMKNSSLYQMDESVGNLVTYTWRLWS 549

Query: 491 KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQ 550
            G   E VDP+   N+Q  + +R + I LLCVQ  AE RP+MS +V+MLT +   L   +
Sbjct: 550 NGSPSELVDPSFGDNYQTSEITRCIHIALLCVQEDAEDRPTMSSIVQMLTTSLIALAEPR 609

Query: 551 PP 552
           PP
Sbjct: 610 PP 611

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	573
255573959	649	kinase, putative [Ricinus communis] gi|2	0.994	0.878	0.733	0.0
225425611	649	PREDICTED: cysteine-rich receptor-like p	0.993	0.876	0.726	0.0
147767572	690	hypothetical protein VITISV_005912 [Viti	0.975	0.810	0.737	0.0
449434953	651	PREDICTED: cysteine-rich receptor-like p	0.991	0.872	0.680	0.0
15223170	646	cysteine-rich receptor-like protein kina	0.993	0.880	0.650	0.0
356567656	656	PREDICTED: cysteine-rich receptor-like p	0.984	0.859	0.657	0.0
356502033	648	PREDICTED: cysteine-rich receptor-like p	0.975	0.862	0.651	0.0
297841809	649	kinase family protein [Arabidopsis lyrat	0.993	0.876	0.649	0.0
255567375	605	kinase, putative [Ricinus communis] gi|2	0.951	0.900	0.525	1e-156
449446869	601	PREDICTED: cysteine-rich receptor-like p	0.954	0.910	0.503	1e-154

>gi|255573959|ref|XP_002527897.1| kinase, putative [Ricinus communis] gi|223532672|gb|EEF34454.1| kinase, putative [Ricinus communis]

 Score =  872 bits (2253), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 423/577 (73%), Positives = 493/577 (85%), Gaps = 7/577 (1%)

Query: 1   MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
           +D VTPL+ARQ+Y AV+NGTG  +VY +GECMKDL   DCNLCFAQCKTQ+L+CLPFQLA
Sbjct: 56  LDAVTPLVARQQYGAVINGTGNTTVYTYGECMKDLDQTDCNLCFAQCKTQILRCLPFQLA 115

Query: 61  TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDF-GGNNTVFGANAIELVRNLSVQ 119
           TRGGR+FYDGCYLRYDDY FFNESL SQDRTVC S+DF GGN T++  NA+EL+RNLSV 
Sbjct: 116 TRGGRLFYDGCYLRYDDYYFFNESLDSQDRTVCASEDFNGGNKTLYSDNAMELMRNLSVL 175

Query: 120 AVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLN 179
             KNDGFFVGSV  +KGN+SV+GLAQCWE VN SACE CL +AVS+I +CT KEEGRVLN
Sbjct: 176 TPKNDGFFVGSV--NKGNISVYGLAQCWELVNTSACETCLADAVSKITNCTPKEEGRVLN 233

Query: 180 AGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVFSL--VAFFVRRKLLQ 237
           +GCYLRYSTQ+FYNNSGP     NGG + LAVILA ++ ++ +V  +    FF+++++ +
Sbjct: 234 SGCYLRYSTQKFYNNSGPANA-DNGGSSHLAVILAAASSSVAVVLLVATAVFFMKKRVAE 292

Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVA 297
           KRR+RK+LGAL +AVN SKLNF+YE+LEKATNYFH SNKLGQGGSGSVYKG LP G+AVA
Sbjct: 293 KRRQRKELGALLIAVNNSKLNFTYESLEKATNYFHLSNKLGQGGSGSVYKGILPDGKAVA 352

Query: 298 VKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF 357
           +KRL +NT QWVDHFFNEVNLIS I HKNLVKLLGCSITGPESLLVYE+VPNQSL D LF
Sbjct: 353 IKRLLFNTRQWVDHFFNEVNLISNIQHKNLVKLLGCSITGPESLLVYEYVPNQSLHDYLF 412

Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
           V ++V+PL+WE+RYKIIL TAEGLAYLHEE++LRIIHRD+KLSN+LLDE+F  KIADFGL
Sbjct: 413 VAKNVQPLTWEMRYKIILGTAEGLAYLHEETELRIIHRDVKLSNVLLDEDFLPKIADFGL 472

Query: 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477
            RLFPED THIS  +AGTLGYMAPEY+VRGKLTEKADVYSFGV++IEVV  KR N F Q+
Sbjct: 473 ARLFPEDKTHISTAIAGTLGYMAPEYIVRGKLTEKADVYSFGVLLIEVVSGKRNNSFVQD 532

Query: 478 SCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK 537
           S SILQ VW+LY  GRL EAVDP LAGNFQE + SRLLQ+GLLCVQASAELRP+MS+ VK
Sbjct: 533 SGSILQMVWNLYGTGRLWEAVDPVLAGNFQEEEASRLLQVGLLCVQASAELRPAMSVAVK 592

Query: 538 MLTGNHEILQPTQPPFLNPN-GSEISSVGTPSTSNSK 573
           ML+G HE+ QPTQPPFLNP+  SEIS    P+TS+S+
Sbjct: 593 MLSGIHELSQPTQPPFLNPSTSSEISPFMRPATSSSQ 629

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225425611|ref|XP_002266015.1| PREDICTED: cysteine-rich receptor-like protein kinase 3 [Vitis vinifera] gi|297739090|emb|CBI28579.3| unnamed protein product [Vitis vinifera]

 Score =  849 bits (2193), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 417/574 (72%), Positives = 483/574 (84%), Gaps = 5/574 (0%)

Query: 1   MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
           MD VTPLI+ QRYA V +GTG+ +V+ FGECM+DLS NDCNLCFA CKTQ+L+C+PFQ +
Sbjct: 58  MDQVTPLISTQRYADVTSGTGSTAVFLFGECMEDLSQNDCNLCFALCKTQLLRCVPFQKS 117

Query: 61  TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
           TRGGR FYDGCY+RYDDY FF+E+LS++D+TVCG+KDF G+ TVF ANAIELVRNLSV+A
Sbjct: 118 TRGGRSFYDGCYIRYDDYKFFDEALSAEDKTVCGTKDFSGDQTVFRANAIELVRNLSVEA 177

Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
             NDGFFVGSV  ++ N+SV+GLAQCWEFV GSAC  CL NA SRI  C  KEEGRVLNA
Sbjct: 178 PGNDGFFVGSV--NRSNISVYGLAQCWEFVKGSACAECLANATSRIGLCPPKEEGRVLNA 235

Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQK 238
           GCYLRYSTQ+FY+NS  D V  N G ++LA+IL   +S+ ALLL+ ++  FFVR+K  ++
Sbjct: 236 GCYLRYSTQKFYDNSTSDFVEENEGSSRLAIILGVTSSSFALLLIIAMTVFFVRKKRAKR 295

Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAV 298
           RRE+KQLG L   VNKSKLNFSYETLEKATNYFH SNKLGQGGSGSVYKG +P G+ VA+
Sbjct: 296 RREKKQLGDLLATVNKSKLNFSYETLEKATNYFHHSNKLGQGGSGSVYKGIMPDGKVVAI 355

Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358
           KRLF+N+ QWVDHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYE+VPNQSL D L V
Sbjct: 356 KRLFFNSRQWVDHFFNEVNLISGIDHKNLVKLLGCSITGPESLLVYEYVPNQSLHDYL-V 414

Query: 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
           +++  PL+WE+RYKI+L  AEGLAYLHEES LRIIHRDIKLSN+LLDE+F AKIADFGL 
Sbjct: 415 KRNAPPLAWEMRYKILLGIAEGLAYLHEESMLRIIHRDIKLSNVLLDEDFAAKIADFGLA 474

Query: 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
           RLFPED THIS  +AGTLGYMAPEYVVRGKLTEK DVY FGV+VIEVVC KR N FTQ+S
Sbjct: 475 RLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKVDVYGFGVLVIEVVCGKRNNSFTQDS 534

Query: 479 CSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM 538
            SILQ VW+LY  GRL+EAVDP+L GNFQE   SR+L++GLLCVQASAELRPSMS+VVKM
Sbjct: 535 FSILQMVWNLYGTGRLYEAVDPSLGGNFQEDMASRVLKVGLLCVQASAELRPSMSLVVKM 594

Query: 539 LTGNHEILQPTQPPFLNPNGSEISSVGTPSTSNS 572
           LT NHE  QPTQPPFL+   +E S +    TS+S
Sbjct: 595 LTENHETPQPTQPPFLHSGNAESSPLVKAETSHS 628

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147767572|emb|CAN64525.1| hypothetical protein VITISV_005912 [Vitis vinifera]

 Score =  846 bits (2186), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 416/564 (73%), Positives = 478/564 (84%), Gaps = 5/564 (0%)

Query: 1   MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
           MD VTPLI+ QRYA V +GTG+ +V+ FGECM+DLS NDCNLCFA CKTQ+L+C+PFQ +
Sbjct: 15  MDQVTPLISTQRYADVTSGTGSTAVFLFGECMEDLSQNDCNLCFALCKTQLLRCVPFQKS 74

Query: 61  TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
           TRGGR FYDGCY+RYDDY FF+E+LS++D+TVCG+KDF G+ TVF ANAIELVRNLSV+A
Sbjct: 75  TRGGRSFYDGCYIRYDDYKFFDEALSAEDKTVCGTKDFSGDQTVFRANAIELVRNLSVEA 134

Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
             NDGFFVGSV  ++ N+SV+GLAQCWEFV GSAC  CL NA SRI  C  KEEGRVLNA
Sbjct: 135 PGNDGFFVGSV--NRSNISVYGLAQCWEFVKGSACAECLANATSRIGLCPPKEEGRVLNA 192

Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQK 238
           GCYLRYSTQ+FY+NS  D V  N G ++LA+IL   +S+ ALLL+ ++  FFVR+K  ++
Sbjct: 193 GCYLRYSTQKFYDNSTSDFVEENEGSSRLAIILGVTSSSFALLLIIAMTVFFVRKKRAKR 252

Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAV 298
           RRERKQLG L   VNKSKLNFSYETLEKATNYFH SNKLGQGGSGSVYKG +P G+ VA+
Sbjct: 253 RRERKQLGDLLATVNKSKLNFSYETLEKATNYFHHSNKLGQGGSGSVYKGIMPDGKVVAI 312

Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358
           KRLF+N+ QWVDHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYE+VPNQSL D L V
Sbjct: 313 KRLFFNSRQWVDHFFNEVNLISGIDHKNLVKLLGCSITGPESLLVYEYVPNQSLHDYL-V 371

Query: 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
           +++  PL+WE+RYKI+L  AEGLAYLHEES LRIIHRDIKLSN+LLDE+F AKIADFGL 
Sbjct: 372 KRNAPPLAWEMRYKILLGIAEGLAYLHEESMLRIIHRDIKLSNVLLDEDFAAKIADFGLA 431

Query: 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
           RLFPED THIS  +AGTLGYMAPEYVVRGKLTEK DVY FGV+VIEVVC KR N FTQ+S
Sbjct: 432 RLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKVDVYGFGVLVIEVVCGKRNNSFTQDS 491

Query: 479 CSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM 538
            SILQ VW+LY  GRL+EAVDP+L GNFQE   SR+L++GLLCVQASAELRPSMS+VVKM
Sbjct: 492 FSILQMVWNLYGTGRLYEAVDPSLGGNFQEDMASRVLKVGLLCVQASAELRPSMSLVVKM 551

Query: 539 LTGNHEILQPTQPPFLNPNGSEIS 562
           LT NHE  QPTQPPFLN   +E S
Sbjct: 552 LTENHETPQPTQPPFLNSGNAESS 575

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449434953|ref|XP_004135260.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Cucumis sativus] gi|449516641|ref|XP_004165355.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Cucumis sativus]

 Score =  791 bits (2044), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 390/573 (68%), Positives = 456/573 (79%), Gaps = 5/573 (0%)

Query: 1   MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
           MD VTPLIA QR+AAV+NGTG  +VYAFGECM DLS  DC+LCFAQ KTQVL+CLPFQLA
Sbjct: 60  MDAVTPLIASQRFAAVINGTGNTTVYAFGECMNDLSQADCDLCFAQMKTQVLRCLPFQLA 119

Query: 61  TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSVQA 120
           TRGGR+FYDGC++RYD Y+FFNESLS+ DRTVCG  D+ GN +VF  +A++L RNLSV A
Sbjct: 120 TRGGRLFYDGCFVRYDYYNFFNESLSAVDRTVCGKLDYSGNRSVFSDSAMKLARNLSVVA 179

Query: 121 VKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLNA 180
            KNDGF VGSV F   NVSV+GL QCW+FV GS+C  CL +A   I SC  K EGRVLNA
Sbjct: 180 PKNDGFAVGSVDFR--NVSVYGLGQCWKFVRGSSCSKCLVDAAKEIGSCPPKSEGRVLNA 237

Query: 181 GCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVF--SLVAFFVRRKLLQK 238
           GCY RYST++FY N+      GN    +LA+ILA+ + A+      S V F  RR++L+K
Sbjct: 238 GCYFRYSTEKFYFNTTATATGGNNS-RRLAIILASVSAAVAAALIISTVLFCARRRVLRK 296

Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAV 298
           R E++QLG L   VNKSKLNFSYETLEKATNYF +SNKLGQGGSGSVYKGTL  G  VA+
Sbjct: 297 RNEKRQLGPLVAIVNKSKLNFSYETLEKATNYFDQSNKLGQGGSGSVYKGTLSDGRVVAI 356

Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358
           KRLF+NT QWVDHFFNEVNLISGI HKNLV LLGCSITGPESLLVYE+VPNQSL D LF 
Sbjct: 357 KRLFFNTRQWVDHFFNEVNLISGIRHKNLVGLLGCSITGPESLLVYEYVPNQSLHDYLFG 416

Query: 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
            ++V+PLSW+ R+KI+L TAEGLAYLHEES ++IIHRDIKLSNILLD +FT KIADFGL 
Sbjct: 417 NKNVQPLSWQSRFKIVLGTAEGLAYLHEESNVKIIHRDIKLSNILLDYDFTPKIADFGLA 476

Query: 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
           RL PED THIS  +AGTLGYMAPEYVVRGKL+EKADVYSFGV  IEV+  +R   F Q+S
Sbjct: 477 RLLPEDKTHISTAIAGTLGYMAPEYVVRGKLSEKADVYSFGVFAIEVITGRRNGHFYQDS 536

Query: 479 CSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM 538
            SILQ VW+LY +GRL+ AVDP LAG++   + SRLLQIGL+CVQA A+LRPSMS+VVKM
Sbjct: 537 TSILQKVWNLYGEGRLYAAVDPILAGDYPRDEASRLLQIGLVCVQAFADLRPSMSMVVKM 596

Query: 539 LTGNHEILQPTQPPFLNPNGSEISSVGTPSTSN 571
           LT N+EI QP QPP+L+P+   +    +  +SN
Sbjct: 597 LTANYEIPQPKQPPYLHPSSGSMKPQNSSDSSN 629

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15223170|ref|NP_177210.1| cysteine-rich receptor-like protein kinase 3 [Arabidopsis thaliana] gi|75333658|sp|Q9CAL2.1|CRK3_ARATH RecName: Full=Cysteine-rich receptor-like protein kinase 3; Short=Cysteine-rich RLK3; Flags: Precursor gi|12325043|gb|AAG52470.1|AC010796_9 putative protein kinase; 41292-38663 [Arabidopsis thaliana] gi|332196954|gb|AEE35075.1| cysteine-rich receptor-like protein kinase 3 [Arabidopsis thaliana]

 Score =  770 bits (1989), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/578 (65%), Positives = 453/578 (78%), Gaps = 9/578 (1%)

Query: 1   MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
           MD V+PL+  + Y  VVNGTG  +VYA+GEC+KDL   DC+LCFAQ K +V +CLPFQ  
Sbjct: 52  MDAVSPLVEAKGYGQVVNGTGNLTVYAYGECIKDLDKKDCDLCFAQIKAKVPRCLPFQKG 111

Query: 61  TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGG-NNTVFGANAIELVRNLSVQ 119
           TRGG+VF DGCY+RYDDY+F+NE+LS QDRTVC  K+  G N TVF  NA ELV+N+SV+
Sbjct: 112 TRGGQVFSDGCYIRYDDYNFYNETLSLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSVE 171

Query: 120 AVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVLN 179
           AV+N GF+ G V   + NV+VHGLAQCWE +N S C  CL  A  RI SC   EEGRVL+
Sbjct: 172 AVRNGGFYAGFV--DRHNVTVHGLAQCWETLNRSGCVECLSKASVRIGSCLVNEEGRVLS 229

Query: 180 AGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLLQ 237
           AGCY+R+STQ+FYNNSG     GNGG N L VILA  +S VA +L+ S   F ++++  +
Sbjct: 230 AGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHAK 289

Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVA 297
           K+RE+KQLG+L +  NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L  G+ VA
Sbjct: 290 KQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVA 349

Query: 298 VKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF 357
           VKRLF+NT QWVDHFFNEVNLIS ++HKNLVKLLGCSITGPESLLVYE++ NQSL D LF
Sbjct: 350 VKRLFFNTKQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLF 409

Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
           VR+DV+PL+W  R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFGL
Sbjct: 410 VRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGL 469

Query: 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477
            RLFPED THIS  +AGTLGYMAPEYVVRGKLTEKADVYSFGV++IEV+  KR N F Q+
Sbjct: 470 ARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQD 529

Query: 478 SCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK 537
           + SILQ+VW LY    + EAVDP L  NF + + SRLLQIGLLCVQA+ + RP+MS+VVK
Sbjct: 530 AGSILQSVWSLYRTSNVEEAVDPILGDNFNKIEASRLLQIGLLCVQAAFDQRPAMSVVVK 589

Query: 538 MLTGNHEILQPTQPPFLNPNGSEI---SSVGTPSTSNS 572
           M+ G+ EI  PTQPPFLNP GS +     + TP+T+ S
Sbjct: 590 MMKGSLEIHTPTQPPFLNP-GSVVEMRKMMMTPTTNQS 626

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356567656|ref|XP_003552033.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Glycine max]

 Score =  770 bits (1987), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 382/581 (65%), Positives = 445/581 (76%), Gaps = 17/581 (2%)

Query: 1   MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
           MD +TPL     + AV NG+  A+VYAFGECM+DLS NDCNLC AQCKTQ+L CLPFQ  
Sbjct: 54  MDALTPLTTSHGHGAVSNGSQNATVYAFGECMRDLSRNDCNLCLAQCKTQLLACLPFQRG 113

Query: 61  TRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDF------------GGNNTVFGAN 108
           TRGGR+F+DGCYLRYDDY+FF E+ S QD TVCG+                 ++ V+ AN
Sbjct: 114 TRGGRLFFDGCYLRYDDYNFFGETRSDQDTTVCGNNSNNNNSNSVANSATNSSSGVYKAN 173

Query: 109 AIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIAS 168
           A+ LV NLS  A K+DGFFVGSV   + NV V+GLAQCWE+VNGSACE CL +AV+RI S
Sbjct: 174 AMALVLNLSELAPKSDGFFVGSV--ERKNVRVYGLAQCWEYVNGSACERCLADAVTRIGS 231

Query: 169 CTQKEEGRVLNAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLL--VFSL 226
           C   +E R LNAGCYLRYS Q+FYNNSG  P  G  G  +LA ILA S+ AL L  V + 
Sbjct: 232 CA-TQEARALNAGCYLRYSAQKFYNNSGVVPTAGKHGKRRLAKILAASSAALALLLVIAT 290

Query: 227 VAFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVY 286
           V FF+R+ ++ +RRER+Q GAL   VNKSKLN  YE LEKATNYF+E+NKLGQGGSGSVY
Sbjct: 291 VVFFIRKNVVTRRRERRQFGALLDTVNKSKLNMPYEVLEKATNYFNEANKLGQGGSGSVY 350

Query: 287 KGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF 346
           KG +P G  VA+KRL +NTTQW DHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYE+
Sbjct: 351 KGVMPDGITVAIKRLSFNTTQWADHFFNEVNLISGIHHKNLVKLLGCSITGPESLLVYEY 410

Query: 347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
           VPNQSL D+  VR+  +PL+WE+R+KI+L  AEG+AYLHEES +RIIHRDIKLSNILL+E
Sbjct: 411 VPNQSLHDHFSVRRTSQPLTWEIRHKILLGIAEGMAYLHEESHVRIIHRDIKLSNILLEE 470

Query: 407 EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +FT KIADFGL RLFPED +HIS  +AGTLGYMAPEYVVRGKLTEKADVYSFGV+VIE+V
Sbjct: 471 DFTPKIADFGLARLFPEDKSHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLVIEIV 530

Query: 467 CRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASA 526
             K+I+ +  NS S+L TVW LY   RL E VDP L G F      +LLQIGLLC QASA
Sbjct: 531 SGKKISAYIMNSSSLLHTVWSLYGSNRLSEVVDPTLEGAFPAEVACQLLQIGLLCAQASA 590

Query: 527 ELRPSMSIVVKMLTGNHEILQPTQPPFLNPNGSEISSVGTP 567
           ELRPSMS+VVKM+  +HEI QPTQPPF+N   SE    G P
Sbjct: 591 ELRPSMSVVVKMVNNDHEIPQPTQPPFMNSGSSEFGKSGLP 631

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356502033|ref|XP_003519826.1| PREDICTED: cysteine-rich receptor-like protein kinase 3-like [Glycine max]

 Score =  761 bits (1966), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 369/566 (65%), Positives = 450/566 (79%), Gaps = 7/566 (1%)

Query: 1   MDIVTPLIARQRYAAVVNGT--GTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQ 58
           ++ +T L+ RQ+YA VV GT    A+VYAFGEC KDL+  DC++CFAQCKT+VL+C PFQ
Sbjct: 52  LEALTALVTRQKYAFVVKGTTQNNATVYAFGECRKDLTKPDCDVCFAQCKTRVLRCSPFQ 111

Query: 59  LATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGGNNTVFGANAIELVRNLSV 118
               GG  F+DGC+LRYD Y+FFNESLS QD TVCG++DF GN +V+ AN +ELVRNLS+
Sbjct: 112 RGIDGGMFFFDGCFLRYDGYNFFNESLSPQDFTVCGTEDFSGNWSVYKANTVELVRNLSI 171

Query: 119 QAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVL 178
           +A KN+GFFVG V  S+ NV+V+GLAQCW+F+NGSAC+NCL  AV+RI SC  K EG+ L
Sbjct: 172 EAPKNEGFFVGYV--SQRNVTVYGLAQCWKFMNGSACQNCLVEAVTRIDSCASKAEGKAL 229

Query: 179 NAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLL 236
           NAGCYLRYST  FYN+S  +    N G   LA+I+A  ++++ALLL+ + V FFVR  LL
Sbjct: 230 NAGCYLRYSTHNFYNSSNNNVPHENQGHKNLAIIVAVASASLALLLIVATVVFFVRTNLL 289

Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAV 296
           ++RRER+Q GAL   VNKSKLN  YE LEKAT+YF  SNKLG+GGSGSVYKG LP G  +
Sbjct: 290 KRRRERRQFGALLNTVNKSKLNMPYEILEKATDYFSHSNKLGEGGSGSVYKGVLPDGNTM 349

Query: 297 AVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
           A+KRL +NT+QW DHFFNEVNLISGI+HKNLVKLLGCSITGPESLLVYEFVPN SL D+L
Sbjct: 350 AIKRLSFNTSQWADHFFNEVNLISGIHHKNLVKLLGCSITGPESLLVYEFVPNHSLYDHL 409

Query: 357 FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
             R++ + L+WEVR+KIIL TAEGLAYLHEES+ RIIHRDIKL+NIL+D+ FT KIADFG
Sbjct: 410 SGRKNSQQLTWEVRHKIILGTAEGLAYLHEESQ-RIIHRDIKLANILVDDNFTPKIADFG 468

Query: 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476
           L RLFPED +H+S  + GTLGYMAPEYVV GKLTEKADVYSFGV+++E++  K+   F +
Sbjct: 469 LARLFPEDKSHLSTAICGTLGYMAPEYVVLGKLTEKADVYSFGVLIMEIISGKKSKSFVE 528

Query: 477 NSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVV 536
           NS SILQTVW LY   RL + VDP L GN+ E +  +LL+IGLLC QASAELRP MS+VV
Sbjct: 529 NSYSILQTVWSLYGSNRLCDIVDPILDGNYPEMEACKLLKIGLLCAQASAELRPPMSVVV 588

Query: 537 KMLTGNHEILQPTQPPFLNPNGSEIS 562
           +M+  NH I QPTQPPFL+ + +E S
Sbjct: 589 EMINNNHGITQPTQPPFLSCSSAEFS 614

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297841809|ref|XP_002888786.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297334627|gb|EFH65045.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  758 bits (1957), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 376/579 (64%), Positives = 447/579 (77%), Gaps = 10/579 (1%)

Query: 1   MDIVTPLIARQRYAAVVN-GTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQL 59
           MD V+PL+  + Y  VVN   G  +VYA+GEC+KDL+  DC+LCFAQ K +V  CLPFQ 
Sbjct: 54  MDAVSPLVEAKGYGQVVNNANGNLTVYAYGECIKDLNKKDCDLCFAQIKAKVPICLPFQR 113

Query: 60  ATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFGG-NNTVFGANAIELVRNLSV 118
            TRGG+VF DGCY+RYDDY+FFNE+L  QDRTVC  K+  G N TVF  NA ELV+N+SV
Sbjct: 114 GTRGGQVFSDGCYIRYDDYNFFNETLGLQDRTVCAPKEITGVNRTVFRDNAAELVKNMSV 173

Query: 119 QAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRVL 178
           +AV+N GF+ G V   + NV+VHGLAQCWE +N S C  CL  A   I SC   EEGRVL
Sbjct: 174 EAVRNGGFYAGFV--DRHNVTVHGLAQCWETLNRSGCVECLSKASVSIGSCLVNEEGRVL 231

Query: 179 NAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILA--TSAVALLLVFSLVAFFVRRKLL 236
           +AGCY+R+STQ+FYNNSG     GNGG N L VILA  +S VA +L+ S   F ++++  
Sbjct: 232 SAGCYMRFSTQKFYNNSGNSTSDGNGGHNHLGVILAVTSSVVAFVLLVSAAGFLLKKRHA 291

Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAV 296
           +K+RE+KQLG+L +  NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L  G+ V
Sbjct: 292 KKQREKKQLGSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTV 351

Query: 297 AVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
           AVKRLF+NT QWVDHFFNEVNLIS +NHKNLVKLLGCSITGPESLLVYE++ NQSL D L
Sbjct: 352 AVKRLFFNTKQWVDHFFNEVNLISQVNHKNLVKLLGCSITGPESLLVYEYIANQSLHDYL 411

Query: 357 FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
           FVR+DV+PL+W  R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFG
Sbjct: 412 FVRKDVQPLNWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFG 471

Query: 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476
           L RLFPED THIS  +AGTLGYMAPEYVVRGKLTEKADVYSFGV++IEV+  KR N F Q
Sbjct: 472 LARLFPEDKTHISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQ 531

Query: 477 NSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVV 536
            + SILQTVW LY    L EAVDP L  NF + + SRLLQIGLLCVQA+ + RP+MS VV
Sbjct: 532 EAGSILQTVWSLYRTRNLEEAVDPILGDNFNKIEASRLLQIGLLCVQAAFDQRPAMSTVV 591

Query: 537 KMLTGNHEILQPTQPPFLNPNGSEI---SSVGTPSTSNS 572
           KM+ G+ EI  PTQPPFLNP GS +     + TP+T+ S
Sbjct: 592 KMMKGSLEIHTPTQPPFLNP-GSVVEMRKMMMTPTTNQS 629

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255567375|ref|XP_002524667.1| kinase, putative [Ricinus communis] gi|223536028|gb|EEF37686.1| kinase, putative [Ricinus communis]

 Score =  557 bits (1435), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 300/571 (52%), Positives = 386/571 (67%), Gaps = 26/571 (4%)

Query: 1   MDIVTPLIARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLA 60
           M+ ++ LI    +A   +   +  +Y   +C +DLS  DC LC+A  +T++ +CLP    
Sbjct: 1   METLSQLITNSHFA-TYHLNSSLPMYVLAQCHQDLSQTDCLLCYAVSRTKIPRCLP---- 55

Query: 61  TRGGRVFYDGCYLRYDDYDFFNESLS-SQDRTVCGSKDFGGNN-----TVFGANAIELVR 114
           +   R+F DGC+LRYD+Y+FF ES+S S D   C  ++  G+N       F  +    + 
Sbjct: 56  SVSARIFLDGCFLRYDNYNFFEESVSVSFDEVKCSQENVSGSNGENDKLRFVKSVEHAIG 115

Query: 115 NLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEE 174
           N+S +AV+N GF V  +        V+ LAQCWE V    C  CL  A   +  C  K+E
Sbjct: 116 NVSSKAVENGGFGVVGIE------GVYALAQCWESVGKDGCRECLRKAGKEVKGCGAKKE 169

Query: 175 GRVLNAGCYLRYSTQRFYNNSGP----DPVPGNGGDNKLAVILATSAVALLLVFSLVAFF 230
           GR LNAGCYLRYST+RFYN  G       + G G    +AV+LA +AV +L +F++ A +
Sbjct: 170 GRGLNAGCYLRYSTERFYNVGGELEAGHTISGLG--VAIAVVLAAAAVLMLSIFAVYAVY 227

Query: 231 VRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL 290
           VRR  ++ + ER  L  + +  +K+ LNF YETLEKAT+YF+ S K+GQGG+GSVY GTL
Sbjct: 228 VRR--MKNKAERINLEKISINFSKTSLNFKYETLEKATDYFNASRKIGQGGAGSVYAGTL 285

Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
           P GE VAVKRL +NT QWVD FFNEVNLISGI HKNLVKLLGCSI GPESLLVYE+VPN+
Sbjct: 286 PNGETVAVKRLTFNTRQWVDEFFNEVNLISGIQHKNLVKLLGCSIEGPESLLVYEYVPNK 345

Query: 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
           SL   +F +     L+W+ R+ II+ TAEGLAYLH  S+ RIIHRDIK SN+LLDE+FT 
Sbjct: 346 SLDQFIFGKDKPTTLNWKQRFDIIVGTAEGLAYLHGGSQERIIHRDIKSSNVLLDEDFTP 405

Query: 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
           KIADFGLVR F  D +H+S  +AGT+GYMAPEY++RG+LTEKADVYSFGV+V+E+V  KR
Sbjct: 406 KIADFGLVRCFGADKSHLSTGIAGTMGYMAPEYLIRGQLTEKADVYSFGVLVLEIVMGKR 465

Query: 471 INLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRP 530
            N FT++S S+LQTVW LY   RL EA DP+L  +F   + SR+LQ GLLC QAS  LRP
Sbjct: 466 CNAFTEDSKSLLQTVWQLYRLNRLVEAADPSLRDDFSAEEVSRVLQTGLLCTQASVALRP 525

Query: 531 SMSIVVKMLTGN-HEILQPTQPPFLNPNGSE 560
           SM+ VV MLT +  EI  P+QPPF+N    E
Sbjct: 526 SMAEVVVMLTNSGGEIPLPSQPPFMNATSLE 556

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449446869|ref|XP_004141193.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Cucumis sativus] gi|449515394|ref|XP_004164734.1| PREDICTED: cysteine-rich receptor-like protein kinase 42-like [Cucumis sativus]

 Score =  553 bits (1424), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 285/566 (50%), Positives = 374/566 (66%), Gaps = 19/566 (3%)

Query: 1   MDIVTPLIARQRYAA-VVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQL 59
           M+ ++ L+  + +    VN T    ++A  +C  DLS  DC LC+A  +T + +CLP   
Sbjct: 1   MEAISELLTTRSWTTHFVNST--PPMFALSQCFNDLSHTDCLLCYAASRTSLPRCLP--- 55

Query: 60  ATRGGRVFYDGCYLRYDDYDFFNESLSSQDRTVCGSKDFG----GNNTVFGANAIELVRN 115
                R+F DGC+LRYD+Y F+ ES  S   +V  + + G        VFG N   +V  
Sbjct: 56  -AISARIFLDGCFLRYDNYSFYKESTDSVRDSVNCTSELGEIDQSERLVFGENVRVVVET 114

Query: 116 LSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEG 175
           ++ +A++  GF +G V+       + GLAQCW  V    C  CLE A   I SC   +EG
Sbjct: 115 VTTKAMEKGGFGMGEVS------GMFGLAQCWGSVEPEGCRACLEKAKRSIGSCLPSKEG 168

Query: 176 RVLNAGCYLRYSTQRFYNNSGPDPVPGNGGDNKLAVILATSAVALLLVFSLVAFFVRRKL 235
           R +NAGCYLRYST +FYN+   D         +  V +A ++ A L++F    F    ++
Sbjct: 169 RAMNAGCYLRYSTVKFYNDKDEDRDHDGFSGRRAVVTIALASAASLIIFFSAVFACYTRI 228

Query: 236 LQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEA 295
            + ++E+K+   + V++  S LNF YETLEKATNYF+ SNK+GQGG+GSVYKGTLP G+ 
Sbjct: 229 SKFKKEKKRQSLIPVSLKDSDLNFKYETLEKATNYFNLSNKIGQGGAGSVYKGTLPNGQI 288

Query: 296 VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
           VAVKRL ++T QWVD FFNEVNLI GI HKNLV LLGCSI GPESLLVYEFV N SL   
Sbjct: 289 VAVKRLVFHTRQWVDEFFNEVNLIRGIQHKNLVALLGCSIEGPESLLVYEFVSNGSLDHF 348

Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
           +F +   + LSW+ R+ II+ TAEGLA+LHE  K+RIIHRDIK SN+LLDE F  KIADF
Sbjct: 349 IFDKNKAQILSWKQRFNIIVGTAEGLAHLHEGCKIRIIHRDIKSSNVLLDENFNPKIADF 408

Query: 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT 475
           GL R F  D +H+S  +AGTLGYMAPEY+VRG+LTEKADVYSFGV+++E+VC +R + FT
Sbjct: 409 GLARHFGADQSHLSTGIAGTLGYMAPEYLVRGQLTEKADVYSFGVLILEIVCGRRNSSFT 468

Query: 476 QNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIV 535
           +NS  +LQTVWDLY   RL EA+D +L  ++   +   +LQIGLLC QA A LRPSM+ +
Sbjct: 469 ENSTPLLQTVWDLYKTERLTEAIDTSLNKDYPAKEAMDILQIGLLCTQALASLRPSMATI 528

Query: 536 VKMLTGNHE--ILQPTQPPFLNPNGS 559
           VK+LT + E  +  P QPPFLNP G+
Sbjct: 529 VKLLTSDVERKVGIPEQPPFLNPCGT 554

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	573
TAIR|locus:2026785	646	CRK3 "cysteine-rich RLK (RECEP	0.568	0.504	0.7	2.3e-185
TAIR|locus:2026821	649	CRK2 "cysteine-rich RLK (RECEP	0.535	0.473	0.518	1.5e-110
TAIR|locus:2139845	625	AT4G28670 [Arabidopsis thalian	0.518	0.475	0.480	2.6e-96
TAIR|locus:2141762	665	CRK26 "cysteine-rich RLK (RECE	0.558	0.481	0.456	3.2e-81
TAIR|locus:2141201	679	CRK29 "cysteine-rich RLK (RECE	0.553	0.466	0.447	2.5e-77
TAIR|locus:2115728	675	CRK25 "cysteine-rich RLK (RECE	0.493	0.419	0.479	5.2e-77
TAIR|locus:2123126	666	CRK31 "cysteine-rich RLK (RECE	0.525	0.451	0.456	1.1e-76
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.551	0.472	0.459	2.9e-76
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.551	0.472	0.442	1.4e-74
TAIR|locus:2121626	830	CRK23 "cysteine-rich RLK (RECE	0.541	0.373	0.449	3.7e-74

TAIR|locus:2026785 CRK3 "cysteine-rich RLK (RECEPTOR-like protein kinase) 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1174 (418.3 bits), Expect = 2.3e-185, Sum P(2) = 2.3e-185
 Identities = 231/330 (70%), Positives = 271/330 (82%)

Query:   246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT 305
             G+L +  NKS L FSYE LE+AT+YF + NKLGQGGSGSVYKG L  G+ VAVKRLF+NT
Sbjct:   298 GSLFMLANKSNLCFSYENLERATDYFSDKNKLGQGGSGSVYKGVLTNGKTVAVKRLFFNT 357

Query:   306 TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
              QWVDHFFNEVNLIS ++HKNLVKLLGCSITGPESLLVYE++ NQSL D LFVR+DV+PL
Sbjct:   358 KQWVDHFFNEVNLISQVDHKNLVKLLGCSITGPESLLVYEYIANQSLHDYLFVRKDVQPL 417

Query:   366 SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
             +W  R+KIIL TAEG+AYLHEES LRIIHRDIKLSNILL+++FT +IADFGL RLFPED 
Sbjct:   418 NWAKRFKIILGTAEGMAYLHEESNLRIIHRDIKLSNILLEDDFTPRIADFGLARLFPEDK 477

Query:   426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
             THIS  +AGTLGYMAPEYVVRGKLTEKADVYSFGV++IEV+  KR N F Q++ SILQ+V
Sbjct:   478 THISTAIAGTLGYMAPEYVVRGKLTEKADVYSFGVLMIEVITGKRNNAFVQDAGSILQSV 537

Query:   486 WDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEI 545
             W LY    + EAVDP L  NF + + SRLLQIGLLCVQA+ + RP+MS+VVKM+ G+ EI
Sbjct:   538 WSLYRTSNVEEAVDPILGDNFNKIEASRLLQIGLLCVQAAFDQRPAMSVVVKMMKGSLEI 597

Query:   546 LQPTQPPFLNPNGSEISS---VGTPSTSNS 572
               PTQPPFLNP GS +     + TP+T+ S
Sbjct:   598 HTPTQPPFLNP-GSVVEMRKMMMTPTTNQS 626

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2026821 CRK2 "cysteine-rich RLK (RECEPTOR-like protein kinase) 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 792 (283.9 bits), Expect = 1.5e-110, Sum P(2) = 1.5e-110
 Identities = 164/316 (51%), Positives = 211/316 (66%)

Query:   255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFN 314
             S LNF Y TLEKAT  F  +NKLGQGG G+VYKG LP G  +AVKRLF+N       F+N
Sbjct:   309 SSLNFKYSTLEKATGSFDNANKLGQGGFGTVYKGVLPDGRDIAVKRLFFNNRHRATDFYN 368

Query:   315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
             EVN+IS + HKNLV+LLGCS +GPESLLVYE++ N+SL   +F     + L W+ RY II
Sbjct:   369 EVNMISTVEHKNLVRLLGCSCSGPESLLVYEYLQNKSLDRFIFDVNRGKTLDWQRRYTII 428

Query:   375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
             + TAEGL YLHE+S ++IIHRDIK SNILLD +  AKIADFGL R F +D +HIS  +AG
Sbjct:   429 VGTAEGLVYLHEQSSVKIIHRDIKASNILLDSKLQAKIADFGLARSFQDDKSHISTAIAG 488

Query:   435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRI--NLFTQNSCSILQTVWDLYVKG 492
             TLGYMAPEY+  G+LTE  DVYSFGV+V+E+V  K+   +  +  S S++   W  +  G
Sbjct:   489 TLGYMAPEYLAHGQLTEMVDVYSFGVLVLEIVTGKQNTKSKMSDYSDSLITEAWKHFQSG 548

Query:   493 RLHEAVDPALAGNFQ------EGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEIL 546
              L +  DP L    Q      + + +R++QIGLLC Q    LRP MS ++ ML    E+L
Sbjct:   549 ELEKIYDPNLDWKSQYDSHIIKKEIARVVQIGLLCTQEIPSLRPPMSKLLHMLKNKEEVL 608

Query:   547 Q-PTQPPFLNPNGSEI 561
               P+ PPF++    E+
Sbjct:   609 PLPSNPPFMDERVMEL 624

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010193 "response to ozone" evidence=IEP

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006457 "protein folding" evidence=RCA

GO:0006857 "oligopeptide transport" evidence=RCA

GO:0009408 "response to heat" evidence=RCA

GO:0009644 "response to high light intensity" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

GO:0042542 "response to hydrogen peroxide" evidence=RCA

TAIR|locus:2139845 AT4G28670 [Arabidopsis thaliana (taxid:3702)]

 Score = 689 (247.6 bits), Expect = 2.6e-96, Sum P(2) = 2.6e-96
 Identities = 148/308 (48%), Positives = 201/308 (65%)

Query:   257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
             ++F Y TL+KATN F+ES KLG GG G V+KGTL  G  +A+KRL  +  +  D   NE+
Sbjct:   317 MSFEYSTLKKATNNFNESCKLGVGGYGEVFKGTLSDGREIAIKRLHVSGKKPRDEIHNEI 376

Query:   317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
             ++IS   HKNLV+LLGC  T   S +VYEF+ N SL   LF  +  + L W+ R  IIL 
Sbjct:   377 DVISRCQHKNLVRLLGCCFTNMNSFIVYEFLANTSLDHILFNPEKKKELDWKKRRTIILG 436

Query:   377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHIS---A 430
             TAEGL YLHE  K  IIHRDIK SNILLD ++  KI+DFGL + +PE   DI   S   +
Sbjct:   437 TAEGLEYLHETCK--IIHRDIKASNILLDLKYKPKISDFGLAKFYPEGGKDIPASSLSPS 494

Query:   431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF-TQNSCSILQT-VWDL 488
             ++AGTLGYMAPEY+ +G+L+ K D YSFGV+V+E+    R N F + NS   L T VW  
Sbjct:   495 SIAGTLGYMAPEYISKGRLSNKIDAYSFGVLVLEITSGFRNNKFRSDNSLETLVTQVWKC 554

Query:   489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ- 547
             +   ++ E +D  +  +  + +  R++QIGLLC Q S +LRP+MS V++M++    +L  
Sbjct:   555 FASNKMEEMIDKDMGEDTDKQEMKRVMQIGLLCTQESPQLRPTMSKVIQMVSSTDIVLPT 614

Query:   548 PTQPPFLN 555
             PT+PPFL+
Sbjct:   615 PTKPPFLH 622

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2141762 CRK26 "cysteine-rich RLK (RECEPTOR-like protein kinase) 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 667 (239.9 bits), Expect = 3.2e-81, Sum P(2) = 3.2e-81
 Identities = 151/331 (45%), Positives = 199/331 (60%)

Query:   252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH 311
             ++   + F +  L+ AT++F   NKLG+GG G+VYKG L  G+ +AVKRL  N  Q    
Sbjct:   325 ISTDSMKFDFSVLQDATSHFSLENKLGEGGFGAVYKGVLSDGQKIAVKRLSKNAQQGETE 384

Query:   312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
             F NE  L++ + H+NLVKLLG SI G E LLVYEF+P+ SL   +F       L WE+RY
Sbjct:   385 FKNEFLLVAKLQHRNLVKLLGYSIEGTERLLVYEFLPHTSLDKFIFDPIQGNELEWEIRY 444

Query:   372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
             KII   A GL YLH++S+LRIIHRD+K SNILLDEE T KIADFG+ RLF  D T    T
Sbjct:   445 KIIGGVARGLLYLHQDSRLRIIHRDLKASNILLDEEMTPKIADFGMARLFDIDHTTQRYT 504

Query:   432 --LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--SILQTVWD 487
               + GT GYMAPEYV+ G+ + K DVYSFGV+V+E++  K+ + F+       ++   W 
Sbjct:   505 NRIVGTFGYMAPEYVMHGQFSFKTDVYSFGVLVLEIISGKKNSGFSSEDSMGDLISFAWR 564

Query:   488 LYVKGRLHEAVDPALA--GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEI 545
              + +G     VD  L    ++      R + IGLLCVQ     RPSM+ VV ML G+   
Sbjct:   565 NWKEGVALNLVDKILMTMSSYSSNMIMRCINIGLLCVQEKVAERPSMASVVLMLDGHTIA 624

Query:   546 L-QPTQPPFL---NPNGSEISSVG-TPSTSN 571
             L +P++P F    N      SS+G    TSN
Sbjct:   625 LSEPSKPAFFSHSNAVSDSSSSLGHNAKTSN 655

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2141201 CRK29 "cysteine-rich RLK (RECEPTOR-like protein kinase) 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 648 (233.2 bits), Expect = 2.5e-77, Sum P(2) = 2.5e-77
 Identities = 149/333 (44%), Positives = 204/333 (61%)

Query:   253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHF 312
             N   L   +ETL+ AT+ F   N+LG+GG GSVYKG  P G+ +AVKRL  N+ Q  + F
Sbjct:   339 NTESLLVHFETLKTATDNFSSENELGRGGFGSVYKGVFPQGQEIAVKRLSGNSGQGDNEF 398

Query:   313 FNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK 372
              NE+ L++ + H+NLV+L+G  I G E LLVYEF+ N SL   +F  +  + L W VRYK
Sbjct:   399 KNEILLLAKLQHRNLVRLIGFCIQGEERLLVYEFIKNASLDQFIFDTEKRQLLDWVVRYK 458

Query:   373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP--EDITH-IS 429
             +I   A GL YLHE+S+ RIIHRD+K SNILLD+E   KIADFGL +LF   + +TH  +
Sbjct:   459 MIGGIARGLLYLHEDSRFRIIHRDLKASNILLDQEMNPKIADFGLAKLFDSGQTMTHRFT 518

Query:   430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS----ILQTV 485
             + +AGT GYMAPEY + G+ + K DV+SFGV+VIE++  KR N    N       +L  V
Sbjct:   519 SRIAGTYGYMAPEYAMHGQFSVKTDVFSFGVLVIEIITGKRNNNGGSNGDEDAEDLLSWV 578

Query:   486 WDLYVKGRLHEAVDPAL-AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG-NH 543
             W  + +  +   +DP+L AG+  E    R + IGLLCVQ SA  RP+M+ V  ML   + 
Sbjct:   579 WRSWREDTILSVIDPSLTAGSRNE--ILRCIHIGLLCVQESAATRPTMATVSLMLNSYSF 636

Query:   544 EILQPTQPPFLN-----PNGSEISSVGTPSTSN 571
              +  P +P F+      P+    S+ G   +SN
Sbjct:   637 TLPTPLRPAFVLESVVIPSNVSSSTEGLQMSSN 669

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005773 "vacuole" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2115728 CRK25 "cysteine-rich RLK (RECEPTOR-like protein kinase) 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 668 (240.2 bits), Expect = 5.2e-77, Sum P(2) = 5.2e-77
 Identities = 137/286 (47%), Positives = 185/286 (64%)

Query:   257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
             L F +  +E ATN F ESNKLG GG G VYKG L  GE VA+KRL   +TQ  + F NEV
Sbjct:   333 LQFQFSAIEAATNKFSESNKLGHGGFGEVYKGQLITGETVAIKRLSQGSTQGAEEFKNEV 392

Query:   317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
             ++++ + H+NL KLLG  + G E +LVYEFVPN+SL   LF  +    L W+ RYKII  
Sbjct:   393 DVVAKLQHRNLAKLLGYCLDGEEKILVYEFVPNKSLDYFLFDNEKRRVLDWQRRYKIIEG 452

Query:   377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGT 435
              A G+ YLH +S+L IIHRD+K SNILLD +   KI+DFG+ R+F  D T  +   + GT
Sbjct:   453 IARGILYLHRDSRLTIIHRDLKASNILLDADMHPKISDFGMARIFGVDQTQANTKRIVGT 512

Query:   436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQT-VWDLYVKGR 493
              GYM+PEY + GK + K+DVYSFGV+V+E++  +K  + + ++    L T VW L+V+  
Sbjct:   513 YGYMSPEYAIHGKYSVKSDVYSFGVLVLELITGKKNSSFYEEDGLGDLVTYVWKLWVENS 572

Query:   494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
               E VD A+ GNFQ  +  R + I LLCVQ  +  RPSM  ++ M+
Sbjct:   573 PLELVDEAMRGNFQTNEVIRCIHIALLCVQEDSSERPSMDDILVMM 618

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000041 "transition metal ion transport" evidence=RCA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)]

 Score = 639 (230.0 bits), Expect = 1.1e-76, Sum P(2) = 1.1e-76
 Identities = 141/309 (45%), Positives = 188/309 (60%)

Query:   257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
             L F + T+E AT+ F  +NKLGQGG G VYKG LP    +AVKRL  N+ Q    F NEV
Sbjct:   325 LQFDFTTIEVATDNFSRNNKLGQGGFGEVYKGMLPNETEIAVKRLSSNSGQGTQEFKNEV 384

Query:   317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
              +++ + HKNLV+LLG  I   E +LVYEFV N+SL   LF  +    L W+ RY II  
Sbjct:   385 VIVAKLQHKNLVRLLGFCIERDEQILVYEFVSNKSLDYFLFDPKMKSQLDWKRRYNIIGG 444

Query:   377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SATLAGT 435
                GL YLH++S+L IIHRDIK SNILLD +   KIADFG+ R F  D T   +  + GT
Sbjct:   445 VTRGLLYLHQDSRLTIIHRDIKASNILLDADMNPKIADFGMARNFRVDQTEDQTGRVVGT 504

Query:   436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS---ILQTVWDLYVKG 492
              GYM PEYV  G+ + K+DVYSFGV+++E+VC K+ + F Q   S   ++  VW L+   
Sbjct:   505 FGYMPPEYVTHGQFSTKSDVYSFGVLILEIVCGKKNSSFFQMDDSGGNLVTHVWRLWNND 564

Query:   493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPP 552
                + +DPA+  ++   +  R + IG+LCVQ +   RP MS + +MLT +   L   +PP
Sbjct:   565 SPLDLIDPAIKESYDNDEVIRCIHIGILCVQETPADRPEMSTIFQMLTNSSITLPVPRPP 624

Query:   553 ---FLN-PN 557
                F N PN
Sbjct:   625 GFFFRNRPN 633

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 668 (240.2 bits), Expect = 2.9e-76, Sum P(2) = 2.9e-76
 Identities = 147/320 (45%), Positives = 197/320 (61%)

Query:   257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
             L   Y T++ AT+ F ESNK+GQGG G VYKGTL  G  VAVKRL  ++ Q    F NEV
Sbjct:   334 LQLDYRTIQTATDDFVESNKIGQGGFGEVYKGTLSDGTEVAVKRLSKSSGQGEVEFKNEV 393

Query:   317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
              L++ + H+NLV+LLG  + G E +LVYE+VPN+SL   LF       L W  RYKII  
Sbjct:   394 VLVAKLQHRNLVRLLGFCLDGEERVLVYEYVPNKSLDYFLFDPAKKGQLDWTRRYKIIGG 453

Query:   377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGT 435
              A G+ YLH++S+L IIHRD+K SNILLD +   KIADFG+ R+F  D T  + + + GT
Sbjct:   454 VARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGLDQTEENTSRIVGT 513

Query:   436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF--TQNSCSILQTVWDLYVKGR 493
              GYM+PEY + G+ + K+DVYSFGV+V+E++  K+ + F  T  +  ++   W L+  GR
Sbjct:   514 YGYMSPEYAMHGQYSMKSDVYSFGVLVLEIISGKKNSSFYQTDGAHDLVSYAWGLWSNGR 573

Query:   494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ-PTQPP 552
               E VDPA+  N Q  +  R + IGLLCVQ     RP++S +V MLT N   L  P QP 
Sbjct:   574 PLELVDPAIVENCQRNEVVRCVHIGLLCVQEDPAERPTLSTIVLMLTSNTVTLPVPRQPG 633

Query:   553 FLNPNGSEISSVGTPSTSNS 572
                 +      + T +TS S
Sbjct:   634 LFFQSRIGKDPLDTDTTSKS 653

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 648 (233.2 bits), Expect = 1.4e-74, Sum P(2) = 1.4e-74
 Identities = 143/323 (44%), Positives = 196/323 (60%)

Query:   257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
             L FS++T+E AT+ F +SN +G+GG G VY+G L  G  VAVKRL   + Q  + F NE 
Sbjct:   331 LQFSFKTIEAATDKFSDSNMIGRGGFGEVYRGKLSSGPEVAVKRLSKTSGQGAEEFKNEA 390

Query:   317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
              L+S + HKNLV+LLG  + G E +LVYEFVPN+SL   LF       L W  RY II  
Sbjct:   391 VLVSKLQHKNLVRLLGFCLEGEEKILVYEFVPNKSLDYFLFDPAKQGELDWTRRYNIIGG 450

Query:   377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGT 435
              A G+ YLH++S+L IIHRD+K SNILLD +   KIADFG+ R+F  D +  +   +AGT
Sbjct:   451 IARGILYLHQDSRLTIIHRDLKASNILLDADMNPKIADFGMARIFGVDQSQANTRRIAGT 510

Query:   436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF--TQNSCSILQT-VWDLYVKG 492
              GYM+PEY +RG  + K+DVYSFGV+V+E++  K+ + F    +S S L T  W L+  G
Sbjct:   511 FGYMSPEYAMRGHFSMKSDVYSFGVLVLEIISGKKNSSFYNIDDSGSNLVTHAWRLWRNG 570

Query:   493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPP 552
                E VDP +  ++Q  + +R + I LLCVQ     RP +  ++ MLT +   L   + P
Sbjct:   571 SPLELVDPTIGESYQSSEATRCIHIALLCVQEDPADRPLLPAIIMMLTSSTTTLHVPRAP 630

Query:   553 FLNPNGSEISSVG---TPSTSNS 572
                 +G ++   G   T STS S
Sbjct:   631 GFCLSGRDLEQDGVEYTESTSRS 653

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121626 CRK23 "cysteine-rich RLK (RECEPTOR-like protein kinase) 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 638 (229.6 bits), Expect = 3.7e-74, Sum P(2) = 3.7e-74
 Identities = 142/316 (44%), Positives = 191/316 (60%)

Query:   257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
             L F ++ +  ATN F   NKLGQGG G VYKGT P G  VAVKRL   + Q    F NEV
Sbjct:   494 LQFDFKAIVAATNNFLPINKLGQGGFGEVYKGTFPSGVQVAVKRLSKTSGQGEREFENEV 553

Query:   317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
              +++ + H+NLV+LLG  + G E +LVYEFV N+SL   LF       L W  RYKII  
Sbjct:   554 VVVAKLQHRNLVRLLGYCLEGEEKILVYEFVHNKSLDYFLFDTTMKRQLDWTRRYKIIGG 613

Query:   377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGT 435
              A G+ YLH++S+L IIHRD+K  NILLD +   K+ADFG+ R+F  D T  +   + GT
Sbjct:   614 IARGILYLHQDSRLTIIHRDLKAGNILLDADMNPKVADFGMARIFGMDQTEANTRRVVGT 673

Query:   436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQN-SCSILQT-VWDLYVKG 492
              GYMAPEY + G+ + K+DVYSFGV+V E++   K  +L+  + S S L T  W L+  G
Sbjct:   674 YGYMAPEYAMYGQFSMKSDVYSFGVLVFEIISGMKNSSLYQMDDSVSNLVTYTWRLWSNG 733

Query:   493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ-PTQP 551
                + VDP+   N+Q    +R + I LLCVQ   + RP+MS +V+MLT +  +L  P QP
Sbjct:   734 SQLDLVDPSFGDNYQTHDITRCIHIALLCVQEDVDDRPNMSAIVQMLTTSSIVLAVPKQP 793

Query:   552 PFL-NPNGSEISSVGT 566
              F       ++  VG+
Sbjct:   794 GFFFRGRHEQVGEVGS 809

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006952 "defense response" evidence=TAS

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9CAL2	CRK3_ARATH	2, ., 7, ., 1, 1, ., -	0.6505	0.9930	0.8808	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00002762001 SubName- Full=Chromosome chr1 scaffold_135, whole genome shotgun sequence; (666 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	573
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	1e-52
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-49
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-46
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	4e-46
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	7e-45
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	1e-44
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-43
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-41
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-38
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-35
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-32
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	5e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-28
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	6e-28
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	8e-28
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	4e-27
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	4e-27
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-27
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-26
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-26
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-26
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-26
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-26
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	8e-26
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-24
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-24
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-24
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	6e-24
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	7e-24
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	8e-24
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-23
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-23
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-23
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	7e-23
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	8e-23
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-23
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-22
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-22
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-22
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-22
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-22
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-22
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	5e-22
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	8e-22
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	8e-22
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-22
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-22
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-21
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-21
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-21
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-20
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-20
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-20
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-20
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-20
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-20
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	4e-20
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	5e-20
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-20
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-20
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-20
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-19
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	3e-19
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-19
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-19
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-19
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	5e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-19
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-19
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-18
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-18
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-18
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-18
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-18
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	6e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-18
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	9e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-17
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	2e-17
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-17
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	5e-17
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-17
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-17
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-17
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	8e-17
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-16
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-16
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-16
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-16
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	3e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-16
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	5e-16
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-15
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-15
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-15
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	3e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	5e-15
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	5e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-15
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	9e-15
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	9e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-14
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-14
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-14
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	2e-14
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	2e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-14
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-14
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-14
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	5e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	6e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-14
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-13
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	2e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-13
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-13
pfam01657	106	pfam01657, Stress-antifung, Salt stress response/a	3e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-13
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-13
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	4e-13
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-13
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-13
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	7e-13
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	9e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-12
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-12
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-12
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-12
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-12
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-12
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	3e-12
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	3e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-12
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-12
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-12
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	7e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	8e-12
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	1e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-11
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-11
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-11
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-11
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	3e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-11
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-11
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-11
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	6e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-11
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	7e-11
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-11
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-10
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-10
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-10
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-10
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-10
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-10
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-10
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	4e-10
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	4e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	8e-10
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-10
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-10
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	9e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	9e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-09
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	1e-09
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-09
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-09
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-09
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	4e-09
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	4e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	7e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	8e-09
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-09
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	9e-09
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-08
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	3e-08
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-08
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-08
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	4e-08
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	4e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	5e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-08
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	6e-08
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	7e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	8e-08
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	8e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-07
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-07
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-07
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	3e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	5e-07
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-06
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-06
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	3e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-06
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	6e-05
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	6e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-04
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-04
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-04
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	6e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.001
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	0.001
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.002

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  178 bits (454), Expect = 1e-52
 Identities = 70/192 (36%), Positives = 106/192 (55%), Gaps = 10/192 (5%)

Query: 277 LGQGGSGSVYKGTLPG-GEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           LG+GG G+VY       G+ VA+K +   +++  ++    E+ ++  +NH N+VKL G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
                  LV E+    SL D   ++++   LS +   +I+L   EGL YLH      IIH
Sbjct: 61  EDENHLYLVMEYCEGGSLKD--LLKENEGKLSEDEILRILLQILEGLEYLHSN---GIIH 115

Query: 395 RDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE-YVVRGKLTEK 452
           RD+K  NILLD      K+ADFGL +L   D   +  T+ GT  YMAPE  + +G  +EK
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSD-KSLLKTIVGTPAYMAPEVLLGKGYYSEK 174

Query: 453 ADVYSFGVVVIE 464
           +D++S GV++ E
Sbjct: 175 SDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  171 bits (435), Expect = 2e-49
 Identities = 74/204 (36%), Positives = 101/204 (49%), Gaps = 13/204 (6%)

Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNL 327
           +    KLG G  G+VYK    G G+ VAVK L   + +         E+ ++  ++H N+
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           V+L+          LV E+     L D L       PLS +   KI L    GL YLH  
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGG---PLSEDEAKKIALQILRGLEYLHSN 117

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
               IIHRD+K  NILLDE    KIADFGL +   +  + ++ T  GT  YMAPE V+ G
Sbjct: 118 ---GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLT-TFVGTPWYMAPE-VLLG 172

Query: 448 KL--TEKADVYSFGVVVIEVVCRK 469
                 K DV+S GV++ E++  K
Sbjct: 173 GNGYGPKVDVWSLGVILYELLTGK 196

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  162 bits (413), Expect = 3e-46
 Identities = 62/198 (31%), Positives = 92/198 (46%), Gaps = 12/198 (6%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
            KLG+G  G VY       G+ VA+K +      +  +    E+ ++  + H N+V+L  
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLR 391
                 +  LV E+     L D L   +    LS  E R+  +      L YLH      
Sbjct: 65  VFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARF-YLRQILSALEYLH---SKG 117

Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
           I+HRD+K  NILLDE+   K+ADFGL R           T  GT  YMAPE ++     +
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKL--TTFVGTPEYMAPEVLLGKGYGK 175

Query: 452 KADVYSFGVVVIEVVCRK 469
             D++S GV++ E++  K
Sbjct: 176 AVDIWSLGVILYELLTGK 193

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  162 bits (413), Expect = 4e-46
 Identities = 86/276 (31%), Positives = 128/276 (46%), Gaps = 35/276 (12%)

Query: 276 KLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
           KLG+G  G VYKGTL          VAVK L    +  +  + F  E +++  ++H N+V
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREE-FLEEASIMKKLSHPNIV 64

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           +LLG    G    +V E++P   LLD  F+R+  E L+ +   ++ L  A+G+ YL   S
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLD--FLRKHGEKLTLKDLLQMALQIAKGMEYLE--S 120

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY-----MAPEY 443
           K   +HRD+   N L+ E    KI+DFGL R    DI           G      MAPE 
Sbjct: 121 K-NFVHRDLAARNCLVTENLVVKISDFGLSR----DIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA 503
           +  GK T K+DV+SFGV++ E+           ++  +L+ +      G       P   
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELL----EDGYRLPR--PENC 229

Query: 504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                  P  L ++ L C     E RP+ S +V+ L
Sbjct: 230 -------PDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  159 bits (404), Expect = 7e-45
 Identities = 83/276 (30%), Positives = 120/276 (43%), Gaps = 36/276 (13%)

Query: 276 KLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
           KLG+G  G VYKG L          VAVK L  + +  Q  + F  E  ++  ++H N+V
Sbjct: 6   KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNVV 64

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           KLLG         +V E++    LL   ++R++   LS        L  A G+ YL    
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLS--YLRKNRPKLSLSDLLSFALQIARGMEYLES-- 120

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
               IHRD+   N L+ E    KI+DFGL R   +D  +        + +MAPE +  GK
Sbjct: 121 -KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179

Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQ-----NSCSILQTVWDLYVKGRLHEAVDPALA 503
            T K+DV+SFGV++ E        +FT         S  + +  L    RL         
Sbjct: 180 FTSKSDVWSFGVLLWE--------IFTLGEQPYPGMSNEEVLEYLKNGYRLP-------- 223

Query: 504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                  P  L  + L C     E RP+ S +V++L
Sbjct: 224 --QPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  158 bits (403), Expect = 1e-44
 Identities = 83/282 (29%), Positives = 125/282 (44%), Gaps = 36/282 (12%)

Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
            KLG+G  G VYKG L G +     VAVK L    +  +  D F  E  ++  + H N+V
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKD-FLKEARVMKKLGHPNVV 59

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLD------NLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           +LLG         LV E++    LLD       +F   +   LS +      +  A+G+ 
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAP 441
           YL      + +HRD+   N L+ E+   KI+DFGL R   +D  +   T     + +MAP
Sbjct: 120 YLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKRI---NLFTQNSCSILQTVWDLYVKGRLHEAV 498
           E +  G  T K+DV+SFGV++ E+          L  +    +L+ +     KG      
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE---VLEYL----RKGYRLPK- 228

Query: 499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
            P          P  L ++ L C Q   E RP+ S +V+ L 
Sbjct: 229 -PEYC-------PDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  154 bits (391), Expect = 5e-43
 Identities = 84/275 (30%), Positives = 122/275 (44%), Gaps = 33/275 (12%)

Query: 276 KLGQGGSGSVYKGTL-----PGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
           KLG+G  G VYKGTL          VAVK L    +  Q  + F  E  ++  ++H N+V
Sbjct: 6   KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEE-FLREARIMRKLDHPNIV 64

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEE 387
           KLLG        ++V E++P   LLD  ++R+   + LS        L  A G+ YL   
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLD--YLRKNRPKELSLSDLLSFALQIARGMEYLES- 121

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
                IHRD+   N L+ E    KI+DFGL R   +D  +        + +MAPE +  G
Sbjct: 122 --KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179

Query: 448 KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF- 506
           K T K+DV+SFGV++ E+        FT                  + E +     G   
Sbjct: 180 KFTSKSDVWSFGVLLWEI--------FTL--GEEPYPGMSNA---EVLEYLK---KGYRL 223

Query: 507 --QEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                 P  L ++ L C     E RP+ S +V++L
Sbjct: 224 PKPPNCPPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  149 bits (378), Expect = 4e-41
 Identities = 67/205 (32%), Positives = 103/205 (50%), Gaps = 18/205 (8%)

Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
             LG+G  GSVY       GE +AVK   L  ++ + ++    E+ ++S + H N+V+  
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 332 GCSIT-GPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEV--RY-KIILSTAEGLAYLHE 386
           G        +L ++ E+V   SL     + +    L   V  +Y + IL   EGLAYLH 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSS---LLKKFGKLPEPVIRKYTRQIL---EGLAYLHS 119

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVV 445
                I+HRDIK +NIL+D +   K+ADFG   RL   +    + ++ GT  +MAPE + 
Sbjct: 120 N---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 446 RGKLTEKADVYSFGVVVIEVVCRKR 470
             +    AD++S G  VIE+   K 
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKP 201

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  141 bits (358), Expect = 2e-38
 Identities = 66/197 (33%), Positives = 94/197 (47%), Gaps = 10/197 (5%)

Query: 270 YFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
            F    K+G+GG G VYK      G+ VA+K +   + +  +   NE+ ++    H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           K  G  +   E  +V EF    SL D L         S  + Y +     +GL YLH   
Sbjct: 61  KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQ-IAY-VCKELLKGLEYLH--- 115

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRG 447
              IIHRDIK +NILL  +   K+ DFGL  +L      +   T+ GT  +MAPE +   
Sbjct: 116 SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMVGTPYWMAPEVINGK 172

Query: 448 KLTEKADVYSFGVVVIE 464
               KAD++S G+  IE
Sbjct: 173 PYDYKADIWSLGITAIE 189

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 2e-35
 Identities = 65/212 (30%), Positives = 107/212 (50%), Gaps = 22/212 (10%)

Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNL 327
           +   + +G+G  G VYKG  L  G+ VA+K++       + +     E++L+  + H N+
Sbjct: 2   YQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNI 61

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           VK +G   T     ++ E+  N SL     + +   P    +    +    +GLAYLHE+
Sbjct: 62  VKYIGSIETSDSLYIILEYAENGSLRQ---IIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVR 446
               +IHRDIK +NIL  ++   K+ADFG+  +L   D++   A++ GT  +MAPE V+ 
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPE-VIE 172

Query: 447 GK-LTEKADVYSFGVVVIEVVCRKRINLFTQN 477
               +  +D++S G  VIE        L T N
Sbjct: 173 MSGASTASDIWSLGCTVIE--------LLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  127 bits (318), Expect = 5e-32
 Identities = 80/299 (26%), Positives = 126/299 (42%), Gaps = 20/299 (6%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINH-KN 326
           +    KLG+G  G VY       + VA+K L     + ++ V+ F  E+ +++ +NH  N
Sbjct: 2   YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +VKL           LV E+V   SL D L       PLS      I+      L YLH 
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 387 ESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITH-----ISATLAGTLGYMA 440
                IIHRDIK  NILLD +    K+ DFGL +L P+  +      + +T  GT GYMA
Sbjct: 120 ---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMA 176

Query: 441 PEYV---VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA 497
           PE +        +  +D++S G+ + E++         +NS +  QT+    +      +
Sbjct: 177 PEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL--KIILELPTPS 234

Query: 498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNP 556
           +   L+ +  E        +    +    + R S S  +      H  L+ +    L  
Sbjct: 235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293

Length = 384

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  118 bits (297), Expect = 5e-30
 Identities = 65/191 (34%), Positives = 93/191 (48%), Gaps = 11/191 (5%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           KLG+G  GSVYK      G+ VA+K       + +     E++++   +   +VK  G  
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIK--VVPVEEDLQEIIKEISILKQCDSPYIVKYYGSY 67

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEESKLRII 393
               +  +V E+    S+ D + +      L+ E     IL  T +GL YLH     + I
Sbjct: 68  FKNTDLWIVMEYCGAGSVSDIMKITNK--TLT-EEEIAAILYQTLKGLEYLH---SNKKI 121

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRDIK  NILL+EE  AK+ADFG V     D      T+ GT  +MAPE +       KA
Sbjct: 122 HRDIKAGNILLNEEGQAKLADFG-VSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKA 180

Query: 454 DVYSFGVVVIE 464
           D++S G+  IE
Sbjct: 181 DIWSLGITAIE 191

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  115 bits (289), Expect = 1e-28
 Identities = 63/202 (31%), Positives = 101/202 (50%), Gaps = 12/202 (5%)

Query: 268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
              +    K+G+G SG VYK T    G+ VA+K++     Q  +   NE+ ++    H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRL-RKQNKELIINEILIMKDCKHPN 76

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +V      + G E  +V E++   SL D   + Q+   ++      +     +GL YLH 
Sbjct: 77  IVDYYDSYLVGDELWVVMEYMDGGSLTD--IITQNFVRMNEPQIAYVCREVLQGLEYLH- 133

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVV 445
                +IHRDIK  NILL ++ + K+ADFG   +L  E       ++ GT  +MAPE V+
Sbjct: 134 --SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYWMAPE-VI 188

Query: 446 RGKL-TEKADVYSFGVVVIEVV 466
           + K    K D++S G++ IE+ 
Sbjct: 189 KRKDYGPKVDIWSLGIMCIEMA 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  113 bits (285), Expect = 2e-28
 Identities = 72/202 (35%), Positives = 95/202 (47%), Gaps = 21/202 (10%)

Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQW---VDHFFNEVNLISGINHKNLVKL 330
             +G G +  VY    LP  E VA+KR+  +  +    VD    EV  +S  NH N+VK 
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRI--DLEKCQTSVDELRKEVQAMSQCNHPNVVKY 64

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNL--FVRQDVEPLSWEVRYKIIL-STAEGLAYLHEE 387
               + G E  LV  ++   SLLD +     +       E     +L    +GL YLH  
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLD---EAIIATVLKEVLKGLEYLH-- 119

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDITHIS-ATLAGTLGYMAPEYV 444
                IHRDIK  NILL E+ + KIADFG+        D T     T  GT  +MAPE +
Sbjct: 120 -SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178

Query: 445 --VRGKLTEKADVYSFGVVVIE 464
             V G    KAD++SFG+  IE
Sbjct: 179 EQVHG-YDFKADIWSFGITAIE 199

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  112 bits (282), Expect = 6e-28
 Identities = 83/261 (31%), Positives = 117/261 (44%), Gaps = 28/261 (10%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CS 334
           KLG G  G V+ GT  G   VAVK L   T    + F  E  ++  + H  LV+L   CS
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRI 392
              P   +V E++   SLLD L   +  E     +   + ++   AEG+AYL        
Sbjct: 72  EEEP-IYIVTEYMSKGSLLDFL---KSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NY 124

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI--THISATLAGTLGYMAPEYVVRGKLT 450
           IHRD+   NIL+ E    KIADFGL RL  +D       A     + + APE    G+ T
Sbjct: 125 IHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFP--IKWTAPEAANYGRFT 182

Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK 510
            K+DV+SFG+++ E+V   R+      +  +L+ V   Y   R+     P          
Sbjct: 183 IKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY---RM-----PR-----PPNC 229

Query: 511 PSRLLQIGLLCVQASAELRPS 531
           P  L  + L C     E RP+
Sbjct: 230 PEELYDLMLQCWDKDPEERPT 250

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  112 bits (282), Expect = 8e-28
 Identities = 75/280 (26%), Positives = 123/280 (43%), Gaps = 20/280 (7%)

Query: 274 SNKLGQGGSGSVYKGTL--PG---GEAVAVKRLFYNTTQWVDH---FFNEVNLISGINHK 325
             +LG+G  G V        G   GE VAVK L  N +    H   F  E+ ++  ++H+
Sbjct: 9   IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTLDHE 66

Query: 326 NLVKLLGCS--ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           N+VK  G      G    L+ E++P+ SL D L   +D   L   + +       +G+ Y
Sbjct: 67  NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS--SQICKGMDY 124

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAP 441
           L  +   R IHRD+   NIL++ E   KI+DFGL ++ PED  +      G     + AP
Sbjct: 125 LGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAP 181

Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF-TQNSCSILQTVWDLYVKGRLHEAVDP 500
           E +   K +  +DV+SFGV + E+      +         ++       +  RL E +  
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE 241

Query: 501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
                     P  +  +  LC +A  + RPS + ++ ++ 
Sbjct: 242 GERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  111 bits (280), Expect = 1e-27
 Identities = 83/275 (30%), Positives = 124/275 (45%), Gaps = 46/275 (16%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           F    KLG G  G V++G       VA+K L  +       F  EV  +  + HK+L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 331 LG-CSITGPESLLVYEFVPNQSLLDNLFVR------QDVEPL---SWEVRYKIILSTAEG 380
              CS+  P   ++ E +   SLL   F+R        V  L   + +V        AEG
Sbjct: 68  FAVCSVGEP-VYIITELMEKGSLLA--FLRSPEGQVLPVASLIDMACQV--------AEG 116

Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
           +AYL E+     IHRD+   NIL+ E+   K+ADFGL RL  ED+ ++S+       + A
Sbjct: 117 MAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTA 172

Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP 500
           PE    G  + K+DV+SFG+++ E+    ++                 Y     HE  D 
Sbjct: 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQVP----------------YPGMNNHEVYDQ 216

Query: 501 ALAGNFQEGKPSR----LLQIGLLCVQASAELRPS 531
             AG ++   P++    + +I L C  A  E RPS
Sbjct: 217 ITAG-YRMPCPAKCPQEIYKIMLECWAAEPEDRPS 250

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  110 bits (276), Expect = 4e-27
 Identities = 71/208 (34%), Positives = 99/208 (47%), Gaps = 15/208 (7%)

Query: 272 HESNKLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLV 328
              NK+G G  G VY    L  GE +AVK  R+  N  + +    +E+ ++  + H NLV
Sbjct: 3   QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           K  G  +   +  +  E+  +   L+ L     +        Y + L   EGLAYLH   
Sbjct: 63  KYYGVEVHREKVYIFMEYC-SGGTLEELLEHGRILDEHVIRVYTLQL--LEGLAYLHSH- 118

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHIS--ATLAGTLGYMAPEYVV 445
              I+HRDIK +NI LD     K+ DFG  V+L     T      +LAGT  YMAPE + 
Sbjct: 119 --GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 446 RGKLTEK---ADVYSFGVVVIEVVCRKR 470
            GK       AD++S G VV+E+   KR
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 4e-27
 Identities = 61/189 (32%), Positives = 99/189 (52%), Gaps = 10/189 (5%)

Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
           +G+G  G V  G   G + VAVK L  ++T     F  E ++++ + H NLV+LLG  + 
Sbjct: 14  IGKGEFGDVMLGDYRG-QKVAVKCLKDDSTA-AQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396
           G    +V E++   SL+D L  R     ++   +    L   EG+ YL  E K   +HRD
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYL--EEK-NFVHRD 127

Query: 397 IKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVY 456
           +   N+L+ E+  AK++DFGL +         S  L   + + APE +   K + K+DV+
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK--EASQGQDSGKLP--VKWTAPEALREKKFSTKSDVW 183

Query: 457 SFGVVVIEV 465
           SFG+++ E+
Sbjct: 184 SFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 5e-27
 Identities = 80/282 (28%), Positives = 132/282 (46%), Gaps = 39/282 (13%)

Query: 277 LGQGGSGSVYKGTLPG---GEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVK 329
           LGQG  G VY+G   G   GE    VA+K +  N + +    F NE +++   N  ++V+
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILSTAEGLA 382
           LLG   TG  +L+V E +    L   L  R+        + P + +   ++    A+G+A
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAP 441
           YL      + +HRD+   N ++ E+ T KI DFG+ R ++  D           + +MAP
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV-DP 500
           E +  G  T K+DV+SFGVV+ E+                  T+ +   +G  +E V   
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMA-----------------TLAEQPYQGLSNEEVLKF 233

Query: 501 ALAGNF---QEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
            + G      E  P +LL++  +C Q + ++RP+   +V  L
Sbjct: 234 VIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  108 bits (272), Expect = 1e-26
 Identities = 69/198 (34%), Positives = 99/198 (50%), Gaps = 14/198 (7%)

Query: 276 KLGQGGSGSVYKGTL--PGGE--AVAVKRLFY-NTTQWVDHFFNEVNLISGINHKNLVKL 330
           KLG G  G V +G     GG+   VAVK L     +  +D F  E  ++  ++H+NL++L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESK 389
            G  +T P  ++V E  P  SLLD L         +S    Y +    A G+ YL  ESK
Sbjct: 62  YGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAV--QIANGMRYL--ESK 116

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVVRG 447
            R IHRD+   NILL  +   KI DFGL+R  P++  H  +   L     + APE +   
Sbjct: 117 -RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTR 175

Query: 448 KLTEKADVYSFGVVVIEV 465
             +  +DV+ FGV + E+
Sbjct: 176 TFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (272), Expect = 2e-26
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 25/202 (12%)

Query: 277 LGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKL 330
           LG G  G+VYKG  +P GE     VA+K L   T+ +      +E  +++ ++H ++V+L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP------LSWEVRYKIILSTAEGLAYL 384
           LG  ++  +  L+ + +P   LLD  +VR   +       L+W V+       A+G++YL
Sbjct: 75  LGICLS-SQVQLITQLMPLGCLLD--YVRNHKDNIGSQYLLNWCVQ------IAKGMSYL 125

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPEY 443
            E+   R++HRD+   N+L+      KI DFGL +L   D     A      + +MA E 
Sbjct: 126 EEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALES 182

Query: 444 VVRGKLTEKADVYSFGVVVIEV 465
           ++    T K+DV+S+GV V E+
Sbjct: 183 ILHRIYTHKSDVWSYGVTVWEL 204

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  107 bits (271), Expect = 2e-26
 Identities = 51/201 (25%), Positives = 91/201 (45%), Gaps = 10/201 (4%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
            ++G+G  G VY       G+   +K   L   + +  +   NEV ++  +NH N++K  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
                  +  +V E+     L   +  + ++ +P   E      +     L YLH     
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR--- 122

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK-L 449
           +I+HRDIK  NI L      K+ DFG+ ++       ++ T+ GT  Y++PE + + K  
Sbjct: 123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVL-SSTVDLAKTVVGTPYYLSPE-LCQNKPY 180

Query: 450 TEKADVYSFGVVVIEVVCRKR 470
             K+D++S G V+ E+   K 
Sbjct: 181 NYKSDIWSLGCVLYELCTLKH 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  107 bits (269), Expect = 3e-26
 Identities = 65/197 (32%), Positives = 93/197 (47%), Gaps = 21/197 (10%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
           LG+G  G V     K T   G+  A+K L        + V+H   E N++S INH  +VK
Sbjct: 1   LGKGSFGKVLLVRKKDT---GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVK 57

Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS-TAEGLAYLHEE 387
           L   +    E L LV E+ P   L  +L         S E R +   +     L YLH  
Sbjct: 58  LH-YAFQTEEKLYLVLEYAPGGELFSHL---SKEGRFS-EERARFYAAEIVLALEYLHS- 111

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
             L II+RD+K  NILLD +   K+ DFGL +    + +  + T  GT  Y+APE ++  
Sbjct: 112 --LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTN-TFCGTPEYLAPEVLLGK 168

Query: 448 KLTEKADVYSFGVVVIE 464
              +  D +S GV++ E
Sbjct: 169 GYGKAVDWWSLGVLLYE 185

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  106 bits (267), Expect = 5e-26
 Identities = 78/265 (29%), Positives = 121/265 (45%), Gaps = 29/265 (10%)

Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +KLG G  G VY+G        VAVK L  +T + V+ F  E  ++  I H NLV+LLG 
Sbjct: 12  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 70

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
               P   ++ EF+   +LLD L    + + ++  V   +    +  + YL +++    I
Sbjct: 71  CTREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FI 126

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRD+   N L+ E    K+ADFGL RL   D     A     + + APE +   K + K+
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 186

Query: 454 DVYSFGVVVIEVVCRKRINLFTQNSCSI-----LQTVWDLYVKGRLHEAVDPALAGNFQE 508
           DV++FGV++ E+              S      L  V++L  KG   E           E
Sbjct: 187 DVWAFGVLLWEIATY---------GMSPYPGIDLSQVYELLEKGYRMER---------PE 228

Query: 509 GKPSRLLQIGLLCVQASAELRPSMS 533
           G P ++ ++   C Q +   RPS +
Sbjct: 229 GCPPKVYELMRACWQWNPSDRPSFA 253

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  106 bits (266), Expect = 8e-26
 Identities = 75/258 (29%), Positives = 124/258 (48%), Gaps = 23/258 (8%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLG G  G V+ G   G   VA+K L   +    + F  E NL+  + H  LV+L    +
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAV-V 70

Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRII 393
           T     ++ E++ N SL+D  F++   E +   +   I ++   AEG+A++  ++    I
Sbjct: 71  TQEPIYIITEYMENGSLVD--FLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YI 124

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRD++ +NIL+ E    KIADFGL RL  ++           + + APE +  G  T K+
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 454 DVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSR 513
           DV+SFG+++ E+V   RI      +  ++Q +       R +    P       +  P  
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL------ERGYRMPRP-------DNCPEE 231

Query: 514 LLQIGLLCVQASAELRPS 531
           L ++  LC +   E RP+
Sbjct: 232 LYELMRLCWKEKPEERPT 249

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  104 bits (260), Expect = 6e-25
 Identities = 76/259 (29%), Positives = 119/259 (45%), Gaps = 24/259 (9%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CS 334
           KLG G  G V++G       VAVK L   T      F  E  ++  + H  L++L   C+
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRI 392
           +  P   +V E +   SLL+ L   Q     + ++   I ++   A G+AYL  ++    
Sbjct: 72  LEEP-IYIVTELMKYGSLLEYL---QGGAGRALKLPQLIDMAAQVASGMAYLEAQN---Y 124

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRD+   N+L+ E    K+ADFGL R+  EDI          + + APE  +  + + K
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIK 184

Query: 453 ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS 512
           +DV+SFG+++ E+V   R+      +  +LQ V   Y   R+     P        G P 
Sbjct: 185 SDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGY---RM-----PC-----PPGCPK 231

Query: 513 RLLQIGLLCVQASAELRPS 531
            L  I L C +   + RP+
Sbjct: 232 ELYDIMLDCWKEDPDDRPT 250

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  102 bits (257), Expect = 1e-24
 Identities = 67/199 (33%), Positives = 99/199 (49%), Gaps = 14/199 (7%)

Query: 275 NKLGQGGSGSVYKGT--LPGGE--AVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVK 329
            +LG G  GSV KG   +  G+   VAVK L           F  E ++++ ++H  +V+
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           L+G    G   +LV E  P   LL  L  R+++     +    +    A G+AYL  ESK
Sbjct: 61  LIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKE---LAHQVAMGMAYL--ESK 114

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVRG 447
              +HRD+   N+LL     AKI+DFG+ R       +  AT AG   L + APE +  G
Sbjct: 115 -HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYG 173

Query: 448 KLTEKADVYSFGVVVIEVV 466
           K + K+DV+S+GV + E  
Sbjct: 174 KFSSKSDVWSYGVTLWEAF 192

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  102 bits (256), Expect = 2e-24
 Identities = 61/191 (31%), Positives = 95/191 (49%), Gaps = 8/191 (4%)

Query: 276 KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDH-FFNEVNLISGINHKNLVKLLGC 333
            LGQG SG VYK    P G+  A+K++  +  +        E+  +       +VK  G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
                E  +V E++   SL D   + + V  +   V   I     +GL YLH  +K  II
Sbjct: 68  FYKEGEISIVLEYMDGGSLAD---LLKKVGKIPEPVLAYIARQILKGLDYLH--TKRHII 122

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRDIK SN+L++ +   KIADFG+ ++  E+      T  GT+ YM+PE +     +  A
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVL-ENTLDQCNTFVGTVTYMSPERIQGESYSYAA 181

Query: 454 DVYSFGVVVIE 464
           D++S G+ ++E
Sbjct: 182 DIWSLGLTLLE 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  101 bits (253), Expect = 3e-24
 Identities = 77/269 (28%), Positives = 122/269 (45%), Gaps = 28/269 (10%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLG G  G V+ G       VAVK L   T   V  F  E NL+  + H  LV+L     
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVVT 71

Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQD-----VEPLSWEVRYKIILSTAEGLAYLHEESKL 390
                 ++ E++   SLLD  F++ D     + P   +   +I    AEG+AY+  ++  
Sbjct: 72  KEEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQI----AEGMAYIERKN-- 123

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
             IHRD++ +N+L+ E    KIADFGL R+  ++           + + APE +  G  T
Sbjct: 124 -YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 182

Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK 510
            K+DV+SFG+++ E+V   +I     ++  ++  +   Y   R+             E  
Sbjct: 183 IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRM-------------ENC 229

Query: 511 PSRLLQIGLLCVQASAELRPSMSIVVKML 539
           P  L  I   C +  AE RP+   +  +L
Sbjct: 230 PDELYDIMKTCWKEKAEERPTFDYLQSVL 258

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  101 bits (254), Expect = 6e-24
 Identities = 58/210 (27%), Positives = 96/210 (45%), Gaps = 26/210 (12%)

Query: 277 LGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVK 329
           LG+G  G V+ G      P  +   VAVK L    +      F  E  L++   H+N+VK
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR-------------QDVEPLSWEVRYKIILS 376
             G    G   ++V+E++ +  L  N F+R               +  L+     +I + 
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDL--NKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGT 435
            A G+ YL   +    +HRD+   N L+  +   KI DFG+ R ++  D   +       
Sbjct: 131 IASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           + +M PE ++  K T ++DV+SFGVV+ E+
Sbjct: 188 IRWMPPESIMYRKFTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  101 bits (252), Expect = 6e-24
 Identities = 77/270 (28%), Positives = 120/270 (44%), Gaps = 26/270 (9%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCS 334
           K+G+G  G VYKG L G   VAVK         +   F  E  ++   +H N+VKL+G  
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +      +V E VP  SLL   F+R+    L+ +   ++ L  A G+ YL  ESK   IH
Sbjct: 62  VQKQPIYIVMELVPGGSLLT--FLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116

Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT----LGYMAPEYVVRGKLT 450
           RD+   N L+ E    KI+DFG+ R   E+   I     G     + + APE +  G+ T
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK 510
            ++DV+S+G+++ E         F+          +      +  E ++        +  
Sbjct: 174 SESDVWSYGILLWET--------FSLGDTP-----YPGMSNQQTRERIESGYRMPAPQLC 220

Query: 511 PSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
           P  + ++ L C     E RPS S +   L 
Sbjct: 221 PEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 6e-24
 Identities = 65/204 (31%), Positives = 97/204 (47%), Gaps = 22/204 (10%)

Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           +    ++G G  G VYK   +  GE VA+K +        +    E++++    H N+V 
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
             G  +   +  +V E+    SL D   V +   PLS      +   T +GLAYLHE  K
Sbjct: 65  YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETGK 122

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA------GTLGYMAPEY 443
              IHRDIK +NILL E+   K+ADFG+          ++AT+A      GT  +MAPE 
Sbjct: 123 ---IHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRKSFIGTPYWMAPEV 172

Query: 444 V---VRGKLTEKADVYSFGVVVIE 464
                +G    K D+++ G+  IE
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIE 196

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  101 bits (254), Expect = 7e-24
 Identities = 95/305 (31%), Positives = 134/305 (43%), Gaps = 47/305 (15%)

Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ----WVDHFF 313
           FS +  EK      E   +G G  G+VY    +   E VA+K++ Y+  Q    W D   
Sbjct: 8   FSKDDPEKLFTDLRE---IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-II 63

Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
            EV  +  + H N ++  GC +    + LV E+    S  D L V +  +PL  EV    
Sbjct: 64  KEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVHK--KPLQ-EVEIAA 119

Query: 374 ILSTA-EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           I   A +GLAYLH   +   IHRDIK  NILL E  T K+ADFG        +   + + 
Sbjct: 120 ICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFG-----SASLVSPANSF 171

Query: 433 AGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY 489
            GT  +MAPE ++    G+   K DV+S G+  IE+  RK   LF  N+ S L       
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP-PLFNMNAMSAL------- 223

Query: 490 VKGRLHEAVD--PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ 547
                H A +  P L+ N               C+Q   + RPS   ++K     H  + 
Sbjct: 224 ----YHIAQNDSPTLSSN---DWSDYFRNFVDSCLQKIPQDRPSSEELLK-----HRFVL 271

Query: 548 PTQPP 552
             +PP
Sbjct: 272 RERPP 276

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  100 bits (250), Expect = 8e-24
 Identities = 77/265 (29%), Positives = 124/265 (46%), Gaps = 21/265 (7%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H  LV L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM-PEAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V EF+   SLLD  F+++ D + L       +    A+G+AY+    ++  IH
Sbjct: 72  EEP-IYIVTEFMGKGSLLD--FLKEGDGKYLKLPQLVDMAAQIADGMAYIE---RMNYIH 125

Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +    KIADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 126 RDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V + R+              +   V   + E V+        +G P  L
Sbjct: 186 VWSFGILLTELVTKGRVP-------------YPGMVNREVLEQVERGYRMPCPQGCPESL 232

Query: 515 LQIGLLCVQASAELRPSMSIVVKML 539
            ++  LC +   + RP+   +   L
Sbjct: 233 HELMKLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 67/211 (31%), Positives = 100/211 (47%), Gaps = 26/211 (12%)

Query: 277 LGQGGSGSVYKGTL--PGGE----AVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVK 329
           LG+G  G VYKG L  P       +VA+K L      +    F  E  L+S + H N+V 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 330 LLG-CSITGPESLLVYEFVPNQSLLDNLFVR---QDVE----------PLSWEVRYKIIL 375
           LLG C+   P  +L +E++ +  L + L       DV            L       I +
Sbjct: 73  LLGVCTKEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131

Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL-FPEDITHISATLAG 434
             A G+ YL   S    +HRD+   N L+ E  T KI+DFGL R  +  D   + +    
Sbjct: 132 QIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188

Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            + +M PE ++ GK T ++D++SFGVV+ E+
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 80/274 (29%), Positives = 132/274 (48%), Gaps = 34/274 (12%)

Query: 277 LGQGGSGSVYKGTL--PGGE--AVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V +G L  PG +   VA+K L    +  Q +D F  E +++   +H N+++L
Sbjct: 12  IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLD-FLTEASIMGQFDHPNIIRL 70

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        +++ E++ N SL  + F+R++    +      ++   A G+ YL   S++
Sbjct: 71  EGVVTKSRPVMIITEYMENGSL--DKFLRENDGKFTVGQLVGMLRGIASGMKYL---SEM 125

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPEYVVRGK 448
             +HRD+   NIL++     K++DFGL R   ED      T  G   + + APE +   K
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRL-EDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 449 LTEKADVYSFGVVVIEVVC---RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN 505
            T  +DV+SFG+V+ EV+    R   ++  Q+   +++ V D Y   RL   +D      
Sbjct: 185 FTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVEDGY---RLPPPMDC----- 233

Query: 506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                PS L Q+ L C Q     RP+ S +V  L
Sbjct: 234 -----PSALYQLMLDCWQKDRNERPTFSQIVSTL 262

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 98.5 bits (245), Expect = 4e-23
 Identities = 67/211 (31%), Positives = 106/211 (50%), Gaps = 8/211 (3%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLG G  G V+ GT  G   VAVK L   T    + F  E  ++  + H  LV+L     
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS-PESFLEEAQIMKKLRHDKLVQLYAVVS 71

Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++  +   L       +    A G+AY+    ++  IH
Sbjct: 72  EEP-IYIVTEYMSKGSLLD--FLKDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNYIH 125

Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +    KIADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 126 RDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
           V+SFG+++ E+V + R+     N+  +L+ V
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 98.6 bits (245), Expect = 4e-23
 Identities = 79/268 (29%), Positives = 128/268 (47%), Gaps = 27/268 (10%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLG G  G V+  T      VAVK +   +   V+ F  E N++  + H  LVKL    +
Sbjct: 13  KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKL-HAVV 70

Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
           T     ++ EF+   SLLD  F++ D    +PL   + +      AEG+A++ + +    
Sbjct: 71  TKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSA--QIAEGMAFIEQRN---Y 123

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTE 451
           IHRD++ +NIL+      KIADFGL R+  ED  + +   A   + + APE +  G  T 
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVI-EDNEYTAREGAKFPIKWTAPEAINFGSFTI 182

Query: 452 KADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKP 511
           K+DV+SFG++++E+V   RI     ++  +++ +   Y   R              E  P
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------------PENCP 229

Query: 512 SRLLQIGLLCVQASAELRPSMSIVVKML 539
             L  I + C +   E RP+   +  +L
Sbjct: 230 EELYNIMMRCWKNRPEERPTFEYIQSVL 257

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 98.0 bits (244), Expect = 7e-23
 Identities = 68/211 (32%), Positives = 106/211 (50%), Gaps = 27/211 (12%)

Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNT---------TQWVDHFFNEVNLISGINHKN 326
           +G G  GSVY G     GE +AVK++   +            +D    E+ L+  + H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 327 LVKLLGCSITGPESLLVYEFVPN---QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           +V+ LG S+      +  E+VP     +LL+N    +  E L   VR   +    +GL Y
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFE--ETL---VR-NFVRQILKGLNY 121

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS-----ATLAGTLGY 438
           LH      IIHRDIK +NIL+D +   KI+DFG+ +    +           +L G++ +
Sbjct: 122 LHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           MAPE V +   T KAD++S G +V+E++  K
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 60/200 (30%), Positives = 98/200 (49%), Gaps = 14/200 (7%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDH-FFNEVNLISGINHKNL 327
           +    ++G+G  G V+K      GE VA+K++        + +    E+  +    H  +
Sbjct: 2   YKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYV 61

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHE 386
           VKLL     G   +LV E++P+  L + L  R +  PL   +V+   +    +G+AY+H 
Sbjct: 62  VKLLDVFPHGSGFVLVMEYMPS-DLSEVL--RDEERPLPEAQVK-SYMRMLLKGVAYMH- 116

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE--YV 444
                I+HRD+K +N+L+  +   KIADFGL RLF E+   + +    T  Y APE  Y 
Sbjct: 117 --ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYG 174

Query: 445 VRGKLTEKADVYSFGVVVIE 464
            R K     D+++ G +  E
Sbjct: 175 AR-KYDPGVDLWAVGCIFAE 193

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 97.5 bits (243), Expect = 9e-23
 Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 23/204 (11%)

Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLF-----YNTTQWVDHFFNEVNLISGINHKNLVKL 330
           LG G  GSVY+G  L  G+  AVK +          + V     E+ L+S + H N+V+ 
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 331 LGCSITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLHE 386
           LG      ++L ++ E VP  SL   L   +        V   I L T +   GL YLH+
Sbjct: 68  LGTEREE-DNLYIFLELVPGGSLAKLL---KKYGSFPEPV---IRLYTRQILLGLEYLHD 120

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
                 +HRDIK +NIL+D     K+ADFG+ +   E     S    G+  +MAPE + +
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS--FKGSPYWMAPEVIAQ 175

Query: 447 -GKLTEKADVYSFGVVVIEVVCRK 469
            G     AD++S G  V+E+   K
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 97.6 bits (243), Expect = 1e-22
 Identities = 64/215 (29%), Positives = 105/215 (48%), Gaps = 34/215 (15%)

Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQ----------WVDHFFNEVNLISGINHK 325
           +G+G  G VY    +  GE +AVK++    T            V    +E+  +  ++H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 326 NLVKLLGCSITGPESLLVY-EFVPNQSLLDNL-----FVRQDVEPLSWEVRYKIILSTAE 379
           N+V+ LG   T  E L ++ E+VP  S+   L     F  Q V   + +          E
Sbjct: 69  NIVQYLGFE-TTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQ--------VLE 119

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA--GTLG 437
           GLAYLH +    I+HRD+K  N+L+D +   KI+DFG+ +   +DI      ++  G++ 
Sbjct: 120 GLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK-SDDIYDNDQNMSMQGSVF 175

Query: 438 YMAPEYV--VRGKLTEKADVYSFGVVVIEVVCRKR 470
           +MAPE +       + K D++S G VV+E+   +R
Sbjct: 176 WMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 97.9 bits (244), Expect = 1e-22
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 17/204 (8%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGINHKNLV 328
             E ++LG+G  GSV K  L     +   +                E+ +        +V
Sbjct: 3   IVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIV 62

Query: 329 KLLGCSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE----GLA 382
           K  G  +    S +    E+    SL D+++ +  V+     +  K++   AE    GL+
Sbjct: 63  KYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKK--VKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           YLH     +IIHRDIK SNILL  +   K+ DFG+     E +  ++ T  GT  YMAPE
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS---GELVNSLAGTFTGTSFYMAPE 173

Query: 443 YVVRGKLTEKADVYSFGVVVIEVV 466
            +     +  +DV+S G+ ++EV 
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVA 197

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 96.8 bits (242), Expect = 2e-22
 Identities = 68/216 (31%), Positives = 100/216 (46%), Gaps = 39/216 (18%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHKN 326
           KLG+G  G VYK      GE VA+K++          +T         E++L+  + H N
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTA------LREISLLKELKHPN 59

Query: 327 LVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTA----E 379
           +VKLL   I     L LV+E+     +  LD       + P        +I S       
Sbjct: 60  IVKLL-DVIHTERKLYLVFEYCDMDLKKYLDKR--PGPLSP-------NLIKSIMYQLLR 109

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GLAY H     RI+HRD+K  NIL++ +   K+ADFGL R F   +   +  +  TL Y 
Sbjct: 110 GLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYR 165

Query: 440 APEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLF 474
           APE ++  K  +   D++S G +  E++  K   LF
Sbjct: 166 APEILLGSKHYSTAVDIWSVGCIFAEMITGK--PLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 96.8 bits (241), Expect = 2e-22
 Identities = 64/191 (33%), Positives = 95/191 (49%), Gaps = 10/191 (5%)

Query: 277 LGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCS 334
           LG G  GSV K   +P G  +A K +       V      E+ ++       +V   G  
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +      +  EF+   SL D ++  +   P+  E+  KI ++  EGL YL+     RI+H
Sbjct: 73  LNENNICMCMEFMDCGSL-DRIY--KKGGPIPVEILGKIAVAVVEGLTYLYN--VHRIMH 127

Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RDIK SNIL++     K+ DFG+     E I  I+ T  GT  YM+PE +  GK T K+D
Sbjct: 128 RDIKPSNILVNSRGQIKLCDFGVS---GELINSIADTFVGTSTYMSPERIQGGKYTVKSD 184

Query: 455 VYSFGVVVIEV 465
           V+S G+ +IE+
Sbjct: 185 VWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 65/222 (29%), Positives = 111/222 (50%), Gaps = 21/222 (9%)

Query: 247 ALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT 305
           ALQ+ V+        +      N+     K+G+G +G V   T    G  VAVK++    
Sbjct: 7   ALQLVVDPG------DPRSYLDNF----VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK 56

Query: 306 TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEP 364
            Q  +  FNEV ++    H N+V++    + G E  +V EF+   +L D +   R + E 
Sbjct: 57  QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQ 116

Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
           ++      + L+  + L++LH +    +IHRDIK  +ILL  +   K++DFG      ++
Sbjct: 117 IA-----TVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE 168

Query: 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +     +L GT  +MAPE + R     + D++S G++VIE+V
Sbjct: 169 VPR-RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 95.8 bits (238), Expect = 4e-22
 Identities = 69/267 (25%), Positives = 119/267 (44%), Gaps = 19/267 (7%)

Query: 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
             ++G G  G V+ G       VA+K +        D F  E  ++  ++H  LV+L G 
Sbjct: 9   VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED-FIEEAQVMMKLSHPKLVQLYGV 67

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
                   LV+EF+ +  L D  ++R      S E    + L   EG+AYL   +   +I
Sbjct: 68  CTERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRD+   N L+ E    K++DFG+ R   +D    S      + + +PE     K + K+
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKS 182

Query: 454 DVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSR 513
           DV+SFGV++ EV    +     +++  +++    +    RL++   P LA          
Sbjct: 183 DVWSFGVLMWEVFSEGKTPYENRSNSEVVE---TINAGFRLYK---PRLA-------SQS 229

Query: 514 LLQIGLLCVQASAELRPSMSIVVKMLT 540
           + ++   C +   E RPS S+++  L 
Sbjct: 230 VYELMQHCWKERPEDRPSFSLLLHQLA 256

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 63/198 (31%), Positives = 99/198 (50%), Gaps = 18/198 (9%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINH---KNLVKLL 331
           +G+G  G+VY+G  +P G  VA+K +  +T    V     EV L+S +      N+ K  
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK--IILSTAEGLAYLHEESK 389
           G  + GP   ++ E+    S      VR  ++      +Y   II      L Y+H   K
Sbjct: 69  GSYLKGPRLWIIMEYAEGGS------VRTLMKAGPIAEKYISVIIREVLVALKYIH---K 119

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
           + +IHRDIK +NIL+      K+ DFG+  L  ++ +  S T  GT  +MAPE +  GK 
Sbjct: 120 VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS-TFVGTPYWMAPEVITEGKY 178

Query: 450 TE-KADVYSFGVVVIEVV 466
            + KAD++S G+ + E+ 
Sbjct: 179 YDTKADIWSLGITIYEMA 196

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 96.0 bits (239), Expect = 5e-22
 Identities = 73/222 (32%), Positives = 110/222 (49%), Gaps = 38/222 (17%)

Query: 277 LGQGGSGSVYK--------GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
           LG+G  GSV           T   GE VAVK+L ++T + +  F  E+ ++  + H N+V
Sbjct: 12  LGKGNFGSVELCRYDPLQDNT---GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIV 68

Query: 329 KLLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA----EGLA 382
           K  G C   G  +L LV E++P  SL D L   ++       + ++ +L  A    +G+ 
Sbjct: 69  KYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE------RLDHRKLLLYASQICKGME 122

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMA 440
           YL      R +HRD+   NIL++ E   KI DFGL ++ P+D  +      G   + + A
Sbjct: 123 YL---GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYA 179

Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT--QNSCS 480
           PE +   K +  +DV+SFGVV+ E        LFT    SCS
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYE--------LFTYSDKSCS 213

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 95.2 bits (237), Expect = 5e-22
 Identities = 74/270 (27%), Positives = 116/270 (42%), Gaps = 31/270 (11%)

Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CSI 335
           LG G  G V+ G   G   VA+K +        D F  E  ++  ++H NLV+L G C+ 
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70

Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
             P   +V E++ N  LL+  ++R+    L  E    +     E + YL        IHR
Sbjct: 71  QRP-IFIVTEYMANGCLLN--YLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHR 124

Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           D+   N L+ E+   K++DFGL R   +D    S      + +  PE     + + K+DV
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 456 YSFGVVVIEVVCRKRINLFTQNSC-----SILQTVWDLYVKGRLHEAVDPALAGNFQEGK 510
           +SFGV++ EV        F++        S  + V  +    RL+    P LA       
Sbjct: 185 WSFGVLMWEV--------FSEGKMPYERFSNSEVVESVSAGYRLYR---PKLA------- 226

Query: 511 PSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
           P+ +  I   C     E RP+   ++  LT
Sbjct: 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 94.7 bits (235), Expect = 8e-22
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 336 TGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ +  + L       +    A G+AY+    ++  +H
Sbjct: 72  EEP-IYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 125

Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 186 VWSFGILLTELTTKGRV 202

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.9 bits (236), Expect = 8e-22
 Identities = 62/202 (30%), Positives = 101/202 (50%), Gaps = 16/202 (7%)

Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
           LGQG  G VY    +  G  +AVK++ ++     T + V+    E+ L+  + H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 331 LGCSITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
            GC +   E+L ++ E++P  S+ D L   +    L+  V  K      EG+ YLH    
Sbjct: 70  YGC-LRDDETLSIFMEYMPGGSVKDQL---KAYGALTETVTRKYTRQILEGVEYLHSN-- 123

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA--TLAGTLGYMAPEYVVRG 447
             I+HRDIK +NIL D     K+ DFG  +      +  +   ++ GT  +M+PE +   
Sbjct: 124 -MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE 182

Query: 448 KLTEKADVYSFGVVVIEVVCRK 469
               KADV+S G  V+E++  K
Sbjct: 183 GYGRKADVWSVGCTVVEMLTEK 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 94.5 bits (235), Expect = 9e-22
 Identities = 63/263 (23%), Positives = 118/263 (44%), Gaps = 22/263 (8%)

Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNL 327
           F   NK+G+G  G V+K          A+K++  +     +     +E  +++ ++   +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           ++     +   +  +V E+  N  L   L   Q   PL  +  ++  +    GLA+LH +
Sbjct: 62  IRYYESFLDKGKLNIVMEYAENGDLHK-LLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
              +I+HRDIK  N+ LD     KI D G+ +L   D T+ + T+ GT  Y++PE     
Sbjct: 121 ---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELCEDK 176

Query: 448 KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ 507
              EK+DV++ GVV+ E  C  +      N  +++  +    ++G       P ++  + 
Sbjct: 177 PYNEKSDVWALGVVLYE-CCTGKHPFDANNQGALILKI----IRGVF-----PPVSQMYS 226

Query: 508 EGKPSRLLQIGLLCVQASAELRP 530
           +    +L Q+   C+      RP
Sbjct: 227 Q----QLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 94.6 bits (236), Expect = 9e-22
 Identities = 54/215 (25%), Positives = 96/215 (44%), Gaps = 25/215 (11%)

Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVN 317
           YE LE           +G+G  G+V K      G+ +  K + Y   T +      +EVN
Sbjct: 2   YEVLET----------IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVN 51

Query: 318 LISGINHKNLVKLLGCSITGPESLLVY---EFVPN---QSLLDNLFVRQDVEPLSWEVRY 371
           ++  + H N+V+     I    +  +Y   E+        L+     +++ + +  E  +
Sbjct: 52  ILRELKHPNIVRYYD-RIIDRSNQTLYIVMEYCEGGDLAQLIQKC--KKERKYIEEEFIW 108

Query: 372 KIILSTAEGLAYLH--EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
           +I+      L   H   +    ++HRD+K +NI LD     K+ DFGL ++   D +  +
Sbjct: 109 RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHD-SSFA 167

Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
            T  GT  YM+PE +      EK+D++S G ++ E
Sbjct: 168 KTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYE 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 56/194 (28%), Positives = 95/194 (48%), Gaps = 9/194 (4%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLG 332
            +LG G SG V K    P G+ +AVK +              E++++   N   +V   G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                 +  +  E++   SL     +++    +   +  KI ++  +GL YLHE  K +I
Sbjct: 67  AFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHE--KHKI 122

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRD+K SNIL++     K+ DFG+     + +  ++ T  GT  YMAPE +     + K
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQGNDYSVK 179

Query: 453 ADVYSFGVVVIEVV 466
           +D++S G+ +IE+ 
Sbjct: 180 SDIWSLGLSLIELA 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 22/197 (11%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGC 333
            +G+G  G VYK       + VA+K +     +  ++    E+  +S      + K  G 
Sbjct: 8   CIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGS 67

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
            + G +  ++ E+    S LD L        L       I+     GL YLHEE K   I
Sbjct: 68  FLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEGK---I 120

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL------AGTLGYMAPEYVVRG 447
           HRDIK +NILL EE   K+ADFG+          +++T+       GT  +MAPE + + 
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVS-------GQLTSTMSKRNTFVGTPFWMAPEVIKQS 173

Query: 448 KLTEKADVYSFGVVVIE 464
              EKAD++S G+  IE
Sbjct: 174 GYDEKADIWSLGITAIE 190

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 94.3 bits (234), Expect = 2e-21
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 11/200 (5%)

Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
            Y     K+G+G +G V   T+   G+ VAVK++     Q  +  FNEV ++    H+N+
Sbjct: 20  TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V++    + G E  +V EF+   +L D +   R + E ++      + L+  + L+ LH 
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLHA 134

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +    +IHRDIK  +ILL  +   K++DFG      +++     +L GT  +MAPE + R
Sbjct: 135 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKSLVGTPYWMAPELISR 190

Query: 447 GKLTEKADVYSFGVVVIEVV 466
                + D++S G++VIE+V
Sbjct: 191 LPYGPEVDIWSLGIMVIEMV 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 64/189 (33%), Positives = 97/189 (51%), Gaps = 6/189 (3%)

Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSI 335
           LG+G  G V+KGTL     VAVK    +  Q +   F +E  ++   +H N+VKL+G   
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
                 +V E VP    L   F+R+  + L  +   K  L  A G+AYL  ESK   IHR
Sbjct: 63  QRQPIYIVMELVPGGDFLS--FLRKKKDELKTKQLVKFALDAAAGMAYL--ESK-NCIHR 117

Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           D+   N L+ E    KI+DFG+ R   + I   S      + + APE +  G+ + ++DV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177

Query: 456 YSFGVVVIE 464
           +S+G+++ E
Sbjct: 178 WSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 3e-21
 Identities = 60/204 (29%), Positives = 94/204 (46%), Gaps = 23/204 (11%)

Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFN--EVNLISGINHKNLVKLLG 332
           K+G+G  G VYK      GE VA+K++               E+ L+  +NH N++KLL 
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 333 CSITGPESL-LVYEFVPNQSLLDNL--FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
                   L LV+EF     +  +L   ++     L   +    +    +GLA+ H    
Sbjct: 66  V-FRHKGDLYLVFEF-----MDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---S 116

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMAPEYVVR 446
             I+HRD+K  N+L++ E   K+ADFGL R F       TH   T      Y APE ++ 
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW----YRAPELLLG 172

Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
            K  +   D++S G +  E++ R+
Sbjct: 173 DKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 93.5 bits (232), Expect = 3e-21
 Identities = 76/271 (28%), Positives = 132/271 (48%), Gaps = 27/271 (9%)

Query: 277 LGQGGSGSVYKGTL--PGGE--AVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V++G L  PG +  AVA+K L   Y   Q  D F +E +++   +H N+++L
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQD-FLSEASIMGQFSHHNIIRL 71

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G       ++++ E++ N +L D      D E  S+++   ++   A G+ YL   S +
Sbjct: 72  EGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQL-VGMLRGIAAGMKYL---SDM 126

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
             +HRD+   NIL++     K++DFGL R+  +D      T  G +   + APE +   K
Sbjct: 127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRK 186

Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T  +DV+SFG+V+ EV+       +  ++  +++ + D +   RL   +D         
Sbjct: 187 FTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGF---RLPAPMDC-------- 235

Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
             PS + Q+ L C Q     RP    +V +L
Sbjct: 236 --PSAVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 94.3 bits (234), Expect = 3e-21
 Identities = 78/221 (35%), Positives = 108/221 (48%), Gaps = 23/221 (10%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGINHK 325
           F   +++G G  G+VY  T     E VAVK++ Y+  Q    W D    EV  +  + H 
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQD-IIKEVKFLQQLKHP 81

Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYL 384
           N ++  GC +    + LV E+    S  D L V +  +PL  EV    I   A +GLAYL
Sbjct: 82  NTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAITHGALQGLAYL 137

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
           H  +    IHRDIK  NILL E    K+ADFG         +  + +  GT  +MAPE +
Sbjct: 138 HSHNM---IHRDIKAGNILLTEPGQVKLADFG-----SASKSSPANSFVGTPYWMAPEVI 189

Query: 445 V---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
           +    G+   K DV+S G+  IE+  RK   LF  N+ S L
Sbjct: 190 LAMDEGQYDGKVDVWSLGITCIELAERKP-PLFNMNAMSAL 229

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 93.4 bits (232), Expect = 3e-21
 Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 29/215 (13%)

Query: 271 FHESNK---LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
           + E+ +   LG+G  G VY    L     +A+K +    +++V     E+ L S + H+N
Sbjct: 7   YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE---VRY--KIILSTAEGL 381
           +V+ LG         +  E VP  SL   L  R    PL      + +  K IL   EGL
Sbjct: 67  IVQYLGSDSENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQIL---EGL 121

Query: 382 AYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFG----LVRLFPEDITHISATLAGTL 436
            YLH+    +I+HRDIK  N+L++      KI+DFG    L  + P      + T  GTL
Sbjct: 122 KYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-----CTETFTGTL 173

Query: 437 GYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRK 469
            YMAPE + +G       AD++S G  ++E+   K
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.9 bits (228), Expect = 8e-21
 Identities = 63/191 (32%), Positives = 107/191 (56%), Gaps = 14/191 (7%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
            +G+G  G+V +G   G + VAVK +  + T     F  E  +++ ++HKNLV+LLG  I
Sbjct: 13  IIGEGEFGAVLQGEYTG-QKVAVKNIKCDVT--AQAFLEETAVMTKLHHKNLVRLLGV-I 68

Query: 336 TGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
                 +V E +   +L++ L  R + +  +   +++   L  AEG+ YL  ESK +++H
Sbjct: 69  LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS--LDVAEGMEYL--ESK-KLVH 123

Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD+   NIL+ E+  AK++DFGL R+    + +    +  T    APE +   K + K+D
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKSD 179

Query: 455 VYSFGVVVIEV 465
           V+S+GV++ EV
Sbjct: 180 VWSYGVLLWEV 190

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 92.8 bits (230), Expect = 8e-21
 Identities = 61/193 (31%), Positives = 103/193 (53%), Gaps = 11/193 (5%)

Query: 276 KLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+G+G +G V   T    G+ VAVK++     Q  +  FNEV ++   +H+N+V +    
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 335 ITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
           + G E  +V EF+   +L D +   R + E ++      + LS    L+YLH +    +I
Sbjct: 89  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQG---VI 140

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRDIK  +ILL  +   K++DFG      +++     +L GT  +MAPE + R     + 
Sbjct: 141 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 454 DVYSFGVVVIEVV 466
           D++S G++VIE++
Sbjct: 200 DIWSLGIMVIEMI 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 13/197 (6%)

Query: 277 LGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKL 330
           LG G  G+VYKG  +P GE     VA+K L  NT+   +    +E  +++G+    + +L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
           LG  +T    L V + +P   LLD  +VR++ + +  +      +  A+G++YL E   +
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCLLD--YVRENKDRIGSQDLLNWCVQIAKGMSYLEE---V 128

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPEYVVRGKL 449
           R++HRD+   N+L+      KI DFGL RL   D T   A      + +MA E ++  + 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF 188

Query: 450 TEKADVYSFGVVVIEVV 466
           T ++DV+S+GV V E++
Sbjct: 189 THQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 91.7 bits (228), Expect = 1e-20
 Identities = 83/288 (28%), Positives = 121/288 (42%), Gaps = 45/288 (15%)

Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNL 327
             LG G  G VY+G   G +       VAVK L    + Q    F  E  ++S  NH+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD----VEPLSWEVR--YKIILSTAEGL 381
           V+L+G S       ++ E +    L    F+R++      P S  ++         A+G 
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKS--FLRENRPRPERPSSLTMKDLLFCARDVAKGC 129

Query: 382 AYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAG---- 434
            YL E      IHRDI   N LL        AKIADFG+ R    DI   S    G    
Sbjct: 130 KYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAM 182

Query: 435 -TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG- 492
             + +M PE  + G  T K DV+SFGV++ E+     +           Q V +    G 
Sbjct: 183 LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPY----PGRTNQEVMEFVTGGG 238

Query: 493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
           RL    DP       +G P  + +I   C Q + E RP+ + +++ + 
Sbjct: 239 RL----DPP------KGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 91.5 bits (227), Expect = 2e-20
 Identities = 70/221 (31%), Positives = 101/221 (45%), Gaps = 41/221 (18%)

Query: 270 YFHESNKLGQGGSGSV----YKGTLPG-GEAVAVKRL-----FYNTTQWVDHFFNEVNLI 319
           Y  +   LG+G  G V    Y     G GE VAVK L       NT+ W      E+N++
Sbjct: 5   YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWK----KEINIL 60

Query: 320 SGINHKNLVKLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
             + H+N+VK  GC          L+ E+VP  SL D L       P     ++K+ L+ 
Sbjct: 61  KTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-------P-----KHKLNLAQ 108

Query: 378 --------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
                    EG+AYLH +     IHRD+   N+LLD +   KI DFGL +  PE   +  
Sbjct: 109 LLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 165

Query: 430 ATLAGT--LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR 468
               G   + + A E +   K +  +DV+SFGV + E++  
Sbjct: 166 VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.1 bits (228), Expect = 2e-20
 Identities = 77/221 (34%), Positives = 109/221 (49%), Gaps = 23/221 (10%)

Query: 271 FHESNKLGQGGSGSVY-KGTLPGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGINHK 325
           F +  ++G G  G+VY    +   E VA+K++ Y+      +W D    EV  +  I H 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQD-IIKEVKFLQRIKHP 85

Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYL 384
           N ++  GC +    + LV E+    S  D L V +  +PL  EV    I   A +GLAYL
Sbjct: 86  NSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAITHGALQGLAYL 141

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
           H  +   +IHRDIK  NILL E    K+ADFG        I   + +  GT  +MAPE +
Sbjct: 142 HSHN---MIHRDIKAGNILLTEPGQVKLADFG-----SASIASPANSFVGTPYWMAPEVI 193

Query: 445 V---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
           +    G+   K DV+S G+  IE+  RK   LF  N+ S L
Sbjct: 194 LAMDEGQYDGKVDVWSLGITCIELAERKP-PLFNMNAMSAL 233

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 91.4 bits (227), Expect = 2e-20
 Identities = 67/218 (30%), Positives = 100/218 (45%), Gaps = 34/218 (15%)

Query: 277 LGQGGSGSVYKGTLPG---GEA---VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVK 329
           +GQG  G V++   PG    E    VAVK L    +      F  E  L++  +H N+VK
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR---------------------QDVEPLSWE 368
           LLG    G    L++E++    L  N F+R                      +  PLS  
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDL--NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCT 130

Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITH 427
            +  I    A G+AYL E    + +HRD+   N L+ E    KIADFGL R ++  D   
Sbjct: 131 EQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK 187

Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            S   A  + +M PE +   + T ++DV+++GVV+ E+
Sbjct: 188 ASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 62/193 (32%), Positives = 98/193 (50%), Gaps = 11/193 (5%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+GQG SG+VY    +  G+ VA+K++        +   NE+ ++    H N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           + G E  +V E++   SL D +      E     V  + +    + L +LH     ++IH
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL----QALEFLHSN---QVIH 138

Query: 395 RDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           RDIK  NILL  + + K+ DFG   ++ PE      +T+ GT  +MAPE V R     K 
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKV 196

Query: 454 DVYSFGVVVIEVV 466
           D++S G++ IE+V
Sbjct: 197 DIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 90.6 bits (225), Expect = 3e-20
 Identities = 74/210 (35%), Positives = 111/210 (52%), Gaps = 24/210 (11%)

Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWV-DHFFNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA----EGLAY 383
           VKLL    T  +  LV+EF+ +Q L   +    D  PLS  +   +I S      +GLA+
Sbjct: 62  VKLLDVIHTENKLYLVFEFL-HQDLKKFM----DASPLS-GIPLPLIKSYLFQLLQGLAF 115

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI---THISATLAGTLGYMA 440
            H     R++HRD+K  N+L++ E   K+ADFGL R F   +   TH       TL Y A
Sbjct: 116 CHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRA 168

Query: 441 PEYVVRGKLTEKA-DVYSFGVVVIEVVCRK 469
           PE ++  K    A D++S G +  E+V R+
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 67/195 (34%), Positives = 99/195 (50%), Gaps = 11/195 (5%)

Query: 276 KLGQGGSGSVYKGT--LPGGE--AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKL 330
            +G+G  G VY+G    P  E  AVAVK     T+  V + F  E  ++   +H ++VKL
Sbjct: 13  CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
           +G  IT     +V E  P   L   L V +    L+  + Y   LSTA  LAYL  ESK 
Sbjct: 73  IGV-ITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTA--LAYL--ESK- 126

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           R +HRDI   N+L+      K+ DFGL R   ++  + ++     + +MAPE +   + T
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186

Query: 451 EKADVYSFGVVVIEV 465
             +DV+ FGV + E+
Sbjct: 187 SASDVWMFGVCMWEI 201

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 90.2 bits (224), Expect = 3e-20
 Identities = 81/269 (30%), Positives = 130/269 (48%), Gaps = 27/269 (10%)

Query: 277 LGQGGSGSVYKGTL----PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLL 331
           +G+G  G VY GTL          AVK L   T  + V+ F  E  ++   +H N++ LL
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 332 GCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
           G  +    S L+V  ++ +  L +  F+R +    + +      L  A+G+ YL  +   
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRN--FIRSETHNPTVKDLIGFGLQVAKGMEYLASK--- 117

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPEYVVRG 447
           + +HRD+   N +LDE FT K+ADFGL R ++ ++   +       L   +MA E +   
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 448 KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ 507
           K T K+DV+SFGV++ E++ R        +S  I  TV+ L  +GR    + P       
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDI--TVYLL--QGR--RLLQP------- 224

Query: 508 EGKPSRLLQIGLLCVQASAELRPSMSIVV 536
           E  P  L ++ L C     E+RP+ S +V
Sbjct: 225 EYCPDPLYEVMLSCWHPKPEMRPTFSELV 253

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 90.4 bits (224), Expect = 4e-20
 Identities = 64/201 (31%), Positives = 107/201 (53%), Gaps = 21/201 (10%)

Query: 277 LGQGGSGSVYKGT-LPGGEA----VAVKRLFYNTTQWVDHFFNEVN----LISGINHKNL 327
           LG G  G+V+KG  +P G++    VA+K +   + +     F E+      +  ++H  +
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGR---QTFQEITDHMLAMGSLDHAYI 71

Query: 328 VKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V+LLG C   G    LV +  P  SLLD   VRQ  + L  +      +  A+G+ YL E
Sbjct: 72  VRLLGICP--GASLQLVTQLSPLGSLLD--HVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVV 445
               R++HR++   NILL  +   +IADFG+   L+P+D  +  +     + +MA E ++
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184

Query: 446 RGKLTEKADVYSFGVVVIEVV 466
            G+ T ++DV+S+GV V E++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 90.3 bits (225), Expect = 5e-20
 Identities = 62/214 (28%), Positives = 98/214 (45%), Gaps = 34/214 (15%)

Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHKNLVK 329
            ++G+G  G VYK      GE VA+K++        + F      E+ L+  + H N+V+
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVR 62

Query: 330 LLG--CSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILST-AEGLAYL 384
           L     S       +V+E++ +    LLD+  V+      + E + K  +    EGL YL
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVK-----FT-ESQIKCYMKQLLEGLQYL 116

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE-- 442
           H      I+HRDIK SNIL++ +   K+ADFGL R + +  +        TL Y  PE  
Sbjct: 117 HSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELL 173

Query: 443 -----YVVRGKLTEKADVYSFGVVVIEVVCRKRI 471
                Y        + D++S G ++ E+   K I
Sbjct: 174 LGATRY------GPEVDMWSVGCILAELFLGKPI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 89.9 bits (224), Expect = 6e-20
 Identities = 51/218 (23%), Positives = 91/218 (41%), Gaps = 36/218 (16%)

Query: 277 LGQGGSGSVYKGTLPG-GEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN-HKNLVKLL 331
           +G+G   +V         +  A+K L        + V +   E  +++ +N H  ++KL 
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68

Query: 332 GCSITGPESL-LVYEFVPNQSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
             +    E+L  V E+ PN  LL     +   D +      R+         L YLH   
Sbjct: 69  -YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEK----CTRF-YAAEILLALEYLH--- 119

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS------------------- 429
              IIHRD+K  NILLD++   KI DFG  ++   + +  S                   
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179

Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           A+  GT  Y++PE +      + +D+++ G ++ +++ 
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLT 217

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 90.1 bits (223), Expect = 6e-20
 Identities = 64/197 (32%), Positives = 106/197 (53%), Gaps = 13/197 (6%)

Query: 277 LGQGGSGSVYKGT-LPGGEAV----AVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKL 330
           LG G  G+VYKG  +P GE V    A+K L   T    +  F +E  +++ ++H +LV+L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
           LG  ++ P   LV + +P+  LLD  +V +  + +  ++     +  A+G+ YL E    
Sbjct: 75  LGVCLS-PTIQLVTQLMPHGCLLD--YVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPEYVVRGKL 449
           R++HRD+   N+L+      KI DFGL RL   D    +A      + +MA E +   K 
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 188

Query: 450 TEKADVYSFGVVVIEVV 466
           T ++DV+S+GV + E++
Sbjct: 189 THQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 89.8 bits (222), Expect = 9e-20
 Identities = 62/205 (30%), Positives = 103/205 (50%), Gaps = 17/205 (8%)

Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN 323
           +K T Y     K+GQG SG+V+    +  G+ VA+K++        +   NE+ ++  + 
Sbjct: 19  KKYTRY----EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK 74

Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLA 382
           + N+V  L   + G E  +V E++   SL D +      E    E +   +     + L 
Sbjct: 75  NPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVV-----TETCMDEAQIAAVCRECLQALE 129

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAP 441
           +LH     ++IHRDIK  N+LL  + + K+ DFG   ++ PE      +T+ GT  +MAP
Sbjct: 130 FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAP 184

Query: 442 EYVVRGKLTEKADVYSFGVVVIEVV 466
           E V R     K D++S G++ IE+V
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 89.3 bits (221), Expect = 1e-19
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 42/224 (18%)

Query: 277 LGQGGSGSVYKGT------LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVK 329
           LG+G  G V K T        G   VAVK L  N +   +    +E NL+  +NH +++K
Sbjct: 8   LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67

Query: 330 LLG-CSITGPESLLVYEFV-------------------------PNQSLLDNLFVRQDVE 363
           L G CS  GP  LL+ E+                           N S LDN     D  
Sbjct: 68  LYGACSQDGP-LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN----PDER 122

Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
            L+           + G+ YL E   ++++HRD+   N+L+ E    KI+DFGL R   E
Sbjct: 123 ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179

Query: 424 DITHISATLAGT-LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           + +++  +     + +MA E +     T ++DV+SFGV++ E+V
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 88.8 bits (220), Expect = 1e-19
 Identities = 85/276 (30%), Positives = 126/276 (45%), Gaps = 40/276 (14%)

Query: 277 LGQGGSGSVYKGTL-----PGGEA--VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
           LG G  G VY+GT      PG     VAVK L    T Q    F  E +L+S  NH N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLF-VRQDVEP---LSWEVRYKIILSTAEGLAY 383
           KLLG C +  P+ +++ E +    LL  L   R +      L+ +    I L  A+G  Y
Sbjct: 63  KLLGVCLLNEPQYIIM-ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 384 LHEESKLRIIHRDIKLSNILLDEE-----FTAKIADFGLVR-LFPEDITHISATLAGTLG 437
           L    ++  IHRD+   N L+ E+        KI DFGL R ++  D           + 
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVR 178

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK--GRLH 495
           +MAPE ++ GK T ++DV+SFGV++ E++   +      N+  +LQ     +V   GRL 
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ-----HVTAGGRLQ 233

Query: 496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPS 531
           +           E  P ++ Q+   C       RP+
Sbjct: 234 KP----------ENCPDKIYQLMTNCWAQDPSERPT 259

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.3 bits (221), Expect = 2e-19
 Identities = 74/221 (33%), Positives = 107/221 (48%), Gaps = 23/221 (10%)

Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGINHK 325
           F +  ++G G  G+VY    +   E VA+K++ Y+  Q    W D    EV  +  + H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 75

Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYL 384
           N ++  GC +    + LV E+    S  D L V +  +PL  EV    +   A +GLAYL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAVTHGALQGLAYL 131

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
           H  +   +IHRD+K  NILL E    K+ DFG        I   +    GT  +MAPE +
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFG-----SASIMAPANXFVGTPYWMAPEVI 183

Query: 445 V---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
           +    G+   K DV+S G+  IE+  RK   LF  N+ S L
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKP-PLFNMNAMSAL 223

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 62/192 (32%), Positives = 98/192 (51%), Gaps = 9/192 (4%)

Query: 276 KLGQGGSGSV-YKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+G+G +G V        G  VAVK +     Q  +  FNEV ++    H+N+V++    
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           + G E  ++ EF+   +L D   V Q    L+ E    +  S  + L YLH +    +IH
Sbjct: 88  LVGEELWVLMEFLQGGALTD--IVSQ--TRLNEEQIATVCESVLQALCYLHSQG---VIH 140

Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RDIK  +ILL  +   K++DFG      +D+     +L GT  +MAPE + R     + D
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRTPYGTEVD 199

Query: 455 VYSFGVVVIEVV 466
           ++S G++VIE+V
Sbjct: 200 IWSLGIMVIEMV 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 70/212 (33%), Positives = 111/212 (52%), Gaps = 27/212 (12%)

Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHK 325
           F + N++G+G  G VY+      GE VA+K++  +  +  D        E+ L+  + H 
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER--DGIPISSLREITLLLNLRHP 66

Query: 326 NLVKLLGCSITGP--ESL-LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYK-IILSTAE 379
           N+V+L    + G   +S+ LV E+      SLLDN+       P S E + K ++L    
Sbjct: 67  NIVELKEV-VVGKHLDSIFLVMEYCEQDLASLLDNM-----PTPFS-ESQVKCLMLQLLR 119

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL YLHE     IIHRD+K+SN+LL ++   KIADFGL R +      ++  +  TL Y 
Sbjct: 120 GLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYR 175

Query: 440 APEYVVRG--KLTEKADVYSFGVVVIEVVCRK 469
           APE ++ G    T   D+++ G ++ E++  K
Sbjct: 176 APE-LLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 88.1 bits (218), Expect = 3e-19
 Identities = 81/293 (27%), Positives = 139/293 (47%), Gaps = 42/293 (14%)

Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
           +LGQG  G VY+G    +  GEA   VAVK +  + + +    F NE +++ G    ++V
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVE------PLSWEVRYKIILSTAEGL 381
           +LLG    G  +L+V E + +  L   L  +R + E      P + +   ++    A+G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG---- 437
           AYL+ +   + +HRD+   N ++  +FT KI DFG+ R    DI        G  G    
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185

Query: 438 -YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +MAPE +  G  T  +D++SFGVV+ E+           ++  +L+ V D    G L +
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---GGYLDQ 242

Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPT 549
                      +  P R+  +  +C Q + ++RP+   +V +L    + L P+
Sbjct: 243 P----------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL---KDDLHPS 282

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 56/226 (24%), Positives = 103/226 (45%), Gaps = 19/226 (8%)

Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
           NE+ ++S + H N++      +     L+  E+    +L D + VRQ  +    E+    
Sbjct: 48  NEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKI-VRQKGQLFEEEMVLWY 106

Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
           +      ++Y+H+     I+HRDIK  NI L +    K+ DFG+ ++   + +  + T+ 
Sbjct: 107 LFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVV 162

Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR 493
           GT  YM+PE     K   K+D+++ G V+ E++  KR    T ++ + L  V  + V+G 
Sbjct: 163 GTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKR----TFDATNPLNLVVKI-VQGN 217

Query: 494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
            +  V             S L+ +    +Q   E RP+   V+   
Sbjct: 218 -YTPVV--------SVYSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 52/172 (30%), Positives = 74/172 (43%), Gaps = 36/172 (20%)

Query: 313 FNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK 372
            NE  ++  +NH  LV L             Y F       +N+++  D+  L  ++RY 
Sbjct: 48  LNERRILQELNHPFLVNLW------------YSFQDE----ENMYLVVDLL-LGGDLRYH 90

Query: 373 I--------------ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
           +              I      L YLH +    IIHRDIK  NILLDE+    I DF + 
Sbjct: 91  LSQKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIA 147

Query: 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
                D   ++ + +GT GYMAPE + R   +   D +S GV   E +  KR
Sbjct: 148 TKVTPD--TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.5 bits (217), Expect = 4e-19
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 30/203 (14%)

Query: 277 LGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           LG G  G VYK      G  A A K +   + + ++ F  E++++S   H N+V L    
Sbjct: 13  LGDGAFGKVYKAQHKETGLFA-AAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAY 71

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
               +  ++ EF    +L D++ +  +    EP   ++RY +     E L +LH     +
Sbjct: 72  FYENKLWILIEFCDGGAL-DSIMLELERGLTEP---QIRY-VCRQMLEALNFLHSH---K 123

Query: 392 IIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           +IHRD+K  NILL  +   K+ADFG+  +           T  GT  +MAPE V      
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMAPEVVA----C 177

Query: 451 E---------KADVYSFGVVVIE 464
           E         KAD++S G+ +IE
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIE 200

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 86.8 bits (215), Expect = 4e-19
 Identities = 68/265 (25%), Positives = 115/265 (43%), Gaps = 19/265 (7%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           +LG G  G V+ G       VA+K +        + F  E  ++  ++H  LV+L G   
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAI-NEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
                 +V EF+ N  LL+  ++RQ    LS ++   +     EG+ YL   S    IHR
Sbjct: 70  QQKPLYIVTEFMENGCLLN--YLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           D+   N L+      K++DFG+ R   +D    S+     + +  PE     K + K+DV
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDV 184

Query: 456 YSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLL 515
           +SFGV++ EV    ++        S  + V  +    RL+    P LA          + 
Sbjct: 185 WSFGVLMWEVFTEGKMPF---EKKSNYEVVEMISRGFRLYR---PKLA-------SMTVY 231

Query: 516 QIGLLCVQASAELRPSMSIVVKMLT 540
           ++   C     E RP+ + +++ +T
Sbjct: 232 EVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 87.8 bits (218), Expect = 4e-19
 Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 36/227 (15%)

Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHK 325
           +    KLG+G  G VYK   +  G  VA+K++  +  +  D F      E+ ++  + H 
Sbjct: 10  YEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHP 67

Query: 326 NLVKLLGCSITGPESLL-----VYEFVPNQ-----SLLDNLFVRQDVEPLSWEVRYKIIL 375
           N+V L+  ++  P+        VY   P        LL+N  V+  +     +     +L
Sbjct: 68  NVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVK--LTESQIKCYMLQLL 125

Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG- 434
              EG+ YLHE     I+HRDIK +NIL+D +   KIADFGL R +     +      G 
Sbjct: 126 ---EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGG 179

Query: 435 ---------TLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
                    T  Y  PE ++  +  T   D++  G V  E+  R+ I
Sbjct: 180 TRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPI 226

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 86.8 bits (215), Expect = 5e-19
 Identities = 75/275 (27%), Positives = 126/275 (45%), Gaps = 33/275 (12%)

Query: 277 LGQGGSGSVYKGTL--PGGEA--VAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V +G L  PG     VA+K L   Y   Q  D F +E +++   +H N++ L
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNIIHL 70

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        +++ EF+ N +L  + F+RQ+    +      ++   A G+ YL   S++
Sbjct: 71  EGVVTKSRPVMIITEFMENGAL--DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---SEM 125

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG------YMAPEYV 444
             +HRD+   NIL++     K++DFGL R   +D +    T   +LG      + APE +
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS--DPTYTSSLGGKIPIRWTAPEAI 183

Query: 445 VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG 504
              K T  +DV+S+G+V+ EV+       +  ++  ++  +   Y   RL   +D     
Sbjct: 184 AYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY---RLPPPMDC---- 236

Query: 505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                 P+ L Q+ L C Q     RP    +V  L
Sbjct: 237 ------PTALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 86.5 bits (214), Expect = 7e-19
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 19/205 (9%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFY--NTTQWVDHFF----NEVNLISGINHKNLVK 329
           LG G   S Y+   +  G  +AVK++ Y  NT+   +        E+ L++ +NH ++++
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           +LG +       L  E++   S+   L            V          GL+YLHE   
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122

Query: 390 LRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDIT---HISATLAGTLGYMAPEYVV 445
            +IIHRD+K +N+L+D      +IADFG         T        L GT+ +MAPE V+
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE-VL 180

Query: 446 RGK-LTEKADVYSFGVVVIEVVCRK 469
           RG+      DV+S G V+IE+   K
Sbjct: 181 RGEQYGRSCDVWSVGCVIIEMATAK 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 86.6 bits (214), Expect = 8e-19
 Identities = 65/212 (30%), Positives = 106/212 (50%), Gaps = 26/212 (12%)

Query: 276 KLGQGGSGSVYKG--TLPG---GEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
           +LG+   G +YKG   LPG    + VA+K L    N  QW + F  E +L++ ++H N+V
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGE-FQQEASLMAELHHPNIV 70

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---DVEPLSWE---VR--------YKII 374
            LLG         +++E++    L + L +R    DV   S E   V+          I 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLA 433
           +  A G+ YL   S    +H+D+   NIL+ E+   KI+D GL R ++  D   +     
Sbjct: 131 IQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             + +M PE ++ GK +  +D++SFGVV+ E+
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 87.2 bits (216), Expect = 1e-18
 Identities = 55/193 (28%), Positives = 91/193 (47%), Gaps = 19/193 (9%)

Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
           L  G  G V+  T PG     V ++    T  +     E  L+  +NH +++++    ++
Sbjct: 74  LTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLI-----EAMLLQNVNHPSVIRMKDTLVS 128

Query: 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396
           G  + +V   +P+ S     ++ +   PL  +    I     EGL YLH +   RIIHRD
Sbjct: 129 GAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRD 182

Query: 397 IKLSNILLDEEFTAKIADFGLVRL---FPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           +K  NI +++     I D G  +     P  +      LAGT+   APE + R K   KA
Sbjct: 183 VKTENIFINDVDQVCIGDLGAAQFPVVAPAFL-----GLAGTVETNAPEVLARDKYNSKA 237

Query: 454 DVYSFGVVVIEVV 466
           D++S G+V+ E++
Sbjct: 238 DIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 85.7 bits (213), Expect = 1e-18
 Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 25/202 (12%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFN--EVNLISGIN-HKNLV 328
           +LG G  GSVY       GE VA+K++   FY+   W +   N  EV  +  +N H N+V
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYS---W-EECMNLREVKSLRKLNEHPNIV 61

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           KL        E   V+E++   +L   L   +  +P S  V   II    +GLA++H   
Sbjct: 62  KLKEVFRENDELYFVFEYM-EGNLYQ-LMKDRKGKPFSESVIRSIIYQILQGLAHIH--- 116

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGL---VRLFPEDITHISATLAGTLGYMAPEYVV 445
           K    HRD+K  N+L+      KIADFGL   +R  P    ++S     T  Y APE ++
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVS-----TRWYRAPEILL 171

Query: 446 R-GKLTEKADVYSFGVVVIEVV 466
           R    +   D+++ G ++ E+ 
Sbjct: 172 RSTSYSSPVDIWALGCIMAELY 193

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 85.5 bits (211), Expect = 2e-18
 Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 43/279 (15%)

Query: 274 SNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVDH---FFNEVNLISGINH 324
           S +LGQG  G VY+G   G         VA+K +  N    +     F NE +++   N 
Sbjct: 11  SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNC 68

Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVE------PLSWEVRYKIILST 377
            ++V+LLG    G  +L++ E +    L   L  +R ++E      P S +   ++    
Sbjct: 69  HHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEI 128

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           A+G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R    DI        G  G
Sbjct: 129 ADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKG 181

Query: 438 -----YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG 492
                +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V    ++G
Sbjct: 182 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV----MEG 237

Query: 493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPS 531
            L +  D           P  L ++  +C Q + ++RPS
Sbjct: 238 GLLDKPDNC---------PDMLFELMRMCWQYNPKMRPS 267

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 73/217 (33%), Positives = 108/217 (49%), Gaps = 35/217 (16%)

Query: 277 LGQGGSGSVYKGTLPGGE------AVAVKRLFYNTT-QWVDHFFNEVNLISGI-NHKNLV 328
           LG+G  G V K    G +       VAVK L  + T + +    +E+ ++  I  HKN++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEPLSWEVRYKIILS-- 376
            LLG C+  GP  ++V E+  + +L D L  R+         D  P    +  K ++S  
Sbjct: 80  NLLGVCTQEGPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 377 --TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS---AT 431
              A G+ +L   SK + IHRD+   N+L+ E+   KIADFGL R    DI HI     T
Sbjct: 139 YQVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKT 191

Query: 432 LAGTLGY--MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
             G L    MAPE +     T ++DV+SFGV++ E+ 
Sbjct: 192 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.5 bits (209), Expect = 2e-18
 Identities = 74/263 (28%), Positives = 123/263 (46%), Gaps = 23/263 (8%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           +LG G  G V  G   G   VA+K +    +   D F  E  ++  ++H+ LV+L G   
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69

Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
                 +V E++ N  LL+  ++R+  +        ++     EG+AYL  ESK + IHR
Sbjct: 70  KQRPIYIVTEYMSNGCLLN--YLREHGKRFQPSQLLEMCKDVCEGMAYL--ESK-QFIHR 124

Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           D+   N L+D++   K++DFGL R   +D    S      + +  PE ++  K + K+DV
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDV 184

Query: 456 YSFGVVVIEVVCRKRI--NLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSR 513
           ++FGV++ EV    ++    F  NS    +TV  +    RL+    P LA         +
Sbjct: 185 WAFGVLMWEVYSLGKMPYERFN-NS----ETVEKVSQGLRLYR---PHLASE-------K 229

Query: 514 LLQIGLLCVQASAELRPSMSIVV 536
           +  I   C    AE RP+   ++
Sbjct: 230 VYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 85.2 bits (211), Expect = 3e-18
 Identities = 84/300 (28%), Positives = 126/300 (42%), Gaps = 57/300 (19%)

Query: 274 SNKLGQGGSGSVYKGTL----PGGE-AVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNL 327
           S+ L +G  G ++ G L    PG E  V VK +  + ++  V     E  L+ G++H+N+
Sbjct: 11  SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNI 70

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST---------- 377
           + +L   I   E   V     N   L  LF++Q       E      LST          
Sbjct: 71  LPILHVCIEDGEPPFVLYPYMNWGNL-KLFLQQ---CRLGEANNPQALSTQQLVHMAIQI 126

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL 436
           A G++YLH   K  +IH+DI   N ++DEE   KI D  L R LFP D   +       +
Sbjct: 127 ACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPV 183

Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL-H 495
            +MA E +V  + +  +DV+SFGV                        +W+L   G+  +
Sbjct: 184 KWMALESLVNKEYSSASDVWSFGV-----------------------LLWELMTLGQTPY 220

Query: 496 EAVDP-ALAGNFQEGK--------PSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEIL 546
             +DP  +A   ++G         P  L  +   C     E RPS S +V+ LT  H  L
Sbjct: 221 VEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQL 280

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 84.6 bits (209), Expect = 3e-18
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 17/202 (8%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------QWVDHFFNEVNLISGINHKNLV 328
             LG+G  G+VY G    G+ +AVK++  +T+      +  +    EV+L+  + H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           + LG  +      +  EFVP  S+   L       PL   V  K      +G+AYLH   
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVR---LFPEDITH--ISATLAGTLGYMAPEY 443
              ++HRDIK +N++L      K+ DFG  R         TH  +  ++ GT  +MAPE 
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179

Query: 444 VVRGKLTEKADVYSFGVVVIEV 465
           +       K+D++S G  V E+
Sbjct: 180 INESGYGRKSDIWSIGCTVFEM 201

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 84.5 bits (209), Expect = 3e-18
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 25/211 (11%)

Query: 277 LGQGGSGSVYKGTLPGGEA----VAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           LG+G  GSV +G L   +     VAVK  +L  +T   ++ F +E   +   +H N++KL
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 331 LGCSITG------PESLLVYEFVPNQSLLDNLF-VRQDVEP--LSWEVRYKIILSTAEGL 381
           +G           P+ +++  F+ +  L   L   R    P  L  +   K ++  A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDI---THISATLAGTLG 437
            YL   S    IHRD+   N +L E+ T  +ADFGL + ++  D      I+      + 
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---PVK 180

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCR 468
           ++A E +     T K+DV++FGV + E+  R
Sbjct: 181 WIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 63/200 (31%), Positives = 99/200 (49%), Gaps = 16/200 (8%)

Query: 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
           F +  ++G+G  G VYKG      E VA+K +        ++    E+ ++S  +   + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY--KIILSTAEGLAYLHE 386
           +  G  + G +  ++ E++   S LD L      +P   E  Y   I+    +GL YLH 
Sbjct: 66  RYYGSYLKGTKLWIIMEYLGGGSALDLL------KPGPLEETYIATILREILKGLDYLHS 119

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTLGYMAPEYVV 445
           E K   IHRDIK +N+LL E+   K+ADFG+     +  T I   T  GT  +MAPE + 
Sbjct: 120 ERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIK 174

Query: 446 RGKLTEKADVYSFGVVVIEV 465
           +     KAD++S G+  IE+
Sbjct: 175 QSAYDFKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.8 bits (207), Expect = 5e-18
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 27/271 (9%)

Query: 277 LGQGGSGSVYKGTL--PGGE--AVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V  G L  PG     VA+K L   Y   Q  D F +E +++   +H N++ L
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRD-FLSEASIMGQFDHPNIIHL 70

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        ++V E++ N SL  + F+R+     +      ++   A G+ YL   S +
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSL--DAFLRKHDGQFTVIQLVGMLRGIASGMKYL---SDM 125

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
             +HRD+   NIL++     K++DFGL R+  +D      T  G +   + APE +   K
Sbjct: 126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 185

Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T  +DV+S+G+V+ EV+       +  ++  +++ + + Y   RL   +D         
Sbjct: 186 FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGY---RLPAPMDC-------- 234

Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
             P+ L Q+ L C Q     RP    +V +L
Sbjct: 235 --PAALHQLMLDCWQKDRNERPKFEQIVSIL 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 84.4 bits (208), Expect = 6e-18
 Identities = 61/194 (31%), Positives = 98/194 (50%), Gaps = 13/194 (6%)

Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+GQG SG+VY    +  G+ VA+K++        +   NE+ ++    + N+V  L   
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYLHEESKLRII 393
           + G E  +V E++   SL D +      E    E +   +     + L +LH     ++I
Sbjct: 86  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALDFLHSN---QVI 137

Query: 394 HRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           HRDIK  NILL  + + K+ DFG   ++ PE      +T+ GT  +MAPE V R     K
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 195

Query: 453 ADVYSFGVVVIEVV 466
            D++S G++ IE+V
Sbjct: 196 VDIWSLGIMAIEMV 209

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 83.1 bits (205), Expect = 7e-18
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 12/196 (6%)

Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
           +G+G  G V  G   G + VAVK +  + T     F  E ++++ + H NLV+LLG  + 
Sbjct: 14  IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 337 GPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
               L +V E++   SL+D L  R     L  +   K  L   E + YL   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126

Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           D+   N+L+ E+  AK++DFGL +    + +    T    + + APE +   K + K+DV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182

Query: 456 YSFGVVVIEVVCRKRI 471
           +SFG+++ E+    R+
Sbjct: 183 WSFGILLWEIYSFGRV 198

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 83.3 bits (206), Expect = 7e-18
 Identities = 59/203 (29%), Positives = 96/203 (47%), Gaps = 30/203 (14%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRL----FY--------NTTQWVDH-FFNEVNLISGI 322
           KLG+G  GSVYK          VKRL    FY        + +Q       NE+ +++ +
Sbjct: 7   KLGKGSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASV 56

Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE-PLSWEVRYKIILSTAEGL 381
           NH N++      + G +  +V E+ P   L   +  R+     +  +  ++I +    GL
Sbjct: 57  NHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGL 116

Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
             LHE    +I+HRD+K +NILL      KI D G+ ++  +++     T  GT  YMAP
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK---TQIGTPHYMAP 170

Query: 442 EYVVRGKLTEKADVYSFGVVVIE 464
           E       + K+D++S G ++ E
Sbjct: 171 EVWKGRPYSYKSDIWSLGCLLYE 193

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 84.4 bits (209), Expect = 9e-18
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 30/209 (14%)

Query: 271 FHESNKLGQGGSGSVY----KGTLPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGIN 323
           F    ++GQGG G V+    K T   GE VA+KR+  +    ++   H   E ++++   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDT---GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK 59

Query: 324 HKNLVKLLGCSITGPESL-LVYEFVPN---QSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
            + LVKLL  +    E L L  E+VP    ++LL+NL V  +        R+ +    AE
Sbjct: 60  SEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH-----ARFYM----AE 109

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
               +    +L  IHRD+K  N L+D     K+ DFGL +     I   + ++ G+  YM
Sbjct: 110 MFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSK----GIVTYANSVVGSPDYM 165

Query: 440 APEYVVRGK-LTEKADVYSFGVVVIEVVC 467
           APE V+RGK      D +S G ++ E +C
Sbjct: 166 APE-VLRGKGYDFTVDYWSLGCMLYEFLC 193

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.1 bits (205), Expect = 1e-17
 Identities = 54/190 (28%), Positives = 98/190 (51%), Gaps = 20/190 (10%)

Query: 296 VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
           VAVK L  + T+   + F  E+ ++S + + N+++LLG  ++     ++ E++ N  L  
Sbjct: 47  VAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDL-- 104

Query: 355 NLFVRQ-----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL 403
           N F+ Q           ++  +S      + +  A G+ YL   + L  +HRD+   N L
Sbjct: 105 NQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCL 161

Query: 404 LDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
           +   +T KIADFG+ R L+  D   I       + +MA E ++ GK T  +DV++FGV +
Sbjct: 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTL 221

Query: 463 IEV--VCRKR 470
            E+  +C+++
Sbjct: 222 WEMFTLCKEQ 231

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 60/209 (28%), Positives = 91/209 (43%), Gaps = 31/209 (14%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRLFYNTTQW---VDHFFNEVNLISGINHKNLVK 329
           + +G  G V+    K T   G+  A+K +          VD    E +++S      +VK
Sbjct: 1   ISKGAYGRVFLAKKKST---GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVK 57

Query: 330 LLGCSITGPESL-LVYEFVPN---QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           L   S  G ++L LV E++P     SLL+N      V  L  +V    I      L YLH
Sbjct: 58  LY-YSFQGKKNLYLVMEYLPGGDLASLLEN------VGSLDEDVARIYIAEIVLALEYLH 110

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-------LFPEDITHISATLAGTLGY 438
                 IIHRD+K  NIL+D     K+ DFGL +       +   D       + GT  Y
Sbjct: 111 ---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167

Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           +APE ++    ++  D +S G ++ E + 
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLV 196

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 83.1 bits (205), Expect = 2e-17
 Identities = 60/203 (29%), Positives = 104/203 (51%), Gaps = 13/203 (6%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L + + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 69  PHVCRLLGICLTSTVQL-ITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 125

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPEY 443
            E    R++HRD+   N+L+      KI DFGL +L   D     A      + +MA E 
Sbjct: 126 EER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALES 182

Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 183 ILHRIYTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 75/287 (26%), Positives = 123/287 (42%), Gaps = 40/287 (13%)

Query: 272 HESNKLGQGGSGSVYKGTLPGGEA------VAVKRLFYNTTQWVDHFFN-EVNLISGINH 324
            E   LG+G  G V+     G E       V VK L     + +   F  E+++   ++H
Sbjct: 8   QEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH 67

Query: 325 KNLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVE------PLSWEVRYKIILST 377
           KN+V+LLG C    P   ++ E+     L   L   +  +      PLS + +  +    
Sbjct: 68  KNVVRLLGLCREAEPH-YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL 436
           A G+ +L   S  R +HRD+   N L+  +   K++   L + ++  +   +   L   L
Sbjct: 127 ALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALI-PL 182

Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            ++APE V     + K+DV+SFGV++ EV        FTQ            +      E
Sbjct: 183 RWLAPEAVQEDDFSTKSDVWSFGVLMWEV--------FTQGELP--------FYGLSDEE 226

Query: 497 AVDPALAGNFQ----EGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
            ++   AG  +    EG PSRL ++   C   + + RPS S +V  L
Sbjct: 227 VLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSAL 273

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.3 bits (206), Expect = 3e-17
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 18/197 (9%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLG 332
           N++G G  G+VYK    P G   A+K ++ N    V      E+ ++  +NH N+VK   
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                 E  ++ EF+   SL +   +    E    +V  +I+     G+AYLH   +  I
Sbjct: 140 MFDHNGEIQVLLEFMDGGSL-EGTHIAD--EQFLADVARQIL----SGIAYLH---RRHI 189

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV----VRGK 448
           +HRDIK SN+L++     KIADFG+ R+  + +   ++++ GT+ YM+PE +      G 
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNHGA 248

Query: 449 LTEKA-DVYSFGVVVIE 464
               A D++S GV ++E
Sbjct: 249 YDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 81.3 bits (200), Expect = 5e-17
 Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 12/198 (6%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
           F +  ++G+G  G V+KG     + V A+K +        ++    E+ ++S  +   + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           K  G  + G +  ++ E++   S LD L      +        K IL   +GL YLH E 
Sbjct: 66  KYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL---KGLDYLHSEK 121

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS-ATLAGTLGYMAPEYVVRG 447
           K   IHRDIK +N+LL E+   K+ADFG+     +  T I   T  GT  +MAPE + + 
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQS 176

Query: 448 KLTEKADVYSFGVVVIEV 465
               KAD++S G+  IE+
Sbjct: 177 AYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 81.5 bits (201), Expect = 5e-17
 Identities = 72/215 (33%), Positives = 108/215 (50%), Gaps = 31/215 (14%)

Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTT-QWVDHFFNEVNLISGIN-HKN 326
           LG+G  G V +    G +         VAVK L  N T + +    +E+ L+  I  HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ--------DV-----EPLSWEVRYK 372
           ++ LLG C+  GP  ++V E+    +L + L  R+        D+     E LS++    
Sbjct: 80  IINLLGVCTQEGPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVS 138

Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A G+ YL  ES+ R IHRD+   N+L+ E+   KIADFGL R    DI +   T 
Sbjct: 139 CAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLARGV-HDIDYYKKTS 194

Query: 433 AGTL--GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            G L   +MAPE +     T ++DV+SFG+++ E+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 81.8 bits (202), Expect = 6e-17
 Identities = 73/199 (36%), Positives = 103/199 (51%), Gaps = 19/199 (9%)

Query: 277 LGQGGSGSVY---KGTLP-GGEAVAVKRLFYNTTQWVDHF--FNEVNLISGINHKNLVKL 330
           LGQG  G V+   K T P  G+  A+K L   T +  D      E ++++ +NH  +VKL
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST-AEGLAYLHEESK 389
                T  +  L+ +F+       +LF R   E +  E   K  L+  A  L +LH    
Sbjct: 64  HYAFQTEGKLYLILDFLRG----GDLFTRLSKEVMFTEEDVKFYLAELALALDHLH---S 116

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA--GTLGYMAPEYVVRG 447
           L II+RD+K  NILLDEE   K+ DFGL +   E I H     +  GT+ YMAPE V R 
Sbjct: 117 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 173

Query: 448 KLTEKADVYSFGVVVIEVV 466
             T+ AD +SFGV++ E++
Sbjct: 174 GHTQSADWWSFGVLMFEML 192

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 80.7 bits (200), Expect = 8e-17
 Identities = 64/206 (31%), Positives = 96/206 (46%), Gaps = 36/206 (17%)

Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRLFYNTTQW-------VDHFFNEVNLISGINHK 325
           LG G  G V    +KG+   G+  A+K L    ++        V+H  NE  ++  I H 
Sbjct: 9   LGTGSFGRVMLVRHKGS---GKYYALKIL----SKAKIVKLKQVEHVLNEKRILQSIRHP 61

Query: 326 NLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRY--KIILSTAEGLA 382
            LV L G S     +L LV E+VP   L      +    P      Y  +++L     L 
Sbjct: 62  FLVNLYG-SFQDDSNLYLVMEYVPGGELFS-HLRKSGRFPEPVARFYAAQVVL----ALE 115

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           YLH      I++RD+K  N+LLD +   KI DFG  +      T+   TL GT  Y+APE
Sbjct: 116 YLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TY---TLCGTPEYLAPE 168

Query: 443 YVVRGKLTEKA-DVYSFGVVVIEVVC 467
            ++  K   KA D ++ G+++ E++ 
Sbjct: 169 -IILSKGYGKAVDWWALGILIYEMLA 193

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 57/201 (28%), Positives = 92/201 (45%), Gaps = 17/201 (8%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKR--LF-YNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           K+G+G    VYK   L  G  VA+K+  +F     +       E++L+  ++H N++K L
Sbjct: 9   KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68

Query: 332 GCSITGPESLLVYEFVPNQSL--LDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHE 386
              I   E  +V E      L  +   F +Q     E   W    K  +     L ++H 
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIW----KYFVQLCSALEHMHS 124

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   RI+HRDIK +N+ +      K+ D GL R F    T  + +L GT  YM+PE +  
Sbjct: 125 K---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-TTAAHSLVGTPYYMSPERIHE 180

Query: 447 GKLTEKADVYSFGVVVIEVVC 467
                K+D++S G ++ E+  
Sbjct: 181 NGYNFKSDIWSLGCLLYEMAA 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 57/211 (27%), Positives = 96/211 (45%), Gaps = 26/211 (12%)

Query: 276 KLGQGGSGSVY----KGTLPGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           +LG+G  G V+       LP  +   VAVK L   +      F  E  L++ + H+++V+
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR--------------QDVEPLSWEVRYKIIL 375
             G    G   L+V+E++ +  L  N F+R                   L+      I  
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDL--NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAG 434
             A G+ YL   + L  +HRD+   N L+ +    KI DFG+ R ++  D   +      
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 186

Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            + +M PE ++  K T ++D++SFGVV+ E+
Sbjct: 187 PIRWMPPESILYRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 80.5 bits (198), Expect = 1e-16
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 13/194 (6%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+GQG SG+VY    +  G+ VA++++        +   NE+ ++    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYLHEESKLRII 393
           + G E  +V E++   SL D +      E    E +   +     + L +LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138

Query: 394 HRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           HRDIK  NILL  + + K+ DFG   ++ PE      +T+ GT  +MAPE V R     K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196

Query: 453 ADVYSFGVVVIEVV 466
            D++S G++ IE++
Sbjct: 197 VDIWSLGIMAIEMI 210

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 67/209 (32%), Positives = 105/209 (50%), Gaps = 22/209 (10%)

Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNL 327
           + +  K+G+G  G VYK      GE VA+K  RL             E++L+  +NH N+
Sbjct: 1   YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 328 VKLLGCSITGPESLLVYEFVPNQSL---LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
           V+LL    +  +  LV+EF+ +  L   +D+  +     PL     Y+++    +G+AY 
Sbjct: 61  VRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLL----QGIAYC 115

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--P-EDITHISATLAGTLGYMAP 441
           H     R++HRD+K  N+L+D E   K+ADFGL R F  P    TH       TL Y AP
Sbjct: 116 HSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVV----TLWYRAP 168

Query: 442 EYVVRGKLTEKA-DVYSFGVVVIEVVCRK 469
           E ++  +      D++S G +  E+V R+
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 36/226 (15%)

Query: 276 KLGQGGSGSVY------------KGTLPGGEA-----VAVKRLFYNTTQWV-DHFFNEVN 317
           KLG+G  G V+            K       A     VAVK L  + +    + F  EV 
Sbjct: 12  KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71

Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ----------DVEPLSW 367
           ++S ++  N+ +LLG     P   ++ E++ N  L  N F+++          + + LS+
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDL--NQFLQKHVAETSGLACNSKSLSF 129

Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDIT 426
                +    A G+ YL     L  +HRD+   N L+ + +T KIADFG+ R L+  D  
Sbjct: 130 STLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY 186

Query: 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV--VCRKR 470
            +       + +MA E V+ GK T K+DV++FGV + E+  +CR++
Sbjct: 187 RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 79.9 bits (198), Expect = 2e-16
 Identities = 56/207 (27%), Positives = 94/207 (45%), Gaps = 24/207 (11%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-----EVNLISGINHKNLV 328
            KLG+G    VYK      G  VA+K++     +      N     E+ L+  + H N++
Sbjct: 6   KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65

Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLDNLFVR---QDVEPLSWEVRYKIILSTAEGLAY 383
            LL          LV+EF+    + ++ +  +     D++  S+      +L T  GL Y
Sbjct: 66  GLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIK--SY------MLMTLRGLEY 117

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      I+HRD+K +N+L+  +   K+ADFGL R F      ++  +  T  Y APE 
Sbjct: 118 LHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-TRWYRAPEL 173

Query: 444 VVRGKL-TEKADVYSFGVVVIEVVCRK 469
           +   +      D++S G +  E++ R 
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 53/204 (25%), Positives = 92/204 (45%), Gaps = 18/204 (8%)

Query: 277 LGQGGSGSVYK--GTLPGGEAVAVKRLFYNTTQW----------VDHFFNEVNLI-SGIN 323
           LG G  G VYK      G   +A+K +  +   +          +    +EV +I   + 
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILSTAEGLA 382
           H N+V+     +      +V + +    L ++   +++  +  + E  + I +     L 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           YLH+E   RI+HRD+  +NI+L E+    I DFGL +    +    S    GT+ Y  PE
Sbjct: 128 YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSV--VGTILYSCPE 183

Query: 443 YVVRGKLTEKADVYSFGVVVIEVV 466
            V      EKADV++FG ++ ++ 
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMC 207

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 74.4 bits (183), Expect = 3e-16
 Identities = 26/72 (36%), Positives = 43/72 (59%), Gaps = 3/72 (4%)

Query: 9   ARQRYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFY 68
           + + +AA  +G    +VY   +C  DLS +DC  C A   +++ +C P +   +GGR++Y
Sbjct: 38  SGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRSCLATAVSELRRCCPNK---KGGRIWY 94

Query: 69  DGCYLRYDDYDF 80
           D C+LRY+ Y F
Sbjct: 95  DSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.0 bits (194), Expect = 3e-16
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
           F +  K+G+G  G V+KG     + V   ++         ++    E+ ++S  +   + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           K  G  +   +  ++ E++   S LD L    +  PL       I+    +GL YLH E 
Sbjct: 66  KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEK 121

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTLGYMAPEYVVRG 447
           K   IHRDIK +N+LL E    K+ADFG+     +  T I      GT  +MAPE + + 
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 176

Query: 448 KLTEKADVYSFGVVVIEV 465
               KAD++S G+  IE+
Sbjct: 177 AYDSKADIWSLGITAIEL 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 82.2 bits (203), Expect = 3e-16
 Identities = 82/334 (24%), Positives = 153/334 (45%), Gaps = 27/334 (8%)

Query: 215 TSAVALLLVFSLVAF---FVR-RKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNY 270
           T  +   LV +LVAF   F+R R  L+ +R   + G  ++    SK++ S  T+    + 
Sbjct: 633 TCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKVSKSI-TINDILSS 691

Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLV 328
             E N + +G  G+ YKG ++  G    VK +   N+        +E+  +  + H N+V
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-----SSEIADMGKLQHPNIV 746

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           KL+G   +   + L++E++  ++L       + +  LSWE R KI +  A+ L +LH   
Sbjct: 747 KLIGLCRSEKGAYLIHEYIEGKNL------SEVLRNLSWERRRKIAIGIAKALRFLHCRC 800

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
              ++  ++    I++D +    +    L  L   D     ++      Y+APE      
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS-----AYVAPETRETKD 854

Query: 449 LTEKADVYSFGVVVIEVVCRKR-INLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN-- 505
           +TEK+D+Y FG+++IE++  K   +       SI++     Y    L   +DP++ G+  
Sbjct: 855 ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS 914

Query: 506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
             + +   ++ + L C       RP  + V+K L
Sbjct: 915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 63/205 (30%), Positives = 97/205 (47%), Gaps = 20/205 (9%)

Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
           LGQG  G VY       G  +AVK++ ++     T++ V+    E+ L+  + H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 331 LGCSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            GC     E  L    E +P  S+ D L   +    L+  V  K      EG++YLH   
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSN- 125

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT----LAGTLGYMAPEYV 444
              I+HRDIK +NIL D     K+ DFG  +        +S T    + GT  +M+PE +
Sbjct: 126 --MIVHRDIKGANILRDSVGNVKLGDFGASKRL--QTICLSGTGMKSVTGTPYWMSPEVI 181

Query: 445 VRGKLTEKADVYSFGVVVIEVVCRK 469
                  KAD++S G  V+E++  K
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 79.0 bits (195), Expect = 5e-16
 Identities = 65/202 (32%), Positives = 89/202 (44%), Gaps = 29/202 (14%)

Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN---HKN 326
           LG+G  G V    YK T   GE  A+K L          V+    E  +    N   H  
Sbjct: 7   LGRGHFGKVLLAEYKKT---GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK--IILSTAEGLAYL 384
           LV L  C  T      V E+     L+  + +  DV      V Y   ++L    GL YL
Sbjct: 64  LVNLFACFQTEDHVCFVMEYAAGGDLM--MHIHTDVFSEPRAVFYAACVVL----GLQYL 117

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAPE 442
           HE    +I++RD+KL N+LLD E   KIADFGL +   E +      +T  GT  ++APE
Sbjct: 118 HEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTFCGTPEFLAPE 171

Query: 443 YVVRGKLTEKADVYSFGVVVIE 464
            +     T   D +  GV++ E
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYE 193

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 77.4 bits (190), Expect = 8e-16
 Identities = 62/205 (30%), Positives = 100/205 (48%), Gaps = 20/205 (9%)

Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
           LGQG  G VY    +  G  +A K++ ++     T++ V     E+ L+  + H+ +V+ 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 331 LGC-SITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            GC      ++L ++ E++P  S+ D L   +    L+  V  K      EG++YLH   
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQL---KAYGALTESVTRKYTRQILEGMSYLHSN- 125

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT----LAGTLGYMAPEYV 444
              I+HRDIK +NIL D     K+ DFG  +        +S T    + GT  +M+PE +
Sbjct: 126 --MIVHRDIKGANILRDSAGNVKLGDFGASKRL--QTICMSGTGIRSVTGTPYWMSPEVI 181

Query: 445 VRGKLTEKADVYSFGVVVIEVVCRK 469
                  KADV+S G  V+E++  K
Sbjct: 182 SGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 77.3 bits (190), Expect = 1e-15
 Identities = 57/195 (29%), Positives = 93/195 (47%), Gaps = 23/195 (11%)

Query: 296 VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
           VAVK L  +  +   + F  EV ++S +   N+++LLG  +      ++ E++ N  L  
Sbjct: 49  VAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQ 108

Query: 355 NLFVRQ---------DVEP-------LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK 398
            L             D  P       +S+     + L  A G+ YL   S L  +HRD+ 
Sbjct: 109 FLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLA 165

Query: 399 LSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYS 457
             N L+ E  T KIADFG+ R L+  D   I       + +MA E ++ GK T  +DV++
Sbjct: 166 TRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWA 225

Query: 458 FGVVVIEV--VCRKR 470
           FGV + E+  +C+++
Sbjct: 226 FGVTLWEILMLCKEQ 240

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 80.3 bits (198), Expect = 1e-15
 Identities = 51/171 (29%), Positives = 84/171 (49%), Gaps = 18/171 (10%)

Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLL-VYEFVPNQSLLDNLFVRQDVEPLSWEVR 370
           F  E  L + + H N+V LL      P  L  V+E+VP ++L + L        L     
Sbjct: 25  FRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVL---AADGALPAGET 81

Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP--EDI 425
            +++L   + LA  H +    I+HRD+K  NI++        AK+ DFG+  L P   D 
Sbjct: 82  GRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138

Query: 426 THISATLA----GTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
              + T      GT  Y APE + RG+ +T  +D+Y++G++ +E +  +R+
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQL-RGEPVTPNSDLYAWGLIFLECLTGQRV 188

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 61/207 (29%), Positives = 88/207 (42%), Gaps = 29/207 (14%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC- 333
           +G+G  G VYK      G+ VA+K +     +  +    E N++    NH N+    G  
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEE-IKEEYNILRKYSNHPNIATFYGAF 72

Query: 334 -----SITGPESLLVYEFVPNQSLLD---NLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
                     +  LV E     S+ D    L  R+  + L  E    I+  T  GLAYLH
Sbjct: 73  IKKNPPGNDDQLWLVMELCGGGSVTDLVKGL--RKKGKRLKEEWIAYILRETLRGLAYLH 130

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPE 442
           E    ++IHRDIK  NILL +    K+ DFG+       +        T  GT  +MAPE
Sbjct: 131 EN---KVIHRDIKGQNILLTKNAEVKLVDFGVSA----QLDSTLGRRNTFIGTPYWMAPE 183

Query: 443 YVV-----RGKLTEKADVYSFGVVVIE 464
            +            ++DV+S G+  IE
Sbjct: 184 VIACDEQPDASYDARSDVWSLGITAIE 210

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 69/226 (30%), Positives = 102/226 (45%), Gaps = 50/226 (22%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
           +G+G  G V+    K T   G+  A+K L         Q + H   E ++++  +   +V
Sbjct: 9   IGRGAFGEVWLVRDKDT---GQVYAMKVLRKSDMIKRNQ-IAHVRAERDILADADSPWIV 64

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           KL   S    E L LV E++P   L+ NL +R+DV P     R+ I    AE +  L   
Sbjct: 65  KLY-YSFQDEEHLYLVMEYMPGGDLM-NLLIRKDVFPEET-ARFYI----AELVLALDSV 117

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGL------------------VRLFPEDIT--- 426
            KL  IHRDIK  NIL+D +   K+ADFGL                    LF +++    
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177

Query: 427 -------HISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIE 464
                    + +  GT  Y+APE V+RG     + D +S GV++ E
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPE-VLRGTPYGLECDWWSLGVILYE 222

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 59/199 (29%), Positives = 100/199 (50%), Gaps = 18/199 (9%)

Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           +LG G  G VYK      G   A K +   + + ++ +  E+ +++  NH  +VKLLG  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
               +  ++ EF P  ++ D + +  D    EP   +++  I     E L YLH    ++
Sbjct: 79  YWDGKLWIMIEFCPGGAV-DAIMLELDRGLTEP---QIQV-ICRQMLEALQYLHS---MK 130

Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
           IIHRD+K  N+LL  +   K+ADFG+     + +     +  GT  +MAPE V+   + +
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR-RDSFIGTPYWMAPEVVMCETMKD 189

Query: 452 -----KADVYSFGVVVIEV 465
                KAD++S G+ +IE+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 38/220 (17%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHF-FNEVNLISGI---NH 324
           + E  ++G+G  G+VYK   L  G  VA+K++    + + +      E+ L+  +    H
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60

Query: 325 KNLVKLLGCSITGPES------LLVYEFVPNQSLLDNLFVRQDVEP---------LSWEV 369
            N+V+LL     GP +       LV+E V +Q L    ++ +  +P         L  + 
Sbjct: 61  PNIVRLLDVC-HGPRTDRELKLTLVFEHV-DQDL--ATYLSKCPKPGLPPETIKDLMRQ- 115

Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
               +L    G+ +LH     RI+HRD+K  NIL+  +   KIADFGL R++  ++   S
Sbjct: 116 ----LLR---GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTS 165

Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
             +  TL Y APE +++       D++S G +  E+  R+
Sbjct: 166 VVV--TLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRR 203

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 23/205 (11%)

Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           F    ++G G  G VYK   +  GE  A+K +     +       E+ ++    H N+V 
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
             G  +   +  +  EF    SL D   V     PLS      +   T +GL YLH + K
Sbjct: 71  YFGSYLRRDKLWICMEFCGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA------GTLGYMAPEY 443
              +HRDIK +NILL +    K+ADFG+          I+AT+A      GT  +MAPE 
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVS-------AQITATIAKRKSFIGTPYWMAPEV 177

Query: 444 VV---RGKLTEKADVYSFGVVVIEV 465
                +G   +  D+++ G+  IE+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 75.8 bits (186), Expect = 5e-15
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)

Query: 277 LGQGGSGSVYKGTLPGGEA--------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYK 372
           ++ LLG C+  GP  ++V E+    +L + L  R+               E LS++    
Sbjct: 86  IINLLGACTQDGPLYVIV-EYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVS 144

Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A G+ YL  +   + IHRD+   N+L+ E+   KIADFGL R    DI HI    
Sbjct: 145 CAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 197

Query: 433 AGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             T G     +MAPE +     T ++DV+SFGV++ E+
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 75.5 bits (186), Expect = 6e-15
 Identities = 62/203 (30%), Positives = 90/203 (44%), Gaps = 26/203 (12%)

Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGI-NHKNLV 328
           LG+G  G V     KGT    E  AVK L          V+    E  +++    H  L 
Sbjct: 3   LGKGSFGKVLLAELKGT---DELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY--KIILSTAEGLAYLHE 386
           +L  C  T      V E+V    L+ ++  R           Y  +I+L    GL +LHE
Sbjct: 60  QLHSCFQTKDRLFFVMEYVNGGDLMFHI-QRSGRFDEPRARFYAAEIVL----GLQFLHE 114

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPEYV 444
                II+RD+KL N+LLD E   KIADFG+ +  +     T   +T  GT  Y+APE +
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT---STFCGTPDYIAPEIL 168

Query: 445 VRGKLTEKADVYSFGVVVIEVVC 467
                    D ++ GV++ E++ 
Sbjct: 169 SYQPYGPAVDWWALGVLLYEMLA 191

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 74.5 bits (183), Expect = 7e-15
 Identities = 64/208 (30%), Positives = 96/208 (46%), Gaps = 23/208 (11%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVA---VKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKL 330
           +++G G  G V  G    G + A   VK L  + T      F  EV     +NH N+++ 
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNL-----FVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           LG  I     LLV EF P   L + L      V Q  +    +V  ++    A GL +LH
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQK---DVLQRMACEVASGLLWLH 117

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYV 444
              +   IH D+ L N  L  + + KI D+GL +  +PED        A  L ++APE V
Sbjct: 118 ---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELV 174

Query: 445 -VRG------KLTEKADVYSFGVVVIEV 465
            +RG        T+K++++S GV + E+
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 74.8 bits (184), Expect = 7e-15
 Identities = 62/213 (29%), Positives = 104/213 (48%), Gaps = 27/213 (12%)

Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRL-FYNTTQWVDHF-FNEV 316
            YE LEK          +G+G  G+V+K       E VA+KR+   +  + V      E+
Sbjct: 1   KYEKLEK----------IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREI 50

Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL---LDNLFVRQDVEPLSWEVRYKI 373
            L+  + HKN+V+L     +  +  LV+E+  +Q L    D+     D++P   E+    
Sbjct: 51  CLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSC--NGDIDP---EIVKSF 104

Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
           +    +GLA+ H      ++HRD+K  N+L+++    K+ADFGL R F   +   SA + 
Sbjct: 105 MFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV 161

Query: 434 GTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEV 465
            TL Y  P+ +   KL +   D++S G +  E+
Sbjct: 162 -TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAEL 193

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.3 bits (186), Expect = 9e-15
 Identities = 61/211 (28%), Positives = 96/211 (45%), Gaps = 32/211 (15%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH---FFNEVNLISGINHKNLVKLLG 332
           +G G  G V        G  VA+K++  N    +        E+ L+  + H+N++ LL 
Sbjct: 8   IGSGAYGVVCSAVDKRTGRKVAIKKIS-NVFDDLIDAKRILREIKLLRHLRHENIIGLL- 65

Query: 333 CSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLA 382
             I  P S        +V E +  ++ L  +      +PL+ + ++Y +  IL    GL 
Sbjct: 66  -DILRPPSPEDFNDVYIVTELM--ETDLHKVIKSP--QPLTDDHIQYFLYQILR---GLK 117

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG---TLGYM 439
           YLH  +   +IHRD+K SNIL++     KI DFGL R    D       L     T  Y 
Sbjct: 118 YLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF-LTEYVVTRWYR 173

Query: 440 APEYVVRGK-LTEKADVYSFGVVVIEVVCRK 469
           APE ++     T+  D++S G +  E++ RK
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 74.7 bits (183), Expect = 9e-15
 Identities = 71/286 (24%), Positives = 124/286 (43%), Gaps = 40/286 (13%)

Query: 276 KLGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           +LG+G  G V+        P  +   VAVK L   T      F  E  L++ + H+++VK
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEP------LSWEVRYKII 374
             G    G   ++V+E++ +  L  N F+R          D +P      L       I 
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDL--NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLA 433
              A G+ YL  +     +HRD+   N L+      KI DFG+ R ++  D   +     
Sbjct: 130 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 186

Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR 493
             + +M PE ++  K T ++DV+SFGV++ E+    +   F  ++  +++ +     +GR
Sbjct: 187 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI----TQGR 242

Query: 494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + E   P +        P  +  I L C Q   + R ++  + K+L
Sbjct: 243 VLER--PRVC-------PKEVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 58/211 (27%), Positives = 94/211 (44%), Gaps = 26/211 (12%)

Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINH-K 325
           N      ++G G  G VYK      G  +AVK++     +        +++++   +   
Sbjct: 15  NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCP 74

Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
            +VK  G  IT  +  +  E +   + LD L  R    P+  ++  K+ ++  + L YL 
Sbjct: 75  YIVKCYGYFITDSDVFICMELM--STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK 131

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE--- 442
           E  K  +IHRD+K SNILLD     K+ DFG+     +      +  AG   YMAPE   
Sbjct: 132 E--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS--AGCAAYMAPERID 187

Query: 443 -------YVVRGKLTEKADVYSFGVVVIEVV 466
                  Y +R      ADV+S G+ ++E+ 
Sbjct: 188 PPDPNPKYDIR------ADVWSLGISLVELA 212

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 74.7 bits (184), Expect = 1e-14
 Identities = 59/212 (27%), Positives = 88/212 (41%), Gaps = 28/212 (13%)

Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFN----E 315
           YE L            +G+G  G V K      GE VA+K+  +  ++  +        E
Sbjct: 3   YEVLGV----------VGEGAYGVVLKCRNKATGEIVAIKK--FKESEDDEDVKKTALRE 50

Query: 316 VNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP--LSWEVRYKI 373
           V ++  + H+N+V L           LV+E+V  ++LL+ L    +  P  L  +     
Sbjct: 51  VKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE-RTLLELL----EASPGGLPPDAVRSY 105

Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
           I    + +AY H      IIHRDIK  NIL+ E    K+ DFG  R              
Sbjct: 106 IWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV 162

Query: 434 GTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIE 464
            T  Y APE +V      K  DV++ G ++ E
Sbjct: 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAE 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 74.0 bits (182), Expect = 1e-14
 Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 23/205 (11%)

Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           K+G+G  G VYKG     G+ VA+K  RL             E++L+  + H N+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 333 CSITGPESLLVYEFVPN--QSLLDNLFVRQDVEP-LSWEVRYKIILSTAEGLAYLHEESK 389
             +      L++EF+    +  LD+L   Q ++  L     Y+I+    +G+ + H    
Sbjct: 67  VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQIL----QGILFCHSR-- 120

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI---THISATLAGTLGYMAPEYVVR 446
            R++HRD+K  N+L+D +   K+ADFGL R F   +   TH       TL Y APE V+ 
Sbjct: 121 -RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV----TLWYRAPE-VLL 174

Query: 447 G--KLTEKADVYSFGVVVIEVVCRK 469
           G  + +   D++S G +  E+  +K
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 58/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)

Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLI 319
           T+ + TN + +   +G G  G V        G+ VA+K++   ++T       + E+ L+
Sbjct: 4   TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLL 63

Query: 320 SGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIILST 377
             + H+N++ L    I+  E +  V E +     L  L   + +E        Y+I+   
Sbjct: 64  KHLRHENIISLSDIFISPLEDIYFVTELLGTD--LHRLLTSRPLEKQFIQYFLYQIL--- 118

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTL 436
             GL Y+H      ++HRD+K SNIL++E    KI DFGL R+    +T ++S     T 
Sbjct: 119 -RGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS-----TR 169

Query: 437 GYMAPEYVVR-GKLTEKADVYSFGVVVIEVV 466
            Y APE ++   K   + D++S G +  E++
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEML 200

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 55/203 (27%), Positives = 83/203 (40%), Gaps = 28/203 (13%)

Query: 277 LGQGGSGSVYKGTL-PGGEAVAVKRL-----FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           LG GG G V    +       A+K +          Q  +H F+E  ++   NH  +VKL
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQ--EHIFSEKEILEECNHPFIVKL 58

Query: 331 LGCSITGPESLLVY---EFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHE 386
                T  +   +Y   E+     L   L   +D      +  R+  I        YLH 
Sbjct: 59  YR---TFKDKKYIYMLMEYCLGGELWTIL---RDRGLFDEYTARF-YIACVVLAFEYLHN 111

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVV 445
                II+RD+K  N+LLD     K+ DFG  + L     T    T  GT  Y+APE ++
Sbjct: 112 RG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW---TFCGTPEYVAPE-II 164

Query: 446 RGK-LTEKADVYSFGVVVIEVVC 467
             K      D +S G+++ E++ 
Sbjct: 165 LNKGYDFSVDYWSLGILLYELLT 187

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 73.6 bits (180), Expect = 2e-14
 Identities = 66/291 (22%), Positives = 121/291 (41%), Gaps = 44/291 (15%)

Query: 276 KLGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           +LG+G  G V+        P  +   VAVK L   +      F  E  L++ + H+++VK
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR---------QDVEP---LSWEVRYKIILST 377
             G  + G   ++V+E++ +  L  N F+R          +      L+      I    
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDL--NKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL 436
           A G+ YL  +     +HRD+   N L+ E    KI DFG+ R ++  D   +       +
Sbjct: 130 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 186

Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +M PE ++  K T ++DV+S GVV+ E+    +   +  ++  +++ +     +GR+ +
Sbjct: 187 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI----TQGRVLQ 242

Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ 547
                         P  +  + L C Q    +R         +   H +LQ
Sbjct: 243 RPRTC---------PKEVYDLMLGCWQREPHMR-------LNIKEIHSLLQ 277

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 73.4 bits (180), Expect = 2e-14
 Identities = 53/187 (28%), Positives = 93/187 (49%), Gaps = 15/187 (8%)

Query: 296 VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL-- 352
           VAVK L  +  +   + F  E+ ++S +   N+++LL   IT     ++ E++ N  L  
Sbjct: 49  VAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQ 108

Query: 353 ------LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
                       + DV  +S+     +    A G+ YL   S L  +HRD+   N L+ +
Sbjct: 109 FLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGK 165

Query: 407 EFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            +T KIADFG+ R L+  D   I       + +M+ E ++ GK T  +DV++FGV + E+
Sbjct: 166 NYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225

Query: 466 V--CRKR 470
           +  C+++
Sbjct: 226 LTLCKEQ 232

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 73.1 bits (179), Expect = 3e-14
 Identities = 63/201 (31%), Positives = 94/201 (46%), Gaps = 25/201 (12%)

Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           ++G G  G VYK   L  GE  AVK +             E+ ++    H N+V   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLRII 393
           ++  +  +  E+    SL D   V     PLS  ++ Y +   T +GLAYLH + K+   
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHV---TGPLSELQIAY-VCRETLQGLAYLHSKGKM--- 128

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA------GTLGYMAPEYVV-- 445
           HRDIK +NILL +    K+ADFG+          I+AT+A      GT  +MAPE     
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVA-------AKITATIAKRKSFIGTPYWMAPEVAAVE 181

Query: 446 -RGKLTEKADVYSFGVVVIEV 465
             G   +  D+++ G+  IE+
Sbjct: 182 KNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 57/195 (29%), Positives = 95/195 (48%), Gaps = 14/195 (7%)

Query: 276 KLGQGGSGSVYKGTLPGGEA-VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           ++G+G  G V+ G L      VAVK             F  E  ++   +H N+V+L+G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
                   +V E V     L   F+R +   L  +   +++ + A G+ YL  ESK   I
Sbjct: 62  CTQKQPIYIVMELVQGGDFLT--FLRTEGPRLKVKELIQMVENAAAGMEYL--ESK-HCI 116

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT----LGYMAPEYVVRGKL 449
           HRD+   N L+ E+   KI+DFG+ R   E+   + A+  G     + + APE +  G+ 
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRY 173

Query: 450 TEKADVYSFGVVVIE 464
           + ++DV+SFG+++ E
Sbjct: 174 SSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 73.7 bits (181), Expect = 3e-14
 Identities = 67/202 (33%), Positives = 101/202 (50%), Gaps = 21/202 (10%)

Query: 277 LGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVDH---FFNEVNLISGI-NHKN 326
           LG G  G V + T  G         VAVK L    T          +E+ ++S + NH+N
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKML--KPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIILSTAEGLAYL 384
           +V LLG C+I GP  L++ E+     LL+  F+R+  E  L+ E         A+G+A+L
Sbjct: 101 IVNLLGACTIGGP-ILVITEYCCYGDLLN--FLRRKRESFLTLEDLLSFSYQVAKGMAFL 157

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEY 443
              SK   IHRD+   N+LL      KI DFGL R    D  ++    A   + +MAPE 
Sbjct: 158 --ASK-NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPES 214

Query: 444 VVRGKLTEKADVYSFGVVVIEV 465
           +     T ++DV+S+G+++ E+
Sbjct: 215 IFNCVYTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 48/128 (37%), Positives = 69/128 (53%), Gaps = 10/128 (7%)

Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
           L+ ++V    L  +L+ R+       EVR  I    AE +  L    +L II+RDIKL N
Sbjct: 82  LILDYVNGGELFTHLYQREHFT--ESEVRVYI----AEIVLALDHLHQLGIIYRDIKLEN 135

Query: 402 ILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT--EKA-DVYSF 458
           ILLD E    + DFGL + F  +    + +  GT+ YMAPE V+RG     +KA D +S 
Sbjct: 136 ILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPE-VIRGGSGGHDKAVDWWSL 194

Query: 459 GVVVIEVV 466
           GV+  E++
Sbjct: 195 GVLTFELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 59/214 (27%), Positives = 103/214 (48%), Gaps = 30/214 (14%)

Query: 276 KLGQGGSGSVYKG----TLPG--GEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
           +LG+   G VYKG    T PG   +AVA+K L       + + F +E  + S + H N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---DV-------------EPLSWEVRYK 372
            LLG         +++ +  +  L + L +R    DV             EP  +     
Sbjct: 72  CLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADF---VH 128

Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISAT 431
           I+   A G+ +L   S   ++H+D+   N+L+ ++   KI+D GL R ++  D   +   
Sbjct: 129 IVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGN 185

Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
               + +M+PE ++ GK +  +D++S+GVV+ EV
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.7 bits (178), Expect = 4e-14
 Identities = 59/188 (31%), Positives = 96/188 (51%), Gaps = 23/188 (12%)

Query: 296 VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
           VAVK L  + T+  +    +E+ ++  I  HKN++ LLG C+  GP  ++V E+    +L
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNL 108

Query: 353 LDNLFVRQ--------DV-----EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399
            + L  R+        D+     E ++++         A G+ YL  +   + IHRD+  
Sbjct: 109 REYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAA 165

Query: 400 SNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRGKLTEKADVYS 457
            N+L+ E    KIADFGL R    +I +   T  G L   +MAPE +     T ++DV+S
Sbjct: 166 RNVLVTENNVMKIADFGLARDV-NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS 224

Query: 458 FGVVVIEV 465
           FGV++ E+
Sbjct: 225 FGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 74.5 bits (183), Expect = 5e-14
 Identities = 60/193 (31%), Positives = 92/193 (47%), Gaps = 29/193 (15%)

Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYM 439
           LA  H  SK  +IHRDIK +NILL      K+ DFG  +++   ++  +  T  GT  Y+
Sbjct: 154 LAVHHVHSK-HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD 499
           APE   R   ++KAD++S GV++ E++  KR   F   +               + E + 
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRP--FDGEN---------------MEEVMH 255

Query: 500 PALAGNFQEGKPS---RLLQIGLLCVQASAELRPSMSIVVKM------LTGNHEILQPTQ 550
             LAG +    PS    + +I    + +  + RPS S ++ M      ++G  EI+Q TQ
Sbjct: 256 KTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLEIVQ-TQ 314

Query: 551 PPFLNPNGSEISS 563
           P F  P    IS 
Sbjct: 315 PGFSGPLRDTISR 327

Length = 496

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.1 bits (180), Expect = 6e-14
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 28/221 (12%)

Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDH---FFNEVN 317
           +T+ +  + +   + +G G  G V        G  VA+K+L     Q   H    + E+ 
Sbjct: 8   KTVWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKL-SRPFQSAIHAKRTYRELR 66

Query: 318 LISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-V 369
           L+  ++H+N++ LL    T   SL       LV   +   + L+N+   Q    LS + +
Sbjct: 67  LLKHMDHENVIGLLDV-FTPASSLEDFQDVYLVTHLM--GADLNNIVKCQ---KLSDDHI 120

Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
           ++ ++     GL Y+H      IIHRD+K SNI ++E+   KI DFGL R   +++T   
Sbjct: 121 QF-LVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMT--- 173

Query: 430 ATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRK 469
                T  Y APE ++      +  D++S G ++ E++  K
Sbjct: 174 -GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 71.7 bits (176), Expect = 7e-14
 Identities = 39/113 (34%), Positives = 53/113 (46%), Gaps = 38/113 (33%)

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
           KI +S  + L YLH   KL +IHRD+K SN+L++     K+ DFG           IS  
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFG-----------ISGY 153

Query: 432 L---------AGTLGYMAPE----------YVVRGKLTEKADVYSFGVVVIEV 465
           L         AG   YMAPE          Y V+      +DV+S G+ +IE+
Sbjct: 154 LVDSVAKTIDAGCKPYMAPERINPELNQKGYDVK------SDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (175), Expect = 8e-14
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 24/207 (11%)

Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKL 330
           LG+G  G VY       G  +AVK++ ++     T++ V+    E+ L+  + H  +V+ 
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 331 LGCSITGPE----SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
            GC +  PE    S+ V E++P  S+ D L   +    L+  V  +      +G++YLH 
Sbjct: 70  YGC-LRDPEEKKLSIFV-EYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLHS 124

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT----LAGTLGYMAPE 442
                I+HRDIK +NIL D     K+ DFG  +        +S T    + GT  +M+PE
Sbjct: 125 N---MIVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICMSGTGIKSVTGTPYWMSPE 179

Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRK 469
            +       KADV+S    V+E++  K
Sbjct: 180 VISGEGYGRKADVWSVACTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 59/210 (28%), Positives = 106/210 (50%), Gaps = 31/210 (14%)

Query: 275 NKLGQGGSGSVYKG----TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGINHKN 326
           N++ +G  G VY+     T   GE VA+K+L     +  + F      E+N++  + H N
Sbjct: 11  NRIEEGTYGVVYRARDKKT---GEIVALKKLKMEKEK--EGFPITSLREINILLKLQHPN 65

Query: 327 LVKL----LGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +V +    +G ++   +  +V E+V +  +SL++ +      +P        ++L    G
Sbjct: 66  IVTVKEVVVGSNLD--KIYMVMEYVEHDLKSLMETM-----KQPFLQSEVKCLMLQLLSG 118

Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
           +A+LH+     I+HRD+K SN+LL+     KI DFGL R +   +   +  L  TL Y A
Sbjct: 119 VAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYT-QLVVTLWYRA 174

Query: 441 PEYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
           PE ++  K  +   D++S G +  E++ +K
Sbjct: 175 PELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 70.7 bits (173), Expect = 1e-13
 Identities = 56/196 (28%), Positives = 98/196 (50%), Gaps = 14/196 (7%)

Query: 276 KLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +LG G  G V KG     +    VA+K L     + V D    E  ++  +++  +V+++
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 332 GCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
           G  +   E+L LV E      L   L  ++D   +S  V  +++   + G+ YL  ++  
Sbjct: 62  G--VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVV--ELMHQVSMGMKYLEGKN-- 115

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVRGK 448
             +HRD+   N+LL  +  AKI+DFGL +    D ++  A  AG   L + APE +   K
Sbjct: 116 -FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRK 174

Query: 449 LTEKADVYSFGVVVIE 464
            + ++DV+S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 52/179 (29%), Positives = 93/179 (51%), Gaps = 10/179 (5%)

Query: 293 GEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESL-LVYEFVPN 349
           GE VAVK L   +    +     E+ ++  + H+N+VK  G C+  G   + L+ EF+P+
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409
            SL + L   ++   L  +++Y +     +G+ YL      + +HRD+   N+L++ E  
Sbjct: 93  GSLKEYLPRNKNKINLKQQLKYAV--QICKGMDYLGSR---QYVHRDLAARNVLVESEHQ 147

Query: 410 AKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            KI DFGL +    D  +  +   L   + + APE +++ K    +DV+SFGV + E++
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.9 bits (174), Expect = 2e-13
 Identities = 59/185 (31%), Positives = 81/185 (43%), Gaps = 46/185 (24%)

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
           KI ++T + L YL EE  L+IIHRD+K SNILLD     K+ DFG           IS  
Sbjct: 111 KIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFG-----------ISGQ 157

Query: 432 L---------AGTLGYMAPEYV---VRGKLTEKADVYSFGVVVIEVVC-----RKRINLF 474
           L         AG   YMAPE +    R     ++DV+S G+ + EV        K  ++F
Sbjct: 158 LVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVF 217

Query: 475 TQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS-RLLQIGLLCVQASAELRPSMS 533
            Q     L  V    VKG      DP +  N +E + S   +    LC+      RP   
Sbjct: 218 DQ-----LTQV----VKG------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYK 262

Query: 534 IVVKM 538
            +++ 
Sbjct: 263 ELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 71.3 bits (175), Expect = 2e-13
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 23/210 (10%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           LG G +G V+        + VAVK++     Q V H   E+ +I  ++H N+VK+    +
Sbjct: 13  LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVY--EV 70

Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-----------EPLSWEVRYKIILSTAEGLAYL 384
            GP    + E V + + L+++++ Q+             PLS E     +     GL Y+
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYI 130

Query: 385 HEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITH---ISATLAGTLGYMA 440
           H  +   ++HRD+K +N+ ++ E+   KI DFGL R+     +H   +S  L  T  Y +
Sbjct: 131 HSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLV-TKWYRS 186

Query: 441 PEYVVR-GKLTEKADVYSFGVVVIEVVCRK 469
           P  ++     T+  D+++ G +  E++  K
Sbjct: 187 PRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 60/197 (30%), Positives = 99/197 (50%), Gaps = 14/197 (7%)

Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           +LG G  G VYK      G   A K +   + + ++ +  E+++++  +H N+VKLL   
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEESKLRII 393
                  ++ EF    ++ D + +  +  PL+ E + +++   T E L YLHE    +II
Sbjct: 72  YYENNLWILIEFCAGGAV-DAVMLELE-RPLT-EPQIRVVCKQTLEALNYLHEN---KII 125

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE-- 451
           HRD+K  NIL   +   K+ADFG+       I     +  GT  +MAPE V+     +  
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 452 ---KADVYSFGVVVIEV 465
              KADV+S G+ +IE+
Sbjct: 185 YDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 59/197 (29%), Positives = 98/197 (49%), Gaps = 16/197 (8%)

Query: 276 KLGQGGSGSVYKG---TLPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG G  G+V KG        + VAVK L    N     D    E N++  +++  +V++
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 331 LGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           +G  I   ES +LV E      L  N F++++       +  +++   + G+ YL E + 
Sbjct: 62  IG--ICEAESWMLVMELAELGPL--NKFLQKNKHVTEKNIT-ELVHQVSMGMKYLEETN- 115

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVRG 447
              +HRD+   N+LL  +  AKI+DFGL +    D  +  A   G   + + APE +   
Sbjct: 116 --FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 448 KLTEKADVYSFGVVVIE 464
           K + K+DV+SFGV++ E
Sbjct: 174 KFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 70.4 bits (172), Expect = 2e-13
 Identities = 63/226 (27%), Positives = 108/226 (47%), Gaps = 13/226 (5%)

Query: 267 ATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF-FNEVNLISGINH 324
           AT+Y +   KLG+G   +VYKG +   G+ VA+K +   T + V      E +L+ G+ H
Sbjct: 4   ATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 325 KNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
            N+V LL   I   E+L  V+E++   + L    ++       + VR   +     GLAY
Sbjct: 63  ANIV-LLHDIIHTKETLTFVFEYM--HTDLAQYMIQHPGGLHPYNVRL-FMFQLLRGLAY 118

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           +H +    I+HRD+K  N+L+      K+ADFGL R         S+ +  TL Y  P+ 
Sbjct: 119 IHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV-TLWYRPPDV 174

Query: 444 VVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL 488
           ++     +   D++  G + IE++  +       +    L+ +W +
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTV 220

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|216632 pfam01657, Stress-antifung, Salt stress response/antifungal

 Score = 65.9 bits (161), Expect = 3e-13
 Identities = 31/95 (32%), Positives = 48/95 (50%), Gaps = 1/95 (1%)

Query: 98  FGGNNTVFGANAIELVRNLSVQAVKNDGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACEN 157
           +   N+ F +N   L+ +LS  A  + G    + T      +V+GLAQC   ++ S C +
Sbjct: 12  YTTANSTFESNLNALLSSLSSNAASSSGKGFAAGTSGAAPDTVYGLAQCRGDLSASDCRS 71

Query: 158 CLENAVSRIAS-CTQKEEGRVLNAGCYLRYSTQRF 191
           CL  AVS +   C  K+ GR+    C+LRY +  F
Sbjct: 72  CLATAVSELRRCCPNKKGGRIWYDSCFLRYESYPF 106

This domain is often found in association with the kinase domains pfam00069 or pfam07714. In many proteins it is duplicated. It contains six conserved cysteines which are involved in disulphide bridges. It has a role in salt stress response and has antifungal activity. Length = 106

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.4 bits (172), Expect = 3e-13
 Identities = 62/216 (28%), Positives = 104/216 (48%), Gaps = 23/216 (10%)

Query: 276 KLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGIN---HKNLV 328
           ++G+G  G V+K      GG  VA+KR+   T +         EV ++  +    H N+V
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 329 KLLG-CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIILSTAEGLA 382
           +L   C+++  +      LV+E V +Q L    ++ +  EP +  E    ++     GL 
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDL--TTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           +LH     R++HRD+K  NIL+      K+ADFGL R++         ++  TL Y APE
Sbjct: 125 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPE 179

Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
            +++       D++S G +  E+  RK   LF  +S
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFRRK--PLFRGSS 213

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 61/202 (30%), Positives = 107/202 (52%), Gaps = 14/202 (6%)

Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
           F +  KLG+G   +VYKG     GE VA+K +  +  +        E++L+  + H+N+V
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +L     T  + +LV+E++    +  +D   VR  ++P +  V+        +G+A+ HE
Sbjct: 62  RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNT--VKS-FTYQLLKGIAFCHE 118

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
               R++HRD+K  N+L+++    K+ADFGL R F   +   S  +  TL Y AP+ V+ 
Sbjct: 119 N---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPD-VLL 173

Query: 447 GKLTEKA--DVYSFGVVVIEVV 466
           G  T     D++S G ++ E++
Sbjct: 174 GSRTYSTSIDIWSVGCIMAEMI 195

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 69.9 bits (171), Expect = 3e-13
 Identities = 53/192 (27%), Positives = 89/192 (46%), Gaps = 17/192 (8%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCS 334
           LG G  G+VYK   L     +AVK +  + T  +     +E+ ++   +   ++   G  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
                  +  EF+   SL        DV   +   V  +I ++  +GL YL     L+I+
Sbjct: 69  FVENRISICTEFMDGGSL--------DVYRKIPEHVLGRIAVAVVKGLTYLW---SLKIL 117

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRD+K SN+L++     K+ DFG+       +  I+ T  GT  YMAPE +   +    +
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 454 DVYSFGVVVIEV 465
           DV+S G+  +E+
Sbjct: 175 DVWSLGISFMEL 186

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.7 bits (170), Expect = 4e-13
 Identities = 66/286 (23%), Positives = 124/286 (43%), Gaps = 36/286 (12%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD-----HFFNEVNLISGINH 324
           F    K+G+G    VY+ T L   + VA+K++     + +D         E++L+  +NH
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKV--QIFEMMDAKARQDCVKEIDLLKQLNH 61

Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAY 383
            N++K L   I   E  +V E      L   + + ++    +     +K  +     + +
Sbjct: 62  PNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           +H     R++HRDIK +N+ +      K+ D GL R F    T  + +L GT  YM+PE 
Sbjct: 122 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPER 177

Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRK------RINLFTQNSCSILQTVWDLYVKGRLHEA 497
           +       K+D++S G ++ E+   +      ++NLF     S+ Q         ++ + 
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLF-----SLCQ---------KIEQC 223

Query: 498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH 543
             P L     E    +L ++  +C+    + RP +  V ++    H
Sbjct: 224 DYPPLPT---EHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 69.2 bits (169), Expect = 5e-13
 Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 19/208 (9%)

Query: 277 LGQGGSGSVYKGTLP----GGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
           LG+G  GSV +  L       + VAVK L     ++  ++ F  E   +   +H N++KL
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 331 LGCSITG------PESLLVYEFVPNQSLLDNLFV-RQDVEP--LSWEVRYKIILSTAEGL 381
           +G S+        P  +++  F+ +  L   L + R   EP  L  +   + ++  A G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMA 440
            YL   S    IHRD+   N +L+E  T  +ADFGL + ++  D           + ++A
Sbjct: 127 EYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCR 468
            E +     T  +DV++FGV + E++ R
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 64/218 (29%), Positives = 99/218 (45%), Gaps = 56/218 (25%)

Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y      G+ VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 24  IGSGAQGIVCAAYDTVT--GQNVAIKKLSRPFQNVTH-AKRAYRELVLMKLVNHKNIIGL 80

Query: 331 LGCSITGPESLLVYEFVPNQSLLD-------------NLF-VRQ---DVEPLSWEVRYKI 373
           L              F P +SL +             NL  V Q   D E +S+ + Y++
Sbjct: 81  LNV------------FTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLL-YQM 127

Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
           +     G+ +LH      IIHRD+K SNI++  + T KI DFGL R      T  ++ + 
Sbjct: 128 LC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR------TAGTSFMM 174

Query: 434 G----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
                T  Y APE ++     E  D++S G ++ E++ 
Sbjct: 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIR 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 69.7 bits (170), Expect = 7e-13
 Identities = 66/215 (30%), Positives = 103/215 (47%), Gaps = 31/215 (14%)

Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTT-QWVDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T + +    +E+ ++  I  HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
           ++ LLG C+  GP  +LV E+    +L + L  R+               E L+++    
Sbjct: 80  IINLLGACTQDGPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVS 138

Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A G+ YL  +   + IHRD+   N+L+ E+   KIADFGL R    +I +   T 
Sbjct: 139 CAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTT 194

Query: 433 AGTL--GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            G L   +MAPE +     T ++DV+SFGV++ E+
Sbjct: 195 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 31/212 (14%)

Query: 277 LGQGGSGSVYKGTLPGGEA---VAVKRLFYNTTQWVDH--FFNEVNLISGIN-HKNLVKL 330
           +G+G  G V K  +         A+KR+    ++  DH  F  E+ ++  +  H N++ L
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINL 73

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQ----DVEP-----------LSWEVRYKIIL 375
           LG         L  E+ P+ +LLD  F+R+    + +P           LS +       
Sbjct: 74  LGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131

Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG- 434
             A G+ YL   S+ + IHRD+   NIL+ E + AKIADFGL R       ++  T+   
Sbjct: 132 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 185

Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            + +MA E +     T  +DV+S+GV++ E+V
Sbjct: 186 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 69.8 bits (171), Expect = 9e-13
 Identities = 70/227 (30%), Positives = 110/227 (48%), Gaps = 29/227 (12%)

Query: 277 LGQGGSGSVYKGTLP-GGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           +G G  G V+  T P  G+ VA+K++   F N        F E+ ++    H N++  L 
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS-CKRVFRELKMLCFFKHDNVLSAL- 65

Query: 333 CSITGPESLLVYE--FVPN---QSLLDNLFVRQDVEPLSWE-VR---YKIILSTAEGLAY 383
             I  P  +  +E  +V     QS L  + V    +PLS + V+   Y+I+     GL Y
Sbjct: 66  -DILQPPHIDPFEEIYVVTELMQSDLHKIIVSP--QPLSSDHVKVFLYQIL----RGLKY 118

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPE 442
           LH      I+HRDIK  N+L++     KI DFGL R+  P++  H++  +  T  Y APE
Sbjct: 119 LHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPE 174

Query: 443 YVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL 488
            ++  +  T   D++S G +  E++ R RI    Q+    L  + DL
Sbjct: 175 ILMGSRHYTSAVDIWSVGCIFAELLGR-RILFQAQSPIQQLDLITDL 220

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 71/289 (24%), Positives = 126/289 (43%), Gaps = 42/289 (14%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHK 325
           F    K+G+G    VY+ T L  G  VA+K++      +     D    E++L+  +NH 
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHP 62

Query: 326 NLVKLLGCSITGPESLLVYEFVP--NQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEG 380
           N++K     I   E  +V E     + S +   F +Q     E   W  +Y + L +A  
Sbjct: 63  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVW--KYFVQLCSA-- 118

Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
           L ++H     R++HRDIK +N+ +      K+ D GL R F    T  + +L GT  YM+
Sbjct: 119 LEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMS 174

Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRK------RINLFTQNSCSILQTVWDLYVKGRL 494
           PE +       K+D++S G ++ E+   +      ++NL++   C             ++
Sbjct: 175 PERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL--CK------------KI 220

Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH 543
            +   P L  +    +  +L+    +C+    E RP ++ V  +    H
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVN---MCINPDPEKRPDITYVYDVAKRMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 18/207 (8%)

Query: 277 LGQGGSGSVYKGTLPGGEA---VAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           LG+G  GSV +G L   ++   VAVK  ++   T   ++ F +E   +   +H N+++L+
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 332 GCSITG------PESLLVYEFVPNQSLLDNL-FVRQDVEP--LSWEVRYKIILSTAEGLA 382
           G  +        P  +++  F+ +  L   L + R    P  L  ++  K +   A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV-RLFPEDITHISATLAGTLGYMAP 441
           YL   S    IHRD+   N +L+E     +ADFGL  +++  D           + ++A 
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCR 468
           E +     T K+DV+SFGV + E+  R
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATR 210

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 35/91 (38%), Positives = 53/91 (58%), Gaps = 8/91 (8%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
           A GL +LH +    II+RD+KL N++LD E   KIADFG+ +  +F    T    T  GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR---TFCGT 164

Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
             Y+APE +      +  D ++FGV++ E++
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 69.3 bits (169), Expect = 1e-12
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 28/209 (13%)

Query: 271 FHESNKLGQGGSG---SVYKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINH 324
           + +   +G G  G   + +   L  G  VAVK+L   F N T      + E+ L+  +NH
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTH-AKRAYRELVLLKCVNH 79

Query: 325 KNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
           KN++ LL    T  +SL       LV E + + +L   + +  D E +S+ + Y+++   
Sbjct: 80  KNIISLLNV-FTPQKSLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-LLYQMLC-- 134

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
             G+ +LH      IIHRD+K SNI++  + T KI DFGL R    +       +  T  
Sbjct: 135 --GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVV--TRY 187

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           Y APE ++     E  D++S G ++ E+V
Sbjct: 188 YRAPEVILGMGYKENVDIWSVGCIMGELV 216

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 67/265 (25%), Positives = 115/265 (43%), Gaps = 53/265 (20%)

Query: 269 NYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGIN 323
           + + +  K+GQG  G V+K       + VA+K++     +  + F      E+ ++  + 
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKILQLLK 69

Query: 324 HKNLVKLLG-CSITG-------PESLLVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKI 373
           H+N+V L+  C               LV+EF  +    LL N  V+  +     E++ K+
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS----EIK-KV 124

Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP---EDITHISA 430
           +     GL Y+H     +I+HRD+K +NIL+ ++   K+ADFGL R F        +   
Sbjct: 125 MKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181

Query: 431 TLAGTLGYMAPEYVVRGKLTEK-----ADVYSFGVVVIEVVCR----------KRINLFT 475
               TL Y  PE +    L E+      D++  G ++ E+  R           ++ L +
Sbjct: 182 NRVVTLWYRPPELL----LGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLIS 237

Query: 476 QNSCSILQTVW------DLYVKGRL 494
           Q   SI   VW      +L+ K  L
Sbjct: 238 QLCGSITPEVWPGVDKLELFKKMEL 262

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 68.4 bits (168), Expect = 2e-12
 Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 55/232 (23%)

Query: 275 NKLGQGGSGSVYKG----TLPGGEAVAVKRLFYNTTQWVDHF---------FNEVNLISG 321
            KLG+G  G V+K     T    E VA+K++F       D F         F E+  +  
Sbjct: 13  QKLGKGAYGIVWKAIDRRT---KEVVALKKIF-------DAFRNATDAQRTFREIMFLQE 62

Query: 322 I-NHKNLVKLLGC--SITGPESLLVYEF-------VPNQSLLDNLFVRQDVEPLSWEVRY 371
           + +H N+VKLL    +    +  LV+E+       V   ++L      +DV       RY
Sbjct: 63  LGDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANIL------EDVH-----KRY 111

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISA 430
            I+    + L Y+H      +IHRD+K SNILL+ +   K+ADFGL R   E +    + 
Sbjct: 112 -IMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENP 167

Query: 431 TLA---GTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRKRINLFTQNS 478
            L     T  Y APE ++      K  D++S G ++ E++  K   LF   S
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK--PLFPGTS 217

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 68.3 bits (167), Expect = 2e-12
 Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 28/225 (12%)

Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHF----FNEVNLI 319
           ++  + F    ++G+G  G VYK      GE VA+K++  +  +  + F      E+ ++
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60

Query: 320 SGINHKNLVKLLGCSITGPESL----------LVYEFVPNQ--SLLDNLFVRQDVEPLSW 367
             +NH+N+V L        ++L          LV+E++ +    LL++  V       S 
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH-----FSE 115

Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
           +     +    EGL Y H   K   +HRDIK SNILL+ +   K+ADFGL RL+  + + 
Sbjct: 116 DHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172

Query: 428 ISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRKRI 471
                  TL Y  PE ++   +     DV+S G ++ E+  +K I
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 68.4 bits (167), Expect = 2e-12
 Identities = 55/205 (26%), Positives = 94/205 (45%), Gaps = 27/205 (13%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +G G  GSV        GE VA+K+L   + +  +    + E+ L+  + H+N++ LL  
Sbjct: 23  VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVE-----PLSWEVRYKIILSTAEGLAYLHEES 388
             +        +F      L   +++ D++     PLS +    ++     GL Y+H   
Sbjct: 83  FTSAVSGDEFQDF-----YLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG 137

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG---TLGYMAPEYVV 445
              IIHRD+K  N+ ++E+   KI DFGL R       H  A + G   T  Y APE ++
Sbjct: 138 ---IIHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVIL 187

Query: 446 RG-KLTEKADVYSFGVVVIEVVCRK 469
                 +  D++S G ++ E++  K
Sbjct: 188 NWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 36/89 (40%), Positives = 57/89 (64%), Gaps = 8/89 (8%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT--HISATLAGTLG 437
           GL +LH++    II+RD+KL N+LLD++   KIADFG+ +   E++     ++T  GT  
Sbjct: 108 GLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCK---ENMNGEGKASTFCGTPD 161

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           Y+APE +   K  E  D +SFGV++ E++
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 67.3 bits (164), Expect = 3e-12
 Identities = 70/217 (32%), Positives = 103/217 (47%), Gaps = 26/217 (11%)

Query: 276 KLGQGGSGSVYKGTLP-GGEAVAVK--RLFYNTTQWVDHFFNEVNLISGI---NHKNLVK 329
           ++G G  G+VYK   P  G  VA+K  R+  N          EV L+  +   +H N+V+
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 330 LL---GCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEP--LSWEVRYKIILSTAEGLA 382
           L+     S T  E+   LV+E V +Q L   L     V P  L  E    ++     GL 
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYL---DKVPPPGLPAETIKDLMRQFLRGLD 122

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTLGYMAP 441
           +LH      I+HRD+K  NIL+      K+ADFGL R++      ++ T +  TL Y AP
Sbjct: 123 FLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAP 176

Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
           E +++       D++S G +  E+  RK   LF  NS
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRK--PLFCGNS 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 67.7 bits (165), Expect = 3e-12
 Identities = 46/130 (35%), Positives = 74/130 (56%), Gaps = 15/130 (11%)

Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRY---KIILSTAEGLAYLHEESKLRIIHRDIK 398
           L+ ++V    +  +L+ R +      EVR+   +IIL+    L +LH   KL I++RDIK
Sbjct: 82  LILDYVSGGEMFTHLYQRDNFS--EDEVRFYSGEIILA----LEHLH---KLGIVYRDIK 132

Query: 399 LSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL--TEKADVY 456
           L NILLD E    + DFGL + F  +    + +  GT+ YMAPE ++RGK    +  D +
Sbjct: 133 LENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-IIRGKGGHGKAVDWW 191

Query: 457 SFGVVVIEVV 466
           S G+++ E++
Sbjct: 192 SLGILIFELL 201

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 66.8 bits (164), Expect = 3e-12
 Identities = 44/149 (29%), Positives = 71/149 (47%), Gaps = 14/149 (9%)

Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW-EVRYKIILSTAEGL 381
           ++ N +KL     T    +L+ +++ +  L D   ++++   LS  EV+ KII    E L
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFD--LLKKE-GKLSEAEVK-KIIRQLVEAL 122

Query: 382 AYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
             LH   K  IIH DIKL N+L D  +    + D+GL +     I    +   GTL Y +
Sbjct: 123 NDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFS 174

Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           PE +         D ++ GV+  E++  K
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203

Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 47/200 (23%), Positives = 91/200 (45%), Gaps = 39/200 (19%)

Query: 293 GEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
           G+ VA+K++   ++          E+ ++    H N++ +    I            P  
Sbjct: 30  GKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIR--DI----------LRPPG 77

Query: 351 SLLDNLFVRQDV------------EPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHR 395
           +   +++V  D+            +PL+ E +RY +  +L    GL Y+H  +   +IHR
Sbjct: 78  ADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLL---RGLKYIHSAN---VIHR 131

Query: 396 DIKLSNILLDEEFTAKIADFGLVRL---FPEDITHISATLAGTLGYMAPEYV-VRGKLTE 451
           D+K SN+L++E+   +I DFG+ R     P +  +       T  Y APE +    + T 
Sbjct: 132 DLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTT 191

Query: 452 KADVYSFGVVVIEVVCRKRI 471
             D++S G +  E++ R+++
Sbjct: 192 AIDMWSVGCIFAEMLGRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 66.0 bits (161), Expect = 6e-12
 Identities = 32/98 (32%), Positives = 49/98 (50%), Gaps = 8/98 (8%)

Query: 372 KIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
           + I   A+   GL +LH+    RI++RD+K  N+LLD+    +I+D GL          I
Sbjct: 96  RAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKI 151

Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
               AGT GYMAPE +         D ++ G  + E++
Sbjct: 152 KGR-AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMI 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 66.2 bits (161), Expect = 6e-12
 Identities = 58/209 (27%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 277 LGQGGSGSVYKGTLP--GGEAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKLL 331
           +G+G  G V +  +   G +  A  ++        DH  F  E+ ++  + +H N++ LL
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69

Query: 332 GCSITGPESLLVYEFVPNQSLLDNL-----------FVRQ--DVEPLSWEVRYKIILSTA 378
           G         +  E+ P  +LLD L           F ++      L+ +   +     A
Sbjct: 70  GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVA 129

Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLG 437
            G+ YL E+   + IHRD+   N+L+ E   +KIADFGL R   E++ ++  T+    + 
Sbjct: 130 TGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEV-YVKKTMGRLPVR 183

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +MA E +     T K+DV+SFGV++ E+V
Sbjct: 184 WMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 65.9 bits (160), Expect = 7e-12
 Identities = 59/209 (28%), Positives = 96/209 (45%), Gaps = 25/209 (11%)

Query: 277 LGQGGSGSVYKGTLP--GGEAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKLL 331
           +G+G  G V K  +   G    A  +         DH  F  E+ ++  + +H N++ LL
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 332 GCSITGPESLLVYEFVPNQSLLDNL-----------FVRQ--DVEPLSWEVRYKIILSTA 378
           G         L  E+ P+ +LLD L           F         LS +         A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLG 437
            G+ YL ++   + IHRD+   NIL+ E + AKIADFGL R   +++ ++  T+    + 
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEV-YVKKTMGRLPVR 176

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +MA E +     T  +DV+S+GV++ E+V
Sbjct: 177 WMAIESLNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 21/209 (10%)

Query: 271 FHESNKLGQGGSGSVY--KGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKN 326
           +    K+G+G  G +Y  K        V +K +       +  +    EV L++ + H N
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCV-IKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-----EPLSWEVRYKIILSTAEGL 381
           +V             +V E+     L+  +  ++ V     + LSW V+  +      GL
Sbjct: 61  IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISL------GL 114

Query: 382 AYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
            ++H+    +I+HRDIK  NI L +    AK+ DFG+ R    D   ++ T  GT  Y++
Sbjct: 115 KHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLS 170

Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           PE         K D++S G V+ E+   K
Sbjct: 171 PEICQNRPYNNKTDIWSLGCVLYELCTLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 43/108 (39%), Positives = 62/108 (57%), Gaps = 7/108 (6%)

Query: 365 LSWEVRYK---IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
           LS   R+K   + + + E +  L    KL II+RDIKL NILLD      + DFGL + F
Sbjct: 96  LSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155

Query: 422 PEDITHISATLAGTLGYMAPEYVVRGKLT--EKA-DVYSFGVVVIEVV 466
            ED    + +  GT+ YMAP+ +VRG     +KA D +S GV++ E++
Sbjct: 156 HEDEVERAYSFCGTIEYMAPD-IVRGGDGGHDKAVDWWSMGVLMYELL 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 29/214 (13%)

Query: 261 YETLEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNT--TQWVDHF-FNEV 316
           YE L            +G+G  G V K      G+ VA+K+ F  +   + V      E+
Sbjct: 3   YENLGL----------VGEGSYGMVMKCKHKETGQIVAIKK-FLESEDDKMVKKIAMREI 51

Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
            ++  + H+NLV L+          LV+EFV + ++LD+L   +    L      K +  
Sbjct: 52  RMLKQLRHENLVNLIEVFRRKKRLYLVFEFV-DHTVLDDL--EKYPNGLDESRVRKYLFQ 108

Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP---EDITHISATLA 433
              G+ + H  +   IIHRDIK  NIL+ +    K+ DFG  R      E  T   A   
Sbjct: 109 ILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVA--- 162

Query: 434 GTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
            T  Y APE +V      +A D+++ G +V E++
Sbjct: 163 -TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEML 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 65.3 bits (159), Expect = 1e-11
 Identities = 65/205 (31%), Positives = 94/205 (45%), Gaps = 19/205 (9%)

Query: 276 KLGQGGSGSVYKGTLPGG---EAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
           ++G G  G V  G +  G     V VK L  + + Q    F  E      + H NL++ L
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 332 G-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR--YKIILSTAEGLAYLHEES 388
           G C+   P  LLV EF P   L   L   +  E ++ +     ++    A GL +LH   
Sbjct: 62  GQCTEVTP-YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLH--- 117

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL-FPEDITHISATLAGTLGYMAPEYV--V 445
           K   IH D+ L N LL  + T KI D+GL    + ED       L   L ++APE V  V
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 446 RGKL-----TEKADVYSFGVVVIEV 465
            G L     T++++V+S GV + E+
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 5/93 (5%)

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
           KI ++   GL YL E  K +I+HRD+K SNIL++     K+ DFG+     + I  ++ +
Sbjct: 103 KISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 157

Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
             GT  YM+PE +     T ++D++S G+ ++E
Sbjct: 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVE 190

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 66.2 bits (161), Expect = 1e-11
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 42/213 (19%)

Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 88

Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 141

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-------LFPEDITHISATLAGTL 436
           LH      IIHRD+K SNI++  + T KI DFGL R       + P  +T          
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY-------- 190

Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
            Y APE ++     E  D++S G ++ E++   
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 65.6 bits (160), Expect = 1e-11
 Identities = 58/194 (29%), Positives = 89/194 (45%), Gaps = 21/194 (10%)

Query: 277 LGQGGSGSVYK-----GTLPG---GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
           LG+GG G V++     G   G      V  K       +   H   E N++  + H  +V
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS-TAEGLAYLHEE 387
            L+    TG +  L+ E++        LF+  + E +  E      LS  +  L +LH  
Sbjct: 64  DLIYAFQTGGKLYLILEYLSG----GELFMHLEREGIFMEDTACFYLSEISLALEHLH-- 117

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPEYVV 445
            +  II+RD+K  NILLD +   K+ DFGL +  +    +TH   T  GT+ YMAPE ++
Sbjct: 118 -QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH---TFCGTIEYMAPEILM 173

Query: 446 RGKLTEKADVYSFG 459
           R    +  D +S G
Sbjct: 174 RSGHGKAVDWWSLG 187

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.5 bits (159), Expect = 1e-11
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)

Query: 271 FHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
           F   ++LG G  G V K    P G  +A K +       + +    E+ ++   N   +V
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
              G   +  E  +  E +   SL     V ++ + +  E+  K+ ++   GLAYL E  
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQ---VLKEAKRIPEEILGKVSIAVLRGLAYLRE-- 121

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
           K +I+HRD+K SNIL++     K+ DFG+     + I  ++ +  GT  YM+PE +    
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTH 178

Query: 449 LTEKADVYSFGVVVIEV 465
            + ++D++S G+ ++E+
Sbjct: 179 YSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 52/147 (35%), Positives = 76/147 (51%), Gaps = 13/147 (8%)

Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           NH  LV L  C  T      V EFV    L+ ++  RQ   P      Y   +S A  L 
Sbjct: 54  NHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHM-QRQRKLPEEHARFYSAEISLA--LN 110

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMA 440
           +LHE     II+RD+KL N+LLD E   K+ D+G+ +  + P D T   +T  GT  Y+A
Sbjct: 111 FLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT---STFCGTPNYIA 164

Query: 441 PEYVVRGKLTE-KADVYSFGVVVIEVV 466
           PE ++RG+      D ++ GV++ E++
Sbjct: 165 PE-ILRGEDYGFSVDWWALGVLMFEMM 190

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 34/101 (33%), Positives = 49/101 (48%), Gaps = 10/101 (9%)

Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P  W  +Y  I     G+  LH+     IIHRDIK  N+L+D+    K+ DFGL R    
Sbjct: 95  PEDWAKQY--IAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR---- 145

Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
                +    GT  Y+APE ++     + +D +S G V+ E
Sbjct: 146 -NGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFE 185

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 64.5 bits (157), Expect = 3e-11
 Identities = 47/148 (31%), Positives = 74/148 (50%), Gaps = 13/148 (8%)

Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGL 381
           NH  L +L  C  T      V EFV    L+ ++   R+  E  +     +I       L
Sbjct: 54  NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIT----SAL 109

Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYM 439
            +LH++    II+RD+KL N+LLD E   K+ADFG+ +   E I +   ++T  GT  Y+
Sbjct: 110 MFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGIFNGKTTSTFCGTPDYI 163

Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVC 467
           APE +         D ++ GV++ E++C
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 36/87 (41%), Positives = 52/87 (59%), Gaps = 5/87 (5%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL  LH+E   RI++RD+K  NILLD+    +I+D GL    PE  T I   + GT+GYM
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 168

Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
           APE V   + T   D ++ G ++ E++
Sbjct: 169 APEVVKNERYTFSPDWWALGCLLYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 64.9 bits (158), Expect = 3e-11
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 17/165 (10%)

Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLV---YEFVPNQSLLDNLFVRQD-VEPLSWEVR 370
           E++++  I+H+ ++ L+          +V   Y+         +LF   D   PL  E  
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC--------DLFTYVDRSGPLPLEQA 187

Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV-RLFPEDITHIS 429
             I     E LAYLH      IIHRD+K  NI LDE   A + DFG   +L     T   
Sbjct: 188 ITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQC 244

Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF 474
              +GTL   +PE +       K D++S G+V+ E+   K + LF
Sbjct: 245 YGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSV-KNVTLF 288

Length = 392

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 8/89 (8%)

Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGY 438
           L YLH      +++RD+KL N++LD++   KI DFGL +   E I+      T  GT  Y
Sbjct: 108 LGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161

Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           +APE +         D +  GVV+ E++C
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMC 190

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 17/199 (8%)

Query: 276 KLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLVKLLG 332
           K+G+G  G V+K      G+ VA+K+   +    V       E+ ++  + H NLV L+ 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIE 67

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                 +  LV+E+  + ++L+ L   ++   +   +  KII  T + + + H   K   
Sbjct: 68  VFRRKRKLHLVFEYC-DHTVLNEL--EKNPRGVPEHLIKKIIWQTLQAVNFCH---KHNC 121

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMAPEYVV-RGK 448
           IHRD+K  NIL+ ++   K+ DFG  R+     +D T   A    T  Y APE +V   +
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVA----TRWYRAPELLVGDTQ 177

Query: 449 LTEKADVYSFGVVVIEVVC 467
                DV++ G V  E++ 
Sbjct: 178 YGPPVDVWAIGCVFAELLT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 63.7 bits (155), Expect = 4e-11
 Identities = 65/222 (29%), Positives = 101/222 (45%), Gaps = 37/222 (16%)

Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVN 317
           YE +EK           G+G  G VYK       E +A+K  RL             E++
Sbjct: 4   YEKVEKI----------GEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREIS 53

Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD-NLFVRQDVEP-LSWEVR----- 370
           L+  + H N+V+L     +     LV+E+      LD +L    D  P  +   R     
Sbjct: 54  LLKEMQHGNIVRLQDVVHSEKRLYLVFEY------LDLDLKKHMDSSPDFAKNPRLIKTY 107

Query: 371 -YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITHI 428
            Y+I+     G+AY H     R++HRD+K  N+L+D    A K+ADFGL R F   +   
Sbjct: 108 LYQIL----RGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160

Query: 429 SATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRK 469
           +  +  TL Y APE ++  +  +   D++S G +  E+V +K
Sbjct: 161 THEVV-TLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 64.0 bits (155), Expect = 6e-11
 Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 28/206 (13%)

Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 81

Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       LV E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 82  LNV-FTPQKSLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 134

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEV 189

Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRK 469
           ++     E  D++S G ++ E+V  K
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 63.0 bits (153), Expect = 6e-11
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 18/202 (8%)

Query: 276 KLGQGGSGSVY---------KGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
           +LG+G  G+VY         +  L   + + V  L  N T        E  L+S ++H  
Sbjct: 7   RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETV---QANQEAQLLSKLDHPA 63

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           +VK     +      ++ E+   + L   L  ++   + LS     +  +    G+ Y+H
Sbjct: 64  IVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMH 123

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
           +    RI+HRD+K  NI L      KI DFG+ RL       ++ T  GT  YM+PE + 
Sbjct: 124 QR---RILHRDLKAKNIFLKNNLL-KIGDFGVSRLLMGS-CDLATTFTGTPYYMSPEALK 178

Query: 446 RGKLTEKADVYSFGVVVIEVVC 467
                 K+D++S G ++ E+ C
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCC 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 63.5 bits (154), Expect = 6e-11
 Identities = 57/165 (34%), Positives = 82/165 (49%), Gaps = 21/165 (12%)

Query: 308 WVD---HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
           WV    H F + +     NH  LV L  C  T      V E+V    L+ ++  RQ   P
Sbjct: 41  WVQTEKHVFEQAS-----NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM-QRQRKLP 94

Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFP 422
                 Y   +S A  L YLHE     II+RD+KL N+LLD E   K+ D+G+ +  L P
Sbjct: 95  EEHARFYSAEISLA--LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP 149

Query: 423 EDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVV 466
            D T   +T  GT  Y+APE ++RG+      D ++ GV++ E++
Sbjct: 150 GDTT---STFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMM 190

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 63.4 bits (154), Expect = 7e-11
 Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 22/200 (11%)

Query: 277 LGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHF---FNEVNLISGINHKNLVKLLG 332
           LG+G  G V    L G GE  AVK L  +     D       E  +++       +  L 
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 333 CSITGPESLL-VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLHEES 388
           C+    E L  V EF+    L+   F  QD         Y+     AE   GL +LH + 
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLM---FHIQDKGRFDL---YRATFYAAEIVCGLQFLHSKG 116

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI--THISATLAGTLGYMAPEYVVR 446
              II+RD+KL N++LD +   KIADFG+ +   E++   + ++T  GT  Y+APE +  
Sbjct: 117 ---IIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 447 GKLTEKADVYSFGVVVIEVV 466
            K T   D +SFGV++ E++
Sbjct: 171 LKYTFSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 64.3 bits (156), Expect = 7e-11
 Identities = 39/166 (23%), Positives = 80/166 (48%), Gaps = 8/166 (4%)

Query: 304 NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV---YEFVPNQSLLDNLFVRQ 360
             ++      NE+  +  +NH+N++K+     +   + ++   Y+F     + D  F  +
Sbjct: 202 AGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK 261

Query: 361 DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
           D  PL  + R  I+      + Y+H++   ++IHRDIKL NI L+ +    + DFG    
Sbjct: 262 D-RPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDFGTAMP 316

Query: 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           F ++         GT+   +PE +      E  D++S G+++++++
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 52/197 (26%), Positives = 98/197 (49%), Gaps = 10/197 (5%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
           F + ++LG G  G V+K +  P G  +A K +       + +    E+ ++   N   +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
              G   +  E  +  E +   SL D +  +    P   ++  K+ ++  +GL YL E+ 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGLTYLREKH 123

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
           K  I+HRD+K SNIL++     K+ DFG+     + I  ++ +  GT  YM+PE +    
Sbjct: 124 K--IMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSFVGTRSYMSPERLQGTH 178

Query: 449 LTEKADVYSFGVVVIEV 465
            + ++D++S G+ ++E+
Sbjct: 179 YSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 35/89 (39%), Positives = 54/89 (60%), Gaps = 8/89 (8%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI--THISATLAGTLG 437
           GL +LH +    I++RD+KL NILLD +   KIADFG+ +   E++     + T  GT  
Sbjct: 108 GLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPD 161

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           Y+APE ++  K     D +SFGV++ E++
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 62.7 bits (153), Expect = 1e-10
 Identities = 59/222 (26%), Positives = 101/222 (45%), Gaps = 48/222 (21%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           + +G+G  G V   T  P G  VA+K++  F + T +      E+ ++    H+N++ +L
Sbjct: 11  SYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT-FCQRTLREIKILRRFKHENIIGIL 69

Query: 332 GCSITGPESL-------LVYEFVP--------NQSLLDN---LFVRQDVEPLSWEVRYKI 373
              I  P S        +V E +          Q L ++    F+            Y+I
Sbjct: 70  --DIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFL------------YQI 115

Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
           +     GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   +  H +  L 
Sbjct: 116 L----RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH-TGFLT 167

Query: 434 ---GTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRKRI 471
               T  Y APE ++  K   KA D++S G ++ E++  + +
Sbjct: 168 EYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 31/210 (14%)

Query: 277 LGQGGSGSVYKG----TLPGGEA----VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
           LGQG    ++KG        GE     V +K L  +   + + FF   +++S ++HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY-LHEE 387
              G  + G ES++V E+V   SL   L   +++  +SW+      L  A+ LA+ LH  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK------LEVAKQLAWALHFL 116

Query: 388 SKLRIIHRDIKLSNILLDEEFTA--------KIADFGL-VRLFPEDITHISATLAGTLGY 438
               + H ++   N+LL  E           K++D G+ + + P++I      L   + +
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------LLERIPW 170

Query: 439 MAPEYVVRGK-LTEKADVYSFGVVVIEVVC 467
           + PE +   + L+  AD +SFG  + E+  
Sbjct: 171 VPPECIENPQNLSLAADKWSFGTTLWEIFS 200

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 11/160 (6%)

Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
           NE  ++  ++H N+++     +     ++V E+ P  +L +  ++++    L  E     
Sbjct: 48  NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAE--YIQKRCNSLLDE---DT 102

Query: 374 ILS--TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITHISA 430
           IL       LA  H  +KL I+HRD+K  NILLD+     KI DFG+ ++        + 
Sbjct: 103 ILHFFVQILLALHHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK--AY 159

Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
           T+ GT  Y++PE        +K+D+++ G V+ E+   KR
Sbjct: 160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKR 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 61.7 bits (149), Expect = 2e-10
 Identities = 59/202 (29%), Positives = 91/202 (45%), Gaps = 19/202 (9%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCS 334
           +G G  G VYKG  +  G+  A+K +   T    +    E+N++   +H +N+    G  
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 335 IT-GPESL-----LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           I   P  +     LV EF    S+ D L        L  E    I      GL++LH+  
Sbjct: 73  IKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH- 130

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
             ++IHRDIK  N+LL E    K+ DFG+       +     T  GT  +MAPE +   +
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDE 187

Query: 449 LTE-----KADVYSFGVVVIEV 465
             +     K+D++S G+  IE+
Sbjct: 188 NPDATYDFKSDLWSLGITAIEM 209

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 61.5 bits (149), Expect = 2e-10
 Identities = 58/238 (24%), Positives = 102/238 (42%), Gaps = 34/238 (14%)

Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
           F  E   +   +H N+V+L G    G   ++V E++ N +L  + F+R+    L      
Sbjct: 53  FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL--DSFLRKHEGQLVAGQLM 110

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
            ++   A G+ YL E   +  +H+ +    +L++ +   KI+ F   RL  +    I  T
Sbjct: 111 GMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTT 165

Query: 432 LAG--TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY 489
           ++G   + + APE +     +  +DV+SFG+V+ EV+                +  WD+ 
Sbjct: 166 MSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGE------------RPYWDMS 213

Query: 490 VKGRLHEAVDPALAGNFQEGKPSR----LLQIGLLCVQASAELRPSMS----IVVKML 539
                 + V  A+   F+   P      L Q+ L C Q     RP  S    I+ KM+
Sbjct: 214 -----GQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 33/92 (35%), Positives = 49/92 (53%), Gaps = 4/92 (4%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           A  L YLHE+    I+HRD+K  N+ L      K+ D G+ R+  E+   +++TL GT  
Sbjct: 112 AMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPY 167

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           YM+PE         K+DV++ G  V E+   K
Sbjct: 168 YMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 61/220 (27%), Positives = 102/220 (46%), Gaps = 28/220 (12%)

Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVK--RLFYNTTQWVDHFFNEV 316
           +YE LEK          +G+G  G VYK      G+ VA+K  RL  +          E+
Sbjct: 2   AYEKLEK----------IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREI 51

Query: 317 NLISGINHKN-LVKLLGCSIT----GPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWE 368
           +L+  ++    +V+LL         G  SL LV+E++ +  +  +D    R    PL  +
Sbjct: 52  SLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMD-SNGRGPGRPLPAK 110

Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITH 427
                +    +G+A+ H   K  ++HRD+K  N+L+D++    KIAD GL R F   +  
Sbjct: 111 TIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKS 167

Query: 428 ISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVV 466
            +  +  TL Y APE ++     +   D++S G +  E+ 
Sbjct: 168 YTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 12/159 (7%)

Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
             H  NE  ++  ++H  +++L           ++ E+VP   L   L         +  
Sbjct: 45  EQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGL 104

Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
                I+   E   YLH      I++RD+K  NILLD+E   K+ DFG    F + +   
Sbjct: 105 FYASEIVCALE---YLHS---KEIVYRDLKPENILLDKEGHIKLTDFG----FAKKLRDR 154

Query: 429 SATLAGTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
           + TL GT  Y+APE V++ K   KA D ++ G+++ E++
Sbjct: 155 TWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEML 192

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 25/227 (11%)

Query: 252 VNKSKLNFSYETLEKATNYFHES----NKLGQGGSGSVYKGTLPGGE--AVAVKRLFYNT 305
           ++K K + S +  ++     +E       LG G  G V   T    +   VA+KR   + 
Sbjct: 9   LHKKKDSDSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSK 68

Query: 306 ---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV 362
               + VDH F+E  +++ INH   V L G         LV EFV         F+R++ 
Sbjct: 69  IIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT--FLRRNK 126

Query: 363 E-PLSWEVRY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
             P      Y  +I+L       YL     L I++RD+K  N+LLD++   K+ DFG  +
Sbjct: 127 RFPNDVGCFYAAQIVLI----FEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAK 179

Query: 420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +    +   + TL GT  Y+APE ++     + AD ++ G+ + E++
Sbjct: 180 V----VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEIL 222

Length = 340

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 61.4 bits (149), Expect = 4e-10
 Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 34/210 (16%)

Query: 271 FHESNKLGQGGSGSV----YKGTLPGGEAVAVKRLFYNTT---QWVDHFFNEVNLISGIN 323
           F     LG G  G V    +KGT   GE  A+K L        + V H   E +++  ++
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGT---GEYYAIKCLKKREILKMKQVQHVAQEKSILMELS 76

Query: 324 HKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNL-----FVRQDVEPLSWEVRYKIILST 377
           H  +V ++ CS      +  + EFV    L  +L     F     +    E+    +L+ 
Sbjct: 77  HPFIVNMM-CSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL----VLA- 130

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
                YLH +    II+RD+K  N+LLD +   K+ DFG    F + +   + TL GT  
Sbjct: 131 ---FEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFG----FAKKVPDRTFTLCGTPE 180

Query: 438 YMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
           Y+APE V++ K   KA D ++ GV++ E +
Sbjct: 181 YLAPE-VIQSKGHGKAVDWWTMGVLLYEFI 209

Length = 329

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 60.9 bits (147), Expect = 4e-10
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 24/212 (11%)

Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF-FNEVN 317
           SYE LEK          LG+G   +VYKG +   G+ VA+K +     +        E +
Sbjct: 6   SYEKLEK----------LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREAS 55

Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP--LSWEVRYKIIL 375
           L+ G+ H N+V L     T     LV+E+V       +L    D  P  L  E     + 
Sbjct: 56  LLKGLKHANIVLLHDIIHTKETLTLVFEYVHT-----DLCQYMDKHPGGLHPENVKLFLF 110

Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
               GL+Y+H+     I+HRD+K  N+L+ +    K+ADFGL R      +H  +    T
Sbjct: 111 QLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARA-KSVPSHTYSNEVVT 166

Query: 436 LGYMAPEYVV-RGKLTEKADVYSFGVVVIEVV 466
           L Y  P+ ++   + +   D++  G + +E++
Sbjct: 167 LWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMI 198

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 60.0 bits (145), Expect = 7e-10
 Identities = 58/204 (28%), Positives = 92/204 (45%), Gaps = 22/204 (10%)

Query: 277 LGQGGSGSVYK-GTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +G+G  G V+K      G   AVK L   ++  + ++  +N +  +S  +H N+VK  G 
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALS--DHPNVVKFYGM 83

Query: 334 -----SITGPESLLVYEFVPNQSLLDNL--FVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
                   G +  LV E     S+ D +  F+++  E +   +   I+     GL +LH 
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRG-ERMEEPIIAYILHEALMGLQHLHV 142

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV-- 444
               + IHRD+K +NILL  E   K+ DFG V            T  GT  +MAPE +  
Sbjct: 143 N---KTIHRDVKGNNILLTTEGGVKLVDFG-VSAQLTSTRLRRNTSVGTPFWMAPEVIAC 198

Query: 445 ---VRGKLTEKADVYSFGVVVIEV 465
              +      + DV+S G+  IE+
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 56/213 (26%), Positives = 97/213 (45%), Gaps = 30/213 (14%)

Query: 271 FHESNKLGQGGSGSV-YKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNL 327
           + +  ++G G  G+V        G  VA+K+L+  + +  +    + E+ L+  + H+N+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENV 76

Query: 328 VKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           + LL    T   SL       LV  F+       +L      E LS +    ++    +G
Sbjct: 77  IGLLDV-FTPDLSLDRFHDFYLVMPFMGT-----DLGKLMKHEKLSEDRIQFLVYQMLKG 130

Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG---TLG 437
           L Y+H      IIHRD+K  N+ ++E+   KI DFGL R          + + G   T  
Sbjct: 131 LKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QTDSEMTGYVVTRW 180

Query: 438 YMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRK 469
           Y APE ++     T+  D++S G ++ E++  K
Sbjct: 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 60.0 bits (145), Expect = 8e-10
 Identities = 52/155 (33%), Positives = 79/155 (50%), Gaps = 14/155 (9%)

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           LV L  C  T     LV E+V    L+ ++  RQ   P      Y   +  A  L +LHE
Sbjct: 58  LVGLHSCFQTTSRLFLVIEYVNGGDLMFHM-QRQRKLPEEHARFYAAEICIA--LNFLHE 114

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPEYV 444
                II+RD+KL N+LLD +   K+ D+G+ +  L P D T   +T  GT  Y+APE +
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT---STFCGTPNYIAPE-I 167

Query: 445 VRGK-LTEKADVYSFGVVVIEVVC-RKRINLFTQN 477
           +RG+      D ++ GV++ E++  R   ++ T N
Sbjct: 168 LRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDN 202

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 59.6 bits (144), Expect = 9e-10
 Identities = 63/221 (28%), Positives = 100/221 (45%), Gaps = 26/221 (11%)

Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG 321
           E+L   T+ +     +G+G  G VYK T     ++A  ++    +   +    E N++  
Sbjct: 15  ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQS 74

Query: 322 I-NHKNLVKLLGC-----SITGPESLLVYEFVPNQS---LLDNLFVRQDV--EPLSWEVR 370
           + NH N+VK  G       + G +  LV E     S   L+  L +      E +   + 
Sbjct: 75  LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134

Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHIS 429
           Y  +L    GL +LH     RIIHRD+K +NILL  E   K+ DFG+  +L    +    
Sbjct: 135 YGALL----GLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR-- 185

Query: 430 ATLAGTLGYMAPEYVVRGKLTE-----KADVYSFGVVVIEV 465
            T  GT  +MAPE +   +  +     + DV+S G+  IE+
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 23/215 (10%)

Query: 270 YFHESNKLGQGGSGSV----YKGTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGI- 322
            +    +LGQG  G V       T    E VA+K++   ++          E+ L+    
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEE-ETVAIKKITNVFSKKILAKRALRELKLLRHFR 59

Query: 323 NHKNLVKLLGCSITGPES---LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK-IILSTA 378
            HKN+  L    I  P +   L +YE +    L  +  +R    PL+ +  ++  I    
Sbjct: 60  GHKNITCLYDMDIVFPGNFNELYLYEELMEADL--HQIIRSGQ-PLT-DAHFQSFIYQIL 115

Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG---T 435
            GL Y+H  +   ++HRD+K  N+L++ +   KI DFGL R F E+    +  +     T
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 436 LGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRK 469
             Y APE ++  +   KA DV+S G ++ E++ RK
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 8/105 (7%)

Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           PL+ E         A G+ +L   +  + IHRD+   NILL E    KI DFGL R   +
Sbjct: 170 PLTMEDLICYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYK 226

Query: 424 DITHI---SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           D  ++   SA L   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 227 DPDYVRKGSARLP--LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 39/106 (36%), Positives = 56/106 (52%), Gaps = 8/106 (7%)

Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
           EPL+ E         A G+ +L   +  + IHRD+   NILL E    KI DFGL R   
Sbjct: 168 EPLTLEDLISYSFQVARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIY 224

Query: 423 EDITHI---SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           +D  ++    A L   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 225 KDPDYVRKGDARLP--LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 36/87 (41%), Positives = 50/87 (57%), Gaps = 5/87 (5%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL  LH E   RI++RD+K  NILLD+    +I+D GL    PE  T I   + GT+GYM
Sbjct: 114 GLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET-IRGRV-GTVGYM 168

Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
           APE V   + T   D +  G ++ E++
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 35/99 (35%), Positives = 54/99 (54%), Gaps = 9/99 (9%)

Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA--TLAGTLGY 438
           L YLH      +++RDIKL N++LD++   KI DFGL +   E I+  +   T  GT  Y
Sbjct: 108 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 161

Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477
           +APE +         D +  GVV+ E++C  R+  + Q+
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQD 199

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 51/180 (28%), Positives = 78/180 (43%), Gaps = 14/180 (7%)

Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
           V H   E  ++    H  L  L     T      V E+V        LF     E +  E
Sbjct: 39  VAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG----GELFFHLSRERVFSE 94

Query: 369 VRYKII-LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
            R +         L YLH     +I++RD+KL N++LD++   KI DFGL +   E IT 
Sbjct: 95  DRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK---EGITD 148

Query: 428 ISA--TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
            +   T  GT  Y+APE +         D +  GVV+ E++C  R+  + Q+   + + +
Sbjct: 149 AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 55/200 (27%), Positives = 97/200 (48%), Gaps = 17/200 (8%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           ++LG+G  GSVYK    P G  +A+K  RL  + +++ +    E++++       +V   
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKF-NQIIMELDILHKAVSPYIVDFY 65

Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
           G         +  E++   SL D L+      E +  +V  +I  +  +GL +L EE   
Sbjct: 66  GAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--H 122

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV------ 444
            IIHRD+K +N+L++     K+ DFG+       +  ++ T  G   YMAPE +      
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNL---VASLAKTNIGCQSYMAPERIKSGGPN 179

Query: 445 VRGKLTEKADVYSFGVVVIE 464
                T ++DV+S G+ ++E
Sbjct: 180 QNPTYTVQSDVWSLGLSILE 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 48/143 (33%), Positives = 71/143 (49%), Gaps = 19/143 (13%)

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS----------TAEGLAY 383
           SIT  +S     FV  +SL D   V ++      E  YK +L+           A+G+ +
Sbjct: 140 SITSSQSSASSGFVEEKSLSD---VEEEEAE--QEDLYKKVLTLEDLICYSFQVAKGMEF 194

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPE 442
           L   +  + IHRD+   NILL E    KI DFGL R   +D  ++    A   L +MAPE
Sbjct: 195 L---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251

Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
            +     T ++DV+SFGV++ E+
Sbjct: 252 TIFDRVYTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.3 bits (143), Expect = 2e-09
 Identities = 34/98 (34%), Positives = 54/98 (55%), Gaps = 4/98 (4%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            L YLH E    +++RD+KL N++LD++   KI DFGL +   +D   +  T  GT  Y+
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYL 163

Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477
           APE +         D +  GVV+ E++C  R+  + Q+
Sbjct: 164 APEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQD 200

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 34/91 (37%), Positives = 54/91 (59%), Gaps = 8/91 (8%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
           A GL +LH +    II+RD+KL N++LD E   KIADFG+ +   E++     + T  GT
Sbjct: 111 AIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENMWDGVTTKTFCGT 164

Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
             Y+APE +      +  D ++FGV++ E++
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 59.3 bits (143), Expect = 3e-09
 Identities = 31/101 (30%), Positives = 59/101 (58%), Gaps = 8/101 (7%)

Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HIS 429
           Y+I+L+       L E    +++HRD+K +NI L      K+ DFG  + + + ++  ++
Sbjct: 176 YQIVLA-------LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVA 228

Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
           ++  GT  Y+APE   R + ++KAD++S GV++ E++   R
Sbjct: 229 SSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHR 269

Length = 478

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 32/90 (35%), Positives = 53/90 (58%), Gaps = 6/90 (6%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL 436
           + GL +LH      II+RD+KL N++LD E   KIADFG+ +    + +T  + T  GT 
Sbjct: 111 SVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT--TRTFCGTP 165

Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            Y+APE +      +  D +++GV++ E++
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAYGVLLYEML 195

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 34/87 (39%), Positives = 49/87 (56%), Gaps = 5/87 (5%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL  L  E   RI++RD+K  NILLD+    +I+D GL    PE  T +   + GT+GYM
Sbjct: 114 GLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-VRGRV-GTVGYM 168

Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
           APE +   K T   D +  G ++ E++
Sbjct: 169 APEVINNEKYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 53/229 (23%)

Query: 271 FHESNKLGQGGSGSVYKG---TLPGGEAVAVKRLFYNTTQWVDHF----FNEVNLISGIN 323
           +     +G+G  G VYK        G+  A+K+ F    +           E+ L+  + 
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60

Query: 324 HKNLVKLLGCSITGPESL--LVYEFV-------------PNQSLLDNLFVRQDVEPLSWE 368
           H+N+V L+   +   +    L++++                +  +    V+     L W+
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKS----LLWQ 116

Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPED 424
                IL    G+ YLH      ++HRD+K +NIL+     E    KI D GL RLF   
Sbjct: 117 -----IL---NGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP 165

Query: 425 ITHISATLAG------TLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
           +      LA       T+ Y APE ++  +   KA D+++ G +  E++
Sbjct: 166 L----KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 40/226 (17%)

Query: 277 LGQGGSGSVYKGTL----------PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
           LGQG   ++YKG L          PG E   V ++  +  +    FF   +L+S ++HK+
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           LVKL G  +   E+++V E+V    L  ++F+ ++   +S   +  +    A  L YL E
Sbjct: 63  LVKLYGVCVR-DENIMVEEYVKFGPL--DVFLHREKNNVSLHWKLDVAKQLASALHYL-E 118

Query: 387 ESKLRIIHRDIKLSNILL-----DEEFT--AKIADFG-----LVRLFPEDITHISATLAG 434
           + KL  +H ++   NIL+     +E +    K++D G     L R    +          
Sbjct: 119 DKKL--VHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE---------- 166

Query: 435 TLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
            + ++APE +  G   LT  AD +SFG  ++E+       L T +S
Sbjct: 167 RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSS 212

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 64/228 (28%), Positives = 97/228 (42%), Gaps = 44/228 (19%)

Query: 275 NKLGQGGSGSVYKG--TLPGGEAVAVKRLFYN--------TTQWVD----HF--FNEVNL 318
             LG+G  G V K   TL G   VA+K++             Q V     HF    E+ +
Sbjct: 15  AHLGEGTYGKVEKAYDTLTGKI-VAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST- 377
           ++ I H+N++ L+   + G    LV + +   S L  +    D +    E + K IL   
Sbjct: 74  MNEIKHENIMGLVDVYVEGDFINLVMDIM--ASDLKKVV---DRKIRLTESQVKCILLQI 128

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--- 434
             GL  LH   K   +HRD+  +NI ++ +   KIADFGL R +       S TL+    
Sbjct: 129 LNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPP--YSDTLSKDET 183

Query: 435 ------------TLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRK 469
                       TL Y APE ++   K     D++S G +  E++  K
Sbjct: 184 MQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231

Length = 335

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 37/103 (35%), Positives = 58/103 (56%), Gaps = 14/103 (13%)

Query: 368 EVRY---KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
           E+R+   +IIL    GL ++H      +++RD+K +NILLDE    +I+D GL   F + 
Sbjct: 98  EMRFYAAEIIL----GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150

Query: 425 ITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             H S    GT GYMAPE + +G      AD +S G ++ +++
Sbjct: 151 KPHAS---VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 56.9 bits (137), Expect = 7e-09
 Identities = 57/202 (28%), Positives = 87/202 (43%), Gaps = 19/202 (9%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCS 334
           +G G  G VYKG  +  G+  A+K +   T    +    E+N++   +H +N+    G  
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAF 82

Query: 335 ITGP------ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           I         +  LV EF    S+ D L        L  +    I      GLA+LH   
Sbjct: 83  IKKSPPGHDDQLWLVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHLHAH- 140

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV--- 445
             ++IHRDIK  N+LL E    K+ DFG+       +     T  GT  +MAPE +    
Sbjct: 141 --KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGR-RNTFIGTPYWMAPEVIACDE 197

Query: 446 --RGKLTEKADVYSFGVVVIEV 465
                   ++D++S G+  IE+
Sbjct: 198 NPDATYDYRSDIWSLGITAIEM 219

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 57.2 bits (138), Expect = 8e-09
 Identities = 32/88 (36%), Positives = 50/88 (56%), Gaps = 8/88 (9%)

Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGY 438
           L +LH      +I+RD+KL NILLD E   K+ADFG+ +   E I +   + T  GT  Y
Sbjct: 109 LMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCK---EGILNGVTTTTFCGTPDY 162

Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +APE +   +     D ++ GV++ E++
Sbjct: 163 IAPEILQELEYGPSVDWWALGVLMYEMM 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 57.4 bits (139), Expect = 8e-09
 Identities = 54/217 (24%), Positives = 90/217 (41%), Gaps = 61/217 (28%)

Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSW 367
           V H   E ++++  ++  +VKL   S      L L+ E++P   ++  L +++D    + 
Sbjct: 45  VAHVRAERDILAEADNPWVVKLY-YSFQDENYLYLIMEYLPGGDMM-TLLMKKDT--FTE 100

Query: 368 EV-RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL--------V 418
           E  R+ I    AE +  +    KL  IHRDIK  N+LLD +   K++DFGL         
Sbjct: 101 EETRFYI----AETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156

Query: 419 RLFPEDITHISAT-------------------------LA----GTLGYMAPEYVVRGKL 449
             F   ++H   +                         LA    GT  Y+APE  ++   
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY 216

Query: 450 TEKADVYSFGVVVIEVV--------------CRKRIN 472
            ++ D +S GV++ E++               RK IN
Sbjct: 217 NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIIN 253

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 56.6 bits (136), Expect = 9e-09
 Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 7/88 (7%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL ++H      +++RD+K +NILLDE    +I+D GL   F +   H S    GT GYM
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 162

Query: 440 APEYVVRGKLTE-KADVYSFGVVVIEVV 466
           APE + +G   +  AD +S G ++ +++
Sbjct: 163 APEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 10/92 (10%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
           A  L YLH    L II+RD+K  NILLD +    + DFGL +   E I H   ++T  GT
Sbjct: 106 ASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGT 159

Query: 436 LGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
             Y+APE V+R +  ++  D +  G V+ E++
Sbjct: 160 PEYLAPE-VLRKQPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            L ++H+    +I+HRDIK  NI L ++ T K+ DFG+ R+       ++ T  GT  Y+
Sbjct: 113 ALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVL-NSTVELARTCIGTPYYL 168

Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           +PE         K+D+++ G V+ E+   K
Sbjct: 169 SPEICENRPYNNKSDIWALGCVLYEMCTLK 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 56.1 bits (135), Expect = 1e-08
 Identities = 31/87 (35%), Positives = 46/87 (52%), Gaps = 5/87 (5%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL  LH E+    ++RD+K  NILLD+    +I+D GL    PE          GT+GYM
Sbjct: 114 GLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--ESIRGRVGTVGYM 168

Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
           APE +   + T   D +  G ++ E++
Sbjct: 169 APEVLNNQRYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 18/152 (11%)

Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLG 332
           +KLG+G   +V+KG +      VA+K +     +        EV+L+  + H N+V L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 333 CSITGPESLLVYEFVPN--QSLLD---NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
              T     LV+E++ +  +  LD   NL    +V+   +++          GL+Y H+ 
Sbjct: 71  IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL--------LRGLSYCHKR 122

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
              +I+HRD+K  N+L++E+   K+ADFGL R
Sbjct: 123 ---KILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGY 438
           GL +LH+    RII+RD+K  N+LLD +   +I+D GL V L  +D    +   AGT G+
Sbjct: 109 GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVEL--KDGQSKTKGYAGTPGF 163

Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           MAPE +   +     D ++ GV + E++  +
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 9/90 (10%)

Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGY 438
           L +LH+     I++RD+K  NILLD      + DFGL +  L     T+   T  GT  Y
Sbjct: 109 LEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTN---TFCGTTEY 162

Query: 439 MAPEYVVRGK-LTEKADVYSFGVVVIEVVC 467
           +APE ++  K  T+  D +S GV+V E+ C
Sbjct: 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCC 192

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 50/176 (28%), Positives = 79/176 (44%), Gaps = 46/176 (26%)

Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVD-HFFNEVN 317
           +Y+ L+K          LG+G   +VYKG +   G+ VA+K +     +        E +
Sbjct: 6   TYKKLDK----------LGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREAS 55

Query: 318 LISGINHKNLVKLLGCSITGPESL-LVYEFV-----------PNQSLLDN--LFVRQDVE 363
           L+  + H N+V  L   I   ++L LV+E++                + N  LF+ Q   
Sbjct: 56  LLKDLKHANIV-TLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQ--- 111

Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
                     +L    GLAY H   + R++HRD+K  N+L+ E    K+ADFGL R
Sbjct: 112 ----------LL---RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 20/199 (10%)

Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLG 332
            KLG+G   +V+KG     E  VA+K +     +        EV+L+  + H N+V L  
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 333 CSITGPESLLVYEFVPN---QSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
              T     LV+E++     Q + D  N+    +V+   +++          GLAY H  
Sbjct: 72  IVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQI--------LRGLAYCH-- 121

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV-R 446
            + +++HRD+K  N+L++E    K+ADFGL R         S  +  TL Y  P+ ++  
Sbjct: 122 -RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 179

Query: 447 GKLTEKADVYSFGVVVIEV 465
            + + + D++  G +  E+
Sbjct: 180 SEYSTQIDMWGVGCIFFEM 198

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 30/98 (30%), Positives = 53/98 (54%), Gaps = 8/98 (8%)

Query: 372 KIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
           ++I  +A+   G+ +LH    + I++RD+K  N+LLD++   +++D GL     +  T  
Sbjct: 96  RVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT-- 150

Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
               AGT GYMAPE +     +   D ++ G  + E+V
Sbjct: 151 ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMV 188

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.6 bits (134), Expect = 3e-08
 Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 16/143 (11%)

Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVE------PLSWEVRYKIILSTAEGLAYLH 385
           G S  G ++ +  E  P  S        +D E      PL  +   +     A+G+ +L 
Sbjct: 172 GFSSQGSDTYV--EMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLA 229

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI---SATLAGTLGYMAPE 442
            ++    IHRD+   N+LL +   AKI DFGL R    D  ++   +A L   + +MAPE
Sbjct: 230 SKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP--VKWMAPE 284

Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
            +     T ++DV+S+G+++ E+
Sbjct: 285 SIFDCVYTVQSDVWSYGILLWEI 307

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 13/160 (8%)

Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVR 370
           F+ E ++++  N   +V+L  C+    + L +V E++P   L+ NL    DV P  W   
Sbjct: 90  FWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLV-NLMSNYDV-PEKWAKF 146

Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
           Y     TAE +  L     + +IHRD+K  N+LLD+    K+ADFG      E       
Sbjct: 147 Y-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201

Query: 431 TLAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVV 466
           T  GT  Y++PE +      G    + D +S GV + E++
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 54.9 bits (132), Expect = 4e-08
 Identities = 50/159 (31%), Positives = 76/159 (47%), Gaps = 9/159 (5%)

Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSW 367
           V H   E  +++ +N   +V L   S   PE L LV  F+    L  +L      E    
Sbjct: 37  VTHTLAERTVLAQVNCPFIVPL-KFSFQSPEKLYLVLAFINGGELFHHL----QREGRFD 91

Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
             R +    TAE L  L    K  +I+RD+K  NILLD +    + DFGL +L  +D   
Sbjct: 92  LSRAR--FYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DD 148

Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            + T  GT  Y+APE ++    T+  D ++ GV++ E++
Sbjct: 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEML 187

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 55.0 bits (132), Expect = 4e-08
 Identities = 33/91 (36%), Positives = 49/91 (53%), Gaps = 8/91 (8%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGT 435
           A  + YLH    L II+RD+K  NILLD +    + DFGL +  + PE+ T   +T  GT
Sbjct: 106 ASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT---STFCGT 159

Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
             Y+APE + +       D +  G V+ E++
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 54.7 bits (131), Expect = 5e-08
 Identities = 58/215 (26%), Positives = 99/215 (46%), Gaps = 22/215 (10%)

Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 10  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 69

Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL   +  P   L  EF  N   L    +  D+      + L+ +    
Sbjct: 70  LKHMKHENVIGLL--DVFTPARSL-EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 124

Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 125 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 179

Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             T  Y APE ++      +  D++S G ++ E++
Sbjct: 180 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 212

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 55.0 bits (132), Expect = 5e-08
 Identities = 34/91 (37%), Positives = 46/91 (50%), Gaps = 5/91 (5%)

Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAG 434
           S    + YLHE    RIIHRDIK  NI ++      + DFG    FP DI  +     AG
Sbjct: 190 SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245

Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           T+   APE + R       D++S G+V+ E+
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 53.8 bits (129), Expect = 6e-08
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 20/163 (12%)

Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
           FF   +++  ++HK++V L G  +   E+++V EFV    L  +LF+ +  + L+   ++
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL--DLFMHRKSDVLTTPWKF 108

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL-----DEEFTA--KIADFGLVRLFPED 424
           K+    A  L+YL ++    ++H ++   NILL     D E     K++D G+       
Sbjct: 109 KVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI------P 159

Query: 425 ITHIS-ATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEV 465
           IT +S       + ++APE V   K L+  AD +SFG  + E+
Sbjct: 160 ITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 45/205 (21%), Positives = 75/205 (36%), Gaps = 29/205 (14%)

Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCS 334
                   + K   P    VAVK++  ++   + +     E+     + H N++  +   
Sbjct: 10  FEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF 68

Query: 335 ITGPESLLVYEFVPNQS---LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           I   E  +V   +   S   LL   F     E L       I+      L Y+H      
Sbjct: 69  IVDSELYVVSPLMAYGSCEDLLKTHFP----EGLPELAIAFILKDVLNALDYIH---SKG 121

Query: 392 IIHRDIKLSNILLDEEFTAKIADF---------GLVRLFPEDITHISATLAGTLGYMAPE 442
            IHR +K S+ILL  +    ++           G  +    D    S      L +++PE
Sbjct: 122 FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN---LPWLSPE 178

Query: 443 YVVRGKL---TEKADVYSFGVVVIE 464
            V++  L    EK+D+YS G+   E
Sbjct: 179 -VLQQNLQGYNEKSDIYSVGITACE 202

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 54.2 bits (130), Expect = 7e-08
 Identities = 41/141 (29%), Positives = 69/141 (48%), Gaps = 11/141 (7%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
           A  L YLH    L I++RD+K  NILLD +    + DFGL +   E+I H   ++T  GT
Sbjct: 106 ASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGT 159

Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD--LYVKGR 493
             Y+APE + +       D +  G V+ E++       +++N+  +   + +  L +K  
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEML-YGLPPFYSRNTAEMYDNILNKPLQLKPN 218

Query: 494 LHEAVDPALAGNFQEGKPSRL 514
           +  +    L G  Q+ +  RL
Sbjct: 219 ITNSARHLLEGLLQKDRTKRL 239

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.2 bits (130), Expect = 8e-08
 Identities = 45/167 (26%), Positives = 77/167 (46%), Gaps = 24/167 (14%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS-ATLAGTL 436
           A G+ +L  ++    +HRD+   N+L+ E    KI DFGL R    D  +IS  +    L
Sbjct: 249 ANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL 305

Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +MAPE +     T  +DV+SFG+++ E+        FT             Y +  ++E
Sbjct: 306 KWMAPESIFNNLYTTLSDVWSFGILLWEI--------FTLGGTP--------YPELPMNE 349

Query: 497 AVDPALAGNFQEGKPS----RLLQIGLLCVQASAELRPSMSIVVKML 539
               A+   ++  KP+     + +I   C +   E+RP  S +V ++
Sbjct: 350 QFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLV 396

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 54.0 bits (130), Expect = 8e-08
 Identities = 47/164 (28%), Positives = 80/164 (48%), Gaps = 21/164 (12%)

Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVR 370
           F+ E ++++  N + +V+L   +    + L +V E++P   L+ NL    D+ P  W   
Sbjct: 90  FWEERDIMAHANSEWIVQLH-YAFQDDKYLYMVMEYMPGGDLV-NLMSNYDI-PEKWARF 146

Query: 371 YKIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDIT 426
           Y     TAE    L  +H    +  IHRD+K  N+LLD+    K+ADFG  +++    + 
Sbjct: 147 Y-----TAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV 198

Query: 427 HISATLAGTLGYMAPEYV----VRGKLTEKADVYSFGVVVIEVV 466
               T  GT  Y++PE +      G    + D +S GV + E++
Sbjct: 199 R-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 29/86 (33%), Positives = 46/86 (53%), Gaps = 4/86 (4%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           G+ ++HE+   R++HRDIK  NI L +    K+ DFG  RL      + + T  GT  Y+
Sbjct: 112 GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY-ACTYVGTPYYV 167

Query: 440 APEYVVRGKLTEKADVYSFGVVVIEV 465
            PE         K+D++S G ++ E+
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.9 bits (129), Expect = 1e-07
 Identities = 59/200 (29%), Positives = 95/200 (47%), Gaps = 22/200 (11%)

Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           +G G  GSV   Y   L   + VAVK+L   + +       + E+ L+  + H+N++ LL
Sbjct: 23  VGSGAYGSVCSAYDTRLR--QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLL 80

Query: 332 GC---SITGPESLLVYEFVPNQSLLD-NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
                + +      VY  V N    D N  V+   + LS E    +I     GL Y+H  
Sbjct: 81  DVFTPATSIENFNEVY-LVTNLMGADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSA 137

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
               IIHRD+K SN+ ++E+   +I DFGL R   +++T   A    T  Y APE ++  
Sbjct: 138 G---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVA----TRWYRAPEIMLNW 190

Query: 448 -KLTEKADVYSFGVVVIEVV 466
               +  D++S G ++ E++
Sbjct: 191 MHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 46/200 (23%)

Query: 293 GEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES-------LL 342
            E VA+K++   F N          E+ L+  ++H+N++ +    I  P          +
Sbjct: 30  NEKVAIKKIANAFDNRID-AKRTLREIKLLRHLDHENVIAIK--DIMPPPHREAFNDVYI 86

Query: 343 VYEFV---------PNQSLLDN---LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
           VYE +          +Q+L D+    F+ Q             +L    GL Y+H  +  
Sbjct: 87  VYELMDTDLHQIIRSSQTLSDDHCQYFLYQ-------------LL---RGLKYIHSAN-- 128

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKL 449
            ++HRD+K SN+LL+     KI DFGL R   E    ++  +  T  Y APE ++   + 
Sbjct: 129 -VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYRAPELLLNCSEY 186

Query: 450 TEKADVYSFGVVVIEVVCRK 469
           T   DV+S G +  E++ RK
Sbjct: 187 TTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 14/160 (8%)

Query: 311 HFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
           H   E N L+  + H  LV L     T  +   V +FV    L  +L  R+   P   E 
Sbjct: 41  HIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHL-QRERSFP---EP 96

Query: 370 RYKI-ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH- 427
           R +      A  L YLH    + I++RD+K  NILLD +    + DFGL +   E I   
Sbjct: 97  RARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQS 150

Query: 428 -ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
             + T  GT  Y+APE + +       D +  G V+ E++
Sbjct: 151 DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 36/157 (22%), Positives = 61/157 (38%), Gaps = 17/157 (10%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV--KLLGC 333
            L  G +  VY       + V +K     + +       EV ++  +  K L   K+L  
Sbjct: 5   LLKGGLTNRVYLLGTKDEDYV-LK--INPSREKGADREREVAILQLLARKGLPVPKVLAS 61

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
             +   S L+ E++  ++L          + +S E +  I    AE LA LH+   L + 
Sbjct: 62  GESDGWSYLLMEWIEGETL----------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLC 111

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPE--DITHI 428
           H D+   NIL+D+     I D+      P   D+   
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGYGPPAFDLAAA 148

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 22/201 (10%)

Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLG 332
           +KLG+G   +VYKG     +  VA+K +     +        EV+L+  + H N+V L  
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 333 CSITGPESLLVYEFVPN---QSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
              T     LV+E++     Q L D  N     +V+   +++          GL Y H  
Sbjct: 72  IIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQL--------LRGLNYCHRR 123

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVV- 445
              +++HRD+K  N+L++E    K+ADFGL R   + I T   +    TL Y  P+ ++ 
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLAR--AKSIPTKTYSNEVVTLWYRPPDILLG 178

Query: 446 RGKLTEKADVYSFGVVVIEVV 466
               + + D++  G +  E+ 
Sbjct: 179 STDYSTQIDMWGVGCIFYEMS 199

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 52.7 bits (126), Expect = 3e-07
 Identities = 34/118 (28%), Positives = 57/118 (48%), Gaps = 4/118 (3%)

Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
           N S + NL      E L+           A G+ +L  ++    +HRD+   N+LL +  
Sbjct: 218 NDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGK 274

Query: 409 TAKIADFGLVRLFPEDITHIS-ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             KI DFGL R    D  ++S  +    + +MAPE +     T  +DV+S+G+++ E+
Sbjct: 275 IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 52.3 bits (125), Expect = 3e-07
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           AE +  +H   +L  +HRDIK  N+LLD     ++ADFG      +D T  S+   GT  
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD 168

Query: 438 YMAPEYVV-----RGKLTEKADVYSFGVVVIEVV 466
           Y++PE +       GK   + D +S GV + E++
Sbjct: 169 YISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 52.9 bits (127), Expect = 4e-07
 Identities = 58/223 (26%), Positives = 95/223 (42%), Gaps = 46/223 (20%)

Query: 276 KLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWV---DHFFNEVNLISGINHKNLVKLL 331
            +G+GG G VY    P     VA+K++  + ++       F  E  + + + H  +V + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 332 G-CSITGPESLLVYEFVPN------QSLLDNLFVRQDVEPLSWEVRYK--------IILS 376
             CS    +   VY  +P       +SLL +  V Q  E LS E+  K        I   
Sbjct: 69  SICS----DGDPVYYTMPYIEGYTLKSLLKS--VWQK-ESLSKELAEKTSVGAFLSIFHK 121

Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-------------VRLFPE 423
               + Y+H +    ++HRD+K  NILL       I D+G              + +   
Sbjct: 122 ICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 424 DITHISAT----LAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
           +I + S T    + GT  YMAPE ++    +E  D+Y+ GV++
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVIL 221

Length = 932

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 51.8 bits (124), Expect = 5e-07
 Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 8/91 (8%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI---SATLAG 434
           A+G+++L  ++    IHRD+   NILL      KI DFGL R    D  ++   +A L  
Sbjct: 224 AKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP- 279

Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            + +MAPE +     T ++DV+S+G+++ E+
Sbjct: 280 -VKWMAPESIFNCVYTFESDVWSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 51.6 bits (123), Expect = 6e-07
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 11/159 (6%)

Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
           F+ E ++++  N   +V+L           +V E++P   L+ NL    DV P  W   Y
Sbjct: 90  FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDV-PEKWARFY 147

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
                TAE +  L     +  IHRD+K  N+LLD+    K+ADFG      ++      T
Sbjct: 148 -----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 202

Query: 432 LAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVV 466
             GT  Y++PE +      G    + D +S GV + E++
Sbjct: 203 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 50.1 bits (120), Expect = 1e-06
 Identities = 42/195 (21%), Positives = 89/195 (45%), Gaps = 19/195 (9%)

Query: 284 SVYKGTLPGGEAVAVKRL--FYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPES 340
           S+YKG     + V ++    F+   +  +D   NE+  +  I+  N++K+ G  I   + 
Sbjct: 35  SIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD 93

Query: 341 L----LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396
           L    L+ E+     L + L   +D   LS++ +  + +   +GL  L++ +     +++
Sbjct: 94  LPRLSLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148

Query: 397 IKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV--VRGKLTEKAD 454
           +   + L+ E +  KI   GL ++    ++         + Y + + +  +  + T K D
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKI----LSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDD 204

Query: 455 VYSFGVVVIEVVCRK 469
           +YS GVV+ E+   K
Sbjct: 205 IYSLGVVLWEIFTGK 219

Length = 283

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 50.1 bits (119), Expect = 2e-06
 Identities = 32/94 (34%), Positives = 49/94 (52%), Gaps = 5/94 (5%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           AE +  +    +L  +HRDIK  NIL+D     ++ADFG      ED T  S+   GT  
Sbjct: 109 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 168

Query: 438 YMAPEYVV-----RGKLTEKADVYSFGVVVIEVV 466
           Y++PE +      +GK   + D +S GV + E++
Sbjct: 169 YISPEILQAMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 49.6 bits (119), Expect = 2e-06
 Identities = 59/211 (27%), Positives = 100/211 (47%), Gaps = 41/211 (19%)

Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGIN-HKNLVKL 330
            K+G+G    V K  +   G+  A+K +   + + + V++   E+  +  ++ H N+++L
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL-REIQALRRLSPHPNILRL 63

Query: 331 LGC---SITGPESL-LVYEFVPNQSLLD-NLF--VRQDVEPLSWEVRYK-IILSTAEGLA 382
           +       TG   L LV+E      L+D NL+  ++    PL  E R K  +    + L 
Sbjct: 64  IEVLFDRKTG--RLALVFE------LMDMNLYELIKGRKRPLP-EKRVKSYMYQLLKSLD 114

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL------FPEDITHISATLAGTL 436
           ++H      I HRDIK  NIL+ ++   K+ADFG  R       + E   +IS     T 
Sbjct: 115 HMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTE---YIS-----TR 162

Query: 437 GYMAPEYVVR-GKLTEKADVYSFGVVVIEVV 466
            Y APE ++  G    K D+++ G V  E++
Sbjct: 163 WYRAPECLLTDGYYGPKMDIWAVGCVFFEIL 193

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 40/143 (27%), Positives = 62/143 (43%), Gaps = 21/143 (14%)

Query: 342 LVYEFVPNQSLLDNLFVRQDVEP----LSWEVRYKIILST-------AEGLAYLHEESKL 390
           L Y F       DNL++  + +P    LS   RY+            AE +  +H   ++
Sbjct: 66  LQYAFQDK----DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV----- 445
             +HRDIK  N+L+D     K+ADFG       +    S    GT  Y+APE +      
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGD 181

Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
            +G    + D +S GV+  E++ 
Sbjct: 182 GKGTYGVECDWWSLGVIAYEMIY 204

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 41/159 (25%), Positives = 68/159 (42%), Gaps = 40/159 (25%)

Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
           L+ EF+P   ++  L +++D   L+ E     I  T   +  +H+   L  IHRDIK  N
Sbjct: 78  LIMEFLPGGDMM-TLLMKKDT--LTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDN 131

Query: 402 ILLDEEFTAKIADFGLV----------------RLFPEDIT------------------H 427
           +LLD +   K++DFGL                    P D T                   
Sbjct: 132 LLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQ 191

Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           ++ +  GT  Y+APE  ++    +  D +S GV++ E++
Sbjct: 192 LAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 40/166 (24%), Positives = 66/166 (39%), Gaps = 48/166 (28%)

Query: 343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI 402
           V +++P   ++ +L +R  +        Y  I      +  +H   K+  IHRDIK  NI
Sbjct: 79  VMDYIPGGDMM-SLLIRLGIFEEDLARFY--IAELTCAIESVH---KMGFIHRDIKPDNI 132

Query: 403 LLDEEFTAKIADFGLVRLF----------------------PEDITHISA---------- 430
           L+D +   K+ DFGL   F                       E+ + I            
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192

Query: 431 ----------TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                     +L GT  Y+APE ++R   T+  D +S GV++ E++
Sbjct: 193 KRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 238

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 49.3 bits (117), Expect = 3e-06
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 40/159 (25%)

Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
           L+ EF+P   ++  L +++D   LS E     I  T   +  +H+   L  IHRDIK  N
Sbjct: 78  LIMEFLPGGDMM-TLLMKKDT--LSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDN 131

Query: 402 ILLDEEFTAKIADFGLV--------RLFPEDITH-------------------------- 427
           +LLD +   K++DFGL           F  ++TH                          
Sbjct: 132 LLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQ 191

Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           ++ +  GT  Y+APE  ++    +  D +S GV++ E++
Sbjct: 192 LAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEML 230

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 3e-06
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 5/93 (5%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           AE +  +    +L  +HRDIK  N+LLD+    ++ADFG       D T  S    GT  
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD 168

Query: 438 YMAPEYVV-----RGKLTEKADVYSFGVVVIEV 465
           Y++PE +      +G+   + D +S GV + E+
Sbjct: 169 YISPEILQAMEDGKGRYGPECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 50/206 (24%), Positives = 92/206 (44%), Gaps = 22/206 (10%)

Query: 276 KLGQGGSGSVYKGTL---PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLL 331
           ++G G  G V    +    G   V VK L  N +++  + F  + +    + H N+++ L
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 332 GCSITGPESLLVYEFVPNQSLLDNL----FVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           G  +     LLV+E+     L   L    + R++ + L  +   ++    A G+ ++H  
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ---RMACEIAAGVTHMH-- 116

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYV-- 444
            K   +H D+ L N  L  + T K+ D+G+    + ED           L ++APE V  
Sbjct: 117 -KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGE 175

Query: 445 VRGKL-----TEKADVYSFGVVVIEV 465
             G L     T+ ++V++ GV + E+
Sbjct: 176 FHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.9 bits (116), Expect = 4e-06
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 55/215 (25%)

Query: 299 KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLF 357
           K+   N  Q V H   E ++++  +++ +VKL   S    ++L  V +++P   ++ +L 
Sbjct: 36  KKDVLNRNQ-VAHVKAERDILAEADNEWVVKLY-YSFQDKDNLYFVMDYIPGGDMM-SLL 92

Query: 358 VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
           +R +V P      Y   L+ A     +    K+  IHRDIK  NIL+D +   K+ DFGL
Sbjct: 93  IRMEVFPEVLARFYIAELTLA-----IESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147

Query: 418 VRLF---------------------PEDI----------------------TH---ISAT 431
              F                     P D+                       H   ++ +
Sbjct: 148 CTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHS 207

Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           L GT  Y+APE ++R   T+  D +S GV++ E++
Sbjct: 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 47.0 bits (111), Expect = 1e-05
 Identities = 54/217 (24%), Positives = 100/217 (46%), Gaps = 22/217 (10%)

Query: 272 HESNKLGQGGSGSVYKGTLPGGE---AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
           +E  K+G+G  G VYK     G+     A+K++    T        E+ L+  + H N++
Sbjct: 4   YEGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI--EGTGISMSACREIALLRELKHPNVI 61

Query: 329 KL--LGCSITGPESLLVYEFVPNQSLLDNLFVRQ---DVEP--LSWEVRYKIILSTAEGL 381
            L  +  S +  +  L++++  +       F R    + +P  L   +   ++    +G+
Sbjct: 62  ALQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGI 121

Query: 382 AYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHIS--ATLAGT 435
            YLH      ++HRD+K +NIL+     E    KIAD G  RLF   +  ++    +  T
Sbjct: 122 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 436 LGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             Y APE ++  +   KA D+++ G +  E++  + I
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 34/94 (36%), Positives = 46/94 (48%), Gaps = 7/94 (7%)

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL-FPEDITHISAT-LAGTLG 437
            L Y+H  +   + HRD+K  NIL + +   KI DFGL R+ F +  T I  T    T  
Sbjct: 115 ALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 438 YMAPEYV--VRGKLTEKADVYSFGVVVIEVVCRK 469
           Y APE       K T   D++S G +  EV+  K
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 41/171 (23%), Positives = 67/171 (39%), Gaps = 52/171 (30%)

Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
            V +++P   ++ +L +R  + P      Y      AE    +    K+  IHRDIK  N
Sbjct: 78  FVMDYIPGGDMM-SLLIRMGIFPEDLARFY-----IAELTCAVESVHKMGFIHRDIKPDN 131

Query: 402 ILLDEEFTAKIADFGLV---------------------------------------RLFP 422
           IL+D +   K+ DFGL                                        RL P
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKP 191

Query: 423 -------EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                  +    ++ +L GT  Y+APE ++R   T+  D +S GV++ E++
Sbjct: 192 LERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 53/217 (24%), Positives = 99/217 (45%), Gaps = 22/217 (10%)

Query: 272 HESNKLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
           +E  K+G+G  G VYK     G+     A+K++    T        E+ L+  + H N++
Sbjct: 4   YEGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI--EGTGISMSACREIALLRELKHPNVI 61

Query: 329 KLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQ---DVEP--LSWEVRYKIILSTAEGL 381
            L    ++  +    L++++  +       F R    + +P  L   +   ++    +G+
Sbjct: 62  SLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGI 121

Query: 382 AYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHIS--ATLAGT 435
            YLH      ++HRD+K +NIL+     E    KIAD G  RLF   +  ++    +  T
Sbjct: 122 HYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178

Query: 436 LGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             Y APE ++  +   KA D+++ G +  E++  + I
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 56/225 (24%), Positives = 105/225 (46%), Gaps = 49/225 (21%)

Query: 277 LGQGGSGSVYKGTL---PGGEAVAVKRLFYNTTQWVDH---------------------- 311
           LGQG   ++Y G L    GGE    +    +     ++                      
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE--PLSWEV 369
           FF   +L+S ++H +L  + G  + G E+++V EFV +  L  ++ +R++    P++W++
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL--DVCLRKEKGRVPVAWKI 120

Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD----EEFTA---KIADFGLVRLFP 422
                L++A  L+YL +++   ++H ++   NILL      E T+   K++D G+     
Sbjct: 121 TVAQQLASA--LSYLEDKN---LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV----- 170

Query: 423 EDITHIS-ATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEV 465
              T +S       + ++APE V  G  L+  AD +SFG  ++E+
Sbjct: 171 -SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.5 bits (103), Expect = 6e-05
 Identities = 35/114 (30%), Positives = 47/114 (41%), Gaps = 19/114 (16%)

Query: 351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
           SL D L VR    PL+ E  + + L     L  LH ++K           NILL  +   
Sbjct: 2   SLADILEVRG--RPLNEEEIWAVCLQCLGALRELHRQAKSG---------NILLTWDGLL 50

Query: 411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
           K+   G V  F                +MAPE +     TEKAD+YS G+ + E
Sbjct: 51  KL--DGSV-AFKTPEQSRPDPY-----FMAPEVIQGQSYTEKADIYSLGITLYE 96

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 45.3 bits (107), Expect = 6e-05
 Identities = 49/192 (25%), Positives = 82/192 (42%), Gaps = 18/192 (9%)

Query: 277 LGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           L  G  G V++ + P   + V VK  +Y ++       +E  L+  ++H  ++ LL   +
Sbjct: 177 LTPGSEGCVFESSHPDYPQRVVVKAGWYASSV------HEARLLRRLSHPAVLALLDVRV 230

Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
            G  + LV   +P        ++   + PL       +       + Y+H E    IIHR
Sbjct: 231 VGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHR 284

Query: 396 DIKLSNILLDEEFTAKIADFG---LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           DIK  N+L++      + DFG     R       H    +AGT+   APE +     T  
Sbjct: 285 DIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG--IAGTVDTNAPEVLAGDPYTPS 342

Query: 453 ADVYSFGVVVIE 464
            D++S G+V+ E
Sbjct: 343 VDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 41/173 (23%), Positives = 69/173 (39%), Gaps = 54/173 (31%)

Query: 342 LVYEFVPNQSLLDNLFVRQDVEPLSWEV-RYKIILSTAEGLAYLHEESKLRIIHRDIKLS 400
           L+ EF+P   L+  + ++ D    S +V R+ +    AE +  +    KL  IHRDIK  
Sbjct: 78  LIMEFLPGGDLM-TMLIKYDT--FSEDVTRFYM----AECVLAIEAVHKLGFIHRDIKPD 130

Query: 401 NILLDEEFTAKIADFGL-------------VRLFPED-------------ITHISATLA- 433
           NIL+D     K++DFGL              +L                 +  I+ T++ 
Sbjct: 131 NILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSS 190

Query: 434 -------------------GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
                              GT  Y+APE  ++    ++ D +S G ++ E + 
Sbjct: 191 KDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLI 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 43.2 bits (102), Expect = 2e-04
 Identities = 41/173 (23%), Positives = 73/173 (42%), Gaps = 26/173 (15%)

Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN---QSLLDNLFVRQDVEPL 365
           +   F E ++++   +  +V +     T     +V E+V      +LL N      +  L
Sbjct: 45  IQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKN------IGAL 98

Query: 366 SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
             ++       T   L YLH      I+HRD+K  N+L+      K+ DFGL ++    +
Sbjct: 99  PVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL 155

Query: 426 T------HISA--------TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
           T      HI           + GT  Y+APE ++R    +  D ++ G+++ E
Sbjct: 156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYE 208

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 42.9 bits (101), Expect = 4e-04
 Identities = 22/53 (41%), Positives = 29/53 (54%), Gaps = 3/53 (5%)

Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL 420
           E+  K I   A  L YLH      IIHRD+K  N+L+  E   K+ DFGL ++
Sbjct: 104 EMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 24/82 (29%), Positives = 38/82 (46%)

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           +H   K  I+HRDIK  N+L+      K+ DFG  R   E           T  Y +PE 
Sbjct: 113 IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPEL 172

Query: 444 VVRGKLTEKADVYSFGVVVIEV 465
           ++     +  D++S G ++ E+
Sbjct: 173 LLGAPYGKAVDMWSVGCILGEL 194

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 42.3 bits (99), Expect = 6e-04
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 34/210 (16%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           N +G G  G VY+   +   E VA+K++  +  Q+ +    E+ ++  +NH N++ L   
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-QYKNR---ELLIMKNLNHINIIFLKDY 127

Query: 334 SITGPESL----------LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
             T  E            +V EF+P      + +        PL     Y   L  A  L
Sbjct: 128 YYT--ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRA--L 183

Query: 382 AYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLF---PEDITHISATLAGTLG 437
           AY+H  SK  I HRD+K  N+L+D    T K+ DFG  +        +++I +       
Sbjct: 184 AYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF----- 235

Query: 438 YMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
           Y APE ++     T   D++S G ++ E++
Sbjct: 236 YRAPELMLGATNYTTHIDLWSLGCIIAEMI 265

Length = 440

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 44/177 (24%), Positives = 67/177 (37%), Gaps = 48/177 (27%)

Query: 275 NKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQW--VDHFFNE----------VN 317
            KLG+G  G VYK +L            +K+     T++  V+ + NE           +
Sbjct: 138 KKLGEGAFGVVYKASLVNKQSKKEGKYVLKK----ATEYGAVEIWMNERVRRACPNSCAD 193

Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---DVEP-LSWEV---- 369
            + G       K         E  LV+ +    +L D +  ++   +VEP L  +V    
Sbjct: 194 FVYGFLEPVSSK------KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247

Query: 370 ----RYKIILSTA-----EGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFG 416
               R   I+ T        L  LH      I+HRD+K  NI+  E   + KI D G
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLG 301

Length = 566

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 40.7 bits (96), Expect = 0.001
 Identities = 65/236 (27%), Positives = 96/236 (40%), Gaps = 52/236 (22%)

Query: 271 FHESNKLGQGGSGSVY----KGTLPGGEAVAVKRLFYNTTQW---VDHFFNEVNLISGIN 323
           F +   LG+G  G V+    KGT   G+  A+K L          V     E  +++ ++
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGT---GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59

Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV-RYKIILSTAE--- 379
           H  L  L     T     LV ++ P   L   L  RQ  + LS EV R+      AE   
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGELFR-LLQRQPGKCLSEEVARFYA----AEVLL 114

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL---------------------- 417
            L YLH    L I++RD+K  NILL E     ++DF L                      
Sbjct: 115 ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 418 ------VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVV 466
                    F E+ +  S +  GT  Y+APE V+ G     A D ++ G+++ E++
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTLGILLYEML 226

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 41.3 bits (96), Expect = 0.001
 Identities = 54/215 (25%), Positives = 92/215 (42%), Gaps = 39/215 (18%)

Query: 315 EVNLISGINHKNLVKLLGCSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLSWEVRYK 372
           EVN++  + HKN+V+ +   +      L  + EF     L  N+   Q    +  ++   
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEH 118

Query: 373 IILSTAE----GLAYLHE----ESKLRIIHRDIKLSNILLDEEF---------------- 408
            I+         LAY H      +  R++HRD+K  NI L                    
Sbjct: 119 AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178

Query: 409 -TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT--EKADVYSFGVVVIEV 465
             AKI DFGL +     I  ++ +  GT  Y +PE ++    +  +K+D+++ G ++ E+
Sbjct: 179 PIAKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236

Query: 466 VCRK----RINLFTQNSCSILQTVWDLYVKGRLHE 496
              K    + N F+Q   S L+   DL +KG+  E
Sbjct: 237 CSGKTPFHKANNFSQ-LISELKRGPDLPIKGKSKE 270

Length = 1021

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 17/212 (8%)

Query: 294 EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL 353
           E + ++ L YN    +D      N I  I+H  + K  GC  +     + Y F+  + L+
Sbjct: 53  ETIVMETLVYNNIYDIDKIALWKN-IHNIDHLGIPKYYGCG-SFKRCRMYYRFILLEKLV 110

Query: 354 DN---LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
           +N   +F R   +    ++   I+      L Y+HE     I H DIK  NI++D     
Sbjct: 111 ENTKEIFKRIKCKNK--KLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG 165

Query: 411 KIADFGLVRLFPEDITHISATLA------GTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
            I D+G+   F     HI  +        GTL Y   +      +T + D+ S G  +++
Sbjct: 166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Query: 465 VVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
               K       ++ +++      ++K RLHE
Sbjct: 226 WAGIKLPWKGFGHNGNLIHAAKCDFIK-RLHE 256

Length = 294

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	573
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.98
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.98
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.98
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.98
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.97
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.92
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
PRK09188	365	serine/threonine protein kinase; Provisional	99.91
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.89
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.88
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.85
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.85
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.84
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.81
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.79
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.79
PRK10345	210	hypothetical protein; Provisional	99.79
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.78
PF01657	106	Stress-antifung: Salt stress response/antifungal;	99.77
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.77
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.76
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.76
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.75
smart00090	237	RIO RIO-like kinase.	99.74
PRK14879	211	serine/threonine protein kinase; Provisional	99.73
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.64
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.63
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.63
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.57
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.4
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.33
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.33
KOG1243	690	consensus Protein kinase [General function predict	99.29
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.24
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.2
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.19
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.19
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.02
KOG3087	229	consensus Serine/threonine protein kinase [General	99.01
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.91
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.88
COG4248	637	Uncharacterized protein with protein kinase and he	98.87
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.83
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.74
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.72
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.53
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.52
PRK09902	216	hypothetical protein; Provisional	98.49
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.37
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.33
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.29
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.21
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.21
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.19
PF01636	239	APH: Phosphotransferase enzyme family This family	98.15
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.1
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.08
PLN02876	822	acyl-CoA dehydrogenase	98.01
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.91
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.87
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	97.87
PRK10593	297	hypothetical protein; Provisional	97.86
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.75
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.74
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.69
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.4
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.35
PRK05231	319	homoserine kinase; Provisional	97.3
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.24
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.2
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.15
PLN02236	344	choline kinase	97.01
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.97
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.95
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.75
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.42
KOG2270	520	consensus Serine/threonine protein kinase involved	96.4
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.25
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.23
PLN02756	418	S-methyl-5-thioribose kinase	96.01
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.0
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	95.86
COG2334	331	Putative homoserine kinase type II (protein kinase	95.81
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.64
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	95.64
PRK12396	409	5-methylribose kinase; Reviewed	95.21
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.21
PRK11768	325	serine/threonine protein kinase; Provisional	95.07
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.07
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.06
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	94.87

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-56  Score=456.74  Aligned_cols=286  Identities=50%  Similarity=0.799  Sum_probs=253.4

Q ss_pred             CccccChHHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeee
Q 008239          255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS  334 (573)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~  334 (573)
                      ....|++.++..+|++|...++||+|+||.||+|.+++|+.||||++.....+...+|.+|+.++.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            44569999999999999999999999999999999999999999988765443145699999999999999999999999


Q ss_pred             ecCCc-eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEe
Q 008239          335 ITGPE-SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA  413 (573)
Q Consensus       335 ~~~~~-~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~  413 (573)
                      .+.+. .+||||||++|+|.++|+..... +++|..|++|+.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls  219 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS  219 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence            99995 99999999999999999876554 89999999999999999999999988899999999999999999999999


Q ss_pred             ecccccccCC-CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCC--CCcchHHHHHHHhh
Q 008239          414 DFGLVRLFPE-DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ--NSCSILQTVWDLYV  490 (573)
Q Consensus       414 Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~  490 (573)
                      |||+++..+. .... .....||.+|+|||++..+..+.|+|||||||+|+||+||+++.....  ....+..|.+..+.
T Consensus       220 DFGLa~~~~~~~~~~-~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  220 DFGLAKLGPEGDTSV-STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             CccCcccCCccccce-eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            9999976654 2221 111179999999999999999999999999999999999998887654  23358899999999


Q ss_pred             cCccccccCcccc-CCCCC-chHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          491 KGRLHEAVDPALA-GNFQE-GKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       491 ~~~~~~~~d~~l~-~~~~~-~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .+++.+++|+.+. ..+.. ....++..++.+|++.+|++||+|.||+++|+..
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~  352 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGI  352 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhh
Confidence            9999999999987 55554 5788899999999999999999999999999443

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-49  Score=398.23  Aligned_cols=260  Identities=29%  Similarity=0.443  Sum_probs=220.3

Q ss_pred             HhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..+.+...+.||+|.||+||.|.++....||||.++... ...+.|.+|+.+|++|+|+|||+++|+|..+..++|||||
T Consensus       204 ~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  204 PREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             cHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            334455688999999999999999988899999997653 3356888999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      |++|+|.++|.. .....+...+.+.++.|||+||+||++++   +|||||.++||||+++..+||+|||||+...++..
T Consensus       283 m~~GsLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y  358 (468)
T KOG0197|consen  283 MPKGSLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEY  358 (468)
T ss_pred             cccCcHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCce
Confidence            999999999965 23456889999999999999999999998   99999999999999999999999999997666666


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......--+..|.|||.+..+.|+.|||||||||+||||+|-.+.+.......++++.             ++...+-..
T Consensus       359 ~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-------------le~GyRlp~  425 (468)
T KOG0197|consen  359 TASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-------------LERGYRLPR  425 (468)
T ss_pred             eecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-------------HhccCcCCC
Confidence            5555555678999999999999999999999999999999987765444332222222             222333345


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE  544 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  544 (573)
                      +..+|..+.+||..||+.+|++|||++.+...|++...
T Consensus       426 P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~  463 (468)
T KOG0197|consen  426 PEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT  463 (468)
T ss_pred             CCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence            77899999999999999999999999999999866543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=392.76  Aligned_cols=255  Identities=34%  Similarity=0.453  Sum_probs=212.2

Q ss_pred             ccccccccccCceeEEEEEcCCCCEEEEEEecccCh--hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC-ceeEEEEec
Q 008239          271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGP-ESLLVYEFV  347 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e~~  347 (573)
                      +...+.||+|+||+||+|.+.....||||++.....  ...+.|.+|+.+|.+++|||||+++|+|.+.. ...+|||||
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            344566999999999999998555599999976432  22568999999999999999999999999988 799999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-cEEEeecccccccCCCCc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~~  426 (573)
                      ++|+|.++++.. ....+++..+++++.|||+||.|||+++.  ||||||||+|||++.++ ++||+|||+++...... 
T Consensus       123 ~~GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-  198 (362)
T KOG0192|consen  123 PGGSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-  198 (362)
T ss_pred             CCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-
Confidence            999999999764 45679999999999999999999999863  99999999999999997 99999999998654322 


Q ss_pred             ccccccccCcCcCchhhhc--cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          427 HISATLAGTLGYMAPEYVV--RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~--~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      ...+...||+.|||||++.  ...|+.|+|||||||+||||+||+.|+.....    .+.+......         ..+.
T Consensus       199 ~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~----~~~~~~v~~~---------~~Rp  265 (362)
T KOG0192|consen  199 TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP----VQVASAVVVG---------GLRP  265 (362)
T ss_pred             ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhc---------CCCC
Confidence            2233468999999999999  56999999999999999999999999765443    2222222222         2223


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .++...+..+..|+.+||+.||..||++.+++.+|+..
T Consensus       266 ~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~  303 (362)
T KOG0192|consen  266 PIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESI  303 (362)
T ss_pred             CCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHH
Confidence            44555788999999999999999999999999999643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=366.66  Aligned_cols=252  Identities=26%  Similarity=0.384  Sum_probs=208.7

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc-eeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-SLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~e~  346 (573)
                      +++..+.||+|..|+|||++++ +++.+|+|.+..+ .....+++.+|+++++..+|||||+++|.|..... ..++|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3445789999999999999986 6889999999655 44556789999999999999999999999999884 9999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      |.+|||.+++..   .+.+++..+-+++.+|++||.|||+..  +||||||||+||||+..|+|||+|||.+..+...  
T Consensus       160 MDgGSLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  160 MDGGSLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             cCCCCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999998843   356899999999999999999999632  3999999999999999999999999999876543  


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                       ...+.+||..|||||.+.++.|+.++||||||+.++|+.+|+.|+..........-.....+..+.     .|    ..
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~p-----pP----~l  302 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEP-----PP----RL  302 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCC-----CC----CC
Confidence             445778999999999999999999999999999999999999998765222211111111112211     12    22


Q ss_pred             CC-chHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          507 QE-GKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       507 ~~-~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +. ..+.++..++..||++||.+||+++|++++
T Consensus       303 P~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  303 PEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             CcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            33 377889999999999999999999999864

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-46  Score=377.47  Aligned_cols=247  Identities=25%  Similarity=0.384  Sum_probs=214.0

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ..|+..+.||+|+|.+||.++. ..|+.||+|++.+.   .....+...+|+++.+.|+|||||+++++|++.+..|+|.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            5689999999999999999998 78999999999653   3445678899999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      |+|++++|.+++.   +..++++.+++.++.||+.||.|||+++   |||||||..|+||+++++|||+|||||..+..+
T Consensus        98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~  171 (592)
T KOG0575|consen   98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD  171 (592)
T ss_pred             EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence            9999999999884   4567999999999999999999999998   999999999999999999999999999987644


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                       .+...+.+||+.|+|||++....++..+||||+|||||-||.|++||....     +...+..++..+.          
T Consensus       172 -~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~-----vkety~~Ik~~~Y----------  235 (592)
T KOG0575|consen  172 -GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT-----VKETYNKIKLNEY----------  235 (592)
T ss_pred             -ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch-----HHHHHHHHHhcCc----------
Confidence             234567899999999999999999999999999999999999999987542     2233333333221          


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+...+.+..+|+.++|+.+|.+|||+++|+.
T Consensus       236 ~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  236 SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            123355667789999999999999999999995

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=3.5e-47  Score=400.85  Aligned_cols=264  Identities=28%  Similarity=0.426  Sum_probs=222.5

Q ss_pred             HHhcCccccccccccCceeEEEEEcC------CCCEEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCC
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGP  338 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  338 (573)
                      ....+.+..+.||+|.||+||+|+..      +.+.||||.++..... ..++|.+|+++|..|+|||||+|+|+|.+++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            34456677899999999999999853      3468999999887655 6789999999999999999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQD-----------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE  407 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~  407 (573)
                      ..++|+|||..|+|.++|..+..           ..+++..+.+.|+.|||.||.||-++.   +|||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence            99999999999999999964321           234889999999999999999999987   9999999999999999


Q ss_pred             CcEEEeecccccc-cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHH
Q 008239          408 FTAKIADFGLVRL-FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVW  486 (573)
Q Consensus       408 ~~~kl~Dfgla~~-~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~  486 (573)
                      ..|||+||||++. +..++........-+.+|||||.|..++|+.+||||||||+||||++-.+-+......    +++.
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn----~EVI  715 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN----QEVI  715 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch----HHHH
Confidence            9999999999984 4555555554566689999999999999999999999999999999866544443332    2334


Q ss_pred             HHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCC
Q 008239          487 DLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEI  545 (573)
Q Consensus       487 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~  545 (573)
                      ....++++         -+.++++|.+++.||..||+.+|++||+++||-..|......
T Consensus       716 e~i~~g~l---------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  716 ECIRAGQL---------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHHHcCCc---------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            44455554         245788999999999999999999999999999999665444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-45  Score=358.17  Aligned_cols=201  Identities=31%  Similarity=0.484  Sum_probs=181.1

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ..+|...++||+|+||+||+|++. ++..||||.+...  .....+.+..|+.+|+.++|||||++++++..++..+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            357888899999999999999985 5899999999765  5566777889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC------CcEEEeecccc
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE------FTAKIADFGLV  418 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~------~~~kl~Dfgla  418 (573)
                      |||.+|+|.++++.+   +.+++.....++.|||.||++||+++   ||||||||+||||+..      -.+||+|||+|
T Consensus        89 EyC~gGDLs~yi~~~---~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRR---GRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             EeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            999999999999654   36899999999999999999999998   9999999999999764      56899999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCC
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ  476 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~  476 (573)
                      +.+..  .....+.+|++-|||||++..++|+.|+|+||+|+||||+++|+.||....
T Consensus       163 R~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t  218 (429)
T KOG0595|consen  163 RFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAET  218 (429)
T ss_pred             hhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccC
Confidence            98763  334457899999999999999999999999999999999999999987544

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-46  Score=342.63  Aligned_cols=256  Identities=23%  Similarity=0.358  Sum_probs=208.6

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeee-eeecCCc-eeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG-CSITGPE-SLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~~-~~lv  343 (573)
                      .+|++.++||+|.||+|||+.. .+|..+|.|.+.-.  +.+..+....|+.+|++|+|||||++++ .+.++.. +.||
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            4578899999999999999985 68999999998654  4455678889999999999999999998 4544444 8899


Q ss_pred             EEeccCCCccccccc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC-CCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          344 YEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESK-LRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~-~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      |||+..|+|...+.. ++....+++..+|+++.|++.||.++|++.. ..|+||||||.||+|+.+|.+||+||||++.+
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999988853 2344568999999999999999999999531 23999999999999999999999999999988


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      .... ......+|||.||+||.+....|+.||||||+||++|||..-+.||....     .-.....+.+++...     
T Consensus       179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-----~~~L~~KI~qgd~~~-----  247 (375)
T KOG0591|consen  179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-----LLSLCKKIEQGDYPP-----  247 (375)
T ss_pred             cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-----HHHHHHHHHcCCCCC-----
Confidence            6543 34456789999999999999999999999999999999999999987641     112222333333211     


Q ss_pred             ccCCCC-CchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          502 LAGNFQ-EGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       502 l~~~~~-~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                          .+ .-.+.++.+|+..|+..||+.||+...+++-+
T Consensus       248 ----~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  248 ----LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             ----CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence                22 34677899999999999999999965555544

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-45  Score=356.55  Aligned_cols=254  Identities=26%  Similarity=0.341  Sum_probs=208.3

Q ss_pred             HhcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChh-------hHHHHHHHHHHHcCCCCCCeeeeeeeeecCC
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQ-------WVDHFFNEVNLISGINHKNLVKLLGCSITGP  338 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  338 (573)
                      ..+.|...+.||+|+||.|-+|.. ++|+.||||++......       ......+|+++|++|+|||||++++++....
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456678899999999999999986 47999999999654211       1123468999999999999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC---CcEEEeec
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADF  415 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~---~~~kl~Df  415 (573)
                      ..|+||||+++|+|.+.+..+   +.+.+..-..++.|++.|+.|||++|   |+||||||+|||+..+   ..+||+||
T Consensus       250 s~YmVlE~v~GGeLfd~vv~n---k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVAN---KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhc---cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence            999999999999999988543   44667777889999999999999998   9999999999999765   78999999


Q ss_pred             ccccccCCCCcccccccccCcCcCchhhhccCC---CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC
Q 008239          416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGK---LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG  492 (573)
Q Consensus       416 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  492 (573)
                      |+|+...  ....+.+.+||+.|.|||++.+..   +..++|+||+||+||-+++|.+||........+.+.+    ..|
T Consensus       324 GlAK~~g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI----~~G  397 (475)
T KOG0615|consen  324 GLAKVSG--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQI----LKG  397 (475)
T ss_pred             chhhccc--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHH----hcC
Confidence            9999875  345677899999999999998753   3358899999999999999999987655543343332    333


Q ss_pred             ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       493 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +...      ......+..++..+++.+||..||++||+++|+++.
T Consensus       398 ~y~f------~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  398 RYAF------GPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cccc------cChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            3311      112234567888999999999999999999999863

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-45  Score=379.65  Aligned_cols=265  Identities=27%  Similarity=0.413  Sum_probs=221.4

Q ss_pred             cChHHHHHHhcCc---------cccccccccCceeEEEEEcCC----CCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCC
Q 008239          259 FSYETLEKATNYF---------HESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINH  324 (573)
Q Consensus       259 ~~~~~~~~~~~~~---------~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h  324 (573)
                      ++|++..++-+.|         .+.++||.|.||+|++|+++-    ...||||.++.. .++....|+.|+.+|.+++|
T Consensus       610 ~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdH  689 (996)
T KOG0196|consen  610 HTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDH  689 (996)
T ss_pred             ccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCC
Confidence            5676655555444         457899999999999999852    357999999875 44556789999999999999


Q ss_pred             CCeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee
Q 008239          325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL  404 (573)
Q Consensus       325 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll  404 (573)
                      |||++|.|+.......++|+|||++|+|+.+|..+.  +.+++.++..++++||.||.||.+.+   +|||||.++|||+
T Consensus       690 PNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILV  764 (996)
T KOG0196|consen  690 PNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILV  764 (996)
T ss_pred             CcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheee
Confidence            999999999999999999999999999999996543  56999999999999999999999987   9999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCccccccccc--CcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcch
Q 008239          405 DEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSI  481 (573)
Q Consensus       405 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~  481 (573)
                      +.+...|++||||++.+.++.....+...|  +.+|.|||.+...+++.+||||||||+|||.++ |++|.....+    
T Consensus       765 NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----  840 (996)
T KOG0196|consen  765 NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----  840 (996)
T ss_pred             ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----
Confidence            999999999999999886665333333333  579999999999999999999999999999876 6666544333    


Q ss_pred             HHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          482 LQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       482 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                                +++.+.++...+-..+.+++..|.+||+.|||+|-.+||++.+|+.+|.+.
T Consensus       841 ----------QdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDkl  891 (996)
T KOG0196|consen  841 ----------QDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKL  891 (996)
T ss_pred             ----------HHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHH
Confidence                      122233344445566889999999999999999999999999999999553

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=387.70  Aligned_cols=261  Identities=31%  Similarity=0.461  Sum_probs=217.4

Q ss_pred             hcCccccccccccCceeEEEEEcCC--CC----EEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG--GE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      ..+.+..+.||+|+||.||.|...+  |.    .||||.+.+. +.+...+|.+|..+|++++|||||+++|++.+....
T Consensus       691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            3455667899999999999998643  43    4899999765 556678999999999999999999999999999999


Q ss_pred             eEEEEeccCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                      ++++|||++|+|..+|...+.    ...++...++.++.|||+|+.||++++   +|||||.++|+||++...|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            999999999999999965421    346888999999999999999999988   9999999999999999999999999


Q ss_pred             ccc-ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc
Q 008239          417 LVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH  495 (573)
Q Consensus       417 la~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  495 (573)
                      ||+ .+..+.........-+.+|||||.+..+.|+.|+|||||||+||||+|...+++......++...   ....+++ 
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~---~~~ggRL-  923 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLD---VLEGGRL-  923 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHH---HHhCCcc-
Confidence            999 44444444444445578999999999999999999999999999999998877766544333221   1222222 


Q ss_pred             cccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 008239          496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE  544 (573)
Q Consensus       496 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  544 (573)
                               +.+..+++.+++||..||+.+|++||++..|++.+.....
T Consensus       924 ---------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  924 ---------DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             ---------CCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence                     3467789999999999999999999999999998855443

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=339.70  Aligned_cols=242  Identities=26%  Similarity=0.320  Sum_probs=203.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+.+++||+|+||+||.++.+ +++.+|+|++++.   .....+...+|..+|.+++||.||+++-.|.+.+.++||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV  103 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV  103 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence            578999999999999999999875 5889999999654   233466788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      +||+.||.|..+|.   +...+++..+.-++..|+.||.|||+++   ||||||||+|||||++|+++|+||||++..-.
T Consensus       104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~  177 (357)
T KOG0598|consen  104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK  177 (357)
T ss_pred             EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence            99999999999994   4456899999999999999999999998   99999999999999999999999999985433


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      . ...+.+.+||+.|||||++.+..|+..+|.||||+++|||++|.+||.....     ....+....+++         
T Consensus       178 ~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~-----~~~~~~I~~~k~---------  242 (357)
T KOG0598|consen  178 D-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV-----KKMYDKILKGKL---------  242 (357)
T ss_pred             C-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH-----HHHHHHHhcCcC---------
Confidence            2 2234458999999999999999999999999999999999999999876442     122222222221         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCC
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRP  530 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RP  530 (573)
                      ...+.-...+..+++...++.+|++|-
T Consensus       243 ~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  243 PLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             CCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            112233456778999999999999995

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=329.39  Aligned_cols=261  Identities=21%  Similarity=0.315  Sum_probs=201.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      +.|+.+.++|+|+||+|||++.+ +|+.||||++..+.  +...+...+|+++|++|+|+|+|.|+++|.....+.||+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            45778899999999999999986 59999999997653  3445667899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |++..-|.++=   .....++.+...+++.|++.|+.|+|+++   +|||||||+||||+.++.+||+|||+|+.+.. .
T Consensus        82 ~~dhTvL~eLe---~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-p  154 (396)
T KOG0593|consen   82 YCDHTVLHELE---RYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-P  154 (396)
T ss_pred             ecchHHHHHHH---hccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-C
Confidence            99875554432   22345888999999999999999999998   99999999999999999999999999998764 2


Q ss_pred             cccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHH----------HHHHhhcC-c
Q 008239          426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT----------VWDLYVKG-R  493 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~-~  493 (573)
                      ....+..+.|.+|.|||++.+ .+|+..+||||+||++.||++|.+.+....+-+.+...          -...+..+ .
T Consensus       155 gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~  234 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPF  234 (396)
T ss_pred             cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCc
Confidence            333456678999999999988 68999999999999999999998654433322111111          01111111 1


Q ss_pred             cccccCcc------ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          494 LHEAVDPA------LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       494 ~~~~~d~~------l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .+-+.-|.      +...++ ....-+++++..|++.||.+|++.++++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhc
Confidence            11111111      111122 23456889999999999999999998874

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-44  Score=360.06  Aligned_cols=268  Identities=28%  Similarity=0.441  Sum_probs=215.9

Q ss_pred             cChHHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec
Q 008239          259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT  336 (573)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  336 (573)
                      .+.++++...+.+...++||+|.||+||+|+|.+  .||||++...  ..+..+.|++|+..+++-+|.||+-+.|+|..
T Consensus       382 ~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~  459 (678)
T KOG0193|consen  382 DSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMN  459 (678)
T ss_pred             ccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcC
Confidence            4457777788888899999999999999999963  4999999765  45568899999999999999999999999998


Q ss_pred             CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                      ++. .||+.+|++.+|..+++..+  ..++....+.|+.||++||.|||.++   |||||||..||+|.++++|||+|||
T Consensus       460 p~~-AIiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFG  533 (678)
T KOG0193|consen  460 PPL-AIITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFG  533 (678)
T ss_pred             Cce-eeeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccc
Confidence            877 99999999999999997654  45888999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCC-cccccccccCcCcCchhhhcc---CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC
Q 008239          417 LVRLFPEDI-THISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG  492 (573)
Q Consensus       417 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  492 (573)
                      |+..-..-. ........|...|||||+++.   .+|+..+||||||+++|||++|..|+.. +....++      |..|
T Consensus       534 Latvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi-~~~dqIi------fmVG  606 (678)
T KOG0193|consen  534 LATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSI-QNRDQII------FMVG  606 (678)
T ss_pred             ceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCC-CChhheE------EEec
Confidence            987432211 111123456778999999975   4799999999999999999999999873 3322111      1112


Q ss_pred             ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 008239          493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE  544 (573)
Q Consensus       493 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  544 (573)
                      +-.-.  +.+. ......+.++.+|+..||..++++||.+.+|+.+|+....
T Consensus       607 rG~l~--pd~s-~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  607 RGYLM--PDLS-KIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             ccccC--ccch-hhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            21111  1111 1234678899999999999999999999999998865543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=348.61  Aligned_cols=263  Identities=27%  Similarity=0.396  Sum_probs=213.8

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .....+.++||+|.||+|..+....+..||||+++.... ...++|.+|+++|.+|+|||||+++|+|..++.+++++||
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            344567899999999999999998889999999987654 3458999999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc-cCCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL-FPEDI  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~-~~~~~  425 (573)
                      |++|+|.+++..+.... +.-....+|+.||+.||+||.+-+   +|||||.++|+|++.++++||+|||+++. +..+.
T Consensus       617 mEnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y  692 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY  692 (807)
T ss_pred             HhcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCc
Confidence            99999999996543222 455667789999999999999987   99999999999999999999999999994 44555


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc--CCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC--RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .......+-+.+|||||.+..++++.+||||+||+.+||+++  .++|+....++ +.++..-.....+.      ....
T Consensus       693 y~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e-~vven~~~~~~~~~------~~~~  765 (807)
T KOG1094|consen  693 YRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE-QVVENAGEFFRDQG------RQVV  765 (807)
T ss_pred             eeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH-HHHHhhhhhcCCCC------ccee
Confidence            555666777899999999999999999999999999999874  55565433221 22222111111111      1111


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...+.-++..++++++.||+.+-++||+++++...|.+
T Consensus       766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            23456788999999999999999999999999998843

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-43  Score=354.53  Aligned_cols=250  Identities=26%  Similarity=0.388  Sum_probs=207.6

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++...+....++-||+|+.|.||+|++. ++.||||++..-       -..+++-|++|+||||+.+.|+|......+||
T Consensus       119 WeiPFe~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIi  190 (904)
T KOG4721|consen  119 WEIPFEEISELEWLGSGAQGAVFLGRLH-NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCII  190 (904)
T ss_pred             ccCCHHHhhhhhhhccCcccceeeeecc-CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEe
Confidence            3333444456789999999999999997 688999987432       23578899999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      ||||+.|-|.+.|...   ..+.......|..+||.||.|||.+.   |||||||.-||||..+..|||+|||-++...+
T Consensus       191 MEfCa~GqL~~VLka~---~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~  264 (904)
T KOG4721|consen  191 MEFCAQGQLYEVLKAG---RPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSD  264 (904)
T ss_pred             eeccccccHHHHHhcc---CccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhh
Confidence            9999999999999433   45778889999999999999999987   99999999999999999999999999987755


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .  .....++||..|||||++.+++.+.|+|||||||+|||||||.-|...-..    ...+   |..|      ...|.
T Consensus       265 ~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds----sAII---wGVG------sNsL~  329 (904)
T KOG4721|consen  265 K--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS----SAII---WGVG------SNSLH  329 (904)
T ss_pred             h--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch----heeE---Eecc------CCccc
Confidence            4  334567899999999999999999999999999999999999988532111    1111   1111      12233


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      -..+..+++.+.-|+.+||+..|.+||++.+|+..|+-.
T Consensus       330 LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  330 LPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             ccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence            345778899999999999999999999999999999543

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.1e-42  Score=315.67  Aligned_cols=262  Identities=26%  Similarity=0.345  Sum_probs=205.6

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEecccChh--hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .+|...++||+|.||.||+|+. .+|+.||||++......  ......+|+..|+.++|+||+.++++|...+...||+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            3577789999999999999986 47999999999765322  23467899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      ||+. +|...+..  +...++..++..++.++++|++|+|+++   |+||||||.|+|++.+|.+||+|||+++.+....
T Consensus        82 fm~t-dLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   82 FMPT-DLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             eccc-cHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            9964 88887743  4456889999999999999999999999   9999999999999999999999999999886554


Q ss_pred             cccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC---cccc---cc
Q 008239          426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG---RLHE---AV  498 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~---~~  498 (573)
                      .... ..+-|.+|.|||++.+ ..|+..+||||.|||+.||+.|.+ +..+..+-+.+..+...+...   ++.+   +.
T Consensus       156 ~~~~-~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P-~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp  233 (318)
T KOG0659|consen  156 RIQT-HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVP-FFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP  233 (318)
T ss_pred             cccc-cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCC-CCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence            3322 2367999999999987 579999999999999999998764 444443322222222222211   1111   11


Q ss_pred             C---------ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          499 D---------PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       499 d---------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      |         +.+ ...-.....+.++++..++..||.+|+++.|++++=
T Consensus       234 dY~~~~~~P~~~~-~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~  282 (318)
T KOG0659|consen  234 DYVKIQQFPKPPL-NNLFPAASSDALDLLSKMLTYNPKKRITASQALKHP  282 (318)
T ss_pred             cHHHHhcCCCCcc-ccccccccHHHHHHHHhhhccCchhcccHHHHhcch
Confidence            1         111 112234566679999999999999999999999765

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=341.31  Aligned_cols=254  Identities=27%  Similarity=0.383  Sum_probs=206.4

Q ss_pred             cCccccccccccCceeEEEEEcCC-CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC--ceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv~e  345 (573)
                      .++...+.||+|+||+||++...+ |+..|||..........+.+.+|+.+|++++|||||+++|.....+  ...+.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            456778999999999999999764 8999999987654444677899999999999999999999855555  5889999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-CCcEEEeecccccccCC-
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPE-  423 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~-  423 (573)
                      |+++|+|.+++.....  .+++..+.+++.||++||+|||+++   ||||||||+||||+. ++.+||+|||++..... 
T Consensus        97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~  171 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK  171 (313)
T ss_pred             ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence            9999999999965433  6999999999999999999999998   999999999999999 79999999999987663 


Q ss_pred             -CCcccccccccCcCcCchhhhccCC-CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          424 -DITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       424 -~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                       ..........||+.|||||++..+. ...++|||||||++.||+||+.|+...   .....+.........        
T Consensus       172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~---~~~~~~~~~ig~~~~--------  240 (313)
T KOG0198|consen  172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF---FEEAEALLLIGREDS--------  240 (313)
T ss_pred             cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh---cchHHHHHHHhccCC--------
Confidence             2222334578999999999998643 335999999999999999998886542   111222222222211        


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                       ...++...+.+..+++.+|++.+|+.|||++++++..
T Consensus       241 -~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp  277 (313)
T KOG0198|consen  241 -LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP  277 (313)
T ss_pred             -CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence             1244566778889999999999999999999999876

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=350.78  Aligned_cols=251  Identities=28%  Similarity=0.418  Sum_probs=216.8

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ...|...++||+|+.|.||.+.. .+++.||||++........+-+.+|+.+|+..+|+|||++++.+...+++|+||||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEy  351 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEY  351 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEee
Confidence            35577788999999999999975 46889999999887777778889999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      |++|+|.+.+..    ..+++.++..|..++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+.....
T Consensus       352 m~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  352 MEGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             cCCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            999999998832    34899999999999999999999998   99999999999999999999999999987765443


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                       .....+||+.|||||++....|+.|.||||||+|++||+-|++|+....    .++.+|....+|..      .+  ..
T Consensus       425 -KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~----PlrAlyLIa~ng~P------~l--k~  491 (550)
T KOG0578|consen  425 -KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN----PLRALYLIATNGTP------KL--KN  491 (550)
T ss_pred             -ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC----hHHHHHHHhhcCCC------Cc--CC
Confidence             4456789999999999999999999999999999999999999987643    24455555455432      12  22


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +...+..+.+++.+||+.|++.||++.|+|+.
T Consensus       492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            34556788999999999999999999999963

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-42  Score=354.93  Aligned_cols=258  Identities=28%  Similarity=0.384  Sum_probs=206.3

Q ss_pred             HhcCccccccccccCceeEEEEEcCC--C--CE-EEEEEecc---cChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPG--G--EA-VAVKRLFY---NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP  338 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--g--~~-vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  338 (573)
                      ..++....++||+|+||+||+|++..  +  .. ||||....   .......+|.+|+++|++++|||||+++|++....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~  234 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE  234 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC
Confidence            33445556999999999999998753  2  23 89999875   34667889999999999999999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      .+++|||+|++|+|.++|.....  .++..++++++.+.|.||+|||+++   +|||||.++|+|++.++.+||+||||+
T Consensus       235 Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs  309 (474)
T KOG0194|consen  235 PLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLS  309 (474)
T ss_pred             ccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccc
Confidence            99999999999999999954332  6899999999999999999999998   999999999999999999999999998


Q ss_pred             cccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      +.-. .........--+.+|+|||.+..+.|+.++|||||||++||+++ |..|+. +.....+..++   ..+      
T Consensus       310 ~~~~-~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~-g~~~~~v~~kI---~~~------  378 (474)
T KOG0194|consen  310 RAGS-QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYP-GMKNYEVKAKI---VKN------  378 (474)
T ss_pred             cCCc-ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCC-CCCHHHHHHHH---Hhc------
Confidence            8543 11111112234789999999999999999999999999999999 455433 32221221111   111      


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                         ..+-..+...+..+..++.+||..+|++||+|.++.+.|+...
T Consensus       379 ---~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  379 ---GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             ---CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence               1122334567888999999999999999999999999995443

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=332.23  Aligned_cols=263  Identities=31%  Similarity=0.400  Sum_probs=203.2

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcC--CCCCCeeeeeeeeecCC----ceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSITGP----ESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~----~~~l  342 (573)
                      ...+..++||+|.||.||||++. ++.||||++.   .+..+.|.+|-++.+.  ++|+||+++++.-....    +.+|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            34556889999999999999997 4999999994   4456678888777655  58999999999876555    8899


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc------CCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE------SKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                      |+||.++|+|.++|.    ...++|....+++..+++||+|||+.      .+++|+|||||++||||.+|++..|+|||
T Consensus       286 Vt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFG  361 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFG  361 (534)
T ss_pred             EeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccc
Confidence            999999999999994    34589999999999999999999975      36789999999999999999999999999


Q ss_pred             cccccCCCCcc-cccccccCcCcCchhhhccCC-CC-----cccchHhHHHHHHHHHcCCCCCCCCCC------------
Q 008239          417 LVRLFPEDITH-ISATLAGTLGYMAPEYVVRGK-LT-----EKADVYSFGVVVIEVVCRKRINLFTQN------------  477 (573)
Q Consensus       417 la~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~~-----~~sDvwslGvil~elltg~~p~~~~~~------------  477 (573)
                      ||..+...... ..-..+||.+|||||++.+.. +.     .+.||||+|.+||||+++-.-......            
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            99977543222 223478999999999997752 22     268999999999999987654321110            


Q ss_pred             CcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          478 SCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ...-.+.++......+....+......   ...+..+.+.+..||..||+.|.|+.=|-+.+...
T Consensus       442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRKKQRPKIPDAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             CCCCHHHHHHHHHhhccCCCChhhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            112344555555444433333322222   24567788999999999999999998777777443

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7e-42  Score=351.14  Aligned_cols=260  Identities=27%  Similarity=0.364  Sum_probs=204.7

Q ss_pred             HhcCccccccccccCceeEEEEEc------CCCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCC
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP  338 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  338 (573)
                      ..++|++.++||+|+||.||+|.+      .+++.||||++.... ....+.+.+|+.++..+ +||||+++++++....
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (338)
T cd05102           5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN   84 (338)
T ss_pred             chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence            456789999999999999999974      235689999986543 33356788999999999 8999999999887644


Q ss_pred             -ceeEEEEeccCCCccccccccCC--------------------------------------------------------
Q 008239          339 -ESLLVYEFVPNQSLLDNLFVRQD--------------------------------------------------------  361 (573)
Q Consensus       339 -~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  361 (573)
                       ..++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (338)
T cd05102          85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD  164 (338)
T ss_pred             CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence             57899999999999988854211                                                        


Q ss_pred             ---CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc-cccccccCcC
Q 008239          362 ---VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLG  437 (573)
Q Consensus       362 ---~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~  437 (573)
                         ..++++..++.++.||++||+|||+.+   |+||||||+|||++.++.+||+|||+++........ ......++..
T Consensus       165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence               135788899999999999999999987   999999999999999999999999999865433221 1223445778


Q ss_pred             cCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHH
Q 008239          438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQ  516 (573)
Q Consensus       438 y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~  516 (573)
                      |+|||++.+..++.++||||||++||||++ |..|+.......    ........+..         ...+...+..+.+
T Consensus       242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~----~~~~~~~~~~~---------~~~~~~~~~~l~~  308 (338)
T cd05102         242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE----EFCQRLKDGTR---------MRAPENATPEIYR  308 (338)
T ss_pred             ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH----HHHHHHhcCCC---------CCCCCCCCHHHHH
Confidence            999999999999999999999999999997 777765433221    11122222211         1113345678899


Q ss_pred             HHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          517 IGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       517 l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      |+.+||+.+|++|||+.||+++|+..
T Consensus       309 li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         309 IMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999999653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-42  Score=340.12  Aligned_cols=261  Identities=25%  Similarity=0.340  Sum_probs=206.0

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--CceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  343 (573)
                      +.|+.+++||+|.||.||||+. .+|+.||+|++..+.  +....-..+||.+|++|+||||++|.+...+.  ..+|||
T Consensus       117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV  196 (560)
T KOG0600|consen  117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV  196 (560)
T ss_pred             HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence            4577789999999999999986 579999999997654  44556678999999999999999999988876  689999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      +|||++ +|.-++..  ..-.+++.++.-++.|++.||+|+|+++   |+|||||.+|||||++|.+||+|||||+.+..
T Consensus       197 FeYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  197 FEYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             Eecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence            999976 66655532  2335899999999999999999999998   99999999999999999999999999998877


Q ss_pred             CCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh--------hcCcc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY--------VKGRL  494 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~~~  494 (573)
                      ......+..+-|.+|.|||++.+. .|+.++|+||.||||.||+.|++.+....+-. .+..+..+-        ...++
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve-Ql~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVE-QLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHH-HHHHHHHHhCCCChhccccccC
Confidence            666656777889999999999875 89999999999999999999997654433221 122222111        11111


Q ss_pred             c--cccC------ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          495 H--EAVD------PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       495 ~--~~~d------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .  ..+.      ..+.+ .-...+...++|+..+|..||.+|.|+.++++
T Consensus       350 P~~~~~kp~~~y~r~l~E-~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRE-TFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CcccccCCCCcccchHHH-HhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            1  1111      11111 12345667789999999999999999999985

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=342.50  Aligned_cols=263  Identities=23%  Similarity=0.317  Sum_probs=207.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHH-HHHHHHHHcCCC-CCCeeeeeeeeecCC-ceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDH-FFNEVNLISGIN-HKNLVKLLGCSITGP-ESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~-~~~E~~~l~~l~-h~niv~l~~~~~~~~-~~~lv  343 (573)
                      -++|...++||.|.||.||+|+.. .|+.||||+++..-..+.+- -.+|+..|++|. |||||++.+++.+.. .+++|
T Consensus         9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV   88 (538)
T KOG0661|consen    9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV   88 (538)
T ss_pred             HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence            467888999999999999999864 68999999997765544432 358999999998 999999999999888 89999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      ||||+ .+|.+++..+  ...+++..+..|+.||++||+|+|.+|   +.||||||+|||+..+..+||+|||||+....
T Consensus        89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence            99995 5898888655  567999999999999999999999998   99999999999999888999999999997755


Q ss_pred             CCcccccccccCcCcCchhhhc-cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc-----
Q 008239          424 DITHISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA-----  497 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  497 (573)
                      ...  .+..+.|.+|.|||++. .+-|+.+.|+||+|||++||.+-++.|-...+- +.+-.+...+........     
T Consensus       163 kpP--YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~-Dqi~KIc~VLGtP~~~~~~eg~~  239 (538)
T KOG0661|consen  163 KPP--YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEI-DQIYKICEVLGTPDKDSWPEGYN  239 (538)
T ss_pred             CCC--cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHH-HHHHHHHHHhCCCccccchhHHH
Confidence            433  34567899999999875 578999999999999999999998765443322 222222222221111110     


Q ss_pred             ----cC---cccc----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          498 ----VD---PALA----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       498 ----~d---~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                          +.   |...    ...-...+.+..+++.+|+++||.+|||++|.+++=
T Consensus       240 La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~p  292 (538)
T KOG0661|consen  240 LASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHP  292 (538)
T ss_pred             HHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCc
Confidence                00   0000    112233678899999999999999999999999864

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=341.06  Aligned_cols=252  Identities=23%  Similarity=0.307  Sum_probs=211.9

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCcee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  341 (573)
                      -.++|..++.||+|+|++|++|+.. .++.+|||++.+.   .+...+....|-+.|.+| .||.|++|+-.|.+...+|
T Consensus        71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY  150 (604)
T KOG0592|consen   71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY  150 (604)
T ss_pred             ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence            3468999999999999999999865 6899999998543   233345667889999999 8999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +|+||.++|+|.++|.   +.+.+++...+.++.+|+.||+|||+.|   ||||||||+|||||.||++||.|||-|+.+
T Consensus       151 FvLe~A~nGdll~~i~---K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l  224 (604)
T KOG0592|consen  151 FVLEYAPNGDLLDLIK---KYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL  224 (604)
T ss_pred             EEEEecCCCcHHHHHH---HhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence            9999999999999994   4467999999999999999999999998   999999999999999999999999999977


Q ss_pred             CCCCcc----------cc--cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh
Q 008239          422 PEDITH----------IS--ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY  489 (573)
Q Consensus       422 ~~~~~~----------~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  489 (573)
                      +.....          .+  ...+||..|.+||++..+..+..+|+|+||||||+|+.|++||...++- .+.+.+..  
T Consensus       225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney-liFqkI~~--  301 (604)
T KOG0592|consen  225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY-LIFQKIQA--  301 (604)
T ss_pred             ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-HHHHHHHH--
Confidence            532221          12  3578999999999999999999999999999999999999998765431 11111111  


Q ss_pred             hcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       490 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                                  +.-.++...++...+|+.+.|..||.+|+|.++|-++.
T Consensus       302 ------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~Hp  339 (604)
T KOG0592|consen  302 ------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHP  339 (604)
T ss_pred             ------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCc
Confidence                        11245666778899999999999999999999998765

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-41  Score=330.24  Aligned_cols=262  Identities=26%  Similarity=0.345  Sum_probs=208.9

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ...|+..+.||.|..++||+|+. +.++.||||++..+. ....+.+.+|+..|+.++||||++++..|..+..+|+||.
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp  104 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP  104 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence            46789999999999999999985 578999999996543 2336889999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      ||.+||+.+.+...-. ..+++..+..|++++++||.|||++|   .||||||+.||||+.+|.|||+|||....+-+..
T Consensus       105 fMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             hhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            9999999998865433 34899999999999999999999998   9999999999999999999999999876443221


Q ss_pred             cc--cc-cccccCcCcCchhhhcc--CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          426 TH--IS-ATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       426 ~~--~~-~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ..  .. ....||+.|||||+++.  .-|+.|+|||||||...||.+|..|+.....-..++..+     ++....+.-.
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tL-----qn~pp~~~t~  255 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTL-----QNDPPTLLTS  255 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHh-----cCCCCCcccc
Confidence            11  11 46789999999999755  368999999999999999999999987655433232221     2222111111


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+..+........+.+++..||+.||+.|||++++++.
T Consensus       256 ~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  256 GLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             cCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            11111122344578899999999999999999998853

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.5e-40  Score=336.07  Aligned_cols=263  Identities=25%  Similarity=0.342  Sum_probs=203.7

Q ss_pred             hcCccccccccccCceeEEEEEcCC-----------------CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG-----------------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVK  329 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  329 (573)
                      .++|...++||+|+||.||++.+.+                 +..||||.+.... ......+.+|+.++.+++||||++
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~   83 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIR   83 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeE
Confidence            3568889999999999999997532                 3469999987643 334567899999999999999999


Q ss_pred             eeeeeecCCceeEEEEeccCCCccccccccC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 008239          330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ----------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII  393 (573)
Q Consensus       330 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ii  393 (573)
                      +++++.+....++||||+++|+|.+++....                ....+++..+++++.||+.||.|||+.+   |+
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---iv  160 (304)
T cd05096          84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FV  160 (304)
T ss_pred             EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999998874321                1134788999999999999999999987   99


Q ss_pred             EecCCCCCeeeCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCC--C
Q 008239          394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK--R  470 (573)
Q Consensus       394 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~--~  470 (573)
                      ||||||+|||++.++.+||+|||+++....... .......++..|+|||++..+.++.++||||||+++|||+++.  .
T Consensus       161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~  240 (304)
T cd05096         161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ  240 (304)
T ss_pred             ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence            999999999999999999999999986533222 1223345678999999999899999999999999999999754  3


Q ss_pred             CCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          471 INLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       471 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      |+... ..................      ......+...+..+.+|+.+||+.+|++|||+++|.++|+
T Consensus       241 p~~~~-~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         241 PYGEL-TDEQVIENAGEFFRDQGR------QVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCcC-CHHHHHHHHHHHhhhccc------cccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            33322 112222222222211110      0001123345678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-41  Score=313.72  Aligned_cols=236  Identities=26%  Similarity=0.332  Sum_probs=203.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||.|+||+|.+++.+ +|..+|+|++.+..   -...+...+|.++|+.+.||+++++++.+.+...+++||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            56788999999999999999976 58899999996643   344567788999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|.|.+++.   +.+.+++..++.++.||+.||+|||+.+   |++|||||+|||||.+|.+||.|||.|+.....
T Consensus       124 eyv~GGElFS~Lr---k~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r  197 (355)
T KOG0616|consen  124 EYVPGGELFSYLR---KSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR  197 (355)
T ss_pred             eccCCccHHHHHH---hcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence            9999999999994   4456999999999999999999999998   999999999999999999999999999977543


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                          ..+.+||+.|+|||.+....++.++|.|||||++|||+.|..||...+.     ..++..+..+++          
T Consensus       198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~-----~~iY~KI~~~~v----------  258 (355)
T KOG0616|consen  198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP-----IQIYEKILEGKV----------  258 (355)
T ss_pred             ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh-----HHHHHHHHhCcc----------
Confidence                4578999999999999999999999999999999999999999876654     122222233332          


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCC
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELR  529 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~R  529 (573)
                      .++.-...++.+|+...++.|-..|
T Consensus       259 ~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  259 KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             cCCcccCHHHHHHHHHHHhhhhHhh
Confidence            3455566778899999999998888

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=343.09  Aligned_cols=262  Identities=29%  Similarity=0.418  Sum_probs=221.2

Q ss_pred             hHHHHHHhcCccccccccccCceeEEEEEcCC-CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc
Q 008239          261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE  339 (573)
Q Consensus       261 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  339 (573)
                      +..|+....+....++||-|.||.||.|.|+. .-.||||.++.+..+ .++|+.|+.+|+.++|||+|+|+|+|.....
T Consensus       259 ~DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~EpP  337 (1157)
T KOG4278|consen  259 ADKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTHEPP  337 (1157)
T ss_pred             cchhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhccCCC
Confidence            35566666677778999999999999999974 568999999776554 7899999999999999999999999999999


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .|||+|||..|+|.++|....+ ..++.-.++.++.||+.||.||..++   +|||||.++|+|+.++..|||+||||++
T Consensus       338 FYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             eEEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhh
Confidence            9999999999999999965443 45777888999999999999999988   9999999999999999999999999999


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ++..+........--++.|.|||.+....++.|+|||+|||+||||.|-...+..+.+    +..++.++.++       
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----lSqVY~LLEkg-------  482 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----LSQVYGLLEKG-------  482 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----HHHHHHHHhcc-------
Confidence            9877665544444457889999999999999999999999999999997765554433    23344444332       


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                        .+-+-+..++..+++||+.||+++|.+||++.|+-+.++
T Consensus       483 --yRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafE  521 (1157)
T KOG4278|consen  483 --YRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFE  521 (1157)
T ss_pred             --ccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHH
Confidence              333447789999999999999999999999988876653

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.9e-40  Score=331.55  Aligned_cols=244  Identities=20%  Similarity=0.280  Sum_probs=198.5

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccCh---hhHHHHHHHHHHHcCCCCCCeeeeeeeeec----CCceeEEEEe
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESLLVYEF  346 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv~e~  346 (573)
                      ...||+|++|.||+|.+ +|+.||||++.....   ...+.+.+|+.+|++++||||++++|++.+    ....++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            46799999999999998 588999999865432   235778899999999999999999999876    3467899999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      +++|+|.+++...   ..+++...++++.+++.||.|||+. +   ++||||||+|||+++++.+||+|||+++......
T Consensus       104 ~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~  177 (283)
T PHA02988        104 CTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP  177 (283)
T ss_pred             CCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc
Confidence            9999999998543   4588999999999999999999985 5   7899999999999999999999999988654322


Q ss_pred             cccccccccCcCcCchhhhcc--CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          426 THISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                          ....++..|+|||++.+  ..++.++|||||||++|||++|+.|+...... .    .......+..        .
T Consensus       178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~-~----~~~~i~~~~~--------~  240 (283)
T PHA02988        178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK-E----IYDLIINKNN--------S  240 (283)
T ss_pred             ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH-H----HHHHHHhcCC--------C
Confidence                23457889999999976  68999999999999999999999998643211 1    1111111111        1


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...+...+..+.+++.+||+.||++|||++|+++.|+.
T Consensus       241 ~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~  278 (283)
T PHA02988        241 LKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSL  278 (283)
T ss_pred             CCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            12233467789999999999999999999999999964

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=332.46  Aligned_cols=249  Identities=26%  Similarity=0.370  Sum_probs=209.6

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..|...++||+|.||.||||... .++.||+|++..+ .....+.+.+|+.+|.+++++||.++|+.+..+..++++|||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey   92 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY   92 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence            45777899999999999999975 5889999999654 445567888999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      |.+|++.+.+..   ...+++..+.-++.++..||.|||.++   .+|||||+.|||+..+|.+||+|||++........
T Consensus        93 ~~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen   93 CGGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hcCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            999999998832   233477778888999999999999998   99999999999999999999999999998766554


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      .. .+.+||+.|||||++....|+.|+||||||++.+||++|.+|.......              ++.-++.+.-...+
T Consensus       167 rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPm--------------rvlflIpk~~PP~L  231 (467)
T KOG0201|consen  167 RR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPM--------------RVLFLIPKSAPPRL  231 (467)
T ss_pred             cc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcc--------------eEEEeccCCCCCcc
Confidence            43 6789999999999999889999999999999999999999986543321              12222222222333


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .......+.+++..||+.+|++||++.++++.
T Consensus       232 ~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  232 DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            44567789999999999999999999998853

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=2.6e-40  Score=327.69  Aligned_cols=255  Identities=22%  Similarity=0.302  Sum_probs=204.3

Q ss_pred             hcCccccccccccCceeEEEEEcC----CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..++||+|+||.||+|.+.    .+..||+|++.... ......+.+|+.++++++||||+++++++..+...++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence            356888999999999999999763    35689999987653 3335678899999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.+|++|||.+....
T Consensus        84 v~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~  158 (266)
T cd05064          84 VTEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDK  158 (266)
T ss_pred             EEEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCccccccc
Confidence            99999999999988543  246899999999999999999999987   9999999999999999999999999876543


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ...........++..|+|||.+.+..++.++||||||+++||+++ |+.|+..... ..+..    ....+.        
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~-~~~~~----~~~~~~--------  225 (266)
T cd05064         159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG-QDVIK----AVEDGF--------  225 (266)
T ss_pred             ccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH-HHHHH----HHHCCC--------
Confidence            222111222345678999999999999999999999999999875 8777643321 11111    111111        


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                       ....+...+..+.+++..||+.+|++||++++|++.|+.
T Consensus       226 -~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         226 -RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence             112244567789999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-40  Score=336.13  Aligned_cols=249  Identities=23%  Similarity=0.334  Sum_probs=207.5

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc----Ch-hhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCC
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN----TT-QWVDHFFNEVNLISGIN-HKNLVKLLGCSITGP  338 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~  338 (573)
                      .....|...+.||+|.||.|+.|... +|+.||||++...    .. ...+.+.+|+.++++++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            34568899999999999999999764 6899999976543    12 23456678999999998 999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC-CcEEEeeccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGL  417 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgl  417 (573)
                      ..++||||+.+|+|.+++..   .+.+.+..+.+++.|++.|++|+|+++   |+||||||+|||++.+ +++||+|||+
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~  167 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL  167 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence            99999999999999999954   456888999999999999999999998   9999999999999999 9999999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhccCC-CC-cccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVRGK-LT-EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH  495 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  495 (573)
                      +.... .........+||+.|+|||++.+.. |+ .++||||+||+||-|++|..||.....     .........++. 
T Consensus       168 s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~-----~~l~~ki~~~~~-  240 (370)
T KOG0583|consen  168 SAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNV-----PNLYRKIRKGEF-  240 (370)
T ss_pred             ccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccH-----HHHHHHHhcCCc-
Confidence            99774 2233456789999999999999877 75 789999999999999999999876321     111111222221 


Q ss_pred             cccCccccCCCCCch-HHHHHHHHHHccCCCCCCCCCHHHHH
Q 008239          496 EAVDPALAGNFQEGK-PSRLLQIGLLCVQASAELRPSMSIVV  536 (573)
Q Consensus       496 ~~~d~~l~~~~~~~~-~~~l~~l~~~cl~~~p~~RPt~~evl  536 (573)
                               .++... +.++..++.+|+..+|..|+++.+|+
T Consensus       241 ---------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  241 ---------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             ---------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence                     223333 77889999999999999999999999

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.9e-40  Score=343.41  Aligned_cols=259  Identities=27%  Similarity=0.368  Sum_probs=204.1

Q ss_pred             HhcCccccccccccCceeEEEEEc------CCCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCC
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP  338 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  338 (573)
                      ..++|+..++||+|+||.||++++      .++..||||++.... ....+.+.+|+.++..+ +||||+++++++....
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            345788899999999999999973      235689999986542 33456788999999999 8999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccCC---------------------------------------------------------
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQD---------------------------------------------------------  361 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------------------------  361 (573)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999999999988853211                                                         


Q ss_pred             ---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          362 ---------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       362 ---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                                     ...+++..+++++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                           124788999999999999999999987   99999999999999999999999999986543322


Q ss_pred             c-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          427 H-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       427 ~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      . ......++..|+|||.+.+..++.++||||||+++|||++ |..|+........    .......+.         ..
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~----~~~~~~~~~---------~~  336 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSK----FYKMIKEGY---------RM  336 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHH----HHHHHHhCc---------cC
Confidence            1 1122345678999999999999999999999999999998 6666543222211    122222211         11


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ..+...+.++.+|+.+||+.+|++||++.||+++|+.
T Consensus       337 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            1122345688999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.3e-41  Score=334.58  Aligned_cols=267  Identities=27%  Similarity=0.349  Sum_probs=218.9

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|.+.+.||+|.||+||||+.+ +.+.||+|.+.+.  .+...+.+.+|+++++.++|||||.++++|+...+.++|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            57888999999999999999876 5789999988554  33446678899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+.+ +|..+|...   +.++++.+..++.+++.||.|||+..   |+|||+||+|||++.++.+|++|||+|+....+ 
T Consensus        82 ~a~g-~L~~il~~d---~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQD---GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-  153 (808)
T ss_pred             hhhh-hHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence            9977 999998543   45899999999999999999999987   999999999999999999999999999987653 


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      +...+.+-||+-|||||+..+++|+..+|.||+|||+||+++|++||....    +.+-+. .+..       |+.   .
T Consensus       154 t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s----i~~Lv~-~I~~-------d~v---~  218 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS----ITQLVK-SILK-------DPV---K  218 (808)
T ss_pred             ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH----HHHHHH-HHhc-------CCC---C
Confidence            344567789999999999999999999999999999999999999986432    222111 1111       111   1


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh--ccCCC-CCCCCCCCccCCCC
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML--TGNHE-ILQPTQPPFLNPNG  558 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L--~~~~~-~~~p~~~~~~~~~~  558 (573)
                      .+......+.+++...++.||..|.+..+++..=  ++... ...|..+.+.....
T Consensus       219 ~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spft  274 (808)
T KOG0597|consen  219 PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFT  274 (808)
T ss_pred             CcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccc
Confidence            2446677899999999999999999999998654  33333 34555565555443

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-39  Score=378.30  Aligned_cols=260  Identities=25%  Similarity=0.402  Sum_probs=210.1

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ...|...++||+|+||.||+|+. .++..||||++......    ...|++.+++++|||||+++|++.+....++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            45677888999999999999997 57899999998643321    23468899999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++|+|.+++.      .++|..+.+++.||++||+|||....++|+||||||+||+++.++.+++. ||........  
T Consensus       765 ~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~--  835 (968)
T PLN00113        765 IEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD--  835 (968)
T ss_pred             CCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC--
Confidence            99999999983      38999999999999999999997655669999999999999999888875 6665433221  


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCC-CcchHHHHHHHhhcCccccccCccccCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN-SCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                         ....+|..|+|||++.+..++.++|||||||++|||++|+.|+..... ...+..|.+...........+|+.+...
T Consensus       836 ---~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  912 (968)
T PLN00113        836 ---TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGD  912 (968)
T ss_pred             ---CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCC
Confidence               123578999999999999999999999999999999999999854332 2245555554444444555666666432


Q ss_pred             --CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          506 --FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       506 --~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                        .+..+..++.+++.+||+.+|++||+|+||+++|+...
T Consensus       913 ~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        913 VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence              23345667889999999999999999999999996543

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.4e-40  Score=323.32  Aligned_cols=255  Identities=29%  Similarity=0.415  Sum_probs=207.3

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .++|+..++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++.+......+++|||+
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   83 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM   83 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence            467889999999999999999988888999998865433 3568899999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++... ....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  159 (261)
T cd05072          84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT  159 (261)
T ss_pred             CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence            999999988543 2345889999999999999999999987   999999999999999999999999999876543322


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......++..|+|||++..+.++.++||||||+++|||++ |+.|+.... .......    ...+.         ....
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-~~~~~~~----~~~~~---------~~~~  225 (261)
T cd05072         160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS-NSDVMSA----LQRGY---------RMPR  225 (261)
T ss_pred             ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCC-HHHHHHH----HHcCC---------CCCC
Confidence            2223345678999999998899999999999999999998 776654321 1111111    11110         0111


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ....+..+.+++.+|++.+|++||++++++++|+.
T Consensus       226 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         226 MENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            23456788999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.7e-40  Score=342.31  Aligned_cols=260  Identities=26%  Similarity=0.380  Sum_probs=204.9

Q ss_pred             HHhcCccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG  337 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  337 (573)
                      -..++|+..+.||+|+||.||+++..      ++..||||++.... ....+.+.+|+.+++.+ +|+||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34457889999999999999998742      34579999997543 33456788999999999 899999999999999


Q ss_pred             CceeEEEEeccCCCccccccccC---------------------------------------------------------
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQ---------------------------------------------------------  360 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~---------------------------------------------------------  360 (573)
                      ...++||||+++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999998874321                                                         


Q ss_pred             ----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc-cc
Q 008239          361 ----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-IS  429 (573)
Q Consensus       361 ----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~  429 (573)
                                ....+++..+++++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++........ ..
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                      1134788999999999999999999987   999999999999999999999999999865432211 12


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCC
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE  508 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  508 (573)
                      ....++..|+|||++....++.++||||||+++|||++ |+.|+........    .......+         .....+.
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~----~~~~~~~~---------~~~~~~~  338 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSK----FYKMVKRG---------YQMSRPD  338 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHH----HHHHHHcc---------cCccCCC
Confidence            22345678999999999999999999999999999997 8887654322111    11111111         1111122


Q ss_pred             chHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          509 GKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       509 ~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ..+.++.+++.+||+.+|++||++.+|+++|++
T Consensus       339 ~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         339 FAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            346788999999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7e-40  Score=322.63  Aligned_cols=252  Identities=26%  Similarity=0.349  Sum_probs=203.3

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      ++|+..+.||+|+||.||++.+.++..+|+|.+..... ..+.+.+|+.++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            45788899999999999999998888999998864332 24678899999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +|+|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||+|+||+++.++.+||+|||+++.........
T Consensus        83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999885432  35889999999999999999999988   9999999999999999999999999988654332222


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.|+..... ......    ...+..         ...+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~-~~~~~~----i~~~~~---------~~~~  223 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSN-YEVVEM----ISRGFR---------LYRP  223 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCH-HHHHHH----HHCCCC---------CCCC
Confidence            223345678999999988899999999999999999999 6766543221 111111    111110         0112


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ...+..+.+++.+||+.+|++||+++++++.|+
T Consensus       224 ~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         224 KLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            234567899999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.5e-40  Score=326.47  Aligned_cols=249  Identities=33%  Similarity=0.492  Sum_probs=194.4

Q ss_pred             ccccccccCceeEEEEEcC-----CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          273 ESNKLGQGGSGSVYKGTLP-----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..+.||.|.||.||+|.+.     .+..|+||.+... ..+..+.+.+|++.+++++||||++++|++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            4678999999999999976     2568999999654 334478899999999999999999999999988889999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC-
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI-  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-  425 (573)
                      +++|+|.+++... ....+++..++.++.||+.||+|||+++   ++|+||+++||+++.++.+||+|||++....... 
T Consensus        83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999654 2356899999999999999999999987   9999999999999999999999999998763222 


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcC-CCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR-KRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      ............|+|||.+....++.++||||||+++|||+++ +.|+... ....+.    .....+..         .
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~-~~~~~~----~~~~~~~~---------~  224 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY-DNEEII----EKLKQGQR---------L  224 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS-CHHHHH----HHHHTTEE---------T
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccc----cccccccc---------c
Confidence            2222334567899999999999999999999999999999995 5553222 211211    11122211         1


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ..+...+..+.+++..||+.+|++||++.++++.|
T Consensus       225 ~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             eeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            22344577899999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.5e-39  Score=325.74  Aligned_cols=252  Identities=23%  Similarity=0.247  Sum_probs=203.1

Q ss_pred             CccccccccccCceeEEEEEc-CCCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .|+..+.||+|+||+||++.. .+|+.||||.+....   ......+.+|+.++++++|+||+++++++.+....++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            367789999999999999987 468999999886432   2233467889999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++|+|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......
T Consensus        81 ~~~~g~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (285)
T cd05631          81 IMNGGDLKFHIYNMG-NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE  156 (285)
T ss_pred             ecCCCcHHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence            999999988775332 235899999999999999999999988   9999999999999999999999999998654322


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      .  .....||..|+|||++.+..++.++|||||||++|||++|+.|+....... ............          ...
T Consensus       157 ~--~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~----------~~~  223 (285)
T cd05631         157 T--VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERV-KREEVDRRVKED----------QEE  223 (285)
T ss_pred             e--ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcch-hHHHHHHHhhcc----------ccc
Confidence            1  234568999999999999999999999999999999999999986543321 111111111110          112


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPS-----MSIVVKM  538 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~~  538 (573)
                      ++...+..+.+|+.+||+.+|++||+     ++++++.
T Consensus       224 ~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         224 YSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             CCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            33445678899999999999999997     7888763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-40  Score=322.80  Aligned_cols=271  Identities=24%  Similarity=0.287  Sum_probs=210.1

Q ss_pred             HHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh--------------hhHHHHHHHHHHHcCCCCCCeee
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--------------QWVDHFFNEVNLISGINHKNLVK  329 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~  329 (573)
                      .+..++|+..+.||+|.||.|-+|... +++.||||++.+...              ...+...+|+.+|++++|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            344578999999999999999999875 689999999854311              11357889999999999999999


Q ss_pred             eeeeeecC--CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC
Q 008239          330 LLGCSITG--PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE  407 (573)
Q Consensus       330 l~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~  407 (573)
                      |+++..+.  ..+|||+|||..|.+...   ......+++.++++++.++..||+|||.++   ||||||||+|+||+++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~---p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~  246 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWC---PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD  246 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccC---CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence            99998765  478999999998877542   233334999999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecccccccCCCC----cccccccccCcCcCchhhhccCC----CCcccchHhHHHHHHHHHcCCCCCCCCCCCc
Q 008239          408 FTAKIADFGLVRLFPEDI----THISATLAGTLGYMAPEYVVRGK----LTEKADVYSFGVVVIEVVCRKRINLFTQNSC  479 (573)
Q Consensus       408 ~~~kl~Dfgla~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGvil~elltg~~p~~~~~~~~  479 (573)
                      |++||+|||.+..++...    .......+||+-|+|||....+.    .+.+.||||+||+||.|+.|+.||.....  
T Consensus       247 g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~--  324 (576)
T KOG0585|consen  247 GTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE--  324 (576)
T ss_pred             CcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH--
Confidence            999999999988663221    11122478999999999997743    34578999999999999999999865432  


Q ss_pred             chHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh--ccCCCCCCCCCCCcc
Q 008239          480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML--TGNHEILQPTQPPFL  554 (573)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L--~~~~~~~~p~~~~~~  554 (573)
                         ....+        ++++..|.-....++.+++.+|++++|++||+.|.+..+|....  ......+++.++...
T Consensus       325 ---~~l~~--------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~~~~s~~~~c  390 (576)
T KOG0585|consen  325 ---LELFD--------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDSPQSSEPSSC  390 (576)
T ss_pred             ---HHHHH--------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCCCccCCcccc
Confidence               11111        22233333222335678899999999999999999999999887  333344444444433

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-40  Score=337.27  Aligned_cols=248  Identities=25%  Similarity=0.323  Sum_probs=211.4

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .-|+.++.||.|+.|.|-.|++ .+|+.+|||++.+.   .......+.+|+.+|+.+.|||++++|+++++..++|+|.
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl   91 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL   91 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence            3477889999999999999997 47999999999654   2233456789999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|.|++++..   .+++++.++.+++.||+.|+.|+|..+   |+||||||+|+|||.++++||+|||+|.+...+
T Consensus        92 Eyv~gGELFdylv~---kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g  165 (786)
T KOG0588|consen   92 EYVPGGELFDYLVR---KGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG  165 (786)
T ss_pred             EecCCchhHHHHHh---hCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence            99999999999954   456999999999999999999999988   999999999999999999999999999875432


Q ss_pred             CcccccccccCcCcCchhhhccCCCC-cccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLT-EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                        ....+.+|++.|.+||++.+.+|. .++||||.|||||.||+|+.||+.+ +-..++..+    ..|..         
T Consensus       166 --klLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd-Nir~LLlKV----~~G~f---------  229 (786)
T KOG0588|consen  166 --KLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD-NIRVLLLKV----QRGVF---------  229 (786)
T ss_pred             --ccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc-cHHHHHHHH----HcCcc---------
Confidence              334567999999999999999874 6899999999999999999998732 222333322    33332         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                       +.+...+.+..+|+.+|+..||+.|.|++||++.-
T Consensus       230 -~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  230 -EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             -cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCc
Confidence             23566788899999999999999999999999865

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=7.7e-40  Score=323.13  Aligned_cols=257  Identities=29%  Similarity=0.411  Sum_probs=211.7

Q ss_pred             HHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ....+|+..++||+|+||.||+|...+++.+++|.+........+.+.+|+.+++.++|+||+++++++......++|||
T Consensus         3 ~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           3 RPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             CcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            34567888999999999999999998899999999987766567789999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++.... ...+++..+++++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        83 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          83 LMEKGSLLAFLRSPE-GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             ecccCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            999999999986432 346899999999999999999999987   9999999999999999999999999998664332


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .. .....++..|+|||.+....++.++||||||++++||++ |+.|+..... .......    ..         ....
T Consensus       159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~-~~~~~~~----~~---------~~~~  223 (261)
T cd05148         159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN-HEVYDQI----TA---------GYRM  223 (261)
T ss_pred             cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHHH----Hh---------CCcC
Confidence            22 123345678999999988899999999999999999998 6666643221 1111111    11         1111


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ..+...+..+.+++.+||+.+|++|||++++++.|+.
T Consensus       224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            2234566789999999999999999999999999963

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=327.29  Aligned_cols=246  Identities=21%  Similarity=0.260  Sum_probs=202.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..++||+|+||.||++... +|+.||||++....   .+..+.+.+|+.++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            36888999999999999999976 68899999986432   234567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~  154 (291)
T cd05612          81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR  154 (291)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence            99999999998853   245889999999999999999999988   999999999999999999999999998865432


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                          .....|++.|+|||.+.+..++.++||||||+++|||++|+.|+.....     .........+..          
T Consensus       155 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~----------  215 (291)
T cd05612         155 ----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP-----FGIYEKILAGKL----------  215 (291)
T ss_pred             ----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCc----------
Confidence                2235689999999999998999999999999999999999998754321     111111111111          


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCC-----HHHHHHHh
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPS-----MSIVVKML  539 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~~L  539 (573)
                      .++......+.+++.+||+.||.+||+     ++++++.-
T Consensus       216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~  255 (291)
T cd05612         216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHR  255 (291)
T ss_pred             CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCc
Confidence            123344567889999999999999995     88888653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.6e-39  Score=324.87  Aligned_cols=256  Identities=28%  Similarity=0.431  Sum_probs=206.8

Q ss_pred             cCccccccccccCceeEEEEEcCC------CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ++|+..+.||+|+||.||+|....      ...|++|.+.... ....+.+.+|+.++++++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            467889999999999999998643      2579999886543 344567899999999999999999999999989999


Q ss_pred             EEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC
Q 008239          342 LVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF  408 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~  408 (573)
                      ++|||+++++|.+++.....             ...+++..++.++.|++.||+|||+.+   ++|+||||+||++++++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence            99999999999998864321             145889999999999999999999988   99999999999999999


Q ss_pred             cEEEeecccccccCCCC-cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHH
Q 008239          409 TAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVW  486 (573)
Q Consensus       409 ~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  486 (573)
                      .+||+|||+++...... ........+++.|+|||.+....++.++||||||+++|||++ |..|+.....     ....
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~-----~~~~  236 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSN-----QEVI  236 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHH
Confidence            99999999998653322 122234456788999999998999999999999999999998 8777653322     1112


Q ss_pred             HHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          487 DLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       487 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ..+..+..         ...+...+.++.+|+.+||+.+|.+||+++||++.|+.
T Consensus       237 ~~i~~~~~---------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EMIRSRQL---------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcCCc---------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            22222211         12344567889999999999999999999999999953

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-39  Score=321.77  Aligned_cols=256  Identities=27%  Similarity=0.378  Sum_probs=206.6

Q ss_pred             HhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..++|+..++||+|++|.||+|...+++.||||.+..... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            3466888999999999999999988888999999865432 356788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++||||||+||++++++.+||+|||++........
T Consensus        83 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          83 MKYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             ccCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            99999999985433 345899999999999999999999987   99999999999999999999999999987653322


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      ........+..|+|||.+.+..++.++||||||+++|||++ |+.|+.....     .........+         ....
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-----~~~~~~~~~~---------~~~~  224 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN-----AEVLQQVDQG---------YRMP  224 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcC---------CCCC
Confidence            21112223467999999998999999999999999999999 7766543211     1111111111         0011


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .+...+..+.+++.+|++.+|++||+++++++.|++
T Consensus       225 ~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         225 CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            233456789999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.2e-39  Score=320.46  Aligned_cols=254  Identities=30%  Similarity=0.428  Sum_probs=206.4

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      ..|...++||+|+||.||+|... .++.||+|++.... ...+.+.+|+++++.++|+||+++++++......+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence            45778899999999999999875 48899999986543 33567889999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++... ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.........
T Consensus        85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~  160 (263)
T cd05052          85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  160 (263)
T ss_pred             CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence            999999988543 2345899999999999999999999987   999999999999999999999999999876543322


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      .......+..|+|||.+.+..++.++||||||+++|||++ |..|+....     ....+.....+         .....
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~-----~~~~~~~~~~~---------~~~~~  226 (263)
T cd05052         161 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-----LSQVYELLEKG---------YRMER  226 (263)
T ss_pred             ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-----HHHHHHHHHCC---------CCCCC
Confidence            2223334678999999999999999999999999999998 776654321     11222222211         11223


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      +...+..+.+++.+||+.+|++||++.+++++|+.
T Consensus       227 ~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         227 PEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            44567789999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.2e-39  Score=319.20  Aligned_cols=252  Identities=26%  Similarity=0.348  Sum_probs=203.5

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      ++|...+.||+|+||+||++.+.++..+|||.+.... ...+.+.+|+.++++++||||+++++++......++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS   82 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence            4577889999999999999998877789999886443 234678999999999999999999999999889999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +++|.+++....  ..+++..++.++.||+.||+|||+.+   ++|+||||+||++++++.+||+|||+++.........
T Consensus        83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            999999885432  25899999999999999999999987   9999999999999999999999999988654433222


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      .....++..|+|||.+....++.++||||||+++|||++ |..|+......     ........+..         ...+
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~-----~~~~~~~~~~~---------~~~~  223 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNS-----ETVEKVSQGLR---------LYRP  223 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHH-----HHHHHHhcCCC---------CCCC
Confidence            223345678999999998889999999999999999998 77775432211     11111111111         1112


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       224 ~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         224 HLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            234678899999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-39  Score=326.05  Aligned_cols=263  Identities=21%  Similarity=0.245  Sum_probs=202.4

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|++.+.||+|+||+||+++.. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            46889999999999999999986 5789999998654  23345678899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |++++.+..+..   ....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  154 (287)
T cd07848          81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS  154 (287)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence            999876654432   2345889999999999999999999987   9999999999999999999999999998764433


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHH----------HHHH-hhcCcc
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT----------VWDL-YVKGRL  494 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~----------~~~~-~~~~~~  494 (573)
                      ........|++.|+|||++.+..++.++|||||||++|||++|+.|+........+...          .+.. ......
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07848         155 NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF  234 (287)
T ss_pred             cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence            33333456899999999999889999999999999999999999887543321111100          0000 001011


Q ss_pred             ccccCcccc------CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          495 HEAVDPALA------GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       495 ~~~~d~~l~------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .....+...      .......+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111001000      0111224567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-39  Score=331.08  Aligned_cols=254  Identities=24%  Similarity=0.365  Sum_probs=201.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCC----EEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .+|+..+.||+|+||.||+|++. +++    .||||++.... ....+++.+|+.+++.++||||++++|++... ..++
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~   85 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL   85 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence            46889999999999999999864 333    48999986543 34456788999999999999999999998764 5779


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ++||+++|+|.+++...  ...+++..+++++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence            99999999999988543  245889999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcccc-cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          423 EDITHIS-ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       423 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ....... ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.....     .........+.       
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~-----~~~~~~~~~~~-------  228 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-----SEISSILEKGE-------  228 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHhCCC-------
Confidence            4332211 12334678999999999999999999999999999998 7777643211     11112211111       


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                        ....+...+..+.+++.+||+.+|.+||++.+++..|...
T Consensus       229 --~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~  268 (316)
T cd05108         229 --RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  268 (316)
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              1111234556789999999999999999999999998544

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-39  Score=333.07  Aligned_cols=254  Identities=23%  Similarity=0.281  Sum_probs=204.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..++||+|+||.||+|+.. +++.||||++....   ....+.+.+|+.++..++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            36888999999999999999976 58899999986542   234567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..... 
T Consensus        81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-  153 (333)
T cd05600          81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-  153 (333)
T ss_pred             eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence            99999999998843   345889999999999999999999988   99999999999999999999999999986543 


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                         ......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .    .+.......  ..+......
T Consensus       154 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~-~----~~~~i~~~~--~~~~~~~~~  223 (333)
T cd05600         154 ---YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPN-E----TWENLKYWK--ETLQRPVYD  223 (333)
T ss_pred             ---ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHH-H----HHHHHHhcc--ccccCCCCC
Confidence               223457899999999999999999999999999999999999987543221 1    111111110  011110000


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ......+.++.+++.+||+.+|.+||+++++++.-
T Consensus       224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~  258 (333)
T cd05600         224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHP  258 (333)
T ss_pred             ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCc
Confidence            00123467889999999999999999999999763

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.1e-39  Score=330.37  Aligned_cols=263  Identities=21%  Similarity=0.308  Sum_probs=204.9

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|+..++||+|+||.||+++.. +|..||+|.+... .....+.+.+|++++++++||||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence            467999999999999999999976 5888999988754 33445678999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++..   ...+++..+..++.|++.||.|||+.+  +|+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            9999999998843   235889999999999999999999853  39999999999999999999999999987653321


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC--c-c--------
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG--R-L--------  494 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~-~--------  494 (573)
                         .....|+..|+|||++.+..++.++||||||+++|||++|+.|+...... .+..........+  . .        
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHhcccccccccCCccccCcccc
Confidence               23456899999999999999999999999999999999999997533211 1111000000000  0 0        


Q ss_pred             -------------------ccccCccc---cCC-CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          495 -------------------HEAVDPAL---AGN-FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       495 -------------------~~~~d~~l---~~~-~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                                         .+..+...   ... .....+.++.+++.+||+.||++|||++|+++.-
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~  302 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHT  302 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcCh
Confidence                               00000000   000 0123467899999999999999999999998754

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=318.46  Aligned_cols=250  Identities=27%  Similarity=0.369  Sum_probs=201.9

Q ss_pred             CccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      +|+..+.||+|+||.||++.+.++..+|+|.+..... ..+.+.+|++++++++||||+++++++......++||||+++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~   83 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN   83 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence            4778899999999999999988778899998864332 245688899999999999999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      ++|.+++....  ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++..........
T Consensus        84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~  158 (256)
T cd05059          84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSS  158 (256)
T ss_pred             CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccccc
Confidence            99999885432  36899999999999999999999988   99999999999999999999999999886543322222


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCC
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE  508 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  508 (573)
                      ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+..... ....    .....+         .....+.
T Consensus       159 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-~~~~----~~~~~~---------~~~~~~~  224 (256)
T cd05059         159 QGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVV----ESVSAG---------YRLYRPK  224 (256)
T ss_pred             CCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH-HHHH----HHHHcC---------CcCCCCC
Confidence            22234568999999999999999999999999999999 5666543221 1111    111111         1112233


Q ss_pred             chHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       509 ~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ..+..+.+++.+||+.+|++|||+.|++++|
T Consensus       225 ~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         225 LAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            4577899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.6e-39  Score=323.20  Aligned_cols=253  Identities=22%  Similarity=0.253  Sum_probs=204.7

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      -.++|+.+..||+|+||.||.++.+ +|+.+|+|++.+..   ....+....|-.+|...++|+||+|+-.|.+.+.+||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            4578999999999999999999865 59999999997753   3446677889999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+|||++..+|.   +...|++..+..++.+.+.|+.-||+.|   +|||||||+|+|||..|++||+||||+..+.
T Consensus       219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~  292 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD  292 (550)
T ss_pred             EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence            999999999999984   4567999999999999999999999998   9999999999999999999999999985321


Q ss_pred             C-----------------------CCc----cc-------------------ccccccCcCcCchhhhccCCCCcccchH
Q 008239          423 E-----------------------DIT----HI-------------------SATLAGTLGYMAPEYVVRGKLTEKADVY  456 (573)
Q Consensus       423 ~-----------------------~~~----~~-------------------~~~~~gt~~y~aPE~~~~~~~~~~sDvw  456 (573)
                      .                       +..    ..                   ....+|||.|||||++.+..|+..+|.|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW  372 (550)
T KOG0605|consen  293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW  372 (550)
T ss_pred             hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence            1                       000    00                   1134699999999999999999999999


Q ss_pred             hHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCC---HH
Q 008239          457 SFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPS---MS  533 (573)
Q Consensus       457 slGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt---~~  533 (573)
                      |||||+||||.|-+||.....     +..|..+.+.+..      +..........+..+||.+|+. ||++|--   ++
T Consensus       373 SLG~ImyEmLvGyPPF~s~tp-----~~T~rkI~nwr~~------l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~  440 (550)
T KOG0605|consen  373 SLGCIMYEMLVGYPPFCSETP-----QETYRKIVNWRET------LKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAE  440 (550)
T ss_pred             HHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHHHhhh------ccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHH
Confidence            999999999999999876543     2333333332211      1111122334778899999999 9999976   55


Q ss_pred             HHHH
Q 008239          534 IVVK  537 (573)
Q Consensus       534 evl~  537 (573)
                      ||-+
T Consensus       441 EIK~  444 (550)
T KOG0605|consen  441 EIKK  444 (550)
T ss_pred             HHhc
Confidence            5543

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-39  Score=316.77  Aligned_cols=269  Identities=26%  Similarity=0.323  Sum_probs=207.4

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcC--CCCCCeeeeeeeeecCC---
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSITGP---  338 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---  338 (573)
                      -....++....+.||+|.||+||+|.+. |+.||||++...++   +.+++|.++...  |+|+||+.+++.-..+.   
T Consensus       206 QRTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~  281 (513)
T KOG2052|consen  206 QRTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSW  281 (513)
T ss_pred             HHhhhheeEEEEEecCccccceeecccc-CCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCce
Confidence            3445577888999999999999999997 88999999965443   467778777765  59999999998765443   


Q ss_pred             -ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-----cCCCCeEEecCCCCCeeeCCCCcEEE
Q 008239          339 -ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-----ESKLRIIHRDIKLSNILLDEEFTAKI  412 (573)
Q Consensus       339 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-----~~~~~iiHrDlk~~NIll~~~~~~kl  412 (573)
                       .++||++|.++|||.|+|..    ..++.+..+++++.+|.||++||.     +++|.|.|||||+.|||+..++...|
T Consensus       282 TQLwLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~I  357 (513)
T KOG2052|consen  282 TQLWLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCI  357 (513)
T ss_pred             EEEEEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEE
Confidence             57899999999999999943    568999999999999999999996     47899999999999999999999999


Q ss_pred             eecccccccCCCCcc---cccccccCcCcCchhhhccCC----CC--cccchHhHHHHHHHHHcCC----------CCCC
Q 008239          413 ADFGLVRLFPEDITH---ISATLAGTLGYMAPEYVVRGK----LT--EKADVYSFGVVVIEVVCRK----------RINL  473 (573)
Q Consensus       413 ~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~----~~--~~sDvwslGvil~elltg~----------~p~~  473 (573)
                      +|+|||-..+.+...   ..+..+||.+|||||++....    +.  ..+||||||+++||+..+-          .|+.
T Consensus       358 ADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyy  437 (513)
T KOG2052|consen  358 ADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYY  437 (513)
T ss_pred             eeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcc
Confidence            999999877655332   234678999999999996532    22  2689999999999998542          2333


Q ss_pred             CCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          474 FTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       474 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      ...+.++-.+.+.+..=.+++...++.+.   .+.+....+.+||..||..+|.-|-|+-.+-+.|.+..
T Consensus       438 d~Vp~DPs~eeMrkVVCv~~~RP~ipnrW---~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  438 DVVPSDPSFEEMRKVVCVQKLRPNIPNRW---KSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             cCCCCCCCHHHHhcceeecccCCCCCccc---ccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            22222333344444333333333333322   24456778899999999999999999998888885544

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2e-39  Score=331.36  Aligned_cols=245  Identities=24%  Similarity=0.317  Sum_probs=202.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||.||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++++......++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            56888999999999999999975 58899999986532   234567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~  171 (329)
T PTZ00263         98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR  171 (329)
T ss_pred             cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence            99999999998853   345788999999999999999999988   999999999999999999999999999866432


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .    ....||+.|+|||.+.+..++.++|||||||++|||++|+.|+.....     .........+..          
T Consensus       172 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~-----~~~~~~i~~~~~----------  232 (329)
T PTZ00263        172 T----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP-----FRIYEKILAGRL----------  232 (329)
T ss_pred             c----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH-----HHHHHHHhcCCc----------
Confidence            2    235789999999999999999999999999999999999999754321     111122222211          


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPS-----MSIVVKM  538 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~~  538 (573)
                      .++...+..+.+++.+||+.||++||+     ++++++.
T Consensus       233 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        233 KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            123334567889999999999999997     6887754

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.6e-39  Score=337.58  Aligned_cols=262  Identities=23%  Similarity=0.299  Sum_probs=206.7

Q ss_pred             HHHhcCccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCC-CCCeeeeeeeeec
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNLVKLLGCSIT  336 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~  336 (573)
                      ....+.|.+.++||+|+||.||+|+..      .+..||||++.... ....+.+.+|+.+++++. ||||+++++++.+
T Consensus        33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~  112 (400)
T cd05105          33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK  112 (400)
T ss_pred             eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            344567889999999999999999853      23479999996543 334567899999999996 9999999999999


Q ss_pred             CCceeEEEEeccCCCccccccccC--------------------------------------------------------
Q 008239          337 GPESLLVYEFVPNQSLLDNLFVRQ--------------------------------------------------------  360 (573)
Q Consensus       337 ~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------------  360 (573)
                      ....++||||+++|+|.+++....                                                        
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            999999999999999998875421                                                        


Q ss_pred             -------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCee
Q 008239          361 -------------------------------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL  403 (573)
Q Consensus       361 -------------------------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIl  403 (573)
                                                           ....+++..++.++.||+.||+|||+.+   |+||||||+|||
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nil  269 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVL  269 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEE
Confidence                                                 0124788889999999999999999987   999999999999


Q ss_pred             eCCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcch
Q 008239          404 LDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSI  481 (573)
Q Consensus       404 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~  481 (573)
                      ++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+........+
T Consensus       270 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~  349 (400)
T cd05105         270 LAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF  349 (400)
T ss_pred             EeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH
Confidence            999999999999999865432221 1223456788999999999999999999999999999997 77776443221111


Q ss_pred             HHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          482 LQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       482 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                          +.....+.         ....+...+..+.+++.+||+.+|++||++.+|.++|+..
T Consensus       350 ----~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         350 ----YNKIKSGY---------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             ----HHHHhcCC---------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence                11111111         1112334567899999999999999999999999999653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3e-39  Score=322.36  Aligned_cols=255  Identities=26%  Similarity=0.400  Sum_probs=206.7

Q ss_pred             cCccccccccccCceeEEEEEcCC------CCEEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ++|.+.+.||+|+||.||+|...+      ++.||||.+...... ..+.+.+|+++++.++|+||+++++++......+
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   84 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI   84 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence            467888999999999999998643      478999998765443 4678999999999999999999999999999999


Q ss_pred             EEEEeccCCCccccccccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcE
Q 008239          342 LVYEFVPNQSLLDNLFVRQ-----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA  410 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~  410 (573)
                      +||||+++++|.+++....           ....+++..+..++.|++.|+.|||+++   ++||||||+||+++.++.+
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~  161 (280)
T cd05049          85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV  161 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence            9999999999999986432           2345789999999999999999999988   9999999999999999999


Q ss_pred             EEeecccccccCCCC-cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHH
Q 008239          411 KIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       411 kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  488 (573)
                      ||+|||++....... ........+++.|+|||++....++.++||||||+++|||++ |+.|+...... ...    ..
T Consensus       162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~-~~~----~~  236 (280)
T cd05049         162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE-EVI----EC  236 (280)
T ss_pred             EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHH-HHH----HH
Confidence            999999987543222 122233445788999999999999999999999999999998 88776533221 111    11


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ...+..         ...+...+..+.+++.+||+.+|++||++.||++.|+
T Consensus       237 ~~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 ITQGRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            122211         1123345678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=3.4e-39  Score=305.06  Aligned_cols=263  Identities=24%  Similarity=0.286  Sum_probs=202.3

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChh--hHHHHHHHHHHHcCCCCCCeeeeeeeeec--CCceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  343 (573)
                      +.|+.+++|++|.||.||+|+.+ +++.||+|+++.+.+.  .--.-.+|+.+|.+.+|||||.+..+...  -+..|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            45778999999999999999985 6889999999765422  22345789999999999999999987764  3568999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      ||||+. +|.+++..-  .+++...+..-+..|+++|++|||.++   |+|||||++|+|+++.|.+||+|||||+.+.+
T Consensus       156 Me~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence            999976 787777432  357888999999999999999999999   99999999999999999999999999998876


Q ss_pred             CCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc---cccc--
Q 008239          424 DITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR---LHEA--  497 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~--  497 (573)
                      ... ..+..+-|.+|.|||++.+ ..|+...|+||+|||+.||+++++.+....+..+ +..+........   +...  
T Consensus       230 p~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQ-l~~If~llGtPte~iwpg~~~  307 (419)
T KOG0663|consen  230 PLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQ-LDKIFKLLGTPSEAIWPGYSE  307 (419)
T ss_pred             Ccc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHH-HHHHHHHhCCCccccCCCccc
Confidence            533 3456677999999999987 4799999999999999999999876554433222 222222222111   0000  


Q ss_pred             ------------cCccccCCCCCc-hHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          498 ------------VDPALAGNFQEG-KPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       498 ------------~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                                  .-..++..+... ..+.-.+|+...+..||.+|-|++|.++.=
T Consensus       308 lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~  362 (419)
T KOG0663|consen  308 LPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHE  362 (419)
T ss_pred             cchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccc
Confidence                        001112222222 345667899999999999999999998653

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.8e-39  Score=328.58  Aligned_cols=242  Identities=23%  Similarity=0.266  Sum_probs=197.7

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      +.||+|+||.||+++.. +|+.||||++....   ......+.+|+.++++++||||+++++++......++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 68999999986532   233456788999999999999999999999999999999999999


Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA  430 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  430 (573)
                      +|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++..... .....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~  153 (323)
T cd05571          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMK  153 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCccc
Confidence            99888843   346899999999999999999999988   999999999999999999999999998753221 11223


Q ss_pred             ccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCch
Q 008239          431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK  510 (573)
Q Consensus       431 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  510 (573)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.|+.....     .........+.          ..++...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~-----~~~~~~~~~~~----------~~~p~~~  218 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEE----------IRFPRTL  218 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCC----------CCCCCCC
Confidence            45789999999999999999999999999999999999998754321     11111111111          1223445


Q ss_pred             HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          511 PSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       511 ~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      +..+.+++.+||+.||++||     ++.++++.
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         219 SPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence            67889999999999999999     79988753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.7e-39  Score=317.50  Aligned_cols=255  Identities=27%  Similarity=0.381  Sum_probs=205.1

Q ss_pred             hcCccccccccccCceeEEEEEcCC----CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..+.||+|+||.||+|.+..    ...||||.+.... ......+.+|+.++++++||||+++++++......++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            3568899999999999999998742    4579999886543 3445678899999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++++|.+++....  ..+++..+++++.|++.||+|||+.+   |+|+||||+|||+++++.+||+|||++....
T Consensus        83 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~  157 (266)
T cd05033          83 ITEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE  157 (266)
T ss_pred             EEEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence            999999999999885432  36899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          423 EDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       423 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ..... ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....     .........+.       
T Consensus       158 ~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~-----~~~~~~~~~~~-------  225 (266)
T cd05033         158 DSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSN-----QDVIKAVEDGY-------  225 (266)
T ss_pred             ccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCH-----HHHHHHHHcCC-------
Confidence            22211 1222344678999999998999999999999999999998 7776533221     11111111111       


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                        ....+...+..+.+++.+||+.+|++||++++|+++|+.
T Consensus       226 --~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         226 --RLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence              111233456789999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=3.8e-39  Score=321.24  Aligned_cols=258  Identities=27%  Similarity=0.407  Sum_probs=203.7

Q ss_pred             HHhcCccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP  338 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  338 (573)
                      ..+++|+..++||+|+||.||+|.+.      .+..||||++.... .....++.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999999753      25679999885432 234557889999999999999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEE
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK  411 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~k  411 (573)
                      ..++||||+++++|.+++.....       ...+++..++.++.|++.||+|||+.+   ++|+||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEE
Confidence            99999999999999998854221       234678899999999999999999987   99999999999999999999


Q ss_pred             EeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHh
Q 008239          412 IADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLY  489 (573)
Q Consensus       412 l~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  489 (573)
                      |+|||+++........ ......++..|+|||.+..+.++.++||||||+++|||++ |..|+... ..    .......
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~-~~----~~~~~~~  234 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-SN----EQVLRFV  234 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC-CH----HHHHHHH
Confidence            9999998755332221 1122345778999999998999999999999999999999 45554322 11    1111221


Q ss_pred             hcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       490 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ..+..         ...+...+..+.+++.+||+.+|++||++.|++++|+
T Consensus       235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         235 MEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HcCCc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            22111         1123345678899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=341.27  Aligned_cols=260  Identities=22%  Similarity=0.283  Sum_probs=212.1

Q ss_pred             HHHhcCccccccccccCceeEEEEEcCCC-CEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeee-eeec-----
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTLPGG-EAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLG-CSIT-----  336 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~-~~~~-----  336 (573)
                      .....++++.+.|.+|||+.||.+.+..+ ..||+|++...++...+.+.+|+++|++|+ |+|||.+++ ....     
T Consensus        33 ~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~  112 (738)
T KOG1989|consen   33 TVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN  112 (738)
T ss_pred             EECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence            34456677889999999999999998765 999999999888999999999999999997 999999999 3322     


Q ss_pred             -CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeec
Q 008239          337 -GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF  415 (573)
Q Consensus       337 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  415 (573)
                       .-+.+|+||||++|+|.+++..+.... |++.++++|+.++++|+++||... ++|||||||.+||||+.++..|||||
T Consensus       113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDF  190 (738)
T KOG1989|consen  113 GVWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDF  190 (738)
T ss_pred             ceeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcc
Confidence             135679999999999999997655444 999999999999999999999975 88999999999999999999999999


Q ss_pred             ccccccCCCC---ccc-----ccccccCcCcCchhhh---ccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHH
Q 008239          416 GLVRLFPEDI---THI-----SATLAGTLGYMAPEYV---VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT  484 (573)
Q Consensus       416 gla~~~~~~~---~~~-----~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~  484 (573)
                      |.+.-.-...   ...     .-...-|+-|.|||.+   .+...++|+|||+|||+||-|.....||+....       
T Consensus       191 GSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-------  263 (738)
T KOG1989|consen  191 GSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-------  263 (738)
T ss_pred             cccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc-------
Confidence            9987332111   110     0022358899999987   467899999999999999999999999865422       


Q ss_pred             HHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          485 VWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       485 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                                ..+++....-.-.......+.+||..||+++|.+||++-+|+..+-...
T Consensus       264 ----------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~  312 (738)
T KOG1989|consen  264 ----------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELA  312 (738)
T ss_pred             ----------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHh
Confidence                      1223333322223568899999999999999999999999998884433

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.5e-40  Score=329.09  Aligned_cols=251  Identities=22%  Similarity=0.312  Sum_probs=212.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc-eeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-SLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~lv~  344 (573)
                      ++|..++++|+|+||.++..+++ +++.+++|.+...  .....+...+|+.++++++|||||.+.+.|.+++. .+|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888999999999999999876 5789999988543  33334577899999999999999999999999988 89999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      +|++||+|.+.+...+ ...++++.+++++.|++.|+.|||++.   |+|||||+.|||++.+..|||+|||+++.....
T Consensus        84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            9999999999886544 456999999999999999999999877   999999999999999999999999999988765


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      . .......||+.||.||.+.+.+|+.|+|||||||++|||.+-+++|...+.. .+...+             .+....
T Consensus       160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~-~Li~ki-------------~~~~~~  224 (426)
T KOG0589|consen  160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS-ELILKI-------------NRGLYS  224 (426)
T ss_pred             h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH-HHHHHH-------------hhccCC
Confidence            4 2344678999999999999999999999999999999999999887654321 111111             111223


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..+.....++..++..|++.+|+.||++.+++.+
T Consensus       225 Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  225 PLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             CCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            4566678889999999999999999999999876

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.3e-40  Score=296.35  Aligned_cols=249  Identities=26%  Similarity=0.317  Sum_probs=210.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..+.||+|.||.||.|+.+ ++-.||+|++.++   ..+...++.+|+++-+.|+||||+++++++.+....+|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            367889999999999999999975 5779999999654   233456788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      +||.++|+|...|... ....+++.....++.|+|.||.|+|..+   ||||||||+|+|++.++.+||+|||-+..-+ 
T Consensus       101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP-  175 (281)
T ss_pred             EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence            9999999999998643 3456888999999999999999999987   9999999999999999999999999987543 


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                        .....+.+||..|.+||...+..++..+|+|++|++.+|++.|.+||..... ......+    ..-   +       
T Consensus       176 --~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~-~etYkrI----~k~---~-------  238 (281)
T KOG0580|consen  176 --SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH-SETYKRI----RKV---D-------  238 (281)
T ss_pred             --CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh-HHHHHHH----HHc---c-------
Confidence              2334578999999999999999999999999999999999999999876542 2222222    111   1       


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      -.++...+....+++.+|+..+|.+|.+..|++..
T Consensus       239 ~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  239 LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            12345566788899999999999999999999863

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=6.2e-39  Score=320.79  Aligned_cols=266  Identities=27%  Similarity=0.385  Sum_probs=203.7

Q ss_pred             CccccccccccCceeEEEEEc-----CCCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--Ccee
Q 008239          270 YFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESL  341 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  341 (573)
                      +|+..+.||+|+||+||++..     .+++.||+|.+.... ......+.+|++++++++||||+++++++...  ...+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (283)
T cd05080           5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQ   84 (283)
T ss_pred             hceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEE
Confidence            458889999999999988653     357889999986543 23456788999999999999999999987654  3578


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+++++|.+++..    ..+++..++.++.|++.||.|||+++   |+||||||+|||+++++.+||+|||++...
T Consensus        85 lv~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          85 LIMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeeccccccc
Confidence            99999999999998843    24899999999999999999999987   999999999999999999999999999866


Q ss_pred             CCCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc-chHHHHHHHhhcCcccccc
Q 008239          422 PEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC-SILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       422 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  498 (573)
                      ......  ......++..|+|||.+....++.++||||||+++|||++|..|+....... ..............+.+.+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELL  237 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhh
Confidence            433221  1122345667999999988899999999999999999999998864332110 0000000000011111222


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      +.......+...+..+.+++.+||+.+|++|||+++|+++|+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         238 ERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            22222233455678899999999999999999999999999654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.3e-39  Score=327.90  Aligned_cols=252  Identities=24%  Similarity=0.289  Sum_probs=201.9

Q ss_pred             CccccccccccCceeEEEEEc----CCCCEEEEEEeccc----ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCce
Q 008239          270 YFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES  340 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  340 (573)
                      +|+..++||+|+||.||+++.    .+++.||+|++...    .....+.+..|+.++..+ +|+||+++++++......
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            478899999999999999875    35789999998643    223345678899999999 599999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~  154 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE  154 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence            9999999999999988543   35889999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      +............||+.|+|||.+.+. .++.++||||||+++|||++|+.|+......... ..+......      .+
T Consensus       155 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~~~~~------~~  227 (332)
T cd05614         155 FLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSRRILK------CD  227 (332)
T ss_pred             ccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHHHHhc------CC
Confidence            544333333456789999999999765 4788999999999999999999998644332211 111111111      11


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      +    .++...+..+.+++.+||+.||++||     +++++++.
T Consensus       228 ~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         228 P----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             C----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            1    22344567788999999999999999     77788764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-39  Score=332.86  Aligned_cols=251  Identities=26%  Similarity=0.389  Sum_probs=208.9

Q ss_pred             ccccccccccCceeEEEEEcC--CCC--EEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          271 FHESNKLGQGGSGSVYKGTLP--GGE--AVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ....++||+|.||.|++|.|.  +|+  .||||.+...... ....|.+|+.+|.+|+|+|+++|||+..+ ....+|+|
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E  190 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE  190 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence            345788999999999999985  354  6899999776544 67899999999999999999999999887 78889999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      +++.|+|.+.|+. .....+....+..++.|||.||.||.+++   +|||||.++|+||-..-.|||+||||.+.+....
T Consensus       191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            9999999999976 45567888999999999999999999988   9999999999999988899999999999776443


Q ss_pred             cc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          426 TH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       426 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ..  .....--..-|+|||.+....|+.+||||+|||.||||+|++..++.+-....++             +.+|..-+
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL-------------~~iD~~er  333 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQIL-------------KNIDAGER  333 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHH-------------Hhcccccc
Confidence            32  2223334678999999999999999999999999999999877655544432222             22333223


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      -.-+..++++++++++.||..+|++|||+..|.+.+
T Consensus       334 LpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  334 LPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             CCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence            344778999999999999999999999999998544

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=8e-39  Score=321.36  Aligned_cols=257  Identities=25%  Similarity=0.363  Sum_probs=208.3

Q ss_pred             cCccccccccccCceeEEEEEcC------CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .+|...+.||+|+||.||+++..      ++..+++|.+........+.+.+|+.++++++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM   84 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence            45778899999999999999742      345789999876666666788999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc
Q 008239          343 VYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT  409 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~  409 (573)
                      ||||+++++|.+++....             ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~  161 (291)
T cd05094          85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL  161 (291)
T ss_pred             EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence            999999999999985432             1235899999999999999999999988   999999999999999999


Q ss_pred             EEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHH
Q 008239          410 AKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWD  487 (573)
Q Consensus       410 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  487 (573)
                      +||+|||++........ .......++..|+|||.+....++.++||||||+++|||++ |+.|+......     ..+.
T Consensus       162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~-----~~~~  236 (291)
T cd05094         162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-----EVIE  236 (291)
T ss_pred             EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH-----HHHH
Confidence            99999999976543221 22234456788999999999999999999999999999999 77775443221     1122


Q ss_pred             HhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          488 LYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       488 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ....+...         ..+...+..+.+++.+||+.+|++||++++|+++|+..
T Consensus       237 ~~~~~~~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         237 CITQGRVL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             HHhCCCCC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            22222211         11234567899999999999999999999999999654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=9.8e-39  Score=319.33  Aligned_cols=256  Identities=26%  Similarity=0.397  Sum_probs=203.5

Q ss_pred             cCccccccccccCceeEEEEEc-----CCCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .+|+..++||+|+||.||+|.+     .++..|++|.+... ..+....+.+|++++++++||||+++++++..+...++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4577889999999999999984     24678999998643 33445678899999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC
Q 008239          343 VYEFVPNQSLLDNLFVRQD--------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF  408 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~  408 (573)
                      ||||+++++|.+++.....              ...+++...+.++.|++.||+|||+++   ++||||||+|||+++++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence            9999999999998853221              235788999999999999999999987   99999999999999999


Q ss_pred             cEEEeecccccccCCCC-cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHH
Q 008239          409 TAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVW  486 (573)
Q Consensus       409 ~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  486 (573)
                      .+||+|||+++...... ........++..|+|||.+.+..++.++||||||+++|||++ |..|+.... .    ..+.
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~-~----~~~~  236 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS-N----QEVI  236 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-H----HHHH
Confidence            99999999998653322 122223445678999999988899999999999999999998 666653321 1    1111


Q ss_pred             HHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          487 DLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       487 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ........         ...+...+.++.+++.+||+.+|++||++.+|+++|..
T Consensus       237 ~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EMVRKRQL---------LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcCCc---------CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            11111111         11234456788999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.8e-39  Score=315.52  Aligned_cols=255  Identities=28%  Similarity=0.417  Sum_probs=205.9

Q ss_pred             HhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..++|+..++||+|+||.||+|...+++.||+|.+..... ..+.+.+|+.++++++|+||+++++++. ....+++|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEY   81 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEc
Confidence            3467888999999999999999998899999999865443 3467889999999999999999999864 4578999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++.... ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          82 MENGSLVDFLKTPE-GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             CCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999885432 346899999999999999999999987   99999999999999999999999999987653332


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      .......++..|+|||.+....++.++||||||++++||++ |+.|+..... ...    ......+         ....
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-~~~----~~~~~~~---------~~~~  223 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTN-PEV----IQNLERG---------YRMP  223 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCCh-HHH----HHHHHcC---------CCCC
Confidence            22223445778999999998899999999999999999999 7777643221 111    1111111         1112


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .+...+.++.+++.+|++.+|++||++++++++|+.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         224 RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence            233456789999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=331.02  Aligned_cols=243  Identities=26%  Similarity=0.324  Sum_probs=204.7

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCcee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  341 (573)
                      ..++|....+||+|+||+|+++.++ +++.+|||.+++..   .+..+..+.|.+++... +||.+++++.+|...++++
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~  445 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLF  445 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEE
Confidence            4477999999999999999999986 57899999998763   45567788898888777 5999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+.+|++..+.    ....+++..+..++..|+.||.|||+++   |||||||.+|||||.+|.+||+||||++.-
T Consensus       446 fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  446 FVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEeccccccccc
Confidence            999999999965544    3356999999999999999999999998   999999999999999999999999999843


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      -. ......+.+||+.|||||++.++.|+..+|.|||||+|||||.|+.||....++.     +.+.+...       . 
T Consensus       519 m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee-----~FdsI~~d-------~-  584 (694)
T KOG0694|consen  519 MG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE-----VFDSIVND-------E-  584 (694)
T ss_pred             CC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHhcC-------C-
Confidence            21 2224568899999999999999999999999999999999999999987655431     11111111       1 


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSM  532 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  532 (573)
                        ..++...+.+...|+.+.+..+|+.|.-+
T Consensus       585 --~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  585 --VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             --CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence              13466778889999999999999999877

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=8.5e-39  Score=315.65  Aligned_cols=254  Identities=29%  Similarity=0.427  Sum_probs=203.8

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .++|++.++||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||+
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYM   82 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEec
Confidence            356888999999999999999988888999999865433 2457889999999999999999999875 45689999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++... ....+++..++.++.+++.||+|||+.+   ++||||||+||++++++.++|+|||++..+......
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          83 SKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            999999988543 2345899999999999999999999987   999999999999999999999999999876443322


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......++..|+|||.+....++.++||||||+++|||++ |..|+... ........    ...+         .....
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~-~~~~~~~~----~~~~---------~~~~~  224 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM-NNREVLEQ----VERG---------YRMPC  224 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC-CHHHHHHH----HHcC---------CCCCC
Confidence            2223345678999999988899999999999999999999 66665332 11111111    1111         11122


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      +...+..+.+++.+|++.+|++|||+++++++|++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         225 PQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            34556789999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=323.41  Aligned_cols=239  Identities=21%  Similarity=0.230  Sum_probs=194.3

Q ss_pred             ccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCc
Q 008239          277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL  352 (573)
Q Consensus       277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  352 (573)
                      ||+|+||.||+++.. +++.||+|++...   .......+.+|+.++.+++||||+++++++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999975 5789999998643   233456778899999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 008239          353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL  432 (573)
Q Consensus       353 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  432 (573)
                      .+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... ......
T Consensus        81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  153 (312)
T cd05585          81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTF  153 (312)
T ss_pred             HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Cccccc
Confidence            998853   345899999999999999999999988   9999999999999999999999999988543222 223345


Q ss_pred             ccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHH
Q 008239          433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS  512 (573)
Q Consensus       433 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  512 (573)
                      .||+.|+|||.+.+..++.++|||||||++|||++|+.|+.....    . ........+.          ..++...+.
T Consensus       154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~----~-~~~~~~~~~~----------~~~~~~~~~  218 (312)
T cd05585         154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENV----N-EMYRKILQEP----------LRFPDGFDR  218 (312)
T ss_pred             cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCH----H-HHHHHHHcCC----------CCCCCcCCH
Confidence            789999999999999999999999999999999999999754321    1 1111111111          122344567


Q ss_pred             HHHHHHHHccCCCCCCCCC---HHHHHH
Q 008239          513 RLLQIGLLCVQASAELRPS---MSIVVK  537 (573)
Q Consensus       513 ~l~~l~~~cl~~~p~~RPt---~~evl~  537 (573)
                      .+.+++.+||+.+|++||+   +.|+++
T Consensus       219 ~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         219 DAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            7889999999999999986   455554

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.1e-38  Score=319.81  Aligned_cols=259  Identities=24%  Similarity=0.369  Sum_probs=207.3

Q ss_pred             hcCccccccccccCceeEEEEEcC------CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      .++|.+.+.||+|+||.||++...      ++..+|+|.+........+.+.+|+.++++++||||+++++++......+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccE
Confidence            356888999999999999999842      34568999987666666778999999999999999999999999999999


Q ss_pred             EEEEeccCCCccccccccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEE
Q 008239          342 LVYEFVPNQSLLDNLFVRQ----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK  411 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~k  411 (573)
                      +||||+++++|.+++....          ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~k  160 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVK  160 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEE
Confidence            9999999999998885322          2235899999999999999999999987   99999999999999999999


Q ss_pred             EeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHh
Q 008239          412 IADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLY  489 (573)
Q Consensus       412 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  489 (573)
                      |+|||++........ .......++..|+|||.+.+..++.++||||||++++||++ |..|+..... ..    .....
T Consensus       161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~-~~----~~~~i  235 (288)
T cd05093         161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NE----VIECI  235 (288)
T ss_pred             eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHH
Confidence            999999986533221 12223345778999999998899999999999999999999 6666543221 11    11222


Q ss_pred             hcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       490 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      ..+...         ..+...+..+.+++.+||+.+|.+|||+++|++.|+...
T Consensus       236 ~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~  280 (288)
T cd05093         236 TQGRVL---------QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLA  280 (288)
T ss_pred             HcCCcC---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence            222211         112234567999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=6.6e-39  Score=330.97  Aligned_cols=248  Identities=23%  Similarity=0.329  Sum_probs=195.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .+|+..++||+|+||+||+++.. +|+.||||++.... ....+.+.+|+++++.++|+||+++++++......++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            34566889999999999999875 68999999986543 34456788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+..       ..++..+..++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.......
T Consensus       154 ~~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~  223 (353)
T PLN00034        154 MDGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD  223 (353)
T ss_pred             CCCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence            9999986532       2467788899999999999999988   99999999999999999999999999986543221


Q ss_pred             ccccccccCcCcCchhhhcc-----CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          427 HISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                       ......||..|+|||.+..     ...+.++|||||||++|||++|+.|+...... ...... .......        
T Consensus       224 -~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~-~~~~~~-~~~~~~~--------  292 (353)
T PLN00034        224 -PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG-DWASLM-CAICMSQ--------  292 (353)
T ss_pred             -cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc-cHHHHH-HHHhccC--------
Confidence             1234568999999998743     23456899999999999999999998633221 111111 0000000        


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       ........+.++.+++.+||+.+|++||++.|+++.
T Consensus       293 -~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 -PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             -CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             112233456789999999999999999999999975

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2e-38  Score=310.99  Aligned_cols=247  Identities=29%  Similarity=0.402  Sum_probs=199.9

Q ss_pred             ccccccCceeEEEEEcCCCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCcc
Q 008239          275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL  353 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  353 (573)
                      ++||+|+||.||+|...+++.+|+|.+.... .+....+.+|+++++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4799999999999998888999999986553 333457889999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccccc
Q 008239          354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA  433 (573)
Q Consensus       354 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~  433 (573)
                      +++...  ...+++..++.++.|++.+|.|||+.+   ++||||+|+||+++.++.+||+|||++...............
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (250)
T cd05085          81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQ  155 (250)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCC
Confidence            988533  245789999999999999999999987   999999999999999999999999998754433222222334


Q ss_pred             cCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHH
Q 008239          434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS  512 (573)
Q Consensus       434 gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  512 (573)
                      ++..|+|||++..+.++.++||||||+++|||++ |..|+.....     .........+         .....+...+.
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~-----~~~~~~~~~~---------~~~~~~~~~~~  221 (250)
T cd05085         156 IPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTN-----QQAREQVEKG---------YRMSCPQKCPD  221 (250)
T ss_pred             CcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHHcC---------CCCCCCCCCCH
Confidence            4678999999998999999999999999999998 7766543221     1111111111         11122344667


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          513 RLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       513 ~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      .+.+++.+|++.+|++||++.|++++|.
T Consensus       222 ~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         222 DVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             HHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            8999999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=7.9e-39  Score=327.86  Aligned_cols=260  Identities=27%  Similarity=0.352  Sum_probs=203.4

Q ss_pred             HhcCccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC-
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG-  337 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  337 (573)
                      ..++|++.++||+|+||.||+|...      +++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++... 
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            4567899999999999999999642      35789999986542 33345678899999999 899999999987644 


Q ss_pred             CceeEEEEeccCCCccccccccCC--------------------------------------------------------
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQD--------------------------------------------------------  361 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  361 (573)
                      ...++++||+++++|.+++.....                                                        
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            567899999999999988753211                                                        


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc-ccccccCcCc
Q 008239          362 --VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SATLAGTLGY  438 (573)
Q Consensus       362 --~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~~~gt~~y  438 (573)
                        ...+++..+.+++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+....... .....++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence              136899999999999999999999987   9999999999999999999999999998654332221 2234456789


Q ss_pred             CchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHH
Q 008239          439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQI  517 (573)
Q Consensus       439 ~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  517 (573)
                      +|||++.+..++.++|||||||++|||++ |..|+.......    ........+..         ...+...+..+.+|
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~----~~~~~~~~~~~---------~~~~~~~~~~~~~l  308 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE----EFCRRLKEGTR---------MRAPEYATPEIYSI  308 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH----HHHHHHhccCC---------CCCCccCCHHHHHH
Confidence            99999999999999999999999999998 877764322211    11111111111         11123445778999


Q ss_pred             HHHccCCCCCCCCCHHHHHHHhccC
Q 008239          518 GLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       518 ~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      +.+||+.+|++||+++||+++|+..
T Consensus       309 ~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         309 MLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHH
Confidence            9999999999999999999999653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-38  Score=321.52  Aligned_cols=263  Identities=22%  Similarity=0.290  Sum_probs=198.7

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|+..++||+|+||.||+|+.. +++.||||++..... .....+.+|+.+++.++||||+++++++.+....++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE   83 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence            467999999999999999999976 688999999865432 223467789999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |++ ++|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  157 (303)
T cd07869          84 YVH-TDLCQYMDKH--PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS  157 (303)
T ss_pred             CCC-cCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence            995 6777776432  345888999999999999999999988   9999999999999999999999999987543221


Q ss_pred             cccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc---c---c--c
Q 008239          426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR---L---H--E  496 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~---~--~  496 (573)
                       .......+++.|+|||.+.+ ..++.++|||||||++|||++|+.|+.....................   +   .  .
T Consensus       158 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         158 -HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             -ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence             12234567899999999865 46889999999999999999999998654322222222111111000   0   0  0


Q ss_pred             ccCc-cccCCC---------CCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          497 AVDP-ALAGNF---------QEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       497 ~~d~-~l~~~~---------~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..++ .+....         ....+..+.+++.+||+.||++|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            0000 000000         0112356789999999999999999999985

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.9e-39  Score=342.59  Aligned_cols=251  Identities=20%  Similarity=0.298  Sum_probs=205.3

Q ss_pred             CccccccccccCceeEEEEEcC-C-CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-G-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .|...+.||+|+||.||++... + ++.||+|.+..........+.+|+.+|+.++|||||++++++...+..++||||+
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~  147 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG  147 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence            4888999999999999999864 3 6788999876666565667888999999999999999999999999999999999


Q ss_pred             cCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          348 PNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       348 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      ++|+|.+++... ....++++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.+.....
T Consensus       148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            999999887543 23456899999999999999999999987   99999999999999999999999999987644322


Q ss_pred             -ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          427 -HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       427 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                       .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.....    .. .......+..         ..
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~----~~-~~~~~~~~~~---------~~  290 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQ----RE-IMQQVLYGKY---------DP  290 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH----HH-HHHHHHhCCC---------CC
Confidence             223355789999999999999999999999999999999999998754221    11 1111111111         11


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .+...+..+.+++.+||+.+|++||++++++.
T Consensus       291 ~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        291 FPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            23345678899999999999999999999864

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=8.9e-39  Score=327.59  Aligned_cols=246  Identities=24%  Similarity=0.290  Sum_probs=202.3

Q ss_pred             hcCccccccccccCceeEEEEEcCC--CCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG--GEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..+.||+|+||.||+|++.+  +..||+|++...   .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l  108 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL  108 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence            3568889999999999999998643  368999998543   23345678899999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++...   ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       109 v~Ey~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRRN---KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999988532   45889999999999999999999988   9999999999999999999999999998654


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ..    .....||+.|+|||++.+..++.++|||||||++|||++|+.|+.....     .........+..        
T Consensus       183 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~~i~~~~~--------  245 (340)
T PTZ00426        183 TR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP-----LLIYQKILEGII--------  245 (340)
T ss_pred             CC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH-----HHHHHHHhcCCC--------
Confidence            32    2345789999999999988899999999999999999999999864321     111111111111        


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                        .++...+..+.+++.+|++.+|++|+     +++++++.
T Consensus       246 --~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 --YFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence              12334456788999999999999995     89998875

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.9e-38  Score=313.69  Aligned_cols=254  Identities=27%  Similarity=0.385  Sum_probs=202.5

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .++|++.++||+|+||.||+|++.++..||+|++..... ..+.+.+|+.+++.++||||+++++.+. ....++||||+
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~   82 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYM   82 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcC
Confidence            356889999999999999999987777899999865332 3457889999999999999999999874 45678999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++|+|.+++... ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++........
T Consensus        83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~  158 (262)
T cd05071          83 SKGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  158 (262)
T ss_pred             CCCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc
Confidence            999999998543 2235789999999999999999999987   999999999999999999999999999866543322


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......++..|+|||++.+..++.++||||||+++|||++ |..|+.... ....    ......+.         ....
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~-~~~~----~~~~~~~~---------~~~~  224 (262)
T cd05071         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV-NREV----LDQVERGY---------RMPC  224 (262)
T ss_pred             cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC-hHHH----HHHHhcCC---------CCCC
Confidence            2223446778999999998899999999999999999999 555543221 1111    11111110         0112


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      +...+..+.+++.+|++.+|++||++.+++++|++
T Consensus       225 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~  259 (262)
T cd05071         225 PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLED  259 (262)
T ss_pred             ccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHH
Confidence            33456788999999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=6.8e-39  Score=326.66  Aligned_cols=242  Identities=24%  Similarity=0.273  Sum_probs=196.6

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      +.||+|+||.||+++.. +|+.||+|++...   .......+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            46999999999999875 6899999998653   2234556778999999999999999999999999999999999999


Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA  430 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  430 (573)
                      +|..++..   ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....... ....
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~  153 (323)
T cd05595          81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMK  153 (323)
T ss_pred             cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Cccc
Confidence            99887743   345899999999999999999999988   9999999999999999999999999987532221 1123


Q ss_pred             ccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCch
Q 008239          431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK  510 (573)
Q Consensus       431 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  510 (573)
                      ...||+.|+|||.+.++.++.++|||||||++|||++|+.|+......     ........+..          .++...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~-----~~~~~~~~~~~----------~~p~~~  218 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----RLFELILMEEI----------RFPRTL  218 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHH-----HHHHHHhcCCC----------CCCCCC
Confidence            456899999999999999999999999999999999999987543221     11111111111          123445


Q ss_pred             HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          511 PSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       511 ~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      +..+.+++.+||+.+|++||     ++.++++.
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         219 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence            67889999999999999998     88888753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.9e-38  Score=324.04  Aligned_cols=242  Identities=24%  Similarity=0.270  Sum_probs=197.7

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      ++||+|+||.||+++.. +|+.||||++...   .......+.+|+.+++.++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999875 6899999998653   2334567788999999999999999999999999999999999999


Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA  430 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  430 (573)
                      +|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ....
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~  153 (328)
T cd05593          81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMK  153 (328)
T ss_pred             CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc-cccc
Confidence            99888743   345899999999999999999999988   9999999999999999999999999987532221 1223


Q ss_pred             ccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCch
Q 008239          431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK  510 (573)
Q Consensus       431 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  510 (573)
                      ...||+.|+|||.+.+..++.++|||||||++|||++|+.|+......     ........+.          ..++...
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~-----~~~~~~~~~~----------~~~p~~~  218 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMED----------IKFPRTL  218 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH-----HHHHHhccCC----------ccCCCCC
Confidence            457899999999999999999999999999999999999997543211     1111111111          1223445


Q ss_pred             HHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          511 PSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       511 ~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      +..+.+++.+||+.+|++||     ++.++++.
T Consensus       219 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         219 SADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            67889999999999999997     89998864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.5e-38  Score=318.21  Aligned_cols=262  Identities=27%  Similarity=0.382  Sum_probs=202.8

Q ss_pred             cCccccccccccCceeEEEEEc-----CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec--CCcee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~  341 (573)
                      .+|+..+.||+|+||.||++..     .+++.||||++........+.+.+|++++++++||||+++++++..  ....+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4678899999999999999974     2578999999987766667789999999999999999999998754  34678


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +|+||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~  158 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL  158 (284)
T ss_pred             EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence            999999999999988532  235899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCccc--ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc------
Q 008239          422 PEDITHI--SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR------  493 (573)
Q Consensus       422 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------  493 (573)
                      .......  .....++..|+|||.+.+..++.++||||||+++|||++|..+......  ..    ........      
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~--~~----~~~~~~~~~~~~~~  232 (284)
T cd05081         159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPA--EF----MRMMGNDKQGQMIV  232 (284)
T ss_pred             cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcch--hh----hhhcccccccccch
Confidence            4432211  1122234569999999988999999999999999999998765422110  00    00000000      


Q ss_pred             --cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          494 --LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       494 --~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                        +.+.+........+...+..+.+++.+||+.+|++|||+.||++.|+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05081         233 YHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEA  282 (284)
T ss_pred             HHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHh
Confidence              000111111112234456789999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.6e-38  Score=312.17  Aligned_cols=247  Identities=25%  Similarity=0.364  Sum_probs=196.7

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCc
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL  352 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  352 (573)
                      ++||+|+||.||+|+.. +++.||+|.+... ..+....+.+|++++++++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            47999999999999875 6889999987643 334456789999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc-ccc
Q 008239          353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SAT  431 (573)
Q Consensus       353 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-~~~  431 (573)
                      .+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......... ...
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9988432  345889999999999999999999987   9999999999999999999999999987543221111 111


Q ss_pred             cccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCch
Q 008239          432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK  510 (573)
Q Consensus       432 ~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~  510 (573)
                      ...+..|+|||.+.++.++.++||||||+++|||++ |..|+.....     .........         ......+...
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~-----~~~~~~~~~---------~~~~~~~~~~  221 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN-----QQTREAIEQ---------GVRLPCPELC  221 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH-----HHHHHHHHc---------CCCCCCcccC
Confidence            223457999999999999999999999999999998 6655532211     111111111         1111223445


Q ss_pred             HHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          511 PSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       511 ~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      +..+.+++.+|++.+|++||++++|+++|.
T Consensus       222 ~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         222 PDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            678999999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.7e-38  Score=318.68  Aligned_cols=261  Identities=25%  Similarity=0.335  Sum_probs=194.6

Q ss_pred             cCccccccccccCceeEEEEEcC--CCCEEEEEEecccC--hhhHHHHHHHHHHHcCC---CCCCeeeeeeeee-----c
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP--GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSI-----T  336 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----~  336 (573)
                      ++|+..+.||+|+||+||+++..  +++.||||++....  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36888999999999999999863  46889999886432  22234556677776655   6999999999875     2


Q ss_pred             CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                      ....++||||++ ++|.+++.... ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg  155 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG  155 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence            456789999996 68888875432 235899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc---Cc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK---GR  493 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~  493 (573)
                      +++.....  .......||+.|+|||.+....++.++||||||+++|||++|+.|+...... .....+......   ..
T Consensus       156 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~-~~~~~i~~~~~~~~~~~  232 (290)
T cd07862         156 LARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEED  232 (290)
T ss_pred             ceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHHhCCCChhh
Confidence            99865433  2233456899999999999889999999999999999999999887654322 112221111100   00


Q ss_pred             cc-------cccCccc---cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          494 LH-------EAVDPAL---AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       494 ~~-------~~~d~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +.       ..+.+.-   ........+..+.+++.+||+.+|++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            00       0000000   00111234567789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-39  Score=333.85  Aligned_cols=251  Identities=27%  Similarity=0.386  Sum_probs=205.8

Q ss_pred             cccccccccCceeEEEEEc-CCCC----EEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          272 HESNKLGQGGSGSVYKGTL-PGGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       272 ~~~~~lg~G~~g~Vy~~~~-~~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ...++||+|+||+||||.+ ++|+    +||||++... ..+..+++.+|+..|.+|+|||+++|+|+|.... ..||++
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq  777 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ  777 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence            4578999999999999986 4444    7899988665 3455678999999999999999999999998766 889999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |||.|+|.+++...  ...+.....+.|..|||+||.|||++.   ++||||.++||||..-..+||.|||+++....+.
T Consensus       778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~  852 (1177)
T KOG1025|consen  778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE  852 (1177)
T ss_pred             hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence            99999999999653  455788999999999999999999987   9999999999999999999999999999887665


Q ss_pred             cccccc-cccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          426 THISAT-LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       426 ~~~~~~-~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .+.... ..-.+.|||-|.+....|++++|||||||.+|||+|-+.-+.....    ...+.+.+..+         .+-
T Consensus       853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~----~~eI~dlle~g---------eRL  919 (1177)
T KOG1025|consen  853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP----AEEIPDLLEKG---------ERL  919 (1177)
T ss_pred             ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC----HHHhhHHHhcc---------ccC
Confidence            554432 2235689999999999999999999999999999985433322222    22333333332         223


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .-++..+.+++.++.+||..|+..||+++++...++.
T Consensus       920 sqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~  956 (1177)
T KOG1025|consen  920 SQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSR  956 (1177)
T ss_pred             CCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHH
Confidence            4467788999999999999999999999999988754

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-39  Score=325.59  Aligned_cols=253  Identities=26%  Similarity=0.388  Sum_probs=211.6

Q ss_pred             cCccccccccccCceeEEEEEcCC---CC--EEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG---GE--AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~---g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      +.....++||.|.||.||+|...+   |+  .||||..+.+ ..+..+.|..|..+|++++|||||+|+|+|.+ ...++
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeE
Confidence            344557889999999999998632   33  6899988774 45568899999999999999999999999976 46789


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      |||.++.|.|.++|..+  ...++......++.||..+|+|||+..   +|||||.++|||+...--|||+||||++.+.
T Consensus       468 vmEL~~~GELr~yLq~n--k~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQN--KDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             EEecccchhHHHHHHhc--cccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            99999999999999644  346888999999999999999999987   9999999999999999999999999999998


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ++.........-+..|||||.+.-..++.+||||.|||.+|||++ |.+||..-.+.              .+.-.+...
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs--------------DVI~~iEnG  608 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS--------------DVIGHIENG  608 (974)
T ss_pred             ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc--------------ceEEEecCC
Confidence            877766666667889999999999999999999999999999986 55565433222              111222222


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      -+...++.++..|+.|+.+||..+|.+||.+.|+...|++
T Consensus       609 eRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsd  648 (974)
T KOG4257|consen  609 ERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSD  648 (974)
T ss_pred             CCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHH
Confidence            3345678899999999999999999999999998887744

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=3.8e-38  Score=328.56  Aligned_cols=252  Identities=22%  Similarity=0.256  Sum_probs=197.5

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .|+.+++||+|+||+||+|+.. +++.||||++...   .....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            5788999999999999999874 5889999998653   23345678899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++|+|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~  155 (381)
T cd05626          82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH  155 (381)
T ss_pred             cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence            9999999998853   345888999999999999999999987   9999999999999999999999999976431100


Q ss_pred             c----------------------------------------------ccccccccCcCcCchhhhccCCCCcccchHhHH
Q 008239          426 T----------------------------------------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFG  459 (573)
Q Consensus       426 ~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG  459 (573)
                      .                                              .......||+.|+|||.+.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (381)
T cd05626         156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG  235 (381)
T ss_pred             ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence            0                                              001235699999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHH--ccCCCCCCCCCHHHHHH
Q 008239          460 VVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLL--CVQASAELRPSMSIVVK  537 (573)
Q Consensus       460 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~--cl~~~p~~RPt~~evl~  537 (573)
                      |++|||++|+.|+........    .........       .+........+.++.+++.+  |+..+|..||+++++++
T Consensus       236 ~il~elltG~~Pf~~~~~~~~----~~~i~~~~~-------~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         236 VILFEMLVGQPPFLAPTPTET----QLKVINWEN-------TLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKA  304 (381)
T ss_pred             hHHHHHHhCCCCCcCCCHHHH----HHHHHcccc-------ccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhc
Confidence            999999999999865432111    111110000       01111112245667778876  56667777999999987


Q ss_pred             H
Q 008239          538 M  538 (573)
Q Consensus       538 ~  538 (573)
                      .
T Consensus       305 h  305 (381)
T cd05626         305 H  305 (381)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-38  Score=330.64  Aligned_cols=256  Identities=21%  Similarity=0.198  Sum_probs=196.3

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .+|+..++||+|+||.||++... +++.||||...      .+.+.+|++++++++||||+++++++......++|+|++
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~  165 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY  165 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence            56999999999999999999874 68899999653      235678999999999999999999999999999999998


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      . ++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++........
T Consensus       166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~  238 (391)
T PHA03212        166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINAN  238 (391)
T ss_pred             C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccc
Confidence            5 688777743   235889999999999999999999987   999999999999999999999999999754332222


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc------chHHHHHHHhhcC--c------
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC------SILQTVWDLYVKG--R------  493 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~------~~~~~~~~~~~~~--~------  493 (573)
                      ......||+.|+|||++.+..++.++|||||||++|||++|+.|+.......      .....+.......  .      
T Consensus       239 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~  318 (391)
T PHA03212        239 KYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ  318 (391)
T ss_pred             ccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence            3335679999999999999999999999999999999999998765432110      0111111100000  0      


Q ss_pred             --ccccc---------CccccCC--CCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          494 --LHEAV---------DPALAGN--FQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       494 --~~~~~---------d~~l~~~--~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        +....         .+.....  .....+.++.+|+.+||+.||++|||++|+++
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence              00000         0000000  00123567889999999999999999999995

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=2.7e-38  Score=315.57  Aligned_cols=254  Identities=26%  Similarity=0.363  Sum_probs=198.9

Q ss_pred             cCccccccccccCceeEEEEEcC-CCC----EEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ++|+..+.||+|+||+||+|++. +++    .+++|.+.... .....++..|+..+++++||||+++++++. ....++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            46778899999999999999874 344    47888775432 233467788999999999999999999875 455789


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ++||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+|||+++++.+||+|||+++...
T Consensus        86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            99999999999998543  245899999999999999999999987   9999999999999999999999999998654


Q ss_pred             CCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          423 EDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       423 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ..... ......++..|+|||.+..+.++.++||||||+++|||++ |+.|+.....     ....+....+...     
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~~~~-----  230 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP-----HEVPDLLEKGERL-----  230 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCH-----HHHHHHHHCCCcC-----
Confidence            33221 2223456778999999999999999999999999999998 7776543211     1111222222111     


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                          ..+...+..+.+++.+||..+|+.||++.|+++.|...
T Consensus       231 ----~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         231 ----AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             ----CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                11222456778999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=5.3e-38  Score=321.36  Aligned_cols=262  Identities=21%  Similarity=0.331  Sum_probs=202.8

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|+..++||+|+||.||++.+. ++..+|+|.+... .....+.+.+|++++++++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   83 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   83 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence            467999999999999999999976 5788999988654 33445678999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++..   ...+++..+..++.+++.||.|||+.+  +|+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            9999999998843   345889999999999999999999752  39999999999999999999999999987553321


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcc-----------
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL-----------  494 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------  494 (573)
                         .....|+..|+|||++.+..++.++|||||||++|||++|+.|+...... .+ .........+..           
T Consensus       159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK-EL-ELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh-HH-HHHhcCcccCCccccccCcccCC
Confidence               22346889999999999889999999999999999999999987543211 00 000000000000           


Q ss_pred             ------------------ccccCcccc---CCC-CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          495 ------------------HEAVDPALA---GNF-QEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       495 ------------------~~~~d~~l~---~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                                        ..+.+....   ... ....+.++.+++.+||+.||++|||++|+++.-
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~  300 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA  300 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence                              000000000   000 112456789999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.5e-38  Score=317.27  Aligned_cols=261  Identities=21%  Similarity=0.279  Sum_probs=198.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..++||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++||||+++++++......++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            46888999999999999999875 68899999986543 23345678999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++ +|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~  158 (288)
T cd07871          85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK  158 (288)
T ss_pred             CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence            974 888877432  234788999999999999999999988   99999999999999999999999999876433221


Q ss_pred             ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh------------cCc
Q 008239          427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV------------KGR  493 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~------------~~~  493 (573)
                       ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+........ .........            ...
T Consensus       159 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T cd07871         159 -TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE-LHLIFRLLGTPTEETWPGITSNEE  236 (288)
T ss_pred             -cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChHHhhccccchh
Confidence             1233467899999998865 5689999999999999999999988754332211 111111110            000


Q ss_pred             cccccCccccC----CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          494 LHEAVDPALAG----NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       494 ~~~~~d~~l~~----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ......+....    ........+..+++.+|++.||.+|||++|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         237 FRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             hhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            11111111100    011223567889999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.7e-38  Score=322.51  Aligned_cols=245  Identities=26%  Similarity=0.326  Sum_probs=195.0

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHH---cCCCCCCeeeeeeeeecCCceeEE
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLI---SGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      |++.++||+|+||.||++... +|+.||||++....   ....+.+.+|++++   +.++||||+++++++......++|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            567889999999999999875 68999999986432   22345566666554   677899999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|..++..    ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05589          81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG  153 (324)
T ss_pred             EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence            999999999887732    35899999999999999999999988   99999999999999999999999999874322


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .. .......|++.|+|||.+.+..++.++||||||+++|||++|+.|+...... ..    ......+..         
T Consensus       154 ~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~-~~----~~~i~~~~~---------  218 (324)
T cd05589         154 FG-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEE-EV----FDSIVNDEV---------  218 (324)
T ss_pred             CC-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHH-HH----HHHHHhCCC---------
Confidence            11 1223457899999999999999999999999999999999999997543221 11    111111111         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                       ..+...+..+.+++.+||+.+|.+||     ++.++++.
T Consensus       219 -~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         219 -RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence             12344567788999999999999999     56666653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3e-38  Score=311.25  Aligned_cols=245  Identities=24%  Similarity=0.366  Sum_probs=195.9

Q ss_pred             cccccCceeEEEEEc---CCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          276 KLGQGGSGSVYKGTL---PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      +||+|+||.||+|.+   .++..+|+|++....  ....+++.+|+.+++.++||||+++++++. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999975   357889999986442  334568899999999999999999999875 45678999999999


Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc--
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI--  428 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~--  428 (573)
                      +|.+++..   ...+++..+.+++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++..........  
T Consensus        81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  154 (257)
T cd05116          81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA  154 (257)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence            99998843   235889999999999999999999988   9999999999999999999999999998664432211  


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      .....++..|+|||.+....++.++||||||+++|||++ |+.|+..... ....    .....+.         ....+
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~-~~~~----~~i~~~~---------~~~~~  220 (257)
T cd05116         155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG-NEVT----QMIESGE---------RMECP  220 (257)
T ss_pred             cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH-HHHH----HHHHCCC---------CCCCC
Confidence            112234678999999988889999999999999999998 7777653221 1111    1112211         11234


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...+..+.+++.+||+.+|++||++++|++.|..
T Consensus       221 ~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         221 QRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            4567789999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-39  Score=331.20  Aligned_cols=253  Identities=22%  Similarity=0.254  Sum_probs=205.1

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||+||+++.. +|+.||||++....   ......+.+|+.++..++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            36888999999999999999976 68999999986532   234567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  154 (350)
T cd05573          81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA  154 (350)
T ss_pred             cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence            999999999988543   56899999999999999999999987   999999999999999999999999999865433


Q ss_pred             C----------------------------cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCC
Q 008239          425 I----------------------------THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ  476 (573)
Q Consensus       425 ~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~  476 (573)
                      .                            ........||+.|+|||.+.+..++.++|||||||++|||++|+.|+....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence            2                            112234568999999999999999999999999999999999999976543


Q ss_pred             CCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCC-HHHHHHHh
Q 008239          477 NSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPS-MSIVVKML  539 (573)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~~L  539 (573)
                      ..    .. +.......      ..+........+..+.+++.+|++ +|.+||+ ++++++.-
T Consensus       235 ~~----~~-~~~i~~~~------~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp  286 (350)
T cd05573         235 LQ----ET-YNKIINWK------ESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHP  286 (350)
T ss_pred             HH----HH-HHHHhccC------CcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCC
Confidence            21    11 11111100      111111112246788999999998 9999999 99999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=341.92  Aligned_cols=261  Identities=23%  Similarity=0.292  Sum_probs=208.9

Q ss_pred             hHHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC
Q 008239          261 YETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG  337 (573)
Q Consensus       261 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  337 (573)
                      ..+.....++|++.++||+|+||+||+++.. +|+.||||++...  .......+.+|+.++..++|+||+++++.+...
T Consensus        24 ~~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~  103 (496)
T PTZ00283         24 EATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKK  103 (496)
T ss_pred             cccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecc
Confidence            3444556689999999999999999999864 6899999998653  344456788999999999999999998876533


Q ss_pred             C--------ceeEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC
Q 008239          338 P--------ESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF  408 (573)
Q Consensus       338 ~--------~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~  408 (573)
                      .        ..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++
T Consensus       104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~  180 (496)
T PTZ00283        104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNG  180 (496)
T ss_pred             cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCC
Confidence            2        3579999999999999886432 3356899999999999999999999987   99999999999999999


Q ss_pred             cEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH
Q 008239          409 TAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD  487 (573)
Q Consensus       409 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~  487 (573)
                      .+||+|||+++.+..... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     .....
T Consensus       181 ~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~-----~~~~~  255 (496)
T PTZ00283        181 LVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM-----EEVMH  255 (496)
T ss_pred             CEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH-----HHHHH
Confidence            999999999986643221 223356789999999999999999999999999999999999998754321     11111


Q ss_pred             HhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          488 LYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       488 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ....+..         ...+...+..+.+++.+||+.+|.+||++.+++++
T Consensus       256 ~~~~~~~---------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        256 KTLAGRY---------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             HHhcCCC---------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1111111         12344566789999999999999999999999864

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.7e-38  Score=315.79  Aligned_cols=263  Identities=25%  Similarity=0.375  Sum_probs=205.0

Q ss_pred             hcCccccccccccCceeEEEEEcCC-----------------CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG-----------------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVK  329 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----------------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~  329 (573)
                      ..+|+..++||+|+||.||++...+                 +..||+|++.... ....+.+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578899999999999999998642                 2468999987553 345678889999999999999999


Q ss_pred             eeeeeecCCceeEEEEeccCCCccccccccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 008239          330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ--------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN  401 (573)
Q Consensus       330 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N  401 (573)
                      +++++..+...++++||+++++|.+++....        ....+++..++.++.|++.||+|||+.+   |+||||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N  160 (296)
T cd05051          84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence            9999999999999999999999999885432        1236899999999999999999999987   9999999999


Q ss_pred             eeeCCCCcEEEeecccccccCCCC-cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc--CCCCCCCCCCC
Q 008239          402 ILLDEEFTAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC--RKRINLFTQNS  478 (573)
Q Consensus       402 Ill~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt--g~~p~~~~~~~  478 (573)
                      |+++.++.++|+|||+++...... ........++..|+|||.+..+.++.++||||||+++|||++  +..|+.... .
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~-~  239 (296)
T cd05051         161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-D  239 (296)
T ss_pred             eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC-h
Confidence            999999999999999988653322 122234456788999999998899999999999999999998  444443221 1


Q ss_pred             cchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          479 CSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ..........+....      .......+...+.++.+++.+||+.+|++|||+.||+++|.
T Consensus       240 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQVIENAGHFFRDDG------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHHHHHhcccccc------ccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            122222222111111      11111123345678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-39  Score=292.78  Aligned_cols=265  Identities=22%  Similarity=0.264  Sum_probs=213.3

Q ss_pred             HHHHhcCccccccccccCceeEEEEE-cCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC----
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----  338 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  338 (573)
                      +....++|.+.++||+|||+-||.++ ..+++.+|+|++.....+..+...+|++.-++++|||+++++++...+.    
T Consensus        16 v~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~   95 (302)
T KOG2345|consen   16 VIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGK   95 (302)
T ss_pred             EEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCc
Confidence            33455789999999999999999998 4578999999998888788889999999999999999999999876544    


Q ss_pred             -ceeEEEEeccCCCccccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          339 -ESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       339 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                       ..||+++|...|+|.+.+...... ..+++.+.+.|+.+|.+||.+||+.. ++++||||||.|||+.+++.++|.|||
T Consensus        96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEecc
Confidence             489999999999999998654433 47999999999999999999999986 689999999999999999999999999


Q ss_pred             cccccCCCCccc--------ccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH
Q 008239          417 LVRLFPEDITHI--------SATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV  485 (573)
Q Consensus       417 la~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~  485 (573)
                      .++..+-.....        -.....|..|.|||++.   +...++++|||||||+||+|+.|..||...-.        
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~--------  246 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ--------  246 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh--------
Confidence            987543211110        01234688999999885   34678899999999999999999999764221        


Q ss_pred             HHHhhcCcccc-ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          486 WDLYVKGRLHE-AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       486 ~~~~~~~~~~~-~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                          ..+.+.- +..+.+.-.-....++.+.+++.+|++.||..||++.+++..+.+
T Consensus       247 ----~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~  299 (302)
T KOG2345|consen  247 ----QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDD  299 (302)
T ss_pred             ----cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHh
Confidence                1111211 112222222233478899999999999999999999999998854

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=327.75  Aligned_cols=252  Identities=21%  Similarity=0.253  Sum_probs=199.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..++||+|+||+||+++.. +|+.||||++....   ......+.+|+.++..++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            46889999999999999999975 58999999996532   234456788999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  154 (364)
T cd05599          81 EYLPGGDMMTLLMKK---DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS  154 (364)
T ss_pred             CCCCCcHHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence            999999999988532   35899999999999999999999988   999999999999999999999999998754321


Q ss_pred             Ccc-------------------------------------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc
Q 008239          425 ITH-------------------------------------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC  467 (573)
Q Consensus       425 ~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt  467 (573)
                      ...                                     ......||+.|+|||++....++.++|||||||++|||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~  234 (364)
T cd05599         155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV  234 (364)
T ss_pred             ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence            100                                     0112468999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 008239          468 RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPS---MSIVVKM  538 (573)
Q Consensus       468 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt---~~evl~~  538 (573)
                      |..|+.....    ........ ...      ..+........+..+.+++.+|+. +|.+|++   ++|+++.
T Consensus       235 G~~Pf~~~~~----~~~~~~i~-~~~------~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         235 GYPPFCSDNP----QETYRKII-NWK------ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCCH----HHHHHHHH-cCC------CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            9999754322    11111111 110      001000111245677889999996 9999998   8888774

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-38  Score=317.11  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=202.2

Q ss_pred             hcCccccccccccCceeEEEEEcCC---------------CCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG---------------GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLL  331 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------------g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~  331 (573)
                      .++|+..++||+|+||.||++...+               ...||+|.+... .....+.+.+|++++++++|+||++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3578899999999999999987642               225899998654 334456789999999999999999999


Q ss_pred             eeeecCCceeEEEEeccCCCccccccccC---------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCe
Q 008239          332 GCSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI  402 (573)
Q Consensus       332 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI  402 (573)
                      +++......++||||+++++|.+++....         ....+++..++.++.|++.||+|||+.+   ++|+||||+||
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Ni  160 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNC  160 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhE
Confidence            99999999999999999999999885321         1124788999999999999999999988   99999999999


Q ss_pred             eeCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCC--CCCCCCCCCc
Q 008239          403 LLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK--RINLFTQNSC  479 (573)
Q Consensus       403 ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~--~p~~~~~~~~  479 (573)
                      ++++++.+||+|||++........ .......++..|+|||.+..+.++.++||||||++++||+++.  .|+..... .
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~-~  239 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD-E  239 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh-H
Confidence            999999999999999876533221 1122334577899999999899999999999999999999854  34332221 1


Q ss_pred             chHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      .........+....      .......+...+..+.+|+.+||+.+|++||++++|+++|.
T Consensus       240 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 QVIENTGEFFRNQG------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHhhhhcc------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            22221111111110      00111123345678999999999999999999999999984

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.8e-38  Score=315.62  Aligned_cols=255  Identities=24%  Similarity=0.332  Sum_probs=204.1

Q ss_pred             cCccccccccccCceeEEEEEcC------CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ++|...++||+|+||.||++...      ++..+|+|.+........+.+.+|+++++.++|+||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   84 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM   84 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence            46778899999999999999642      356899999877666667789999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCC------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcE
Q 008239          343 VYEFVPNQSLLDNLFVRQD------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA  410 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~  410 (573)
                      +|||+++++|.+++.....            ...+++..++.++.|++.||+|||+.+   ++||||||+|||+++++.+
T Consensus        85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~  161 (280)
T cd05092          85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV  161 (280)
T ss_pred             EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence            9999999999998854321            135889999999999999999999988   9999999999999999999


Q ss_pred             EEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHH
Q 008239          411 KIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       411 kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  488 (573)
                      ||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..... .....    .
T Consensus       162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~~~----~  236 (280)
T cd05092         162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN-TEAIE----C  236 (280)
T ss_pred             EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCH-HHHHH----H
Confidence            9999999875533221 11223345778999999999999999999999999999998 6666532211 11111    1


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ...+.         ....+...+..+.+++.+||+.+|++||++++|++.|+
T Consensus       237 ~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 ITQGR---------ELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHcCc---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            11111         01122345677899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2e-38  Score=317.00  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=202.3

Q ss_pred             CccccccccccCceeEEEEEcC------CCCEEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      +|+..++||+|+||.||+|...      +++.||||++..... ...+.+.+|+.+++.++||||+++++++......++
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~   85 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM   85 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence            4677889999999999999864      257899999975433 334678899999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc
Q 008239          343 VYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT  409 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~  409 (573)
                      ++||+++++|.+++....             ....+++..+++++.|++.||.|||+.+   |+||||||.||++++++.
T Consensus        86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~  162 (283)
T cd05091          86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN  162 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence            999999999998875321             1235888999999999999999999987   999999999999999999


Q ss_pred             EEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHH
Q 008239          410 AKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWD  487 (573)
Q Consensus       410 ~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~  487 (573)
                      +||+|||+++....... .......+++.|+|||.+..+.++.++||||||+++|||++ |..|+.. ...    .....
T Consensus       163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~-~~~----~~~~~  237 (283)
T cd05091         163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCG-YSN----QDVIE  237 (283)
T ss_pred             eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCC-CCH----HHHHH
Confidence            99999999886533221 11223345788999999998899999999999999999998 5555432 211    11122


Q ss_pred             HhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          488 LYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       488 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ....+..         ...+...+..+.+++..||+.+|++||++++|++.|+
T Consensus       238 ~i~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~  281 (283)
T cd05091         238 MIRNRQV---------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLR  281 (283)
T ss_pred             HHHcCCc---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhh
Confidence            2222211         1234556788999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.9e-38  Score=312.96  Aligned_cols=259  Identities=22%  Similarity=0.340  Sum_probs=207.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||.||+|+.. +++.||||.+...   .......+.+|+++++.++||||+++++++......++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            47889999999999999999975 6899999987542   2344567889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       345 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      ||+++++|.+++... .....+++..++.++.|++.||+|||+++   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            999999998887432 22345789999999999999999999987   99999999999999999999999999887644


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......  ..... .......     .+.  
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~--~~~~~-~~~~~~~-----~~~--  227 (267)
T cd08228         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LFSLC-QKIEQCD-----YPP--  227 (267)
T ss_pred             hhHH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc--HHHHH-HHHhcCC-----CCC--
Confidence            3221 12345788999999999888999999999999999999999987543221  11111 1111111     111  


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                       ......+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       228 -~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         228 -LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             -CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence             11223457789999999999999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.7e-38  Score=315.63  Aligned_cols=258  Identities=26%  Similarity=0.338  Sum_probs=206.1

Q ss_pred             hcCccccccccccCceeEEEEEcCC-----CCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec-CCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  340 (573)
                      .++|+..+.||+|+||.||+|.+.+     +..|++|++... .....+.+.+|+.+++.++|+||+++++++.. +...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4678889999999999999999765     688999988654 33445678899999999999999999998776 5678


Q ss_pred             eEEEEeccCCCccccccccCCC-----CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeec
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDV-----EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF  415 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  415 (573)
                      ++++||+++++|.+++......     ..+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+||
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~  161 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN  161 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence            8999999999999988543322     46899999999999999999999987   999999999999999999999999


Q ss_pred             ccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCc
Q 008239          416 GLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGR  493 (573)
Q Consensus       416 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  493 (573)
                      |+++.+...... ......++..|+|||++.+..++.++||||||+++||+++ |+.|+.... ...    .......+.
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~-~~~----~~~~~~~~~  236 (280)
T cd05043         162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID-PFE----MAAYLKDGY  236 (280)
T ss_pred             CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC-HHH----HHHHHHcCC
Confidence            999865433221 2223446778999999998899999999999999999999 877764321 111    111111111


Q ss_pred             cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       494 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                               ........+..+.+++.+||+.+|++|||+.+++++|+..
T Consensus       237 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         237 ---------RLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                     1111233467889999999999999999999999999654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4e-38  Score=316.15  Aligned_cols=256  Identities=27%  Similarity=0.345  Sum_probs=203.3

Q ss_pred             CccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      +|+..+.||+|+||.||+|+..      ....+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4778899999999999999853      23578999886543 3345678899999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 008239          343 VYEFVPNQSLLDNLFVRQ---------------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN  401 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N  401 (573)
                      ++||+++++|.+++....                     ....+++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence            999999999998875321                     1235889999999999999999999987   9999999999


Q ss_pred             eeeCCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCc
Q 008239          402 ILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSC  479 (573)
Q Consensus       402 Ill~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~  479 (573)
                      ||+++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+... .  
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~-~--  234 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI-A--  234 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC-C--
Confidence            99999999999999999865332221 1223345678999999988899999999999999999998 77665322 1  


Q ss_pred             chHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                        .+..+.....+         .....+...+..+.+++.+||+.+|++||+++|+++.|++.
T Consensus       235 --~~~~~~~~~~~---------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         235 --PERLFNLLKTG---------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             --HHHHHHHHhCC---------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence              12222222211         11122344567899999999999999999999999999654

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.2e-38  Score=325.13  Aligned_cols=260  Identities=20%  Similarity=0.274  Sum_probs=195.4

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC-----cee
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESL  341 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  341 (573)
                      +|+..++||+|+||.||+|+.. +|+.||||++...  .......+.+|++++++++||||+++++++....     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            4788899999999999999965 6899999998643  2233456889999999999999999999876432     479


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+. ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~  153 (338)
T cd07859          81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA  153 (338)
T ss_pred             EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence            9999995 688887743   345899999999999999999999988   999999999999999999999999999854


Q ss_pred             CCCCcc--cccccccCcCcCchhhhcc--CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHH-----------
Q 008239          422 PEDITH--ISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVW-----------  486 (573)
Q Consensus       422 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~-----------  486 (573)
                      ......  ......||+.|+|||++.+  ..++.++|||||||++|||++|+.|+....... ....+.           
T Consensus       154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH-QLDLITDLLGTPSPETI  232 (338)
T ss_pred             ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH-HHHHHHHHhCCCCHHHH
Confidence            322211  1234568999999999876  678999999999999999999998875432211 111110           


Q ss_pred             HHhhcCcccccc---Cc----cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          487 DLYVKGRLHEAV---DP----ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       487 ~~~~~~~~~~~~---d~----~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..+........+   .+    .+... ....+..+.+++.+||+.+|++||+++|+++.
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQK-FPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHh-cCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            001111000000   00    00000 11235667899999999999999999999964

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.7e-38  Score=331.19  Aligned_cols=263  Identities=24%  Similarity=0.344  Sum_probs=206.7

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCC-CCCeeeeeeeee
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNLVKLLGCSI  335 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  335 (573)
                      ++...++|...++||+|+||.||+|++.      .++.||||++.... ....+.+.+|+.+|.++. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            4445567888999999999999999853      34689999997543 233457889999999997 999999999999


Q ss_pred             cCCceeEEEEeccCCCccccccccCC------------------------------------------------------
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQD------------------------------------------------------  361 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~~------------------------------------------------------  361 (573)
                      .....++|+||+++|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            99999999999999999998854211                                                      


Q ss_pred             -----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q 008239          362 -----------------------------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLS  400 (573)
Q Consensus       362 -----------------------------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~  400 (573)
                                                               ...+++..+++++.||+.||+|||+.+   ++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence                                                     124678888999999999999999987   999999999


Q ss_pred             CeeeCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCC
Q 008239          401 NILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNS  478 (573)
Q Consensus       401 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~  478 (573)
                      |||+++++.+||+|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |+.|+......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986533221 11223456788999999998899999999999999999998 67665432211


Q ss_pred             cchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          479 CSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                          +........+         .....+...+..+.+|+.+||+.+|+.||+++||++.|+..
T Consensus       349 ----~~~~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         349 ----EQFYNAIKRG---------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             ----HHHHHHHHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                1111111111         11122334567899999999999999999999999999754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.1e-38  Score=326.30  Aligned_cols=253  Identities=21%  Similarity=0.209  Sum_probs=203.1

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..++||+|+||+||+++.. +|+.||||++....   .+..+.+.+|+.+++.++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            46888999999999999999875 68899999986542   234567888999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~  155 (330)
T cd05601          81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN  155 (330)
T ss_pred             CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence            999999999988543  246899999999999999999999988   999999999999999999999999999876544


Q ss_pred             CcccccccccCcCcCchhhhc------cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          425 ITHISATLAGTLGYMAPEYVV------RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      .........||+.|+|||++.      ...++.++||||||+++|||++|+.|+......    ..............  
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~----~~~~~i~~~~~~~~--  229 (330)
T cd05601         156 KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSA----KTYNNIMNFQRFLK--  229 (330)
T ss_pred             CceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHH----HHHHHHHcCCCccC--
Confidence            333333457899999999986      456789999999999999999999997543321    11111111111100  


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                           -......+..+.+++..|++ +|++||+++++++.
T Consensus       230 -----~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         230 -----FPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             -----CCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                 01112346678899999998 99999999999864

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.1e-38  Score=318.55  Aligned_cols=261  Identities=26%  Similarity=0.332  Sum_probs=206.5

Q ss_pred             HHHhcCccccccccccCceeEEEEEcC------CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeec
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT  336 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  336 (573)
                      +...++|+..+.||+|+||.||++...      ....+|+|++... ..+....+.+|++++.++ +|+||+++++++..
T Consensus         8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   87 (293)
T cd05053           8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ   87 (293)
T ss_pred             ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence            344567888999999999999999864      2367999988754 233456788999999999 89999999999999


Q ss_pred             CCceeEEEEeccCCCcccccccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCee
Q 008239          337 GPESLLVYEFVPNQSLLDNLFVR-------------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL  403 (573)
Q Consensus       337 ~~~~~lv~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIl  403 (573)
                      ....+++|||+++|+|.+++...             .....+++..+++++.|++.||+|||+.+   |+||||||+|||
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil  164 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL  164 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence            99999999999999999988542             22346899999999999999999999987   999999999999


Q ss_pred             eCCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcch
Q 008239          404 LDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSI  481 (573)
Q Consensus       404 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~  481 (573)
                      +++++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.....    
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~----  240 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV----  240 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH----
Confidence            999999999999999865433221 1122334678999999998999999999999999999998 6666532211    


Q ss_pred             HHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          482 LQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       482 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                       .........+.         ....+...+..+.+|+.+||+.+|++|||+.|+++.|+..
T Consensus       241 -~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         241 -EELFKLLKEGY---------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             -HHHHHHHHcCC---------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence             11122221111         1122344567899999999999999999999999999653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.5e-38  Score=313.50  Aligned_cols=247  Identities=19%  Similarity=0.242  Sum_probs=197.5

Q ss_pred             ccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCc
Q 008239          277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL  352 (573)
Q Consensus       277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  352 (573)
                      ||+|+||+||++... +|+.||+|.+....   ....+.+..|+++++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999875 68899999986432   22345677899999999999999999999999999999999999999


Q ss_pred             ccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 008239          353 LDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT  431 (573)
Q Consensus       353 ~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  431 (573)
                      .+++... .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++..+..... ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            8877432 23456899999999999999999999987   99999999999999999999999999986543322 2234


Q ss_pred             cccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchH
Q 008239          432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKP  511 (573)
Q Consensus       432 ~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  511 (573)
                      ..||+.|+|||.+.+..++.++||||||+++|||++|+.|+......... .......        ....  ..++...+
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~--------~~~~--~~~~~~~~  225 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRI--------LNDS--VTYPDKFS  225 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHHhh--------cccC--CCCcccCC
Confidence            56899999999999999999999999999999999999997654322111 1111111        0110  12234466


Q ss_pred             HHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          512 SRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       512 ~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      ..+.+++.+||+.+|++||     +++++++.
T Consensus       226 ~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         226 PASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            7889999999999999999     67777753

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.2e-38  Score=321.58  Aligned_cols=247  Identities=21%  Similarity=0.264  Sum_probs=196.6

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      +.||+|+||.||+++.. +++.||+|++...   .....+.+..|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 5789999998753   233455677899888776 899999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~-~~~  153 (329)
T cd05618          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG-DTT  153 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC-Ccc
Confidence            999887743   345899999999999999999999988   9999999999999999999999999987532211 122


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCC----cchHHHHHHHhhcCccccccCccccCC
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS----CSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~----~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+......    .....+.+........          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----------~  223 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCC----------C
Confidence            3457899999999999999999999999999999999999998532211    1122222222222111          2


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCC------HHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPS------MSIVVKM  538 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt------~~evl~~  538 (573)
                      ++...+..+.+++.+||+.||++||+      +.++++.
T Consensus       224 ~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         224 IPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            34455677889999999999999998      4666543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.9e-38  Score=311.56  Aligned_cols=256  Identities=27%  Similarity=0.392  Sum_probs=204.5

Q ss_pred             hcCccccccccccCceeEEEEEcCC-C---CEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG-G---EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..+.||+|+||.||+|+... +   ..+++|.+... .....+.+.+|++++++++|+||+++++++......++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            3568889999999999999998752 3   37999988654 33445678999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  158 (268)
T cd05063          84 ITEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE  158 (268)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence            99999999999988532  346899999999999999999999987   9999999999999999999999999988654


Q ss_pred             CCCccccc--ccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          423 EDITHISA--TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       423 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ........  ....+..|+|||++....++.++||||||+++|||++ |+.|+......     ........+       
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~-----~~~~~i~~~-------  226 (268)
T cd05063         159 DDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH-----EVMKAINDG-------  226 (268)
T ss_pred             cccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH-----HHHHHHhcC-------
Confidence            32221111  1223457999999998899999999999999999997 88886543211     111111111       


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                        .........+..+.+++.+||+.+|++||++.+|++.|++.
T Consensus       227 --~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         227 --FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              11112334567889999999999999999999999999653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.3e-38  Score=319.05  Aligned_cols=258  Identities=24%  Similarity=0.321  Sum_probs=202.1

Q ss_pred             cCccccccccccCceeEEEEEcCC-CC--EEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG-GE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++|++.+.||+|+||.||+|...+ +.  .+++|.+... .....+.+.+|+.++.++ +||||+++++++......++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            568889999999999999998753 33  4788888643 334456788999999999 799999999999999999999


Q ss_pred             EEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcE
Q 008239          344 YEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA  410 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~  410 (573)
                      +||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   |+||||||+|||+++++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence            99999999999885432             1235889999999999999999999987   9999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHh
Q 008239          411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLY  489 (573)
Q Consensus       411 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  489 (573)
                      ||+|||++........  ......+..|+|||.+....++.++||||||+++|||++ |..|+...... .    .....
T Consensus       159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~-~----~~~~~  231 (297)
T cd05089         159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA-E----LYEKL  231 (297)
T ss_pred             EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH-H----HHHHH
Confidence            9999999864321111  111223567999999998899999999999999999998 87776432211 1    11111


Q ss_pred             hcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCC
Q 008239          490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEI  545 (573)
Q Consensus       490 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~  545 (573)
                      ..+         .....+...+..+.+|+.+||+.+|.+||+++++++.|+.....
T Consensus       232 ~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~  278 (297)
T cd05089         232 PQG---------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEA  278 (297)
T ss_pred             hcC---------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            111         11122334567889999999999999999999999998655443

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.6e-38  Score=313.53  Aligned_cols=257  Identities=28%  Similarity=0.367  Sum_probs=202.5

Q ss_pred             HhcCccccccccccCceeEEEEEcCC------CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE  339 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  339 (573)
                      .+++|+..+.||+|+||.||+|.+.+      +..|++|.+.... ......+.+|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            35678899999999999999998753      5678999886443 3334578899999999999999999999999999


Q ss_pred             eeEEEEeccCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC---cEEE
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKI  412 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl  412 (573)
                      .++||||+++++|.+++.....    ...+++..+++++.||+.||+|||+.+   ++||||||+||+++.++   .+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            9999999999999998854321    235899999999999999999999987   99999999999998654   6999


Q ss_pred             eecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhh
Q 008239          413 ADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYV  490 (573)
Q Consensus       413 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  490 (573)
                      +|||+++....... ........+..|+|||++.+..++.++|||||||++|||++ |..|+...... .    ......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~-~----~~~~~~  235 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQ-E----VMEFVT  235 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH-H----HHHHHH
Confidence            99999986532221 11112234568999999999999999999999999999997 76665432211 1    111111


Q ss_pred             cCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          491 KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       491 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ..         .....+...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       236 ~~---------~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         236 GG---------GRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             cC---------CcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            11         011223445678999999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.2e-38  Score=310.59  Aligned_cols=254  Identities=24%  Similarity=0.361  Sum_probs=200.0

Q ss_pred             ccccccccccCceeEEEEEcCC----CCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc-----
Q 008239          271 FHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-----  339 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  339 (573)
                      |+..+.||+|+||.||+|++..    +..||||++...  .....+.+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999998642    367999998754  23445678999999999999999999998876554     


Q ss_pred             -eeEEEEeccCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeec
Q 008239          340 -SLLVYEFVPNQSLLDNLFVRQ---DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF  415 (573)
Q Consensus       340 -~~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  415 (573)
                       .++++||+++++|..++....   ....+++..++.++.|++.||.|||+.+   ++||||||+||++++++.+||+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence             789999999999998875432   2346899999999999999999999987   999999999999999999999999


Q ss_pred             ccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCc
Q 008239          416 GLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGR  493 (573)
Q Consensus       416 gla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  493 (573)
                      |+++........ ......++..|+|||.+....++.++||||||+++|||++ |..|+.. .....+...    ...+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~-~~~~~~~~~----~~~~~  232 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG-VENHEIYDY----LRHGN  232 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC-CCHHHHHHH----HHcCC
Confidence            999865433221 1122334678999999988899999999999999999999 5555432 221122111    11111


Q ss_pred             cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       494 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .         ...+...+..+.+++.+||+.+|++||++.|+++.|+.
T Consensus       233 ~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~  271 (273)
T cd05035         233 R---------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLEN  271 (273)
T ss_pred             C---------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            1         12234566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8e-39  Score=308.62  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=210.6

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ..+|++.+.||+|.||.|-++.. ..|+.||||.+.++   +++..-.+.+|+++|+.|+||||++++.+|+..+.++||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            35678889999999999999986 67999999998665   455566788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||..+|.|.+++..   .+.+++.+...++.||..|+.|+|.+.   ++|||||.+|||+|.++++||+||||+.++..
T Consensus       132 MEYaS~GeLYDYiSe---r~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  132 MEYASGGELYDYISE---RGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEecCCccHHHHHHH---hccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999999999999943   456999999999999999999999987   99999999999999999999999999998754


Q ss_pred             CCcccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      +  ....+++|++-|.+||.+.+.+| ++.+|-|||||+||-|+.|..||+.....     .+...+..|...       
T Consensus       206 ~--kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk-----~lvrQIs~GaYr-------  271 (668)
T KOG0611|consen  206 K--KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHK-----RLVRQISRGAYR-------  271 (668)
T ss_pred             c--cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHH-----HHHHHhhccccc-------
Confidence            3  34567899999999999999887 57899999999999999999998654321     111222333322       


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                          .++.+....-||.|||..+|++|-|+.+|...-
T Consensus       272 ----EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  272 ----EPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ----CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                223455667899999999999999999998764

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=6.4e-38  Score=309.43  Aligned_cols=253  Identities=29%  Similarity=0.429  Sum_probs=202.0

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      ++|...++||+|++|.||++.+.++..+|+|++.... ...+.+.+|+.++++++|+|++++++++. ....++||||++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~   83 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG   83 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence            5688889999999999999998877789999876433 23467889999999999999999999875 456789999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..........
T Consensus        84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05069          84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence            99999988543 2345889999999999999999999987   9999999999999999999999999998664433222


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+.... ....    ......+ .        ....+
T Consensus       160 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~----~~~~~~~-~--------~~~~~  225 (260)
T cd05069         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMV-NREV----LEQVERG-Y--------RMPCP  225 (260)
T ss_pred             cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCC-HHHH----HHHHHcC-C--------CCCCC
Confidence            223345678999999998899999999999999999999 666653321 1111    1111111 0        01123


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...+..+.+++.+||+.+|++||++++|+++|+.
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         226 QGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            3456789999999999999999999999999853

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=7.6e-38  Score=324.22  Aligned_cols=253  Identities=21%  Similarity=0.250  Sum_probs=195.4

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..++||+|+||+||++... +++.||||++....   ......+.+|+.++.+++|+||+++++.+.+....++||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            46889999999999999999875 58899999986532   233456788999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~  154 (363)
T cd05628          81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA  154 (363)
T ss_pred             cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence            99999999998853   346899999999999999999999988   999999999999999999999999998754321


Q ss_pred             Cc----------------------------------ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCC
Q 008239          425 IT----------------------------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR  470 (573)
Q Consensus       425 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~  470 (573)
                      ..                                  .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~  234 (363)
T cd05628         155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (363)
T ss_pred             ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence            10                                  00123579999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHcc--CCCCCCCCCHHHHHHH
Q 008239          471 INLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCV--QASAELRPSMSIVVKM  538 (573)
Q Consensus       471 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl--~~~p~~RPt~~evl~~  538 (573)
                      |+......     ..............+.+      ......++.+++.+++  ..++..||+++||++.
T Consensus       235 Pf~~~~~~-----~~~~~i~~~~~~~~~p~------~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         235 PFCSETPQ-----ETYKKVMNWKETLIFPP------EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCCHH-----HHHHHHHcCcCcccCCC------cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            98543221     11111111110000111      1113345666666533  3344567999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.5e-38  Score=320.65  Aligned_cols=243  Identities=24%  Similarity=0.303  Sum_probs=196.1

Q ss_pred             cccccccCceeEEEEEc----CCCCEEEEEEecccC----hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          274 SNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      +++||+|+||.||+++.    .+++.||||++....    ......+.+|+.+|+.++||||+++++++..+...++|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36799999999999985    357899999986431    2234567789999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++..   ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        81 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (323)
T cd05584          81 YLSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG  154 (323)
T ss_pred             CCCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCC
Confidence            9999999988843   345788889999999999999999988   9999999999999999999999999987532221


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                       .......||+.|+|||++.+..++.++||||||+++|||++|+.|+......    . .......+.          ..
T Consensus       155 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~----~-~~~~~~~~~----------~~  218 (323)
T cd05584         155 -TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK----K-TIDKILKGK----------LN  218 (323)
T ss_pred             -CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH----H-HHHHHHcCC----------CC
Confidence             1223457899999999999888999999999999999999999987543211    1 111111111          12


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      .+...+..+.+++.+||+.+|++||     +++++++.
T Consensus       219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         219 LPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence            2344567889999999999999999     78888763

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=8.7e-38  Score=309.32  Aligned_cols=258  Identities=23%  Similarity=0.348  Sum_probs=208.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||.||+|... +|+.||+|.++..   .....+.+.+|++++++++|+||+++++++...+..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57889999999999999999986 7899999988532   2334567889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       345 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      ||+++++|.+++... .....+++..++.++.+++.||.|||+.+   ++||||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            999999999887542 22345899999999999999999999987   99999999999999999999999999886543


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++|+.|+......  .. ........+..         
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~-~~~~~~~~~~~---------  225 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LY-SLCKKIEKCDY---------  225 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc--HH-HHHhhhhcCCC---------
Confidence            3221 22345788999999999889999999999999999999999987543211  11 11111111111         


Q ss_pred             CCCCC-chHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          504 GNFQE-GKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       504 ~~~~~-~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ...+. ..+..+.+++.+||+.+|++||++.+|+++|.+.
T Consensus       226 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         226 PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            11122 4556788999999999999999999999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-38  Score=310.59  Aligned_cols=256  Identities=30%  Similarity=0.425  Sum_probs=207.1

Q ss_pred             HhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..++|++.++||+|+||.||++..++++.||||.+..... ..+.+.+|+.++++++|+||+++++++......++||||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   82 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEY   82 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEec
Confidence            3567889999999999999999988888999999875433 346788999999999999999999999988999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++.... ...+++..+..++.+++.||.|||+++   ++|+||+|+||++++++.+||+|||++........
T Consensus        83 ~~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (261)
T cd05034          83 MSKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY  158 (261)
T ss_pred             cCCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence            99999999885432 235899999999999999999999987   99999999999999999999999999887654322


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      ........+..|+|||.+.+..++.++||||||++++||++ |+.|+... ........    ...+         ....
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~-~~~~~~~~----~~~~---------~~~~  224 (261)
T cd05034         159 TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM-TNREVLEQ----VERG---------YRMP  224 (261)
T ss_pred             hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC-CHHHHHHH----HHcC---------CCCC
Confidence            22223334678999999998899999999999999999999 77665322 11111111    1111         1111


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .+...+..+.+++.+|++.+|++||+++++++.|+.
T Consensus       225 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         225 RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            233446789999999999999999999999998853

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.1e-37  Score=309.78  Aligned_cols=253  Identities=24%  Similarity=0.346  Sum_probs=197.8

Q ss_pred             cccccccccCceeEEEEEcCCC-C--EEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC------Cce
Q 008239          272 HESNKLGQGGSGSVYKGTLPGG-E--AVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------PES  340 (573)
Q Consensus       272 ~~~~~lg~G~~g~Vy~~~~~~g-~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~  340 (573)
                      .+.++||+|+||.||+|++.++ +  .||+|.+...  .....+.+.+|+.+++.++|+||+++++++...      ...
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   81 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP   81 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence            4578999999999999997643 2  6899988653  344467788999999999999999999987532      246


Q ss_pred             eEEEEeccCCCcccccccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          341 LLVYEFVPNQSLLDNLFVR---QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ++++||+++|+|.+++...   .....+++.....++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+
T Consensus        82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~  158 (272)
T cd05075          82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL  158 (272)
T ss_pred             EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence            8999999999998877432   12345899999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccc
Q 008239          418 VRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLH  495 (573)
Q Consensus       418 a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  495 (573)
                      ++........ ......+++.|++||.+....++.++||||||+++|||++ |+.|+.. ...    ...+.....+...
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~~----~~~~~~~~~~~~~  233 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG-VEN----SEIYDYLRQGNRL  233 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC-CCH----HHHHHHHHcCCCC
Confidence            9876433221 1223345678999999999999999999999999999999 5655532 211    1222222222211


Q ss_pred             cccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       496 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                               ..+...+..+.+++.+||+.+|++|||++++++.|+.
T Consensus       234 ---------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         234 ---------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             ---------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                     1123456778999999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=305.99  Aligned_cols=266  Identities=20%  Similarity=0.310  Sum_probs=202.6

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecc--cChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec-----C
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFY--NTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-----G  337 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~  337 (573)
                      .....|...+.||+|+||.|..+... +|+.||||++..  ...-..++..+|+.+|+.++|+||+.+++.+..     -
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f   98 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF   98 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence            44566777899999999999999875 689999999973  344556788899999999999999999998865     3


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ...++|+|+| ..+|...+.   ....++......++.|+++||.|+|+.+   |+||||||+|+|++.+..+||+||||
T Consensus        99 ~DvYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   99 NDVYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ceeEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence            4679999999 568887773   2334899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCC-CcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcch--H--------HHH
Q 008239          418 VRLFPED-ITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSI--L--------QTV  485 (573)
Q Consensus       418 a~~~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~--~--------~~~  485 (573)
                      |+..... .....+..+.|.+|.|||++.. ..|+...||||.|||+.||++|+..|.....-.++  +        ...
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            9987543 1223356678999999998865 68999999999999999999999776543321100  0        000


Q ss_pred             HHHhhcCccccccC-------ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          486 WDLYVKGRLHEAVD-------PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       486 ~~~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      .......+....+.       ..+...++ ......++|+.+||..||.+|+|++|.++.=
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~hP  311 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAHP  311 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcCh
Confidence            11111111100000       00111122 4456678999999999999999999999743

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-38  Score=313.94  Aligned_cols=256  Identities=29%  Similarity=0.442  Sum_probs=205.1

Q ss_pred             hcCccccccccccCceeEEEEEcCC------CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      .++|+..+.||+|+||.||+|...+      +..||+|.+.... ......+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~   84 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT   84 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence            4678889999999999999998642      4689999986543 33456788999999999999999999999999999


Q ss_pred             eEEEEeccCCCccccccccCC-------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEe
Q 008239          341 LLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA  413 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~  413 (573)
                      ++||||+++++|.+++.....       ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+
T Consensus        85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~  161 (277)
T cd05032          85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG  161 (277)
T ss_pred             EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence            999999999999998854321       234789999999999999999999987   9999999999999999999999


Q ss_pred             ecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhc
Q 008239          414 DFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       414 Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      |||+++....... .......++..|+|||.+..+.++.++||||||+++|||++ |+.|+.... ....    ......
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~-~~~~----~~~~~~  236 (277)
T cd05032         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-NEEV----LKFVID  236 (277)
T ss_pred             CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC-HHHH----HHHHhc
Confidence            9999886543221 12233456789999999988899999999999999999998 666653222 1111    111111


Q ss_pred             CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       492 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      +..         ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       237 ~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 GGH---------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CCC---------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            111         1223445778999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.4e-38  Score=330.11  Aligned_cols=254  Identities=19%  Similarity=0.179  Sum_probs=202.0

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ..++|+..++||+|+||.||+++.. +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+....++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l  120 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM  120 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence            4567899999999999999999875 5889999998642   22334557789999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~  193 (370)
T cd05596         121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence            9999999999998743    24788889999999999999999987   9999999999999999999999999998664


Q ss_pred             CCCcccccccccCcCcCchhhhccC----CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRG----KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      ...........||+.|+|||.+...    .++.++|||||||++|||++|+.|+.....    ... +.....+..    
T Consensus       194 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~-~~~i~~~~~----  264 (370)
T cd05596         194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGT-YSKIMDHKN----  264 (370)
T ss_pred             CCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH----HHH-HHHHHcCCC----
Confidence            3322223345789999999998653    478899999999999999999999764332    111 111111110    


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAEL--RPSMSIVVKM  538 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~  538 (573)
                        .+.-......+..+.+++.+||+.+|.+  ||+++|+++.
T Consensus       265 --~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         265 --SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             --cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence              0110111235678889999999999987  9999999865

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.2e-38  Score=324.15  Aligned_cols=238  Identities=27%  Similarity=0.256  Sum_probs=193.1

Q ss_pred             ccccccCceeEEEEEc----CCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          275 NKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      +.||+|+||.||+++.    .+|+.||+|++....  ......+.+|++++++++||||+++++++......++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            6799999999999875    357899999986532  2234466789999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +|+|.+++..   ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....... ..
T Consensus        82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~  154 (318)
T cd05582          82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KK  154 (318)
T ss_pred             CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Cc
Confidence            9999988843   345899999999999999999999988   9999999999999999999999999988653322 12


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE  508 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  508 (573)
                      .....|++.|+|||.+....++.++||||||+++|||++|+.|+.....    ....... ....          ...+.
T Consensus       155 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~----~~~~~~i-~~~~----------~~~p~  219 (318)
T cd05582         155 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR----KETMTMI-LKAK----------LGMPQ  219 (318)
T ss_pred             eecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH----HHHHHHH-HcCC----------CCCCC
Confidence            2345789999999999988899999999999999999999998754321    1111111 1111          12234


Q ss_pred             chHHHHHHHHHHccCCCCCCCCCHHH
Q 008239          509 GKPSRLLQIGLLCVQASAELRPSMSI  534 (573)
Q Consensus       509 ~~~~~l~~l~~~cl~~~p~~RPt~~e  534 (573)
                      ..+..+.+++.+||+.+|++||++.+
T Consensus       220 ~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         220 FLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence            45677889999999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.6e-38  Score=310.38  Aligned_cols=258  Identities=23%  Similarity=0.354  Sum_probs=207.1

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||.||++.. .+++.++||.+...   .....+.+.+|+.+++.++||||+++++++..+...+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4678889999999999999996 47899999987542   2334567889999999999999999999999999999999


Q ss_pred             EeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       345 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      ||+++++|.+++... .....+++..++.++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..+..
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            999999999887532 22346899999999999999999999988   99999999999999999999999999886643


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .... .....++..|+|||.+.+..++.++||||||+++|||++|..|+......  . ........     ....+.+ 
T Consensus       159 ~~~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~-~~~~~~~~-----~~~~~~~-  228 (267)
T cd08229         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--L-YSLCKKIE-----QCDYPPL-  228 (267)
T ss_pred             CCcc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch--H-HHHhhhhh-----cCCCCCC-
Confidence            3221 22345788999999999889999999999999999999999987533211  1 11111111     1111111 


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                        .....+..+.+++.+||+.+|++||||.+|++++++
T Consensus       229 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         229 --PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             --CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence              123456789999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6e-38  Score=326.19  Aligned_cols=261  Identities=24%  Similarity=0.308  Sum_probs=199.1

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC-----cee
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESL  341 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  341 (573)
                      +|+..++||+|+||.||++... +|+.||||++...  .....+.+.+|+++++.++|+||+++++++....     ..+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            4788999999999999999974 6899999998643  2234567889999999999999999999988766     789


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +|+||+. ++|.+.+..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~  153 (372)
T cd07853          81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE  153 (372)
T ss_pred             EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence            9999996 577776632   346899999999999999999999988   999999999999999999999999999865


Q ss_pred             CCCCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc-----
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH-----  495 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-----  495 (573)
                      ............+++.|+|||.+.+. .++.++|||||||++|||++|+.|+....... ....+..........     
T Consensus       154 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~  232 (372)
T cd07853         154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ-QLDLITDLLGTPSLEAMRSA  232 (372)
T ss_pred             ccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHHHh
Confidence            44333333345678999999998774 57899999999999999999998875433211 111111110000000     


Q ss_pred             ----------cccCc-cc--cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          496 ----------EAVDP-AL--AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       496 ----------~~~d~-~l--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                                ....+ ..  ........+..+.+++.+||+.||++|||++|+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                      00000 00  001223346678899999999999999999999974

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=6.7e-38  Score=320.18  Aligned_cols=246  Identities=22%  Similarity=0.258  Sum_probs=197.0

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ++||+|+||.||+++.. +++.||||++...   .....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            46999999999999875 5889999999753   233455678899999888 799999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|.+++..   ...+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (329)
T cd05588          81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTT  153 (329)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-Ccc
Confidence            999887743   246899999999999999999999988   9999999999999999999999999987422111 122


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc----chHHHHHHHhhcCccccccCccccCC
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC----SILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......    ....+..........          .
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~----------~  223 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI----------R  223 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCC----------C
Confidence            34578999999999999999999999999999999999999986422111    111222222222111          1


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCC------HHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPS------MSIVVK  537 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt------~~evl~  537 (573)
                      .+...+..+.+++.+||+.+|.+||+      ++++++
T Consensus       224 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence            23445677899999999999999997      677764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.6e-37  Score=312.67  Aligned_cols=263  Identities=24%  Similarity=0.344  Sum_probs=202.4

Q ss_pred             hcCccccccccccCceeEEEEEcC-----------------CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-----------------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVK  329 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-----------------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~  329 (573)
                      .++|+..++||+|+||.||++...                 ++..||+|++... .....+.+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356889999999999999998542                 2346899998754 3344568899999999999999999


Q ss_pred             eeeeeecCCceeEEEEeccCCCccccccccCC--------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 008239          330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQD--------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN  401 (573)
Q Consensus       330 l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N  401 (573)
                      +++++......++||||+++++|.+++.....        ...+++..+++++.|++.||+|||+.+   ++|+||||+|
T Consensus        84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~N  160 (296)
T cd05095          84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRN  160 (296)
T ss_pred             EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhe
Confidence            99999999999999999999999998864321        134788899999999999999999988   9999999999


Q ss_pred             eeeCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc--CCCCCCCCCCC
Q 008239          402 ILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC--RKRINLFTQNS  478 (573)
Q Consensus       402 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt--g~~p~~~~~~~  478 (573)
                      ||++.++.++|+|||++..+..... .......++..|++||....+.++.++||||||+++|||++  |..|+..... 
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~-  239 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD-  239 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh-
Confidence            9999999999999999886533221 11222344678999999988899999999999999999998  4455432221 


Q ss_pred             cchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          479 CSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ................      ......+...+..+.+++.+||+.+|++||++.+|++.|+
T Consensus       240 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 EQVIENTGEFFRDQGR------QVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HHHHHHHHHHHhhccc------cccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            1111111111111100      0011112345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-38  Score=309.90  Aligned_cols=251  Identities=25%  Similarity=0.363  Sum_probs=203.4

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-----hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ++|+..+.||+|++|.||++... +++.||+|.+....     ....+.+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            56889999999999999999864 68999999886432     1234578899999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      |+||+++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||++....
T Consensus        82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~  155 (263)
T cd06625          82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ  155 (263)
T ss_pred             EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence            9999999999988843   245889999999999999999999988   9999999999999999999999999987654


Q ss_pred             CCCcccc--cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          423 EDITHIS--ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       423 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      .......  ....++..|+|||.+.+..++.++||||||+++|||++|+.|+.....    ..........         
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~---------  222 (263)
T cd06625         156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEA----MAAIFKIATQ---------  222 (263)
T ss_pred             ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccch----HHHHHHHhcc---------
Confidence            3222111  234578899999999998899999999999999999999988643221    1111111111         


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ......+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            01122344566788999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.5e-38  Score=312.93  Aligned_cols=252  Identities=24%  Similarity=0.250  Sum_probs=202.6

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      +|+..++||+|+||+||++... +++.||||++....   ......+.+|+.+++.++||||+++++.+..+...++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            4778899999999999999874 68899999986532   2223457789999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++|+|.+++... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~  156 (285)
T cd05605          81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE  156 (285)
T ss_pred             ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence            99999999887543 2345899999999999999999999988   9999999999999999999999999988654322


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      .  .....|+..|+|||++.+..++.++||||||+++|||++|+.|+...... .....+.......          ...
T Consensus       157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~-~~~~~~~~~~~~~----------~~~  223 (285)
T cd05605         157 T--IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEK-VKREEVERRVKED----------QEE  223 (285)
T ss_pred             c--cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchh-hHHHHHHHHhhhc----------ccc
Confidence            2  12346899999999999899999999999999999999999987643221 1111111111110          112


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      ++...+..+.+|+.+||+.||++||     +++++++.
T Consensus       224 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         224 YSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            2344567889999999999999999     88888764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.1e-37  Score=307.26  Aligned_cols=246  Identities=22%  Similarity=0.343  Sum_probs=195.6

Q ss_pred             cccccCceeEEEEEcC---CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCC
Q 008239          276 KLGQGGSGSVYKGTLP---GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS  351 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  351 (573)
                      .||+|+||.||+|.+.   .+..||+|++.... ....+.+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999764   35579999986553 334567899999999999999999999875 457899999999999


Q ss_pred             ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc--
Q 008239          352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--  429 (573)
Q Consensus       352 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~--  429 (573)
                      |.+++...  ...+++..+++++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++...........  
T Consensus        81 L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          81 LNKFLSGK--KDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             HHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            99988532  346899999999999999999999987   99999999999999999999999999986543322111  


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCC
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE  508 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  508 (573)
                      ....++..|+|||.+..+.++.++||||||+++|||++ |+.|+.....     ..+......+.         ....+.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~---------~~~~~~  221 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG-----PEVMSFIEQGK---------RLDCPA  221 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH-----HHHHHHHHCCC---------CCCCCC
Confidence            12233578999999988889999999999999999996 8777643221     11112222221         112344


Q ss_pred             chHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          509 GKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       509 ~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ..+.++.+++.+||+.+|++||++.+|.+.|..
T Consensus       222 ~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~  254 (257)
T cd05115         222 ECPPEMYALMKDCWIYKWEDRPNFAKVEERMRT  254 (257)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhh
Confidence            567889999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.9e-38  Score=308.25  Aligned_cols=251  Identities=27%  Similarity=0.390  Sum_probs=201.9

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      .+|+..+.||+|+||.||++.+.+++.+|+|.+..... ..+.+.+|++++++++|||++++++++......++|+||++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~   82 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME   82 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence            46778899999999999999987788999998865432 24578899999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +++|.+++...  ...+++..++.++.+++.+|+|||+.+   ++|+||||+||+++.++.+||+|||++..........
T Consensus        83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            99999888532  235789999999999999999999987   9999999999999999999999999988654332222


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      .....++.+|+|||.+.++.++.++||||||+++|||++ |..|+..... ..+...    ...+  ....       .+
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~~~~----~~~~--~~~~-------~~  223 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSN-SEVVET----INAG--FRLY-------KP  223 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCH-HHHHHH----HhCC--CCCC-------CC
Confidence            223345678999999998899999999999999999998 7766543221 111111    1111  0111       12


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ...+..+.+|+.+||+.+|++||++.+++++|
T Consensus       224 ~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         224 RLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            23457899999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.7e-38  Score=312.28  Aligned_cols=255  Identities=25%  Similarity=0.356  Sum_probs=202.3

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..+|+..+.||+|+||.||+|+. .+++.||+|++..........+.+|+.++++++||||+++++++......++||||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~   87 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY   87 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence            35788999999999999999997 46889999998765555556788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++........
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06646          88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA  161 (267)
T ss_pred             CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence            999999998843   245889999999999999999999987   99999999999999999999999999986543221


Q ss_pred             ccccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          427 HISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                       ......++..|+|||.+.   ...++.++||||||+++|||++|+.|+.........    . .......   ..+.+.
T Consensus       162 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~----~-~~~~~~~---~~~~~~  232 (267)
T cd06646         162 -KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----F-LMSKSNF---QPPKLK  232 (267)
T ss_pred             -ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhh----e-eeecCCC---CCCCCc
Confidence             122346788999999884   345788999999999999999999886432211000    0 0000000   011111


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                        .....+..+.+++.+||+.+|++||+++++++.|
T Consensus       233 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         233 --DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             --cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence              1123456889999999999999999999999754

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=8.4e-38  Score=307.46  Aligned_cols=250  Identities=23%  Similarity=0.347  Sum_probs=205.3

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..+.||+|++|.||+++.. +++.|++|.+...  .....+.+.+|+++++.++||||+++++++......++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            4777899999999999999875 5889999988643  344567788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            9999999988643 2346899999999999999999999987   99999999999999999999999999886654322


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                       ......+++.|+|||++.+..++.++||||||+++|||++|+.|+.....     .........+.         ....
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~---------~~~~  221 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ-----GALILKIIRGV---------FPPV  221 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCC---------CCCC
Confidence             22344678899999999999999999999999999999999998754431     11111111111         1122


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +...+..+.+++.+||+.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         222 SQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            33456788999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.3e-38  Score=321.23  Aligned_cols=260  Identities=25%  Similarity=0.324  Sum_probs=203.7

Q ss_pred             hcCccccccccccCceeEEEEEcC--------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG  337 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  337 (573)
                      ..+|++.+.||+|+||.||++...        .+..||+|.+.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD   90 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence            456888999999999999999742        12368999886542 34467889999999999 899999999999999


Q ss_pred             CceeEEEEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL  404 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll  404 (573)
                      ...++++||+++|+|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill  167 (334)
T cd05100          91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLV  167 (334)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEE
Confidence            99999999999999999885432             1235788999999999999999999987   9999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchH
Q 008239          405 DEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSIL  482 (573)
Q Consensus       405 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~  482 (573)
                      +.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.. ..    .
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~-~~----~  242 (334)
T cd05100         168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG-IP----V  242 (334)
T ss_pred             cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC-CC----H
Confidence            99999999999999865432211 1122234567999999999999999999999999999998 5555432 11    1


Q ss_pred             HHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 008239          483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE  544 (573)
Q Consensus       483 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  544 (573)
                      .........+.         ....+...+..+.+++.+||+.+|++||++.|+++.|.....
T Consensus       243 ~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~  295 (334)
T cd05100         243 EELFKLLKEGH---------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLT  295 (334)
T ss_pred             HHHHHHHHcCC---------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhh
Confidence            11222222111         111233456788999999999999999999999999965543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=7.6e-38  Score=308.91  Aligned_cols=255  Identities=27%  Similarity=0.401  Sum_probs=204.7

Q ss_pred             HhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..++|+..++||+|+||.||++...++..+++|.+.... ...+.+.+|+.+++.++|+||+++++++.. ...+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~   81 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEF   81 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEe
Confidence            346788999999999999999998878889999886543 335678899999999999999999999887 778999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++... ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  157 (260)
T cd05073          82 MAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEY  157 (260)
T ss_pred             CCCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCc
Confidence            9999999998543 2345788999999999999999999987   99999999999999999999999999986644322


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      .......++..|+|||++..+.++.++||||||++++||++ |+.|+.... ...+.    .....+.         ...
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~-~~~~~----~~~~~~~---------~~~  223 (260)
T cd05073         158 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS-NPEVI----RALERGY---------RMP  223 (260)
T ss_pred             ccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC-HHHHH----HHHhCCC---------CCC
Confidence            22223345678999999998899999999999999999999 666654321 11111    1111111         111


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .....+..+.+++.+|++.+|++||++.+++++|+.
T Consensus       224 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         224 RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            223456789999999999999999999999999953

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5.3e-38  Score=314.25  Aligned_cols=259  Identities=23%  Similarity=0.362  Sum_probs=203.2

Q ss_pred             cCccccccccccCceeEEEEEc-----CCCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--Cce
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES  340 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  340 (573)
                      +.|+..+.||+|+||.||++++     .++..||+|.+.... ....+.+.+|+.+++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578899999999999999974     357889999986543 44456789999999999999999999988775  567


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++++|.+++...  ...+++..++.++.|++.||+|||+++   ++||||||+||+++.++.+||+|||+++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  158 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence            8999999999999988432  235899999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCC----------CcchHHHHHHH
Q 008239          421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN----------SCSILQTVWDL  488 (573)
Q Consensus       421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~----------~~~~~~~~~~~  488 (573)
                      .......  ......++..|+|||.+.+..++.++||||||+++|||++++.|......          ...........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05079         159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRV  238 (284)
T ss_pred             cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6433221  12234567789999999888999999999999999999998765432111          00001111111


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...+         .....+...+..+.+++.+||+.+|++||+++++++.|+.
T Consensus       239 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         239 LEEG---------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHcC---------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            1111         1112234467789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.7e-38  Score=327.65  Aligned_cols=255  Identities=18%  Similarity=0.171  Sum_probs=200.3

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ...++|+..++||+|+||.||+++.. +++.+|+|++...   .....+.+.+|+.+++.++||||+++++++.++...+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            34577999999999999999999976 5789999998542   2233456788999999999999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+++|+|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~  192 (370)
T cd05621         120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM  192 (370)
T ss_pred             EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence            99999999999998842    24788999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcccccccccCcCcCchhhhccC----CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRG----KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      ............||+.|+|||++...    .++.++|||||||++|||++|+.|+.....    ............    
T Consensus       193 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~----~~~~~~i~~~~~----  264 (370)
T cd05621         193 DETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL----VGTYSKIMDHKN----  264 (370)
T ss_pred             ccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCc----
Confidence            43332223456799999999999754    378899999999999999999999864322    111111111110    


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAEL--RPSMSIVVKM  538 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~  538 (573)
                         .+.-......+..+.+++..|++.++.+  ||+++|+++.
T Consensus       265 ---~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         265 ---SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ---ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence               0100111234566788888999765543  8999999986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-38  Score=307.51  Aligned_cols=250  Identities=27%  Similarity=0.428  Sum_probs=204.6

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .++|+..+.||+|+||.||++... |+.||||.+..... ..+++.+|+.+++.++|+||+++++++......++||||+
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence            357888999999999999999876 78999999976544 4678899999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||+++....... 
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            9999999885432 235899999999999999999999988   99999999999999999999999999986632221 


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                         ....+..|+|||.+..+.++.++||||||+++|||++ |..|+.... .    .........+         .....
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~----~~~~~~~~~~---------~~~~~  220 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-L----KDVVPHVEKG---------YRMEA  220 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCC-H----HHHHHHHhcC---------CCCCC
Confidence               2234668999999998899999999999999999997 776653321 1    1111111111         01122


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      +...+..+.+++.+||+.+|++||+++|++++|+.
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         221 PEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            33456789999999999999999999999999953

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.4e-37  Score=314.28  Aligned_cols=241  Identities=24%  Similarity=0.279  Sum_probs=191.8

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcC-CCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISG-INHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      +.||+|+||.||+|+.. +++.||||++....   ....+.+..|..++.. .+||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 57899999986532   2334455667777765 4899999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~  153 (316)
T cd05592          81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKA  153 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccc
Confidence            999888743   245889999999999999999999987   9999999999999999999999999998543222 223


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.|+.....     ..........          ...++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~----------~~~~~~~  218 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE-----DELFDSILND----------RPHFPRW  218 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcC----------CCCCCCC
Confidence            345789999999999999999999999999999999999998754321     1111111111          1122344


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 008239          510 KPSRLLQIGLLCVQASAELRPSMS-IVVK  537 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~~-evl~  537 (573)
                      .+..+.+++.+||+.+|++||++. ++++
T Consensus       219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHHc
Confidence            566788999999999999999975 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=5.5e-38  Score=320.36  Aligned_cols=242  Identities=23%  Similarity=0.263  Sum_probs=196.1

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      +.||+|+||.||+++.. +|+.||+|++...   .......+.+|++++..++||||+++++++......++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999864 6889999998653   2233456778999999999999999999999999999999999999


Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      +|.+++..   ...+++..+..++.||+.||+|||+ .+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~  153 (325)
T cd05594          81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TM  153 (325)
T ss_pred             cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-cc
Confidence            99887743   3458999999999999999999997 56   99999999999999999999999999875322211 12


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+......     ........+.          ..++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~-----~~~~~i~~~~----------~~~p~~  218 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE-----KLFELILMEE----------IRFPRT  218 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHH-----HHHHHHhcCC----------CCCCCC
Confidence            3456899999999999999999999999999999999999987543211     1111111111          112344


Q ss_pred             hHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          510 KPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      .+..+.+++.+||+.||++|+     ++.++++.
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         219 LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence            567889999999999999996     89999864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.1e-38  Score=302.42  Aligned_cols=265  Identities=23%  Similarity=0.315  Sum_probs=200.8

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChh--hHHHHHHHHHHHcCCCCCC-eeeeeeeeecCC-----
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKN-LVKLLGCSITGP-----  338 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~-----  338 (573)
                      ...|+..++||+|.||+||+|+.+ +|+.||+|++....++  .-....+|+.+|++|+|+| ||++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            345777889999999999999975 6899999999765432  3345678999999999999 999999998777     


Q ss_pred             -ceeEEEEeccCCCccccccccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          339 -ESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       339 -~~~lv~e~~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                       ..++|+||+. .+|..++...... ..++...+..++.||+.||+|||+++   |+||||||+||||+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccc
Confidence             7889999994 5888887543321 34667889999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC---
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG---  492 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  492 (573)
                      +|+.+.-.. ...+...+|.+|.|||++.+. .|+...||||+|||+.||++++..|....+ .+.+..+.......   
T Consensus       166 lAra~~ip~-~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-~~ql~~If~~lGtP~e~  243 (323)
T KOG0594|consen  166 LARAFSIPM-RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-IDQLFRIFRLLGTPNEK  243 (323)
T ss_pred             hHHHhcCCc-ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-HHHHHHHHHHcCCCCcc
Confidence            999664222 223456789999999999886 799999999999999999997765544333 22222232222211   


Q ss_pred             cccccc---C--ccccCC-----CC---CchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          493 RLHEAV---D--PALAGN-----FQ---EGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       493 ~~~~~~---d--~~l~~~-----~~---~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+....   +  ......     ..   ........+++.+|++.+|.+|.+++.++++
T Consensus       244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            111111   1  011100     00   1112467899999999999999999999986

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9.3e-38  Score=315.31  Aligned_cols=258  Identities=26%  Similarity=0.370  Sum_probs=204.8

Q ss_pred             HhcCccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCC
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP  338 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  338 (573)
                      ..++|+..+.||+|+||.||++...      .+..||||++.... ....+.+.+|+.+++++ +||||+++++++....
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            3467899999999999999999742      34579999886543 33456788999999999 7999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++||||+++|+|.+++.... ...+++..+..++.|++.||+|||+++   |+|+||||+|||++.++.+||+|||++
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence            9999999999999999885432 234899999999999999999999987   999999999999999999999999999


Q ss_pred             cccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          419 RLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       419 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      ......... ......++..|+|||.+....++.++||||||+++|||++ |+.|+........    .......+    
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~----~~~~~~~~----  260 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK----FYKLIKEG----  260 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH----HHHHHHcC----
Confidence            865433221 1122345778999999999999999999999999999998 7777543322111    11111111    


Q ss_pred             ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       497 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                           .....+...+.++.+++.+|++.+|++||++.|+++.|..
T Consensus       261 -----~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         261 -----YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             -----CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence                 1111123345789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-37  Score=306.76  Aligned_cols=248  Identities=29%  Similarity=0.458  Sum_probs=200.2

Q ss_pred             ccccccCceeEEEEEcCC--C--CEEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLPG--G--EAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~--g--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ++||+|++|.||+|.+.+  +  ..||||.+..... ...+.+.+|+.++++++||||+++++.+.. ...++|+||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            478999999999998743  3  3699999977655 567789999999999999999999999888 888999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc--
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--  427 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--  427 (573)
                      ++|.+++..... ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++..+......  
T Consensus        80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999865432 46899999999999999999999987   999999999999999999999999999876442221  


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.|+...... ......   .....         ....
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-~~~~~~---~~~~~---------~~~~  222 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS-QILKKI---DKEGE---------RLER  222 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHH---HhcCC---------cCCC
Confidence            1123456788999999999999999999999999999998 88876432211 111111   11110         0112


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      +...+..+.+++.+|++.+|++||++.+|++.|.
T Consensus       223 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         223 PEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            2345678999999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.3e-38  Score=327.81  Aligned_cols=252  Identities=22%  Similarity=0.260  Sum_probs=197.2

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .+|+..++||+|+||+||+++.. +++.||||++....   ......+.+|+++|++++|+||+++++.+.+++..++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            36889999999999999999875 58899999986432   223456788999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~  154 (376)
T cd05598          81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (376)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence            99999999999843   345788999999999999999999988   999999999999999999999999997533100


Q ss_pred             C------------------------------------------cccccccccCcCcCchhhhccCCCCcccchHhHHHHH
Q 008239          425 I------------------------------------------THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV  462 (573)
Q Consensus       425 ~------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil  462 (573)
                      .                                          ........||+.|+|||++.+..++.++|||||||++
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  234 (376)
T cd05598         155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  234 (376)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence            0                                          0001134689999999999999999999999999999


Q ss_pred             HHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCC---CHHHHHHH
Q 008239          463 IEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRP---SMSIVVKM  538 (573)
Q Consensus       463 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP---t~~evl~~  538 (573)
                      |||++|+.|+.......    ..... ....      ..+........+..+.+++.+|+ .+|.+|+   ++.++++.
T Consensus       235 yell~G~~Pf~~~~~~~----~~~~i-~~~~------~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         235 YEMLVGQPPFLADTPAE----TQLKV-INWE------TTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             eehhhCCCCCCCCCHHH----HHHHH-hccC------ccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            99999999986543211    11111 1100      00111111234566777888766 5999999   88988865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=7.1e-38  Score=313.93  Aligned_cols=256  Identities=29%  Similarity=0.412  Sum_probs=203.7

Q ss_pred             hcCccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      .++|+..+.||+|+||.||++..+      ++..||+|++.... .+..+.+.+|+.++++++||||+++++++..+...
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~   83 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM   83 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence            467899999999999999999863      46789999986543 34456788999999999999999999999999999


Q ss_pred             eEEEEeccCCCccccccccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCC
Q 008239          341 LLVYEFVPNQSLLDNLFVRQ-------------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN  401 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~N  401 (573)
                      ++|+||+++++|.+++....                   ....+++..++.++.|++.||+|||+.+   ++||||||+|
T Consensus        84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n  160 (288)
T cd05050          84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN  160 (288)
T ss_pred             EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence            99999999999999885321                   1234788999999999999999999987   9999999999


Q ss_pred             eeeCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCc
Q 008239          402 ILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSC  479 (573)
Q Consensus       402 Ill~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~  479 (573)
                      |+++.++.+||+|||++........ ........+..|+|||.+.+..++.++||||||+++|||++ |..|+.... . 
T Consensus       161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~-~-  238 (288)
T cd05050         161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA-H-  238 (288)
T ss_pred             eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC-H-
Confidence            9999999999999999875432221 11222334678999999998999999999999999999998 655653221 1 


Q ss_pred             chHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                         .........+...         ..+...+.++.+++.+||+.+|++|||+.|+++.|+
T Consensus       239 ---~~~~~~~~~~~~~---------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         239 ---EEVIYYVRDGNVL---------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             ---HHHHHHHhcCCCC---------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence               1111222222211         123345678999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=9.3e-38  Score=313.14  Aligned_cols=260  Identities=26%  Similarity=0.412  Sum_probs=203.2

Q ss_pred             HHhcCccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP  338 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  338 (573)
                      ...++|++.++||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45678999999999999999999753      24589999886443 233456788999999999999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEE
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQ-------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK  411 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~k  411 (573)
                      ..++||||+++|+|.+++....       ....+++..+.+++.|++.||.|||+++   |+||||||+||++++++.+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            9999999999999999985422       1234677889999999999999999987   99999999999999999999


Q ss_pred             EeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHh
Q 008239          412 IADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLY  489 (573)
Q Consensus       412 l~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  489 (573)
                      |+|||+++....... .......++..|+|||.+.++.++.++||||||+++|||++ |..|+.. .....    .....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~-~~~~~----~~~~~  234 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG-LSNEQ----VLKFV  234 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC-CCHHH----HHHHH
Confidence            999999885533221 11222345678999999999999999999999999999999 4555432 11111    11111


Q ss_pred             hcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       490 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ..+..         ...+...+..+.+++.+|++.+|++||++.++++.|.+.
T Consensus       235 ~~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         235 MDGGY---------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             HcCCC---------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence            11111         112234467899999999999999999999999999543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.2e-37  Score=308.64  Aligned_cols=254  Identities=25%  Similarity=0.369  Sum_probs=203.0

Q ss_pred             cCccccccccccCceeEEEEEcC-C---CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-G---GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .+|+..+.||+|+||.||+|.+. +   +..+|+|.+.... ....+.+.+|+.++++++||||+++++++......++|
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV   83 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence            56788999999999999999864 2   3379999886542 33456789999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.++|+|||++.....
T Consensus        84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd05066          84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED  158 (267)
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence            9999999999988543  245899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCccccc--ccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          424 DITHISA--TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       424 ~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      .......  ...++..|+|||.+.++.++.++||||||+++||+++ |..|+..... ....    .....+.       
T Consensus       159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~-~~~~----~~~~~~~-------  226 (267)
T cd05066         159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSN-QDVI----KAIEEGY-------  226 (267)
T ss_pred             ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCH-HHHH----HHHhCCC-------
Confidence            3322111  1223568999999998899999999999999999887 8877643321 1111    1111110       


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                        ....+...+..+.+++.+|++.+|.+||+|.++++.|..
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         227 --RLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             --cCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence              111223456788999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.4e-37  Score=310.35  Aligned_cols=256  Identities=27%  Similarity=0.377  Sum_probs=201.1

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCC----EEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      .++|+..++||+|+||+||+|++. +|+    .||+|++... .....+.+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~   84 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ   84 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence            356888999999999999999853 444    4899998654 33445678899999999999999999999875 4578


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +++||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||+++++.+||+|||+++..
T Consensus        85 l~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~  159 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeec
Confidence            999999999999988542  345899999999999999999999987   999999999999999999999999999876


Q ss_pred             CCCCccc-ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          422 PEDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       422 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ....... .....++..|+|||.+.+..++.++||||||+++|||++ |..|+.... ...+    ......+..     
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~-~~~~----~~~~~~~~~-----  229 (279)
T cd05109         160 DIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP-AREI----PDLLEKGER-----  229 (279)
T ss_pred             ccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC-HHHH----HHHHHCCCc-----
Confidence            4332211 112234678999999998999999999999999999998 666653221 1111    111121111     


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                          ...+...+..+.+++.+||+.+|++||++.++++.|....
T Consensus       230 ----~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~  269 (279)
T cd05109         230 ----LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMA  269 (279)
T ss_pred             ----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence                1112345678899999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9e-38  Score=315.59  Aligned_cols=255  Identities=25%  Similarity=0.334  Sum_probs=199.8

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCC--EEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..+.||+|+||.||+|.+. ++.  .+++|.+... .......+.+|++++.++ +|+||+++++++......++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            357888999999999999999875 344  4688877543 334456788999999999 89999999999999999999


Q ss_pred             EEEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc
Q 008239          343 VYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT  409 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~  409 (573)
                      |+||+++++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+|||++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999886432             1235889999999999999999999987   999999999999999999


Q ss_pred             EEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHH
Q 008239          410 AKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       410 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  488 (573)
                      +||+|||++.......  .......+..|+|||.+....++.++||||||+++|||++ |..|+..... .....    .
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-~~~~~----~  235 (303)
T cd05088         163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AELYE----K  235 (303)
T ss_pred             EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCCh-HHHHH----H
Confidence            9999999986432111  1112234668999999988889999999999999999998 7777643221 11111    1


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...+         .....+...+..+.+++.+||+.+|++||++++++++|..
T Consensus       236 ~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~  279 (303)
T cd05088         236 LPQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  279 (303)
T ss_pred             HhcC---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            1110         1111223345678999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=5.4e-38  Score=327.67  Aligned_cols=251  Identities=22%  Similarity=0.252  Sum_probs=194.9

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .|+..++||+|+||+||+++.. +++.||||++....   ....+.+.+|+.++++++||||+++++.+.+....++|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            5888999999999999999875 58899999986532   2345678899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++|+|.+++...   ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~  155 (382)
T cd05625          82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (382)
T ss_pred             CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence            99999999988432   45788999999999999999999988   9999999999999999999999999975331100


Q ss_pred             ----------------------------------------------cccccccccCcCcCchhhhccCCCCcccchHhHH
Q 008239          426 ----------------------------------------------THISATLAGTLGYMAPEYVVRGKLTEKADVYSFG  459 (573)
Q Consensus       426 ----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslG  459 (573)
                                                                    ........||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG  235 (382)
T cd05625         156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence                                                          0001234689999999999999999999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCC---HHHHH
Q 008239          460 VVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPS---MSIVV  536 (573)
Q Consensus       460 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt---~~evl  536 (573)
                      |++|||++|+.|+......    .........       ...+........+....+++.+++ .+|++|++   +++++
T Consensus       236 vil~elltG~~Pf~~~~~~----~~~~~i~~~-------~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         236 VILYEMLVGQPPFLAQTPL----ETQMKVINW-------QTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             HHHHHHHhCCCCCCCCCHH----HHHHHHHcc-------CCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHh
Confidence            9999999999998643321    111111110       001111111233456667777665 59999997   77776


Q ss_pred             HH
Q 008239          537 KM  538 (573)
Q Consensus       537 ~~  538 (573)
                      +.
T Consensus       304 ~h  305 (382)
T cd05625         304 AH  305 (382)
T ss_pred             cC
Confidence            53

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.2e-37  Score=317.10  Aligned_cols=241  Identities=24%  Similarity=0.329  Sum_probs=194.2

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ++||+|+||+||+++.. +++.||||++...   .....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 5889999998643   223455677888888876 799999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|.+++...   ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~i~~~---~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~~  153 (320)
T cd05590          81 GDLMFHIQKS---RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KTT  153 (320)
T ss_pred             chHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Ccc
Confidence            9999887432   45889999999999999999999988   9999999999999999999999999987532221 122


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....     .........+..          ..+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~-----~~~~~~i~~~~~----------~~~~~  218 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDEV----------VYPTW  218 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHhcCCC----------CCCCC
Confidence            345789999999999999999999999999999999999999754321     111111221111          12333


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 008239          510 KPSRLLQIGLLCVQASAELRPSM------SIVVK  537 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~------~evl~  537 (573)
                      .+..+.+++.+||+.||++||++      +++++
T Consensus       219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~  252 (320)
T cd05590         219 LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILR  252 (320)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHc
Confidence            56678999999999999999998      56554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-37  Score=306.16  Aligned_cols=240  Identities=23%  Similarity=0.334  Sum_probs=188.3

Q ss_pred             ccccccCceeEEEEEcCC-------------CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          275 NKLGQGGSGSVYKGTLPG-------------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~-------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      +.||+|+||.||+|++..             ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            468999999999998532             2258999886655555668889999999999999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc-------EEEee
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-------AKIAD  414 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~-------~kl~D  414 (573)
                      +||||+++++|..++...  ...+++..+++++.||+.||+|||+.+   |+||||||+|||++.++.       +|++|
T Consensus        81 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK--SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             EEEecccCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            999999999998877432  345899999999999999999999987   999999999999986654       89999


Q ss_pred             cccccccCCCCcccccccccCcCcCchhhhc-cCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcC
Q 008239          415 FGLVRLFPEDITHISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKG  492 (573)
Q Consensus       415 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  492 (573)
                      ||++......     ....++..|+|||.+. ...++.++||||||+++|||++ |..|+.. ..   ... ..... .+
T Consensus       156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~-~~---~~~-~~~~~-~~  224 (262)
T cd05077         156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD-KT---LAE-KERFY-EG  224 (262)
T ss_pred             CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC-cc---hhH-HHHHH-hc
Confidence            9998754322     1235678899999886 4678999999999999999985 5544322 11   111 11111 11


Q ss_pred             ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       493 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ..          .........+.+|+.+||+.+|++||++.+|++.|+
T Consensus       225 ~~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         225 QC----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             Cc----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            10          011223567889999999999999999999998773

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-38  Score=326.67  Aligned_cols=253  Identities=22%  Similarity=0.261  Sum_probs=197.4

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..++||+|+||+||+++.. +++.||||++...   ..+..+.+.+|++++++++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            46888999999999999999864 6889999998643   2334567888999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+...
T Consensus        81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~  154 (377)
T cd05629          81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ  154 (377)
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence            99999999998853   345889999999999999999999988   999999999999999999999999998643211


Q ss_pred             Ccc----------------------------------------------cccccccCcCcCchhhhccCCCCcccchHhH
Q 008239          425 ITH----------------------------------------------ISATLAGTLGYMAPEYVVRGKLTEKADVYSF  458 (573)
Q Consensus       425 ~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwsl  458 (573)
                      ...                                              ......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl  234 (377)
T cd05629         155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL  234 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence            000                                              0012468999999999999999999999999


Q ss_pred             HHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCC---CCHHHH
Q 008239          459 GVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELR---PSMSIV  535 (573)
Q Consensus       459 Gvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R---Pt~~ev  535 (573)
                      ||++|||++|..|+......    ...... ....  .    .+.-.-....+..+.+++.+|++ +|.+|   |++.|+
T Consensus       235 Gvil~elltG~~Pf~~~~~~----~~~~~i-~~~~--~----~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         235 GAIMFECLIGWPPFCSENSH----ETYRKI-INWR--E----TLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             chhhhhhhcCCCCCCCCCHH----HHHHHH-HccC--C----ccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHH
Confidence            99999999999997543221    111111 1100  0    00000011245678899999997 66665   699998


Q ss_pred             HHHh
Q 008239          536 VKML  539 (573)
Q Consensus       536 l~~L  539 (573)
                      ++.-
T Consensus       303 l~hp  306 (377)
T cd05629         303 KSHP  306 (377)
T ss_pred             hcCC
Confidence            8763

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.1e-37  Score=309.25  Aligned_cols=253  Identities=26%  Similarity=0.406  Sum_probs=201.3

Q ss_pred             CccccccccccCceeEEEEEcCC-C---CEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLPG-G---EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~~-g---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .|+..+.||+|+||.||+|.+.. +   ..||||.+... .....+.|..|+.++++++||||+++++++......++||
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   84 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT   84 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence            47788999999999999998753 3   36999998654 3445678999999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......
T Consensus        85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            999999999988543  345899999999999999999999987   999999999999999999999999998765432


Q ss_pred             Cccc--ccccc--cCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          425 ITHI--SATLA--GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       425 ~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ....  .....  .+..|+|||.+....++.++||||||+++|||++ |..|+..... ......+    ...       
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~-~~~~~~i----~~~-------  227 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-QDVINAI----EQD-------  227 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH-HHHHHHH----HcC-------
Confidence            2111  11111  2457999999999999999999999999999886 7777643221 1111111    110       


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                        .....+.+.+..+.+++.+||+.+|.+||++++|+++|+.
T Consensus       228 --~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         228 --YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             --CcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence              0111233456778999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8.7e-38  Score=316.35  Aligned_cols=258  Identities=25%  Similarity=0.326  Sum_probs=203.5

Q ss_pred             hcCccccccccccCceeEEEEEcC--------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG  337 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  337 (573)
                      .++|.+.+.||+|+||.||+++..        ++..+|+|.+.... ......+.+|+++++.+ +||||+++++++...
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   96 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   96 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence            467899999999999999999752        23579999987542 34456788899999999 799999999999999


Q ss_pred             CceeEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL  404 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll  404 (573)
                      ...++||||+++|+|.+++.....             ...+++..+++++.|++.||+|||+.+   ++||||||+||++
T Consensus        97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  173 (307)
T cd05098          97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  173 (307)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence            999999999999999999865321             135889999999999999999999987   9999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchH
Q 008239          405 DEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSIL  482 (573)
Q Consensus       405 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~  482 (573)
                      +.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |+.|+.. ...    
T Consensus       174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~-~~~----  248 (307)
T cd05098         174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG-VPV----  248 (307)
T ss_pred             cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc-CCH----
Confidence            99999999999998765432111 1112234568999999998899999999999999999998 6555532 211    


Q ss_pred             HHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       483 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .........+.         ....+...+..+.+++.+||+.+|++||++.+|++.|...
T Consensus       249 ~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         249 EELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             HHHHHHHHcCC---------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            11111111111         1122334567889999999999999999999999999654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-37  Score=317.08  Aligned_cols=242  Identities=22%  Similarity=0.272  Sum_probs=195.1

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ++||+|+||.||+|+.. +++.||||++...   .....+.+..|.+++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            46999999999999875 5789999998653   223345677889988866 899999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      ++|..++...   ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~~  153 (321)
T cd05591          81 GDLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VTT  153 (321)
T ss_pred             CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC-ccc
Confidence            9998887432   35889999999999999999999988   9999999999999999999999999987543222 122


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+...... ..    ......+..          ..+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~-~~----~~~i~~~~~----------~~p~~  218 (321)
T cd05591         154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED-DL----FESILHDDV----------LYPVW  218 (321)
T ss_pred             cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH-HH----HHHHHcCCC----------CCCCC
Confidence            3456899999999999999999999999999999999999987643321 11    111111111          12233


Q ss_pred             hHHHHHHHHHHccCCCCCCCC-------CHHHHHHH
Q 008239          510 KPSRLLQIGLLCVQASAELRP-------SMSIVVKM  538 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RP-------t~~evl~~  538 (573)
                      .+..+.+++..||+.+|++||       +++++++.
T Consensus       219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            456788999999999999999       78888754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.8e-37  Score=307.86  Aligned_cols=247  Identities=20%  Similarity=0.206  Sum_probs=194.6

Q ss_pred             ccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCc
Q 008239          277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL  352 (573)
Q Consensus       277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  352 (573)
                      ||+|+||.||+++.. +|+.||+|.+....   ......+..|++++++++||||+++++++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999875 58999999985432   12234456799999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 008239          353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL  432 (573)
Q Consensus       353 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  432 (573)
                      .+++.... ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~~  154 (277)
T cd05607          81 KYHIYNVG-ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQR  154 (277)
T ss_pred             HHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeecc
Confidence            88875432 235889999999999999999999987   9999999999999999999999999988654322  12334


Q ss_pred             ccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHH
Q 008239          433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS  512 (573)
Q Consensus       433 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  512 (573)
                      .|+..|+|||++.+..++.++|||||||++|||++|+.|+............. .......        +. ......+.
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~--------~~-~~~~~~~~  224 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELK-RRTLEDE--------VK-FEHQNFTE  224 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHH-HHhhccc--------cc-cccccCCH
Confidence            68899999999999899999999999999999999999875432211111111 1111111        10 01123466


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          513 RLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       513 ~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ++.+++.+||+.+|++||++.|+++.+
T Consensus       225 ~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         225 ESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             HHHHHHHHHhccCHhhCCCCccchhhh
Confidence            789999999999999999998776544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.5e-37  Score=312.79  Aligned_cols=250  Identities=26%  Similarity=0.384  Sum_probs=205.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .+|+..+.||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~   99 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence            57888999999999999999864 68899999997765555678889999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus       100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-  171 (296)
T cd06654         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (296)
T ss_pred             CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence            99999998742    34789999999999999999999988   99999999999999999999999999886533221 


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+.........    ......+.      +.+  ..+
T Consensus       172 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~----~~~~~~~~------~~~--~~~  239 (296)
T cd06654         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL----YLIATNGT------PEL--QNP  239 (296)
T ss_pred             ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH----HHHhcCCC------CCC--CCc
Confidence            122346788999999999888999999999999999999999998654321111    11111110      001  112


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...+..+.+++.+||..+|++||++.++++.
T Consensus       240 ~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             cccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            3455678899999999999999999999974

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=304.78  Aligned_cols=247  Identities=28%  Similarity=0.404  Sum_probs=196.5

Q ss_pred             ccccccCceeEEEEEcCC----CCEEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ++||+|+||.||+|++..    +..+|+|.+..... ...+.+.+|+.+++.++|+||+++++++. ....++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            479999999999997532    36899999876543 34567889999999999999999999876 4568999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      ++|.+++...   ..+++..++.++.|++.||+|||+.+   ++|+||||+|||++.++.+||+|||+++..........
T Consensus        80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~  153 (257)
T cd05060          80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR  153 (257)
T ss_pred             CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence            9999998543   26899999999999999999999987   99999999999999999999999999986643332211


Q ss_pred             c--ccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          430 A--TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       430 ~--~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      .  ...++..|+|||.+....++.++||||||+++|||++ |..|+..... ..+.    .....+..         ...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~-~~~~----~~~~~~~~---------~~~  219 (257)
T cd05060         154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-AEVI----AMLESGER---------LPR  219 (257)
T ss_pred             cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH-HHHH----HHHHcCCc---------CCC
Confidence            1  2223567999999998999999999999999999998 7777643321 1121    11221111         112


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      +...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       220 ~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         220 PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            344567889999999999999999999999999654

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.1e-37  Score=315.06  Aligned_cols=261  Identities=24%  Similarity=0.320  Sum_probs=205.6

Q ss_pred             HhcCccccccccccCceeEEEEEcC--------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeec
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT  336 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  336 (573)
                      ..++|++.+.||+|+||.||+++..        ++..||+|.+.... ....+.+.+|+.+++.+ +||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            3567888999999999999999741        24579999886542 34456788999999999 89999999999999


Q ss_pred             CCceeEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCee
Q 008239          337 GPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL  403 (573)
Q Consensus       337 ~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIl  403 (573)
                      ....++||||+++|+|.+++.....             ...+++..++.++.||+.||.|||+++   ++||||||+||+
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil  169 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL  169 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence            9999999999999999999864321             235788999999999999999999987   999999999999


Q ss_pred             eCCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcch
Q 008239          404 LDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSI  481 (573)
Q Consensus       404 l~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~  481 (573)
                      ++.++.+||+|||+++........ ......++..|+|||.+.+..++.++||||||+++|||++ |..|+.. ..    
T Consensus       170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~-~~----  244 (304)
T cd05101         170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG-IP----  244 (304)
T ss_pred             EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc-CC----
Confidence            999999999999999866433222 1223345678999999998899999999999999999998 5555422 11    


Q ss_pred             HHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 008239          482 LQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE  544 (573)
Q Consensus       482 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  544 (573)
                      ..........+..         ...+...+..+.+++.+||+.+|++||++.||++.|.....
T Consensus       245 ~~~~~~~~~~~~~---------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~  298 (304)
T cd05101         245 VEELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILT  298 (304)
T ss_pred             HHHHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHH
Confidence            1122222222111         11233456789999999999999999999999999966543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.9e-37  Score=316.26  Aligned_cols=246  Identities=23%  Similarity=0.253  Sum_probs=197.1

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCC-CeeeeeeeeecCCceeEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHK-NLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~  344 (573)
                      +|+..+.||+|+||.||+|+.. +++.||||++...   .....+.+..|++++..++|+ +|+++++++...+..++||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            4788999999999999999876 4789999998653   233456778899999999765 5888999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05587          81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG  154 (324)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence            99999999988843   245889999999999999999999987   999999999999999999999999998743221


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... ....    ......          .
T Consensus       155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~-~~~~----~i~~~~----------~  218 (324)
T cd05587         155 G-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED-ELFQ----SIMEHN----------V  218 (324)
T ss_pred             C-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH-HHHH----HHHcCC----------C
Confidence            1 1223456899999999999999999999999999999999999987543211 1111    111111          1


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSM-----SIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~-----~evl~  537 (573)
                      .++...+..+.+++.+||+.+|.+||+.     +++++
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  256 (324)
T cd05587         219 SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIRE  256 (324)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            2234456778899999999999999986     56654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=7.6e-38  Score=331.31  Aligned_cols=261  Identities=21%  Similarity=0.274  Sum_probs=194.0

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--------
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--------  337 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  337 (573)
                      ...+|+..++||+|+||.||+|... +++.||||++....    ....+|+.+|+.++||||+++++++...        
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999875 58899999885432    2335799999999999999999876432        


Q ss_pred             CceeEEEEeccCCCccccccc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-cEEEeec
Q 008239          338 PESLLVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADF  415 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~Df  415 (573)
                      ...++||||+++ +|.+++.. ......+++..++.++.||+.||+|||+.+   |+||||||+|||++.++ .+||+||
T Consensus       140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence            135689999975 67665532 223456899999999999999999999988   99999999999999664 7999999


Q ss_pred             ccccccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC--
Q 008239          416 GLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG--  492 (573)
Q Consensus       416 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  492 (573)
                      |+++.+.....  .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+........+. .........  
T Consensus       216 Gla~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~-~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV-RIIQVLGTPTE  292 (440)
T ss_pred             ccchhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH-HHHHHhCCCCH
Confidence            99986643222  223567999999999876 468999999999999999999998875433221111 111111000  


Q ss_pred             --------ccc-----cccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          493 --------RLH-----EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       493 --------~~~-----~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                              ...     ......+...++...+.++.+++.+||+.+|.+|||+.|+++.
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                    000     0011111122333456788999999999999999999999854

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-37  Score=307.12  Aligned_cols=249  Identities=25%  Similarity=0.350  Sum_probs=194.8

Q ss_pred             ccccccCceeEEEEEcCC-CC--EEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLPG-GE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      +.||+|+||.||+|++++ +.  .+++|.+... .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            469999999999999754 43  5688888643 344556788999999999 899999999999999999999999999


Q ss_pred             CCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          350 QSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       350 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                      ++|.+++....             ....+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            99999885432             1235789999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLH  495 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  495 (573)
                      ++.......  .......+..|+|||++....++.++||||||+++|||++ |..|+..... ...    ......+   
T Consensus       158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~-~~~----~~~~~~~---  227 (270)
T cd05047         158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-AEL----YEKLPQG---  227 (270)
T ss_pred             Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCH-HHH----HHHHhCC---
Confidence            986332111  1111223567999999988899999999999999999997 7777643211 111    1111111   


Q ss_pred             cccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       496 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                            .....+...+..+.+++.+||+.+|.+||++.++++.|...
T Consensus       228 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 ------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                  01112233456789999999999999999999999999653

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.5e-37  Score=305.41  Aligned_cols=250  Identities=29%  Similarity=0.390  Sum_probs=194.2

Q ss_pred             ccccccCceeEEEEEcC----CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeee-cCCceeEEEEecc
Q 008239          275 NKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESLLVYEFVP  348 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~~  348 (573)
                      +.||+|+||.||+|.+.    ++..||||++... .....+.+.+|+.+++.++||||+++++++. .+...++|+||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999863    2457999988543 3344678889999999999999999999776 4556789999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc-
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-  427 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-  427 (573)
                      +++|.+++...  ...+++..+..++.||+.||+|||+.+   ++||||||+|||+++++.+||+|||+++........ 
T Consensus        81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~  155 (262)
T cd05058          81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS  155 (262)
T ss_pred             CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence            99999988543  234678888999999999999999987   999999999999999999999999998855332111 


Q ss_pred             --cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          428 --ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       428 --~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                        ......++..|+|||.+....++.++||||||+++|||++|+.|+............    ...+..         ..
T Consensus       156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~  222 (262)
T cd05058         156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVY----LLQGRR---------LL  222 (262)
T ss_pred             ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH----HhcCCC---------CC
Confidence              111334567899999998889999999999999999999977665443322121111    111110         11


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .+...+..+.+++.+||+.+|++||++.+|++.|+..
T Consensus       223 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         223 QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            1223456889999999999999999999999999654

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.4e-37  Score=307.86  Aligned_cols=256  Identities=26%  Similarity=0.342  Sum_probs=204.3

Q ss_pred             cCccccccccccCceeEEEEEcC------CCCEEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ++|+..+.||+|+||.||+++.+      +.+.|++|.+.....+ ..+.+.+|++++++++|+||+++++++.+....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   84 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY   84 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence            56888999999999999999864      2467999988654443 5678999999999999999999999999989999


Q ss_pred             EEEEeccCCCccccccccCCC------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeec
Q 008239          342 LVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF  415 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  415 (573)
                      +||||+++++|.+++......      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+||
T Consensus        85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~  161 (275)
T cd05046          85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL  161 (275)
T ss_pred             EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence            999999999999998644322      26899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCcc
Q 008239          416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRL  494 (573)
Q Consensus       416 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  494 (573)
                      |++...............++..|+|||.+.+...+.++||||||++++||++ |..|+... ....    .......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~-~~~~----~~~~~~~~~~  236 (275)
T cd05046         162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGL-SDEE----VLNRLQAGKL  236 (275)
T ss_pred             ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc-chHH----HHHHHHcCCc
Confidence            9987543322222233456778999999988889999999999999999999 55554321 1111    1112222221


Q ss_pred             ccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       495 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      .        ...+...+..+.+++.+||+.+|++||++.|++++|+
T Consensus       237 ~--------~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         237 E--------LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             C--------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1        1123345678999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3e-37  Score=306.05  Aligned_cols=258  Identities=25%  Similarity=0.327  Sum_probs=203.9

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ++.+++++.....||+|+||.||+|+.. ++..|++|.+.....+..+.+.+|+.+++.++|+||+++++++..++..++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   82 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI   82 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence            4456677777889999999999999865 578899999877666667789999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-CCcEEEeeccccccc
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLF  421 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~  421 (573)
                      |+||+++++|.+++.........++..+..++.||+.||+|||+.+   |+||||||+||+++. ++.+||+|||++...
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            9999999999998864322212278888999999999999999987   999999999999986 679999999998765


Q ss_pred             CCCCcccccccccCcCcCchhhhccCC--CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ..... ......++..|+|||++....  ++.++||||||+++|||++|+.|+.......   ...+.....        
T Consensus       160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~---~~~~~~~~~--------  227 (268)
T cd06624         160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ---AAMFKVGMF--------  227 (268)
T ss_pred             ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh---hhHhhhhhh--------
Confidence            33221 122345788999999986643  7889999999999999999998875432211   111110000        


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       .....++.....++.+++.+||+.+|++|||+.|+++
T Consensus       228 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         228 -KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence             0111234445678899999999999999999999986

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=2.1e-37  Score=309.15  Aligned_cols=249  Identities=22%  Similarity=0.332  Sum_probs=199.6

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..++||+|+||.||++.. .+++.||+|++... .....+.+.+|++++++++||||+++++++......++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            3577889999999999999986 46889999998654 334456788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|..+.       .+++..+..++.|++.||.|||+.+   |+|+||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-  149 (279)
T cd06619          81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-  149 (279)
T ss_pred             CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence            9999986542       3678889999999999999999988   9999999999999999999999999998654322 


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcc--hHHHHHHHhhcCccccccCccccC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS--ILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                        .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........  .............     .+.+  
T Consensus       150 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----~~~~--  220 (279)
T cd06619         150 --AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED-----PPVL--  220 (279)
T ss_pred             --ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC-----CCCC--
Confidence              2245688999999999998999999999999999999999998754322111  1111111111110     1111  


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       .....+.++.+++.+|++.+|+.||+++|+++.
T Consensus       221 -~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 -PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             -CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence             112345678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.3e-37  Score=315.84  Aligned_cols=240  Identities=24%  Similarity=0.273  Sum_probs=190.2

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHH-HHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      +.||+|+||+||+++.. +|+.||||++...   .......+..|.. +++.++||||+++++.+......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999875 6899999998653   2223345555654 56789999999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~  153 (325)
T cd05604          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DTT  153 (325)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CCc
Confidence            999887743   346899999999999999999999988   9999999999999999999999999987532211 122


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.|+.....    . ........+..          .....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~----~-~~~~~~~~~~~----------~~~~~  218 (325)
T cd05604         154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV----A-EMYDNILHKPL----------VLRPG  218 (325)
T ss_pred             ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH----H-HHHHHHHcCCc----------cCCCC
Confidence            345789999999999999999999999999999999999998754321    1 11111111111          11223


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCHHHHH
Q 008239          510 KPSRLLQIGLLCVQASAELRPSMSIVV  536 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~~evl  536 (573)
                      .+..+.+++.+|++.+|++||++.+.+
T Consensus       219 ~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         219 ASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             CCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence            556788999999999999999986433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-37  Score=303.54  Aligned_cols=247  Identities=29%  Similarity=0.423  Sum_probs=198.4

Q ss_pred             ccccccCceeEEEEEcCCCCEEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCcc
Q 008239          275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL  353 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  353 (573)
                      ++||+|+||.||++.+.+++.|++|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999999877999999988665433 5668899999999999999999999999999999999999999999


Q ss_pred             ccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc-ccc
Q 008239          354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS-ATL  432 (573)
Q Consensus       354 ~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~-~~~  432 (573)
                      +++...  ...+++..++.++.+++.+|+|||+++   ++||||+|+||+++.++.+||+|||++........... ...
T Consensus        81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            988543  235789999999999999999999987   99999999999999999999999999886543222111 122


Q ss_pred             ccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchH
Q 008239          433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKP  511 (573)
Q Consensus       433 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  511 (573)
                      ..+..|+|||.+.++.++.++||||||++++||++ |..|+..... ...    ......+         .....+...+
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~-~~~----~~~~~~~---------~~~~~~~~~~  221 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSN-QQT----RERIESG---------YRMPAPQLCP  221 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCH-HHH----HHHHhcC---------CCCCCCccCC
Confidence            34567999999988899999999999999999999 5555432221 111    1111111         0111234456


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          512 SRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       512 ~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ..+.+++.+|++.+|++||+++||++.|.
T Consensus       222 ~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         222 EEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             HHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            78999999999999999999999999884

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.4e-37  Score=315.39  Aligned_cols=246  Identities=24%  Similarity=0.255  Sum_probs=197.1

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      +|+..+.||+|+||.||+++.. +++.||||++....   ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4778999999999999999876 57899999986532   22344567788888777 5899999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~  154 (323)
T cd05616          81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD  154 (323)
T ss_pred             cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence            99999999888743   245889999999999999999999987   999999999999999999999999998754322


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      . .......||+.|+|||++.+..++.++|||||||++|||++|+.|+...... .+..    ......          .
T Consensus       155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~-~~~~----~i~~~~----------~  218 (323)
T cd05616         155 G-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED-ELFQ----SIMEHN----------V  218 (323)
T ss_pred             C-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH-HHHH----HHHhCC----------C
Confidence            1 1223457899999999999999999999999999999999999987543221 1111    111111          1


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSM-----SIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~-----~evl~  537 (573)
                      .++...+.++.+++.+|++.+|++|++.     .++.+
T Consensus       219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~  256 (323)
T cd05616         219 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  256 (323)
T ss_pred             CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhc
Confidence            2234456788999999999999999985     56553

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=7.8e-37  Score=303.25  Aligned_cols=253  Identities=26%  Similarity=0.332  Sum_probs=193.1

Q ss_pred             ccccccCceeEEEEEcCC---CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          275 NKLGQGGSGSVYKGTLPG---GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      +.||+|+||.||+|...+   +..+|+|.+.... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            368999999999998653   4579999886543 233457889999999999999999999999999999999999999


Q ss_pred             CccccccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc-
Q 008239          351 SLLDNLFVRQ--DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-  427 (573)
Q Consensus       351 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-  427 (573)
                      +|.+++....  .....++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++......... 
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            9999986432  2234677888899999999999999987   999999999999999999999999998754332221 


Q ss_pred             cccccccCcCcCchhhhccC-------CCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          428 ISATLAGTLGYMAPEYVVRG-------KLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ......++..|+|||++...       .++.++||||||+++|||++ |+.|+...... .....    ...+......+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~-~~~~~----~~~~~~~~~~~  232 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE-QVLTY----TVREQQLKLPK  232 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH-HHHHH----HhhcccCCCCC
Confidence            12234567889999998642       35789999999999999996 88776443221 11111    11111112222


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      +.+    ....+..+.+++..|+ .+|++|||++||+..|+
T Consensus       233 ~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         233 PRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             Ccc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            222    2234566788999999 58999999999999885

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.6e-38  Score=305.72  Aligned_cols=259  Identities=24%  Similarity=0.290  Sum_probs=195.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC-----ceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~l  342 (573)
                      -.|...+++|.|+||.||+|++. +++.||||+...+..-    -.+|+.+|+.++|||||+|+-+|....     ...+
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnl   99 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNL   99 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHH
Confidence            35677899999999999999975 4789999998665431    236999999999999999998876432     2358


Q ss_pred             EEEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC-CcEEEeecccccc
Q 008239          343 VYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRL  420 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~~  420 (573)
                      ||||||. +|.+.+... .....++...+.-+..||.+||+|||+.+   |+||||||.|+|+|.+ |.+||+|||.|+.
T Consensus       100 VleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~  175 (364)
T KOG0658|consen  100 VLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKV  175 (364)
T ss_pred             HHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCccee
Confidence            9999986 787777431 12345677778889999999999999987   9999999999999966 9999999999998


Q ss_pred             cCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcc-----
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL-----  494 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  494 (573)
                      +..+...  .....|.-|.|||++.+ ..|+.+.||||.||++.||+-|+..|...... +.+..+.+.+....-     
T Consensus       176 L~~~epn--iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG~Pt~e~I~~  252 (364)
T KOG0658|consen  176 LVKGEPN--ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLGTPTREDIKS  252 (364)
T ss_pred             eccCCCc--eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhCCCCHHHHhh
Confidence            8665544  34456889999999987 58999999999999999999998766543332 222222222221110     


Q ss_pred             -----ccccCcccc-----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          495 -----HEAVDPALA-----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       495 -----~~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                           .+.-.+.+.     .-+....+.+.++++.++++.+|.+|.++.|++.+
T Consensus       253 mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  253 MNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             cCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                 011111121     11344567889999999999999999999988854

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-37  Score=302.57  Aligned_cols=249  Identities=32%  Similarity=0.453  Sum_probs=203.1

Q ss_pred             ccccccCceeEEEEEcCC----CCEEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ++||+|+||.||++....    +..|++|.+...... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999999764    789999999765433 367889999999999999999999999999999999999999


Q ss_pred             CCccccccccCC------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          350 QSLLDNLFVRQD------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       350 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      ++|.+++.....      ...+++..++.++.|++.||+|||+++   ++|+||+|+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            999999865421      367899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcC-CCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          424 DIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR-KRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       424 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ... .......++..|+|||.+....++.++||||||++++||+++ ..|+.... .    ...+.....+.        
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~-~----~~~~~~~~~~~--------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS-N----EEVLEYLRKGY--------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC-H----HHHHHHHHcCC--------
Confidence            321 222344578899999999888999999999999999999995 66654431 1    11222222111        


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                       ....+...+.++.+++.+||+.+|++||++.|+++.|+
T Consensus       225 -~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 -RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             11223445778999999999999999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-37  Score=311.51  Aligned_cols=259  Identities=26%  Similarity=0.390  Sum_probs=205.0

Q ss_pred             cCccccccccccCceeEEEEEcC-----CCCEEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeec--CCce
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-----GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSIT--GPES  340 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  340 (573)
                      ++|+..+.||+|+||.||++++.     +++.+|||.+...... ..+.+.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            45777899999999999999853     3678999999765443 56789999999999999999999999877  5578


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            99999999999999985432  35899999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc----------chHHHHHHH
Q 008239          421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC----------SILQTVWDL  488 (573)
Q Consensus       421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~----------~~~~~~~~~  488 (573)
                      .......  ......++..|++||.+....++.++||||||+++|||++|+.|+.......          .........
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            6532211  1112345567999999998899999999999999999999998865432111          001111111


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ..         .......+...+.++.+++.+||+.+|++||++.||+++|+.
T Consensus       239 ~~---------~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~  282 (284)
T cd05038         239 LK---------EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDR  282 (284)
T ss_pred             HH---------cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhh
Confidence            11         111112233456789999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.7e-37  Score=314.22  Aligned_cols=242  Identities=24%  Similarity=0.275  Sum_probs=195.4

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      +.||+|+||+||++... +++.||||++....   ....+.+..|..++..+ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999876 57899999987532   23455677888998887 799999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|..++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++....... ..
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (318)
T cd05570          81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TT  153 (318)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-cc
Confidence            999888743   345899999999999999999999988   99999999999999999999999999874322111 12


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....|++.|+|||++.+..++.++|||||||++|||++|+.|+.....     ............          .++..
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~-----~~~~~~i~~~~~----------~~~~~  218 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE-----DELFQSILEDEV----------RYPRW  218 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCC----------CCCCc
Confidence            245689999999999999999999999999999999999998753321     111111111111          12334


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCH-----HHHHHH
Q 008239          510 KPSRLLQIGLLCVQASAELRPSM-----SIVVKM  538 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~-----~evl~~  538 (573)
                      .+..+.+++.+||+.+|.+||++     .++++.
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            56788999999999999999999     888754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.9e-37  Score=315.18  Aligned_cols=247  Identities=20%  Similarity=0.232  Sum_probs=196.8

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ++||+|+||+||+++.. +++.||+|++...   .....+.+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999875 5789999999754   223455678899999888 699999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|..++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (327)
T cd05617          81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTT  153 (327)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Cce
Confidence            999887743   245899999999999999999999988   9999999999999999999999999987432211 122


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--chHHHHHHHhhcCccccccCccccCCCC
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--SILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......  ..............          ...+
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------~~~p  223 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------IRIP  223 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------CCCC
Confidence            34578999999999999999999999999999999999999986432211  22222322222211          1123


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSM------SIVVKM  538 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~------~evl~~  538 (573)
                      ...+..+.+++.+||+.||++||++      +++++.
T Consensus       224 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         224 RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            3456778899999999999999984      566543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2e-37  Score=318.48  Aligned_cols=260  Identities=25%  Similarity=0.317  Sum_probs=200.2

Q ss_pred             HhcCccccccccccCceeEEEEEc------CCCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC-
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG-  337 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~-  337 (573)
                      ..++|+..++||+|+||.||+|..      .+++.||||++.... ....+.+.+|+.++.++ +||||+++++++... 
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            346789999999999999999973      347889999997543 33456788999999999 689999999987654 


Q ss_pred             CceeEEEEeccCCCccccccccCC--------------------------------------------------------
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQD--------------------------------------------------------  361 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~--------------------------------------------------------  361 (573)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            467899999999999988753210                                                        


Q ss_pred             --------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc-ccccc
Q 008239          362 --------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-ISATL  432 (573)
Q Consensus       362 --------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~  432 (573)
                              ...+++..+.+++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......... .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                    124688889999999999999999987   999999999999999999999999998865332211 11223


Q ss_pred             ccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchH
Q 008239          433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKP  511 (573)
Q Consensus       433 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  511 (573)
                      .++..|+|||.+.+..++.++||||||+++|||++ |..|+......    .........+..         ...+....
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~----~~~~~~~~~~~~---------~~~~~~~~  308 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID----EEFCRRLKEGTR---------MRAPDYTT  308 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc----HHHHHHHhccCC---------CCCCCCCC
Confidence            45678999999999999999999999999999997 66665432211    111111222111         11122234


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          512 SRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       512 ~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ..+.+++..||+.+|++||++.||++.|+..
T Consensus       309 ~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         309 PEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            5789999999999999999999999999643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-37  Score=307.32  Aligned_cols=239  Identities=24%  Similarity=0.315  Sum_probs=186.6

Q ss_pred             cccccCceeEEEEEcCC-------------------------CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeee
Q 008239          276 KLGQGGSGSVYKGTLPG-------------------------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL  330 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~~~-------------------------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l  330 (573)
                      .||+|+||.||+|.+..                         ...|++|++..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999997421                         13589998866555556678899999999999999999


Q ss_pred             eeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC--
Q 008239          331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF--  408 (573)
Q Consensus       331 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~--  408 (573)
                      ++++......++||||+++|+|..++...  ...+++..+.+++.||++||+|||+++   |+||||||+|||++.++  
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~  156 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA  156 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence            99999999999999999999998887432  345889999999999999999999987   99999999999997543  


Q ss_pred             -----cEEEeecccccccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHH-cCCCCCCCCCCCcch
Q 008239          409 -----TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVV-CRKRINLFTQNSCSI  481 (573)
Q Consensus       409 -----~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~ell-tg~~p~~~~~~~~~~  481 (573)
                           .+|++|||++.......     ...++..|+|||.+.+ ..++.++||||||+++|||+ +|+.|+..... ...
T Consensus       157 ~~~~~~~kl~d~g~~~~~~~~~-----~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-~~~  230 (274)
T cd05076         157 EGTSPFIKLSDPGVSFTALSRE-----ERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP-SEK  230 (274)
T ss_pred             cCccceeeecCCcccccccccc-----ccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh-HHH
Confidence                 48999999876432221     2346788999998865 56899999999999999995 56666543221 111


Q ss_pred             HHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          482 LQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       482 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ..    .....       .    ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       231 ~~----~~~~~-------~----~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 ER----FYEKK-------H----RLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HH----HHHhc-------c----CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            11    11100       0    111223356889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=2.2e-37  Score=321.11  Aligned_cols=260  Identities=18%  Similarity=0.173  Sum_probs=203.6

Q ss_pred             HHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC
Q 008239          262 ETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG  337 (573)
Q Consensus       262 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  337 (573)
                      .++....++|+..+.||+|+||.||+++.. +++.+|+|++...   .....+.+.+|+.+++.++||||+++++.+.++
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            344555688999999999999999999976 5789999998542   223345677899999999999999999999999


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ...++||||+++|+|.+++..    ..+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCc
Confidence            999999999999999988843    24788889999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhccC----CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVRG----KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR  493 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  493 (573)
                      +...............||+.|+|||++...    .++.++|||||||++|||++|+.|+.....    ............
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~----~~~~~~i~~~~~  264 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL----VGTYSKIMNHKN  264 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH----HHHHHHHHcCCC
Confidence            987654333233456799999999998754    378899999999999999999999864321    111111111111


Q ss_pred             cccccCccccCCCCCchHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 008239          494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAEL--RPSMSIVVKML  539 (573)
Q Consensus       494 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~L  539 (573)
                      .       +.-......+..+.+++..|++..+.+  ||+++|+++..
T Consensus       265 ~-------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         265 S-------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             c-------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            0       000112245667889999999854443  78999999865

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.8e-37  Score=311.43  Aligned_cols=240  Identities=24%  Similarity=0.252  Sum_probs=192.0

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ++||+|+||.||+++.. +|+.||+|.+....   ....+.+..|..++..+ +||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            46999999999999976 58899999986532   23345567788887754 899999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (316)
T cd05620          81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD-NRA  153 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC-Cce
Confidence            999888743   245889999999999999999999988   9999999999999999999999999987432111 122


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     .........+.          ..++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~-----~~~~~~~~~~~----------~~~~~~  218 (316)
T cd05620         154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-----DELFESIRVDT----------PHYPRW  218 (316)
T ss_pred             eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC----------CCCCCC
Confidence            345689999999999999999999999999999999999998754321     11111111111          112333


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCHH-HHH
Q 008239          510 KPSRLLQIGLLCVQASAELRPSMS-IVV  536 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~~-evl  536 (573)
                      ...++.+++.+||+.||++||++. +++
T Consensus       219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         219 ITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            566788999999999999999984 665

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=3.1e-37  Score=303.72  Aligned_cols=248  Identities=27%  Similarity=0.395  Sum_probs=198.8

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeee-cCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~lv~e~~  347 (573)
                      .+|+..+.||+|+||.||++... |+.|++|.+....  ..+.+.+|+.++++++|+|++++++++. .+...++|+||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888999999999999999876 7889999886433  3467889999999999999999999764 556789999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++.... ...+++..++.++.|++.||+|||+++   ++||||||+||++++++.+||+|||++.......  
T Consensus        83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          83 AKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            9999999885432 235889999999999999999999987   9999999999999999999999999987543221  


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                        .....+..|+|||++....++.++||||||+++|||++ |+.|+.... ...+.    .....+         .....
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~-~~~~~----~~~~~~---------~~~~~  220 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP-LKDVV----PRVEKG---------YKMDA  220 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCC-HHHHH----HHHhcC---------CCCCC
Confidence              12334568999999998899999999999999999998 776654221 11111    111111         01122


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      +...+..+.+++.+|++.+|++|||+.++++.|..
T Consensus       221 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         221 PDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            34456789999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.6e-37  Score=315.17  Aligned_cols=237  Identities=24%  Similarity=0.275  Sum_probs=188.9

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHH-HHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      +.||+|+||+||+++.. +|+.||||++....   ......+..|.. +++.++||||+++++.+......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            46999999999999975 68999999986432   222334455554 56889999999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|.+++..   ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (323)
T cd05575          81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTT  153 (323)
T ss_pred             CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Ccc
Confidence            999988843   346889999999999999999999988   9999999999999999999999999987532211 122


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.|+.....     .........+..          .....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~----------~~~~~  218 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT-----AEMYDNILNKPL----------RLKPN  218 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCH-----HHHHHHHHcCCC----------CCCCC
Confidence            345689999999999999999999999999999999999998754321     111111111111          12234


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCHH
Q 008239          510 KPSRLLQIGLLCVQASAELRPSMS  533 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~~  533 (573)
                      .+..+.+++.+||+.+|++||++.
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         219 ISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             CCHHHHHHHHHHhhcCHHhCCCCC
Confidence            467789999999999999999984

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.7e-37  Score=313.72  Aligned_cols=258  Identities=26%  Similarity=0.336  Sum_probs=202.8

Q ss_pred             hcCccccccccccCceeEEEEEcC--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG  337 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  337 (573)
                      .++|...++||+|+||.||+++..        ....+|+|++... .......+.+|+.+++++ +||||+++++++...
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            467888999999999999999742        2457899988654 234456788999999999 699999999999998


Q ss_pred             CceeEEEEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL  404 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll  404 (573)
                      ...++||||+++|+|.+++....             ....+++..+.+++.|++.||.|||+++   ++||||||+|||+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill  167 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLV  167 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEE
Confidence            89999999999999999885432             1245889999999999999999999987   9999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchH
Q 008239          405 DEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSIL  482 (573)
Q Consensus       405 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~  482 (573)
                      ++++.+||+|||+++........ ......++..|+|||.+.++.++.++||||||+++|||++ |..|+... ..    
T Consensus       168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~-~~----  242 (314)
T cd05099         168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI-PV----  242 (314)
T ss_pred             cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC-CH----
Confidence            99999999999999865432211 1112234567999999999999999999999999999999 66665321 11    


Q ss_pred             HHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       483 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .........+..         ...+...+..+.+++.+||+.+|++||++.++++.|...
T Consensus       243 ~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         243 EELFKLLREGHR---------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HHHHHHHHcCCC---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111122222111         112344567888999999999999999999999999543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.3e-37  Score=306.64  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=202.0

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|+..++||+|+||.||+++.. +++.||+|.+..........+.+|+.+++.++||||+++++.+......++|+||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~   87 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEec
Confidence            356788899999999999999874 5889999998766555556788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++........
T Consensus        88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd06645          88 CGGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA  161 (267)
T ss_pred             cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc
Confidence            999999998743   345899999999999999999999988   99999999999999999999999999876543221


Q ss_pred             ccccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          427 HISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                       ......|+..|+|||.+.   ...++.++|||||||++|||++|+.|+.........    .... ....   ..+.+.
T Consensus       162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~----~~~~-~~~~---~~~~~~  232 (267)
T cd06645         162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL----FLMT-KSNF---QPPKLK  232 (267)
T ss_pred             -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH----Hhhh-ccCC---CCCccc
Confidence             223456889999999984   456889999999999999999999887543321111    1111 1110   011111


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .  ....+..+.+++.+|++.+|++||++++|+++
T Consensus       233 ~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         233 D--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             c--cCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence            0  11234578899999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-38  Score=324.26  Aligned_cols=248  Identities=24%  Similarity=0.349  Sum_probs=200.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecc----cChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc--ee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFY----NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE--SL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~----~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--~~  341 (573)
                      +..+..++||+|+|-+||||.+. +|-+||--.++.    ..++..++|..|+.+|+.|+|||||+++.++.+...  ..
T Consensus        40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in  119 (632)
T KOG0584|consen   40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN  119 (632)
T ss_pred             ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence            34456789999999999999985 476776544322    244556899999999999999999999999987665  77


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-CCcEEEeecccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRL  420 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~  420 (573)
                      +|+|.|..|+|..|+..   ...++...+..|+.||++||.|||++. |+|||||||-.||+|+. -|.|||+|+|||..
T Consensus       120 ~iTEL~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  120 FITELFTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             eeeecccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHH
Confidence            99999999999999854   345788899999999999999999986 89999999999999985 58999999999997


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      .....   .....|||.|||||+.. ..|+..+||||||+.++||+|+..|..--.+...++..+-.......+.++   
T Consensus       196 ~r~s~---aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV---  268 (632)
T KOG0584|consen  196 LRKSH---AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV---  268 (632)
T ss_pred             hhccc---cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc---
Confidence            75433   23478999999999776 899999999999999999999999976655544443333222222222222   


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                               .-.++.++|.+|+.. .++|||+.|+|+
T Consensus       269 ---------~dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  269 ---------KDPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             ---------CCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence                     234677999999999 999999999995

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6.6e-37  Score=303.71  Aligned_cols=253  Identities=25%  Similarity=0.325  Sum_probs=190.3

Q ss_pred             ccccccCceeEEEEEcCC---CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          275 NKLGQGGSGSVYKGTLPG---GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|+.+++.++|+||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            369999999999997543   3578888875443 334567889999999999999999999999999999999999999


Q ss_pred             CccccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc-c
Q 008239          351 SLLDNLFVRQD--VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-H  427 (573)
Q Consensus       351 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~  427 (573)
                      +|.+++.....  ....++.....++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........ .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            99999865332  233567888999999999999999987   99999999999999999999999999875432211 1


Q ss_pred             cccccccCcCcCchhhhcc-------CCCCcccchHhHHHHHHHHHcC-CCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          428 ISATLAGTLGYMAPEYVVR-------GKLTEKADVYSFGVVVIEVVCR-KRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGvil~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ......++..|+|||++..       ..++.++||||||+++|||+++ ..|+... .....   .......+ ...+.+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~-~~~~~---~~~~~~~~-~~~~~~  232 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL-SDEQV---LKQVVREQ-DIKLPK  232 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC-CHHHH---HHHHhhcc-CccCCC
Confidence            1223345778999998743       3568899999999999999994 4444322 11111   11111111 112222


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      +.    .+...+..+.+++..|+ .+|++||++++|+++|+
T Consensus       233 ~~----~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         233 PQ----LDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             Cc----ccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence            22    23345667788889998 59999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.7e-37  Score=308.06  Aligned_cols=262  Identities=22%  Similarity=0.330  Sum_probs=198.9

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..+.||+|++|.||+|+.. +++.||||++....  ....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            4778899999999999999975 68899999986432  23346788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      ++ ++|.+++........+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.+||+|||++....... 
T Consensus        81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  155 (285)
T cd07861          81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-  155 (285)
T ss_pred             CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCc-
Confidence            97 688888755444457899999999999999999999987   9999999999999999999999999987553322 


Q ss_pred             ccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHH----------HHHHhhc-Cc-
Q 008239          427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT----------VWDLYVK-GR-  493 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~~-~~-  493 (573)
                      .......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+............          .|..... .. 
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (285)
T cd07861         156 RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDY  235 (285)
T ss_pred             ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHH
Confidence            112233568899999988654 5789999999999999999998887543221111100          0000000 00 


Q ss_pred             ---cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          494 ---LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       494 ---~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                         ........+ .......+.++.+++.+||+.||++|||+++|++
T Consensus       236 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         236 KNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             HhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence               000000000 0112235667889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=4.3e-37  Score=312.34  Aligned_cols=241  Identities=24%  Similarity=0.290  Sum_probs=192.0

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcC-CCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISG-INHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      +.||+|+||+||+|+.. +++.||||++....   ....+.+..|..++.. ++||||+++++++.+....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            46999999999999975 47899999986542   2334556678888876 4999999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........ ..
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~  153 (316)
T cd05619          81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KT  153 (316)
T ss_pred             CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-ce
Confidence            999988843   245889999999999999999999987   99999999999999999999999999875322111 22


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....||..|+|||++.+..++.++|||||||++|||++|+.|+.....     .........+.      +    .++..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~-----~~~~~~i~~~~------~----~~~~~  218 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE-----EELFQSIRMDN------P----CYPRW  218 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCC------C----CCCcc
Confidence            345689999999999999999999999999999999999998754321     11111111111      1    12233


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 008239          510 KPSRLLQIGLLCVQASAELRPSMS-IVVK  537 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~~-evl~  537 (573)
                      ....+.+++.+||+.+|++||++. ++.+
T Consensus       219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         219 LTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            456788999999999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-37  Score=306.92  Aligned_cols=241  Identities=24%  Similarity=0.363  Sum_probs=191.7

Q ss_pred             ccccccCceeEEEEEcCC--------CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          275 NKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +.||+|+||.||+|....        ...|++|.+........+.+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            479999999999998642        235888888665555667889999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc--------EEEeecccc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--------AKIADFGLV  418 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~--------~kl~Dfgla  418 (573)
                      +++|+|.+++....  ..+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.        ++++|||++
T Consensus        81 ~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          81 VKFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             CCCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            99999999985432  35889999999999999999999987   999999999999987764        699999988


Q ss_pred             cccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      ......     ....++..|+|||++.+ ..++.++||||||+++|||++|..++..........    .... .     
T Consensus       156 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~----~~~~-~-----  220 (258)
T cd05078         156 ITVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL----QFYE-D-----  220 (258)
T ss_pred             cccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH----HHHH-c-----
Confidence            754321     23457889999999976 457899999999999999999965543222111100    0111 0     


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                           ....+.....++.+++.+||+.+|++|||++++++.|+
T Consensus       221 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 -----RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             -----cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                 01223344567899999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=4.5e-37  Score=307.18  Aligned_cols=252  Identities=25%  Similarity=0.360  Sum_probs=201.0

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      .|+..+.||+|+||.||++... ++..+++|.+.....+..+.+.+|+++++.++||||+++++++..+...++|+||++
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~   85 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCA   85 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecC
Confidence            3667889999999999999976 477889999876666667788999999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +++|..++...  ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........ .
T Consensus        86 ~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~  159 (282)
T cd06643          86 GGAVDAVMLEL--ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-R  159 (282)
T ss_pred             CCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc-c
Confidence            99998877432  346899999999999999999999987   99999999999999999999999999876533221 2


Q ss_pred             ccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          429 SATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .....++..|+|||++.     ...++.++|||||||++|||++|+.|+......    ...... .....     +.+ 
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~~-~~~~~-----~~~-  228 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPM----RVLLKI-AKSEP-----PTL-  228 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHH----HHHHHH-hhcCC-----CCC-
Confidence            23446889999999984     345788999999999999999999886432211    111111 11110     111 


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                       ..+...+..+.+++.+||+.+|.+||++.++++.-
T Consensus       229 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  263 (282)
T cd06643         229 -AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHP  263 (282)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCC
Confidence             11233456889999999999999999999998643

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=4.8e-37  Score=302.05  Aligned_cols=249  Identities=29%  Similarity=0.411  Sum_probs=203.5

Q ss_pred             cCccccccccccCceeEEEEEcCC-CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      ++|+..++||+|+||.||++...+ ++.+++|.+.....  .+.+.+|++++++++|+||+++++++......++++||+
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence            578899999999999999999865 78999999865433  678999999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          81 GAGSVSDIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             CCCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            999999988432  346899999999999999999999987   99999999999999999999999999886644321 


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.|+..........     .....     ..+.+  ..+
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~-----~~~~~-----~~~~~--~~~  222 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIF-----MIPNK-----PPPTL--SDP  222 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhh-----hhccC-----CCCCC--Cch
Confidence            2233457889999999998899999999999999999999999875432211100     00000     00111  112


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ......+.+++.+||+.+|++||+++||++
T Consensus       223 ~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         223 EKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             hhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            234567899999999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=3.5e-37  Score=307.12  Aligned_cols=247  Identities=27%  Similarity=0.404  Sum_probs=200.8

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .|+..+.||+|+||.||+|.+. +++.||+|.+.... ....+.+.+|+.++++++||||+++++++..+...++|+||+
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL   84 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence            4667788999999999999865 57889999886443 344567889999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++..    ..+++..+..++.|++.||.|||+++   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06642          85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence            99999988732    45889999999999999999999987   99999999999999999999999999886543321 


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ...    ....         .......
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~~~----~~~~---------~~~~~~~  222 (277)
T cd06642         157 KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMR-VLF----LIPK---------NSPPTLE  222 (277)
T ss_pred             hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhh-HHh----hhhc---------CCCCCCC
Confidence            1223457889999999998899999999999999999999998864322111 000    0011         1111223


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...+..+.+++.+||+.+|++||++.+++++
T Consensus       223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         223 GQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            3456778999999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.4e-37  Score=307.26  Aligned_cols=253  Identities=25%  Similarity=0.327  Sum_probs=199.2

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC------
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG------  337 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~------  337 (573)
                      .+++.|+..+.||+|+||.||+|... +++.||+|++.... .....+.+|+.+++++ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            45677888999999999999999875 57899999986543 3345788899999998 799999999988753      


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.+||+|||+
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~  157 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV  157 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence            3578999999999999988542 2345889999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG  492 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  492 (573)
                      +....... .......|+..|+|||++.     ...++.++||||||+++|||++|+.|+......    ......... 
T Consensus       158 ~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~----~~~~~~~~~-  231 (272)
T cd06637         158 SAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPM----RALFLIPRN-  231 (272)
T ss_pred             ceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHH----HHHHHHhcC-
Confidence            88654322 2233456889999999986     346788999999999999999999987532211    111111110 


Q ss_pred             ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       493 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .     ...   ......+..+.+++.+||+.+|.+|||++++++
T Consensus       232 ~-----~~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         232 P-----APR---LKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             C-----CCC---CCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            0     011   112234567899999999999999999999985

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.7e-37  Score=305.73  Aligned_cols=254  Identities=24%  Similarity=0.328  Sum_probs=202.4

Q ss_pred             cCccccccccccCceeEEEEEcCC----CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++|...++||+|+||.||+|...+    ...|+||...... .+..+.+.+|+.++++++||||+++++++.+ ...++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv   84 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV   84 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence            457788999999999999998643    2468999886654 4556789999999999999999999998875 557899


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++...  ...+++..++.++.+++.||+|||+.+   ++|+||||+||+++.++.+||+|||+++....
T Consensus        85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence            9999999999998543  235899999999999999999999987   99999999999999999999999999986644


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ..........++..|+|||.+....++.++||||||+++|||++ |..|+...... ....    ....+..        
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~-~~~~----~~~~~~~--------  226 (270)
T cd05056         160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNN-DVIG----RIENGER--------  226 (270)
T ss_pred             ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHH----HHHcCCc--------
Confidence            32222223334568999999988889999999999999999996 88776433221 1111    1111110        


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                       ...+...+..+.+++.+|+..+|++|||+.++++.|+..
T Consensus       227 -~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         227 -LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             -CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             112344567899999999999999999999999999653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=6.9e-37  Score=309.87  Aligned_cols=262  Identities=21%  Similarity=0.311  Sum_probs=201.1

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..++||+|+||.||++... ++..+|+|.+... .....+++.+|++++++++||||+++++++..+...++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            36889999999999999999875 5788999988654 333456788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++...   ..+++..+..++.|+++||.|||+..  +++|+||||+|||++.++.+||+|||++....... 
T Consensus        81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            9999999998533   45889999999999999999999742  39999999999999999999999999987553221 


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcc------------
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL------------  494 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------------  494 (573)
                        .....++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ...............            
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK-ELEAMFGRPVSEGEAKESHRPVSGHPP  231 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh-hHHHhhcCccccccccCCcccccCCCC
Confidence              22456789999999998888999999999999999999999987533211 110000000000000            


Q ss_pred             --------ccccCccc---cCCCC-CchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          495 --------HEAVDPAL---AGNFQ-EGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       495 --------~~~~d~~l---~~~~~-~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                              .+..+...   ....+ ...+..+.+++.+||+.+|++||++.+|++..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~  288 (308)
T cd06615         232 DSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHP  288 (308)
T ss_pred             CccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcCh
Confidence                    00000000   00001 12456789999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.3e-37  Score=315.33  Aligned_cols=255  Identities=20%  Similarity=0.175  Sum_probs=198.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..++||+|+||+||+++.. +++.||+|++...   .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            46889999999999999999975 5788999998642   2223456788999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++...  ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~  155 (331)
T cd05624          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD  155 (331)
T ss_pred             eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence            999999999998542  245889999999999999999999988   999999999999999999999999999866544


Q ss_pred             CcccccccccCcCcCchhhhcc-----CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .........||+.|+|||++..     +.++.++||||||+++|||++|+.|+.....    ..............    
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~----~~~~~~i~~~~~~~----  227 (331)
T cd05624         156 GTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHEERF----  227 (331)
T ss_pred             CceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCH----HHHHHHHHcCCCcc----
Confidence            3333334578999999999875     5688899999999999999999999754321    11111111111000    


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAEL--RPSMSIVVKM  538 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~  538 (573)
                       .+ .......+.++.+++.+|++..+++  |++++++++.
T Consensus       228 -~~-p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 -QF-PSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             -cC-CCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence             00 0111234567888999988865544  5688888765

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.5e-37  Score=313.11  Aligned_cols=237  Identities=24%  Similarity=0.272  Sum_probs=188.3

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHH-HHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ++||+|+||.||+++.. +|+.||+|++....   ......+..|.. +++.++||||+++++++.+....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            46999999999999975 58899999986432   222334555554 67889999999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      ++|..++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~  153 (321)
T cd05603          81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETT  153 (321)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Ccc
Confidence            999887743   345788899999999999999999987   9999999999999999999999999987532221 122


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....||+.|+|||.+.+..++.++|||||||++|||++|+.|+.....    .. .......+.          ...+..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~----~~-~~~~i~~~~----------~~~~~~  218 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDV----SQ-MYDNILHKP----------LQLPGG  218 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCH----HH-HHHHHhcCC----------CCCCCC
Confidence            345689999999999988999999999999999999999998754321    11 111111111          122344


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCHH
Q 008239          510 KPSRLLQIGLLCVQASAELRPSMS  533 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~~  533 (573)
                      ....+.+++.+||+.+|.+||+..
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         219 KTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             CCHHHHHHHHHHccCCHhhcCCCC
Confidence            567889999999999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.2e-37  Score=308.75  Aligned_cols=250  Identities=24%  Similarity=0.275  Sum_probs=200.4

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      |+..+.||+|+||+||++... +++.||||.+....   .+..+.+.+|+.++++++|+||+++++.+......++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            677889999999999999875 68899999886432   22335677899999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........
T Consensus        82 ~~g~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05630          82 MNGGDLKFHIYHMG-EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT  157 (285)
T ss_pred             cCCCcHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc
Confidence            99999998875432 235889999999999999999999987   99999999999999999999999999876543221


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                        .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+........ ..........          ....+
T Consensus       158 --~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~-~~~~~~~~~~----------~~~~~  224 (285)
T cd05630         158 --IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIK-REEVERLVKE----------VQEEY  224 (285)
T ss_pred             --ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccch-HHHHHhhhhh----------hhhhc
Confidence              1234689999999999999999999999999999999999999865332111 0111111100          01112


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPS-----MSIVVK  537 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  537 (573)
                      +...+..+.+++.+||+.+|++|||     ++|+++
T Consensus       225 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         225 SEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             CccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence            3345667889999999999999999     788886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=7.9e-37  Score=303.11  Aligned_cols=254  Identities=22%  Similarity=0.307  Sum_probs=191.1

Q ss_pred             ccccccCceeEEEEEcCCC---CEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          275 NKLGQGGSGSVYKGTLPGG---EAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      +.||+|+||+||++...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999976433   346677665433 344678999999999999999999999999999999999999999


Q ss_pred             CccccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC-Cccc
Q 008239          351 SLLDNLFVRQD-VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED-ITHI  428 (573)
Q Consensus       351 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~-~~~~  428 (573)
                      +|.+++..... ....++..+..++.||+.||+|||+.+   ++||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999864322 234677788899999999999999987   999999999999999999999999997643211 1122


Q ss_pred             ccccccCcCcCchhhhcc-------CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          429 SATLAGTLGYMAPEYVVR-------GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      .....++..|+|||++..       ..++.++||||||+++|||+++..++...........   ... .+....+.++.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~---~~~-~~~~~~~~~~~  233 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN---HVI-KDQQVKLFKPQ  233 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHH-hhcccccCCCc
Confidence            234567889999998753       2457899999999999999986554332222111111   111 22223333433


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      +.    ......+.+++..|| .+|++||++++|++.|.
T Consensus       234 ~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         234 LE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            32    234567888999999 67999999999999884

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.8e-37  Score=302.85  Aligned_cols=250  Identities=19%  Similarity=0.276  Sum_probs=203.2

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      +|+..++||+|+||.||+++.. +++.+|+|.+... .....+.+.+|+.+++.++|+||+++++.+......++||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            4778899999999999999875 5889999988543 3345677889999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++... ....+++..++.++.|++.||.|||+.+   |+|+||||+||++++++.++|+|||++........ 
T Consensus        81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-  155 (255)
T cd08219          81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-  155 (255)
T ss_pred             CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence            999998887432 2345789999999999999999999988   99999999999999999999999999886543221 


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      ......++..|+|||++.+..++.++||||||+++|+|++|+.|+.....    ....... ..+..         ...+
T Consensus       156 ~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~----~~~~~~~-~~~~~---------~~~~  221 (255)
T cd08219         156 YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSW----KNLILKV-CQGSY---------KPLP  221 (255)
T ss_pred             ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCH----HHHHHHH-hcCCC---------CCCC
Confidence            22345688899999999988999999999999999999999998754321    1111111 11111         1122


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...+..+.+++.+||+.+|++||++.+++..
T Consensus       222 ~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         222 SHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            3345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.1e-37  Score=312.89  Aligned_cols=255  Identities=19%  Similarity=0.184  Sum_probs=197.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||+||+++.. +++.||||++...   .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            46889999999999999999975 5889999998642   2233456888999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (331)
T cd05597          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD  155 (331)
T ss_pred             ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence            999999999988432  235889999999999999999999988   999999999999999999999999998765443


Q ss_pred             CcccccccccCcCcCchhhhcc-----CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .........||+.|+|||++..     +.++.++|||||||++|||++|+.|+.....    .+.............   
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~----~~~~~~i~~~~~~~~---  228 (331)
T cd05597         156 GTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL----VETYGKIMNHKEHFQ---  228 (331)
T ss_pred             CCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCH----HHHHHHHHcCCCccc---
Confidence            3323334568999999999863     4678899999999999999999998754321    111111111111101   


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCC--CCCCCCCHHHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQA--SAELRPSMSIVVKM  538 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~--~p~~RPt~~evl~~  538 (573)
                        +. ......+..+.+++.+|+..  ++..||+++++++.
T Consensus       229 --~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         229 --FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             --CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence              00 11123456777888886654  44448899999876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=5.9e-37  Score=308.72  Aligned_cols=250  Identities=26%  Similarity=0.373  Sum_probs=204.4

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..+|+..++||+|+||.||++.. .+++.||+|.+........+.+.+|+.+++.++|+||+++++++..+...++||||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   97 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   97 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence            36788899999999999999996 46899999999766555567788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~  170 (297)
T cd06656          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (297)
T ss_pred             cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence            999999998732    34788999999999999999999987   99999999999999999999999999876543322


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                       ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+..........    .....+      .+.  ...
T Consensus       171 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~----~~~~~~------~~~--~~~  237 (297)
T cd06656         171 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIATNG------TPE--LQN  237 (297)
T ss_pred             -CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee----eeccCC------CCC--CCC
Confidence             1223467889999999999899999999999999999999999875433211100    000000      000  011


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +...+..+.+++.+||+.+|++||+++++++
T Consensus       238 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         238 PERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            2334567889999999999999999999997

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=7.9e-37  Score=305.92  Aligned_cols=251  Identities=23%  Similarity=0.251  Sum_probs=199.8

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      |+..++||+|+||+||++... +++.||+|.+....   ......+.+|++++++++|+||+++++.+..++..++||||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            667789999999999999875 68899999986432   22334577899999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++........
T Consensus        82 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~  157 (285)
T cd05632          82 MNGGDLKFHIYNMG-NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES  157 (285)
T ss_pred             ccCccHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCc
Confidence            99999988875432 345899999999999999999999987   99999999999999999999999999876543221


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                        .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+........ ............          ..+
T Consensus       158 --~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~~~~~~~----------~~~  224 (285)
T cd05632         158 --IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDRRVLETE----------EVY  224 (285)
T ss_pred             --ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhhhccc----------ccc
Confidence              2244689999999999989999999999999999999999998764322111 111111111110          112


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPS-----MSIVVKM  538 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~~  538 (573)
                      ....+..+.+|+..|++.+|++||+     ++++++.
T Consensus       225 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         225 SAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             CccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence            3345667889999999999999999     6666653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.3e-37  Score=338.49  Aligned_cols=258  Identities=21%  Similarity=0.290  Sum_probs=201.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..++||+|+||.||+|... +|+.||||++...   .....+++.+|++++++++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            47889999999999999999975 5899999998653   2334567899999999999999999999999999999999


Q ss_pred             EeccCCCccccccccC--------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          345 EFVPNQSLLDNLFVRQ--------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                      ||+++++|.+++....        ....+++..+++++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence            9999999999885321        1234567788999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCc-----------------ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc
Q 008239          417 LVRLFPEDIT-----------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC  479 (573)
Q Consensus       417 la~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~  479 (573)
                      +++.......                 .......||+.|+|||.+.+..++.++|||||||++|||++|+.|+...... 
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~-  237 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGR-  237 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchh-
Confidence            9986521110                 0112346899999999999999999999999999999999999987542211 


Q ss_pred             chHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCC-CHHHHHHHhcc
Q 008239          480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRP-SMSIVVKMLTG  541 (573)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~  541 (573)
                      ...   .    ...   ..++.-. ......+..+.+++.+|++.+|++|| +++++++.|+.
T Consensus       238 ki~---~----~~~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        238 KIS---Y----RDV---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             hhh---h----hhh---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            100   0    000   0111000 00124566788999999999999995 56667666643

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7e-37  Score=303.46  Aligned_cols=253  Identities=24%  Similarity=0.376  Sum_probs=201.1

Q ss_pred             CccccccccccCceeEEEEEcCC--CCEEEEEEeccc----------ChhhHHHHHHHHHHHcC-CCCCCeeeeeeeeec
Q 008239          270 YFHESNKLGQGGSGSVYKGTLPG--GEAVAVKRLFYN----------TTQWVDHFFNEVNLISG-INHKNLVKLLGCSIT  336 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~  336 (573)
                      +|+..+.||+|+||.||++.+..  ++.+|+|.+...          .......+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47788999999999999999865  688999987532          22234567788888865 799999999999999


Q ss_pred             CCceeEEEEeccCCCccccccc-cCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCeeeCCCCcEEEee
Q 008239          337 GPESLLVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIAD  414 (573)
Q Consensus       337 ~~~~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~kl~D  414 (573)
                      +...+++|||+++++|.+++.. ......+++..+++++.|++.||.|||+ .+   ++|+||+|+||+++.++.+||+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999888743 2234568999999999999999999996 44   99999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcc
Q 008239          415 FGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL  494 (573)
Q Consensus       415 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  494 (573)
                      ||++.......  ......++..|++||.+.+..++.++||||||+++|||++|+.|+.....    .... .....+..
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~----~~~~-~~~~~~~~  230 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNM----LSLA-TKIVEAVY  230 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCH----HHHH-HHHhhccC
Confidence            99998654432  22345678899999999988899999999999999999999988643221    1111 11111111


Q ss_pred             ccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       495 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      .    +    ......+..+.+++.+||+.+|++||++.|+.++|+
T Consensus       231 ~----~----~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         231 E----P----LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             C----c----CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            1    0    011234567899999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-37  Score=323.78  Aligned_cols=259  Identities=20%  Similarity=0.282  Sum_probs=197.6

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ...|.+.++||+|+||.||++.+. .++.||||...      ...+.+|+++|++++|+|||++++++......++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            457889999999999999999986 47889999642      23456899999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +. ++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.......
T Consensus       242 ~~-~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        242 YR-SDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWS  315 (461)
T ss_pred             cC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccccc
Confidence            94 6888877432  236899999999999999999999988   99999999999999999999999999986543222


Q ss_pred             -ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCC---cchHHHHHHHhhcCccc-----cc
Q 008239          427 -HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS---CSILQTVWDLYVKGRLH-----EA  497 (573)
Q Consensus       427 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~-----~~  497 (573)
                       .......||..|+|||++.+..++.++|||||||+||||++|..++......   ......+..........     ..
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~  395 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH  395 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence             1223457999999999999999999999999999999999988765443211   11111222222111110     00


Q ss_pred             cCc------------cccCCCC-------CchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          498 VDP------------ALAGNFQ-------EGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       498 ~d~------------~l~~~~~-------~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...            .......       ......+.+|+.+||+.||++|||+.|+++.
T Consensus       396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            000            0000000       0123467899999999999999999999974

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.6e-37  Score=303.49  Aligned_cols=250  Identities=26%  Similarity=0.397  Sum_probs=201.5

Q ss_pred             CccccccccccCceeEEEEEcCCCCEEEEEEecccC------hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      +|+..+.||+|+||+||+|...+|+.+|||.+....      .+..+.+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            467889999999999999998889999999886432      22345688999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      +||+++++|.+++...   ..+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  154 (265)
T cd06631          81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW  154 (265)
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence            9999999999988432   45789999999999999999999987   99999999999999999999999999875432


Q ss_pred             C-----CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          424 D-----ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       424 ~-----~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      .     .........++..|+|||.+.+..++.++||||||++++||++|+.|+.........    .. .....     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~----~~-~~~~~-----  224 (265)
T cd06631         155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM----FY-IGAHR-----  224 (265)
T ss_pred             ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH----HH-hhhcc-----
Confidence            1     111122346788999999999888999999999999999999999987543211110    00 00000     


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ......+...+..+.+++.+||+.+|++||++.++++
T Consensus       225 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         225 --GLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             --CCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence              0011223445678899999999999999999999985

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.7e-37  Score=313.51  Aligned_cols=242  Identities=22%  Similarity=0.232  Sum_probs=189.9

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHH-HHHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEV-NLISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      +.||+|+||+||+++.. +++.||+|++....   ......+..|. .+++.++||||+++++++......++||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999976 57889999986432   12223444444 457889999999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      ++|.+++..   ...+.+..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...... ...
T Consensus        81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~  153 (325)
T cd05602          81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTT  153 (325)
T ss_pred             CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCc
Confidence            999988843   235778888999999999999999988   9999999999999999999999999987542221 123


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....||+.|+|||++.+..++.++|||||||++|||++|+.|+......    . .+........          .....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----~-~~~~i~~~~~----------~~~~~  218 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA----E-MYDNILNKPL----------QLKPN  218 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH----H-HHHHHHhCCc----------CCCCC
Confidence            3457899999999999999999999999999999999999987643211    1 1111111110          12234


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          510 KPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+..+.+++.+|++.+|.+||++.+.+..
T Consensus       219 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~  247 (325)
T cd05602         219 ITNSARHLLEGLLQKDRTKRLGAKDDFME  247 (325)
T ss_pred             CCHHHHHHHHHHcccCHHHCCCCCCCHHH
Confidence            56778899999999999999998754433

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4.3e-37  Score=310.68  Aligned_cols=254  Identities=26%  Similarity=0.387  Sum_probs=199.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCC----EEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ++|+..+.||+|+||.||+|.+. +|+    .||+|.+..... ....++.+|+.+++.++||||+++++++... ...+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~   85 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL   85 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence            56778899999999999999864 344    578898865432 3344788999999999999999999988754 5679


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ++||+++|+|.+++...  ...+++..++.++.|++.||.|||+++   |+|+||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence            99999999999988543  235889999999999999999999987   9999999999999999999999999998664


Q ss_pred             CCCccc-ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          423 EDITHI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       423 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ...... .....++..|+|||.+.+..++.++||||||+++|||++ |+.|+....     ..........+..      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~-----~~~~~~~~~~~~~------  229 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP-----TREIPDLLEKGER------  229 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC-----HHHHHHHHHCCCC------
Confidence            332221 122345678999999998999999999999999999997 777764321     1112222222111      


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                         ...+...+..+.+++..||..+|++||++++++++|...
T Consensus       230 ---~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         230 ---LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               011233456788999999999999999999999999653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-37  Score=304.96  Aligned_cols=248  Identities=29%  Similarity=0.388  Sum_probs=202.9

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..+.||.|++|.||+|+.. +++.||+|.+.... ......+.+|+.+++.++|+||+++++++.++...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            35788899999999999999975 58899999986543 34456788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++...    .+++..++.++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||+++.......
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  153 (274)
T cd06609          81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS  153 (274)
T ss_pred             eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence            9999999988432    6899999999999999999999987   99999999999999999999999999987654321


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......    ... .......     .+.+    
T Consensus       154 -~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~----~~~-~~~~~~~-----~~~~----  218 (274)
T cd06609         154 -KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPM----RVL-FLIPKNN-----PPSL----  218 (274)
T ss_pred             -ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchH----HHH-HHhhhcC-----CCCC----
Confidence             223446788999999999888999999999999999999999987543211    111 1111111     1111    


Q ss_pred             CCc-hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          507 QEG-KPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       507 ~~~-~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ... .+..+.+++.+||+.+|++|||++++++.
T Consensus       219 ~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             cccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            111 45678899999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-37  Score=302.47  Aligned_cols=254  Identities=27%  Similarity=0.363  Sum_probs=205.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|+..+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++++......+++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            367889999999999999999875 5788999999776666677899999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++...  ...+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        82 ~~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  156 (262)
T cd06613          82 CGGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA  156 (262)
T ss_pred             CCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh
Confidence            9999999887432  245889999999999999999999987   99999999999999999999999999886543221


Q ss_pred             ccccccccCcCcCchhhhccC---CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          427 HISATLAGTLGYMAPEYVVRG---KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                       ......++..|+|||.+...   .++.++||||||+++|||++|+.|+.........    .. ......   ..+.+ 
T Consensus       157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~----~~-~~~~~~---~~~~~-  226 (262)
T cd06613         157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL----FL-ISKSNF---PPPKL-  226 (262)
T ss_pred             -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH----HH-HHhccC---CCccc-
Confidence             12234678899999998776   8899999999999999999999887543321111    11 111100   00111 


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       ......+..+.+++.+||+.+|.+|||+++|+.
T Consensus       227 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         227 -KDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             -cchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence             112234667899999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=8.4e-37  Score=300.88  Aligned_cols=239  Identities=26%  Similarity=0.361  Sum_probs=188.2

Q ss_pred             ccccccCceeEEEEEcCCCC-----------EEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          275 NKLGQGGSGSVYKGTLPGGE-----------AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~g~-----------~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      +.||+|+||.||+|.+.+..           .+++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            47999999999999986432           5788877554433 6788899999999999999999999988 778999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-------cEEEeecc
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-------TAKIADFG  416 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-------~~kl~Dfg  416 (573)
                      |||+++|+|.+++....  ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++       .+||+|||
T Consensus        79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg  153 (259)
T cd05037          79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG  153 (259)
T ss_pred             EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence            99999999999885432  26889999999999999999999987   99999999999999887       79999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccC--CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL  494 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  494 (573)
                      ++.....     .....++..|+|||++...  .++.++||||||+++|||++|..++..........    ..+.... 
T Consensus       154 ~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~----~~~~~~~-  223 (259)
T cd05037         154 IPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE----RFYQDQH-  223 (259)
T ss_pred             ccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH----HHHhcCC-
Confidence            9886533     1223456789999999876  78999999999999999999644332222111111    1111100 


Q ss_pred             ccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       495 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                                ..+......+.+++.+||+.+|++||++.+|++.|+
T Consensus       224 ----------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         224 ----------RLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ----------CCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                      011112268889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=8.9e-37  Score=300.34  Aligned_cols=251  Identities=23%  Similarity=0.329  Sum_probs=205.4

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..+.||+|+||.||.++.. +++.+++|.+...  .....+.+.+|+.++++++|+||+++++++.+....+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            4788999999999999999864 5889999987543  344456788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999885432 346899999999999999999999987   99999999999999999999999999986644332


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                       ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+.....    .+.... ...+..         ...
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~~~~~~-~~~~~~---------~~~  221 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP----LNLVVK-IVQGNY---------TPV  221 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH----HHHHHH-HHcCCC---------CCC
Confidence             22345688999999999888899999999999999999999988754321    111111 111211         111


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      +...+..+.+++.+||+.+|.+||+++++++.+
T Consensus       222 ~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         222 VSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             ccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence            234567789999999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.5e-37  Score=321.47  Aligned_cols=259  Identities=23%  Similarity=0.271  Sum_probs=198.8

Q ss_pred             hcCccccccccccCceeEEEEEcC---CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ..+|+..++||+|+||.||++...   .+..||||.+...     ....+|+++|++++||||+++++++......++||
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~  165 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM  165 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence            357999999999999999999753   3578999988543     23467999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      |++. ++|.+++.   ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus       166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            9985 68888772   3356899999999999999999999988   999999999999999999999999999865433


Q ss_pred             Cc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--chHHHHHHHhhcCccc--c---
Q 008239          425 IT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--SILQTVWDLYVKGRLH--E---  496 (573)
Q Consensus       425 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~--~---  496 (573)
                      .. .......||+.|+|||++....++.++|||||||++|||++|+.|+.......  ..+..+..........  .   
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            22 22234678999999999999999999999999999999999999986544322  1111111111100000  0   


Q ss_pred             --------ccCccccCCC-------CCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          497 --------AVDPALAGNF-------QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       497 --------~~d~~l~~~~-------~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                              .........+       ....+.++.+++.+||+.+|++||++.|++.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                    0000000000       11234577899999999999999999999974

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=9e-37  Score=312.31  Aligned_cols=255  Identities=19%  Similarity=0.185  Sum_probs=197.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..++||+|+||+||+++.+ +++.+|+|++...   .....+.+.+|+.++..++|+||+++++++.+....++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            46888999999999999999976 4778999998542   2223445788999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~  155 (332)
T cd05623          81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  155 (332)
T ss_pred             eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence            999999999998542  235889999999999999999999988   999999999999999999999999998765433


Q ss_pred             CcccccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .........||+.|+|||++.     .+.++.++|||||||++|||++|+.|+....    ................   
T Consensus       156 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~----~~~~~~~i~~~~~~~~---  228 (332)
T cd05623         156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES----LVETYGKIMNHKERFQ---  228 (332)
T ss_pred             CcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC----HHHHHHHHhCCCcccc---
Confidence            332333457899999999986     3468899999999999999999999975432    1122211111110000   


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCC--CCCCCHHHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASA--ELRPSMSIVVKM  538 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p--~~RPt~~evl~~  538 (573)
                        + .......+..+.+++.+|+..++  ..||+++|+++.
T Consensus       229 --~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 --F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              0 01112345678888888775544  447899999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.2e-37  Score=307.05  Aligned_cols=254  Identities=28%  Similarity=0.381  Sum_probs=203.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..++||+|+||+||++... +|+.||+|++.... ....+.+.+|+++++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF   84 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence            56788899999999999999875 58899999886543 34467889999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++..   .+.+++..+..++.+++.+|.|||+..  +++||||+|+||++++++.++|+|||++....... 
T Consensus        85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~-  158 (284)
T cd06620          85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI-  158 (284)
T ss_pred             CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence            999999888743   346899999999999999999999742  39999999999999999999999999987543221 


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc-------chHHHHHHHhhcCccccccC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC-------SILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~d  499 (573)
                        .....++..|+|||++.++.++.++||||||+++|||++|+.|+.......       .+......... +.     .
T Consensus       159 --~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----~  230 (284)
T cd06620         159 --ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQ-EP-----P  230 (284)
T ss_pred             --cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhh-cc-----C
Confidence              124568999999999988899999999999999999999999986543321       11111111110 00     0


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      +.+.   ....+..+.+++.+|++.+|++||+++|++++.
T Consensus       231 ~~~~---~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~  267 (284)
T cd06620         231 PRLP---SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMP  267 (284)
T ss_pred             CCCC---chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCc
Confidence            1110   112556789999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=5.4e-37  Score=308.82  Aligned_cols=249  Identities=26%  Similarity=0.402  Sum_probs=204.7

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .+|+..+.||.|+||.||+|.. .+|+.|++|.+........+.+.+|+.+++.++||||+++++++......++|+||+
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   98 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL   98 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence            4688899999999999999986 468999999987665555678889999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++..    ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++.........
T Consensus        99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  171 (296)
T cd06655          99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK  171 (296)
T ss_pred             CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence            99999988732    34899999999999999999999988   999999999999999999999999998865433221


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                       .....++..|+|||.+.+..++.++||||||+++|||++|+.|+........    .......+ .     +.+  ..+
T Consensus       172 -~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~----~~~~~~~~-~-----~~~--~~~  238 (296)
T cd06655         172 -RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA----LYLIATNG-T-----PEL--QNP  238 (296)
T ss_pred             -CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHhcC-C-----ccc--CCc
Confidence             2234678899999999988899999999999999999999998755432111    11111111 0     001  112


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ...+..+.+++.+||+.+|++||++.++++
T Consensus       239 ~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         239 EKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             ccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence            345567889999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-37  Score=311.78  Aligned_cols=252  Identities=22%  Similarity=0.278  Sum_probs=214.1

Q ss_pred             HhcCccccccccccCceeEEEEEcCC-CCEEEEEEecccCh---hhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCcee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTT---QWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESL  341 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  341 (573)
                      ....|+..+.||+|.||.||+++.+. |+.+|+|.+.+...   ...+.+.+|+.+|++++ |||||++.+.+++....+
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            44678888999999999999999875 99999999966533   23468899999999998 999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC----CCcEEEeeccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE----EFTAKIADFGL  417 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~----~~~~kl~Dfgl  417 (573)
                      +|||++.+|.|.+.+...    .+++..+..++.||+.++.|||+.+   |+||||||+|+|+..    ++.+|++|||+
T Consensus       113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            999999999999998655    3999999999999999999999988   999999999999963    35899999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      +.....  .......+||+.|+|||++....|+..+||||+|+++|.|++|..||..........     ....+++   
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-----~i~~~~~---  255 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-----AILRGDF---  255 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-----HHHcCCC---
Confidence            998765  445567899999999999999999999999999999999999999988766433222     1222222   


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                         .+..+.-........+++..++..||..|+|+.++++.
T Consensus       256 ---~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  256 ---DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ---CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence               22233344567788899999999999999999999984

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.3e-38  Score=288.46  Aligned_cols=254  Identities=22%  Similarity=0.323  Sum_probs=205.2

Q ss_pred             HHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-----C---hhhHHHHHHHHHHHcCC-CCCCeeeeeeee
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-----T---TQWVDHFFNEVNLISGI-NHKNLVKLLGCS  334 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  334 (573)
                      ....+.|...+.||+|..++|-+..++ +|++.|+|++-..     .   .+..+.-.+|+.+|+++ .||||+++.+++
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            344567888999999999999998765 6888999988321     1   12234556799999998 699999999999


Q ss_pred             ecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEee
Q 008239          335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD  414 (573)
Q Consensus       335 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  414 (573)
                      +.+...++|+|.|+.|.|.++|.   ..-.+++....+|+.|+.+|+.|||..+   ||||||||+|||+|++.++||+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence            99999999999999999999994   3456899999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCcCcCchhhhccC------CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH
Q 008239          415 FGLVRLFPEDITHISATLAGTLGYMAPEYVVRG------KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       415 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  488 (573)
                      ||.++.++..  ......+||++|+|||.+...      .|+..+|+|+.|||+|-|+.|.+||+....-     -+..+
T Consensus       167 FGFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQm-----lMLR~  239 (411)
T KOG0599|consen  167 FGFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQM-----LMLRM  239 (411)
T ss_pred             cceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHH-----HHHHH
Confidence            9999987653  345678999999999988543      4788999999999999999999997643210     11122


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +..|+..      +..+.-.+.+....+|+.+||+.||++|.|.+|.++
T Consensus       240 ImeGkyq------F~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  240 IMEGKYQ------FRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHhcccc------cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            2233321      111222345667889999999999999999999875

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.3e-36  Score=303.00  Aligned_cols=248  Identities=25%  Similarity=0.384  Sum_probs=203.3

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..|+..++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.+++++.||||+++++++.++...++||||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEY   83 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEec
Confidence            35677889999999999999975 58899999886543 44567888999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++..    ..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06640          84 LGGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI  156 (277)
T ss_pred             CCCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc
Confidence            999999998742    35888999999999999999999987   99999999999999999999999999976543322


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                       ......++..|+|||.+.+..++.++||||||+++|||++|+.|+....... .   . ..         +........
T Consensus       157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~-~---~-~~---------~~~~~~~~~  221 (277)
T cd06640         157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMR-V---L-FL---------IPKNNPPTL  221 (277)
T ss_pred             -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHh-H---h-hh---------hhcCCCCCC
Confidence             1223457889999999998899999999999999999999998865432110 0   0 00         011111223


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ....+..+.+++.+||+.+|++||+++++++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            34567789999999999999999999999865

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=5.5e-37  Score=304.13  Aligned_cols=249  Identities=31%  Similarity=0.431  Sum_probs=197.0

Q ss_pred             ccccccCceeEEEEEcCC-------CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          275 NKLGQGGSGSVYKGTLPG-------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +.||+|+||.||+|+..+       ++.+|||.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            469999999999998643       2579999876543 23456788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-----cEEEeeccc
Q 008239          347 VPNQSLLDNLFVRQ----DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-----TAKIADFGL  417 (573)
Q Consensus       347 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-----~~kl~Dfgl  417 (573)
                      +++++|.+++....    ....+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.+.     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence            99999999986432    2234789999999999999999999987   99999999999999877     899999999


Q ss_pred             ccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccc
Q 008239          418 VRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLH  495 (573)
Q Consensus       418 a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  495 (573)
                      +........ .......++..|+|||.+.++.++.++||||||+++|||++ |+.|+..... .....    ....+.  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~-~~~~~----~~~~~~--  230 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNN-QEVLQ----HVTAGG--  230 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCH-HHHHH----HHhcCC--
Confidence            875532211 11223345678999999999999999999999999999998 7777643221 11111    111111  


Q ss_pred             cccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       496 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                             ....+...+..+.+++.+||+.+|++||++++|+++|.
T Consensus       231 -------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 -------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                   11223445678899999999999999999999999985

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.2e-37  Score=313.47  Aligned_cols=241  Identities=23%  Similarity=0.269  Sum_probs=193.6

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  344 (573)
                      +|+..+.||+|+||+||+++.. +|+.||||++....   ....+.+..|..++..+. |++|+++++++...+..++||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4677899999999999999875 68899999986532   233456778899988885 577888999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~  154 (323)
T cd05615          81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD  154 (323)
T ss_pred             cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence            99999999988843   345899999999999999999999988   999999999999999999999999998754322


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      . .......||+.|+|||++.+..++.++||||||+++|||++|+.|+..... ......    .....          .
T Consensus       155 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~-~~~~~~----i~~~~----------~  218 (323)
T cd05615         155 G-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQS----IMEHN----------V  218 (323)
T ss_pred             C-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH-HHHHHH----HHhCC----------C
Confidence            1 122345689999999999999999999999999999999999998754321 111111    11111          1


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSM  532 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~  532 (573)
                      .++...+..+.+++.+||+.+|.+|++.
T Consensus       219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         219 SYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             CCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence            2233456678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1e-36  Score=309.98  Aligned_cols=258  Identities=21%  Similarity=0.330  Sum_probs=187.5

Q ss_pred             cccccccCceeEEEEEcC---CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec--CCceeEEEEecc
Q 008239          274 SNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLVYEFVP  348 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  348 (573)
                      .++||+|+||+||+|+..   +++.||+|.+....  ....+.+|+.++++++||||+++++++..  ....++|+||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            578999999999999864   46789999986442  23457789999999999999999998864  345789999986


Q ss_pred             CCCcccccccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee----CCCCcEEEeecccc
Q 008239          349 NQSLLDNLFVR------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLV  418 (573)
Q Consensus       349 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll----~~~~~~kl~Dfgla  418 (573)
                       ++|.+++...      .....+++..+..++.||+.||.|||+++   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             4777665321      12235889999999999999999999988   9999999999999    45678999999999


Q ss_pred             cccCCCCcc--cccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--------chHHHH--
Q 008239          419 RLFPEDITH--ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--------SILQTV--  485 (573)
Q Consensus       419 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--------~~~~~~--  485 (573)
                      +.+......  ......+|+.|+|||++.+ ..++.++|||||||++|||++|+.|+.......        .....+  
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            876543222  2234578999999999876 468999999999999999999999886443211        001111  


Q ss_pred             ---------HHHhhc-CccccccCc---------ccc---CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          486 ---------WDLYVK-GRLHEAVDP---------ALA---GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       486 ---------~~~~~~-~~~~~~~d~---------~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                               |..... .........         .+.   ..........+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~  313 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQ  313 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhc
Confidence                     111000 000000000         000   0000112345789999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=317.47  Aligned_cols=244  Identities=29%  Similarity=0.392  Sum_probs=204.0

Q ss_pred             cccccCceeEEEEEcCC-CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCccc
Q 008239          276 KLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD  354 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  354 (573)
                      +||+|.||+||.|++.+ ...+|||-+.....+..+-+..|+.+-++|+|.|||+++|.+.+++..-+.||-+|+|+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            69999999999999865 55789999987777778889999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCC--CHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC-CCCcEEEeecccccccCCCCcccccc
Q 008239          355 NLFVRQDVEPL--SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISAT  431 (573)
Q Consensus       355 ~l~~~~~~~~l--~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~  431 (573)
                      +|.  .+-+++  ++...-.+..||++||.|||++.   |||||||-.||||+ -.|.+||+|||-++.+.. ......+
T Consensus       662 LLr--skWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TET  735 (1226)
T KOG4279|consen  662 LLR--SKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTET  735 (1226)
T ss_pred             HHH--hccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc-CCccccc
Confidence            984  344556  77888889999999999999988   99999999999997 578999999999886533 2334456


Q ss_pred             cccCcCcCchhhhccC--CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          432 LAGTLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       432 ~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ..||..|||||++..+  .|+..+|||||||.+.||.||++||........      .+++.|-.      ....+++.+
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA------AMFkVGmy------KvHP~iPee  803 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA------AMFKVGMY------KVHPPIPEE  803 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH------hhhhhcce------ecCCCCcHH
Confidence            7899999999999876  488899999999999999999999865443211      11111110      112355677


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          510 KPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ...+...++++|+.++|.+||++.++++
T Consensus       804 lsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  804 LSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence            8888999999999999999999999985

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-36  Score=306.06  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=201.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      +.|++.++||+|+||.||+|+.. +++.|++|.+........+.+.+|+.+++.++||||+++++.+..+...++||||+
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   91 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC   91 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence            56888999999999999999975 48899999998776666788899999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|..++...  ...+++..++.++.|++.+|+|||+.+   ++||||||+||+++.++.+||+|||++....... .
T Consensus        92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~  165 (292)
T cd06644          92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q  165 (292)
T ss_pred             CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence            999998876432  235899999999999999999999987   9999999999999999999999999987543221 1


Q ss_pred             cccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          428 ISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ......++..|+|||++.     ...++.++||||||+++|||++|+.|+......    ...... ....     .+.+
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~-~~~~-----~~~~  235 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM----RVLLKI-AKSE-----PPTL  235 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH----HHHHHH-hcCC-----CccC
Confidence            122345788999999884     345788999999999999999999886543211    111111 1111     1111


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ..+...+..+.+++.+||+.+|++||+++++++
T Consensus       236 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         236 --SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             --CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence              112344567889999999999999999999986

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.5e-36  Score=300.75  Aligned_cols=248  Identities=28%  Similarity=0.422  Sum_probs=200.3

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccCh---------hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPE  339 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  339 (573)
                      +|.....||+|+||.||+|... +++.+|+|.+.....         +..+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            3667889999999999999874 578999998864322         223567889999999999999999999999999


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++|+||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.+||+|||+++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~  154 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK  154 (267)
T ss_pred             cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence            9999999999999998843   345889999999999999999999987   9999999999999999999999999988


Q ss_pred             ccCCCCcc-----cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcc
Q 008239          420 LFPEDITH-----ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL  494 (573)
Q Consensus       420 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  494 (573)
                      ........     ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......    ..+....     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~~-----  225 (267)
T cd06628         155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL----QAIFKIG-----  225 (267)
T ss_pred             ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH----HHHHHHh-----
Confidence            66432111     112345788999999999888999999999999999999999987543211    1111110     


Q ss_pred             ccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       495 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       .    ......+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       226 -~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         226 -E----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             -c----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence             0    1111233445678899999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-36  Score=303.92  Aligned_cols=254  Identities=23%  Similarity=0.357  Sum_probs=201.9

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..+.||+|+||.||++... +|+.||+|.+... .....+.+.+|+.++++++|+||+++++.+......++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            35788999999999999999986 6899999988654 333456788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|..++........+++..+..++.+++.||.|||+..  +|+|+||||+||+++.++.+||+|||++..+.... 
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            999999888754333457899999999999999999999741  39999999999999999999999999987653322 


Q ss_pred             ccccccccCcCcCchhhhccC------CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          427 HISATLAGTLGYMAPEYVVRG------KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                        .....++..|+|||.+.+.      .++.++||||||+++|||++|+.|+...... ........ ...+.       
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~-~~~~~-------  226 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA-NIFAQLSA-IVDGD-------  226 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh-hHHHHHHH-HhhcC-------
Confidence              2234578899999998554      3588999999999999999999987543221 11111111 11111       


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                        ....+...+..+.+++.+||+.+|++||+++++++.
T Consensus       227 --~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         227 --PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             --CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence              112234466788999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-36  Score=297.75  Aligned_cols=251  Identities=33%  Similarity=0.485  Sum_probs=200.6

Q ss_pred             ccccccccccCceeEEEEEcCC-----CCEEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          271 FHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      |++.+.||+|+||.||+++..+     +..||+|++...... ..+.+.+|+.++..++|+||+++++++.+....+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            3567899999999999999764     478999999665433 5678899999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++..... ..+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++......
T Consensus        81 e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~  156 (258)
T smart00219       81 EYMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD  156 (258)
T ss_pred             eccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence            99999999998854322 12899999999999999999999987   999999999999999999999999999866544


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .........++..|+|||.+....++.++||||||++++||++ |..|+.. .....+..    ....+..         
T Consensus       157 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~-~~~~~~~~----~~~~~~~---------  222 (258)
T smart00219      157 DYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG-MSNEEVLE----YLKKGYR---------  222 (258)
T ss_pred             cccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC-CCHHHHHH----HHhcCCC---------
Confidence            2222212336789999999988889999999999999999999 4444432 22111111    1111111         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ...+...+.++.+++.+|++.+|++|||+.|++++|
T Consensus       223 ~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            112233567899999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.1e-36  Score=299.71  Aligned_cols=250  Identities=23%  Similarity=0.315  Sum_probs=201.5

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeec-CCceeEEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPESLLVYE  345 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv~e  345 (573)
                      .|+..+.||+|++|.||+++.. +++.||+|++....  ....+.+.+|++++++++|+|++++++.+.. ....+++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4788999999999999999875 57899999986532  3445678899999999999999999998764 445789999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++... ....+++.+++.++.+++.|++|||+.+   ++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            99999999888543 2345899999999999999999999988   9999999999999999999999999998664332


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      . ......+++.|+|||.+.+..++.++||||||++++||++|+.|+.....    ...... ...+..         ..
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~----~~~~~~-~~~~~~---------~~  221 (257)
T cd08223         157 D-MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDM----NSLVYR-IIEGKL---------PP  221 (257)
T ss_pred             C-ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH----HHHHHH-HHhcCC---------CC
Confidence            2 22345678999999999999999999999999999999999988653221    111111 111111         12


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+...+..+.+++.+|++.+|++||++.++++.
T Consensus       222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            234456789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.3e-37  Score=304.86  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=204.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|++.++||+|+||.||++... +++.+|+|.+........+.+.+|++++++++||||+++++.+..+...++||||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   83 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF   83 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence            467889999999999999999975 5889999999777666677899999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++...  ...+++..+..++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++........
T Consensus        84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  158 (280)
T cd06611          84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ  158 (280)
T ss_pred             cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence            9999999987532  235899999999999999999999988   99999999999999999999999999875533221


Q ss_pred             ccccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          427 HISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                       ......++..|+|||.+.     ...++.++||||||+++|||++|+.|+......    ... .....+..     +.
T Consensus       159 -~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~----~~~-~~~~~~~~-----~~  227 (280)
T cd06611         159 -KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPM----RVL-LKILKSEP-----PT  227 (280)
T ss_pred             -ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHH----HHH-HHHhcCCC-----CC
Confidence             222446789999999985     345778999999999999999999887543211    111 11111111     11


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +  ..+...+..+.+++..||+.+|.+||++.++++.
T Consensus       228 ~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 L--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             c--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence            1  1123345678899999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.8e-37  Score=303.38  Aligned_cols=252  Identities=31%  Similarity=0.422  Sum_probs=199.9

Q ss_pred             ccccccccccCceeEEEEEcCC-CCEEEEEEecccChhhHH--HHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD--HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      |+..+.||+|+||+||+++... ++.+|+|++.........  ...+|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            5678999999999999999864 668999999776543322  3456999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++.   ....+++..++.++.|+++||.+||+.+   |+|+||||+||+++.++.++|+|||.+..... ...
T Consensus        81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~  153 (260)
T PF00069_consen   81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNE  153 (260)
T ss_dssp             TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTS
T ss_pred             cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc-ccc
Confidence            9999999885   3345899999999999999999999988   99999999999999999999999999876422 222


Q ss_pred             cccccccCcCcCchhhhc-cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~-~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......++..|+|||.+. ...++.++||||+|+++|+|++|..|+...... ........... ...    ...  ...
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~-~~~~~~~~~~~-~~~----~~~--~~~  225 (260)
T PF00069_consen  154 NFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSD-DQLEIIEKILK-RPL----PSS--SQQ  225 (260)
T ss_dssp             EBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHH-HHHHHHHHHHH-THH----HHH--TTS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccch-hhhhhhhhccc-ccc----ccc--ccc
Confidence            334566899999999998 788999999999999999999999887654111 11111111100 000    000  001


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .......+.+++.+||+.+|++||++.++++
T Consensus       226 ~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  226 SREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             cchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            1122478999999999999999999999986

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.9e-36  Score=296.76  Aligned_cols=247  Identities=28%  Similarity=0.394  Sum_probs=201.8

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC-----hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      +|+..+.||+|+||.||+|... +++.|++|.+....     .+..+.+.+|+.+++.++|+||+++++++......+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            3677889999999999999986 78999999886533     33556789999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      +||+++++|.+++..   ...+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~  154 (258)
T cd06632          81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE  154 (258)
T ss_pred             EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence            999999999998843   245889999999999999999999987   99999999999999999999999999886543


Q ss_pred             CCcccccccccCcCcCchhhhccCC-CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ..  ......++..|++||.+.... ++.++|+||||+++|||++|+.|+.....    ....+........        
T Consensus       155 ~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~----~~~~~~~~~~~~~--------  220 (258)
T cd06632         155 FS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG----VAAVFKIGRSKEL--------  220 (258)
T ss_pred             cc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcH----HHHHHHHHhcccC--------
Confidence            32  223456788999999987766 89999999999999999999998754331    1111111110111        


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       ...+......+.+++.+||+.+|.+||+++++++
T Consensus       221 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         221 -PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             -CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence             1223345677889999999999999999999985

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.1e-36  Score=305.17  Aligned_cols=260  Identities=26%  Similarity=0.343  Sum_probs=193.2

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCC---CCCCeeeeeeeeecC-----C
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSITG-----P  338 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~-----~  338 (573)
                      +|+..+.||+|+||+||++... +|+.||+|.+....  ......+.+|+.+++.+   +||||+++++++...     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4778899999999999999875 58899999886532  22233456677776655   799999999987642     3


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++||||+++ +|.+++.... ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            57899999974 8888774332 245899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC---ccc
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG---RLH  495 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~  495 (573)
                      +......  ......+|..|+|||++.+..++.++|||||||++|||++|+.|+...... .............   .+.
T Consensus       156 ~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~  232 (288)
T cd07863         156 RIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLPPEDDWP  232 (288)
T ss_pred             ccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHH-HHHHHHHHHhCCCChhhCc
Confidence            8664322  122456789999999999999999999999999999999998877543322 1122221111100   000


Q ss_pred             c-------ccCccc---cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          496 E-------AVDPAL---AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       496 ~-------~~d~~l---~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .       ...+..   ........+..+.+++.+|++.||++|||+.|++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            0       000000   00112234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-36  Score=302.55  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=202.0

Q ss_pred             cCccccccccccCceeEEEEEcCC-CC----EEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG-GE----AVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .+|+..++||+|+||.||+|.+++ |+    .+|+|.+.... ......+.+|+.++++++||||+++++++.. ...++
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   85 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL   85 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence            567888999999999999998643 33    58999886553 3445678899999999999999999999887 78899


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      |+||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+||++++++.+||+|||+++...
T Consensus        86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            99999999999988543  335899999999999999999999987   9999999999999999999999999998765


Q ss_pred             CCCcccc-cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          423 EDITHIS-ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       423 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ....... ....++..|+|||.+....++.++||||||+++|||++ |+.|+.....     .........+..      
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~~~------  229 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-----VEIPDLLEKGER------  229 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH-----HHHHHHHhCCCC------
Confidence            3322211 12223568999999988899999999999999999998 8877643321     111111121111      


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                         ...+...+..+.+++.+||..+|.+||++.++++.|+..
T Consensus       230 ---~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         230 ---LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence               112233456788999999999999999999999999653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.5e-36  Score=310.05  Aligned_cols=256  Identities=20%  Similarity=0.262  Sum_probs=193.9

Q ss_pred             cccccccc--CceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          273 ESNKLGQG--GSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       273 ~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      ..++||+|  +|++||+++.. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            46789999  78999999874 6899999998654  2344567778999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++|+|.+++.... ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.++++||+...........
T Consensus        82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999885432 234899999999999999999999988   999999999999999999999999865433211110


Q ss_pred             ------cccccccCcCcCchhhhcc--CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          428 ------ISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       428 ------~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                            ......++..|+|||++.+  ..++.++|||||||++|||++|+.|+............     ..+.....++
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~-----~~~~~~~~~~  232 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEK-----LNGTVPCLLD  232 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHH-----hcCCcccccc
Confidence                  1112346778999999976  46899999999999999999999997543221111110     0011100000


Q ss_pred             -------------------ccc-----------------cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          500 -------------------PAL-----------------AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       500 -------------------~~l-----------------~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                                         ..+                 ...........+.+++.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~  306 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN  306 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence                               000                 00112234567889999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=7.3e-37  Score=316.57  Aligned_cols=252  Identities=22%  Similarity=0.271  Sum_probs=196.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||+||+++.. +++.||||++...   .......+.+|+.++..++||||+++++.+.+....++||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            36888999999999999999875 5889999998643   2334567788999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~  154 (360)
T cd05627          81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA  154 (360)
T ss_pred             eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence            99999999998843   345889999999999999999999988   999999999999999999999999998754221


Q ss_pred             Cc----------------------------------ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCC
Q 008239          425 IT----------------------------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR  470 (573)
Q Consensus       425 ~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~  470 (573)
                      ..                                  .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~  234 (360)
T cd05627         155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP  234 (360)
T ss_pred             cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence            10                                  00123468999999999999999999999999999999999999


Q ss_pred             CCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCC---HHHHHHH
Q 008239          471 INLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPS---MSIVVKM  538 (573)
Q Consensus       471 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt---~~evl~~  538 (573)
                      |+......    . .............+.+      ......++.+++.+++ .+|.+|++   ++|+++.
T Consensus       235 Pf~~~~~~----~-~~~~i~~~~~~~~~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         235 PFCSETPQ----E-TYRKVMNWKETLVFPP------EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCCCCCHH----H-HHHHHHcCCCceecCC------CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            87543321    1 1111111110000010      1123456778887766 49999985   5666644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.2e-36  Score=308.20  Aligned_cols=262  Identities=21%  Similarity=0.273  Sum_probs=197.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|...++||+|+||.||+|+.. +++.||+|.+.... ......+.+|+.++++++||||+++++++..+...++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            56888999999999999999875 57889999986543 22334677899999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++ +|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  159 (309)
T cd07872          86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK  159 (309)
T ss_pred             CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence            975 787776432  235788999999999999999999987   99999999999999999999999999876433221


Q ss_pred             ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHH----------HHHHhhcCc-c
Q 008239          427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT----------VWDLYVKGR-L  494 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~~-~  494 (573)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........+...          .|..+.... .
T Consensus       160 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         160 -TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             -ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence             1223457889999998865 56899999999999999999999887543322111110          111110000 0


Q ss_pred             ccccCcccc----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          495 HEAVDPALA----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       495 ~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ...-.+...    .......+..+.+++.+||+.||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            000000000    0011234567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-38  Score=315.65  Aligned_cols=245  Identities=30%  Similarity=0.455  Sum_probs=199.3

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccChhh---HHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQW---VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .|..++.||.|+||.||.++.. +.+.||||++.....+.   -+.+.+|++.|.+++|||+|.+.|++......|||||
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME  106 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME  106 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence            3667889999999999999974 67899999997765443   3567899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      ||- ||-.+++...  ..++.+..+..|..+.+.||+|||+.+   .||||||+.|||+++.|.|||+|||.+.....  
T Consensus       107 YCl-GSAsDlleVh--kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P--  178 (948)
T KOG0577|consen  107 YCL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP--  178 (948)
T ss_pred             HHh-ccHHHHHHHH--hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence            994 5666666432  346888999999999999999999998   99999999999999999999999999886543  


Q ss_pred             cccccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          426 THISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                         ...++|||.|||||++.   .+.|+-|+|||||||+..||.-.++|.+..+.    ....+....+      -.|.|
T Consensus       179 ---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA----MSALYHIAQN------esPtL  245 (948)
T KOG0577|consen  179 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQN------ESPTL  245 (948)
T ss_pred             ---hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH----HHHHHHHHhc------CCCCC
Confidence               23578999999999985   47899999999999999999988876554332    1122222111      12333


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .   ..+-+..+.+++..||+.-|++|||.+++++.
T Consensus       246 q---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  246 Q---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             C---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence            2   34456678899999999999999999888764

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=2.1e-36  Score=313.12  Aligned_cols=260  Identities=24%  Similarity=0.289  Sum_probs=195.9

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC-----
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----  338 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----  338 (573)
                      ..++|+..+.||+|+||.||++... +|+.||||++...  .......+.+|+.+++.++||||+++++++....     
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            3478999999999999999999875 5889999998643  2344567889999999999999999999886543     


Q ss_pred             -ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          339 -ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       339 -~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                       ..++||||+++ +|.+.+.     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~  169 (359)
T cd07876          99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  169 (359)
T ss_pred             ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence             46899999975 5555542     23788899999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH----------
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD----------  487 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~----------  487 (573)
                      ++......  ......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+........ ......          
T Consensus       170 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  246 (359)
T cd07876         170 ARTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ-WNKVIEQLGTPSAEFM  246 (359)
T ss_pred             ccccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCcHHHH
Confidence            97543221  22345689999999999999999999999999999999999998764322110 000000          


Q ss_pred             ---------HhhcC-cc-----ccccCcccc---CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          488 ---------LYVKG-RL-----HEAVDPALA---GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       488 ---------~~~~~-~~-----~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                               ..... ..     .+.......   ..........+.+++.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         247 NRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                     00000 00     000000000   00111234678899999999999999999999974

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.4e-36  Score=297.05  Aligned_cols=256  Identities=29%  Similarity=0.374  Sum_probs=205.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..+.||.|+||+||+|... ++..+++|++.... ....+.+.+|+.+++.++|+||+++++.+......++|+|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            46888999999999999999965 57899999986542 33567889999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++........+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.++|+|||++..+.....
T Consensus        81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~  157 (267)
T cd06610          81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD  157 (267)
T ss_pred             cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence            999999999854333356899999999999999999999987   99999999999999999999999999886644322


Q ss_pred             c---cccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          427 H---ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       427 ~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      .   ......++..|+|||.+... .++.++||||||+++|||++|+.|+.......    ........      ..+.+
T Consensus       158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~----~~~~~~~~------~~~~~  227 (267)
T cd06610         158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK----VLMLTLQN------DPPSL  227 (267)
T ss_pred             ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh----hHHHHhcC------CCCCc
Confidence            2   22344688999999999877 78999999999999999999999875433211    11111111      01111


Q ss_pred             cCCC-CCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          503 AGNF-QEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       503 ~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .... ....+..+.+++.+||+.+|++||+++++++
T Consensus       228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            1111 1245678899999999999999999999986

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.4e-37  Score=337.43  Aligned_cols=258  Identities=24%  Similarity=0.329  Sum_probs=200.8

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec--CC
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GP  338 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~  338 (573)
                      .+...++|++.++||+|+||+||+++.. ++..||+|.+...  .......+..|+.+|++|+|||||++++++..  ..
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence            3445578999999999999999999975 4778999988643  33445678899999999999999999998854  34


Q ss_pred             ceeEEEEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCC----CCeEEecCCCCCeeeCC-------
Q 008239          339 ESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESK----LRIIHRDIKLSNILLDE-------  406 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~----~~iiHrDlk~~NIll~~-------  406 (573)
                      ..+|||||+++++|.++|... .....+++..++.|+.||+.||.|||+.+.    .+||||||||+||||+.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            688999999999999988542 223569999999999999999999998541    34999999999999964       


Q ss_pred             ----------CCcEEEeecccccccCCCCcccccccccCcCcCchhhhcc--CCCCcccchHhHHHHHHHHHcCCCCCCC
Q 008239          407 ----------EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLF  474 (573)
Q Consensus       407 ----------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~  474 (573)
                                .+.+||+|||++..+....  ......||+.|+|||++..  ..++.++||||||||||||++|+.||..
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s--~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIES--MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccc--cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                      2358999999998654322  2234568999999999864  4588999999999999999999999864


Q ss_pred             CCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          475 TQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       475 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ....    ..+...+..+       +.+.   ....+..+.+|+..||+.+|.+||++.|+++
T Consensus       246 ~~~~----~qli~~lk~~-------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        246 ANNF----SQLISELKRG-------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             CCcH----HHHHHHHhcC-------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            3321    1111111111       1110   1234577899999999999999999999984

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.1e-36  Score=302.67  Aligned_cols=262  Identities=21%  Similarity=0.289  Sum_probs=199.1

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|+..++||+|+||.||+++.. +|+.||+|++....  ....+.+.+|+.++++++|+||+++++++......++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            46888999999999999999986 58999999886432  2234567899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|..++.   ....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07847          81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG  154 (286)
T ss_pred             ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence            999988877653   2235899999999999999999999987   9999999999999999999999999998764432


Q ss_pred             cccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHH----------HHhhcCcc
Q 008239          426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVW----------DLYVKGRL  494 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~----------~~~~~~~~  494 (573)
                      . ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+........+.....          ..+.....
T Consensus       155 ~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07847         155 D-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF  233 (286)
T ss_pred             c-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccc
Confidence            1 1223456789999999876 5678999999999999999999988754332211111000          00000000


Q ss_pred             c-cccCccccC-----CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          495 H-EAVDPALAG-----NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       495 ~-~~~d~~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      . ....+....     ......+..+.+++.+||+.+|++||++.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            0 000000000     001234567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.5e-37  Score=305.35  Aligned_cols=264  Identities=24%  Similarity=0.306  Sum_probs=203.6

Q ss_pred             cChHHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeee-
Q 008239          259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI-  335 (573)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  335 (573)
                      +.++.+..+.++|+..+.||+|+||.||+++.. +++.+|+|++.... ...+.+.+|+.+++.+ +||||+++++++. 
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   86 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK   86 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence            344556677889999999999999999999875 57899999875432 2245678899999999 6999999999874 


Q ss_pred             ----cCCceeEEEEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcE
Q 008239          336 ----TGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA  410 (573)
Q Consensus       336 ----~~~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~  410 (573)
                          .+...++||||+++++|.+++... .....+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~  163 (286)
T cd06638          87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV  163 (286)
T ss_pred             cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence                345689999999999999877532 23346889999999999999999999987   9999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccCcCcCchhhhcc-----CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH
Q 008239          411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV  485 (573)
Q Consensus       411 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~  485 (573)
                      ||+|||++........ ......|+..|+|||++..     ..++.++||||||+++|||++|+.|+........+    
T Consensus       164 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~----  238 (286)
T cd06638         164 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL----  238 (286)
T ss_pred             EEccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH----
Confidence            9999999886543221 2223468899999998853     45788999999999999999999987543221111    


Q ss_pred             HHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          486 WDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       486 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      .. .....     .+.+  ..+...+..+.+++.+||+.+|++||++.||++.+
T Consensus       239 ~~-~~~~~-----~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         239 FK-IPRNP-----PPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             hh-ccccC-----CCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            00 00100     0111  01222346788999999999999999999999753

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.7e-36  Score=298.14  Aligned_cols=247  Identities=28%  Similarity=0.425  Sum_probs=197.2

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      ++|+..+.||+|+||.||++.. +++.||+|.+....  ..+.+.+|+.++++++|||++++++++... ..++||||++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence            4578899999999999999975 57889999986543  245788999999999999999999988654 5799999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +++|.+++.... ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.......   
T Consensus        82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~---  154 (254)
T cd05083          82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV---  154 (254)
T ss_pred             CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence            999999986432 235789999999999999999999987   9999999999999999999999999987543221   


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                       .....+..|+|||.+.++.++.++||||||+++|||++ |+.|+.....     .........+         ......
T Consensus       155 -~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~-----~~~~~~~~~~---------~~~~~~  219 (254)
T cd05083         155 -DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSL-----KEVKECVEKG---------YRMEPP  219 (254)
T ss_pred             -CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCH-----HHHHHHHhCC---------CCCCCC
Confidence             12234567999999988899999999999999999998 6666533211     1111111111         111123


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...+..+.+++.+||+.+|++||+++++++.|..
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         220 EGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             CcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence            3456788999999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-36  Score=314.02  Aligned_cols=257  Identities=23%  Similarity=0.306  Sum_probs=192.7

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..+|++.+.||+|+||.||+|+.. +++.||+|+....      ....|+.++++++||||+++++++......++|+||
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  138 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPH  138 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEc
Confidence            457999999999999999999976 4678999975332      234699999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +. ++|.+++..  ....+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       139 ~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  210 (357)
T PHA03209        139 YS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA--  210 (357)
T ss_pred             cC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC--
Confidence            95 688887743  2346899999999999999999999987   999999999999999999999999998753222  


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--c----hHHHHHHHhhc-C----ccc
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--S----ILQTVWDLYVK-G----RLH  495 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--~----~~~~~~~~~~~-~----~~~  495 (573)
                      .......||..|+|||++.+..++.++|||||||++|||+++..++.......  .    ....+...... +    .+.
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  290 (357)
T PHA03209        211 PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP  290 (357)
T ss_pred             cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence            12234568999999999999999999999999999999999776654332211  0    00111111000 0    000


Q ss_pred             ---------cccCc-cc-cCCC-------CCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          496 ---------EAVDP-AL-AGNF-------QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       496 ---------~~~d~-~l-~~~~-------~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                               ..++. .. ....       ....+..+..++.+||+.||++|||+.|+++.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence                     00000 00 0000       01234456679999999999999999999863

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.9e-36  Score=306.56  Aligned_cols=258  Identities=21%  Similarity=0.325  Sum_probs=187.2

Q ss_pred             cccccccCceeEEEEEcC---CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec--CCceeEEEEecc
Q 008239          274 SNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLVYEFVP  348 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~  348 (573)
                      ..+||+|+||+||+|+..   ++..||+|.+....  ....+.+|+.++++++||||+++++++..  +...++|+||++
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            468999999999999865   35789999886542  23467789999999999999999998854  456789999986


Q ss_pred             CCCcccccccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee----CCCCcEEEeecccc
Q 008239          349 NQSLLDNLFVR------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLV  418 (573)
Q Consensus       349 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll----~~~~~~kl~Dfgla  418 (573)
                      + +|.+++...      .....+++..++.++.||+.||.|||+.+   |+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            5 676665321      12235889999999999999999999988   9999999999999    56679999999999


Q ss_pred             cccCCCCcc--cccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--------chHHH---
Q 008239          419 RLFPEDITH--ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--------SILQT---  484 (573)
Q Consensus       419 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--------~~~~~---  484 (573)
                      +........  ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+.......        .....   
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            876543222  1234568999999999876 458999999999999999999998876433211        00000   


Q ss_pred             --------HHHHhhc-CccccccC---------cccc---CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          485 --------VWDLYVK-GRLHEAVD---------PALA---GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       485 --------~~~~~~~-~~~~~~~d---------~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                              .|..... ........         ..+.   ..........+.+|+.+|++.||.+|||++|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~  313 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQ  313 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhc
Confidence                    0110000 00000000         0000   0011122356788999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.1e-36  Score=299.58  Aligned_cols=249  Identities=26%  Similarity=0.390  Sum_probs=194.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-----hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--Cce
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES  340 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  340 (573)
                      .+|+..+.||+|+||.||++... ++..|++|++....     .+..+.+.+|+.++++++||||+++++++...  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            47889999999999999999875 58899999885431     23355788999999999999999999988653  567


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++++||+++++|.+++...   ..+++...+.++.|++.||+|||+.+   |+||||+|+||+++.++.+||+|||++..
T Consensus        82 ~l~~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~  155 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY---GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence            8999999999999988432   34789999999999999999999987   99999999999999999999999999875


Q ss_pred             cCCCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      .......  ......++..|+|||.+.+..++.++||||||+++|||++|+.|+.....    ...........     .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~----~~~~~~~~~~~-----~  226 (266)
T cd06651         156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEA----MAAIFKIATQP-----T  226 (266)
T ss_pred             cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccch----HHHHHHHhcCC-----C
Confidence            5322111  11234578899999999988899999999999999999999998753321    11111111100     0


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .+    ..+......+..++ .||..+|++||+++||++
T Consensus       227 ~~----~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         227 NP----QLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             CC----CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            11    12223344555666 788899999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.3e-36  Score=305.53  Aligned_cols=250  Identities=27%  Similarity=0.394  Sum_probs=201.3

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      +.|.....||+|+||.||++... +++.||||.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~  101 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFL  101 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCC
Confidence            33444677999999999999875 58899999987665566677899999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++..    ..+++..++.++.||+.||+|||+++   |+||||||+||++++++.+||+|||++........ 
T Consensus       102 ~~~~L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~-  173 (292)
T cd06658         102 EGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP-  173 (292)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc-
Confidence            99999988732    34889999999999999999999987   99999999999999999999999999876543222 


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      ......++..|+|||.+.+..++.++||||||+++|||++|+.|+......    ..... ...     .+.+.+..  .
T Consensus       174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~~~-~~~-----~~~~~~~~--~  241 (292)
T cd06658         174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPL----QAMRR-IRD-----NLPPRVKD--S  241 (292)
T ss_pred             cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HHh-----cCCCcccc--c
Confidence            223356789999999998889999999999999999999999987543221    11111 110     11111111  1


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...+..+.+++.+|++.+|++|||++++++.
T Consensus       242 ~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         242 HKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            2245578899999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.1e-36  Score=299.26  Aligned_cols=252  Identities=26%  Similarity=0.372  Sum_probs=203.3

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..+.||+|+||.||++... +++.+++|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            35778899999999999999986 58899999987653 34456788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      +++++|.+++....  ..+++..+..++.|++.||+|||+ .+   ++|+||+|+||++++++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~  155 (265)
T cd06605          81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL  155 (265)
T ss_pred             cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence            99999999885432  568899999999999999999999 76   9999999999999999999999999987553221


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc-chHHHHHHHhhcCccccccCccccC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC-SILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .   ....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ......... ..+.     .+.+. 
T Consensus       156 ~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~-----~~~~~-  225 (265)
T cd06605         156 A---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI-VNEP-----PPRLP-  225 (265)
T ss_pred             h---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHH-hcCC-----CCCCC-
Confidence            1   12567889999999999999999999999999999999999876543211 122221111 1111     01111 


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ....+..+.+++.+||..+|++|||+.+++.
T Consensus       226 --~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         226 --SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             --hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence              1115667899999999999999999999985

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.7e-36  Score=296.94  Aligned_cols=250  Identities=20%  Similarity=0.306  Sum_probs=203.4

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..++||+|+||.+|+++.. +|+.||+|++...  .....+++.+|+.++++++||||+++++++......++|+||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            4788999999999999999875 6889999998643  233456789999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++.... ...+++..+++++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          81 CEGGDLYKKINAQR-GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            99999998885432 235789999999999999999999987   99999999999999999999999999986543321


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                       ......++..|+|||.+.++.++.++||||||++++||++|+.|+.....    ....... ..+..         ...
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~----~~~~~~~-~~~~~---------~~~  221 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM----KNLVLKI-IRGSY---------PPV  221 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH----HHHHHHH-hcCCC---------CCC
Confidence             12234578899999999988999999999999999999999988754321    1111111 11111         112


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +...+..+.+++.+||+.+|++||++.+|++.
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             cccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            34456788999999999999999999999973

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=5.2e-36  Score=301.90  Aligned_cols=261  Identities=23%  Similarity=0.286  Sum_probs=198.1

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccChh-----hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ-----WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      +|+..+.||+|+||.||+|... +|+.|+||.+......     ....+.+|++++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            3777889999999999999975 6899999998654322     344667899999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+ +++|.+++....  ..+++..++.++.||++||.|||+++   |+|+||+|+||+++.++.+||+|||++.....
T Consensus        81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~  154 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS  154 (298)
T ss_pred             Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence            9999 899999885432  36899999999999999999999988   99999999999999999999999999986644


Q ss_pred             CCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC---------c
Q 008239          424 DITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG---------R  493 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~  493 (573)
                      .... .....++..|+|||.+.+ ..++.++||||||++++||++|..++.... ...............         .
T Consensus       155 ~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (298)
T cd07841         155 PNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDS-DIDQLGKIFEALGTPTEENWPGVTS  232 (298)
T ss_pred             CCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCc-cHHHHHHHHHHcCCCchhhhhhccc
Confidence            3211 122345778999998865 467899999999999999999965543322 211111111110000         0


Q ss_pred             cccccCcccc-----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          494 LHEAVDPALA-----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       494 ~~~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..........     .......+..+.+++.+||+.+|++|||+.|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000000000     01113346788999999999999999999999975

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.2e-36  Score=304.65  Aligned_cols=261  Identities=24%  Similarity=0.332  Sum_probs=198.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|+..++||+|+||.||++..+ +++.||+|++....  ....+.+.+|+++++.++||||+++++++..+...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            36888999999999999999986 58899999886532  2234578899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.++...   ...+++..++.++.||+.||+|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~  154 (286)
T cd07846          81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  154 (286)
T ss_pred             cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence            9999888876532   234899999999999999999999987   9999999999999999999999999988654332


Q ss_pred             cccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc--Cccccc-----
Q 008239          426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK--GRLHEA-----  497 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~-----  497 (573)
                       .......++..|+|||++.+ ..++.++||||||+++|||++|+.|+...... ............  ......     
T Consensus       155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         155 -EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-DQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             -cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchH-HHHHHHHHHhCCCchhhHHHhccch
Confidence             22223457889999999875 45788999999999999999998776433211 111111100000  000000     


Q ss_pred             -c----Ccccc-----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          498 -V----DPALA-----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       498 -~----d~~l~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       .    .+...     .......+..+.+++.+||+.+|++||++.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence             0    00000     0012244677999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.9e-36  Score=312.88  Aligned_cols=261  Identities=23%  Similarity=0.272  Sum_probs=196.6

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC------
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------  337 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  337 (573)
                      ..++|+..+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   94 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF   94 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence            4578999999999999999999864 5889999998653  233456778899999999999999999987643      


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~  165 (355)
T cd07874          95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  165 (355)
T ss_pred             ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence            346899999965 5655552     24788999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHH-----------
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVW-----------  486 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~-----------  486 (573)
                      ++......  ......+|..|+|||++.+..++.++||||||+++|||++|+.|+..............           
T Consensus       166 ~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  243 (355)
T cd07874         166 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMK  243 (355)
T ss_pred             cccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            98653321  22345689999999999999999999999999999999999998754321111000000           


Q ss_pred             -------HHhhc-CccccccCcc-----cc---CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          487 -------DLYVK-GRLHEAVDPA-----LA---GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       487 -------~~~~~-~~~~~~~d~~-----l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                             ..... ........+.     +.   ..........+.+++.+||+.||++|||+.|+++.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         244 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             hhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   00000 0000000000     00   01112234678899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-36  Score=303.03  Aligned_cols=261  Identities=22%  Similarity=0.293  Sum_probs=198.0

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..++||+|+||.||+++.. +|+.||+|++....  ......+.+|+.++++++||||+++++++.+....++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            4778899999999999999975 68999999986432  22335677899999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      ++ ++|.+++...  ...+++..++.++.||++||.|||+.+   |+||||||+||+++.++.+||+|||+++.+.....
T Consensus        81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  154 (284)
T cd07839          81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR  154 (284)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence            97 5787776432  345899999999999999999999987   99999999999999999999999999886543222


Q ss_pred             ccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc------cccccC
Q 008239          427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR------LHEAVD  499 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~d  499 (573)
                      . .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+.....................      +....+
T Consensus       155 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07839         155 C-YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPD  233 (284)
T ss_pred             C-cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhccc
Confidence            1 1234568899999998764 4789999999999999999999987554332211111111100000      000000


Q ss_pred             cc----cc-----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          500 PA----LA-----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       500 ~~----l~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..    ..     .......+..+.+++.+||+.||.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         234 YKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             ccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00    00     0112234567889999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-35  Score=297.98  Aligned_cols=261  Identities=25%  Similarity=0.271  Sum_probs=202.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--CceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  344 (573)
                      ++|+..++||.|++|.||++... +++.+|+|.+.... ......+.+|++++++++||||+++++++...  ...++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            36788999999999999999985 57899999986543 24456789999999999999999999988653  4679999


Q ss_pred             EeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       345 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      ||+++++|.+++... .....+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            999999998876432 23456889999999999999999999988   99999999999999999999999999875432


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ...   ....++..|+|||.+.+..++.++||||||+++|||++|+.|+........................+.+. . 
T Consensus       158 ~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-  232 (287)
T cd06621         158 SLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE-P-  232 (287)
T ss_pred             ccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccC-C-
Confidence            211   23456889999999999999999999999999999999999876543211111111111111111111100 0 


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       ......+..+.+++.+||+.+|++|||+.|+++.
T Consensus       233 -~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         233 -GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             -CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence             0112346788999999999999999999999973

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2e-36  Score=313.76  Aligned_cols=260  Identities=24%  Similarity=0.299  Sum_probs=196.3

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC------
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------  337 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  337 (573)
                      ..++|+..+.||+|+||.||++... .++.||||++...  .....+.+.+|+.+++.++||||+++++++...      
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            3578999999999999999999865 5889999998653  233456778999999999999999999987543      


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ...++||||+++ +|.+.+.     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~  172 (364)
T cd07875         102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  172 (364)
T ss_pred             CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence            356899999965 6666652     23788999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH----------
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD----------  487 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~----------  487 (573)
                      ++......  ......+|..|+|||++.+..++.++|||||||++|||++|+.|+........ ...+..          
T Consensus       173 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~  249 (364)
T cd07875         173 ARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ-WNKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCCHHHH
Confidence            98653321  22345689999999999999999999999999999999999998754322110 000000          


Q ss_pred             -H-------hhcCc--c-----ccccCcccc---CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          488 -L-------YVKGR--L-----HEAVDPALA---GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       488 -~-------~~~~~--~-----~~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       .       +...+  .     .+.....+.   ..........+.+++.+|++.||.+|||++|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence             0       00000  0     000000000   01111234578899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=3.1e-36  Score=310.26  Aligned_cols=260  Identities=21%  Similarity=0.285  Sum_probs=199.9

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CC-----CeeeeeeeeecCCcee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HK-----NLVKLLGCSITGPESL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~~~~~~~  341 (573)
                      .+|++.+.||+|.||.|.|+... +++.||||+++.. ....++...|+.+|..|+ |.     |+|+++++|...++.+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlc  264 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLC  264 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccccee
Confidence            47899999999999999999864 6999999999654 445667788999999996 43     8999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC--CCcEEEeeccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--EFTAKIADFGLVR  419 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~--~~~~kl~Dfgla~  419 (573)
                      ||+|.+ ..+|.+++...+ ...++...++.++.||+.||..||+.+   |||+||||+||||.+  ...+||+|||.++
T Consensus       265 iVfELL-~~NLYellK~n~-f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  265 IVFELL-STNLYELLKNNK-FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             eeehhh-hhhHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccc
Confidence            999999 569999996543 445999999999999999999999988   999999999999974  3479999999999


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc--------
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK--------  491 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------  491 (573)
                      .......    ...-+..|.|||++.+.+|+.+.||||||||+.||++|.+.+ .+.+..+.+..+.+....        
T Consensus       340 ~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLf-pG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  340 FESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLF-PGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             ccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCcccc-CCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            7643322    455678999999999999999999999999999999996543 333322222221111110        


Q ss_pred             -CccccccCc--------------------------------cccC--------CCCCchHHHHHHHHHHccCCCCCCCC
Q 008239          492 -GRLHEAVDP--------------------------------ALAG--------NFQEGKPSRLLQIGLLCVQASAELRP  530 (573)
Q Consensus       492 -~~~~~~~d~--------------------------------~l~~--------~~~~~~~~~l~~l~~~cl~~~p~~RP  530 (573)
                       .+....++.                                ....        ......-..+++++++|+++||..|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence             000000100                                0000        01113345679999999999999999


Q ss_pred             CHHHHHHHh
Q 008239          531 SMSIVVKML  539 (573)
Q Consensus       531 t~~evl~~L  539 (573)
                      |..|.++.=
T Consensus       495 tp~qal~Hp  503 (586)
T KOG0667|consen  495 TPAQALNHP  503 (586)
T ss_pred             CHHHHhcCc
Confidence            999999754

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.2e-36  Score=297.74  Aligned_cols=254  Identities=25%  Similarity=0.379  Sum_probs=200.1

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccCh----------hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT----------QWVDHFFNEVNLISGINHKNLVKLLGCSITGP  338 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  338 (573)
                      +|...+.||+|+||.||+|... +|+.||||.+.....          ...+.+.+|+.+++.++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            4667889999999999999864 688999998753211          12346788999999999999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++||||+++++|.+++...   ..+++..+..++.||+.||.|||+.+   ++||||+|+||+++.++.++|+|||++
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~  155 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS  155 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence            999999999999999988433   46889999999999999999999987   999999999999999999999999998


Q ss_pred             cccCCCCcc-cccccccCcCcCchhhhccCC--CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc
Q 008239          419 RLFPEDITH-ISATLAGTLGYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH  495 (573)
Q Consensus       419 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  495 (573)
                      ......... ......++..|+|||.+....  ++.++||||||+++||+++|..|+.....    .......... ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~-~~~  230 (272)
T cd06629         156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEA----IAAMFKLGNK-RSA  230 (272)
T ss_pred             ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcch----HHHHHHhhcc-ccC
Confidence            865432221 123456788999999987654  88999999999999999999988743221    1111111111 111


Q ss_pred             cccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       496 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..+.    .......+..+.+++.+||+.+|++||++++|++.
T Consensus       231 ~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         231 PPIP----PDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CcCC----ccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            1111    12223456788999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=3.6e-36  Score=300.98  Aligned_cols=262  Identities=23%  Similarity=0.326  Sum_probs=201.2

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..+.||+|+||.||+|+.. +|+.|+||++....  ....+.+.+|+.++++++||||+++++++..+...++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            4778899999999999999975 68999999986543  33456788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      + +++|.+++....  ..+++..++.++.||+.||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (286)
T cd07832          81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP  154 (286)
T ss_pred             c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence            9 999999875432  56899999999999999999999987   99999999999999999999999999987654432


Q ss_pred             ccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC------------c
Q 008239          427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG------------R  493 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------------~  493 (573)
                      .......++..|+|||.+.+. .++.++||||||++++||++|..++..... ..............            .
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         155 RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND-IEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH-HHHHHHHHHHcCCCChHHHhhccCcch
Confidence            223345688899999988654 568999999999999999999655433221 11111111111000            0


Q ss_pred             cccccCccc----cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          494 LHEAVDPAL----AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       494 ~~~~~d~~l----~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...+..+.-    ......+.+..+.+++.+|++.+|++||+++++++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            000000000    001112345788999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.9e-36  Score=296.52  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=201.4

Q ss_pred             CccccccccccCceeEEEEEc-CCCCEEEEEEecccC------hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      +|+..+.||+|++|.||++.. .+++.||+|.+....      ....+.+.+|+.++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            477889999999999999986 468999999886432      2235678899999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-cEEEeeccccccc
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLF  421 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~  421 (573)
                      |+||+++++|.+++..   ..++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||++...
T Consensus        81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~  154 (268)
T cd06630          81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL  154 (268)
T ss_pred             EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence            9999999999998843   246889999999999999999999988   99999999999998775 6999999998866


Q ss_pred             CCCCcc---cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          422 PEDITH---ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       422 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      ......   ......++..|+|||.+.+..++.++||||||++++||++|+.|+....... ...........       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~-------  226 (268)
T cd06630         155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN-HLALIFKIASA-------  226 (268)
T ss_pred             ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcc-hHHHHHHHhcc-------
Confidence            443211   1223467889999999988889999999999999999999998875332211 11111111000       


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ......+......+.+++.+|++.+|++||++.++++
T Consensus       227 --~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         227 --TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             --CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence              0012233445678899999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.8e-36  Score=301.37  Aligned_cols=259  Identities=25%  Similarity=0.332  Sum_probs=202.2

Q ss_pred             ChHHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeec-
Q 008239          260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT-  336 (573)
Q Consensus       260 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~-  336 (573)
                      ++.++..+.+.|+..+.||+|+||.||+|+.. +++.+|+|.+..... ....+..|+.+++++ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED-EEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH-HHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            45566667789999999999999999999974 588999998855432 345688899999998 69999999998863 


Q ss_pred             -----CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEE
Q 008239          337 -----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK  411 (573)
Q Consensus       337 -----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~k  411 (573)
                           ....+++|||+++|+|.+++.... ...+++..+..++.||+.||.|||+.+   |+|+||+|+||++++++.++
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~  161 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK-GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK  161 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence                 356789999999999998885432 345788889999999999999999987   99999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHH
Q 008239          412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVW  486 (573)
Q Consensus       412 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~  486 (573)
                      |+|||++........ ......++..|+|||.+.     ...++.++||||||+++|||++|+.|+.........    .
T Consensus       162 l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~----~  236 (282)
T cd06636         162 LVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL----F  236 (282)
T ss_pred             EeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh----h
Confidence            999999875532211 123456888999999885     346788999999999999999999887533211111    0


Q ss_pred             HHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          487 DLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       487 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .. .     ....+.+   .....+..+.+++.+||+.+|.+||++.|+++
T Consensus       237 ~~-~-----~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         237 LI-P-----RNPPPKL---KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             hH-h-----hCCCCCC---cccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            00 0     0001111   12235678999999999999999999999975

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.9e-36  Score=304.93  Aligned_cols=248  Identities=27%  Similarity=0.373  Sum_probs=200.5

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      |....+||+|+||.||++... +++.||||.+........+.+.+|+.+++.++||||+++++++..+...++|+||+++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~  102 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQG  102 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCC
Confidence            334567999999999999875 6899999998665555567788999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      ++|.+++..    ..+++..++.++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++........ ..
T Consensus       103 ~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~-~~  174 (297)
T cd06659         103 GALTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP-KR  174 (297)
T ss_pred             CCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-cc
Confidence            999887632    35889999999999999999999987   99999999999999999999999999876543322 22


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....++..|+|||++.+..++.++||||||++++||++|+.|+......    ...... ....     .+..  .....
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~-~~~~-----~~~~--~~~~~  242 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV----QAMKRL-RDSP-----PPKL--KNAHK  242 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH-hccC-----CCCc--cccCC
Confidence            3456889999999999889999999999999999999999987643221    111111 1110     0000  11223


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          510 KPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+..+.+++.+||+.+|++||+++++++.
T Consensus       243 ~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         243 ISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             CCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            45678899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=7e-36  Score=296.89  Aligned_cols=254  Identities=24%  Similarity=0.371  Sum_probs=196.7

Q ss_pred             ccccccccccCceeEEEEEcC----CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC------
Q 008239          271 FHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------  338 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  338 (573)
                      |...+.||+|+||.||+|.+.    +++.||||++...  .....+++.+|+.++++++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            566789999999999999853    3688999998654  3344667889999999999999999999886532      


Q ss_pred             ceeEEEEeccCCCcccccccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeec
Q 008239          339 ESLLVYEFVPNQSLLDNLFVR---QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF  415 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  415 (573)
                      ..++++||+++|+|.+++...   .+...+++...++++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence            236889999999998876432   12235789999999999999999999987   999999999999999999999999


Q ss_pred             ccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCc
Q 008239          416 GLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGR  493 (573)
Q Consensus       416 gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  493 (573)
                      |+++....... .......++..|++||.+....++.++||||||+++|||++ |+.|+.. .....+..    ....+.
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~-~~~~~~~~----~~~~~~  232 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG-VENSEIYN----YLIKGN  232 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC-CCHHHHHH----HHHcCC
Confidence            99886543221 11223345678999999998899999999999999999999 5555432 22111111    111111


Q ss_pred             cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       494 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .       +  ..+...+..+.+++.+||+.+|++||++.++++.|+.
T Consensus       233 ~-------~--~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         233 R-------L--KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             c-------C--CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            0       0  1123456789999999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.4e-36  Score=304.86  Aligned_cols=261  Identities=22%  Similarity=0.285  Sum_probs=198.2

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..++||+|+||.||+++.. +++.||+|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            56888999999999999999875 57899999986543 23345677899999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      ++ ++|.+++...  ...+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++........
T Consensus        86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  159 (301)
T cd07873          86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  159 (301)
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence            97 5888877533  235789999999999999999999987   99999999999999999999999999875433221


Q ss_pred             ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH-----------HHHhhcC-c
Q 008239          427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV-----------WDLYVKG-R  493 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~-----------~~~~~~~-~  493 (573)
                      . .....+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ......           |..+... .
T Consensus       160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (301)
T cd07873         160 T-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEE  237 (301)
T ss_pred             c-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCChhhchhhhcccc
Confidence            1 123356889999998865 45788999999999999999999887543221 111111           1111000 0


Q ss_pred             cccccCcccc----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          494 LHEAVDPALA----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       494 ~~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ....-.+...    .......+..+.+|+.+|++.||.+|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         238 FKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             ccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            0000001000    0112234567889999999999999999999996

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-38  Score=283.98  Aligned_cols=251  Identities=21%  Similarity=0.289  Sum_probs=204.1

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++.|+..+.||+|.|+.|++... ++|+.+|+|++...  .....+++.+|+++-+.|+|||||+|.+...+....++|+
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF   89 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   89 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence            46678889999999999999875 47889999877432  3346778999999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC---CCCcEEEeeccccccc
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLF  421 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~---~~~~~kl~Dfgla~~~  421 (573)
                      |+|.+++|..-+..+   .-+++..+-..+.||+++|.|.|.++   |||||+||.|+|+-   ..--+||+|||++..+
T Consensus        90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            999999997666433   34677888899999999999999998   99999999999995   3346999999999987


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      +  ....-...+||++|||||++...+|+..+|||+.|||||-|+.|..||......     .+++.+..+..      .
T Consensus       164 ~--~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~-----rlye~I~~g~y------d  230 (355)
T KOG0033|consen  164 N--DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYEQIKAGAY------D  230 (355)
T ss_pred             C--CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH-----HHHHHHhcccc------C
Confidence            6  333444678999999999999999999999999999999999999998764322     22222333322      1


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +....-....+...+|+.+||..||.+|.|+.|.++
T Consensus       231 ~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  231 YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            111223345667789999999999999999988764

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-36  Score=302.80  Aligned_cols=262  Identities=23%  Similarity=0.299  Sum_probs=201.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|+..++||+|+||.||++... +++.|+||++...  .....+.+.+|++++++++|+||+++++++...+..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            36888999999999999999976 5889999988643  23345678999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |++++.+..+..   ....+++..+..++.||+.||.|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~  154 (288)
T cd07833          81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP  154 (288)
T ss_pred             cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence            999876655442   2245899999999999999999999987   9999999999999999999999999998765543


Q ss_pred             cccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh-----------hc-C
Q 008239          426 THISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY-----------VK-G  492 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~-~  492 (573)
                      ........++..|+|||++... .++.++||||||+++|||++|+.|+........+ ......+           .. .
T Consensus       155 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         155 ASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL-YLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             cccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHhhhcccCc
Confidence            3233345678899999999887 8899999999999999999999876543221111 1100000           00 0


Q ss_pred             c-----cccccCc-cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          493 R-----LHEAVDP-ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       493 ~-----~~~~~d~-~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .     ..+..++ .+...++...+..+.+++.+||+.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0     0000000 0001122334778999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4e-36  Score=296.70  Aligned_cols=254  Identities=22%  Similarity=0.334  Sum_probs=202.7

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec--CCceeEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLVY  344 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~  344 (573)
                      +|+..+.||.|+||.||++... +++.+|+|.+...  .....+.+.+|+.+++.++|+||+++++++..  +...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            4778899999999999999864 6789999988643  23445678899999999999999999997764  44578999


Q ss_pred             EeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEES--KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       345 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      ||+++++|.+++... .....+++..++.++.|++.||+|||..+  ..+++|+||+|+||++++++.+||+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999988543 22456899999999999999999999332  234999999999999999999999999999876


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ...... .....++..|+|||.+....++.++||||||+++|+|++|+.|+.....     .........+.        
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~--------  226 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ-----LQLASKIKEGK--------  226 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH-----HHHHHHHhcCC--------
Confidence            543321 2234678999999999988899999999999999999999988754321     11111112211        


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       ....+...+..+.+++.+|++.+|++||++++|+++
T Consensus       227 -~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 -FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             -CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence             122344566789999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.1e-36  Score=296.68  Aligned_cols=250  Identities=26%  Similarity=0.342  Sum_probs=196.3

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-----ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--Cce
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES  340 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  340 (573)
                      ++|+..++||+|+||.||++... +|+.||||.+...     .....+.+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            57888999999999999999875 5889999987532     123356788999999999999999999988764  457


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      +++|||+++++|.+++...   ..+++...++++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..
T Consensus        82 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~  155 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY---GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR  155 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence            7999999999999987432   34788889999999999999999988   99999999999999999999999999885


Q ss_pred             cCCCCc--ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          421 FPEDIT--HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       421 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      ......  .......++..|+|||.+.+..++.++||||||+++|||++|+.|+......    ......... .     
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~----~~~~~~~~~-~-----  225 (265)
T cd06652         156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAM----AAIFKIATQ-P-----  225 (265)
T ss_pred             cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchH----HHHHHHhcC-C-----
Confidence            532211  1122345788999999998888999999999999999999999987532211    111111100 0     


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                         .....+......+.+++.+|+. +|++||+++||++.
T Consensus       226 ---~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         226 ---TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence               0112233455678889999985 99999999999863

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-36  Score=304.32  Aligned_cols=252  Identities=21%  Similarity=0.224  Sum_probs=201.3

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh---hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||.||++... +++.||||.+.....   ...+.+.+|+++++.++|+||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            36888999999999999999976 489999999865432   24567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+.+++|.+++... ....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  156 (316)
T cd05574          81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE  156 (316)
T ss_pred             EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence            999999999987532 3356899999999999999999999987   999999999999999999999999998754322


Q ss_pred             Ccc----------------------------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCC
Q 008239          425 ITH----------------------------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ  476 (573)
Q Consensus       425 ~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~  476 (573)
                      ...                            ......|+..|+|||++.+..++.++||||||+++|||++|+.|+....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~  236 (316)
T cd05574         157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN  236 (316)
T ss_pred             ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence            110                            1113457889999999998889999999999999999999999975433


Q ss_pred             CCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCC----HHHHHH
Q 008239          477 NSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPS----MSIVVK  537 (573)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt----~~evl~  537 (573)
                      ....+    ....         +...........+..+.+++.+||+.+|++||+    ++|+++
T Consensus       237 ~~~~~----~~~~---------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         237 RDETF----SNIL---------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             hHHHH----HHHh---------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            21111    1111         111111111225678999999999999999999    666665

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7.4e-36  Score=295.01  Aligned_cols=251  Identities=29%  Similarity=0.430  Sum_probs=201.7

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccCh--hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..+.||+|+||.||++... +++.|++|.+.....  ...+.+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            4778899999999999999865 688999999876544  3577899999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++..   ...+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.+||+|||++........
T Consensus        81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~  154 (264)
T cd06626          81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT  154 (264)
T ss_pred             CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence            999999998853   234788999999999999999999988   99999999999999999999999999887654333


Q ss_pred             cccc---ccccCcCcCchhhhccCC---CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          427 HISA---TLAGTLGYMAPEYVVRGK---LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       427 ~~~~---~~~gt~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ....   ...++..|+|||++....   .+.++||||||+++|||++|+.|+........   ..... ..+.     .+
T Consensus       155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~---~~~~~-~~~~-----~~  225 (264)
T cd06626         155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ---IMFHV-GAGH-----KP  225 (264)
T ss_pred             cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH---HHHHH-hcCC-----CC
Confidence            2221   346788999999998766   88999999999999999999998754322111   11110 0010     11


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .+.  .....+..+.+++.+||+.+|++||++.+++.
T Consensus       226 ~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         226 PIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             CCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            111  11123667889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.1e-36  Score=303.77  Aligned_cols=255  Identities=19%  Similarity=0.260  Sum_probs=201.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||.||++... .++.|++|.+....   ....+.+.+|+++++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            46888999999999999999875 57899999886543   233557789999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++..   ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.....
T Consensus        81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~  154 (305)
T cd05609          81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS  154 (305)
T ss_pred             ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence            99999999999843   245899999999999999999999987   999999999999999999999999998642111


Q ss_pred             Cc--------------ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh
Q 008239          425 IT--------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV  490 (573)
Q Consensus       425 ~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  490 (573)
                      ..              .......++..|+|||.+....++.++||||||+++|||++|+.|+.....     ........
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~-----~~~~~~~~  229 (305)
T cd05609         155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP-----EELFGQVI  229 (305)
T ss_pred             ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHH
Confidence            00              011124578899999999888999999999999999999999998753221     11111111


Q ss_pred             cCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          491 KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       491 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .+...   .+.    .....+..+.+++.+||+.+|++||++.++.+.|+.
T Consensus       230 ~~~~~---~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SDDIE---WPE----GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hcccC---CCC----ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            11110   110    112356778999999999999999998777777744

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=6.1e-36  Score=300.75  Aligned_cols=251  Identities=27%  Similarity=0.389  Sum_probs=204.1

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..+|+..+.||+|+||.||++... +++.|++|.+........+.+.+|+.+++.++||||+++++++......++|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            367888999999999999999864 6789999998665555567889999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++..    ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~  170 (293)
T cd06647          98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  170 (293)
T ss_pred             CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence            999999998843    24788999999999999999999988   99999999999999999999999999876543322


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      . .....+++.|+|||.+..+.++.++||||||+++|||++|+.|+........+.    .....+.      +.+  ..
T Consensus       171 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~----~~~~~~~------~~~--~~  237 (293)
T cd06647         171 K-RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY----LIATNGT------PEL--QN  237 (293)
T ss_pred             c-cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee----ehhcCCC------CCC--CC
Confidence            1 223467889999999988889999999999999999999999875433211110    0000000      000  11


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +...+..+.+++.+||+.+|++||++++++++
T Consensus       238 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         238 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            22345678899999999999999999999976

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5.8e-36  Score=295.65  Aligned_cols=252  Identities=27%  Similarity=0.395  Sum_probs=207.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..+.||+|++|.||+++.. +++.|+||++..... ...+.+.+|+..+.+++|+||+++++++......++|+||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            36888999999999999999986 489999999876544 4567899999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      +++++|.+++...   ..+++..++.++.|+++||+|||+ .+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~  154 (264)
T cd06623          81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL  154 (264)
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence            9999999998543   568999999999999999999999 87   9999999999999999999999999988664433


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      .. .....++..|+|||.+....++.++||||||+++|||++|+.|+...... ...+.. .......     .    ..
T Consensus       155 ~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~-~~~~~~-~~~~~~~-----~----~~  222 (264)
T cd06623         155 DQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQP-SFFELM-QAICDGP-----P----PS  222 (264)
T ss_pred             Cc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccccc-CHHHHH-HHHhcCC-----C----CC
Confidence            22 12345788999999999999999999999999999999999987554321 111111 1111111     0    11


Q ss_pred             CCCc-hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          506 FQEG-KPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       506 ~~~~-~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+.. .+..+.+++.+||+.+|++||++.++++.
T Consensus       223 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            2233 56789999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=7.3e-36  Score=293.64  Aligned_cols=248  Identities=22%  Similarity=0.334  Sum_probs=201.0

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..+.||+|+||.||++... +++.+|||.+...  ..+..+.+.+|++++++++||||+++++.+......++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            4778899999999999999874 6889999988653  234466888999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC-CcEEEeecccccccCCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~~~~~~~  425 (573)
                      +++++|.+++.... ...+++..+..++.+++.+|+|||+++   ++|+||+|+||+++++ +.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999985432 345899999999999999999999987   9999999999999855 468999999998664332


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                        ......++..|+|||.+....++.++||||||+++|||++|+.|+....... ...    ....+..         ..
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~-~~~----~~~~~~~---------~~  220 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA-LVL----KIMSGTF---------AP  220 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH-HHH----HHHhcCC---------CC
Confidence              1223567889999999998889999999999999999999998875432211 111    1111111         11


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .+...+..+.+++.+||+.+|++|||++|+++
T Consensus       221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            23345678899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-36  Score=292.82  Aligned_cols=253  Identities=23%  Similarity=0.215  Sum_probs=205.7

Q ss_pred             cCccccccccccCceeEEEEEcCC-CCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      +.|+.+++||+|.-|+||++++.+ +..+|+|++.+..   .+...+...|-++|+.++||.++.||..++.+...++||
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            456778999999999999999875 5899999996542   334456778999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC-
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-  423 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~-  423 (573)
                      |||+||+|..+.+. +....+++..++.++..|+-||+|||..|   ||+|||||+||||.++|++-|+||.|+..... 
T Consensus       157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999887754 45567999999999999999999999988   99999999999999999999999998643210 


Q ss_pred             --------------------------------CCc----------------------ccccccccCcCcCchhhhccCCC
Q 008239          424 --------------------------------DIT----------------------HISATLAGTLGYMAPEYVVRGKL  449 (573)
Q Consensus       424 --------------------------------~~~----------------------~~~~~~~gt~~y~aPE~~~~~~~  449 (573)
                                                      ...                      ..+...+||-.|+|||++.+.-.
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                      01224568999999999999999


Q ss_pred             CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCC
Q 008239          450 TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELR  529 (573)
Q Consensus       450 ~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R  529 (573)
                      +.++|.|+|||+||||+.|..||....+...+...             +...+.-......+..+.+||.+.|.+||++|
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI-------------v~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kR  379 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI-------------VGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKR  379 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH-------------hcCCCcCCCCCcchhHHHHHHHHHhccChhhh
Confidence            99999999999999999999999887665433222             11112111122556788999999999999999


Q ss_pred             CC----HHHHHHH
Q 008239          530 PS----MSIVVKM  538 (573)
Q Consensus       530 Pt----~~evl~~  538 (573)
                      ..    +.||-+.
T Consensus       380 lg~~rGA~eIK~H  392 (459)
T KOG0610|consen  380 LGSKRGAAEIKRH  392 (459)
T ss_pred             hccccchHHhhcC
Confidence            98    6666543

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.1e-35  Score=298.41  Aligned_cols=244  Identities=25%  Similarity=0.325  Sum_probs=201.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||.||++... +++.||+|.+....   .+..+.+.+|++++++++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            46888999999999999999975 58999999986532   234567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++......
T Consensus        81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  154 (290)
T cd05580          81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR  154 (290)
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence            999999999988543   46889999999999999999999987   999999999999999999999999998876443


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                          .....+++.|+|||.+.+...+.++||||||+++|||++|+.|+.....     .........+.          .
T Consensus       155 ----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~----------~  215 (290)
T cd05580         155 ----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNP-----IQIYEKILEGK----------V  215 (290)
T ss_pred             ----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCC----------c
Confidence                2344688999999999888899999999999999999999988754331     11111111111          1


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  537 (573)
                      .++...+..+.+++.+||+.+|.+||     +++|+++
T Consensus       216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence            22334467889999999999999999     7777764

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.4e-36  Score=308.79  Aligned_cols=259  Identities=23%  Similarity=0.301  Sum_probs=194.8

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-----
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----  337 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----  337 (573)
                      ...++|+..+.||+|+||+||++... +++.||||++....  ....+.+.+|+.++++++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            44578999999999999999999864 67899999986532  22345677899999999999999999987543     


Q ss_pred             -CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          338 -PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       338 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                       ...++++|++ +++|.+++.    ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg  163 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG  163 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence             3468999987 778877663    245899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc----
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK----  491 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~----  491 (573)
                      +++.....    .....+|+.|+|||++.+ ..++.++||||||+++|||++|+.|+....... ...........    
T Consensus       164 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~  238 (343)
T cd07878         164 LARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPE  238 (343)
T ss_pred             cceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHH
Confidence            99865432    223468999999999876 578999999999999999999998875432211 11111110000    


Q ss_pred             -------Cc-------cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          492 -------GR-------LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       492 -------~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                             ..       +.......+. .........+.+++.+|++.||.+|||+.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         239 VLKKISSEHARKYIQSLPHMPQQDLK-KIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHHhcchhhHHHHhhccccccchhHH-HhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                   00       0000000000 0011223457899999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.5e-36  Score=301.32  Aligned_cols=263  Identities=26%  Similarity=0.305  Sum_probs=203.8

Q ss_pred             cChHHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeec
Q 008239          259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT  336 (573)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  336 (573)
                      +...++..+.++|+..+.||+|+||.||++... +++.+|+|.+.... .....+.+|+.++.++ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            445566677899999999999999999999874 68899999885432 2345677899999998 89999999998875


Q ss_pred             C-----CceeEEEEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcE
Q 008239          337 G-----PESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA  410 (573)
Q Consensus       337 ~-----~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~  410 (573)
                      .     ...++|+||+++++|.+++... .....+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            3     3578999999999999887532 23346899999999999999999999987   9999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccCcCcCchhhhccC-----CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH
Q 008239          411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-----KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV  485 (573)
Q Consensus       411 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~  485 (573)
                      ||+|||++........ ......++..|+|||.+...     .++.++||||||+++|||++|+.|+......    ...
T Consensus       168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~----~~~  242 (291)
T cd06639         168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV----KTL  242 (291)
T ss_pred             EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH----HHH
Confidence            9999999886543221 12234678899999998654     3688999999999999999999887543221    111


Q ss_pred             HHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          486 WDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       486 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ... ..+....     +.  .+......+.+++.+||+.+|++||++.|+++.
T Consensus       243 ~~~-~~~~~~~-----~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         243 FKI-PRNPPPT-----LL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             HHH-hcCCCCC-----CC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            111 1111111     10  122344578999999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-36  Score=299.55  Aligned_cols=262  Identities=22%  Similarity=0.288  Sum_probs=196.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..+.||+|++|.||+|+.. +++.||||.+..... .....+.+|++++++++|+||+++++++.+....++||||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY   84 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence            57888999999999999999976 688999999865432 2234567899999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++ +|.+++....  ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus        85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  158 (291)
T cd07844          85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK  158 (291)
T ss_pred             CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence            984 8988775432  36889999999999999999999987   99999999999999999999999999875432211


Q ss_pred             ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc---ccc------
Q 008239          427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR---LHE------  496 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~------  496 (573)
                       ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+.............+.......   +..      
T Consensus       159 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         159 -TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             -cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence             1122346788999998875 46889999999999999999999887543321111221221111100   000      


Q ss_pred             --------ccCccccCCC-CCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          497 --------AVDPALAGNF-QEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       497 --------~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                              .....+.... .......+.+++.+|++.+|++||+++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                    0000000000 1111267789999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-36  Score=309.11  Aligned_cols=240  Identities=24%  Similarity=0.264  Sum_probs=187.1

Q ss_pred             ccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCC---CCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ||+|+||+||+++.. +++.||||++....   ......+..|..++..+   +||||+++++.+......++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999875 58999999985432   12233455666776655   699999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~~  153 (330)
T cd05586          81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KTT  153 (330)
T ss_pred             ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CCc
Confidence            999888743   345899999999999999999999988   9999999999999999999999999987543222 122


Q ss_pred             cccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCC
Q 008239          430 ATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE  508 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  508 (573)
                      ....||+.|+|||.+.+. .++.++|||||||++|||++|+.|+.....     ...+.....+..      .+.   ..
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~-----~~~~~~i~~~~~------~~~---~~  219 (330)
T cd05586         154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDT-----QQMYRNIAFGKV------RFP---KN  219 (330)
T ss_pred             cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCH-----HHHHHHHHcCCC------CCC---Cc
Confidence            345789999999998764 489999999999999999999999754321     112222222211      011   11


Q ss_pred             chHHHHHHHHHHccCCCCCCCC----CHHHHHH
Q 008239          509 GKPSRLLQIGLLCVQASAELRP----SMSIVVK  537 (573)
Q Consensus       509 ~~~~~l~~l~~~cl~~~p~~RP----t~~evl~  537 (573)
                      ..+..+.+++.+||+.+|++||    ++.++++
T Consensus       220 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         220 VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             cCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            2456788999999999999998    5666665

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1e-35  Score=296.59  Aligned_cols=247  Identities=26%  Similarity=0.398  Sum_probs=200.8

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      -|+..++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++++++||||+++++++..+...++||||+
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   84 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL   84 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence            3667889999999999999864 68899999875432 334567889999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++..    ..+++..+..++.|++.++.|||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        85 ~~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06641          85 GGGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence            99999988742    35889999999999999999999987   99999999999999999999999999876543221 


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      ......++..|+|||.+....++.++||||||+++|||++|..|+.....    .... .....+.         .....
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~----~~~~-~~~~~~~---------~~~~~  222 (277)
T cd06641         157 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHP----MKVL-FLIPKNN---------PPTLE  222 (277)
T ss_pred             hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccch----HHHH-HHHhcCC---------CCCCC
Confidence            12234578899999999888899999999999999999999988643221    1111 1111111         11223


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...+..+.+++.+||+.+|.+||++.++++.
T Consensus       223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         223 GNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             cccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            3456778999999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=5.8e-36  Score=299.12  Aligned_cols=251  Identities=23%  Similarity=0.334  Sum_probs=194.2

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHH-HcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNL-ISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|+..+.||+|+||.||+++.. +|+.||||++.... .+....+..|+.. ++.++||||+++++++..+...+++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            46888999999999999999975 68999999986542 2233455566665 666799999999999999999999999


Q ss_pred             eccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          346 FVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       346 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |++ |+|.+++... .....+++..++.++.||+.||+|||++ +   ++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~  156 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD  156 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            996 6787776432 2335689999999999999999999986 5   99999999999999999999999999886543


Q ss_pred             CCcccccccccCcCcCchhhhcc----CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          424 DITHISATLAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ..  ......++..|+|||.+.+    ..++.++|+||||+++|||++|+.|+......   .+...... .+.     .
T Consensus       157 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~~~-~~~-----~  225 (283)
T cd06617         157 SV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP---FQQLKQVV-EEP-----S  225 (283)
T ss_pred             cc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC---HHHHHHHH-hcC-----C
Confidence            21  1223467889999998864    45688999999999999999999987532221   11111111 110     1


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +.+.   ....+..+.+++.+||+.+|++||+++++++
T Consensus       226 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         226 PQLP---AEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             CCCC---ccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            1110   1234577899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-35  Score=295.85  Aligned_cols=248  Identities=27%  Similarity=0.431  Sum_probs=199.3

Q ss_pred             CccccccccccCceeEEEEEc-CCCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCC---CCCeeeeeeeeecCCceeEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .|+..+.||+|+||.||+|.+ .+++.||||.+... .....+++.+|+.++++++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            477889999999999999997 46899999998654 3344567888999999986   999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++..    ..+++..++.++.|++.||.|||+.+   |+|+||+|+||+++.++.++|+|||++..+...
T Consensus        82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06917          82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN  154 (277)
T ss_pred             ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence            99999999988732    26899999999999999999999988   999999999999999999999999999876543


Q ss_pred             CcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .. ......|+..|+|||.+.++ .++.++||||||+++|||++|+.|+......    ... ....     ....+.+.
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~----~~~-~~~~-----~~~~~~~~  223 (277)
T cd06917         155 SS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAF----RAM-MLIP-----KSKPPRLE  223 (277)
T ss_pred             cc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChh----hhh-hccc-----cCCCCCCC
Confidence            32 22344688899999988754 5789999999999999999999987533211    110 0000     00111111


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                         ....+..+.+++.+||+.+|++||++.+++++
T Consensus       224 ---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         224 ---DNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             ---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence               11256788999999999999999999999864

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.6e-35  Score=296.54  Aligned_cols=248  Identities=27%  Similarity=0.390  Sum_probs=201.5

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      .|...++||+|++|.||++... +++.+++|++........+.+.+|+.+++.++||||+++++++......++++||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            3455679999999999999864 688999999876555556778899999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +++|.+++..    ..+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.++|+|||++........ .
T Consensus       100 ~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~  171 (285)
T cd06648         100 GGALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R  171 (285)
T ss_pred             CCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence            9999998843    35889999999999999999999988   99999999999999999999999998876543322 1


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE  508 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  508 (573)
                      .....|+..|+|||.+.+..++.++||||||+++|||++|+.|+.....    ...... ...+.     .+.+.  ...
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~----~~~~~~-~~~~~-----~~~~~--~~~  239 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPP----LQAMKR-IRDNL-----PPKLK--NLH  239 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCH----HHHHHH-HHhcC-----CCCCc--ccc
Confidence            2234688999999999888899999999999999999999998754321    111111 11110     11111  122


Q ss_pred             chHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          509 GKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       509 ~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+..+.+++.+||+.+|++||++.++++
T Consensus       240 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         240 KVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            35578999999999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-36  Score=304.09  Aligned_cols=254  Identities=24%  Similarity=0.368  Sum_probs=204.7

Q ss_pred             HHhcCccccccccccCceeEEEEEcCCCCEEEEEEecc--cChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeE
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  342 (573)
                      .....|+.+++||+||.+.||++...+.+.+|+|++..  .+.+...-|.+|+.+|.+| .|.+||+|++|-..++.+|+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm  437 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM  437 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence            34466889999999999999999998888899997743  4567788899999999999 59999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||- ..+|..+|..+... ...| .+..+..|++.++.++|+++   |||-||||.|+|+-.+ .+||+|||+|..+.
T Consensus       438 vmE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVkG-~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  438 VMECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVKG-RLKLIDFGIANAIQ  510 (677)
T ss_pred             Eeecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEee-eEEeeeechhcccC
Confidence            99986 55888888544332 2345 67788899999999999998   9999999999998754 89999999999887


Q ss_pred             CCCcccc-cccccCcCcCchhhhccC-----------CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh
Q 008239          423 EDITHIS-ATLAGTLGYMAPEYVVRG-----------KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV  490 (573)
Q Consensus       423 ~~~~~~~-~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  490 (573)
                      .+.+... ...+||+.||+||.+...           +.+.+|||||+|||||+|+.|+.||....+          .+ 
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----------~~-  579 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----------QI-  579 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------HH-
Confidence            7665543 367899999999998543           256799999999999999999999753221          11 


Q ss_pred             cCccccccCccccCCCCCc-hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          491 KGRLHEAVDPALAGNFQEG-KPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       491 ~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       .+++.+.||....+++.- ...+++++|..||+.||.+||++.|+|+.
T Consensus       580 -aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 -AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence             134455666444333322 23349999999999999999999999963

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-35  Score=298.48  Aligned_cols=264  Identities=22%  Similarity=0.284  Sum_probs=197.6

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++++|...+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++|+||+++++++..+...++|+
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            3578999999999999999999864 688999999865432 22346778999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+. ++|.+++...  ...+++..+..++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||+++.....
T Consensus        83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  156 (291)
T cd07870          83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP  156 (291)
T ss_pred             eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence            9995 6777766432  235788889999999999999999987   999999999999999999999999998754322


Q ss_pred             CcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC---------cc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG---------RL  494 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---------~~  494 (573)
                      .. ......++..|+|||.+.+. .++.++||||||+++|||++|+.|+.............|......         ..
T Consensus       157 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         157 SQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             CC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence            11 12234568899999998754 578899999999999999999998764432212222222211100         00


Q ss_pred             ccccCccccC-------C--CCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          495 HEAVDPALAG-------N--FQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       495 ~~~~d~~l~~-------~--~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..........       .  .....+..+.+++.+|++.+|++|||++|++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence            0000000000       0  00122467789999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-36  Score=327.32  Aligned_cols=264  Identities=25%  Similarity=0.342  Sum_probs=214.6

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEcC----C----CCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeee
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTLP----G----GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLG  332 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~----g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~  332 (573)
                      .++...++.+..+.||+|.||.|++|...    .    ...||||.++... ....+.+..|+++|+.+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            45556666677779999999999999853    1    3579999997653 34567899999999999 6999999999


Q ss_pred             eeecCCceeEEEEeccCCCccccccccC-----C------C--CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q 008239          333 CSITGPESLLVYEFVPNQSLLDNLFVRQ-----D------V--EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL  399 (573)
Q Consensus       333 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~------~--~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~  399 (573)
                      +|......++|+||+..|+|.+++...+     .      .  ..++...++.++.|||.||+||++..   +|||||.+
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhh
Confidence            9999999999999999999999997554     0      0  23888999999999999999999987   99999999


Q ss_pred             CCeeeCCCCcEEEeecccccccCCCCcccccccc--cCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCC
Q 008239          400 SNILLDEEFTAKIADFGLVRLFPEDITHISATLA--GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN  477 (573)
Q Consensus       400 ~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~  477 (573)
                      +|||+..+..+||+|||+++..............  -+..|||||.+....|+.|+|||||||+||||+|.+.++.....
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999965444333322222  35679999999999999999999999999999998887765522


Q ss_pred             CcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          478 SCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                         ....++.....|..         -+.+..+..+++++|+.||+.+|++||++.++++.++.
T Consensus       527 ---~~~~l~~~l~~G~r---------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  527 ---PTEELLEFLKEGNR---------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             ---cHHHHHHHHhcCCC---------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence               12222334444432         23355678899999999999999999999999999966

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.2e-36  Score=322.80  Aligned_cols=265  Identities=18%  Similarity=0.284  Sum_probs=191.1

Q ss_pred             HhcCccccccccccCceeEEEEEcCC--CCEEEEEE--------------ec---ccChhhHHHHHHHHHHHcCCCCCCe
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPG--GEAVAVKR--------------LF---YNTTQWVDHFFNEVNLISGINHKNL  327 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~--------------~~---~~~~~~~~~~~~E~~~l~~l~h~ni  327 (573)
                      ..++|++.++||+|+||+||++.+..  +...++|.              +.   .........+.+|+.+|++++||||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI  225 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI  225 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence            34689999999999999999987532  22222221              10   1122334568899999999999999


Q ss_pred             eeeeeeeecCCceeEEEEeccCCCccccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC
Q 008239          328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD--VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD  405 (573)
Q Consensus       328 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~  405 (573)
                      +++++++......++|+|++. ++|.+++.....  ........+..++.||+.||.|||+++   |+||||||+|||++
T Consensus       226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~  301 (501)
T PHA03210        226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN  301 (501)
T ss_pred             CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence            999999999999999999985 567666643211  122345667889999999999999987   99999999999999


Q ss_pred             CCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcc---hH
Q 008239          406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS---IL  482 (573)
Q Consensus       406 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~---~~  482 (573)
                      .++.+||+|||+++.+............||..|+|||++.+..++.++|||||||++|||++|+.++........   +.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            999999999999987755443334456789999999999999999999999999999999999876544332211   11


Q ss_pred             HHH-----------------HHHhhcCcccc---ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          483 QTV-----------------WDLYVKGRLHE---AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       483 ~~~-----------------~~~~~~~~~~~---~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..+                 +..+....+..   .+.+.+.   ....+..+.+++.+||+.||.+|||+.|++++
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIR---NLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHH---hcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            110                 01000000000   0000000   01234567788999999999999999999874

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=9.7e-36  Score=297.81  Aligned_cols=260  Identities=24%  Similarity=0.319  Sum_probs=198.6

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--CceeEEEE
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLVYE  345 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~e  345 (573)
                      |+..++||+|+||.||+|+.. +++.+|+|++....  ....+.+.+|+.++++++|+|++++++++...  ...++|+|
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            567889999999999999976 48899999997653  33456788999999999999999999999888  78999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++ +|.+++...  ...+++..++.++.||+.||+|||+.+   ++|+||+|+||++++++.+||+|||++.......
T Consensus        81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~  154 (287)
T cd07840          81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN  154 (287)
T ss_pred             cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence            9975 888877433  246899999999999999999999987   9999999999999999999999999998665443


Q ss_pred             cccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc---Cccc------
Q 008239          426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK---GRLH------  495 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~------  495 (573)
                      ........++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ...........   ..+.      
T Consensus       155 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         155 SADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE-QLEKIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             cccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchhhccccccch
Confidence            222233456788999997765 467899999999999999999998875433211 11111111000   0000      


Q ss_pred             --------cccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          496 --------EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       496 --------~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                              ......+...+....+..+.+++.+||+.+|++||+++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence                    000011111111223678899999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-36  Score=297.26  Aligned_cols=255  Identities=28%  Similarity=0.364  Sum_probs=200.6

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCC-----
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP-----  338 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~-----  338 (573)
                      .++++|+..+.||+|++|.||+|... +++.+++|++..... ..+.+.+|+.+++++ +|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            35688999999999999999999985 578999999865543 346788999999999 7999999999987654     


Q ss_pred             -ceeEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          339 -ESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       339 -~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                       ..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence             4799999999999998875422 2456899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhcc-----CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      ++....... .......++..|+|||.+..     ..++.++||||||++++||++|+.|+........+.    .. ..
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~----~~-~~  232 (275)
T cd06608         159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF----KI-PR  232 (275)
T ss_pred             cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH----Hh-hc
Confidence            987654322 22234457889999998753     346789999999999999999999875322111111    11 11


Q ss_pred             CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       492 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +.     .+.+.  .+...+..+.+++.+||..||++|||+.++++
T Consensus       233 ~~-----~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         233 NP-----PPTLK--SPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             cC-----CCCCC--chhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            10     11111  12224567889999999999999999999986

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.5e-35  Score=297.88  Aligned_cols=261  Identities=24%  Similarity=0.339  Sum_probs=198.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--CceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  343 (573)
                      ++|+..+.||+|+||.||+|... +++.+++|.+....  ......+.+|+.++++++||||+++++++...  ...++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999986 58899999986543  22334567899999999999999999998877  889999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      +||++ ++|.+++....  ..+++..++.++.||+.||+|||+.+   ++|+||+|+||+++.++.+||+|||++.....
T Consensus        85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  158 (293)
T cd07843          85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS  158 (293)
T ss_pred             ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence            99997 48888775432  36899999999999999999999988   99999999999999999999999999886654


Q ss_pred             CCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHH-----------HHHHhh-
Q 008239          424 DITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT-----------VWDLYV-  490 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~-----------~~~~~~-  490 (573)
                      .... .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+....... ....           .|..+. 
T Consensus       159 ~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         159 PLKP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEID-QLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             Cccc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCchHHHHHhhc
Confidence            3211 1234568899999998754 46899999999999999999998875432211 1111           111110 


Q ss_pred             -----cCccccccCccccCCCCCc-hHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          491 -----KGRLHEAVDPALAGNFQEG-KPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       491 -----~~~~~~~~d~~l~~~~~~~-~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                           ...........+...++.. ....+.+++.+||+.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                 0011111111122222222 4667889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=8.6e-36  Score=302.79  Aligned_cols=264  Identities=19%  Similarity=0.306  Sum_probs=197.0

Q ss_pred             CccccccccccCceeEEEEEcC---CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--Ccee
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESL  341 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~  341 (573)
                      .|+..++||+|+||.||+|+..   +++.||||.+....   ....+.+.+|+.+++.++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            3778899999999999999975   47899999997633   34456778899999999999999999999988  7899


Q ss_pred             EEEEeccCCCccccccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC----CCcEEEeec
Q 008239          342 LVYEFVPNQSLLDNLFVRQ--DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE----EFTAKIADF  415 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~----~~~~kl~Df  415 (573)
                      +||||+++ +|.+++....  ....+++..++.++.||+.||+|||+.+   |+||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 6666553222  2236889999999999999999999988   999999999999999    899999999


Q ss_pred             ccccccCCCCc--ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--------chHHH
Q 008239          416 GLVRLFPEDIT--HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--------SILQT  484 (573)
Q Consensus       416 gla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--------~~~~~  484 (573)
                      |++........  .......++..|+|||.+.+ ..++.++||||||++++||++|+.|+.......        .....
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99986643322  12234567889999998876 458899999999999999999998876443321        00001


Q ss_pred             HHHHhh------------cCccccccCccccCCCC-----------CchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          485 VWDLYV------------KGRLHEAVDPALAGNFQ-----------EGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       485 ~~~~~~------------~~~~~~~~d~~l~~~~~-----------~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +.....            ........+......++           .....++.+++.+|++.+|++|||+.|+++
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            100000            00000000000000111           134567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7.5e-36  Score=298.51  Aligned_cols=261  Identities=25%  Similarity=0.363  Sum_probs=197.0

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..+.||+|++|.||+|+.. +|+.||||++....  ....+.+.+|++++++++||||+++++++.+....++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            4788999999999999999875 68899999886432  22345788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +. ++|.+++.... ...+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.+||+|||++........
T Consensus        81 ~~-~~l~~~~~~~~-~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~  155 (284)
T cd07860          81 LH-QDLKKFMDASP-LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  155 (284)
T ss_pred             cc-cCHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence            96 68888775432 346899999999999999999999987   99999999999999999999999999876543221


Q ss_pred             ccccccccCcCcCchhhhccCC-CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH----------HHHhhc----
Q 008239          427 HISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV----------WDLYVK----  491 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~----------~~~~~~----  491 (573)
                      . .....++..|+|||.+.+.. ++.++||||||+++|||++|+.|+..........+..          |.....    
T Consensus       156 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         156 T-YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             c-cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            1 22334678999999886644 6889999999999999999998875433221111111          000000    


Q ss_pred             -CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          492 -GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       492 -~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       ..........+. .........+.+++.+||+.||++|||++++++
T Consensus       235 ~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         235 KPSFPKWARQDFS-KVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HhhcccccccCHH-HHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence             000000000000 011223456789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.8e-35  Score=296.27  Aligned_cols=255  Identities=26%  Similarity=0.393  Sum_probs=206.1

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ..++.|+..+.||+|++|.||++.++ +++.|++|++..... ..+.+.+|+++++.++|+|++++++++......++|+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   94 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM   94 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence            34567888899999999999999986 688999999876544 4567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  169 (286)
T cd06614          95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE  169 (286)
T ss_pred             eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence            9999999999986433  36899999999999999999999987   999999999999999999999999998755432


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .. ......++..|++||.+.+..++.++||||||+++|||++|+.|+......    ..... ........     +  
T Consensus       170 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~----~~~~~-~~~~~~~~-----~--  236 (286)
T cd06614         170 KS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL----RALFL-ITTKGIPP-----L--  236 (286)
T ss_pred             hh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHH----HHHHH-HHhcCCCC-----C--
Confidence            21 122345788999999998888999999999999999999999886533221    11111 11111100     0  


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ......+..+.+++.+||+.+|..||++.++++..
T Consensus       237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  271 (286)
T cd06614         237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHP  271 (286)
T ss_pred             cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhCh
Confidence            11122456789999999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-35  Score=292.69  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=201.4

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..+.||+|+||.||++... +|..+|+|.+....  ....+.+.+|+.+++.++|+||+++++.+......++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            4778899999999999999986 57899999986532  23356788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDI  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~  425 (573)
                      +++++|.+++.... ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++ .+||+|||.+.......
T Consensus        81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          81 CDGGDLMKRINRQR-GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             CCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            99999999885432 235799999999999999999999987   99999999999999875 56999999988664332


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      . ......|++.|+|||.+....++.++||||||+++|||++|+.|+.....    ........ .+..         ..
T Consensus       157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~----~~~~~~~~-~~~~---------~~  221 (257)
T cd08225         157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNL----HQLVLKIC-QGYF---------AP  221 (257)
T ss_pred             c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHh-cccC---------CC
Confidence            1 22234578899999999888899999999999999999999998753321    11211111 1111         11


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .....+..+.+++.+|++.+|++|||+.|+++.
T Consensus       222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         222 ISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence            223456688999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.6e-35  Score=288.36  Aligned_cols=250  Identities=29%  Similarity=0.416  Sum_probs=204.5

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      +|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4677899999999999999986 688999999977655566789999999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +++|.+++....  ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||++++++.++|+|||.+........  
T Consensus        81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            999999885432  46899999999999999999999987   99999999999999999999999999886654332  


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE  508 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  508 (573)
                      .....++..|+|||.+.....+.++||||||++++||++|+.|+......    ...... .......     +.  ...
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~~-~~~~~~~-----~~--~~~  221 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPM----KALFKI-ATNGPPG-----LR--NPE  221 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchH----HHHHHH-HhcCCCC-----cC--ccc
Confidence            23456788999999998888999999999999999999999886543211    111111 1111101     10  011


Q ss_pred             chHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          509 GKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       509 ~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..+..+.+++.+||+.+|++|||+.++++.
T Consensus       222 ~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         222 KWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             ccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            125678999999999999999999999863

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-38  Score=291.66  Aligned_cols=249  Identities=27%  Similarity=0.371  Sum_probs=205.1

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      -|.++++||+|+||.|||+.++ .|+.+|||.+..+  ...+++.+|+.+|.+.+.|++|++||.+.....+++|||||.
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG  111 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence            3667899999999999999876 6999999998644  346789999999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      .|++.+.+..  ++.++++.++..++...++||+|||...   -||||||+.|||++.+|.+||+|||.+..+.+... .
T Consensus       112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-K  185 (502)
T KOG0574|consen  112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-K  185 (502)
T ss_pred             CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHH-h
Confidence            9999999854  4567999999999999999999999876   89999999999999999999999999987754433 3


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE  508 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  508 (573)
                      ..++.||+.|||||++..-.|+.++||||||+...||.-|++|...-..-+.+       +   -+.....|.++  -+.
T Consensus       186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-------F---MIPT~PPPTF~--KPE  253 (502)
T KOG0574|consen  186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-------F---MIPTKPPPTFK--KPE  253 (502)
T ss_pred             hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-------E---eccCCCCCCCC--ChH
Confidence            44678999999999999999999999999999999999999885321110000       0   00001112222  133


Q ss_pred             chHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          509 GKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       509 ~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .-+.++-+++..||-..|++|-|+-++++.
T Consensus       254 ~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  254 EWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            446678899999999999999999887764

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.9e-35  Score=299.25  Aligned_cols=247  Identities=30%  Similarity=0.455  Sum_probs=196.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ..|+..++||+|+||+||+|+.. +|+.||+|.+...   ..+..+.+.+|+++++.++||||+++++++......++|+
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~   94 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM   94 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence            45888899999999999999875 6889999988543   2334467889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||++ |+|.+++...  ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        95 e~~~-g~l~~~~~~~--~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          95 EYCL-GSASDILEVH--KKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             HhhC-CCHHHHHHHc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9997 5776666332  235899999999999999999999987   999999999999999999999999998755332


Q ss_pred             CcccccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          425 ITHISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                           ....++..|+|||.+.   .+.++.++||||||+++|||++|+.|+.....    ....... ....     .+.
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~----~~~~~~~-~~~~-----~~~  233 (307)
T cd06607         169 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHI-AQND-----SPT  233 (307)
T ss_pred             -----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccH----HHHHHHH-hcCC-----CCC
Confidence                 2345788999999874   45688999999999999999999988653321    1111111 1110     011


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      +   .....+..+.+++.+||+.+|++||++.+|+++.
T Consensus       234 ~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         234 L---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             C---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            1   1123456789999999999999999999998753

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-36  Score=287.28  Aligned_cols=263  Identities=23%  Similarity=0.317  Sum_probs=214.2

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEcC------CCCEEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeeeee
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSI  335 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~  335 (573)
                      ++.....+++....+-+|.||.||+|.|.      +.+.|-+|.++.+.. -....+..|.-++..+.|||+..+.+++.
T Consensus       278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~i  357 (563)
T KOG1024|consen  278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSI  357 (563)
T ss_pred             hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence            44455566788888999999999999654      345678888766533 34667889999999999999999999887


Q ss_pred             cC-CceeEEEEeccCCCcccccc-----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc
Q 008239          336 TG-PESLLVYEFVPNQSLLDNLF-----VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT  409 (573)
Q Consensus       336 ~~-~~~~lv~e~~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~  409 (573)
                      +. ...++++.++.-|+|..+|.     +......++..+...++.|++.||+|||+++   +||.||.++|++||+..+
T Consensus       358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~Lq  434 (563)
T KOG1024|consen  358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQ  434 (563)
T ss_pred             eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhee
Confidence            54 56789999999999999997     3344456778889999999999999999998   999999999999999999


Q ss_pred             EEEeeccccc-ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH
Q 008239          410 AKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       410 ~kl~Dfgla~-~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  488 (573)
                      +||+|=.+++ .++.+..........+..||+||.+.+..|+..+|||||||+||||+|-...+....+..+    +...
T Consensus       435 VkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE----m~~y  510 (563)
T KOG1024|consen  435 VKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE----MEHY  510 (563)
T ss_pred             EEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH----HHHH
Confidence            9999999998 5567777777777788999999999999999999999999999999986654443332222    2222


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      +.+|         .+-.-+.++|+++..+|.-||...|++||++++++.-|++
T Consensus       511 lkdG---------yRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLse  554 (563)
T KOG1024|consen  511 LKDG---------YRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSE  554 (563)
T ss_pred             Hhcc---------ceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHH
Confidence            2222         1223367899999999999999999999999999998854

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.2e-35  Score=295.00  Aligned_cols=262  Identities=24%  Similarity=0.355  Sum_probs=199.4

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      +|+..++||+|++|.||+|+.. +|+.||||.+..... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            4788999999999999999985 588999999875532 23456778999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++ +|.+++........+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||++........ 
T Consensus        81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-  155 (284)
T cd07836          81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-  155 (284)
T ss_pred             Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence            85 88887755444456899999999999999999999987   99999999999999999999999999976543221 


Q ss_pred             cccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHH----------HHHHhhcC-ccc
Q 008239          428 ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT----------VWDLYVKG-RLH  495 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~----------~~~~~~~~-~~~  495 (573)
                      ......++..|++||.+.+. .++.++||||||+++|||++|+.|+............          .|..+... ...
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            12234568899999988654 5788999999999999999999887543322111110          01111100 000


Q ss_pred             ccc----CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          496 EAV----DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       496 ~~~----d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+    +... .......+..+.+++.+|++.+|.+||++.++++
T Consensus       236 ~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         236 PTFPRYPPQDL-QQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             ccccCCChHHH-HHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000    0000 0111233567889999999999999999999985

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.1e-35  Score=318.15  Aligned_cols=263  Identities=22%  Similarity=0.248  Sum_probs=190.6

Q ss_pred             HHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCC------CCCeeeeeeee
Q 008239          262 ETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN------HKNLVKLLGCS  334 (573)
Q Consensus       262 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~  334 (573)
                      +++...+++|++.++||+|+||+||++... .++.||||++.... .....+..|+.++..++      |.+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            334455788999999999999999999875 57889999985432 22334555666666654      45688999988


Q ss_pred             ecC-CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCC----
Q 008239          335 ITG-PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEF----  408 (573)
Q Consensus       335 ~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~----  408 (573)
                      ... ...++|||++ +++|.+++..   ...+++..+..++.||+.||+|||++ +   ||||||||+|||++.++    
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~  273 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD  273 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence            754 4678999988 6788887743   24689999999999999999999974 6   99999999999998765    


Q ss_pred             ------------cEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCC
Q 008239          409 ------------TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ  476 (573)
Q Consensus       409 ------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~  476 (573)
                                  .+||+|||++.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus       274 ~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        274 PVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             cccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                        499999998764321    2235678999999999999999999999999999999999999886543


Q ss_pred             CCcchHHHHHHH--------------------hh-cCccccccCcc-c---cC--CC-CCchHHHHHHHHHHccCCCCCC
Q 008239          477 NSCSILQTVWDL--------------------YV-KGRLHEAVDPA-L---AG--NF-QEGKPSRLLQIGLLCVQASAEL  528 (573)
Q Consensus       477 ~~~~~~~~~~~~--------------------~~-~~~~~~~~d~~-l---~~--~~-~~~~~~~l~~l~~~cl~~~p~~  528 (573)
                      .... ...+...                    +. .+.+....++. +   ..  .. .......+.+|+.+||+.||++
T Consensus       350 ~~~~-~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        350 NLEH-LHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             hHHH-HHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            2211 1111000                    00 00000000000 0   00  00 0012345779999999999999


Q ss_pred             CCCHHHHHH
Q 008239          529 RPSMSIVVK  537 (573)
Q Consensus       529 RPt~~evl~  537 (573)
                      |||++|+++
T Consensus       429 R~ta~e~L~  437 (467)
T PTZ00284        429 RLNARQMTT  437 (467)
T ss_pred             CCCHHHHhc
Confidence            999999997

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.5e-36  Score=328.26  Aligned_cols=254  Identities=27%  Similarity=0.399  Sum_probs=192.1

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec-------
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-------  336 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------  336 (573)
                      ....+|++++.||+||||.|||++.+ ||+.||||++... +......+.+|+.+|++|+|||||+++..+.+       
T Consensus       476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            45678999999999999999999986 8999999999665 33445678899999999999999999854211       


Q ss_pred             --------------------------------------------------------------------------------
Q 008239          337 --------------------------------------------------------------------------------  336 (573)
Q Consensus       337 --------------------------------------------------------------------------------  336 (573)
                                                                                                      
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------C--------CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 008239          337 ------------------------G--------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL  384 (573)
Q Consensus       337 ------------------------~--------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL  384 (573)
                                              .        ..+||-||||+...|.+++..+...  -.....|+++.+|+.||+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~--~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN--SQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc--hhhHHHHHHHHHHHHHHHHH
Confidence                                    0        1235778888887776666432211  14677899999999999999


Q ss_pred             HhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC------C-----------CCcccccccccCcCcCchhhhccC
Q 008239          385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP------E-----------DITHISATLAGTLGYMAPEYVVRG  447 (573)
Q Consensus       385 H~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~------~-----------~~~~~~~~~~gt~~y~aPE~~~~~  447 (573)
                      |+++   ||||||||.||+++++..|||+|||+++...      +           ......+..+||.-|+|||++.+.
T Consensus       714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~  790 (1351)
T KOG1035|consen  714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT  790 (1351)
T ss_pred             HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence            9998   9999999999999999999999999998621      0           011133466899999999999764


Q ss_pred             ---CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCC
Q 008239          448 ---KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQA  524 (573)
Q Consensus       448 ---~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~  524 (573)
                         +|+.|+|+|||||||+||+   .||...++....+..    ++.+.+..-      ..+.......-..++.++++.
T Consensus       791 ~~~~Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~----LR~g~iP~~------~~f~~~~~~~e~slI~~Ll~h  857 (1351)
T KOG1035|consen  791 SSNKYNSKIDMYSLGIVLFEML---YPFGTSMERASILTN----LRKGSIPEP------ADFFDPEHPEEASLIRWLLSH  857 (1351)
T ss_pred             ccccccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHh----cccCCCCCC------cccccccchHHHHHHHHHhcC
Confidence               5999999999999999998   456655543333222    233333222      111223334446899999999


Q ss_pred             CCCCCCCHHHHHH
Q 008239          525 SAELRPSMSIVVK  537 (573)
Q Consensus       525 ~p~~RPt~~evl~  537 (573)
                      ||.+|||+.|+++
T Consensus       858 dP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  858 DPSKRPTATELLN  870 (1351)
T ss_pred             CCccCCCHHHHhh
Confidence            9999999999985

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2e-35  Score=291.09  Aligned_cols=247  Identities=25%  Similarity=0.257  Sum_probs=202.9

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      +|+..++||+|+||.||++... +++.||+|.+....   ....+.+.+|++++++++||||+++++.+......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            4788999999999999999986 58999999986532   2446788999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++...   ..+++..+..++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  154 (258)
T cd05578          81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT  154 (258)
T ss_pred             CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence            99999999888432   46889999999999999999999987   9999999999999999999999999988654432


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                        ......++..|+|||.+....++.++||||||+++|+|++|+.|+......  ...........          ....
T Consensus       155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~~~~~~~----------~~~~  220 (258)
T cd05578         155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQET----------ADVL  220 (258)
T ss_pred             --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCcc--HHHHHHHHhcc----------cccc
Confidence              223456788999999999888999999999999999999999987654432  11111111110          1112


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCH--HHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSM--SIVV  536 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~--~evl  536 (573)
                      .+...+..+.+++.+||+.+|.+||++  +|++
T Consensus       221 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         221 YPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             CcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            334456889999999999999999999  6654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.4e-35  Score=295.55  Aligned_cols=254  Identities=25%  Similarity=0.341  Sum_probs=195.9

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..++||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~   84 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL   84 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence            4566789999999999999875 58999999986542 344567889999999996 99999999999998999999999


Q ss_pred             ccCCCccccccc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          347 VPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       347 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      ++. +|.++...  ......+++..+..++.+++.||+|||+. +   ++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            864 55443211  11235689999999999999999999975 5   99999999999999999999999999976543


Q ss_pred             CCcccccccccCcCcCchhhhccC---CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRG---KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ...  .....++..|+|||.+...   .++.++||||||+++|||++|+.|+....   ........... +     ..+
T Consensus       161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~-~-----~~~  229 (288)
T cd06616         161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN---SVFDQLTQVVK-G-----DPP  229 (288)
T ss_pred             CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc---hHHHHHhhhcC-C-----CCC
Confidence            221  1233578899999998766   68999999999999999999999875432   11111111111 1     112


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+........+..+.+++.+||+.+|++|||+++|++.
T Consensus       230 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         230 ILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            22222223467789999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=295.40  Aligned_cols=260  Identities=25%  Similarity=0.352  Sum_probs=196.5

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      |+..++||.|++|.||+|... +|+.||||++....  ....+.+.+|++++++++|||++++++++.+....+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            567889999999999999875 68999999986543  223456888999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      + ++|.+++..... ..+++..++.++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~  155 (283)
T cd07835          81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT  155 (283)
T ss_pred             C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence            5 688888754322 35899999999999999999999987   999999999999999999999999998765332211


Q ss_pred             cccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH----------HHHhhc-Cc--
Q 008239          428 ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV----------WDLYVK-GR--  493 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~----------~~~~~~-~~--  493 (573)
                       .....++..|+|||++.+. .++.++||||||+++|||++|+.|+........+....          |..... ..  
T Consensus       156 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         156 -YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             -cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence             1223468899999988654 57899999999999999999998875432211111100          000000 00  


Q ss_pred             --cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          494 --LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       494 --~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ......... .......+..+.+++.+|++.+|++|||++|+++
T Consensus       235 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         235 PTFPKWARQDL-SKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhcccccccch-hhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence              000000000 1112344567889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.1e-35  Score=287.45  Aligned_cols=250  Identities=27%  Similarity=0.353  Sum_probs=205.9

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--CceeEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLVY  344 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv~  344 (573)
                      +|+..+.||+|++|.||+|... +++.|++|++....  ....+.+.+|+.++++++|+||+++++.+...  ...++|+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4677899999999999999986 68899999986554  24567889999999999999999999999988  8899999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++...   ..+++..++.++.|++.+|+|||+.+   ++|+||+|+||+++.++.++|+|||.+......
T Consensus        81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  154 (260)
T cd06606          81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI  154 (260)
T ss_pred             EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence            999999999988543   27899999999999999999999987   999999999999999999999999999876544


Q ss_pred             Ccc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 ITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ... ......++..|+|||.+.....+.++||||||++++||++|..|+.....   .....+....         ....
T Consensus       155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~~---------~~~~  222 (260)
T cd06606         155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN---PMAALYKIGS---------SGEP  222 (260)
T ss_pred             cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHhccc---------cCCC
Confidence            321 12345678899999999888899999999999999999999998765431   1122211111         1111


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ...+...+..+.+++.+|++.+|++||++.++++
T Consensus       223 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         223 PEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             cCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            2234445778999999999999999999999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=4.8e-35  Score=297.67  Aligned_cols=245  Identities=29%  Similarity=0.417  Sum_probs=195.9

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      |+..+.||+|+||.||+++.. +++.||+|++...   ..+..+.+.+|+++++.++|||++++++++......++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            667889999999999999975 6889999998643   233456788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      ++ |+|.+.+...  ...+++..+..++.|++.||.|||+.+   |+||||+|+||+++.++.+||+|||++......  
T Consensus       107 ~~-g~l~~~~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         107 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             CC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            97 5777766432  345899999999999999999999987   999999999999999999999999998754322  


Q ss_pred             ccccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          427 HISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                         ....++..|+|||.+.   .+.++.++||||||+++|||++|+.|+......    ... .....+..        .
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~----~~~-~~~~~~~~--------~  242 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SAL-YHIAQNES--------P  242 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHH----HHH-HHHHhccC--------C
Confidence               2345788999999974   457889999999999999999999887543211    111 11111110        0


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      .......+..+.+++.+||+.+|.+||++.+|++.+
T Consensus       243 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~  278 (317)
T cd06635         243 TLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM  278 (317)
T ss_pred             CCCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence            111223456788999999999999999999999866

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=3.6e-35  Score=290.02  Aligned_cols=242  Identities=22%  Similarity=0.252  Sum_probs=196.4

Q ss_pred             ccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCc
Q 008239          277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL  352 (573)
Q Consensus       277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  352 (573)
                      ||.|+||.||+++.. +++.|++|.+....   ....+.+.+|+.+++.++||||+++++.+.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999986 48899999986532   23456789999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 008239          353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL  432 (573)
Q Consensus       353 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  432 (573)
                      .+++...   ..+++..+..++.||+.||+|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .....
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~  152 (262)
T cd05572          81 WTILRDR---GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTF  152 (262)
T ss_pred             HHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccc
Confidence            9988532   34889999999999999999999987   9999999999999999999999999998765432  22334


Q ss_pred             ccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHH
Q 008239          433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS  512 (573)
Q Consensus       433 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  512 (573)
                      .++..|++||.+....++.++|+||||+++|||++|+.|+.......  ... ......        ......++...+.
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~-~~~~~~--------~~~~~~~~~~~~~  221 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP--MEI-YNDILK--------GNGKLEFPNYIDK  221 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH--HHH-HHHHhc--------cCCCCCCCcccCH
Confidence            67889999999988889999999999999999999999876543211  111 111110        0111223344467


Q ss_pred             HHHHHHHHccCCCCCCCCC-----HHHHHH
Q 008239          513 RLLQIGLLCVQASAELRPS-----MSIVVK  537 (573)
Q Consensus       513 ~l~~l~~~cl~~~p~~RPt-----~~evl~  537 (573)
                      .+.+++.+||+.+|++||+     ++|+++
T Consensus       222 ~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         222 AAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            8999999999999999999     677765

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=7.1e-35  Score=300.92  Aligned_cols=260  Identities=25%  Similarity=0.311  Sum_probs=197.4

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC------
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------  337 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  337 (573)
                      ..++|+..+.||+|+||.||++... +|+.||||++...  .....+.+.+|+.++++++||||+++++++...      
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   93 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF   93 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence            4578999999999999999999875 6899999998643  333456778899999999999999999987643      


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ...++||||+. ++|.+.+..     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~  164 (353)
T cd07850          94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL  164 (353)
T ss_pred             CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence            35689999996 477776632     2788999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHH-----------
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVW-----------  486 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~-----------  486 (573)
                      ++.......  .....++..|+|||.+.+..++.++||||||+++|||++|+.|+....... ....+.           
T Consensus       165 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  241 (353)
T cd07850         165 ARTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDEFM  241 (353)
T ss_pred             ceeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence            986543221  233457889999999999999999999999999999999998875432110 000000           


Q ss_pred             -------HHhhcCc-------cccccCcccc----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          487 -------DLYVKGR-------LHEAVDPALA----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       487 -------~~~~~~~-------~~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                             ..+....       +.+.+...+.    .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         242 SRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   0000000       0011111100    01122346678899999999999999999999954

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.6e-35  Score=292.89  Aligned_cols=259  Identities=18%  Similarity=0.200  Sum_probs=185.4

Q ss_pred             hcCccccccccccCceeEEEEEcCC----CCEEEEEEecccChhhH-----------HHHHHHHHHHcCCCCCCeeeeee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQWV-----------DHFFNEVNLISGINHKNLVKLLG  332 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~l~~  332 (573)
                      .+.|++.++||+|+||.||+|...+    +..+|+|+.........           .....+...+..++|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            4679999999999999999999754    34566665432221110           11223445567789999999999


Q ss_pred             eeecCC----ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC
Q 008239          333 CSITGP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF  408 (573)
Q Consensus       333 ~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~  408 (573)
                      ++....    ..++++|++.. ++.+.+.   .....++..+..++.|++.||+|||+.+   |+||||||+|||++.++
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~  163 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLVE-NTKEIFK---RIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNN  163 (294)
T ss_pred             eeeEecCCceEEEEEEehhcc-CHHHHHH---hhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCC
Confidence            766543    23567776633 4444442   1223578888999999999999999987   99999999999999999


Q ss_pred             cEEEeecccccccCCCCcc------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchH
Q 008239          409 TAKIADFGLVRLFPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL  482 (573)
Q Consensus       409 ~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~  482 (573)
                      .++|+|||+++.+......      ......||+.|+|||.+.+..++.++|||||||++|||++|+.|+..........
T Consensus       164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999999866432211      1123468999999999999999999999999999999999999986553332222


Q ss_pred             HHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       483 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ......+.    ..+..+.+.   ....+..+.+++..|++.+|++||+++++++.|+
T Consensus       244 ~~~~~~~~----~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HAAKCDFI----KRLHEGKIK---IKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HHhHHHHH----HHhhhhhhc---cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            21111110    000111110   1234678899999999999999999999998773

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=6.9e-35  Score=292.60  Aligned_cols=251  Identities=25%  Similarity=0.271  Sum_probs=198.3

Q ss_pred             CccccccccccCceeEEEEEc----CCCCEEEEEEecccC----hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCce
Q 008239          270 YFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES  340 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  340 (573)
                      +|+..+.||+|+||.||+++.    .+|+.||+|++....    ....+.+.+|+.++.++ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            477889999999999999986    368899999986532    23346778899999999 699999999999998899


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++|+||+++++|.+++...   ..+++..+..++.|++.||.|||+.+   ++||||+|+|||++.++.+||+|||++..
T Consensus        81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  154 (290)
T cd05613          81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE  154 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence            9999999999999988532   45788999999999999999999987   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccCcCcCchhhhccC--CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      .............|+..|+|||.+...  .++.++||||||+++|||++|+.|+...................       
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~-------  227 (290)
T cd05613         155 FHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS-------  227 (290)
T ss_pred             cccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc-------
Confidence            644333333345688999999998753  46789999999999999999999875432222211111111110       


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVK  537 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  537 (573)
                          ...++......+.+++.+||+.+|++||     +.++++.
T Consensus       228 ----~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         228 ----EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             ----CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence                0122344567788999999999999997     6677665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=5.2e-35  Score=295.17  Aligned_cols=264  Identities=25%  Similarity=0.339  Sum_probs=198.6

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC----
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----  338 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----  338 (573)
                      ...++|+..+.||+|+||.||+|..+ +|+.||||++....  ......+.+|+.++++++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999986 58899999986543  223356778999999999999999999887654    


Q ss_pred             ------ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEE
Q 008239          339 ------ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI  412 (573)
Q Consensus       339 ------~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl  412 (573)
                            ..++|+||+++ +|...+...  ...+++..++.++.||+.||+|||+.+   |+|+||+|+||++++++.+||
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl  157 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL  157 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence                  78999999976 666665332  346899999999999999999999987   999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc
Q 008239          413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       413 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      +|||++...............++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .....+......
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~~  236 (302)
T cd07864         158 ADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCGS  236 (302)
T ss_pred             CcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCC
Confidence            9999998765433222223345778999998865 45789999999999999999998877543221 111112111110


Q ss_pred             C---cccccc--------C------ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          492 G---RLHEAV--------D------PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       492 ~---~~~~~~--------d------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .   ....+.        +      ..+. ......+..+.+++.+||+.+|++||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         237 PCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             CChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            0   000000        0      0000 011234678899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.9e-35  Score=292.26  Aligned_cols=255  Identities=24%  Similarity=0.276  Sum_probs=201.2

Q ss_pred             CccccccccccCceeEEEEEc----CCCCEEEEEEecccC----hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCce
Q 008239          270 YFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES  340 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  340 (573)
                      +|+..+.||+|+||.||+++.    .+++.||||.+....    ....+.+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            367789999999999999975    357889999986432    23345688999999999 599999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++++|.+++..   ...+++..+..++.|++++|.|||+.+   ++||||+|+||+++.++.++|+|||+++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~  154 (288)
T cd05583          81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE  154 (288)
T ss_pred             EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence            999999999999988843   245889999999999999999999987   99999999999999999999999999886


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCC--CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      +............++..|+|||.+.+..  .+.++||||||+++|||++|..|+......... ..........      
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~-~~~~~~~~~~------  227 (288)
T cd05583         155 FLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ-SEISRRILKS------  227 (288)
T ss_pred             cccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH-HHHHHHHHcc------
Confidence            5443322223456789999999987655  788999999999999999999987543221111 1111111110      


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .    ...+...+..+.+++.+||+.+|++|||+.++.+.|+.
T Consensus       228 ~----~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 K----PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             C----CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            0    12233455678899999999999999999998887743

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=6.5e-35  Score=293.39  Aligned_cols=261  Identities=21%  Similarity=0.315  Sum_probs=195.6

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|+..+.||+|++|+||+|+.. +|+.||+|++....  ....+.+.+|++++++++||||+++++++......++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            46888999999999999999975 68899999886532  2334578899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-CCcEEEeecccccccCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPED  424 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~  424 (573)
                      |++ ++|.+++.... ...+++..+..++.||+.||+|||+++   ++|+||+|+||+++. ++.+||+|||++......
T Consensus        82 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSP-DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP  156 (294)
T ss_pred             ccc-ccHHHHHHhCC-CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence            996 57777764322 234678888999999999999999987   999999999999985 567999999999765432


Q ss_pred             CcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc-----
Q 008239          425 ITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV-----  498 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  498 (573)
                      .. ......+++.|+|||.+.+ ..++.++||||||+++|||++|+.|+........+. ......... .....     
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~-~~~~~~~~~-~~~~~~~~~~  233 (294)
T PLN00009        157 VR-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIFRILGTP-NEETWPGVTS  233 (294)
T ss_pred             cc-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH-HHHHHhCCC-Chhhcccccc
Confidence            11 1223456889999998866 457899999999999999999988875433211111 111111000 00000     


Q ss_pred             --C-----cccc----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          499 --D-----PALA----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       499 --d-----~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        +     +...    .......+..+.+++.+|++.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence              0     0000    0112234567889999999999999999999996

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.6e-35  Score=286.66  Aligned_cols=251  Identities=23%  Similarity=0.340  Sum_probs=206.4

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..+.||+|+||.||++... +++.+++|++....  .+..+.+.+|+++++.++|+|++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            4778899999999999999975 58899999986543  24566788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          347 VPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      +++++|.+++.... ....+++..+..++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            99999999885432 2357899999999999999999999987   9999999999999999999999999998765443


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                       .......+++.|+|||.+....++.++||||||+++++|++|+.|+.....     ...........         ...
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~---------~~~  222 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENL-----LELALKILKGQ---------YPP  222 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcH-----HHHHHHHhcCC---------CCC
Confidence             223345678899999999888999999999999999999999988644321     11111111111         112


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+...+..+.+++.+||..+|++||++.++++.
T Consensus       223 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         223 IPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            233566789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1e-34  Score=289.41  Aligned_cols=244  Identities=21%  Similarity=0.245  Sum_probs=193.8

Q ss_pred             ccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCc
Q 008239          277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL  352 (573)
Q Consensus       277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  352 (573)
                      ||+|+||+||++... +|+.||+|.+....   ......+.+|+++++.++||||+++++.+...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999865 68899999986432   22344567899999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 008239          353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL  432 (573)
Q Consensus       353 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  432 (573)
                      .+++..... ..+++..++.++.|++.||.|||+.+   ++||||+|+||++++++.+||+|||++.......  .....
T Consensus        81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~  154 (277)
T cd05577          81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGR  154 (277)
T ss_pred             HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC--ccccc
Confidence            998864432 46899999999999999999999988   9999999999999999999999999987654321  12234


Q ss_pred             ccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHH
Q 008239          433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS  512 (573)
Q Consensus       433 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  512 (573)
                      .++..|+|||.+.++.++.++||||||++++||++|+.|+........ ..........          .....+...+.
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~----------~~~~~~~~~~~  223 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEELKRRTLE----------MAVEYPDKFSP  223 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHHHHhcccc----------ccccCCccCCH
Confidence            577899999999888899999999999999999999998754432111 1111110000          01123344577


Q ss_pred             HHHHHHHHccCCCCCCCC-----CHHHHHH
Q 008239          513 RLLQIGLLCVQASAELRP-----SMSIVVK  537 (573)
Q Consensus       513 ~l~~l~~~cl~~~p~~RP-----t~~evl~  537 (573)
                      .+.+++.+||+.+|++||     ++.++++
T Consensus       224 ~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         224 EAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            889999999999999999     6666664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=6.1e-35  Score=293.22  Aligned_cols=245  Identities=26%  Similarity=0.382  Sum_probs=198.0

Q ss_pred             ccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCC
Q 008239          273 ESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQS  351 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gs  351 (573)
                      ...+||+|+||.||++... +|+.||||++........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++
T Consensus        24 ~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  103 (292)
T cd06657          24 NFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA  103 (292)
T ss_pred             hHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCc
Confidence            3468999999999999874 689999999866555556778999999999999999999999999999999999999999


Q ss_pred             ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccc
Q 008239          352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT  431 (573)
Q Consensus       352 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~  431 (573)
                      |.+++..    ..+++.....++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........ ....
T Consensus       104 L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~  175 (292)
T cd06657         104 LTDIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKS  175 (292)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc-cccc
Confidence            9887632    34789999999999999999999987   99999999999999999999999999876543321 1233


Q ss_pred             cccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchH
Q 008239          432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKP  511 (573)
Q Consensus       432 ~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~  511 (573)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.|+...... ....    .....     ..+.+.  .....+
T Consensus       176 ~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~-~~~~----~~~~~-----~~~~~~--~~~~~~  243 (292)
T cd06657         176 LVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL-KAMK----MIRDN-----LPPKLK--NLHKVS  243 (292)
T ss_pred             cccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHH----HHHhh-----CCcccC--CcccCC
Confidence            46788999999998888999999999999999999999986543211 1111    11110     011111  112345


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          512 SRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       512 ~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+.+++.+||+.+|.+||++.++++
T Consensus       244 ~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         244 PSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             HHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            67889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4e-35  Score=288.30  Aligned_cols=249  Identities=25%  Similarity=0.353  Sum_probs=203.7

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..++||+|+||.||+++.. +++.+++|.+...  .......+.+|+.+++.++|+||+++++++......++|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            4778899999999999999865 6789999998653  233456778899999999999999999999999999999999


Q ss_pred             ccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          347 VPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      +++++|.+++.... ....+++..++.++.|++.||+|||+.+   ++|+||+|.||++++++.+||+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            99999999885422 2356899999999999999999999988   999999999999999999999999999876544 


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                        ......++..|++||.+.+..++.++|+||||+++|||++|+.|+.....     .........+..         ..
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-----~~~~~~~~~~~~---------~~  220 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM-----QDLRYKVQRGKY---------PP  220 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHhcCCC---------CC
Confidence              22234578899999999999999999999999999999999988754321     111111111111         12


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+...+.++.+++.+|++.+|++||++.++++.
T Consensus       221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             CchhhCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            233456789999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.9e-35  Score=293.23  Aligned_cols=263  Identities=21%  Similarity=0.278  Sum_probs=195.4

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCc-----
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPE-----  339 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~-----  339 (573)
                      ++|+..+.||+|+||.||+|... +++.||||++....  ......+.+|+.+++.++ ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            36888999999999999999975 68999999876542  223457888999999995 6999999999887665     


Q ss_pred             eeEEEEeccCCCccccccccCC--CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-CCcEEEeecc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQD--VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFG  416 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfg  416 (573)
                      .++||||+++ +|.+++.....  ...+++..++.++.||+.||.|||+.+   |+||||+|+||+++. ++.+||+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            7999999985 78887754322  346899999999999999999999987   999999999999998 8999999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcc-
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL-  494 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-  494 (573)
                      ++..+..... ......+++.|+|||.+.+ ..++.++||||||+++|||++|..|+.......... .+......... 
T Consensus       157 ~~~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~  234 (295)
T cd07837         157 LGRAFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLGTPTEQ  234 (295)
T ss_pred             cceecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHHHHhCCCChh
Confidence            9886533211 1122346788999998865 457899999999999999999998875432211111 11010000000 


Q ss_pred             --ccc---c--------CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          495 --HEA---V--------DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       495 --~~~---~--------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ...   .        .+..........+..+.+++.+||+.+|.+||+++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         235 VWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             hCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence              000   0        000000111235677899999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-34  Score=286.78  Aligned_cols=249  Identities=24%  Similarity=0.355  Sum_probs=197.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-----ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--Cce
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES  340 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  340 (573)
                      .+|+..+.||+|+||.||++... +++.||+|.+...     ..+....+.+|+.++++++|+||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46889999999999999999875 5899999987432     233456788999999999999999999988764  457


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++++||+++++|.+++..   ...+++....+++.||+.||.|||+.+   ++|+||+|+||+++.++.++|+|||+++.
T Consensus        82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~  155 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR  155 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence            899999999999988843   234788999999999999999999988   99999999999999999999999999986


Q ss_pred             cCCCCc--ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          421 FPEDIT--HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       421 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      ......  .......++..|+|||.+.+..++.++||||||++++||++|+.|+.....    .........        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~--------  223 (264)
T cd06653         156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEA----MAAIFKIAT--------  223 (264)
T ss_pred             cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCH----HHHHHHHHc--------
Confidence            532111  111234578899999999988899999999999999999999998753211    111111111        


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       .......+....+.+.+++.+|++ +|..||+..+++.
T Consensus       224 -~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         224 -QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             -CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence             011122345566789999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-35  Score=301.12  Aligned_cols=262  Identities=20%  Similarity=0.313  Sum_probs=195.3

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-----Cce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  340 (573)
                      +++|+..++||+|+||.||+|+.. +|+.||||++... .......+.+|+.++++++|+||+++++++...     ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            468999999999999999999864 6899999998643 334456788899999999999999999876644     357


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++|+||+++ +|.+.+.    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~  155 (336)
T cd07849          84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI  155 (336)
T ss_pred             EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence            899999964 7766652    235899999999999999999999988   99999999999999999999999999886


Q ss_pred             cCCCCcc--cccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC---cc
Q 008239          421 FPEDITH--ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG---RL  494 (573)
Q Consensus       421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~  494 (573)
                      .......  ......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .............   .+
T Consensus       156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~-~~~~~~~~~~~~~~~~~~  234 (336)
T cd07849         156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL-HQLNLILGVLGTPSQEDL  234 (336)
T ss_pred             ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHcCCCCHHHH
Confidence            5432211  1123467899999998755 56899999999999999999999887432211 1111111111100   00


Q ss_pred             ccccCcc-------cc--C-----CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          495 HEAVDPA-------LA--G-----NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       495 ~~~~d~~-------l~--~-----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..+.+..       +.  .     ......+..+.+++.+||+.+|++|||+.|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            0000000       00  0     0012235678899999999999999999999986

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-34  Score=281.96  Aligned_cols=247  Identities=27%  Similarity=0.451  Sum_probs=203.9

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccCh--hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|+..+.||+|++|.||+++.. +++.|++|.+.....  ...+.+.+|++++++++|+|++++++++.+....++++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            4778899999999999999875 578999999976543  4567889999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++...   ..+++..++.++.|++.||.|||+.+   |+||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  154 (254)
T cd06627          81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK  154 (254)
T ss_pred             CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence            9999999988433   56899999999999999999999987   99999999999999999999999999987654332


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      . .....++..|+|||.+.....+.++||||||++++||++|+.|+.....    ....+.... ..         ....
T Consensus       155 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~----~~~~~~~~~-~~---------~~~~  219 (254)
T cd06627         155 D-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNP----MAALFRIVQ-DD---------HPPL  219 (254)
T ss_pred             c-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccH----HHHHHHHhc-cC---------CCCC
Confidence            1 2334678899999999888889999999999999999999988754321    111222111 10         1122


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +...+..+.+++.+||+.+|++||++.+++.
T Consensus       220 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         220 PEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            3345678899999999999999999999985

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-35  Score=291.69  Aligned_cols=247  Identities=24%  Similarity=0.330  Sum_probs=208.8

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .-|...+.||+|.|..|-++++ -.|+.||||++-+.  +.-....+++|++.|+.++|||||+||++......+|||+|
T Consensus        18 GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLE   97 (864)
T KOG4717|consen   18 GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILE   97 (864)
T ss_pred             eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEE
Confidence            4577788899999999999986 47999999999543  23345678899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-CCcEEEeecccccccCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPED  424 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~  424 (573)
                      .-.+|+|.+++....  ..+.+....+++.||+.|+.|.|+.+   +|||||||+||.+-+ -|-|||.|||++..+...
T Consensus        98 LGD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   98 LGDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             ecCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            999999999996543  45899999999999999999999988   999999999998864 588999999999877543


Q ss_pred             CcccccccccCcCcCchhhhccCCCC-cccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLT-EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                        ...++.+|+..|-|||.+.+..|+ +++||||||||||-|++|+.||...++.+.             +..++|-.. 
T Consensus       173 --~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET-------------LTmImDCKY-  236 (864)
T KOG4717|consen  173 --KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET-------------LTMIMDCKY-  236 (864)
T ss_pred             --chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh-------------hhhhhcccc-
Confidence              345678999999999999998876 589999999999999999999877655322             222333221 


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       ..+.....++.+||..||..||++|-+.+||+.
T Consensus       237 -tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  237 -TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence             235567789999999999999999999999985

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=9.6e-35  Score=294.33  Aligned_cols=264  Identities=25%  Similarity=0.312  Sum_probs=195.9

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--CceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~l  342 (573)
                      .++|+..++||+|+||.||+|... +|+.||+|++....  ......+.+|+.++++++|+||+++++++...  +..++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            467899999999999999999975 58999999986432  22233567899999999999999999998755  46799


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+.+ +|.+++...  ...+++..++.++.||+.||+|||+.+   ++||||||+||++++++.+||+|||++....
T Consensus        86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~  159 (309)
T cd07845          86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG  159 (309)
T ss_pred             EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence            9999964 787777432  246899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC--cc-cccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG--RL-HEAV  498 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~-~~~~  498 (573)
                      ..... .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .....+.......  .. ....
T Consensus       160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         160 LPAKP-MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEI-EQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             CccCC-CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChhhchhhh
Confidence            33211 222345788999999865 56789999999999999999999887543221 1111111111000  00 0000


Q ss_pred             ------CccccC-------CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          499 ------DPALAG-------NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       499 ------d~~l~~-------~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                            .-.+..       ......+..+.+++.+|++.||++|||++++++.-
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~  291 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESS  291 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence                  000000       00012356678999999999999999999999644

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-36  Score=305.23  Aligned_cols=252  Identities=22%  Similarity=0.315  Sum_probs=201.6

Q ss_pred             cCccccccccccCceeEEEEEcCCC-CEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGG-EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      +.|+++..||.|+||.|||++.++. -..|-|++.....+..+.+.-|+++|..++||+||+|++.|...+.++++.|||
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC  111 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC  111 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence            3456788899999999999998753 345777777777777889999999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      .||-.+..+..-.  ..+.+.++.-+..|++.||.|||++.   |||||||+.|||++-+|.++|+|||.+..... ...
T Consensus       112 ~GGAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~-t~q  185 (1187)
T KOG0579|consen  112 GGGAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS-TRQ  185 (1187)
T ss_pred             CCchHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh-HHh
Confidence            9999988875433  35899999999999999999999998   99999999999999999999999999764322 122


Q ss_pred             cccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          428 ISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ....+.||+.|||||+.+     ..+|+.++||||||+.|.||..+.+|..--+.-+.++    ..      .+--.|.|
T Consensus       186 kRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVll----Ki------aKSePPTL  255 (1187)
T KOG0579|consen  186 KRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL----KI------AKSEPPTL  255 (1187)
T ss_pred             hhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHH----HH------hhcCCCcc
Confidence            334678999999999885     3589999999999999999999988754322211111    11      11112222


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..  +..-...+.+++.+||..||..||++.++++.
T Consensus       256 lq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  256 LQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             cC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence            21  22234568899999999999999999888764

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.6e-35  Score=290.26  Aligned_cols=243  Identities=22%  Similarity=0.218  Sum_probs=188.5

Q ss_pred             cccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHH---HHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          276 KLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVN---LISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~---~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      .||+|+||.||++... +++.+|+|.+....   ......+.+|..   ++...+||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999875 58899999886432   122223344443   3444579999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+|||+++++.++|+|||++.......   
T Consensus        81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---  151 (279)
T cd05633          81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (279)
T ss_pred             CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence            9999988743   345899999999999999999999988   9999999999999999999999999987553322   


Q ss_pred             ccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          429 SATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      .....|+..|+|||.+.. ..++.++||||||++++||++|..|+........  ........          ......+
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~----------~~~~~~~  219 (279)
T cd05633         152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK--HEIDRMTL----------TVNVELP  219 (279)
T ss_pred             ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCH--HHHHHHhh----------cCCcCCc
Confidence            123468999999999864 5689999999999999999999998764332211  11111110          0111233


Q ss_pred             CchHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 008239          508 EGKPSRLLQIGLLCVQASAELRP-----SMSIVVKML  539 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~L  539 (573)
                      ...+.++.+++.+||+.+|++||     +++|++++-
T Consensus       220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~  256 (279)
T cd05633         220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHV  256 (279)
T ss_pred             cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCc
Confidence            44567889999999999999999     599998863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.7e-34  Score=295.08  Aligned_cols=260  Identities=22%  Similarity=0.256  Sum_probs=192.4

Q ss_pred             cccccc--CceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQG--GSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ..||+|  +||+||++++. +|+.||||++...  ..+..+.+.+|+.+++.++||||+++++++..+...++|+||+++
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            456777  89999999974 6899999998653  233457788999999999999999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc-
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-  428 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~-  428 (573)
                      ++|.+++.... ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++++||+.+.......... 
T Consensus        84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            99998875432 235889999999999999999999987   9999999999999999999999998654322111100 


Q ss_pred             -----ccccccCcCcCchhhhccC--CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH--------------
Q 008239          429 -----SATLAGTLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD--------------  487 (573)
Q Consensus       429 -----~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~--------------  487 (573)
                           .....++..|+|||++.+.  .++.++||||||+++|||++|+.|+...............              
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                 0112345679999999764  4789999999999999999999987543221111111000              


Q ss_pred             --Hhhc----------------CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          488 --LYVK----------------GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       488 --~~~~----------------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                        .+..                +......+..+...........+.+++.+||+.||++|||++|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence              0000                00000111111112233456788999999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.7e-34  Score=288.24  Aligned_cols=257  Identities=21%  Similarity=0.259  Sum_probs=191.9

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccCh-hhHHHHHHHHHHHcCCC-CCCeeeeeeeeecC--CceeEEEE
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISGIN-HKNLVKLLGCSITG--PESLLVYE  345 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~lv~e  345 (573)
                      |+..++||+|+||.||+++.. +++.||+|++..... .......+|+.++.++. |+||+++++++.+.  +..++|+|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            567889999999999999865 688999999865422 22234457889998885 99999999999887  88999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |++ ++|.+.+...  ...+++..++.++.|++.||+|||+.+   ++||||+|+||+++. +.+||+|||++.......
T Consensus        81 ~~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          81 LMD-MNLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             cCC-ccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            997 5887777432  246899999999999999999999987   999999999999999 999999999998654322


Q ss_pred             cccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh-----------hcCc
Q 008239          426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY-----------VKGR  493 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-----------~~~~  493 (573)
                      .  .....++..|+|||.+.. +.++.++|||||||++|||++|+.|+...... +.........           ....
T Consensus       154 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         154 P--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNEL-DQIAKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             C--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHH-HHHHHHHHHcCCCCHHHHHhhcccc
Confidence            2  123457889999997754 56788999999999999999998877443221 1111111111           0000


Q ss_pred             cccccCcccc----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          494 LHEAVDPALA----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       494 ~~~~~d~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ......+...    .......+..+.+++.+||+.+|++||+++++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            0000000000    0011245688999999999999999999999986

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.7e-34  Score=293.24  Aligned_cols=262  Identities=19%  Similarity=0.198  Sum_probs=193.7

Q ss_pred             ccccccccCceeEEEEEcCCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      +.+.+|.|+++.|++++. +++.||||++...  ..+..+.+.+|+++++.++|+||+++++++......+++|||++++
T Consensus         6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (314)
T cd08216           6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG   84 (314)
T ss_pred             hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence            344556666666666655 6899999998654  3455678999999999999999999999999999999999999999


Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc----
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT----  426 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~----  426 (573)
                      +|.+++.... ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||.+........    
T Consensus        85 ~l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          85 SCEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            9999885432 235889999999999999999999988   99999999999999999999999998875432111    


Q ss_pred             --ccccccccCcCcCchhhhcc--CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh----h-------c
Q 008239          427 --HISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY----V-------K  491 (573)
Q Consensus       427 --~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~----~-------~  491 (573)
                        .......++..|+|||.+..  ..++.++||||||+++|||++|+.|+..........+......    .       .
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE  240 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence              11123456778999999876  3588999999999999999999998765432222211111000    0       0


Q ss_pred             Ccccc----ccCccc----cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          492 GRLHE----AVDPAL----AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       492 ~~~~~----~~d~~l----~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      .....    ..++..    ..........++.+++.+||+.+|++|||++++++.-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p  296 (314)
T cd08216         241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHS  296 (314)
T ss_pred             CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCc
Confidence            00000    000000    0111223456788999999999999999999999643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.7e-36  Score=279.48  Aligned_cols=267  Identities=20%  Similarity=0.326  Sum_probs=199.1

Q ss_pred             cCccccccccccCceeEEEEEcCC-----CCEEEEEEecccCh--hhHHHHHHHHHHHcCCCCCCeeeeeeeeec-CCce
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPES  340 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  340 (573)
                      ..|+....||+|.||.|||+.-.+     ...+|||+++....  .......+|+.+++.++||||+.|..++.+ +...
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            468889999999999999996432     23789999965532  334567899999999999999999999887 7788


Q ss_pred             eEEEEeccCCCcccccccc--CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC----CcEEEee
Q 008239          341 LLVYEFVPNQSLLDNLFVR--QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE----FTAKIAD  414 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~----~~~kl~D  414 (573)
                      ++++||.+. +|...++-.  .+...++......|+.||+.|+.|||++.   |+||||||.||||..+    |.|||+|
T Consensus       104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            999999976 787777432  23356888999999999999999999999   9999999999999877    8999999


Q ss_pred             cccccccCCCCccc--ccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--------chHH
Q 008239          415 FGLVRLFPEDITHI--SATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--------SILQ  483 (573)
Q Consensus       415 fgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--------~~~~  483 (573)
                      ||+++.+.......  ...++-|.+|.|||++.+ ..|+.+.|||+.|||+.||++-++.|.......        +.+.
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99999987655443  346678999999999987 479999999999999999999887664322110        1111


Q ss_pred             HHHHHhhc---Cccccc---------c--------Ccc-ccCCC--CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          484 TVWDLYVK---GRLHEA---------V--------DPA-LAGNF--QEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       484 ~~~~~~~~---~~~~~~---------~--------d~~-l~~~~--~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      .+...+..   ..+..+         +        ++. |..-+  .......-++|+.++|+.||..|.|+++.++..
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            11111111   011000         0        000 00000  011122367899999999999999999999866

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-35  Score=303.82  Aligned_cols=256  Identities=26%  Similarity=0.367  Sum_probs=201.7

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC------cee
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------ESL  341 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~~~  341 (573)
                      .+...+.||+|+||.||+|+++ .|+.||||.+... .....+...+|+++|++|+|+|||+++++-.+..      ..+
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v   93 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV   93 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence            3566789999999999999964 7999999998653 3344677889999999999999999999766543      568


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC--CCC--cEEEeeccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEF--TAKIADFGL  417 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~--~~~--~~kl~Dfgl  417 (573)
                      +|||||++|||...|....+...+++.+.+.++.++..||.|||+++   |+||||||.||++-  ++|  .-||+|||.
T Consensus        94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            99999999999999988777778999999999999999999999988   99999999999994  334  479999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc-
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH-  495 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  495 (573)
                      |+.++++.  ......||..|++||+... +.|+..+|.|||||++||.+||..||.............|.......-. 
T Consensus       171 Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v  248 (732)
T KOG4250|consen  171 ARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGV  248 (732)
T ss_pred             cccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCce
Confidence            99876654  5567899999999999985 8899999999999999999999999988776654444444443322110 


Q ss_pred             -cccCccccC------------CCCCchHHHHHHHHHHccCCCCCCCC
Q 008239          496 -EAVDPALAG------------NFQEGKPSRLLQIGLLCVQASAELRP  530 (573)
Q Consensus       496 -~~~d~~l~~------------~~~~~~~~~l~~l~~~cl~~~p~~RP  530 (573)
                       -...+...+            .........+-.++..++..+|++|-
T Consensus       249 ~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  249 AIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence             001111110            11122344556677777888888887

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.6e-34  Score=290.92  Aligned_cols=253  Identities=24%  Similarity=0.363  Sum_probs=194.1

Q ss_pred             hcCccccccccccCceeEEEEEcCC-CCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .++|+..++||+|+||.||++++.+ ++.||||++.... ......+..|+.++.++ .||||+++++++......+++|
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            3567889999999999999999875 8899999986543 23345566777777666 5999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      ||++ ++|.+++...  ...+++..+..++.||+.||+|||+. +   |+||||+|+||++++++.+||+|||++..+..
T Consensus        94 e~~~-~~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~  167 (296)
T cd06618          94 ELMS-TCLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD  167 (296)
T ss_pred             eccC-cCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence            9985 4666655332  23689999999999999999999974 5   99999999999999999999999999876543


Q ss_pred             CCcccccccccCcCcCchhhhccCC----CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGK----LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ...  .....++..|+|||.+.+..    ++.++||||||+++|||++|+.|+.......   +....... +..     
T Consensus       168 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~---~~~~~~~~-~~~-----  236 (296)
T cd06618         168 SKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF---EVLTKILQ-EEP-----  236 (296)
T ss_pred             CCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH---HHHHHHhc-CCC-----
Confidence            222  12335778999999987553    7889999999999999999999875432211   11111111 110     


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      +.+  ......+.++.+++.+||+.+|++||++++++++-
T Consensus       237 ~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         237 PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            001  11113467889999999999999999999998653

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.3e-35  Score=286.93  Aligned_cols=245  Identities=22%  Similarity=0.276  Sum_probs=196.1

Q ss_pred             ccccCceeEEEEEcC-CCCEEEEEEecccCh---hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCc
Q 008239          277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL  352 (573)
Q Consensus       277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  352 (573)
                      ||+|+||.||+++.. +|+.+++|.+.....   ...+.+.+|++++++++||||+++++.+......++++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999986 489999999865433   4456788999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc------
Q 008239          353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT------  426 (573)
Q Consensus       353 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~------  426 (573)
                      .+++...   ..+++..+..++.||+.||+|||+.+   ++|+||+|+||++++++.++|+|||++........      
T Consensus        81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  154 (265)
T cd05579          81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD  154 (265)
T ss_pred             HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence            9988532   36899999999999999999999987   99999999999999999999999999875433211      


Q ss_pred             -ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          427 -HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       427 -~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                       .......++..|++||.+.....+.++||||||++++||++|+.|+......    ... .....+...        ..
T Consensus       155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~----~~~-~~~~~~~~~--------~~  221 (265)
T cd05579         155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE----EIF-QNILNGKIE--------WP  221 (265)
T ss_pred             cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH----HHH-HHHhcCCcC--------CC
Confidence             1223445788999999998888999999999999999999999887543321    111 111111110        00


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      .....+..+.+++.+||+.+|++|||+.++.+.|+
T Consensus       222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence            01113678899999999999999999977766663

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.4e-35  Score=299.31  Aligned_cols=261  Identities=21%  Similarity=0.298  Sum_probs=197.6

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-----Cc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PE  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  339 (573)
                      .+.|...+.||+|+||+||+++.. +++.||||.+...  .......+.+|+.+++.++|+||+++++++...     ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            457889999999999999999864 6899999998643  233345677899999999999999999987644     34


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++|+||+. ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.
T Consensus        84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~  156 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR  156 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence            799999996 688877742   346899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh---------
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY---------  489 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~---------  489 (573)
                      ...... .......++..|+|||.+.. ..++.++||||||+++|||++|+.|+..... ...........         
T Consensus       157 ~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07858         157 TTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY-VHQLKLITELLGSPSEEDLG  234 (337)
T ss_pred             ccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCCh-HHHHHHHHHHhCCCChHHhh
Confidence            664332 22233457889999998865 5689999999999999999999988743321 11111111110         


Q ss_pred             --hcCcccccc-------CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          490 --VKGRLHEAV-------DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       490 --~~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                        ..+...+.+       ++.+. ......+..+.+++.+||+.+|++|||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         235 FIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence              000000000       01010 1123456778999999999999999999999976

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-34  Score=296.83  Aligned_cols=262  Identities=24%  Similarity=0.331  Sum_probs=196.9

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC--Cce
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG--PES  340 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~~~  340 (573)
                      ..++|+..+.||+|+||.||+|... +|+.+|||++...  .......+.+|+.+++++ +||||+++++++...  ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            3567888999999999999999975 5889999988542  233345677899999999 999999999988653  357


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||++ ++|.+++...    .+++..+..++.||+.||+|||+.+   |+||||+|+||+++.++.+||+|||++..
T Consensus        85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~  156 (337)
T cd07852          85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS  156 (337)
T ss_pred             EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence            99999997 5888877432    6789999999999999999999987   99999999999999999999999999986


Q ss_pred             cCCCCc----ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH-------
Q 008239          421 FPEDIT----HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL-------  488 (573)
Q Consensus       421 ~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~-------  488 (573)
                      ......    .......++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ........       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~  235 (337)
T cd07852         157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN-QLEKIIEVIGPPSAE  235 (337)
T ss_pred             cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHH
Confidence            543322    12224467889999998765 567889999999999999999998874332211 11111000       


Q ss_pred             ----hhcCccccccC-------ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          489 ----YVKGRLHEAVD-------PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       489 ----~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                          +........++       ..+ .......+..+.+++.+||+.+|++|||+.++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         236 DIESIKSPFAATMLDSLPSRPRKPL-DELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHhhhHHHhhhhcccccccch-hhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                00000000010       000 01112256788999999999999999999999975

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=287.53  Aligned_cols=249  Identities=22%  Similarity=0.251  Sum_probs=204.9

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .+.|..-++||+|+||.||-.+.. +|+.+|.|++.+.   ..+......+|-.+|.+++.+.||.+--.++..+.+++|
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV  263 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV  263 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence            466888899999999999999865 6899999988432   233344567899999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      +..|.+|+|.-+|+.... ..+++..++.++.+|+.||++||+..   ||.|||||+|||+|+.|+++|+|.|||..++.
T Consensus       264 LtlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~  339 (591)
T KOG0986|consen  264 LTLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE  339 (591)
T ss_pred             EEeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence            999999999999976554 56999999999999999999999987   99999999999999999999999999998876


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ....  ...+||.+|||||++.++.|+...|.|||||+||||+-|+.||........ .+.+......       +   .
T Consensus       340 g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk-~eEvdrr~~~-------~---~  406 (591)
T KOG0986|consen  340 GKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVK-REEVDRRTLE-------D---P  406 (591)
T ss_pred             CCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhh-HHHHHHHHhc-------c---h
Confidence            5443  234899999999999999999999999999999999999999865432110 0011111111       1   1


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMS  533 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  533 (573)
                      .+++...+++...|....|+.||++|....
T Consensus       407 ~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  407 EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            245667788888999999999999997643

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-34  Score=287.18  Aligned_cols=259  Identities=24%  Similarity=0.334  Sum_probs=198.4

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccCh--hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      |+..+.||+|++|.||++... +|+.+++|++.....  .....+.+|+.++++++|+||+++++++..+...++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            566789999999999999875 688999999865432  24567888999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++ +|.+++....  ..+++..++.++.|++.||.|||+.+   |+|+||+|+||+++.++.+||+|||.+....... .
T Consensus        81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~  153 (283)
T cd05118          81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-R  153 (283)
T ss_pred             CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-c
Confidence            75 8877774422  46899999999999999999999988   9999999999999999999999999998765443 1


Q ss_pred             cccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC---ccccccC----
Q 008239          428 ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG---RLHEAVD----  499 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d----  499 (573)
                      ......++..|+|||.+.+. .++.++||||||+++|+|++|+.|+....... ............   .+....+    
T Consensus       154 ~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         154 PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEID-QLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCchHhcccchhhhhh
Confidence            12234577889999998876 78999999999999999999987764433211 111111100000   0000000    


Q ss_pred             --ccc-------cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          500 --PAL-------AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       500 --~~l-------~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ..+       ........+.++.+++.+||+.+|.+||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence              000       00112234678899999999999999999999986

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.5e-34  Score=291.19  Aligned_cols=263  Identities=22%  Similarity=0.299  Sum_probs=192.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc-----
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-----  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  339 (573)
                      -++|+..++||+|+||.||+++.. +++.||||++....  ......+.+|+.++++++||||+++++++.....     
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            356889999999999999999875 58899999886432  2223456789999999999999999998876543     


Q ss_pred             ---eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          340 ---SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       340 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                         .++||||+.+ +|.+.+...  ...+++..++.++.||+.||+|||+++   ++|+||||+||+++.++.+||+|||
T Consensus        91 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          91 KGSFYLVFEFCEH-DLAGLLSNK--NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             CceEEEEEcCCCc-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence               4899999964 777766432  235899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCcc---cccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh--
Q 008239          417 LVRLFPEDITH---ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV--  490 (573)
Q Consensus       417 la~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--  490 (573)
                      ++.........   ......++..|+|||.+.+. .++.++||||||+++|||++|..|+...... .....+.....  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~-~~~~~~~~~~~~~  243 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQ-HQLTLISQLCGSI  243 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence            99865432211   11234567889999988664 4788999999999999999998776543221 11111111110  


Q ss_pred             -cCccc-----cccCc---------cccCCC-CCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          491 -KGRLH-----EAVDP---------ALAGNF-QEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       491 -~~~~~-----~~~d~---------~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       .....     +..+.         ...... +......+.+++.+||+.+|++|||++|+++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence             00000     00000         000000 0112345679999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=7.6e-34  Score=281.55  Aligned_cols=246  Identities=21%  Similarity=0.220  Sum_probs=189.6

Q ss_pred             HHHhcCccccccc--cccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCce
Q 008239          265 EKATNYFHESNKL--GQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES  340 (573)
Q Consensus       265 ~~~~~~~~~~~~l--g~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  340 (573)
                      ....++|+..+.+  |+|+||.||+++.+ ++..+|+|.+........     |+.....+ +||||+++++.+......
T Consensus        10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            3344566666666  99999999999874 678899998854322111     22222222 799999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-cEEEeeccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVR  419 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~  419 (573)
                      ++||||+++++|.+++...   ..+++..++.++.|+++||.|||+.+   ++||||+|+||+++.++ .++|+|||++.
T Consensus        85 ~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~  158 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK  158 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence            9999999999999988433   36899999999999999999999988   99999999999999988 99999999987


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ......     ...++..|+|||++.+..++.++||||||++++||++|+.|+................. ..       
T Consensus       159 ~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~-------  225 (267)
T PHA03390        159 IIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QK-------  225 (267)
T ss_pred             ecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cc-------
Confidence            654321     23578899999999998999999999999999999999998864332211111111111 10       


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPS-MSIVVK  537 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~  537 (573)
                       .  .......+..+.+++.+||+.+|.+||+ ++++++
T Consensus       226 -~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        226 -K--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -c--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence             0  0112245678899999999999999996 698874

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-34  Score=283.47  Aligned_cols=244  Identities=22%  Similarity=0.237  Sum_probs=190.9

Q ss_pred             ccccccCceeEEEEEcC-CCCEEEEEEecccCh---hhHHHHHHHHHH-HcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEVNL-ISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      +.||+|+||.||+|... +|+.||||.+.....   .....+..|..+ ....+|+|++++++++......++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            56999999999999875 588999999865421   222334455544 4556899999999999999999999999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      ++|.+++..   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.+||+|||++.....     .
T Consensus        82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~  150 (260)
T cd05611          82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----N  150 (260)
T ss_pred             CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----c
Confidence            999998843   245889999999999999999999987   99999999999999999999999999875432     2


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                      ....++..|+|||.+.+..++.++||||||++++||++|..|+.....     ...+.....+...      ........
T Consensus       151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~------~~~~~~~~  219 (260)
T cd05611         151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP-----DAVFDNILSRRIN------WPEEVKEF  219 (260)
T ss_pred             ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhcccC------CCCccccc
Confidence            234578899999999888899999999999999999999998754322     1122222221110      01112224


Q ss_pred             hHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          510 KPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       510 ~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      .+..+.+++.+||+.+|++||++.++.+.|+
T Consensus       220 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         220 CSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             CCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            5678899999999999999998877666653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.2e-34  Score=296.93  Aligned_cols=264  Identities=20%  Similarity=0.309  Sum_probs=198.1

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeec----CCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  340 (573)
                      .++|+..+.||+|+||.||++... +|+.||+|++....  ....+.+.+|+.++++++||||+++++++..    ....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            368899999999999999999875 58999999986542  2345677889999999999999999998763    3467


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++|+||+. ++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||+++.++.+||+|||++..
T Consensus        84 ~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~  156 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG  156 (334)
T ss_pred             EEEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence            89999995 688887743   345899999999999999999999987   99999999999999999999999999876


Q ss_pred             cCCCCcc---cccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH--------
Q 008239          421 FPEDITH---ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL--------  488 (573)
Q Consensus       421 ~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~--------  488 (573)
                      .......   ......++..|+|||.+.. ..++.++||||||+++|||++|+.|+....... ....+...        
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~-~~~~~~~~~g~~~~~~  235 (334)
T cd07855         157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH-QLKLILSVLGSPSEEV  235 (334)
T ss_pred             ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH-HHHHHHHHhCCChhHh
Confidence            5432221   1123467889999999865 468899999999999999999998875432111 00000000        


Q ss_pred             ---hhcCccccccCc---ccc---CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          489 ---YVKGRLHEAVDP---ALA---GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       489 ---~~~~~~~~~~d~---~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                         ...+.+.+.++.   ...   .......+..+.+++.+||+.+|++||+++++++.-
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         236 LNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             hhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence               000000000000   000   001123467899999999999999999999999754

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=3.2e-34  Score=290.37  Aligned_cols=247  Identities=28%  Similarity=0.432  Sum_probs=195.6

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      +.|+..+.||+|+||.||+|+.. +++.+++|.+...   .....+.+.+|+++++.++|+|++++++++......++|+
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            34677889999999999999975 5788999988542   2334567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+. |+|.+.+...  ...+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.+||+|||++......
T Consensus        95 e~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  168 (308)
T cd06634          95 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  168 (308)
T ss_pred             EccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc
Confidence            9996 6777766432  245889999999999999999999987   999999999999999999999999998765432


Q ss_pred             CcccccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          425 ITHISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                           ....++..|+|||.+.   .+.++.++||||||+++|||++|+.|+......    ..... ...+..     +.
T Consensus       169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~~~-~~~~~~-----~~  233 (308)
T cd06634         169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYH-IAQNES-----PA  233 (308)
T ss_pred             -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHH----HHHHH-HhhcCC-----CC
Confidence                 2345788999999975   356788999999999999999999886443211    11111 111111     11


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                         ......+..+.+++.+||+.+|++||+++++++..
T Consensus       234 ---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~  268 (308)
T cd06634         234 ---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  268 (308)
T ss_pred             ---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCc
Confidence               11224556788999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=2e-34  Score=287.18  Aligned_cols=248  Identities=22%  Similarity=0.294  Sum_probs=202.4

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++|+..+.||+|+||.||+++.. +|+.|++|++...   .....+.+.+|+.++++++ ||||+++++++......++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            46888999999999999999975 6899999998653   2233467888999999998 99999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~  154 (280)
T cd05581          81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP  154 (280)
T ss_pred             EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence            999999999998843   236999999999999999999999988   99999999999999999999999999886543


Q ss_pred             CCc-------------------ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHH
Q 008239          424 DIT-------------------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT  484 (573)
Q Consensus       424 ~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~  484 (573)
                      ...                   .......++..|+|||.+....++.++||||||++++|+++|+.|+.....    ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~  230 (280)
T cd05581         155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNE----YLT  230 (280)
T ss_pred             ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccH----HHH
Confidence            321                   122234578899999999888899999999999999999999988764331    111


Q ss_pred             HHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCH----HHHHH
Q 008239          485 VWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSM----SIVVK  537 (573)
Q Consensus       485 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~----~evl~  537 (573)
                      ..... .          .....+...+..+.+++.+||+.+|++||++    +++++
T Consensus       231 ~~~~~-~----------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         231 FQKIL-K----------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             HHHHH-h----------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            11111 0          1112334456788999999999999999999    77764

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=6.4e-34  Score=284.74  Aligned_cols=259  Identities=25%  Similarity=0.333  Sum_probs=192.5

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCC---CCCCeeeeeeeeecCCc-----
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPE-----  339 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~-----  339 (573)
                      |++.+.||+|+||.||+|+.+ +++.||||++....  ......+.+|+.+++++   +|+||+++++++.....     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999986 48999999986432  22234566777776655   69999999999987776     


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .+++|||++ ++|.+++.... ...+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++.
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence            899999997 47888774322 235899999999999999999999987   9999999999999999999999999988


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc-Cc--cc-
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK-GR--LH-  495 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~-~~--~~-  495 (573)
                      .+.....  .....++..|+|||.+.+..++.++||||||+++|||++|..|+...... .....+...... ..  .. 
T Consensus       156 ~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07838         156 IYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWPR  232 (287)
T ss_pred             eccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcCC
Confidence            7643321  12334688999999999999999999999999999999997776543221 111111111100 00  00 


Q ss_pred             ------cccCcccc---CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          496 ------EAVDPALA---GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       496 ------~~~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                            ........   ..........+.+++.+||+.+|++||+++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                  00000000   0111233567789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=8e-34  Score=283.12  Aligned_cols=242  Identities=22%  Similarity=0.223  Sum_probs=188.2

Q ss_pred             cccccCceeEEEEEcC-CCCEEEEEEecccCh---hhHHHHHHHH---HHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          276 KLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEV---NLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      .||+|+||.||++... +++.||+|.+.....   .....+..|.   .+++...||||+++++++...+..++||||++
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999875 588999998865321   1122233343   44555689999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +++|.+++..   ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+....   
T Consensus        81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---  151 (278)
T cd05606          81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---  151 (278)
T ss_pred             CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence            9999888742   346899999999999999999999987   9999999999999999999999999987553322   


Q ss_pred             ccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      .....|+..|+|||.+.++ .++.++||||||+++|||++|+.|+.........  ........      ..    ...+
T Consensus       152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~--~~~~~~~~------~~----~~~~  219 (278)
T cd05606         152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--EIDRMTLT------MA----VELP  219 (278)
T ss_pred             CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchH--HHHHHhhc------cC----CCCC
Confidence            1234689999999999754 6899999999999999999999987654321111  11111100      01    1223


Q ss_pred             CchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      ...+..+.+++.+|++.+|.+||     ++.++++.
T Consensus       220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence            34567899999999999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=7.1e-34  Score=288.47  Aligned_cols=244  Identities=30%  Similarity=0.439  Sum_probs=192.9

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      |...++||+|+||+||+|+.. +|+.|++|++...   .....+.+.+|+++++.++|||++++++++.+....++||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            556788999999999999874 5889999998643   223345788899999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +. ++|.+++...  ...+++..++.++.||+.+|.|||+.+   ++|+||+|+||+++.++.+||+|||++.....   
T Consensus       103 ~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---  173 (313)
T cd06633         103 CL-GSASDLLEVH--KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP---  173 (313)
T ss_pred             CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence            96 5777766432  345899999999999999999999987   99999999999999999999999999864322   


Q ss_pred             ccccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          427 HISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                        .....++..|+|||++.   .+.++.++||||||+++|||++|..|+......    ........ ...     +.  
T Consensus       174 --~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~----~~~~~~~~-~~~-----~~--  239 (313)
T cd06633         174 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM----SALYHIAQ-NDS-----PT--  239 (313)
T ss_pred             --CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChH----HHHHHHHh-cCC-----CC--
Confidence              12346788999999984   456888999999999999999999886543221    11111111 111     10  


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       ......+..+.+++.+||+.+|.+||++.+++..
T Consensus       240 -~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         240 -LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             -CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1112334568899999999999999999999964

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-34  Score=294.47  Aligned_cols=247  Identities=24%  Similarity=0.290  Sum_probs=206.8

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ...|.....||+|.|+.|..+++. ++..||||.+.+.  .....+.+.+|+++|+.|.|||||+++.+......+++||
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~  134 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVM  134 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEE
Confidence            467888999999999999999875 6899999988654  2333456889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||..+|.+.+++...   +.+.+..+..++.|+.++++|+|+++   |+|||||++||||+.+..+||+|||++..+.. 
T Consensus       135 eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~-  207 (596)
T KOG0586|consen  135 EYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY-  207 (596)
T ss_pred             EeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc-
Confidence            999999999999644   34566888899999999999999998   99999999999999999999999999998753 


Q ss_pred             CcccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                       .......+|++.|.|||+..+..| ++++|+||+|++||-|++|..||+...-                 .++-++.+.
T Consensus       208 -~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-----------------k~Lr~rvl~  269 (596)
T KOG0586|consen  208 -GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-----------------KELRPRVLR  269 (596)
T ss_pred             -cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----------------ccccchhee
Confidence             345567899999999999988765 6799999999999999999999865321                 111112222


Q ss_pred             CC--CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          504 GN--FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       504 ~~--~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      +.  ++.-...++.+++.+++-.+|..|++++++.+.-
T Consensus       270 gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~  307 (596)
T KOG0586|consen  270 GKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDR  307 (596)
T ss_pred             eeecccceeechhHHHHHHhhccCccccCCHHHhhhhc
Confidence            21  2333456788999999999999999999998643

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-35  Score=269.44  Aligned_cols=251  Identities=24%  Similarity=0.378  Sum_probs=198.0

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +.+.+..||.|..|.|++.... .|..+|||.+.+. ..+..+++...++++..- +.|+||+.+|+|..+...++.||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMel  172 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMEL  172 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHH
Confidence            3445778999999999999876 5889999999765 445566777888877665 599999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      |.- .+..++.  .-.+++++..+-++...+.+||.||.+++  +|||||+||+|||+|+.|++|++|||++..+-+.. 
T Consensus       173 Ms~-C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk-  246 (391)
T KOG0983|consen  173 MST-CAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK-  246 (391)
T ss_pred             HHH-HHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeeccc-
Confidence            843 3444442  22356888889999999999999999876  69999999999999999999999999998664332 


Q ss_pred             ccccccccCcCcCchhhhcc---CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          427 HISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                       ..+..+|-+.|||||.+..   ..|+.++||||||+.|+||.||+.|+.....+-..+..+    .+++     .|.|.
T Consensus       247 -AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkv----ln~e-----PP~L~  316 (391)
T KOG0983|consen  247 -AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKV----LNEE-----PPLLP  316 (391)
T ss_pred             -ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHH----HhcC-----CCCCC
Confidence             2345578899999999864   468889999999999999999999987655443333332    1111     13333


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .  ....+..+.+++..||+.|+.+||...++++.
T Consensus       317 ~--~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  317 G--HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             c--ccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            2  23367889999999999999999999999864

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-34  Score=285.39  Aligned_cols=259  Identities=24%  Similarity=0.333  Sum_probs=194.8

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccChh-hHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeEEEEec
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      |+..+.||+|++|+||+|+.. +++.|+||++...... ......+|+..+++++ |+||+++++++..+...++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            567889999999999999986 4789999998654321 2234457999999999 999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                       +|+|.+++.... ...+++..+..++.|++.+|.|||+++   ++|+||+|+||++++++.++|+|||++........ 
T Consensus        81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~-  154 (283)
T cd07830          81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP-  154 (283)
T ss_pred             -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence             889988875432 246899999999999999999999987   99999999999999999999999999886543221 


Q ss_pred             cccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH--------h-----hcCc
Q 008239          428 ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL--------Y-----VKGR  493 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~-----~~~~  493 (573)
                       .....++..|+|||.+.. ..++.++||||||+++|||++|+.|+......... ......        +     ....
T Consensus       155 -~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         155 -YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQL-YKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHH-HHHHHhcCCCChhhhhhHhhhhcc
Confidence             123457889999998754 45789999999999999999998776443221111 000000        0     0000


Q ss_pred             cccccC----ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          494 LHEAVD----PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       494 ~~~~~d----~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +...+.    ..+. ......+..+.+++.+||+.+|++|||++|++..
T Consensus       233 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLH-QLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHH-HHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            000000    0010 1111225778999999999999999999999863

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-34  Score=284.41  Aligned_cols=258  Identities=28%  Similarity=0.371  Sum_probs=197.8

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      |+..+.||+|++|.||+|+.. +++.+++|++....  ....+.+.+|+.+++.++|+||+++++++.+....++|+||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            556788999999999999986 48999999987653  334567788999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      + ++|.+++....  ..+++..+..++.|++.||+|||+.+   |+||||+|+||++++++.+||+|||++........ 
T Consensus        81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-  153 (282)
T cd07829          81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-  153 (282)
T ss_pred             C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence            7 58998885432  46899999999999999999999987   99999999999999999999999999886643322 


Q ss_pred             cccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH-----------HHHhhcC---
Q 008239          428 ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV-----------WDLYVKG---  492 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~-----------~~~~~~~---  492 (573)
                      ......++..|+|||.+... .++.++||||||+++|||++|+.|+...... ......           |..+..-   
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEI-DQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHHHHhCCCcHHHHHhhcccccc
Confidence            12233457789999998776 8899999999999999999998776443211 111111           1111000   


Q ss_pred             --ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          493 --RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       493 --~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ........... ......+..+.+++..||+.+|++||++++++.
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         233 KPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence              00000000000 111123567999999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.6e-34  Score=295.42  Aligned_cols=261  Identities=21%  Similarity=0.302  Sum_probs=200.0

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC-----cee
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-----ESL  341 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~~  341 (573)
                      +|++.++||+|+||.||+++.. +++.||||++....  ....+.+.+|+.+++.++|+||+++++++....     ..+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            4788899999999999999976 48999999986543  344567889999999999999999999988765     789


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||++ ++|.+++..   ...+++..++.++.|++.||+|||+.+   |+||||||.|||++.++.++|+|||++...
T Consensus        81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~  153 (330)
T cd07834          81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV  153 (330)
T ss_pred             EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence            9999997 478877743   236899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCc--ccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh---------
Q 008239          422 PEDIT--HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY---------  489 (573)
Q Consensus       422 ~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~---------  489 (573)
                      .....  .......++..|+|||.+.+. .++.++||||||+++|||++|+.|+...... ..........         
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~  232 (330)
T cd07834         154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYI-DQLNLIVEVLGTPSEEDLK  232 (330)
T ss_pred             cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHH-HHHHHHHHhcCCCChhHhh
Confidence            54321  112334578899999999887 8899999999999999999999887543321 1111111100         


Q ss_pred             --hcCccccccC---cc---ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          490 --VKGRLHEAVD---PA---LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       490 --~~~~~~~~~d---~~---l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                        ........+.   ..   -........+..+.+++.+||+.+|.+||+++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              0000000000   00   0001122356778999999999999999999999985

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=6.4e-34  Score=288.28  Aligned_cols=262  Identities=25%  Similarity=0.331  Sum_probs=192.9

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh--hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGP------  338 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  338 (573)
                      .++|+..++||+|+||.||+++.. +++.+|||++.....  .....+.+|+++++.++||||+++++++....      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            478999999999999999999975 588999998854322  22345678999999999999999999875443      


Q ss_pred             --ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          339 --ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       339 --~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                        ..++|+||+.. +|...+..  ....+++..+..++.|+++||+|||+.+   |+|+||||+||++++++.+||+|||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg  160 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG  160 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence              45899999865 56665533  2346899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCcc----------cccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH
Q 008239          417 LVRLFPEDITH----------ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV  485 (573)
Q Consensus       417 la~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~  485 (573)
                      ++.........          ......+++.|+|||.+.+. .++.++||||||+++|||++|+.|+...... ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~-~~~~~~  239 (311)
T cd07866         161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDI-DQLHLI  239 (311)
T ss_pred             cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Confidence            99865432211          11233567889999988654 5889999999999999999999886533221 111222


Q ss_pred             HHHhhcC---------ccccc--------cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          486 WDLYVKG---------RLHEA--------VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       486 ~~~~~~~---------~~~~~--------~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +......         .+...        ..+.+.. ........+.+++.+|++.+|++|||+.|++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEE-RFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHH-HcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            2111100         00000        0001100 01123356889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=8.3e-34  Score=290.88  Aligned_cols=262  Identities=22%  Similarity=0.250  Sum_probs=195.5

Q ss_pred             cCcc-ccccccccCceeEEEEEcC-CCCEEEEEEecccChhh--------------HHHHHHHHHHHcCCCCCCeeeeee
Q 008239          269 NYFH-ESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQW--------------VDHFFNEVNLISGINHKNLVKLLG  332 (573)
Q Consensus       269 ~~~~-~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~l~~  332 (573)
                      ++|. ..+.||+|+||+||++... +++.||||.+.......              ...+.+|+++++.++|+||+++++
T Consensus         8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   87 (335)
T PTZ00024          8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD   87 (335)
T ss_pred             cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence            3444 4577999999999999965 68999999886432211              124678999999999999999999


Q ss_pred             eeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEE
Q 008239          333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI  412 (573)
Q Consensus       333 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl  412 (573)
                      ++......++||||++ ++|.+++..   ...+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.+||
T Consensus        88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence            9999999999999996 688888742   345889999999999999999999987   999999999999999999999


Q ss_pred             eecccccccCCCC-------------cccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCC
Q 008239          413 ADFGLVRLFPEDI-------------THISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNS  478 (573)
Q Consensus       413 ~Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~  478 (573)
                      +|||++.......             ........++..|+|||.+.+. .++.++||||||+++|||++|+.|+......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999988654111             0111123467889999998764 4789999999999999999998887544321


Q ss_pred             cchHHHHHHHhhcCc---cccc------------cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          479 CSILQTVWDLYVKGR---LHEA------------VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       479 ~~~~~~~~~~~~~~~---~~~~------------~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                       .....+........   +...            ..+.+. ......+..+.+++.+||+.+|++||+++|++..-
T Consensus       241 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~  314 (335)
T PTZ00024        241 -DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLK-TIFPNASDDAIDLLQSLLKLNPLERISAKEALKHE  314 (335)
T ss_pred             -HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHH-HhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCc
Confidence             12222222111100   0000            000000 11123456788999999999999999999999754

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-33  Score=290.57  Aligned_cols=262  Identities=22%  Similarity=0.329  Sum_probs=197.1

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC--
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--  338 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--  338 (573)
                      +....++|+..+.||+|+||.||++... +|+.||||++...  .....+.+.+|+.++++++||||+++++++....  
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07880          10 IWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSL   89 (343)
T ss_pred             hhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccc
Confidence            4445678999999999999999999864 6899999998543  2333456889999999999999999999887554  


Q ss_pred             ----ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEee
Q 008239          339 ----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD  414 (573)
Q Consensus       339 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  414 (573)
                          ..++||||+ +++|.+++.    ...+++..++.++.||+.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        90 ~~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~d  161 (343)
T cd07880          90 DRFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILD  161 (343)
T ss_pred             cccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEee
Confidence                348999998 678877763    245899999999999999999999987   99999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHH----------
Q 008239          415 FGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQ----------  483 (573)
Q Consensus       415 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~----------  483 (573)
                      ||++.......    ....+++.|+|||.+.+ ..++.++||||||+++++|++|+.|+...........          
T Consensus       162 fg~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  237 (343)
T cd07880         162 FGLARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSK  237 (343)
T ss_pred             cccccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence            99988654322    23456889999999876 4688999999999999999999998754322111100          


Q ss_pred             HHHHHhhcCccccccC--ccc----cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          484 TVWDLYVKGRLHEAVD--PAL----AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       484 ~~~~~~~~~~~~~~~d--~~l----~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+..+........+.  +..    ...........+.+++.+|++.+|++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         238 EFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0001110000000000  000    00112334567889999999999999999999994

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.3e-34  Score=291.25  Aligned_cols=256  Identities=21%  Similarity=0.328  Sum_probs=191.7

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------  338 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  338 (573)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...  .......+.+|+.+++.++||||+++++++....      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            478999999999999999999964 6899999998653  2233456789999999999999999999887543      


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++|+||+.. +|..++     ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~  164 (342)
T cd07879          94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA  164 (342)
T ss_pred             eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence            45899999864 565543     125889999999999999999999987   999999999999999999999999998


Q ss_pred             cccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH---------
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL---------  488 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~---------  488 (573)
                      +.....    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .....+..         
T Consensus       165 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  239 (342)
T cd07879         165 RHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEFV  239 (342)
T ss_pred             cCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHHH
Confidence            754322    123456888999999876 468899999999999999999999876432111 11111110         


Q ss_pred             --hhcCcccccc-------CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          489 --YVKGRLHEAV-------DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       489 --~~~~~~~~~~-------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                        +.........       ...+. ......+..+.+++.+||+.+|++||++++++..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h  297 (342)
T cd07879         240 QKLEDKAAKSYIKSLPKYPRKDFS-TLFPKASPQAVDLLEKMLELDVDKRLTATEALEH  297 (342)
T ss_pred             HHhcccchHHHHhhcCCcccchHH-HHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence              0000000000       00000 0011245568899999999999999999999954

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-33  Score=289.17  Aligned_cols=264  Identities=22%  Similarity=0.304  Sum_probs=197.8

Q ss_pred             hHHHHHHhcCccccccccccCceeEEEEEc-CCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC
Q 008239          261 YETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG  337 (573)
Q Consensus       261 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  337 (573)
                      ..++...+++|+..+.||+|+||.||++.. .+++.||+|++....  ....+.+.+|+.++++++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            455667789999999999999999999986 468899999986532  22345678899999999999999999987643


Q ss_pred             ------CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEE
Q 008239          338 ------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK  411 (573)
Q Consensus       338 ------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~k  411 (573)
                            ...+++++++ +++|.+++..    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k  160 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK  160 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence                  3357777776 7788777632    34899999999999999999999988   99999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh-
Q 008239          412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY-  489 (573)
Q Consensus       412 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~-  489 (573)
                      |+|||++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ......... 
T Consensus       161 l~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~  235 (345)
T cd07877         161 ILDFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVG  235 (345)
T ss_pred             Eeccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhC
Confidence            9999998854322    223467889999998866 568899999999999999999998874332211 111110000 


Q ss_pred             ----------hcCc-------cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          490 ----------VKGR-------LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       490 ----------~~~~-------~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                                ....       +.......+ .+.....+..+.+++.+|++.+|.+||++.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         236 TPGAELLKKISSESARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             CCCHHHHhhcccHhHHHHHHHhcccCCcch-hhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                      0000       000000000 00111235678899999999999999999999864

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=271.36  Aligned_cols=242  Identities=24%  Similarity=0.271  Sum_probs=200.4

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      -++|..+++||+|.||.|-.++-+ .|+.+|||++++..   .+....-..|-++|...+||.+..|.-.+...+.+++|
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV  246 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV  246 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence            467888999999999999999865 68999999997653   23344556799999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||..+|.|.-+|.   +...+++...+.+-..|+.||.|||+++   ||.||||.+|.|+|.+|++||.||||++.-- 
T Consensus       247 MeyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I-  319 (516)
T KOG0690|consen  247 MEYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEI-  319 (516)
T ss_pred             EEEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcc-
Confidence            99999999988883   3456888888889999999999999988   9999999999999999999999999988421 


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .......+.+||+.|+|||++....|+..+|.|.+||++|||++|+.||......     ....++..++          
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~-----kLFeLIl~ed----------  384 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE-----KLFELILMED----------  384 (516)
T ss_pred             cccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh-----HHHHHHHhhh----------
Confidence            2233456789999999999999999999999999999999999999998754332     1112222111          


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCC
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPS  531 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt  531 (573)
                      -.++.....+...|+...|..||.+|..
T Consensus       385 ~kFPr~ls~eAktLLsGLL~kdP~kRLG  412 (516)
T KOG0690|consen  385 LKFPRTLSPEAKTLLSGLLKKDPKKRLG  412 (516)
T ss_pred             ccCCccCCHHHHHHHHHHhhcChHhhcC
Confidence            1345556667788889999999999953

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.1e-33  Score=288.75  Aligned_cols=262  Identities=22%  Similarity=0.301  Sum_probs=196.6

Q ss_pred             HHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec-CCce
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPES  340 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~  340 (573)
                      ...+++|+..+.||+|+||.||++... +++.||||++...  .....+.+.+|+.+++.++||||+++++++.. ....
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   85 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI   85 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence            446788999999999999999999865 7899999987542  23345677899999999999999999998865 5578


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++++||+ +++|.+++.    ...+++.....++.|++.||.|||+.+   |+||||+|+||++++++.+||+|||++..
T Consensus        86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~  157 (328)
T cd07856          86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI  157 (328)
T ss_pred             EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence            8999998 568877763    235788888999999999999999988   99999999999999999999999999875


Q ss_pred             cCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchH----------HHHHHHh
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL----------QTVWDLY  489 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~----------~~~~~~~  489 (573)
                      .....    ....++..|+|||.+.+ ..++.++||||||++++||++|+.|+..........          +.++...
T Consensus       158 ~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (328)
T cd07856         158 QDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTI  233 (328)
T ss_pred             cCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            43221    23356788999998766 578999999999999999999998775432110000          0011111


Q ss_pred             hcCccccccCc-cccC-----CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          490 VKGRLHEAVDP-ALAG-----NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       490 ~~~~~~~~~d~-~l~~-----~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..+...+.+.. ....     ......+..+.+++.+|++.+|++||++++++..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         234 CSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             cchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            01110000000 0000     0112345788999999999999999999999865

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=5.4e-34  Score=293.02  Aligned_cols=263  Identities=22%  Similarity=0.318  Sum_probs=194.3

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC---------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG---------  337 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~---------  337 (573)
                      ..+|...+.||+|+||.||+|... +|+.||+|++........+.+.+|+++++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367899999999999999999875 5889999998766656667888999999999999999999876543         


Q ss_pred             -----CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC-CCCcEE
Q 008239          338 -----PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAK  411 (573)
Q Consensus       338 -----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~k  411 (573)
                           ...++|+||++ ++|.+++.    ...+++..++.++.||+.||.|||+.+   |+||||||+||+++ +++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                 34689999997 58877763    235889999999999999999999987   99999999999997 556799


Q ss_pred             EeecccccccCCCCccc--ccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH
Q 008239          412 IADFGLVRLFPEDITHI--SATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       412 l~Dfgla~~~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  488 (573)
                      |+|||++..........  .....++..|+|||.+.. ..++.++|||||||++|||++|+.|+................
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999987653322111  122356889999998754 568889999999999999999999885433211111110000


Q ss_pred             hhc-----CccccccCcccc----------CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          489 YVK-----GRLHEAVDPALA----------GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       489 ~~~-----~~~~~~~d~~l~----------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...     ......+...+.          .........++.+++.+||+.+|++|||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            000     000000000000          00112345678899999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=7.8e-34  Score=280.14  Aligned_cols=249  Identities=24%  Similarity=0.340  Sum_probs=194.5

Q ss_pred             CccccccccccCceeEEEEEcCC-CCEEEEEEeccc-----ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      +|...++||+|+||.||+++... +..+++|.++..     ......++..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            47788999999999999998753 445566655431     122334567899999999999999999999999999999


Q ss_pred             EEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          344 YEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      +||+++++|.+++... .....+++..++.++.|++.||.|||+.+   ++|+||+|+||++++ +.+||+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            9999999999887542 23356899999999999999999999987   999999999999986 469999999987654


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      .... ......++..|+|||.+....++.++||||||+++|+|++|..|+....    ........ ..+.     .   
T Consensus       157 ~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~----~~~~~~~~-~~~~-----~---  222 (260)
T cd08222         157 GSCD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQN----FLSVVLRI-VEGP-----T---  222 (260)
T ss_pred             CCcc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCcc----HHHHHHHH-HcCC-----C---
Confidence            3221 2223457889999999988888999999999999999999998874321    11111111 1111     1   


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       ...+...+..+.+++.+||+.+|++||++.|+++
T Consensus       223 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         223 -PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             -CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence             1123445678899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=321.80  Aligned_cols=256  Identities=29%  Similarity=0.348  Sum_probs=204.6

Q ss_pred             HHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ...+-+++...+||.|.||.||.+... +|+..|+|-+...  .......+.+|..+|..++|||+|+++|+-..++..+
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence            344566778899999999999999864 6889999977544  3444567889999999999999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      |.||||++|+|.+.+..   ....++.....+..|++.|++|||++|   ||||||||.||+|+.+|.+|++|||.|..+
T Consensus      1311 IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred             HHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence            99999999999998832   223556666678899999999999998   999999999999999999999999999987


Q ss_pred             CCCCc---ccccccccCcCcCchhhhccCC---CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc
Q 008239          422 PEDIT---HISATLAGTLGYMAPEYVVRGK---LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH  495 (573)
Q Consensus       422 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  495 (573)
                      ..+..   .......||+-|||||++.+..   ..-+.||||+||+++||+||++|+....+...+.-.    +..|.. 
T Consensus      1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~----V~~gh~- 1459 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYH----VAAGHK- 1459 (1509)
T ss_pred             cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhH----HhccCC-
Confidence            65432   2233568999999999997643   456899999999999999999997654443211111    112221 


Q ss_pred             cccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       496 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                              +.++...+.+=.+++..|++.||+.|.++.|+++.-
T Consensus      1460 --------Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~ 1495 (1509)
T KOG4645|consen 1460 --------PQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHA 1495 (1509)
T ss_pred             --------CCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhh
Confidence                    234445566667899999999999999998888765

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-34  Score=281.12  Aligned_cols=258  Identities=26%  Similarity=0.295  Sum_probs=201.8

Q ss_pred             HHhcCccccccccccCceeEEEEEc-CCCCEEEEEEecccC-------hhhHHHHHHHHHHHcCCCCCCeeeeeeeeec-
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-------TQWVDHFFNEVNLISGINHKNLVKLLGCSIT-  336 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-  336 (573)
                      ...++|-.+++||+|+|+.|||+.+ ...+.||||+-..+.       ....+...+|.++-+.|+||.||++|+++.- 
T Consensus       460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD  539 (775)
T KOG1151|consen  460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD  539 (775)
T ss_pred             chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence            3446677889999999999999985 467899999875431       2234556789999999999999999998874 


Q ss_pred             CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---CCcEEEe
Q 008239          337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIA  413 (573)
Q Consensus       337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~  413 (573)
                      ....+-|+|||++.+|+-+|..   ...+++.++..|+.||+.||.||.+.. ++|||-||||.|||+.+   -|.+||.
T Consensus       540 tdsFCTVLEYceGNDLDFYLKQ---hklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKIT  615 (775)
T KOG1151|consen  540 TDSFCTVLEYCEGNDLDFYLKQ---HKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKIT  615 (775)
T ss_pred             cccceeeeeecCCCchhHHHHh---hhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEee
Confidence            4567899999999999888843   345899999999999999999999875 88999999999999954   4789999


Q ss_pred             ecccccccCCCCcc------cccccccCcCcCchhhhcc----CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHH
Q 008239          414 DFGLVRLFPEDITH------ISATLAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQ  483 (573)
Q Consensus       414 Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~  483 (573)
                      ||||++.+.++...      ......||.+|++||.+.-    .+.+.|+||||.|||+|+.+.|++||.......++++
T Consensus       616 DFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILq  695 (775)
T KOG1151|consen  616 DFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQ  695 (775)
T ss_pred             ecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHh
Confidence            99999988654332      2335689999999998753    3578899999999999999999999988766555554


Q ss_pred             HHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHH
Q 008239          484 TVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVV  536 (573)
Q Consensus       484 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl  536 (573)
                      +. ..+...++.      +  ...+....+...+|.+||+..-++|.+..++.
T Consensus       696 eN-TIlkAtEVq------F--P~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  696 EN-TILKATEVQ------F--PPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             hh-chhcceecc------C--CCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            42 111111110      1  11223456678999999999999997766654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-33  Score=273.46  Aligned_cols=236  Identities=28%  Similarity=0.309  Sum_probs=193.1

Q ss_pred             ccccCceeEEEEEcC-CCCEEEEEEecccCh---hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCc
Q 008239          277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL  352 (573)
Q Consensus       277 lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL  352 (573)
                      ||+|+||.||++... +++.+++|.+.....   ...+.+.+|+.++++++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999976 588999999865432   2456788999999999999999999999999999999999999999


Q ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccccccc
Q 008239          353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL  432 (573)
Q Consensus       353 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~  432 (573)
                      .+++...   ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~  153 (250)
T cd05123          81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTF  153 (250)
T ss_pred             HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCC
Confidence            9988433   35899999999999999999999987   9999999999999999999999999988654332 122345


Q ss_pred             ccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHH
Q 008239          433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS  512 (573)
Q Consensus       433 ~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  512 (573)
                      .++..|++||...+...+.++|+||||+++|||++|+.|+..... ....    .....+.          ...+...+.
T Consensus       154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~-~~~~----~~~~~~~----------~~~~~~~~~  218 (250)
T cd05123         154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR-KEIY----EKILKDP----------LRFPEFLSP  218 (250)
T ss_pred             cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-HHHH----HHHhcCC----------CCCCCCCCH
Confidence            678899999999888889999999999999999999988754322 1111    1111111          123344467


Q ss_pred             HHHHHHHHccCCCCCCCCCHHH
Q 008239          513 RLLQIGLLCVQASAELRPSMSI  534 (573)
Q Consensus       513 ~l~~l~~~cl~~~p~~RPt~~e  534 (573)
                      .+.+++.+||..+|++||++.+
T Consensus       219 ~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         219 EARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHHHhcCCHhhCCCccc
Confidence            8899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.8e-33  Score=285.58  Aligned_cols=260  Identities=23%  Similarity=0.288  Sum_probs=190.4

Q ss_pred             CccccccccccCceeEEEEEcC-C--CCEEEEEEeccc--ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC----Cc
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-G--GEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG----PE  339 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~--g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~----~~  339 (573)
                      +|+..+.||+|+||.||+++.. .  +..||||++...  .....+.+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999975 3  778999988643  222345678899999999 599999999875432    34


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++++||+. ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++.
T Consensus        81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~  153 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR  153 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence            678888885 688887742   346899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCcc---cccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHH---------
Q 008239          420 LFPEDITH---ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVW---------  486 (573)
Q Consensus       420 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~---------  486 (573)
                      .+......   ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .......         
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~  232 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV-DQLNQILQVLGTPDEE  232 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHH-HHHHHHHHHhCCCCHH
Confidence            65432211   1223468899999998765 46899999999999999999999876543211 1111100         


Q ss_pred             --HHhhcCccccc------cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          487 --DLYVKGRLHEA------VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       487 --~~~~~~~~~~~------~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ..+........      ................+.+++.+|++.+|++|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             HHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence              00000000000      0000000111223567889999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.1e-33  Score=290.76  Aligned_cols=259  Identities=21%  Similarity=0.316  Sum_probs=196.7

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc---
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE---  339 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---  339 (573)
                      ...++|+..+.||+|++|.||+|+.. +++.||||++...  .....+.+.+|+.+++.++||||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            34678999999999999999999985 5789999988643  23334667789999999999999999998776554   


Q ss_pred             ---eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          340 ---SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       340 ---~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                         .++|+||+ +++|.+++..    ..+++..++.++.|++.||+|||+.+   |+||||+|+||++++++.+||+|||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg  163 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG  163 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence               89999998 5688887742    45899999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH--------
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD--------  487 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~--------  487 (573)
                      ++......    .....++..|+|||.+.+ ..++.++||||||+++|||++|+.|+....... .......        
T Consensus       164 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~  238 (343)
T cd07851         164 LARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEE  238 (343)
T ss_pred             cccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHH
Confidence            98865432    223457888999999865 367899999999999999999998875332211 1111100        


Q ss_pred             ---HhhcCccccccC-------ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          488 ---LYVKGRLHEAVD-------PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       488 ---~~~~~~~~~~~d-------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                         .+........+.       +.+. ......+..+.+++.+||+.+|++|||+.+|++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         239 LLQKISSESARNYIQSLPQMPKKDFK-EVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHhhccchhHHHHHHhccccCCCCHH-HHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence               000000000000       0000 0011236678999999999999999999999863

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=263.69  Aligned_cols=261  Identities=24%  Similarity=0.287  Sum_probs=201.8

Q ss_pred             ChHHHHHHhcCccccccccccCceeEEEEE-cCCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecC
Q 008239          260 SYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITG  337 (573)
Q Consensus       260 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~-~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  337 (573)
                      .++++.+.|     .+.||+|+|+.|--++ +.+|.++|||++.+.......+..+|++++.+.+ |+||++|+++|+++
T Consensus        74 ~F~d~YkLt-----~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd  148 (463)
T KOG0607|consen   74 KFEDMYKLT-----SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD  148 (463)
T ss_pred             hHHHHHHhH-----HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence            355555554     5689999999999887 5789999999998777677788999999999994 99999999999999


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC---cEEEee
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIAD  414 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl~D  414 (573)
                      ...|||||-|.+|+|..+++.+   ..+++.++.+++.+|+.||.+||.++   |.||||||+|||..+-.   -+||+|
T Consensus       149 ~~FYLVfEKm~GGplLshI~~~---~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD  222 (463)
T KOG0607|consen  149 TRFYLVFEKMRGGPLLSHIQKR---KHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD  222 (463)
T ss_pred             ceEEEEEecccCchHHHHHHHh---hhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence            9999999999999999999654   45899999999999999999999998   99999999999996543   489999


Q ss_pred             cccccccC--CCCcc----cccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc----
Q 008239          415 FGLVRLFP--EDITH----ISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC----  479 (573)
Q Consensus       415 fgla~~~~--~~~~~----~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~----  479 (573)
                      |.|.....  .+.+.    ...+.+|+..|||||+..     ...|+.+.|.||||||||-||+|-.||...=...    
T Consensus       223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd  302 (463)
T KOG0607|consen  223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD  302 (463)
T ss_pred             cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence            99976432  22222    223567888999999873     2468899999999999999999999986532111    


Q ss_pred             ------chHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          480 ------SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       480 ------~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                            .-.+.....+..|.. +..|+..     ...+.+..+++...+-.++.+|-++.++++
T Consensus       303 rGe~Cr~CQ~~LFesIQEGkY-eFPdkdW-----ahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  303 RGEVCRVCQNKLFESIQEGKY-EFPDKDW-----AHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             CCCccHHHHHHHHHHHhccCC-cCChhhh-----HHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence                  111222223333332 1111111     123455667777888899999999998886

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=304.11  Aligned_cols=261  Identities=21%  Similarity=0.201  Sum_probs=209.0

Q ss_pred             hHHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec
Q 008239          261 YETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT  336 (573)
Q Consensus       261 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  336 (573)
                      ..++....++|+++++||+|+||.|..++.+ +++.||.|++.+-   ......-|..|-.+|..-..+-|++++-.|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            3445556688999999999999999999986 5788999999652   23334568889999999999999999999999


Q ss_pred             CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                      ...+|+|||||+||+|..++.   +...+++..+..++..|+.||.-||+.|   +|||||||.|||||..|++||+|||
T Consensus       147 ~~~LYlVMdY~pGGDlltLlS---k~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLS---KFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             ccceEEEEecccCchHHHHHh---hcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence            999999999999999999984   3336899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhcc-----CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      -+-.+..+..-.+...+|||.|++||++..     +.|+...|.||+||++|||+.|..||....    ++...-.....
T Consensus       221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads----lveTY~KIm~h  296 (1317)
T KOG0612|consen  221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS----LVETYGKIMNH  296 (1317)
T ss_pred             hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH----HHHHHHHHhch
Confidence            998887776667778899999999999952     679999999999999999999999987542    33332222222


Q ss_pred             CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCC---HHHHHHHh
Q 008239          492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPS---MSIVVKML  539 (573)
Q Consensus       492 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt---~~evl~~L  539 (573)
                      .+...+.+       ....++...+||...+. +|+.|..   ++++-..-
T Consensus       297 k~~l~FP~-------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  297 KESLSFPD-------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             hhhcCCCc-------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence            11111111       12355666777766553 5666666   88887654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.1e-32  Score=305.42  Aligned_cols=145  Identities=27%  Similarity=0.341  Sum_probs=130.2

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|.+.++||+|+||+||+|.+. +++.||||++...   .......+..|+.++..++||||+++++++......++||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            57889999999999999999976 6899999998643   2334567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus        84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999998843   235788999999999999999999987   9999999999999999999999999975

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-34  Score=265.40  Aligned_cols=255  Identities=24%  Similarity=0.311  Sum_probs=194.0

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEecccCh-hhHHHHHHHHHHHcC-CCCCCeeeeeeeeecCCceeEEEEec
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-QWVDHFFNEVNLISG-INHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .+.+..||.|.||+|+|-.++ .|+..|||++..... ...+++..|.+...+ -+.||||+++|.+..++.-|+.||.|
T Consensus        66 Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM  145 (361)
T KOG1006|consen   66 LQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM  145 (361)
T ss_pred             HHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence            344678999999999999875 699999999976543 556678888887555 47999999999999999999999999


Q ss_pred             cCCCccccccc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          348 PNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       348 ~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      . .||+.+...  ......+++..+-+|..-.+.||.||.+..  .|||||+||+|||++..|.+||+|||++..+.+..
T Consensus       146 d-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  146 D-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             h-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence            4 466443211  112345888888889999999999998764  69999999999999999999999999988664432


Q ss_pred             cccccccccCcCcCchhhhccC--CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          426 THISATLAGTLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .  .+.-+|-..|||||.+...  .|+.+|||||||+.|+|+.||+.|......   +.+.+.... .|....+..+   
T Consensus       223 A--kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s---vfeql~~Vv-~gdpp~l~~~---  293 (361)
T KOG1006|consen  223 A--KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS---VFEQLCQVV-IGDPPILLFD---  293 (361)
T ss_pred             H--hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH---HHHHHHHHH-cCCCCeecCc---
Confidence            2  2345678899999999643  488999999999999999999988644322   233333322 2222222111   


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       .-.......+..++..|+.+|..+||..+++.++
T Consensus       294 -~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  294 -KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence             1113456778899999999999999999998865

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-33  Score=239.99  Aligned_cols=262  Identities=23%  Similarity=0.306  Sum_probs=199.0

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +|...++||+|.||+||||+.. +++.||+|++..++  +.......+|+-+|+.++|.|||++++....+..+-+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            4566789999999999999975 58899999987643  33345678999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      |. .+|..+..  .-++.++.+....++.|+++||.+.|+++   +.||||||+|.||+.+|+.|++|||+++.+.-...
T Consensus        83 cd-qdlkkyfd--slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr  156 (292)
T KOG0662|consen   83 CD-QDLKKYFD--SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR  156 (292)
T ss_pred             hh-HHHHHHHH--hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence            94 46666552  23467889999999999999999999998   99999999999999999999999999998765433


Q ss_pred             ccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh---cCc---cccccC
Q 008239          427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV---KGR---LHEAVD  499 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~---~~~~~d  499 (573)
                      ..+ ..+-|.+|.+|.++.+. -|+...|+||-|||+.||....+|.+.+..-.+.+..+.....   ++.   +.++.|
T Consensus       157 cys-aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpd  235 (292)
T KOG0662|consen  157 CYS-AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPD  235 (292)
T ss_pred             eee-ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCC
Confidence            322 33568999999999875 5899999999999999999988887776554332222222221   111   123333


Q ss_pred             ccccCCCCCc-----h----HHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          500 PALAGNFQEG-----K----PSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       500 ~~l~~~~~~~-----~----~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ......++..     .    ...=.+++...+.-+|..|.++++.++.
T Consensus       236 yk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  236 YKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            3333222221     1    1112356666777799999999988763

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=260.17  Aligned_cols=255  Identities=21%  Similarity=0.222  Sum_probs=200.6

Q ss_pred             HhcCccc-cccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeec----CCc
Q 008239          267 ATNYFHE-SNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT----GPE  339 (573)
Q Consensus       267 ~~~~~~~-~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~~  339 (573)
                      .+++|.+ .++||-|-.|.|-....+ +|+.+|+|++...     ....+|+++--.. .|||||.+++++..    ...
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            3555654 478999999999999875 6899999998543     3446788874444 79999999998763    456


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC---CCCcEEEeecc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFG  416 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~---~~~~~kl~Dfg  416 (573)
                      +++|||.|++|.|++.+..+. ...+++.++-.|+.||..|+.|||+.+   |.||||||+|+|..   .|..+||+|||
T Consensus       134 LLiVmE~meGGeLfsriq~~g-~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG  209 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRG-DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG  209 (400)
T ss_pred             eEeeeecccchHHHHHHHHcc-cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence            789999999999999986544 456999999999999999999999988   99999999999996   45679999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      +|+.-..  .....+.+-|+.|.|||++..++|+...|+||+||++|-|++|-+||..... ..+..-++..+..+.. +
T Consensus       210 FAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg-~aispgMk~rI~~gqy-~  285 (400)
T KOG0604|consen  210 FAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG-LAISPGMKRRIRTGQY-E  285 (400)
T ss_pred             cccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC-ccCChhHHhHhhccCc-c
Confidence            9986433  2334466789999999999999999999999999999999999988875443 3333344444444432 1


Q ss_pred             ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       497 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ..++.     -...++...+++...|+.+|++|.|+.+++..=
T Consensus       286 FP~pE-----Ws~VSe~aKdlIR~LLkt~PteRlTI~~~m~hp  323 (400)
T KOG0604|consen  286 FPEPE-----WSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHP  323 (400)
T ss_pred             CCChh-----HhHHHHHHHHHHHHHhcCCchhheeHHHhhcCc
Confidence            11111     123456778999999999999999999998643

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.8e-32  Score=266.67  Aligned_cols=219  Identities=19%  Similarity=0.135  Sum_probs=176.0

Q ss_pred             cCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCccccccc
Q 008239          280 GGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV  358 (573)
Q Consensus       280 G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  358 (573)
                      |.+|.||+++.. +++.+|+|++....     .+..|...+....||||+++++++......++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            899999999975 68899999986543     233455555666799999999999999999999999999999998853


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccCcCc
Q 008239          359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY  438 (573)
Q Consensus       359 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y  438 (573)
                      .   ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++++|||++.......    ....++..|
T Consensus        79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y  148 (237)
T cd05576          79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMY  148 (237)
T ss_pred             h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCccc
Confidence            3   34899999999999999999999987   9999999999999999999999999877553321    223456789


Q ss_pred             CchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHH
Q 008239          439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIG  518 (573)
Q Consensus       439 ~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  518 (573)
                      +|||.+..+.++.++||||+|++++||++|+.++......               .    ........+...+..+.+++
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---------------~----~~~~~~~~~~~~~~~~~~li  209 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---------------I----NTHTTLNIPEWVSEEARSLL  209 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---------------c----ccccccCCcccCCHHHHHHH
Confidence            9999998888999999999999999999998764321110               0    00000112334567788999


Q ss_pred             HHccCCCCCCCCCH
Q 008239          519 LLCVQASAELRPSM  532 (573)
Q Consensus       519 ~~cl~~~p~~RPt~  532 (573)
                      .+|++.||++||++
T Consensus       210 ~~~l~~dp~~R~~~  223 (237)
T cd05576         210 QQLLQFNPTERLGA  223 (237)
T ss_pred             HHHccCCHHHhcCC
Confidence            99999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.98  E-value=9e-33  Score=283.30  Aligned_cols=240  Identities=23%  Similarity=0.263  Sum_probs=195.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++.|+....+|.|+|+.|-++... +++..++|++.+...    .-.+|+.++... +||||+++.+.+.++.+.++|||
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e  396 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME  396 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence            567888888999999999999864 688899999966522    223567665555 79999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee-CCCCcEEEeecccccccCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL-DEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll-~~~~~~kl~Dfgla~~~~~~  424 (573)
                      .+.++-|.+.+....    .....+..|+.+|+.++.|||+++   +|||||||+|||+ ++.++++|+|||.++.....
T Consensus       397 ~l~g~ell~ri~~~~----~~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  397 LLDGGELLRRIRSKP----EFCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             hccccHHHHHHHhcc----hhHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999998877764322    222677789999999999999988   9999999999999 58899999999999977554


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                          ....+-|..|.|||++....|+.++|+||||++|||||+|+.|+.....+..    +......            +
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~e----i~~~i~~------------~  529 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIE----IHTRIQM------------P  529 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHH----HHHhhcC------------C
Confidence                2334568899999999999999999999999999999999999876655411    1122222            2


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .++...+....+|+.+||+.||.+||+|+++...
T Consensus       530 ~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  530 KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence            2335567778899999999999999999999853

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.98  E-value=6.6e-32  Score=284.90  Aligned_cols=259  Identities=20%  Similarity=0.254  Sum_probs=181.3

Q ss_pred             hcCccccccccccCceeEEEEEc-----------------CCCCEEEEEEecccChhhHHHH--------------HHHH
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-----------------PGGEAVAVKRLFYNTTQWVDHF--------------FNEV  316 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-----------------~~g~~vavK~~~~~~~~~~~~~--------------~~E~  316 (573)
                      .++|++.++||+|+||+||+|.+                 .+++.||||++........++|              ..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999964                 2356899999865443323333              3466


Q ss_pred             HHHcCCCCCCe-----eeeeeeeec--------CCceeEEEEeccCCCccccccccCC---------------------C
Q 008239          317 NLISGINHKNL-----VKLLGCSIT--------GPESLLVYEFVPNQSLLDNLFVRQD---------------------V  362 (573)
Q Consensus       317 ~~l~~l~h~ni-----v~l~~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~  362 (573)
                      .++.+++|.++     ++++++|..        ....+|||||+++++|.++++....                     .
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766654     677777653        3567999999999999998864211                     1


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccCcCcCchh
Q 008239          363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE  442 (573)
Q Consensus       363 ~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE  442 (573)
                      ..+++..+..++.|++.+|.|||+.+   |+||||||+|||++.++.+||+|||++...............+++.|+|||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            23567889999999999999999987   999999999999999999999999999755433222222233578999999


Q ss_pred             hhccCCC----------------------CcccchHhHHHHHHHHHcCCCCCCCCCCC-c------chHHHHHHHhhcCc
Q 008239          443 YVVRGKL----------------------TEKADVYSFGVVVIEVVCRKRINLFTQNS-C------SILQTVWDLYVKGR  493 (573)
Q Consensus       443 ~~~~~~~----------------------~~~sDvwslGvil~elltg~~p~~~~~~~-~------~~~~~~~~~~~~~~  493 (573)
                      .+.....                      ..+.||||+||+++||+++..+....... .      .-....|..+....
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~  460 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQK  460 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccC
Confidence            8854321                      23579999999999999987633221100 0      00111122221111


Q ss_pred             cccccCccccCCCCCchHHHHHHHHHHccCCCC---CCCCCHHHHHH
Q 008239          494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASA---ELRPSMSIVVK  537 (573)
Q Consensus       494 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p---~~RPt~~evl~  537 (573)
                      .    +    -...........+++.+++..+|   .+|+|++|+++
T Consensus       461 ~----~----~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        461 Y----D----FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             C----C----cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            1    1    01122345677899999998765   68999999985

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=7.4e-34  Score=258.94  Aligned_cols=265  Identities=23%  Similarity=0.340  Sum_probs=192.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--------
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--------  337 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--------  337 (573)
                      ..|+...+||+|.||+||+++.. +|+.||+|+...+  .........+|+++|..|+|+|++.+++.|...        
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34566789999999999999975 5788999876442  223344567899999999999999999987632        


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ...++|+++|+. +|.-+|.  .....++..++.++..++..||.|+|...   |+|||+||.|+||+.++.+||+|||+
T Consensus        97 ~t~ylVf~~ceh-DLaGlLs--n~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen   97 ATFYLVFDFCEH-DLAGLLS--NRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             ceeeeeHHHhhh-hHHHHhc--CccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence            347899999975 6665552  23356889999999999999999999987   99999999999999999999999999


Q ss_pred             ccccCCCCcc---cccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcch--HH--------
Q 008239          418 VRLFPEDITH---ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSI--LQ--------  483 (573)
Q Consensus       418 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~--~~--------  483 (573)
                      ++.+......   ..+..+-|..|.+||.+.+ ..|+++.|||.-|||+.||+++.+.+....+...+  +.        
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            9876533222   2234566999999999876 57999999999999999999998776654433211  11        


Q ss_pred             HHHHHhhcCcccccc--CccccCCC--------CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          484 TVWDLYVKGRLHEAV--DPALAGNF--------QEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       484 ~~~~~~~~~~~~~~~--d~~l~~~~--------~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      .+|....+-.+.+.+  .|.-.+.+        +-.......+|+..++..||.+|++.++++..-
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            112111111111111  00000000        001123567889999999999999999988644

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.98  E-value=1.2e-31  Score=260.34  Aligned_cols=238  Identities=26%  Similarity=0.306  Sum_probs=193.3

Q ss_pred             CceeEEEEEcC-CCCEEEEEEecccChhh-HHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCccccccc
Q 008239          281 GSGSVYKGTLP-GGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV  358 (573)
Q Consensus       281 ~~g~Vy~~~~~-~g~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  358 (573)
                      +||.||+++.. +|+.+++|++....... .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999987 48999999997654443 67899999999999999999999999999999999999999999998853


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccCcCc
Q 008239          359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY  438 (573)
Q Consensus       359 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y  438 (573)
                      ..   .+++..++.++.+++.++.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  ......++..|
T Consensus        81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~  152 (244)
T smart00220       81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEY  152 (244)
T ss_pred             cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCC
Confidence            22   2889999999999999999999987   9999999999999999999999999998765432  22345678899


Q ss_pred             CchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHH
Q 008239          439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIG  518 (573)
Q Consensus       439 ~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  518 (573)
                      ++||.+....++.++||||||++++||++|..|+........    .......+....       .......+..+.+++
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~----~~~~~~~~~~~~-------~~~~~~~~~~~~~~i  221 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLE----LFKKIGKPKPPF-------PPPEWKISPEAKDLI  221 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHH----HHHHHhccCCCC-------ccccccCCHHHHHHH
Confidence            999999988899999999999999999999988754322111    111111111100       000111567899999


Q ss_pred             HHccCCCCCCCCCHHHHHH
Q 008239          519 LLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       519 ~~cl~~~p~~RPt~~evl~  537 (573)
                      .+|+..+|++||++.++++
T Consensus       222 ~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      222 RKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHccCCchhccCHHHHhh
Confidence            9999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.98  E-value=9.1e-32  Score=290.94  Aligned_cols=260  Identities=20%  Similarity=0.221  Sum_probs=170.3

Q ss_pred             HhcCccccccccccCceeEEEEEcC-C----CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeee------ee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-G----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC------SI  335 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~------~~  335 (573)
                      ..++|+..++||+|+||.||+|++. +    +..||||++......  +.+..|  .+....+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~--e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV--EIWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh--HHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4578999999999999999999975 4    689999987543221  111111  1222223333332221      24


Q ss_pred             cCCceeEEEEeccCCCccccccccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQDV-----------------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK  398 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk  398 (573)
                      .....++|+||+++++|.+++......                 ....+..+..++.||+.||+|||+++   |+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence            566789999999999999888543210                 01123445679999999999999987   9999999


Q ss_pred             CCCeeeCC-CCcEEEeecccccccCCCCcccccccccCcCcCchhhhccC----------------------CCCcccch
Q 008239          399 LSNILLDE-EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG----------------------KLTEKADV  455 (573)
Q Consensus       399 ~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~sDv  455 (573)
                      |+|||+++ ++.+||+|||+++.+............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999985 58999999999986644433344456789999999966322                      23456799


Q ss_pred             HhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC----ccccccCccc----cC--CCCCchHHHHHHHHHHccCCC
Q 008239          456 YSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG----RLHEAVDPAL----AG--NFQEGKPSRLLQIGLLCVQAS  525 (573)
Q Consensus       456 wslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~d~~l----~~--~~~~~~~~~l~~l~~~cl~~~  525 (573)
                      |||||+||||+++..+...     .+..........+    .+...+.+..    ..  +..........+|+.+||+.|
T Consensus       363 wSlGviL~el~~~~~~~~~-----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDS-----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             HHHHHHHHHHHhCcCCCch-----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            9999999999986654221     1111111100000    0001111110    00  001112234568999999999


Q ss_pred             CCCCCCHHHHHHH
Q 008239          526 AELRPSMSIVVKM  538 (573)
Q Consensus       526 p~~RPt~~evl~~  538 (573)
                      |++|||++++++.
T Consensus       438 P~kR~ta~e~L~H  450 (566)
T PLN03225        438 GRQRISAKAALAH  450 (566)
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999974

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.7e-32  Score=265.60  Aligned_cols=242  Identities=24%  Similarity=0.257  Sum_probs=195.6

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  342 (573)
                      ..+|..+.+||+|+||.|.++..+ +.+.+|||+++++.   .+..+--..|-++|... +-|.++++..++..-+.+++
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            356888999999999999999876 46789999997652   12233345677788777 57899999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+.+|+|-.++..-   +.+.+..+..++..||-||-+||+++   ||.||||..|||+|.+|++||.|||+++.--
T Consensus       428 VMEyvnGGDLMyhiQQ~---GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni  501 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQV---GKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI  501 (683)
T ss_pred             EEEEecCchhhhHHHHh---cccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc
Confidence            99999999998888543   44677888999999999999999998   9999999999999999999999999987321


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      - ......+.+||+.|+|||.+..++|+..+|.|||||+||||+.|+.|+....++. +.+    .+...+         
T Consensus       502 ~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e-lF~----aI~ehn---------  566 (683)
T KOG0696|consen  502 F-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE-LFQ----AIMEHN---------  566 (683)
T ss_pred             c-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH-HHH----HHHHcc---------
Confidence            1 1223457899999999999999999999999999999999999999987655431 111    111111         


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCC
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPS  531 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt  531 (573)
                       -.++...+.+...|....+..+|.+|..
T Consensus       567 -vsyPKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  567 -VSYPKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             -CcCcccccHHHHHHHHHHhhcCCccccC
Confidence             1356667778888888899999998854

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=281.12  Aligned_cols=262  Identities=26%  Similarity=0.352  Sum_probs=208.3

Q ss_pred             cChHHHHHHhcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeee-
Q 008239          259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI-  335 (573)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-  335 (573)
                      ..++.+...++-|++.+.||.|.+|.||+++. ++++.+|||++...... .+++..|.++|+.+ .|||++.++|++. 
T Consensus         9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k   87 (953)
T KOG0587|consen    9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIK   87 (953)
T ss_pred             cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence            34455556678899999999999999999986 46889999988654332 46778899999888 6999999999886 


Q ss_pred             ----cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEE
Q 008239          336 ----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK  411 (573)
Q Consensus       336 ----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~k  411 (573)
                          .++.+|||||||.+||..+++..-. ...+.|..+.-|+..++.|+.+||.+.   ++|||||-.|||++.++.||
T Consensus        88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK  163 (953)
T KOG0587|consen   88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK  163 (953)
T ss_pred             ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence                3568899999999999999886544 567899999999999999999999987   99999999999999999999


Q ss_pred             EeecccccccCCCCcccccccccCcCcCchhhhccC-----CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHH
Q 008239          412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-----KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVW  486 (573)
Q Consensus       412 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~  486 (573)
                      |.|||++..+...-. ...+..||+.|||||++...     .|+.++|+||||++..||--|.+|........       
T Consensus       164 LvDFGvSaQldsT~g-rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr-------  235 (953)
T KOG0587|consen  164 LVDFGVSAQLDSTVG-RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR-------  235 (953)
T ss_pred             Eeeeeeeeeeecccc-cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh-------
Confidence            999999987654332 33466899999999999643     57789999999999999999998865433211       


Q ss_pred             HHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          487 DLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       487 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .++.   +....-|.|.  -+..-..++.+++..||..|-+.||++.+++++
T Consensus       236 aLF~---IpRNPPPkLk--rp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  236 ALFL---IPRNPPPKLK--RPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             hhcc---CCCCCCcccc--chhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            1110   1111122222  133446789999999999999999999888753

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.5e-31  Score=249.55  Aligned_cols=247  Identities=21%  Similarity=0.255  Sum_probs=199.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|..+++||+|+|..|..+++. +.+.+|+|++++.   ..+..+....|-.++.+- +||.+|.+..++...+.+++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff  328 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF  328 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence            467889999999999999999985 5788999988653   344455666777777666 79999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      |.||+++|+|--++.   +...++++.+..+...|..||.|||+.+   ||.||||..|||+|..|++||.|+|+.+.--
T Consensus       329 vieyv~ggdlmfhmq---rqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l  402 (593)
T KOG0695|consen  329 VIEYVNGGDLMFHMQ---RQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL  402 (593)
T ss_pred             EEEEecCcceeeehh---hhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence            999999999977774   3345899999999999999999999998   9999999999999999999999999987422


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCC---cchHHHHHHHhhcCccccccC
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS---CSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~---~~~~~~~~~~~~~~~~~~~~d  499 (573)
                       .......+.+||+.|.|||.+.+..|+..+|.|+|||+++||+.|+.||..-..+   .....+..+.+....+     
T Consensus       403 -~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqi-----  476 (593)
T KOG0695|consen  403 -GPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQI-----  476 (593)
T ss_pred             -CCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcc-----
Confidence             2223345789999999999999999999999999999999999999999764322   2333344443333221     


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCC
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPS  531 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt  531 (573)
                           .++...+.+...++..-+++||.+|..
T Consensus       477 -----riprslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  477 -----RIPRSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             -----cccceeehhhHHHHHHhhcCCcHHhcC
Confidence                 124444556678888899999999853

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1.1e-31  Score=259.08  Aligned_cols=262  Identities=21%  Similarity=0.276  Sum_probs=200.1

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCC-C-C----CeeeeeeeeecCC
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-H-K----NLVKLLGCSITGP  338 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-~----niv~l~~~~~~~~  338 (573)
                      ..+++|.+...+|+|.||.|-..... .+..||||+++.- ....+...-|+++|.++. + |    -+|++.+++.-.+
T Consensus        86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrg  164 (415)
T KOG0671|consen   86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRG  164 (415)
T ss_pred             ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccC
Confidence            34788999999999999999999865 4789999988543 334456677999999993 2 2    3788889999999


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC------------
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE------------  406 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~------------  406 (573)
                      +.++|+|.+ +-|+.+++.. ++..+++..++..++.|+++++++||+..   ++|-||||+|||+.+            
T Consensus       165 hiCivfell-G~S~~dFlk~-N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  165 HICIVFELL-GLSTFDFLKE-NNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             ceEEEEecc-ChhHHHHhcc-CCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence            999999998 5589998843 34567899999999999999999999987   999999999999832            


Q ss_pred             --------CCcEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCC
Q 008239          407 --------EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS  478 (573)
Q Consensus       407 --------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~  478 (573)
                              +..+||+|||.|+......    ..++.|..|.|||++.+-.++..+||||+||||.|+.+|...|....+.
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                    3458999999998654433    4567899999999999999999999999999999999999887766543


Q ss_pred             cch--HHHHHH--------------HhhcCccc-----------cccCc--ccc--CCCCCchHHHHHHHHHHccCCCCC
Q 008239          479 CSI--LQTVWD--------------LYVKGRLH-----------EAVDP--ALA--GNFQEGKPSRLLQIGLLCVQASAE  527 (573)
Q Consensus       479 ~~~--~~~~~~--------------~~~~~~~~-----------~~~d~--~l~--~~~~~~~~~~l~~l~~~cl~~~p~  527 (573)
                      +.+  .+.+..              ....+++.           ...++  .+.  -.....+..+|.+|+..+|..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            311  111110              01111110           00000  000  011334567899999999999999


Q ss_pred             CCCCHHHHHH
Q 008239          528 LRPSMSIVVK  537 (573)
Q Consensus       528 ~RPt~~evl~  537 (573)
                      +|+|+.|++.
T Consensus       396 ~RiTl~EAL~  405 (415)
T KOG0671|consen  396 RRITLREALS  405 (415)
T ss_pred             ccccHHHHhc
Confidence            9999999985

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.97  E-value=7.8e-32  Score=267.91  Aligned_cols=243  Identities=23%  Similarity=0.301  Sum_probs=191.4

Q ss_pred             cccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          274 SNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      .+.||+|.||+||-|++. +|+.||||++.+.  ......++.+|+.+|.++.||.||.+--.|+..+..++|||-+ +|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence            578999999999999874 7999999998543  3344578899999999999999999999999999999999999 56


Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---CCcEEEeecccccccCCCCcc
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      +..+.+... ..+.+++.....++.||+.||.|||.++   |+|.||||+|||+..   -.++||+|||.|+.+.+..  
T Consensus       648 DMLEMILSs-EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--  721 (888)
T KOG4236|consen  648 DMLEMILSS-EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--  721 (888)
T ss_pred             hHHHHHHHh-hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence            766666443 4467899888899999999999999998   999999999999964   3589999999999987643  


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      ....++||+.|+|||++.++.|...-|+||.|||+|--++|.-||..+.+-.+.+       .+-..   +-|   .+--
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQI-------QNAaF---MyP---p~PW  788 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQI-------QNAAF---MYP---PNPW  788 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHh-------hcccc---ccC---CCch
Confidence            3456789999999999999999999999999999999999998875433211111       11111   000   0111


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVV  536 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl  536 (573)
                      .+.....+++|...|+..-.+|-+.+.-+
T Consensus       789 ~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  789 SEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             hhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence            23345566777777788777777765443

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.4e-32  Score=268.92  Aligned_cols=249  Identities=21%  Similarity=0.255  Sum_probs=204.0

Q ss_pred             cCccccccccccCceeEEEEEcCCCC-EEEEEEecc---cChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFY---NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~-~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .+++.+..||-|+||.|-++..++.. .+|+|++++   .+....+.+..|-++|...+.|.||++|..|.+....|++|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm  499 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM  499 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence            45566778999999999999876544 378887754   34555678889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      |-|-+|.|+..|..   .+.++......++..+.+|++|||+++   ||.|||||+|++++.+|-+||.|||.|+.+...
T Consensus       500 EaClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g  573 (732)
T KOG0614|consen  500 EACLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG  573 (732)
T ss_pred             HhhcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence            99999999999954   456888889999999999999999998   999999999999999999999999999987543


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                        ..+.+.+||+.|.|||.+.+.-.+..+|.||||++++||++|.+||.....-   ..  +..+..|     +|.   -
T Consensus       574 --~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm---kt--Yn~ILkG-----id~---i  638 (732)
T KOG0614|consen  574 --RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM---KT--YNLILKG-----IDK---I  638 (732)
T ss_pred             --CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH---HH--HHHHHhh-----hhh---h
Confidence              4567899999999999999999999999999999999999999998754431   11  1111111     111   1


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPS-----MSIVVKM  538 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~~  538 (573)
                      .++........+++++....+|.+|..     +.+|-+.
T Consensus       639 ~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  639 EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence            234455667789999999999999976     5666544

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=4e-31  Score=234.61  Aligned_cols=210  Identities=26%  Similarity=0.339  Sum_probs=171.1

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEc-CCCCEEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCc
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPE  339 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~  339 (573)
                      .++...++...+..||+|++|.|-+-++ ++|+..|+|++... ..+..++..+|+++..+. ..|.+|.++|.......
T Consensus        40 ~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   40 NFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             ccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            3556666777789999999999998886 57999999998654 334456778899886555 79999999999999999


Q ss_pred             eeEEEEeccCCCccccccc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          340 SLLVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      .++.||.|. .||..+... -...+.+++..+-+|+..|.+||.|||++-  .+||||+||+||||+.+|++||+|||++
T Consensus       120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence            999999994 467654422 134467889999999999999999999964  6999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhcc----CCCCcccchHhHHHHHHHHHcCCCCCCCCCC
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVVCRKRINLFTQN  477 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~sDvwslGvil~elltg~~p~~~~~~  477 (573)
                      ..+.+....  +...|-..|||||.+..    ..|+.||||||||+.+.||.+++.|......
T Consensus       197 G~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  197 GYLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             eeehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            877543322  22456778999998864    3689999999999999999999998765443

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-31  Score=278.66  Aligned_cols=245  Identities=28%  Similarity=0.340  Sum_probs=186.1

Q ss_pred             ccccccccccCcee-EEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEEecc
Q 008239          271 FHESNKLGQGGSGS-VYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       271 ~~~~~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      |...+.+|.|..|+ ||+|... |+.||||++....   .+...+|+..|+.- +|||||++++.-.++...|+..|.| 
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence            55567899999976 8999986 7899999985433   34556899999988 6999999999999999999999999 


Q ss_pred             CCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---C--CcEEEeecccccccC
Q 008239          349 NQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---E--FTAKIADFGLVRLFP  422 (573)
Q Consensus       349 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~--~~~kl~Dfgla~~~~  422 (573)
                      ..+|.+++... ...........+.+..|+++||++||+-+   ||||||||+||||+.   +  .+++|+|||+++.+.
T Consensus       586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            56999998653 11111122445778899999999999977   999999999999975   3  579999999999887


Q ss_pred             CCCccccc--ccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCC-CCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          423 EDITHISA--TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK-RINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       423 ~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .+......  ...||-+|+|||.+....-+..+||||+||++|+.++|+ .||.-...     ....-...+..+..+  
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~-----R~~NIl~~~~~L~~L--  735 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLE-----RQANILTGNYTLVHL--  735 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHH-----hhhhhhcCccceeee--
Confidence            66554433  567999999999999988889999999999999999985 45533211     111111011111110  


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                             ....-.+..+||.+|++++|..||++.+|+.
T Consensus       736 -------~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  736 -------EPLPDCEAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             -------ccCchHHHHHHHHHhcCCCcccCCCHHHHhC
Confidence                   1111116679999999999999999999974

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=4e-31  Score=237.92  Aligned_cols=256  Identities=18%  Similarity=0.277  Sum_probs=197.4

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCC--ceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGP--ESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~~~lv  343 (573)
                      .++|++.+++|+|.+++||.|.. .++++++||+++...   .+.+.+|+.+|..|. ||||++|++...++.  ...|+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            46789999999999999999985 568899999996433   457889999999996 999999999887654  45799


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC-CcEEEeecccccccC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFP  422 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~~~~  422 (573)
                      +||+.+.+...+.      +.++...+...+.+++.||.|+|+.|   |+|||+||.|++||.. -.++|+|+|||..+.
T Consensus       114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            9999887776544      34777888899999999999999998   9999999999999965 579999999999875


Q ss_pred             CCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcc-------
Q 008239          423 EDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL-------  494 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------  494 (573)
                      ....  -...+.+.-|.-||++.. +.|+..-|+|||||+|.+|+..+.||+.+....+.+-.+...+...++       
T Consensus       185 p~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  185 PGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             CCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            4322  223345677889999865 678999999999999999999999998876554333333332221111       


Q ss_pred             ccccCccccC----------------CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          495 HEAVDPALAG----------------NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       495 ~~~~d~~l~~----------------~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .-.+|+.+..                +-..-...+.++++...|..|-++|||++|.+.
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence            1112332211                001112467789999999999999999999874

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.6e-31  Score=246.21  Aligned_cols=262  Identities=23%  Similarity=0.314  Sum_probs=196.6

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-----Ccee
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PESL  341 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~~  341 (573)
                      +.+..+.||-|+||.||..+++ +|+.||+|++..--  --..+.+.+|+.+|..++|.|++..++...-.     .++|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            3455788999999999999985 79999999985432  22356788999999999999999998876543     2567


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +++|.|. .+|...+.   ....++...+.-+..||++||.|||+.+   |.||||||.|.|++.+..+||+|||+++..
T Consensus       134 V~TELmQ-SDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARve  206 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHH-hhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEeccccccccc
Confidence            8889884 47777774   3456888888889999999999999998   999999999999999999999999999988


Q ss_pred             CCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcc------
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL------  494 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------  494 (573)
                      ..+.....+..+-|..|.|||.+++ ..|+...||||.|||+.||+.++-.|..... ...++-+-+++....+      
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~P-iqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGP-IEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccCh-HHHHHHHHHHhCCCcHHHHHHH
Confidence            7777766777778999999999987 4799999999999999999976654433222 1111222222211110      


Q ss_pred             -----ccccC--------ccccC-CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          495 -----HEAVD--------PALAG-NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       495 -----~~~~d--------~~l~~-~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                           ..++.        +.+.. ..+.....+-..+..+++..+|..|.+..+.+..+
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                 01111        11111 11122334556777888999999999999999887

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.5e-30  Score=262.19  Aligned_cols=204  Identities=25%  Similarity=0.354  Sum_probs=173.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .-|..++.||-|+||+|.++... +...+|.|.|.+.+   .......+.|-.||..-+.+-||+||-.|.+.+.+|+||
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM  708 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM  708 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence            44778899999999999999754 46678999886643   334556778999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc---
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---  421 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~---  421 (573)
                      ||+++|++-.+|.   +.+.+.+..++.++..+..|+++.|..|   +|||||||+|||||.+|++||.||||+.-+   
T Consensus       709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT  782 (1034)
T KOG0608|consen  709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  782 (1034)
T ss_pred             eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence            9999999999884   4456889999999999999999999988   999999999999999999999999998633   


Q ss_pred             ------CCCCcc--------------------------------cccccccCcCcCchhhhccCCCCcccchHhHHHHHH
Q 008239          422 ------PEDITH--------------------------------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVI  463 (573)
Q Consensus       422 ------~~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~  463 (573)
                            .+....                                .....+||+.|+|||++....++...|.||.||||+
T Consensus       783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~  862 (1034)
T KOG0608|consen  783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY  862 (1034)
T ss_pred             cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence                  111000                                011346999999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCCC
Q 008239          464 EVVCRKRINLFTQNS  478 (573)
Q Consensus       464 elltg~~p~~~~~~~  478 (573)
                      ||+.|+.||......
T Consensus       863 em~~g~~pf~~~tp~  877 (1034)
T KOG0608|consen  863 EMLVGQPPFLADTPG  877 (1034)
T ss_pred             HHhhCCCCccCCCCC
Confidence            999999998766554

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=1.1e-28  Score=233.74  Aligned_cols=211  Identities=36%  Similarity=0.564  Sum_probs=183.8

Q ss_pred             ccccCceeEEEEEcCC-CCEEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCccc
Q 008239          277 LGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD  354 (573)
Q Consensus       277 lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~  354 (573)
                      ||+|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++|+++++++......++++||+++++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999864 899999999765432 35678999999999999999999999999999999999999999999


Q ss_pred             cccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-CCcEEEeecccccccCCCCcccccccc
Q 008239          355 NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHISATLA  433 (573)
Q Consensus       355 ~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~~~~~~~  433 (573)
                      ++....  ..+++..++.++.++++++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus        81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (215)
T cd00180          81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV  154 (215)
T ss_pred             HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence            885332  45889999999999999999999987   999999999999999 89999999999986644321 122345


Q ss_pred             cCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHH
Q 008239          434 GTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS  512 (573)
Q Consensus       434 gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~  512 (573)
                      +...|++||.+... ..+.++|+|++|+++++|                                              .
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------~  188 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------P  188 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------H
Confidence            67889999999877 888999999999999998                                              5


Q ss_pred             HHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          513 RLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       513 ~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      .+.+++..|++.+|++||++.++++.|
T Consensus       189 ~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         189 ELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             HHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence            678999999999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.5e-27  Score=229.31  Aligned_cols=199  Identities=34%  Similarity=0.473  Sum_probs=172.0

Q ss_pred             ccccccccccCceeEEEEEcCC-CCEEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      |...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            4567899999999999999875 889999999766544 67788999999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +++|.+++.....  .+++...+.++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||++..........
T Consensus        81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            9999998854321  1789999999999999999999987   9999999999999999999999999998765443112


Q ss_pred             ccccccCcCcCchhhh-ccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 008239          429 SATLAGTLGYMAPEYV-VRGKLTEKADVYSFGVVVIEVVCRKRINLF  474 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg~~p~~~  474 (573)
                      .....++..|++||.+ ....++.++|||+||++++||++|+.|+..
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            2345677889999998 667788899999999999999999988744

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=2.7e-29  Score=256.78  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=203.0

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ...++|+..+++|.|.+|.|||++.. .++..|||+++........-+.+|+-+++..+|||||.++|.+.....+++.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            34578899999999999999999975 68999999998877777777888999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+.+|+|.+.-+.   .+++++.++..+.+..++||+|||+.+   -+|||||-.|||+++.|.+|+.|||.+-.+...
T Consensus        92 EycgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitat  165 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITAT  165 (829)
T ss_pred             EecCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhh
Confidence            99999999987643   357899999999999999999999998   799999999999999999999999998766433


Q ss_pred             CcccccccccCcCcCchhhh---ccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc-
Q 008239          425 ITHISATLAGTLGYMAPEYV---VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP-  500 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~-  500 (573)
                      .. ......||+.|||||+.   ..+-|..++|||++|+...|+---+.|.+.-...+    ...-+-.     ...++ 
T Consensus       166 i~-KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr----~l~LmTk-----S~~qpp  235 (829)
T KOG0576|consen  166 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMR----ALFLMTK-----SGFQPP  235 (829)
T ss_pred             hh-hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHH----HHHHhhc-----cCCCCC
Confidence            22 23456799999999987   45789999999999999999876666543222111    1100000     11121 


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .+.+  ...-.+.+-++++.|+..+|++||+++.+++
T Consensus       236 ~lkD--k~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  236 TLKD--KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cccC--CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1211  1223556789999999999999999876553

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=5.3e-28  Score=228.39  Aligned_cols=256  Identities=25%  Similarity=0.276  Sum_probs=190.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC------c
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------E  339 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------~  339 (573)
                      .+|..+..+|.|.- .|..+.+. .++.||+|++...  .....++..+|+.++..+.|+||++++.++.-..      +
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            45677888998888 56555543 5889999988543  2233456788999999999999999999887543      5


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++|||+| ..+|...++     ..++-+.+..+..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+++
T Consensus        96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar  166 (369)
T KOG0665|consen   96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR  166 (369)
T ss_pred             HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence            68999999 558877775     23667788899999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH------------
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD------------  487 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~------------  487 (573)
                      .-..+  -..+..+.|.-|.|||++.+..+...+||||+||++.||++|+-.+....   .+.+|...            
T Consensus       167 ~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d---~idQ~~ki~~~lgtpd~~F~  241 (369)
T KOG0665|consen  167 TEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKD---HIDQWNKIIEQLGTPDPSFM  241 (369)
T ss_pred             ccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCch---HHHHHHHHHHHhcCCCHHHH
Confidence            64433  34556788999999999999889999999999999999999986543111   11111111            


Q ss_pred             ---------Hhhc-Cc-----ccccc-CccccC--CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          488 ---------LYVK-GR-----LHEAV-DPALAG--NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       488 ---------~~~~-~~-----~~~~~-d~~l~~--~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                               ...+ .+     ..+++ |..+..  +.+........+++.+||-.+|++|-+.+++++.=
T Consensus       242 ~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HP  311 (369)
T KOG0665|consen  242 KQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHP  311 (369)
T ss_pred             HHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCC
Confidence                     1110 00     00111 111111  11123345677999999999999999999999753

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.7e-28  Score=247.18  Aligned_cols=196  Identities=24%  Similarity=0.366  Sum_probs=165.1

Q ss_pred             cCccccccccccCceeEEEEEcCC-CCEEEEEEecccCh---hhH-----HHHHHHHHHHcCCC---CCCeeeeeeeeec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTT---QWV-----DHFFNEVNLISGIN---HKNLVKLLGCSIT  336 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~---~~~-----~~~~~E~~~l~~l~---h~niv~l~~~~~~  336 (573)
                      .+|...+.||+|+||.|+.+.++. ...|+||.+.++.-   .|.     -..-.|+.+|..|+   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            457888999999999999999864 56899998865421   111     12345999999997   9999999999999


Q ss_pred             CCceeEEEEec-cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeec
Q 008239          337 GPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF  415 (573)
Q Consensus       337 ~~~~~lv~e~~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  415 (573)
                      ++..+|+||-. ++-+|.+++.   ....+++.++.-|+.||+.|+++||+++   |||||||-+||.++.+|-+||+||
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf  714 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF  714 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence            99999999975 5668888884   3456899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCcCcCchhhhccCCCC-cccchHhHHHHHHHHHcCCCCCC
Q 008239          416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT-EKADVYSFGVVVIEVVCRKRINL  473 (573)
Q Consensus       416 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~  473 (573)
                      |.+.......   .....||..|.|||++.+.+|- ..-|||++|++||-++..+.|+.
T Consensus       715 gsaa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  715 GSAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             cchhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9988654332   3357899999999999998874 55799999999999998877753

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3e-27  Score=234.29  Aligned_cols=131  Identities=27%  Similarity=0.401  Sum_probs=110.4

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCC-----C---CCeeeeeeeee----
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----H---KNLVKLLGCSI----  335 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~----  335 (573)
                      .+|.+.++||-|.|++||++.+. +.+.||+|+.+. .....+....|+++|++++     |   .+||+|++.|.    
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            67899999999999999999864 567899998753 3455667789999999883     3   36999999887    


Q ss_pred             cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL  404 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll  404 (573)
                      .+.+.++|+|++ +-+|..+|.... ...++...+.+|+.||+.||.|||.+.  +|||-||||+|||+
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl  221 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL  221 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence            456789999999 668888885543 345899999999999999999999986  69999999999998

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.9e-27  Score=218.21  Aligned_cols=252  Identities=19%  Similarity=0.263  Sum_probs=186.6

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeee-eecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC-SITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~-~~~~~~~~lv~  344 (573)
                      .+.|.+.+.||+|.||.+-++.++ +.+.+++|.+...-. ...+|.+|..---.| .|.||+.-++. |...+..++++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t-t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q  101 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT-TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ  101 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh-hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence            356888999999999999999986 577899998865432 256788888776666 59999998874 55666778999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC--CCCcEEEeecccccccC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEFTAKIADFGLVRLFP  422 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~--~~~~~kl~Dfgla~~~~  422 (573)
                      ||+|.|+|.+.+..    ..+.+....+++.|+++|+.|||+++   +||||||.+||||-  +..++||+|||+.+...
T Consensus       102 E~aP~gdL~snv~~----~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g  174 (378)
T KOG1345|consen  102 EFAPRGDLRSNVEA----AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG  174 (378)
T ss_pred             ccCccchhhhhcCc----ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence            99999999887732    34778888999999999999999998   99999999999993  34589999999988543


Q ss_pred             CCCcccccccccCcCcCchhhhccC-----CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRG-----KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      ..-.    ...-+..|.+||.....     ...+.+|||.||++++.+++|+.|+......+. .-|.|..|..+....+
T Consensus       175 ~tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~-~Y~~~~~w~~rk~~~~  249 (378)
T KOG1345|consen  175 TTVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK-PYWEWEQWLKRKNPAL  249 (378)
T ss_pred             ceeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc-hHHHHHHHhcccCccC
Confidence            2211    22335679999987542     346789999999999999999999864333222 2233444544443322


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                           ...+ ....+.++.+..+-+..+|++|=...++-++
T Consensus       250 -----P~~F-~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~  284 (378)
T KOG1345|consen  250 -----PKKF-NPFSEKALRLFKKSLTPRFKDRCKIWTAKKM  284 (378)
T ss_pred             -----chhh-cccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence                 1111 2345677888889999999999444444333

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=1.5e-27  Score=233.59  Aligned_cols=265  Identities=25%  Similarity=0.377  Sum_probs=201.2

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcC----CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCC
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP  338 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  338 (573)
                      +....+.|...++||+|.|++||++++.    ..+.||+|.+...+.  ...+.+|+++|..+ .+.||+++.+++..++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~--p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS--PSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC--chHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3445567889999999999999999864    367899998854332  35688999999999 5999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-CCcEEEeeccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGL  417 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgl  417 (573)
                      ...+|+||++.-...+++.      .++...+...++.++.||+++|.+|   ||||||||+|+|.+. -+.-.|.||||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence            9999999999988888773      3678889999999999999999998   999999999999985 46789999999


Q ss_pred             ccccCCCC-------------c------------------------------ccccccccCcCcCchhhhcc-CCCCccc
Q 008239          418 VRLFPEDI-------------T------------------------------HISATLAGTLGYMAPEYVVR-GKLTEKA  453 (573)
Q Consensus       418 a~~~~~~~-------------~------------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~s  453 (573)
                      +.......             .                              ......+||++|.|||++.. ...++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            87211000             0                              00113469999999999875 5789999


Q ss_pred             chHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh----------cCc--ccc---------------ccC-cccc--
Q 008239          454 DVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV----------KGR--LHE---------------AVD-PALA--  503 (573)
Q Consensus       454 DvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----------~~~--~~~---------------~~d-~~l~--  503 (573)
                      ||||-|||++-+++++.||+....+.+.+.++.....          .|+  +.+               -++ ..+.  
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            9999999999999999999877665433322221111          111  000               000 0011  


Q ss_pred             -------CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          504 -------GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       504 -------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                             .......+..+++++.+|++.||.+|.|+++.|+.-
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHp  382 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHP  382 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCc
Confidence                   011222345789999999999999999999998753

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=1.1e-26  Score=263.65  Aligned_cols=197  Identities=17%  Similarity=0.158  Sum_probs=139.2

Q ss_pred             cCCCC-CCeeeeeeeee-------cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 008239          320 SGINH-KNLVKLLGCSI-------TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR  391 (573)
Q Consensus       320 ~~l~h-~niv~l~~~~~-------~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  391 (573)
                      +.++| +||+++++++.       .....++++||+ +++|.+++...  ...+++..++.++.||++||+|||+++   
T Consensus        27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---  100 (793)
T PLN00181         27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---  100 (793)
T ss_pred             chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            45566 68888888772       334567888887 66999998532  345899999999999999999999988   


Q ss_pred             eEEecCCCCCeeeCC-------------------CCcEEEeecccccccCCCCc---------------ccccccccCcC
Q 008239          392 IIHRDIKLSNILLDE-------------------EFTAKIADFGLVRLFPEDIT---------------HISATLAGTLG  437 (573)
Q Consensus       392 iiHrDlk~~NIll~~-------------------~~~~kl~Dfgla~~~~~~~~---------------~~~~~~~gt~~  437 (573)
                      |+||||||+||||+.                   ++.+||+|||+++.......               .......||+.
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            999999999999954                   44566666666653211000               00112357889


Q ss_pred             cCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHH
Q 008239          438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQI  517 (573)
Q Consensus       438 y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  517 (573)
                      |||||++.+..++.++|||||||+||||+++..|+....   ....    .....    .+.+..     .........+
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~---~~~~----~~~~~----~~~~~~-----~~~~~~~~~~  244 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS---RTMS----SLRHR----VLPPQI-----LLNWPKEASF  244 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH---HHHH----HHHHh----hcChhh-----hhcCHHHHHH
Confidence            999999999999999999999999999999876532110   0111    01100    111111     1122345688


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 008239          518 GLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       518 ~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +.+||+.+|.+||+|.|+++.
T Consensus       245 ~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        245 CLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHhCCCChhhCcChHHHhhc
Confidence            899999999999999999864

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.93  E-value=6.5e-27  Score=232.96  Aligned_cols=269  Identities=20%  Similarity=0.196  Sum_probs=203.4

Q ss_pred             ChHHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCC------CCCeeeeee
Q 008239          260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN------HKNLVKLLG  332 (573)
Q Consensus       260 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~  332 (573)
                      .+.--+.....|.+....|+|-|++|.+|... -|+.||||++..+.. ..+.=+.|+++|++|.      --|.++|+-
T Consensus       423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r  501 (752)
T KOG0670|consen  423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLFR  501 (752)
T ss_pred             EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence            34445556678888899999999999999976 478999999976532 2334467999999995      348999999


Q ss_pred             eeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC-CcEE
Q 008239          333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAK  411 (573)
Q Consensus       333 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~k  411 (573)
                      .|...++++||+|-+ ..+|.++|.....+..|....+..++.|+.-||..|..-+   |+|.||||.|||+++. ..+|
T Consensus       502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence            999999999999988 5689999977777777888999999999999999999877   9999999999999865 5789


Q ss_pred             EeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHH-----
Q 008239          412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVW-----  486 (573)
Q Consensus       412 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~-----  486 (573)
                      |||||.|....++..   +...-+..|.|||.+.+-+|+...|+||.||.||||.||+-.|....+.. ++...-     
T Consensus       578 LCDfGSA~~~~enei---tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~-MLrl~me~KGk  653 (752)
T KOG0670|consen  578 LCDFGSASFASENEI---TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ-MLRLFMELKGK  653 (752)
T ss_pred             eccCccccccccccc---cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH-HHHHHHHhcCC
Confidence            999999987655432   23344668999999999999999999999999999999997654433221 111110     


Q ss_pred             ---HHhhcCcc---------------------------ccccCc------cccC--CCCCc---hHHHHHHHHHHccCCC
Q 008239          487 ---DLYVKGRL---------------------------HEAVDP------ALAG--NFQEG---KPSRLLQIGLLCVQAS  525 (573)
Q Consensus       487 ---~~~~~~~~---------------------------~~~~d~------~l~~--~~~~~---~~~~l~~l~~~cl~~~  525 (573)
                         .++..+.+                           ...+.|      .|..  .++.+   ....+.+|+..|+..|
T Consensus       654 ~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~Ld  733 (752)
T KOG0670|consen  654 FPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILD  733 (752)
T ss_pred             CcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccC
Confidence               11111110                           001111      1111  12332   3456788999999999


Q ss_pred             CCCCCCHHHHHH
Q 008239          526 AELRPSMSIVVK  537 (573)
Q Consensus       526 p~~RPt~~evl~  537 (573)
                      |+.|.|..+.|+
T Consensus       734 P~KRit~nqAL~  745 (752)
T KOG0670|consen  734 PEKRITVNQALK  745 (752)
T ss_pred             hhhcCCHHHHhc
Confidence            999999999886

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.92  E-value=3.6e-26  Score=210.87  Aligned_cols=246  Identities=21%  Similarity=0.307  Sum_probs=192.6

Q ss_pred             ccccccccCceeEEEEEcCCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      ...+|.+...|+.|+|+++. ..+++|++...  .......|..|.-.|+.+.||||+.++|.|...+.+.++..|||.|
T Consensus       194 l~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~g  272 (448)
T KOG0195|consen  194 LITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFG  272 (448)
T ss_pred             hhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccch
Confidence            45678999999999999984 45666776432  4455667889999999999999999999999999999999999999


Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEe--ecccccccCCCCccc
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA--DFGLVRLFPEDITHI  428 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~--Dfgla~~~~~~~~~~  428 (573)
                      +|.+.++.... -..+..++.+++.+||+||+|||+.. +-|.---|.+..|+||++.+.+|+  |--++.  .      
T Consensus       273 slynvlhe~t~-vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltarismad~kfsf--q------  342 (448)
T KOG0195|consen  273 SLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSF--Q------  342 (448)
T ss_pred             HHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhheecccceeee--e------
Confidence            99999976543 34667789999999999999999986 224444689999999999998886  211111  0      


Q ss_pred             ccccccCcCcCchhhhccCCC---CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKL---TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~---~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      .....-.+.||+||.+...+-   -..+|+|||.++||||.|++-||..-.+-+             --.++.-..++..
T Consensus       343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme-------------cgmkialeglrv~  409 (448)
T KOG0195|consen  343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME-------------CGMKIALEGLRVH  409 (448)
T ss_pred             ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh-------------hhhhhhhcccccc
Confidence            112234678999999987653   347899999999999999999875433211             1123334455666


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      +++..+..+.+|+.-|+..||.+||.++.|+-+|+..
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence            7888888999999999999999999999999988754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=4.6e-25  Score=204.20  Aligned_cols=165  Identities=25%  Similarity=0.243  Sum_probs=124.0

Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccc
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS  429 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~  429 (573)
                      |+|.+++..+  ...+++..++.++.||+.||.|||+++         ||+|||++.++.+|+  ||++.......    
T Consensus         1 GsL~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~----   63 (176)
T smart00750        1 VSLADILEVR--GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ----   63 (176)
T ss_pred             CcHHHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence            6788888532  345999999999999999999999875         999999999999999  99988654322    


Q ss_pred             cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCc
Q 008239          430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG  509 (573)
Q Consensus       430 ~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~  509 (573)
                        ..||+.|||||++.+..++.++|||||||++|||++|+.|+....................      ++.- ......
T Consensus        64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------~~~~-~~~~~~  134 (176)
T smart00750       64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPAD------DPRD-RSNLES  134 (176)
T ss_pred             --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccC------Cccc-cccHHH
Confidence              2578999999999999999999999999999999999998754332222222111111100      0000 001112


Q ss_pred             hHH--HHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          510 KPS--RLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       510 ~~~--~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ...  .+.+++.+||+.+|++||++.|+++.+.
T Consensus       135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~  167 (176)
T smart00750      135 VSAARSFADFMRVCASRLPQRREAANHYLAHCR  167 (176)
T ss_pred             HHhhhhHHHHHHHHHhcccccccCHHHHHHHHH
Confidence            222  6899999999999999999999999884

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.91  E-value=6.4e-24  Score=215.24  Aligned_cols=176  Identities=20%  Similarity=0.186  Sum_probs=134.8

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcC--CCCEEEEEEeccc-----ChhhHHHHHHHHHHHcCCCCCCeee-eeeeee
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLP--GGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVK-LLGCSI  335 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~  335 (573)
                      .....+.|...++||+|+||+||+|.+.  +++.||||++...     .....+.+.+|+++|++++|+|++. ++++  
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~--   90 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT--   90 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc--
Confidence            3455678999999999999999999874  5778899987532     2233567899999999999999985 4432  


Q ss_pred             cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecC-CCCCeeeCCCCcEEEee
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDI-KLSNILLDEEFTAKIAD  414 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDl-k~~NIll~~~~~~kl~D  414 (573)
                        ...++||||+++++|.. +.   .   ..   ...++.+++++|.|||+.+   |+|||| ||+|||++.++.+||+|
T Consensus        91 --~~~~LVmE~~~G~~L~~-~~---~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiD  155 (365)
T PRK09188         91 --GKDGLVRGWTEGVPLHL-AR---P---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVID  155 (365)
T ss_pred             --CCcEEEEEccCCCCHHH-hC---c---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEE
Confidence              45799999999999862 21   1   11   1467889999999999988   999999 99999999999999999


Q ss_pred             cccccccCCCCccc-------ccccccCcCcCchhhhccCC------CCcccchH
Q 008239          415 FGLVRLFPEDITHI-------SATLAGTLGYMAPEYVVRGK------LTEKADVY  456 (573)
Q Consensus       415 fgla~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~------~~~~sDvw  456 (573)
                      ||+++.+.......       -....+++.|+|||.+....      .+..+|-|
T Consensus       156 FGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        156 FQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             CccceecccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            99999765432111       13556788999999986432      23346666

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.89  E-value=3.5e-22  Score=203.02  Aligned_cols=258  Identities=21%  Similarity=0.196  Sum_probs=193.4

Q ss_pred             CccccccccccCceeEEEEEcCCC--CEEEEEEecccChhhHHHHHHHHHHHcCCCC----CCeeeeeeee-ecCCceeE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLPGG--EAVAVKRLFYNTTQWVDHFFNEVNLISGINH----KNLVKLLGCS-ITGPESLL  342 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~~g--~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h----~niv~l~~~~-~~~~~~~l  342 (573)
                      .|.+.++||+|+||.||++...+.  ..+|+|............+..|+.++..+.+    +++.++++.. ......++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999997653  4788888765433323367788888888863    5888999888 47778899


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC-----CcEEEeeccc
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-----FTAKIADFGL  417 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~-----~~~kl~Dfgl  417 (573)
                      ||+.+ +.+|.++..... ...++..+.++++.|++.+|.+||+.|   ++||||||.|+++...     ..+.|.|||+
T Consensus        99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl  173 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL  173 (322)
T ss_pred             EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence            99988 779988764433 567999999999999999999999998   9999999999999754     4699999999


Q ss_pred             cc--ccCCCCcc------c-ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH
Q 008239          418 VR--LFPEDITH------I-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       418 a~--~~~~~~~~------~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  488 (573)
                      ++  .+......      . .....||.+|+++....+...+.+.|+||++.++.|++.|..|+........ ...+...
T Consensus       174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-~~~~~~~  252 (322)
T KOG1164|consen  174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-KSKFEKD  252 (322)
T ss_pred             CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-HHHHHHH
Confidence            99  43222211      1 1234599999999999999999999999999999999999977643322111 1111111


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ...    .....     .....+..+.++...+-..+..++|....+...|.+.
T Consensus       253 ~~~----~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  253 PRK----LLTDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             hhh----hcccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            111    00010     1233456666777777779999999999999887443

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.88  E-value=3.2e-21  Score=195.33  Aligned_cols=261  Identities=29%  Similarity=0.363  Sum_probs=197.2

Q ss_pred             ccccccccccCceeEEEEEcCCCCEEEEEEecccChh---hHHHHHHHHHHHcCCCCC-CeeeeeeeeecCCceeEEEEe
Q 008239          271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ---WVDHFFNEVNLISGINHK-NLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~lv~e~  346 (573)
                      |...+.||.|+||.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +++++++.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            567789999999999999987  78999988665332   467899999999999988 799999999777778999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDI  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~  425 (573)
                      +.++++.+++........+.......++.|++.++.|+|+.+   ++|||+||.||+++..+ .+++.|||+++.+....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~  156 (384)
T COG0515          80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG  156 (384)
T ss_pred             CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence            999999966532211125888999999999999999999998   99999999999999988 79999999998654433


Q ss_pred             cc-----cccccccCcCcCchhhhcc---CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          426 TH-----ISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       426 ~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      ..     ......|+..|++||.+..   ...+...|+|++|+++++++++..|+...... ......+......... .
T Consensus       157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~~~~-~  234 (384)
T COG0515         157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS-SATSQTLKIILELPTP-S  234 (384)
T ss_pred             ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc-ccHHHHHHHHHhcCCc-c
Confidence            22     2356789999999999987   68889999999999999999999985443321 0111222222111110 0


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ................+.+++..|+..+|..|.++.+....
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         235 LASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000001223577899999999999999999887754

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.9e-21  Score=183.43  Aligned_cols=171  Identities=11%  Similarity=0.104  Sum_probs=133.8

Q ss_pred             HhcCccccccccccCceeEEEEEcCCCCEEEEEEecccCh---hhHHH------HHHHHHHHcCCCCCCeeeeeeeeecC
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT---QWVDH------FFNEVNLISGINHKNLVKLLGCSITG  337 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~---~~~~~------~~~E~~~l~~l~h~niv~l~~~~~~~  337 (573)
                      ..++|...++||.|+||.||.... ++..+|||.+.....   .....      +.+|+..+.++.|++|..+.+++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468899999999999999999765 577899999965422   22222      67899999999999999999886643


Q ss_pred             --------CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc
Q 008239          338 --------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT  409 (573)
Q Consensus       338 --------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~  409 (573)
                              ...+|||||+++.+|.++.       .++.    ....+++.+|..||+.+   ++|||++|+||++++++ 
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~-------~~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP-------EISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh-------hccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence                    3578999999999997763       1222    24568999999999998   99999999999999988 


Q ss_pred             EEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHH
Q 008239          410 AKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV  466 (573)
Q Consensus       410 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ell  466 (573)
                      ++|+|||.......+...             ..+.....+..++|+|+||+.+.-+.
T Consensus       173 i~liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988755332211             11344556778999999999987664

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.85  E-value=5.8e-21  Score=196.98  Aligned_cols=216  Identities=28%  Similarity=0.412  Sum_probs=164.3

Q ss_pred             HcCCCCCCeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q 008239          319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK  398 (573)
Q Consensus       319 l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk  398 (573)
                      |+.+.|.|+.+++|.+.+++..+.|.+|+..|+|.+.+..  ....++|.....++.+|+.||+|||...  -..|+.|+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence            4678999999999999999999999999999999999964  3456899999999999999999999864  23999999


Q ss_pred             CCCeeeCCCCcEEEeecccccccCCCC-cccccccccCcCcCchhhhccC-------CCCcccchHhHHHHHHHHHcCCC
Q 008239          399 LSNILLDEEFTAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRG-------KLTEKADVYSFGVVVIEVVCRKR  470 (573)
Q Consensus       399 ~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-------~~~~~sDvwslGvil~elltg~~  470 (573)
                      ++|+++|....+||+|||+........ ...........-|.|||.+...       ..+.+.||||||++++||++.+.
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            999999999999999999988764311 1111112234569999999763       14678999999999999999999


Q ss_pred             CCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          471 INLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       471 p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      |+..........+.+ ..... .....+.|.+...  .+.++.+..++..||..+|++||++++|-..++..
T Consensus       157 ~~~~~~~~~~~~eii-~~~~~-~~~~~~rP~i~~~--~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  157 PFDLRNLVEDPDEII-LRVKK-GGSNPFRPSIELL--NELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             ccccccccCChHHHH-HHHHh-cCCCCcCcchhhh--hhcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            987754443322222 22222 1122233333211  14455799999999999999999999999888543

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=7e-22  Score=213.39  Aligned_cols=253  Identities=21%  Similarity=0.253  Sum_probs=186.8

Q ss_pred             cccccccccCceeEEEEEcC-CCCEEEEEEec-----ccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          272 HESNKLGQGGSGSVYKGTLP-GGEAVAVKRLF-----YNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~-----~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ...+++|.|++|.|+..... ..+..+.|...     ..... ....+..|+.+-..+.|+|++..+....+.....-+|
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m  400 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM  400 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence            45778999999988877643 23333344322     11111 1222566888888899999998888777777666669


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||++. +|...+...   ..+....+.-++.|+..|+.|||+.+   |.|||||++|++++.++.+||+|||.+..+...
T Consensus       401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            99999 999888433   34777888899999999999999998   999999999999999999999999999876533


Q ss_pred             Cc---ccccccccCcCcCchhhhccCCCCc-ccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          425 IT---HISATLAGTLGYMAPEYVVRGKLTE-KADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       425 ~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ..   .......|+..|+|||.+.+..|.+ ..||||.|+++..|++|+.|+.......+....   .... ........
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~---~~~~-~~~~~~~~  549 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT---NNYS-DQRNIFEG  549 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh---hccc-cccccccC
Confidence            22   4455788999999999999999887 579999999999999999887765543322100   0000 00000000


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       . ..+....+.+...++.++|+.+|..|-|+++|++
T Consensus       550 -~-~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  550 -P-NRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             -h-HHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence             0 1123345677889999999999999999999985

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.85  E-value=3.8e-21  Score=175.09  Aligned_cols=256  Identities=18%  Similarity=0.233  Sum_probs=189.6

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCC-CCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ...|..+++||+|+||.+|.|.. .+|++||||.-.....  ..++.-|..+.+.|+| ..|..+..+..+.....+|||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd   91 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD   91 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence            46789999999999999999985 6799999998654332  3466778899988875 577778888888999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---CCcEEEeecccccccC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLVRLFP  422 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla~~~~  422 (573)
                      .+ +.||.+++.-..  ..++-.+.+-++-|++.-++|+|.++   +|||||||+|.|..-   -..+.++||||++.+.
T Consensus        92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~  165 (341)
T KOG1163|consen   92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR  165 (341)
T ss_pred             cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence            98 778888764322  34788899999999999999999998   999999999999963   3579999999999775


Q ss_pred             CCCcc------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          423 EDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       423 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      +..+.      ......||.+|.+--...+-..+.+.|+-|+|.+|.++.-|..|+..-... .-.+. +..+.+.++.-
T Consensus       166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~-tk~QK-yEkI~EkK~s~  243 (341)
T KOG1163|consen  166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAA-TKKQK-YEKISEKKMST  243 (341)
T ss_pred             cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchh-hHHHH-HHHHHHhhcCC
Confidence            43322      234667999999888877778899999999999999999999886532221 11111 11111111111


Q ss_pred             ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       497 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+.     ..-...|.++...+.-|-...-++-|+...+-++
T Consensus       244 ~ie-----~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrql  280 (341)
T KOG1163|consen  244 PIE-----VLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQL  280 (341)
T ss_pred             CHH-----HHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHH
Confidence            111     1123456677777778888888888886554443

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=6e-21  Score=178.07  Aligned_cols=139  Identities=17%  Similarity=0.162  Sum_probs=108.1

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChh--h------------------------HHHHHHHHHHHcCCCCCCe
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--W------------------------VDHFFNEVNLISGINHKNL  327 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~ni  327 (573)
                      ...||+|+||.||+|...+|+.||||++......  .                        ......|++.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4689999999999999888999999998654211  0                        0122359999999988776


Q ss_pred             eeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEecCCCCCeeeCC
Q 008239          328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL-HEESKLRIIHRDIKLSNILLDE  406 (573)
Q Consensus       328 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~iiHrDlk~~NIll~~  406 (573)
                      .....+..  ...++||||++++++.....   ....+++.....++.|++.+|.|| |+.+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-  152 (190)
T cd05147          82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-  152 (190)
T ss_pred             CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence            44333222  23489999999877755432   224688999999999999999999 6877   99999999999998 


Q ss_pred             CCcEEEeeccccccc
Q 008239          407 EFTAKIADFGLVRLF  421 (573)
Q Consensus       407 ~~~~kl~Dfgla~~~  421 (573)
                      ++.++|+|||++...
T Consensus       153 ~~~v~LiDFG~a~~~  167 (190)
T cd05147         153 DGKLYIIDVSQSVEH  167 (190)
T ss_pred             CCcEEEEEccccccC
Confidence            478999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=3.1e-20  Score=176.59  Aligned_cols=199  Identities=21%  Similarity=0.260  Sum_probs=166.0

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .-+|.+.++||+|.||+.+.|+. -+++.||||.-...+  ...++..|.+..+.| ..++|...+-+..++....||+|
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid  104 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID  104 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence            34689999999999999999984 579999999754332  235677888888888 57999999988888889999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-----CCcEEEeecccccc
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRL  420 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-----~~~~kl~Dfgla~~  420 (573)
                      .+ +-||.+++.-..  ..++......+|.|++.-++|+|++.   +|.|||||+|.||..     ...+.|+|||+|+.
T Consensus       105 LL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~  178 (449)
T KOG1165|consen  105 LL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE  178 (449)
T ss_pred             hh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence            98 678877663222  24889999999999999999999998   999999999999953     34689999999998


Q ss_pred             cCCCCcc------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 008239          421 FPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF  474 (573)
Q Consensus       421 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~  474 (573)
                      +.+..+.      ......||.+||+--...+...+.+.|.-|||-++.+.|-|..|+..
T Consensus       179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQG  238 (449)
T KOG1165|consen  179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG  238 (449)
T ss_pred             hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccc
Confidence            7554332      23456799999999988999999999999999999999999998654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.83  E-value=4.7e-20  Score=172.63  Aligned_cols=141  Identities=18%  Similarity=0.183  Sum_probs=111.4

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChh--------------------------hHHHHHHHHHHHcCCCCCCe
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--------------------------WVDHFFNEVNLISGINHKNL  327 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~--------------------------~~~~~~~E~~~l~~l~h~ni  327 (573)
                      ...||+|+||.||+|...+|+.||||++......                          ....+..|.+.+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            4689999999999999888999999998654211                          01223578999999999987


Q ss_pred             eeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCeeeCC
Q 008239          328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDE  406 (573)
Q Consensus       328 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NIll~~  406 (573)
                      .....+...  ..++||||++++++.....   ....++......++.|++.++.+||+ .+   |+||||||+|||++ 
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-  152 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-  152 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence            554443332  3489999999886544322   12357788899999999999999999 77   99999999999999 


Q ss_pred             CCcEEEeecccccccCC
Q 008239          407 EFTAKIADFGLVRLFPE  423 (573)
Q Consensus       407 ~~~~kl~Dfgla~~~~~  423 (573)
                      ++.++|+|||++...+.
T Consensus       153 ~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCCEEEEEcccceecCC
Confidence            78999999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=2.8e-19  Score=165.09  Aligned_cols=188  Identities=13%  Similarity=0.047  Sum_probs=140.9

Q ss_pred             cccccccccCceeEEEEEcCCCCEEEEEEecccCh--h--hHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeEEEEe
Q 008239          272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--Q--WVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .+...|++|+||+||.+.. .+.+++.+.+.....  .  ....+.+|+++|++|. |+++.+++++    ...+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4577899999999997766 577888777754432  1  1125789999999995 5889999886    457999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecC-CCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDI-KLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDl-k~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      +.+.+|...+.         . ....++.|++.+|.++|+++   |+|||| ||.|||++.++.++|+|||++.......
T Consensus        80 I~G~~L~~~~~---------~-~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~  146 (218)
T PRK12274         80 LAGAAMYQRPP---------R-GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRA  146 (218)
T ss_pred             ecCccHHhhhh---------h-hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcc
Confidence            99988864331         0 11357789999999999998   999999 7999999999999999999998654433


Q ss_pred             cc----c--------ccccccCcCcCchhhhccC-CCC-cccchHhHHHHHHHHHcCCCCCCCCCC
Q 008239          426 TH----I--------SATLAGTLGYMAPEYVVRG-KLT-EKADVYSFGVVVIEVVCRKRINLFTQN  477 (573)
Q Consensus       426 ~~----~--------~~~~~gt~~y~aPE~~~~~-~~~-~~sDvwslGvil~elltg~~p~~~~~~  477 (573)
                      ..    .        ......++.|+.|+...-. ..+ ...+.++-|..+|.++|++.+.....+
T Consensus       147 ~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        147 RWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             hHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            10    0        0112357788888854322 233 567999999999999999988765544

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.79  E-value=3.3e-19  Score=173.29  Aligned_cols=234  Identities=19%  Similarity=0.224  Sum_probs=148.3

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCC----------CCeeeeeeee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINH----------KNLVKLLGCS  334 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~  334 (573)
                      ..+...+.||.|+++.||.+++. +|+++|||++....   ....+++++|.-....+.+          -.++.-++..
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~   91 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL   91 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred             eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence            44566889999999999999986 48999999885432   2345666666655554332          1222222221


Q ss_pred             e---------cCC--------ceeEEEEeccCCCcccccc---ccCCC-CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeE
Q 008239          335 I---------TGP--------ESLLVYEFVPNQSLLDNLF---VRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRII  393 (573)
Q Consensus       335 ~---------~~~--------~~~lv~e~~~~gsL~~~l~---~~~~~-~~l~~~~~~~i~~~ia~~l~yLH~~~~~~ii  393 (573)
                      .         ...        ..+++|+-+ .++|.+++.   ..... ..+....++.+..|+++.+++||+.+   ++
T Consensus        92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lV  167 (288)
T PF14531_consen   92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LV  167 (288)
T ss_dssp             EETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             EEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eE
Confidence            1         111        234566666 567766542   22221 22334556677789999999999998   99


Q ss_pred             EecCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccC--------CCCcccchHhHHHHHHHH
Q 008239          394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG--------KLTEKADVYSFGVVVIEV  465 (573)
Q Consensus       394 HrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~sDvwslGvil~el  465 (573)
                      |+||+|+|++++.+|.++|+||+...........    ...+..|.+||.....        .++.+.|.|+||++||.|
T Consensus       168 Hgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  168 HGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             EST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             ecccceeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            9999999999999999999999877654432221    2345779999977542        578899999999999999


Q ss_pred             HcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCC
Q 008239          466 VCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELR  529 (573)
Q Consensus       466 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R  529 (573)
                      +++..|+...........                 .+ .... +.++.+..|+..+|+.+|.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~-----------------~f-~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW-----------------DF-SRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG-----------------GG-TTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc-----------------cc-hhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999876433211000                 11 1233 678899999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.79  E-value=8.7e-20  Score=196.91  Aligned_cols=248  Identities=23%  Similarity=0.232  Sum_probs=176.5

Q ss_pred             CccccccccccCceeEEEEEcCCCCEEEEEEecccCh-hhHHHHHH---HHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFN---EVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~---E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++...+.||++.|=.|.++++++|. |+||++.+..+ -..+.|.+   |++ ...++|||.+.+.-+-......+||-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            5677889999999999999999888 99999876543 22334443   444 556699999999888777777888888


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc--ccCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPE  423 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~--~~~~  423 (573)
                      |+.+ +|.|.+.   ..+-+..-+..=|+.|++.||...|..+   |+|||||.+||||+.=..+.|+||.-.+  .+++
T Consensus       102 yvkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe  174 (1431)
T KOG1240|consen  102 YVKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPE  174 (1431)
T ss_pred             HHhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCC
Confidence            8854 7777662   2233555666678999999999999998   9999999999999999999999999876  3344


Q ss_pred             CCccccc----ccccCcCcCchhhhccC----------C-CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH
Q 008239          424 DITHISA----TLAGTLGYMAPEYVVRG----------K-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       424 ~~~~~~~----~~~gt~~y~aPE~~~~~----------~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  488 (573)
                      +......    +...-..|+|||.+...          . .+++-||||+||++.||++-+.|.+.-.   ++..+    
T Consensus       175 DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS---QL~aY----  247 (1431)
T KOG1240|consen  175 DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS---QLLAY----  247 (1431)
T ss_pred             CCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH---HHHhH----
Confidence            3332222    22233469999987541          1 5678899999999999999866644211   11111    


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                       +.+. ...... +.+.++   ...+.++++.|++.||+.|-++++.++.-
T Consensus       248 -r~~~-~~~~e~-~Le~Ie---d~~~Rnlil~Mi~rdPs~RlSAedyL~~y  292 (1431)
T KOG1240|consen  248 -RSGN-ADDPEQ-LLEKIE---DVSLRNLILSMIQRDPSKRLSAEDYLQKY  292 (1431)
T ss_pred             -hccC-ccCHHH-HHHhCc---CccHHHHHHHHHccCchhccCHHHHHHhh
Confidence             1111 000000 111111   12567999999999999999999999874

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=9e-19  Score=164.92  Aligned_cols=138  Identities=17%  Similarity=0.201  Sum_probs=106.9

Q ss_pred             ccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCC-----CCCCeeeeeeeeecCC---cee-
Q 008239          271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-----NHKNLVKLLGCSITGP---ESL-  341 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~~-  341 (573)
                      +...+.||+|+||.||.  +++....+||++........+.+.+|+.+++.+     +||||++++|++.++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            34578899999999996  543333479988765445567889999999999     5799999999998864   223 


Q ss_pred             EEEEe--ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHH-HHHHhcCCCCeEEecCCCCCeeeCC----CCcEEEee
Q 008239          342 LVYEF--VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL-AYLHEESKLRIIHRDIKLSNILLDE----EFTAKIAD  414 (573)
Q Consensus       342 lv~e~--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l-~yLH~~~~~~iiHrDlk~~NIll~~----~~~~kl~D  414 (573)
                      +|+||  +++++|.+++..    ..+++.  ..++.+++.++ +|||+++   |+||||||+|||++.    +..++|+|
T Consensus        82 ~I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            78999  668999999943    125554  35677888777 9999998   999999999999973    34899999


Q ss_pred             ccccc
Q 008239          415 FGLVR  419 (573)
Q Consensus       415 fgla~  419 (573)
                      |+.+.
T Consensus       153 g~G~~  157 (210)
T PRK10345        153 NIGES  157 (210)
T ss_pred             CCCCc
Confidence            55443

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.78  E-value=3.4e-19  Score=149.40  Aligned_cols=99  Identities=35%  Similarity=0.668  Sum_probs=73.3

Q ss_pred             eeec---CCCCCCCchhhhHHHHHHHHHHHHHhccC--CCceeeeecccCCCceEEEEeeeccCCCcchhhhHHHHHHhh
Q 008239           91 TVCG---SKDFGGNNTVFGANAIELVRNLSVQAVKN--DGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSR  165 (573)
Q Consensus        91 ~~~~---~~~~~~~~~~f~~~~~~ll~~l~~~a~~~--~~~~~~~~~~~~~~~~vy~l~qC~~dl~~~~C~~Cl~~~~~~  165 (573)
                      ..|+   ..++.++...|+.++..||..|+..++..  .+|++++.+  .++++||||+||++||++.+|..||+.++..
T Consensus         2 ~~Cs~~~~~~~~~~~~~f~~~l~~ll~~l~~~a~~~~~~~f~~~~~~--~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~   79 (106)
T PF01657_consen    2 HFCSSNTNNNYTTDNSTFEQNLNSLLSSLVSNAASSSSKGFATGSAG--SGPDTVYGLAQCRGDLSPSDCRACLADAVAN   79 (106)
T ss_dssp             --E---SSB----TT-THHHHHHHHHHHHHHHGGGTT-TEEEEEE----ST---EEEEEEE-TTS-HHHHHHHHHHHHCC
T ss_pred             CcCCCCCCCCcCCCCchHHHHHHHHHHHHHHHHhhccccCcEEeecC--CCCCeEEEEEEcCCCCChhhhHHHHHHHHHH
Confidence            4566   22232334559999999999999998854  679988864  5788999999999999999999999999999


Q ss_pred             ccc-ccCCCCcEEeccceeeecccccc
Q 008239          166 IAS-CTQKEEGRVLNAGCYLRYSTQRF  191 (573)
Q Consensus       166 ~~~-c~~~~~g~v~~~~C~~ry~~~~f  191 (573)
                      +.. |..+.||++++.+|++||++++|
T Consensus        80 ~~~~C~~~~g~~v~~~~C~lRY~~~~F  106 (106)
T PF01657_consen   80 ISSCCPGSRGGRVWYDSCFLRYENYPF  106 (106)
T ss_dssp             HHHHTTSBSSEEEEESSEEEEEESS--
T ss_pred             HHHhCCCCceEEEECCCEEEEEECCCC
Confidence            998 66789999999999999999887

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>PF01657 Stress-antifung: Salt stress response/antifungal; InterPro: IPR002902 This domain is found in plants and has no known function

Probab=99.77  E-value=2.3e-19  Score=150.45  Aligned_cols=76  Identities=39%  Similarity=0.888  Sum_probs=61.0

Q ss_pred             Cccccccccc---ccEEeeeCCCCCcEEEEEecCCCCChhhhHHHHHHHHHHHHhhCCCCCCcccEEEEccceEEEecCC
Q 008239            2 DIVTPLIARQ---RYAAVVNGTGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDY   78 (573)
Q Consensus         2 ~~l~~~~~~~---~~~~~~~~~~~~~vygl~~C~~d~~~~~C~~Cl~~~~~~~~~~c~~~~~~~~~~~~~~~C~~ry~~~   78 (573)
                      +.|.+.++..   +|+++..|.++++|||++||++|+++++|..||+.++..++.+|+++   +||+||+++|+||||++
T Consensus        28 ~~l~~~a~~~~~~~f~~~~~~~~~~~vYgl~qC~~Dls~~dC~~Cl~~a~~~~~~~C~~~---~g~~v~~~~C~lRY~~~  104 (106)
T PF01657_consen   28 SSLVSNAASSSSKGFATGSAGSGPDTVYGLAQCRGDLSPSDCRACLADAVANISSCCPGS---RGGRVWYDSCFLRYENY  104 (106)
T ss_dssp             HHHHHHGGGTT-TEEEEEE--ST---EEEEEEE-TTS-HHHHHHHHHHHHCCHHHHTTSB---SSEEEEESSEEEEEESS
T ss_pred             HHHHHHHhhccccCcEEeecCCCCCeEEEEEEcCCCCChhhhHHHHHHHHHHHHHhCCCC---ceEEEECCCEEEEEECC
Confidence            4566665543   89999888899999999999999999999999999999999999986   99999999999999999


Q ss_pred             Cc
Q 008239           79 DF   80 (573)
Q Consensus        79 ~f   80 (573)
                      +|
T Consensus       105 ~F  106 (106)
T PF01657_consen  105 PF  106 (106)
T ss_dssp             --
T ss_pred             CC
Confidence            98

The structure of this domain is known and it is thought to be involved in antifungal responses in plants []. Two copies of this domain are also found together in cysteine-rich protein kinases and cysteine-rich repeat secretory proteins. The domain contains four conserved cysteines.; PDB: 3A2E_D.

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.77  E-value=1.5e-19  Score=182.97  Aligned_cols=175  Identities=26%  Similarity=0.356  Sum_probs=131.6

Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      .+++.|+++...+|.+||..+......++.....++.|++.|+.|   ++   .+|+|+||.||+...+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            467999999999999999877777778899999999999999999   55   999999999999999999999999998


Q ss_pred             cccCCCC-----cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc
Q 008239          419 RLFPEDI-----THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR  493 (573)
Q Consensus       419 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  493 (573)
                      .......     ....+...||..||+||.+.++.|+.|+||||||+||+|++.-   +......    .....-.+.+.
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~---f~T~~er----~~t~~d~r~g~  476 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ---FSTQFER----IATLTDIRDGI  476 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH---hccHHHH----HHhhhhhhcCC
Confidence            8665444     2234466799999999999999999999999999999999961   1111100    00001111221


Q ss_pred             cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHH
Q 008239          494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIV  535 (573)
Q Consensus       494 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev  535 (573)
                      +    +|....+++     .-..++.+++...|.+||++.++
T Consensus       477 i----p~~~~~d~p-----~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  477 I----PPEFLQDYP-----EEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             C----ChHHhhcCc-----HHHHHHHHhcCCCcccCchHHHH
Confidence            1    111111222     22478889999999999955443

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.76  E-value=2.8e-19  Score=184.35  Aligned_cols=225  Identities=25%  Similarity=0.194  Sum_probs=172.5

Q ss_pred             cccccCceeEEEEEc----CCCCEEEEEEecccChh--hHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeEEEEecc
Q 008239          276 KLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      .+|+|.||.|+....    +.|..+|.|.+.+....  .......|-.++...+ ||.+|++.-.+..+...+++.++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999998753    34778888887653211  1114456788888886 9999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +|.|...+..   ...+++.........++-+++++|+.+   |+|||+|++||+++.+|.+++.|||+.+..-+...  
T Consensus        81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--  152 (612)
T KOG0603|consen   81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--  152 (612)
T ss_pred             cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhh--
Confidence            9999887733   334666667777888999999999988   99999999999999999999999999886533221  


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE  508 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  508 (573)
                         .+||..|||||.+.  .....+|.||||++++||++|-.|+..        +.......         ..  -..+.
T Consensus       153 ---~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--------~~~~~Il~---------~~--~~~p~  208 (612)
T KOG0603|consen  153 ---ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--------DTMKRILK---------AE--LEMPR  208 (612)
T ss_pred             ---cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--------HHHHHHhh---------hc--cCCch
Confidence               28999999999987  667899999999999999999988765        11111111         00  12344


Q ss_pred             chHHHHHHHHHHccCCCCCCCCCH
Q 008239          509 GKPSRLLQIGLLCVQASAELRPSM  532 (573)
Q Consensus       509 ~~~~~l~~l~~~cl~~~p~~RPt~  532 (573)
                      +......+++..++..+|.+|--.
T Consensus       209 ~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  209 ELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             hhhHHHHHHHHHHHhhCHHHHhcc
Confidence            555666677777777888887554

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=3.5e-18  Score=166.25  Aligned_cols=196  Identities=25%  Similarity=0.295  Sum_probs=136.0

Q ss_pred             CCCCeeeeeeeeec---------------------------CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHH
Q 008239          323 NHKNLVKLLGCSIT---------------------------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL  375 (573)
Q Consensus       323 ~h~niv~l~~~~~~---------------------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~  375 (573)
                      +|||||++.++|.+                           +..+|+||.-.+ .+|.+++..+    ..+.....-++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~----~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR----HRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC----CCchHHHHHHHH
Confidence            59999999987653                           224577887664 4777777432    355667778899


Q ss_pred             HHHHHHHHHHhcCCCCeEEecCCCCCeee--CCCC--cEEEeecccccccCC-----CCcccccccccCcCcCchhhhcc
Q 008239          376 STAEGLAYLHEESKLRIIHRDIKLSNILL--DEEF--TAKIADFGLVRLFPE-----DITHISATLAGTLGYMAPEYVVR  446 (573)
Q Consensus       376 ~ia~~l~yLH~~~~~~iiHrDlk~~NIll--~~~~--~~kl~Dfgla~~~~~-----~~~~~~~~~~gt~~y~aPE~~~~  446 (573)
                      |+++|+.|||+++   |.|||||++||||  |+|.  .+.|+|||.+-.-..     +.........|.-.-||||+...
T Consensus       349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta  425 (598)
T KOG4158|consen  349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA  425 (598)
T ss_pred             HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence            9999999999998   9999999999999  3443  578899997642111     12222234567778999998754


Q ss_pred             C--CC----CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHH
Q 008239          447 G--KL----TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLL  520 (573)
Q Consensus       447 ~--~~----~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~  520 (573)
                      .  +.    -.|+|.|+.|-+.|||+....||....+. .+...   .+.+.++         ...+...+..+.+++..
T Consensus       426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r---~Yqe~qL---------Palp~~vpp~~rqlV~~  492 (598)
T KOG4158|consen  426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTR---TYQESQL---------PALPSRVPPVARQLVFD  492 (598)
T ss_pred             CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechh---hhhhhhC---------CCCcccCChHHHHHHHH
Confidence            3  22    24899999999999999998887652211 00000   0111111         22355667788899999


Q ss_pred             ccCCCCCCCCCHHHHHHHh
Q 008239          521 CVQASAELRPSMSIVVKML  539 (573)
Q Consensus       521 cl~~~p~~RPt~~evl~~L  539 (573)
                      .++.||++||+..-....|
T Consensus       493 lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  493 LLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HhcCCccccCCccHHHhHH
Confidence            9999999999975444443

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.75  E-value=2.2e-18  Score=189.83  Aligned_cols=198  Identities=22%  Similarity=0.241  Sum_probs=156.7

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCC---CCCeeeeeeeeecCCc
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPE  339 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~  339 (573)
                      +.+.....|.+.+.||+|+||+||+|...+|+.||+|+-+....   -+|.-=..++.+|+   -+-|+.+...+.-.+.
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~  768 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQNA  768 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCCc
Confidence            34455577888999999999999999998899999997644321   11211222333343   2345555556666788


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC-------CCCcEEE
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-------EEFTAKI  412 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~-------~~~~~kl  412 (573)
                      -+||+||.+.|+|.+++.   ..+.++|.....++.|++..+..||..+   |||+||||+|.||.       +...++|
T Consensus       769 S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 SVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             ceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEE
Confidence            899999999999999995   5567999999999999999999999988   99999999999994       2346999


Q ss_pred             eeccccccc---CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCC
Q 008239          413 ADFGLVRLF---PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRI  471 (573)
Q Consensus       413 ~Dfgla~~~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p  471 (573)
                      +|||.+--+   ++.  ......++|-.+-.+|...+.+++...|.|.|.-+++-||.|+..
T Consensus       843 IDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             EecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            999988633   222  233456788999999999999999999999999999999999853

>smart00090 RIO RIO-like kinase

Probab=99.74  E-value=2.7e-17  Score=158.74  Aligned_cols=145  Identities=18%  Similarity=0.139  Sum_probs=111.9

Q ss_pred             hcCccccccccccCceeEEEEE--cCCCCEEEEEEecccChh------------------------hHHHHHHHHHHHcC
Q 008239          268 TNYFHESNKLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ------------------------WVDHFFNEVNLISG  321 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~--~~~g~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~  321 (573)
                      ...|...+.||+|+||.||+|.  ..+|+.||||++......                        ....+..|+..+.+
T Consensus        27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~  106 (237)
T smart00090       27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR  106 (237)
T ss_pred             CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            3457788999999999999998  568999999998643210                        11235689999999


Q ss_pred             CCCCC--eeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q 008239          322 INHKN--LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL  399 (573)
Q Consensus       322 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~  399 (573)
                      +.+.+  +.+++++    ...++||||+++.+|......   ...+.......++.||+.++.+||+.+  +|+||||||
T Consensus       107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp  177 (237)
T smart00090      107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK---DVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSE  177 (237)
T ss_pred             HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc---cCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCCh
Confidence            97533  3444443    245899999999888765422   223556667899999999999999875  499999999


Q ss_pred             CCeeeCCCCcEEEeecccccccC
Q 008239          400 SNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       400 ~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      +||+++ ++.++|+|||++....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987543

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.73  E-value=1.8e-17  Score=158.12  Aligned_cols=134  Identities=18%  Similarity=0.248  Sum_probs=112.7

Q ss_pred             ccccccCceeEEEEEcCCCCEEEEEEecccCh--------hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      +.||+|++|.||+|.+ .|..++||+......        .....+.+|+.++..+.|+++.....++......++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            5799999999999988 577899998653321        1124577899999999999998877777777888999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      +++++|.+++...      .+ .+..++.+++.+|.+||+.+   ++|+|++|.|||++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999887421      12 78899999999999999988   99999999999999 78999999998774

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.73  E-value=2.9e-17  Score=154.97  Aligned_cols=144  Identities=21%  Similarity=0.191  Sum_probs=111.5

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChh----------------------hHHHHHHHHHHHcC
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ----------------------WVDHFFNEVNLISG  321 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~----------------------~~~~~~~E~~~l~~  321 (573)
                      +......|...+.||+|+||.||++...+|+.||||++......                      ....+..|+.++..
T Consensus        10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   89 (198)
T cd05144          10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA   89 (198)
T ss_pred             HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence            33333447778999999999999999988999999987543210                      11235678889998


Q ss_pred             CCCCC--eeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCC
Q 008239          322 INHKN--LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL  399 (573)
Q Consensus       322 l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~  399 (573)
                      +.|++  +.+.++    ....++||||+++++|.+...         ......++.+++.++.++|+.+   |+||||+|
T Consensus        90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p  153 (198)
T cd05144          90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSE  153 (198)
T ss_pred             HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence            88774  444443    245689999999998876541         0235678899999999999987   99999999


Q ss_pred             CCeeeCCCCcEEEeecccccccCC
Q 008239          400 SNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       400 ~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      +||++++++.++|+|||++.....
T Consensus       154 ~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         154 FNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             ccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999875543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=4.3e-17  Score=176.93  Aligned_cols=139  Identities=20%  Similarity=0.274  Sum_probs=112.8

Q ss_pred             HhcCccccccccccCceeEEEEEcCCCCEEEEEEe-ccc-------ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRL-FYN-------TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP  338 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~-~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  338 (573)
                      ....|...++||+|+||+||+|.+.+.. +++|+. ...       .....+.+.+|++++..++|++++....++....
T Consensus       331 ~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~  409 (535)
T PRK09605        331 VKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE  409 (535)
T ss_pred             cccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence            3445567899999999999999886544 444432 211       1112356889999999999999998888887777


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++||||+++++|.+++.           ....++.+++.+|.|||+.+   ++||||||+|||+ +++.++|+|||++
T Consensus       410 ~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla  474 (535)
T PRK09605        410 EKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLG  474 (535)
T ss_pred             CCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccc
Confidence            8899999999999988773           35678999999999999988   9999999999999 6779999999998


Q ss_pred             ccc
Q 008239          419 RLF  421 (573)
Q Consensus       419 ~~~  421 (573)
                      +..
T Consensus       475 ~~~  477 (535)
T PRK09605        475 KYS  477 (535)
T ss_pred             ccC
Confidence            753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=5.7e-17  Score=153.14  Aligned_cols=130  Identities=19%  Similarity=0.293  Sum_probs=106.0

Q ss_pred             cccccCceeEEEEEcCCCCEEEEEEecccCh--------hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .||+|+||.||+|.+ +|..|++|+......        ....++.+|++++..++|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999986 478899998654211        11356778999999999887666555566667789999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++++|.+.+....          ..++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999988763211          078999999999999988   99999999999999 78999999999875

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.64  E-value=2.7e-16  Score=170.23  Aligned_cols=215  Identities=20%  Similarity=0.252  Sum_probs=144.4

Q ss_pred             hcCccccccccccCceeEEEEEcCC-CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..+|+.++.|..|++|.||..+++. .+.+|+|+-+.+      .+.+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~------lilRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN------LILRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhcccccc------hhhhc--cccccCCccee------------------
Confidence            3678889999999999999999874 566777432111      01110  22233344333                  


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC-
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI-  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-  425 (573)
                         |+=...+   +..++++...        +.+++|||+.+   |+|||+||.|.+|+.-|++|+.|||+.+...... 
T Consensus       136 ---gDc~tll---k~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a  198 (1205)
T KOG0606|consen  136 ---GDCATLL---KNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA  198 (1205)
T ss_pred             ---chhhhhc---ccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence               2222222   1223333222        67899999988   9999999999999999999999999987431111 


Q ss_pred             ------------ccc-ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC
Q 008239          426 ------------THI-SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG  492 (573)
Q Consensus       426 ------------~~~-~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  492 (573)
                                  .+. ...++||+.|.|||++..+-|+..+|.|++|+|+||.+-|..||+.+..+.-+.+.+.+..   
T Consensus       199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i---  275 (1205)
T KOG0606|consen  199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI---  275 (1205)
T ss_pred             chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc---
Confidence                        011 2256899999999999999999999999999999999999999887654322211111110   


Q ss_pred             ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       493 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .+.         +-....+.+..+++.+.|+.+|..|--....++
T Consensus       276 ~wp---------E~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~e  311 (1205)
T KOG0606|consen  276 EWP---------EEDEALPPEAQDLIEQLLRQNPLCRLGTGGALE  311 (1205)
T ss_pred             ccc---------ccCcCCCHHHHHHHHHHHHhChHhhcccchhhh
Confidence            111         113344567888999999999999955444333

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.63  E-value=2.6e-15  Score=134.48  Aligned_cols=135  Identities=24%  Similarity=0.188  Sum_probs=114.6

Q ss_pred             ccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCC--CCeeeeeeeeecCCceeEEEEeccCC
Q 008239          273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH--KNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      +.+.||+|.++.||++...+ ..++||.......  ...+.+|+.++..++|  .++.+++++....+..++++||++++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            45789999999999999865 7899998865433  4578899999999976  58999999888888899999999887


Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      .+..+          +......++.+++++|++||.....+++|+||+|+||++++++.+++.|||.+..
T Consensus        79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            77543          5566778899999999999986545699999999999999989999999998774

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.63  E-value=1.4e-15  Score=142.08  Aligned_cols=137  Identities=21%  Similarity=0.211  Sum_probs=97.4

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhh--HHH----------------------HHHHHHHHcCCCCCC--e
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQW--VDH----------------------FFNEVNLISGINHKN--L  327 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~n--i  327 (573)
                      .+.||+|+||+||++...+|+.||||++.......  ...                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            56899999999999998889999999886532211  111                      124555555554332  3


Q ss_pred             eeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCeeeCC
Q 008239          328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDE  406 (573)
Q Consensus       328 v~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NIll~~  406 (573)
                      .+.++.    ...++||||++++.+.........   .. .....++.+++.++.++|. .+   |+|+||||+||+++ 
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence            334432    246899999999654322111100   11 5678899999999999999 76   99999999999999 


Q ss_pred             CCcEEEeecccccccC
Q 008239          407 EFTAKIADFGLVRLFP  422 (573)
Q Consensus       407 ~~~~kl~Dfgla~~~~  422 (573)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8899999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=1.1e-14  Score=140.78  Aligned_cols=136  Identities=21%  Similarity=0.263  Sum_probs=104.7

Q ss_pred             ccccc-ccCceeEEEEEcCCCCEEEEEEecccC-------------hhhHHHHHHHHHHHcCCCCCCe--eeeeeeeecC
Q 008239          274 SNKLG-QGGSGSVYKGTLPGGEAVAVKRLFYNT-------------TQWVDHFFNEVNLISGINHKNL--VKLLGCSITG  337 (573)
Q Consensus       274 ~~~lg-~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~  337 (573)
                      ...|| .|+.|+||+.... +..++||++....             ......+.+|++++.+|+|++|  ++.+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            45787 8999999999886 6789999874311             1223467889999999998875  6777764433


Q ss_pred             Cc----eeEEEEeccC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEE
Q 008239          338 PE----SLLVYEFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI  412 (573)
Q Consensus       338 ~~----~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl  412 (573)
                      ..    .++|+|++++ .+|.+++..    ..++..    .+.+|+.+|.+||+.+   |+||||||.|||++.++.++|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~L  183 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWL  183 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEE
Confidence            22    2599999997 688877632    234443    3568899999999998   999999999999999889999


Q ss_pred             eeccccccc
Q 008239          413 ADFGLVRLF  421 (573)
Q Consensus       413 ~Dfgla~~~  421 (573)
                      +|||.+...
T Consensus       184 IDfg~~~~~  192 (239)
T PRK01723        184 IDFDRGELR  192 (239)
T ss_pred             EECCCcccC
Confidence            999988753

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.57  E-value=4.8e-16  Score=168.28  Aligned_cols=254  Identities=22%  Similarity=0.241  Sum_probs=189.7

Q ss_pred             hcCccccccccccCceeEEEEEcCC--CCEEEEEEecccC--hhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG--GEAVAVKRLFYNT--TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~l  342 (573)
                      ...|...+.||+|.|+.|-......  ...+|+|.+....  .........|..+-..+. |+|++.+++.....+..++
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~   98 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL   98 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence            3457778889999999998887643  3456666664432  333445556777777776 9999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEEecCCCCCeeeCCCC-cEEEeecccccc
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH-EESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRL  420 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~  420 (573)
                      +.+|..++++.+.+. .......+....-..+.|+..++.|+| ..+   +.|+||||+|.+++..+ ..+++|||++..
T Consensus        99 ~~~~s~g~~~f~~i~-~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKIS-HPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             ccCcccccccccccc-cCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            999999999988773 122223555666788999999999999 766   99999999999999999 999999999997


Q ss_pred             cCC--CCccccccccc-CcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          421 FPE--DITHISATLAG-TLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       421 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      +..  .........+| ++.|+|||...+ +...+..|+||.|+++.-+++|..|.........            ....
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~------------~~~~  242 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG------------RYSS  242 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc------------ccee
Confidence            765  22333345677 999999999887 4567789999999999999999998766544321            1111


Q ss_pred             ccCccc--cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          497 AVDPAL--AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       497 ~~d~~l--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+...  .............++..+++..+|..|.+.+++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             ecccccccccCccccCChhhhhcccccccCCchhccccccccc
Confidence            111110  01112334556778888899999999999888753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.48  E-value=2.5e-13  Score=142.76  Aligned_cols=142  Identities=21%  Similarity=0.208  Sum_probs=99.0

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhhHH----------------------------------------HHH
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD----------------------------------------HFF  313 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~----------------------------------------~~~  313 (573)
                      .+.||.|++|.||+|++.+|+.||||+.+....+...                                        .|.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            4689999999999999999999999998654211100                                        123


Q ss_pred             HHHHHHcCC----CCCCeeeeeeee-ecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHH-HHHHHHhc
Q 008239          314 NEVNLISGI----NHKNLVKLLGCS-ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE-GLAYLHEE  387 (573)
Q Consensus       314 ~E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-~l~yLH~~  387 (573)
                      +|++.+.++    +|.+-+.+-..+ ......+|||||+++++|.+.......  ..   .+.+++..++. .+..+|..
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~  276 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD  276 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence            344444443    233333333322 234567999999999999887632211  12   23456666665 47788988


Q ss_pred             CCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       388 ~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      +   ++|+|++|.||++++++++++.|||++..++.
T Consensus       277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            7   99999999999999999999999999986643

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.42  E-value=1e-13  Score=132.44  Aligned_cols=205  Identities=18%  Similarity=0.233  Sum_probs=138.6

Q ss_pred             HHHHcCCCCCCeeeeeeeeec-----CCceeEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 008239          316 VNLISGINHKNLVKLLGCSIT-----GPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESK  389 (573)
Q Consensus       316 ~~~l~~l~h~niv~l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~  389 (573)
                      ..-|-++.|.|||+++.|+.+     ..+..+++|||..|+|..+|.... ....+......+|.-||..||.|||+-. 
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-
Confidence            334556679999999988764     345789999999999999996533 3456778888899999999999999975 


Q ss_pred             CCeEEecCCCCCeeeCCCCcEEEeecccccccC---CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHH
Q 008239          390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP---EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV  466 (573)
Q Consensus       390 ~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ell  466 (573)
                      |+|+|+++.-+-|++..++-+||+--.-.....   ...........+-++|.+||+=...+.+-.+|||+||+-.+||.
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             CccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            889999999999999999999985321111000   00000111223567899999877777788999999999999998


Q ss_pred             cCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          467 CRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       467 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      -+.--...... ....+..    ....+ ..+...+           -..++..|++..|..||+|.+++..
T Consensus       277 ilEiq~tnseS-~~~~ee~----ia~~i-~~len~l-----------qr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSES-KVEVEEN----IANVI-IGLENGL-----------QRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcc-eeehhhh----hhhhe-eeccCcc-----------ccCcCcccccCCCCCCcchhhhhcC
Confidence            77632111110 0000100    00000 0001111           1245668999999999999988754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.40  E-value=4e-13  Score=139.22  Aligned_cols=249  Identities=24%  Similarity=0.303  Sum_probs=181.0

Q ss_pred             cCccccccccc--cCceeEEEEEc---CCCCEEEEEEecc--cChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCce
Q 008239          269 NYFHESNKLGQ--GGSGSVYKGTL---PGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES  340 (573)
Q Consensus       269 ~~~~~~~~lg~--G~~g~Vy~~~~---~~g~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  340 (573)
                      ..|.....+|.  |.+|.||.+..   .++..+|+|+-+.  ........=.+|+...+.+ .|+|.++.+..+...+..
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l  193 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL  193 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence            34667888999  99999999987   3578899997432  2222223334567666666 599999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHH----HHHHHHhcCCCCeEEecCCCCCeeeCCC-CcEEEeec
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE----GLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADF  415 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~Df  415 (573)
                      ++-+|++. .+|.++.+...  ..++...++....+...    ||.++|+..   ++|-|+||.||+...+ ...+++||
T Consensus       194 fiqtE~~~-~sl~~~~~~~~--~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df  267 (524)
T KOG0601|consen  194 FIQTELCG-ESLQSYCHTPC--NFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDF  267 (524)
T ss_pred             eeeecccc-chhHHhhhccc--ccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCc
Confidence            99999885 67777765432  23566677777888878    999999988   9999999999999999 89999999


Q ss_pred             ccccccCCCCcc----cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc
Q 008239          416 GLVRLFPEDITH----ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       416 gla~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      |+...+.+..-.    ......+...|++||++ ++-++..+|+|++|.+++|-.++-..+......      .|...+.
T Consensus       268 ~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~~~r~  340 (524)
T KOG0601|consen  268 GLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS------SWSQLRQ  340 (524)
T ss_pred             ceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC------Ccccccc
Confidence            999877654321    12233577789999976 456788999999999999999887765443211      1222121


Q ss_pred             CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       492 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +.        +..++-.....++..++.++++.+|..|++.+.+...
T Consensus       341 ~~--------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  341 GY--------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             cc--------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            11        1112222233445558889999999999998877653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.33  E-value=1.5e-12  Score=138.45  Aligned_cols=146  Identities=18%  Similarity=0.192  Sum_probs=92.4

Q ss_pred             HhcCccccccccccCceeEEEEEcCC-CCEEEEEEecccChh----------------------------------hHHH
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQ----------------------------------WVDH  311 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~----------------------------------~~~~  311 (573)
                      ....|+. +.||+|++|.||+|++++ |+.||||+......+                                  ..+.
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3445665 789999999999999987 999999998654211                                  1112


Q ss_pred             HHHHHHH------HcCC----CCCCeeeeeeeeec-CCceeEEEEeccCCCccccccccCCC---CCCCHHHHHHHHHHH
Q 008239          312 FFNEVNL------ISGI----NHKNLVKLLGCSIT-GPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILST  377 (573)
Q Consensus       312 ~~~E~~~------l~~l----~h~niv~l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~---~~l~~~~~~~i~~~i  377 (573)
                      +.+|+++      +.++    .+.+.+.+-.++.+ ....+|||||++++.+.+.-......   ..+.......++.  
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~--  274 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFT--  274 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHH--
Confidence            2233333      2222    23333333333322 45678999999999997642111110   0122222222223  


Q ss_pred             HHHHHHHHhcCCCCeEEecCCCCCeeeCCCC----cEEEeecccccccCC
Q 008239          378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFGLVRLFPE  423 (573)
Q Consensus       378 a~~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfgla~~~~~  423 (573)
                           .+...+   ++|+|+||.||+++.++    ++++.|||++..++.
T Consensus       275 -----Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 -----QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 334455   99999999999999888    999999999987654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.33  E-value=5.2e-12  Score=115.83  Aligned_cols=130  Identities=20%  Similarity=0.156  Sum_probs=97.2

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCee-eeeeeeecCCceeEEEEeccCCCc
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGCSITGPESLLVYEFVPNQSL  352 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~~gsL  352 (573)
                      .+.|+.|.++.||+++.. ++.+++|........ ...+..|+..+..+.+.+++ +++.+.  ....++||||+++.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~-~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL-LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc-ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            467899999999999876 778999987554321 23467899999988665554 444443  3346899999999887


Q ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES--KLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       353 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .+..        .   ....++.+++++|+.||+.+  ...++|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            6431        0   11245678999999999976  23469999999999999 6689999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.29  E-value=3.1e-11  Score=126.41  Aligned_cols=167  Identities=17%  Similarity=0.167  Sum_probs=125.0

Q ss_pred             cCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHH
Q 008239          290 LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV  369 (573)
Q Consensus       290 ~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~  369 (573)
                      ..++.+|.|...........+...+-+..|+.++||||+++++.++.....|||+|-+.  .|..++..      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            34688899998877666656677888999999999999999999999999999999873  34444421      23445


Q ss_pred             HHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccCCC
Q 008239          370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL  449 (573)
Q Consensus       370 ~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  449 (573)
                      ..-.+.||+.||.+||..+  .++|++|.-..|+++..|..||++|.++...+.... ......---.|..|+.+.... 
T Consensus       106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~-  181 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE-  181 (690)
T ss_pred             HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc-
Confidence            5567889999999999765  499999999999999999999999998875432221 001111122456666543222 


Q ss_pred             CcccchHhHHHHHHHHHcCC
Q 008239          450 TEKADVYSFGVVVIEVVCRK  469 (573)
Q Consensus       450 ~~~sDvwslGvil~elltg~  469 (573)
                       -..|.|-||++++|++.|.
T Consensus       182 -~s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  182 -WSIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             -cchhhhhHHHHHHHHhCcc
Confidence             2469999999999999983

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.24  E-value=1.4e-10  Score=117.90  Aligned_cols=170  Identities=21%  Similarity=0.308  Sum_probs=132.5

Q ss_pred             CceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeee----cCCceeEEEEeccC-CCccc
Q 008239          281 GSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI----TGPESLLVYEFVPN-QSLLD  354 (573)
Q Consensus       281 ~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~lv~e~~~~-gsL~~  354 (573)
                      -..+.||+.. .||..|++|+++....+.......-++.++++.|.|+|++.+++.    .+..+++||+|.|+ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3467899976 489999999996554444445556788999999999999999877    34567899999986 67776


Q ss_pred             cccccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          355 NLFVRQ------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       355 ~l~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      +.+...            .....++..+|.++.|+..||.++|+.|   +.-+-|.+++||++.+.+++|+..|......
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeec
Confidence            654321            1224678999999999999999999998   8889999999999999999999999877665


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCC
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRI  471 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p  471 (573)
                      .+...               -+..   -.+-|.=.||.+++.|.||...
T Consensus       445 ~d~~~---------------~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  445 EDPTE---------------PLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCCc---------------chhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            44311               1111   1356888999999999999654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.20  E-value=2e-10  Score=110.10  Aligned_cols=143  Identities=24%  Similarity=0.283  Sum_probs=110.7

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccCh-hhHHHHHHHHHHHcCCCC--CCeeeeeeeeecCC---ceeEEEEec
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINH--KNLVKLLGCSITGP---ESLLVYEFV  347 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~---~~~lv~e~~  347 (573)
                      .+.|+.|.++.||++...+|+.+++|....... .....+..|+.++..+.+  .++.+++.+.....   ..++||||+
T Consensus         3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             ceecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            467899999999999987778999998754332 134577899999999975  34567777766542   568999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES---------------------------------------  388 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------  388 (573)
                      ++.++.+.+..    ..++......++.++++.|..||+..                                       
T Consensus        83 ~G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          83 DGRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CCEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99888776521    34677778888888888888888531                                       


Q ss_pred             --------------CCCeEEecCCCCCeeeCC--CCcEEEeecccccc
Q 008239          389 --------------KLRIIHRDIKLSNILLDE--EFTAKIADFGLVRL  420 (573)
Q Consensus       389 --------------~~~iiHrDlk~~NIll~~--~~~~kl~Dfgla~~  420 (573)
                                    ...++|+|+++.||++++  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          245899999999999998  66789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.19  E-value=3.3e-10  Score=104.91  Aligned_cols=138  Identities=12%  Similarity=0.070  Sum_probs=98.9

Q ss_pred             cccccccCceeEEEEEcCC-------CCEEEEEEecccC----------------------hhhHHHHH----HHHHHHc
Q 008239          274 SNKLGQGGSGSVYKGTLPG-------GEAVAVKRLFYNT----------------------TQWVDHFF----NEVNLIS  320 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~----------------------~~~~~~~~----~E~~~l~  320 (573)
                      ...||.|--+.||.|...+       +..+|||+.+...                      ....+.+.    +|++.|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999998653       4799999874211                      01122333    7999998


Q ss_pred             CCCC--CCeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHH-HhcCCCCeEEecC
Q 008239          321 GINH--KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL-HEESKLRIIHRDI  397 (573)
Q Consensus       321 ~l~h--~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yL-H~~~~~~iiHrDl  397 (573)
                      ++..  -++.+.+++    ...+|||||+.+..+.....   +...++......+..+++.+|..| |+.+   |+|+||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence            8853  456666654    56789999997654422211   112344556677889999999999 7777   999999


Q ss_pred             CCCCeeeCCCCcEEEeecccccccC
Q 008239          398 KLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       398 k~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ++.|||+++ +.+.|+|||.+....
T Consensus       152 s~~NIL~~~-~~v~iIDF~qav~~~  175 (197)
T cd05146         152 SEYNMLWHD-GKVWFIDVSQSVEPT  175 (197)
T ss_pred             CHHHEEEEC-CcEEEEECCCceeCC
Confidence            999999974 689999999877543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=1.4e-11  Score=127.89  Aligned_cols=247  Identities=20%  Similarity=0.187  Sum_probs=178.4

Q ss_pred             HHhcCccccccccccCceeEEEEEcC--CCCEEEEEEecccChhhHHHH--HHHHHHHcCC-CCCCeeeeeeeeecCCce
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP--GGEAVAVKRLFYNTTQWVDHF--FNEVNLISGI-NHKNLVKLLGCSITGPES  340 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~~~~~~~~~--~~E~~~l~~l-~h~niv~l~~~~~~~~~~  340 (573)
                      ....+|..+..||.|.|+.|++...+  ++..+++|.+.........++  ..|+-+...+ .|.+++++...+......
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            34567889999999999999998754  577899998866544333332  3566666666 599999998888888888


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC-CcEEEeeccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVR  419 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~  419 (573)
                      ++--||++++++...+.   -...+++..++++..|++.++.++|+..   ++|+|++|+||++..+ +.-+++|||...
T Consensus       342 ~ip~e~~~~~s~~l~~~---~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSV---TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cCchhhhcCcchhhhhH---HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccc
Confidence            89999999988866552   2234677788999999999999999877   9999999999999876 888999999986


Q ss_pred             ccCCCCcccccccccCcCcC--chhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          420 LFPEDITHISATLAGTLGYM--APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      .+.-    .........++.  +|+......+..+.|++|||.-+.|.+++.........        |.....+..   
T Consensus       416 ~~~~----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--------~~~i~~~~~---  480 (524)
T KOG0601|consen  416 RLAF----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--------SLTIRSGDT---  480 (524)
T ss_pred             ccce----ecccccccccccccchhhccccccccccccccccccccccccCcccCccccc--------ceeeecccc---
Confidence            3211    111122233444  56666667889999999999999999998754322211        111111111   


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                            ...+ .....+..+...+...++..||.+.++..+..
T Consensus       481 ------p~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  481 ------PNLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ------cCCC-chHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                  1112 22366778888899999999999988876653

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.02  E-value=2.7e-09  Score=95.46  Aligned_cols=131  Identities=21%  Similarity=0.301  Sum_probs=99.1

Q ss_pred             ccccccCceeEEEEEcCCCCEEEEEEeccc---Chh-----hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYN---TTQ-----WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~---~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ..+++|+-+.+|.+.+. |.++++|.=...   .++     ....-.+|++++.+++--.|.--+=+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46789999999999775 444666643211   111     123556799999998766665555566778888999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      +++..|.+.+...          ...++..|-.-+.-||..+   |+|+||.++||++..+. +.++||||+..
T Consensus        81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9998888887432          2456677777788999998   99999999999998875 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.01  E-value=1.9e-09  Score=95.85  Aligned_cols=143  Identities=23%  Similarity=0.256  Sum_probs=105.2

Q ss_pred             ccccccccCceeEEEEEcCCCCEEEEEE-eccc-------ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          273 ESNKLGQGGSGSVYKGTLPGGEAVAVKR-LFYN-------TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~-~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ....|-||+-+.|+++.++ |+...||. +.+.       ..-...+.++|+++|.++.--.|.--.-++.+.....|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5778999999999999987 67767763 3221       1112346678999999887555555555677778889999


Q ss_pred             EeccC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC---cEEEeecccccc
Q 008239          345 EFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGLVRL  420 (573)
Q Consensus       345 e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl~Dfgla~~  420 (573)
                      ||+++ .++.+++...-..+ ........++..|-+.+.-||.++   |||+||..+||+|..++   .+.++|||++..
T Consensus        90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            99977 46677765433222 233334678888899999999998   99999999999997554   458999999764

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.91  E-value=5.1e-10  Score=122.30  Aligned_cols=249  Identities=17%  Similarity=0.142  Sum_probs=167.3

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ..+.|...+-+-+|.++.++.++-. .|...++|......   ....+....+-.++-...||-++...--+.......|
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            4466777788889999999887643 24334444332211   1112222233333334456777766666667788899


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      |++|..+++|...|+...   ..+.+-....+..+...++|||+..   +.|+|++|.|+|+..++..++.|||......
T Consensus       882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg  955 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG  955 (1205)
T ss_pred             hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence            999999999988885433   4555556667778889999999975   8999999999999999999999998433211


Q ss_pred             C------C------------------------CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCC
Q 008239          423 E------D------------------------ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRIN  472 (573)
Q Consensus       423 ~------~------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~  472 (573)
                      .      .                        .........+|+.|.+||.+.+......+|.|++|+.++|.++|..|+
T Consensus       956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence            0      0                        001122456899999999999999999999999999999999999987


Q ss_pred             CCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHH
Q 008239          473 LFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS  533 (573)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  533 (573)
                      .......     +.+...++.+. .      ...+........+++...+..+|..|-.+.
T Consensus      1036 na~tpq~-----~f~ni~~~~~~-~------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQ-----IFENILNRDIP-W------PEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCcchhh-----hhhccccCCCC-C------CCCccccChhhhhhhhhhhccCchhccCcc
Confidence            6544321     11111111110 0      111233445566777778888898887765

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.88  E-value=1.3e-08  Score=93.91  Aligned_cols=126  Identities=25%  Similarity=0.264  Sum_probs=81.6

Q ss_pred             eEEEEEcCCCCEEEEEEecccC-------------h-------------hhHHHHHHHHHHHcCCCCC--Ceeeeeeeee
Q 008239          284 SVYKGTLPGGEAVAVKRLFYNT-------------T-------------QWVDHFFNEVNLISGINHK--NLVKLLGCSI  335 (573)
Q Consensus       284 ~Vy~~~~~~g~~vavK~~~~~~-------------~-------------~~~~~~~~E~~~l~~l~h~--niv~l~~~~~  335 (573)
                      .||.|...+|+.+|||+.....             .             .......+|++.|.++..-  ++.+.+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            4899999999999999874321             0             0123456799999999765  45666654  


Q ss_pred             cCCceeEEEEecc--CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHH-HHhcCCCCeEEecCCCCCeeeCCCCcEEE
Q 008239          336 TGPESLLVYEFVP--NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY-LHEESKLRIIHRDIKLSNILLDEEFTAKI  412 (573)
Q Consensus       336 ~~~~~~lv~e~~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y-LH~~~~~~iiHrDlk~~NIll~~~~~~kl  412 (573)
                        ...+|||||++  +..+..+....     ++......++.+++..+.. +|..+   |+|+||.+.|||++++ .+.|
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i  147 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI  147 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence              25689999998  54443322111     1123345677777775555 46776   9999999999999988 9999


Q ss_pred             eecccccccC
Q 008239          413 ADFGLVRLFP  422 (573)
Q Consensus       413 ~Dfgla~~~~  422 (573)
                      +|||.+....
T Consensus       148 IDf~qav~~~  157 (188)
T PF01163_consen  148 IDFGQAVDSS  157 (188)
T ss_dssp             --GTTEEETT
T ss_pred             EecCcceecC
Confidence            9999877543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.87  E-value=1.1e-07  Score=94.73  Aligned_cols=254  Identities=15%  Similarity=0.170  Sum_probs=153.2

Q ss_pred             ccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeee------eecCCc-eeEEE
Q 008239          273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC------SITGPE-SLLVY  344 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~------~~~~~~-~~lv~  344 (573)
                      ....||+|+-+.+|-.-.-  ...+-|+.+........   +.+..|... .||-+-.-+.+      .-+... .-++|
T Consensus        15 ~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm   89 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM   89 (637)
T ss_pred             CCccccCCccceeeecchh--hchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence            4678999999999964321  11345666654433222   123334333 56644331111      111222 45667


Q ss_pred             EeccCCCcccccc----ccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          345 EFVPNQSLLDNLF----VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       345 e~~~~gsL~~~l~----~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ..+++.--...++    .++.....+|...++.+..++.+.+-||..|   .+-+|++++|+|+++++.+.|.|-.....
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi  166 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI  166 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence            7666542222222    3445567899999999999999999999998   89999999999999999999997654332


Q ss_pred             cCCCCcccccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcC-CCCCCCCCCCc---chHHHHHHHhhc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCR-KRINLFTQNSC---SILQTVWDLYVK  491 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg-~~p~~~~~~~~---~~~~~~~~~~~~  491 (573)
                      -  .......-.+|...|.+||.-.     +-.-+..+|-|.||+++++++.| +.|+..-....   ...+   ..+..
T Consensus       167 ~--~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E---~~Ia~  241 (637)
T COG4248         167 N--ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE---TDIAH  241 (637)
T ss_pred             c--cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch---hhhhc
Confidence            2  1122223456788999999764     23456789999999999999998 55553211110   1111   00111


Q ss_pred             CccccccCcc--cc---CCCC-CchHHHHHHHHHHccCC--CCCCCCCHHHHHHHh
Q 008239          492 GRLHEAVDPA--LA---GNFQ-EGKPSRLLQIGLLCVQA--SAELRPSMSIVVKML  539 (573)
Q Consensus       492 ~~~~~~~d~~--l~---~~~~-~~~~~~l~~l~~~cl~~--~p~~RPt~~evl~~L  539 (573)
                      +.....-+..  +.   ...+ .-.+..+..+..+|+..  ++.-|||.+-.+..|
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl  297 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAAL  297 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHH
Confidence            1111111111  10   0111 12356778888889865  477899998887776

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.83  E-value=3.3e-08  Score=96.88  Aligned_cols=141  Identities=15%  Similarity=0.113  Sum_probs=98.7

Q ss_pred             ccccccCceeEEEEEcCCCCEEEEEEecccCh-hhHH----------HHHHHHHHHcCCCCCCe--eeeeeeeec-----
Q 008239          275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVD----------HFFNEVNLISGINHKNL--VKLLGCSIT-----  336 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~----------~~~~E~~~l~~l~h~ni--v~l~~~~~~-----  336 (573)
                      +.+-.-....|++..+ +|+.+.||+...... +..+          .+.+|.+.+.+|...+|  .+.+++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444455777666 478899997743321 1111          36789888888743333  344444432     


Q ss_pred             CCceeEEEEeccCC-CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-------CC
Q 008239          337 GPESLLVYEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-------EF  408 (573)
Q Consensus       337 ~~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-------~~  408 (573)
                      ....+||+|++++. +|.+++.... ..+.+......++.+++..+.-||..+   |+|+||+++|||++.       +.
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence            23468999999886 7887763221 234556777889999999999999998   999999999999975       46


Q ss_pred             cEEEeecccccc
Q 008239          409 TAKIADFGLVRL  420 (573)
Q Consensus       409 ~~kl~Dfgla~~  420 (573)
                      .+.++||+.+..
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998753

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.74  E-value=8.7e-08  Score=91.01  Aligned_cols=135  Identities=21%  Similarity=0.179  Sum_probs=96.0

Q ss_pred             ccccccccccCceeEEEEEcCCCCEEEEEEecccCh------------------h----hHHHHHHHHHHHcCCCCC--C
Q 008239          271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------------------Q----WVDHFFNEVNLISGINHK--N  326 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~----~~~~~~~E~~~l~~l~h~--n  326 (573)
                      ..+.++||-|.-+.||.|..++|.++|||.-.....                  .    ......+|.+.|.+|...  .
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            345789999999999999999999999996532211                  1    122456788999888654  5


Q ss_pred             eeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC
Q 008239          327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE  406 (573)
Q Consensus       327 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~  406 (573)
                      +.+.++    .+...+||||+++-.|...-        ++.+..-.++..|+.-+.-+-..|   |||+|+++-||++++
T Consensus       173 VP~P~~----~nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~  237 (304)
T COG0478         173 VPKPIA----WNRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCccc----cccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence            666554    45678999999886664422        122223344444555555554555   999999999999999


Q ss_pred             CCcEEEeecccccc
Q 008239          407 EFTAKIADFGLVRL  420 (573)
Q Consensus       407 ~~~~kl~Dfgla~~  420 (573)
                      ||.+.++||--+..
T Consensus       238 dg~~~vIDwPQ~v~  251 (304)
T COG0478         238 DGDIVVIDWPQAVP  251 (304)
T ss_pred             CCCEEEEeCccccc
Confidence            99999999976553

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.72  E-value=5.3e-09  Score=110.39  Aligned_cols=154  Identities=20%  Similarity=0.329  Sum_probs=107.9

Q ss_pred             HHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC--------cccccccccCcCcCchhhhc
Q 008239          374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI--------THISATLAGTLGYMAPEYVV  445 (573)
Q Consensus       374 ~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~--------~~~~~~~~gt~~y~aPE~~~  445 (573)
                      +.+++.||.|+|..-  ++||++|.|++|.++.++..||+.|+.+.......        ........-...|.|||++.
T Consensus       105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~  182 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL  182 (700)
T ss_pred             hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence            445669999999864  69999999999999999999999999876433211        11111223456799999999


Q ss_pred             cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCC
Q 008239          446 RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQAS  525 (573)
Q Consensus       446 ~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~  525 (573)
                      ....+.++|+||+|++++-+..++.+.............          ....+..-.-.++.+.+.++.+=+.+.+..+
T Consensus       183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~----------~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~  252 (700)
T KOG2137|consen  183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF----------SRNLLNAGAFGYSNNLPSELRESLKKLLNGD  252 (700)
T ss_pred             cccccccccceeeeeEEEEEecCCcchhhccCCcchhhh----------hhcccccccccccccCcHHHHHHHHHHhcCC
Confidence            989999999999999999999666554333221111110          0001111112344667888999999999999


Q ss_pred             CCCCCCHHHHHHHh
Q 008239          526 AELRPSMSIVVKML  539 (573)
Q Consensus       526 p~~RPt~~evl~~L  539 (573)
                      +.-||++.++....
T Consensus       253 ~~~rp~~~~l~~~~  266 (700)
T KOG2137|consen  253 SAVRPTLDLLLSIP  266 (700)
T ss_pred             cccCcchhhhhccc
Confidence            99999888776544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.53  E-value=4.9e-07  Score=95.98  Aligned_cols=143  Identities=17%  Similarity=0.214  Sum_probs=91.0

Q ss_pred             ccccccCceeEEEEEcCCCCEEEEEEecccChhhH------------------------------HH----------HHH
Q 008239          275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWV------------------------------DH----------FFN  314 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~------------------------------~~----------~~~  314 (573)
                      +.|+.++-|.||+|++++|+.||||+.+.+-.+..                              ++          +.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67999999999999999999999998865432211                              11          112


Q ss_pred             HHHHHcCC----CCCCeeeeeeee-ecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 008239          315 EVNLISGI----NHKNLVKLLGCS-ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK  389 (573)
Q Consensus       315 E~~~l~~l----~h~niv~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~  389 (573)
                      |..-+.++    ++..-+++=.++ .-....+|+|||++|-.+.+....+.  ..++...+.....++.  +..+-..+ 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k~ia~~~~~~f--~~q~~~dg-  285 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRKELAELLVRAF--LRQLLRDG-  285 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHHHHHHHHHHHH--HHHHHhcC-
Confidence            32222222    222222222222 23467789999999988888753222  2344333322222221  22333344 


Q ss_pred             CCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       390 ~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                        ++|.|.+|.||+++.++++.+.|||+...+++.
T Consensus       286 --ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         286 --FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              999999999999999999999999998876543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.52  E-value=4.7e-07  Score=85.70  Aligned_cols=106  Identities=23%  Similarity=0.238  Sum_probs=80.6

Q ss_pred             HHHHHHHHHHcCCCCC--CeeeeeeeeecCC----ceeEEEEeccCC-CccccccccCCCCCCCHHHHHHHHHHHHHHHH
Q 008239          310 DHFFNEVNLISGINHK--NLVKLLGCSITGP----ESLLVYEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA  382 (573)
Q Consensus       310 ~~~~~E~~~l~~l~h~--niv~l~~~~~~~~----~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~  382 (573)
                      ....+|...+..|...  ...+.+++.....    ..++|+|++++. +|.+++.....   .+......++.+++..++
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            4567788877777433  3445555555432    347999999884 78887743221   556677889999999999


Q ss_pred             HHHhcCCCCeEEecCCCCCeeeCCCC---cEEEeeccccccc
Q 008239          383 YLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGLVRLF  421 (573)
Q Consensus       383 yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl~Dfgla~~~  421 (573)
                      -||..+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       133 ~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999998   99999999999999886   8999999987743

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.49  E-value=1.7e-06  Score=80.45  Aligned_cols=138  Identities=22%  Similarity=0.176  Sum_probs=100.7

Q ss_pred             cccccCceeEEEEEcCCCCEEEEEEecccC------hhhHHHHHHHHHHHcCCCCC--Ceeeeeeeee-cC----CceeE
Q 008239          276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNT------TQWVDHFFNEVNLISGINHK--NLVKLLGCSI-TG----PESLL  342 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~-~~----~~~~l  342 (573)
                      --|+||.+-|++-.+. |+.+-+|+-....      +-....|.+|+..|.+|..-  .+.+.. ++. ..    -.-+|
T Consensus        25 N~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~L  102 (216)
T PRK09902         25 NYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALL  102 (216)
T ss_pred             CcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEE
Confidence            3467899999997775 4478889764211      22456899999999888533  244444 332 11    23579


Q ss_pred             EEEeccC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc--EEEeeccccc
Q 008239          343 VYEFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--AKIADFGLVR  419 (573)
Q Consensus       343 v~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~--~kl~Dfgla~  419 (573)
                      |+|-+++ .+|.+++... ...+.+...+..++.+|+..++-||+.+   +.|+|+.+.||+++.++.  ++++||.-++
T Consensus       103 VTe~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        103 VTEDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEEeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            9997764 5777776332 2335677788899999999999999998   999999999999986666  9999998665

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.37  E-value=4.2e-06  Score=80.27  Aligned_cols=140  Identities=14%  Similarity=0.149  Sum_probs=84.9

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCC--eeeeeeeeecCCceeEEEEeccCCC
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLLGCSITGPESLLVYEFVPNQS  351 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~~~gs  351 (573)
                      -..||+|..+.||+.   .|..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|..
T Consensus         6 ~~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~   80 (226)
T TIGR02172         6 WTQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR   80 (226)
T ss_pred             heeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence            357899999999984   25567888875433  2345688999998886443  4566777777777789999998863


Q ss_pred             -ccccccc--------------------cCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHhc-CCCCeEEecC
Q 008239          352 -LLDNLFV--------------------RQDVEPLSWEVRYK-IIL----------STAE-GLAYLHEE-SKLRIIHRDI  397 (573)
Q Consensus       352 -L~~~l~~--------------------~~~~~~l~~~~~~~-i~~----------~ia~-~l~yLH~~-~~~~iiHrDl  397 (573)
                       +...+..                    .............. +..          .+.. ...+|... ..+.++|+|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence             2111100                    00000111111100 000          0001 12222211 2345799999


Q ss_pred             CCCCeeeCCCCcEEEeeccccc
Q 008239          398 KLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       398 k~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .|.||++++++ +.|+||+.+.
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcC
Confidence            99999999888 9999999766

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.33  E-value=3.7e-06  Score=79.32  Aligned_cols=154  Identities=20%  Similarity=0.191  Sum_probs=97.8

Q ss_pred             cChHHHHHHhcCcccccc---ccccCceeEEEEEcCCCCEEEEEEecccChhhHH------------------------H
Q 008239          259 FSYETLEKATNYFHESNK---LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD------------------------H  311 (573)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~---lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~------------------------~  311 (573)
                      .+.+.+....+...+.+.   |+.|.-..||+|...++..+|||++........+                        .
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            455666666666555444   5677778899999888999999998644221110                        1


Q ss_pred             HHHHHHHHcCCC--CCCeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 008239          312 FFNEVNLISGIN--HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK  389 (573)
Q Consensus       312 ~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~  389 (573)
                      ..+|+.-|+++.  +-.+.+-+++    ....|||||+....+-.-.   -+..++.......+..++++.|.-|-... 
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a-  186 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA-  186 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence            123444444442  2222233322    2457999999654211111   01112333356777888888888887732 


Q ss_pred             CCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       390 ~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                       ++||+||+.-|||+. ++.+.|+|||-+....
T Consensus       187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -CcccccchhhheEEE-CCeEEEEECccccccC
Confidence             399999999999999 7799999999877543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.29  E-value=1.5e-07  Score=98.39  Aligned_cols=197  Identities=19%  Similarity=0.112  Sum_probs=139.2

Q ss_pred             cChHHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCC-eeeeeeeeecC
Q 008239          259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-LVKLLGCSITG  337 (573)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~  337 (573)
                      |....++..+.-+...+-+++|+.+.++|.+-.-.+....+.+...     ....-++++|.+++||| .+..++-+..+
T Consensus       232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E  306 (829)
T KOG0576|consen  232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGE  306 (829)
T ss_pred             CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcc
Confidence            4444445555555556678899999999987543344445544322     34456899999999999 77888878788


Q ss_pred             CceeEEEEeccCC-CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          338 PESLLVYEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       338 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                      ...+++++++..+ +-.....  .....+...+...+...-.++++|||+..   =+|+|    ||+..+ +..|..||+
T Consensus       307 ~~~~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~  376 (829)
T KOG0576|consen  307 DYLWIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFA  376 (829)
T ss_pred             cccchhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-ccccccccc
Confidence            8889999999876 2221110  01112333344455566678899999853   48888    777766 589999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCC
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRIN  472 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~  472 (573)
                      ....+....  ......+|+.|+|||+...+.+..+.|+|++|+--.++--|-.|.
T Consensus       377 v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  377 VPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             CCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            988776544  344667899999999999999999999999999777777666553

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.21  E-value=2e-05  Score=73.66  Aligned_cols=136  Identities=15%  Similarity=0.119  Sum_probs=86.3

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHH---------HHHHHHHcCCC---CCCeeeeeeeee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHF---------FNEVNLISGIN---HKNLVKLLGCSI  335 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~---------~~E~~~l~~l~---h~niv~l~~~~~  335 (573)
                      ..+|...+++-......|.+-.. +|+.+++|..........+.|         .+++..+..++   --....++-+..
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            45666667776666666665555 478899998865443322222         12333233332   222223222222


Q ss_pred             -----cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcE
Q 008239          336 -----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA  410 (573)
Q Consensus       336 -----~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~  410 (573)
                           -....+++|||++|..|.+..       .+++    .++..+.+.+.-||+.|   +.|+|.+|.|++++++ .+
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~-------~i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIE-------DIDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccch-------hcCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence                 223456899999998886653       1222    24456778899999998   9999999999999966 49


Q ss_pred             EEeeccccc
Q 008239          411 KIADFGLVR  419 (573)
Q Consensus       411 kl~Dfgla~  419 (573)
                      ++.||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998765

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.21  E-value=1.1e-05  Score=78.60  Aligned_cols=140  Identities=18%  Similarity=0.150  Sum_probs=85.7

Q ss_pred             cccccCc-eeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeEEEEeccCCCcc
Q 008239          276 KLGQGGS-GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQSLL  353 (573)
Q Consensus       276 ~lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gsL~  353 (573)
                      .|..|.+ ..||+.... +..+.||+.....   ...+.+|+++++.+. +--+.+++++....+..++|||++++.+|.
T Consensus         5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence            4555666 789999765 4778888875432   335667888888773 444557777777666789999999998776


Q ss_pred             cccc-------------------ccCC-CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----c
Q 008239          354 DNLF-------------------VRQD-VEPLSW--EVRYKIIL--------------------STAEGLAYLHE----E  387 (573)
Q Consensus       354 ~~l~-------------------~~~~-~~~l~~--~~~~~i~~--------------------~ia~~l~yLH~----~  387 (573)
                      ....                   .-.. ..++..  ...+....                    .+...+..|-.    .
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            4321                   0000 001110  00000000                    01111222211    1


Q ss_pred             CCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       388 ~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      ..+.++|+|+.|.|||++++..+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            23569999999999999998778999998765

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.19  E-value=8.8e-06  Score=75.49  Aligned_cols=105  Identities=25%  Similarity=0.198  Sum_probs=83.6

Q ss_pred             HHHHHHHcCCCC-CCeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 008239          313 FNEVNLISGINH-KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR  391 (573)
Q Consensus       313 ~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  391 (573)
                      ..|.-+|..+++ +++.+++|+|    ..++|.||.+.+++...-..-...-..+|..+.+|+.++++.+.+|+......
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            358888999976 6999999998    45889999988766432100011124689999999999999999999865455


Q ss_pred             eEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          392 IIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       392 iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +.-.|++++|+-+++++++|+.|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            899999999999999999999999876643

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.15  E-value=1.2e-05  Score=77.53  Aligned_cols=143  Identities=20%  Similarity=0.198  Sum_probs=84.3

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCC--Ceeeeeeeeec---CCceeEEEEecc
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK--NLVKLLGCSIT---GPESLLVYEFVP  348 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~---~~~~~lv~e~~~  348 (573)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+.+|..+++.+...  .+.+++.....   ....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4678999999999999887 68999987544  4456777888888887533  34566654432   234689999999


Q ss_pred             CCCccc----------------cc---ccc-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 008239          349 NQSLLD----------------NL---FVR-QDVEPLSWEV---------RYKI------------ILSTAE-GLAYLHE  386 (573)
Q Consensus       349 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-~l~yLH~  386 (573)
                      +..+..                .+   +.. .....+.+..         ....            ...+.. .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987776                01   000 0111111110         0000            111222 3333332


Q ss_pred             ----cCCCCeEEecCCCCCeeeC-CCCcEEEeeccccc
Q 008239          387 ----ESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVR  419 (573)
Q Consensus       387 ----~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~  419 (573)
                          .....++|+|+.|.|||++ +++.+-|+||+.+.
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence                1345699999999999999 66677899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.10  E-value=2e-05  Score=83.58  Aligned_cols=143  Identities=17%  Similarity=0.194  Sum_probs=88.5

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhh-------------------------------HHH------HHHHH
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQW-------------------------------VDH------FFNEV  316 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-------------------------------~~~------~~~E~  316 (573)
                      .+.||.-+.|.||+|++++|+.||||+-+..-++.                               .+.      |.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            46799999999999999999999999865432211                               111      12222


Q ss_pred             H----HHcCCCCCCe---eeeeeee-ecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 008239          317 N----LISGINHKNL---VKLLGCS-ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES  388 (573)
Q Consensus       317 ~----~l~~l~h~ni---v~l~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~  388 (573)
                      +    ..+.+.|-++   |.+=.++ .-....+|+||||+|..+.+.-.-..  ..++...+..-+.+...-+-+  ..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i~~~l~~~~~~qIf--~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDILNKLVEAYLEQIF--KTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHHHHHHHHHHHHHHH--hcC
Confidence            2    2222345551   1122222 23357899999999988877643222  224444433333332221222  223


Q ss_pred             CCCeEEecCCCCCeeeCC----CCcEEEeecccccccCC
Q 008239          389 KLRIIHRDIKLSNILLDE----EFTAKIADFGLVRLFPE  423 (573)
Q Consensus       389 ~~~iiHrDlk~~NIll~~----~~~~kl~Dfgla~~~~~  423 (573)
                         ++|.|=+|.||+++.    ++.+.+-|||+......
T Consensus       322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             ---CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence               999999999999983    67899999999886543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.08  E-value=2.3e-05  Score=87.93  Aligned_cols=198  Identities=21%  Similarity=0.171  Sum_probs=139.6

Q ss_pred             HHHHHHHHcCCCCCCeeeeeeeeecCCcee----EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc
Q 008239          312 FFNEVNLISGINHKNLVKLLGCSITGPESL----LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE  387 (573)
Q Consensus       312 ~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~  387 (573)
                      ..-|+..+.++.|+|++.++.|..+....-    +..|+++.-++...+   +....++....+.+..++.+||+|+|+.
T Consensus       229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~---q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLL---QSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHH---hhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            345777788899999999999887654433    445677777776666   3445678888999999999999999998


Q ss_pred             CCCCeEEecCCCC---CeeeCCCCcEEEe--ecccccccCCCCcccccccccCcCcCchhhhccCCCCc--ccchHhHHH
Q 008239          388 SKLRIIHRDIKLS---NILLDEEFTAKIA--DFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE--KADVYSFGV  460 (573)
Q Consensus       388 ~~~~iiHrDlk~~---NIll~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~--~sDvwslGv  460 (573)
                      .   +.|.-|..+   +...+.++.+.++  ||+....++.......  ..-+..|.+||.........  ..|+|.+|.
T Consensus       306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~--~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS--DLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             c---cceeEEecccccccccCccceeecchhhhcccccCCCcccchh--hcCccccccccccccccchhhhhhHHHHHHH
Confidence            5   666666666   6666777788888  9998886655443322  23355677888776655444  479999999


Q ss_pred             HHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          461 VVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       461 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ++..+..+..+.......                ..+++        .............|+..++++|+...+++.+..
T Consensus       381 l~~~~~~~~~i~~~~~~~----------------~~~l~--------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAVP----------------VSLLD--------VLSTSELLDALPKCLDEDSEERLSALELLTHPF  436 (1351)
T ss_pred             HHhhhhhcCcccccccch----------------hhhhc--------cccchhhhhhhhhhcchhhhhccchhhhhhchh
Confidence            999999887653221110                00001        111114567778899999999999999998773


Q ss_pred             c
Q 008239          541 G  541 (573)
Q Consensus       541 ~  541 (573)
                      .
T Consensus       437 ~  437 (1351)
T KOG1035|consen  437 L  437 (1351)
T ss_pred             c
Confidence            3

>PLN02876 acyl-CoA dehydrogenase

Probab=98.01  E-value=7.7e-05  Score=85.48  Aligned_cols=80  Identities=11%  Similarity=0.241  Sum_probs=58.3

Q ss_pred             cccccccCceeEEEEEcCCC---CEEEEEEecccC-hhhHHHHHHHHHHHcCCC-CCCe--eeeeeeeecC---CceeEE
Q 008239          274 SNKLGQGGSGSVYKGTLPGG---EAVAVKRLFYNT-TQWVDHFFNEVNLISGIN-HKNL--VKLLGCSITG---PESLLV  343 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~~lv  343 (573)
                      .+.|+.|.+..+|+....++   ..+++|+..... ......+.+|+++|+.+. |.++  .+++.++.+.   ...++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            67789999999999887654   467778764322 122356789999999995 6665  7778877654   357899


Q ss_pred             EEeccCCCcc
Q 008239          344 YEFVPNQSLL  353 (573)
Q Consensus       344 ~e~~~~gsL~  353 (573)
                      |||+++..+.
T Consensus       123 ME~v~G~~~~  132 (822)
T PLN02876        123 MEYLEGRIFV  132 (822)
T ss_pred             EEecCCcccC
Confidence            9999886543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.91  E-value=0.00015  Score=67.68  Aligned_cols=130  Identities=21%  Similarity=0.262  Sum_probs=88.4

Q ss_pred             cccccccccCceeEEEEEcCCCCEEEEEEecccC----------------hhhHHHHHHHHHHHcCCC------CCCeee
Q 008239          272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT----------------TQWVDHFFNEVNLISGIN------HKNLVK  329 (573)
Q Consensus       272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~  329 (573)
                      .....||+|+.-.||.  +++.....||+.....                ....++..+|+.-...+.      +.+|.+
T Consensus         4 ~~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r   81 (199)
T PF10707_consen    4 SESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPR   81 (199)
T ss_pred             CCCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCccccccc
Confidence            3467899999999996  5556667888886554                122345556665544444      889999


Q ss_pred             eeeeeecCCceeEEEEeccC--C----CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCee
Q 008239          330 LLGCSITGPESLLVYEFVPN--Q----SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL  403 (573)
Q Consensus       330 l~~~~~~~~~~~lv~e~~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIl  403 (573)
                      ++|+..++....+|+|.+.+  |    +|.+++    ....++. ...+.+   -+-..||-+.+   |+.+||+|.||+
T Consensus        82 ~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l----~~~~~~~-~~~~~L---~~f~~~l~~~~---Iv~~dl~~~NIv  150 (199)
T PF10707_consen   82 FYGFVETNLGLGLVVELIRDADGNISPTLEDYL----KEGGLTE-ELRQAL---DEFKRYLLDHH---IVIRDLNPHNIV  150 (199)
T ss_pred             EeEEEecCCceEEEEEEEECCCCCcCccHHHHH----HcCCccH-HHHHHH---HHHHHHHHHcC---CeecCCCcccEE
Confidence            99999999999999998743  3    445555    2223444 333333   34456776666   999999999999


Q ss_pred             eCCC--C--cEEEee
Q 008239          404 LDEE--F--TAKIAD  414 (573)
Q Consensus       404 l~~~--~--~~kl~D  414 (573)
                      +...  +  .+.|+|
T Consensus       151 ~~~~~~~~~~lvlID  165 (199)
T PF10707_consen  151 VQRRDSGEFRLVLID  165 (199)
T ss_pred             EEecCCCceEEEEEe
Confidence            9532  2  466665

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.87  E-value=0.00012  Score=70.83  Aligned_cols=75  Identities=15%  Similarity=0.288  Sum_probs=46.6

Q ss_pred             cccccccCce-eEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCC---CeeeeeeeeecC---CceeEEEEe
Q 008239          274 SNKLGQGGSG-SVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK---NLVKLLGCSITG---PESLLVYEF  346 (573)
Q Consensus       274 ~~~lg~G~~g-~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~lv~e~  346 (573)
                      ++.|+.|+.. .||+.    +..+++|.....  .....+.+|++++..+...   -+.+.++.....   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567877776 58875    345777865432  2245788899988777532   233444433322   234789999


Q ss_pred             ccCCCccc
Q 008239          347 VPNQSLLD  354 (573)
Q Consensus       347 ~~~gsL~~  354 (573)
                      +++.++.+
T Consensus        76 i~G~~l~~   83 (235)
T cd05155          76 LEGETATA   83 (235)
T ss_pred             ecCCCCCc
Confidence            99977754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=97.87  E-value=0.00014  Score=67.38  Aligned_cols=125  Identities=28%  Similarity=0.432  Sum_probs=90.1

Q ss_pred             cCccccccccccCc-eeEEEEEcCCCCEEEEEEecc---cC--------h----------hhHHHHHHHHHHHcCCC---
Q 008239          269 NYFHESNKLGQGGS-GSVYKGTLPGGEAVAVKRLFY---NT--------T----------QWVDHFFNEVNLISGIN---  323 (573)
Q Consensus       269 ~~~~~~~~lg~G~~-g~Vy~~~~~~g~~vavK~~~~---~~--------~----------~~~~~~~~E~~~l~~l~---  323 (573)
                      .+++.++.||.|.- |.|||+++. |+.+|+|.+..   ..        .          ....-|..|.+...+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            77889999999999 999999996 67999999321   00        0          12235788999888774   


Q ss_pred             CCCe--eeeeeeeecC------------------CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHH
Q 008239          324 HKNL--VKLLGCSITG------------------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY  383 (573)
Q Consensus       324 h~ni--v~l~~~~~~~------------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~y  383 (573)
                      +.++  |+.+||..-.                  ....||.||++...            .+.    .+-+.+|.+-|..
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~  179 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI  179 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence            5566  8999987422                  12357888776532            112    2335566677888


Q ss_pred             HHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       384 LH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      +|..+   |+-+|+++.|..     .-||+|||.+
T Consensus       180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence            99987   999999999986     5689999854

>PRK10593 hypothetical protein; Provisional

Probab=97.86  E-value=0.00039  Score=69.73  Aligned_cols=79  Identities=9%  Similarity=-0.032  Sum_probs=57.2

Q ss_pred             ccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCC---CCeeeeeeeeec---CCceeEEE
Q 008239          271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH---KNLVKLLGCSIT---GPESLLVY  344 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~~~lv~  344 (573)
                      ....+.||.|..+.||+....+++ +.+|..+..  .....+..|.+.|+.|.-   -.+.++++++..   .+..+|||
T Consensus        16 ~~~~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm   92 (297)
T PRK10593         16 LSRVECISEQPYAALWALYDSQGN-PMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL   92 (297)
T ss_pred             hheeeecCCccceeEEEEEcCCCC-EEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence            344678999999999999876664 666764321  123578889999888842   367788877654   35689999


Q ss_pred             EeccCCCc
Q 008239          345 EFVPNQSL  352 (573)
Q Consensus       345 e~~~~gsL  352 (573)
                      |++++.++
T Consensus        93 E~i~G~~~  100 (297)
T PRK10593         93 ERLRGVSV  100 (297)
T ss_pred             eccCCEec
Confidence            99998765

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.75  E-value=0.00026  Score=68.45  Aligned_cols=141  Identities=20%  Similarity=0.236  Sum_probs=82.0

Q ss_pred             cccccccCceeEEEEEcCC--CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCe-eeeeeeeecCCceeEEEEeccCC
Q 008239          274 SNKLGQGGSGSVYKGTLPG--GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~--g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      .+.|..|-...+|+....+  ++.|++|+....... .....+|+.++..+...++ .++++...    ..++|||+++.
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            4567788889999998764  678999976543222 1223468888888853333 44444332    24899999987


Q ss_pred             Ccccccc-----------------ccCCC--------CCC-CHHHHHHHHH----------------------HHHHHHH
Q 008239          351 SLLDNLF-----------------VRQDV--------EPL-SWEVRYKIIL----------------------STAEGLA  382 (573)
Q Consensus       351 sL~~~l~-----------------~~~~~--------~~l-~~~~~~~i~~----------------------~ia~~l~  382 (573)
                      ++.....                 .....        ... .+..+..+..                      .+..-+.
T Consensus        78 ~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  157 (235)
T cd05157          78 TLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEIS  157 (235)
T ss_pred             cCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHH
Confidence            7632200                 00000        011 1222212111                      1111112


Q ss_pred             HH----Hhc-CCCCeEEecCCCCCeeeCC-CCcEEEeeccccc
Q 008239          383 YL----HEE-SKLRIIHRDIKLSNILLDE-EFTAKIADFGLVR  419 (573)
Q Consensus       383 yL----H~~-~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~  419 (573)
                      .|    ... ....++|+|+.+.|||+++ +..+.|+||..+.
T Consensus       158 ~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         158 WLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             HHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            22    211 2346999999999999998 5789999998766

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.74  E-value=0.00022  Score=69.97  Aligned_cols=139  Identities=15%  Similarity=0.112  Sum_probs=79.2

Q ss_pred             cccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCe-eeeeeeeecCCceeEEEEeccCCCccc
Q 008239          276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFVPNQSLLD  354 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gsL~~  354 (573)
                      .+..|-...+|+... +++.+++|+.........-...+|.++++.+....+ .+++...    ..++|+||+++..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~----~~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN----EHWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe----CCEEEEEeccCccccc
Confidence            456688889999874 467888887654332221234678888888854333 3344332    2478999999876643


Q ss_pred             c-----------------ccccC-CCCCCCHHHH-HHHHHH---------HHHHHHHHHhc-----CCCCeEEecCCCCC
Q 008239          355 N-----------------LFVRQ-DVEPLSWEVR-YKIILS---------TAEGLAYLHEE-----SKLRIIHRDIKLSN  401 (573)
Q Consensus       355 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~~l~yLH~~-----~~~~iiHrDlk~~N  401 (573)
                      .                 ++... ...+++.... .....+         +...+..+...     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            2                 01100 0111222111 111111         11112222211     12358999999999


Q ss_pred             eeeCCCCcEEEeecccccc
Q 008239          402 ILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       402 Ill~~~~~~kl~Dfgla~~  420 (573)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999987763

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.69  E-value=0.00023  Score=63.71  Aligned_cols=129  Identities=17%  Similarity=0.192  Sum_probs=86.3

Q ss_pred             cccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeee-eeeeeecCCceeEEEEeccCC
Q 008239          272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK-LLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      ...+.|++|.+|.||++.+. |..+|+|+-..++.  ...+..|+++|..+.-.++.. ++.|.    ..++.|||+.+-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~--r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSP--RRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcc--hhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCc
Confidence            45678999999999999997 45788887654433  467888999999988766654 44332    234559999887


Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC-CCCeeeCCCCcEEEeecccccc
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK-LSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk-~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      .|.++-..      .+-.+    +..+++.---|...|   |-|+.|. |...+|..+..+.|+||.-|+.
T Consensus        98 ~L~~~~~~------~~rk~----l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIG------GDRKH----LLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhc------ccHHH----HHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            88765421      12222    334444433444444   8899887 4444444444999999998873

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.40  E-value=0.0022  Score=64.28  Aligned_cols=143  Identities=15%  Similarity=0.144  Sum_probs=85.6

Q ss_pred             ccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCC--Ceeeeeee------eecCCceeEEE
Q 008239          273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK--NLVKLLGC------SITGPESLLVY  344 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~  344 (573)
                      ..+.|..|....+|+....+ ..+++|+....   ..+.+..|++++..+.+.  .+.+++..      ....+..++|+
T Consensus        18 ~i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~   93 (296)
T cd05153          18 SFEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV   93 (296)
T ss_pred             heecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence            35678888888999987654 46888987542   234566778877777433  24444432      12334568999


Q ss_pred             EeccCCCcccc----c----------ccc--C-C-----CCCCCHHHHH----------HHHHHHHHHHHHHHh----cC
Q 008239          345 EFVPNQSLLDN----L----------FVR--Q-D-----VEPLSWEVRY----------KIILSTAEGLAYLHE----ES  388 (573)
Q Consensus       345 e~~~~gsL~~~----l----------~~~--~-~-----~~~l~~~~~~----------~i~~~ia~~l~yLH~----~~  388 (573)
                      +|+++..+...    +          +..  . .     .....|....          .....+...+.++.+    ..
T Consensus        94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~  173 (296)
T cd05153          94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL  173 (296)
T ss_pred             EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence            99998776430    0          000  0 0     0111222111          011123334555543    12


Q ss_pred             CCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       389 ~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      ...++|+|+.|.||+++++..+.|.||+.+.
T Consensus       174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         174 PRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            2359999999999999998778999998766

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.35  E-value=0.001  Score=66.95  Aligned_cols=141  Identities=23%  Similarity=0.298  Sum_probs=83.4

Q ss_pred             cccccccCceeEEEEEcCC-------CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCe-eeeeeeeecCCceeEEEE
Q 008239          274 SNKLGQGGSGSVYKGTLPG-------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYE  345 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~-------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e  345 (573)
                      .+.|..|-...+|+....+       ++.+++|+...... ......+|++++..+....+ .++++++.    ..+|+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e   77 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE-LLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEE   77 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc-ceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhh
Confidence            3456667778999988765       57899998754432 22345678888877753333 34555443    246899


Q ss_pred             eccCCCcccccc-----------------ccCCC--------CCCCHHHHHHH--------------------------H
Q 008239          346 FVPNQSLLDNLF-----------------VRQDV--------EPLSWEVRYKI--------------------------I  374 (573)
Q Consensus       346 ~~~~gsL~~~l~-----------------~~~~~--------~~l~~~~~~~i--------------------------~  374 (573)
                      |+++..+.....                 .....        .+.-|..+.++                          .
T Consensus        78 ~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (302)
T cd05156          78 FIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFL  157 (302)
T ss_pred             eeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHH
Confidence            998877643110                 10000        00011111111                          1


Q ss_pred             HHHHHHHHHHHh------cCCCCeEEecCCCCCeeeCCC----CcEEEeeccccc
Q 008239          375 LSTAEGLAYLHE------ESKLRIIHRDIKLSNILLDEE----FTAKIADFGLVR  419 (573)
Q Consensus       375 ~~ia~~l~yLH~------~~~~~iiHrDlk~~NIll~~~----~~~kl~Dfgla~  419 (573)
                      ..+..-+..|..      .....++|+|+.+.|||++++    +.+.++||..+.
T Consensus       158 ~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         158 EDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             HHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            122223334432      234579999999999999985    789999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.30  E-value=0.0043  Score=62.99  Aligned_cols=142  Identities=16%  Similarity=0.168  Sum_probs=76.5

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-----CCCeeeee-e--eeecCCceeEEEE
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----HKNLVKLL-G--CSITGPESLLVYE  345 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e  345 (573)
                      .+.|+.|....+|+....+| .+++|+......   +....|+.++..|.     .|.++.-. |  +....+..++++|
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            45677788789999887655 688898752222   23334455554442     33333211 1  1123456789999


Q ss_pred             eccCCCcccc----c----------cccC-C-------CCCCCH-HHHHH------------HHHH-HHHHHHHHHhc--
Q 008239          346 FVPNQSLLDN----L----------FVRQ-D-------VEPLSW-EVRYK------------IILS-TAEGLAYLHEE--  387 (573)
Q Consensus       346 ~~~~gsL~~~----l----------~~~~-~-------~~~l~~-~~~~~------------i~~~-ia~~l~yLH~~--  387 (573)
                      |+++..+...    .          +... .       ...+.| .....            .+.+ +...++.+.+.  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            9998754211    0          1000 0       001112 11111            1111 11122333211  


Q ss_pred             --CCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       388 --~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                        -..+++|+|+.+.||+++++...-|+||+.+.
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              23469999999999999977556899999876

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.24  E-value=0.0049  Score=63.88  Aligned_cols=76  Identities=16%  Similarity=0.141  Sum_probs=54.6

Q ss_pred             cccccccCceeEEEEEcCCC-CEEEEEEeccc-------ChhhHHHHHHHHHHHcCCC---CCCeeeeeeeeecCCceeE
Q 008239          274 SNKLGQGGSGSVYKGTLPGG-EAVAVKRLFYN-------TTQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g-~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~l  342 (573)
                      .+.||.|.+..||+....+| +.|+||.-...       ..-..+++..|.+.|..+.   ..++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46799999999999999877 58999974311       1223456777888887762   3456777766  4456789


Q ss_pred             EEEeccCCC
Q 008239          343 VYEFVPNQS  351 (573)
Q Consensus       343 v~e~~~~gs  351 (573)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.20  E-value=0.0047  Score=61.75  Aligned_cols=138  Identities=17%  Similarity=0.231  Sum_probs=83.0

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEec-ccChhhHHHHHHHHHHHcCCCC--CCeeeeeeeeecCC--ceeEEEEecc
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINH--KNLVKLLGCSITGP--ESLLVYEFVP  348 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~-~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~lv~e~~~  348 (573)
                      .+.+..|-.-.+|..... ++++++++-. ...........+|+++|+.+.-  --+...++.|.++.  ..+.||+|++
T Consensus        30 v~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~ve  108 (321)
T COG3173          30 VEEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVE  108 (321)
T ss_pred             eeeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEec
Confidence            344444444445555444 7778888221 1233445566778888877742  23345566676665  6699999998


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHH-HHHHHHHH---------------------------------------------
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKII-LSTAEGLA---------------------------------------------  382 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~~l~---------------------------------------------  382 (573)
                      +..+.+.+....    ..    ..++ ..+++.|+                                             
T Consensus       109 Ge~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~  180 (321)
T COG3173         109 GEVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA  180 (321)
T ss_pred             ceeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence            854443331100    00    1111 13333333                                             


Q ss_pred             -----HHHhc-----CCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          383 -----YLHEE-----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       383 -----yLH~~-----~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                           ||+.+     +.+.++|+|+.+.||+++++.-+-|.||+++..
T Consensus       181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                 34332     345699999999999999988899999999874

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.15  E-value=0.0084  Score=60.52  Aligned_cols=143  Identities=16%  Similarity=0.183  Sum_probs=81.5

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCC--Ceeeeeee------eecCCceeEEEE
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK--NLVKLLGC------SITGPESLLVYE  345 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~------~~~~~~~~lv~e  345 (573)
                      .+.++.|....+|+....+| .+++|+......  .+....|++++..|...  .+.+++..      ....+..++++|
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            55677787789999876555 577887654321  23445566666666322  23344331      122345689999


Q ss_pred             eccCCCcccc--------------ccccCC----C--C---CCCHHHHHH------------HHHHHHHHHHHHHh----
Q 008239          346 FVPNQSLLDN--------------LFVRQD----V--E---PLSWEVRYK------------IILSTAEGLAYLHE----  386 (573)
Q Consensus       346 ~~~~gsL~~~--------------l~~~~~----~--~---~l~~~~~~~------------i~~~ia~~l~yLH~----  386 (573)
                      |++|..+...              ++....    .  .   .-.|.....            ....+.+.++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            9988654311              111000    0  0   011211110            01123344555543    


Q ss_pred             cCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       387 ~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .....++|+|+.+.||++++++.+.|.||+.+.
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            123469999999999999988777899999765

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PLN02236 choline kinase

Probab=97.01  E-value=0.0048  Score=63.25  Aligned_cols=142  Identities=19%  Similarity=0.292  Sum_probs=83.6

Q ss_pred             cccccccCceeEEEEEcCC-----CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCee-eeeeeeecCCceeEEEEec
Q 008239          274 SNKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~  347 (573)
                      .+.|-.|-.-.+|+....+     ++.|++|+.........++ .+|..+++.+..-++. ++++.+..+    .|+||+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeech-HHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            4456567888999987543     3678999876554333333 6788888888544443 455555322    589999


Q ss_pred             cCCCcccc-----------------ccccC---CCCCCCHHHHHHHHHHH-----------------HHHHHHH----Hh
Q 008239          348 PNQSLLDN-----------------LFVRQ---DVEPLSWEVRYKIILST-----------------AEGLAYL----HE  386 (573)
Q Consensus       348 ~~gsL~~~-----------------l~~~~---~~~~l~~~~~~~i~~~i-----------------a~~l~yL----H~  386 (573)
                      ++.+|...                 +|...   ......+..+.++..++                 ...+..|    ..
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87666421                 11100   00111233333332211                 1112222    21


Q ss_pred             -cCCCCeEEecCCCCCeeeCC-CCcEEEeecccccc
Q 008239          387 -ESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRL  420 (573)
Q Consensus       387 -~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~  420 (573)
                       .....++|+|+++.|||+++ ++.+.++||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             22346999999999999986 46899999988763

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.97  E-value=0.0073  Score=59.82  Aligned_cols=31  Identities=23%  Similarity=0.483  Sum_probs=25.9

Q ss_pred             CCeEEecCCCCCeeeCCCCc-EEEeecccccc
Q 008239          390 LRIIHRDIKLSNILLDEEFT-AKIADFGLVRL  420 (573)
Q Consensus       390 ~~iiHrDlk~~NIll~~~~~-~kl~Dfgla~~  420 (573)
                      +.++|+|+++.|||+++++. .-|.||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            45999999999999997555 56999998763

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.95  E-value=0.0076  Score=59.83  Aligned_cols=75  Identities=17%  Similarity=0.190  Sum_probs=47.8

Q ss_pred             cccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCC---CCCCeeeeeeeeecCCceeEEEEecc
Q 008239          272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      +..+.|+.|....+|+.. .+++.+.||.-..   .....|..|.+-|+.|   .--.+.+.+++....+..+||+||++
T Consensus        20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~   95 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE   95 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred             eeeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence            346778989999999988 5678899998752   2234677787777776   34567788888877777899999998


Q ss_pred             CC
Q 008239          349 NQ  350 (573)
Q Consensus       349 ~g  350 (573)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            76

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.75  E-value=0.0033  Score=61.81  Aligned_cols=145  Identities=18%  Similarity=0.228  Sum_probs=95.5

Q ss_pred             cChHHHHHHhc---CccccccccccCceeEEEEEcCCCCEEEEEEecccC------------------hhhH----HHHH
Q 008239          259 FSYETLEKATN---YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT------------------TQWV----DHFF  313 (573)
Q Consensus       259 ~~~~~~~~~~~---~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~------------------~~~~----~~~~  313 (573)
                      +++-.+.....   -+.+++.||-|.-+.||.+...+|++.++|......                  ..|.    -...
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~  158 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAAT  158 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHH
Confidence            44444444433   356789999999999999999999999999542210                  1111    1234


Q ss_pred             HHHHHHcCCC-CC-CeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 008239          314 NEVNLISGIN-HK-NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR  391 (573)
Q Consensus       314 ~E~~~l~~l~-h~-niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  391 (573)
                      +|+..|+.|. |. -+.+.+    +....++|||++.+-.|...-+.      .+...+.   ..+..-+.-|..+|   
T Consensus       159 kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly---~~lm~~Iv~la~~G---  222 (465)
T KOG2268|consen  159 KEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLY---DDLMGLIVRLANHG---  222 (465)
T ss_pred             HHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHH---HHHHHHHHHHHHcC---
Confidence            6777777774 32 233333    34567899999988777554311      2222332   23333345566666   


Q ss_pred             eEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          392 IIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       392 iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      +||+|..-=||+++++..++++||--..
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQmv  250 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQMV  250 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechHhh
Confidence            9999999999999999999999997543

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.42  E-value=0.00055  Score=79.00  Aligned_cols=161  Identities=9%  Similarity=-0.022  Sum_probs=113.5

Q ss_pred             HHHHHHHHHHcCCCCCCeeeeeeeeec--CCceeEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHh
Q 008239          310 DHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHE  386 (573)
Q Consensus       310 ~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~  386 (573)
                      +....|...++...|+++.....-...  ..+.+.+++|+..|.+.+.+.... +..+++..-....-.+......-.|+
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            344556666777899998877654432  345688999999999999886533 33344443333333332444444443


Q ss_pred             cC--CCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHH
Q 008239          387 ES--KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE  464 (573)
Q Consensus       387 ~~--~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~e  464 (573)
                      ..  ..-.+|++||+-|.+|..+..+|++++|+.+..... ........+++-|+.|+....-.++.++|+|..|+.+++
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~-~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~ 1432 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV-LSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYL 1432 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCch-HhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHH
Confidence            32  234789999999999999999999999999843322 223335567888999999888889999999999999999


Q ss_pred             HHcCCCC
Q 008239          465 VVCRKRI  471 (573)
Q Consensus       465 lltg~~p  471 (573)
                      .--|..+
T Consensus      1433 rs~~n~~ 1439 (2724)
T KOG1826|consen 1433 RSDGNAY 1439 (2724)
T ss_pred             HhcccHH
Confidence            8766654

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.40  E-value=0.011  Score=59.20  Aligned_cols=140  Identities=16%  Similarity=0.153  Sum_probs=92.8

Q ss_pred             ccccccccCceeEEEEEcCCCCEEEEEEecccC-------------------------hhh-HHHHHHHHHHHcCCCCCC
Q 008239          273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT-------------------------TQW-VDHFFNEVNLISGINHKN  326 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-------------------------~~~-~~~~~~E~~~l~~l~h~n  326 (573)
                      +...|..|.-..||.+.-.+|..+|||+++-+.                         ... .-....|++-|.+|....
T Consensus       148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG  227 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG  227 (520)
T ss_pred             cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence            345688999999999999999999999874220                         000 112234666666654333


Q ss_pred             eeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC
Q 008239          327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE  406 (573)
Q Consensus       327 iv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~  406 (573)
                      |.----...  ...+|||+|+....   |-.-..+...++...+..+-.+++.-|.-|.+.+  ++||.||.--|+|+-+
T Consensus       228 IP~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd  300 (520)
T KOG2270|consen  228 IPCPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD  300 (520)
T ss_pred             CCCCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC
Confidence            221000000  13469999995322   2222223345777788888899999999998876  5999999999998865


Q ss_pred             CCcEEEeecccccc
Q 008239          407 EFTAKIADFGLVRL  420 (573)
Q Consensus       407 ~~~~kl~Dfgla~~  420 (573)
                      + .+.|+|-+-+..
T Consensus       301 G-~lyiIDVSQSVE  313 (520)
T KOG2270|consen  301 G-KLYIIDVSQSVE  313 (520)
T ss_pred             C-EEEEEEcccccc
Confidence            4 899999887653

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.25  E-value=0.044  Score=55.33  Aligned_cols=31  Identities=23%  Similarity=0.375  Sum_probs=27.8

Q ss_pred             CCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       389 ~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      ...++|+|+.+.|||+++++.+.|+||..+.
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            3469999999999999999999999998776

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.23  E-value=0.0022  Score=66.62  Aligned_cols=48  Identities=23%  Similarity=0.280  Sum_probs=37.1

Q ss_pred             HHHHHHHHHHcCCCCCCeeeeeeeeecC-CceeEEEEeccCCCccccccc
Q 008239          310 DHFFNEVNLISGINHKNLVKLLGCSITG-PESLLVYEFVPNQSLLDNLFV  358 (573)
Q Consensus       310 ~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~  358 (573)
                      .++.-...+++.+.|+|+..++++-... ....+|+|++ +.||.+.+..
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence            4556678889999999999999877644 3467889988 6688877743

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.01  E-value=0.097  Score=54.26  Aligned_cols=73  Identities=10%  Similarity=0.128  Sum_probs=50.2

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEeccc----Ch---hhHHHHHHHHHHHcCCC---CCCeeeeeeeeecCCceeEE
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN----TT---QWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~----~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv  343 (573)
                      .+.||.|....||+.... ++.++||+-...    ..   -..++...|.+.|+.+.   ..++.+++.++.  +..+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv  113 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG  113 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence            667899999999998875 556999976411    11   12334445666666553   357778888776  456889


Q ss_pred             EEeccC
Q 008239          344 YEFVPN  349 (573)
Q Consensus       344 ~e~~~~  349 (573)
                      ||++++
T Consensus       114 ME~L~~  119 (418)
T PLN02756        114 MRYLEP  119 (418)
T ss_pred             EeecCC
Confidence            999976

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.00  E-value=0.041  Score=55.97  Aligned_cols=73  Identities=15%  Similarity=0.119  Sum_probs=48.2

Q ss_pred             cccccCceeEEEEEcCCC-CEEEEEEecc-------cChhhHHHHHHHHHHHcCCC--CC-CeeeeeeeeecCCceeEEE
Q 008239          276 KLGQGGSGSVYKGTLPGG-EAVAVKRLFY-------NTTQWVDHFFNEVNLISGIN--HK-NLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~~~g-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv~  344 (573)
                      .||.|....||++..++| +.|+||.-..       +.+-..++..-|.+.|+...  -| .+.+++.  .+.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence            579999999999998765 6899996421       11223445566777776652  34 3444443  3556667999


Q ss_pred             EeccCC
Q 008239          345 EFVPNQ  350 (573)
Q Consensus       345 e~~~~g  350 (573)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=95.86  E-value=0.055  Score=55.14  Aligned_cols=142  Identities=18%  Similarity=0.239  Sum_probs=80.4

Q ss_pred             cccccccCceeEEEEEcCC----CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCee-eeeeeeecCCceeEEEEecc
Q 008239          274 SNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~lv~e~~~  348 (573)
                      .+.|..|-...+|+....+    +..|++|+......... .-.+|..+++.+..-++- ++++++..  .  +|.+|++
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~--G--~i~~fi~   93 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVI-DRERELQAIKYLSAAGFGAKLLGVFGN--G--MIQSFIN   93 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEe-chHHHHHHHHHHHhcCCCCceeEEeCC--c--Eeehhhc
Confidence            3455557778899887543    23788998765443222 235788888888655553 45555422  1  5899997


Q ss_pred             CCCcccc-------c----------cccC---CCCCCCHHHHHHHHHHH----------------------HHHHH----
Q 008239          349 NQSLLDN-------L----------FVRQ---DVEPLSWEVRYKIILST----------------------AEGLA----  382 (573)
Q Consensus       349 ~gsL~~~-------l----------~~~~---~~~~l~~~~~~~i~~~i----------------------a~~l~----  382 (573)
                      +..|...       +          |...   ...+..|..+.++..++                      ..-+.    
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            7655321       0          1100   00111233332222221                      11111    


Q ss_pred             HHHh-cCCCCeEEecCCCCCeeeCC-CCcEEEeecccccc
Q 008239          383 YLHE-ESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRL  420 (573)
Q Consensus       383 yLH~-~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~  420 (573)
                      ++.. .....++|.||.+.|||+++ ++.++++||..+..
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1111 11235899999999999974 57899999998763

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.81  E-value=0.11  Score=52.57  Aligned_cols=141  Identities=20%  Similarity=0.295  Sum_probs=82.5

Q ss_pred             ccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCC------eeeeee----eeecCCceeEEE
Q 008239          275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN------LVKLLG----CSITGPESLLVY  344 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~----~~~~~~~~~lv~  344 (573)
                      ..|.+ .-..+|+....+|+. ++|+....  ....++..|+.+|..|.-.+      +..+-|    ....+...+.++
T Consensus        32 ~~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf  107 (331)
T COG2334          32 RGLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALF  107 (331)
T ss_pred             ccccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEE
Confidence            34444 556789988887776 88887655  33456667777777773111      222222    111224678899


Q ss_pred             EeccCCCccc-ccc--------------c--cC----C---CCCCCHHH-------------HHHHHHHHHHHHHHHHhc
Q 008239          345 EFVPNQSLLD-NLF--------------V--RQ----D---VEPLSWEV-------------RYKIILSTAEGLAYLHEE  387 (573)
Q Consensus       345 e~~~~gsL~~-~l~--------------~--~~----~---~~~l~~~~-------------~~~i~~~ia~~l~yLH~~  387 (573)
                      +|++|..+.. .-.              .  +.    +   .....|..             ......++...+..+.+.
T Consensus       108 ~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~  187 (331)
T COG2334         108 EYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLAR  187 (331)
T ss_pred             EecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhh
Confidence            9999988873 110              0  00    0   11233320             011233344444444443


Q ss_pred             ----CC---CCeEEecCCCCCeeeCCCCc-EEEeeccccc
Q 008239          388 ----SK---LRIIHRDIKLSNILLDEEFT-AKIADFGLVR  419 (573)
Q Consensus       388 ----~~---~~iiHrDlk~~NIll~~~~~-~kl~Dfgla~  419 (573)
                          -.   ..+||+|+.|.||+++++.. +.+.||+-+.
T Consensus       188 ~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         188 LPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             chhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                11   22899999999999998875 8999999766

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.64  E-value=0.22  Score=47.03  Aligned_cols=76  Identities=18%  Similarity=0.251  Sum_probs=51.7

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCC---CCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI---NHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      .+.+.-|.--..|.... +..++-||+-.   .+....|..|+.-|..|   +.-++.+++.+..+....++|+||++-+
T Consensus        21 r~~v~gG~inea~~v~d-g~~~~FvK~n~---~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~   96 (286)
T COG3001          21 REEVSGGDINEAWRLRD-GTDPFFVKCNQ---REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTG   96 (286)
T ss_pred             ccccCCccccceeEeec-CCcceEEEecc---hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCC
Confidence            44555555555555443 35678888642   33345666776655555   4567888898888999999999999987


Q ss_pred             Ccc
Q 008239          351 SLL  353 (573)
Q Consensus       351 sL~  353 (573)
                      .+.
T Consensus        97 ~~d   99 (286)
T COG3001          97 PLD   99 (286)
T ss_pred             CCC
Confidence            776

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=95.64  E-value=0.021  Score=54.05  Aligned_cols=29  Identities=28%  Similarity=0.476  Sum_probs=21.0

Q ss_pred             CeEEecCCCCCeee-CCCCcEEEeeccccc
Q 008239          391 RIIHRDIKLSNILL-DEEFTAKIADFGLVR  419 (573)
Q Consensus       391 ~iiHrDlk~~NIll-~~~~~~kl~Dfgla~  419 (573)
                      .+.|+||.+.|||+ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            58999999999999 888999999998876

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.21  E-value=0.046  Score=56.29  Aligned_cols=74  Identities=14%  Similarity=0.041  Sum_probs=49.0

Q ss_pred             cccccccCceeEEEEEcCC-CCEEEEEEecc------cChhhHHHHHHHHHHHcCCC--CC-CeeeeeeeeecCCceeEE
Q 008239          274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFY------NTTQWVDHFFNEVNLISGIN--HK-NLVKLLGCSITGPESLLV  343 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~lv  343 (573)
                      .+.||-|.-.-||++...+ ++.|+||.-..      +.+-..++..-|.+.|+.+.  -| .+.+++.  .+.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence            5678999999999999853 56899996421      11233556667778777663  34 3445554  345566778


Q ss_pred             EEeccC
Q 008239          344 YEFVPN  349 (573)
Q Consensus       344 ~e~~~~  349 (573)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            888754

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.21  E-value=0.077  Score=49.63  Aligned_cols=153  Identities=18%  Similarity=0.189  Sum_probs=90.0

Q ss_pred             cCceeEEEEEcCCCCEEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCCCccccccc
Q 008239          280 GGSGSVYKGTLPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV  358 (573)
Q Consensus       280 G~~g~Vy~~~~~~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~  358 (573)
                      ++-.+.-+++.+-| +..+|++....-. ...-|.++.+++.++.  .|+++..-  .....-++.|+|-....      
T Consensus        73 ~gNsTl~~~kt~iG-~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i------  141 (308)
T PF07387_consen   73 NGNSTLLIGKTKIG-PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI------  141 (308)
T ss_pred             CCceEEEEeccccc-hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc------
Confidence            34445555544333 3456666443333 2345677888888775  46666632  33445688888733111      


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccCcCc
Q 008239          359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY  438 (573)
Q Consensus       359 ~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y  438 (573)
                            .   ..-.|..+ +..|.-.|+.. ...+|+|-.|+||+-|..|.+||.|=+..-.  .           +..|
T Consensus       142 ------~---~~N~i~ag-i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--~-----------~V~~  197 (308)
T PF07387_consen  142 ------N---FSNFITAG-IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--N-----------QVNM  197 (308)
T ss_pred             ------c---hhHHHHHh-HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhhhhh--h-----------eeeE
Confidence                  0   01112222 46677888654 4699999999999999999999999764221  0           1122


Q ss_pred             CchhhhccCCCCcccchHhHHHHHHHHHcCCC
Q 008239          439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR  470 (573)
Q Consensus       439 ~aPE~~~~~~~~~~sDvwslGvil~elltg~~  470 (573)
                      .--|   ....+.++.+=+|=.-++++....+
T Consensus       198 vN~~---Y~~lT~~aE~~~fv~s~l~~v~~~~  226 (308)
T PF07387_consen  198 VNIE---YESLTQEAEVKVFVKSCLKLVEKQR  226 (308)
T ss_pred             Eeee---ccccChHHHHHHHHHHHHHHHHHHh
Confidence            2211   2334667788788777787765443

The function of this family is unknown.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.07  E-value=0.68  Score=47.08  Aligned_cols=95  Identities=11%  Similarity=-0.014  Sum_probs=53.6

Q ss_pred             cccChHHHHHHhcCcccc---c-cccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCC--Ceeee
Q 008239          257 LNFSYETLEKATNYFHES---N-KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK--NLVKL  330 (573)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~---~-~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l  330 (573)
                      ..++.+.+..+...+...   + ..=.+.-..||+....+|..+++|+.... .....++..|++.+..|...  .++..
T Consensus         9 ~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~-~~~~~~i~~E~~~l~~L~~~gipv~~p   87 (325)
T PRK11768          9 QTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPE-RWSDAQILEEHAFALELAEAEIPVVAP   87 (325)
T ss_pred             CCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCcc-cCCHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            345566666655554321   1 11123456799998888888999987432 12345566677777666311  12221


Q ss_pred             e---e--eeecCCceeEEEEeccCCCc
Q 008239          331 L---G--CSITGPESLLVYEFVPNQSL  352 (573)
Q Consensus       331 ~---~--~~~~~~~~~lv~e~~~~gsL  352 (573)
                      .   |  ....++..+.++++++|...
T Consensus        88 ~~~~G~~~~~~~g~~~~l~~~~~G~~~  114 (325)
T PRK11768         88 LAFNGQTLHEHQGFRFALFPRRGGRAP  114 (325)
T ss_pred             ccCCCCEEEEECCEEEEEEeeeCCCCC
Confidence            1   2  12224556789999987654

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.07  E-value=0.33  Score=48.91  Aligned_cols=29  Identities=28%  Similarity=0.407  Sum_probs=25.2

Q ss_pred             CCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          390 LRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       390 ~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      ..++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            46999999999999988 578999998654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.06  E-value=0.1  Score=53.22  Aligned_cols=61  Identities=16%  Similarity=0.171  Sum_probs=39.9

Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD  405 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~  405 (573)
                      ..+|+-+|+++-++..++..    ...++....+++.--+.++--|---.  .++|.|+.|.||++.
T Consensus       319 ~~vl~E~~~~Gl~v~~~v~~----~~~pe~l~kkva~lg~~AllkMl~vD--NFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  319 DLVLVETYERGLSVLRFVKW----KSQPEALVKKVAKLGVNALLKMLIVD--NFVHADLHPGNVLIR  379 (565)
T ss_pred             cceeeeeccccccHHhhhhc----ccChHHHHHHHHHHHHHHHHHHHHhh--cceecccCCCcEEEE
Confidence            34566678888888777732    22444556666665556654443222  299999999999994

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=94.87  E-value=0.096  Score=52.68  Aligned_cols=54  Identities=31%  Similarity=0.354  Sum_probs=47.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       365 l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      ..|++...++.+.+.-++-+..+-  +.-||||.-.||||+ +|+|-|+||-+++..
T Consensus       318 ~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEeeeeecc
Confidence            568899999999888888887754  699999999999999 999999999999943

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	573
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		5e-56
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		6e-56
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-42
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		9e-42
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-40
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-40
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-40
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-38
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-23
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-23
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-23
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-23
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-23
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-23
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-23
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-23
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-23
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-23
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-23
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-23
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-23
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-22
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-22
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		5e-22
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		6e-22
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-22
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		8e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-20
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-20
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-20
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-20
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		5e-20
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-20
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-20
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-20
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		6e-20
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		6e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-20
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-20
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		7e-20
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		7e-20
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		7e-20
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-20
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-20
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		9e-20
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-19
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-19
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		1e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-19
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-19
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-19
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-19
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-19
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		2e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		2e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		2e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-19
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-19
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		3e-19
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-19
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-19
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-19
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		5e-19
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-19
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-19
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		7e-19
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-19
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		8e-19
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		2e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-18
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-18
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-18
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-18
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		4e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-18
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-18
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		5e-18
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		5e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		5e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		5e-18
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		5e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-18
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		6e-18
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		6e-18
4fie_A	423	Full-Length Human Pak4 Length = 423		6e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		7e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-18
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		7e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-18
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		7e-18
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		7e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		8e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		8e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		8e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		9e-18
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		9e-18
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-18
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-17
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-17
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		3e-17
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		3e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-17
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-17
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-17
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		6e-17
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		7e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		8e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		9e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-17
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-16
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-16
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		1e-16
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-16
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-16
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-16
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-16
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-16
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-16
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-16
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-16
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-16
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-16
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-16
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-16
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-16
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-16
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-16
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-16
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-16
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-16
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-16
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-16
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-16
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-16
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-16
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-16
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-16
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-16
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-16
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-16
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-16
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-16
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-16
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-16
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		7e-16
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		7e-16
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		8e-16
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		1e-15
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-15
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-15
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-15
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-15
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-15
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-15
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		7e-15
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		8e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-15
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		9e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-14
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-14
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		1e-14
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-14
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-14
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-14
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		3e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-14
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		3e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-14
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-14
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-14
3g51_A	325	Structural Diversity Of The Active Conformation Of		4e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		4e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-14
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-14
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-14
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-14
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		4e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-14
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-14
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		5e-14
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		5e-14
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		5e-14
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-14
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		6e-14
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		7e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-14
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-14
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		8e-14
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-14
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		8e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-14
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		9e-14
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		9e-14
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-14
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-14
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-13
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-13
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-13
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		1e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-13
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-13
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-13
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-13
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-13
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-13
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-13
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-13
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		2e-13
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-13
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		2e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-13
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-13
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-13
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		2e-13
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		3e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		3e-13
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-13
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-13
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		4e-13
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-13
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-13
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-13
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		4e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		4e-13
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-13
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-13
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		5e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		6e-13
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		6e-13
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-13
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		6e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-13
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-13
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		9e-13
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-13
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-13
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-13
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-12
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-12
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-12
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-12
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-12
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-12
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-12
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-12
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-12
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-12
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-12
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-12
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-12
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-12
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-12
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-12
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-12
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-12
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		3e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-12
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-12
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-12
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		3e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-12
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-12
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		3e-12
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-12
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-12
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-12
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-12
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-12
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-12
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-12
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-12
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-12
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-12
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-12
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-12
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		4e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-12
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		5e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-12
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		5e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		6e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		8e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		8e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		8e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-12
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-12
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		1e-11
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		1e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		1e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-11
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-11
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-11
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-11
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-11
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-11
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-11
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-11
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-11
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-11
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-11
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-11
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-11
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		3e-11
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-11
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-11
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-11
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		5e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		5e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		5e-11
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		5e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		5e-11
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-11
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		6e-11
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		6e-11
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		6e-11
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-11
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-11
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-11
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		7e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-11
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		8e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		8e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		9e-11
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		9e-11
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-11
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		9e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		9e-11
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-11
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-10
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-10
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-10
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		1e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-10
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-10
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		2e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-10
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-10
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		2e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-10
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-10
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		4e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-10
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		4e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		4e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		4e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		4e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-10
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		5e-10
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		5e-10
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-10
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		6e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		6e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		6e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		6e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		6e-10
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		6e-10
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		7e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		7e-10
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		7e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-10
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		7e-10
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		8e-10
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-10
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		8e-10
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-10
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-10
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		9e-10
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		9e-10
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		9e-10
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-10
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		9e-10
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		9e-10
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		9e-10
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		1e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-09
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-09
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-09
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		1e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		1e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-09
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-09
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-09
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-09
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-09
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-09
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-09
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-09
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-09
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		2e-09
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-09
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-09
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-09
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-09
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-09
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		3e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		3e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		3e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-09
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-09
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		4e-09
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		4e-09
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		4e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-09
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		5e-09
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		5e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-09
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		5e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		6e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		6e-09
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		8e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		8e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		8e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		8e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		8e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		9e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		9e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		9e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		9e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-08
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-08
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-08
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		2e-08
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-08
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		2e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-08
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-08
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-08
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		3e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-08
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-08
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		4e-08
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-08
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		5e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		6e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		6e-08
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		6e-08
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-08
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-08
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		7e-08
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-08
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-08
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		8e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-08
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		8e-08
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		8e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		8e-08
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		8e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-08
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		9e-08
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		9e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		9e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-08
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		9e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		9e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		9e-08
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		9e-08
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-08
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		9e-08
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		9e-08
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-08
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		9e-08
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		9e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-08
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		9e-08
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		9e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		9e-08
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		9e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-07
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-07
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-07
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-07
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-07
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-07
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-07
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-07
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		1e-07
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		1e-07
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-07
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		1e-07
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-07
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-07
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-07
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-07
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-07
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-07
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-07
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-07
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-07
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-07
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-07
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-07
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-07
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-07
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-07
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-07
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-07
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-07
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-07
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-07
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-07
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-07
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-07
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-07
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-07
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-07
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		2e-07
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-07
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-07
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-07
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-07
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-07
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-07
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-07
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-07
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-07
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-07
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-07
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-07
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-07
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-07
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-07
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-07
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-07
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-07
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		2e-07
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-07
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-07
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-07
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		2e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-07
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		3e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		3e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-07
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-07
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		4e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-07
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		5e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-07
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-07
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		7e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		7e-07
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		7e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		7e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		8e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		8e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		8e-07
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		9e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		9e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		9e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-06
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-06
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-06
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		1e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-06
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-06
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-06
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-06
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-06
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-06
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-06
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		2e-06
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		2e-06
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-06
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-06
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-06
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		5e-06
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		5e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		6e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-06
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		8e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-06
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-05
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-05
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-05
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-05
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-05
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-05
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-05
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-05
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-05
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-05
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-05
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-05
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-05
3soa_A	444	Full-Length Human Camkii Length = 444		3e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		3e-05
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-05
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		4e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		4e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		5e-05
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		5e-05
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-05
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		5e-05
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		6e-05
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		6e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-05
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		6e-05
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-05
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		7e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		7e-05
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		7e-05
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-05
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-05
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-05
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		9e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-04
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-04
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-04
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-04
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		1e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-04
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-04
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-04
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-04
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-04
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-04
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-04
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		3e-04
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-04
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		6e-04
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		6e-04
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-04
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		6e-04
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-04
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-04
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-04
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  215 bits (548), Expect = 5e-56,   Method: Compositional matrix adjust.
 Identities = 121/291 (41%), Positives = 173/291 (59%), Gaps = 6/291 (2%)
Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD-HFFNEV 316
            FS   L+ A++ F   N LG+GG G VYKG L  G  VAVKRL    TQ  +  F  EV
Sbjct: 19  RFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEV 78
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIIL 375
            +IS   H+NL++L G  +T  E LLVY ++ N S+   L  R + +P L W  R +I L
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
            +A GLAYLH+    +IIHRD+K +NILLDEEF A + DFGL +L      H+   + G 
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGX 198
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR----INLFTQNSCSILQTVWDLYVK 491
           +G++APEY+  GK +EK DV+ +GV+++E++  +R      L   +   +L  V  L  +
Sbjct: 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 258
Query: 492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN 542
            +L   VD  L GN+++ +  +L+Q+ LLC Q+S   RP MS VV+ML G+
Sbjct: 259 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  215 bits (547), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 121/291 (41%), Positives = 173/291 (59%), Gaps = 6/291 (2%)
Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD-HFFNEV 316
            FS   L+ A++ F   N LG+GG G VYKG L  G  VAVKRL     Q  +  F  EV
Sbjct: 27  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEV 86
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIIL 375
            +IS   H+NL++L G  +T  E LLVY ++ N S+   L  R + +P L W  R +I L
Sbjct: 87  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 146
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
            +A GLAYLH+    +IIHRD+K +NILLDEEF A + DFGL +L      H+   + GT
Sbjct: 147 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGT 206
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR----INLFTQNSCSILQTVWDLYVK 491
           +G++APEY+  GK +EK DV+ +GV+++E++  +R      L   +   +L  V  L  +
Sbjct: 207 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKE 266
Query: 492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN 542
            +L   VD  L GN+++ +  +L+Q+ LLC Q+S   RP MS VV+ML G+
Sbjct: 267 KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 317

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  171 bits (433), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 106/277 (38%), Positives = 157/277 (56%), Gaps = 7/277 (2%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN 323
           LE+ATN F     +G G  G VYKG L  G  VA+KR    ++Q ++ F  E+  +S   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLA 382
           H +LV L+G      E +L+Y+++ N +L  +L+        +SWE R +I +  A GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAP 441
           YLH  +   IIHRD+K  NILLDE F  KI DFG+ +   E D TH+   + GTLGY+ P
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKR--INLFTQNSCSILQTVWDLYVKGRLHEAVD 499
           EY ++G+LTEK+DVYSFGVV+ EV+C +   +    +   ++ +   + +  G+L + VD
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVV 536
           P LA   +     +     + C+  S+E RPSM  V+
Sbjct: 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  168 bits (425), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 105/277 (37%), Positives = 156/277 (56%), Gaps = 7/277 (2%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN 323
           LE+ATN F     +G G  G VYKG L  G  VA+KR    ++Q ++ F  E+  +S   
Sbjct: 34  LEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCR 93
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLA 382
           H +LV L+G      E +L+Y+++ N +L  +L+        +SWE R +I +  A GL 
Sbjct: 94  HPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLH 153
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAP 441
           YLH  +   IIHRD+K  NILLDE F  KI DFG+ +   E   TH+   + GTLGY+ P
Sbjct: 154 YLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDP 210
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKR--INLFTQNSCSILQTVWDLYVKGRLHEAVD 499
           EY ++G+LTEK+DVYSFGVV+ EV+C +   +    +   ++ +   + +  G+L + VD
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVV 536
           P LA   +     +     + C+  S+E RPSM  V+
Sbjct: 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  164 bits (414), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 98/222 (44%), Positives = 134/222 (60%), Gaps = 20/222 (9%)
Query: 258 NFSYETLEKATNYFHE------SNKLGQGGSGSVYKGTLPGGEAVAVKRLF----YNTTQ 307
           +FS+  L+  TN F E       NK+G+GG G VYKG +     VAVK+L       T +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
               F  E+ +++   H+NLV+LLG S  G +  LVY ++PN SLLD L       PLSW
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL---FPED 424
            +R KI    A G+ +LHE      IHRDIK +NILLDE FTAKI+DFGL R    F + 
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +  + + + GT  YMAPE  +RG++T K+D+YSFGVV++E++
Sbjct: 190 V--MXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEII 228

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  163 bits (412), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 98/222 (44%), Positives = 133/222 (59%), Gaps = 20/222 (9%)
Query: 258 NFSYETLEKATNYFHE------SNKLGQGGSGSVYKGTLPGGEAVAVKRLF----YNTTQ 307
           +FS+  L+  TN F E       NK+G+GG G VYKG +     VAVK+L       T +
Sbjct: 8   SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 66
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
               F  E+ +++   H+NLV+LLG S  G +  LVY ++PN SLLD L       PLSW
Sbjct: 67  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 126
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL---FPED 424
            +R KI    A G+ +LHE      IHRDIK +NILLDE FTAKI+DFGL R    F + 
Sbjct: 127 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 183
Query: 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +  +   + GT  YMAPE  +RG++T K+D+YSFGVV++E++
Sbjct: 184 V--MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEII 222

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  163 bits (412), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 98/222 (44%), Positives = 133/222 (59%), Gaps = 20/222 (9%)
Query: 258 NFSYETLEKATNYFHE------SNKLGQGGSGSVYKGTLPGGEAVAVKRLF----YNTTQ 307
           +FS+  L+  TN F E       NK+G+GG G VYKG +     VAVK+L       T +
Sbjct: 14  SFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 72
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
               F  E+ +++   H+NLV+LLG S  G +  LVY ++PN SLLD L       PLSW
Sbjct: 73  LKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW 132
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL---FPED 424
            +R KI    A G+ +LHE      IHRDIK +NILLDE FTAKI+DFGL R    F + 
Sbjct: 133 HMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189
Query: 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +  +   + GT  YMAPE  +RG++T K+D+YSFGVV++E++
Sbjct: 190 V--MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEII 228

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  155 bits (393), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 97/222 (43%), Positives = 128/222 (57%), Gaps = 20/222 (9%)
Query: 258 NFSYETLEKATNYFHE------SNKLGQGGSGSVYKGTLPGGEAVAVKRLF----YNTTQ 307
           +FS+  L+  TN F E       NK G+GG G VYKG +     VAVK+L       T +
Sbjct: 5   SFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEE 63
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
               F  E+ + +   H+NLV+LLG S  G +  LVY + PN SLLD L       PLSW
Sbjct: 64  LKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSW 123
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL---FPED 424
             R KI    A G+ +LHE      IHRDIK +NILLDE FTAKI+DFGL R    F + 
Sbjct: 124 HXRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQX 180
Query: 425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +    + + GT  Y APE  +RG++T K+D+YSFGVV++E++
Sbjct: 181 VX--XSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEII 219

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 24/281 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 85
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IH
Sbjct: 86  VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 141
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+D
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 201
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L
Sbjct: 202 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEEL 248
Query: 515 LQIGLLCVQASAELRPSM----SIVVKMLTGNHEILQPTQP 551
            Q+  LC +   E RP+     S++    T      QP QP
Sbjct: 249 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQFQP-QP 288

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 24/281 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 84
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IH
Sbjct: 85  VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 140
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+D
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 200
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L
Sbjct: 201 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEEL 247
Query: 515 LQIGLLCVQASAELRPSM----SIVVKMLTGNHEILQPTQP 551
            Q+  LC +   E RP+     S++    T      QP QP
Sbjct: 248 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP-QP 287

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 24/281 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G +G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IH
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +  + KIADFGL RL  +            + + APE +  G  T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEEL 239
Query: 515 LQIGLLCVQASAELRPSM----SIVVKMLTGNHEILQPTQP 551
            Q+  LC +   E RP+     S++    T      QP QP
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP-QP 279

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 24/281 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 82
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IH
Sbjct: 83  VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+D
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L
Sbjct: 199 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEEL 245
Query: 515 LQIGLLCVQASAELRPSM----SIVVKMLTGNHEILQPTQP 551
            Q+  LC +   E RP+     S++    T      QP QP
Sbjct: 246 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP-QP 285

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 24/281 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IH
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEEL 239
Query: 515 LQIGLLCVQASAELRPSM----SIVVKMLTGNHEILQPTQP 551
            Q+  LC +   E RP+     S++    T      QP QP
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP-QP 279

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 19/265 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 77
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IH
Sbjct: 78  VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 133
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+D
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 193
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L
Sbjct: 194 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEEL 240
Query: 515 LQIGLLCVQASAELRPSMSIVVKML 539
            Q+  LC +   E RP+   +  +L
Sbjct: 241 YQLMRLCWKERPEDRPTFDYLRSVL 265

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 19/265 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 78
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IH
Sbjct: 79  VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 134
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+D
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 194
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L
Sbjct: 195 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEEL 241
Query: 515 LQIGLLCVQASAELRPSMSIVVKML 539
            Q+  LC +   E RP+   +  +L
Sbjct: 242 YQLMRLCWKERPEDRPTFDYLRSVL 266

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 132/281 (46%), Gaps = 24/281 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 86
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IH
Sbjct: 87  VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 142
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+D
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 202
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L
Sbjct: 203 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEEL 249
Query: 515 LQIGLLCVQASAELRPSM----SIVVKMLTGNHEILQPTQP 551
            Q+  LC +   E RP+     S++    T      QP QP
Sbjct: 250 YQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEGQYQP-QP 289

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  106 bits (264), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 127/264 (48%), Gaps = 19/264 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    +
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV-V 77
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
           T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IHR
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 133
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           D++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+DV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDV 193
Query: 456 YSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLL 515
           +SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L 
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEELY 240
Query: 516 QIGLLCVQASAELRPSMSIVVKML 539
           Q+  LC +   E RP+   +  +L
Sbjct: 241 QLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 19/265 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 76
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IH
Sbjct: 77  VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 132
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L
Sbjct: 193 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEEL 239
Query: 515 LQIGLLCVQASAELRPSMSIVVKML 539
            Q+  LC +   E RP+   +  +L
Sbjct: 240 YQLMRLCWKERPEDRPTFDYLRSVL 264

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 19/265 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 82
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IH
Sbjct: 83  VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 138
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+D
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L
Sbjct: 199 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEEL 245
Query: 515 LQIGLLCVQASAELRPSMSIVVKML 539
            Q+  LC +   E RP+   +  +L
Sbjct: 246 YQLMRLCWKERPEDRPTFDYLRSVL 270

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  105 bits (263), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 127/265 (47%), Gaps = 19/265 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 81
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IH
Sbjct: 82  VTQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIH 137
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+D
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 197
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L
Sbjct: 198 VWSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEEL 244
Query: 515 LQIGLLCVQASAELRPSMSIVVKML 539
            Q+  LC +   E RP+   +  +L
Sbjct: 245 YQLMRLCWKERPEDRPTFDYLRSVL 269

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  105 bits (262), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 78/264 (29%), Positives = 127/264 (48%), Gaps = 19/264 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    +
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV-V 72
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
           T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IHR
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 128
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           D++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+DV
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 456 YSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLL 515
           +SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L 
Sbjct: 189 WSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEELY 235
Query: 516 QIGLLCVQASAELRPSMSIVVKML 539
           Q+  LC +   E RP+   +  +L
Sbjct: 236 QLMRLCWKERPEDRPTFDYLRSVL 259

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  104 bits (260), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 87/289 (30%), Positives = 136/289 (47%), Gaps = 35/289 (12%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW-------VDHFFNEVNL 318
           A N      ++G+GG G V+KG L   ++V A+K L    ++           F  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
           +S +NH N+VKL G     P   +V EFVP   L   L  +    P+ W V+ +++L  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIA 132
Query: 379 EGLAYLHEESKLRIIHRDIKLSNIL---LDE--EFTAKIADFGLVRLFPEDITHISATLA 433
            G+ Y+  ++   I+HRD++  NI    LDE     AK+ADFGL     +   H  + L 
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGLL 187
Query: 434 GTLGYMAPEYV--VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK 491
           G   +MAPE +       TEKAD YSF +++  ++  +    F + S   ++     ++ 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE--GPFDEYSYGKIK-----FIN 240
Query: 492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
               E + P +     E  P RL  +  LC     + RP  S +VK L+
Sbjct: 241 MIREEGLRPTIP----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  103 bits (257), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 77/264 (29%), Positives = 127/264 (48%), Gaps = 19/264 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    +
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV-V 73
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
           T     ++ E++ N SL+D L     ++ L+      +    AEG+A++ E +    IHR
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEERN---YIHR 129
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           +++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G  T K+DV
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 456 YSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLL 515
           +SFG+++ E+V   RI      +  ++Q +       R +  V P       +  P  L 
Sbjct: 190 WSFGILLTEIVTHGRIPYPGMTNPEVIQNL------ERGYRMVRP-------DNCPEELY 236
Query: 516 QIGLLCVQASAELRPSMSIVVKML 539
           Q+  LC +   E RP+   +  +L
Sbjct: 237 QLMRLCWKERPEDRPTFDYLRSVL 260

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 135/289 (46%), Gaps = 35/289 (12%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW-------VDHFFNEVNL 318
           A N      ++G+GG G V+KG L   ++V A+K L    ++           F  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
           +S +NH N+VKL G     P   +V EFVP   L   L  +    P+ W V+ +++L  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIA 132
Query: 379 EGLAYLHEESKLRIIHRDIKLSNIL---LDE--EFTAKIADFGLVRLFPEDITHISATLA 433
            G+ Y+  ++   I+HRD++  NI    LDE     AK+ADFG      +   H  + L 
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS----QQSVHSVSGLL 187
Query: 434 GTLGYMAPEYV--VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK 491
           G   +MAPE +       TEKAD YSF +++  ++  +    F + S   ++     ++ 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE--GPFDEYSYGKIK-----FIN 240
Query: 492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
               E + P +     E  P RL  +  LC     + RP  S +VK L+
Sbjct: 241 MIREEGLRPTIP----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 67/192 (34%), Positives = 100/192 (52%), Gaps = 5/192 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGC 333
           K+G G  G+V++    G + VAVK L       + V+ F  EV ++  + H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWHGSD-VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
               P   +V E++   SL   L      E L    R  +    A+G+ YLH  +   I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIV 161
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRD+K  N+L+D+++T K+ DFGL RL        S   AGT  +MAPE +      EK+
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL-XSKXAAGTPEWMAPEVLRDEPSNEKS 220
Query: 454 DVYSFGVVVIEV 465
           DVYSFGV++ E+
Sbjct: 221 DVYSFGVILWEL 232

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 86/289 (29%), Positives = 135/289 (46%), Gaps = 35/289 (12%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW-------VDHFFNEVNL 318
           A N      ++G+GG G V+KG L   ++V A+K L    ++           F  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
           +S +NH N+VKL G     P   +V EFVP   L   L  +    P+ W V+ +++L  A
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIA 132
Query: 379 EGLAYLHEESKLRIIHRDIKLSNIL---LDE--EFTAKIADFGLVRLFPEDITHISATLA 433
            G+ Y+  ++   I+HRD++  NI    LDE     AK+ADF L     +   H  + L 
Sbjct: 133 LGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS----QQSVHSVSGLL 187
Query: 434 GTLGYMAPEYV--VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK 491
           G   +MAPE +       TEKAD YSF +++  ++  +    F + S   ++     ++ 
Sbjct: 188 GNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGE--GPFDEYSYGKIK-----FIN 240
Query: 492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
               E + P +     E  P RL  +  LC     + RP  S +VK L+
Sbjct: 241 MIREEGLRPTIP----EDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 66/192 (34%), Positives = 101/192 (52%), Gaps = 5/192 (2%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGC 333
           K+G G  G+V++    G + VAVK L       + V+ F  EV ++  + H N+V  +G 
Sbjct: 44  KIGAGSFGTVHRAEWHGSD-VAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
               P   +V E++   SL   L      E L    R  +    A+G+ YLH  +   I+
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIV 161
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HR++K  N+L+D+++T K+ DFGL RL        S + AGT  +MAPE +      EK+
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS-SKSAAGTPEWMAPEVLRDEPSNEKS 220
Query: 454 DVYSFGVVVIEV 465
           DVYSFGV++ E+
Sbjct: 221 DVYSFGVILWEL 232

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.4 bits (246), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 139/269 (51%), Gaps = 25/269 (9%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 18  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS--TAEGLAYLHEESKLRI 392
            T P+  +V ++    SL  +L   +      +E++  I ++  TA G+ YLH +S   I
Sbjct: 78  -TKPQLAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---I 129
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVVRGKLTE 451
           IHRD+K +NI L E+ T KI DFGL  +      +H    L+G++ +MAPE V+R + + 
Sbjct: 130 IHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 188
Query: 452 ----KADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ 507
               ++DVY+FG+V+ E++  +       N   I++ V      GR   ++ P L+   +
Sbjct: 189 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV------GR--GSLSPDLS-KVR 239
Query: 508 EGKPSRLLQIGLLCVQASAELRPSMSIVV 536
              P R+ ++   C++   + RPS   ++
Sbjct: 240 SNCPKRMKRLMAECLKKKRDERPSFPRIL 268

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 138/269 (51%), Gaps = 25/269 (9%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS--TAEGLAYLHEESKLRI 392
            T P+  +V ++    SL  +L   +      +E++  I ++  TA G+ YLH +S   I
Sbjct: 90  -TAPQLAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVVRGKLTE 451
           IHRD+K +NI L E+ T KI DFGL         +H    L+G++ +MAPE V+R + + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 200
Query: 452 ----KADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ 507
               ++DVY+FG+V+ E++  +       N   I++ V      GR   ++ P L+   +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV------GR--GSLSPDLS-KVR 251
Query: 508 EGKPSRLLQIGLLCVQASAELRPSMSIVV 536
              P R+ ++   C++   + RPS   ++
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 98.6 bits (244), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 77/270 (28%), Positives = 123/270 (45%), Gaps = 28/270 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            KLG G  G V+ G       VAVK L   T   V  F  E NL+  + H  LV+L    
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD-----VEPLSWEVRYKIILSTAEGLAYLHEESK 389
                  ++ EF+   SLLD  F++ D     + P   +   +I    AEG+AY+  ++ 
Sbjct: 77  TKEEPIYIITEFMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQI----AEGMAYIERKN- 129
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
              IHRD++ +N+L+ E    KIADFGL R+  ++           + + APE +  G  
Sbjct: 130 --YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF 187
Query: 450 TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG 509
           T K++V+SFG+++ E+V   +I    + +  ++  +   Y   R+             E 
Sbjct: 188 TIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRM-------------EN 234
Query: 510 KPSRLLQIGLLCVQASAELRPSMSIVVKML 539
            P  L  I  +C +  AE RP+   +  +L
Sbjct: 235 CPDELYDIMKMCWKEKAEERPTFDYLQSVL 264

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 81/269 (30%), Positives = 138/269 (51%), Gaps = 25/269 (9%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 30  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS--TAEGLAYLHEESKLRI 392
            T P+  +V ++    SL  +L   +      +E++  I ++  TA G+ YLH +S   I
Sbjct: 90  -TKPQLAIVTQWCEGSSLYHHLHASE----TKFEMKKLIDIARQTARGMDYLHAKS---I 141
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVVRGKLTE 451
           IHRD+K +NI L E+ T KI DFGL         +H    L+G++ +MAPE V+R + + 
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 200
Query: 452 ----KADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ 507
               ++DVY+FG+V+ E++  +       N   I++ V      GR   ++ P L+   +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV------GR--GSLSPDLS-KVR 251
Query: 508 EGKPSRLLQIGLLCVQASAELRPSMSIVV 536
              P R+ ++   C++   + RPS   ++
Sbjct: 252 SNCPKRMKRLMAECLKKKRDERPSFPRIL 280

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII------LSTAEGLAYLHEES 388
            T P+  +V ++    SL  +L +         E ++++I        TA+G+ YLH +S
Sbjct: 74  -TAPQLAIVTQWCEGSSLYHHLHII--------ETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV-- 445
              IIHRD+K +NI L E+ T KI DFGL  +      +H    L+G++ +MAPE +   
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
            +   + ++DVY+FG+V+ E++ 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMT 204

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 41  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII------LSTAEGLAYLHEES 388
            T P+  +V ++    SL  +L +         E ++++I        TA+G+ YLH +S
Sbjct: 101 -TKPQLAIVTQWCEGSSLYHHLHI--------IETKFEMIKLIDIARQTAQGMDYLHAKS 151
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV-- 445
              IIHRD+K +NI L E+ T KI DFGL  +      +H    L+G++ +MAPE +   
Sbjct: 152 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
            +   + ++DVY+FG+V+ E++ 
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMT 231

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII------LSTAEGLAYLHEES 388
            T P+  +V ++    SL  +L +         E ++++I        TA+G+ YLH +S
Sbjct: 102 -TKPQLAIVTQWCEGSSLYHHLHI--------IETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV-- 445
              IIHRD+K +NI L E+ T KI DFGL  +      +H    L+G++ +MAPE +   
Sbjct: 153 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
            +   + ++DVY+FG+V+ E++ 
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMT 232

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 97.8 bits (242), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 126/268 (47%), Gaps = 25/268 (9%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            KLG G  G V+  T      VAVK +   +   V+ F  E N++  + H  LVKL    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV- 251
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           +T     ++ EF+   SLLD  F++ D    +PL   + +   +  AEG+A++ + +   
Sbjct: 252 VTKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQRN--- 304
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
            IHRD++ +NIL+      KIADFGL R+  ++           + + APE +  G  T 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 364
Query: 452 KADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKP 511
           K+DV+SFG++++E+V   RI     ++  +++ +   Y   R              E  P
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------------PENCP 411
Query: 512 SRLLQIGLLCVQASAELRPSMSIVVKML 539
             L  I + C +   E RP+   +  +L
Sbjct: 412 EELYNIMMRCWKNRPEERPTFEYIQSVL 439

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII------LSTAEGLAYLHEES 388
            T P+  +V ++    SL  +L +         E ++++I        TA+G+ YLH +S
Sbjct: 79  -TKPQLAIVTQWCEGSSLYHHLHII--------ETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV-- 445
              IIHRD+K +NI L E+ T KI DFGL  +      +H    L+G++ +MAPE +   
Sbjct: 130 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
            +   + ++DVY+FG+V+ E++ 
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMT 209

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII------LSTAEGLAYLHEES 388
            T P+  +V ++    SL  +L +         E ++++I        TA+G+ YLH +S
Sbjct: 79  -TKPQLAIVTQWCEGSSLYHHLHII--------ETKFEMIKLIDIARQTAQGMDYLHAKS 129
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV-- 445
              IIHRD+K +NI L E+ T KI DFGL  +      +H    L+G++ +MAPE +   
Sbjct: 130 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
            +   + ++DVY+FG+V+ E++ 
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMT 209

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/270 (28%), Positives = 123/270 (45%), Gaps = 28/270 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G       VAVK L   T   V  F  E NL+  + H  LV+L    
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD-----VEPLSWEVRYKIILSTAEGLAYLHEESK 389
                  ++ E++   SLLD  F++ D     + P   +   +I    AEG+AY+  ++ 
Sbjct: 78  TREEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQI----AEGMAYIERKN- 130
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
              IHRD++ +N+L+ E    KIADFGL R+  ++           + + APE +  G  
Sbjct: 131 --YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF 188
Query: 450 TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG 509
           T K+DV+SFG+++ E+V   +I    + +  ++  +   Y   R+             E 
Sbjct: 189 TIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQGYRMPRV-------------EN 235
Query: 510 KPSRLLQIGLLCVQASAELRPSMSIVVKML 539
            P  L  I  +C +  AE RP+   +  +L
Sbjct: 236 CPDELYDIMKMCWKEKAEERPTFDYLQSVL 265

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII------LSTAEGLAYLHEES 388
            T P+  +V ++    SL  +L +         E ++++I        TA+G+ YLH +S
Sbjct: 76  -TKPQLAIVTQWCEGSSLYHHLHII--------ETKFEMIKLIDIARQTAQGMDYLHAKS 126
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV-- 445
              IIHRD+K +NI L E+ T KI DFGL  +      +H    L+G++ +MAPE +   
Sbjct: 127 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
            +   + ++DVY+FG+V+ E++ 
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMT 206

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 125/269 (46%), Gaps = 25/269 (9%)
Query: 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
             KLG G  G V+  T      VAVK +   +   V+ F  E N++  + H  LVKL   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV 78
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            +T     ++ EF+   SLLD  F++ D    +PL   + +      AEG+A++ + +  
Sbjct: 79  -VTKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSA--QIAEGMAFIEQRN-- 131
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
             IHRD++ +NIL+      KIADFGL R+  ++           + + APE +  G  T
Sbjct: 132 -YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT 190
Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK 510
            K+DV+SFG++++E+V   RI     ++  +++ +   Y   R              E  
Sbjct: 191 IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------------PENC 237
Query: 511 PSRLLQIGLLCVQASAELRPSMSIVVKML 539
           P  L  I + C +   E RP+   +  +L
Sbjct: 238 PEELYNIMMRCWKNRPEERPTFEYIQSVL 266

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 109/203 (53%), Gaps = 22/203 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII------LSTAEGLAYLHEES 388
            T P+  +V ++    SL  +L +         E ++++I        TA+G+ YLH +S
Sbjct: 74  -TKPQLAIVTQWCEGSSLYHHLHII--------ETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV-- 445
              IIHRD+K +NI L E+ T KI DFGL  +      +H    L+G++ +MAPE +   
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
            +   + ++DVY+FG+V+ E++ 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMT 204

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 80/261 (30%), Positives = 121/261 (46%), Gaps = 21/261 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +KLG G  G VY G        VAVK L  +T + V+ F  E  ++  I H NLV+LLG 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 96
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
               P   +V E++P  +LLD  ++R+ + E ++  V   +    +  + YL    K   
Sbjct: 97  CTLEPPFYIVTEYMPYGNLLD--YLRECNREEVTAVVLLYMATQISSAMEYL---EKKNF 151
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRD+   N L+ E    K+ADFGL RL   D     A     + + APE +     + K
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIK 211
Query: 453 ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS 512
           +DV++FGV++ E+         +      L  V+DL  KG   E           EG P 
Sbjct: 212 SDVWAFGVLLWEIATYG----MSPYPGIDLSQVYDLLEKGYRMEQ---------PEGCPP 258
Query: 513 RLLQIGLLCVQASAELRPSMS 533
           ++ ++   C + S   RPS +
Sbjct: 259 KVYELMRACWKWSPADRPSFA 279

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 22/203 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII------LSTAEGLAYLHEES 388
            T P+  +V ++    SL  +L +         E ++++I        TA+G+ YLH +S
Sbjct: 102 -TKPQLAIVTQWCEGSSLYHHLHI--------IETKFEMIKLIDIARQTAQGMDYLHAKS 152
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV-- 445
              IIHRD+K +NI L E+ T KI DFGL         +H    L+G++ +MAPE +   
Sbjct: 153 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
            +   + ++DVY+FG+V+ E++ 
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMT 232

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 22/203 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII------LSTAEGLAYLHEES 388
            T P+  +V ++    SL  +L +         E ++++I        TA+G+ YLH +S
Sbjct: 94  -TKPQLAIVTQWCEGSSLYHHLHI--------IETKFEMIKLIDIARQTAQGMDYLHAKS 144
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV-- 445
              IIHRD+K +NI L E+ T KI DFGL         +H    L+G++ +MAPE +   
Sbjct: 145 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
            +   + ++DVY+FG+V+ E++ 
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMT 224

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 96.3 bits (238), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
            KLG G  G V +G    P G+ V+V     K    +  + +D F  EVN +  ++H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           ++L G  +T P  + V E  P  SLLD L   Q    L    RY +    AEG+ YL  E
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--E 138
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVV 445
           SK R IHRD+   N+LL      KI DFGL+R  P++  H  +         + APE + 
Sbjct: 139 SK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 446 RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
               +  +D + FGV + E+    +      N   IL  +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
            KLG G  G V +G    P G+ V+V     K    +  + +D F  EVN +  ++H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           ++L G  +T P  + V E  P  SLLD L   Q    L    RY +    AEG+ YL  E
Sbjct: 84  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--E 138
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVV 445
           SK R IHRD+   N+LL      KI DFGL+R  P++  H  +         + APE + 
Sbjct: 139 SK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 446 RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
               +  +D + FGV + E+    +      N   IL  +
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 63/197 (31%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  I H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ ++ + L       +    A G+AY+    ++  +H
Sbjct: 84  EEP-IYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 95.9 bits (237), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
            KLG G  G V +G    P G+ V+V     K    +  + +D F  EVN +  ++H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           ++L G  +T P  + V E  P  SLLD L   Q    L    RY +    AEG+ YL  E
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--E 132
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVV 445
           SK R IHRD+   N+LL      KI DFGL+R  P++  H  +         + APE + 
Sbjct: 133 SK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 446 RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
               +  +D + FGV + E+    +      N   IL  +
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
            KLG G  G V +G    P G+ V+V     K    +  + +D F  EVN +  ++H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           ++L G  +T P  + V E  P  SLLD L   Q    L    RY +    AEG+ YL  E
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--E 128
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVV 445
           SK R IHRD+   N+LL      KI DFGL+R  P++  H  +         + APE + 
Sbjct: 129 SK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 446 RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
               +  +D + FGV + E+    +      N   IL  +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
            KLG G  G V +G    P G+ V+V     K    +  + +D F  EVN +  ++H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           ++L G  +T P  + V E  P  SLLD L   Q    L    RY +    AEG+ YL  E
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--E 128
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVV 445
           SK R IHRD+   N+LL      KI DFGL+R  P++  H  +         + APE + 
Sbjct: 129 SK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 446 RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
               +  +D + FGV + E+    +      N   IL  +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 66/203 (32%), Positives = 108/203 (53%), Gaps = 22/203 (10%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII------LSTAEGLAYLHEES 388
            T P+  +V ++    SL  +L +         E ++++I        TA+G+ YLH +S
Sbjct: 74  -TKPQLAIVTQWCEGSSLYHHLHII--------ETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV-- 445
              IIHRD+K +NI L E+ T KI DFGL         +H    L+G++ +MAPE +   
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 446 -RGKLTEKADVYSFGVVVIEVVC 467
            +   + ++DVY+FG+V+ E++ 
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMT 204

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
            KLG G  G V +G    P G+ V+V     K    +  + +D F  EVN +  ++H+NL
Sbjct: 18  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 77
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           ++L G  +T P  + V E  P  SLLD L   Q    L    RY +    AEG+ YL  E
Sbjct: 78  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--E 132
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVV 445
           SK R IHRD+   N+LL      KI DFGL+R  P++  H  +         + APE + 
Sbjct: 133 SK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 446 RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
               +  +D + FGV + E+    +      N   IL  +
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 231

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 129/288 (44%), Gaps = 25/288 (8%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWV 309
           A++ S  N+    +E+        +KLG G  G VY+G        VAVK L  +T + V
Sbjct: 2   AMDPSSPNYDKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-V 58
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSW 367
           + F  E  ++  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +  
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-- 116
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
            V   +    +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D   
Sbjct: 117 -VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT 172
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD 487
             A     + + APE +   K + K+DV++FGV++ E+         +      L  V++
Sbjct: 173 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYE 228
Query: 488 LYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIV 535
           L  K    E           EG P ++ ++   C Q +   RPS + +
Sbjct: 229 LLEKDYRMER---------PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 72/220 (32%), Positives = 103/220 (46%), Gaps = 15/220 (6%)
Query: 275 NKLGQGGSGSVYKGTL--PGGEAVAV-----KRLFYNTTQWVDHFFNEVNLISGINHKNL 327
            KLG G  G V +G    P G+ V+V     K    +  + +D F  EVN +  ++H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           ++L G  +T P  + V E  P  SLLD L   Q    L    RY +    AEG+ YL  E
Sbjct: 74  IRLYGVVLTPPMKM-VTELAPLGSLLDRLRKHQGHFLLGTLSRYAV--QVAEGMGYL--E 128
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVV 445
           SK R IHRD+   N+LL      KI DFGL+R  P++  H  +         + APE + 
Sbjct: 129 SK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 446 RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
               +  +D + FGV + E+    +      N   IL  +
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ +  + L       +    A G+AY+    ++  +H
Sbjct: 250 EEP-IYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 364 VWSFGILLTELTTKGRV 380

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ +  + L       +    A G+AY+    ++  +H
Sbjct: 333 EEP-IYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 386
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 447 VWSFGILLTELTTKGRV 463

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ +  + L       +    A G+AY+    ++  +H
Sbjct: 250 EEP-IYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 364 VWSFGILLTELTTKGRV 380

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 95.5 bits (236), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ ++ + L       +    A G+AY+    ++  +H
Sbjct: 84  EEP-IYIVIEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 95.1 bits (235), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 109/213 (51%), Gaps = 10/213 (4%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ GT  G   VA+K L   T    + F  E  ++  + H  LV+L    
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMS-PESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRI 392
              P   +V E++   SLLD L   +D E  + ++   + ++   A G+AY+    ++  
Sbjct: 74  SEEP-IYIVTEYMNKGSLLDFL---KDGEGRALKLPNLVDMAAQVAAGMAYIE---RMNY 126
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRD++ +NIL+      KIADFGL RL  ++           + + APE  + G+ T K
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 186
Query: 453 ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
           +DV+SFG+++ E+V + R+     N+  +L+ V
Sbjct: 187 SDVWSFGILLTELVTKGRVPYPGMNNREVLEQV 219

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ +  + L       +    A G+AY+    ++  +H
Sbjct: 74  EEP-IXIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 127
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 128 RDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSD 187
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 188 VWSFGILLTELTTKGRV 204

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ ++ + L       +    A G+AY+    ++  +H
Sbjct: 84  EEP-IYIVIEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/271 (28%), Positives = 126/271 (46%), Gaps = 41/271 (15%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            KLG G  G V+  T      VAVK +   +   V+ F  E N++  + H  LVKL    
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV- 245
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           +T     ++ EF+   SLLD  F++ D    +PL   + +   +  AEG+A++ + +   
Sbjct: 246 VTKEPIYIITEFMAKGSLLD--FLKSDEGSKQPLPKLIDFSAQI--AEGMAFIEQRN--- 298
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRL---FPEDITHISATLAGTLGYMAPEYVVRGK 448
            IHRD++ +NIL+      KIADFGL R+   FP             + + APE +  G 
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLARVGAKFP-------------IKWTAPEAINFGS 345
Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T K+DV+SFG++++E+V   RI     ++  +++ +   Y   R              E
Sbjct: 346 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------------PE 392
Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
             P  L  I + C +   E RP+   +  +L
Sbjct: 393 NCPEELYNIMMRCWKNRPEERPTFEYIQSVL 423

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ ++ + L       +    A G+AY+    ++  +H
Sbjct: 73  EEP-IYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 126
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 127 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 186
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 187 VWSFGILLTELTTKGRV 203

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 129/288 (44%), Gaps = 25/288 (8%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWV 309
           A++ S  N+    +E+        +KLG G  G VY+G        VAVK L  +T + V
Sbjct: 2   AMDPSSPNYDKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-V 58
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSW 367
           + F  E  ++  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +  
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV-- 116
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
            V   +    +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D   
Sbjct: 117 -VLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 172
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD 487
             A     + + APE +   K + K+DV++FGV++ E+         +      L  V++
Sbjct: 173 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYE 228
Query: 488 LYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIV 535
           L  K    E           EG P ++ ++   C Q +   RPS + +
Sbjct: 229 LLEKDYRMER---------PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 129/288 (44%), Gaps = 25/288 (8%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWV 309
           A++ S  N+    +E+        +KLG G  G VY+G        VAVK L  +T + V
Sbjct: 2   AMDPSSPNYDKWEMERTD--ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-V 58
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSW 367
           + F  E  ++  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +  
Sbjct: 59  EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV-- 116
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
            V   +    +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D   
Sbjct: 117 -VLLYMATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 172
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD 487
             A     + + APE +   K + K+DV++FGV++ E+         +      L  V++
Sbjct: 173 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYE 228
Query: 488 LYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIV 535
           L  K    E           EG P ++ ++   C Q +   RPS + +
Sbjct: 229 LLEKDYRMER---------PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ ++ + L       +    A G+AY+    ++  +H
Sbjct: 75  EEP-IYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 128
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 129 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 188
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 189 VWSFGILLTELTTKGRV 205

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ +  + L       +    A G+AY+    ++  +H
Sbjct: 250 EEP-IYIVGEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 303
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 364 VWSFGILLTELTTKGRV 380

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 63
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQ 120
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 121 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPI 177
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 233
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
                      EG P ++ ++   C Q +   RPS +
Sbjct: 234 R---------PEGCPEKVYELMRACWQWNPSDRPSFA 261

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ ++ + L       +    A G+AY+    ++  +H
Sbjct: 84  EEP-IYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 124/279 (44%), Gaps = 23/279 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQ 124
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 125 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 237
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIV 535
                      EG P ++ ++   C Q +   RPS + +
Sbjct: 238 R---------PEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 9   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 67
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQ 124
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 125 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 181
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 182 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 237
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
                      EG P ++ ++   C Q +   RPS +
Sbjct: 238 R---------PEGCPEKVYELMRACWQWNPSDRPSFA 265

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 124/279 (44%), Gaps = 23/279 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQ 123
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 124 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 180
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 181 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 236
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIV 535
                      EG P ++ ++   C Q +   RPS + +
Sbjct: 237 R---------PEGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 103/197 (52%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ ++ + L       +    A G+AY+    ++  +H
Sbjct: 84  EEP-IYIVCEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQ 119
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 232
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
                      EG P ++ ++   C Q +   RPS +
Sbjct: 233 R---------PEGCPEKVYELMRACWQWNPSDRPSFA 260

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/280 (29%), Positives = 125/280 (44%), Gaps = 23/280 (8%)
Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNE 315
           ++ +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E
Sbjct: 3   MDPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKE 61
Query: 316 VNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKI 373
             ++  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +
Sbjct: 62  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYM 118
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
               +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A   
Sbjct: 119 ATQISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 175
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR 493
             + + APE +   K + K+DV++FGV++ E+         +      L  V++L  K  
Sbjct: 176 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDY 231
Query: 494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
             E           EG P ++ ++   C Q +   RPS +
Sbjct: 232 RMER---------PEGCPEKVYELMRACWQWNPSDRPSFA 262

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ +  + L       +    A G+AY+    ++  +H
Sbjct: 77  EEP-IYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 130
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 131 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 190
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 191 VWSFGILLTELTTKGRV 207

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 5   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 63
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQ 120
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 121 ISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI 177
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 178 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 233
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
                      EG P ++ ++   C Q +   RPS +
Sbjct: 234 R---------PEGCPEKVYELMRACWQWNPSDRPSFA 261

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 64
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQ 121
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 122 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPI 178
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 234
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
                      EG P ++ ++   C Q +   RPS +
Sbjct: 235 R---------PEGCPEKVYELMRACWQWNPSDRPSFA 262

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 120/265 (45%), Gaps = 23/265 (8%)
Query: 274 SNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
            +KLG G  G VY+G        VAVK L  +T + V+ F  E  ++  I H NLV+LLG
Sbjct: 31  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 89
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
                P   ++ EF+   +LLD L    RQ+V  +   V   +    +  + YL    K 
Sbjct: 90  VCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYL---EKK 143
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
             IHRD+   N L+ E    K+ADFGL RL   D     A     + + APE +   K +
Sbjct: 144 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK 510
            K+DV++FGV++ E+         +      L  V++L  K    E           EG 
Sbjct: 204 IKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRMER---------PEGC 250
Query: 511 PSRLLQIGLLCVQASAELRPSMSIV 535
           P ++ ++   C Q +   RPS + +
Sbjct: 251 PEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQ 119
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 232
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
                      EG P ++ ++   C Q +   RPS +
Sbjct: 233 R---------PEGCPEKVYELMRACWQWNPSDRPSFA 260

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 124/279 (44%), Gaps = 23/279 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQ 119
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 232
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIV 535
                      EG P ++ ++   C Q +   RPS + +
Sbjct: 233 R---------PEGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQ 119
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 232
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
                      EG P ++ ++   C Q +   RPS +
Sbjct: 233 R---------PEGCPEKVYELMRACWQWNPSDRPSFA 260

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQ 119
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 232
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
                      EG P ++ ++   C Q +   RPS +
Sbjct: 233 R---------PEGCPEKVYELMRACWQWNPSDRPSFA 260

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 123/277 (44%), Gaps = 23/277 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 4   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 62
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQ 119
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 120 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 232
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
                      EG P ++ ++   C Q +   RPS +
Sbjct: 233 R---------PEGCPEKVYELMRACWQWNPSDRPSFA 260

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/279 (29%), Positives = 124/279 (44%), Gaps = 23/279 (8%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 6   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 64
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILS 376
           +  I H NLV+LLG     P   ++ EF+   +LLD L    RQ+V  +   V   +   
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQ 121
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            +  + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     +
Sbjct: 122 ISSAMEYL---EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 178
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            + APE +   K + K+DV++FGV++ E+         +      L  V++L  K    E
Sbjct: 179 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRME 234
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIV 535
                      EG P ++ ++   C Q +   RPS + +
Sbjct: 235 R---------PEGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ +  + L       +    A G+AY+    ++  +H
Sbjct: 81  EEP-IYIVTEYMNKGSLLD--FLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 195 VWSFGILLTELTTKGRV 211

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ ++ + L       +    A G+AY+    ++  +H
Sbjct: 84  EEP-IYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD+  +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 138 RDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +KLG G  G VY+G        VAVK L  +T + V+ F  E  ++  I H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 334 SITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
               P   ++ EF+   +LLD L    RQ+V  +   V   +    +  + YL    K  
Sbjct: 76  CTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYL---EKKN 129
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
            IHRD+   N L+ E    K+ADFGL RL   D     A     + + APE +   K + 
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 452 KADVYSFGVVVIEV 465
           K+DV++FGV++ E+
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ +  + L       +    A G+AY+    ++  +H
Sbjct: 81  EEP-IYIVTEYMNKGSLLD--FLKGETGKYLRLPQLVDMSAQIASGMAYVE---RMNYVH 134
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 135 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 194
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 195 VWSFGILLTELTTKGRV 211

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++    LLD  F++ ++ + L       +    A G+AY+    ++  +H
Sbjct: 84  EEP-IYIVMEYMSKGCLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +KLG G  G VY+G        VAVK L  +T + V+ F  E  ++  I H NLV+LLG 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 334 SITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
               P   ++ EF+   +LLD L    RQ+V  +   V   +    +  + YL    K  
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYL---EKKN 129
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
            IHRD+   N L+ E    K+ADFGL RL   D     A     + + APE +   K + 
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 452 KADVYSFGVVVIEV 465
           K+DV++FGV++ E+
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 27/285 (9%)
Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGTL--PGGE--AVAVKRLF--YNTTQWVDHFFNEV 316
           T E   +  H    +G G SG V  G L  PG     VA+K L   Y   Q  D F +E 
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEA 101
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
           +++   +H N+++L G    G  +++V E++ N SL  + F+R      +      ++  
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL--DTFLRTHDGQFTIMQLVGMLRG 159
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
              G+ YL   S L  +HRD+   N+L+D     K++DFGL R+  +D      T  G +
Sbjct: 160 VGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKI 216
Query: 437 G--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL 494
              + APE +     +  +DV+SFGVV+ EV+       +   +  ++ +V + Y   RL
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RL 273
Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                PA  G      P  L Q+ L C       RP  S +V +L
Sbjct: 274 -----PAPMGC-----PHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L     
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++    LLD  F++ ++ + L       +    A G+AY+    ++  +H
Sbjct: 84  EEP-IYIVTEYMSKGCLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 137
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 138 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 197
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 198 VWSFGILLTELTTKGRV 214

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 120/264 (45%), Gaps = 23/264 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +KLG G  G VY+G        VAVK L  +T + V+ F  E  ++  I H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 334 SITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
               P   ++ EF+   +LLD L    RQ+V  +   V   +    +  + YL    K  
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYL---EKKN 338
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
            IHR++   N L+ E    K+ADFGL RL   D     A     + + APE +   K + 
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 452 KADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKP 511
           K+DV++FGV++ E+         +      L  V++L  K    E           EG P
Sbjct: 399 KSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRMER---------PEGCP 445
Query: 512 SRLLQIGLLCVQASAELRPSMSIV 535
            ++ ++   C Q +   RPS + +
Sbjct: 446 EKVYELMRACWQWNPSDRPSFAEI 469

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 97/194 (50%), Gaps = 10/194 (5%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +KLG G  G VY+G        VAVK L  +T + V+ F  E  ++  I H NLV+LLG 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 75
Query: 334 SITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
               P   ++ EF+   +LLD L    RQ+V  +   V   +    +  + YL    K  
Sbjct: 76  CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYL---EKKN 129
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
            IHRD+   N L+ E    K+ADFGL RL   D     A     + + APE +   K + 
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 452 KADVYSFGVVVIEV 465
           K+DV++FGV++ E+
Sbjct: 190 KSDVWAFGVLLWEI 203

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 136/295 (46%), Gaps = 33/295 (11%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT 305
           G+L + ++ S+L F  E              +G G  G V+ G     + VA+K +   +
Sbjct: 18  GSLHMVIDPSELTFVQE--------------IGSGQFGLVHLGYWLNKDKVAIKTIKEGS 63
Query: 306 TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
               D F  E  ++  ++H  LV+L G  +      LV+EF+ +  L D L  ++ +   
Sbjct: 64  MS-EDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGL--F 120
Query: 366 SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
           + E    + L   EG+AYL E     +IHRD+   N L+ E    K++DFG+ R   +D 
Sbjct: 121 AAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 177
Query: 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
              S      + + +PE     + + K+DV+SFGV++ EV    +I    +++  +++  
Sbjct: 178 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE-- 235
Query: 486 WDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
            D+    RL++   P LA        + + QI   C +   E RP+ S +++ L 
Sbjct: 236 -DISTGFRLYK---PRLAS-------THVYQIMNHCWKERPEDRPAFSRLLRQLA 279

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 129/285 (45%), Gaps = 27/285 (9%)
Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGTL--PGGE--AVAVKRLF--YNTTQWVDHFFNEV 316
           T E   +  H    +G G SG V  G L  PG     VA+K L   Y   Q  D F +E 
Sbjct: 43  TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEA 101
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
           +++   +H N+++L G    G  +++V E++ N SL  + F+R      +      ++  
Sbjct: 102 SIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL--DTFLRTHDGQFTIMQLVGMLRG 159
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
              G+ YL   S L  +HRD+   N+L+D     K++DFGL R+  +D      T  G +
Sbjct: 160 VGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 437 G--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL 494
              + APE +     +  +DV+SFGVV+ EV+       +   +  ++ +V + Y   RL
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RL 273
Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                PA  G      P  L Q+ L C       RP  S +V +L
Sbjct: 274 -----PAPMGC-----PHALHQLMLDCWHKDRAQRPRFSQIVSVL 308

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 102/197 (51%), Gaps = 8/197 (4%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           KLGQG  G V+ GT  G   VA+K L        + F  E  ++  + H+ LV+L     
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
             P   +V E++   SLLD  F++ ++ + L       +    A G+AY+    ++  +H
Sbjct: 251 EEP-IYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVE---RMNYVH 304
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+D
Sbjct: 305 RDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 364
Query: 455 VYSFGVVVIEVVCRKRI 471
           V+SFG+++ E+  + R+
Sbjct: 365 VWSFGILLTELTTKGRV 381

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 92.4 bits (228), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 120/264 (45%), Gaps = 23/264 (8%)
Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +KLG G  G VY+G        VAVK L  +T + V+ F  E  ++  I H NLV+LLG 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 323
Query: 334 SITGPESLLVYEFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
               P   ++ EF+   +LLD L    RQ+V  +   V   +    +  + YL    K  
Sbjct: 324 CTREPPFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYL---EKKN 377
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
            IHR++   N L+ E    K+ADFGL RL   D     A     + + APE +   K + 
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 452 KADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKP 511
           K+DV++FGV++ E+         +      L  V++L  K    E           EG P
Sbjct: 438 KSDVWAFGVLLWEIATYG----MSPYPGIDLSQVYELLEKDYRMER---------PEGCP 484
Query: 512 SRLLQIGLLCVQASAELRPSMSIV 535
            ++ ++   C Q +   RPS + +
Sbjct: 485 EKVYELMRACWQWNPSDRPSFAEI 508

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 92.4 bits (228), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 136/303 (44%), Gaps = 31/303 (10%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEA-----VAVKR 300
           GA+    N++ L F+ E              +G G  G VYKG L          VA+K 
Sbjct: 24  GAMGSDPNQAVLKFTTEIHPSCVT---RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT 80
Query: 301 LF--YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV 358
           L   Y   Q VD F  E  ++   +H N+++L G        +++ E++ N +L  + F+
Sbjct: 81  LKAGYTEKQRVD-FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGAL--DKFL 137
Query: 359 RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV 418
           R+     S      ++   A G+ YL   + +  +HRD+   NIL++     K++DFGL 
Sbjct: 138 REKDGEFSVLQLVGMLRGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
Query: 419 RLFPEDITHISATLAGTLG--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476
           R+  +D      T  G +   + APE +   K T  +DV+SFG+V+ EV+       +  
Sbjct: 195 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 254
Query: 477 NSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVV 536
           ++  +++ + D +   RL   +D           PS + Q+ + C Q     RP  + +V
Sbjct: 255 SNHEVMKAINDGF---RLPTPMD----------CPSAIYQLMMQCWQQERARRPKFADIV 301
Query: 537 KML 539
            +L
Sbjct: 302 SIL 304

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 125/269 (46%), Gaps = 30/269 (11%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
           +G+G  G V K      + VA+K++   + +    F  E+  +S +NH N+VKL G  + 
Sbjct: 17  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 73
Query: 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII---LSTAEGLAYLHEESKLRII 393
                LV E+    SL +   V    EPL +      +   L  ++G+AYLH      +I
Sbjct: 74  --PVCLVMEYAEGGSLYN---VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 128
Query: 394 HRDIKLSNILLDEEFTA-KIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTE 451
           HRD+K  N+LL    T  KI DFG       DI TH++    G+  +MAPE       +E
Sbjct: 129 HRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVFEGSNYSE 183
Query: 452 KADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKP 511
           K DV+S+G+++ EV+ R++   F +      + +W       +H    P L  N     P
Sbjct: 184 KCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMW------AVHNGTRPPLIKNL----P 231
Query: 512 SRLLQIGLLCVQASAELRPSMSIVVKMLT 540
             +  +   C       RPSM  +VK++T
Sbjct: 232 KPIESLMTRCWSKDPSQRPSMEEIVKIMT 260

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 92.0 bits (227), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/269 (29%), Positives = 125/269 (46%), Gaps = 30/269 (11%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
           +G+G  G V K      + VA+K++   + +    F  E+  +S +NH N+VKL G  + 
Sbjct: 16  VGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII---LSTAEGLAYLHEESKLRII 393
                LV E+    SL +   V    EPL +      +   L  ++G+AYLH      +I
Sbjct: 73  --PVCLVMEYAEGGSLYN---VLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALI 127
Query: 394 HRDIKLSNILLDEEFTA-KIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTE 451
           HRD+K  N+LL    T  KI DFG       DI TH++    G+  +MAPE       +E
Sbjct: 128 HRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNN-KGSAAWMAPEVFEGSNYSE 182
Query: 452 KADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKP 511
           K DV+S+G+++ EV+ R++   F +      + +W       +H    P L  N     P
Sbjct: 183 KCDVFSWGIILWEVITRRKP--FDEIGGPAFRIMW------AVHNGTRPPLIKNL----P 230
Query: 512 SRLLQIGLLCVQASAELRPSMSIVVKMLT 540
             +  +   C       RPSM  +VK++T
Sbjct: 231 KPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 126/267 (47%), Gaps = 19/267 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G V+ G     + VA+K +        D F  E  ++  ++H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +      LV+EF+ +  L D L  ++ +   + E    + L   EG+AYL E S   +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEAS---VIH 126
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD+   N L+ E    K++DFG+ R   +D    S      + + +PE     + + K+D
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFGV++ EV    +I    +++  +++   D+    RL++   P LA        + +
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVE---DISTGFRLYK---PRLAS-------THV 233
Query: 515 LQIGLLCVQASAELRPSMSIVVKMLTG 541
            QI   C +   E RP+ S +++ L  
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLLRQLAA 260

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 195 SKFSVASDVWSFGVVLYEL 213

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL  + 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 133
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 192 SKFSVASDVWSFGVVLYEL 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 22  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 81
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL    
Sbjct: 82  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL---G 136
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 197 SKFSVASDVWSFGVVLYEL 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
            +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
             G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL  +
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK 164
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVV 445
              R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE + 
Sbjct: 165 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 446 RGKLTEKADVYSFGVVVIEV 465
             K +  +DV+SFGVV+ E+
Sbjct: 222 ESKFSVASDVWSFGVVLYEL 241

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL  + 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 151
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 152 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 210 SKFSVASDVWSFGVVLYEL 228

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 23  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 82
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL    
Sbjct: 83  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL---G 137
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 198 SKFSVASDVWSFGVVLYEL 216

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 35  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 94
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL  + 
Sbjct: 95  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 151
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 152 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 210 SKFSVASDVWSFGVVLYEL 228

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 24  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 83
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL    
Sbjct: 84  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL---G 138
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 199 SKFSVASDVWSFGVVLYEL 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 21  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 80
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL  + 
Sbjct: 81  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 137
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 138 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 196 SKFSVASDVWSFGVVLYEL 214

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL  + 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 133
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 192 SKFSVASDVWSFGVVLYEL 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 16  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 75
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL  + 
Sbjct: 76  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 132
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 133 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 191 SKFSVASDVWSFGVVLYEL 209

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 104/200 (52%), Gaps = 14/200 (7%)
Query: 275 NKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
            +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
             G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL  +
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK 131
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVV 445
              R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE + 
Sbjct: 132 ---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 446 RGKLTEKADVYSFGVVVIEV 465
             K +  +DV+SFGVV+ E+
Sbjct: 189 ESKFSVASDVWSFGVVLYEL 208

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 17  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL  + 
Sbjct: 77  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYLGTK- 133
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 134 --RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 192 SKFSVASDVWSFGVVLYEL 210

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/226 (31%), Positives = 116/226 (51%), Gaps = 35/226 (15%)
Query: 256 KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN----TTQWVDH 311
           +++F+  TLE+          +G GG G VY+    G E VAVK   ++     +Q +++
Sbjct: 3   EIDFAELTLEEI---------IGIGGFGKVYRAFWIGDE-VAVKAARHDPDEDISQTIEN 52
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV---PNQSLLDNLFVRQDVEPLSWE 368
              E  L + + H N++ L G  +  P   LV EF    P   +L    +  D+  ++W 
Sbjct: 53  VRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL-VNWA 111
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF--------TAKIADFGLVRL 420
           V+       A G+ YLH+E+ + IIHRD+K SNIL+ ++           KI DFGL R 
Sbjct: 112 VQ------IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE 165
Query: 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +    T +SA  AG   +MAPE +     ++ +DV+S+GV++ E++
Sbjct: 166 W-HRTTKMSA--AGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELL 208

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 102/199 (51%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  +++   E +      +      +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQAHAERIDHIKLLQYTSQICKGMEYL---G 134
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 195 SKFSVASDVWSFGVVLYEL 213

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 140/295 (47%), Gaps = 42/295 (14%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
           +LGQG  G VY+G    +  GEA   VAVK +  + + +    F NE +++ G    ++V
Sbjct: 21  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 80
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAEGL 381
           +LLG    G  +L+V E + +  L   L  +R + E      P + +   ++    A+G+
Sbjct: 81  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 140
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG---- 437
           AYL+ +   + +HRD+   N ++  +FT KI DFG+ R    DI        G  G    
Sbjct: 141 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 193
Query: 438 -YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +MAPE +  G  T  +D++SFGVV+ E+           ++  +L+ V D    G L +
Sbjct: 194 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---GGYLDQ 250
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
                      +  P R+  +  +C Q + ++RP+   +V +L  +   L P+ P
Sbjct: 251 P----------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD---LHPSFP 292

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 140/295 (47%), Gaps = 42/295 (14%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
           +LGQG  G VY+G    +  GEA   VAVK +  + + +    F NE +++ G    ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAEGL 381
           +LLG    G  +L+V E + +  L   L  +R + E      P + +   ++    A+G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG---- 437
           AYL+ +   + +HRD+   N ++  +FT KI DFG+ R    DI        G  G    
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 196
Query: 438 -YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +MAPE +  G  T  +D++SFGVV+ E+           ++  +L+ V D    G L +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---GGYLDQ 253
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
                      +  P R+  +  +C Q + ++RP+   +V +L  +   L P+ P
Sbjct: 254 P----------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD---LHPSFP 295

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ YL 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R ++ ++   +       L   +MA E
Sbjct: 150 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALE 206
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 258
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 259 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 292

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/199 (32%), Positives = 103/199 (51%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 20  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 79
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ EF+P  SL +  ++++  E +      +      +G+ YL    
Sbjct: 80  KGVCYSAGRRNLKLIMEFLPYGSLRE--YLQKHKERIDHIKLLQYTSQICKGMEYL---G 134
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVR 446
             R IHRD+   NIL++ E   KI DFGL ++ P+D         G   + + APE +  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 195 SKFSVASDVWSFGVVLYEL 213

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 276 KLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +LG+G  GSV    Y       GE VAVK+L ++T + +  F  E+ ++  + H N+VK 
Sbjct: 18  QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 77
Query: 331 LG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL    
Sbjct: 78  KGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL---G 132
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYVVR 446
             R IHR++   NIL++ E   KI DFGL ++ P+D  +      G   + + APE +  
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 447 GKLTEKADVYSFGVVVIEV 465
            K +  +DV+SFGVV+ E+
Sbjct: 193 SKFSVASDVWSFGVVLYEL 211

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 126/271 (46%), Gaps = 27/271 (9%)
Query: 277 LGQGGSGSVYKG--TLPGGEAVAVK----RLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V  G   LPG   VAV     ++ Y   Q  D F  E +++   +H N+V L
Sbjct: 51  IGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRD-FLCEASIMGQFDHPNVVHL 109
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G    G   ++V EF+ N +L  + F+R+     +      ++   A G+ YL   + +
Sbjct: 110 EGVVTRGKPVMIVIEFMENGAL--DAFLRKHDGQFTVIQLVGMLRGIAAGMRYL---ADM 164
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
             +HRD+   NIL++     K++DFGL R+  +D   +  T  G +   + APE +   K
Sbjct: 165 GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRK 224
Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T  +DV+S+G+V+ EV+       +  ++  +++ + + Y   RL   +D         
Sbjct: 225 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY---RLPAPMD--------- 272
Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
             P+ L Q+ L C Q     RP    +V +L
Sbjct: 273 -CPAGLHQLMLDCWQKERAERPKFEQIVGIL 302

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           +Y     K+G+G +G V   T+   G+ VAVK++     Q  +  FNEV ++    H+N+
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V++    + G E  +V EF+   +L D +   R + E ++      + L+  + L+ LH 
Sbjct: 89  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHA 143
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +    +IHRDIK  +ILL  +   K++DFG      +++      L GT  +MAPE + R
Sbjct: 144 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISR 199
Query: 447 GKLTEKADVYSFGVVVIEVV 466
                + D++S G++VIE+V
Sbjct: 200 LPYGPEVDIWSLGIMVIEMV 219

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 139/295 (47%), Gaps = 42/295 (14%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
           +LGQG  G VY+G    +  GEA   VAVK +  + + +    F NE +++ G    ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAEGL 381
           +LLG    G  +L+V E + +  L   L  +R + E      P + +   ++    A+G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG---- 437
           AYL+ +   + +HRD+   N ++  +FT KI DFG+ R    DI        G  G    
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIXETDXXRKGGKGLLPV 196
Query: 438 -YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +MAPE +  G  T  +D++SFGVV+ E+           ++  +L+ V D    G L +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---GGYLDQ 253
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
                      +  P R+  +  +C Q +  +RP+   +V +L  +   L P+ P
Sbjct: 254 P----------DNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD---LHPSFP 295

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           +Y     K+G+G +G V   T+   G+ VAVK++     Q  +  FNEV ++    H+N+
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V++    + G E  +V EF+   +L D +   R + E ++      + L+  + L+ LH 
Sbjct: 91  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHA 145
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +    +IHRDIK  +ILL  +   K++DFG      +++      L GT  +MAPE + R
Sbjct: 146 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISR 201
Query: 447 GKLTEKADVYSFGVVVIEVV 466
                + D++S G++VIE+V
Sbjct: 202 LPYGPEVDIWSLGIMVIEMV 221

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ YL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R ++ ++   +       L   +MA E
Sbjct: 151 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 259
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 260 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 87/289 (30%), Positives = 138/289 (47%), Gaps = 34/289 (11%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ YL 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYLA 148
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R ++ ++   +       L   +MA E
Sbjct: 149 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 205
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 257
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT-------GNHE 544
                E  P  L ++ L C    AE+RPS S +V  ++       G HE
Sbjct: 258 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHE 301

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ YL 
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYLA 149
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R ++ ++   +       L   +MA E
Sbjct: 150 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 206
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 207 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 258
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 259 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 292

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ YL 
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYLA 142
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R ++ ++   +       L   +MA E
Sbjct: 143 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 199
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 200 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 251
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 252 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 285

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ YL 
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYLA 145
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R ++ ++   +       L   +MA E
Sbjct: 146 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 202
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 254
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 255 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 288

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           +Y     K+G+G +G V   T+   G+ VAVK++     Q  +  FNEV ++    H+N+
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V++    + G E  +V EF+   +L D +   R + E ++      + L+  + L+ LH 
Sbjct: 80  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHA 134
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +    +IHRDIK  +ILL  +   K++DFG      +++      L GT  +MAPE + R
Sbjct: 135 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISR 190
Query: 447 GKLTEKADVYSFGVVVIEVV 466
                + D++S G++VIE+V
Sbjct: 191 LPYGPEVDIWSLGIMVIEMV 210

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ YL 
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYLA 168
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R ++ ++   +       L   +MA E
Sbjct: 169 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 225
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 226 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 277
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 278 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 311

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 145/311 (46%), Gaps = 33/311 (10%)
Query: 246 GALQVAVNKSKLN------FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEA---- 295
           GA  V ++ S LN        +  +  ++   H +  +G+G  G VY GTL   +     
Sbjct: 60  GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 119
Query: 296 VAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESLLVYEFVPNQSLL 353
            AVK L   T    V  F  E  ++   +H N++ LLG C  +    L+V  ++ +  L 
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179
Query: 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
           +  F+R +    + +      L  A+G+ +L  +   + +HRD+   N +LDE+FT K+A
Sbjct: 180 N--FIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVA 234
Query: 414 DFGLVRLFPE---DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
           DFGL R   +   D  H        + +MA E +   K T K+DV+SFGV++ E++ R  
Sbjct: 235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 294
Query: 471 INLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRP 530
                 N+  I  TV+ L  +GR    + P       E  P  L ++ L C    AE+RP
Sbjct: 295 PPYPDVNTFDI--TVYLL--QGR--RLLQP-------EYCPDPLYEVMLKCWHPKAEMRP 341
Query: 531 SMSIVVKMLTG 541
           S S +V  ++ 
Sbjct: 342 SFSELVSRISA 352

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 89.4 bits (220), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           +Y     K+G+G +G V   T+   G+ VAVK++     Q  +  FNEV ++    H+N+
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V++    + G E  +V EF+   +L D +   R + E ++      + L+  + L+ LH 
Sbjct: 84  VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHA 138
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +    +IHRDIK  +ILL  +   K++DFG      +++      L GT  +MAPE + R
Sbjct: 139 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISR 194
Query: 447 GKLTEKADVYSFGVVVIEVV 466
                + D++S G++VIE+V
Sbjct: 195 LPYGPEVDIWSLGIMVIEMV 214

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ YL 
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYLA 147
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R ++ ++   +       L   +MA E
Sbjct: 148 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 204
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 205 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 256
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 257 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 290

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 89.4 bits (220), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ YL 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYLA 150
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R ++ ++   +       L   +MA E
Sbjct: 151 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 207
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 259
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 260 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           +Y     K+G+G +G V   T+   G+ VAVK++     Q  +  FNEV ++    H+N+
Sbjct: 74  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 133
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V++    + G E  +V EF+   +L D +   R + E ++      + L+  + L+ LH 
Sbjct: 134 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHA 188
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +    +IHRDIK  +ILL  +   K++DFG      +++      L GT  +MAPE + R
Sbjct: 189 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISR 244
Query: 447 GKLTEKADVYSFGVVVIEVV 466
                + D++S G++VIE+V
Sbjct: 245 LPYGPEVDIWSLGIMVIEMV 264

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 61/200 (30%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           +Y     K+G+G +G V   T+   G+ VAVK++     Q  +  FNEV ++    H+N+
Sbjct: 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 210
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V++    + G E  +V EF+   +L D +   R + E ++      + L+  + L+ LH 
Sbjct: 211 VEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLQALSVLHA 265
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +    +IHRDIK  +ILL  +   K++DFG      +++      L GT  +MAPE + R
Sbjct: 266 QG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR-RKXLVGTPYWMAPELISR 321
Query: 447 GKLTEKADVYSFGVVVIEVV 466
                + D++S G++VIE+V
Sbjct: 322 LPYGPEVDIWSLGIMVIEMV 341

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ YL 
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYLA 169
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R ++ ++   +       L   +MA E
Sbjct: 170 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALE 226
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 227 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 278
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 279 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 312

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 90/311 (28%), Positives = 145/311 (46%), Gaps = 33/311 (10%)
Query: 246 GALQVAVNKSKLN------FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEA---- 295
           GA  V ++ S LN        +  +  ++   H +  +G+G  G VY GTL   +     
Sbjct: 1   GANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIH 60
Query: 296 VAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESLLVYEFVPNQSLL 353
            AVK L   T    V  F  E  ++   +H N++ LLG C  +    L+V  ++ +  L 
Sbjct: 61  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 120
Query: 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
           +  F+R +    + +      L  A+G+ +L  +   + +HRD+   N +LDE+FT K+A
Sbjct: 121 N--FIRNETHNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVA 175
Query: 414 DFGLVRLFPE---DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
           DFGL R   +   D  H        + +MA E +   K T K+DV+SFGV++ E++ R  
Sbjct: 176 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA 235
Query: 471 INLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRP 530
                 N+  I  TV+ L  +GR    + P       E  P  L ++ L C    AE+RP
Sbjct: 236 PPYPDVNTFDI--TVYLL--QGR--RLLQP-------EYCPDPLYEVMLKCWHPKAEMRP 282
Query: 531 SMSIVVKMLTG 541
           S S +V  ++ 
Sbjct: 283 SFSELVSRISA 293

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 125/266 (46%), Gaps = 19/266 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G V+ G     + VA+K +        D F  E  ++  ++H  LV+L G  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +      LV+EF+ +  L D L  ++ +   + E    + L   EG+AYL E     +IH
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEAC---VIH 126
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD+   N L+ E    K++DFG+ R   +D    S      + + +PE     + + K+D
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFGV++ EV    +I    +++  +++   D+    RL++   P LA        + +
Sbjct: 187 VWSFGVLMWEVFSEGKIPYENRSNSEVVE---DISTGFRLYK---PRLAS-------THV 233
Query: 515 LQIGLLCVQASAELRPSMSIVVKMLT 540
            QI   C +   E RP+ S +++ L 
Sbjct: 234 YQIMNHCWKERPEDRPAFSRLLRQLA 259

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 101/193 (52%), Gaps = 11/193 (5%)
Query: 276 KLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+G+G +G V   T    G+ VAVK++     Q  +  FNEV ++   +H N+V +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 335 ITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
           + G E  +V EF+   +L D +   R + E ++      + LS    L+YLH +    +I
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHNQG---VI 163
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRDIK  +ILL  +   K++DFG      +++      L GT  +MAPE + R     + 
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RKXLVGTPYWMAPEVISRLPYGTEV 222
Query: 454 DVYSFGVVVIEVV 466
           D++S G++VIE++
Sbjct: 223 DIWSLGIMVIEMI 235

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 65/197 (32%), Positives = 106/197 (53%), Gaps = 13/197 (6%)
Query: 277 LGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKL 330
           LG G  G+VYKG  +P GE     VA+K L  NT+   +    +E  +++G+    + +L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
           LG  +T    L V + +P   LLD+  VR++   L  +      +  A+G++YL +   +
Sbjct: 85  LGICLTSTVQL-VTQLMPYGCLLDH--VRENRGRLGSQDLLNWCMQIAKGMSYLED---V 138
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPEYVVRGKL 449
           R++HRD+   N+L+      KI DFGL RL   D T   A      + +MA E ++R + 
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRF 198
Query: 450 TEKADVYSFGVVVIEVV 466
           T ++DV+S+GV V E++
Sbjct: 199 THQSDVWSYGVTVWELM 215

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 133/279 (47%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ +L 
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFLA 148
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAGTLGYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R   +   D  H        + +MA E
Sbjct: 149 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 205
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 206 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 257
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 258 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 291

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 125/266 (46%), Gaps = 19/266 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G V+ G     + VA+K +        D F  E  ++  ++H  LV+L G  
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 74
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +      LV+EF+ +  L D L  ++ +   + E    + L   EG+AYL E     +IH
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEAC---VIH 129
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD+   N L+ E    K++DFG+ R   +D    S      + + +PE     + + K+D
Sbjct: 130 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 189
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFGV++ EV    +I    +++  +++   D+    RL++   P LA        + +
Sbjct: 190 VWSFGVLMWEVFSEGKIPYENRSNSEVVE---DISTGFRLYK---PRLAS-------THV 236
Query: 515 LQIGLLCVQASAELRPSMSIVVKMLT 540
            QI   C +   E RP+ S +++ L 
Sbjct: 237 YQIMNHCWRERPEDRPAFSRLLRQLA 262

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 89.0 bits (219), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 141/295 (47%), Gaps = 42/295 (14%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
           +LGQG  G VY+G    +  GEA   VAVK +  + + +    F NE +++ G    ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAEGL 381
           +LLG    G  +L+V E + +  L   L  +R + E      P + +   ++    A+G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG---- 437
           AYL+ +   + +HRD+   N ++  +FT KI DFG+ R    DI   +    G  G    
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETAYYRKGGKGLLPV 196
Query: 438 -YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +MAPE +  G  T  +D++SFGVV+ E+           ++  +L+ V D    G L +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---GGYLDQ 253
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
                      +  P R+  +  +C Q + ++RP+   +V +L  +   L P+ P
Sbjct: 254 P----------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD---LHPSFP 295

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 133/279 (47%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ +L 
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFLA 150
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAGTLGYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R   +   D  H        + +MA E
Sbjct: 151 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 207
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 208 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 259
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 260 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 133/279 (47%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ +L 
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFLA 155
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAGTLGYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R   +   D  H        + +MA E
Sbjct: 156 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 212
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 213 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 264
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 265 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 298

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 133/279 (47%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ +L 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAGTLGYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R   +   D  H        + +MA E
Sbjct: 152 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALE 208
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 260
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 261 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 294

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 133/279 (47%), Gaps = 27/279 (9%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H +  +G+G  G VY GTL   +      AVK L   T    V  F  E  ++   +H N
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ +L 
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFLA 151
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAGTLGYMAPE 442
            +   + +HRD+   N +LDE+FT K+ADFGL R   +   D  H        + +MA E
Sbjct: 152 SK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALE 208
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
            +   K T K+DV+SFGV++ E++ R        N+  I  TV+ L  +GR    + P  
Sbjct: 209 SLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI--TVYLL--QGR--RLLQP-- 260
Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
                E  P  L ++ L C    AE+RPS S +V  ++ 
Sbjct: 261 -----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISA 294

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 140/295 (47%), Gaps = 42/295 (14%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
           +LGQG  G VY+G    +  GEA   VAVK +  + + +    F NE +++ G    ++V
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAEGL 381
           +LLG    G  +L+V E + +  L   L  +R + E      P + +   ++    A+G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG---- 437
           AYL+ +   + +HRD+   N ++  +FT KI DFG+ R    DI        G  G    
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 195
Query: 438 -YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +MAPE +  G  T  +D++SFGVV+ E+           ++  +L+ V D    G L +
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---GGYLDQ 252
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
                      +  P R+  +  +C Q + ++RP+   +V +L  +   L P+ P
Sbjct: 253 P----------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD---LHPSFP 294

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 88.6 bits (218), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 125/266 (46%), Gaps = 19/266 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G V+ G     + VA+K +        D F  E  ++  ++H  LV+L G  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 69
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +      LV+EF+ +  L D L  ++ +   + E    + L   EG+AYL E     +IH
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEAC---VIH 124
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD+   N L+ E    K++DFG+ R   +D    S      + + +PE     + + K+D
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFGV++ EV    +I    +++  +++   D+    RL++   P LA        + +
Sbjct: 185 VWSFGVLMWEVFSEGKIPYENRSNSEVVE---DISTGFRLYK---PRLAS-------THV 231
Query: 515 LQIGLLCVQASAELRPSMSIVVKMLT 540
            QI   C +   E RP+ S +++ L 
Sbjct: 232 YQIMNHCWKERPEDRPAFSRLLRQLA 257

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 140/295 (47%), Gaps = 42/295 (14%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
           +LGQG  G VY+G    +  GEA   VAVK +  + + +    F NE +++ G    ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAEGL 381
           +LLG    G  +L+V E + +  L   L  +R + E      P + +   ++    A+G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG---- 437
           AYL+ +   + +HRD+   N ++  +FT KI DFG+ R    DI        G  G    
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 196
Query: 438 -YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +MAPE +  G  T  +D++SFGVV+ E+           ++  +L+ V D    G L +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---GGYLDQ 253
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
                      +  P R+  +  +C Q + ++RP+   +V +L  +   L P+ P
Sbjct: 254 P----------DNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD---LHPSFP 295

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 133/292 (45%), Gaps = 42/292 (14%)
Query: 271 FHESNKLGQGGSGSVY-KGTLPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGINHK 325
           F +  ++G G  G+VY    +   E VA+K++ Y+  Q    W D    EV  +  + H 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 114
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYL 384
           N ++  GC +    + LV E+    S  D L V +  +PL  EV    +   A +GLAYL
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAVTHGALQGLAYL 170
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
           H  +   +IHRD+K  NILL E    K+ DFG        I   +    GT  +MAPE +
Sbjct: 171 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPYWMAPEVI 222
Query: 445 V---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA 501
           +    G+   K DV+S G+  IE+  RK   LF  N+ S L  +          +   PA
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKP-PLFNMNAMSALYHI---------AQNESPA 272
Query: 502 LAGNFQEGKPSRLLQIGL-LCVQASAELRPSMSIVVKMLTGNHEILQPTQPP 552
           L    Q G  S   +  +  C+Q   + RP+  +++K     H  +   +PP
Sbjct: 273 L----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK-----HRFVLRERPP 315

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 88/292 (30%), Positives = 133/292 (45%), Gaps = 42/292 (14%)
Query: 271 FHESNKLGQGGSGSVY-KGTLPGGEAVAVKRLFYNTTQ----WVDHFFNEVNLISGINHK 325
           F +  ++G G  G+VY    +   E VA+K++ Y+  Q    W D    EV  +  + H 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQD-IIKEVRFLQKLRHP 75
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYL 384
           N ++  GC +    + LV E+    S  D L V +  +PL  EV    +   A +GLAYL
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAVTHGALQGLAYL 131
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
           H  +   +IHRD+K  NILL E    K+ DFG        I   +    GT  +MAPE +
Sbjct: 132 HSHN---MIHRDVKAGNILLSEPGLVKLGDFGSA-----SIMAPANXFVGTPYWMAPEVI 183
Query: 445 V---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA 501
           +    G+   K DV+S G+  IE+  RK   LF  N+ S L  +          +   PA
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKP-PLFNMNAMSALYHI---------AQNESPA 233
Query: 502 LAGNFQEGKPSRLLQIGL-LCVQASAELRPSMSIVVKMLTGNHEILQPTQPP 552
           L    Q G  S   +  +  C+Q   + RP+  +++K     H  +   +PP
Sbjct: 234 L----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK-----HRFVLRERPP 276

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 277 LGQGGSGSVYKG--TLPGGE--AVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V  G   LPG     VA+K  ++ Y   Q  D F  E +++   +H N++ L
Sbjct: 30  IGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIHL 88
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        ++V E++ N SL  + F++++    +      ++   + G+ YL   S +
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSL--DTFLKKNDGQFTVIQLVGMLRGISAGMKYL---SDM 143
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
             +HRD+   NIL++     K++DFGL R+  +D      T  G +   + APE +   K
Sbjct: 144 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRK 203
Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T  +DV+S+G+V+ EVV       +   +  +++ V + Y   RL   +D         
Sbjct: 204 FTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGY---RLPSPMD--------- 251
Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
             P+ L Q+ L C Q     RP    +V ML
Sbjct: 252 -CPAALYQLMLDCWQKERNSRPKFDEIVNML 281

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 115/223 (51%), Gaps = 19/223 (8%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNT 305
           A N+++L    ET  K          LG G  G+VYKG  +P GE     VA+K L   T
Sbjct: 26  APNQAQLRILKETELKRVKV------LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 79
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
               +  F +E  +++ ++H +LV+LLG  ++ P   LV + +P+  LL+  +V +  + 
Sbjct: 80  GPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLE--YVHEHKDN 136
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
           +  ++     +  A+G+ YL E    R++HRD+   N+L+      KI DFGL RL   D
Sbjct: 137 IGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 193
Query: 425 ITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
               +A      + +MA E +   K T ++DV+S+GV + E++
Sbjct: 194 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 236

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 115/223 (51%), Gaps = 19/223 (8%)
Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAV----AVKRLFYNT 305
           A N+++L    ET  K          LG G  G+VYKG  +P GE V    A+K L   T
Sbjct: 3   APNQAQLRILKETELKRVKV------LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT 56
Query: 306 TQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
               +  F +E  +++ ++H +LV+LLG  ++ P   LV + +P+  LL+  +V +  + 
Sbjct: 57  GPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQLVTQLMPHGCLLE--YVHEHKDN 113
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
           +  ++     +  A+G+ YL E    R++HRD+   N+L+      KI DFGL RL   D
Sbjct: 114 IGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 170
Query: 425 ITHISATLAGT-LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
               +A      + +MA E +   K T ++DV+S+GV + E++
Sbjct: 171 EKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 213

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 263 TLEKATNYFHESNK------------LGQGGSGSVYKG--TLPGGEAVAVK----RLFYN 304
           T E  T   HE  K            +G G  G V  G   LP  + ++V     ++ Y 
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 305 TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
             Q  D F  E +++   +H N+++L G        ++V E++ N SL D+   + D + 
Sbjct: 87  EKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQF 144
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
              ++   ++   A G+ YL   S +  +HRD+   NIL++     K++DFGL R+  +D
Sbjct: 145 TVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDD 200
Query: 425 ITHISATLAGTLG--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 T  G +   + +PE +   K T  +DV+S+G+V+ EV+       +  ++  ++
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V + Y   RL   +D           P+ L Q+ L C Q     RP    +V +L
Sbjct: 261 KAVDEGY---RLPPPMD----------CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 263 TLEKATNYFHESNK------------LGQGGSGSVYKG--TLPGGEAVAVK----RLFYN 304
           T E  T   HE  K            +G G  G V  G   LP  + ++V     ++ Y 
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 305 TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
             Q  D F  E +++   +H N+++L G        ++V E++ N SL D+   + D + 
Sbjct: 87  EKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQF 144
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
              ++   ++   A G+ YL   S +  +HRD+   NIL++     K++DFGL R+  +D
Sbjct: 145 TVIQL-VGMLRGIASGMKYL---SDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 425 ITHISATLAGTLG--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 T  G +   + +PE +   K T  +DV+S+G+V+ EV+       +  ++  ++
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V + Y   RL   +D           P+ L Q+ L C Q     RP    +V +L
Sbjct: 261 KAVDEGY---RLPPPMD----------CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 87.0 bits (214), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/266 (26%), Positives = 124/266 (46%), Gaps = 19/266 (7%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G V+ G     + VA+K +        D F  E  ++  ++H  LV+L G  
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED-FIEEAEVMMKLSHPKLVQLYGVC 72
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +      LV EF+ +  L D L  ++ +   + E    + L   EG+AYL E     +IH
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGL--FAAETLLGMCLDVCEGMAYLEEAC---VIH 127
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD+   N L+ E    K++DFG+ R   +D    S      + + +PE     + + K+D
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 455 VYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRL 514
           V+SFGV++ EV    +I    +++  +++   D+    RL++   P LA        + +
Sbjct: 188 VWSFGVLMWEVFSEGKIPYENRSNSEVVE---DISTGFRLYK---PRLAS-------THV 234
Query: 515 LQIGLLCVQASAELRPSMSIVVKMLT 540
            QI   C +   E RP+ S +++ L 
Sbjct: 235 YQIMNHCWRERPEDRPAFSRLLRQLA 260

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/303 (27%), Positives = 139/303 (45%), Gaps = 42/303 (13%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-HFFNEVN 317
           E A      S +LGQG  G VY+G   G         VA+K +    +      F NE +
Sbjct: 6   EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 65
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVR 370
           ++   N  ++V+LLG    G  +L++ E +    L   L  +R ++E      P S    
Sbjct: 66  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 125
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
            ++    A+G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R    DI     
Sbjct: 126 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDX 178
Query: 431 TLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
              G  G     +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 238
Query: 486 WDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEI 545
               ++G L +  D           P  LL++  +C Q + ++RPS    +++++   E 
Sbjct: 239 ----MEGGLLDKPDNC---------PDMLLELMRMCWQYNPKMRPSF---LEIISSIKEE 282
Query: 546 LQP 548
           ++P
Sbjct: 283 MEP 285

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 263 TLEKATNYFHESNK------------LGQGGSGSVYKG--TLPGGEAVAVK----RLFYN 304
           T E  T   HE  K            +G G  G V  G   LP  + ++V     ++ Y 
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 305 TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
             Q  D F  E +++   +H N+++L G        ++V E++ N SL D+   + D + 
Sbjct: 87  EKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQF 144
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
              ++   ++   A G+ YL   S +  +HRD+   NIL++     K++DFGL R+  +D
Sbjct: 145 TVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 425 ITHISATLAGTLG--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 T  G +   + +PE +   K T  +DV+S+G+V+ EV+       +  ++  ++
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V + Y   RL   +D           P+ L Q+ L C Q     RP    +V +L
Sbjct: 261 KAVDEGY---RLPPPMD----------CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 263 TLEKATNYFHESNK------------LGQGGSGSVYKG--TLPGGEAVAVK----RLFYN 304
           T E  T   HE  K            +G G  G V  G   LP  + ++V     ++ Y 
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 305 TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
             Q  D F  E +++   +H N+++L G        ++V E++ N SL D+   + D + 
Sbjct: 87  EKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQF 144
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
              ++   ++   A G+ YL   S +  +HRD+   NIL++     K++DFGL R+  +D
Sbjct: 145 TVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 425 ITHISATLAGTLG--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 T  G +   + +PE +   K T  +DV+S+G+V+ EV+       +  ++  ++
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V + Y   RL   +D           P+ L Q+ L C Q     RP    +V +L
Sbjct: 261 KAVDEGY---RLPPPMD----------CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 263 TLEKATNYFHESNK------------LGQGGSGSVYKG--TLPGGEAVAVK----RLFYN 304
           T E  T   HE  K            +G G  G V  G   LP  + ++V     ++ Y 
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 305 TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
             Q  D F  E +++   +H N+++L G        ++V E++ N SL D+   + D + 
Sbjct: 87  EKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQF 144
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
              ++   ++   A G+ YL   S +  +HRD+   NIL++     K++DFGL R+  +D
Sbjct: 145 TVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200
Query: 425 ITHISATLAGTLG--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 T  G +   + +PE +   K T  +DV+S+G+V+ EV+       +  ++  ++
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V + Y   RL   +D           P+ L Q+ L C Q     RP    +V +L
Sbjct: 261 KAVDEGY---RLPPPMD----------CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 263 TLEKATNYFHESNK------------LGQGGSGSVYKG--TLPGGEAVAVK----RLFYN 304
           T E  T   HE  K            +G G  G V  G   LP  + ++V     ++ Y 
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 305 TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
             Q  D F  E +++   +H N+++L G        ++V E++ N SL D+   + D + 
Sbjct: 87  EKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQF 144
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
              ++   ++   A G+ YL   S +  +HRD+   NIL++     K++DFGL R+  +D
Sbjct: 145 TVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 425 ITHISATLAGTLG--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 T  G +   + +PE +   K T  +DV+S+G+V+ EV+       +  ++  ++
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V + Y   RL   +D           P+ L Q+ L C Q     RP    +V +L
Sbjct: 261 KAVDEGY---RLPPPMD----------CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 124/273 (45%), Gaps = 29/273 (10%)
Query: 277 LGQGGSGSVYKG--TLPGGEA--VAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V  G   LPG     VA+K L   Y   Q  D F +E +++   +H N++ L
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNVIHL 99
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        +++ EF+ N SL  + F+RQ+    +      ++   A G+ YL   + +
Sbjct: 100 EGVVTKSTPVMIITEFMENGSL--DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADM 154
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLG--YMAPEYVVR 446
             +HRD+   NIL++     K++DFGL R   +D +  + T  L G +   + APE +  
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 214
Query: 447 GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF 506
            K T  +DV+S+G+V+ EV+       +   +  ++  +   Y   RL   +D       
Sbjct: 215 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY---RLPPPMD------- 264
Query: 507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
               PS L Q+ L C Q     RP    +V  L
Sbjct: 265 ---CPSALHQLMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 139/295 (47%), Gaps = 42/295 (14%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
           +LGQG  G VY+G    +  GEA   VAVK +  + + +    F NE +++ G    ++V
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAEGL 381
           +LLG    G  +L+V E + +  L   L  +R + E      P + +   ++    A+G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG---- 437
           AYL+ +   + +HR++   N ++  +FT KI DFG+ R    DI        G  G    
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 197
Query: 438 -YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +MAPE +  G  T  +D++SFGVV+ E+           ++  +L+ V D    G L +
Sbjct: 198 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---GGYLDQ 254
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
                      +  P R+  +  +C Q +  +RP+   +V +L  +   L P+ P
Sbjct: 255 P----------DNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD---LHPSFP 296

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 263 TLEKATNYFHESNK------------LGQGGSGSVYKG--TLPGGEAVAVK----RLFYN 304
           T E  T   HE  K            +G G  G V  G   LP  + ++V     ++ Y 
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 305 TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
             Q  D F  E +++   +H N+++L G        ++V E++ N SL D+   + D + 
Sbjct: 87  EKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQF 144
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
              ++   ++   A G+ YL   S +  +HRD+   NIL++     K++DFGL R+  +D
Sbjct: 145 TVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 425 ITHISATLAGTLG--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 T  G +   + +PE +   K T  +DV+S+G+V+ EV+       +  ++  ++
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V + Y   RL   +D           P+ L Q+ L C Q     RP    +V +L
Sbjct: 261 KAVDEGY---RLPPPMD----------CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 138/283 (48%), Gaps = 25/283 (8%)
Query: 274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           S ++G G  G+VYKG   G  AV + ++   T +    F NEV ++    H N++  +G 
Sbjct: 41  STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
            +T     +V ++    SL  +L V Q+ +   +++   I   TA+G+ YLH ++   II
Sbjct: 101 -MTKDNLAIVTQWCEGSSLYKHLHV-QETKFQMFQL-IDIARQTAQGMDYLHAKN---II 154
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVVRGK---- 448
           HRD+K +NI L E  T KI DFGL  +      +       G++ +MAPE V+R +    
Sbjct: 155 HRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE-VIRMQDNNP 213
Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            + ++DVYS+G+V+ E++  +       N   I      +++ GR + + D        +
Sbjct: 214 FSFQSDVYSYGIVLYELMTGELPYSHINNRDQI------IFMVGRGYASPD---LSKLYK 264
Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
             P  + ++   CV+   E RP    ++  +    E+LQ + P
Sbjct: 265 NCPKAMKRLVADCVKKVKEERPLFPQILSSI----ELLQHSLP 303

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 132/297 (44%), Gaps = 39/297 (13%)
Query: 263 TLEKATNYFHESNK------------LGQGGSGSVYKG--TLPGGEAVAVK----RLFYN 304
           T E  T   HE  K            +G G  G V  G   LP  + ++V     ++ Y 
Sbjct: 25  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 84
Query: 305 TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
             Q  D F  E +++   +H N+++L G        ++V E++ N SL D+   + D + 
Sbjct: 85  EKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQF 142
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
              ++   ++   A G+ YL   S +  +HRD+   NIL++     K++DFGL R+  +D
Sbjct: 143 TVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 198
Query: 425 ITHISATLAGTLG--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 T  G +   + +PE +   K T  +DV+S+G+V+ EV+       +  ++  ++
Sbjct: 199 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 258
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V + Y   RL   +D           P+ L Q+ L C Q     RP    +V +L
Sbjct: 259 KAVDEGY---RLPPPMD----------CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 302

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 139/295 (47%), Gaps = 42/295 (14%)
Query: 276 KLGQGGSGSVYKGT---LPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLV 328
           +LGQG  G VY+G    +  GEA   VAVK +  + + +    F NE +++ G    ++V
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAEGL 381
           +LLG    G  +L+V E + +  L   L  +R + E      P + +   ++    A+G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG---- 437
           AYL+ +   + +HR++   N ++  +FT KI DFG+ R    DI        G  G    
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 196
Query: 438 -YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +MAPE +  G  T  +D++SFGVV+ E+           ++  +L+ V D    G L +
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD---GGYLDQ 253
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
                      +  P R+  +  +C Q +  +RP+   +V +L  +   L P+ P
Sbjct: 254 P----------DNCPERVTDLMRMCWQFNPNMRPTFLEIVNLLKDD---LHPSFP 295

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 85.9 bits (211), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 99/193 (51%), Gaps = 11/193 (5%)
Query: 276 KLGQGGSGSV-YKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+G+G +G V        G  VAVK +     Q  +  FNEV ++    H N+V++    
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 335 ITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
           + G E  ++ EF+   +L D +  VR + E ++      +  +  + LAYLH +    +I
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA-----TVCEAVLQALAYLHAQG---VI 163
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRDIK  +ILL  +   K++DFG      +D+      L GT  +MAPE + R     + 
Sbjct: 164 HRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RKXLVGTPYWMAPEVISRSLYATEV 222
Query: 454 DVYSFGVVVIEVV 466
           D++S G++VIE+V
Sbjct: 223 DIWSLGIMVIEMV 235

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 81/303 (26%), Positives = 138/303 (45%), Gaps = 42/303 (13%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-HFFNEVN 317
           E A      S +LGQG  G VY+G   G         VA+K +    +      F NE +
Sbjct: 15  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 74
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVR 370
           ++   N  ++V+LLG    G  +L++ E +    L   L  +R ++E      P S    
Sbjct: 75  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKM 134
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
            ++    A+G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R    DI     
Sbjct: 135 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXETDX 187
Query: 431 TLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
              G  G     +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V
Sbjct: 188 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 247
Query: 486 WDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEI 545
               ++G L +  D           P  L ++  +C Q + ++RPS    +++++   E 
Sbjct: 248 ----MEGGLLDKPDNC---------PDMLFELMRMCWQYNPKMRPSF---LEIISSIKEE 291
Query: 546 LQP 548
           ++P
Sbjct: 292 MEP 294

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 277 LGQGGSGSVYKGTL--PGGEA--VAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V  G L  PG     VA+K L   Y   Q  D F +E +++   +H N++ L
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNIIHL 95
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        +++ E++ N SL  + F+R++    +      ++     G+ YL   S +
Sbjct: 96  EGVVTKCKPVMIITEYMENGSL--DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 150
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
             +HRD+   NIL++     K++DFG+ R+  +D      T  G +   + APE +   K
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T  +DV+S+G+V+ EV+       +  ++  +++ + + Y   RL   +D  +A     
Sbjct: 211 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY---RLPPPMDCPIA----- 262
Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                L Q+ L C Q     RP    +V ML
Sbjct: 263 -----LHQLMLDCWQKERSDRPKFGQIVNML 288

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 126/271 (46%), Gaps = 27/271 (9%)
Query: 277 LGQGGSGSVYKG--TLPGGEAVAVK----RLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V  G   LP  + ++V     ++ Y   Q  D F  E +++   +H N+++L
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 99
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        ++V E++ N SL D+   + D +    ++   ++   A G+ YL   S +
Sbjct: 100 EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQL-VGMLRGIASGMKYL---SDM 154
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
             +HRD+   NIL++     K++DFGL R+  +D      T  G +   + +PE +   K
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 214
Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T  +DV+S+G+V+ EV+       +  ++  +++ V + Y   RL   +D         
Sbjct: 215 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPPPMDC-------- 263
Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
             P+ L Q+ L C Q     RP    +V +L
Sbjct: 264 --PAALYQLMLDCWQKDRNNRPKFEQIVSIL 292

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 126/271 (46%), Gaps = 27/271 (9%)
Query: 277 LGQGGSGSVYKG--TLPGGEAVAVK----RLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V  G   LP  + ++V     ++ Y   Q  D F  E +++   +H N+++L
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 82
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        ++V E++ N SL D+   + D +    ++   ++   A G+ YL   S +
Sbjct: 83  EGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQL-VGMLRGIASGMKYL---SDM 137
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
             +HRD+   NIL++     K++DFGL R+  +D      T  G +   + +PE +   K
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T  +DV+S+G+V+ EV+       +  ++  +++ V + Y   RL   +D         
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPPPMDC-------- 246
Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
             P+ L Q+ L C Q     RP    +V +L
Sbjct: 247 --PAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 131/297 (44%), Gaps = 39/297 (13%)
Query: 263 TLEKATNYFHESNK------------LGQGGSGSVYKG--TLPGGEAVAVK----RLFYN 304
           T E  T   HE  K            +G G  G V  G   LP  + ++V     ++ Y 
Sbjct: 27  TFEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 305 TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
             Q  D F  E +++   +H N+++L G        ++V E + N SL D+   + D + 
Sbjct: 87  EKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQF 144
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
              ++   ++   A G+ YL   S +  +HRD+   NIL++     K++DFGL R+  +D
Sbjct: 145 TVIQL-VGMLRGIASGMKYL---SDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 425 ITHISATLAGTLG--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 T  G +   + +PE +   K T  +DV+S+G+V+ EV+       +  ++  ++
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V + Y   RL   +D           P+ L Q+ L C Q     RP    +V +L
Sbjct: 261 KAVDEGY---RLPPPMD----------CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 120
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRK 469
             K    A D++S G +  E+V R+
Sbjct: 177 GXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 277 LGQGGSGSVYKGTL--PGGEA--VAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V  G L  PG     VA+K L   Y   Q  D F +E +++   +H N++ L
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNIIHL 80
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        +++ E++ N SL  + F+R++    +      ++     G+ YL   S +
Sbjct: 81  EGVVTKCKPVMIITEYMENGSL--DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 135
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
             +HRD+   NIL++     K++DFG+ R+  +D      T  G +   + APE +   K
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T  +DV+S+G+V+ EV+       +  ++  +++ + + Y   RL   +D  +A     
Sbjct: 196 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY---RLPPPMDCPIA----- 247
Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                L Q+ L C Q     RP    +V ML
Sbjct: 248 -----LHQLMLDCWQKERSDRPKFGQIVNML 273

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 127
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 184 GXKYYSTAVDIWSLGCIFAEMVTRRAL 210

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/271 (26%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 277 LGQGGSGSVYKGTL--PGGE--AVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V  G L  PG     VA+K L   Y   Q  D F +E +++   +H N++ L
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRD-FLSEASIMGQFDHPNIIHL 74
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        +++ E++ N SL  + F+R++    +      ++     G+ YL   S +
Sbjct: 75  EGVVTKCKPVMIITEYMENGSL--DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL---SDM 129
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
             +HRD+   NIL++     K++DFG+ R+  +D      T  G +   + APE +   K
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T  +DV+S+G+V+ EV+       +  ++  +++ + + Y   RL   +D  +A     
Sbjct: 190 FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGY---RLPPPMDCPIA----- 241
Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                L Q+ L C Q     RP    +V ML
Sbjct: 242 -----LHQLMLDCWQKERSDRPKFGQIVNML 267

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/309 (26%), Positives = 140/309 (45%), Gaps = 42/309 (13%)
Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-H 311
           F  +  E A      S +LGQG  G VY+G   G         VA+K +    +      
Sbjct: 6   FVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 65
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------P 364
           F NE +++   N  ++V+LLG    G  +L++ E +    L   L  +R ++E      P
Sbjct: 66  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP 125
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
            S     ++    A+G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R    D
Sbjct: 126 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----D 178
Query: 425 ITHISATLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC 479
           I        G  G     +M+PE +  G  T  +DV+SFGVV+ E+           ++ 
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE 238
Query: 480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
            +L+ V    ++G L +  D           P  L ++  +C Q + ++RPS    ++++
Sbjct: 239 QVLRFV----MEGGLLDKPDNC---------PDMLFELMRMCWQYNPKMRPSF---LEII 282
Query: 540 TGNHEILQP 548
           +   E ++P
Sbjct: 283 SSIKEEMEP 291

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 121
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 177
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRAL 204

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 120
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRAL 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 72  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 127
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 128 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 183
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 184 GCKYYSTAVDIWSLGCIFAEMVTRRAL 210

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 119
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRK 469
             K    A D++S G +  E+V R+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 110/207 (53%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    ++ +D   +     PL     ++++    +GLA+ H
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 123
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRAL 206

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 12/206 (5%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE-PLSWEVRYKIILSTAEGLAYLHE 386
           VKLL    T  +  LV+EF+ +Q L D +        PL     Y  +    +GLA+ H 
Sbjct: 65  VKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSY--LFQLLQGLAFCHS 121
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
               R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++ 
Sbjct: 122 H---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILLG 177
Query: 447 GKLTEKA-DVYSFGVVVIEVVCRKRI 471
            K    A D++S G +  E+V R+ +
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRAL 203

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 76/297 (25%), Positives = 131/297 (44%), Gaps = 39/297 (13%)
Query: 263 TLEKATNYFHESNK------------LGQGGSGSVYKG--TLPGGEAVAVK----RLFYN 304
           T E  T   HE  K            +G G  G V  G   LP  + ++V     ++ Y 
Sbjct: 27  TYEDPTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 86
Query: 305 TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
             Q  D F  E +++   +H N+++L G        ++V E + N SL D+   + D + 
Sbjct: 87  EKQRRD-FLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQF 144
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
              ++   ++   A G+ YL   S +  +HRD+   NIL++     K++DFGL R+  +D
Sbjct: 145 TVIQL-VGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 200
Query: 425 ITHISATLAGTLG--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 T  G +   + +PE +   K T  +DV+S+G+V+ EV+       +  ++  ++
Sbjct: 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V + Y   RL   +D           P+ L Q+ L C Q     RP    +V +L
Sbjct: 261 KAVDEGY---RLPPPMD----------CPAALYQLMLDCWQKDRNNRPKFEQIVSIL 304

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 120
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRK 469
             K    A D++S G +  E+V R+
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 119
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRK 469
             K    A D++S G +  E+V R+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 124
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 180
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRK 469
             K    A D++S G +  E+V R+
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 136/294 (46%), Gaps = 42/294 (14%)
Query: 274 SNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKN 326
           S +LGQG  G VY+G   G         VA+K +    +      F NE +++   N  +
Sbjct: 24  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 83
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAE 379
           +V+LLG    G  +L++ E +    L   L  +R ++E      P S     ++    A+
Sbjct: 84  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 143
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG-- 437
           G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R    DI        G  G  
Sbjct: 144 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 196
Query: 438 ---YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL 494
              +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V    ++G L
Sbjct: 197 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----MEGGL 252
Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQP 548
            +  D           P  L ++  +C Q + ++RPS    +++++   E ++P
Sbjct: 253 LDKPDNC---------PDMLFELMRMCWQYNPKMRPSF---LEIISSIKEEMEP 294

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 84.3 bits (207), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 136/294 (46%), Gaps = 42/294 (14%)
Query: 274 SNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKN 326
           S +LGQG  G VY+G   G         VA+K +    +      F NE +++   N  +
Sbjct: 17  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAE 379
           +V+LLG    G  +L++ E +    L   L  +R ++E      P S     ++    A+
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG-- 437
           G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R    DI        G  G  
Sbjct: 137 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 189
Query: 438 ---YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL 494
              +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V    ++G L
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----MEGGL 245
Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQP 548
            +  D           P  L ++  +C Q + ++RPS    +++++   E ++P
Sbjct: 246 LDKPDNC---------PDMLFELMRMCWQYNPKMRPSF---LEIISSIKEEMEP 287

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 120
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRAL 203

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 85/326 (26%), Positives = 146/326 (44%), Gaps = 46/326 (14%)
Query: 246 GALQVAVNKSKLN----FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEA 295
           G L  +VN    +    +  +  E A      S +LGQG  G VY+G   G         
Sbjct: 20  GVLYASVNPEYFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR 79
Query: 296 VAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
           VA+K +    +      F NE +++   N  ++V+LLG    G  +L++ E +    L  
Sbjct: 80  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 139
Query: 355 NLF-VRQDVE------PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE 407
            L  +R ++E      P S     ++    A+G+AYL+     + +HRD+   N ++ E+
Sbjct: 140 YLRSLRPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 196
Query: 408 FTAKIADFGLVRLFPEDITHISATLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVV 462
           FT KI DFG+ R    DI        G  G     +M+PE +  G  T  +DV+SFGVV+
Sbjct: 197 FTVKIGDFGMTR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 252
Query: 463 IEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCV 522
            E+           ++  +L+ V    ++G L +  D           P  L ++  +C 
Sbjct: 253 WEIATLAEQPYQGLSNEQVLRFV----MEGGLLDKPDNC---------PDMLFELMRMCW 299
Query: 523 QASAELRPSMSIVVKMLTGNHEILQP 548
           Q + ++RPS    +++++   E ++P
Sbjct: 300 QYNPKMRPSF---LEIISSIKEEMEP 322

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 14/205 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 120
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRK 469
             K    A D++S G +  E+V R+
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 123
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRAL 206

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 121
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRAL 204

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 121
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 122 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRAL 204

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 119
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 175
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 68  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 123
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 122
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRAL 205

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 120
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRAL 203

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 136/294 (46%), Gaps = 42/294 (14%)
Query: 274 SNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKN 326
           S +LGQG  G VY+G   G         VA+K +    +      F NE +++   N  +
Sbjct: 23  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAE 379
           +V+LLG    G  +L++ E +    L   L  +R ++E      P S     ++    A+
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG-- 437
           G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R    DI        G  G  
Sbjct: 143 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 195
Query: 438 ---YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL 494
              +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V    ++G L
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----MEGGL 251
Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQP 548
            +  D           P  L ++  +C Q + ++RPS    +++++   E ++P
Sbjct: 252 LDKPDNC---------PDMLFELMRMCWQYNPKMRPSF---LEIISSIKEEMEP 293

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 122
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRAL 205

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 66  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 121
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 122 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRAL 204

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 120
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 176
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRAL 203

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 69  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 124
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 125 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 180
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 181 GCKYYSTAVDIWSLGCIFAEMVTRRAL 207

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 67  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 122
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 123 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRAL 205

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 108/205 (52%), Gaps = 14/205 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 119
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 175
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRK 469
             K    A D++S G +  E+V R+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/296 (27%), Positives = 134/296 (45%), Gaps = 44/296 (14%)
Query: 274 SNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKN 326
           S +LGQG  G VY+G   G         VA+K +    +      F NE +++   N  +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVE------PLSWEVRYKIILSTAE 379
           +V+LLG    G  +L++ E +    L   L  +R ++E      P S     ++    A+
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 149
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG-- 437
           G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R    DI        G  G  
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 202
Query: 438 ---YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL 494
              +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V    ++G L
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----MEGGL 258
Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSM-----SIVVKMLTGNHEI 545
            +  D           P  L ++  +C Q + ++RPS      SI  +M  G  E+
Sbjct: 259 LDKPDNC---------PDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 305

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 79/294 (26%), Positives = 136/294 (46%), Gaps = 42/294 (14%)
Query: 274 SNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKN 326
           S +LGQG  G VY+G   G         VA+K +    +      F NE +++   N  +
Sbjct: 23  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 82
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAE 379
           +V+LLG    G  +L++ E +    L   L  +R ++E      P S     ++    A+
Sbjct: 83  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 142
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG-- 437
           G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R    DI        G  G  
Sbjct: 143 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 195
Query: 438 ---YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL 494
              +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V    ++G L
Sbjct: 196 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----MEGGL 251
Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQP 548
            +  D           P  L ++  +C Q + ++RPS    +++++   E ++P
Sbjct: 252 LDKPDNC---------PDMLFELMRMCWQYNPKMRPSF---LEIISSIKEEMEP 293

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 125/271 (46%), Gaps = 27/271 (9%)
Query: 277 LGQGGSGSVYKG--TLPGGEAVAVK----RLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V  G   LP  + ++V     ++ Y   Q  D F  E +++   +H N+++L
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNIIRL 82
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        ++V E + N SL D+   + D +    ++   ++   A G+ YL   S +
Sbjct: 83  EGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQL-VGMLRGIASGMKYL---SDM 137
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG--YMAPEYVVRGK 448
             +HRD+   NIL++     K++DFGL R+  +D      T  G +   + +PE +   K
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T  +DV+S+G+V+ EV+       +  ++  +++ V + Y   RL   +D         
Sbjct: 198 FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPPPMDC-------- 246
Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
             P+ L Q+ L C Q     RP    +V +L
Sbjct: 247 --PAALYQLMLDCWQKDRNNRPKFEQIVSIL 275

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 136/294 (46%), Gaps = 42/294 (14%)
Query: 274 SNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKN 326
           S +LGQG  G VY+G   G         VA+K +    +      F NE +++   N  +
Sbjct: 17  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 76
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE------PLSWEVRYKIILSTAE 379
           +V+LLG    G  +L++ E +    L   L  +R ++E      P S     ++    A+
Sbjct: 77  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIAD 136
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG-- 437
           G+AYL+     + +HRD+   N  + E+FT KI DFG+ R    DI        G  G  
Sbjct: 137 GMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 189
Query: 438 ---YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL 494
              +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V    ++G L
Sbjct: 190 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----MEGGL 245
Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQP 548
            +  D           P  LL++  +C Q + ++RPS    +++++   E ++P
Sbjct: 246 LDKPDNC---------PDMLLELMRMCWQYNPKMRPSF---LEIISSIKEEMEP 287

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 123
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRAL 206

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 67  VKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 122
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 123 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 178
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 179 GCKYYSTAVDIWSLGCIFAEMVTRRAL 205

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 68  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 123
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 124 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRAL 206

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 66  VKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 121
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 122 SH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 177
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 178 GCKYYSTAVDIWSLGCIFAEMVTRRAL 204

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+E V    ++ +D   +     PL     ++++    +GLA+ H
Sbjct: 64  VKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 119
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRK 469
             K    A D++S G +  E+V R+
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 66/205 (32%), Positives = 109/205 (53%), Gaps = 14/205 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GL++ H
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLSFCH 120
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRK 469
             K    A D++S G +  E+V R+
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/194 (30%), Positives = 98/194 (50%), Gaps = 13/194 (6%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+GQG SG+VY    +  G+ VA++++        +   NE+ ++    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYLHEESKLRII 393
           + G E  +V E++   SL D +      E    E +   +     + L +LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 394 HRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           HRDIK  NILL  + + K+ DFG   ++ PE      +T+ GT  +MAPE V R     K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 196
Query: 453 ADVYSFGVVVIEVV 466
            D++S G++ IE++
Sbjct: 197 VDIWSLGIMAIEMI 210

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 75/273 (27%), Positives = 123/273 (45%), Gaps = 29/273 (10%)
Query: 277 LGQGGSGSVYKG--TLPGGEA--VAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V  G   LPG     VA+K L   Y   Q  D F +E +++   +H N++ L
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRD-FLSEASIMGQFDHPNVIHL 73
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G        +++ EF+ N SL  + F+RQ+    +      ++   A G+ YL   + +
Sbjct: 74  EGVVTKSTPVMIITEFMENGSL--DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADM 128
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLG--YMAPEYVVR 446
             +HR +   NIL++     K++DFGL R   +D +  + T  L G +   + APE +  
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY 188
Query: 447 GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF 506
            K T  +DV+S+G+V+ EV+       +   +  ++  +   Y   RL   +D       
Sbjct: 189 RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY---RLPPPMD------- 238
Query: 507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
               PS L Q+ L C Q     RP    +V  L
Sbjct: 239 ---CPSALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 82.8 bits (203), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 74/260 (28%), Positives = 118/260 (45%), Gaps = 25/260 (9%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
            +LG G  G V  G   G   VAVK +   +    D FF E   +  ++H  LVK  G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
           S   P   +V E++ N  LL+  ++R   + L      ++     EG+A+L      + I
Sbjct: 73  SKEYP-IYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEGMAFLESH---QFI 126
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRD+   N L+D +   K++DFG+ R   +D    S      + + APE     K + K+
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 454 DVYSFGVVVIEVVCRKRI--NLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKP 511
           DV++FG+++ EV    ++  +L+T NS  +L+         + H    P LA +      
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYT-NSEVVLKV-------SQGHRLYRPHLASD------ 232
Query: 512 SRLLQIGLLCVQASAELRPS 531
             + QI   C     E RP+
Sbjct: 233 -TIYQIMYSCWHELPEKRPT 251

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 82.4 bits (202), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 108/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K++  +T T+ V      E++L+  +NH N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+E V    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 68  VKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 123
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +      +  TL Y APE ++
Sbjct: 124 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEILL 179
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 180 GCKYYSTAVDIWSLGCIFAEMVTRRAL 206

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+ ++  +T T+ V      E++L+  +NH N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 65  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 120
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 121 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 176
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 177 GCKYYSTAVDIWSLGCIFAEMVTRRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 109/207 (52%), Gaps = 14/207 (6%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNT-TQWVDHF-FNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+ ++  +T T+ V      E++L+  +NH N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           VKLL    T  +  LV+EF+    +  +D   +     PL     ++++    +GLA+ H
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL----QGLAFCH 119
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                R++HRD+K  N+L++ E   K+ADFGL R F   +   +  +  TL Y APE ++
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEILL 175
Query: 446 RGKLTEKA-DVYSFGVVVIEVVCRKRI 471
             K    A D++S G +  E+V R+ +
Sbjct: 176 GCKYYSTAVDIWSLGCIFAEMVTRRAL 202

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 74/271 (27%), Positives = 107/271 (39%), Gaps = 35/271 (12%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           LG+G  G   K T    GE + +K L     +    F  EV ++  + H N++K +G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
                  + E++   +L     ++       W  R       A G+AYLH    + IIHR
Sbjct: 78  KDKRLNFITEYIKGGTLRG--IIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHR 132
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLF------PEDITHISA-------TLAGTLGYMAPE 442
           D+   N L+ E     +ADFGL RL       PE +  +         T+ G   +MAPE
Sbjct: 133 DLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPE 192
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD--LYVKGRLHEAVDP 500
            +      EK DV+SFG+V+ E++ R             L    D  L V+G L     P
Sbjct: 193 MINGRSYDEKVDVFSFGIVLCEIIGR------VNADPDYLPRTMDFGLNVRGFLDRYCPP 246
Query: 501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPS 531
                     P     I + C     E RPS
Sbjct: 247 NC--------PPSFFPITVRCCDLDPEKRPS 269

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 82.0 bits (201), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 133/312 (42%), Gaps = 54/312 (17%)
Query: 269 NYFHESNKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI 322
            Y  +   LG+G  G V    Y  T  G GE VAVK L  +   Q    +  E++++  +
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 323 NHKNLVKLLGC-SITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--- 377
            H++++K  GC    G  SL LV E+VP  SL D L             R+ I L+    
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL------------PRHSIGLAQLLL 138
Query: 378 -----AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE--DITHISA 430
                 EG+AYLH +     IHRD+   N+LLD +   KI DFGL +  PE  +   +  
Sbjct: 139 FAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVRE 195
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR---------KRINL--FTQNSC 479
                + + APE +   K    +DV+SFGV + E++           K + L    Q   
Sbjct: 196 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 255
Query: 480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           ++L          RL E ++        +  P+ +  +   C +  A  RP+   ++ +L
Sbjct: 256 TVL----------RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305
Query: 540 TGNHEILQPTQP 551
              HE  Q   P
Sbjct: 306 KTVHEKYQGQAP 317

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/303 (26%), Positives = 136/303 (44%), Gaps = 42/303 (13%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-HFFNEVN 317
           E A      S +LGQG  G VY+G   G         VA+K +    +      F NE +
Sbjct: 11  EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEAS 70
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPN-------QSLLDNLFVRQDVEPLSWEVR 370
           ++   N  ++V+LLG    G  +L++ E +         +SL   +     + P S    
Sbjct: 71  VMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKM 130
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
            ++    A+G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R    DI     
Sbjct: 131 IQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDY 183
Query: 431 TLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
              G  G     +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V
Sbjct: 184 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV 243
Query: 486 WDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEI 545
               ++G L +  D           P  L ++  +C Q + ++RPS    +++++   E 
Sbjct: 244 ----MEGGLLDKPDNC---------PDMLFELMRMCWQYNPKMRPSF---LEIISSIKEE 287
Query: 546 LQP 548
           ++P
Sbjct: 288 MEP 290

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 134/294 (45%), Gaps = 42/294 (14%)
Query: 274 SNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKN 326
           S +LGQG  G VY+G   G         VA+K +    +      F NE +++   N  +
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 327 LVKLLGCSITGPESLLVYEFVPN-------QSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
           +V+LLG    G  +L++ E +         +SL   +     + P S     ++    A+
Sbjct: 90  VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG-- 437
           G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R    DI        G  G  
Sbjct: 150 GMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLL 202
Query: 438 ---YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL 494
              +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V    ++G L
Sbjct: 203 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----MEGGL 258
Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQP 548
            +  D           P  L ++  +C Q + ++RPS    +++++   E ++P
Sbjct: 259 LDKPDNC---------PDMLFELMRMCWQYNPKMRPSF---LEIISSIKEEMEP 300

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVKLLGCS 334
           +G G +  V      P  E VA+KR+     Q  +D    E+  +S  +H N+V      
Sbjct: 23  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 82
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEP-------LSWEVRYKIILSTAEGLAYLHEE 387
           +   E  LV + +   S+LD   ++  V         L       I+    EGL YLH+ 
Sbjct: 83  VVKDELWLVMKLLSGGSVLD--IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE--DITH--ISATLAGTLGYMAPEY 443
            +   IHRD+K  NILL E+ + +IADFG+        DIT   +  T  GT  +MAPE 
Sbjct: 141 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197
Query: 444 V--VRGKLTEKADVYSFGVVVIEV 465
           +  VRG    KAD++SFG+  IE+
Sbjct: 198 MEQVRG-YDFKADIWSFGITAIEL 220

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 27/204 (13%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAV------------KRLFYNTTQWVDHFFNEVNLISGIN 323
           LG G  G+V+KG  +P GE++ +            ++ F   T   DH       I  ++
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT---DHMLA----IGSLD 73
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           H ++V+LLG    G    LV +++P  SLLD+  VRQ    L  ++     +  A+G+ Y
Sbjct: 74  HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDH--VRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPE 442
           L E     ++HR++   N+LL      ++ADFG+  L P D   +  + A T + +MA E
Sbjct: 131 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187
Query: 443 YVVRGKLTEKADVYSFGVVVIEVV 466
            +  GK T ++DV+S+GV V E++
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELM 211

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 81.6 bits (200), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 105/204 (51%), Gaps = 27/204 (13%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAV------------KRLFYNTTQWVDHFFNEVNLISGIN 323
           LG G  G+V+KG  +P GE++ +            ++ F   T   DH       I  ++
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVT---DHMLA----IGSLD 91
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           H ++V+LLG    G    LV +++P  SLLD+  VRQ    L  ++     +  A+G+ Y
Sbjct: 92  HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDH--VRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPE 442
           L E     ++HR++   N+LL      ++ADFG+  L P D   +  + A T + +MA E
Sbjct: 149 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 205
Query: 443 YVVRGKLTEKADVYSFGVVVIEVV 466
            +  GK T ++DV+S+GV V E++
Sbjct: 206 SIHFGKYTHQSDVWSYGVTVWELM 229

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/204 (32%), Positives = 97/204 (47%), Gaps = 21/204 (10%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVKLLGCS 334
           +G G +  V      P  E VA+KR+     Q  +D    E+  +S  +H N+V      
Sbjct: 18  IGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF 77
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEP-------LSWEVRYKIILSTAEGLAYLHEE 387
           +   E  LV + +   S+LD   ++  V         L       I+    EGL YLH+ 
Sbjct: 78  VVKDELWLVMKLLSGGSVLD--IIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 135
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE--DITH--ISATLAGTLGYMAPEY 443
            +   IHRD+K  NILL E+ + +IADFG+        DIT   +  T  GT  +MAPE 
Sbjct: 136 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 192
Query: 444 V--VRGKLTEKADVYSFGVVVIEV 465
           +  VRG    KAD++SFG+  IE+
Sbjct: 193 MEQVRG-YDFKADIWSFGITAIEL 215

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
            KLG+G  GSVYK      G+ VA+K++   +   +     E++++   +  ++VK  G 
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGS 92
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
                +  +V E+    S+ D + +R     L+ +    I+ ST +GL YLH    +R I
Sbjct: 93  YFKNTDLWIVMEYCGAGSVSDIIRLRNKT--LTEDEIATILQSTLKGLEYLH---FMRKI 147
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRDIK  NILL+ E  AK+ADFG+     + +   +  + GT  +MAPE +        A
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVI-GTPFWMAPEVIQEIGYNCVA 206
Query: 454 DVYSFGVVVIEV 465
           D++S G+  IE+
Sbjct: 207 DIWSLGITAIEM 218

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 81.3 bits (199), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 57/167 (34%), Positives = 85/167 (50%), Gaps = 12/167 (7%)
Query: 304 NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE 363
           N  ++ +  +NE++L+  ++H N++KL           LV EF     L + +  R   +
Sbjct: 85  NIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD 144
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRL 420
                   K ILS   G+ YLH   K  I+HRDIK  NILL+ +      KI DFGL   
Sbjct: 145 ECDAANIMKQILS---GICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           F +D  +      GT  Y+APE V++ K  EK DV+S GV++  ++C
Sbjct: 199 FSKD--YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLC 242

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+GQG SG+VY    +  G+ VA++++        +   NE+ ++    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYLHEESKLRII 393
           + G E  +V E++   SL D +      E    E +   +     + L +LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 394 HRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           HRDIK  NILL  + + K+ DFG   ++ PE      + + GT  +MAPE V R     K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGPK 196
Query: 453 ADVYSFGVVVIEVV 466
            D++S G++ IE++
Sbjct: 197 VDIWSLGIMAIEMI 210

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+GQG SG+VY    +  G+ VA++++        +   NE+ ++    + N+V  L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYLHEESKLRII 393
           + G E  +V E++   SL D +      E    E +   +     + L +LH     ++I
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 394 HRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           HRDIK  NILL  + + K+ DFG   ++ PE      + + GT  +MAPE V R     K
Sbjct: 140 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGPK 197
Query: 453 ADVYSFGVVVIEVV 466
            D++S G++ IE++
Sbjct: 198 VDIWSLGIMAIEMI 211

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 13/194 (6%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+GQG SG+VY    +  G+ VA++++        +   NE+ ++    + N+V  L   
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYLHEESKLRII 393
           + G E  +V E++   SL D +      E    E +   +     + L +LH     ++I
Sbjct: 87  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 138
Query: 394 HRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           HRDIK  NILL  + + K+ DFG   ++ PE      + + GT  +MAPE V R     K
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVTRKAYGPK 196
Query: 453 ADVYSFGVVVIEVV 466
            D++S G++ IE++
Sbjct: 197 VDIWSLGIMAIEMI 210

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 98/194 (50%), Gaps = 13/194 (6%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           K+GQG SG+VY    +  G+ VA++++        +   NE+ ++    + N+V  L   
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA-EGLAYLHEESKLRII 393
           + G E  +V E++   SL D +      E    E +   +     + L +LH     ++I
Sbjct: 88  LVGDELWVVMEYLAGGSLTDVV-----TETCMDEGQIAAVCRECLQALEFLHSN---QVI 139
Query: 394 HRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           HR+IK  NILL  + + K+ DFG   ++ PE      +T+ GT  +MAPE V R     K
Sbjct: 140 HRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPK 197
Query: 453 ADVYSFGVVVIEVV 466
            D++S G++ IE++
Sbjct: 198 VDIWSLGIMAIEMI 211

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 76/213 (35%), Positives = 109/213 (51%), Gaps = 20/213 (9%)
Query: 265 EKA-TNYFHESNKLGQGGSGSVY---KGTLP-GGEAVAVKRLFYNTTQWVDHFFN--EVN 317
           EKA  ++F     LGQG  G V+   K T P  G   A+K L   T +  D      E +
Sbjct: 23  EKADPSHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERD 82
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
           +++ +NH  +VKL     T  +  L+ +F+       +LF R   E +  E   K  L+ 
Sbjct: 83  ILADVNHPFVVKLHYAFQTEGKLYLILDFLRG----GDLFTRLSKEVMFTEEDVKFYLAE 138
Query: 378 -AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAG 434
            A GL +LH    L II+RD+K  NILLDEE   K+ DFGL +   E I H   + +  G
Sbjct: 139 LALGLDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCG 192
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           T+ YMAPE V R   +  AD +S+GV++ E++ 
Sbjct: 193 TVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLT 225

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 75/284 (26%), Positives = 126/284 (44%), Gaps = 27/284 (9%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTL--PGGEA--VAVKRLFYN-TTQWVDHFFNEVNLI 319
           E   +Y      +G G  G V +G L  PG +   VA+K L    T +    F +E +++
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIM 71
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
               H N+++L G        +++ EF+ N +L  + F+R +    +      ++   A 
Sbjct: 72  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL--DSFLRLNDGQFTVIQLVGMLRGIAS 129
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLG 437
           G+ YL E S    +HRD+   NIL++     K++DFGL R   E+ +  + T  L G + 
Sbjct: 130 GMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIP 186
Query: 438 --YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH 495
             + APE +   K T  +D +S+G+V+ EV+       +  ++  ++  +   Y   RL 
Sbjct: 187 IRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDY---RLP 243
Query: 496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
              D           P+ L Q+ L C Q     RP    VV  L
Sbjct: 244 PPPD----------CPTSLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 86/309 (27%), Positives = 130/309 (42%), Gaps = 66/309 (21%)
Query: 272 HESNKLGQGGSGSVYKGTLPGGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKN 326
           H    +G+G  G VY G            A+K L   T  Q V+ F  E  L+ G+NH N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ L+G  I  P   L +  +P     D L F+R      + +      L  A G+ YL 
Sbjct: 84  VLALIG--IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLA 141
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI---------THISATLAGTL 436
           E+   + +HRD+   N +LDE FT K+ADFGL R    DI          H  A L   +
Sbjct: 142 EQ---KFVHRDLAARNCMLDESFTVKVADFGLAR----DILDREYYSVQQHRHARLP--V 192
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR-LH 495
            + A E +   + T K+DV+SFGV+                       +W+L  +G   +
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVL-----------------------LWELLTRGAPPY 229
Query: 496 EAVDPALAGNF-QEGK--------PSRLLQIGLLCVQASAELRPSMSI-------VVKML 539
             +DP    +F  +G+        P  L Q+   C +A   +RP+  +       +V  L
Sbjct: 230 RHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289
Query: 540 TGNHEILQP 548
            G+H +  P
Sbjct: 290 LGDHYVQLP 298

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 77/285 (27%), Positives = 127/285 (44%), Gaps = 29/285 (10%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTL--PGGEA--VAVKRLFYN-TTQWVDHFFNEVNLI 319
           E   +Y      +G G  G V +G L  PG +   VA+K L    T +    F +E +++
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIM 69
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
               H N+++L G        +++ EF+ N +L  + F+R +    +      ++   A 
Sbjct: 70  GQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL--DSFLRLNDGQFTVIQLVGMLRGIAS 127
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAGTL 436
           G+ YL E S    +HRD+   NIL++     K++DFGL R   E   D T+ S +L G +
Sbjct: 128 GMRYLAEMS---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTS-SLGGKI 183
Query: 437 G--YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL 494
              + APE +   K T  +D +S+G+V+ EV+       +  ++  ++  +   Y   RL
Sbjct: 184 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQDY---RL 240
Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
               D           P+ L Q+ L C Q     RP    VV  L
Sbjct: 241 PPPPD----------CPTSLHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 116/228 (50%), Gaps = 19/228 (8%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKR 300
           GA+  A N++ L    ET       F +   LG G  G+VYKG  +P GE     VA+K 
Sbjct: 1   GAMGEAPNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 54
Query: 301 LFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR 359
           L   T+   +    +E  +++ +++ ++ +LLG  +T    L+  + +P   LLD  +VR
Sbjct: 55  LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVR 111
Query: 360 QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
           +  + +  +      +  A+G+ YL +    R++HRD+   N+L+      KI DFGL +
Sbjct: 112 EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 420 LF-PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           L   E+  + +      + +MA E ++    T ++DV+S+GV V E++
Sbjct: 169 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 79.0 bits (193), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/207 (32%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 268 TNYFHESNKLGQGGSGSVY--KGTLPGGEAVA--VKRLFYNTTQWVDHFFNEVNLISGIN 323
           ++ +    KLG G  G V   K  L G E     +K+    TT       +EV ++  ++
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           H N++KL           LV E      L D + +RQ    +   V  K +LS   G  Y
Sbjct: 63  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---GTTY 119
Query: 384 LHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
           LH   K  I+HRD+K  N+LL+    +   KI DFGL   F  ++        GT  Y+A
Sbjct: 120 LH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYYIA 174
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVC 467
           PE V+R K  EK DV+S GV++  ++C
Sbjct: 175 PE-VLRKKYDEKCDVWSCGVILYILLC 200

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 98/207 (47%), Gaps = 16/207 (7%)
Query: 268 TNYFHESNKLGQGGSGSVY--KGTLPGGEAVA--VKRLFYNTTQWVDHFFNEVNLISGIN 323
           ++ +    KLG G  G V   K  L G E     +K+    TT       +EV ++  ++
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           H N++KL           LV E      L D + +RQ    +   V  K +LS   G  Y
Sbjct: 80  HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLS---GTTY 136
Query: 384 LHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
           LH+ +   I+HRD+K  N+LL+    +   KI DFGL   F  ++        GT  Y+A
Sbjct: 137 LHKHN---IVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYYIA 191
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVC 467
           PE V+R K  EK DV+S GV++  ++C
Sbjct: 192 PE-VLRKKYDEKCDVWSCGVILYILLC 217

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 79.0 bits (193), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 116/228 (50%), Gaps = 19/228 (8%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKR 300
           GA+  A N++ L    ET       F +   LG G  G+VYKG  +P GE     VA+K 
Sbjct: 1   GAMGEAPNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 54
Query: 301 LFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR 359
           L   T+   +    +E  +++ +++ ++ +LLG  +T    L+  + +P   LLD  +VR
Sbjct: 55  LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVR 111
Query: 360 QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
           +  + +  +      +  A+G+ YL +    R++HRD+   N+L+      KI DFGL +
Sbjct: 112 EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 420 LF-PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           L   E+  + +      + +MA E ++    T ++DV+S+GV V E++
Sbjct: 169 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 130/294 (44%), Gaps = 26/294 (8%)
Query: 269 NYFHESNKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI 322
            Y  +   LG+G  G V    Y  T  G GE VAVK L      Q    +  E+ ++  +
Sbjct: 9   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL 68
Query: 323 NHKNLVKLLGC-SITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL---ST 377
            H+++VK  GC    G +S+ LV E+VP  SL D L       P       +++L     
Sbjct: 69  YHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-------PRHCVGLAQLLLFAQQI 121
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--T 435
            EG+AYLH +     IHR +   N+LLD +   KI DFGL +  PE   +      G   
Sbjct: 122 CEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 178
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSCSILQTVWDLYVKGR 493
           + + APE +   K    +DV+SFGV + E++  C    +  T+ +  I  T   + V  R
Sbjct: 179 VFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVL-R 237
Query: 494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ 547
           L E ++        +  P  +  +   C +  A  RP+   +V +L    E  Q
Sbjct: 238 LTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ 291

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 131/305 (42%), Gaps = 54/305 (17%)
Query: 269 NYFHESNKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI 322
            Y  +   LG+G  G V    Y  T  G GE VAVK L  +   Q    +  E++++  +
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTL 73
Query: 323 NHKNLVKLLGC-SITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--- 377
            H++++K  GC    G +SL LV E+VP  SL D L             R+ I L+    
Sbjct: 74  YHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL------------PRHSIGLAQLLL 121
Query: 378 -----AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                 EG+AYLH +     IHR++   N+LLD +   KI DFGL +  PE   +     
Sbjct: 122 FAQQICEGMAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 433 AG--TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR---------KRINL--FTQNSC 479
            G   + + APE +   K    +DV+SFGV + E++           K + L    Q   
Sbjct: 179 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 238
Query: 480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           ++L          RL E ++        +  P  +  +   C +  A  RP+   ++ +L
Sbjct: 239 TVL----------RLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288
Query: 540 TGNHE 544
              HE
Sbjct: 289 KTVHE 293

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 78.6 bits (192), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 101/230 (43%), Gaps = 32/230 (13%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWVD-HFFNEVN 317
           E   N       +G+G  G V++   PG         VAVK L    +  +   F  E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD----------------NLFVRQD 361
           L++  ++ N+VKLLG    G    L++E++    L +                +L  R  
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 362 VE-----PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
           V      PLS   +  I    A G+AYL E    + +HRD+   N L+ E    KIADFG
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFG 219
Query: 417 LVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           L R ++  D        A  + +M PE +   + T ++DV+++GVV+ E+
Sbjct: 220 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 269

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/305 (27%), Positives = 131/305 (42%), Gaps = 54/305 (17%)
Query: 269 NYFHESNKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI 322
            Y  +   LG+G  G V    Y  T  G GE VAVK L  +   Q    +  E++++  +
Sbjct: 14  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTL 73
Query: 323 NHKNLVKLLGC-SITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--- 377
            H++++K  GC    G +SL LV E+VP  SL D L             R+ I L+    
Sbjct: 74  YHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYL------------PRHSIGLAQLLL 121
Query: 378 -----AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                 EG+AYLH +     IHR++   N+LLD +   KI DFGL +  PE   +     
Sbjct: 122 FAQQICEGMAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE 178
Query: 433 AG--TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR---------KRINL--FTQNSC 479
            G   + + APE +   K    +DV+SFGV + E++           K + L    Q   
Sbjct: 179 DGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM 238
Query: 480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           ++L          RL E ++        +  P  +  +   C +  A  RP+   ++ +L
Sbjct: 239 TVL----------RLTELLERGERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPIL 288
Query: 540 TGNHE 544
              HE
Sbjct: 289 KTVHE 293

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 86/294 (29%), Positives = 130/294 (44%), Gaps = 26/294 (8%)
Query: 269 NYFHESNKLGQGGSGSV----YKGTLPG-GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI 322
            Y  +   LG+G  G V    Y  T  G GE VAVK L      Q    +  E+ ++  +
Sbjct: 8   RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTL 67
Query: 323 NHKNLVKLLGC-SITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL---ST 377
            H+++VK  GC    G +S+ LV E+VP  SL D L       P       +++L     
Sbjct: 68  YHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-------PRHCVGLAQLLLFAQQI 120
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--T 435
            EG+AYLH +     IHR +   N+LLD +   KI DFGL +  PE   +      G   
Sbjct: 121 CEGMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 177
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSCSILQTVWDLYVKGR 493
           + + APE +   K    +DV+SFGV + E++  C    +  T+ +  I  T   + V  R
Sbjct: 178 VFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSPHTKFTELIGHTQGQMTVL-R 236
Query: 494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ 547
           L E ++        +  P  +  +   C +  A  RP+   +V +L    E  Q
Sbjct: 237 LTELLERGERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQTAQEKYQ 290

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 276 KLGQGGSGSVY----KGTLPGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           +LG+G  G V+       LP  +   VAVK L   +      F  E  L++ + H+++V+
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR------------QDVEP--LSWEVRYKIIL 375
             G    G   L+V+E++ +  L  N F+R            +DV P  L       +  
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDL--NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAG 434
             A G+ YL   + L  +HRD+   N L+ +    KI DFG+ R ++  D   +      
Sbjct: 143 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 199
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            + +M PE ++  K T ++DV+SFGVV+ E+
Sbjct: 200 PIRWMPPESILYRKFTTESDVWSFGVVLWEI 230

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 117/228 (51%), Gaps = 19/228 (8%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKR 300
           G++  A N++ L    ET       F +   LG G  G+VYKG  +P GE     VA+K 
Sbjct: 1   GSMGEAPNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 54
Query: 301 LFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR 359
           L   T+   +    +E  +++ +++ ++ +LLG  +T    L++ + +P   LLD  +VR
Sbjct: 55  LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLD--YVR 111
Query: 360 QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
           +  + +  +      +  A+G+ YL +    R++HRD+   N+L+      KI DFGL +
Sbjct: 112 EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 420 LF-PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           L   E+  + +      + +MA E ++    T ++DV+S+GV V E++
Sbjct: 169 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 276 KLGQGGSGSVY----KGTLPGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           +LG+G  G V+       LP  +   VAVK L   +      F  E  L++ + H+++V+
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR------------QDVEP--LSWEVRYKIIL 375
             G    G   L+V+E++ +  L  N F+R            +DV P  L       +  
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDL--NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAG 434
             A G+ YL   + L  +HRD+   N L+ +    KI DFG+ R ++  D   +      
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 222
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            + +M PE ++  K T ++DV+SFGVV+ E+
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEI 253

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 99/211 (46%), Gaps = 26/211 (12%)
Query: 276 KLGQGGSGSVY----KGTLPGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           +LG+G  G V+       LP  +   VAVK L   +      F  E  L++ + H+++V+
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR------------QDVEP--LSWEVRYKIIL 375
             G    G   L+V+E++ +  L  N F+R            +DV P  L       +  
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDL--NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAG 434
             A G+ YL   + L  +HRD+   N L+ +    KI DFG+ R ++  D   +      
Sbjct: 137 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTML 193
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            + +M PE ++  K T ++DV+SFGVV+ E+
Sbjct: 194 PIRWMPPESILYRKFTTESDVWSFGVVLWEI 224

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 104/199 (52%), Gaps = 14/199 (7%)
Query: 275 NKLGQGGSGSVY--KGTLPGGEAVAVKRLFY---NTTQWVDHFFNEVNLISGINHKNLVK 329
           +KLG GG  +VY  + T+   + VA+K +F       + +  F  EV+  S ++H+N+V 
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIK-VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           ++          LV E++   +L + +   +   PLS +          +G+ + H+   
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHD--- 129
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
           +RI+HRDIK  NIL+D   T KI DFG+ +   E     +  + GT+ Y +PE   +G+ 
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQ-AKGEA 188
Query: 450 TEK-ADVYSFGVVVIEVVC 467
           T++  D+YS G+V+ E++ 
Sbjct: 189 TDECTDIYSIGIVLYEMLV 207

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 130/262 (49%), Gaps = 18/262 (6%)
Query: 267 ATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHF-FNEVNLISGINH 324
           +++ F +  KLG G   +VYKG     G  VA+K +  ++ +        E++L+  + H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 325 KNLVKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           +N+V+L     T  +  LV+EF+ N  +  +D+  V      L   +         +GLA
Sbjct: 63  ENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLA 122
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           + HE    +I+HRD+K  N+L+++    K+ DFGL R F   +   S+ +  TL Y AP+
Sbjct: 123 FCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPD 178
Query: 443 YVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA 501
            ++  +  +   D++S G ++ E++  K +   T N    L+ ++D  + G  +E++ P+
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT-NDEEQLKLIFD--IMGTPNESLWPS 235
Query: 502 LAG------NFQEGKPSRLLQI 517
           +        N Q+  P  L Q+
Sbjct: 236 VTKLPKYNPNIQQRPPRDLRQV 257

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  AEG+ YL
Sbjct: 74  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAEGMNYL 130
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 131 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 187
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 188 ILHRIYTHQSDVWSYGVTVWELM 210

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.8 bits (190), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 116/228 (50%), Gaps = 19/228 (8%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE----AVAVKR 300
           G++  A N++ L    ET       F +   LG G  G+VYKG  +P GE     VA+K 
Sbjct: 1   GSMGEAPNQALLRILKET------EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKE 54
Query: 301 LFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR 359
           L   T+   +    +E  +++ +++ ++ +LLG  +T    L+  + +P   LLD  +VR
Sbjct: 55  LREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVR 111
Query: 360 QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
           +  + +  +      +  A+G+ YL +    R++HRD+   N+L+      KI DFGL +
Sbjct: 112 EHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 420 LF-PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           L   E+  + +      + +MA E ++    T ++DV+S+GV V E++
Sbjct: 169 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 216

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/222 (32%), Positives = 104/222 (46%), Gaps = 41/222 (18%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNL--ISGINHKNLVKLL--G 332
           +G+G  G+VYKG+L     VAVK   +   Q   +F NE N+  +  + H N+ + +   
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 333 CSITGP---ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-- 387
             +T     E LLV E+ PN SL   L +        W    ++  S   GLAYLH E  
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS----DWVSSCRLAHSVTRGLAYLHTELP 132
Query: 388 ----SKLRIIHRDIKLSNILLDEEFTAKIADFG---------LVRLFPEDITHISATLAG 434
                K  I HRD+   N+L+  + T  I+DFG         LVR   ED   IS    G
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV--G 190
Query: 435 TLGYMAPEYVVRGKLT--------EKADVYSFGVVVIEVVCR 468
           T+ YMAPE V+ G +         ++ D+Y+ G++  E+  R
Sbjct: 191 TIRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L++ + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 78  PHVCRLLGICLTSTVQLIM-QLMPFGXLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELM 214

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L++ + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L++ + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 78  PHVCRLLGICLTSTVQLIM-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 134
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 135 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 191
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 192 ILHRIYTHQSDVWSYGVTVWELM 214

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L++ + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQLIM-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 126/298 (42%), Gaps = 71/298 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
           LG G  G VY+G +      P    VAVK L   Y+    +D F  E  +IS  NH+N+V
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELD-FLMEALIISKFNHQNIV 111
Query: 329 KLLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEV 369
           + +G S+      ++ E +               P+Q    ++LD L V +D+       
Sbjct: 112 RCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI------- 164
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDIT 426
                   A G  YL E      IHRDI   N LL        AKI DFG+ R    DI 
Sbjct: 165 --------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIY 209
Query: 427 HISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSI 481
             S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +
Sbjct: 210 RASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEV 269
Query: 482 LQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           L+ V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 270 LEFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 107/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L++ + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 81  PHVCRLLGICLTSTVQLIM-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELM 217

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +G+G  G V++G     E    AVA+K     T+  V + F  E   +   +H ++VKL+
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G  IT     ++ E      L   L VR+    L+  + Y   LSTA  LAYL  ESK R
Sbjct: 80  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYL--ESK-R 133
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLT 450
            +HRDI   N+L+      K+ DFGL R + ED T+  A+     + +MAPE +   + T
Sbjct: 134 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 192
Query: 451 EKADVYSFGVVVIEVV 466
             +DV+ FGV + E++
Sbjct: 193 SASDVWMFGVCMWEIL 208

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 83  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 139
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 140 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 196
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 197 ILHRIYTHQSDVWSYGVTVWELM 219

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 102 PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 158
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 159 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 215
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 216 ILHRIYTHQSDVWSYGVTVWELM 238

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +G+G  G V++G     E    AVA+K     T+  V + F  E   +   +H ++VKL+
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G     P   ++ E      L   L VR+    L+  + Y   LSTA  LAYL  ESK R
Sbjct: 75  GVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYL--ESK-R 128
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLT 450
            +HRDI   N+L+      K+ DFGL R + ED T+  A+     + +MAPE +   + T
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 187
Query: 451 EKADVYSFGVVVIEVV 466
             +DV+ FGV + E++
Sbjct: 188 SASDVWMFGVCMWEIL 203

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 102/200 (51%), Gaps = 19/200 (9%)
Query: 277 LGQGGSGSVYK-GTLPGGEA---VAVKRLFYNTTQWVDHFFN--EVNLISGINHKNLVKL 330
           LGQG  G V+    + G +A    A+K L   T +  D      E +++  +NH  +VKL
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST-AEGLAYLHEESK 389
                T  +  L+ +F+       +LF R   E +  E   K  L+  A  L +LH    
Sbjct: 92  HYAFQTEGKLYLILDFLRG----GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 144
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVVRG 447
           L II+RD+K  NILLDEE   K+ DFGL +   E I H   + +  GT+ YMAPE V R 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 448 KLTEKADVYSFGVVVIEVVC 467
             T+ AD +SFGV++ E++ 
Sbjct: 202 GHTQSADWWSFGVLMFEMLT 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 87  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 143
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 144 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 200
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 201 ILHRIYTHQSDVWSYGVTVWELM 223

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 79  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELM 215

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +G+G  G V++G     E    AVA+K     T+  V + F  E   +   +H ++VKL+
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G  IT     ++ E      L   L VR+    L+  + Y   LSTA  LAYL  ESK R
Sbjct: 81  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYL--ESK-R 134
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLT 450
            +HRDI   N+L+      K+ DFGL R + ED T+  A+     + +MAPE +   + T
Sbjct: 135 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 193
Query: 451 EKADVYSFGVVVIEVV 466
             +DV+ FGV + E++
Sbjct: 194 SASDVWMFGVCMWEIL 209

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +G+G  G V++G     E    AVA+K     T+  V + F  E   +   +H ++VKL+
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G  IT     ++ E      L   L VR+    L+  + Y   LSTA  LAYL  ESK R
Sbjct: 83  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYL--ESK-R 136
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLT 450
            +HRDI   N+L+      K+ DFGL R + ED T+  A+     + +MAPE +   + T
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 195
Query: 451 EKADVYSFGVVVIEVV 466
             +DV+ FGV + E++
Sbjct: 196 SASDVWMFGVCMWEIL 211

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           LG+G  G VY G  L     +A+K +    +++      E+ L   + HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA---EGLAYLHEESKLRI 392
                 +  E VP  SL  +  +R    PL  +    I   T    EGL YLH+    +I
Sbjct: 90  ENGFIKIFMEQVPGGSL--SALLRSKWGPLK-DNEQTIGFYTKQILEGLKYLHDN---QI 143
Query: 393 IHRDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK--L 449
           +HRDIK  N+L++      KI+DFG  +     I   + T  GTL YMAPE + +G    
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 450 TEKADVYSFGVVVIEVVCRK 469
            + AD++S G  +IE+   K
Sbjct: 203 GKAADIWSLGCTIIEMATGK 222

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +G+G  G V++G     E    AVA+K     T+  V + F  E   +   +H ++VKL+
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G  IT     ++ E      L   L VR+    L+  + Y   LSTA  LAYL  ESK R
Sbjct: 106 GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYL--ESK-R 159
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLT 450
            +HRDI   N+L+      K+ DFGL R + ED T+  A+     + +MAPE +   + T
Sbjct: 160 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 218
Query: 451 EKADVYSFGVVVIEVV 466
             +DV+ FGV + E++
Sbjct: 219 SASDVWMFGVCMWEIL 234

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELM 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +G+G  G V++G     E    AVA+K     T+  V + F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G  IT     ++ E      L   L VR+    L+  + Y   LSTA  LAYL  ESK R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYL--ESK-R 131
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLT 450
            +HRDI   N+L+      K+ DFGL R + ED T+  A+     + +MAPE +   + T
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 451 EKADVYSFGVVVIEVV 466
             +DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 102/200 (51%), Gaps = 19/200 (9%)
Query: 277 LGQGGSGSVYK-GTLPGGEA---VAVKRLFYNTTQWVDHFFN--EVNLISGINHKNLVKL 330
           LGQG  G V+    + G +A    A+K L   T +  D      E +++  +NH  +VKL
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST-AEGLAYLHEESK 389
                T  +  L+ +F+       +LF R   E +  E   K  L+  A  L +LH    
Sbjct: 92  HYAFQTEGKLYLILDFLRG----GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 144
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVVRG 447
           L II+RD+K  NILLDEE   K+ DFGL +   E I H   + +  GT+ YMAPE V R 
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 448 KLTEKADVYSFGVVVIEVVC 467
             T+ AD +SFGV++ E++ 
Sbjct: 202 GHTQSADWWSFGVLMFEMLT 221

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGXLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/200 (35%), Positives = 102/200 (51%), Gaps = 19/200 (9%)
Query: 277 LGQGGSGSVYK-GTLPGGEA---VAVKRLFYNTTQWVDHFFN--EVNLISGINHKNLVKL 330
           LGQG  G V+    + G +A    A+K L   T +  D      E +++  +NH  +VKL
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST-AEGLAYLHEESK 389
                T  +  L+ +F+       +LF R   E +  E   K  L+  A  L +LH    
Sbjct: 93  HYAFQTEGKLYLILDFLRG----GDLFTRLSKEVMFTEEDVKFYLAELALALDHLHS--- 145
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVVRG 447
           L II+RD+K  NILLDEE   K+ DFGL +   E I H   + +  GT+ YMAPE V R 
Sbjct: 146 LGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNRR 202
Query: 448 KLTEKADVYSFGVVVIEVVC 467
             T+ AD +SFGV++ E++ 
Sbjct: 203 GHTQSADWWSFGVLMFEMLT 222

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 71  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELM 207

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +G+G  G V++G     E    AVA+K     T+  V + F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G  IT     ++ E      L   L VR+    L+  + Y   LSTA  LAYL  ESK R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA--LAYL--ESK-R 131
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLT 450
            +HRDI   N+L+      K+ DFGL R + ED T+  A+     + +MAPE +   + T
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 451 EKADVYSFGVVVIEVV 466
             +DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/284 (27%), Positives = 133/284 (46%), Gaps = 33/284 (11%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           ++LG+G  GSV            G  VAVK+L ++       F  E+ ++  ++   +VK
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 330 LLGCSI-TGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
             G S   G +SL LV E++P+  L D  F+++    L      +++L +++   G+ YL
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDAS---RLLLYSSQICKGMEYL 130
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPE 442
                 R +HRD+   NIL++ E   KIADFGL +L P D  +      G   + + APE
Sbjct: 131 ---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 187
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS-------ILQTVWDLYVKGRLH 495
            +     + ++DV+SFGVV+ E+        +   SCS       ++ +  D+    RL 
Sbjct: 188 SLSDNIFSRQSDVWSFGVVLYELFT------YCDKSCSPSAEFLRMMGSERDVPALSRLL 241
Query: 496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           E ++           P+ + ++  LC   S + RPS S +   L
Sbjct: 242 ELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQL 285

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
           +G+G  G V  G   G + VAVK +  + T     F  E ++++ + H NLV+LLG  + 
Sbjct: 29  IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 337 GPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
               L +V E++   SL+D L  R     L  +   K  L   E + YL   +    +HR
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 141
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           D+   N+L+ E+  AK++DFGL +    + +    T    + + APE +   K + K+DV
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 456 YSFGVVVIEVVCRKRI 471
           +SFG+++ E+    R+
Sbjct: 198 WSFGILLWEIYSFGRV 213

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 278 GQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSIT 336
            +G  G V+K  L   E VAVK       Q W + +  EV  + G+ H+N+++ +G    
Sbjct: 33  ARGRFGCVWKAQLLN-EYVAVKIFPIQDKQSWQNEY--EVYSLPGMKHENILQFIGAEKR 89
Query: 337 GP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE----- 387
           G     +  L+  F    SL D  F++ +V  +SW     I  + A GLAYLHE+     
Sbjct: 90  GTSVDVDLWLITAFHEKGSLSD--FLKANV--VSWNELCHIAETMARGLAYLHEDIPGLK 145
Query: 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYV 444
              K  I HRDIK  N+LL    TA IADFGL   F    +   +    GT  YMAPE V
Sbjct: 146 DGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE-V 204
Query: 445 VRGKLT------EKADVYSFGVVVIEVVCR 468
           + G +        + D+Y+ G+V+ E+  R
Sbjct: 205 LEGAINFQRDAFLRIDMYAMGLVLWELASR 234

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 75.9 bits (185), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
           +G+G  G V  G   G + VAVK +  + T     F  E ++++ + H NLV+LLG  + 
Sbjct: 201 IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 337 GPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
               L +V E++   SL+D L  R     L  +   K  L   E + YL   +    +HR
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 313
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           D+   N+L+ E+  AK++DFGL +    + +    T    + + APE +   K + K+DV
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 369
Query: 456 YSFGVVVIEVVCRKRI 471
           +SFG+++ E+    R+
Sbjct: 370 WSFGILLWEIYSFGRV 385

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 100/196 (51%), Gaps = 13/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +G+G  G V++G     E    AVA+K     T+  V + F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G  IT     ++ E      L   L VR+    L+  + Y   LSTA  LAYL  ESK R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYL--ESK-R 131
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLT 450
            +HRDI   N+L+      K+ DFGL R + ED T+  A+     + +MAPE +   + T
Sbjct: 132 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 190
Query: 451 EKADVYSFGVVVIEVV 466
             +DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 75.5 bits (184), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/196 (30%), Positives = 99/196 (50%), Gaps = 12/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
           +G+G  G V  G   G + VAVK +  + T     F  E ++++ + H NLV+LLG  + 
Sbjct: 14  IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 337 GPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
               L +V E++   SL+D L  R     L  +   K  L   E + YL   +    +HR
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 126
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           D+   N+L+ E+  AK++DFGL +    + +    T    + + APE +   K + K+DV
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 456 YSFGVVVIEVVCRKRI 471
           +SFG+++ E+    R+
Sbjct: 183 WSFGILLWEIYSFGRV 198

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           LG+G  G VY G  L     +A+K +    +++      E+ L   + HKN+V+ LG   
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA---EGLAYLHEESKLRI 392
                 +  E VP  SL  +  +R    PL  +    I   T    EGL YLH+    +I
Sbjct: 76  ENGFIKIFMEQVPGGSL--SALLRSKWGPLK-DNEQTIGFYTKQILEGLKYLHDN---QI 129
Query: 393 IHRDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK--L 449
           +HRDIK  N+L++      KI+DFG  +     I   + T  GTL YMAPE + +G    
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 450 TEKADVYSFGVVVIEVVCRK 469
            + AD++S G  +IE+   K
Sbjct: 189 GKAADIWSLGCTIIEMATGK 208

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +G+G  G V++G     E    AVA+K     T+  V + F  E   +   +H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G     P   ++ E      L   L VR+    L+  + Y   LSTA  LAYL  ESK R
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYL--ESK-R 511
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLT 450
            +HRDI   N+L+      K+ DFGL R + ED T+  A+     + +MAPE +   + T
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 451 EKADVYSFGVVVIEVV 466
             +DV+ FGV + E++
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           ++LG+G  GSV            G  VAVK+L ++       F  E+ ++  ++   +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 330 LLGCSI-TGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
             G S   G +SL LV E++P+  L D  F+++    L      +++L +++   G+ YL
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDAS---RLLLYSSQICKGMEYL 143
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPE 442
                 R +HRD+   NIL++ E   KIADFGL +L P D  +      G   + + APE
Sbjct: 144 ---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 200
Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
            +     + ++DV+SFGVV+ E+
Sbjct: 201 SLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 97/198 (48%), Gaps = 12/198 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
           F +  ++G+G  G V+KG      + VA+K +        ++    E+ ++S  +   + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           K  G  + G +  ++ E++   S LD L      +        K IL   +GL YLH E 
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL---KGLDYLHSEK 140
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTLGYMAPEYVVRG 447
           K   IHRDIK +N+LL E+   K+ADFG+     +  T I   T  GT  +MAPE + + 
Sbjct: 141 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIQQS 195
Query: 448 KLTEKADVYSFGVVVIEV 465
               KAD++S G+  IE+
Sbjct: 196 AYDSKADIWSLGITAIEL 213

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLV 328
           +H   K+G+G  G VYK     GE  A+K  RL             E++++  + H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           KL     T    +LV+E +    + LLD       +E ++ +     +L    G+AY H+
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAK---SFLLQLLNGIAYCHD 118
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV- 445
               R++HRD+K  N+L++ E   KIADFGL R F   +   +  +  TL Y AP+ ++ 
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMG 174
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
             K +   D++S G +  E+V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMV 195

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 104/203 (51%), Gaps = 20/203 (9%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           ++LG+G  GSV            G  VAVK+L ++       F  E+ ++  ++   +VK
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 330 LLGCSI-TGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
             G S   G +SL LV E++P+  L D  F+++    L      +++L +++   G+ YL
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDAS---RLLLYSSQICKGMEYL 131
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGYMAPE 442
                 R +HRD+   NIL++ E   KIADFGL +L P D  +      G   + + APE
Sbjct: 132 ---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPE 188
Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
            +     + ++DV+SFGVV+ E+
Sbjct: 189 SLSDNIFSRQSDVWSFGVVLYEL 211

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 102/203 (50%), Gaps = 20/203 (9%)
Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           ++LG+G  GSV            G  VAVK+L ++       F  E+ ++  ++   +VK
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 330 LLGCSITG--PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
             G S     PE  LV E++P+  L D  F+++    L      +++L +++   G+ YL
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRD--FLQRHRARLDAS---RLLLYSSQICKGMEYL 127
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP--EDITHISATLAGTLGYMAPE 442
                 R +HRD+   NIL++ E   KIADFGL +L P  +D   +       + + APE
Sbjct: 128 GSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPE 184
Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
            +     + ++DV+SFGVV+ E+
Sbjct: 185 SLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/196 (34%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +G+G  G V++G     E    AVA+K     T+  V + F  E   +   +H ++VKL+
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G  IT     ++ E      L   L VR+    L+  + Y   LSTA  LAYL  ESK R
Sbjct: 78  GV-ITENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYL--ESK-R 131
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLT 450
            +HRDI   N+L+      K+ DFGL R + ED T   A+     + +MAPE +   + T
Sbjct: 132 FVHRDIAARNVLVSSNDCVKLGDFGLSR-YMEDSTXXKASKGKLPIKWMAPESINFRRFT 190
Query: 451 EKADVYSFGVVVIEVV 466
             +DV+ FGV + E++
Sbjct: 191 SASDVWMFGVCMWEIL 206

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 99/196 (50%), Gaps = 13/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLL 331
           +G+G  G V++G     E    AVA+K     T+  V + F  E   +   +H ++VKL+
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G     P   ++ E      L   L VR+    L+  + Y   LSTA  LAYL  ESK R
Sbjct: 458 GVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA--LAYL--ESK-R 511
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLT 450
            +HRDI   N+L+      K+ DFGL R + ED T+  A+     + +MAPE +   + T
Sbjct: 512 FVHRDIAARNVLVSATDCVKLGDFGLSR-YMEDSTYYKASKGKLPIKWMAPESINFRRFT 570
Query: 451 EKADVYSFGVVVIEVV 466
             +DV+ FGV + E++
Sbjct: 571 SASDVWMFGVCMWEIL 586

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
           F + +++G+G  G VYKG      E VA+K +        ++    E+ ++S  +   + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           +  G  +   +  ++ E++   S LD L       PL       I+    +GL YLH E 
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHSER 136
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTLGYMAPEYVVRG 447
           K   IHRDIK +N+LL E+   K+ADFG+     +  T I      GT  +MAPE + + 
Sbjct: 137 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQS 191
Query: 448 KLTEKADVYSFGVVVIEV 465
               KAD++S G+  IE+
Sbjct: 192 AYDFKADIWSLGITAIEL 209

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLV 328
           +H   K+G+G  G VYK     GE  A+K  RL             E++++  + H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           KL     T    +LV+E +    + LLD       +E ++ +     +L    G+AY H+
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAK---SFLLQLLNGIAYCHD 118
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV- 445
               R++HRD+K  N+L++ E   KIADFGL R F   +   +  +  TL Y AP+ ++ 
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMG 174
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
             K +   D++S G +  E+V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMV 195

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/201 (30%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNLV 328
           +H   K+G+G  G VYK     GE  A+K  RL             E++++  + H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63
Query: 329 KLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           KL     T    +LV+E +    + LLD       +E ++ +     +L    G+AY H+
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAK---SFLLQLLNGIAYCHD 118
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV- 445
               R++HRD+K  N+L++ E   KIADFGL R F   +   +  +  TL Y AP+ ++ 
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYRAPDVLMG 174
Query: 446 RGKLTEKADVYSFGVVVIEVV 466
             K +   D++S G +  E+V
Sbjct: 175 SKKYSTTIDIWSVGCIFAEMV 195

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 126/297 (42%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS +NH+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 164
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 165 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 210
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
            S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 270
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 271 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/198 (29%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
           F +  K+G+G  G V+KG     + V   ++         ++    E+ ++S  +   + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           K  G  +   +  ++ E++   S LD L    +  PL       I+    +GL YLH E 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEK 124
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTLGYMAPEYVVRG 447
           K   IHRDIK +N+LL E    K+ADFG+     +  T I   T  GT  +MAPE + + 
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQS 179
Query: 448 KLTEKADVYSFGVVVIEV 465
               KAD++S G+  IE+
Sbjct: 180 AYDSKADIWSLGITAIEL 197

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 126/297 (42%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS +NH+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 150
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 151 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 196
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
            S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 256
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 257 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 100/211 (47%), Gaps = 13/211 (6%)
Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRL--FYNTTQWVDHFFNE 315
           N  +++++     F +  K+G+G  G V+KG     + V   ++         ++    E
Sbjct: 17  NLYFQSMD-PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQE 75
Query: 316 VNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL 375
           + ++S  +   + K  G  +   +  ++ E++   S LD L    +  PL       I+ 
Sbjct: 76  ITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILR 131
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAG 434
              +GL YLH E K   IHRDIK +N+LL E    K+ADFG+     +  T I   T  G
Sbjct: 132 EILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVG 186
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           T  +MAPE + +     KAD++S G+  IE+
Sbjct: 187 TPFWMAPEVIKQSAYDSKADIWSLGITAIEL 217

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
           S+E   K   +  E   LG G  G V  G   G   VA+K +   +    D F  E  ++
Sbjct: 18  SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 73
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
             ++H+ LV+L G         ++ E++ N  LL+  ++R+       +   ++     E
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCE 131
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            + YL  ESK + +HRD+   N L++++   K++DFGL R   +D    S      + + 
Sbjct: 132 AMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWS 188
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEV 465
            PE ++  K + K+D+++FGV++ E+
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   L  G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L++ + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 84  PHVCRLLGICLTSTVQLIM-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELM 220

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L++ + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFG  +L   E+  + +      + +MA E 
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELM 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L++ + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 79  PHVCRLLGICLTSTVQLIM-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFG  +L   E+  + +      + +MA E 
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS  NH+N+V+
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 164
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 165 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 210
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
            S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 211 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 270
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 271 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
           S+E   K   +  E   LG G  G V  G   G   VA+K +   +    D F  E  ++
Sbjct: 18  SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 73
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
             ++H+ LV+L G         ++ E++ N  LL+  ++R+       +   ++     E
Sbjct: 74  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCE 131
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            + YL  ESK + +HRD+   N L++++   K++DFGL R   +D    S      + + 
Sbjct: 132 AMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEV 465
            PE ++  K + K+D+++FGV++ E+
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEI 214

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 106/203 (52%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L++ + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 81  PHVCRLLGICLTSTVQLIM-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 137
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFG  +L   E+  + +      + +MA E 
Sbjct: 138 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 194
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 195 ILHRIYTHQSDVWSYGVTVWELM 217

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
           S+E   K   +  E   LG G  G V  G   G   VA+K +   +    D F  E  ++
Sbjct: 2   SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 57
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
             ++H+ LV+L G         ++ E++ N  LL+  ++R+       +   ++     E
Sbjct: 58  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCE 115
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            + YL  ESK + +HRD+   N L++++   K++DFGL R   +D    S      + + 
Sbjct: 116 AMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 172
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEV 465
            PE ++  K + K+D+++FGV++ E+
Sbjct: 173 PPEVLMYSKFSSKSDIWAFGVLMWEI 198

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P   +   L   Q +     +     I   A  L+Y H 
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALSYCHS 131
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE +  
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEG 185
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS  NH+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 149
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 150 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 195
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
            S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 256 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
           S+E   K   +  E   LG G  G V  G   G   VA+K +   +    D F  E  ++
Sbjct: 9   SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 64
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
             ++H+ LV+L G         ++ E++ N  LL+  ++R+       +   ++     E
Sbjct: 65  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCE 122
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            + YL  ESK + +HRD+   N L++++   K++DFGL R   +D    S      + + 
Sbjct: 123 AMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 179
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEV 465
            PE ++  K + K+D+++FGV++ E+
Sbjct: 180 PPEVLMYSKFSSKSDIWAFGVLMWEI 205

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS  NH+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 150
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 151 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 196
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
            S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 256
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 257 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
           S+E   K   +  E   LG G  G V  G   G   VA+K +   +    D F  E  ++
Sbjct: 3   SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 58
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
             ++H+ LV+L G         ++ E++ N  LL+  ++R+       +   ++     E
Sbjct: 59  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCE 116
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            + YL  ESK + +HRD+   N L++++   K++DFGL R   +D    S      + + 
Sbjct: 117 AMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 173
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEV 465
            PE ++  K + K+D+++FGV++ E+
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   L  G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELM 220

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 100/206 (48%), Gaps = 9/206 (4%)
Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
           S+E   K   +  E   LG G  G V  G   G   VA+K +   +    D F  E  ++
Sbjct: 3   SWEIDPKDLTFLKE---LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVM 58
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
             ++H+ LV+L G         ++ E++ N  LL+  ++R+       +   ++     E
Sbjct: 59  MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCE 116
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            + YL  ESK + +HRD+   N L++++   K++DFGL R   +D    S      + + 
Sbjct: 117 AMEYL--ESK-QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWS 173
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEV 465
            PE ++  K + K+D+++FGV++ E+
Sbjct: 174 PPEVLMYSKFSSKSDIWAFGVLMWEI 199

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 84  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 140
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFG  +L   E+  + +      + +MA E 
Sbjct: 141 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 197
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 198 ILHRIYTHQSDVWSYGVTVWELM 220

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS  NH+N+V+
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 156
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 157 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 202
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
            S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 203 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 262
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 263 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 95/191 (49%), Gaps = 6/191 (3%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V  G   G   VA+K +    +   D F  E  ++  ++H+ LV+L G  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIK-MIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
                  ++ E++ N  LL+  ++R+       +   ++     E + YL  ESK + +H
Sbjct: 69  TKQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYL--ESK-QFLH 123
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD+   N L++++   K++DFGL R   +D    S      + +  PE ++  K + K+D
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 455 VYSFGVVVIEV 465
           +++FGV++ E+
Sbjct: 184 IWAFGVLMWEI 194

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/196 (29%), Positives = 98/196 (50%), Gaps = 12/196 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
           +G+G  G V  G   G + VAVK +  + T     F  E ++++ + H NLV+LLG  + 
Sbjct: 20  IGKGEFGDVMLGDYRGNK-VAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 337 GPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR 395
               L +V E++   SL+D L  R     L  +   K  L   E + YL   +    +HR
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHR 132
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADV 455
           D+   N+L+ E+  AK++DFGL +    + +    T    + + APE +     + K+DV
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFSTKSDV 188
Query: 456 YSFGVVVIEVVCRKRI 471
           +SFG+++ E+    R+
Sbjct: 189 WSFGILLWEIYSFGRV 204

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 79  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 135
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFG  +L   E+  + +      + +MA E 
Sbjct: 136 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 192
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 193 ILHRIYTHQSDVWSYGVTVWELM 215

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFG  +L   E+  + +      + +MA E 
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS  NH+N+V+
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 149
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 150 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 195
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
            S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 196 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 256 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   L  G  G+VYKG  +P GE     VA+K L   T+   +    +E  +++ +++
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 77  PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 133
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 134 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 190
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 191 ILHRIYTHQSDVWSYGVTVWELM 213

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS  NH+N+V+
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 176
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 177 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 222
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
            S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 223 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 282
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 283 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS  NH+N+V+
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 141
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 142 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 187
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
            S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 188 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 247
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 248 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 81/297 (27%), Positives = 125/297 (42%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS  NH+N+V+
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 166
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 167 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 212
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
            S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 213 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 272
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 273 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-----FVRQDVEPLSWE 368
           NE+ ++  I H N+V L     +G    L+ + V    L D +     +  +D       
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL---LDEEFTAKIADFGLVRLFPEDI 425
              ++I    + + YLH+   L I+HRD+K  N+L   LDE+    I+DFGL ++  ED 
Sbjct: 120 ---RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDP 171
Query: 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
             + +T  GT GY+APE + +   ++  D +S GV+   ++C
Sbjct: 172 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 105/203 (51%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTTQWVD-HFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+  L   T+   +    +E  +++ +++
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T    L+  + +P   LLD  +VR+  + +  +      +  A+G+ YL
Sbjct: 111 PHVCRLLGICLTSTVQLIT-QLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL 167
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 168 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 224
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++    T ++DV+S+GV V E++
Sbjct: 225 ILHRIYTHQSDVWSYGVTVWELM 247

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 68/286 (23%), Positives = 122/286 (42%), Gaps = 36/286 (12%)
Query: 274 SNKLGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
             +LG+G  G V+        P  +   VAVK L   T      F  E  L++ + H+++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 328 VKLLGCSITGPESLLVYEFV-------------PNQSLLDNLFVRQDVEPLSWEVRYKII 374
           VK  G    G   ++V+E++             P+  +L +   RQ    L       I 
Sbjct: 80  VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLA 433
              A G+ YL  +     +HRD+   N L+      KI DFG+ R ++  D   +     
Sbjct: 140 SQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR 493
             + +M PE ++  K T ++DV+SFGV++ E+    +   F  ++  +++ +     +GR
Sbjct: 197 LPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI----TQGR 252
Query: 494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + E   P +        P  +  + L C Q   + R ++  + K+L
Sbjct: 253 VLER--PRVC-------PKEVYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 99/215 (46%), Gaps = 30/215 (13%)
Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLG 332
            ++G+G  G V+ G    GE VAVK +F+ T +    +F E  +   +   H+N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVK-VFFTTEE--ASWFRETEIYQTVLMRHENILGFIA 98
Query: 333 CSITGPESL----LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE- 387
             I G  S     L+ ++  N SL D L        L  +   K+  S+  GL +LH E 
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 388 ----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMA 440
                K  I HRD+K  NIL+ +  T  IAD GL   F  D   +     T  GT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 441 PEYVVRGKLTEK-------ADVYSFGVVVIEVVCR 468
           PE V+   L          AD+YSFG+++ EV  R
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKNLVKLLG 332
           LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N+++L G
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                    L+ E+ P  ++   L   Q +     +     I   A  L+Y H +   R+
Sbjct: 93  YFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSK---RV 146
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE +      EK
Sbjct: 147 IHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGRMHDEK 203
Query: 453 ADVYSFGVVVIEVVCRK 469
            D++S GV+  E +  K
Sbjct: 204 VDLWSLGVLCYEFLVGK 220

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 131
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE +  
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEG 185
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 129
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +   A L GTL Y+ PE +  
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDYLPPEMIEG 183
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-----FVRQDVEPLSWE 368
           NE+ ++  I H N+V L     +G    L+ + V    L D +     +  +D       
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL---LDEEFTAKIADFGLVRLFPEDI 425
              ++I    + + YLH+   L I+HRD+K  N+L   LDE+    I+DFGL ++  ED 
Sbjct: 120 ---RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDP 171
Query: 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
             + +T  GT GY+APE + +   ++  D +S GV+   ++C
Sbjct: 172 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 129
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE +  
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEG 183
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 184 RMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 126
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE +  
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEG 180
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKNLVKLLG 332
           LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                    L+ E+ P  ++   L   Q +     +     I   A  L+Y H +   R+
Sbjct: 81  YFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSK---RV 134
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE +      EK
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEXIEGRXHDEK 191
Query: 453 ADVYSFGVVVIEVVCRK 469
            D++S GV+  E +  K
Sbjct: 192 VDLWSLGVLCYEFLVGK 208

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 97/204 (47%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 127
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +    TL+GTL Y+ PE ++ 
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSCHAP---SSRRTTLSGTLDYLPPE-MIE 180
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 125/293 (42%), Gaps = 44/293 (15%)
Query: 274 SNKLGQGGSGSVYKGTL----PGGEA--VAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
             +LG+G  G V+        P  +   VAVK L   +      F  E  L++ + H+++
Sbjct: 18  KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 77
Query: 328 VKLLGCSITGPESLLVYEFVPNQSL--------LDNLFVRQDVEP--LSWEVRYKIILST 377
           VK  G  + G   ++V+E++ +  L         D + + +   P  L+      I    
Sbjct: 78  VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL 436
           A G+ YL  +     +HRD+   N L+ E    KI DFG+ R ++  D   +       +
Sbjct: 138 AAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 194
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            +M PE ++  K T ++DV+S GVV+ E+    +   +  ++  +++ +     +GR+  
Sbjct: 195 RWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI----TQGRV-- 248
Query: 497 AVDPALAGNFQEGK--PSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ 547
                     Q  +  P  + ++ L C Q    +R       K + G H +LQ
Sbjct: 249 ---------LQRPRTCPQEVYELMLGCWQREPHMR-------KNIKGIHTLLQ 285

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 73.2 bits (178), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-----FVRQDVEPLSWE 368
           NE+ ++  I H N+V L     +G    L+ + V    L D +     +  +D       
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL---LDEEFTAKIADFGLVRLFPEDI 425
              ++I    + + YLH+   L I+HRD+K  N+L   LDE+    I+DFGL ++  ED 
Sbjct: 120 ---RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDP 171
Query: 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
             + +T  GT GY+APE + +   ++  D +S GV+   ++C
Sbjct: 172 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/197 (31%), Positives = 91/197 (46%), Gaps = 13/197 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKNLVKLLG 332
           LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                    L+ E+ P  ++   L   Q +     +     I   A  L+Y H +   R+
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSK---RV 155
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE +      EK
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGRMHDEK 212
Query: 453 ADVYSFGVVVIEVVCRK 469
            D++S GV+  E +  K
Sbjct: 213 VDLWSLGVLCYEFLVGK 229

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 22/233 (9%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD 310
           ++ ++L ++ E  E   N       LG G  G V + T  G G+  AV ++     +   
Sbjct: 30  IDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 311 H------FFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE 363
           H        +E+ ++S +  H+N+V LLG    G   L++ E+     LL+  F+R+   
Sbjct: 89  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN--FLRRKSR 146
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKL----------RIIHRDIKLSNILLDEEFTAKIA 413
            L  +  + I  STA     LH  S++            IHRD+   N+LL     AKI 
Sbjct: 147 VLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIG 206
Query: 414 DFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           DFGL R    D  +I    A   + +MAPE +     T ++DV+S+G+++ E+
Sbjct: 207 DFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 24/232 (10%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD 310
           ++ ++L ++ E  E   N       LG G  G V + T  G G+  AV ++     +   
Sbjct: 22  IDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 80
Query: 311 H------FFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL------- 356
           H        +E+ ++S +  H+N+V LLG    G   L++ E+     LL+ L       
Sbjct: 81  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAD 140
Query: 357 FVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414
             ++D  PL  E+R  +  S+  A+G+A+L  ++    IHRD+   N+LL     AKI D
Sbjct: 141 LDKEDGRPL--ELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGD 195
Query: 415 FGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           FGL R    D  +I    A   + +MAPE +     T ++DV+S+G+++ E+
Sbjct: 196 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 247

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 81/162 (50%), Gaps = 21/162 (12%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-----FVRQDVEPLSWE 368
           NE+ ++  I H N+V L     +G    L+ + V    L D +     +  +D       
Sbjct: 65  NEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDAS----- 119
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL---LDEEFTAKIADFGLVRLFPEDI 425
              ++I    + + YLH+   L I+HRD+K  N+L   LDE+    I+DFGL ++  ED 
Sbjct: 120 ---RLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDP 171
Query: 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
             + +T  GT GY+APE + +   ++  D +S GV+   ++C
Sbjct: 172 GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 213

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/203 (31%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 127
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE +  
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRDTLCGTLDYLPPEMIEG 181
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
           F +  K+G+G  G V+KG     + V   ++         ++    E+ ++S  +   + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           K  G  +   +  ++ E++   S LD L    +  PL       I+    +GL YLH E 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEK 139
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTLGYMAPEYVVRG 447
           K   IHRDIK +N+LL E    K+ADFG+     +  T I      GT  +MAPE + + 
Sbjct: 140 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQS 194
Query: 448 KLTEKADVYSFGVVVIEVV 466
               KAD++S G+  IE+ 
Sbjct: 195 AYDSKADIWSLGITAIELA 213

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 124/297 (41%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS  NH+N+V+
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 190
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 191 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 236
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 237 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 297 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 125/297 (42%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS  NH+N+V+
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 150
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+     +DI  
Sbjct: 151 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----QDIYR 196
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
            S    G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 197 ASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 256
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 257 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 24/232 (10%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD 310
           ++ ++L ++ E  E   N       LG G  G V + T  G G+  AV ++     +   
Sbjct: 30  IDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 311 H------FFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL------- 356
           H        +E+ ++S +  H+N+V LLG    G   L++ E+     LL+ L       
Sbjct: 89  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAD 148
Query: 357 FVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414
             ++D  PL  E+R  +  S+  A+G+A+L  ++    IHRD+   N+LL     AKI D
Sbjct: 149 LDKEDGRPL--ELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGD 203
Query: 415 FGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           FGL R    D  +I    A   + +MAPE +     T ++DV+S+G+++ E+
Sbjct: 204 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 255

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
           F +  K+G+G  G V+KG     + V   ++         ++    E+ ++S  +   + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           K  G  +   +  ++ E++   S LD L    +  PL       I+    +GL YLH E 
Sbjct: 69  KYYGSYLKDTKLWIIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHSEK 124
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTLGYMAPEYVVRG 447
           K   IHRDIK +N+LL E    K+ADFG+     +  T I      GT  +MAPE + + 
Sbjct: 125 K---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNXFVGTPFWMAPEVIKQS 179
Query: 448 KLTEKADVYSFGVVVIEV 465
               KAD++S G+  IE+
Sbjct: 180 AYDSKADIWSLGITAIEL 197

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 130
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE ++ 
Sbjct: 131 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPE-MIE 183
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGK 207

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 129
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE ++ 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPE-MIE 182
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/297 (26%), Positives = 124/297 (41%), Gaps = 69/297 (23%)
Query: 277 LGQGGSGSVYKGTL------PGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVK 329
           LG G  G VY+G +      P    VAVK L    ++  +  F  E  +IS  NH+N+V+
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 330 LLGCSITGPESLLVYEFV---------------PNQ----SLLDNLFVRQDVEPLSWEVR 370
            +G S+      ++ E +               P+Q    ++LD L V +D+        
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI-------- 167
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITH 427
                  A G  YL E      IHRDI   N LL        AKI DFG+ R    DI  
Sbjct: 168 -------ACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYR 213
Query: 428 ISATLAG-----TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL 482
                 G      + +M PE  + G  T K D +SFGV++ E+     +   ++++  +L
Sbjct: 214 AGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 273
Query: 483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           + V      GR+    DP       +  P  + +I   C Q   E RP+ +I+++ +
Sbjct: 274 EFVTS---GGRM----DPP------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 72.4 bits (176), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 126
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +   A L GTL Y+ PE ++ 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDYLPPE-MIE 179
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 125
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE ++ 
Sbjct: 126 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPE-MIE 178
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 179 GRMHDEKVDLWSLGVLCYEFLVGK 202

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 71/221 (32%), Positives = 105/221 (47%), Gaps = 43/221 (19%)
Query: 277 LGQGGSGSVYKGTLPGGEA--------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------------KI 373
           ++ LLG C+  GP  ++V E+    +L + L  R   EP   E  Y            K 
Sbjct: 96  IINLLGACTQDGPLYVIV-EYASKGNLREYLQAR---EPPGLEYSYNPSHNPEEQLSSKD 151
Query: 374 ILS----TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
           ++S     A G+ YL   +  + IHRD+   N+L+ E+   KIADFGL R    DI HI 
Sbjct: 152 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 204
Query: 430 ATLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
                T G     +MAPE +     T ++DV+SFGV++ E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/198 (31%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 277 LGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKNLVKLLG 332
           LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N+++L G
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                    L+ E+ P   +   L   Q +     +     I   A  L+Y H +   R+
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKEL---QKLSKFDEQRTATYITELANALSYCHSK---RV 134
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL-TE 451
           IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE ++ G++  E
Sbjct: 135 IHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLXGTLDYLPPE-MIEGRMHDE 190
Query: 452 KADVYSFGVVVIEVVCRK 469
           K D++S GV+  E +  K
Sbjct: 191 KVDLWSLGVLCYEFLVGK 208

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKL 330
           LG+G  G V   Y  T   G+ VA+K +        D       E++ +  + H +++KL
Sbjct: 22  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 79
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
                +  E ++V E+  N+ L D +  R  +        ++ I+S  E   Y H     
Sbjct: 80  YDVIKSKDEIIMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE---YCHRH--- 132
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           +I+HRD+K  N+LLDE    KIADFGL  +  +   +   T  G+  Y APE V+ GKL 
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE-VISGKLY 189
Query: 451 --EKADVYSFGVVVIEVVCRK 469
              + DV+S GV++  ++CR+
Sbjct: 190 AGPEVDVWSCGVILYVMLCRR 210

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 30/215 (13%)
Query: 275 NKLGQGGSGSVYKGTL----PG--GEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNL 327
            +LG+   G VYKG L    PG   +AVA+K L       + + F +E  L + + H N+
Sbjct: 32  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 91
Query: 328 VKLLGC-SITGPESLL--------VYEFV----PNQ---SLLDNLFVRQDVEPLSWEVRY 371
           V LLG  +   P S++        ++EF+    P+    S  D+  V+  +EP  +    
Sbjct: 92  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF---V 148
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISA 430
            ++   A G+ YL   S   ++H+D+   N+L+ ++   KI+D GL R ++  D   +  
Sbjct: 149 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 205
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
                + +MAPE ++ GK +  +D++S+GVV+ EV
Sbjct: 206 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 240

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKL 330
           LG+G  G V   Y  T   G+ VA+K +        D       E++ +  + H +++KL
Sbjct: 12  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 69
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
                +  E ++V E+  N+ L D +  R  +        ++ I+S  E   Y H     
Sbjct: 70  YDVIKSKDEIIMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE---YCHRH--- 122
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           +I+HRD+K  N+LLDE    KIADFGL  +  +   +   T  G+  Y APE V+ GKL 
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE-VISGKLY 179
Query: 451 --EKADVYSFGVVVIEVVCRK 469
              + DV+S GV++  ++CR+
Sbjct: 180 AGPEVDVWSCGVILYVMLCRR 200

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKL 330
           LG+G  G V   Y  T   G+ VA+K +        D       E++ +  + H +++KL
Sbjct: 21  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 78
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
                +  E ++V E+  N+ L D +  R  +        ++ I+S  E   Y H     
Sbjct: 79  YDVIKSKDEIIMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE---YCHRH--- 131
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           +I+HRD+K  N+LLDE    KIADFGL  +  +   +   T  G+  Y APE V+ GKL 
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE-VISGKLY 188
Query: 451 --EKADVYSFGVVVIEVVCRK 469
              + DV+S GV++  ++CR+
Sbjct: 189 AGPEVDVWSCGVILYVMLCRR 209

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/201 (30%), Positives = 99/201 (49%), Gaps = 20/201 (9%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKL 330
           LG+G  G V   Y  T   G+ VA+K +        D       E++ +  + H +++KL
Sbjct: 16  LGEGSFGKVKLAYHTT--TGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKL 73
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
                +  E ++V E+  N+ L D +  R  +        ++ I+S  E   Y H     
Sbjct: 74  YDVIKSKDEIIMVIEYAGNE-LFDYIVQRDKMSEQEARRFFQQIISAVE---YCHRH--- 126
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           +I+HRD+K  N+LLDE    KIADFGL  +  +   +   T  G+  Y APE V+ GKL 
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE-VISGKLY 183
Query: 451 --EKADVYSFGVVVIEVVCRK 469
              + DV+S GV++  ++CR+
Sbjct: 184 AGPEVDVWSCGVILYVMLCRR 204

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNT---TQWVDH-FFNEVNLISGINHKNLVKLLG 332
           LG+G  G+VY       + +   ++ + T      V+H    EV + S + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                    L+ E+ P  ++   L   Q +     +     I   A  L+Y H +   R+
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSYCHSK---RV 133
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE +      EK
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 453 ADVYSFGVVVIEVVC 467
            D++S GV+  E + 
Sbjct: 191 VDLWSLGVLCYEFLV 205

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 109/215 (50%), Gaps = 30/215 (13%)
Query: 275 NKLGQGGSGSVYKGTL----PG--GEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNL 327
            +LG+   G VYKG L    PG   +AVA+K L       + + F +E  L + + H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74
Query: 328 VKLLGC-SITGPESLL--------VYEFV----PNQ---SLLDNLFVRQDVEPLSWEVRY 371
           V LLG  +   P S++        ++EF+    P+    S  D+  V+  +EP  +    
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF---V 131
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISA 430
            ++   A G+ YL   S   ++H+D+   N+L+ ++   KI+D GL R ++  D   +  
Sbjct: 132 HLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
                + +MAPE ++ GK +  +D++S+GVV+ EV
Sbjct: 189 NSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEV 223

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 123
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE ++ 
Sbjct: 124 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPE-MIE 176
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 177 GRMHDEKVDLWSLGVLCYEFLVGK 200

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGEA--------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
           ++ LLG C+  GP  ++V E+    +L + L  R+               E LS +    
Sbjct: 96  IINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVS 154
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A G+ YL   +  + IHRD+   N+L+ E+   KIADFGL R    DI HI    
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDXXK 207
Query: 433 AGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             T G     +MAPE +     T ++DV+SFGV++ E+
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 99/225 (44%), Gaps = 38/225 (16%)
Query: 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           F E   +G GG G V+K      G+   ++R+ YN  +       EV  ++ ++H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAE----REVKALAKLDHVNIVH 69
Query: 330 LLGC-------SITGPESLLVYEFVPNQS---------------------LLDNLFVRQD 361
             GC         T  +SL   ++ P  S                      L+    ++ 
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
            E L   +  ++     +G+ Y+H +   ++IHRD+K SNI L +    KI DFGLV   
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
             D     +   GTL YM+PE +      ++ D+Y+ G+++ E++
Sbjct: 187 KNDGKRTRS--KGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 88/195 (45%), Gaps = 13/195 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNT---TQWVDH-FFNEVNLISGINHKNLVKLLG 332
           LG+G  G+VY       + +   ++ + T      V+H    EV + S + H N+++L G
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                    L+ E+ P  ++   L   Q +     +     I   A  L+Y H +   R+
Sbjct: 80  YFHDATRVYLILEYAPLGTVYREL---QKLSRFDEQRTATYITELANALSYCHSK---RV 133
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRDIK  N+LL      KIADFG     P   +    TL GTL Y+ PE +      EK
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAP---SSRRDTLCGTLDYLPPEMIEGRMHDEK 190
Query: 453 ADVYSFGVVVIEVVC 467
            D++S GV+  E + 
Sbjct: 191 VDLWSLGVLCYEFLV 205

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 101/216 (46%), Gaps = 28/216 (12%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCS 334
           +G+G  G V++G L  GE+VAVK       Q    +F E  + + +   H N++  +   
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQ---SWFRETEIYNTVLLRHDNILGFIASD 71
Query: 335 ITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--- 387
           +T   S     L+  +  + SL D    RQ +EP    +  ++ +S A GLA+LH E   
Sbjct: 72  MTSRNSSTQLWLITHYHEHGSLYD-FLQRQTLEP---HLALRLAVSAACGLAHLHVEIFG 127
Query: 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPE 442
              K  I HRD K  N+L+       IAD GL  +  +   ++        GT  YMAPE
Sbjct: 128 TQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 443 YV---VRGKLTEK---ADVYSFGVVVIEVVCRKRIN 472
            +   +R    E     D+++FG+V+ E+  R  +N
Sbjct: 188 VLDEQIRTDCFESYKWTDIWAFGLVLWEIARRTIVN 223

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/236 (27%), Positives = 111/236 (47%), Gaps = 28/236 (11%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD 310
           ++ ++L ++ E  E   N       LG G  G V + T  G G+  AV ++     +   
Sbjct: 30  IDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 311 H------FFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE 363
           H        +E+ ++S +  H+N+V LLG    G   L++ E+     LL+  F+R+   
Sbjct: 89  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN--FLRRKSR 146
Query: 364 PLSWEVRYKIILST-------------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
            L  +  + I  ST             A+G+A+L  ++    IHRD+   N+LL     A
Sbjct: 147 VLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVA 203
Query: 411 KIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           KI DFGL R    D  +I    A   + +MAPE +     T ++DV+S+G+++ E+
Sbjct: 204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 259

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G +G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 183 FHAEPVDVWSCGIVL 197

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 128
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIA+FG     P   +    TL GTL Y+ PE ++ 
Sbjct: 129 K---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP---SSRRTTLCGTLDYLPPE-MIE 181
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 182 GRMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 71  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 127
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE +  
Sbjct: 128 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEG 181
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 182 RMHDEKVDLWSLGVLCYEFLVGK 204

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 126
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE +  
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEG 180
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 126
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE +  
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTELCGTLDYLPPEMIEG 180
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGEA--------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
           ++ LLG C+  GP  ++V E+    +L + L  R+               E LS +    
Sbjct: 81  IINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 139
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A G+ YL   +  + IHRD+   N+L+ E+   KIADFGL R    DI HI    
Sbjct: 140 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 192
Query: 433 AGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             T G     +MAPE +     T ++DV+SFGV++ E+
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 126
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   ++IHRDIK  N+LL      KIADFG     P   +   A L GTL Y+ PE ++ 
Sbjct: 127 K---KVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDYLPPE-MIE 179
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 75  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 131
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE +  
Sbjct: 132 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEG 185
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 186 RMHDEKVDLWSLGVLCYEFLVGK 208

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 72  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 128
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE +  
Sbjct: 129 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLCGTLDYLPPEMIEG 182
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 183 RMHDEKVDLWSLGVLCYEFLVGK 205

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 98/212 (46%), Gaps = 25/212 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           F E   +G GG G V+K      G+   +KR+ YN  +       EV  ++ ++H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE----REVKALAKLDHVNIVH 68
Query: 330 LLGC---------------SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
             GC               S +  + L +     ++  L+    ++  E L   +  ++ 
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
               +G+ Y+H +   ++I+RD+K SNI L +    KI DFGLV     D     +   G
Sbjct: 129 EQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS--KG 183
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           TL YM+PE +      ++ D+Y+ G+++ E++
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGEA--------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
           ++ LLG C+  GP  ++V E+    +L + L  R+               E LS +    
Sbjct: 88  IINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 146
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A G+ YL   +  + IHRD+   N+L+ E+   KIADFGL R    DI HI    
Sbjct: 147 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 199
Query: 433 AGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             T G     +MAPE +     T ++DV+SFGV++ E+
Sbjct: 200 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 237

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGEA--------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
           ++ LLG C+  GP  ++V E+    +L + L  R+               E LS +    
Sbjct: 96  IINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVS 154
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A G+ YL   +  + IHRD+   N+L+ E+   KIADFGL R    DI HI    
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 207
Query: 433 AGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             T G     +MAPE +     T ++DV+SFGV++ E+
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 91/203 (44%), Gaps = 13/203 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 126
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE +  
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEG 180
Query: 447 GKLTEKADVYSFGVVVIEVVCRK 469
               EK D++S GV+  E +  K
Sbjct: 181 RMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 100/214 (46%), Gaps = 19/214 (8%)
Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFY-NTTQWVDHF-FN 314
           N  ++++EK  N       +G+G  G V K      G  VA+K+    +  + V      
Sbjct: 18  NLYFQSMEKYENL----GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMR 73
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP--LSWEVRYK 372
           E+ L+  + H+NLV LL          LV+EFV + ++LD+L    ++ P  L ++V  K
Sbjct: 74  EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDL----ELFPNGLDYQVVQK 128
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
            +     G+ + H  +   IIHRDIK  NIL+ +    K+ DFG  R        +    
Sbjct: 129 YLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP-GEVYDDE 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEV 465
             T  Y APE +V   K  +  DV++ G +V E+
Sbjct: 185 VATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEM 218

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGEA--------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
           ++ LLG C+  GP  ++V E+    +L + L  R+               E LS +    
Sbjct: 85  IINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 143
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A G+ YL   +  + IHRD+   N+L+ E+   KIADFGL R    DI HI    
Sbjct: 144 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 196
Query: 433 AGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             T G     +MAPE +     T ++DV+SFGV++ E+
Sbjct: 197 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 234

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNLV 328
           + +  K+G+G  G VYK     G  VA+KR+  +            E++L+  ++H N+V
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 329 KLLGCSITGPESLLVYEFVPN---QSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYL 384
            L+    +     LV+EF+     + L +N    QD +        KI L     G+A+ 
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQ-------IKIYLYQLLRGVAHC 135
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
           H+    RI+HRD+K  N+L++ +   K+ADFGL R F   +   +  +  TL Y AP+ +
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 445 V-RGKLTEKADVYSFGVVVIEVVCRK 469
           +   K +   D++S G +  E++  K
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGEA--------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
           ++ LLG C+  GP  ++V E+    +L + L  R+               E LS +    
Sbjct: 96  IINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 154
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A G+ YL   +  + IHRD+   N+L+ E+   KIADFGL R    DI HI    
Sbjct: 155 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 207
Query: 433 AGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             T G     +MAPE +     T ++DV+SFGV++ E+
Sbjct: 208 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 245

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNLV 328
           + +  K+G+G  G VYK     G  VA+KR+  +            E++L+  ++H N+V
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 329 KLLGCSITGPESLLVYEFVPN---QSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYL 384
            L+    +     LV+EF+     + L +N    QD +        KI L     G+A+ 
Sbjct: 83  SLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQ-------IKIYLYQLLRGVAHC 135
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
           H+    RI+HRD+K  N+L++ +   K+ADFGL R F   +   +  +  TL Y AP+ +
Sbjct: 136 HQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVL 191
Query: 445 V-RGKLTEKADVYSFGVVVIEVVCRK 469
           +   K +   D++S G +  E++  K
Sbjct: 192 MGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVVIEVVC 467
              E  DV+S G+V+  ++ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA 202

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 102/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGEA--------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
           ++ LLG C+  GP  ++V E+    +L + L  R+               E LS +    
Sbjct: 89  IINLLGACTQDGPLYVIV-EYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 147
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A G+ YL   +  + IHRD+   N+L+ E+   KIADFGL R    DI HI    
Sbjct: 148 CAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYK 200
Query: 433 AGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             T G     +MAPE +     T ++DV+SFGV++ E+
Sbjct: 201 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 238

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 129
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIA+FG     P   +    TL GTL Y+ PE ++ 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP---SSRRTTLCGTLDYLPPE-MIE 182
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLMA----GVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 449 L-TEKADVYSFGVVVIEVVC 467
              E  DV+S G+V+  ++ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 183 FHAEPVDVWSCGIVL 197

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 43/221 (19%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI------------ 373
           ++ LLG C+  GP  ++V E+    +L + L  R+   P   E  Y I            
Sbjct: 103 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARR---PPGMEXSYDINRVPEEQMTFKD 158
Query: 374 ----ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
                   A G+ YL  +   + IHRD+   N+L+ E    KIADFGL R    DI +I 
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 430 ATLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
                T G     +MAPE +     T ++DV+SFGV++ E+
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 96/195 (49%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ + + +NH+N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINAMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 184 FHAEPVDVWSCGIVL 198

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/191 (32%), Positives = 94/191 (49%), Gaps = 29/191 (15%)
Query: 296 VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
           VAVK L  + T+  +    +E+ ++  I  HKN++ LLG C+  GP  ++V E+    +L
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNL 162
Query: 353 LDNLFVRQDV-------------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399
            + L  R+               E LS +         A G+ YL   +  + IHRD+  
Sbjct: 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 219
Query: 400 SNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG-----YMAPEYVVRGKLTEKAD 454
            N+L+ E+   KIADFGL R    DI HI      T G     +MAPE +     T ++D
Sbjct: 220 RNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 275
Query: 455 VYSFGVVVIEV 465
           V+SFGV++ E+
Sbjct: 276 VWSFGVLLWEI 286

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLMA----GVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVVIEVVC 467
              E  DV+S G+V+  ++ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA 202

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 126
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE ++ 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTXLCGTLDYLPPE-MIE 179
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 15/220 (6%)
Query: 248 LQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEA-VAVKRLFYNTT 306
           L  AV K K   ++E L           ++G+G  G V+ G L      VAVK       
Sbjct: 100 LHRAVPKDKWVLNHEDLVLG-------EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP 152
Query: 307 QWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
             +   F  E  ++   +H N+V+L+G         +V E V     L   F+R +   L
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT--FLRTEGARL 210
Query: 366 SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
             +   +++   A G+ YL  ESK   IHRD+   N L+ E+   KI+DFG+ R   + +
Sbjct: 211 RVKTLLQMVGDAAAGMEYL--ESKC-CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
Query: 426 THISATLAGT-LGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
              S  L    + + APE +  G+ + ++DV+SFG+++ E
Sbjct: 268 XAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEIXINKMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 183
Query: 449 L-TEKADVYSFGVVVIEVVC 467
              E  DV+S G+V+  ++ 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLA 203

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 68/221 (30%), Positives = 101/221 (45%), Gaps = 43/221 (19%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI------------ 373
           ++ LLG C+  GP  ++V E+    +L + L  R+   P   E  Y I            
Sbjct: 103 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARR---PPGMEYSYDINRVPEEQMTFKD 158
Query: 374 ----ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
                   A G+ YL  +   + IHRD+   N+L+ E    KIADFGL R    DI +I 
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNID 211
Query: 430 ATLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEV 465
                T G     +MAPE +     T ++DV+SFGV++ E+
Sbjct: 212 XXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 278 GQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSIT 336
            +G  G V+K  L   + VAVK       Q W      E+    G+ H+NL++ +     
Sbjct: 24  ARGRFGCVWKAQL-MNDFVAVKIFPLQDKQSWQSE--REIFSTPGMKHENLLQFIAAEKR 80
Query: 337 GP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE----- 387
           G     E  L+  F    SL D  +++ ++  ++W     +  + + GL+YLHE+     
Sbjct: 81  GSNLEVELWLITAFHDKGSLTD--YLKGNI--ITWNELCHVAETMSRGLSYLHEDVPWCR 136
Query: 388 ---SKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEY 443
               K  I HRD K  N+LL  + TA +ADFGL VR  P      +    GT  YMAPE 
Sbjct: 137 GEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPE- 195
Query: 444 VVRGKLT------EKADVYSFGVVVIEVVCR 468
           V+ G +        + D+Y+ G+V+ E+V R
Sbjct: 196 VLEGAINFQRDAFLRIDMYAMGLVLWELVSR 226

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 72/265 (27%), Positives = 118/265 (44%), Gaps = 61/265 (23%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESN-----KLGQGGSGSVYKGTL------PGGE 294
           G L ++V+      +++ LE     F   N      LG+G  G V K T        G  
Sbjct: 1   GPLSLSVD------AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYT 54
Query: 295 AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
            VAVK L  N +   +    +E N++  +NH +++KL G CS  GP  LL+ E+    SL
Sbjct: 55  TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSL 113
Query: 353 LDNLFVRQDVEP-----------------------------LSWEVRYKIILSTAEGLAY 383
              L   + V P                              +W++        ++G+ Y
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI--------SQGMQY 165
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPE 442
           L E   ++++HRD+   NIL+ E    KI+DFGL R   E+ +++  +     + +MA E
Sbjct: 166 LAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVC 467
            +     T ++DV+SFGV++ E+V 
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 126
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE ++ 
Sbjct: 127 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLCGTLDYLPPE-MIE 179
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 180 GRMHDEKVDLWSLGVLCYEFLVGK 203

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 66/286 (23%), Positives = 120/286 (41%), Gaps = 36/286 (12%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHK 325
           F    K+G+G    VY+   L  G  VA+K++      +     D    E++L+  +NH 
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARAD-CIKEIDLLKQLNHP 92
Query: 326 NLVKLLGCSITGPESLLVYEFVP--NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           N++K     I   E  +V E     + S +   F +Q    +     +K  +     L +
Sbjct: 93  NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK-RLIPERTVWKYFVQLCSALEH 151
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           +H     R++HRDIK +N+ +      K+ D GL R F    T  + +L GT  YM+PE 
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPER 207
Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRK------RINLFTQNSCSILQTVWDLYVKGRLHEA 497
           +       K+D++S G ++ E+   +      ++NL++              +  ++ + 
Sbjct: 208 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYS--------------LCKKIEQC 253
Query: 498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH 543
             P L  +        L Q+  +C+    E RP ++ V  +    H
Sbjct: 254 DYPPLPSDHYS---EELRQLVNMCINPDPEKRPDVTYVYDVAKRMH 296

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 90/197 (45%), Gaps = 13/197 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKNLVKLLG 332
           LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N+++L G
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                    L+ E+ P  ++   L   Q +     +     I   A  L+Y H +   R+
Sbjct: 102 YFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHSK---RV 155
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE +      EK
Sbjct: 156 IHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRDDLCGTLDYLPPEMIEGRMHDEK 212
Query: 453 ADVYSFGVVVIEVVCRK 469
            D++S GV+  E +  K
Sbjct: 213 VDLWSLGVLCYEFLVGK 229

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 121
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 182 FHAEPVDVWSCGIVL 196

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 17/181 (9%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
           G  VA+K    + TQ     +   F EV ++  +NH N+VKL     T     L+ E+  
Sbjct: 37  GREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 94
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              + D L     ++      +++ I+S  +   Y H++   RI+HRD+K  N+LLD + 
Sbjct: 95  GGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQK---RIVHRDLKAENLLLDADM 148
Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE--KADVYSFGVVVIEVV 466
             KIADFG    F   +     T  G+  Y APE + +GK  +  + DV+S GV++  +V
Sbjct: 149 NIKIADFGFSNEFT--VGGKLDTFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 205
Query: 467 C 467
Sbjct: 206 S 206

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S + H N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 129
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   R+IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE ++ 
Sbjct: 130 K---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLCGTLDYLPPE-MIE 182
Query: 447 GKL-TEKADVYSFGVVVIEVVCRK 469
           G++  EK D++S GV+  E +  K
Sbjct: 183 GRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLMA----GVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 184 FHAEPVDVWSCGIVL 198

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLMA----GVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 184 FHAEPVDVWSCGIVL 198

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/201 (31%), Positives = 95/201 (47%), Gaps = 15/201 (7%)
Query: 268 TNYFHESNKLGQGGSGSVY--KGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINH 324
           +  +    KLG G  G V   +  +   E A+ + R    +T        EV ++  ++H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            N++KL           LV E      L D +  R     +   V  K +LS   G+ YL
Sbjct: 96  PNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS---GVTYL 152
Query: 385 HEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
           H   K  I+HRD+K  N+LL+   ++   KI DFGL  +F E+   +   L GT  Y+AP
Sbjct: 153 H---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERL-GTAYYIAP 207
Query: 442 EYVVRGKLTEKADVYSFGVVV 462
           E V+R K  EK DV+S GV++
Sbjct: 208 E-VLRKKYDEKCDVWSIGVIL 227

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLMA----GVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 184 FHAEPVDVWSCGIVL 198

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 111/224 (49%), Gaps = 37/224 (16%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGIN-HKNLVKLL 331
           KLG+G  G V+K      GE VAVK++F  +  +      F E+ +++ ++ H+N+V LL
Sbjct: 16  KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL 75
Query: 332 GC--SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKIILSTAEGLAYLHEES 388
               +    +  LV++++  ++ L  +     +EP+  + V Y++I    + + YLH   
Sbjct: 76  NVLRADNDRDVYLVFDYM--ETDLHAVIRANILEPVHKQYVVYQLI----KVIKYLHSGG 129
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP--------------------EDITHI 428
              ++HRD+K SNILL+ E   K+ADFGL R F                     +D   I
Sbjct: 130 ---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 429 SATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRKRI 471
                 T  Y APE ++   K T+  D++S G ++ E++C K I
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPI 230

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI------------ 373
           ++ LLG C+  GP  ++V E+    +L + L  R+   P   E  Y I            
Sbjct: 103 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARR---PPGMEYSYDINRVPEEQMTFKD 158
Query: 374 ----ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
                   A G+ YL  +   + IHRD+   N+L+ E    KIADFGL R    +I +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYK 214
Query: 430 ATLAGTL--GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            T  G L   +MAPE +     T ++DV+SFGV++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 183 FHAEPVDVWSCGIVL 197

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 183 FHAEPVDVWSCGIVL 197

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 18/206 (8%)
Query: 268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFF--NEVNLISGINHK 325
           +++F   ++LG+G +  VY+    G +     ++   T   VD      E+ ++  ++H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVRTEIGVLLRLSHP 108
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           N++KL     T  E  LV E V    L D +  +            K IL   E +AYLH
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQIL---EAVAYLH 165
Query: 386 EESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           E     I+HRD+K  N+L      +   KIADFGL ++    +  +  T+ GT GY APE
Sbjct: 166 ENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV--LMKTVCGTPGYCAPE 220
Query: 443 YVVRG-KLTEKADVYSFGVVVIEVVC 467
            ++RG     + D++S G++   ++C
Sbjct: 221 -ILRGCAYGPEVDMWSVGIITYILLC 245

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 183 FHAEPVDVWSCGIVL 197

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 183 FHAEPVDVWSCGIVL 197

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 184 FHAEPVDVWSCGIVL 198

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 123
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 184 FHAEPVDVWSCGIVL 198

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 102/220 (46%), Gaps = 15/220 (6%)
Query: 248 LQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEA-VAVKRLFYNTT 306
           L  AV K K   ++E L           ++G+G  G V+ G L      VAVK       
Sbjct: 100 LHRAVPKDKWVLNHEDLVLG-------EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP 152
Query: 307 QWVD-HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
             +   F  E  ++   +H N+V+L+G         +V E V     L   F+R +   L
Sbjct: 153 PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT--FLRTEGARL 210
Query: 366 SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
             +   +++   A G+ YL  ESK   IHRD+   N L+ E+   KI+DFG+ R   + +
Sbjct: 211 RVKTLLQMVGDAAAGMEYL--ESKC-CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV 267
Query: 426 THISATLAGT-LGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
              S  L    + + APE +  G+ + ++DV+SFG+++ E
Sbjct: 268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWE 307

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI------------ 373
           ++ LLG C+  GP  ++V E+    +L + L  R+   P   E  Y I            
Sbjct: 103 IITLLGACTQDGPLYVIV-EYASKGNLREYLRARR---PPGMEYSYDINRVPEEQMTFKD 158
Query: 374 ----ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
                   A G+ YL  +   + IHRD+   N+L+ E    KIADFGL R    +I +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYK 214
Query: 430 ATLAGTL--GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            T  G L   +MAPE +     T ++DV+SFGV++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 183 FHAEPVDVWSCGIVL 197

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/265 (27%), Positives = 117/265 (44%), Gaps = 61/265 (23%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESN-----KLGQGGSGSVYKGTL------PGGE 294
           G L ++V+      +++ LE     F   N      LG+G  G V K T        G  
Sbjct: 1   GPLSLSVD------AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYT 54
Query: 295 AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
            VAVK L  N +   +    +E N++  +NH +++KL G CS  GP  LL+ E+    SL
Sbjct: 55  TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSL 113
Query: 353 LDNLFVRQDVEP-----------------------------LSWEVRYKIILSTAEGLAY 383
              L   + V P                              +W++        ++G+ Y
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI--------SQGMQY 165
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPE 442
           L E   ++++HRD+   NIL+ E    KI+DFGL R ++ ED     +     + +MA E
Sbjct: 166 LAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIE 222
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVC 467
            +     T ++DV+SFGV++ E+V 
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 183 FHAEPVDVWSCGIVL 197

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/195 (32%), Positives = 95/195 (48%), Gaps = 20/195 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVV 462
              E  DV+S G+V+
Sbjct: 183 FHAEPVDVWSCGIVL 197

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI------------ 373
           ++ LLG C+  GP  ++V E+    +L + L  R+   P   E  Y I            
Sbjct: 103 IIHLLGACTQDGPLYVIV-EYASKGNLREYLRARR---PPGMEYSYDINRVPEEQMTFKD 158
Query: 374 ----ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
                   A G+ YL  +   + IHRD+   N+L+ E    KIADFGL R    +I +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYK 214
Query: 430 ATLAGTL--GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            T  G L   +MAPE +     T ++DV+SFGV++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 92/207 (44%), Gaps = 13/207 (6%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNTTQW--VDH-FFNEVNLISGI 322
           A   F     LG+G  G+VY       + + A+K LF    +   V+H    EV + S +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
            H N+++L G         L+ E+ P  ++   L   Q +     +     I   A  L+
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALS 125
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           Y H +   R+IHRDIK  N+LL      KIADFG     P   +     L GTL Y+ PE
Sbjct: 126 YCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRDDLCGTLDYLPPE 179
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRK 469
            +      EK D++S GV+  E +  K
Sbjct: 180 MIEGRMHDEKVDLWSLGVLCYEFLVGK 206

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 20/200 (10%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK    +  + VD   +   E+ +   +NH+N+VK  G
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVK--IVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV---EPLSWEVRYKIILSTAEGLAYLHEESK 389
               G    L  E+     L D   +  D+   EP +    ++++     G+ YLH    
Sbjct: 72  HRREGNIQYLFLEYCSGGELFDR--IEPDIGMPEPDAQRFFHQLM----AGVVYLH---G 122
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP-EDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R +
Sbjct: 123 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRRE 182
Query: 449 L-TEKADVYSFGVVVIEVVC 467
              E  DV+S G+V+  ++ 
Sbjct: 183 FHAEPVDVWSCGIVLTAMLA 202

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 28/204 (13%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           +LG G  G VYK      G   A K +   + + ++ +  E+ +++  +H  +VKLLG  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
               +  ++ EF P  ++ D + +  D    EP    V  +++    E L +LH +   R
Sbjct: 78  YHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---R 129
Query: 392 IIHRDIKLSNILLDEEFTAKIADFG-----LVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           IIHRD+K  N+L+  E   ++ADFG     L  L   D      +  GT  +MAPE V+ 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD------SFIGTPYWMAPEVVMC 183
Query: 447 GKLTE-----KADVYSFGVVVIEV 465
             + +     KAD++S G+ +IE+
Sbjct: 184 ETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 87/195 (44%), Gaps = 14/195 (7%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQ---WVDHFFNEVNLISGINHKN 326
           F   N LG+G    VY+  ++  G  VA+K +          V    NEV +   + H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L           LV E   N  +  N +++  V+P S       +     G+ YLH 
Sbjct: 73  ILELYNYFEDSNYVYLVLEMCHNGEM--NRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDITHISATLAGTLGYMAPEYV 444
                I+HRD+ LSN+LL      KIADFGL      P +  +   TL GT  Y++PE  
Sbjct: 131 HG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY---TLCGTPNYISPEIA 184
Query: 445 VRGKLTEKADVYSFG 459
            R     ++DV+S G
Sbjct: 185 TRSAHGLESDVWSLG 199

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 28/204 (13%)
Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           +LG G  G VYK      G   A K +   + + ++ +  E+ +++  +H  +VKLLG  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQD---VEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
               +  ++ EF P  ++ D + +  D    EP    V  +++    E L +LH +   R
Sbjct: 86  YHDGKLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQML----EALNFLHSK---R 137
Query: 392 IIHRDIKLSNILLDEEFTAKIADFG-----LVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           IIHRD+K  N+L+  E   ++ADFG     L  L   D      +  GT  +MAPE V+ 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRD------SFIGTPYWMAPEVVMC 191
Query: 447 GKLTE-----KADVYSFGVVVIEV 465
             + +     KAD++S G+ +IE+
Sbjct: 192 ETMKDTPYDYKADIWSLGITLIEM 215

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 293 GEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESL-LVYEFVPN 349
           GE VAVK L   +    +     E+ ++  + H+N+VK  G C+  G   + L+ EF+P+
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409
            SL + L   ++   L  +++Y +     +G+ YL      + +HRD+   N+L++ E  
Sbjct: 110 GSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYL---GSRQYVHRDLAARNVLVESEHQ 164
Query: 410 AKIADFGLVRLFPED--ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            KI DFGL +    D     +       + + APE +++ K    +DV+SFGV + E++
Sbjct: 165 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 223

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI------------ 373
           ++ LLG C+  GP  ++V E+    +L + L  R+   P   E  Y I            
Sbjct: 103 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARR---PPGMEYSYDINRVPEEQMTFKD 158
Query: 374 ----ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
                   A G+ YL  +   + IHRD+   N+L+ E    KIADFGL R    +I +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYK 214
Query: 430 ATLAGTL--GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            T  G L   +MAPE +     T ++DV+SFGV++ E+
Sbjct: 215 NTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 88/181 (48%), Gaps = 17/181 (9%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
           G  VAVK    + TQ     +   F EV ++  +NH N+VKL     T     LV E+  
Sbjct: 40  GREVAVK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYAS 97
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              + D L     ++      +++ I+S  +   Y H++    I+HRD+K  N+LLD + 
Sbjct: 98  GGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKY---IVHRDLKAENLLLDGDM 151
Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE--KADVYSFGVVVIEVV 466
             KIADFG    F   + +   T  G+  Y APE + +GK  +  + DV+S GV++  +V
Sbjct: 152 NIKIADFGFSNEFT--VGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 208
Query: 467 C 467
Sbjct: 209 S 209

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/179 (28%), Positives = 91/179 (50%), Gaps = 10/179 (5%)
Query: 293 GEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESL-LVYEFVPN 349
           GE VAVK L   +    +     E+ ++  + H+N+VK  G C+  G   + L+ EF+P+
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409
            SL + L   ++   L  +++Y +     +G+ YL      + +HRD+   N+L++ E  
Sbjct: 98  GSLKEYLPKNKNKINLKQQLKYAV--QICKGMDYL---GSRQYVHRDLAARNVLVESEHQ 152
Query: 410 AKIADFGLVRLFPED--ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            KI DFGL +    D     +       + + APE +++ K    +DV+SFGV + E++
Sbjct: 153 VKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELL 211

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 89/181 (49%), Gaps = 17/181 (9%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
           G+ VAVK +  + TQ     +   F EV ++  +NH N+VKL     T     LV E+  
Sbjct: 39  GKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              + D L     ++      +++ I+S  +   Y H++    I+HRD+K  N+LLD + 
Sbjct: 97  GGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF---IVHRDLKAENLLLDADM 150
Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE--KADVYSFGVVVIEVV 466
             KIADFG    F     +   T  G+  Y APE + +GK  +  + DV+S GV++  +V
Sbjct: 151 NIKIADFGFSNEF--TFGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 467 C 467
Sbjct: 208 S 208

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 89/181 (49%), Gaps = 17/181 (9%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
           G+ VAVK +  + TQ     +   F EV ++  +NH N+VKL     T     LV E+  
Sbjct: 39  GKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              + D L     ++      +++ I+S  +   Y H++    I+HRD+K  N+LLD + 
Sbjct: 97  GGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF---IVHRDLKAENLLLDADM 150
Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE--KADVYSFGVVVIEVV 466
             KIADFG    F     +   T  G+  Y APE + +GK  +  + DV+S GV++  +V
Sbjct: 151 NIKIADFGFSNEFT--FGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 467 C 467
Sbjct: 208 S 208

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCS 334
           +G+G  G V++G+   GE VAVK +F +  +    +F E  L + +   H+N++  +   
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVK-IFSSRDE--KSWFRETELYNTVMLRHENILGFIASD 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-----SK 389
           +T   S      + +   + +L+    +  L      +I+LS A GLA+LH E      K
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEYVVR 446
             I HRD+K  NIL+ +     IAD GL  +  +    +        GT  YMAPE +  
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 447 GKLTE------KADVYSFGVVVIEVVCR 468
               +      + D+++FG+V+ EV  R
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI------------ 373
           ++ LLG C+  GP  ++V E+    +L + L  R+   P   E  Y I            
Sbjct: 103 IINLLGACTQDGPLYVIV-EYASKGNLREYLRARR---PPGMEYSYDINRVPEEQMTFKD 158
Query: 374 ----ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
                   A G+ YL  +   + IHRD+   N+L+ E    +IADFGL R    +I +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDI-NNIDYYK 214
Query: 430 ATLAGTL--GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            T  G L   +MAPE +     T ++DV+SFGV++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 93/191 (48%), Gaps = 29/191 (15%)
Query: 296 VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
           VAVK L  + T+  +    +E+ ++  I  HKN++ LLG C+  GP  ++V E+    +L
Sbjct: 59  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNL 117
Query: 353 LDNLFVRQDVEPLSWEVRYKI----------------ILSTAEGLAYLHEESKLRIIHRD 396
            + L  R+   P   E  Y I                    A G+ YL  +   + IHRD
Sbjct: 118 REYLRARR---PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD 171
Query: 397 IKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRGKLTEKAD 454
           +   N+L+ E    KIADFGL R    +I +   T  G L   +MAPE +     T ++D
Sbjct: 172 LAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 230
Query: 455 VYSFGVVVIEV 465
           V+SFGV++ E+
Sbjct: 231 VWSFGVLMWEI 241

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCS 334
           +G+G  G V++G+  G E VAVK +F +  +    +F E  L + +   H+N++  +   
Sbjct: 45  VGKGRYGEVWRGSWQG-ENVAVK-IFSSRDE--KSWFRETELYNTVMLRHENILGFIASD 100
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-----SK 389
           +T   S      + +   + +L+    +  L      +I+LS A GLA+LH E      K
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 160
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEYVVR 446
             I HRD+K  NIL+ +     IAD GL  +  +    +        GT  YMAPE +  
Sbjct: 161 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 220
Query: 447 GKLTE------KADVYSFGVVVIEVVCR 468
               +      + D+++FG+V+ EV  R
Sbjct: 221 TIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 93/191 (48%), Gaps = 29/191 (15%)
Query: 296 VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
           VAVK L  + T+  +    +E+ ++  I  HKN++ LLG C+  GP  ++V E+    +L
Sbjct: 62  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNL 120
Query: 353 LDNLFVRQDVEPLSWEVRYKI----------------ILSTAEGLAYLHEESKLRIIHRD 396
            + L  R+   P   E  Y I                    A G+ YL  +   + IHRD
Sbjct: 121 REYLRARR---PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD 174
Query: 397 IKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRGKLTEKAD 454
           +   N+L+ E    KIADFGL R    +I +   T  G L   +MAPE +     T ++D
Sbjct: 175 LAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 233
Query: 455 VYSFGVVVIEV 465
           V+SFGV++ E+
Sbjct: 234 VWSFGVLMWEI 244

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 20/208 (9%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCS 334
           +G+G  G V++G+   GE VAVK +F +  +    +F E  L + +   H+N++  +   
Sbjct: 16  VGKGRYGEVWRGSW-QGENVAVK-IFSSRDE--KSWFRETELYNTVMLRHENILGFIASD 71
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-----SK 389
           +T   S      + +   + +L+    +  L      +I+LS A GLA+LH E      K
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEYVVR 446
             I HRD+K  NIL+ +     IAD GL  +  +    +        GT  YMAPE +  
Sbjct: 132 PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191
Query: 447 GKLTE------KADVYSFGVVVIEVVCR 468
               +      + D+++FG+V+ EV  R
Sbjct: 192 TIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 93/192 (48%), Gaps = 29/192 (15%)
Query: 295 AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQS 351
            VAVK L  + T+  +    +E+ ++  I  HKN++ LLG C+  GP  ++V E+    +
Sbjct: 56  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGN 114
Query: 352 LLDNLFVRQDVEPLSWEVRYKI----------------ILSTAEGLAYLHEESKLRIIHR 395
           L + L  R+   P   E  Y I                    A G+ YL  +   + IHR
Sbjct: 115 LREYLRARR---PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHR 168
Query: 396 DIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRGKLTEKA 453
           D+   N+L+ E    KIADFGL R    +I +   T  G L   +MAPE +     T ++
Sbjct: 169 DLTARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 227
Query: 454 DVYSFGVVVIEV 465
           DV+SFGV++ E+
Sbjct: 228 DVWSFGVLMWEI 239

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 61/191 (31%), Positives = 93/191 (48%), Gaps = 29/191 (15%)
Query: 296 VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
           VAVK L  + T+  +    +E+ ++  I  HKN++ LLG C+  GP  ++V E+    +L
Sbjct: 116 VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIV-EYASKGNL 174
Query: 353 LDNLFVRQDVEPLSWEVRYKI----------------ILSTAEGLAYLHEESKLRIIHRD 396
            + L  R+   P   E  Y I                    A G+ YL  +   + IHRD
Sbjct: 175 REYLRARR---PPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD 228
Query: 397 IKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRGKLTEKAD 454
           +   N+L+ E    KIADFGL R    +I +   T  G L   +MAPE +     T ++D
Sbjct: 229 LAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287
Query: 455 VYSFGVVVIEV 465
           V+SFGV++ E+
Sbjct: 288 VWSFGVLMWEI 298

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/265 (27%), Positives = 116/265 (43%), Gaps = 61/265 (23%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESN-----KLGQGGSGSVYKGTL------PGGE 294
           G L ++V+      +++ LE     F   N      LG+G  G V K T        G  
Sbjct: 1   GPLSLSVD------AFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYT 54
Query: 295 AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESLLVYEFVPNQSL 352
            VAVK L  N +   +    +E N++  +NH +++KL G CS  GP  LL+ E+    SL
Sbjct: 55  TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP-LLLIVEYAKYGSL 113
Query: 353 LDNLFVRQDVEP-----------------------------LSWEVRYKIILSTAEGLAY 383
              L   + V P                              +W++        ++G+ Y
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQI--------SQGMQY 165
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPE 442
           L E S   ++HRD+   NIL+ E    KI+DFGL R ++ ED     +     + +MA E
Sbjct: 166 LAEMS---LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIE 222
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVC 467
            +     T ++DV+SFGV++ E+V 
Sbjct: 223 SLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 71/235 (30%), Positives = 108/235 (45%), Gaps = 23/235 (9%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVK--RLFYNTTQWVDHFFNEVNLI---S 320
           AT+ +    ++G G  G+VYK   P  G  VA+K  R+             EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 321 GINHKNLVKLLGCSITGP-----ESLLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKII 374
              H N+V+L+    T       +  LV+E V +Q L    ++ +   P L  E    ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDL--RTYLDKAPPPGLPAETIKDLM 118
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
                GL +LH      I+HRD+K  NIL+    T K+ADFGL R++   +    A +  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LAPVVV 173
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS-CSILQTVWDL 488
           TL Y APE +++       D++S G +  E+  RK   LF  NS    L  ++DL
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK--PLFCGNSEADQLGKIFDL 226

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 40/218 (18%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCS 334
           +G+G  G V++G   G E VAVK +F +  +    +F E  +   +   H+N++  +   
Sbjct: 12  IGKGRFGEVWRGKWRG-EEVAVK-IFSSREE--RSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 335 I----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--- 387
                T  +  LV ++  + SL D L    +   ++ E   K+ LSTA GLA+LH E   
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 123
Query: 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT---------LAGTL 436
              K  I HRD+K  NIL+ +  T  IAD GL       + H SAT           GT 
Sbjct: 124 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA------VRHDSATDTIDIAPNHRVGTK 177
Query: 437 GYMAPEYV---VRGKLTE---KADVYSFGVVVIEVVCR 468
            YMAPE +   +  K  E   +AD+Y+ G+V  E+  R
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 215

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 40/218 (18%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCS 334
           +G+G  G V++G   G E VAVK +F +  +    +F E  +   +   H+N++  +   
Sbjct: 14  IGKGRFGEVWRGKWRG-EEVAVK-IFSSREE--RSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 335 I----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--- 387
                T  +  LV ++  + SL D L    +   ++ E   K+ LSTA GLA+LH E   
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 125
Query: 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT---------LAGTL 436
              K  I HRD+K  NIL+ +  T  IAD GL       + H SAT           GT 
Sbjct: 126 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA------VRHDSATDTIDIAPNHRVGTK 179
Query: 437 GYMAPEYV---VRGKLTE---KADVYSFGVVVIEVVCR 468
            YMAPE +   +  K  E   +AD+Y+ G+V  E+  R
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 217

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 101/207 (48%), Gaps = 21/207 (10%)
Query: 276 KLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGIN---HKNLV 328
           ++G+G  G V+K      GG  VA+KR+   T +         EV ++  +    H N+V
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 329 KLLG-CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIILSTAEGLA 382
           +L   C+++  +      LV+E V +Q L    ++ +  EP +  E    ++     GL 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDL--TTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           +LH     R++HRD+K  NIL+      K+ADFGL R++   +   S  +  TL Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPE 189
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRK 469
            +++       D++S G +  E+  RK
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 40/218 (18%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCS 334
           +G+G  G V++G   G E VAVK +F +  +    +F E  +   +   H+N++  +   
Sbjct: 17  IGKGRFGEVWRGKWRG-EEVAVK-IFSSREE--RSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 335 I----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--- 387
                T  +  LV ++  + SL D L    +   ++ E   K+ LSTA GLA+LH E   
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 128
Query: 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT---------LAGTL 436
              K  I HRD+K  NIL+ +  T  IAD GL       + H SAT           GT 
Sbjct: 129 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA------VRHDSATDTIDIAPNHRVGTK 182
Query: 437 GYMAPEYV---VRGKLTE---KADVYSFGVVVIEVVCR 468
            YMAPE +   +  K  E   +AD+Y+ G+V  E+  R
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 220

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 92/199 (46%), Gaps = 15/199 (7%)
Query: 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKL 330
           + LG G  G V  G     G  VAVK L     + +D       E+  +    H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
                T  +  +V E+V    L D +     VE +     ++ ILS  +   Y H     
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD---YCHRHM-- 131
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
            ++HRD+K  N+LLD    AKIADFGL  +  +       T  G+  Y APE V+ G+L 
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCGSPNYAAPE-VISGRLY 187
Query: 451 --EKADVYSFGVVVIEVVC 467
              + D++S GV++  ++C
Sbjct: 188 AGPEVDIWSCGVILYALLC 206

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 92/192 (47%), Gaps = 15/192 (7%)
Query: 277 LGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLVKLLGC 333
           LG+G  G V K       +  AVK +   + +  D      EV L+  ++H N++KL   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
                   +V E      L D +  R+     S     +II     G+ Y+H   K  I+
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAARIIKQVFSGITYMH---KHNIV 143
Query: 394 HRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           HRD+K  NILL   +++   KI DFGL   F ++ T +   + GT  Y+APE V+RG   
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGTYD 200
Query: 451 EKADVYSFGVVV 462
           EK DV+S GV++
Sbjct: 201 EKCDVWSAGVIL 212

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 40/218 (18%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCS 334
           +G+G  G V++G   G E VAVK +F +  +    +F E  +   +   H+N++  +   
Sbjct: 11  IGKGRFGEVWRGKWRG-EEVAVK-IFSSREE--RSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 335 I----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--- 387
                T  +  LV ++  + SL D L    +   ++ E   K+ LSTA GLA+LH E   
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT---------LAGTL 436
              K  I HRD+K  NIL+ +  T  IAD GL       + H SAT           GT 
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA------VRHDSATDTIDIAPNHRVGTK 176
Query: 437 GYMAPEYV---VRGKLTE---KADVYSFGVVVIEVVCR 468
            YMAPE +   +  K  E   +AD+Y+ G+V  E+  R
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 214

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 266 KATNYFHESNKLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISG 321
           +A   +    ++G+G  G V+K      GG  VA+KR+   T +         EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 322 IN---HKNLVKLLG-CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYK 372
           +    H N+V+L   C+++  +      LV+E V +Q L    ++ +  EP +  E    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDL--TTYLDKVPEPGVPTETIKD 124
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           ++     GL +LH     R++HRD+K  NIL+      K+ADFGL R++   +   S  +
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
             TL Y APE +++       D++S G +  E+  RK
Sbjct: 182 --TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 77/153 (50%), Gaps = 12/153 (7%)
Query: 313 FNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK 372
             EV L+  ++H N++KL           +V E      L D +  R+     S     +
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAAR 125
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHIS 429
           II     G+ Y+H   K  I+HRD+K  NILL   +++   KI DFGL   F ++ T + 
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMK 181
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
             + GT  Y+APE V+RG   EK DV+S GV++
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 77/153 (50%), Gaps = 12/153 (7%)
Query: 313 FNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK 372
             EV L+  ++H N++KL           +V E      L D +  R+     S     +
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK---RFSEHDAAR 125
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHIS 429
           II     G+ Y+H   K  I+HRD+K  NILL   +++   KI DFGL   F ++ T + 
Sbjct: 126 IIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMK 181
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
             + GT  Y+APE V+RG   EK DV+S GV++
Sbjct: 182 DRI-GTAYYIAPE-VLRGTYDEKCDVWSAGVIL 212

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 40/218 (18%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCS 334
           +G+G  G V++G   G E VAVK +F +  +    +F E  +   +   H+N++  +   
Sbjct: 37  IGKGRFGEVWRGKWRG-EEVAVK-IFSSREE--RSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 335 I----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--- 387
                T  +  LV ++  + SL D L    +   ++ E   K+ LSTA GLA+LH E   
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 148
Query: 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT---------LAGTL 436
              K  I HRD+K  NIL+ +  T  IAD GL       + H SAT           GT 
Sbjct: 149 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA------VRHDSATDTIDIAPNHRVGTK 202
Query: 437 GYMAPEYV---VRGKLTE---KADVYSFGVVVIEVVCR 468
            YMAPE +   +  K  E   +AD+Y+ G+V  E+  R
Sbjct: 203 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 21/217 (9%)
Query: 266 KATNYFHESNKLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISG 321
           +A   +    ++G+G  G V+K      GG  VA+KR+   T +         EV ++  
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67
Query: 322 IN---HKNLVKLLG-CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYK 372
           +    H N+V+L   C+++  +      LV+E V +Q L    ++ +  EP +  E    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDL--TTYLDKVPEPGVPTETIKD 124
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           ++     GL +LH     R++HRD+K  NIL+      K+ADFGL R++   +   S  +
Sbjct: 125 MMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 181
Query: 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
             TL Y APE +++       D++S G +  E+  RK
Sbjct: 182 --TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 88/181 (48%), Gaps = 17/181 (9%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
           G+ VAV+    + TQ     +   F EV ++  +NH N+VKL     T     LV E+  
Sbjct: 39  GKEVAVR--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              + D L     ++      +++ I+S  +   Y H++    I+HRD+K  N+LLD + 
Sbjct: 97  GGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF---IVHRDLKAENLLLDADM 150
Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE--KADVYSFGVVVIEVV 466
             KIADFG    F     +   T  G+  Y APE + +GK  +  + DV+S GV++  +V
Sbjct: 151 NIKIADFGFSNEFT--FGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 467 C 467
Sbjct: 208 S 208

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVK--RLFYNTTQWVDHFFNEVNLI---S 320
           AT+ +    ++G G  G+VYK   P  G  VA+K  R+             EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 321 GINHKNLVKLLGCSITGP-----ESLLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKII 374
              H N+V+L+    T       +  LV+E V +Q L    ++ +   P L  E    ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDL--RTYLDKAPPPGLPAETIKDLM 118
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
                GL +LH      I+HRD+K  NIL+    T K+ADFGL R++   +      +  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVV-- 173
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS-CSILQTVWDL 488
           TL Y APE +++       D++S G +  E+  RK   LF  NS    L  ++DL
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK--PLFCGNSEADQLGKIFDL 226

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 104/218 (47%), Gaps = 40/218 (18%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCS 334
           +G+G  G V++G   G E VAVK +F +  +    +F E  +   +   H+N++  +   
Sbjct: 50  IGKGRFGEVWRGKWRG-EEVAVK-IFSSREE--RSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 335 I----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--- 387
                T  +  LV ++  + SL D L    +   ++ E   K+ LSTA GLA+LH E   
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 161
Query: 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT---------LAGTL 436
              K  I HRD+K  NIL+ +  T  IAD GL       + H SAT           GT 
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA------VRHDSATDTIDIAPNHRVGTK 215
Query: 437 GYMAPEYV---VRGKLTE---KADVYSFGVVVIEVVCR 468
            YMAPE +   +  K  E   +AD+Y+ G+V  E+  R
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 100/207 (48%), Gaps = 18/207 (8%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVK------RLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           LG+G  GSV +G L   +  ++K      +L  ++ + ++ F +E   +   +H N+++L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 331 LGCSITG-----PESLLVYEFVPNQSLLDNL-FVRQDVEP--LSWEVRYKIILSTAEGLA 382
           LG  I       P+ +++  F+    L   L + R +  P  +  +   K ++  A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV-RLFPEDITHISATLAGTLGYMAP 441
           YL   S    +HRD+   N +L ++ T  +ADFGL  +++  D           + ++A 
Sbjct: 162 YL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCR 468
           E +     T K+DV++FGV + E+  R
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIATR 245

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 312 FFNEVNLISGINHKNLVKLLGC----SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
           F  E    + +NH  +V +       +  GP   +V E+V   +L D +       P++ 
Sbjct: 59  FRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTP 115
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
           +   ++I    + L + H+     IIHRD+K +NI++      K+ DFG+ R   +    
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 428 ISATLA--GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++ T A  GT  Y++PE      +  ++DVYS G V+ EV+ 
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 113/245 (46%), Gaps = 37/245 (15%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD 310
           ++ ++L ++ E  E   N       LG G  G V + T  G G+  AV ++     +   
Sbjct: 15  IDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 73
Query: 311 H------FFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL------- 356
           H        +E+ ++S +  H+N+V LLG    G   L++ E+     LL+ L       
Sbjct: 74  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAM 133
Query: 357 -------------FVRQDVEPLSWEVRYKIILST--AEGLAYLHEESKLRIIHRDIKLSN 401
                          ++D  PL  E+R  +  S+  A+G+A+L  ++    IHRD+   N
Sbjct: 134 LGPSLAPGQDPEGLDKEDGRPL--ELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARN 188
Query: 402 ILLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGV 460
           +LL     AKI DFGL R    D  +I    A   + +MAPE +     T ++DV+S+G+
Sbjct: 189 VLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGI 248
Query: 461 VVIEV 465
           ++ E+
Sbjct: 249 LLWEI 253

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
           G  VA+K    + TQ     +   F EV ++  +NH N+VKL     T     L+ E+  
Sbjct: 40  GREVAIK--IIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYAS 97
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              + D L     ++      +++ I+S  +   Y H++   RI+HRD+K  N+LLD + 
Sbjct: 98  GGEVFDYLVAHGRMKEKEARSKFRQIVSAVQ---YCHQK---RIVHRDLKAENLLLDADM 151
Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE--KADVYSFGVVVIEVV 466
             KIADFG    F   +        G   Y APE + +GK  +  + DV+S GV++  +V
Sbjct: 152 NIKIADFGFSNEFT--VGGKLDAFCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 208

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQ---WVDHFFNEVNLISGINHKNLVKLLG 332
           LG GG   V+    L     VAVK L  +  +   +   F  E    + +NH  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 333 C----SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
                +  GP   +V E+V   +L D +       P++ +   ++I    + L + H+  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG 136
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA--GTLGYMAPEYVVR 446
              IIHRD+K +NI++      K+ DFG+ R   +    ++ T A  GT  Y++PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 447 GKLTEKADVYSFGVVVIEVVC 467
             +  ++DVYS G V+ EV+ 
Sbjct: 194 DSVDARSDVYSLGCVLYEVLT 214

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 104/233 (44%), Gaps = 26/233 (11%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW 308
            +L +     E   +       LG+G  G V +    G         VAVK L    T  
Sbjct: 15  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATH- 73
Query: 309 VDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFV-RQDVE 363
            +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L   L   R +  
Sbjct: 74  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 133
Query: 364 PLSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
           P   E  YK  L+           A+G+ +L   +  + IHRD+   NILL E+   KI 
Sbjct: 134 PYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIC 190
Query: 414 DFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           DFGL R   +D   +    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 191 DFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 107/238 (44%), Gaps = 34/238 (14%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW 308
            +L +     E   +       LG+G  G V +    G +       VAVK L    T  
Sbjct: 4   ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH- 62
Query: 309 VDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSL------LDNLFV 358
            +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L        N FV
Sbjct: 63  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFV 122
Query: 359 RQDVEPLSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              V P   E  YK  L+           A+G+ +L   +  + IHRD+   NILL E+ 
Sbjct: 123 PYKVAP---EDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN 176
Query: 409 TAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             KI DFGL R   +D  ++    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 177 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 91/201 (45%), Gaps = 16/201 (7%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQ---WVDHFFNEVNLISGINHKNLVKLLG 332
           LG GG   V+    L     VAVK L  +  +   +   F  E    + +NH  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 333 C----SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
                +  GP   +V E+V   +L D +       P++ +   ++I    + L + H+  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG 136
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA--GTLGYMAPEYVVR 446
              IIHRD+K +NIL+      K+ DFG+ R   +    +  T A  GT  Y++PE    
Sbjct: 137 ---IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARG 193
Query: 447 GKLTEKADVYSFGVVVIEVVC 467
             +  ++DVYS G V+ EV+ 
Sbjct: 194 DSVDARSDVYSLGCVLYEVLT 214

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 107/238 (44%), Gaps = 34/238 (14%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW 308
            +L +     E   +       LG+G  G V +    G +       VAVK L    T  
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH- 71
Query: 309 VDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSL------LDNLFV 358
            +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L        N FV
Sbjct: 72  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 359 RQDVEPLSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              V P   E  YK  L+           A+G+ +L   +  + IHRD+   NILL E+ 
Sbjct: 132 PYKVAP---EDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN 185
Query: 409 TAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             KI DFGL R   +D  ++    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI------------ 373
           ++ LLG C+  GP  ++V  +    +L + L  R+   P   E  Y I            
Sbjct: 103 IINLLGACTQDGPLYVIV-AYASKGNLREYLRARR---PPGMEYSYDINRVPEEQMTFKD 158
Query: 374 ----ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
                   A G+ YL  +   + IHRD+   N+L+ E    KIADFGL R    +I +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYK 214
Query: 430 ATLAGTL--GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            T  G L   +MAPE +     T ++DV+SFGV++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQ---WVDHFFNEVNLISGINHKNLVKLLG 332
           LG GG   V+    L     VAVK L  +  +   +   F  E    + +NH  +V +  
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 333 C----SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
                +  GP   +V E+V   +L D +       P++ +   ++I    + L + H+  
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG 136
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA--GTLGYMAPEYVVR 446
              IIHRD+K +NI++      K+ DFG+ R   +    ++ T A  GT  Y++PE    
Sbjct: 137 ---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 447 GKLTEKADVYSFGVVVIEVVC 467
             +  ++DVYS G V+ EV+ 
Sbjct: 194 DSVDARSDVYSLGCVLYEVLT 214

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 56/181 (30%), Positives = 89/181 (49%), Gaps = 17/181 (9%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
           G+ VAVK +  + TQ     +   F EV ++  +NH N+VKL     T     LV E+  
Sbjct: 32  GKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 89
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              + D L     ++      +++ I+S  +   Y H++    I+HRD+K  N+LLD + 
Sbjct: 90  GGEVFDYLVAHGWMKEKEARAKFRQIVSAVQ---YCHQKF---IVHRDLKAENLLLDADM 143
Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE--KADVYSFGVVVIEVV 466
             KIADFG    F     +   T  G+  Y APE + +GK  +  + DV+S GV++  +V
Sbjct: 144 NIKIADFGFSNEFT--FGNKLDTFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 200
Query: 467 C 467
Sbjct: 201 S 201

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 108/240 (45%), Gaps = 34/240 (14%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTT 306
           +  +L +     E   +       LG+G  G V +    G +       VAVK L    T
Sbjct: 2   HAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 61
Query: 307 QWVDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSL------LDNL 356
              +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L        N 
Sbjct: 62  H-SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE 120
Query: 357 FVRQDVEPLSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
           FV   V P   E  YK  L+           A+G+ +L   +  + IHRD+   NILL E
Sbjct: 121 FVPYKVAP---EDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 174
Query: 407 EFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           +   KI DFGL R   +D  ++    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 175 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 312 FFNEVNLISGINHKNLVKLLGC----SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
           F  E    + +NH  +V +       +  GP   +V E+V   +L D +       P++ 
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTP 115
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
           +   ++I    + L + H+     IIHRD+K +NI++      K+ DFG+ R   +    
Sbjct: 116 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 172
Query: 428 ISATLA--GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++ T A  GT  Y++PE      +  ++DVYS G V+ EV+ 
Sbjct: 173 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTT 306
           +  +L +     E   +       LG+G  G V +    G +       VAVK L    T
Sbjct: 2   HAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 61
Query: 307 QWVDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSL------LDNL 356
              +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L        N 
Sbjct: 62  H-SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 120
Query: 357 FVRQDVEPLSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
           FV   V P   E  YK  L+           A+G+ +L   +  + IHRD+   NILL E
Sbjct: 121 FVPYKVAP---EDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 174
Query: 407 EFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           +   KI DFGL R   +D   +    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 175 KNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 106/238 (44%), Gaps = 34/238 (14%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW 308
            +L +     E   +       LG+G  G V +    G +       VAVK L    T  
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH- 71
Query: 309 VDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSL------LDNLFV 358
            +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L        N FV
Sbjct: 72  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 359 RQDVEPLSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              V P   E  YK  L+           A+G+ +L   +  + IHRD+   NILL E+ 
Sbjct: 132 PYKVAP---EDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN 185
Query: 409 TAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             KI DFGL R   +D   +    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 186 VVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 108/238 (45%), Gaps = 30/238 (12%)
Query: 252 VNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD 310
           ++ ++L ++ E  E   N       LG G  G V + T  G G+  AV ++     +   
Sbjct: 30  IDPTQLPYN-EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 311 H------FFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE 363
           H        +E+ ++S +  H+N+V LLG    G   L++ E+     LL+  F+R+   
Sbjct: 89  HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN--FLRRKRP 146
Query: 364 P---------------LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
           P               LS           A+G+A+L  ++    IHRD+   N+LL    
Sbjct: 147 PGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGH 203
Query: 409 TAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            AKI DFGL R    D  +I    A   + +MAPE +     T ++DV+S+G+++ E+
Sbjct: 204 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 261

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 107/238 (44%), Gaps = 34/238 (14%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW 308
            +L +     E   +       LG+G  G V +    G +       VAVK L    T  
Sbjct: 50  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH- 108
Query: 309 VDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSL------LDNLFV 358
            +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L        N FV
Sbjct: 109 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 168
Query: 359 RQDVEPLSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              V P   E  YK  L+           A+G+ +L   +  + IHRD+   NILL E+ 
Sbjct: 169 PYKVAP---EDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN 222
Query: 409 TAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             KI DFGL R   +D  ++    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 21/162 (12%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-----FVRQDVEPLSWE 368
           NE+ ++  I H+N+V L     +     LV + V    L D +     +  +D   L   
Sbjct: 69  NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTL--- 125
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDI 425
                I    + + YLH   ++ I+HRD+K  N+L    DEE    I+DFGL ++  E  
Sbjct: 126 -----IRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGK 175
Query: 426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
             + +T  GT GY+APE + +   ++  D +S GV+   ++C
Sbjct: 176 GDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLC 217

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 44/162 (27%), Positives = 77/162 (47%), Gaps = 12/162 (7%)
Query: 312 FFNEVNLISGINHKNLVKLLGC----SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
           F  E    + +NH  +V +       +  GP   +V E+V   +L D +       P++ 
Sbjct: 76  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTP 132
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
           +   ++I    + L + H+     IIHRD+K +NI++      K+ DFG+ R   +    
Sbjct: 133 KRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNS 189
Query: 428 ISATLA--GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++ T A  GT  Y++PE      +  ++DVYS G V+ EV+ 
Sbjct: 190 VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 231

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 26/232 (11%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW 308
            +L +     E   +  +    LG+G  G V +    G         VAVK L    T  
Sbjct: 13  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATH- 71
Query: 309 VDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
            +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L   L  +++ E 
Sbjct: 72  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-EF 130
Query: 365 LSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414
           + ++  YK  L+           A+G+ +L   +  + IHRD+   NILL E+   KI D
Sbjct: 131 VPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICD 187
Query: 415 FGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           FGL R   +D  ++    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 188 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 71/240 (29%), Positives = 107/240 (44%), Gaps = 34/240 (14%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTT 306
           +  +L +     E   +       LG+G  G V +    G +       VAVK L    T
Sbjct: 2   HAERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 61
Query: 307 QWVDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSL------LDNL 356
              +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L        N 
Sbjct: 62  H-SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE 120
Query: 357 FVRQDVEPLSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
           FV   V P   E  YK  L+           A+G+ +L   +  + IHRD+   NILL E
Sbjct: 121 FVPYKVAP---EDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 174
Query: 407 EFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           +   KI DFGL R   +D   +    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 175 KNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 70/235 (29%), Positives = 107/235 (45%), Gaps = 23/235 (9%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVK--RLFYNTTQWVDHFFNEVNLI---S 320
           AT+ +    ++G G  G+VYK   P  G  VA+K  R+             EV L+    
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 321 GINHKNLVKLLGCSITGP-----ESLLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKII 374
              H N+V+L+    T       +  LV+E V +Q L    ++ +   P L  E    ++
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDL--RTYLDKAPPPGLPAETIKDLM 118
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
                GL +LH      I+HRD+K  NIL+    T K+ADFGL R++   +      +  
Sbjct: 119 RQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVV-- 173
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS-CSILQTVWDL 488
           TL Y APE +++       D++S G +  E+  RK   LF  NS    L  ++DL
Sbjct: 174 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK--PLFCGNSEADQLGKIFDL 226

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 100/218 (45%), Gaps = 37/218 (16%)
Query: 277 LGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
           LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI------------ 373
           ++ LLG C+  GP  ++V  +    +L + L  R+   P   E  Y I            
Sbjct: 103 IINLLGACTQDGPLYVIV-GYASKGNLREYLRARR---PPGMEYSYDINRVPEEQMTFKD 158
Query: 374 ----ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS 429
                   A G+ YL  +   + IHRD+   N+L+ E    KIADFGL R    +I +  
Sbjct: 159 LVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYK 214
Query: 430 ATLAGTL--GYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            T  G L   +MAPE +     T ++DV+SFGV++ E+
Sbjct: 215 KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 252

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           +LG G  G VYK        +A  ++    + + ++ +  E+++++  +H N+VKLL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
                  ++ EF    ++ D + +  +  PL+      +   T + L YLH+    +IIH
Sbjct: 104 YYENNLWILIEFCAGGAV-DAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV-----RGKL 449
           RD+K  NIL   +   K+ADFG+       I     +  GT  +MAPE V+         
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR-RDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 450 TEKADVYSFGVVVIEV 465
             KADV+S G+ +IE+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/238 (28%), Positives = 106/238 (44%), Gaps = 26/238 (10%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFF-----NEVNLI- 319
           AT+ +    ++G G  G+VYK   P  G  VA+K +                  EV L+ 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 320 --SGINHKNLVKLLGCSITGP-----ESLLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRY 371
                 H N+V+L+    T       +  LV+E V +Q L    ++ +   P L  E   
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDL--RTYLDKAPPPGLPAETIK 123
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
            ++     GL +LH      I+HRD+K  NIL+    T K+ADFGL R++   +      
Sbjct: 124 DLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV 180
Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS-CSILQTVWDL 488
           +  TL Y APE +++       D++S G +  E+  RK   LF  NS    L  ++DL
Sbjct: 181 V--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK--PLFCGNSEADQLGKIFDL 234

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 17/181 (9%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
           G+ VAVK +  + TQ     +   F EV ++  +NH N+VKL     T     LV E+  
Sbjct: 39  GKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              + D L     ++      +++ I+S  +   Y H++    I+HRD+K  N+LLD + 
Sbjct: 97  GGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF---IVHRDLKAENLLLDADM 150
Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE--KADVYSFGVVVIEVV 466
             KIADFG    F     +      G   Y APE + +GK  +  + DV+S GV++  +V
Sbjct: 151 NIKIADFGFSNEF--TFGNKLDAFCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 467 C 467
Sbjct: 208 S 208

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 94/196 (47%), Gaps = 12/196 (6%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           +LG G  G VYK        +A  ++    + + ++ +  E+++++  +H N+VKLL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
                  ++ EF    ++ D + +  +  PL+      +   T + L YLH+    +IIH
Sbjct: 104 YYENNLWILIEFCAGGAV-DAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV-----RGKL 449
           RD+K  NIL   +   K+ADFG+       I     +  GT  +MAPE V+         
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR-RDSFIGTPYWMAPEVVMCETSKDRPY 217
Query: 450 TEKADVYSFGVVVIEV 465
             KADV+S G+ +IE+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/240 (30%), Positives = 107/240 (44%), Gaps = 38/240 (15%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW 308
            +L +     E   +       LG+G  G V +    G +       VAVK L    T  
Sbjct: 13  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH- 71
Query: 309 VDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSL------LDNLFV 358
            +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L        N FV
Sbjct: 72  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 131
Query: 359 RQDVEPLSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              V P   E  YK  L+           A+G+ +L   +  + IHRD+   NILL E+ 
Sbjct: 132 PYKVAP---EDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKN 185
Query: 409 TAKIADFGLVRLF---PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             KI DFGL R     P+ +    A L   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 186 VVKICDFGLARDIYKDPDXVRKGDARLP--LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKL 330
           + LG G  G V  G     G  VAVK L     + +D       E+  +    H +++KL
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
                T  +  +V E+V    L D +     VE +     ++ ILS  +   Y H     
Sbjct: 77  YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVD---YCHRHM-- 131
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
            ++HRD+K  N+LLD    AKIADFGL  +  +          G+  Y APE V+ G+L 
Sbjct: 132 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRDSCGSPNYAAPE-VISGRLY 187
Query: 451 --EKADVYSFGVVVIEVVC 467
              + D++S GV++  ++C
Sbjct: 188 AGPEVDIWSCGVILYALLC 206

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 109/232 (46%), Gaps = 26/232 (11%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW 308
            +L +     E   +  +    LG+G  G V +    G         VAVK L    T  
Sbjct: 13  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATH- 71
Query: 309 VDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
            +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L   L  +++ E 
Sbjct: 72  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-EF 130
Query: 365 LSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414
           + ++  YK  L+           A+G+ +L   +  + IHRD+   NILL E+   KI D
Sbjct: 131 VPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXD 187
Query: 415 FGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           FGL R   +D  ++    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 188 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 239

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 100/214 (46%), Gaps = 16/214 (7%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQW--VDHFFNEVNLISGINHKNL 327
           + +  K+G+G  G+V+K       E VA+KR+  +            E+ L+  + HKN+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLF--VRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           V+L     +  +  LV+EF      L   F     D++P   E+    +    +GL + H
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQD--LKKYFDSCNGDLDP---EIVKSFLFQLLKGLGFCH 118
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
             +   ++HRD+K  N+L++     K+ADFGL R F   +   SA +  TL Y  P+ + 
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 446 RGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNS 478
             KL +   D++S G +  E+    R  LF  N 
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAAR-PLFPGND 207

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 137/318 (43%), Gaps = 48/318 (15%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-- 301
           V ++ ++L + ++  E   N       LG G  G V + T  G         VAVK L  
Sbjct: 21  VXIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 79
Query: 302 FYNTTQWVDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVR 359
             + T+  +   +E+ ++S + NH N+V LLG C+I GP +L++ E+     LL+  F+R
Sbjct: 80  SAHLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLN--FLR 135
Query: 360 QDVEPLSWEVRYKIIL-----------------STAEGLAYLHEESKLRIIHRDIKLSNI 402
           +  +          I+                   A+G+A+L  ++    IHRD+   NI
Sbjct: 136 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 192
Query: 403 LLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVV 461
           LL      KI DFGL R    D  ++    A   + +MAPE +     T ++DV+S+G+ 
Sbjct: 193 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 252
Query: 462 VIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLC 521
           + E        LF+  S         + V  + ++ +         E  P+ +  I   C
Sbjct: 253 LWE--------LFSLGSSPYP----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 300
Query: 522 VQASAELRPSMSIVVKML 539
             A    RP+   +V+++
Sbjct: 301 WDADPLKRPTFKQIVQLI 318

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/196 (28%), Positives = 93/196 (47%), Gaps = 12/196 (6%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           +LG G  G VYK        +A  ++    + + ++ +  E+++++  +H N+VKLL   
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
                  ++ EF    ++ D + +  +  PL+      +   T + L YLH+    +IIH
Sbjct: 104 YYENNLWILIEFCAGGAV-DAVMLELE-RPLTESQIQVVCKQTLDALNYLHDN---KIIH 158
Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV-----RGKL 449
           RD+K  NIL   +   K+ADFG+       I        GT  +MAPE V+         
Sbjct: 159 RDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR-RDXFIGTPYWMAPEVVMCETSKDRPY 217
Query: 450 TEKADVYSFGVVVIEV 465
             KADV+S G+ +IE+
Sbjct: 218 DYKADVWSLGITLIEM 233

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 42/213 (19%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-------LFPEDITHISATLAGTL 436
           LH      IIHRD+K SNI++  + T KI DFGL R       + PE +T          
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-------- 190
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
            Y APE ++     E  D++S G ++ E+VC K
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 96/199 (48%), Gaps = 17/199 (8%)
Query: 277 LGQGGSGSVYK-----GTLPG---GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
           LG+GG G V++     G   G      V  K +     +   H   E N++  + H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS-TAEGLAYLHEE 387
            L+    TG +  L+ E++        LF++ + E +  E      L+  +  L +LH++
Sbjct: 85  DLIYAFQTGGKLYLILEYLSG----GELFMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
               II+RD+K  NI+L+ +   K+ DFGL +    D T ++ T  GT+ YMAPE ++R 
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHTFCGTIEYMAPEILMRS 196
Query: 448 KLTEKADVYSFGVVVIEVV 466
                 D +S G ++ +++
Sbjct: 197 GHNRAVDWWSLGALMYDML 215

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTTQW-VDHFFNEVNLISG 321
           K  N      +LG G  GSV +G     +    VA+K L   T +   +    E  ++  
Sbjct: 7   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 66
Query: 322 INHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +++  +V+L+G  +   E+L LV E      L   L  +++  P+S     +++   + G
Sbjct: 67  LDNPYIVRLIG--VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVS--NVAELLHQVSMG 122
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGY 438
           + YL E++    +HRD+   N+LL     AKI+DFGL +    D ++ +A  AG   L +
Sbjct: 123 MKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            APE +   K + ++DV+S+GV + E +
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEAL 207

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISG 321
           +E   + F + ++LG G  G V+K    P G  +A K +       + +    E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
            N   +V   G   +  E  +  E +   SL D +  +    P   ++  K+ ++  +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGL 117
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
            YL E+ K  I+HRD+K SNIL++     K+ DFG+       I  ++ +  GT  YM+P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 442 EYVVRGKLTEKADVYSFGVVVIEV 465
           E +     + ++D++S G+ ++E+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 87/181 (48%), Gaps = 17/181 (9%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
           G+ VAV+    + TQ     +   F EV ++  +NH N+VKL     T     LV E+  
Sbjct: 39  GKEVAVR--IIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYAS 96
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              + D L     ++      +++ I+S  +   Y H++    I+HRD+K  N+LLD + 
Sbjct: 97  GGEVFDYLVAHGRMKEKEARAKFRQIVSAVQ---YCHQKF---IVHRDLKAENLLLDADM 150
Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE--KADVYSFGVVVIEVV 466
             KIADFG    F     +      G+  Y APE + +GK  +  + DV+S GV++  +V
Sbjct: 151 NIKIADFGFSNEFT--FGNKLDEFCGSPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 467 C 467
Sbjct: 208 S 208

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISG 321
           +E   + F + ++LG G  G V+K    P G  +A K +       + +    E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
            N   +V   G   +  E  +  E +   SL D +  +    P   ++  K+ ++  +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGL 117
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
            YL E+ K  I+HRD+K SNIL++     K+ DFG+       I  ++ +  GT  YM+P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 442 EYVVRGKLTEKADVYSFGVVVIEV 465
           E +     + ++D++S G+ ++E+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 265 EKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGI 322
           E   + F   ++LG G  G V K    P G  +A K +       + +    E+ ++   
Sbjct: 12  ELKDDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHEC 71
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           N   +V   G   +  E  +  E +   SL     V ++ + +  E+  K+ ++   GLA
Sbjct: 72  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ---VLKEAKRIPEEILGKVSIAVLRGLA 128
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           YL E  K +I+HRD+K SNIL++     K+ DFG+       I  ++ +  GT  YMAPE
Sbjct: 129 YLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMAPE 183
Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
            +     + ++D++S G+ ++E+
Sbjct: 184 RLQGTHYSVQSDIWSMGLSLVEL 206

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISG 321
           +E   + F + ++LG G  G V+K    P G  +A K +       + +    E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
            N   +V   G   +  E  +  E +   SL D +  +    P   ++  K+ ++  +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGL 117
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
            YL E+ K  I+HRD+K SNIL++     K+ DFG+       I  ++ +  GT  YM+P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 442 EYVVRGKLTEKADVYSFGVVVIEV 465
           E +     + ++D++S G+ ++E+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISG 321
           +E   + F + ++LG G  G V+K    P G  +A K +       + +    E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
            N   +V   G   +  E  +  E +   SL D +  +    P   ++  K+ ++  +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGL 117
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
            YL E+ K  I+HRD+K SNIL++     K+ DFG+       I  ++ +  GT  YM+P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 442 EYVVRGKLTEKADVYSFGVVVIEV 465
           E +     + ++D++S G+ ++E+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 137/318 (43%), Gaps = 48/318 (15%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-- 301
           V ++ ++L + ++  E   N       LG G  G V + T  G         VAVK L  
Sbjct: 28  VYIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 86
Query: 302 FYNTTQWVDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVR 359
             + T+  +   +E+ ++S + NH N+V LLG C+I GP +L++ E+     LL+  F+R
Sbjct: 87  SAHLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLN--FLR 142
Query: 360 QDVEPLSWEVRYKIIL-----------------STAEGLAYLHEESKLRIIHRDIKLSNI 402
           +  +          I+                   A+G+A+L  ++    IHRD+   NI
Sbjct: 143 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 199
Query: 403 LLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVV 461
           LL      KI DFGL R    D  ++    A   + +MAPE +     T ++DV+S+G+ 
Sbjct: 200 LLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 259
Query: 462 VIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLC 521
           + E        LF+  S         + V  + ++ +         E  P+ +  I   C
Sbjct: 260 LWE--------LFSLGSSPYP----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 307
Query: 522 VQASAELRPSMSIVVKML 539
             A    RP+   +V+++
Sbjct: 308 WDADPLKRPTFKQIVQLI 325

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 137/318 (43%), Gaps = 48/318 (15%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-- 301
           V ++ ++L + ++  E   N       LG G  G V + T  G         VAVK L  
Sbjct: 5   VYIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63
Query: 302 FYNTTQWVDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVR 359
             + T+  +   +E+ ++S + NH N+V LLG C+I GP +L++ E+     LL+  F+R
Sbjct: 64  SAHLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLN--FLR 119
Query: 360 QDVEPLSWEVRYKIIL-----------------STAEGLAYLHEESKLRIIHRDIKLSNI 402
           +  +          I+                   A+G+A+L  ++    IHRD+   NI
Sbjct: 120 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 176
Query: 403 LLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVV 461
           LL      KI DFGL R    D  ++    A   + +MAPE +     T ++DV+S+G+ 
Sbjct: 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 236
Query: 462 VIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLC 521
           + E        LF+  S         + V  + ++ +         E  P+ +  I   C
Sbjct: 237 LWE--------LFSLGSSPYP----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 284
Query: 522 VQASAELRPSMSIVVKML 539
             A    RP+   +V+++
Sbjct: 285 WDADPLKRPTFKQIVQLI 302

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 99/204 (48%), Gaps = 10/204 (4%)
Query: 264 LEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISG 321
           +E   + F + ++LG G  G V+K    P G  +A K +       + +    E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
            N   +V   G   +  E  +  E +   SL D +  +    P   ++  K+ ++  +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGL 117
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
            YL E+ K  I+HRD+K SNIL++     K+ DFG+       I  ++ +  GT  YM+P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 442 EYVVRGKLTEKADVYSFGVVVIEV 465
           E +     + ++D++S G+ ++E+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 112/250 (44%), Gaps = 50/250 (20%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH----- 324
           F E   LGQG  G V K          A+K++ + T + +    +EV L++ +NH     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 325 --------KNLVKLLGCSITGPESLLVYEFVPNQSLLD-----NLFVRQDVEPLSWEVRY 371
                   +N VK +          +  E+  N++L D     NL  ++D     W +  
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE---YWRLFR 123
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL----------VRLF 421
           +I+    E L+Y+H +    IIHRD+K  NI +DE    KI DFGL          ++L 
Sbjct: 124 QIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 422 PEDITHISATLAGTLG---YMAPEYVV-RGKLTEKADVYSFGVVVIEVVC-----RKRIN 472
            +++   S  L   +G   Y+A E +   G   EK D+YS G++  E++       +R+N
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236
Query: 473 LFTQ-NSCSI 481
           +  +  S SI
Sbjct: 237 ILKKLRSVSI 246

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 137/318 (43%), Gaps = 48/318 (15%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-- 301
           V ++ ++L + ++  E   N       LG G  G V + T  G         VAVK L  
Sbjct: 28  VYIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 86
Query: 302 FYNTTQWVDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVR 359
             + T+  +   +E+ ++S + NH N+V LLG C+I GP +L++ E+     LL+  F+R
Sbjct: 87  SAHLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLN--FLR 142
Query: 360 QDVEPLSWEVRYKIIL-----------------STAEGLAYLHEESKLRIIHRDIKLSNI 402
           +  +          I+                   A+G+A+L  ++    IHRD+   NI
Sbjct: 143 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 199
Query: 403 LLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVV 461
           LL      KI DFGL R    D  ++    A   + +MAPE +     T ++DV+S+G+ 
Sbjct: 200 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 259
Query: 462 VIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLC 521
           + E        LF+  S         + V  + ++ +         E  P+ +  I   C
Sbjct: 260 LWE--------LFSLGSSPYP----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 307
Query: 522 VQASAELRPSMSIVVKML 539
             A    RP+   +V+++
Sbjct: 308 WDADPLKRPTFKQIVQLI 325

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 37  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 93
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 94  LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 146
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 147 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 201
Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRK 469
           ++     E  D++S G ++ E+VC K
Sbjct: 202 ILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 34/237 (14%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
           ++KSK++  + ++E   + F           +G G  G V   Y   L     VA+K+L 
Sbjct: 1   MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 58
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSL 352
             F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L
Sbjct: 59  RPFQNQTH-AKRAYRELVLMKXVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANL 115
Query: 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
              + +  D E +S+     ++     G+ +LH      IIHRD+K SNI++  + T KI
Sbjct: 116 XQVIQMELDHERMSY-----LLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKI 167
Query: 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
            DFGL R      + +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 137/318 (43%), Gaps = 48/318 (15%)
Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRL-- 301
           V ++ ++L + ++  E   N       LG G  G V + T  G         VAVK L  
Sbjct: 23  VYIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 81
Query: 302 FYNTTQWVDHFFNEVNLISGI-NHKNLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVR 359
             + T+  +   +E+ ++S + NH N+V LLG C+I GP +L++ E+     LL+  F+R
Sbjct: 82  SAHLTE-REALMSELKVLSYLGNHMNIVNLLGACTIGGP-TLVITEYCCYGDLLN--FLR 137
Query: 360 QDVEPLSWEVRYKIIL-----------------STAEGLAYLHEESKLRIIHRDIKLSNI 402
           +  +          I+                   A+G+A+L  ++    IHRD+   NI
Sbjct: 138 RKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI 194
Query: 403 LLDEEFTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVV 461
           LL      KI DFGL R    D  ++    A   + +MAPE +     T ++DV+S+G+ 
Sbjct: 195 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIF 254
Query: 462 VIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLC 521
           + E        LF+  S         + V  + ++ +         E  P+ +  I   C
Sbjct: 255 LWE--------LFSLGSSPYP----GMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 302
Query: 522 VQASAELRPSMSIVVKML 539
             A    RP+   +V+++
Sbjct: 303 WDADPLKRPTFKQIVQLI 320

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 101/206 (49%), Gaps = 28/206 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 26  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 82
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 83  LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 135
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 190
Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRK 469
           ++     E  D++S G ++ E+VC K
Sbjct: 191 ILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 277 LGQGGSGSVYKGTLPGG---EAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKL 330
           +G+G  G V K  +         A+KR+    ++  DH  F  E+ ++  + +H N++ L
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINL 91
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQ----DVEP-----------LSWEVRYKIIL 375
           LG         L  E+ P+ +LLD  F+R+    + +P           LS +       
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG- 434
             A G+ YL   S+ + IHRD+   NIL+ E + AKIADFGL R       ++  T+   
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 203
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            + +MA E +     T  +DV+S+GV++ E+V
Sbjct: 204 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 265 EKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGI 322
           E   + F + ++LG G  G V+K    P G  +A K +       + +    E+ ++   
Sbjct: 64  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 123
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           N   +V   G   +  E  +  E +   SL D +  +    P   ++  K+ ++  +GL 
Sbjct: 124 NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGLT 180
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           YL E  K +I+HRD+K SNIL++     K+ DFG+       I  ++ +  GT  YM+PE
Sbjct: 181 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPE 235
Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
            +     + ++D++S G+ ++E+
Sbjct: 236 RLQGTHYSVQSDIWSMGLSLVEM 258

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 67/239 (28%), Positives = 107/239 (44%), Gaps = 36/239 (15%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW 308
            +L +     E   +       LG+G  G V +    G +       VAVK L    T  
Sbjct: 15  ERLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH- 73
Query: 309 VDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEF-----------------V 347
            +H    +E+ ++  I H  N+V LLG C+  G   +++ EF                 V
Sbjct: 74  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 133
Query: 348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE 407
           P +   ++L+  +D   L   + Y      A+G+ +L   +  + IHRD+   NILL E+
Sbjct: 134 PYKEAPEDLY--KDFLTLEHLICYS--FQVAKGMEFL---ASRKCIHRDLAARNILLSEK 186
Query: 408 FTAKIADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
              KI DFGL R   +D  ++    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 187 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 245

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 108/234 (46%), Gaps = 27/234 (11%)
Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW 308
            +L +     E   +  +    LG+G  G V +    G +       VAVK L    T  
Sbjct: 14  ERLPYDASKWEFPRDRLNLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH- 72
Query: 309 VDH--FFNEVNLISGINHK-NLVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQD--V 362
            +H    +E+ ++  I H  N+V LLG C+  G   +++ EF    +L   L  +++  V
Sbjct: 73  SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV 132
Query: 363 EPLSWEVRYKIILS----------TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
              + E  YK  L+           A+G+ +L   +  + IHRD+   NILL E+   KI
Sbjct: 133 PYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKI 189
Query: 413 ADFGLVRLFPEDITHISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            DFGL R   +D   +    A   L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 190 CDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 42/213 (19%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-------LFPEDITHISATLAGTL 436
           LH      IIHRD+K SNI++  + T KI DFGL R       + PE +T          
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRY-------- 190
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
            Y APE ++     E  D++S G ++ E+VC K
Sbjct: 191 -YRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 277 LGQGGSGSVYKGTLPGG---EAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKL 330
           +G+G  G V K  +         A+KR+    ++  DH  F  E+ ++  + +H N++ L
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINL 81
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQ----DVEP-----------LSWEVRYKIIL 375
           LG         L  E+ P+ +LLD  F+R+    + +P           LS +       
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG- 434
             A G+ YL   S+ + IHRD+   NIL+ E + AKIADFGL R       ++  T+   
Sbjct: 140 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 193
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            + +MA E +     T  +DV+S+GV++ E+V
Sbjct: 194 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 96/215 (44%), Gaps = 28/215 (13%)
Query: 277 LGQGGSGSVYKGTLPGGEA-VAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           LG+GG G V++      +   A+KR+   N     +    EV  ++ + H  +V+     
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 335 ITG-------PESLLVYEFVPNQ-----SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           +         P S  VY ++  Q     +L D +  R  +E     V   I L  AE + 
Sbjct: 73  LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVE 132
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED------ITHISATL---- 432
           +LH +    ++HRD+K SNI    +   K+ DFGLV    +D      +T + A      
Sbjct: 133 FLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 433 -AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
             GT  YM+PE +     + K D++S G+++ E++
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 67/237 (28%), Positives = 110/237 (46%), Gaps = 34/237 (14%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
           ++KSK++  + ++E   + F           +G G  G V   Y   L     VA+K+L 
Sbjct: 1   MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 58
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSL 352
             F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L
Sbjct: 59  RPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANL 115
Query: 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
              + +  D E +S+     ++     G+ +LH      IIHRD+K SNI++  + T KI
Sbjct: 116 XQVIQMELDHERMSY-----LLYQMLXGIKHLHSAG---IIHRDLKPSNIVVKSDXTLKI 167
Query: 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
            DFGL R      + +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   K+ADFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 28/199 (14%)
Query: 277 LGQGGSGSVY--KGTLPGGE-AVAV--KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           LG+G  G V   K  + G E AV V  KR     T   +    EV L+  ++H N++KL 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-KESLLREVQLLKQLDHPNIMKLY 92
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                     LV E      L D +  R+    +      +II     G+ Y+H   K +
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMH---KNK 146
Query: 392 IIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLA-----GTLGYMAPEY 443
           I+HRD+K  N+LL+   ++   +I DFGL        TH  A+       GT  Y+APE 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKDKIGTAYYIAPE- 198
Query: 444 VVRGKLTEKADVYSFGVVV 462
           V+ G   EK DV+S GV++
Sbjct: 199 VLHGTYDEKCDVWSTGVIL 217

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 265 EKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGI 322
           E   + F + ++LG G  G V+K    P G  +A K +       + +    E+ ++   
Sbjct: 21  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 80
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           N   +V   G   +  E  +  E +   SL D +  +    P   ++  K+ ++  +GL 
Sbjct: 81  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGLT 137
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           YL E+ K  I+HRD+K SNIL++     K+ DFG+       I  ++ +  GT  YM+PE
Sbjct: 138 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPE 192
Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
            +     + ++D++S G+ ++E+
Sbjct: 193 RLQGTHYSVQSDIWSMGLSLVEM 215

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 85/180 (47%), Gaps = 8/180 (4%)
Query: 293 GEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLVKLLGCSI--TGPESLLVYEFVP 348
           G+ +  K L Y +    +     +EVNL+  + H N+V+     I  T     +V E+  
Sbjct: 31  GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90
Query: 349 NQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESK--LRIIHRDIKLSNILLD 405
              L   +    ++ + L  E   +++      L   H  S     ++HRD+K +N+ LD
Sbjct: 91  GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 150
Query: 406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            +   K+ DFGL R+   D T  + T  GT  YM+PE + R    EK+D++S G ++ E+
Sbjct: 151 GKQNVKLGDFGLARILNHD-TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 10/203 (4%)
Query: 265 EKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGI 322
           E   + F + ++LG G  G V+K    P G  +A K +       + +    E+ ++   
Sbjct: 29  ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 88
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           N   +V   G   +  E  +  E +   SL D +  +    P   ++  K+ ++  +GL 
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGLT 145
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           YL E+ K  I+HRD+K SNIL++     K+ DFG+       I  ++ +  GT  YM+PE
Sbjct: 146 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPE 200
Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
            +     + ++D++S G+ ++E+
Sbjct: 201 RLQGTHYSVQSDIWSMGLSLVEM 223

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 28/199 (14%)
Query: 277 LGQGGSGSVY--KGTLPGGE-AVAV--KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           LG+G  G V   K  + G E AV V  KR     T   +    EV L+  ++H N++KL 
Sbjct: 57  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-KESLLREVQLLKQLDHPNIMKLY 115
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                     LV E      L D +  R+    +      +II     G+ Y+H   K +
Sbjct: 116 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMH---KNK 169
Query: 392 IIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLA-----GTLGYMAPEY 443
           I+HRD+K  N+LL+   ++   +I DFGL        TH  A+       GT  Y+APE 
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKDKIGTAYYIAPE- 221
Query: 444 VVRGKLTEKADVYSFGVVV 462
           V+ G   EK DV+S GV++
Sbjct: 222 VLHGTYDEKCDVWSTGVIL 240

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/199 (29%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 275 NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVD---HFFNEVNLISGINHKNLVKL 330
           + LG G  G V  G     G  VAVK L     + +D       E+  +    H +++KL
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
                T  +  +V E+V    L D +     ++       ++ ILS   G+ Y H     
Sbjct: 82  YQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS---GVDYCHRHM-- 136
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
            ++HRD+K  N+LLD    AKIADFGL  +  +          G+  Y APE V+ G+L 
Sbjct: 137 -VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRXSCGSPNYAAPE-VISGRLY 192
Query: 451 --EKADVYSFGVVVIEVVC 467
              + D++S GV++  ++C
Sbjct: 193 AGPEVDIWSSGVILYALLC 211

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 113/237 (47%), Gaps = 34/237 (14%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
           ++KSK++  + ++E   + F           +G G  G V   Y   L     VA+K+L 
Sbjct: 39  MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 96
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSL 352
             F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L
Sbjct: 97  RPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANL 153
Query: 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
              + +  D E +S+ + Y+++     G+ +LH      IIHRD+K SNI++  + T KI
Sbjct: 154 CQVIQMELDHERMSY-LLYQMLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 205
Query: 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
            DFGL R      + +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 206 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 28/199 (14%)
Query: 277 LGQGGSGSVY--KGTLPGGE-AVAV--KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           LG+G  G V   K  + G E AV V  KR     T   +    EV L+  ++H N++KL 
Sbjct: 58  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-KESLLREVQLLKQLDHPNIMKLY 116
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                     LV E      L D +  R+    +      +II     G+ Y+H   K +
Sbjct: 117 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYMH---KNK 170
Query: 392 IIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLA-----GTLGYMAPEY 443
           I+HRD+K  N+LL+   ++   +I DFGL        TH  A+       GT  Y+APE 
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKDKIGTAYYIAPE- 222
Query: 444 VVRGKLTEKADVYSFGVVV 462
           V+ G   EK DV+S GV++
Sbjct: 223 VLHGTYDEKCDVWSTGVIL 241

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/174 (33%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 298 VKRLFYNTTQWVDHFFNEVNLIS-GINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL 356
           VK+   N  + +D    E ++     NH  LV L  C  T      V E+V    L+ ++
Sbjct: 85  VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 144
Query: 357 FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
             RQ   P      Y   +S A  L YLHE     II+RD+KL N+LLD E   K+ D+G
Sbjct: 145 -QRQRKLPEEHARFYSAEISLA--LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 417 LVR--LFPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVC 467
           + +  L P D T   +T  GT  Y+APE ++RG+      D ++ GV++ E++ 
Sbjct: 199 MCKEGLRPGDTT---STFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 248

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 64/199 (32%), Positives = 92/199 (46%), Gaps = 28/199 (14%)
Query: 277 LGQGGSGSVY--KGTLPGGE-AVAV--KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           LG+G  G V   K  + G E AV V  KR     T   +    EV L+  ++H N++KL 
Sbjct: 40  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-KESLLREVQLLKQLDHPNIMKLY 98
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                     LV E      L D +  R+    +      +II     G+ Y+H   K +
Sbjct: 99  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA---RIIRQVLSGITYMH---KNK 152
Query: 392 IIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLA-----GTLGYMAPEY 443
           I+HRD+K  N+LL+   ++   +I DFGL        TH  A+       GT  Y+APE 
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKDKIGTAYYIAPE- 204
Query: 444 VVRGKLTEKADVYSFGVVV 462
           V+ G   EK DV+S GV++
Sbjct: 205 VLHGTYDEKCDVWSTGVIL 223

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSW 367
           V+H  +E  ++S + H  ++++ G      +  ++ +++    L   L   Q    P++ 
Sbjct: 50  VEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK 109
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               ++ L+    L YLH +    II+RD+K  NILLD+    KI DFG  +  P+    
Sbjct: 110 FYAAEVCLA----LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 158
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++  L GT  Y+APE V      +  D +SFG+++ E++ 
Sbjct: 159 VTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLA 198

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/198 (28%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFF--NEVNLISGINHKN 326
           +Y+    +LG G  G V++        V V + F NT   +D +   NE+++++ ++H  
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAK-FINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           L+ L        E +L+ EF+    L D +   +D +    EV    +    EGL ++HE
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGELFDRI-AAEDYKMSEAEV-INYMRQACEGLKHMHE 167
Query: 387 ESKLRIIHRDIKLSNILLD--EEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEY 443
            S   I+H DIK  NI+ +  +  + KI DFGL  +L P++I  ++     T  + APE 
Sbjct: 168 HS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT---TATAEFAAPEI 221
Query: 444 VVRGKLTEKADVYSFGVV 461
           V R  +    D+++ GV+
Sbjct: 222 VDREPVGFYTDMWAIGVL 239

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 28/206 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 81
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  ++L       LV E + + +L   + +  D E +S+     ++     G+ +
Sbjct: 82  LNV-FTPQKTLEEFQDVYLVMELM-DANLXQVIQMELDHERMSY-----LLYQMLXGIKH 134
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 189
Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRK 469
           ++     E  D++S G ++ E+V  K
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/217 (24%), Positives = 102/217 (47%), Gaps = 21/217 (9%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           + +   LG GG+G V+        + VA+K++     Q V H   E+ +I  ++H N+VK
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE-----------PLSWEVRYKIILSTA 378
           +    I GP    + + V + + L+++++ Q+             PL  E     +    
Sbjct: 73  VF--EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMYQLL 130
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAG--T 435
            GL Y+H  +   ++HRD+K +N+ ++ E+   KI DFGL R+     +H      G  T
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 436 LGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRI 471
             Y +P  ++     T+  D+++ G +  E++  K +
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTL 224

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 10/203 (4%)
Query: 265 EKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISGI 322
           E   + F + ++LG G  G V+K    P G  +A K +       + +    E+ ++   
Sbjct: 5   ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHEC 64
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           N   +V   G   +  E  +  E +   SL D +  +    P   ++  K+ ++  +GL 
Sbjct: 65  NSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGLT 121
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           YL E+ K  I+HRD+K SNIL++     K+ DFG+       I  ++    GT  YM+PE
Sbjct: 122 YLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDEMANEFVGTRSYMSPE 176
Query: 443 YVVRGKLTEKADVYSFGVVVIEV 465
            +     + ++D++S G+ ++E+
Sbjct: 177 RLQGTHYSVQSDIWSMGLSLVEM 199

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 96/201 (47%), Gaps = 15/201 (7%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQW--VDHFFNEVNLISGINHKNL 327
           + +  K+G+G  G+V+K       E VA+KR+  +            E+ L+  + HKN+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLF--VRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           V+L     +  +  LV+EF      L   F     D++P   E+    +    +GL + H
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQD--LKKYFDSCNGDLDP---EIVKSFLFQLLKGLGFCH 118
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
             +   ++HRD+K  N+L++     K+A+FGL R F   +   SA +  TL Y  P+ + 
Sbjct: 119 SRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLF 174
Query: 446 RGKL-TEKADVYSFGVVVIEV 465
             KL +   D++S G +  E+
Sbjct: 175 GAKLYSTSIDMWSAGCIFAEL 195

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 85/181 (46%), Gaps = 17/181 (9%)
Query: 293 GEAVAVKRLFYNTTQW----VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
           G+ VAVK +  + TQ     +   F EV +   +NH N+VKL     T     LV E+  
Sbjct: 39  GKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYAS 96
Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              + D L      +      +++ I+S  +   Y H++    I+HRD+K  N+LLD + 
Sbjct: 97  GGEVFDYLVAHGRXKEKEARAKFRQIVSAVQ---YCHQKF---IVHRDLKAENLLLDADX 150
Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE--KADVYSFGVVVIEVV 466
             KIADFG    F     +      G   Y APE + +GK  +  + DV+S GV++  +V
Sbjct: 151 NIKIADFGFSNEFT--FGNKLDAFCGAPPYAAPE-LFQGKKYDGPEVDVWSLGVILYTLV 207
Query: 467 C 467
Sbjct: 208 S 208

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 113/237 (47%), Gaps = 34/237 (14%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
           ++KSK++  + ++E   + F           +G G  G V   Y   L     VA+K+L 
Sbjct: 1   MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 58
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSL 352
             F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L
Sbjct: 59  RPFQNQTH-AKRAYRELVLMKXVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANL 115
Query: 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
              + +  D E +S+ + Y+++     G+ +LH      IIHRD+K SNI++  + T KI
Sbjct: 116 XQVIQMELDHERMSY-LLYQMLC----GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKI 167
Query: 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
            DFGL R      + +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 146 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            + TL GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 195 RTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 104/241 (43%), Gaps = 26/241 (10%)
Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYN 304
           G+L  A  + + +F  +T+E           L +GG   VY+    G G   A+KRL  N
Sbjct: 5   GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64
Query: 305 TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPES--------LLVYEFVPNQSLLDN 355
             +       EV  +  ++ H N+V+    +  G E         LL+ E    Q L++ 
Sbjct: 65  EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQ-LVEF 123
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
           L   +   PLS +   KI   T   + ++H + K  IIHRD+K+ N+LL  + T K+ DF
Sbjct: 124 LKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQGTIKLCDF 182
Query: 416 G---LVRLFPE--------DITHISATLAGTLGYMAPEYV---VRGKLTEKADVYSFGVV 461
           G    +  +P+         +     T   T  Y  PE +       + EK D+++ G +
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242
Query: 462 V 462
           +
Sbjct: 243 L 243

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 13/159 (8%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLS 366
           ++  + E+ ++  ++H N+VKL+       E  L  V+E V    +++       ++PLS
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME----VPTLKPLS 135
Query: 367 WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
            +          +G+ YLH +   +IIHRDIK SN+L+ E+   KIADFG+   F     
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDA 192
Query: 427 HISATLAGTLGYMAPEYV--VRGKLTEKA-DVYSFGVVV 462
            +S T+ GT  +MAPE +   R   + KA DV++ GV +
Sbjct: 193 LLSNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 69/250 (27%), Positives = 111/250 (44%), Gaps = 50/250 (20%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH----- 324
           F E   LGQG  G V K          A+K++ + T + +    +EV L++ +NH     
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVR 66
Query: 325 --------KNLVKLLGCSITGPESLLVYEFVPNQSLLD-----NLFVRQDVEPLSWEVRY 371
                   +N VK +          +  E+  N +L D     NL  ++D     W +  
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE---YWRLFR 123
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL----------VRLF 421
           +I+    E L+Y+H +    IIHRD+K  NI +DE    KI DFGL          ++L 
Sbjct: 124 QIL----EALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 422 PEDITHISATLAGTLG---YMAPEYVV-RGKLTEKADVYSFGVVVIEVVC-----RKRIN 472
            +++   S  L   +G   Y+A E +   G   EK D+YS G++  E++       +R+N
Sbjct: 177 SQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVN 236
Query: 473 LFTQ-NSCSI 481
           +  +  S SI
Sbjct: 237 ILKKLRSVSI 246

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH----FFNEVNLISGINHKNLVKLLG 332
           LG+GG    Y+ T    + V   ++   +     H       E+ +   +++ ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                    +V E    +SLL+    R+ V EP   E RY  +  T +G+ YLH     R
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP---EARY-FMRQTIQGVQYLHNN---R 162
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
           +IHRD+KL N+ L+++   KI DFGL      D      TL GT  Y+APE + +   + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKTLCGTPNYIAPEVLCKKGHSF 221
Query: 452 KADVYSFGVVVIEVVCRK 469
           + D++S G ++  ++  K
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E++P   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   K+ADFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 17/199 (8%)
Query: 277 LGQGGSGSVYK-----GTLPG---GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
           LG+GG G V++     G   G      V  K +     +   H   E N++  + H  +V
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS-TAEGLAYLHEE 387
            L+    TG +  L+ E++        LF++ + E +  E      L+  +  L +LH++
Sbjct: 85  DLIYAFQTGGKLYLILEYLSG----GELFMQLEREGIFMEDTACFYLAEISMALGHLHQK 140
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
               II+RD+K  NI+L+ +   K+ DFGL +    D T ++    GT+ YMAPE ++R 
Sbjct: 141 G---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT-VTHXFCGTIEYMAPEILMRS 196
Query: 448 KLTEKADVYSFGVVVIEVV 466
                 D +S G ++ +++
Sbjct: 197 GHNRAVDWWSLGALMYDML 215

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E++P   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   K+ADFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 16/198 (8%)
Query: 277 LGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHF---FNEVNLIS-GINHKNLVKLL 331
           LG+G  G V    +   G+  AVK L  +     D       E  ++S   NH  L +L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
            C  T      V EFV    L+ ++   +  +          I+S    L +LH++    
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS---ALMFLHDKG--- 144
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVVRGKL 449
           II+RD+KL N+LLD E   K+ADFG+ +   E I +   +AT  GT  Y+APE +     
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYIAPEILQEMLY 201
Query: 450 TEKADVYSFGVVVIEVVC 467
               D ++ GV++ E++C
Sbjct: 202 GPAVDWWAMGVLLYEMLC 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 113/237 (47%), Gaps = 34/237 (14%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
           ++KSK++  + ++E   + F           +G G  G V   Y   L     VA+K+L 
Sbjct: 1   MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 58
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSL 352
             F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L
Sbjct: 59  RPFQNQTH-AKRAYRELVLMKXVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANL 115
Query: 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
              + +  D E +S+ + Y+++     G+ +LH      IIHRD+K SNI++  + T KI
Sbjct: 116 CQVIQMELDHERMSY-LLYQMLC----GIKHLHSAG---IIHRDLKPSNIVVKSDXTLKI 167
Query: 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
            DFGL R      + +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 113/237 (47%), Gaps = 34/237 (14%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
           ++KSK++  + ++E   + F           +G G  G V   Y   L     VA+K+L 
Sbjct: 39  MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 96
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSL 352
             F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L
Sbjct: 97  RPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANL 153
Query: 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
              + +  D E +S+ + Y+++     G+ +LH      IIHRD+K SNI++  + T KI
Sbjct: 154 CQVIQMELDHERMSY-LLYQMLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 205
Query: 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
            DFGL R      + +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 206 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 103/219 (47%), Gaps = 34/219 (15%)
Query: 277 LGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLV 328
           LG G  G V   T  G         VAVK L     +   +   +E+ +++ + +H+N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVR--------------------QDVEPLSW 367
            LLG C+++GP   L++E+     LL+ L  +                    +D+  L++
Sbjct: 113 NLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
           E         A+G+ +L  +S    +HRD+   N+L+      KI DFGL R    D  +
Sbjct: 172 EDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 428 ISATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           +    A   + +MAPE +  G  T K+DV+S+G+++ E+
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEI 267

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 277 LGQGGSGSVYKG--TLPGGEA--VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
           LG+G  G VY+G  T   GE   VAVK    + T    + F +E  ++  ++H ++VKL+
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G     P + ++ E  P   L   L   ++   +   V Y   L   + +AYL     + 
Sbjct: 80  GIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKAMAYLE---SIN 133
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
            +HRDI + NIL+      K+ DFGL R   ++  + ++     + +M+PE +   + T 
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 452 KADVYSFGVVVIEVV 466
            +DV+ F V + E++
Sbjct: 194 ASDVWMFAVCMWEIL 208

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 277 LGQGGSGSVYKG--TLPGGEA--VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
           LG+G  G VY+G  T   GE   VAVK    + T    + F +E  ++  ++H ++VKL+
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G     P + ++ E  P   L   L   ++   +   V Y   L   + +AYL     + 
Sbjct: 92  GIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKAMAYLE---SIN 145
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
            +HRDI + NIL+      K+ DFGL R   ++  + ++     + +M+PE +   + T 
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 205
Query: 452 KADVYSFGVVVIEVV 466
            +DV+ F V + E++
Sbjct: 206 ASDVWMFAVCMWEIL 220

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 95/195 (48%), Gaps = 11/195 (5%)
Query: 277 LGQGGSGSVYKG--TLPGGEA--VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
           LG+G  G VY+G  T   GE   VAVK    + T    + F +E  ++  ++H ++VKL+
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G     P + ++ E  P   L   L   ++   +   V Y   L   + +AYL     + 
Sbjct: 76  GIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYS--LQICKAMAYLE---SIN 129
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
            +HRDI + NIL+      K+ DFGL R   ++  + ++     + +M+PE +   + T 
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 189
Query: 452 KADVYSFGVVVIEVV 466
            +DV+ F V + E++
Sbjct: 190 ASDVWMFAVCMWEIL 204

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 31/212 (14%)
Query: 277 LGQGGSGSVYKGTLPGG---EAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKL 330
           +G+G  G V K  +         A+KR+    ++  DH  F  E+ ++  + +H N++ L
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINL 88
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQ----DVEP-----------LSWEVRYKIIL 375
           LG         L  E+ P+ +LLD  F+R+    + +P           LS +       
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLD--FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG- 434
             A G+ YL   S+ + IHR++   NIL+ E + AKIADFGL R       ++  T+   
Sbjct: 147 DVARGMDYL---SQKQFIHRNLAARNILVGENYVAKIADFGLSR---GQEVYVKKTMGRL 200
Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            + +MA E +     T  +DV+S+GV++ E+V
Sbjct: 201 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 80/160 (50%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 71  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 130
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 131 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 179
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            + TL GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 180 RTWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 113/237 (47%), Gaps = 34/237 (14%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
           ++KSK++  + ++E   + F           +G G  G V   Y   L     VA+K+L 
Sbjct: 1   MSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLS 58
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSL 352
             F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L
Sbjct: 59  RPFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANL 115
Query: 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
              + +  D E +S+ + Y+++     G+ +LH      IIHRD+K SNI++  + T KI
Sbjct: 116 CQVIQMELDHERMSY-LLYQMLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 167
Query: 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
            DFGL R      + +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 12/157 (7%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
           NE+ ++  I H+N+V L     +     LV + V    L D +  R         +  + 
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ 114
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISA 430
           +LS    + YLHE     I+HRD+K  N+L    +E     I DFGL ++   +   I +
Sbjct: 115 VLS---AVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMS 165
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           T  GT GY+APE + +   ++  D +S GV+   ++C
Sbjct: 166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLC 202

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 273 ESNKLGQGGSGSVYKG-----TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           E  +LG G  G+V KG      +    AV + +   N     D    E N++  +++  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 328 VKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V+++G  I   ES +LV E      L  N +++Q+       +  +++   + G+ YL E
Sbjct: 69  VRMIG--ICEAESWMLVMEMAELGPL--NKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE 123
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYV 444
            +    +HRD+   N+LL  +  AKI+DFGL +    D  +  A   G   + + APE +
Sbjct: 124 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 445 VRGKLTEKADVYSFGVVVIEV 465
              K + K+DV+SFGV++ E 
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEA 201

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 103/208 (49%), Gaps = 14/208 (6%)
Query: 266 KATNYFHESNKLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTTQW-VDHFFNEVNLISG 321
           K  N      +LG G  GSV +G     +    VA+K L   T +   +    E  ++  
Sbjct: 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 392
Query: 322 INHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +++  +V+L+G  +   E+L LV E      L   L  +++  P+S     +++   + G
Sbjct: 393 LDNPYIVRLIG--VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVA--ELLHQVSMG 448
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG--TLGY 438
           + YL E++    +HR++   N+LL     AKI+DFGL +    D ++ +A  AG   L +
Sbjct: 449 MKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            APE +   K + ++DV+S+GV + E +
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEAL 533

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 34/236 (14%)
Query: 253 NKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL-- 301
           +KSK++  + ++E   + F           +G G  G V   Y   L     VA+K+L  
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR 60
Query: 302 -FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLL 353
            F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L 
Sbjct: 61  PFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANLC 117
Query: 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
             + +  D E +S+ + Y+++     G+ +LH      IIHRD+K SNI++  + T KI 
Sbjct: 118 QVIQMELDHERMSY-LLYQMLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 169
Query: 414 DFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           DFGL R      + +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 170 DFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 34/236 (14%)
Query: 253 NKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL-- 301
           +KSK++  + ++E   + F           +G G  G V   Y   L     VA+K+L  
Sbjct: 2   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR 59
Query: 302 -FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLL 353
            F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L 
Sbjct: 60  PFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANLC 116
Query: 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
             + +  D E +S+ + Y+++     G+ +LH      IIHRD+K SNI++  + T KI 
Sbjct: 117 QVIQMELDHERMSY-LLYQMLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 168
Query: 414 DFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           DFGL R      + +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 169 DFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 34/236 (14%)
Query: 253 NKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL-- 301
           +KSK++  + ++E   + F           +G G  G V   Y   L     VA+K+L  
Sbjct: 3   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR 60
Query: 302 -FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLL 353
            F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L 
Sbjct: 61  PFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANLC 117
Query: 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
             + +  D E +S+ + Y+++     G+ +LH      IIHRD+K SNI++  + T KI 
Sbjct: 118 QVIQMELDHERMSY-LLYQMLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 169
Query: 414 DFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           DFGL R      + +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 170 DFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 34/236 (14%)
Query: 253 NKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL-- 301
           +KSK++  + ++E   + F           +G G  G V   Y   L     VA+K+L  
Sbjct: 1   SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVL--DRNVAIKKLSR 58
Query: 302 -FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLL 353
            F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L 
Sbjct: 59  PFQNQTH-AKRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANLC 115
Query: 354 DNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
             + +  D E +S+ + Y+++     G+ +LH      IIHRD+K SNI++  + T KI 
Sbjct: 116 QVIQMELDHERMSY-LLYQMLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKIL 167
Query: 414 DFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           DFGL R      + +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 168 DFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 221

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 84/180 (46%), Gaps = 8/180 (4%)
Query: 293 GEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLVKLLGCSI--TGPESLLVYEFVP 348
           G+ +  K L Y +    +     +EVNL+  + H N+V+     I  T     +V E+  
Sbjct: 31  GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90
Query: 349 NQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESK--LRIIHRDIKLSNILLD 405
              L   +    ++ + L  E   +++      L   H  S     ++HRD+K +N+ LD
Sbjct: 91  GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 150
Query: 406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            +   K+ DFGL R+   D T  +    GT  YM+PE + R    EK+D++S G ++ E+
Sbjct: 151 GKQNVKLGDFGLARILNHD-TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/194 (31%), Positives = 89/194 (45%), Gaps = 18/194 (9%)
Query: 277 LGQGGSGSVY--KGTLPGGE-AVAV--KRLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           LG+G  G V   K  + G E AV V  KR     T   +    EV L+  ++H N+ KL 
Sbjct: 34  LGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD-KESLLREVQLLKQLDHPNIXKLY 92
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                     LV E      L D +  R+    +      +II     G+ Y H   K +
Sbjct: 93  EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD---AARIIRQVLSGITYXH---KNK 146
Query: 392 IIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
           I+HRD+K  N+LL+   ++   +I DFGL   F  + +       GT  Y+APE V+ G 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKIGTAYYIAPE-VLHGT 203
Query: 449 LTEKADVYSFGVVV 462
             EK DV+S GV++
Sbjct: 204 YDEKCDVWSTGVIL 217

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 273 ESNKLGQGGSGSVYKG-----TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           E  +LG G  G+V KG      +    AV + +   N     D    E N++  +++  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 328 VKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V+++G  I   ES +LV E      L  N +++Q+       +  +++   + G+ YL E
Sbjct: 433 VRMIG--ICEAESWMLVMEMAELGPL--NKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE 487
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYV 444
            +    +HRD+   N+LL  +  AKI+DFGL +    D  +  A   G   + + APE +
Sbjct: 488 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 445 VRGKLTEKADVYSFGVVVIEV 465
              K + K+DV+SFGV++ E 
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEA 565

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 273 ESNKLGQGGSGSVYKG-----TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           E  +LG G  G+V KG      +    AV + +   N     D    E N++  +++  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 328 VKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V+++G  I   ES +LV E      L  N +++Q+       +  +++   + G+ YL E
Sbjct: 434 VRMIG--ICEAESWMLVMEMAELGPL--NKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE 488
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYV 444
            +    +HRD+   N+LL  +  AKI+DFGL +    D  +  A   G   + + APE +
Sbjct: 489 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 445 VRGKLTEKADVYSFGVVVIEV 465
              K + K+DV+SFGV++ E 
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEA 566

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 273 ESNKLGQGGSGSVYKG-----TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           E  +LG G  G+V KG      +    AV + +   N     D    E N++  +++  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 328 VKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V+++G  I   ES +LV E      L  N +++Q+       +  +++   + G+ YL E
Sbjct: 75  VRMIG--ICEAESWMLVMEMAELGPL--NKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE 129
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYV 444
            +    +HRD+   N+LL  +  AKI+DFGL +    D  +  A   G   + + APE +
Sbjct: 130 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 445 VRGKLTEKADVYSFGVVVIE 464
              K + K+DV+SFGV++ E
Sbjct: 187 NYYKFSSKSDVWSFGVLMWE 206

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 273 ESNKLGQGGSGSVYKG-----TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           E  +LG G  G+V KG      +    AV + +   N     D    E N++  +++  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 328 VKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V+++G  I   ES +LV E      L  N +++Q+       +  +++   + G+ YL E
Sbjct: 81  VRMIG--ICEAESWMLVMEMAELGPL--NKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE 135
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYV 444
            +    +HRD+   N+LL  +  AKI+DFGL +    D  +  A   G   + + APE +
Sbjct: 136 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 445 VRGKLTEKADVYSFGVVVIE 464
              K + K+DV+SFGV++ E
Sbjct: 193 NYYKFSSKSDVWSFGVLMWE 212

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 273 ESNKLGQGGSGSVYKG-----TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           E  +LG G  G+V KG      +    AV + +   N     D    E N++  +++  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 328 VKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V+++G  I   ES +LV E      L  N +++Q+       +  +++   + G+ YL E
Sbjct: 71  VRMIG--ICEAESWMLVMEMAELGPL--NKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE 125
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYV 444
            +    +HRD+   N+LL  +  AKI+DFGL +    D  +  A   G   + + APE +
Sbjct: 126 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 445 VRGKLTEKADVYSFGVVVIE 464
              K + K+DV+SFGV++ E
Sbjct: 183 NYYKFSSKSDVWSFGVLMWE 202

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 82
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  ++L       LV E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 83  LNV-FTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 135
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 190
Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRK 469
           ++     E  D++S G ++ E+V  K
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 20/202 (9%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD-HFFNEVNLI-SGINHKNLVKLLG 332
           ++G+G  GSV K    P G+ +AVKR+     +        +++++    +   +V+  G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 333 CSITGPESLLVYEFVPNQSLLDNLF-----VRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
                 +  +  E +   +  D  +     V  DV P   E+  KI L+T + L +L E 
Sbjct: 89  ALFREGDCWICMELM--STSFDKFYKYVYSVLDDVIPE--EILGKITLATVKALNHLKE- 143
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV--- 444
             L+IIHRDIK SNILLD     K+ DFG+     + I       AG   YMAPE +   
Sbjct: 144 -NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRD--AGCRPYMAPERIDPS 200
Query: 445 -VRGKLTEKADVYSFGVVVIEV 465
             R     ++DV+S G+ + E+
Sbjct: 201 ASRQGYDVRSDVWSLGITLYEL 222

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLV 328
           +    +LG GG G V +      GE VA+K+     + +  + +  E+ ++  +NH N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 329 KLL----GCSITGPESL--LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
                  G     P  L  L  E+     L   L   ++   L       ++   +  L 
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 136
Query: 383 YLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           YLHE    RIIHRD+K  NI+L    +    KI D G  +    D   +     GTL Y+
Sbjct: 137 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYL 191
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
           APE + + K T   D +SFG +  E +
Sbjct: 192 APELLEQKKYTVTVDYWSFGTLAFECI 218

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 16/207 (7%)
Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLV 328
           +    +LG GG G V +      GE VA+K+     + +  + +  E+ ++  +NH N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 329 KLL----GCSITGPESL--LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
                  G     P  L  L  E+     L   L   ++   L       ++   +  L 
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALR 135
Query: 383 YLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           YLHE    RIIHRD+K  NI+L    +    KI D G  +    D   +     GTL Y+
Sbjct: 136 YLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL--DQGELCTEFVGTLQYL 190
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
           APE + + K T   D +SFG +  E +
Sbjct: 191 APELLEQKKYTVTVDYWSFGTLAFECI 217

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 98/201 (48%), Gaps = 16/201 (7%)
Query: 273 ESNKLGQGGSGSVYKG-----TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           E  +LG G  G+V KG      +    AV + +   N     D    E N++  +++  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 328 VKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V+++G  I   ES +LV E      L  N +++Q+       +  +++   + G+ YL E
Sbjct: 89  VRMIG--ICEAESWMLVMEMAELGPL--NKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE 143
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYV 444
            +    +HRD+   N+LL  +  AKI+DFGL +    D  +  A   G   + + APE +
Sbjct: 144 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 200
Query: 445 VRGKLTEKADVYSFGVVVIEV 465
              K + K+DV+SFGV++ E 
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEA 221

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 97/210 (46%), Gaps = 23/210 (10%)
Query: 277 LGQGGSGSVYKGTLPGGEA----VAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKL 330
           LG+G  GSV +  L   +     VAVK L  +   +  ++ F  E   +   +H ++ KL
Sbjct: 31  LGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKL 90
Query: 331 LGCSITG------PESLLVYEFVPNQSLLDNLFVRQDVE-----PLSWEVRYKIILSTAE 379
           +G S+        P  +++  F+ +  L   L   +  E     PL   VR+  ++  A 
Sbjct: 91  VGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF--MVDIAC 148
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
           G+ YL   S    IHRD+   N +L E+ T  +ADFGL R ++  D           + +
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKW 205
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCR 468
           +A E +     T  +DV++FGV + E++ R
Sbjct: 206 LALESLADNLYTVHSDVWAFGVTMWEIMTR 235

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 273 ESNKLGQGGSGSVYKG-----TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           E  +LG G  G+V KG      +    AV + +   N     D    E N++  +++  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 328 VKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V+++G  I   ES +LV E      L  N +++Q+       +  +++   + G+ YL E
Sbjct: 91  VRMIG--ICEAESWMLVMEMAELGPL--NKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE 145
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYV 444
            +    +HRD+   N+LL  +  AKI+DFGL +    D  +  A   G   + + APE +
Sbjct: 146 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 445 VRGKLTEKADVYSFGVVVIE 464
              K + K+DV+SFGV++ E
Sbjct: 203 NYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 16/200 (8%)
Query: 273 ESNKLGQGGSGSVYKG-----TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           E  +LG G  G+V KG      +    AV + +   N     D    E N++  +++  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 328 VKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V+++G  I   ES +LV E      L  N +++Q+       +  +++   + G+ YL E
Sbjct: 91  VRMIG--ICEAESWMLVMEMAELGPL--NKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE 145
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYV 444
            +    +HRD+   N+LL  +  AKI+DFGL +    D  +  A   G   + + APE +
Sbjct: 146 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 445 VRGKLTEKADVYSFGVVVIE 464
              K + K+DV+SFGV++ E
Sbjct: 203 NYYKFSSKSDVWSFGVLMWE 222

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 25  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 81
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  ++L       LV E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 82  LNV-FTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 134
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 135 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 189
Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRK 469
           ++     E  D++S G ++ E+V  K
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHK 215

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 114/234 (48%), Gaps = 34/234 (14%)
Query: 252 VNKSKLNFSYETLEKATNYF------HESNKLGQGGSGSV---YKGTLPGGEAVAVKRL- 301
           ++KSK++  + ++E A + F       +   +G G  G V   +   L  G  VAVK+L 
Sbjct: 1   MSKSKVDNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLS 58
Query: 302 --FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSL 352
             F N T      + E+ L+  +NHKN++ LL    T  ++L       LV E + + +L
Sbjct: 59  RPFQNQTH-AKRAYRELVLLKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANL 115
Query: 353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
              + +  D E +S+ + Y+++     G+ +LH      IIHRD+K SNI++  + T KI
Sbjct: 116 CQVIHMELDHERMSY-LLYQMLC----GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKI 167
Query: 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            DFGL R    +   +      T  Y APE ++        D++S G ++ E+V
Sbjct: 168 LDFGLARTACTNF--MMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELV 219

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 28/203 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH-AKRAYRELVLMKVVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y++++    G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-LLYQMLV----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 196
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++     E  D++S GV++ E++
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMI 219

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/206 (30%), Positives = 100/206 (48%), Gaps = 28/206 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 26  IGSGAQGIVCAAYDAVL--DRNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIISL 82
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  ++L       LV E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 83  LNV-FTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 135
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 136 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 190
Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRK 469
           ++     E  D++S G ++ E+V  K
Sbjct: 191 ILGMGYKENVDIWSVGCIMGEMVRHK 216

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 28/209 (13%)
Query: 271 FHESNKLGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINH 324
           + +   +G G  G V   +   L  G  VAVK+L   F N T      + E+ L+  +NH
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVL--GINVAVKKLSRPFQNQTH-AKRAYRELVLLKCVNH 80
Query: 325 KNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
           KN++ LL    T  ++L       LV E + + +L   + +  D E +S+ + Y+++   
Sbjct: 81  KNIISLLNV-FTPQKTLEEFQDVYLVMELM-DANLCQVIHMELDHERMSY-LLYQMLC-- 135
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
             G+ +LH      IIHRD+K SNI++  + T KI DFGL R    +       +  T  
Sbjct: 136 --GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVV--TRY 188
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           Y APE ++     E  D++S G ++ E+V
Sbjct: 189 YRAPEVILGMGYKENVDIWSVGCIMGELV 217

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 45/223 (20%)
Query: 277 LGQGGSGSV-YKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLIS-GINHKNLVKLLGCS 334
           LG G SG+V ++G+   G  VAVKR+  +   + D    E+ L++   +H N+++   CS
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-CS 95
Query: 335 ITGPESLLVYEFVPNQSLLD----------NLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            T    L +   + N +L D          NL ++++  P+S      ++   A G+A+L
Sbjct: 96  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------LLRQIASGVAHL 149
Query: 385 HEESKLRIIHRDIKLSNILL--DEEFTAK-----------IADFGLVRLFPEDITHISAT 431
           H    L+IIHRD+K  NIL+     FTA            I+DFGL +            
Sbjct: 150 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN 206
Query: 432 L---AGTLGYMAPEYV---VRGKLTEKADVYSFGVVVIEVVCR 468
           L   +GT G+ APE +    + +LT   D++S G V   ++ +
Sbjct: 207 LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 106/223 (47%), Gaps = 45/223 (20%)
Query: 277 LGQGGSGSV-YKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLIS-GINHKNLVKLLGCS 334
           LG G SG+V ++G+   G  VAVKR+  +   + D    E+ L++   +H N+++   CS
Sbjct: 41  LGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-CS 95
Query: 335 ITGPESLLVYEFVPNQSLLD----------NLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            T    L +   + N +L D          NL ++++  P+S      ++   A G+A+L
Sbjct: 96  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------LLRQIASGVAHL 149
Query: 385 HEESKLRIIHRDIKLSNILL--DEEFTAK-----------IADFGLVRLFPEDITHISAT 431
           H    L+IIHRD+K  NIL+     FTA            I+DFGL +            
Sbjct: 150 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN 206
Query: 432 L---AGTLGYMAPEYV---VRGKLTEKADVYSFGVVVIEVVCR 468
           L   +GT G+ APE +    + +LT   D++S G V   ++ +
Sbjct: 207 LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSK 249

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 14/175 (8%)
Query: 297 AVKRLFYNTTQWVDHFFNEVNLIS-GINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
            VK+   N  + +D    E ++     NH  LV L  C  T      V E+V    L+ +
Sbjct: 52  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 111
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
           +  RQ   P      Y   +S A  L YLHE     II+RD+KL N+LLD E   K+ D+
Sbjct: 112 M-QRQRKLPEEHARFYSAEISLA--LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 165
Query: 416 GLVR--LFPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVC 467
           G+ +  L P D T   +   GT  Y+APE ++RG+      D ++ GV++ E++ 
Sbjct: 166 GMCKEGLRPGDTT---SXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 216

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 77/165 (46%), Gaps = 11/165 (6%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
           V + F E+ ++ G+ H  LV L        +  +V + +    L  +L  +Q+V     E
Sbjct: 59  VRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL--QQNVH-FKEE 115
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
                I      L YL  +   RIIHRD+K  NILLDE     I DF +  + P + T I
Sbjct: 116 TVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQI 171
Query: 429 SATLAGTLGYMAPEYVVRGK---LTEKADVYSFGVVVIEVVCRKR 470
           + T+AGT  YMAPE     K    +   D +S GV   E++  +R
Sbjct: 172 T-TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 106 IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 165
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 166 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 214
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 215 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR 145
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 146 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 68/250 (27%), Positives = 113/250 (45%), Gaps = 50/250 (20%)
Query: 271 FHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           F E   LGQG  G V K          A+K++ + T + +    +EV L++ +NH+ +V+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVXLLASLNHQYVVR 66
Query: 330 LLGC------------SITGPESLLV-YEFVPNQSLLD-----NLFVRQDVEPLSWEVRY 371
                           ++    +L +  E+  N++L D     NL  ++D     W +  
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE---YWRLFR 123
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL----------VRLF 421
           +I+    E L+Y+H +    IIHR++K  NI +DE    KI DFGL          ++L 
Sbjct: 124 QIL----EALSYIHSQG---IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
Query: 422 PEDITHISATLA---GTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVC-----RKRIN 472
            +++   S  L    GT  Y+A E +   G   EK D YS G++  E +       +R+N
Sbjct: 177 SQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXIYPFSTGXERVN 236
Query: 473 LFTQ-NSCSI 481
           +  +  S SI
Sbjct: 237 ILKKLRSVSI 246

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 101/203 (49%), Gaps = 28/203 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVVAAYDAILERN--VAIKKLSRPFQNQTH-AKRAYRELVLMKVVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y++++    G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-LLYQMLV----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 196
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++     E  D++S GV++ E++
Sbjct: 197 ILGMGYKENVDIWSVGVIMGEMI 219

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 146 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 58/194 (29%), Positives = 92/194 (47%), Gaps = 14/194 (7%)
Query: 276 KLGQGGSGSVY--KGTLPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVKLLG 332
           KLG G  G V+  +    G E V +K +  + +Q  ++    E+ ++  ++H N++K+  
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERV-IKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                    +V E      LL+ +   Q   + LS     +++      LAY H +    
Sbjct: 88  VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---H 144
Query: 392 IIHRDIKLSNILLDE---EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
           ++H+D+K  NIL  +       KI DFGL  LF  D    S   AGT  YMAPE V +  
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTALYMAPE-VFKRD 201
Query: 449 LTEKADVYSFGVVV 462
           +T K D++S GVV+
Sbjct: 202 VTFKCDIWSAGVVM 215

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 146 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 146 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 78  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHAR 137
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 138 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 186
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 187 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 226

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 16/200 (8%)
Query: 273 ESNKLGQGGSGSVYKG-----TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           E  +LG G  G+V KG      +    AV + +   N     D    E N++  +++  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 328 VKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           V+++G  I   ES +LV E      L  N +++Q+       +  +++   + G+ YL E
Sbjct: 75  VRMIG--ICEAESWMLVMEMAELGPL--NKYLQQNRHVKDKNI-IELVHQVSMGMKYLEE 129
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT--LGYMAPEYV 444
            +    +HRD+   N+LL  +  AKI+DFGL +    D     A   G   + + APE +
Sbjct: 130 SN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 445 VRGKLTEKADVYSFGVVVIE 464
              K + K+DV+SFGV++ E
Sbjct: 187 NYYKFSSKSDVWSFGVLMWE 206

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 14/175 (8%)
Query: 297 AVKRLFYNTTQWVDHFFNEVNLIS-GINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
            VK+   N  + +D    E ++     NH  LV L  C  T      V E+V    L+ +
Sbjct: 41  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 100
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
           +  RQ   P      Y   +S A  L YLHE     II+RD+KL N+LLD E   K+ D+
Sbjct: 101 M-QRQRKLPEEHARFYSAEISLA--LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154
Query: 416 GLVR--LFPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVC 467
           G+ +  L P D T   +   GT  Y+APE ++RG+      D ++ GV++ E++ 
Sbjct: 155 GMCKEGLRPGDTT---SXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 205

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 145
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 146 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH----FFNEVNLISGINHKNLVKLLG 332
           LG+GG    Y+ T    + V   ++   +     H       E+ +   +++ ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                    +V E    +SLL+    R+ V EP   E RY  +  T +G+ YLH     R
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP---EARY-FMRQTIQGVQYLHNN---R 162
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
           +IHRD+KL N+ L+++   KI DFGL      D       L GT  Y+APE + +   + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKXLCGTPNYIAPEVLCKKGHSF 221
Query: 452 KADVYSFGVVVIEVVCRK 469
           + D++S G ++  ++  K
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  +   +N   LVKL           +V E+ P   +  +L  + +  EP + 
Sbjct: 86  IEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHAR 145
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   K+ADFG    F + +  
Sbjct: 146 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKG 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH----FFNEVNLISGINHKNLVKLLG 332
           LG+GG    Y+ T    + V   ++   +     H       E+ +   +++ ++V   G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                    +V E    +SLL+    R+ V EP   E RY  +  T +G+ YLH     R
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP---EARY-FMRQTIQGVQYLHNN---R 162
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
           +IHRD+KL N+ L+++   KI DFGL      D       L GT  Y+APE + +   + 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLCGTPNYIAPEVLCKKGHSF 221
Query: 452 KADVYSFGVVVIEVVCRK 469
           + D++S G ++  ++  K
Sbjct: 222 EVDIWSLGCILYTLLVGK 239

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/175 (32%), Positives = 85/175 (48%), Gaps = 14/175 (8%)
Query: 297 AVKRLFYNTTQWVDHFFNEVNLIS-GINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
            VK+   N  + +D    E ++     NH  LV L  C  T      V E+V    L+ +
Sbjct: 37  VVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFH 96
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
           +  RQ   P      Y   +S A  L YLHE     II+RD+KL N+LLD E   K+ D+
Sbjct: 97  M-QRQRKLPEEHARFYSAEISLA--LNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 150
Query: 416 GLVR--LFPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVC 467
           G+ +  L P D T   +   GT  Y+APE ++RG+      D ++ GV++ E++ 
Sbjct: 151 GMCKEGLRPGDTT---SXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMA 201

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 92/198 (46%), Gaps = 13/198 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH----FFNEVNLISGINHKNLVKLLG 332
           LG+GG    Y+ T    + V   ++   +     H       E+ +   +++ ++V   G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                    +V E    +SLL+    R+ V EP   E RY  +  T +G+ YLH     R
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEP---EARY-FMRQTIQGVQYLHNN---R 146
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTE 451
           +IHRD+KL N+ L+++   KI DFGL      D       L GT  Y+APE + +   + 
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFD-GERKKDLCGTPNYIAPEVLCKKGHSF 205
Query: 452 KADVYSFGVVVIEVVCRK 469
           + D++S G ++  ++  K
Sbjct: 206 EVDIWSLGCILYTLLVGK 223

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 105/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 42  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 101
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 102 KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 161
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 162 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 210
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   + TL GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 211 RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRY-- 371
           E+++   + H+++V   G         +V E    +SLL+    R+ + EP   E RY  
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARYYL 123
Query: 372 -KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
            +I+L    G  YLH     R+IHRD+KL N+ L+E+   KI DFGL      D      
Sbjct: 124 RQIVL----GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           TL GT  Y+APE + +   + + DV+S G ++  ++  K
Sbjct: 176 TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRY-- 371
           E+++   + H+++V   G         +V E    +SLL+    R+ + EP   E RY  
Sbjct: 67  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARYYL 123
Query: 372 -KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
            +I+L    G  YLH     R+IHRD+KL N+ L+E+   KI DFGL      D      
Sbjct: 124 RQIVL----GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           TL GT  Y+APE + +   + + DV+S G ++  ++  K
Sbjct: 176 TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 51/159 (32%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRY-- 371
           E+++   + H+++V   G         +V E    +SLL+    R+ + EP   E RY  
Sbjct: 71  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARYYL 127
Query: 372 -KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
            +I+L    G  YLH     R+IHRD+KL N+ L+E+   KI DFGL      D      
Sbjct: 128 RQIVL----GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKK 179
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           TL GT  Y+APE + +   + + DV+S G ++  ++  K
Sbjct: 180 TLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 218

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 107/227 (47%), Gaps = 49/227 (21%)
Query: 277 LGQGGSGSV-YKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLIS-GINHKNLVKLLGCS 334
           LG G SG+V ++G+   G  VAVKR+  +   + D    E+ L++   +H N+++   CS
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-CS 77
Query: 335 ITGPESLLVYEFVPNQSLLD----------NLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            T    L +   + N +L D          NL ++++  P+S      ++   A G+A+L
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------LLRQIASGVAHL 131
Query: 385 HEESKLRIIHRDIKLSNILL--DEEFTAK-----------IADFGLVRLFPEDITHISAT 431
           H    L+IIHRD+K  NIL+     FTA            I+DFGL +      +     
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN 188
Query: 432 L---AGTLGYMAPEYV-------VRGKLTEKADVYSFGVVVIEVVCR 468
           L   +GT G+ APE +        + +LT   D++S G V   ++ +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+VP   +  +L  + +  EP + 
Sbjct: 78  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHAR 137
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 138 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 186
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 187 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 226

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 19/215 (8%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
           F   + LG+G  G V   T  P GE VA+K++  ++   +      E+ ++    H+N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 329 KLLGCSITGPESLLVYE--FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
            +   +I  P+S   +   ++  + +  +L      + LS +     I  T   +  LH 
Sbjct: 73  TIF--NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS---------ATLAGTLG 437
            +   +IHRD+K SN+L++     K+ DFGL R+  E     S              T  
Sbjct: 131 SN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRW 187
Query: 438 YMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++   K +   DV+S G ++ E+  R+ I
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+ P   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+++D++   K+ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+ P   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+++D++   K+ DFGL +     +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFGLAK----RVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+ P   +  +L  + +  EP + 
Sbjct: 86  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 145
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+++D++   K+ DFG    F + +  
Sbjct: 146 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKG 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 13/195 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAV-AVKRLFYNT--TQWVDH-FFNEVNLISGINHKNLVKLLG 332
           LG+G  G+VY       + + A+K LF +    + V+H    E+ + S + H N++++  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                    L+ EF P   L   L   Q       +     +   A+ L Y HE    ++
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCHER---KV 136
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRDIK  N+L+  +   KIADFG     P   +     + GTL Y+ PE +      EK
Sbjct: 137 IHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRXMCGTLDYLPPEMIEGKTHDEK 193
Query: 453 ADVYSFGVVVIEVVC 467
            D++  GV+  E + 
Sbjct: 194 VDLWCAGVLCYEFLV 208

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
           F   + LG+G  G V   T  P GE VA+K++  ++   +      E+ ++    H+N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 329 KLLGCSITGPESLLVYE--FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
            +   +I  P+S   +   ++  + +  +L      + LS +     I  T   +  LH 
Sbjct: 73  TIF--NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAG------TLG 437
            +   +IHRD+K SN+L++     K+ DFGL R+  E   D +  +   +G      T  
Sbjct: 131 SN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRW 187
Query: 438 YMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++   K +   DV+S G ++ E+  R+ I
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+ P   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+++D++   K+ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 34  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 90
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 91  LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 143
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 144 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMVPFVVTRYYRAPEV 198
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++     E  D++S G ++ E++
Sbjct: 199 ILGMGYKENVDIWSVGCIMGEMI 221

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 101/215 (46%), Gaps = 19/215 (8%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
           F   + LG+G  G V   T  P GE VA+K++  ++   +      E+ ++    H+N++
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENII 72
Query: 329 KLLGCSITGPESLLVYE--FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
            +   +I  P+S   +   ++  + +  +L      + LS +     I  T   +  LH 
Sbjct: 73  TIF--NIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG 130
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAG------TLG 437
            +   +IHRD+K SN+L++     K+ DFGL R+  E   D +  +   +G      T  
Sbjct: 131 SN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRW 187
Query: 438 YMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++   K +   DV+S G ++ E+  R+ I
Sbjct: 188 YRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKL 330
           S+ LGQG + +V++G     G+  A+K +F N +  + VD    E  ++  +NHKN+VKL
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIK-VFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 331 LGC--SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEE 387
                  T    +L+ EF P  SL   L    +   L  E  + I+L     G+ +L E 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP-ESEFLIVLRDVVGGMNHLREN 131
Query: 388 SKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
               I+HR+IK  NI+     D +   K+ DFG  R   +D   +S  L GT  Y+ P+ 
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVS--LYGTEEYLHPDM 186
Query: 444 VVRGKLTEK--------ADVYSFGV 460
             R  L +          D++S GV
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGV 211

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/108 (35%), Positives = 58/108 (53%), Gaps = 9/108 (8%)
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P+   +  K+ ++  + L YL E  K  +IHRD+K SNILLDE    K+ DFG+     +
Sbjct: 120 PIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTE-----KADVYSFGVVVIEVV 466
           D     +  AG   YMAPE +     T+     +ADV+S G+ ++E+ 
Sbjct: 178 DKAKDRS--AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 13/195 (6%)
Query: 277 LGQGGSGSVYKGTLPGGEAV-AVKRLFYNT--TQWVDH-FFNEVNLISGINHKNLVKLLG 332
           LG+G  G+VY       + + A+K LF +    + V+H    E+ + S + H N++++  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                    L+ EF P   L   L   Q       +     +   A+ L Y HE    ++
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCHER---KV 135
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHRDIK  N+L+  +   KIADFG     P   +     + GTL Y+ PE +      EK
Sbjct: 136 IHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRXMCGTLDYLPPEMIEGKTHDEK 192
Query: 453 ADVYSFGVVVIEVVC 467
            D++  GV+  E + 
Sbjct: 193 VDLWCAGVLCYEFLV 207

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 51/87 (58%), Gaps = 5/87 (5%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL  LH E   RI++RD+K  NILLD+    +I+D GL    PE  T I   + GT+GYM
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 352
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
           APE V   + T   D ++ G ++ E++
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMI 379

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 36/87 (41%), Positives = 51/87 (58%), Gaps = 5/87 (5%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL  LH E   RI++RD+K  NILLD+    +I+D GL    PE  T I   + GT+GYM
Sbjct: 298 GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYM 352
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVV 466
           APE V   + T   D ++ G ++ E++
Sbjct: 353 APEVVKNERYTFSPDWWALGCLLYEMI 379

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  LAGT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 17/202 (8%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI 335
           +G G  G VYKG       +A  ++   T    +    E+N++    +H+N+    G  I
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 336 T-GPESL-----LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
              P  +     LV EF    S+ D L        L  E    I      GL++LH+   
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLHQH-- 148
Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
            ++IHRDIK  N+LL E    K+ DFG+       +   + T  GT  +MAPE +   + 
Sbjct: 149 -KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIACDEN 206
Query: 450 TE-----KADVYSFGVVVIEVV 466
            +     K+D++S G+  IE+ 
Sbjct: 207 PDATYDFKSDLWSLGITAIEMA 228

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 106/227 (46%), Gaps = 49/227 (21%)
Query: 277 LGQGGSGSV-YKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLIS-GINHKNLVKLLGCS 334
           LG G SG+V ++G+   G  VAVKR+  +   + D    E+ L++   +H N+++   CS
Sbjct: 23  LGYGSSGTVVFQGSF-QGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYY-CS 77
Query: 335 ITGPESLLVYEFVPNQSLLD----------NLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            T    L +   + N +L D          NL ++++  P+S      ++   A G+A+L
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS------LLRQIASGVAHL 131
Query: 385 HEESKLRIIHRDIKLSNILL--DEEFTAK-----------IADFGLVRLFPEDITHISAT 431
           H    L+IIHRD+K  NIL+     FTA            I+DFGL +            
Sbjct: 132 HS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN 188
Query: 432 L---AGTLGYMAPEYV-------VRGKLTEKADVYSFGVVVIEVVCR 468
           L   +GT G+ APE +        + +LT   D++S G V   ++ +
Sbjct: 189 LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/180 (26%), Positives = 83/180 (46%), Gaps = 8/180 (4%)
Query: 293 GEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLVKLLGCSI--TGPESLLVYEFVP 348
           G+ +  K L Y +    +     +EVNL+  + H N+V+     I  T     +V E+  
Sbjct: 31  GKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCE 90
Query: 349 NQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESK--LRIIHRDIKLSNILLD 405
              L   +    ++ + L  E   +++      L   H  S     ++HRD+K +N+ LD
Sbjct: 91  GGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLD 150
Query: 406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            +   K+ DFGL R+   D    +    GT  YM+PE + R    EK+D++S G ++ E+
Sbjct: 151 GKQNVKLGDFGLARILNHD-EDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 101/210 (48%), Gaps = 42/210 (20%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-------LFPEDITHISATLAGTL 436
           LH      IIHRD+K SNI++  + T KI DFGL R       + PE +T          
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRY-------- 190
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            Y APE ++     E  D++S G ++ E++
Sbjct: 191 -YRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 55/89 (61%), Gaps = 8/89 (8%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLG 437
           GL +LH +    I++RD+KL NILLD++   KIADFG+ +   E++   + T    GT  
Sbjct: 130 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNXFCGTPD 183
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           Y+APE ++  K     D +SFGV++ E++
Sbjct: 184 YIAPEILLGQKYNHSVDWWSFGVLLYEML 212

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 33  IGSGAQGIVCAAYDAIL--ERNVAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 89
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 90  LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 142
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 143 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 197
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++     E  D++S G ++ E++
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMI 220

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 196
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++     E  D++S G ++ E++
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 14/199 (7%)
Query: 277 LGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFN-----EVNLISGINHKNLVKL 330
           LG+G   +VYK       + VA+K++            N     E+ L+  ++H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
           L          LV++F+        + ++ +   L+       +L T +GL YLH+    
Sbjct: 78  LDAFGHKSNISLVFDFMETDL---EVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW-- 132
Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
            I+HRD+K +N+LLDE    K+ADFGL + F          +  T  Y APE +   ++ 
Sbjct: 133 -ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLFGARMY 190
Query: 451 E-KADVYSFGVVVIEVVCR 468
               D+++ G ++ E++ R
Sbjct: 191 GVGVDMWAVGCILAELLLR 209

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/89 (39%), Positives = 55/89 (61%), Gaps = 8/89 (8%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLG 437
           GL +LH +    I++RD+KL NILLD++   KIADFG+ +   E++   + T    GT  
Sbjct: 131 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNEFCGTPD 184
Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           Y+APE ++  K     D +SFGV++ E++
Sbjct: 185 YIAPEILLGQKYNHSVDWWSFGVLLYEML 213

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 28/203 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH-AKRAYRELVLMKVVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y++++    G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-LLYQMLV----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 196
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++     E  D++S G ++ E++
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 105/213 (49%), Gaps = 17/213 (7%)
Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHFFNEVNL-I 319
           ++E   +      +LG+G  G V K   +P G+ +AVKR+     +Q       ++++ +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP---LSWEVRYKIILS 376
             ++    V   G      +  +  E + + SL  + F +Q ++    +  ++  KI +S
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSL--DKFYKQVIDKGQTIPEDILGKIAVS 117
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
             + L +LH  SKL +IHRD+K SN+L++     K+ DFG+     +D+       AG  
Sbjct: 118 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--KDIDAGCK 173
Query: 437 GYMAPEYV----VRGKLTEKADVYSFGVVVIEV 465
            YMAPE +     +   + K+D++S G+ +IE+
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIEL 206

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 277 LGQGGSGSVYKGTLP-GGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +G G  GSV        GE VA+K+L   + +  +    + E+ L+  + H+N++ LL  
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPL-----SWEVRYKIILSTAEGLAYLHEES 388
                     Y+F      L   F++ D++ +     S E    ++    +GL Y+H   
Sbjct: 110 FTPASSLRNFYDFY-----LVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHSAG 164
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG---TLGYMAPEYVV 445
              ++HRD+K  N+ ++E+   KI DFGL R       H  A + G   T  Y APE ++
Sbjct: 165 ---VVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVIL 214
Query: 446 RG-KLTEKADVYSFGVVVIEVVCRKRI 471
                 +  D++S G ++ E++  K +
Sbjct: 215 SWMHYNQTVDIWSVGCIMAEMLTGKTL 241

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+ P   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+++D++   ++ DFGL +     +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFGLAK----RVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   L KL           +V E+ P   +  +L  + +  EP + 
Sbjct: 86  IEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHAR 145
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+++D++   K+ DFG    F + +  
Sbjct: 146 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKG 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 27/207 (13%)
Query: 277 LGQGGSGSVYKGTLP-GGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +G G  GSV        GE VA+K+L   + +  +    + E+ L+  + H+N++ LL  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPL-----SWEVRYKIILSTAEGLAYLHEES 388
                     Y+F      L   F++ D++ +     S E    ++    +GL Y+H   
Sbjct: 92  FTPASSLRNFYDFY-----LVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHSAG 146
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG---TLGYMAPEYVV 445
              ++HRD+K  N+ ++E+   KI DFGL R       H  A + G   T  Y APE ++
Sbjct: 147 ---VVHRDLKPGNLAVNEDCELKILDFGLAR-------HADAEMTGYVVTRWYRAPEVIL 196
Query: 446 RG-KLTEKADVYSFGVVVIEVVCRKRI 471
                 +  D++S G ++ E++  K +
Sbjct: 197 SWMHYNQTVDIWSVGCIMAEMLTGKTL 223

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLCQVIQMELDHERMSY-LLYQMLC----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 196
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++     E  D++S G ++ E++
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKL 330
           S+ LGQG + +V++G     G+  A+K +F N +  + VD    E  ++  +NHKN+VKL
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIK-VFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72
Query: 331 LGC--SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEE 387
                  T    +L+ EF P  SL   L    +   L  E  + I+L     G+ +L E 
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLP-ESEFLIVLRDVVGGMNHLREN 131
Query: 388 SKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
               I+HR+IK  NI+     D +   K+ DFG  R   +D   +   L GT  Y+ P+ 
Sbjct: 132 G---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFV--XLYGTEEYLHPDM 186
Query: 444 VVRGKLTEK--------ADVYSFGV 460
             R  L +          D++S GV
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGV 211

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRY-- 371
           E+++   + H+++V   G         +V E    +SLL+    R+ + EP   E RY  
Sbjct: 65  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARYYL 121
Query: 372 -KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
            +I+L    G  YLH     R+IHRD+KL N+ L+E+   KI DFGL      D      
Sbjct: 122 RQIVL----GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKK 173
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
            L GT  Y+APE + +   + + DV+S G ++
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 205

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+ P   +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+++D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLMIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            L YLH E    +++RD+KL N++LD++   KI DFGL +   +D   +  T  GT  Y+
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYL 316
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
           APE +         D +  GVV+ E++C  R+  + Q+   + + +
Sbjct: 317 APEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI 361

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   L KL           +V E+ P   +  +L  + +  EP + 
Sbjct: 86  IEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 145
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+++D++   K+ DFG    F + +  
Sbjct: 146 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKG 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/159 (31%), Positives = 79/159 (49%), Gaps = 15/159 (9%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRY-- 371
           E+++   + H+++V   G         +V E    +SLL+    R+ + EP   E RY  
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARYYL 147
Query: 372 -KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
            +I+L    G  YLH     R+IHRD+KL N+ L+E+   KI DFGL      D      
Sbjct: 148 RQIVL----GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKK 199
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
            L GT  Y+APE + +   + + DV+S G ++  ++  K
Sbjct: 200 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 108/223 (48%), Gaps = 17/223 (7%)
Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVD 310
           +K+ ++   +  E   +      +LG+G  G V K   +P G+ +AVKR+     +Q   
Sbjct: 35  SKACISIGNQNFEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQK 94
Query: 311 HFFNEVNL-ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF--VRQDVEPLSW 367
               ++++ +  ++    V   G      +  +  E +   + LD  +  V    + +  
Sbjct: 95  RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM--DTSLDKFYKQVIDKGQTIPE 152
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
           ++  KI +S  + L +LH  SKL +IHRD+K SN+L++     K+ DFG+       +  
Sbjct: 153 DILGKIAVSIVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL---VDS 207
Query: 428 ISATL-AGTLGYMAPEYV----VRGKLTEKADVYSFGVVVIEV 465
           ++ T+ AG   YMAPE +     +   + K+D++S G+ +IE+
Sbjct: 208 VAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIEL 250

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 8   KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 67
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 68  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 127
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+DE+   ++ DFG    F +
Sbjct: 128 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDEQGYIQVTDFG----FAK 176
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 177 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 220

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   L KL           +V E+ P   +  +L  + +  EP + 
Sbjct: 86  IEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHAR 145
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+++D++   K+ DFG    F + +  
Sbjct: 146 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKG 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 195 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/106 (32%), Positives = 57/106 (53%), Gaps = 4/106 (3%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            L YLH E    +++RD+KL N++LD++   KI DFGL +   +D   +  T  GT  Y+
Sbjct: 263 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYL 319
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
           APE +         D +  GVV+ E++C  R+  + Q+   + + +
Sbjct: 320 APEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI 364

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-LLYQMLC----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 196
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++     E  D++S G ++ E++
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 49/152 (32%), Positives = 76/152 (50%), Gaps = 15/152 (9%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRY-- 371
           E+++   + H+++V   G         +V E    +SLL+    R+ + EP   E RY  
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARYYL 145
Query: 372 -KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
            +I+L    G  YLH     R+IHRD+KL N+ L+E+   KI DFGL      D      
Sbjct: 146 RQIVL----GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKK 197
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
            L GT  Y+APE + +   + + DV+S G ++
Sbjct: 198 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIM 229

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 42  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 101
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 102 KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE 161
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 162 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 210
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 211 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 254

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH-AKRAYRELVLMKVVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-LLYQMLC----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 196
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++     E  D++S G ++ E++
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 28/203 (13%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
           +G G  G V   Y   L     VA+K+L   F N T      + E+ L+  +NHKN++ L
Sbjct: 32  IGSGAQGIVCAAYDAILERN--VAIKKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGL 88
Query: 331 LGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L    T  +SL       +V E + + +L   + +  D E +S+ + Y+++     G+ +
Sbjct: 89  LNV-FTPQKSLEEFQDVYIVMELM-DANLSQVIQMELDHERMSY-LLYQMLC----GIKH 141
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      IIHRD+K SNI++  + T KI DFGL R      + +      T  Y APE 
Sbjct: 142 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEV 196
Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           ++     E  D++S G ++ E++
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMI 219

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 13/200 (6%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQW--VDH-FFNEVNLISGINHKN 326
           F     LG+G  G+VY          VA+K LF +  +   V+H    E+ + + ++H N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L           L+ E+ P   L   L   Q       +    I+   A+ L Y H 
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKEL---QKSCTFDEQRTATIMEELADALMYCHG 141
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
           +   ++IHRDIK  N+LL  +   KIADFG     P   +    T+ GTL Y+ PE +  
Sbjct: 142 K---KVIHRDIKPENLLLGLKGELKIADFGWSVHAP---SLRRKTMCGTLDYLPPEMIEG 195
Query: 447 GKLTEKADVYSFGVVVIEVV 466
               EK D++  GV+  E++
Sbjct: 196 RMHNEKVDLWCIGVLCYELL 215

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/91 (43%), Positives = 55/91 (60%), Gaps = 7/91 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            L +LH   KL II+RDIKL NILLD      + DFGL + F  D T  +    GT+ YM
Sbjct: 171 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227
Query: 440 APEYVVRGKLT--EKA-DVYSFGVVVIEVVC 467
           AP+ +VRG  +  +KA D +S GV++ E++ 
Sbjct: 228 APD-IVRGGDSGHDKAVDWWSLGVLMYELLT 257

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 22  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 81
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 82  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 141
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 142 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 190
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 191 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 234

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 16  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 75
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 76  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXE 135
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 136 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 184
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 185 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 228

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+++D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLIIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAA 233

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 44/138 (31%), Positives = 68/138 (49%), Gaps = 10/138 (7%)
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDV-----EPLSWEVRYKIILSTAEGLAYLHEES 388
           S+T  ES     F  ++SL D +   +D      EP++ E         A G+ +L   S
Sbjct: 161 SVTSSESFASSGFQEDKSLSD-VEEEEDSDGFYKEPITMEDLISYSFQVARGMEFL---S 216
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SATLAGTLGYMAPEYVVRG 447
             + IHRD+   NILL E    KI DFGL R   ++  ++        L +MAPE +   
Sbjct: 217 SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDK 276
Query: 448 KLTEKADVYSFGVVVIEV 465
             + K+DV+S+GV++ E+
Sbjct: 277 IYSTKSDVWSYGVLLWEI 294

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSW 367
           ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  EP + 
Sbjct: 85  IEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHAR 144
Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
               +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F + +  
Sbjct: 145 FYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKG 193
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  L GT  Y+APE ++     +  D ++ GV++ E+  
Sbjct: 194 RTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 104/238 (43%), Gaps = 35/238 (14%)
Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNLVKLLG 332
           K+GQG  G V+K      G+ VA+K++     +  +      E+ ++  + H+N+V L+ 
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 333 CSITGPESL--------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
              T             LV++F  +    LL N+ V+  +  +      +++     GL 
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQMLLNGLY 139
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYM 439
           Y+H     +I+HRD+K +N+L+  +   K+ADFGL R F        +       TL Y 
Sbjct: 140 YIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYR 196
Query: 440 APEYVVRGK-LTEKADVYSFGVVVIEVVCR----------KRINLFTQNSCSILQTVW 486
            PE ++  +      D++  G ++ E+  R           ++ L +Q   SI   VW
Sbjct: 197 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 254

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 99/221 (44%), Gaps = 42/221 (19%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNL 327
           + +   +G G  G+V        G  VA+K+L+  + +  +    + E+ L+  + H+N+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLD-------NLFVRQDV------EPLSWEVRYKII 374
           + LL              F P+++L D         F+  D+      E L  +    ++
Sbjct: 87  IGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLV 134
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
               +GL Y+H      IIHRD+K  N+ ++E+   KI DFGL R          + + G
Sbjct: 135 YQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-------QADSEMXG 184
Query: 435 ---TLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRI 471
              T  Y APE ++   + T+  D++S G ++ E++  K +
Sbjct: 185 XVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 35/243 (14%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNL 327
           + +  K+GQG  G V+K      G+ VA+K++     +  +      E+ ++  + H+N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 328 VKLLGCSITGPESL--------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILST 377
           V L+    T             LV++F  +    LL N+ V+  +  +      +++   
Sbjct: 80  VNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQML 134
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAG 434
             GL Y+H     +I+HRD+K +N+L+  +   K+ADFGL R F        +       
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 435 TLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCR----------KRINLFTQNSCSILQ 483
           TL Y  PE ++  +      D++  G ++ E+  R           ++ L +Q   SI  
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 484 TVW 486
            VW
Sbjct: 252 EVW 254

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 35/243 (14%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNL 327
           + +  K+GQG  G V+K      G+ VA+K++     +  +      E+ ++  + H+N+
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 79
Query: 328 VKLLGCSITGPESL--------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILST 377
           V L+    T             LV++F  +    LL N+ V+  +  +      +++   
Sbjct: 80  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQML 134
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAG 434
             GL Y+H     +I+HRD+K +N+L+  +   K+ADFGL R F        +       
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 435 TLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCR----------KRINLFTQNSCSILQ 483
           TL Y  PE ++  +      D++  G ++ E+  R           ++ L +Q   SI  
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 484 TVW 486
            VW
Sbjct: 252 EVW 254

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 92/192 (47%), Gaps = 16/192 (8%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN---EVNLISGINHKNLVKLLG 332
           LG+G  G V   T     + VA+K +     +  D       E++ +  + H +++KL  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
              T  + ++V E+   + L D +  ++ +        ++ I+   E   Y H     +I
Sbjct: 77  VITTPTDIVMVIEYAGGE-LFDYIVEKKRMTEDEGRRFFQQIICAIE---YCHRH---KI 129
Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT-- 450
           +HRD+K  N+LLD+    KIADFGL  +  +   +   T  G+  Y APE V+ GKL   
Sbjct: 130 VHRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE-VINGKLYAG 186
Query: 451 EKADVYSFGVVV 462
            + DV+S G+V+
Sbjct: 187 PEVDVWSCGIVL 198

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/243 (23%), Positives = 106/243 (43%), Gaps = 35/243 (14%)
Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNL 327
           + +  K+GQG  G V+K      G+ VA+K++     +  +      E+ ++  + H+N+
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 78
Query: 328 VKLLGCSITGPESL--------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILST 377
           V L+    T             LV++F  +    LL N+ V+  +  +      +++   
Sbjct: 79  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIK-----RVMQML 133
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAG 434
             GL Y+H     +I+HRD+K +N+L+  +   K+ADFGL R F        +       
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 435 TLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCR----------KRINLFTQNSCSILQ 483
           TL Y  PE ++  +      D++  G ++ E+  R           ++ L +Q   SI  
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250
Query: 484 TVW 486
            VW
Sbjct: 251 EVW 253

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/191 (25%), Positives = 93/191 (48%), Gaps = 19/191 (9%)
Query: 293 GEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV---KLLGCSITGPESLLVYEFV 347
           G+ VA+K++   ++          E+ ++    H N++    +L  ++   E   VY  +
Sbjct: 80  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL 139
Query: 348 PNQSLLDNLF--VRQDVEPLSWE-VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL 404
               L+++    +    +PL+ E VRY  +     GL Y+H     ++IHRD+K SN+L+
Sbjct: 140 ---DLMESDLHQIIHSSQPLTLEHVRY-FLYQLLRGLKYMH---SAQVIHRDLKPSNLLV 192
Query: 405 DEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGV 460
           +E    KI DFG+ R     P +  +       T  Y APE ++   + T+  D++S G 
Sbjct: 193 NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGC 252
Query: 461 VVIEVVCRKRI 471
           +  E++ R+++
Sbjct: 253 IFGEMLARRQL 263

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            L YLH      +++RDIKL N++LD++   KI DFGL +    D   +  T  GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYL 172
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD 499
           APE +         D +  GVV+ E++C  R+  + Q+   + + +  L  + R    + 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELI--LMEEIRFPRTLS 229
Query: 500 PA----LAGNFQEGKPSRL 514
           P     LAG  ++    RL
Sbjct: 230 PEAKSLLAGLLKKDPKQRL 248

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            L YLH      +++RDIKL N++LD++   KI DFGL +    D   +  T  GT  Y+
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYL 172
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD 499
           APE +         D +  GVV+ E++C  R+  + Q+   + + +  L  + R    + 
Sbjct: 173 APEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELI--LMEEIRFPRTLS 229
Query: 500 PA----LAGNFQEGKPSRL 514
           P     LAG  ++    RL
Sbjct: 230 PEAKSLLAGLLKKDPKQRL 248

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 67/139 (48%), Gaps = 11/139 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            L YLH      +++RDIKL N++LD++   KI DFGL +    D   +  T  GT  Y+
Sbjct: 120 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYL 175
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD 499
           APE +         D +  GVV+ E++C  R+  + Q+   + + +  L  + R    + 
Sbjct: 176 APEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELI--LMEEIRFPRTLS 232
Query: 500 PA----LAGNFQEGKPSRL 514
           P     LAG  ++    RL
Sbjct: 233 PEAKSLLAGLLKKDPKQRL 251

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
              A+G+ +L   +  + IHRD+   NILL E+   KI DFGL R   +D  ++    A 
Sbjct: 205 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 261
Query: 435 -TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 262 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 293

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 95/221 (42%), Gaps = 19/221 (8%)
Query: 254 KSKLNFSYETLEKATNYFHESNKLGQGGSG----SVYKGTLPGGEAVAVKRLFYNTTQWV 309
           +  L F   T      Y+   N +G+G  G    +V KGT     A  + + F      V
Sbjct: 11  RENLYFQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---V 67
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
           D F  E+ ++  ++H N+++L        +  LV E      L + + V + V   S   
Sbjct: 68  DRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAA 126
Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDIT 426
           R  I+      +AY H   KL + HRD+K  N L      +   K+ DFGL   F     
Sbjct: 127 R--IMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-- 179
Query: 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +  T  GT  Y++P+ V+ G    + D +S GV++  ++C
Sbjct: 180 KMMRTKVGTPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLC 219

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+APE ++     +  D ++ GV++ ++  
Sbjct: 190 RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAA 233

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 51/89 (57%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     + +  GT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +     ++ +D+++ G ++ ++V 
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVA 229

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
              A+G+ +L   +  + IHRD+   NILL E+   KI DFGL R   +D  ++    A 
Sbjct: 207 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 263
Query: 435 -TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 264 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
              A+G+ +L   +  + IHRD+   NILL E+   KI DFGL R   +D  ++    A 
Sbjct: 200 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256
Query: 435 -TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 257 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 288

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 52/92 (56%), Gaps = 4/92 (4%)
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
              A+G+ +L   +  + IHRD+   NILL E+   KI DFGL R   +D  ++    A 
Sbjct: 198 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 254
Query: 435 -TLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
             L +MAPE +     T ++DV+SFGV++ E+
Sbjct: 255 LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 286

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 91/189 (48%), Gaps = 15/189 (7%)
Query: 293 GEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV---KLLGCSITGPESLLVYEFV 347
           G+ VA+K++   ++          E+ ++    H N++    +L  ++   E   VY  V
Sbjct: 79  GQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVY-VV 137
Query: 348 PNQSLLDNLFVRQDVEPLSWE-VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
            +    D   +    +PL+ E VRY  +     GL Y+H     ++IHRD+K SN+L++E
Sbjct: 138 LDLMESDLHQIIHSSQPLTLEHVRY-FLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNE 193
Query: 407 EFTAKIADFGLVRLF---PEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVV 462
               KI DFG+ R     P +  +       T  Y APE ++   + T+  D++S G + 
Sbjct: 194 NCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF 253
Query: 463 IEVVCRKRI 471
            E++ R+++
Sbjct: 254 GEMLARRQL 262

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 4/106 (3%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            L YLH E    +++RD+KL N++LD++   KI DFGL +   +D   +     GT  Y+
Sbjct: 121 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYL 177
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
           APE +         D +  GVV+ E++C  R+  + Q+   + + +
Sbjct: 178 APEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI 222

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 19/212 (8%)
Query: 267 ATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGIN 323
           + + +    KLG+G  G VYK       E VA+KR  L +           EV+L+  + 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ 91
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKIILSTAEGLA 382
           H+N+++L           L++E+  N     +L    D  P +S  V    +     G+ 
Sbjct: 92  HRNIIELKSVIHHNHRLHLIFEYAEN-----DLKKYMDKNPDVSMRVIKSFLYQLINGVN 146
Query: 383 YLHEESKLRIIHRDIKLSNILL-----DEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           + H     R +HRD+K  N+LL      E    KI DFGL R F   I   +  +  TL 
Sbjct: 147 FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLW 202
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCR 468
           Y  PE ++  +  +   D++S   +  E++ +
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMK 234

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 4/106 (3%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            L YLH E    +++RD+KL N++LD++   KI DFGL +   +D   +     GT  Y+
Sbjct: 120 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYL 176
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
           APE +         D +  GVV+ E++C  R+  + Q+   + + +
Sbjct: 177 APEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI 221

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 56/106 (52%), Gaps = 4/106 (3%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            L YLH E    +++RD+KL N++LD++   KI DFGL +   +D   +     GT  Y+
Sbjct: 122 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKX-FCGTPEYL 178
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
           APE +         D +  GVV+ E++C  R+  + Q+   + + +
Sbjct: 179 APEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHEKLFELI 223

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 75/161 (46%), Gaps = 18/161 (11%)
Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL--DNLFVRQDVEP--- 364
           D F NE+ +I+ I ++  +   G      E  ++YE++ N S+L  D  F   D      
Sbjct: 88  DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
           +  +V   II S     +Y+H E    I HRD+K SNIL+D+    K++DFG      E 
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFG------ES 199
Query: 425 ITHISATLAGTLG---YMAPEYVVRGKLTE--KADVYSFGV 460
              +   + G+ G   +M PE+          K D++S G+
Sbjct: 200 EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGI 240

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 77/160 (48%), Gaps = 13/160 (8%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVR 370
           F+ E ++++  N   +V+L  C+    + L +V E++P   L+ NL    DV P  W   
Sbjct: 122 FWEERDIMAFANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLV-NLMSNYDV-PEKWAKF 178
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
           Y     TAE +  L     + +IHRD+K  N+LLD+    K+ADFG      E       
Sbjct: 179 Y-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCD 233
Query: 431 TLAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVV 466
           T  GT  Y++PE +      G    + D +S GV + E++
Sbjct: 234 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML 273

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 91/206 (44%), Gaps = 19/206 (9%)
Query: 269 NYFHESNKLGQGGSG----SVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH 324
            Y+   N +G+G  G    +V KGT     A  + + F      VD F  E+ ++  ++H
Sbjct: 9   QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDH 65
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            N+++L        +  LV E      L + + V + V   S   R  I+      +AY 
Sbjct: 66  PNIIRLYETFEDNTDIYLVMELCTGGELFERV-VHKRVFRESDAAR--IMKDVLSAVAYC 122
Query: 385 HEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
           H   KL + HRD+K  N L      +   K+ DFGL   F      +  T  GT  Y++P
Sbjct: 123 H---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSP 177
Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVC 467
           + V+ G    + D +S GV++  ++C
Sbjct: 178 Q-VLEGLYGPECDEWSAGVMMYVLLC 202

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 260 SYETLEKATNYFHESNK--------------LGQGGSGSVYKG-TLPGGEAVAVKRLF-- 302
           S+ + E+ T Y  E NK              +G G  GSV        G  VAVK+L   
Sbjct: 19  SHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP 78
Query: 303 YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV 362
           + +       + E+ L+  + H+N++ LL    T   SL   EF  N   L    +  D+
Sbjct: 79  FQSIIHAKRTYRELRLLKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADL 133
Query: 363 ------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
                 + L+ +    +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFG
Sbjct: 134 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 190
Query: 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           L R   +++T   A    T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 191 LARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 260 SYETLEKATNYFHESNK--------------LGQGGSGSVYKG-TLPGGEAVAVKRLF-- 302
           S+ + E+ T Y  E NK              +G G  GSV        G  VAVK+L   
Sbjct: 18  SHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP 77
Query: 303 YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV 362
           + +       + E+ L+  + H+N++ LL    T   SL   EF  N   L    +  D+
Sbjct: 78  FQSIIHAKRTYRELRLLKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADL 132
Query: 363 ------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
                 + L+ +    +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFG
Sbjct: 133 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 189
Query: 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           L R   +++T   A    T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 190 LARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 7/160 (4%)
Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
           V +   E +++S ++H   VKL  C     +      +  N  LL   ++R+ +      
Sbjct: 81  VPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGELLK--YIRK-IGSFDET 137
Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITH 427
                       L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE    
Sbjct: 138 CTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 194
Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +    GT  Y++PE +      + +D+++ G ++ ++V 
Sbjct: 195 RANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 234

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT  Y+AP  ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     + +  GT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 71  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R       H    +
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM 175
Query: 433 AG---TLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           AG   T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 176 AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 9/181 (4%)
Query: 296 VAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
           VA+K++  +    +      E+ ++    H+N++ +    I  P    + +    Q L++
Sbjct: 53  VAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDI-IRAPTIEQMKDVYIVQDLME 111
Query: 355 -NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
            +L+     + LS +     +     GL Y+H  +   ++HRD+K SN+LL+     KI 
Sbjct: 112 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTSDLKIC 168
Query: 414 DFGLVRLFPEDITHIS--ATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKR 470
           DFGL R+   D  H         T  Y APE ++  K  T+  D++S G ++ E++  + 
Sbjct: 169 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228
Query: 471 I 471
           I
Sbjct: 229 I 229

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 277 LGQGGSG---SVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           +G+G  G   S Y         VA+K++  +    +      E+ ++    H+N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGI-N 89
Query: 333 CSITGPESLLVYEFVPNQSLLD-NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
             I  P    + +    Q L++ +L+     + LS +     +     GL Y+H  +   
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAPEYVVRGK- 448
           ++HRD+K SN+LL+     KI DFGL R+   D  H         T  Y APE ++  K 
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 449 LTEKADVYSFGVVVIEVVCRKRI 471
            T+  D++S G ++ E++  + I
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPI 229

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA---GTL 436
            L YLH      +++RDIKL N++LD++   KI DFGL +   E I+   AT+    GT 
Sbjct: 122 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISD-GATMKXFCGTP 174
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            Y+APE +         D +  GVV+ E++C  R+  + Q+   + + +  L  + R   
Sbjct: 175 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELI--LMEEIRFPR 231
Query: 497 AVDPA----LAGNFQEGKPSRL 514
            + P     LAG  ++    RL
Sbjct: 232 TLSPEAKSLLAGLLKKDPKQRL 253

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA---GTL 436
            L YLH      +++RDIKL N++LD++   KI DFGL +   E I+   AT+    GT 
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISD-GATMKXFCGTP 169
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            Y+APE +         D +  GVV+ E++C  R+  + Q+   + + +  L  + R   
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELI--LMEEIRFPR 226
Query: 497 AVDPA----LAGNFQEGKPSRL 514
            + P     LAG  ++    RL
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA---GTL 436
            L YLH      +++RDIKL N++LD++   KI DFGL +   E I+   AT+    GT 
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISD-GATMKXFCGTP 169
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            Y+APE +         D +  GVV+ E++C  R+  + Q+   + + +  L  + R   
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELI--LMEEIRFPR 226
Query: 497 AVDPA----LAGNFQEGKPSRL 514
            + P     LAG  ++    RL
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R       H    +
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM 179
Query: 433 AG---TLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           AG   T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 180 AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 98/219 (44%), Gaps = 28/219 (12%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R       H    +
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM 179
Query: 433 AG---TLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           AG   T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 180 AGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 70/142 (49%), Gaps = 17/142 (11%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA---GTL 436
            L YLH      +++RDIKL N++LD++   KI DFGL +   E I+   AT+    GT 
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCK---EGISD-GATMKXFCGTP 169
Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
            Y+APE +         D +  GVV+ E++C  R+  + Q+   + + +  L  + R   
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMC-GRLPFYNQDHERLFELI--LMEEIRFPR 226
Query: 497 AVDPA----LAGNFQEGKPSRL 514
            + P     LAG  ++    RL
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 71  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 180
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 181 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 313 FNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
             EV+++  ++ H N+++L     T     LV++ +    L D  ++ + V     E R 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD--YLTEKVTLSEKETR- 127
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISA 430
           KI+ +  E +  LH   KL I+HRD+K  NILLD++   K+ DFG   +L P +      
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR--- 181
Query: 431 TLAGTLGYMAPEYVV------RGKLTEKADVYSFGVVV 462
           ++ GT  Y+APE +            ++ D++S GV++
Sbjct: 182 SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 201 VSPELLTEKSAXKSSDLWALGCIIYQLVA 229

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 50/89 (56%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     + +  GT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 107/254 (42%), Gaps = 21/254 (8%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAV-AVKRLFYNT---TQWVDHFFNEVN-LISGINHK 325
           FH    +G+G  G V        E   AVK L        +   H  +E N L+  + H 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS-TAEGLAYL 384
            LV L     T  +   V +++        LF     E    E R +   +  A  L YL
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYING----GELFYHLQRERCFLEPRARFYAAEIASALGYL 155
Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGTLGYMAPE 442
           H    L I++RD+K  NILLD +    + DFGL +   E+I H   ++T  GT  Y+APE
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPE 209
Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD--LYVKGRLHEAVDP 500
            + +       D +  G V+ E++       +++N+  +   + +  L +K  +  +   
Sbjct: 210 VLHKQPYDRTVDWWCLGAVLYEMLY-GLPPFYSRNTAEMYDNILNKPLQLKPNITNSARH 268
Query: 501 ALAGNFQEGKPSRL 514
            L G  Q+ +  RL
Sbjct: 269 LLEGLLQKDRTKRL 282

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 32/88 (36%), Positives = 50/88 (56%), Gaps = 4/88 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL +LH   K  II+RD+KL N++LD E   KIADFG+ +    D    +    GT  Y+
Sbjct: 132 GLFFLH---KRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV-TTREFCGTPDYI 187
Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVC 467
           APE +      +  D +++GV++ E++ 
Sbjct: 188 APEIIAYQPYGKSVDWWAYGVLLYEMLA 215

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 145 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 202 VSPELLTEKSACKSSDLWALGCIIYQLVA 230

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 377 TAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATL 432
           TAE    L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +   
Sbjct: 115 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            GT  Y++PE +      + +D+++ G ++ ++V 
Sbjct: 172 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 206

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 156 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 63/234 (26%), Positives = 102/234 (43%), Gaps = 36/234 (15%)
Query: 258 NFSYETLEKATNYFHESNK--------------LGQGGSGSVYKG-TLPGGEAVAVKRLF 302
           +  + + E+ T Y  E NK              +G G  GSV        G  VAVK+L 
Sbjct: 3   HHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLS 62
Query: 303 --YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ 360
             + +       + E+ L+  + H+N++ LL    T   SL   EF  N   L    +  
Sbjct: 63  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGA 117
Query: 361 DV------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414
           D+      + L+ +    +I     GL Y+H      IIHRD+K SN+ ++E+   KI D
Sbjct: 118 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD 174
Query: 415 FGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           FGL R   +++T        T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 175 FGLARHTDDEMT----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 377 TAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATL 432
           TAE    L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +   
Sbjct: 116 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            GT  Y++PE +      + +D+++ G ++ ++V 
Sbjct: 173 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 207

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 56/105 (53%), Gaps = 14/105 (13%)
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED------IT 426
           I +  AE + +LH +    ++HRD+K SNI    +   K+ DFGLV    +D      +T
Sbjct: 169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 427 HIS--ATLAGTLG---YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            +   AT  G +G   YM+PE +     + K D++S G+++ E++
Sbjct: 226 PMPAYATHXGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 8/91 (8%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
           A GL +L  +    II+RD+KL N++LD E   KIADFG+ +   E+I     +    GT
Sbjct: 452 AIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGT 505
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
             Y+APE +      +  D ++FGV++ E++
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEML 536

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 100/227 (44%), Gaps = 36/227 (15%)
Query: 265 EKATNYFHESNK--------------LGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQ 307
           E+ T Y  E NK              +G G  GSV        G  VAVK+L   + +  
Sbjct: 14  ERPTFYRQELNKTIWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSII 73
Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV----- 362
                + E+ L+  + H+N++ LL    T   SL   EF  N   L    +  D+     
Sbjct: 74  HAKRTYRELRLLKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVK 128
Query: 363 -EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
            + L+ +    +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R  
Sbjct: 129 CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT 185
Query: 422 PEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
            +++T   A    T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 186 DDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 228

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR-YKI 373
           E+ ++  +NH  ++K+        +  +V E +    L D +   + ++  + ++  Y++
Sbjct: 204 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISA 430
           +L+    + YLHE     IIHRD+K  N+LL   +E+   KI DFG  ++  E  T +  
Sbjct: 263 LLA----VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMR 313
Query: 431 TLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVV 462
           TL GT  Y+APE +V           D +S GV++
Sbjct: 314 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 348

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 147 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 204 VSPELLTEKSACKSSDLWALGCIIYQLVA 232

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL ++H      +++RD+K +NILLDE    +I+D GL   F +   H S    GT GYM
Sbjct: 303 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 356
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV--WDLYVKGRLHE 496
           APE + +G      AD +S G ++ +++  +  + F Q+       +    L +   L +
Sbjct: 357 APEVLQKGVAYDSSADWFSLGCMLFKLL--RGHSPFRQHKTKDKHEIDRMTLTMAVELPD 414
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNP 556
           +  P L  +  EG   R +   L C+   A+     S   + L      LQ   PP + P
Sbjct: 415 SFSPELR-SLLEGLLQRDVNRRLGCLGRGAQ-EVKESPFFRSLDWQMVFLQKYPPPLIPP 472
Query: 557 NGS 559
            G 
Sbjct: 473 RGE 475

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL----------------LDNLFVRQDV 362
           +  + H+N++ LL              F P +SL                L+N+   Q +
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
                 V++ +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   
Sbjct: 123 T--DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTD 176
Query: 423 EDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           +++T   A    T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 177 DEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL ++H      +++RD+K +NILLDE    +I+D GL   F +   H S    GT GYM
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 357
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV--WDLYVKGRLHE 496
           APE + +G      AD +S G ++ +++  +  + F Q+       +    L +   L +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLL--RGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNP 556
           +  P L  +  EG   R +   L C+   A+     S   + L      LQ   PP + P
Sbjct: 416 SFSPELR-SLLEGLLQRDVNRRLGCLGRGAQ-EVKESPFFRSLDWQMVFLQKYPPPLIPP 473
Query: 557 NGS 559
            G 
Sbjct: 474 RGE 476

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 144 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 201 VSPELLTEKSACKSSDLWALGCIIYQLVA 229

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 377 TAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATL 432
           TAE    L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +   
Sbjct: 113 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            GT  Y++PE +      + +D+++ G ++ ++V 
Sbjct: 170 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 204

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 136 GLKYIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 227

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 142 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 199 VSPELLTEKSACKSSDLWALGCIIYQLVA 227

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 52/95 (54%), Gaps = 7/95 (7%)
Query: 377 TAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATL 432
           TAE    L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +   
Sbjct: 114 TAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 170
Query: 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            GT  Y++PE +      + +D+++ G ++ ++V 
Sbjct: 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 20  KTIWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 80  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA-- 189
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 190 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 94/212 (44%), Gaps = 40/212 (18%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           +G G  GSV   Y   L   + VAVK+L   + +       + E+ L+  + H+N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 332 GCSITGPESLLVYEFVPNQSLLD-------NLFVRQDV------EPLSWEVRYKIILSTA 378
                         F P  S+ D          +  D+      + LS E    ++    
Sbjct: 94  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
            GL Y+H      IIHRD+K SN+ ++E+   +I DFGL R   E++T   A    T  Y
Sbjct: 142 RGLKYIHSAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA----TRWY 194
Query: 439 MAPEYVVRG-KLTEKADVYSFGVVVIEVVCRK 469
            APE ++      +  D++S G ++ E++  K
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 103/224 (45%), Gaps = 21/224 (9%)
Query: 254 KSKLNF--SYETLEKATNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNTT- 306
           K+K +F   +ET  + T    + +++   G+GS  +  L      G   A+K L      
Sbjct: 21  KAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVV 80
Query: 307 --QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVE 363
             + ++H  NE  ++  +N   LVKL           +V E+V    +  +L  + +  E
Sbjct: 81  KLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE 140
Query: 364 PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           P +     +I+L+      YLH    L +I+RD+K  N+L+D++   ++ DFG    F +
Sbjct: 141 PHARFYAAQIVLT----FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFG----FAK 189
Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
            +   +  L GT   +APE ++     +  D ++ GV++ E+  
Sbjct: 190 RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAA 233

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLT 218

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 260 SYETLEKATNYFHESNK--------------LGQGGSGSVYKG-TLPGGEAVAVKRLF-- 302
           S+ + E+ T Y  E NK              +G G  GSV        G  VAVK+L   
Sbjct: 18  SHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 77
Query: 303 YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV 362
           + +       + E+ L+  + H+N++ LL    T   SL   EF  N   L    +  D+
Sbjct: 78  FQSIIHAKRTYRELRLLKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADL 132
Query: 363 ------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
                 + L+ +    +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFG
Sbjct: 133 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 189
Query: 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           L R   +++T   A    T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 190 LARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 237

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 23/206 (11%)
Query: 271 FHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNL 327
           + +  K+G+G  G V+K      G+ VA+K+   +    V       E+ ++  + H NL
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD------VEPLSWEVRYKIILSTAEGL 381
           V LL          LV+E+  + ++L  L   Q       V+ ++W+        T + +
Sbjct: 65  VNLLEVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQ--------TLQAV 115
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
            + H+ +    IHRD+K  NIL+ +    K+ DFG  RL      +    +A T  Y +P
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA-TRWYRSP 171
Query: 442 EYVV-RGKLTEKADVYSFGVVVIEVV 466
           E +V   +     DV++ G V  E++
Sbjct: 172 ELLVGDTQYGPPVDVWAIGCVFAELL 197

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           +G G  GSV   Y   L   + VAVK+L   + +       + E+ L+  + H+N++ LL
Sbjct: 36  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 332 -----GCSITG-PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
                  SI    E  LV   +     L+N+   Q    LS E    ++     GL Y+H
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGAD--LNNIVKSQ---ALSDEHVQFLVYQLLRGLKYIH 148
Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                 IIHRD+K SN+ ++E+   +I DFGL R   E++T   A    T  Y APE ++
Sbjct: 149 SAG---IIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVA----TRWYRAPEIML 201
Query: 446 RG-KLTEKADVYSFGVVVIEVVCRK 469
                 +  D++S G ++ E++  K
Sbjct: 202 NWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/155 (28%), Positives = 78/155 (50%), Gaps = 17/155 (10%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR-YKI 373
           E+ ++  +NH  ++K+        +  +V E +    L D +   + ++  + ++  Y++
Sbjct: 190 EIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISA 430
           +L+    + YLHE     IIHRD+K  N+LL   +E+   KI DFG  ++  E  T +  
Sbjct: 249 LLA----VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMR 299
Query: 431 TLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVV 462
           TL GT  Y+APE +V           D +S GV++
Sbjct: 300 TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL ++H      +++RD+K +NILLDE    +I+D GL   F +   H S    GT GYM
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 357
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV--WDLYVKGRLHE 496
           APE + +G      AD +S G ++ +++  +  + F Q+       +    L +   L +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLL--RGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNP 556
           +  P L  +  EG   R +   L C+   A+     S   + L      LQ   PP + P
Sbjct: 416 SFSPELR-SLLEGLLQRDVNRRLGCLGRGAQ-EVKESPFFRSLDWQMVFLQKYPPPLIPP 473
Query: 557 NGS 559
            G 
Sbjct: 474 RGE 476

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 277 LGQGGSG---SVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           +G+G  G   S Y         VA+K++  +    +      E+ ++    H+N++ +  
Sbjct: 33  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 89
Query: 333 CSITGPESLLVYEFVPNQSLLD-NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
             I  P    + +    Q L++ +L+     + LS +     +     GL Y+H  +   
Sbjct: 90  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 146
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAPEYVVRGK- 448
           ++HRD+K SN+LL+     KI DFGL R+   D  H         T  Y APE ++  K 
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 449 LTEKADVYSFGVVVIEVVCRKRI 471
            T+  D++S G ++ E++  + I
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPI 229

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 83/183 (45%), Gaps = 13/183 (7%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           GL ++H      +++RD+K +NILLDE    +I+D GL   F +   H S    GT GYM
Sbjct: 304 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYM 357
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV--WDLYVKGRLHE 496
           APE + +G      AD +S G ++ +++  +  + F Q+       +    L +   L +
Sbjct: 358 APEVLQKGVAYDSSADWFSLGCMLFKLL--RGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNP 556
           +  P L  +  EG   R +   L C+   A+     S   + L      LQ   PP + P
Sbjct: 416 SFSPELR-SLLEGLLQRDVNRRLGCLGRGAQ-EVKESPFFRSLDWQMVFLQKYPPPLIPP 473
Query: 557 NGS 559
            G 
Sbjct: 474 RGE 476

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 104/223 (46%), Gaps = 28/223 (12%)
Query: 258 NFSYETLEKATNYFHESNKLGQG--GSGSVYKGTLPGGEAVA----VKRLFYNTTQWVDH 311
           N  ++++EK    +    K+G+G  G   + K T  G + V     + R+   +++  + 
Sbjct: 17  NLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM---SSKEREE 69
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR-----QDVEPLS 366
              EV +++ + H N+V+            +V ++     L   +  +     Q+ + L 
Sbjct: 70  SRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILD 129
Query: 367 WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
           W V  +I L+    L ++H+    +I+HRDIK  NI L ++ T ++ DFG+ R+    + 
Sbjct: 130 WFV--QICLA----LKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
              A + GT  Y++PE         K+D+++ G V+ E+   K
Sbjct: 181 LARACI-GTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLK 222

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/232 (28%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 260 SYETLEKATNYFHESNK--------------LGQGGSGSVYKG-TLPGGEAVAVKRLF-- 302
           S+ + E+ T Y  E NK              +G G  GSV        G  VAVK+L   
Sbjct: 19  SHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP 78
Query: 303 YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV 362
           + +       + E+ L+  + H+N++ LL    T   SL   EF  N   L    +  D+
Sbjct: 79  FQSIIHAKRTYRELRLLKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADL 133
Query: 363 ------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
                 + L+ +    +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFG
Sbjct: 134 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 190
Query: 417 LVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           L R   +++T   A    T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 191 LARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 40/209 (19%)
Query: 277 LGQGGSGSV---YKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           +G G  GSV   Y   L   + VAVK+L   + +       + E+ L+  + H+N++ LL
Sbjct: 28  VGSGAYGSVCSAYDARL--RQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 332 GCSITGPESLLVYEFVPNQSLLD-------NLFVRQDV------EPLSWEVRYKIILSTA 378
                         F P  S+ D          +  D+      + LS E    ++    
Sbjct: 86  DV------------FTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
            GL Y+H      IIHRD+K SN+ ++E+   +I DFGL R   E++T   A    T  Y
Sbjct: 134 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGYVA----TRWY 186
Query: 439 MAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
            APE ++      +  D++S G ++ E++
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAELL 215

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 141 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 198 VSPELLTEKSACKSSDLWALGCIIYQLVA 226

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 19/159 (11%)
Query: 313 FNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
             EV+++  ++ H N+++L     T     LV++ +    L D  ++ + V     E R 
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD--YLTEKVTLSEKETR- 127
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFP-EDITHIS 429
           KI+ +  E +  LH   KL I+HRD+K  NILLD++   K+ DFG   +L P E +  + 
Sbjct: 128 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV- 183
Query: 430 ATLAGTLGYMAPEYVV------RGKLTEKADVYSFGVVV 462
               GT  Y+APE +            ++ D++S GV++
Sbjct: 184 ---CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 219

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 277 LGQGGSG---SVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           +G+G  G   S Y         VA+K++  +    +      E+ ++    H+N++ +  
Sbjct: 39  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 95
Query: 333 CSITGPESLLVYEFVPNQSLLD-NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
             I  P    + +    Q L++ +L+     + LS +     +     GL Y+H  +   
Sbjct: 96  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 152
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAPEYVVRGK- 448
           ++HRD+K SN+LL+     KI DFGL R+   D  H         T  Y APE ++  K 
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 449 LTEKADVYSFGVVVIEVVCRKRI 471
            T+  D++S G ++ E++  + I
Sbjct: 213 YTKSIDIWSVGCILAEMLSNRPI 235

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 277 LGQGGSG---SVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           +G+G  G   S Y         VA+K++  +    +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 333 CSITGPESLLVYEFVPNQSLLD-NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
             I  P    + +    Q L++ +L+     + LS +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAPEYVVRGK- 448
           ++HRD+K SN+LL+     KI DFGL R+   D  H         T  Y APE ++  K 
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 449 LTEKADVYSFGVVVIEVVCRKRI 471
            T+  D++S G ++ E++  + I
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPI 227

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 80  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA-- 189
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 190 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 79/158 (50%), Gaps = 17/158 (10%)
Query: 313 FNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
             EV+++  ++ H N+++L     T     LV++ +    L D  ++ + V     E R 
Sbjct: 58  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFD--YLTEKVTLSEKETR- 114
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISA 430
           KI+ +  E +  LH   KL I+HRD+K  NILLD++   K+ DFG   +L P +      
Sbjct: 115 KIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLR--- 168
Query: 431 TLAGTLGYMAPEYVV------RGKLTEKADVYSFGVVV 462
            + GT  Y+APE +            ++ D++S GV++
Sbjct: 169 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIM 206

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 92/203 (45%), Gaps = 14/203 (6%)
Query: 277 LGQGGSG---SVYKGTLPGGEAVAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           +G+G  G   S Y         VA+K++  +    +      E+ ++    H+N++ +  
Sbjct: 31  IGEGAYGMVCSAYDNV--NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-N 87
Query: 333 CSITGPESLLVYEFVPNQSLLD-NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
             I  P    + +    Q L++ +L+     + LS +     +     GL Y+H  +   
Sbjct: 88  DIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN--- 144
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAPEYVVRGK- 448
           ++HRD+K SN+LL+     KI DFGL R+   D  H         T  Y APE ++  K 
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 449 LTEKADVYSFGVVVIEVVCRKRI 471
            T+  D++S G ++ E++  + I
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPI 227

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 30/89 (33%), Positives = 49/89 (55%), Gaps = 4/89 (4%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
            L YLH +    IIHRD+K  NILL+E+   +I DFG  + L PE     +    GT  Y
Sbjct: 126 ALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           ++PE +      + +D+++ G ++ ++V 
Sbjct: 183 VSPELLTEKSACKSSDLWALGCIIYQLVA 211

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 101/235 (42%), Gaps = 42/235 (17%)
Query: 260 SYETLEKATNYFHESNK--------------LGQGGSGSVYKG-TLPGGEAVAVKRLF-- 302
           S+ + E+ T Y  E NK              +G G  GSV        G  VAVK+L   
Sbjct: 19  SHMSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRP 78
Query: 303 YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV 362
           + +       + E+ L+  + H+N++ LL    T   SL   EF  N   L    +  D+
Sbjct: 79  FQSIIHAKRTYRELRLLKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADL 133
Query: 363 ------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG 416
                 + L+ +    +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFG
Sbjct: 134 NNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFG 190
Query: 417 LVRLFPEDITHISATLAG---TLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           L R       H    + G   T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 191 LAR-------HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 238

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL----------------LDNLFVRQDV 362
           +  + H+N++ LL              F P +SL                L+N+   Q +
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKXQKL 122
Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
                 V++ +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   
Sbjct: 123 T--DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD 176
Query: 423 EDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           +++T   A    T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 177 DEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 85/181 (46%), Gaps = 9/181 (4%)
Query: 296 VAVKRLF-YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLD 354
           VA+K++  +    +      E+ ++    H+N++ +    I  P    + +    Q L++
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGI-NDIIRAPTIEQMKDVYIVQDLME 129
Query: 355 -NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA 413
            +L+     + LS +     +     GL Y+H  +   ++HRD+K SN+LL+     KI 
Sbjct: 130 TDLYKLLKTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKIC 186
Query: 414 DFGLVRLFPEDITHIS--ATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKR 470
           DFGL R+   D  H         T  Y APE ++  K  T+  D++S G ++ E++  + 
Sbjct: 187 DFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246
Query: 471 I 471
           I
Sbjct: 247 I 247

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE------PLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+        L+ +    
Sbjct: 71  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCAKLTDDHVQF 125
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 180
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 181 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR-YK 372
            E+ ++  +NH  ++K+        +  +V E +    L D +   + ++  + ++  Y+
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHIS 429
           ++L+    + YLHE     IIHRD+K  N+LL   +E+   KI DFG  ++  E  T + 
Sbjct: 123 MLLA----VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLM 173
Query: 430 ATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVV 462
            TL GT  Y+APE +V           D +S GV++
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR-YK 372
            E+ ++  +NH  ++K+        +  +V E +    L D +   + ++  + ++  Y+
Sbjct: 63  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 121
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHIS 429
           ++L+    + YLHE     IIHRD+K  N+LL   +E+   KI DFG  ++  E  T + 
Sbjct: 122 MLLA----VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLM 172
Query: 430 ATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVV 462
            TL GT  Y+APE +V           D +S GV++
Sbjct: 173 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 208

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 134 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 225

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 141 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 232

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 86  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 140
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVA-- 195
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 196 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 142 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 233

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 133 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 224

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR-YK 372
            E+ ++  +NH  ++K+        +  +V E +    L D +   + ++  + ++  Y+
Sbjct: 70  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 128
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHIS 429
           ++L+    + YLHE     IIHRD+K  N+LL   +E+   KI DFG  ++  E  T + 
Sbjct: 129 MLLA----VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLM 179
Query: 430 ATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVV 462
            TL GT  Y+APE +V           D +S GV++
Sbjct: 180 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 215

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 134 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 225

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 82  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-- 191
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 192 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR-YK 372
            E+ ++  +NH  ++K+        +  +V E +    L D +   + ++  + ++  Y+
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHIS 429
           ++L+    + YLHE     IIHRD+K  N+LL   +E+   KI DFG  ++  E  T + 
Sbjct: 123 MLLA----VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLM 173
Query: 430 ATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVV 462
            TL GT  Y+APE +V           D +S GV++
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 7/101 (6%)
Query: 372 KIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
           + I  TA+   GL +LH+ +   II+RD+K  N+LLD++   +I+D GL        T  
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
               AGT G+MAPE ++  +     D ++ GV + E++  +
Sbjct: 347 KG-YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 78/156 (50%), Gaps = 17/156 (10%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR-YK 372
            E+ ++  +NH  ++K+        +  +V E +    L D +   + ++  + ++  Y+
Sbjct: 64  TEIEILKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQ 122
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHIS 429
           ++L+    + YLHE     IIHRD+K  N+LL   +E+   KI DFG  ++  E  T + 
Sbjct: 123 MLLA----VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLM 173
Query: 430 ATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVV 462
            TL GT  Y+APE +V           D +S GV++
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 209

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 140 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 7/101 (6%)
Query: 372 KIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
           + I  TA+   GL +LH+ +   II+RD+K  N+LLD++   +I+D GL        T  
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
               AGT G+MAPE ++  +     D ++ GV + E++  +
Sbjct: 347 KG-YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/95 (34%), Positives = 51/95 (53%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHIS--ATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H         T  
Sbjct: 141 GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 232

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 13  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 72
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 73  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 127
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 128 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 182
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 183 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 216

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 99/226 (43%), Gaps = 42/226 (18%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSL----------------LDNLFVRQDV 362
           +  + H+N++ LL              F P +SL                L+N+   Q +
Sbjct: 75  LKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKSQKL 122
Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
                 V++ +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   
Sbjct: 123 T--DDHVQF-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLCRHTD 176
Query: 423 EDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           +++T   A    T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 177 DEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 7/101 (6%)
Query: 372 KIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
           + I  TA+   GL +LH+ +   II+RD+K  N+LLD++   +I+D GL        T  
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
               AGT G+MAPE ++  +     D ++ GV + E++  +
Sbjct: 347 KG-YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/101 (32%), Positives = 55/101 (54%), Gaps = 7/101 (6%)
Query: 372 KIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
           + I  TA+   GL +LH+ +   II+RD+K  N+LLD++   +I+D GL        T  
Sbjct: 290 RAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
               AGT G+MAPE ++  +     D ++ GV + E++  +
Sbjct: 347 KG-YAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/92 (35%), Positives = 52/92 (56%), Gaps = 8/92 (8%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--ISATLAGT 435
           A GL +L  +    II+RD+KL N++LD E   KIADFG+ +   E+I     +    GT
Sbjct: 131 AIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKXFCGT 184
Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
             Y+APE +      +  D ++FGV++ E++ 
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 216

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 82  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-- 191
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 192 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 95/213 (44%), Gaps = 15/213 (7%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHFFNEVNL- 318
           E  E   +      +LG+G  G V K   +P G+  AVKR+     +Q       ++++ 
Sbjct: 27  ENFEVKADDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDIS 86
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF--VRQDVEPLSWEVRYKIILS 376
              ++    V   G      +  +  E     + LD  +  V    + +  ++  KI +S
Sbjct: 87  XRTVDCPFTVTFYGALFREGDVWICXEL--XDTSLDKFYKQVIDKGQTIPEDILGKIAVS 144
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
             + L +LH  SKL +IHRD+K SN+L++     K  DFG+     +D+       AG  
Sbjct: 145 IVKALEHLH--SKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVA--KDIDAGCK 200
Query: 437 GYMAPEYV----VRGKLTEKADVYSFGVVVIEV 465
            Y APE +     +   + K+D++S G+  IE+
Sbjct: 201 PYXAPERINPELNQKGYSVKSDIWSLGITXIEL 233

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 87  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 196
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 197 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 86
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 87  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 196
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 197 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 82  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVA-- 191
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 192 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 26  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 85
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 86  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 140
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 141 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 195
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 196 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 229

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 11  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 71  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 125
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 126 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 180
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 181 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 214

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 27  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRL 86
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 87  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 141
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 142 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 196
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 197 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 230

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 72  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 126
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 181
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 182 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 77  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 186
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 187 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 80  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 189
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 190 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 14  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 73
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 74  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 128
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 129 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 183
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 184 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 217

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 77  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 186
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 187 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 12  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 71
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 72  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 126
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 127 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 181
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 182 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 215

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 20  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 79
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 80  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 134
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 135 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 189
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 190 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 223

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 16/170 (9%)
Query: 296 VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
           +  KR+  NT + +      + L  G  H N+VKL         + LV E +    L + 
Sbjct: 43  IISKRMEANTQKEI----TALKLCEG--HPNIVKLHEVFHDQLHTFLVMELLNGGELFER 96
Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKI 412
           +  ++       E  Y I+      ++++H+   + ++HRD+K  N+L  +E      KI
Sbjct: 97  IKKKKHFS--ETEASY-IMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKI 150
Query: 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
            DFG  RL P D   +  T   TL Y APE + +    E  D++S GV++
Sbjct: 151 IDFGFARLKPPDNQPLK-TPCFTLHYAAPELLNQNGYDESCDLWSLGVIL 199

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 98  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 207
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 208 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 22  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 81
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 82  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 136
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 137 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 191
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 192 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 77  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 186
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 187 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 17  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 76
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 77  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 131
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 132 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVA-- 186
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 187 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 220

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 103/234 (44%), Gaps = 36/234 (15%)
Query: 258 NFSYETLEKATNYFHESNK--------------LGQGGSGSVYKG-TLPGGEAVAVKRLF 302
           +  + + E+ T Y  E NK              +G G  GSV        G  VAVK+L 
Sbjct: 3   HHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLS 62
Query: 303 --YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ 360
             + +       + E+ L+  + H+N++ LL    T   SL   EF  N   L    +  
Sbjct: 63  RPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGA 117
Query: 361 DV------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD 414
           D+      + L+ +    +I     GL Y+H      IIHRD+K SN+ ++E+   KI D
Sbjct: 118 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILD 174
Query: 415 FGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           FGL R   +++T   A    T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 175 FGLARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 81  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVA-- 190
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 191 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 21  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 80
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 81  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 135
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++T   A  
Sbjct: 136 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-- 190
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 191 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 224

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPAFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/281 (22%), Positives = 118/281 (41%), Gaps = 49/281 (17%)
Query: 276 KLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC- 333
           KL +  SG ++KG   G +  V V ++   +T+    F  E   +   +H N++ +LG  
Sbjct: 17  KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 334 -SITGPESLLVYEFVPNQSLLD------NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
            S   P   L+  ++P  SL +      N  V Q           K  L  A G+A+LH 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQA-------VKFALDMARGMAFLHT 129
Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
              L I    +   ++++DE+ TA+I+           +  +  +        AP +V  
Sbjct: 130 LEPL-IPRHALNSRSVMIDEDMTARIS-----------MADVKFSFQSPGRMYAPAWVAP 177
Query: 447 GKLTEK--------ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV 498
             L +K        AD++SF V++ E+V R+          S ++    + ++G L   +
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTRE----VPFADLSNMEIGMKVALEG-LRPTI 232
Query: 499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
            P ++ +      S+L++I   C+      RP   ++V +L
Sbjct: 233 PPGISPHV-----SKLMKI---CMNEDPAKRPKFDMIVPIL 265

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 103/233 (44%), Gaps = 36/233 (15%)
Query: 259 FSYETLEKATNYFHESNK--------------LGQGGSGSVYKG-TLPGGEAVAVKRLF- 302
           F+    E+ T Y  E NK              +G G  GSV     +  G  +AVK+L  
Sbjct: 27  FTMSHKERPTFYRQELNKTIWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSR 86
Query: 303 -YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD 361
            + +       + E+ L+  + H+N++ LL   +  P + L  EF  N   L    +  D
Sbjct: 87  PFQSIIHAKRTYRELRLLKHMKHENVIGLL--DVFTPATSLE-EF--NDVYLVTHLMGAD 141
Query: 362 V------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
           +      + L+ +    +I     GL Y+H      IIHRD+K SN+ ++E+   KI DF
Sbjct: 142 LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDF 198
Query: 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
           GL R   +++T   A    T  Y APE ++         D++S G ++ E++ 
Sbjct: 199 GLARHTDDEMTGYVA----TRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 99/203 (48%), Gaps = 17/203 (8%)
Query: 267 ATNYFHESNK---LGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI 322
           A N F+  +K   LG G  G V+K      G  +A K +     +  +   NE+++++ +
Sbjct: 84  AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL 143
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGL 381
           +H NL++L     +  + +LV E+V    L D +     ++  L   +  K I    EG+
Sbjct: 144 DHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI---CEGI 200
Query: 382 AYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLF-PEDITHISATLAGTLGY 438
            ++H+   + I+H D+K  NIL    +    KI DFGL R + P +   ++    GT  +
Sbjct: 201 RHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVN---FGTPEF 254
Query: 439 MAPEYVVRGKLTEKADVYSFGVV 461
           +APE V    ++   D++S GV+
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVI 277

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 75/152 (49%), Gaps = 18/152 (11%)
Query: 275 NKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLG 332
           +KLG+G   +VYKG +      VA+K +     +        EV+L+  + H N+V L  
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 333 CSITGPESLLVYEFVPN---QSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
              T     LV+E++     Q L D  N+    +V+   +++          GLAY H +
Sbjct: 68  IIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQL--------LRGLAYCHRQ 119
Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR 419
              +++HRD+K  N+L++E    K+ADFGL R
Sbjct: 120 ---KVLHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 53/95 (55%), Gaps = 6/95 (6%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PE-DITHISATLAGTLG 437
           GL Y+H  +   ++HRD+K SN+L++     KI DFGL R+  PE D T        T  
Sbjct: 156 GLKYIHSAN---VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 438 YMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRI 471
           Y APE ++  K  T+  D++S G ++ E++  + I
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 247

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/279 (23%), Positives = 113/279 (40%), Gaps = 38/279 (13%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT 336
           +G+G  G VY G   G  A+ +  +  +    +  F  EV       H+N+V  +G  ++
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD 396
            P   ++      ++L     VR     L      +I     +G+ YLH +    I+H+D
Sbjct: 101 PPHLAIITSLCKGRTLYS--VVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 397 IKLSNILLDEEFTAKIADFGLVRL-------FPEDITHISATLAGTLGYMAPEYVV---- 445
           +K  N+  D      I DFGL  +         ED   I     G L ++APE +     
Sbjct: 156 LKSKNVFYDNGKVV-ITDFGLFSISGVLQAGRREDKLRIQ---NGWLCHLAPEIIRQLSP 211
Query: 446 -----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP 500
                +   ++ +DV++ G +  E+  R+     TQ + +I   +W +         + P
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHARE-WPFKTQPAEAI---IWQMGT------GMKP 261
Query: 501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
            L+   Q G    +  I L C     E RP+ + ++ ML
Sbjct: 262 NLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 119
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 120 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 174
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 205

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 63  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 119
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 120 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 174
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 175 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 205

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 99/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI D+GL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 28/219 (12%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 38  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 97
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 98  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 152
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R       H    +
Sbjct: 153 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEM 202
Query: 433 AG---TLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
            G   T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 203 XGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 241

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 22/228 (9%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
           YE  E+     H+  +LG+G  G V++      G   AVK++     +       E+   
Sbjct: 86  YEYREEVHWATHQL-RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-----AEELMAC 139
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA- 378
           +G+    +V L G    GP   +  E +   SL   L   Q   P   E R    L  A 
Sbjct: 140 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLP---EDRALYYLGQAL 195
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFT-AKIADFG-LVRLFPEDITHISAT---LA 433
           EGL YLH     RI+H D+K  N+LL  + + A + DFG  V L P+ +     T   + 
Sbjct: 196 EGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP 252
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSC 479
           GT  +MAPE V+      K DV+S   +++ ++  C      F    C
Sbjct: 253 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLC 300

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 71/151 (47%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  I H N++ L        + +L+ E V    L D L    + E L+ E   + +
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL---AEKESLTEEEATEFL 120
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
                G+ YLH    L+I H D+K  NI LLD        KI DFGL      D  +   
Sbjct: 121 KQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFK 175
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 33/214 (15%)
Query: 271 FHESNKLGQGGSGSVYKGT---------LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG 321
           F+ES  LGQG    ++KG          L   E V +K L      + + FF   +++S 
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETE-VLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
           ++HK+LV   G  + G E++LV EFV   SL   L   ++   + W++  ++    A  +
Sbjct: 69  LSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKL--EVAKQLAAAM 126
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL---------FPEDITHISATL 432
            +L E +   +IH ++   NILL  E   K  +   ++L          P+DI      L
Sbjct: 127 HFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI------L 177
Query: 433 AGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEV 465
              + ++ PE +   K L    D +SFG  + E+
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 6/97 (6%)
Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
           +  +  T   LA+LH +    ++H D+K +NI L      K+ DFGL  L          
Sbjct: 160 WGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGE 214
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
              G   YMAPE +++G     ADV+S G+ ++EV C
Sbjct: 215 VQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVAC 250

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 13/152 (8%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           E  +   + H N+V+L           LV++ V    L +++  R   E  S       I
Sbjct: 78  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCI 134
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGL-VRLFPEDITHISA 430
               E +AY H      I+HR++K  N+LL  +      K+ADFGL + +   +  H   
Sbjct: 135 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 188
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
             AGT GY++PE + +   ++  D+++ GV++
Sbjct: 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 220

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
           F+ E ++++  N   +V+L           +V E++P   L+ NL    DV P  W   Y
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDV-PEKWARFY 173
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
                TAE +  L     +  IHRD+K  N+LLD+    K+ADFG      ++      T
Sbjct: 174 -----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 228
Query: 432 LAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVVC 467
             GT  Y++PE +      G    + D +S GV + E++ 
Sbjct: 229 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
           F+ E ++++  N   +V+L           +V E++P   L+ NL    DV P  W   Y
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDV-PEKWARFY 178
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
                TAE +  L     +  IHRD+K  N+LLD+    K+ADFG      ++      T
Sbjct: 179 -----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 432 LAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVVC 467
             GT  Y++PE +      G    + D +S GV + E++ 
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 90/205 (43%), Gaps = 28/205 (13%)
Query: 277 LGQGGSGS-VYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCS 334
           LG G  G+ VY+G     + VAVKR+      + D    EV L+   + H N+++     
Sbjct: 32  LGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFAD---REVQLLRESDEHPNVIRYFCTE 87
Query: 335 ITGPESLLVYEFVP---NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                  +  E       + +    F    +EP++      ++  T  GLA+LH    L 
Sbjct: 88  KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPIT------LLQQTTSGLAHLH---SLN 138
Query: 392 IIHRDIKLSNILLDE-----EFTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAPEYV 444
           I+HRD+K  NIL+       +  A I+DFGL +         S  + + GT G++APE +
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 445 ---VRGKLTEKADVYSFGVVVIEVV 466
               +   T   D++S G V   V+
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVI 223

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 98/228 (42%), Gaps = 22/228 (9%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
           YE  E+     H+  +LG+G  G V++      G   AVK++     +       E+   
Sbjct: 67  YEYREEVHWATHQL-RLGRGSFGEVHRMEDKQTGFQCAVKKVRLEVFR-----AEELMAC 120
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA- 378
           +G+    +V L G    GP   +  E +   SL   L   Q   P   E R    L  A 
Sbjct: 121 AGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLVKEQGCLP---EDRALYYLGQAL 176
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFT-AKIADFG-LVRLFPEDITHISAT---LA 433
           EGL YLH     RI+H D+K  N+LL  + + A + DFG  V L P+ +     T   + 
Sbjct: 177 EGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIP 233
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSC 479
           GT  +MAPE V+      K DV+S   +++ ++  C      F    C
Sbjct: 234 GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLC 281

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/160 (28%), Positives = 73/160 (45%), Gaps = 11/160 (6%)
Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
           F+ E ++++  N   +V+L           +V E++P   L+ NL    DV P  W   Y
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDV-PEKWARFY 178
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
                TAE +  L     +  IHRD+K  N+LLD+    K+ADFG      ++      T
Sbjct: 179 -----TAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDT 233
Query: 432 LAGTLGYMAPEYVVR----GKLTEKADVYSFGVVVIEVVC 467
             GT  Y++PE +      G    + D +S GV + E++ 
Sbjct: 234 AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 273

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI DF L R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 13/152 (8%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           E  +   + H N+V+L           LV++ V    L +++  R   E  S       I
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCI 111
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGL-VRLFPEDITHISA 430
               E +AY H      I+HR++K  N+LL  +      K+ADFGL + +   +  H   
Sbjct: 112 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 165
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
             AGT GY++PE + +   ++  D+++ GV++
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 13/152 (8%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           E  +   + H N+V+L           LV++ V    L +++  R   E  S       I
Sbjct: 54  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCI 110
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGL-VRLFPEDITHISA 430
               E +AY H      I+HR++K  N+LL  +      K+ADFGL + +   +  H   
Sbjct: 111 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 164
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
             AGT GY++PE + +   ++  D+++ GV++
Sbjct: 165 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 196

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 13/152 (8%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           E  +   + H N+V+L           LV++ V    L +++  R   E  S       I
Sbjct: 55  EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCI 111
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGL-VRLFPEDITHISA 430
               E +AY H      I+HR++K  N+LL  +      K+ADFGL + +   +  H   
Sbjct: 112 QQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH--- 165
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
             AGT GY++PE + +   ++  D+++ GV++
Sbjct: 166 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVIL 197

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI  FGL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 70/153 (45%), Gaps = 8/153 (5%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYK 372
            E ++   + H ++V+LL    +     +V+EF+    L   +  R D   +  E V   
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHIS 429
            +    E L Y H+ +   IIHRD+K  N+LL   +     K+ DFG+     E    ++
Sbjct: 135 YMRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGES-GLVA 190
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
               GT  +MAPE V R    +  DV+  GV++
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 77/152 (50%), Gaps = 18/152 (11%)
Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           H +++ L+    +     LV++ +    L D  ++ + V     E R  I+ S  E +++
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFD--YLTEKVALSEKETR-SIMRSLLEAVSF 215
Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPE 442
           LH  +   I+HRD+K  NILLD+    +++DFG    L P +       L GT GY+APE
Sbjct: 216 LHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLR---ELCGTPGYLAPE 269
Query: 443 YVVRGKLTE-------KADVYSFGVVVIEVVC 467
            +++  + E       + D+++ GV++  ++ 
Sbjct: 270 -ILKCSMDETHPGYGKEVDLWACGVILFTLLA 300

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  + H N++ L        + +L+ E V    L D  F+ Q  E LS E     I
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFD--FLAQK-ESLSEEEATSFI 121
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
               +G+ YLH +   +I H D+K  NI LLD+       K+ DFGL     + +     
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--K 176
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI D GL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 22/228 (9%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
           YE  E+     H+  +LG+G  G V++      G   AVK++     +       E+   
Sbjct: 65  YEYREEVHWMTHQP-RLGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVAC 118
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA- 378
           +G++   +V L G    GP   +  E +   SL   L  +    P   E R    L  A 
Sbjct: 119 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLP---EDRALYYLGQAL 174
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFT-AKIADFG-LVRLFPEDITHISAT---LA 433
           EGL YLH     RI+H D+K  N+LL  + + A + DFG  + L P+ +     T   + 
Sbjct: 175 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 231
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSC 479
           GT  +MAPE V+      K D++S   +++ ++  C      F    C
Sbjct: 232 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 279

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           AE +  +    +L  +HRDIK  NIL+D     ++ADFG      ED T  S+   GT  
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241
Query: 438 YMAPEYVV-----RGKLTEKADVYSFGVVVIEVV 466
           Y++PE +      +G+   + D +S GV + E++
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEML 275

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI D GL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  + H N++ L        + +L+ E V    L D  F+ Q  E LS E     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD--FLAQK-ESLSEEEATSFI 121
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
               +G+ YLH +   +I H D+K  NI LLD+       K+ DFGL     + +     
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--K 176
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 96/215 (44%), Gaps = 35/215 (16%)
Query: 271 FHESNKLGQGGSGSVYKGT---------LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG 321
           F+ES  LGQG    ++KG          L   E V +K L      + + FF   +++S 
Sbjct: 12  FNES--LGQGTFTKIFKGVRREVGDYGQLHETE-VLLKVLDKAHRNYSESFFEAASMMSK 68
Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
           ++HK+LV   G    G E++LV EFV   SL   L   ++   + W+      L  A+ L
Sbjct: 69  LSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWK------LEVAKQL 122
Query: 382 AY-LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL---------FPEDITHISAT 431
           A+ +H   +  +IH ++   NILL  E   K  +   ++L          P+DI      
Sbjct: 123 AWAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI------ 176
Query: 432 LAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEV 465
           L   + ++ PE +   K L    D +SFG  + E+
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEI 211

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  + H N++ L        + +L+ E V    L D  F+ Q  E LS E     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD--FLAQK-ESLSEEEATSFI 121
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
               +G+ YLH +   +I H D+K  NI LLD+       K+ DFGL     + +     
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--K 176
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  + H N++ L        + +L+ E V    L D  F+ Q  E LS E     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD--FLAQK-ESLSEEEATSFI 121
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
               +G+ YLH +   +I H D+K  NI LLD+       K+ DFGL     + +     
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--K 176
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  + H N++ L        + +L+ E V    L D  F+ Q  E LS E     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD--FLAQK-ESLSEEEATSFI 121
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
               +G+ YLH +   +I H D+K  NI LLD+       K+ DFGL     + +     
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--K 176
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EVN++  I H N++ L        + +L+ E V    L D L    + E L+ +   + +
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFL 114
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEF---TAKIADFGLVRLFPEDITHISA 430
               +G+ YLH +   RI H D+K  NI LLD+       K+ DFG+      +  +   
Sbjct: 115 KQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFK 169
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 170 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 94/208 (45%), Gaps = 19/208 (9%)
Query: 265 EKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVK----RLFYNTTQWV--DHFFNEVN 317
           E   +++    +LG G    V K    G G+  A K    R   ++ + V  +    EVN
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
           ++  I H N++ L        + +L+ E V    L D L    + E L+ +   + +   
Sbjct: 68  ILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFLKQI 124
Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA----KIADFGLVRLFPEDITHISATLA 433
            +G+ YLH +   RI H D+K  NI+L ++       K+ DFG+      +  +    + 
Sbjct: 125 LDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFKNIF 179
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVV 461
           GT  ++APE V    L  +AD++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EVN++  I H N++ L        + +L+ E V    L D L    + E L+ +   + +
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFL---AEKESLTEDEATQFL 135
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEF---TAKIADFGLVRLFPEDITHISA 430
               +G+ YLH +   RI H D+K  NI LLD+       K+ DFG+      +  +   
Sbjct: 136 KQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI--EAGNEFK 190
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 191 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 221

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 98/216 (45%), Gaps = 22/216 (10%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLF--YNTTQWVDHFFNEVNL 318
           +T+ +    +   + +G G  GSV        G  VAVK+L   + +       + E+ L
Sbjct: 15  KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 74
Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV------EPLSWEVRYK 372
           +  + H+N++ LL    T   SL   EF  N   L    +  D+      + L+ +    
Sbjct: 75  LKHMKHENVIGLLDV-FTPARSL--EEF--NDVYLVTHLMGADLNNIVKCQKLTDDHVQF 129
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
           +I     GL Y+H      IIHRD+K SN+ ++E+   KI D GL R   +++T   A  
Sbjct: 130 LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMTGYVA-- 184
Query: 433 AGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVC 467
             T  Y APE ++      +  D++S G ++ E++ 
Sbjct: 185 --TRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLT 218

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 91/225 (40%), Gaps = 30/225 (13%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAV-------KRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
           ++G+G   +VYKG L     V V       ++L  +  Q    F  E   + G+ H N+V
Sbjct: 33  EIGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQ---RFKEEAEXLKGLQHPNIV 88
Query: 329 KLLGC---SITGPESLLVYEFVPNQSLLDNLFVRQDVEPL----SWEVRYKIILSTAEGL 381
           +       ++ G + +++   +     L     R  V  +    SW           +GL
Sbjct: 89  RFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSW------CRQILKGL 142
Query: 382 AYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
            +LH  +   IIHRD+K  NI +     + KI D GL  L        +  + GT  + A
Sbjct: 143 QFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFXA 198
Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV 485
           PE     K  E  DVY+FG   +E    +      QN+  I + V
Sbjct: 199 PE-XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRV 242

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 12/151 (7%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  + H N++ L        + +L+ E V    L D  F+ Q  E LS E     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFD--FLAQK-ESLSEEEATSFI 121
Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNI-LLDEEFTA---KIADFGLVRLFPEDITHISA 430
               +G+ YLH +   +I H D+K  NI LLD+       K+ DFGL     + +     
Sbjct: 122 KQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--K 176
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y   L     
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRS 168
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P ++++I +     
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRY--- 221
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             Y APE +      T   DV+S G V+ E++
Sbjct: 222 --YRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 41/218 (18%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ------WVDHFF-----NEVNLISGINHK 325
           +  G  G+V  G    G  VA+KR+F   +         D F       E+ L++  +H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR------------YKI 373
           N++ L    +   E  +      ++  L    +R D+  +  + R            Y I
Sbjct: 90  NILGLRDIFVHFEEPAM------HKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
           +L    GL  LHE     ++HRD+   NILL +     I DF L R   ED    + T  
Sbjct: 144 LL----GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHY 193
Query: 434 GT-LGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRK 469
            T   Y APE V++ K  T+  D++S G V+ E+  RK
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 114
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y   L     
Sbjct: 115 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRS 172
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P ++++I +     
Sbjct: 173 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRY--- 225
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             Y APE +      T   DV+S G V+ E++
Sbjct: 226 --YRAPELIFGATDYTSSIDVWSAGCVLAELL 255

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 112
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y   L     
Sbjct: 113 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRS 170
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P ++++I +     
Sbjct: 171 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRY--- 223
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             Y APE +      T   DV+S G V+ E++
Sbjct: 224 --YRAPELIFGATDYTSSIDVWSAGCVLAELL 253

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 60/218 (27%), Positives = 92/218 (42%), Gaps = 41/218 (18%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ------WVDHFF-----NEVNLISGINHK 325
           +  G  G+V  G    G  VA+KR+F   +         D F       E+ L++  +H 
Sbjct: 30  ISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHP 89
Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR------------YKI 373
           N++ L    +   E  +      ++  L    +R D+  +  + R            Y I
Sbjct: 90  NILGLRDIFVHFEEPAM------HKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHI 143
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
           +L    GL  LHE     ++HRD+   NILL +     I DF L R   ED    + T  
Sbjct: 144 LL----GLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR---EDTADANKTHY 193
Query: 434 GT-LGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRK 469
            T   Y APE V++ K  T+  D++S G V+ E+  RK
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 104
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y   L     
Sbjct: 105 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRS 162
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P ++++I +     
Sbjct: 163 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRY--- 215
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             Y APE +      T   DV+S G V+ E++
Sbjct: 216 --YRAPELIFGATDYTSSIDVWSAGCVLAELL 245

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 155
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y   L     
Sbjct: 156 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRS 213
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P ++++I +     
Sbjct: 214 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRY--- 266
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRI 471
             Y APE +      T   DV+S G V+ E++  + I
Sbjct: 267 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 301

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 22/228 (9%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
           YE  E+     H+  ++G+G  G V++      G   AVK++     +       E+   
Sbjct: 51  YEYREEVHWMTHQP-RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVAC 104
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA- 378
           +G++   +V L G    GP   +  E +   SL   L  +    P   E R    L  A 
Sbjct: 105 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLP---EDRALYYLGQAL 160
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFT-AKIADFG-LVRLFPEDITHISAT---LA 433
           EGL YLH     RI+H D+K  N+LL  + + A + DFG  + L P+ +     T   + 
Sbjct: 161 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSC 479
           GT  +MAPE V+      K D++S   +++ ++  C      F    C
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 32/217 (14%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 81
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y   L     
Sbjct: 82  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRS 139
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P ++++I +     
Sbjct: 140 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRY--- 192
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRI 471
             Y APE +      T   DV+S G V+ E++  + I
Sbjct: 193 --YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 227

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 13/201 (6%)
Query: 268 TNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGINH 324
           T+ +    +LG+G    V +   +P G+  A K +        DH     E  +   + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            N+V+L           LV++ V    L +++  R   E  S       I    E + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR---EYYSEADASHCIQQILESVNHC 119
Query: 385 HEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
           H      I+HRD+K  N+LL  +      K+ADFGL      D        AGT GY++P
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD-QQAWFGFAGTPGYLSP 175
Query: 442 EYVVRGKLTEKADVYSFGVVV 462
           E + +    +  D+++ GV++
Sbjct: 176 EVLRKDPYGKPVDMWACGVIL 196

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 89
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 90  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 147
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P ++++I +     
Sbjct: 148 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRY--- 200
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             Y APE +      T   DV+S G V+ E++
Sbjct: 201 --YRAPELIFGATDYTSSIDVWSAGCVLAELL 230

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 99/228 (43%), Gaps = 22/228 (9%)
Query: 261 YETLEKATNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLI 319
           YE  E+     H+  ++G+G  G V++      G   AVK++     +       E+   
Sbjct: 67  YEYREEVHWMTHQP-RVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-----VEELVAC 120
Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA- 378
           +G++   +V L G    GP   +  E +   SL   L  +    P   E R    L  A 
Sbjct: 121 AGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-GQLIKQMGCLP---EDRALYYLGQAL 176
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFT-AKIADFG-LVRLFPEDITHISAT---LA 433
           EGL YLH     RI+H D+K  N+LL  + + A + DFG  + L P+ +     T   + 
Sbjct: 177 EGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 233
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSC 479
           GT  +MAPE V+      K D++S   +++ ++  C      F    C
Sbjct: 234 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 281

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/201 (25%), Positives = 85/201 (42%), Gaps = 13/201 (6%)
Query: 268 TNYFHESNKLGQGGSGSVYK-GTLPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGINH 324
           T+ +    +LG+G    V +   +P G+  A K +        DH     E  +   + H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            N+V+L           LV++ V    L +++  R   E  S       I    E + + 
Sbjct: 63  PNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR---EYYSEADASHCIQQILESVNHC 119
Query: 385 HEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
           H      I+HRD+K  N+LL  +      K+ADFGL      D        AGT GY++P
Sbjct: 120 HLNG---IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGD-QQAWFGFAGTPGYLSP 175
Query: 442 EYVVRGKLTEKADVYSFGVVV 462
           E + +    +  D+++ GV++
Sbjct: 176 EVLRKDPYGKPVDMWACGVIL 196

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 32/212 (15%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P ++++I +     
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRY--- 187
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             Y APE +      T   DV+S G V+ E++
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 110
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y   L     
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRS 168
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P +++ I +     
Sbjct: 169 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSXICSRY--- 221
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             Y APE +      T   DV+S G V+ E++
Sbjct: 222 --YRAPELIFGATDYTSSIDVWSAGCVLAELL 251

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 47/194 (24%), Positives = 84/194 (43%), Gaps = 13/194 (6%)
Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLVKLL 331
            +LG+G    V +   +  G+  A K +        DH     E  +   + H N+V+L 
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLH 87
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                     L+++ V    L +++  R   E  S       I    E + + H+   + 
Sbjct: 88  DSISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQ---MG 141
Query: 392 IIHRDIKLSNILLDEEF---TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
           ++HRD+K  N+LL  +      K+ADFGL  +  E         AGT GY++PE + +  
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 449 LTEKADVYSFGVVV 462
             +  D+++ GV++
Sbjct: 201 YGKPVDLWACGVIL 214

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 83/177 (46%), Gaps = 24/177 (13%)
Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP-LSWEVRYKI 373
           E+ ++S + H N++K+L          LV E   + S LD LF   D  P L   +   I
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVME--KHGSGLD-LFAFIDRHPRLDEPLASYI 135
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
                  + YL  +    IIHRDIK  NI++ E+FT K+ DFG       +   +  T  
Sbjct: 136 FRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL--ERGKLFYTFC 190
Query: 434 GTLGYMAPEYVV----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS-CSILQTV 485
           GT+ Y APE ++    RG    + +++S GV +  +V       F +N  C + +TV
Sbjct: 191 GTIEYCAPEVLMGNPYRGP---ELEMWSLGVTLYTLV-------FEENPFCELEETV 237

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 84
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 85  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 142
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITHISATLAGTLGYM 439
           LAY+H      I HRDIK  N+LLD +    K+ DFG  +       ++S   +    Y 
Sbjct: 143 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YR 197
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVV 466
           APE +      T   DV+S G V+ E++
Sbjct: 198 APELIFGATDYTSSIDVWSAGCVLAELL 225

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 88
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 146
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P +++ I +     
Sbjct: 147 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSXICSRY--- 199
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             Y APE +      T   DV+S G V+ E++
Sbjct: 200 --YRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 95
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 96  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 153
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITHISATLAGTLGYM 439
           LAY+H      I HRDIK  N+LLD +    K+ DFG  +       ++S   +    Y 
Sbjct: 154 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YR 208
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVV 466
           APE +      T   DV+S G V+ E++
Sbjct: 209 APELIFGATDYTSSIDVWSAGCVLAELL 236

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 69/152 (45%), Gaps = 10/152 (6%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
            E  +   + H N+V+L           LV++ V    L +++  R   E  S       
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR---EYYSEADASHC 135
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHISA 430
           I    E + ++H+     I+HRD+K  N+LL  +      K+ADFGL  +  +       
Sbjct: 136 IHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWF 191
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
             AGT GY++PE + +    +  D+++ GV++
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVIL 223

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 88
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 89  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 146
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P +++ I +     
Sbjct: 147 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSXICSRY--- 199
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             Y APE +      T   DV+S G V+ E++
Sbjct: 200 --YRAPELIFGATDYTSSIDVWSAGCVLAELL 229

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++          F N E+ ++  ++H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIV 76
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P ++++I +     
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRY--- 187
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             Y APE +      T   DV+S G V+ E++
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 42/214 (19%)
Query: 296 VAVKRLFYNTTQWVD--HFFNEVNLISGINHKNLVKLLGCSITGPESLLVY-EFVPNQSL 352
           VA+K++       +D      E+ +++ +NH ++VK+L   I  P+ +  + E      +
Sbjct: 81  VAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVI--PKDVEKFDELYVVLEI 138
Query: 353 LDNLFVRQDVEPLSW-EVRYKIIL-STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA 410
            D+ F +    P+   E+  K +L +   G+ Y+H      I+HRD+K +N L++++ + 
Sbjct: 139 ADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSV 195
Query: 411 KIADFGLVRL--FPED---------------------ITHISATLAG---TLGYMAPEYV 444
           K+ DFGL R   +PE+                       ++   L G   T  Y APE +
Sbjct: 196 KVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI 255
Query: 445 -VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN 477
            ++   TE  DV+S G +  E+     +N+  +N
Sbjct: 256 LLQENYTEAIDVWSIGCIFAEL-----LNMIKEN 284

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 80
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 81  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 138
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITHISATLAGTLGYM 439
           LAY+H      I HRDIK  N+LLD +    K+ DFG  +       ++S   +    Y 
Sbjct: 139 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YR 193
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVV 466
           APE +      T   DV+S G V+ E++
Sbjct: 194 APELIFGATDYTSSIDVWSAGCVLAELL 221

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 97/212 (45%), Gaps = 32/212 (15%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++          F N E+ ++  ++H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIV 76
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFG----LVRLFPEDITHISATLAGT 435
           LAY+H      I HRDIK  N+LLD +    K+ DFG    LVR  P ++++I +     
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP-NVSYICSRY--- 187
Query: 436 LGYMAPEYVVRG-KLTEKADVYSFGVVVIEVV 466
             Y APE +      T   DV+S G V+ E++
Sbjct: 188 --YRAPELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITHISATLAGTLGYM 439
           LAY+H      I HRDIK  N+LLD +    K+ DFG  +       ++S   +    Y 
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YR 189
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVV 466
           APE +      T   DV+S G V+ E++
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 77  RLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITHISATLAGTLGYM 439
           LAY+H      I HRDIK  N+LLD +    K+ DFG  +       ++S   +    Y 
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YR 189
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVV 466
           APE +      T   DV+S G V+ E++
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 77
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 78  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 135
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITHISATLAGTLGYM 439
           LAY+H      I HRDIK  N+LLD +    K+ DFG  +       ++S   +    Y 
Sbjct: 136 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YR 190
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVV 466
           APE +      T   DV+S G V+ E++
Sbjct: 191 APELIFGATDYTSSIDVWSAGCVLAELL 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 93/208 (44%), Gaps = 24/208 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIV 76
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITHISATLAGTLGYM 439
           LAY+H      I HRDIK  N+LLD +    K+ DFG  +       ++S   +    Y 
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YR 189
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVV 466
           APE +      T   DV+S G V+ E++
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 44/83 (53%), Gaps = 5/83 (6%)
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV--- 445
           +L  +HRDIK  N+LLD     ++ADFG      +D T  S+   GT  Y++PE +    
Sbjct: 209 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAME 268
Query: 446 --RGKLTEKADVYSFGVVVIEVV 466
              GK   + D +S GV + E++
Sbjct: 269 DGMGKYGPECDWWSLGVCMYEML 291

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 44/83 (53%), Gaps = 5/83 (6%)
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV--- 445
           +L  +HRDIK  N+LLD     ++ADFG      +D T  S+   GT  Y++PE +    
Sbjct: 193 QLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAME 252
Query: 446 --RGKLTEKADVYSFGVVVIEVV 466
              GK   + D +S GV + E++
Sbjct: 253 DGMGKYGPECDWWSLGVCMYEML 275

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 68/152 (44%), Gaps = 10/152 (6%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
            E  +   + H N+V+L           LV++ V    L +++  R   E  S       
Sbjct: 52  REARICRLLKHSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAR---EYYSEADASHC 108
Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHISA 430
           I    E + + H+   + ++HRD+K  N+LL  +      K+ADFGL      D      
Sbjct: 109 IQQILEAVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGD-QQAWF 164
Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
             AGT GY++PE + +    +  D+++ GV++
Sbjct: 165 GFAGTPGYLSPEVLRKEAYGKPVDIWACGVIL 196

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 19/209 (9%)
Query: 263 TLEKATNYFHESNKLGQGGSGSVYK--GTLPGGEAVAV----KRLFYNTTQWVDHFFNEV 316
           T  + T  +    +LG+G    V +    L G E  A+    K+L     Q ++    E 
Sbjct: 5   TCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLE---REA 61
Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
            +   + H N+V+L           L+++ V    L +++  R   E  S       I  
Sbjct: 62  RICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQ 118
Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGLVRLFPEDITHISATLA 433
             E + + H+   + ++HR++K  N+LL  +      K+ADFGL  +  E         A
Sbjct: 119 ILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFA 174
Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
           GT GY++PE + +    +  D+++ GV++
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGVIL 203

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 89/205 (43%), Gaps = 23/205 (11%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFN------EVNLI----SGINHK 325
           LG+GG G+V+ G  L     VA+K +  N         +      EV L+    +G  H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 326 NLVKLLGCSITGPESLLVYEF-VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            +++LL    T    +LV E  +P Q L D +    +  PL               + + 
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYI---TEKGPLGEGPSRCFFGQVVAAIQHC 155
Query: 385 HEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           H      ++HRDIK  NIL+D     AK+ DFG   L  ++         GT  Y  PE+
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY---TDFDGTRVYSPPEW 209
Query: 444 VVRGKLTE-KADVYSFGVVVIEVVC 467
           + R +     A V+S G+++ ++VC
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVC 234

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 12/95 (12%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGLVRLFPEDITHI 428
           ++I    EG+ YLH+ +   I+H D+K  NILL   +     KI DFG+ R     I H 
Sbjct: 135 RLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSR----KIGHA 187
Query: 429 SA--TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
                + GT  Y+APE +    +T   D+++ G++
Sbjct: 188 CELREIMGTPEYLAPEILNYDPITTATDMWNIGII 222

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 270 YFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNL 327
           Y  + + LG+G    V     L   +  AVK +           F EV ++     H+N+
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           ++L+          LV+E +   S+L ++  R+    L   V   ++   A  L +LH +
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNK 130
Query: 388 SKLRIIHRDIKLSNILLDEE---FTAKIADFGL---VRLFPEDITHISA----TLAGTLG 437
               I HRD+K  NIL +        KI DFGL   ++L   D + IS     T  G+  
Sbjct: 131 G---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN-GDCSPISTPELLTPCGSAE 186
Query: 438 YMAPEYVVRGKLTEKA-------DVYSFGVVV 462
           YMAPE V     +E+A       D++S GV++
Sbjct: 187 YMAPEVV--EAFSEEASIYDKRCDLWSLGVIL 216

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 67/144 (46%), Gaps = 11/144 (7%)
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
            H N++ L      G    LV E +    LLD + +RQ     S      ++ +  + + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKI-LRQKF--FSEREASFVLHTIGKTVE 135
Query: 383 YLHEESKLRIIHRDIKLSNIL-LDEEFTA---KIADFGLVRLFPEDITHISATLAGTLGY 438
           YLH +    ++HRD+K SNIL +DE       +I DFG  +    +   +  T   T  +
Sbjct: 136 YLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE-NGLLMTPCYTANF 191
Query: 439 MAPEYVVRGKLTEKADVYSFGVVV 462
           +APE + R    E  D++S G+++
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 66/144 (45%), Gaps = 11/144 (7%)
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
            H N++ L      G    LV E +    LLD +  RQ     S      ++ +  + + 
Sbjct: 79  QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKIL-RQKF--FSEREASFVLHTIGKTVE 135
Query: 383 YLHEESKLRIIHRDIKLSNIL-LDEEFTA---KIADFGLVRLFPEDITHISATLAGTLGY 438
           YLH +    ++HRD+K SNIL +DE       +I DFG  +    +   +  T   T  +
Sbjct: 136 YLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAE-NGLLMTPCYTANF 191
Query: 439 MAPEYVVRGKLTEKADVYSFGVVV 462
           +APE + R    E  D++S G+++
Sbjct: 192 VAPEVLKRQGYDEGCDIWSLGILL 215

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-------- 322
           +H   KLG G   +V+      G+     ++  +   + +   +E+ L+  +        
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 82
Query: 323 NHKNLVKLLG----CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
           N + +V+LL       + G    +V+E + +  L     ++ + + L      KII    
Sbjct: 83  NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLL--KWIIKSNYQGLPLPCVKKIIQQVL 140
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIA 413
           +GL YLH  +K RIIH DIK  NILL  +E++  ++A
Sbjct: 141 QGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLA 175

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I+ S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 135 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 188
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D++S GV++  ++C
Sbjct: 189 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 228

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 92/208 (44%), Gaps = 24/208 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLV 328
           + ++  +G G  G VY+  L   GE VA+K++          F N E+ ++  ++H N+V
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKA-----FKNRELQIMRKLDHCNIV 76
Query: 329 KLLGCSITGPESL------LVYEFVPNQ--SLLDNLFVRQDVEPLSWEVRYKIILSTAEG 380
           +L     +  E        LV ++VP     +  +    +   P+ +   Y  +      
Sbjct: 77  RLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLY--MYQLFRS 134
Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLFPEDITHISATLAGTLGYM 439
           LAY+H      I HRDIK  N+LLD +    K+ DFG  +       ++S   +    Y 
Sbjct: 135 LAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY--YR 189
Query: 440 APEYVVRG-KLTEKADVYSFGVVVIEVV 466
           APE +      T   DV+S G V+ E++
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELL 217

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I+ S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 127 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 180
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D++S GV++  ++C
Sbjct: 181 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 220

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 72/157 (45%), Gaps = 18/157 (11%)
Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-------- 322
           +H   KLG G   +V+      G+     ++  +   + +   +E+ L+  +        
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98
Query: 323 NHKNLVKLLG----CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
           N + +V+LL       + G    +V+E + +  L     ++ + + L      KII    
Sbjct: 99  NREMVVQLLDDFKISGVNGTHICMVFEVLGHHLL--KWIIKSNYQGLPLPCVKKIIQQVL 156
Query: 379 EGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIA 413
           +GL YLH  +K RIIH DIK  NILL  +E++  ++A
Sbjct: 157 QGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLA 191

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 10/106 (9%)
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHI 428
           ++    +G+ YLH      ++HRD+K +NIL+     E    KIAD G  RLF   +  +
Sbjct: 133 LLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189
Query: 429 S--ATLAGTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRKRI 471
           +    +  T  Y APE ++  +   KA D+++ G +  E++  + I
Sbjct: 190 ADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 235

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I+ S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 179
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D++S GV++  ++C
Sbjct: 180 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 219

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I+ S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 125 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 178
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D++S GV++  ++C
Sbjct: 179 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 218

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I+ S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 172
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D++S GV++  ++C
Sbjct: 173 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 212

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 115/262 (43%), Gaps = 37/262 (14%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKN--LVKLL 331
           ++G GGS  V++      +  A+K   L     Q +D + NE+  ++ +   +  +++L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
              IT     +V E   N  L   L  ++ ++P   +  +K +L   E +  +H+     
Sbjct: 123 DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNML---EAVHTIHQHG--- 175
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLV-RLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           I+H D+K +N L+ +    K+ DFG+  ++ P+  + +  +  GT+ YM PE +     +
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 451 EK-----------ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD 499
            +           +DV+S G ++  +   K    F Q    I+  +       +LH  +D
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQ----IINQI------SKLHAIID 282
Query: 500 PALAGNFQEGKPSRLLQIGLLC 521
           P     F +  P + LQ  L C
Sbjct: 283 PNHEIEFPD-IPEKDLQDVLKC 303

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 45.4 bits (106), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I+ S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 120 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 173
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D++S GV++  ++C
Sbjct: 174 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 213

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I+ S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 165 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 218
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D++S GV++  ++C
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I+ S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 174
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D++S GV++  ++C
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 214

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTA--KIADFGLVRLFPEDITHISA-TLAGTL 436
           G++Y H    ++I HRD+KL N LLD       KI DFG  +     + H    +  GT 
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 181
Query: 437 GYMAPEYVVRGKLTEK-ADVYSFGVVV 462
            Y+APE ++R +   K ADV+S GV +
Sbjct: 182 AYIAPEVLLRQEYDGKIADVWSCGVTL 208

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 115/262 (43%), Gaps = 37/262 (14%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKN--LVKLL 331
           ++G GGS  V++      +  A+K   L     Q +D + NE+  ++ +   +  +++L 
Sbjct: 63  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
              IT     +V E   N  L   L  ++ ++P   +  +K +L   E +  +H+     
Sbjct: 123 DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNML---EAVHTIHQHG--- 175
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLV-RLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           I+H D+K +N L+ +    K+ DFG+  ++ P+  + +  +  GT+ YM PE +     +
Sbjct: 176 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 451 EK-----------ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD 499
            +           +DV+S G ++  +   K    F Q    I+  +       +LH  +D
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQ----IINQI------SKLHAIID 282
Query: 500 PALAGNFQEGKPSRLLQIGLLC 521
           P     F +  P + LQ  L C
Sbjct: 283 PNHEIEFPD-IPEKDLQDVLKC 303

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I+ S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 171 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 224
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D++S GV++  ++C
Sbjct: 225 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 264

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I+ S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 121 EIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 174
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D++S GV++  ++C
Sbjct: 175 SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 214

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 65/144 (45%), Gaps = 11/144 (7%)
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
            H N++ L      G    +V E +    LLD +  RQ     S      ++ +  + + 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELMKGGELLDKIL-RQKF--FSEREASAVLFTITKTVE 130
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFGLVRLFPEDITHISATLAGTLGY 438
           YLH +    ++HRD+K SNIL  +E     + +I DFG  +    +   +  T   T  +
Sbjct: 131 YLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLMTPCYTANF 186
Query: 439 MAPEYVVRGKLTEKADVYSFGVVV 462
           +APE + R       D++S GV++
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLL 210

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 115/262 (43%), Gaps = 37/262 (14%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKN--LVKLL 331
           ++G GGS  V++      +  A+K   L     Q +D + NE+  ++ +   +  +++L 
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
              IT     +V E   N  L   L  ++ ++P   +  +K +L   E +  +H+     
Sbjct: 76  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNML---EAVHTIHQHG--- 128
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLV-RLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           I+H D+K +N L+ +    K+ DFG+  ++ P+  + +  +  GT+ YM PE +     +
Sbjct: 129 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 451 EK-----------ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD 499
            +           +DV+S G ++  +   K    F Q    I+  +       +LH  +D
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQ----IINQI------SKLHAIID 235
Query: 500 PALAGNFQEGKPSRLLQIGLLC 521
           P     F +  P + LQ  L C
Sbjct: 236 PNHEIEFPD-IPEKDLQDVLKC 256

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 8/153 (5%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYK 372
            E ++   + H ++V+LL    +     +V+EF+    L   +  R D   +  E V   
Sbjct: 77  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 136
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHIS 429
            +    E L Y H+ +   IIHRD+K   +LL   +     K+  FG+     E    ++
Sbjct: 137 YMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVA 192
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
               GT  +MAPE V R    +  DV+  GV++
Sbjct: 193 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 225

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           +++    +LG G  G V++ T    G   A K +        +    E+  +S + H  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           V L        E +++YEF+    L +   V  +   +S +   + +    +GL ++HE 
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEK--VADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274
Query: 388 SKLRIIHRDIKLSNILLDEEFTA--KIADFGLV-RLFPEDITHISATLAGTLGYMAPEYV 444
           +    +H D+K  NI+   + +   K+ DFGL   L P+    ++    GT  + APE  
Sbjct: 275 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVA 328
Query: 445 VRGKLTEKADVYSFGVV 461
               +    D++S GV+
Sbjct: 329 EGKPVGYYTDMWSVGVL 345

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/87 (37%), Positives = 48/87 (55%), Gaps = 10/87 (11%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTA--KIADFGLVRLFPEDITHISATLA-GTL 436
           G++Y H    +++ HRD+KL N LLD       KIADFG  +     + H     A GT 
Sbjct: 127 GVSYAH---AMQVAHRDLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTP 180
Query: 437 GYMAPEYVVRGKLTEK-ADVYSFGVVV 462
            Y+APE +++ +   K ADV+S GV +
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 68/153 (44%), Gaps = 8/153 (5%)
Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYK 372
            E ++   + H ++V+LL    +     +V+EF+    L   +  R D   +  E V   
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASH 134
Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHIS 429
            +    E L Y H+ +   IIHRD+K   +LL   +     K+  FG+     E    ++
Sbjct: 135 YMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL-VA 190
Query: 430 ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVV 462
               GT  +MAPE V R    +  DV+  GV++
Sbjct: 191 GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVIL 223

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 51/100 (51%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I+ S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 172
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D++S GV++  ++C
Sbjct: 173 SLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 212

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/144 (26%), Positives = 64/144 (44%), Gaps = 11/144 (7%)
Query: 323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
            H N++ L      G    +V E      LLD +  RQ     S      ++ +  + + 
Sbjct: 74  QHPNIITLKDVYDDGKYVYVVTELXKGGELLDKIL-RQKF--FSEREASAVLFTITKTVE 130
Query: 383 YLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFGLVRLFPEDITHISATLAGTLGY 438
           YLH +    ++HRD+K SNIL  +E     + +I DFG  +    +   +  T   T  +
Sbjct: 131 YLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE-NGLLXTPCYTANF 186
Query: 439 MAPEYVVRGKLTEKADVYSFGVVV 462
           +APE + R       D++S GV++
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLL 210

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 60/262 (22%), Positives = 115/262 (43%), Gaps = 37/262 (14%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKN--LVKLL 331
           ++G GGS  V++      +  A+K   L     Q +D + NE+  ++ +   +  +++L 
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
              IT     +V E   N  L   L  ++ ++P   +  +K +L   E +  +H+     
Sbjct: 95  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNML---EAVHTIHQHG--- 147
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLV-RLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           I+H D+K +N L+ +    K+ DFG+  ++ P+  + +  +  GT+ YM PE +     +
Sbjct: 148 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 451 EK-----------ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD 499
            +           +DV+S G ++  +   K    F Q    I+  +       +LH  +D
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGK--TPFQQ----IINQI------SKLHAIID 254
Query: 500 PALAGNFQEGKPSRLLQIGLLC 521
           P     F +  P + LQ  L C
Sbjct: 255 PNHEIEFPD-IPEKDLQDVLKC 275

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 12/197 (6%)
Query: 269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
           +++    +LG G  G V++ T    G   A K +        +    E+  +S + H  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           V L        E +++YEF+    L +   V  +   +S +   + +    +GL ++HE 
Sbjct: 111 VNLHDAFEDDNEMVMIYEFMSGGELFEK--VADEHNKMSEDEAVEYMRQVCKGLCHMHEN 168
Query: 388 SKLRIIHRDIKLSNILLDEEFTA--KIADFGLV-RLFPEDITHISATLAGTLGYMAPEYV 444
           +    +H D+K  NI+   + +   K+ DFGL   L P+    ++    GT  + APE  
Sbjct: 169 N---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT---TGTAEFAAPEVA 222
Query: 445 VRGKLTEKADVYSFGVV 461
               +    D++S GV+
Sbjct: 223 EGKPVGYYTDMWSVGVL 239

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKN--LVKLL 331
           ++G GGS  V++      +  A+K   L     Q +D + NE+  ++ +   +  +++L 
Sbjct: 19  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 78
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
              IT     +V E   N  L   L  ++ ++P   +  +K +L   E +  +H+     
Sbjct: 79  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNML---EAVHTIHQHG--- 131
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLV-RLFPEDITHISATLAGTLGYMAPEYV 444
           I+H D+K +N L+ +    K+ DFG+  ++ P+  + +  +  GT+ YM PE +
Sbjct: 132 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 184

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 84/174 (48%), Gaps = 13/174 (7%)
Query: 276 KLGQGGSGSVYKGTLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKN--LVKLL 331
           ++G GGS  V++      +  A+K   L     Q +D + NE+  ++ +   +  +++L 
Sbjct: 15  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
              IT     +V E   N  L   L  ++ ++P   +  +K +L   E +  +H+     
Sbjct: 75  DYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNML---EAVHTIHQHG--- 127
Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLV-RLFPEDITHISATLAGTLGYMAPEYV 444
           I+H D+K +N L+ +    K+ DFG+  ++ P+  + +  +  GT+ YM PE +
Sbjct: 128 IVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 180

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/72 (37%), Positives = 39/72 (54%), Gaps = 2/72 (2%)
Query: 394 HRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           HRD+K  NIL+  +  A + DFG+      E +T +  T+ GTL Y APE       T +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYXAPERFSESHATYR 215
Query: 453 ADVYSFGVVVIE 464
           AD+Y+   V+ E
Sbjct: 216 ADIYALTCVLYE 227

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 103/241 (42%), Gaps = 37/241 (15%)
Query: 275 NKLGQGGSGSV-YKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
            KLG+GG   V     L  G   A+KR+  +  Q  +    E ++    NH N+++L+  
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 334 SI----TGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEES 388
            +       E+ L+  F    +L + +   +D    L+ +    ++L    GL  +H + 
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG-----------TLG 437
                HRD+K +NILL +E    + D G +    +   H+  +              T+ 
Sbjct: 155 ---YAHRDLKPTNILLGDEGQPVLMDLGSMN---QACIHVEGSRQALTLQDWAAQRCTIS 208
Query: 438 YMAPE-YVVRGK--LTEKADVYSFGVVV---------IEVVCRK--RINLFTQNSCSILQ 483
           Y APE + V+    + E+ DV+S G V+          ++V +K   + L  QN  SI Q
Sbjct: 209 YRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ 268
Query: 484 T 484
           +
Sbjct: 269 S 269

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 97/218 (44%), Gaps = 20/218 (9%)
Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLIS 320
           E   K  + F      GQG  G+V  G     G +VA+K++  +  ++ +     +  ++
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLA 74
Query: 321 GINHKNLVKLLGCSITGPESL-------LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRY 371
            ++H N+V+L     T  E         +V E+VP+       N + RQ   P    +  
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPP---PILI 131
Query: 372 KIIL-STAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPEDITHIS 429
           K+ L      +  LH  S + + HRDIK  N+L++E + T K+ DFG  +       +++
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVA 190
Query: 430 ATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVV 466
              +    Y APE +   +  T   D++S G +  E++
Sbjct: 191 YICSRY--YRAPELIFGNQHYTTAVDIWSVGCIFAEMM 226

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 92/212 (43%), Gaps = 28/212 (13%)
Query: 270 YFHESNKLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNL 327
           Y  + + LG+G    V     L   +  AVK +           F EV ++     H+N+
Sbjct: 14  YQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNV 73
Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           ++L+          LV+E +   S+L ++  R+    L   V   ++   A  L +LH +
Sbjct: 74  LELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV---VVQDVASALDFLHNK 130
Query: 388 SKLRIIHRDIKLSNILLDEE---FTAKIADFGL---VRLFPEDITHISA----TLAGTLG 437
               I HRD+K  NIL +        KI DF L   ++L   D + IS     T  G+  
Sbjct: 131 G---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN-GDCSPISTPELLTPCGSAE 186
Query: 438 YMAPEYVVRGKLTEKA-------DVYSFGVVV 462
           YMAPE V     +E+A       D++S GV++
Sbjct: 187 YMAPEVV--EAFSEEASIYDKRCDLWSLGVIL 216

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/199 (24%), Positives = 86/199 (43%), Gaps = 19/199 (9%)
Query: 277 LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLVKLLGCSI 335
           +G G  G V++  L   + VA+K++  +       F N E+ ++  + H N+V L     
Sbjct: 48  IGNGSFGVVFQAKLVESDEVAIKKVLQDK-----RFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 336 TGPESL------LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           +  +        LV E+VP      +    +  + +   +    +      LAY+H    
Sbjct: 103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS--- 159
Query: 390 LRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG- 447
           + I HRDIK  N+LLD      K+ DFG  ++      ++S   +    Y APE +    
Sbjct: 160 IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--YRAPELIFGAT 217
Query: 448 KLTEKADVYSFGVVVIEVV 466
             T   D++S G V+ E++
Sbjct: 218 NYTTNIDIWSTGCVMAELM 236

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 93/211 (44%), Gaps = 35/211 (16%)
Query: 338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDI 397
           P   +V E+V  QSL  +   +    P++  + Y  +L     L+YLH    + +++ D+
Sbjct: 157 PVGYIVMEYVGGQSLKRS---KGQKLPVAEAIAY--LLEILPALSYLH---SIGLVYNDL 208
Query: 398 KLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYS 457
           K  NI+L EE   K+ D G V        +    L GT G+ APE +VR   T   D+Y+
Sbjct: 209 KPENIMLTEE-QLKLIDLGAVSRI-----NSFGYLYGTPGFQAPE-IVRTGPTVATDIYT 261
Query: 458 FGVVVIEVVCRKRINLFTQN---------SCSILQTVWDLYVKGR-LHEAVDPALAGNFQ 507
            G  +  +     ++L T+N            +L+T +D Y  GR L  A+DP     F 
Sbjct: 262 VGRTLAALT----LDLPTRNGRYVDGLPEDDPVLKT-YDSY--GRLLRRAIDPDPRQRFT 314
Query: 508 EGKPSRLLQIGLL---CVQASAELRPSMSIV 535
             +       G+L     Q +   RP +S +
Sbjct: 315 TAEEMSAQLTGVLREVVAQDTGVPRPGLSTI 345

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVD-----HFFNEVNLISGINH--KNL 327
           LG GG GSVY G  +     VA+K +  +  + W +         EV L+  ++     +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 328 VKLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++LL      P+S  L++    P Q L D +  R  ++    E+         E + + H
Sbjct: 76  IRLLDW-FERPDSFVLILERMEPVQDLFDFITERGALQE---ELARSFFWQVLEAVRHCH 131
Query: 386 EESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
                 ++HRDIK  NIL+D      K+ DFG   L  + +        GT  Y  PE++
Sbjct: 132 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 185
Query: 445 VRGKLTEK-ADVYSFGVVVIEVVC 467
              +   + A V+S G+++ ++VC
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVC 209

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 48/100 (48%), Gaps = 10/100 (10%)
Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRLFPEDITHI 428
           +I  S  E + YLH    + I HRD+K  N+L   +      K+ DFG  +   E  +H 
Sbjct: 165 EIXKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHN 218
Query: 429 SATLAG-TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           S T    T  Y+APE +   K  +  D +S GV+   ++C
Sbjct: 219 SLTTPCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLC 258

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTA--KIADFGLVRLFPEDITHISA-TLAGTL 436
           G++Y H    +++ HRD+KL N LLD       KI DFG  +     + H    +  GT 
Sbjct: 127 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 180
Query: 437 GYMAPEYVVRGKLTEK-ADVYSFGVVV 462
            Y+APE +++ +   K ADV+S GV +
Sbjct: 181 AYIAPEVLLKKEYDGKVADVWSCGVTL 207

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 31/87 (35%), Positives = 47/87 (54%), Gaps = 10/87 (11%)
Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTA--KIADFGLVRLFPEDITHISA-TLAGTL 436
           G++Y H    +++ HRD+KL N LLD       KI DFG  +     + H    +  GT 
Sbjct: 126 GVSYCH---AMQVCHRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTP 179
Query: 437 GYMAPEYVVRGKLTEK-ADVYSFGVVV 462
            Y+APE +++ +   K ADV+S GV +
Sbjct: 180 AYIAPEVLLKKEYDGKVADVWSCGVTL 206

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 59/252 (23%), Positives = 101/252 (40%), Gaps = 63/252 (25%)
Query: 277 LGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVD--HFFNEVNLISGINHKNLVKLLGC 333
           +G+G  G VY        + VA+K++       +D      E+ +++ +    +++L   
Sbjct: 36  IGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLHDL 95
Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK------------IILSTAEGL 381
            I  PE LL +         D L++  ++     +  +K            I+ +   G 
Sbjct: 96  II--PEDLLKF---------DELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGE 144
Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI-THISATLAG------ 434
            ++HE     IIHRD+K +N LL+++ + KI DFGL R    D   HI   L        
Sbjct: 145 KFIHESG---IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEE 201
Query: 435 -----------------TLGYMAPEYV-VRGKLTEKADVYSFGVVVIEV--VCRKRIN-- 472
                            T  Y APE + ++   T   D++S G +  E+  + +  IN  
Sbjct: 202 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNP 261
Query: 473 -----LFTQNSC 479
                LF  +SC
Sbjct: 262 TNRFPLFPGSSC 273

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVD-----HFFNEVNLISGINH--KNL 327
           LG GG GSVY G  +     VA+K +  +  + W +         EV L+  ++     +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 328 VKLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++LL      P+S  L++    P Q L D +  R  ++    E+         E + + H
Sbjct: 72  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQE---ELARSFFWQVLEAVRHCH 127
Query: 386 EESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
                 ++HRDIK  NIL+D      K+ DFG   L  + +        GT  Y  PE++
Sbjct: 128 NXG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 181
Query: 445 VRGKLTEK-ADVYSFGVVVIEVVC 467
              +   + A V+S G+++ ++VC
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVC 205

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVD-----HFFNEVNLISGINH--KNL 327
           LG GG GSVY G  +     VA+K +  +  + W +         EV L+  ++     +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 328 VKLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++LL      P+S  L++    P Q L D +  R  ++    E+         E + + H
Sbjct: 77  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQE---ELARSFFWQVLEAVRHCH 132
Query: 386 EESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
                 ++HRDIK  NIL+D      K+ DFG   L  + +        GT  Y  PE++
Sbjct: 133 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 186
Query: 445 VRGKLTEK-ADVYSFGVVVIEVVC 467
              +   + A V+S G+++ ++VC
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVC 210

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVD-----HFFNEVNLISGINH--KNL 327
           LG GG GSVY G  +     VA+K +  +  + W +         EV L+  ++     +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 328 VKLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++LL      P+S  L++    P Q L D +  R  ++    E+         E + + H
Sbjct: 119 IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQE---ELARSFFWQVLEAVRHCH 174
Query: 386 EESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
                 ++HRDIK  NIL+D      K+ DFG   L  + +        GT  Y  PE++
Sbjct: 175 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 228
Query: 445 VRGKLTEK-ADVYSFGVVVIEVVC 467
              +   + A V+S G+++ ++VC
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVC 252

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVD-----HFFNEVNLISGINH--KNL 327
           LG GG GSVY G  +     VA+K +  +  + W +         EV L+  ++     +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 328 VKLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++LL      P+S  L++    P Q L D +  R  ++    E+         E + + H
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQE---ELARSFFWQVLEAVRHCH 147
Query: 386 EESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
                 ++HRDIK  NIL+D      K+ DFG   L  + +        GT  Y  PE++
Sbjct: 148 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 201
Query: 445 VRGKLTEK-ADVYSFGVVVIEVVC 467
              +   + A V+S G+++ ++VC
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVC 225

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVD-----HFFNEVNLISGINH--KNL 327
           LG GG GSVY G  +     VA+K +  +  + W +         EV L+  ++     +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 328 VKLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++LL      P+S  L++    P Q L D +  R  ++    E+         E + + H
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQE---ELARSFFWQVLEAVRHCH 146
Query: 386 EESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
                 ++HRDIK  NIL+D      K+ DFG   L  + +        GT  Y  PE++
Sbjct: 147 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 200
Query: 445 VRGKLTEK-ADVYSFGVVVIEVVC 467
              +   + A V+S G+++ ++VC
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVC 224

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVD-----HFFNEVNLISGINH--KNL 327
           LG GG GSVY G  +     VA+K +  +  + W +         EV L+  ++     +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 328 VKLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++LL      P+S  L++    P Q L D +  R  ++    E+         E + + H
Sbjct: 92  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQE---ELARSFFWQVLEAVRHCH 147
Query: 386 EESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
                 ++HRDIK  NIL+D      K+ DFG   L  + +        GT  Y  PE++
Sbjct: 148 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 201
Query: 445 VRGKLTEK-ADVYSFGVVVIEVVC 467
              +   + A V+S G+++ ++VC
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVC 225

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 91/204 (44%), Gaps = 23/204 (11%)
Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVD-----HFFNEVNLISGINH--KNL 327
           LG GG GSVY G  +     VA+K +  +  + W +         EV L+  ++     +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 328 VKLLGCSITGPES--LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++LL      P+S  L++    P Q L D +  R  ++    E+         E + + H
Sbjct: 91  IRLLDW-FERPDSFVLILERPEPVQDLFDFITERGALQE---ELARSFFWQVLEAVRHCH 146
Query: 386 EESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
                 ++HRDIK  NIL+D      K+ DFG   L  + +        GT  Y  PE++
Sbjct: 147 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 200
Query: 445 VRGKLTEK-ADVYSFGVVVIEVVC 467
              +   + A V+S G+++ ++VC
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVC 224
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	573
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-139
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-123
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-123
3soc_A	322	Activin receptor type-2A; structural genomics cons	5e-84
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-68
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-64
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-61
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-58
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-57
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-56
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-56
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	6e-55
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-54
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-53
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-53
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	6e-50
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-40
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-40
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-40
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	6e-40
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-40
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-40
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-38
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-37
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-37
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-37
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-37
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	8e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-36
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	3e-36
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-36
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	4e-36
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-36
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	7e-36
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	9e-36
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-35
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-35
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-35
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-35
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	3e-35
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-35
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	4e-35
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	4e-35
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-35
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	5e-35
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	5e-35
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	8e-35
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-34
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	1e-34
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-34
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	2e-34
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-34
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-34
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	3e-34
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-34
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-34
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-34
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-34
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-34
2a19_B	284	Interferon-induced, double-stranded RNA-activated	8e-34
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	9e-34
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-33
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-33
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-33
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-33
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-33
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	7e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-32
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-32
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-32
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-32
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	4e-32
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	4e-32
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-32
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	7e-32
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	7e-32
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-31
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-31
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-31
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-31
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-30
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-30
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-29
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-29
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-29
3aln_A	327	Dual specificity mitogen-activated protein kinase;	6e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	8e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-28
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	4e-28
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	4e-28
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-28
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-27
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-27
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-27
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	8e-27
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	9e-27
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	9e-27
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	2e-26
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-26
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-26
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-26
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-25
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-25
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	6e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-24
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-24
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-23
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-23
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-23
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-23
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	4e-23
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	5e-23
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	7e-23
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	7e-23
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-22
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-22
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-22
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-22
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	6e-22
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-21
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-21
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-21
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-21
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-21
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-21
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-21
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-21
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-21
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	3e-21
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	3e-21
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-21
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-21
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	6e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-21
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	9e-21
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	9e-21
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-20
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-20
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-20
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-20
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-20
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	9e-20
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-20
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-19
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	6e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-18
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-17
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	2e-17
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	3e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-17
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-17
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-17
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-17
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	9e-17
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-16
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-16
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-16
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-16
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	3e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-16
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	4e-16
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	5e-16
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-08
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-15
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-15
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-15
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	5e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	6e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-15
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-13
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	6e-13
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	8e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	4e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-09
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-07
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	5e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-06
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	1e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-05
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-05
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  406 bits (1046), Expect = e-139
 Identities = 121/290 (41%), Positives = 175/290 (60%), Gaps = 6/290 (2%)

Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH-FFNEVN 317
           FS   L+ A++ F   N LG+GG G VYKG L  G  VAVKRL    TQ  +  F  EV 
Sbjct: 20  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79

Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILS 376
           +IS   H+NL++L G  +T  E LLVY ++ N S+   L    +   PL W  R +I L 
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139

Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
           +A GLAYLH+    +IIHRD+K +NILLDEEF A + DFGL +L     TH++  + GT+
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTI 199

Query: 437 GYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRIN---LFTQNSCSILQTVWDLYVKG 492
           G++APEY+  GK +EK DV+ +GV+++E++  ++  +   L   +   +L  V  L  + 
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259

Query: 493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN 542
           +L   VD  L GN+++ +  +L+Q+ LLC Q+S   RP MS VV+ML G+
Sbjct: 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD 309

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  364 bits (937), Expect = e-123
 Identities = 105/295 (35%), Positives = 156/295 (52%), Gaps = 18/295 (6%)

Query: 259 FSYETLEKATNYFHE------SNKLGQGGSGSVYKGTLPGGEAVAVKRL----FYNTTQW 308
           FS+  L+  TN F E       NK+G+GG G VYKG +     VAVK+L       T + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTT-VAVKKLAAMVDITTEEL 73

Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
              F  E+ +++   H+NLV+LLG S  G +  LVY ++PN SLLD L       PLSW 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 133

Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITH 427
           +R KI    A G+ +LHE      IHRDIK +NILLDE FTAKI+DFGL R   +   T 
Sbjct: 134 MRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190

Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD 487
           +++ + GT  YMAPE  +RG++T K+D+YSFGVV++E++         +    +L    +
Sbjct: 191 MTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEE 249

Query: 488 LYV-KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
           +   +  + + +D  +  +        +  +   C+      RP +  V ++L  
Sbjct: 250 IEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  363 bits (934), Expect = e-123
 Identities = 111/295 (37%), Positives = 160/295 (54%), Gaps = 7/295 (2%)

Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD 310
            V           LE+ATN F     +G G  G VYKG L  G  VA+KR    ++Q ++
Sbjct: 21  LVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIE 80

Query: 311 HFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF-VRQDVEPLSWEV 369
            F  E+  +S   H +LV L+G      E +L+Y+++ N +L  +L+        +SWE 
Sbjct: 81  EFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQ 140

Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHI 428
           R +I +  A GL YLH  +   IIHRD+K  NILLDE F  KI DFG+ +   E D TH+
Sbjct: 141 RLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL 197

Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINL-FTQNSCSILQTVW 486
           S  + GTLGY+ PEY ++G+LTEK+DVYSFGVV+ EV+C R  I     +   ++ +   
Sbjct: 198 STVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257

Query: 487 DLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG 541
           + +  G+L + VDP LA   +     +     + C+  S+E RPSM  V+  L  
Sbjct: 258 ESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEY 312

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  263 bits (675), Expect = 5e-84
 Identities = 82/311 (26%), Positives = 120/311 (38%), Gaps = 33/311 (10%)

Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQ-WVDHFF 313
           S ++   E L   +          +G  G V+K      E VAVK       Q W     
Sbjct: 10  SGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSW--QNE 66

Query: 314 NEVNLISGINHKNLVKLLGCSITGP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
            EV  + G+ H+N+++ +G    G     +  L+  F    SL D L        +SW  
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSWNE 122

Query: 370 RYKIILSTAEGLAYLHEE-------SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
              I  + A GLAYLHE+        K  I HRDIK  N+LL    TA IADFGL   F 
Sbjct: 123 LCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFE 182

Query: 423 EDITHISAT-LAGTLGYMAPEYV-----VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ 476
              +        GT  YMAPE +      +     + D+Y+ G+V+ E+  R        
Sbjct: 183 AGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPV 242

Query: 477 NSCSIL--QTVWDLYVKGRLHEAV-----DPALAGNFQEGKPSRLL-QIGLLCVQASAEL 528
           +   +   + +        + E V      P L   +Q+     +L +    C    AE 
Sbjct: 243 DEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEA 302

Query: 529 RPSMSIVVKML 539
           R S   V + +
Sbjct: 303 RLSAGCVGERI 313

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  223 bits (571), Expect = 2e-68
 Identities = 74/322 (22%), Positives = 117/322 (36%), Gaps = 48/322 (14%)

Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEV 316
           +  +        +       +G+G  G+VYKG+L     VAVK     +     +F NE 
Sbjct: 1   MEAAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEK 56

Query: 317 N--LISGINHKNLVKLLGCSITGPES-----LLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
           N   +  + H N+ + +              LLV E+ PN SL   L +        W  
Sbjct: 57  NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH----TSDWVS 112

Query: 370 RYKIILSTAEGLAYLHEE------SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-- 421
             ++  S   GLAYLH E       K  I HRD+   N+L+  + T  I+DFGL      
Sbjct: 113 SCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTG 172

Query: 422 -----PEDITHISATLAGTLGYMAPEY-------VVRGKLTEKADVYSFGVVVIEVVCRK 469
                P +  + + +  GT+ YMAPE               ++ D+Y+ G++  E+  R 
Sbjct: 173 NRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC 232

Query: 470 RINLFTQNSCSILQTVWDLYVKGR----------LHEAVDPALAGNFQ--EGKPSRLLQI 517
             +LF   S    Q  +   V               E   P     ++        L + 
Sbjct: 233 T-DLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKET 291

Query: 518 GLLCVQASAELRPSMSIVVKML 539
              C    AE R +     + +
Sbjct: 292 IEDCWDQDAEARLTAQXAEERM 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  211 bits (539), Expect = 5e-64
 Identities = 88/296 (29%), Positives = 143/296 (48%), Gaps = 38/296 (12%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG 332
            K+G G  G+V++     G  VAVK L       + V+ F  EV ++  + H N+V  +G
Sbjct: 43  EKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                P   +V E++   SL   L      E L    R  +    A+G+ YLH      I
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPI 160

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTLGYMAPEYVVRGKL-T 450
           +HR++K  N+L+D+++T K+ DFGL RL  +  T +S+   AGT  +MAPE V+R +   
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPE-VLRDEPSN 217

Query: 451 EKADVYSFGVVVIEVVCRKR--INLFTQNSCSILQTVWDLYVKG-RLH--EAVDPALAGN 505
           EK+DVYSFGV++ E+   ++   NL      +  Q V  +  K  RL     ++P +A  
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNL------NPAQVVAAVGFKCKRLEIPRNLNPQVA-- 269

Query: 506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNPNGSEI 561
                   +++    C       RPS + ++ +L     +++   PP   PN S++
Sbjct: 270 -------AIIE---GCWTNEPWKRPSFATIMDLLR---PLIKSAVPP---PNRSDL 309

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  203 bits (519), Expect = 3e-61
 Identities = 77/293 (26%), Positives = 122/293 (41%), Gaps = 28/293 (9%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
                 +G+G  G V K      + VA+K++   +      F  E+  +S +NH N+VKL
Sbjct: 10  IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKL 66

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G     P  L V E+    SL + L   + +   +        L  ++G+AYLH     
Sbjct: 67  YGAC-LNPVCL-VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPK 124

Query: 391 RIIHRDIKLSNILLDEEFT-AKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
            +IHRD+K  N+LL    T  KI DFG       DI        G+  +MAPE V  G  
Sbjct: 125 ALIHRDLKPPNLLLVAGGTVLKICDFGTAC----DIQTHMTNNKGSAAWMAPE-VFEGSN 179

Query: 450 -TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH--EAVDPALAGNF 506
            +EK DV+S+G+++ EV+ R++   F +      + +W ++   R    + +   +    
Sbjct: 180 YSEKCDVFSWGIILWEVITRRK--PFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIE--- 234

Query: 507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNPNGS 559
                  L+     C       RPSM  +VK++T           P   P   
Sbjct: 235 ------SLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  195 bits (497), Expect = 3e-58
 Identities = 82/283 (28%), Positives = 127/283 (44%), Gaps = 39/283 (13%)

Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFY-------NTTQWVDHFFNEVNLISGINHKN 326
            ++G+GG G V+KG L      VA+K L            +    F  EV ++S +NH N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +VKL G     P   +V EFVP   L   L       P+ W V+ +++L  A G+ Y+  
Sbjct: 85  IVKLYGLMHNPP--RMVMEFVPCGDLYHRL--LDKAHPIKWSVKLRLMLDIALGIEYMQN 140

Query: 387 ESKLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
           +    I+HRD++  NI L          AK+ADFGL +     ++     L G   +MAP
Sbjct: 141 Q-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS----GLLGNFQWMAP 195

Query: 442 EYVVRGKL---TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG-RLHEA 497
           E  +  +    TEKAD YSF +++  ++  +    F + S   ++ +  +  +G R    
Sbjct: 196 E-TIGAEEESYTEKADTYSFAMILYTILTGEG--PFDEYSYGKIKFINMIREEGLRP--- 249

Query: 498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
                     E  P RL  +  LC     + RP  S +VK L+
Sbjct: 250 -------TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  190 bits (486), Expect = 9e-57
 Identities = 61/278 (21%), Positives = 115/278 (41%), Gaps = 41/278 (14%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG 332
            KL +  SG ++KG    G  + VK L     +T+    F  E   +   +H N++ +LG
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 333 CSITGPESLL--VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
              + P      +  ++P  SL + L        +      K  L  A G+A+LH    L
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLEPL 133

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK-- 448
            I    +   ++++DE+ TA+I+   +   F                ++APE  ++ K  
Sbjct: 134 -IPRHALNSRSVMIDEDMTARISMADVKFSFQSP------GRMYAPAWVAPE-ALQKKPE 185

Query: 449 --LTEKADVYSFGVVVIEVVCRKR--INLFTQNSCSILQTVWDLYVKG-RLH--EAVDPA 501
                 AD++SF V++ E+V R+    +L      S ++    + ++G R      + P 
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADL------SNMEIGMKVALEGLRPTIPPGISPH 239

Query: 502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           ++         +L++I   C+      RP   ++V +L
Sbjct: 240 VS---------KLMKI---CMNEDPAKRPKFDMIVPIL 265

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (483), Expect = 2e-56
 Identities = 71/283 (25%), Positives = 123/283 (43%), Gaps = 45/283 (15%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLVKL 330
             +G GG G VY+     G+ VAVK        + +Q +++   E  L + + H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G  +  P   LV EF     L   L  ++    +  ++     +  A G+ YLH+E+ +
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIV 127

Query: 391 RIIHRDIKLSNILLDEEF--------TAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
            IIHRD+K SNIL+ ++           KI DFGL R +         + AG   +MAPE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK---MSAAGAYAWMAPE 184

Query: 443 YVVRGKL-TEKADVYSFGVVVIEVVCRKR--INLFTQNSCSILQTVWDLYVKG-RLH--E 496
            V+R  + ++ +DV+S+GV++ E++  +     +        L   + + +    L    
Sbjct: 185 -VIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI------DGLAVAYGVAMNKLALPIPS 237

Query: 497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                 A         +L++    C       RPS + ++  L
Sbjct: 238 TCPEPFA---------KLME---DCWNPDPHSRPSFTNILDQL 268

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  191 bits (486), Expect = 2e-56
 Identities = 72/279 (25%), Positives = 107/279 (38%), Gaps = 31/279 (11%)

Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
             LG+G  G   K T    GE + +K L     +    F  EV ++  + H N++K +G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
                    + E++   +L     ++       W  R       A G+AYLH    + II
Sbjct: 76  LYKDKRLNFITEYIKGGTLRG--IIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNII 130

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-------------TLAGTLGYMA 440
           HRD+   N L+ E     +ADFGL RL  ++ T                 T+ G   +MA
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP 500
           PE +      EK DV+SFG+V+ E++ R                 + L V+G L     P
Sbjct: 191 PEMINGRSYDEKVDVFSFGIVLCEIIGRVNA----DPDYLPRTMDFGLNVRGFLDRYC-P 245

Query: 501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                     P     I + C     E RPS   +   L
Sbjct: 246 -------PNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  186 bits (475), Expect = 6e-55
 Identities = 69/297 (23%), Positives = 120/297 (40%), Gaps = 45/297 (15%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNE--VNLISGINHKNLVKLLG 332
             +G+G  G V++G+   GE VAVK      ++    +F E  +     + H+N++  + 
Sbjct: 14  ECVGKGRYGEVWRGSW-QGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 333 CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE- 387
             +T   S     L+  +    SL D L     +  L      +I+LS A GLA+LH E 
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125

Query: 388 ----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMA 440
                K  I HRD+K  NIL+ +     IAD GL  +  +    +        GT  YMA
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185

Query: 441 PEYVVRGKL-------TEKADVYSFGVVVIEVVCRKRINLFTQN----------SCSILQ 483
           PE V+   +        ++ D+++FG+V+ EV  R   N   ++          +    +
Sbjct: 186 PE-VLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFE 244

Query: 484 TVWDLYVKGRLHEAVDPALAGNFQEGK-PSRLLQIGLLCVQASAELRPSMSIVVKML 539
            +  +    +      P +   +      + L ++   C   +   R +   + K L
Sbjct: 245 DMRKVVCVDQQR----PNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  187 bits (476), Expect = 1e-54
 Identities = 74/293 (25%), Positives = 120/293 (40%), Gaps = 37/293 (12%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNE--VNLISGINHKNLVKLLG 332
            ++G+G  G V+ G    GE VAVK  F   T     +F E  +     + H+N++  + 
Sbjct: 43  KQIGKGRYGEVWMGKW-RGEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIA 98

Query: 333 CSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE- 387
             I G  S     L+ ++  N SL D  +++     L  +   K+  S+  GL +LH E 
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYD--YLKS--TTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 388 ----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI---SATLAGTLGYMA 440
                K  I HRD+K  NIL+ +  T  IAD GL   F  D   +     T  GT  YM 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 441 PEYVVRGKL-------TEKADVYSFGVVVIEVVCRKRINLFTQ------NSCSILQTVWD 487
           PE V+   L          AD+YSFG+++ EV  R       +      +        ++
Sbjct: 215 PE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273

Query: 488 LYVKGRLHEAVDPALAGNFQEGK-PSRLLQIGLLCVQASAELRPSMSIVVKML 539
              +    + + P+    +   +   ++ ++   C   +   R +   V K L
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  185 bits (472), Expect = 5e-54
 Identities = 73/296 (24%), Positives = 124/296 (41%), Gaps = 43/296 (14%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNE--VNLISGINHKNLVKLLG 332
             +G+G  G V++G    GE VAVK      ++    +F E  +     + H+N++  + 
Sbjct: 48  ESIGKGRFGEVWRGKW-RGEEVAVKIFS---SREERSWFREAEIYQTVMLRHENILGFIA 103

Query: 333 CSI----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE- 387
                  T  +  LV ++  + SL D L    +   ++ E   K+ LSTA GLA+LH E 
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEI 159

Query: 388 ----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMA 440
                K  I HRD+K  NIL+ +  T  IAD GL        + I        GT  YMA
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219

Query: 441 PEYVVRGKL-------TEKADVYSFGVVVIEVVCRKRINLFTQN----------SCSILQ 483
           PE V+   +        ++AD+Y+ G+V  E+  R  I    ++          S   ++
Sbjct: 220 PE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278

Query: 484 TVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
            +  +  + +L   +             +++++    C  A+   R +   + K L
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTL 331

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  182 bits (464), Expect = 2e-53
 Identities = 83/276 (30%), Positives = 132/276 (47%), Gaps = 33/276 (11%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
            ++G G  G+VYKG   G   VAVK L     T Q +  F NEV ++    H N++  +G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
            S T P+  +V ++    SL     +         +    I   TA G+ YLH +S   I
Sbjct: 88  YS-TAPQLAIVTQWCEGSSLYH--HLHASETKFEMKKLIDIARQTARGMDYLHAKS---I 141

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT-LAGTLGYMAPEYVVRGKL-- 449
           IHRD+K +NI L E+ T KI DFGL               L+G++ +MAPE V+R +   
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 200

Query: 450 --TEKADVYSFGVVVIEVVCRKR----INLFTQNSCSILQTVWDLYVKGRLHEAVDPALA 503
             + ++DVY+FG+V+ E++  +     IN   Q    I++ V     +G L     P L+
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ----IIEMV----GRGSLS----PDLS 248

Query: 504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
              +   P R+ ++   C++   + RPS   ++  +
Sbjct: 249 -KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEI 283

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  174 bits (443), Expect = 6e-50
 Identities = 61/281 (21%), Positives = 109/281 (38%), Gaps = 38/281 (13%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
             +G+G  G VY G   G   VA++ +    +    +  F  EV       H+N+V  +G
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
             ++ P   ++      ++L     VR     L      +I     +G+ YLH +    I
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYS--VVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---I 151

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRL----FPEDITHISATLAGTLGYMAPEYVVRGK 448
           +H+D+K  N+  D      I DFGL  +                 G L ++APE ++R  
Sbjct: 152 LHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPE-IIRQL 209

Query: 449 L----------TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV 498
                      ++ +DV++ G +  E+  R+    +   +      +W +    +     
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHARE----WPFKTQPAEAIIWQMGTGMK----- 260

Query: 499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
            P L+   Q G    +  I L C     E RP+ + ++ ML
Sbjct: 261 -PNLS---QIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  147 bits (373), Expect = 2e-40
 Identities = 75/284 (26%), Positives = 122/284 (42%), Gaps = 32/284 (11%)

Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
            +LG+G  GSV            GE VAVK+L ++T + +  F  E+ ++  + H N+VK
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
             G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL   
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL--G 131

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVV 445
           +K R IHRD+   NIL++ E   KI DFGL ++ P+D         G     + APE + 
Sbjct: 132 TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190

Query: 446 RGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA 503
             K +  +DV+SFGVV+ E+     K  +   +    I        +   L E +     
Sbjct: 191 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL----- 245

Query: 504 GNFQEGK--------PSRLLQIGLLCVQASAELRPSMSIVVKML 539
              +           P  +  I   C   +   RPS   +   +
Sbjct: 246 ---KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 286

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  147 bits (373), Expect = 4e-40
 Identities = 75/284 (26%), Positives = 123/284 (43%), Gaps = 32/284 (11%)

Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
            +LG+G  GSV            GE VAVK+L ++T + +  F  E+ ++  + H N+VK
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
             G C   G  +L L+ E++P  SL D  ++++  E +      +      +G+ YL   
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRD--YLQKHKERIDHIKLLQYTSQICKGMEYL--G 162

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVV 445
           +K R IHRD+   NIL++ E   KI DFGL ++ P+D  +      G     + APE + 
Sbjct: 163 TK-RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 221

Query: 446 RGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA 503
             K +  +DV+SFGVV+ E+     K  +   +    I        +   L E +     
Sbjct: 222 ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL----- 276

Query: 504 GNFQEGK--------PSRLLQIGLLCVQASAELRPSMSIVVKML 539
              +           P  +  I   C   +   RPS   +   +
Sbjct: 277 ---KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  146 bits (370), Expect = 5e-40
 Identities = 60/270 (22%), Positives = 107/270 (39%), Gaps = 28/270 (10%)

Query: 270 YFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKN 326
           +     ++G+G   +VYKG        VA    +    T      F  E  ++ G+ H N
Sbjct: 27  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 86

Query: 327 LVKLLGC---SITGPESLLVY-EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           +V+       ++ G + +++  E + + +L       +  + +  +V         +GL 
Sbjct: 87  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKT---YLKRFKVMKIKVLRSWCRQILKGLQ 143

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
           +LH  +   IIHRD+K  NI +     + KI D GL  L           + GT  +MAP
Sbjct: 144 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAP 199

Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA 501
           E +   K  E  DVY+FG+ ++E+   +      QN+  I + V          +   P 
Sbjct: 200 E-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 258

Query: 502 LAGNFQEGKPSRLLQIGLLCVQASAELRPS 531
           +     E            C++ + + R S
Sbjct: 259 VK-EIIE-----------GCIRQNKDERYS 276

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  146 bits (371), Expect = 6e-40
 Identities = 70/292 (23%), Positives = 124/292 (42%), Gaps = 36/292 (12%)

Query: 269 NYFHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRL--FYNTTQWVDHFFNEVNLISG 321
            +      LG+G  G V            GE VAVK L          D    E+ ++  
Sbjct: 21  RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIAD-LKKEIEILRN 79

Query: 322 INHKNLVKLLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
           + H+N+VK  G C+  G   + L+ EF+P+ SL +  ++ ++   ++ + + K  +   +
Sbjct: 80  LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE--YLPKNKNKINLKQQLKYAVQICK 137

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--G 437
           G+ YL   S+ + +HRD+   N+L++ E   KI DFGL +    D  + +          
Sbjct: 138 GMDYL--GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVF 194

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSCSILQTVWDLYVKGRLH 495
           + APE +++ K    +DV+SFGV + E++  C    +        I  T   + V  RL 
Sbjct: 195 WYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT-RLV 253

Query: 496 EAVDPALAGNFQEGK--------PSRLLQIGLLCVQASAELRPSMSIVVKML 539
             +        +EGK        P  + Q+   C +     R S   +++  
Sbjct: 254 NTL--------KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGF 297

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  147 bits (372), Expect = 6e-40
 Identities = 82/297 (27%), Positives = 127/297 (42%), Gaps = 36/297 (12%)

Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
             LG+G  G V            GE VAVK L      Q    +  E++++  + H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 329 KLLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           K  G C   G  SL LV E+VP  SL D  ++ +    L+  + +       EG+AYLH 
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRD--YLPRHSIGLAQLLLF--AQQICEGMAYLHA 152

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYV 444
                 IHRD+   N+LLD +   KI DFGL +  PE   +      G     + APE +
Sbjct: 153 ---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECL 209

Query: 445 VRGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
              K    +DV+SFGV + E++  C    +  T+    I      + V  RL E +    
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVL-RLTELL---- 264

Query: 503 AGNFQEGK--------PSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
               + G+        P+ +  +   C +  A  RP+   ++ +L   HE  Q   P
Sbjct: 265 ----ERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQAP 317

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  148 bits (376), Expect = 7e-40
 Identities = 63/279 (22%), Positives = 112/279 (40%), Gaps = 45/279 (16%)

Query: 276 KLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLG- 332
           ++G+G  G V+ G L      VAVK             F  E  ++   +H N+V+L+G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
           C+   P   +V E V     L   F+R +   L  +   +++   A G+ YL  +     
Sbjct: 181 CTQKQP-IYIVMELVQGGDFLT--FLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CC 234

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVRGKLT 450
           IHRD+   N L+ E+   KI+DFG+ R   + + + ++     +     APE +  G+ +
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGV-YAASGGLRQVPVKWTAPEALNYGRYS 293

Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR-------LHEAVDPALA 503
            ++DV+SFG++                       +W+ +  G          +  +    
Sbjct: 294 SESDVWSFGIL-----------------------LWETFSLGASPYPNLSNQQTREFVEK 330

Query: 504 G---NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           G      E  P  + ++   C       RPS S + + L
Sbjct: 331 GGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  146 bits (371), Expect = 1e-39
 Identities = 79/312 (25%), Positives = 132/312 (42%), Gaps = 37/312 (11%)

Query: 275 NKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           ++LG+G  GSV            G  VAVK+L ++       F  E+ ++  ++   +VK
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 330 LLG-CSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
             G     G +SL LV E++P+  L D  F+++    L             +G+ YL   
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRD--FLQRHRARLDASRLLLYSSQICKGMEYL--G 144

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVV 445
           S+ R +HRD+   NIL++ E   KIADFGL +L P D  +      G     + APE + 
Sbjct: 145 SR-RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLS 203

Query: 446 RGKLTEKADVYSFGVVVIEVV--CRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA 503
               + ++DV+SFGVV+ E+   C K  +   +    +        +  RL E +     
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS-RLLELL----- 257

Query: 504 GNFQEGK--------PSRLLQIGLLCVQASAELRPSMSIVV----KMLTGNHEILQPTQP 551
              +EG+        P+ + ++  LC   S + RPS S +      + +G+         
Sbjct: 258 ---EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETHAFT 314

Query: 552 PFLNPNGSEISS 563
                    +S 
Sbjct: 315 AHPEGKHHSLSF 326

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  141 bits (358), Expect = 3e-38
 Identities = 61/197 (30%), Positives = 91/197 (46%), Gaps = 18/197 (9%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI 335
           LG+G  G VY G  L     +A+K +    +++      E+ L   + HKN+V+ LG   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 336 TGPESLLVYEFVPNQSLLDNLFVR----QDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                 +  E VP  SL   L  +    +D E     +         EGL YLH+    +
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT---IG-FYTKQILEGLKYLHDN---Q 142

Query: 392 IIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL- 449
           I+HRDIK  N+L++      KI+DFG  +     I   + T  GTL YMAPE ++     
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPE-IIDKGPR 200

Query: 450 --TEKADVYSFGVVVIE 464
              + AD++S G  +IE
Sbjct: 201 GYGKAADIWSLGCTIIE 217

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  139 bits (352), Expect = 2e-37
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 14/204 (6%)

Query: 272 HESNKLGQGGSGSVYKGTLPGGE----AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKN 326
           H    +G+G  G VY G            A+K L   T  Q V+ F  E  L+ G+NH N
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83

Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           ++ L+G          ++  ++ +  LL   F+R      + +      L  A G+ YL 
Sbjct: 84  VLALIGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEYL- 140

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTL--GYMAPE 442
              + + +HRD+   N +LDE FT K+ADFGL R   + +   +       L   + A E
Sbjct: 141 -AEQ-KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 443 YVVRGKLTEKADVYSFGVVVIEVV 466
            +   + T K+DV+SFGV++ E++
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELL 222

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  140 bits (354), Expect = 2e-37
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)

Query: 275 NKLGQGGSGSVYKGTL--PGGEA---VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
             LG G  G+VYKG     G +    VA+K L   T+        +E  +++ +++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           +LLG         L+ + +P   LLD  +VR+  + +  +      +  A+G+ YL  E 
Sbjct: 81  RLLGI-CLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL--ED 135

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT---LGYMAPEYVV 445
           + R++HRD+   N+L+      KI DFGL +L   +     A   G    + +MA E ++
Sbjct: 136 R-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESIL 192

Query: 446 RGKLTEKADVYSFGVVVIEVV 466
               T ++DV+S+GV V E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  143 bits (363), Expect = 3e-37
 Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 21/267 (7%)

Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +KLG G  G VY+G        VAVK L  +T + V+ F  E  ++  I H NLV+LLG 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
               P   ++ EF+   +LLD  ++R+ + + +S  V   +    +  + YL  E K   
Sbjct: 285 CTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NF 339

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
           IHR++   N L+ E    K+ADFGL RL   D     A     + + APE +   K + K
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

Query: 453 ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS 512
           +DV++FGV++ E+           +   + + +   Y   R+     P          P 
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMER---PEGC-------PE 446

Query: 513 RLLQIGLLCVQASAELRPSMSIVVKML 539
           ++ ++   C Q +   RPS + + +  
Sbjct: 447 KVYELMRACWQWNPSDRPSFAEIHQAF 473

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  138 bits (349), Expect = 3e-37
 Identities = 63/195 (32%), Positives = 96/195 (49%), Gaps = 14/195 (7%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-CS 334
           +LG G  G V  G   G   VAVK +   +    D FF E   +  ++H  LVK  G CS
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
              P   +V E++ N  LL+  ++R   + L      ++     EG+A+L  ES  + IH
Sbjct: 74  KEYP-IYIVTEYISNGCLLN--YLRSHGKGLEPSQLLEMCYDVCEGMAFL--ESH-QFIH 127

Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL---GYMAPEYVVRGKLTE 451
           RD+   N L+D +   K++DFG+ R   +D    S    GT     + APE     K + 
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSS---VGTKFPVKWSAPEVFHYFKYSS 184

Query: 452 KADVYSFGVVVIEVV 466
           K+DV++FG+++ EV 
Sbjct: 185 KSDVWAFGILMWEVF 199

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  138 bits (350), Expect = 3e-37
 Identities = 54/196 (27%), Positives = 99/196 (50%), Gaps = 14/196 (7%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
            +LG G  G V  G   G   VA+K +   +    D F  E  ++  ++H+ LV+L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
           +   P   ++ E++ N  LL+  ++R+       +   ++     E + YL  ESK + +
Sbjct: 89  TKQRP-IFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYL--ESK-QFL 142

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL---GYMAPEYVVRGKLT 450
           HRD+   N L++++   K++DFGL R   +D    S    G+     +  PE ++  K +
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS---VGSKFPVRWSPPEVLMYSKFS 199

Query: 451 EKADVYSFGVVVIEVV 466
            K+D+++FGV++ E+ 
Sbjct: 200 SKSDIWAFGVLMWEIY 215

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  136 bits (346), Expect = 8e-37
 Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 14/196 (7%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
            ++G G  G V+ G     + VA+K +        + F  E  ++  ++H  LV+L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
               P   LV EF+ +  L D  ++R      + E    + L   EG+AYL  E    +I
Sbjct: 73  LEQAP-ICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYL--EEA-CVI 126

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL---GYMAPEYVVRGKLT 450
           HRD+   N L+ E    K++DFG+ R   +D    S    GT     + +PE     + +
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS---TGTKFPVKWASPEVFSFSRYS 183

Query: 451 EKADVYSFGVVVIEVV 466
            K+DV+SFGV++ EV 
Sbjct: 184 SKSDVWSFGVLMWEVF 199

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  141 bits (356), Expect = 1e-36
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 24/284 (8%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV- 247

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
           ++     +V E++   SLLD  F++    + L       +    A G+AY+  E     +
Sbjct: 248 VSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYV 302

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 454 DVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSR 513
           DV+SFG+++ E+  + R+      +  +L  V   Y   R+     P          P  
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY---RMPC---P-------PECPES 409

Query: 514 LLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNPN 557
           L  +   C +   E RP+   +   L    +    T+P +    
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQAFL---EDYFTSTEPQYQPGE 450

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  141 bits (358), Expect = 2e-36
 Identities = 74/267 (27%), Positives = 120/267 (44%), Gaps = 23/267 (8%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            KLGQG  G V+ GT  G   VA+K L   T    + F  E  ++  + H+ LV+L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAV- 330

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
           ++     +V E++   SLLD  F++    + L       +    A G+AY+  E     +
Sbjct: 331 VSEEPIYIVTEYMSKGSLLD--FLKGETGKYLRLPQLVDMAAQIASGMAYV--ERM-NYV 385

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRD++ +NIL+ E    K+ADFGL RL  ++           + + APE  + G+ T K+
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 454 DVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG-RLHEAVDPALAGNFQEGKPS 512
           DV+SFG+++ E+  + R+           + V D   +G R+     P          P 
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMV----NREVLDQVERGYRMPC---P-------PECPE 491

Query: 513 RLLQIGLLCVQASAELRPSMSIVVKML 539
            L  +   C +   E RP+   +   L
Sbjct: 492 SLHDLMCQCWRKEPEERPTFEYLQAFL 518

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  136 bits (345), Expect = 3e-36
 Identities = 50/235 (21%), Positives = 93/235 (39%), Gaps = 24/235 (10%)

Query: 254 KSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHF 312
           +  L F    +     ++    KLG+GG   V     L  G   A+KR+  +  Q  +  
Sbjct: 14  RENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEA 73

Query: 313 FNEVNLISGINHKNLVKLLGCSITGPES----LLVYEFVPNQSLLDNLFVR-QDVEPLS- 366
             E ++    NH N+++L+   +    +     L+  F    +L + +         L+ 
Sbjct: 74  QREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE 133

Query: 367 WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
            ++   ++L    GL  +H        HRD+K +NILL +E    + D G +      + 
Sbjct: 134 DQIL-WLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE 189

Query: 427 HIS--------ATLAGTLGYMAPEYVVRGK----LTEKADVYSFGVVVIEVVCRK 469
                      A    T+ Y APE +   +    + E+ DV+S G V+  ++  +
Sbjct: 190 GSRQALTLQDWAAQRCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  137 bits (346), Expect = 3e-36
 Identities = 83/312 (26%), Positives = 131/312 (41%), Gaps = 47/312 (15%)

Query: 276 KLGQGGSGSVYKGTL--PGGEA---VAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
            +G G  G VYKG L    G+    VA+K L    T  Q VD F  E  ++   +H N++
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVD-FLGEAGIMGQFSHHNII 109

Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           +L G  S   P  +++ E++ N +L    F+R+     S      ++   A G+ YL   
Sbjct: 110 RLEGVISKYKP-MMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYL--A 164

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVV 445
           +    +HRD+   NIL++     K++DFGL R+  +D      T  G +     APE + 
Sbjct: 165 NM-NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 223

Query: 446 RGKLTEKADVYSFGVVVIEVVCRKRI------NLFTQNSCSILQTVWDLYVKG-RLHEAV 498
             K T  +DV+SFG+V+ EV+           N            V      G RL    
Sbjct: 224 YRKFTSASDVWSFGIVMWEVMTYGERPYWELSN----------HEVMKAINDGFRLPT-- 271

Query: 499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNPNG 558
            P          PS + Q+ + C Q     RP  + +V +L    ++++         + 
Sbjct: 272 -P-------MDCPSAIYQLMMQCWQQERARRPKFADIVSIL---DKLIRAPDSLKTLADF 320

Query: 559 SEISSVGTPSTS 570
               S+  PSTS
Sbjct: 321 DPRVSIRLPSTS 332

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  137 bits (346), Expect = 4e-36
 Identities = 54/235 (22%), Positives = 94/235 (40%), Gaps = 19/235 (8%)

Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEA 295
           + +R   +    +  +   KL        +  ++     ++G+G  G V++      G  
Sbjct: 26  KLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQ 85

Query: 296 VAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
            AVK++     +       E+   +G++   +V L G    GP   +  E +   SL   
Sbjct: 86  CAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQL 140

Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIAD 414
           +   + +  L  +     +    EGL YLH     RI+H D+K  N+LL  +   A + D
Sbjct: 141 I---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCD 194

Query: 415 FG----LVRLFPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIE 464
           FG    L              + GT  +MAPE VV GK    K D++S   +++ 
Sbjct: 195 FGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLH 248

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  135 bits (342), Expect = 7e-36
 Identities = 51/238 (21%), Positives = 99/238 (41%), Gaps = 26/238 (10%)

Query: 249 QVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKR--LFYNTT 306
              V+    N  ++++      +    ++G GGS  V++      +  A+K   L     
Sbjct: 8   SSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADN 67

Query: 307 QWVDHFFNEVNLISGINHKNL--VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
           Q +D + NE+  ++ +   +   ++L    IT     +V E   N  L   L   +  + 
Sbjct: 68  QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKS 123

Query: 365 LS-WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           +  WE +     +  E +  +H+     I+H D+K +N L+ +    K+ DFG+      
Sbjct: 124 IDPWERKS-YWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQP 178

Query: 424 DITHISA-TLAGTLGYMAPE-----------YVVRGKLTEKADVYSFGVVVIEVVCRK 469
           D T +   +  GT+ YM PE              + K++ K+DV+S G ++  +   K
Sbjct: 179 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  135 bits (341), Expect = 7e-36
 Identities = 55/199 (27%), Positives = 93/199 (46%), Gaps = 16/199 (8%)

Query: 276 KLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKL 330
           +LG G  G+V KG     +    VAVK L          D    E N++  +++  +V++
Sbjct: 24  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83

Query: 331 LG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           +G C       +LV E      L    +++Q+   +  +   +++   + G+ YL  E  
Sbjct: 84  IGIC--EAESWMLVMEMAELGPLNK--YLQQN-RHVKDKNIIELVHQVSMGMKYL--EES 136

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRG 447
              +HRD+   N+LL  +  AKI+DFGL +    D  +  A   G     + APE +   
Sbjct: 137 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195

Query: 448 KLTEKADVYSFGVVVIEVV 466
           K + K+DV+SFGV++ E  
Sbjct: 196 KFSSKSDVWSFGVLMWEAF 214

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  134 bits (339), Expect = 8e-36
 Identities = 64/196 (32%), Positives = 101/196 (51%), Gaps = 14/196 (7%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV+L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAV- 76

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
           +T     ++ E++ N SL+D  F++      L+      +    AEG+A++  E +   I
Sbjct: 77  VTQEPIYIITEYMENGSLVD--FLKTPSGIKLTINKLLDMAAQIAEGMAFI--EER-NYI 131

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL---GYMAPEYVVRGKLT 450
           HRD++ +NIL+ +  + KIADFGL RL  ++         G      + APE +  G  T
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR---EGAKFPIKWTAPEAINYGTFT 188

Query: 451 EKADVYSFGVVVIEVV 466
            K+DV+SFG+++ E+V
Sbjct: 189 IKSDVWSFGILLTEIV 204

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  134 bits (340), Expect = 9e-36
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 12/197 (6%)

Query: 276 KLGQGGSGSVYKGTLPGGE---AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
           +LG G  GSV +G     +    VA+K L   T     +    E  ++  +++  +V+L+
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76

Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G        +LV E      L    F+    E +      +++   + G+ YL  E K  
Sbjct: 77  GV-CQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYL--EEK-N 130

Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRGKL 449
            +HRD+   N+LL     AKI+DFGL +    D ++ +A  AG     + APE +   K 
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 190

Query: 450 TEKADVYSFGVVVIEVV 466
           + ++DV+S+GV + E +
Sbjct: 191 SSRSDVWSYGVTMWEAL 207

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  135 bits (343), Expect = 1e-35
 Identities = 49/216 (22%), Positives = 92/216 (42%), Gaps = 26/216 (12%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNL- 327
           +    ++G GGS  V++      +  A+K   L     Q +D + NE+  ++ +   +  
Sbjct: 11  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70

Query: 328 -VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLH 385
            ++L    IT     +V E   N  L   L   +  + +  WE +     +  E +  +H
Sbjct: 71  IIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKS-YWKNMLEAVHTIH 125

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTLGYMAPE-- 442
           +     I+H D+K +N L+ +    K+ DFG+      D T +   +  GT+ YM PE  
Sbjct: 126 QH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 443 ---------YVVRGKLTEKADVYSFGVVVIEVVCRK 469
                       + K++ K+DV+S G ++  +   K
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  136 bits (345), Expect = 1e-35
 Identities = 48/218 (22%), Positives = 91/218 (41%), Gaps = 30/218 (13%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNL- 327
           +    ++G GGS  V++      +  A+K   L     Q +D + NE+  ++ +   +  
Sbjct: 58  YSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117

Query: 328 -VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAY 383
            ++L    IT     +V E   N  L   L   +  + +  WE +     +L     +  
Sbjct: 118 IIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKNMLE---AVHT 170

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTLGYMAPE 442
           +H+     I+H D+K +N L+ +    K+ DFG+      D T +   +  G + YM PE
Sbjct: 171 IHQH---GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

Query: 443 -----------YVVRGKLTEKADVYSFGVVVIEVVCRK 469
                         + K++ K+DV+S G ++  +   K
Sbjct: 227 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  135 bits (342), Expect = 2e-35
 Identities = 46/224 (20%), Positives = 94/224 (41%), Gaps = 14/224 (6%)

Query: 251 AVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQ 307
            V+    N  ++++EK    +    K+G+G  G          G    +K +  +  +++
Sbjct: 10  GVDLGTENLYFQSMEK----YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65

Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
             +    EV +++ + H N+V+            +V ++     L       Q       
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDL-FKRINAQKGVLFQE 124

Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
           +      +     L ++H+    +I+HRDIK  NI L ++ T ++ DFG+ R+       
Sbjct: 125 DQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST-VE 180

Query: 428 ISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKR 470
           ++    GT  Y++PE +   K    K+D+++ G V+ E+   K 
Sbjct: 181 LARACIGTPYYLSPE-ICENKPYNNKSDIWALGCVLYELCTLKH 223

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  134 bits (340), Expect = 2e-35
 Identities = 56/201 (27%), Positives = 99/201 (49%), Gaps = 17/201 (8%)

Query: 275 NKLGQGGSGSVYKGTL--PGGEA---VAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLV 328
             LG G  G+VYKG     G +    VA+K L   T+        +E  +++ +++ ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           +LLG         L+ + +P   LLD  +VR+  + +  +      +  A+G+ YL  E 
Sbjct: 81  RLLGI-CLTSTVQLITQLMPFGCLLD--YVREHKDNIGSQYLLNWCVQIAKGMNYL--ED 135

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT---LGYMAPEYVV 445
           + R++HRD+   N+L+      KI DFGL +L   +     A   G    + +MA E ++
Sbjct: 136 R-RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE--GGKVPIKWMALESIL 192

Query: 446 RGKLTEKADVYSFGVVVIEVV 466
               T ++DV+S+GV V E++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELM 213

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  133 bits (338), Expect = 2e-35
 Identities = 62/202 (30%), Positives = 103/202 (50%), Gaps = 16/202 (7%)

Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
             +G+G  G VY GTL   +      AVK L    +  +    F  E  ++   +H N++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 89

Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
            LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ YL   
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL--A 145

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTL--GYMAPEYV 444
           SK + +HRD+   N +LDE+FT K+ADFGL R ++ ++   +       L   +MA E +
Sbjct: 146 SK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESL 204

Query: 445 VRGKLTEKADVYSFGVVVIEVV 466
              K T K+DV+SFGV++ E++
Sbjct: 205 QTQKFTTKSDVWSFGVLLWELM 226

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  134 bits (339), Expect = 3e-35
 Identities = 82/314 (26%), Positives = 127/314 (40%), Gaps = 54/314 (17%)

Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKN 326
             LG G  G VY+G + G         VAVK L    +    +D F  E  +IS  NH+N
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 94

Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ------DVEPLSWEVRYKIILSTAE 379
           +V+ +G    + P   ++ E +    L    F+R+          L+      +    A 
Sbjct: 95  IVRCIGVSLQSLP-RFILMELMAGGDLKS--FLRETRPRPSQPSSLAMLDLLHVARDIAC 151

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTL 436
           G  YL  E     IHRDI   N LL        AKI DFG+ R    DI   S    G  
Sbjct: 152 GCQYL--EEN-HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGC 204

Query: 437 GY-----MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK 491
                  M PE  + G  T K D +SFGV++ E+     +   ++++  +L+     +V 
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE-----FVT 259

Query: 492 --GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML---TGNHEIL 546
             GR+     P       +  P  + +I   C Q   E RP+ +I+++ +   T + +++
Sbjct: 260 SGGRMDP---P-------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 309

Query: 547 QPTQPPFLNPNGSE 560
               P    P   E
Sbjct: 310 NTALPIEYGPLVEE 323

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  133 bits (336), Expect = 3e-35
 Identities = 66/196 (33%), Positives = 99/196 (50%), Gaps = 12/196 (6%)

Query: 275 NKLGQGGSGSVYKGTLPGGE-AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +KLG G  G VY+G        VAVK L  +T + V+ F  E  ++  I H NLV+LLG 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
               P   ++ EF+   +LLD  ++R+ + + +S  V   +    +  + YL  E K   
Sbjct: 78  CTREPPFYIITEFMTYGNLLD--YLRECNRQEVSAVVLLYMATQISSAMEYL--EKK-NF 132

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVRGKLT 450
           IHRD+   N L+ E    K+ADFGL RL   D    +A           APE +   K +
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY--TAHAGAKFPIKWTAPESLAYNKFS 190

Query: 451 EKADVYSFGVVVIEVV 466
            K+DV++FGV++ E+ 
Sbjct: 191 IKSDVWAFGVLLWEIA 206

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  134 bits (338), Expect = 3e-35
 Identities = 57/231 (24%), Positives = 92/231 (39%), Gaps = 31/231 (13%)

Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF-YNTTQWVD 310
           ++S  N  +   +           LGQG + +V++G     G+  A+K     +  + VD
Sbjct: 3   SQSTSNHLWLLSDI----------LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD 52

Query: 311 HFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
               E  ++  +NHKN+VKL       T    +L+ EF P  SL   L    +   L   
Sbjct: 53  VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112

Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPED 424
               ++     G+ +L    +  I+HR+IK  NI+     D +   K+ DFG  R   +D
Sbjct: 113 EFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169

Query: 425 ITHISATLAGTLGYMAPEYVVRGKL--------TEKADVYSFGVVVIEVVC 467
                 +L GT  Y+ P+   R  L            D++S GV       
Sbjct: 170 --EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  133 bits (338), Expect = 4e-35
 Identities = 61/199 (30%), Positives = 100/199 (50%), Gaps = 13/199 (6%)

Query: 275 NKLGQGGSGSVYKGTL--PGGEA---VAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
             LG G  G+V+KG     G      V +K +   +  Q      + +  I  ++H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           +LLG    G    LV +++P  SLLD   VRQ    L  ++     +  A+G+ YL  E 
Sbjct: 79  RLLGL-CPGSSLQLVTQYLPLGSLLD--HVRQHRGALGPQLLLNWGVQIAKGMYYL--EE 133

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT-LGYMAPEYVVRG 447
              ++HR++   N+LL      ++ADFG+  L P D   +  + A T + +MA E +  G
Sbjct: 134 H-GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG 192

Query: 448 KLTEKADVYSFGVVVIEVV 466
           K T ++DV+S+GV V E++
Sbjct: 193 KYTHQSDVWSYGVTVWELM 211

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  132 bits (335), Expect = 4e-35
 Identities = 66/201 (32%), Positives = 96/201 (47%), Gaps = 17/201 (8%)

Query: 276 KLGQGGSGSVYKGTL--PGGEA--VAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLV 328
           KLG G  G V +G    P G+   VAVK L     +  + +D F  EVN +  ++H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84

Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           +L G      P   +V E  P  SLLD   +R+           +  +  AEG+ YL  E
Sbjct: 85  RLYGVV--LTPPMKMVTELAPLGSLLD--RLRKHQGHFLLGTLSRYAVQVAEGMGYL--E 138

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVV 445
           SK R IHRD+   N+LL      KI DFGL+R  P++  H        + +   APE + 
Sbjct: 139 SK-RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197

Query: 446 RGKLTEKADVYSFGVVVIEVV 466
               +  +D + FGV + E+ 
Sbjct: 198 TRTFSHASDTWMFGVTLWEMF 218

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  133 bits (337), Expect = 5e-35
 Identities = 60/200 (30%), Positives = 95/200 (47%), Gaps = 14/200 (7%)

Query: 275 NKLGQGGSGSVYKGTL--PGGE--AVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
             +G G SG V  G L  PG     VA+K L    T  Q  D F +E +++   +H N++
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD-FLSEASIMGQFDHPNII 113

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           +L G    G  +++V E++ N SL    F+R      +      ++     G+ YL    
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL--SD 169

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVR 446
               +HRD+   N+L+D     K++DFGL R+  +D      T  G +     APE +  
Sbjct: 170 L-GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAF 228

Query: 447 GKLTEKADVYSFGVVVIEVV 466
              +  +DV+SFGVV+ EV+
Sbjct: 229 RTFSSASDVWSFGVVMWEVL 248

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  133 bits (336), Expect = 5e-35
 Identities = 50/214 (23%), Positives = 94/214 (43%), Gaps = 32/214 (14%)

Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNL 327
             LG+G  GSV +G L   +     VAVK +     +  +  + F +E   +   +H N+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEE-FLSEAACMKDFSHPNV 98

Query: 328 VKLLG-CSITGPES----LLVYEFVPNQSLLDNLFVRQ-----DVEPLSWEVRYKIILST 377
           ++LLG C     +     +++  F+    L    ++         + +  +   K ++  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHT--YLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           A G+ YL   ++   +HRD+   N +L ++ T  +ADFGL +     I        G + 
Sbjct: 157 ALGMEYL--SNR-NFLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIA 209

Query: 438 -----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                ++A E +     T K+DV++FGV + E+ 
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  133 bits (337), Expect = 5e-35
 Identities = 53/214 (24%), Positives = 91/214 (42%), Gaps = 31/214 (14%)

Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLV 328
             LG+G  GSV +  L   +     VAVK L  +     D   F  E   +   +H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 329 KLLG-CSITGPES-----LLVYEFVPNQSLLDNLFVR-----QDVEPLSWEVRYKIILST 377
           KL+G    +  +      +++  F+ +  L    F+      ++   L  +   + ++  
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHA--FLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           A G+ YL   S+   IHRD+   N +L E+ T  +ADFGL R     I        G   
Sbjct: 147 ACGMEYL--SSR-NFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCAS 199

Query: 438 -----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                ++A E +     T  +DV++FGV + E++
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  132 bits (334), Expect = 8e-35
 Identities = 53/217 (24%), Positives = 88/217 (40%), Gaps = 33/217 (15%)

Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
            +LG+G  G V+               VAVK L   T      F  E  L++ + H+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST---------- 377
           K  G C    P  ++V+E++ +  L   L        +  + + +               
Sbjct: 81  KFYGVCGDGDP-LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 378 ---AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
              A G+ YL   +    +HRD+   N L+      KI DFG+ R    D+        G
Sbjct: 140 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 192

Query: 435 TLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                   +M PE ++  K T ++DV+SFGV++ E+ 
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  135 bits (342), Expect = 1e-34
 Identities = 61/192 (31%), Positives = 94/192 (48%), Gaps = 6/192 (3%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            KLG G  G V+  T      VAVK +   +   V+ F  E N++  + H  LVKL    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAV- 251

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
           +T     ++ EF+   SLLD L   +                 AEG+A++  E +   IH
Sbjct: 252 VTKEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLIDFSAQIAEGMAFI--EQR-NYIH 307

Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKAD 454
           RD++ +NIL+      KIADFGL R+  ++           + + APE +  G  T K+D
Sbjct: 308 RDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSD 367

Query: 455 VYSFGVVVIEVV 466
           V+SFG++++E+V
Sbjct: 368 VWSFGILLMEIV 379

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  132 bits (333), Expect = 1e-34
 Identities = 59/203 (29%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
              +    K+GQG SG+VY    +  G+ VA++++        +   NE+ ++    + N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +V  L   + G E  +V E++   SL D +      E    ++   +     + L +LH 
Sbjct: 79  IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEG---QIAA-VCRECLQALEFLHS 134

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEY 443
               ++IHRDIK  NILL  + + K+ DFG    F   IT   +   T+ GT  +MAPE 
Sbjct: 135 N---QVIHRDIKSDNILLGMDGSVKLTDFG----FCAQITPEQSKRSTMVGTPYWMAPEV 187

Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
           V R     K D++S G++ IE++
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMI 210

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  133 bits (337), Expect = 1e-34
 Identities = 80/314 (25%), Positives = 126/314 (40%), Gaps = 54/314 (17%)

Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKN 326
             LG G  G VY+G + G         VAVK L    +    +D F  E  +IS  NH+N
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELD-FLMEALIISKFNHQN 135

Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQ------DVEPLSWEVRYKIILSTAE 379
           +V+ +G    + P   ++ E +    L    F+R+          L+      +    A 
Sbjct: 136 IVRCIGVSLQSLP-RFILLELMAGGDLKS--FLRETRPRPSQPSSLAMLDLLHVARDIAC 192

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTL 436
           G  YL    +   IHRDI   N LL        AKI DFG+ R    DI        G  
Sbjct: 193 GCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGC 245

Query: 437 GY-----MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK 491
                  M PE  + G  T K D +SFGV++ E+     +   ++++  +L+     +V 
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLE-----FVT 300

Query: 492 --GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML---TGNHEIL 546
             GR+     P       +  P  + +I   C Q   E RP+ +I+++ +   T + +++
Sbjct: 301 SGGRMDP---P-------KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350

Query: 547 QPTQPPFLNPNGSE 560
               P    P   E
Sbjct: 351 NTALPIEYGPLVEE 364

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  132 bits (334), Expect = 1e-34
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 15/201 (7%)

Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
                   K+G+G +G V        G  VAVK +     Q  +  FNEV ++    H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +V++    + G E  ++ EF+   +L D +   +  E    ++   +  +  + LAYLH 
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEE---QIAT-VCEAVLQALAYLHA 159

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEY 443
           +    +IHRDIK  +ILL  +   K++DFG    F   I+       +L GT  +MAPE 
Sbjct: 160 Q---GVIHRDIKSDSILLTLDGRVKLSDFG----FCAQISKDVPKRKSLVGTPYWMAPEV 212

Query: 444 VVRGKLTEKADVYSFGVVVIE 464
           + R     + D++S G++VIE
Sbjct: 213 ISRSLYATEVDIWSLGIMVIE 233

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  131 bits (332), Expect = 1e-34
 Identities = 66/300 (22%), Positives = 118/300 (39%), Gaps = 26/300 (8%)

Query: 258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN---TTQWVDHFF 313
           +  Y TL      F    K+G+G    VY+   L  G  VA+K++        +      
Sbjct: 25  DMGYNTLAN----FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCI 80

Query: 314 NEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYK 372
            E++L+  +NH N++K     I   E  +V E      L   +   ++    +     +K
Sbjct: 81  KEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140

Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
             +     L ++H     R++HRDIK +N+ +      K+ D GL R F    T    +L
Sbjct: 141 YFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAH-SL 196

Query: 433 AGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK 491
            GT  YM+PE  +       K+D++S G ++ E+   +    F  +  ++      L  K
Sbjct: 197 VGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQS--PFYGDKMNLYS----LCKK 249

Query: 492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
                   P  + ++       L Q+  +C+    E RP ++ V  +    H     +  
Sbjct: 250 I-EQCDYPPLPSDHY----SEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLE 304

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  133 bits (336), Expect = 2e-34
 Identities = 61/204 (29%), Positives = 100/204 (49%), Gaps = 20/204 (9%)

Query: 275 NKLGQGGSGSVYKGTLPGGE----AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLV 328
             +G+G  G VY GTL   +      AVK L    +  +    F  E  ++   +H N++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQ-FLTEGIIMKDFSHPNVL 153

Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
            LLG C  +    L+V  ++ +  L +  F+R +    + +      L  A+G+ +L   
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL--A 209

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG-----YMAPE 442
           SK + +HRD+   N +LDE+FT K+ADFGL R   +      +    T       +MA E
Sbjct: 210 SK-KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD--SVHNKTGAKLPVKWMALE 266

Query: 443 YVVRGKLTEKADVYSFGVVVIEVV 466
            +   K T K+DV+SFGV++ E++
Sbjct: 267 SLQTQKFTTKSDVWSFGVLLWELM 290

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  131 bits (332), Expect = 2e-34
 Identities = 72/238 (30%), Positives = 108/238 (45%), Gaps = 27/238 (11%)

Query: 232 RRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-L 290
              +  +   R+QL  L       +    ++ LEK          LG+G  GSVYK    
Sbjct: 2   LETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEK----------LGEGSYGSVYKAIHK 51

Query: 291 PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ 350
             G+ VA+K++       +     E++++   +  ++VK  G      +  +V E+    
Sbjct: 52  ETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAG 109

Query: 351 SLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409
           S+ D + +R     L+ E     IL ST +GL YLH     R IHRDIK  NILL+ E  
Sbjct: 110 SVSDIIRLRNK--TLT-EDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGH 163

Query: 410 AKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
           AK+ADFG        +T   A   T+ GT  +MAPE +        AD++S G+  IE
Sbjct: 164 AKLADFG----VAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  133 bits (336), Expect = 2e-34
 Identities = 58/231 (25%), Positives = 92/231 (39%), Gaps = 31/231 (13%)

Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF-YNTTQWVD 310
           ++S  N  +   +           LGQG + +V++G     G+  A+K     +  + VD
Sbjct: 3   SQSTSNHLWLLSDI----------LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVD 52

Query: 311 HFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
               E  ++  +NHKN+VKL       T    +L+ EF P  SL   L    +   L   
Sbjct: 53  VQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES 112

Query: 369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPED 424
               ++     G+ +L E     I+HR+IK  NI+     D +   K+ DFG  R   +D
Sbjct: 113 EFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD 169

Query: 425 ITHISATLAGTLGYMAPEYVVRGKL--------TEKADVYSFGVVVIEVVC 467
                 +L GT  Y+ P+   R  L            D++S GV       
Sbjct: 170 --EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAAT 218

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  136 bits (344), Expect = 2e-34
 Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 12/197 (6%)

Query: 276 KLGQGGSGSVYKGTLPGGEA---VAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLL 331
           +LG G  GSV +G     +    VA+K L   T     +    E  ++  +++  +V+L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR 391
           G        +LV E      L    F+    E +      +++   + G+ YL  E K  
Sbjct: 403 GV-CQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGMKYL--EEK-N 456

Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVRGKL 449
            +HR++   N+LL     AKI+DFGL +    D ++ +A  AG       APE +   K 
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 516

Query: 450 TEKADVYSFGVVVIEVV 466
           + ++DV+S+GV + E +
Sbjct: 517 SSRSDVWSYGVTMWEAL 533

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  130 bits (330), Expect = 2e-34
 Identities = 60/308 (19%), Positives = 109/308 (35%), Gaps = 51/308 (16%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLV 328
           F     LG+GG G V++          A+KR+     +   +    EV  ++ + H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 329 KLLGCSITGPE---------SLLVY---EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
           +     +              + +Y   +    ++L D +  R  +E     V   I L 
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQ 126

Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-----------PEDI 425
            AE + +LH +    ++HRD+K SNI    +   K+ DFGLV              P   
Sbjct: 127 IAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 426 THISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT 484
                   GT  YM+PE  + G   + K D++S G+++ E++        TQ        
Sbjct: 184 YARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLYP----FSTQME---RVR 235

Query: 485 VWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE 544
                   +      P     +       ++Q     +  S   RP    +++     + 
Sbjct: 236 TLTDVRNLKF----PPLFTQKYPCEY--VMVQ---DMLSPSPMERPEAINIIE-----NA 281

Query: 545 ILQPTQPP 552
           + +    P
Sbjct: 282 VFEDLDFP 289

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  130 bits (329), Expect = 3e-34
 Identities = 59/196 (30%), Positives = 96/196 (48%), Gaps = 18/196 (9%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
             +G+G  G V  G   G + VAVK +  + T     F  E ++++ + H NLV+LLG  
Sbjct: 27  QTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                   +V E++   SL+D  ++R      L  +   K  L   E + YL  E     
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NF 138

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVRGKLT 450
           +HRD+   N+L+ E+  AK++DFGL +    + +  S    G L     APE +   K +
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLTK----EAS--STQDTGKLPVKWTAPEALREKKFS 192

Query: 451 EKADVYSFGVVVIEVV 466
            K+DV+SFG+++ E+ 
Sbjct: 193 TKSDVWSFGILLWEIY 208

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  132 bits (334), Expect = 3e-34
 Identities = 77/306 (25%), Positives = 132/306 (43%), Gaps = 32/306 (10%)

Query: 275 NKLGQGGSGSVYKGTL--PGGE--AVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLV 328
             +G G  G V  G L  P  +  +VA+K L    T  Q  D F  E +++   +H N++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRD-FLGEASIMGQFDHPNII 109

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           +L G        ++V E++ N SL    F+R+     +      ++   A G+ YL   S
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL---S 164

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY--MAPEYVVR 446
            +  +HRD+   NIL++     K++DFGL R+  +D      T  G +     +PE +  
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAY 224

Query: 447 GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF 506
            K T  +DV+S+G+V+ EV+       +  ++  +++ V + Y   RL     P      
Sbjct: 225 RKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGY---RLPP---P------ 272

Query: 507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNPNGSEISSVGT 566
               P+ L Q+ L C Q     RP    +V +L    ++++   P  L    S  +    
Sbjct: 273 -MDCPAALYQLMLDCWQKDRNNRPKFEQIVSIL---DKLIR--NPGSLKIITSAAARPSN 326

Query: 567 PSTSNS 572
                S
Sbjct: 327 LLLDQS 332

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  130 bits (329), Expect = 3e-34
 Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 42/229 (18%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           F E   LGQG  G V K          A+K++ +   + +    +EV L++ +NH+ +V+
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66

Query: 330 LLGC----------SITGPESLLVY---EFVPNQSLLDNLFVRQDV---EPLSWEVRYKI 373
                              +   ++   E+  N +L D L   +++       W +  +I
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDEYWRLFRQI 125

Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA--- 430
           +    E L+Y+H +    IIHRD+K  NI +DE    KI DFGL +     +  +     
Sbjct: 126 L----EALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 431 ----------TLAGTLGYMAPEYVVRGKLT--EKADVYSFGVVVIEVVC 467
                     +  GT  Y+A E V+ G     EK D+YS G++  E++ 
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIY 226

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  130 bits (330), Expect = 4e-34
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 30/213 (14%)

Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNL 327
            +LGQG  G VY+G   G         VA+K +    +      F NE +++   N  ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ---------DVEPLSWEVRYKIILSTA 378
           V+LLG    G  +L++ E +    L    ++R           + P S     ++    A
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKS--YLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
           +G+AYL   +  + +HRD+   N ++ E+FT KI DFG+ R    DI        G  G 
Sbjct: 149 DGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 201

Query: 439 -----MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                M+PE +  G  T  +DV+SFGVV+ E+ 
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  133 bits (337), Expect = 4e-34
 Identities = 58/197 (29%), Positives = 96/197 (48%), Gaps = 20/197 (10%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
             +G+G  G V  G   G + VAVK +  + T     F  E ++++ + H NLV+LLG  
Sbjct: 199 QTIGKGEFGDVMLGDYRGNK-VAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                   +V E++   SL+D  ++R      L  +   K  L   E + YL  E     
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVD--YLRSRGRSVLGGDCLLKFSLDVCEAMEYL--EGN-NF 310

Query: 393 IHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT---LGYMAPEYVVRGKL 449
           +HRD+   N+L+ E+  AK++DFGL +         S+T       + + APE +   K 
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKF 363

Query: 450 TEKADVYSFGVVVIEVV 466
           + K+DV+SFG+++ E+ 
Sbjct: 364 STKSDVWSFGILLWEIY 380

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  129 bits (327), Expect = 5e-34
 Identities = 52/200 (26%), Positives = 92/200 (46%), Gaps = 19/200 (9%)

Query: 276 KLGQGGSGSVYKGTLPGGEA----VAVKRLFYNTTQW-VDHFFNEVNLISGINHKNLVKL 330
            LG+G  G VY+G     +     VAVK    + T    + F +E  ++  ++H ++VKL
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 331 LG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           +G        + ++ E  P   L    ++ ++   L         L   + +AYL  ES 
Sbjct: 79  IGII--EEEPTWIIMELYPYGELGH--YLERNKNSLKVLTLVLYSLQICKAMAYL--ESI 132

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL---GYMAPEYVVR 446
              +HRDI + NIL+      K+ DFGL R   ++  + +   + T     +M+PE +  
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKA---SVTRLPIKWMSPESINF 188

Query: 447 GKLTEKADVYSFGVVVIEVV 466
            + T  +DV+ F V + E++
Sbjct: 189 RRFTTASDVWMFAVCMWEIL 208

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  128 bits (325), Expect = 8e-34
 Identities = 69/311 (22%), Positives = 122/311 (39%), Gaps = 67/311 (21%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           F E   +G GG G V+K      G+   +KR+ YN     +    EV  ++ ++H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68

Query: 330 LLGC-------------SITGPESLLVY---EFVPNQSLLDNLFVRQDV---EPLSWEVR 370
             GC             + +  ++  ++   EF    +L   +  R+     + L+    
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL--- 125

Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
            ++     +G+ Y+H +   ++I+RD+K SNI L +    KI DFGLV     D      
Sbjct: 126 -ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR--T 179

Query: 431 TLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY 489
              GTL YM+PE  +  +   ++ D+Y+ G+++ E++       F  +        +   
Sbjct: 180 RSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCD-TAFETSK------FFTDL 231

Query: 490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPT 549
             G + +  D              LLQ     +    E RP+ S          EIL   
Sbjct: 232 RDGIISDIFDKKE---------KTLLQ---KLLSKKPEDRPNTS----------EIL--- 266

Query: 550 QPPFLNPNGSE 560
           +   +     E
Sbjct: 267 RTLTVWKKSPE 277

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  128 bits (325), Expect = 9e-34
 Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 15/198 (7%)

Query: 276 KLGQGGSGSVYKGTL--PGGE--AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKL 330
            +G+G  G V++G    P     AVA+K     T+    + F  E   +   +H ++VKL
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
           +G  IT     ++ E      L    F++     L            +  LAYL  ESK 
Sbjct: 82  IGV-ITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYL--ESK- 135

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRGK 448
           R +HRDI   N+L+      K+ DFGL R   +          G L   +MAPE +   +
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFRR 193

Query: 449 LTEKADVYSFGVVVIEVV 466
            T  +DV+ FGV + E++
Sbjct: 194 FTSASDVWMFGVCMWEIL 211

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  130 bits (328), Expect = 1e-33
 Identities = 57/216 (26%), Positives = 90/216 (41%), Gaps = 32/216 (14%)

Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
            +LG+G  G V+               VAVK L   +      F  E  L++ + H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 329 KLLG-CSITGPESLLVYEFVPNQSLLDNL------------FVRQDVEPLSWEVRYKIIL 375
           +  G C+   P  L+V+E++ +  L   L                   PL       +  
Sbjct: 107 RFFGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
             A G+ YL   + L  +HRD+   N L+ +    KI DFG+ R    DI        G 
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGG 218

Query: 436 LG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                  +M PE ++  K T ++DV+SFGVV+ E+ 
Sbjct: 219 RTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  128 bits (325), Expect = 2e-33
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 40/225 (17%)

Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNL 327
             LG+G  G V K T    +       VAVK L  N +   +    +E N++  +NH ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST---------- 377
           +KL G        LL+ E+    SL   L   + V P           S+          
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 378 -----------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
                      ++G+ YL      +++HRD+   NIL+ E    KI+DFGL R    D+ 
Sbjct: 149 MGDLISFAWQISQGMQYL--AEM-KLVHRDLAARNILVAEGRKMKISDFGLSR----DVY 201

Query: 427 HISATLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
              + +  + G     +MA E +     T ++DV+SFGV++ E+V
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  128 bits (324), Expect = 2e-33
 Identities = 54/238 (22%), Positives = 91/238 (38%), Gaps = 16/238 (6%)

Query: 239 RRERKQLGALQVAVNKSKLNFSYETLEKATNY---FHESNKLGQGGSGSVYKGT-LPGGE 294
            + + +  + +   +++  +  Y+     + +   F   ++LG G  G V+K      G 
Sbjct: 24  HQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGR 83

Query: 295 AVAVK--RLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQS 351
             AVK     +   +       EV     +  H   V+L      G    L  E     S
Sbjct: 84  LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPS 142

Query: 352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAK 411
           L  +         L     +  +  T   LA+LH +    ++H D+K +NI L      K
Sbjct: 143 LQQHC--EAWGASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCK 197

Query: 412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           + DFGL+               G   YMAPE +++G     ADV+S G+ ++EV C  
Sbjct: 198 LGDFGLLVEL--GTAGAGEVQEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNM 252

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  128 bits (325), Expect = 3e-33
 Identities = 65/217 (29%), Positives = 98/217 (45%), Gaps = 33/217 (15%)

Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
             LG G  G V + T  G         VAVK L         +   +E+ ++S +  H+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILST------- 377
           +V LLG C+  GP  L++ E+     LL+ L    + +E            ST       
Sbjct: 112 IVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 378 ---AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
              A+G+A+L   SK   IHRD+   N+LL     AKI DFGL R    DI + S  +  
Sbjct: 171 SQVAQGMAFL--ASK-NCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDSNYIVK 223

Query: 435 TLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                   +MAPE +     T ++DV+S+G+++ E+ 
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  128 bits (323), Expect = 4e-33
 Identities = 67/221 (30%), Positives = 99/221 (44%), Gaps = 37/221 (16%)

Query: 275 NKLGQGGSGSVYKGTLPGGEA------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
             LG G  G V + T  G         VAVK L  +      +   +E+ ++S + NH N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNL------FVRQDVEPLSWEVRYKIILST-- 377
           +V LLG C+I GP +L++ E+     LL+ L      F+     P   E     +     
Sbjct: 89  IVNLLGACTIGGP-TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 378 -------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA 430
                  A+G+A+L   SK   IHRD+   NILL      KI DFGL R    DI + S 
Sbjct: 148 LSFSYQVAKGMAFL--ASK-NCIHRDLAARNILLTHGRITKICDFGLAR----DIKNDSN 200

Query: 431 TLAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
            +          +MAPE +     T ++DV+S+G+ + E+ 
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  127 bits (322), Expect = 4e-33
 Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 34/219 (15%)

Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
             LG+G  G V +    G +       VAVK L    T        +E+ ++  I +H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST-------- 377
           +V LLG C+  G   +++ EF    +L   L  +++           +            
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 378 -----AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A+G+ +L   S+ + IHRD+   NILL E+   KI DFGL R    DI      +
Sbjct: 153 YSFQVAKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYV 205

Query: 433 AGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                     +MAPE +     T ++DV+SFGV++ E+ 
Sbjct: 206 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  126 bits (320), Expect = 5e-33
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 34/218 (15%)

Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNL 327
            +LG+   G VYKG L G        AVA+K L         + F +E  L + + H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 328 VKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--------- 377
           V LLG  +   P   +++ +  +  L + L +R     +      + + S          
Sbjct: 75  VCLLGVVTKDQP-LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 378 ----AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
               A G+ YL   S   ++H+D+   N+L+ ++   KI+D GL R    ++        
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKL 186

Query: 434 GTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                    +MAPE ++ GK +  +D++S+GVV+ EV 
Sbjct: 187 LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  127 bits (320), Expect = 7e-33
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 16/199 (8%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLV 328
           F +  K+G+G  G V+KG      + VA+K +     +  ++    E+ ++S  +   + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           K  G  +   +  ++ E++   S LD L      E    ++   I+    +GL YLH E 
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET---QIAT-ILREILKGLDYLHSE- 138

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEYVV 445
             + IHRDIK +N+LL E    K+ADFG        +T       T  GT  +MAPE + 
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFG----VAGQLTDTQIKRNTFVGTPFWMAPEVIK 192

Query: 446 RGKLTEKADVYSFGVVVIE 464
           +     KAD++S G+  IE
Sbjct: 193 QSAYDSKADIWSLGITAIE 211

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (326), Expect = 1e-32
 Identities = 56/210 (26%), Positives = 91/210 (43%), Gaps = 22/210 (10%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVK 329
           F   + LG G  G++    +     VAVKR+      + D    EV L+   + H N+++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVIR 82

Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
              C+    +   +  E     + L     ++D   L  E    ++  T  GLA+LH   
Sbjct: 83  YF-CTEKDRQFQYIAIELCA--ATLQEYVEQKDFAHLGLEPI-TLLQQTTSGLAHLHS-- 136

Query: 389 KLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAP 441
            L I+HRD+K  NIL+       +  A I+DFGL +         S  + + GT G++AP
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195

Query: 442 EYV---VRGKLTEKADVYSFGVVVIEVVCR 468
           E +    +   T   D++S G V   V+  
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  127 bits (321), Expect = 1e-32
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 35/220 (15%)

Query: 275 NKLGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
             LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-------------FVRQDVEPLSWEVRY 371
           KN++ LLG         ++ E+    +L + L               R   E ++++   
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
                 A G+ YL   S+ + IHRD+   N+L+ E    KIADFGL R    DI +I   
Sbjct: 161 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 213

Query: 432 LAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
              T G     +MAPE +     T ++DV+SFGV++ E+ 
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  125 bits (317), Expect = 2e-32
 Identities = 62/202 (30%), Positives = 89/202 (44%), Gaps = 17/202 (8%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
            +G G +  V      P  E VA+KR+        +D    E+  +S  +H N+V     
Sbjct: 22  VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81

Query: 334 SITGPESLLVYEFVPNQSLLD-----NLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEE 387
            +   E  LV + +   S+LD               L  E     IL    EGL YLH+ 
Sbjct: 82  FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLD-ESTIATILREVLEGLEYLHKN 140

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFG----LVRLFPEDITHISATLAGTLGYMAPEY 443
            +   IHRD+K  NILL E+ + +IADFG    L          +  T  GT  +MAPE 
Sbjct: 141 GQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEV 197

Query: 444 VVRGKL-TEKADVYSFGVVVIE 464
           + + +    KAD++SFG+  IE
Sbjct: 198 MEQVRGYDFKADIWSFGITAIE 219

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  125 bits (317), Expect = 2e-32
 Identities = 54/204 (26%), Positives = 96/204 (47%), Gaps = 20/204 (9%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           +    +LG G  G VYK      G   A K +   + + ++ +  E+ +++  +H  +VK
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEES 388
           LLG      +  ++ EF P  ++     + +    L+ E + +++     E L +LH + 
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDA--IMLELDRGLT-EPQIQVVCRQMLEALNFLHSK- 136

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPEYVV 445
             RIIHRD+K  N+L+  E   ++ADFG                 +  GT  +MAPE V+
Sbjct: 137 --RIIHRDLKAGNVLMTLEGDIRLADFG----VSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 446 RGKLTE-----KADVYSFGVVVIE 464
              + +     KAD++S G+ +IE
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIE 214

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  131 bits (330), Expect = 2e-32
 Identities = 55/204 (26%), Positives = 86/204 (42%), Gaps = 18/204 (8%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLVKLL-- 331
           +LG GG G V +      GE VA+K+     + +  + +  E+ ++  +NH N+V     
Sbjct: 21  RLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREV 80

Query: 332 ----GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
                        LL  E+     L   L   ++   L       ++   +  L YLHE 
Sbjct: 81  PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHE- 139

Query: 388 SKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
              RIIHRD+K  NI+L    +    KI D G  +   +    +     GTL Y+APE +
Sbjct: 140 --NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCTEFVGTLQYLAPE-L 194

Query: 445 VRGKL-TEKADVYSFGVVVIEVVC 467
           +  K  T   D +SFG +  E + 
Sbjct: 195 LEQKKYTVTVDYWSFGTLAFECIT 218

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  127 bits (321), Expect = 2e-32
 Identities = 64/220 (29%), Positives = 99/220 (45%), Gaps = 35/220 (15%)

Query: 275 NKLGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
             LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL---------FVRQDVEPLSWEVRYKIIL 375
           KN++ LLG         ++ E+    +L + L         +          ++  K ++
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 376 S----TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
           S     A G+ YL   SK + IHRD+   N+L+ E+   KIADFGL R    DI HI   
Sbjct: 195 SCAYQVARGMEYL--ASK-KCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247

Query: 432 LAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
              T G     +MAPE +     T ++DV+SFGV++ E+ 
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  126 bits (318), Expect = 3e-32
 Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 48/274 (17%)

Query: 234 KLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHE--------SNKLGQGGSGSV 285
           K  ++ R   QL  +QV  +     F  +  E   +   E           LG G  G V
Sbjct: 2   KYKKQFRYESQLQMVQVTGSSDNEYFYVDFREYEYDLKWEFPRENLEFGKVLGSGAFGKV 61

Query: 286 YKGTLPGGEA------VAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKNLVKLLGCSITG 337
              T  G         VAVK L         +   +E+ +++ + +H+N+V LLG     
Sbjct: 62  MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121

Query: 338 PESLLVYEFVPNQSLLDNL----------FVRQDVEPLSWEVRYKIILST---------- 377
               L++E+     LL+ L           +  + +    E     +L+           
Sbjct: 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV 181

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           A+G+ +L  E K   +HRD+   N+L+      KI DFGL R    DI   S  +     
Sbjct: 182 AKGMEFL--EFK-SCVHRDLAARNVLVTHGKVVKICDFGLAR----DIMSDSNYVVRGNA 234

Query: 438 -----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                +MAPE +  G  T K+DV+S+G+++ E+ 
Sbjct: 235 RLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  130 bits (328), Expect = 3e-32
 Identities = 57/199 (28%), Positives = 86/199 (43%), Gaps = 17/199 (8%)

Query: 276 KLGQGGSGSVYKGTL--PGGEA--VAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVK 329
            +G+G  G V++G    P   A  VA+K     T+       F  E   +   +H ++VK
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREK-FLQEALTMRQFDHPHIVK 455

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           L+G  IT     ++ E      L    F++     L            +  LAYL  ESK
Sbjct: 456 LIGV-ITENPVWIIMELCTLGELRS--FLQVRKFSLDLASLILYAYQLSTALAYL--ESK 510

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL--GYMAPEYVVRG 447
            R +HRDI   N+L+      K+ DFGL R   +          G L   +MAPE +   
Sbjct: 511 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY--YKASKGKLPIKWMAPESINFR 567

Query: 448 KLTEKADVYSFGVVVIEVV 466
           + T  +DV+ FGV + E++
Sbjct: 568 RFTSASDVWMFGVCMWEIL 586

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  125 bits (317), Expect = 4e-32
 Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 15/197 (7%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF---YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           LG+GG    ++ +     E  A K +           +    E+++   + H+++V   G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKLR 391
                    +V E    +SLL+    R+ + EP   E RY  +     G  YLH   + R
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARY-YLRQIVLGCQYLH---RNR 161

Query: 392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL-T 450
           +IHRD+KL N+ L+E+   KI DFGL      D       L GT  Y+APE V+  K  +
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPE-VLSKKGHS 219

Query: 451 EKADVYSFGVVVIEVVC 467
            + DV+S G ++  ++ 
Sbjct: 220 FEVDVWSIGCIMYTLLV 236

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  124 bits (313), Expect = 4e-32
 Identities = 48/215 (22%), Positives = 85/215 (39%), Gaps = 41/215 (19%)

Query: 276 KLGQGGSGSVYKGTL--PGGEA------VAVKRLFYNTTQWVDHFFNEVNLISGINHKNL 327
            LGQG    ++KG     G         V +K L      + + FF   +++S ++HK+L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           V   G  + G E++LV EFV   SL    +++++   ++   + ++    A  + +L  E
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHFL--E 130

Query: 388 SKLRIIHRDIKLSNILLDEEFT--------AKIADFGLVRLFPEDITHISATLAGTLGY- 438
               +IH ++   NILL  E           K++D G+                      
Sbjct: 131 EN-TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK------------DIL 177

Query: 439 ------MAPEYVVRGKL-TEKADVYSFGVVVIEVV 466
                 + PE +   K      D +SFG  + E+ 
Sbjct: 178 QERIPWVPPECIENPKNLNLATDKWSFGTTLWEIC 212

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  126 bits (318), Expect = 5e-32
 Identities = 62/220 (28%), Positives = 97/220 (44%), Gaps = 35/220 (15%)

Query: 275 NKLGQGGSGSVYKGTLPGGE--------AVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
             LG+G  G V      G +         VAVK L  + T+  +    +E+ ++  I  H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-------------FVRQDVEPLSWEVRY 371
           KN++ LLG         ++ E+    +L + L               R   E ++++   
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
                 A G+ YL   S+ + IHRD+   N+L+ E    KIADFGL R    DI +I   
Sbjct: 207 SCTYQLARGMEYL--ASQ-KCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDYY 259

Query: 432 LAGTLG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
              T G     +MAPE +     T ++DV+SFGV++ E+ 
Sbjct: 260 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  126 bits (318), Expect = 5e-32
 Identities = 44/204 (21%), Positives = 79/204 (38%), Gaps = 19/204 (9%)

Query: 275 NKLGQGGS--GSVYKGT-LPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGINHKNLVK 329
             +G+G     +V      P GE V V+R  L   + + V     E+++    NH N+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLHEES 388
                I   E  +V  F+   S  D L     ++ ++ E+    IL    + L Y+H   
Sbjct: 91  YRATFIADNELWVVTSFMAYGSAKD-LICTHFMDGMN-ELAIAYILQGVLKALDYIHHMG 148

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED------ITHISATLAGTLGYMAPE 442
               +HR +K S+IL+  +    ++                 +          L +++PE
Sbjct: 149 Y---VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE 205

Query: 443 YVVRGKL--TEKADVYSFGVVVIE 464
            + +       K+D+YS G+   E
Sbjct: 206 VLQQNLQGYDAKSDIYSVGITACE 229

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  123 bits (312), Expect = 7e-32
 Identities = 56/198 (28%), Positives = 92/198 (46%), Gaps = 17/198 (8%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF---YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           LG+GG    ++ +     E  A K +           +    E+++   + H+++V   G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 333 CSITGPESL-LVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILSTAEGLAYLHEESKL 390
                 + + +V E    +SLL+    R+ + EP   E RY  +     G  YLH   + 
Sbjct: 83  F-FEDNDFVFVVLELCRRRSLLELHKRRKALTEP---EARY-YLRQIVLGCQYLH---RN 134

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL- 449
           R+IHRD+KL N+ L+E+   KI DFGL      D       L GT  Y+APE V+  K  
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD-GERKKVLCGTPNYIAPE-VLSKKGH 192

Query: 450 TEKADVYSFGVVVIEVVC 467
           + + DV+S G ++  ++ 
Sbjct: 193 SFEVDVWSIGCIMYTLLV 210

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  124 bits (314), Expect = 7e-32
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 35/216 (16%)

Query: 275 NKLGQGGSGSVYKGTLPGGEA---VAVKRL--FYNTTQWVDHFFNEVNLISGI-NHKNLV 328
           + +G+G  G V K  +         A+KR+  + +     D F  E+ ++  + +H N++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD-FAGELEVLCKLGHHPNII 89

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST----------- 377
            LLG         L  E+ P+ +LLD L   + +E            ST           
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 378 --AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
             A G+ YL   S+ + IHRD+   NIL+ E + AKIADFGL R            +  T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKT 199

Query: 436 LG-----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
           +G     +MA E +     T  +DV+S+GV++ E+V
Sbjct: 200 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 235

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  122 bits (309), Expect = 1e-31
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 11/204 (5%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLG 332
            +G G  G   K      G+ +  K L Y   T        +EVNL+  + H N+V+   
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 333 CSITGPESLL--VYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLHE--E 387
             I    + L  V E+     L   +    ++ + L  E   +++      L   H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
               ++HRD+K +N+ LD +   K+ DFGL R+   D T  + T  GT  YM+PE  +  
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKTFVGTPYYMSPE-QMNR 190

Query: 448 KL-TEKADVYSFGVVVIEVVCRKR 470
               EK+D++S G ++ E+     
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMP 214

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  122 bits (309), Expect = 1e-31
 Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 16/198 (8%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLG 332
           LG+G    VY+   +  G  VA+K +          V    NEV +   + H ++++L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLR 391
                    LV E   N  +   L  R   +P S  E R+  +     G+ YLH      
Sbjct: 79  YFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSENEARH-FMHQIITGMLYLH---SHG 132

Query: 392 IIHRDIKLSNILLDEEFTAKIADFGL-VRLFPEDITHISATLAGTLGYMAPEYVVRGKL- 449
           I+HRD+ LSN+LL      KIADFGL  +L      H   TL GT  Y++PE +      
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH--YTLCGTPNYISPE-IATRSAH 189

Query: 450 TEKADVYSFGVVVIEVVC 467
             ++DV+S G +   ++ 
Sbjct: 190 GLESDVWSLGCMFYTLLI 207

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  123 bits (311), Expect = 2e-31
 Identities = 53/241 (21%), Positives = 95/241 (39%), Gaps = 34/241 (14%)

Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLF---------- 302
           N   LN   +  +K  N +     L QG    +        +  A+K+            
Sbjct: 15  NLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDF 73

Query: 303 -------YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLD 354
                   +     D F NE+ +I+ I ++  +   G  IT  + + ++YE++ N S+L 
Sbjct: 74  TKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILK 132

Query: 355 NL-----FVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT 409
                    +     +  +V   II S     +Y+H  ++  I HRD+K SNIL+D+   
Sbjct: 133 FDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGR 190

Query: 410 AKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT---EKADVYSFGVVVIEVV 466
            K++DFG      +          GT  +M PE     + +    K D++S G+ +  + 
Sbjct: 191 VKLSDFGESEYMVDKKIK---GSRGTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMF 246

Query: 467 C 467
            
Sbjct: 247 Y 247

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  123 bits (311), Expect = 3e-31
 Identities = 59/226 (26%), Positives = 91/226 (40%), Gaps = 42/226 (18%)

Query: 275 NKLGQGGSGSVYKGTLPGGE------AVAVKRL--FYNTTQWVDHFFNEVNLISGINHKN 326
             +G+G  G V++   PG         VAVK L    +     D F  E  L++  ++ N
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQAD-FQREAALMAEFDNPN 111

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST--------- 377
           +VKLLG    G    L++E++    L + L         S         +          
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 378 ------------AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
                       A G+AYL   S+ + +HRD+   N L+ E    KIADFGL R    +I
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NI 224

Query: 426 THISATLAGTLGY-----MAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                  A          M PE +   + T ++DV+++GVV+ E+ 
Sbjct: 225 YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  121 bits (305), Expect = 5e-31
 Identities = 59/198 (29%), Positives = 86/198 (43%), Gaps = 15/198 (7%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKL 330
             LG+G  G+VY          +A+K LF               EV + S + H N+++L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H     
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCH---SK 128

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL- 449
           R+IHRDIK  N+LL      KIADFG     P         L GTL Y+ PE ++ G++ 
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---DLCGTLDYLPPE-MIEGRMH 184

Query: 450 TEKADVYSFGVVVIEVVC 467
            EK D++S GV+  E + 
Sbjct: 185 DEKVDLWSLGVLCYEFLV 202

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  123 bits (309), Expect = 6e-31
 Identities = 56/234 (23%), Positives = 108/234 (46%), Gaps = 18/234 (7%)

Query: 238 KRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAV 296
           K+ E  +L   Q    ++ L    +  E   + F + ++LG G  G V+K +  P G  +
Sbjct: 2   KKLEELELDEQQRKRLEAFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVM 61

Query: 297 AVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDN 355
           A K +       + +    E+ ++   N   +V   G   +  E  +  E +   SL   
Sbjct: 62  ARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ- 120

Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
             V +    +  ++  K+ ++  +GL YL E+   +I+HRD+K SNIL++     K+ DF
Sbjct: 121 --VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDF 176

Query: 416 G----LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
           G    L+         ++ +  GT  YM+PE +     + ++D++S G+ ++E+
Sbjct: 177 GVSGQLID-------SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  124 bits (312), Expect = 6e-31
 Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 37/229 (16%)

Query: 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKNL 327
           N       LG G SG+V       G  VAVKR+      + D    E+  L    +H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71

Query: 328 VKLLGCSITGPESL-LVYEFVPNQSLLD----NLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           ++   CS T    L +  E   N +L D         ++++         ++   A G+A
Sbjct: 72  IRYY-CSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129

Query: 383 YLHEESKLRIIHRDIKLSNILLD-------------EEFTAKIADFGLVRLFPEDITHIS 429
           +LH    L+IIHRD+K  NIL+              E     I+DFGL +      +   
Sbjct: 130 HLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFR 186

Query: 430 ATL---AGTLGYMAPE-------YVVRGKLTEKADVYSFGVVVIEVVCR 468
             L   +GT G+ APE          + +LT   D++S G V   ++ +
Sbjct: 187 TNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (306), Expect = 9e-31
 Identities = 60/248 (24%), Positives = 99/248 (39%), Gaps = 26/248 (10%)

Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN 304
           G+L  A  + + +F  +T+E           L +GG   VY+   +  G   A+KRL  N
Sbjct: 5   GSLGGASGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN 64

Query: 305 TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES-------LLVYEFVPNQSLLDNL 356
             +       EV  +  +  H N+V+    +  G E         L+   +    L++ L
Sbjct: 65  EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFL 124

Query: 357 FVRQDVEPLS-WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
              +   PLS   V  KI   T   + ++H   K  IIHRD+K+ N+LL  + T K+ DF
Sbjct: 125 KKMESRGPLSCDTVL-KIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDF 182

Query: 416 GLVRLFPEDITHIS-----------ATLAGTLGYMAPE--YVVRGK-LTEKADVYSFGVV 461
           G          +              T   T  Y  PE   +     + EK D+++ G +
Sbjct: 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCI 242

Query: 462 VIEVVCRK 469
           +  +  R+
Sbjct: 243 LYLLCFRQ 250

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  121 bits (306), Expect = 1e-30
 Identities = 63/208 (30%), Positives = 97/208 (46%), Gaps = 32/208 (15%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFF---NEVNLISGINHKN 326
           F +  ++G G  G+VY    +   E VA+K++ Y+  Q  + +     EV  +  + H N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIIL-STAEGLAYLH 385
            ++  GC +    + LV E+    S  D L V +  +PL  EV    +     +GLAYLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQ-EVEIAAVTHGALQGLAYLH 171

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA------GTLGYM 439
                 +IHRD+K  NILL E    K+ DFG            ++ +A      GT  +M
Sbjct: 172 SH---NMIHRDVKAGNILLSEPGLVKLGDFG-----------SASIMAPANSFVGTPYWM 217

Query: 440 APEYVVRGKLTE---KADVYSFGVVVIE 464
           APE ++     +   K DV+S G+  IE
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIE 245

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  120 bits (303), Expect = 1e-30
 Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 16/196 (8%)

Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
           KLG GG  +VY      L     VA+K +        + +  F  EV+  S ++H+N+V 
Sbjct: 18  KLGGGGMSTVYLAEDTIL--NIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVS 75

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           ++          LV E++   +L + +   +   PLS +          +G+ + H+   
Sbjct: 76  MIDVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKHAHDM-- 130

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED-ITHISATLAGTLGYMAPEYVVRGK 448
            RI+HRDIK  NIL+D   T KI DFG+ +   E  +T  +  L GT+ Y +PE      
Sbjct: 131 -RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEA 188

Query: 449 LTEKADVYSFGVVVIE 464
             E  D+YS G+V+ E
Sbjct: 189 TDECTDIYSIGIVLYE 204

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  121 bits (305), Expect = 2e-30
 Identities = 41/263 (15%), Positives = 77/263 (29%), Gaps = 30/263 (11%)

Query: 231 VRRKLLQKRRER-KQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT 289
           +  KLL    +             K          +  +   +  + LG+G    VY+ T
Sbjct: 26  LIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEAT 85

Query: 290 LPG------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV 343
                     +   +K                +  +        +K     +    S+LV
Sbjct: 86  QGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLV 145

Query: 344 YEFVPNQSLLD--NLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSN 401
            E     +LL+  NL+     + +   +     +     +  +H      IIH DIK  N
Sbjct: 146 GELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDN 202

Query: 402 ILL-----------DEEFTAKIADFGL---VRLFPEDITHISATLAGTLGYMAPEYVVRG 447
            +L           D      + D G    ++LFP+           T G+   E ++  
Sbjct: 203 FILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT--AKCETSGFQCVE-MLSN 259

Query: 448 KL-TEKADVYSFGVVVIEVVCRK 469
           K    + D +     V  ++   
Sbjct: 260 KPWNYQIDYFGVAATVYCMLFGT 282

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  118 bits (299), Expect = 4e-30
 Identities = 64/307 (20%), Positives = 104/307 (33%), Gaps = 59/307 (19%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKR--LFYNTTQWVDHFFNEVNLISGI-NHKN 326
           FHE  K+G G  GSV+K      G   A+KR       +    +   EV   + +  H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           +V+           L+  E+    SL D +    + +          ++L    GL Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 386 EESKLRIIHRDIKLSNILLDEE-------------------FTAKIADFGLVRLFPEDIT 426
                 ++H DIK SNI +                         KI D G V        
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--- 186

Query: 427 HISATLAGTLGYMAPEYVVRGKL--TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT 484
                  G   ++A E V++       KAD+++  + V+     +   L           
Sbjct: 187 --PQVEEGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAEP--LPRNGD------ 235

Query: 485 VWDLYVKGRLHEAVDPALAGNF-QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH 543
            W    +GRL     P +     QE     LL+   + +    E RPS    + ++   H
Sbjct: 236 QWHEIRQGRL-----PRIPQVLSQEFT--ELLK---VMIHPDPERRPS---AMALV--KH 280

Query: 544 EILQPTQ 550
            +L    
Sbjct: 281 SVLLSAS 287

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  116 bits (294), Expect = 1e-29
 Identities = 56/199 (28%), Positives = 86/199 (43%), Gaps = 21/199 (10%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVK 329
           LG+G  G+VY    K        +A+K LF +             E+ + S + H N+++
Sbjct: 22  LGKGKFGNVYLAREKQN---KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILR 78

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           +           L+ EF P   L   L   Q       +     +   A+ L Y H   +
Sbjct: 79  MYNYFHDRKRIYLMLEFAPRGELYKEL---QKHGRFDEQRSATFMEELADALHYCH---E 132

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
            ++IHRDIK  N+L+  +   KIADFG     P        T+ GTL Y+ PE ++ GK 
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR---TMCGTLDYLPPE-MIEGKT 188

Query: 450 -TEKADVYSFGVVVIEVVC 467
             EK D++  GV+  E + 
Sbjct: 189 HDEKVDLWCAGVLCYEFLV 207

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  121 bits (305), Expect = 3e-29
 Identities = 48/203 (23%), Positives = 79/203 (38%), Gaps = 23/203 (11%)

Query: 276 KLGQGGSGSVYKG--TLPGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLL- 331
            +  GG G +Y        G  V +K L ++   +       E   ++ + H ++V++  
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 332 ----GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
                     P   +V E+V  QSL      +   + L        +L     L+YLH  
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKR---SKG--QKLPVAEAIAYLLEILPALSYLHSI 201

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
               +++ D+K  NI+L EE   K+ D G V      I        GT G+ APE +VR 
Sbjct: 202 ---GLVYNDLKPENIMLTEE-QLKLIDLGAVSR----INSFGYLY-GTPGFQAPE-IVRT 251

Query: 448 KLTEKADVYSFGVVVIEVVCRKR 470
             T   D+Y+ G  +  +     
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLP 274

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  116 bits (292), Expect = 6e-29
 Identities = 60/233 (25%), Positives = 98/233 (42%), Gaps = 35/233 (15%)

Query: 253 NKSKLNFSYE-TLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWV 309
           +  KL  S E   +       +  ++G+G  GSV K    P G+ +AVKR+      +  
Sbjct: 5   SSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQ 64

Query: 310 DHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL--FVRQDVEPLS 366
                +++ ++   +   +V+  G      +  +  E + + S             + + 
Sbjct: 65  KQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIP 123

Query: 367 WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT 426
            E+  KI L+T + L +L     L+IIHRDIK SNILLD     K+ DFG          
Sbjct: 124 EEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFG---------- 171

Query: 427 HISATL---------AGTLGYMAPEYVVRGKLTE-----KADVYSFGVVVIEV 465
            IS  L         AG   YMAPE  +    +      ++DV+S G+ + E+
Sbjct: 172 -ISGQLVDSIAKTRDAGCRPYMAPE-RIDPSASRQGYDVRSDVWSLGITLYEL 222

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  115 bits (291), Expect = 6e-29
 Identities = 54/203 (26%), Positives = 90/203 (44%), Gaps = 20/203 (9%)

Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
            LG GG   V+            VAVK L         +   F  E    + +NH  +V 
Sbjct: 19  ILGFGGMSEVHLARDLRD--HRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVA 76

Query: 330 LL--GCSITGPESL--LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           +   G + T    L  +V E+V   +L D +       P++ +   ++I    + L + H
Sbjct: 77  VYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQALNFSH 133

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLGYMAPEY 443
           +     IIHRD+K +NI++      K+ DFG+ R   +    ++ T  + GT  Y++PE 
Sbjct: 134 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190

Query: 444 VVRGKLTEKADVYSFGVVVIEVV 466
                +  ++DVYS G V+ EV+
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVL 213

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  115 bits (289), Expect = 8e-29
 Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 33/221 (14%)

Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT-TQWVDHFFNEVN-LI 319
           ++E   +      +LG+G  G V K   +P G+ +AVKR+     +Q       +++  +
Sbjct: 1   SMEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISM 60

Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-FVRQDVEPLSWEVRYKIILSTA 378
             ++    V   G      +  +  E + + SL      V    + +  ++  KI +S  
Sbjct: 61  RTVDCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIV 119

Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL------ 432
           + L +LH  SKL +IHRD+K SN+L++     K+ DFG           IS  L      
Sbjct: 120 KALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG-----------ISGYLVDDVAK 166

Query: 433 ---AGTLGYMAPEYVVRGKLTE-----KADVYSFGVVVIEV 465
              AG   YMAPE  +  +L +     K+D++S G+ +IE+
Sbjct: 167 DIDAGCKPYMAPE-RINPELNQKGYSVKSDIWSLGITMIEL 206

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  115 bits (290), Expect = 1e-28
 Identities = 60/229 (26%), Positives = 93/229 (40%), Gaps = 27/229 (11%)

Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH 311
            +S        L      F     +G G  G VYKG  +  G+  A+K +     +  + 
Sbjct: 8   ARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEE- 66

Query: 312 FFNEVNLISGI-NHKNLVKLLGCSITGPESL------LVYEFVPNQSLLDNLFVRQDVEP 364
              E+N++    +H+N+    G  I            LV EF    S+ D L        
Sbjct: 67  IKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNT 125

Query: 365 LS-WEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
           L    + Y I      GL++LH+    ++IHRDIK  N+LL E    K+ DFG+      
Sbjct: 126 LKEEWIAY-ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA---- 177

Query: 424 DITHISA---TLAGTLGYMAPEYVVRGKLTE-----KADVYSFGVVVIE 464
            +        T  GT  +MAPE +   +  +     K+D++S G+  IE
Sbjct: 178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  115 bits (288), Expect = 4e-28
 Identities = 34/236 (14%), Positives = 72/236 (30%), Gaps = 53/236 (22%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFY----------------------------NTTQ 307
           LGQ    +  + T    GE+  V   ++                               +
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 308 WVDHFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFV--PNQSLLDNLFVRQDV- 362
               F    +L+     K ++++      +       +Y  +    Q+  + L       
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
           + L    R ++ L     LA LH      ++H  ++  +I+LD+     +  F  +    
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257

Query: 423 EDITHISATLAGTLGYMAPEYVV-----------RGKLTEKADVYSFGVVVIEVVC 467
                     + + G+  PE              R  +T   D ++ G+V+  + C
Sbjct: 258 AR-----VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  113 bits (285), Expect = 4e-28
 Identities = 45/196 (22%), Positives = 76/196 (38%), Gaps = 16/196 (8%)

Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
            +G+GG G VY+           VA+K +     +   +      E      +   ++V 
Sbjct: 41  LVGRGGMGDVYEAEDTVR--ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVP 98

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           +        +  +    +    L   L   +   PL+      I+      L   H    
Sbjct: 99  IHDFGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDAAHAA-- 153

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED-ITHISATLAGTLGYMAPEYVVRGK 448
               HRD+K  NIL+  +  A + DFG+     ++ +T +  T+ GTL YMAPE      
Sbjct: 154 -GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESH 211

Query: 449 LTEKADVYSFGVVVIE 464
            T +AD+Y+   V+ E
Sbjct: 212 ATYRADIYALTCVLYE 227

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  114 bits (286), Expect = 6e-28
 Identities = 24/230 (10%), Positives = 56/230 (24%), Gaps = 46/230 (20%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLF---YNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           L  G    V+    +   E  A+K       N+   ++         + +  ++  +   
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 333 C--------------------------SITGPESLLVYEFV-----PNQSLLDNLFVRQD 361
                                             LL+            S LD ++V + 
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFR- 188

Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
                    + +        A L       ++H      N+ +  +    + D   +   
Sbjct: 189 -GDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV 244

Query: 422 PEDITHISATLAGTLGYMAPEYVVRGKL--TEKADVYSFGVVVIEVVCRK 469
                      +  + Y   E++       T   + +  G+ +  V C  
Sbjct: 245 GT----RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  111 bits (279), Expect = 3e-27
 Identities = 56/238 (23%), Positives = 100/238 (42%), Gaps = 34/238 (14%)

Query: 246 GALQVAVNKS-KLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFY 303
           G+   +  ++  L    +  +   N      ++G G  G V+K      G  +AVK++  
Sbjct: 1   GSSGSSGKQTGYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60

Query: 304 NTT-QWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD 361
           +   +       +++ ++   +   +V+  G  IT  +  +  E +           ++ 
Sbjct: 61  SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEK--LKKRM 117

Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
             P+   +  K+ ++  + L YL    K  +IHRD+K SNILLDE    K+ DFG     
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFG----- 170

Query: 422 PEDITHISATL---------AGTLGYMAPEYVVRGKLTE-----KADVYSFGVVVIEV 465
                 IS  L         AG   YMAPE +     T+     +ADV+S G+ ++E+
Sbjct: 171 ------ISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  114 bits (287), Expect = 3e-27
 Identities = 60/237 (25%), Positives = 91/237 (38%), Gaps = 27/237 (11%)

Query: 237 QKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEA 295
                 ++    Q  +  +   F        +  +    KLG G  G V           
Sbjct: 5   HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64

Query: 296 VAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL 353
            A+K +     +T        EV ++  ++H N++KL           LV E      L 
Sbjct: 65  RAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELF 124

Query: 354 DNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL--- 404
           D +  R          ++       II     G+ YLH+     I+HRD+K  N+LL   
Sbjct: 125 DEIIHRM---------KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESK 172

Query: 405 DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
           +++   KI DFGL  +F            GT  Y+APE V+R K  EK DV+S GV+
Sbjct: 173 EKDALIKIVDFGLSAVFENQ--KKMKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  110 bits (276), Expect = 4e-27
 Identities = 55/205 (26%), Positives = 86/205 (41%), Gaps = 22/205 (10%)

Query: 268 TNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHK 325
            + F    KLG G  G V+       G    +K +  + +Q  ++    E+ ++  ++H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAE 379
           N++K+           +V E      LL+ +     V   +           +++     
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERI-----VSAQARGKALSEGYVAELMKQMMN 135

Query: 380 GLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
            LAY H      ++H+D+K  NIL          KI DFGL  LF  D    S   AGT 
Sbjct: 136 ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD--EHSTNAAGTA 190

Query: 437 GYMAPEYVVRGKLTEKADVYSFGVV 461
            YMAPE V +  +T K D++S GVV
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVV 214

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  111 bits (278), Expect = 7e-27
 Identities = 60/260 (23%), Positives = 87/260 (33%), Gaps = 55/260 (21%)

Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTT 306
            +  L F   +L +    +H    +GQG  G V            A+K     ++     
Sbjct: 10  GRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINP 69

Query: 307 QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS 366
           + V+    EV L+  ++H N+ +L           LV E      LLD L V  D     
Sbjct: 70  KDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGK 129

Query: 367 WEVRY-------------------------------------KIILSTAEGLAYLHEESK 389
             +                                        I+      L YLH    
Sbjct: 130 CAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---N 186

Query: 390 LRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFP---EDITHISATLAGTLGYMAPEYV 444
             I HRDIK  N L   ++ F  K+ DFGL + F        +   T AGT  ++APE V
Sbjct: 187 QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPE-V 245

Query: 445 VRGKL---TEKADVYSFGVV 461
           +         K D +S GV+
Sbjct: 246 LNTTNESYGPKCDAWSAGVL 265

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  113 bits (284), Expect = 8e-27
 Identities = 62/230 (26%), Positives = 96/230 (41%), Gaps = 38/230 (16%)

Query: 255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL------------ 301
           +   +  +   K    + +  KLG G  G V       G    A+K +            
Sbjct: 22  NPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSD 81

Query: 302 -FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ 360
              N  ++ +  +NE++L+  ++H N++KL           LV EF     L + +  R 
Sbjct: 82  DNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRH 141

Query: 361 DVEPLSWEVRY------KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAK 411
                    ++       I+     G+ YLH+     I+HRDIK  NILL   +     K
Sbjct: 142 ---------KFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIK 189

Query: 412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
           I DFGL   F +D  +      GT  Y+APE V++ K  EK DV+S GV+
Sbjct: 190 IVDFGLSSFFSKD--YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVI 236

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  112 bits (283), Expect = 9e-27
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 29/221 (13%)

Query: 253 NKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWV 309
           +  + N  ++        ++    LG+G  G V K       +  AVK +       +  
Sbjct: 8   SSGRENLYFQ--GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDT 65

Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEV 369
                EV L+  ++H N++KL           +V E      L D +  R+         
Sbjct: 66  STILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK--------- 116

Query: 370 RY------KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRL 420
           R+      +II     G+ Y+H+     I+HRD+K  NILL   +++   KI DFGL   
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC 173

Query: 421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
           F ++         GT  Y+APE V+RG   EK DV+S GV+
Sbjct: 174 FQQN--TKMKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVI 211

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  112 bits (283), Expect = 9e-27
 Identities = 59/223 (26%), Positives = 94/223 (42%), Gaps = 16/223 (7%)

Query: 246 GALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--- 301
           G++   ++ +   F   +    ++ +     LG+G  G V        G+  AVK +   
Sbjct: 3   GSMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKR 62

Query: 302 FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD 361
                   +    EV L+  ++H N++KL           LV E      L D +  R  
Sbjct: 63  QVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR-- 120

Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLV 418
            +  S     +II     G+ Y+H+    +I+HRD+K  N+LL    ++   +I DFGL 
Sbjct: 121 -KRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176

Query: 419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
             F            GT  Y+APE V+ G   EK DV+S GV+
Sbjct: 177 THFEAS--KKMKDKIGTAYYIAPE-VLHGTYDEKCDVWSTGVI 216

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  108 bits (271), Expect = 2e-26
 Identities = 59/198 (29%), Positives = 87/198 (43%), Gaps = 27/198 (13%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
            LG+G  G V K       +  AVK +       +       EV L+  ++H N++KL  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHE 386
                    +V E      L D +  R+         R+      +II     G+ Y+H+
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRK---------RFSEHDAARIIKQVFSGITYMHK 139

Query: 387 ESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
                I+HRD+K  NILL   +++   KI DFGL   F ++         GT  Y+APE 
Sbjct: 140 ---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN--TKMKDRIGTAYYIAPE- 193

Query: 444 VVRGKLTEKADVYSFGVV 461
           V+RG   EK DV+S GV+
Sbjct: 194 VLRGTYDEKCDVWSAGVI 211

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  107 bits (269), Expect = 4e-26
 Identities = 45/196 (22%), Positives = 80/196 (40%), Gaps = 25/196 (12%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            +G+G  G V            A K++     + VD F  E+ ++  ++H N+++L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
               +  LV E      L + +  ++          +      +I+      +AY H+  
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKR---------VFRESDAARIMKDVLSAVAYCHK-- 124

Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
            L + HRD+K  N L      +   K+ DFGL   F      +  T  GT  Y++P+ V+
Sbjct: 125 -LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG--KMMRTKVGTPYYVSPQ-VL 180

Query: 446 RGKLTEKADVYSFGVV 461
            G    + D +S GV+
Sbjct: 181 EGLYGPECDEWSAGVM 196

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  109 bits (275), Expect = 4e-26
 Identities = 52/211 (24%), Positives = 88/211 (41%), Gaps = 26/211 (12%)

Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQWVDH---FFNEVNL 318
            + +  S  LG G  G V         + VA++     +    + +  D       E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193

Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKIILST 377
           +  +NH  ++K+        +  +V E +    L D +   + + E       Y+++   
Sbjct: 194 LKKLNHPCIIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML--- 249

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAG 434
              + YLHE     IIHRD+K  N+LL   +E+   KI DFG  ++  E    +  TL G
Sbjct: 250 -LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCG 303

Query: 435 TLGYMAPE---YVVRGKLTEKADVYSFGVVV 462
           T  Y+APE    V         D +S GV++
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVIL 334

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  107 bits (269), Expect = 6e-26
 Identities = 52/197 (26%), Positives = 80/197 (40%), Gaps = 25/197 (12%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            LG G    V+       G+  A+K +  +         NE+ ++  I H+N+V L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
            +     LV + V    L D +  R           Y       +I      + YLHE  
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERG---------VYTEKDASLVIQQVLSAVKYLHE-- 124

Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
              I+HRD+K  N+L    +E     I DFGL ++    I     T  GT GY+APE + 
Sbjct: 125 -NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS---TACGTPGYVAPEVLA 180

Query: 446 RGKLTEKADVYSFGVVV 462
           +   ++  D +S GV+ 
Sbjct: 181 QKPYSKAVDCWSIGVIT 197

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  109 bits (273), Expect = 7e-26
 Identities = 30/232 (12%), Positives = 66/232 (28%), Gaps = 42/232 (18%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFY----------------------------NTTQ 307
           LGQ    +  + T    GE+  V   ++                               +
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 308 WVDHFFNEVNLISGINHKNLVKLLGC--SITGPESLLVYEFV--PNQSLLDNLFVRQDV- 362
               F    +L+     K ++++      +       +Y  +    Q+  + L       
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 363 EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
           + L    R ++ L     LA LH      ++H  ++  +I+LD+     +  F  +    
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 423 EDITHISATLAGTLGYMAPEYV-----VRGKLTEKADVYSFGVVVIEVVCRK 469
                            A   +         +T   D ++ G+ +  + C  
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  106 bits (267), Expect = 1e-25
 Identities = 52/261 (19%), Positives = 88/261 (33%), Gaps = 36/261 (13%)

Query: 227 VAFFVRRKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVY 286
           V F  + K+               A+ + +L       EK         KL   G    +
Sbjct: 21  VVFEAKNKVDDC----------NYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYF 70

Query: 287 KGTLPGGEAVAVKRLFYNTTQWVDH------------FFNEVNLISGINHKNLVKLLGCS 334
              L        + +     +                   ++  +   + KN V  L  S
Sbjct: 71  NAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPS 130

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
                  +  +    ++L D +  R  +E     V   I +  AE + +LH +    ++H
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMH 187

Query: 395 RDIKLSNILLDEEFTAKIADFGLVR-----------LFPEDITHISATLAGTLGYMAPEY 443
           RD+K SNI    +   K+ DFGLV            L P           GT  YM+PE 
Sbjct: 188 RDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQ 247

Query: 444 VVRGKLTEKADVYSFGVVVIE 464
           +     + K D++S G+++ E
Sbjct: 248 IHGNNYSHKVDIFSLGLILFE 268

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  105 bits (265), Expect = 3e-25
 Identities = 59/199 (29%), Positives = 88/199 (44%), Gaps = 20/199 (10%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGC 333
           +G+G    V     +  G  VA+K +         +   F EV ++  +NH N+VKL   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
             T     L+ E+     + D L     + E    E R K   I+S    + Y H   + 
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMKEK---EARSKFRQIVS---AVQYCH---QK 133

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           RI+HRD+K  N+LLD +   KIADFG    F            G   Y APE + +GK  
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG--GKLDAFCGAPPYAAPE-LFQGKKY 190

Query: 451 E--KADVYSFGVVVIEVVC 467
           +  + DV+S GV++  +V 
Sbjct: 191 DGPEVDVWSLGVILYTLVS 209

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  105 bits (265), Expect = 4e-25
 Identities = 47/196 (23%), Positives = 78/196 (39%), Gaps = 14/196 (7%)

Query: 276 KLGQGGSGSVYKGTLPG-GEAVAVK-----RLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
            +G+G    V +      G+  AVK     +   +     +    E ++   + H ++V+
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           LL    +     +V+EF+    L   +  R       S  V    +    E L Y H+  
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD-- 148

Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
              IIHRD+K   +LL   +     K+  FG+     E    ++    GT  +MAPE V 
Sbjct: 149 -NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGES-GLVAGGRVGTPHFMAPEVVK 206

Query: 446 RGKLTEKADVYSFGVV 461
           R    +  DV+  GV+
Sbjct: 207 REPYGKPVDVWGCGVI 222

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  104 bits (262), Expect = 6e-25
 Identities = 51/208 (24%), Positives = 80/208 (38%), Gaps = 38/208 (18%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQWVDH---FFNEVNLISGINHKN 326
            LG G  G V         + VA+K     +    + +  D       E+ ++  +NH  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEG 380
           ++K+        +  +V E +    L D +   +         R                
Sbjct: 77  IIKIKN-FFDAEDYYIVLELMEGGELFDKVVGNK---------RLKEATCKLYFYQMLLA 126

Query: 381 LAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           + YLHE     IIHRD+K  N+LL   +E+   KI DFG  ++  E    +  TL GT  
Sbjct: 127 VQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET--SLMRTLCGTPT 181

Query: 438 YMAPEYVVRGKL----TEKADVYSFGVV 461
           Y+APE V+            D +S GV+
Sbjct: 182 YLAPE-VLVSVGTAGYNRAVDCWSLGVI 208

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  103 bits (258), Expect = 2e-24
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 39/210 (18%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK----RLFYNTTQWV-----DHFFNEVNLISGIN-H 324
            LG+G S  V +    P  +  AVK        + +        +    EV+++  ++ H
Sbjct: 24  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 83

Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTA 378
            N+++L     T     LV++ +    L D L  +                  KI+ +  
Sbjct: 84  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---------TLSEKETRKIMRALL 134

Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
           E +  LH+   L I+HRD+K  NILLD++   K+ DFG               + GT  Y
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSY 189

Query: 439 MAPEYVVRGKL-------TEKADVYSFGVV 461
           +APE ++   +        ++ D++S GV+
Sbjct: 190 LAPE-IIECSMNDNHPGYGKEVDMWSTGVI 218

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  101 bits (255), Expect = 3e-24
 Identities = 49/196 (25%), Positives = 82/196 (41%), Gaps = 22/196 (11%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           +LG+G    V +      G   A K     +L   + +       E  +   + H N+V+
Sbjct: 13  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL---SARDFQKLEREARICRKLQHPNIVR 69

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           L           LV++ V    L +++  R   E  S       I    E +AY H    
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS--- 123

Query: 390 LRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
             I+HR++K  N+LL    +    K+ADFGL     +         AGT GY++PE V++
Sbjct: 124 NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE-VLK 180

Query: 447 GKL-TEKADVYSFGVV 461
               ++  D+++ GV+
Sbjct: 181 KDPYSKPVDIWACGVI 196

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  103 bits (258), Expect = 4e-24
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 24/217 (11%)

Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW 308
           V   +  +N  Y           ++  LG G  G V+K      G  +A K +     + 
Sbjct: 78  VTAKQGAVNSFYT--------VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD 129

Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWE 368
            +   NE+++++ ++H NL++L     +  + +LV E+V    L D   + +       +
Sbjct: 130 KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDR-IIDESYNLTELD 188

Query: 369 VRY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPED 424
                K I    EG+ ++H   ++ I+H D+K  NIL    +    KI DFGL R +   
Sbjct: 189 TILFMKQIC---EGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242

Query: 425 ITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGV 460
                    GT  ++APE VV    ++   D++S GV
Sbjct: 243 --EKLKVNFGTPEFLAPE-VVNYDFVSFPTDMWSVGV 276

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  101 bits (254), Expect = 9e-24
 Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 26/196 (13%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           +LG+G +  VY+       +  A+K L    T        E+ ++  ++H N++KL    
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
            T  E  LV E V    L D +  +           Y        +    E +AYLHE  
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKG---------YYSERDAADAVKQILEAVAYLHE-- 166

Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
              I+HRD+K  N+L      +   KIADFGL ++       +  T+ GT GY APE + 
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ--VLMKTVCGTPGYCAPEILR 223

Query: 446 RGKLTEKADVYSFGVV 461
                 + D++S G++
Sbjct: 224 GCAYGPEVDMWSVGII 239

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  100 bits (252), Expect = 1e-23
 Identities = 53/182 (29%), Positives = 83/182 (45%), Gaps = 28/182 (15%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL-------FYNTTQWVDHFFNEVNLISGINHKN 326
            KLG G   +VYKG     G  VA+K +         +T         E++L+  + H+N
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTA------IREISLMKELKHEN 64

Query: 327 LVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           +V+L    I     L LV+EF+ N  +  +D+  V      L   +         +GLA+
Sbjct: 65  IVRLYDV-IHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI---THISATLAGTLGYMA 440
            HE    +I+HRD+K  N+L+++    K+ DFGL R F   +   +        TL Y A
Sbjct: 124 CHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV----TLWYRA 176

Query: 441 PE 442
           P+
Sbjct: 177 PD 178

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  100 bits (252), Expect = 2e-23
 Identities = 46/209 (22%), Positives = 86/209 (41%), Gaps = 38/209 (18%)

Query: 276 KLGQGGSGSVYKGTLPG-GEAVAVKRL--------FYNTTQWVDHFFNEVNLISGI-NHK 325
            +G+G S  V +      G   AVK +             +  +    E +++  +  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAE 379
           +++ L+    +     LV++ +    L D L  +         V         I+ S  E
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEK---------VALSEKETRSIMRSLLE 211

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            +++LH      I+HRD+K  NILLD+    +++DFG               L GT GY+
Sbjct: 212 AVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLRELCGTPGYL 266

Query: 440 APEYVVRGKL-------TEKADVYSFGVV 461
           APE +++  +        ++ D+++ GV+
Sbjct: 267 APE-ILKCSMDETHPGYGKEVDLWACGVI 294

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  101 bits (255), Expect = 2e-23
 Identities = 44/193 (22%), Positives = 82/193 (42%), Gaps = 15/193 (7%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           +LG+G    V +   +  G+  A   +     + +       E  +   + H N+V+L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                    L+++ V    L +++  R   E  S       I    E + + H+   + +
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQ---MGV 131

Query: 393 IHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
           +HR++K  N+LL    +    K+ADFGL      +        AGT GY++PE V+R   
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAGTPGYLSPE-VLRKDP 189

Query: 450 -TEKADVYSFGVV 461
             +  D+++ GV+
Sbjct: 190 YGKPVDLWACGVI 202

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 99.2 bits (248), Expect = 4e-23
 Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 29/217 (13%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-----EVNL---ISG 321
           +    ++G G  G+VYK      G  VA+K +                  EV L   +  
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70

Query: 322 INHKNLVKLL----GCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKII 374
             H N+V+L+             + LV+E V    ++ LD          L  E    ++
Sbjct: 71  FEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKA----PPPGLPAETIKDLM 126

Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDITHISATL 432
                GL +LH      I+HRD+K  NIL+    T K+ADFGL R++     +T     +
Sbjct: 127 RQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP----V 179

Query: 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
             TL Y APE +++       D++S G +  E+  RK
Sbjct: 180 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  100 bits (251), Expect = 4e-23
 Identities = 53/202 (26%), Positives = 85/202 (42%), Gaps = 14/202 (6%)

Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISG 321
               +Y+    +LG G  G V++      G     K  F NT   +D     NE+++++ 
Sbjct: 47  GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQ 104

Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
           ++H  L+ L        E +L+ EF+    L D +        +S       +    EGL
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEVINYMRQACEGL 162

Query: 382 AYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            ++HE     I+H DIK  NI+    +  + KI DFGL      D   I      T  + 
Sbjct: 163 KHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFA 217

Query: 440 APEYVVRGKLTEKADVYSFGVV 461
           APE V R  +    D+++ GV+
Sbjct: 218 APEIVDREPVGFYTDMWAIGVL 239

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 99.7 bits (249), Expect = 5e-23
 Identities = 49/193 (25%), Positives = 80/193 (41%), Gaps = 16/193 (8%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGINHKNLVKLLG 332
           +LG+G    V +      G   A K +        D      E  +   + H N+V+L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
                    LV++ V    L +++  R   E  S       I    E +AY H      I
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHS---NGI 149

Query: 393 IHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
           +HR++K  N+LL    +    K+ADFGL     +         AGT GY++PE V++   
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS--EAWHGFAGTPGYLSPE-VLKKDP 206

Query: 450 -TEKADVYSFGVV 461
            ++  D+++ GV+
Sbjct: 207 YSKPVDIWACGVI 219

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 97.7 bits (244), Expect = 7e-23
 Identities = 62/199 (31%), Positives = 91/199 (45%), Gaps = 19/199 (9%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK---RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           LG G  G V  G     G  VAVK   R    +   V     E+  +    H +++KL  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
              T  +  +V E+V    L D +     VE +  E R     ILS    + Y H   + 
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKHGRVEEM--EARRLFQQILS---AVDYCH---RH 130

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
            ++HRD+K  N+LLD    AKIADFGL  +  +       T  G+  Y APE V+ G+L 
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPE-VISGRLY 187

Query: 451 E--KADVYSFGVVVIEVVC 467
              + D++S GV++  ++C
Sbjct: 188 AGPEVDIWSCGVILYALLC 206

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 98.6 bits (246), Expect = 7e-23
 Identities = 54/208 (25%), Positives = 85/208 (40%), Gaps = 31/208 (14%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRL------FYNTTQWVDHFFNEVNLISGINHK--NL 327
           LG GG GSVY G  +     VA+K +       +           EV L+  ++     +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 328 VKLLGCSITGPESLLVYEFV-PNQSLLDNLFVRQDV-EPLSWEVRYK---IILSTAEGLA 382
           ++LL         +L+ E   P Q L D +  R  + E      R     ++    E + 
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEE---LARSFFWQVL----EAVR 163

Query: 383 YLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
           + H      ++HRDIK  NIL+D      K+ DFG   L  + +        GT  Y  P
Sbjct: 164 HCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPP 217

Query: 442 EYVVRGKLTE--KADVYSFGVVVIEVVC 467
           E  +R        A V+S G+++ ++VC
Sbjct: 218 E-WIRYHRYHGRSAAVWSLGILLYDMVC 244

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 98.3 bits (245), Expect = 1e-22
 Identities = 53/206 (25%), Positives = 82/206 (39%), Gaps = 27/206 (13%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK--------RLFYNTTQWVDHFFNEVNLISGINHKNL 327
           LG G  G V+        + V VK           +     +     E+ ++S + H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 328 VKLLGCSITGPESLLVYEF-VPNQSLLDNLFVRQDV-EPLSWEVRYKI--ILSTAEGLAY 383
           +K+L          LV E       L   +     + EP      Y    ++S    + Y
Sbjct: 92  IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEP---LASYIFRQLVS---AVGY 145

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           L       IIHRDIK  NI++ E+FT K+ DFG           +  T  GT+ Y APE 
Sbjct: 146 LR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG--KLFYTFCGTIEYCAPE- 199

Query: 444 VVRGKLTE--KADVYSFGVVVIEVVC 467
           V+ G      + +++S GV +  +V 
Sbjct: 200 VLMGNPYRGPELEMWSLGVTLYTLVF 225

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  100 bits (251), Expect = 1e-22
 Identities = 47/200 (23%), Positives = 81/200 (40%), Gaps = 12/200 (6%)

Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN 323
           +   +++    +LG G  G V++ T    G   A K +        +    E+  +S + 
Sbjct: 153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 212

Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           H  LV L        E +++YEF+    L + +    +   +S +   + +    +GL +
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCH 270

Query: 384 LHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
           +HE      +H D+K  NI+         K+ DFGL                GT  + AP
Sbjct: 271 MHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--QSVKVTTGTAEFAAP 325

Query: 442 EYVVRGK-LTEKADVYSFGV 460
           E V  GK +    D++S GV
Sbjct: 326 E-VAEGKPVGYYTDMWSVGV 344

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 97.2 bits (243), Expect = 2e-22
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 46/216 (21%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHKN 326
            K+G+G  G VYK     G  VA+KR+          +T         E++L+  ++H N
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTA------IREISLLKELHHPN 80

Query: 327 LVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           +V L+   I     L LV+EF+    + +LD          L        +     G+A+
Sbjct: 81  IVSLIDV-IHSERCLTLVFEFMEKDLKKVLDENKT-----GLQDSQIKIYLYQLLRGVAH 134

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMA 440
            H+    RI+HRD+K  N+L++ +   K+ADFGL R F       TH       TL Y A
Sbjct: 135 CHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRA 187

Query: 441 PE-------YVVRGKLTEKADVYSFGVVVIEVVCRK 469
           P+       Y      +   D++S G +  E++  K
Sbjct: 188 PDVLMGSKKY------STSVDIWSIGCIFAEMITGK 217

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 97.3 bits (243), Expect = 3e-22
 Identities = 51/180 (28%), Positives = 84/180 (46%), Gaps = 25/180 (13%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-----EVNLISGINHKNLV 328
           + LG+G   +VYK       + VA+K++            N     E+ L+  ++H N++
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 75

Query: 329 KLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
            LL        ++ LV++F+    + ++ +  +      L+       +L T +GL YLH
Sbjct: 76  GLLDA-FGHKSNISLVFDFMETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLH 129

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMAPE 442
           +     I+HRD+K +N+LLDE    K+ADFGL + F       TH       T  Y APE
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV----TRWYRAPE 182

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 44/224 (19%), Positives = 82/224 (36%), Gaps = 26/224 (11%)

Query: 252 VNKSKLNFSYETLEKATNYFHE-----SNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNT 305
            + S L   ++  E       +        LG G +G V +      G+  A+K L    
Sbjct: 7   HHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL---- 62

Query: 306 TQWVDHFFNEVN-LISGINHKNLVKLLG----CSITGPESLLVYEFVPNQSLLDNLFVRQ 360
                    EV+         ++V +L             L++ E +    L   +   +
Sbjct: 63  -YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI-QER 120

Query: 361 DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGL 417
             +  +     +I+      + +LH      I HRD+K  N+L    +++   K+ DFG 
Sbjct: 121 GDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGF 177

Query: 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            +   ++      T   T  Y+APE +   K  +  D++S GV+
Sbjct: 178 AKETTQNALQ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVI 218

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.9 bits (242), Expect = 3e-22
 Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 25/211 (11%)

Query: 265 EKATNYFHESNKLGQGGSGSVY----KGTLPGGEAVAVK----RLFYNTTQWVDH--FFN 314
           +K  +++    +LG G    V     K T   G   A K    R    + + V       
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKST---GLEYAAKFIKKRQSRASRRGVSREEIER 64

Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKII 374
           EV+++  + H N++ L        + +L+ E V    L D L  +   E LS E     I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFI 121

Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHISA 430
               +G+ YLH     +I H D+K  NI+L          K+ DFGL     +       
Sbjct: 122 KQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFK 176

Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
            + GT  ++APE V    L  +AD++S GV+
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 47/204 (23%), Positives = 83/204 (40%), Gaps = 27/204 (13%)

Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKN 326
           +   +   LG+G      K       +A AVK +   + +   +   E+  +     H N
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPN 67

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEG 380
           +VKL         + LV E +    L + +  ++          +       I+      
Sbjct: 68  IVKLHEVFHDQLHTFLVMELLNGGELFERIKKKK---------HFSETEASYIMRKLVSA 118

Query: 381 LAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           ++++H+   + ++HRD+K  N+L    ++    KI DFG  RL P D      T   TL 
Sbjct: 119 VSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPLKTPCFTLH 174

Query: 438 YMAPEYVVRGKLTEKADVYSFGVV 461
           Y APE + +    E  D++S GV+
Sbjct: 175 YAAPELLNQNGYDESCDLWSLGVI 198

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 96.0 bits (240), Expect = 3e-22
 Identities = 56/179 (31%), Positives = 81/179 (45%), Gaps = 27/179 (15%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFN-----EVNLISGINHKNLVK 329
            K+G+G  G VYK     GE  A+K++        D         E++++  + H N+VK
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKE---DEGIPSTTIREISILKELKHSNIVK 64

Query: 330 LLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           L    I   + L LV+E +    + LLD          L        +L    G+AY H+
Sbjct: 65  LYDV-IHTKKRLVLVFEHLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHD 118

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYMAPE 442
               R++HRD+K  N+L++ E   KIADFGL R F       TH       TL Y AP+
Sbjct: 119 R---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV----TLWYRAPD 170

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 95.8 bits (239), Expect = 4e-22
 Identities = 54/223 (24%), Positives = 89/223 (39%), Gaps = 52/223 (23%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK-----RLFYNTTQW---------------------V 309
           +G+G  G V            A+K     +L                            +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESL---LVYEFVPNQSLLDNLFVRQDVEPLS 366
           +  + E+ ++  ++H N+VKL+   +  P      +V+E V    +++         PLS
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPVME--VPTLK--PLS 135

Query: 367 WEV--RY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP 422
            +    Y   +I     G+ YLH     +IIHRDIK SN+L+ E+   KIADFG+   F 
Sbjct: 136 EDQARFYFQDLIK----GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF- 187

Query: 423 EDITHISATLAGTLGYMAPEYVVRGKLTE----KADVYSFGVV 461
           +    + +   GT  +MAPE  +            DV++ GV 
Sbjct: 188 KGSDALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVT 229

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 95.8 bits (239), Expect = 6e-22
 Identities = 50/208 (24%), Positives = 80/208 (38%), Gaps = 36/208 (17%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCS 334
           LG+G    V     L   +  AVK +           F EV ++     H+N+++L+   
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KIILSTAEGLAYLHEES 388
                  LV+E +   S+L ++  R+          +       ++   A  L +LH   
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRR---------HFNELEASVVVQDVASALDFLHN-- 129

Query: 389 KLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISA------TLAGTLGYM 439
              I HRD+K  NIL    ++    KI DF L      +            T  G+  YM
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 440 APEYVVRGKLT------EKADVYSFGVV 461
           APE VV           ++ D++S GV+
Sbjct: 189 APE-VVEAFSEEASIYDKRCDLWSLGVI 215

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 94.2 bits (235), Expect = 1e-21
 Identities = 61/195 (31%), Positives = 93/195 (47%), Gaps = 22/195 (11%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN---EVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK +  +  + VD   N   E+ +   +NH+N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAYLHEESK 389
               G    L  E+     L D +        +   + +     +++   G+ YLH    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMA---GVVYLH---G 123

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE +++ +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRR 182

Query: 449 L--TEKADVYSFGVV 461
               E  DV+S G+V
Sbjct: 183 EFHAEPVDVWSCGIV 197

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 97.6 bits (243), Expect = 1e-21
 Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 19/199 (9%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK---RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           LG G  G V  G     G  VAVK   R    +   V     E+  +    H +++KL  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
              T  +  +V E+V    L D +     ++    E R     ILS   G+ Y H   + 
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGRLDEK--ESRRLFQQILS---GVDYCH---RH 135

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
            ++HRD+K  N+LLD    AKIADFGL  +  +       T  G+  Y APE V+ G+L 
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRTSCGSPNYAAPE-VISGRLY 192

Query: 451 E--KADVYSFGVVVIEVVC 467
              + D++S GV++  ++C
Sbjct: 193 AGPEVDIWSSGVILYALLC 211

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 58/221 (26%), Positives = 93/221 (42%), Gaps = 39/221 (17%)

Query: 271 FHESNKLGQGGSGSVYKG--TLPGGEAVAVKRL--------FYNTTQWVDHFFNEVNL-- 318
           +    ++G+G  G V+K      GG  VA+KR+           +T        EV +  
Sbjct: 13  YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLST------IREVAVLR 66

Query: 319 -ISGINHKNLVKLL----GCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVR 370
            +    H N+V+L              L LV+E V     + LD +        +  E  
Sbjct: 67  HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPGVPTETI 122

Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDITHI 428
             ++     GL +LH     R++HRD+K  NIL+      K+ADFGL R++     +T  
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTS- 178

Query: 429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
              +  TL Y APE +++       D++S G +  E+  RK
Sbjct: 179 ---VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 46/183 (25%), Positives = 78/183 (42%), Gaps = 34/183 (18%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHK 325
            K+G+G  G+V+K       E VA+KR+          ++         E+ L+  + HK
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSA------LREICLLKELKHK 61

Query: 326 NLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           N+V+L    +   + L LV+EF     +   D+         L  E+    +    +GL 
Sbjct: 62  NIVRLHDV-LHSDKKLTLVFEFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLG 115

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYM 439
           + H      ++HRD+K  N+L++     K+A+FGL R F       +        TL Y 
Sbjct: 116 FCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV----TLWYR 168

Query: 440 APE 442
            P+
Sbjct: 169 PPD 171

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 95.0 bits (237), Expect = 1e-21
 Identities = 51/237 (21%), Positives = 86/237 (36%), Gaps = 31/237 (13%)

Query: 237 QKRRERKQLGALQVAVNK-SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGE 294
                   LG   +        N  Y    K         +LG+G    V +      G+
Sbjct: 5   HHHSSGVDLGTENLYFQSMENFNNFYILTSK---------ELGRGKFAVVRQCISKSTGQ 55

Query: 295 AVAVK--RLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYEFVPNQS 351
             A K  +             +E+ ++        ++ L        E +L+ E+     
Sbjct: 56  EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115

Query: 352 LLDNLFVRQDVEPLS-WEVRY--KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---D 405
           +     + +  E +S  +V    K IL   EG+ YLH+     I+H D+K  NILL    
Sbjct: 116 IFSLC-LPELAEMVSENDVIRLIKQIL---EGVYYLHQ---NNIVHLDLKPQNILLSSIY 168

Query: 406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVV 461
                KI DFG+ R            + GT  Y+APE ++    +T   D+++ G++
Sbjct: 169 PLGDIKIVDFGMSRKIGHA--CELREIMGTPEYLAPE-ILNYDPITTATDMWNIGII 222

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 50/186 (26%), Positives = 82/186 (44%), Gaps = 33/186 (17%)

Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRL-------FYNTTQWVDHFFNEVNLISGI 322
           + + +KLG+G   +VYKG        VA+K +          T         EV+L+  +
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTA------IREVSLLKDL 57

Query: 323 NHKNLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
            H N+V L    I   +SL LV+E++    +  LD+         ++       +     
Sbjct: 58  KHANIVTLHDI-IHTEKSLTLVFEYLDKDLKQYLDDCGN-----IINMHNVKLFLFQLLR 111

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTL 436
           GLAY H +   +++HRD+K  N+L++E    K+ADFGL R      +   +       TL
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----TL 164

Query: 437 GYMAPE 442
            Y  P+
Sbjct: 165 WYRPPD 170

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 53/198 (26%), Positives = 85/198 (42%), Gaps = 21/198 (10%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK----RLFYNTTQWVDH--FFNEVNLISGINHKNLV 328
           +LG G    V K      G+  A K    R   ++ + V       EVN++  I H N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            L        + +L+ E V    L D L  +   E L+ +   + +    +G+ YLH   
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHS-- 126

Query: 389 KLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
             RI H D+K  NI+L          K+ DFG+              + GT  ++APE +
Sbjct: 127 -KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF--KNIFGTPEFVAPE-I 182

Query: 445 VRGK-LTEKADVYSFGVV 461
           V  + L  +AD++S GV+
Sbjct: 183 VNYEPLGLEADMWSIGVI 200

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 94.1 bits (235), Expect = 2e-21
 Identities = 57/183 (31%), Positives = 85/183 (46%), Gaps = 33/183 (18%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHK 325
            K+G+G  G VYK      GE VA+K++          +T         E++L+  +NH 
Sbjct: 9   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTA------IREISLLKELNHP 62

Query: 326 NLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           N+VKLL   I     L LV+EF+    +  +D   +      +   +    +    +GLA
Sbjct: 63  NIVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASALT----GIPLPLIKSYLFQLLQGLA 117

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTLGYM 439
           + H     R++HRD+K  N+L++ E   K+ADFGL R F       TH       TL Y 
Sbjct: 118 FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYR 170

Query: 440 APE 442
           APE
Sbjct: 171 APE 173

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 94.6 bits (236), Expect = 2e-21
 Identities = 61/224 (27%), Positives = 86/224 (38%), Gaps = 43/224 (19%)

Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDH 311
           YE L            +G+G  G V K      G  VA+K+                   
Sbjct: 27  YENLGL----------VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIA----- 71

Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN--QSLLDNLFVRQDVEPLSWEV 369
              E+ L+  + H+NLV LL          LV+EFV +     L+          L ++V
Sbjct: 72  -MREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN-----GLDYQV 125

Query: 370 RYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDIT 426
             K +     G+ + H      IIHRDIK  NIL+ +    K+ DFG  R      E   
Sbjct: 126 VQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD 182

Query: 427 HISATLAGTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRK 469
              AT      Y APE +V      KA DV++ G +V E+   +
Sbjct: 183 DEVATRW----YRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 94.7 bits (236), Expect = 2e-21
 Identities = 61/195 (31%), Positives = 93/195 (47%), Gaps = 22/195 (11%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN---EVNLISGINHKNLVKLLG 332
           LG+G  G V         EAVAVK +  +  + VD   N   E+ +   +NH+N+VK  G
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIV--DMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAYLHEESK 389
               G    L  E+     L D +        +   + +     +++   G+ YLH    
Sbjct: 73  HRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMA---GVVYLH---G 123

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEYVVRGK 448
           + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE +++ +
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE-LLKRR 182

Query: 449 L--TEKADVYSFGVV 461
               E  DV+S G+V
Sbjct: 183 EFHAEPVDVWSCGIV 197

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 53/208 (25%), Positives = 83/208 (39%), Gaps = 19/208 (9%)

Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK------RLFYNTTQWVDHFFNEVN 317
           +K  +++    +LG G    V K      G   A K                +    EV+
Sbjct: 8   QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67

Query: 318 LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
           ++  + H N++ L        + +L+ E V    L D L  +   E LS E     I   
Sbjct: 68  ILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFIKQI 124

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVRLFPEDITHISATLA 433
            +G+ YLH     +I H D+K  NI+L          K+ DFGL     +        + 
Sbjct: 125 LDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG--VEFKNIF 179

Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVV 461
           GT  ++APE V    L  +AD++S GV+
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVI 207

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 95.0 bits (237), Expect = 2e-21
 Identities = 52/237 (21%), Positives = 97/237 (40%), Gaps = 48/237 (20%)

Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN---- 314
           + E   K  + F      GQG  G+V  G     G +VA+K++  +       F N    
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-----FRNRELQ 68

Query: 315 EVNLISGINHKNLVKLLGCSITGPES-------LLVYEFVP---NQSLLDNLFVRQDVEP 364
            +  ++ ++H N+V+L     T  E         +V E+VP   ++   +    +    P
Sbjct: 69  IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPP 128

Query: 365 LSWEVRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLF 421
           +   ++  +  ++     +  LH  S + + HRDIK  N+L++E   T K+ DFG  +  
Sbjct: 129 I--LIKVFLFQLI---RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 422 PEDITHIS--ATLAGTLGYMAPE-------YVVRGKLTEKADVYSFGVVVIEVVCRK 469
                +++   +      Y APE       Y      T   D++S G +  E++  +
Sbjct: 183 SPSEPNVAYICSRY----YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 94.3 bits (235), Expect = 3e-21
 Identities = 55/199 (27%), Positives = 94/199 (47%), Gaps = 20/199 (10%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK---RLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           LG+G  G V   T     + VA+K   R     +        E++ +  + H +++KL  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76

Query: 333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKL 390
              T  + ++V E+   + L D +  ++ +     E R     I+     + Y H   + 
Sbjct: 77  VITTPTDIVMVIEYAGGE-LFDYIVEKKRMTE--DEGRRFFQQIIC---AIEYCH---RH 127

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           +I+HRD+K  N+LLD+    KIADFGL  +  +   +   T  G+  Y APE V+ GKL 
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--NFLKTSCGSPNYAAPE-VINGKLY 184

Query: 451 E--KADVYSFGVVVIEVVC 467
              + DV+S G+V+  ++ 
Sbjct: 185 AGPEVDVWSCGIVLYVMLV 203

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 95.2 bits (237), Expect = 3e-21
 Identities = 48/202 (23%), Positives = 79/202 (39%), Gaps = 20/202 (9%)

Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKN 326
           +Y   S  LG G +G V +       E  A+K L     Q       EV          +
Sbjct: 62  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 116

Query: 327 LVKLLGC---SITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           +V+++        G + L +V E +    L   +   +  +  +     +I+ S  E + 
Sbjct: 117 IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 383 YLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           YLH    + I HRD+K  N+L          K+ DFG  +       +   T   T  Y+
Sbjct: 176 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYV 230

Query: 440 APEYVVRGKLTEKADVYSFGVV 461
           APE +   K  +  D++S GV+
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVI 252

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 93.1 bits (232), Expect = 4e-21
 Identities = 56/210 (26%), Positives = 88/210 (41%), Gaps = 33/210 (15%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYN-TTQWVD-----HFFNEVN----LISGINHK 325
           LG+GG G+V+ G  L     VA+K +  N    W           EV     + +G  H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 326 NLVKLLGCSITGPESLLVYEF-VPNQSLLDNLFVRQDV-EPLSWEVRYK---IILSTAEG 380
            +++LL    T    +LV E  +P Q L D +  +  + E      R     ++      
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEG---PSRCFFGQVV----AA 151

Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           + + H      ++HRDIK  NIL+D     AK+ DFG   L  ++         GT  Y 
Sbjct: 152 IQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT---DFDGTRVYS 205

Query: 440 APEYVVRGKLTE--KADVYSFGVVVIEVVC 467
            PE  +         A V+S G+++ ++VC
Sbjct: 206 PPE-WISRHQYHALPATVWSLGILLYDMVC 234

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 95.6 bits (238), Expect = 5e-21
 Identities = 55/226 (24%), Positives = 98/226 (43%), Gaps = 26/226 (11%)

Query: 256 KLNFSYETLEKAT-NYFHESNKLGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQ 307
            L + +   +    ++F +   LG+GG G V+    K T   G+  A K+L        +
Sbjct: 171 FLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKAT---GKLYACKKLNKKRLKKRK 227

Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLS 366
                  E  +++ ++ + +V L     T    L LV   +    +  +++   +  P  
Sbjct: 228 GYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCLVMTIMNGGDIRYHIYNVDEDNPGF 286

Query: 367 WEVRYK-----IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
            E R       I+     GL +LH+     II+RD+K  N+LLD++   +I+D GL    
Sbjct: 287 QEPRAIFYTAQIVS----GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVEL 339

Query: 422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
               T      AGT G+MAPE ++  +     D ++ GV + E++ 
Sbjct: 340 KAGQTKTK-GYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 93.1 bits (232), Expect = 6e-21
 Identities = 38/209 (18%), Positives = 72/209 (34%), Gaps = 31/209 (14%)

Query: 265 EKATNYFHESNKLGQGGSGSVY----KGTLPGGEAVAVKRLFYNTTQW-VDHFFNEVNLI 319
           ++    +  +  LG+G  G V+      +    +    K  F             E++++
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSS---KKTYMAK--FVKVKGTDQVLVKKEISIL 55

Query: 320 SGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY------KI 373
           +   H+N++ L     +  E ++++EF+    + + +                       
Sbjct: 56  NIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTS--------AFELNEREIVSY 107

Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHISAT 431
           +    E L +LH      I H DI+  NI+       T KI +FG  R            
Sbjct: 108 VHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG--DNFRL 162

Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGV 460
           L     Y APE      ++   D++S G 
Sbjct: 163 LFTAPEYYAPEVHQHDVVSTATDMWSLGT 191

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 92.2 bits (230), Expect = 8e-21
 Identities = 56/220 (25%), Positives = 90/220 (40%), Gaps = 35/220 (15%)

Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKG----TLPGGEAVAVKRL-FYNTTQWVDHF-FN 314
           YE + K          +G+G  G V+K     T   G+ VA+K+         +      
Sbjct: 5   YEKIGK----------IGEGSYGVVFKCRNRDT---GQIVAIKKFLESEDDPVIKKIALR 51

Query: 315 EVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKI 373
           E+ ++  + H NLV LL         L LV+E+  + ++L    + +    +   +   I
Sbjct: 52  EIRMLKQLKHPNLVNLLEV-FRRKRRLHLVFEYC-DHTVLH--ELDRYQRGVPEHLVKSI 107

Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF--PEDI-THISA 430
              T + + + H   K   IHRD+K  NIL+ +    K+ DFG  RL   P D      A
Sbjct: 108 TWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164

Query: 431 TLAGTLGYMAPEYVVRGKLTEKA-DVYSFGVVVIEVVCRK 469
               T  Y +PE +V         DV++ G V  E++   
Sbjct: 165 ----TRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 92.7 bits (231), Expect = 9e-21
 Identities = 43/226 (19%), Positives = 85/226 (37%), Gaps = 33/226 (14%)

Query: 252 VNKSKLNFSYETLEKATNYFHE----SNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTT 306
           +    ++   + L + +  F +       +G G      +          AVK +  + +
Sbjct: 1   MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII--DKS 58

Query: 307 QWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
           +       E+  L+    H N++ L      G    +V E +    LLD +  ++     
Sbjct: 59  K--RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQK----- 111

Query: 366 SWEVRY------KIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADF 415
                +       ++ +  + + YLH      ++HRD+K SNIL         + +I DF
Sbjct: 112 ----FFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDF 164

Query: 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVV 461
           G  +    +   +  T   T  ++APE + R       D++S GV+
Sbjct: 165 GFAKQLRAE-NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVL 209

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 92.3 bits (230), Expect = 9e-21
 Identities = 57/225 (25%), Positives = 86/225 (38%), Gaps = 53/225 (23%)

Query: 265 EKATNYFHESNKLGQGGSGSVY----KGTLPGGEAVAVKRL------FYNTTQWVDHFFN 314
           E   +Y+    +LG G    V     K T   G   A K +              +    
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKST---GLQYAAKFIKKRRTKSSRRGVSREDIER 63

Query: 315 EVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNL-------------FVRQD 361
           EV+++  I H N++ L        + +L+ E V    L D L             F++Q 
Sbjct: 64  EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ- 122

Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGL 417
                       IL    G+ YLH    L+I H D+K  NI+L      +   KI DFGL
Sbjct: 123 ------------IL---NGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164

Query: 418 VRLFPEDITHISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVV 461
                         + GT  ++APE +V  + L  +AD++S GV+
Sbjct: 165 AHKIDFGNEF--KNIFGTPEFVAPE-IVNYEPLGLEADMWSIGVI 206

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 50/203 (24%), Positives = 82/203 (40%), Gaps = 31/203 (15%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVK----RLFYNTTQWVDHFFNEVNLISGINHKNLVKLL 331
           LG+G  G V +          AVK    +          +   E+ L+  + HKN+++L+
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 332 GCSITGPES----LLVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYK---IILSTAEGLA 382
              +   E      +V E+     Q +LD++  ++       +       +I    +GL 
Sbjct: 73  --DVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV---CQAHGYFCQLI----DGLE 123

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAP 441
           YLH      I+H+DIK  N+LL    T KI+  G+     P        T  G+  +  P
Sbjct: 124 YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPP 180

Query: 442 EYVVRGKLT---EKADVYSFGVV 461
           E +  G  T    K D++S GV 
Sbjct: 181 E-IANGLDTFSGFKVDIWSAGVT 202

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 55/209 (26%), Positives = 91/209 (43%), Gaps = 30/209 (14%)

Query: 276 KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFN-EVNLISGINHKNLVKLLGC 333
            +G G  G VY+  L   GE VA+K++  +       F N E+ ++  ++H N+V+L   
Sbjct: 61  VIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-----FKNRELQIMRKLDHCNIVRLRYF 115

Query: 334 SITGPESL------LVYEFVP---NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
             +  E        LV ++VP    +        +Q +  +   V+   +      LAY+
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVI--YVKL-YMYQLFRSLAYI 172

Query: 385 HEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAP 441
           H      I HRDIK  N+LLD +    K+ DFG  +       ++S   +      Y AP
Sbjct: 173 H---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY----YRAP 225

Query: 442 EYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
           E +      T   DV+S G V+ E++  +
Sbjct: 226 ELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 91.5 bits (228), Expect = 2e-20
 Identities = 50/194 (25%), Positives = 83/194 (42%), Gaps = 36/194 (18%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISG 321
           + +  K+GQG  G V+K      G+ VA+K++        F  T         E+ ++  
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITA------LREIKILQL 72

Query: 322 INHKNLVKLLG-------CSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRY 371
           + H+N+V L+               S+ LV++F  +    LL N+ V       +     
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIK 127

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT 431
           +++     GL Y+H     +I+HRD+K +N+L+  +   K+ADFGL R F          
Sbjct: 128 RVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNR 184

Query: 432 LAG---TLGYMAPE 442
                 TL Y  PE
Sbjct: 185 YTNRVVTLWYRPPE 198

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 53/188 (28%), Positives = 76/188 (40%), Gaps = 40/188 (21%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL--------FYNTTQWVDHFFNEVNLISGINHK 325
            KLG+G  G VYK       E VA+KR+           T         EV+L+  + H+
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTA------IREVSLLKELQHR 93

Query: 326 NLVKLLGCSITGPESL-LVYEFVPN--QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           N+++L    I     L L++E+  N  +  +D          +S  V    +     G+ 
Sbjct: 94  NIIELKSV-IHHNHRLHLIFEYAENDLKKYMDKN------PDVSMRVIKSFLYQLINGVN 146

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTA-----KIADFGLVRLF---PEDITHISATLAG 434
           + H     R +HRD+K  N+LL     +     KI DFGL R F       TH       
Sbjct: 147 FCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII---- 199

Query: 435 TLGYMAPE 442
           TL Y  PE
Sbjct: 200 TLWYRPPE 207

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 91.6 bits (228), Expect = 4e-20
 Identities = 53/223 (23%), Positives = 95/223 (42%), Gaps = 31/223 (13%)

Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFN--EVNLI 319
           +T E+    +     +G G  G V++  L   + VA+K++        D  F   E+ ++
Sbjct: 33  KTGEQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVL------QDKRFKNRELQIM 86

Query: 320 SGINHKNLVKLLGCSITGPESL------LVYEFVP---NQSLLDNLFVRQDVEPLSWEVR 370
             + H N+V L     +  +        LV E+VP    ++      ++Q +  L   ++
Sbjct: 87  RIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPML--LIK 144

Query: 371 YKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHIS 429
              +      LAY+H    + I HRDIK  N+LLD      K+ DFG  ++      ++S
Sbjct: 145 L-YMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS 200

Query: 430 --ATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
              +      Y APE +      T   D++S G V+ E++  +
Sbjct: 201 YICSRY----YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 92.5 bits (230), Expect = 5e-20
 Identities = 64/224 (28%), Positives = 98/224 (43%), Gaps = 25/224 (11%)

Query: 256 KLNFSYETLEKAT-NYFHESNKLGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQ 307
            L + +   +  T N F +   LG+GG G V     + T   G+  A K+L        +
Sbjct: 170 FLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRAT---GKMYACKKLEKKRIKKRK 226

Query: 308 WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLS 366
                 NE  ++  +N + +V L     T  ++L LV   +    L  ++      +   
Sbjct: 227 GEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLTLMNGGDLKFHI--YHMGQAGF 283

Query: 367 WEVRYKIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE 423
            E R       AE   GL  LH E   RI++RD+K  NILLD+    +I+D GL    PE
Sbjct: 284 PEARAVFY--AAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338

Query: 424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
             T       GT+GYMAPE V   + T   D ++ G ++ E++ 
Sbjct: 339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIA 380

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.3 bits (229), Expect = 9e-20
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 31/206 (15%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN--- 326
           +G+GG G VY      T   G+  A+K L        Q      NE  ++S ++  +   
Sbjct: 197 IGRGGFGEVYGCRKADT---GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 327 LVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLA 382
           +V +     T P+ L  + + +    L  +L  +  V   +    Y      AE   GL 
Sbjct: 254 IVCMSYAFHT-PDKLSFILDLMNGGDLHYHLS-QHGVFSEADMRFY-----AAEIILGLE 306

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           ++H      +++RD+K +NILLDE    +I+D GL   F +   H      GT GYMAPE
Sbjct: 307 HMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH---ASVGTHGYMAPE 360

Query: 443 YVVRGKL-TEKADVYSFGVVVIEVVC 467
            + +G      AD +S G ++ +++ 
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLR 386

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 90.5 bits (225), Expect = 9e-20
 Identities = 54/172 (31%), Positives = 77/172 (44%), Gaps = 25/172 (14%)

Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDV---EP 364
           V + F E+ ++ G+ H  LV L        E + +V + +    L  +L  +Q+V   E 
Sbjct: 59  VRNVFKELQIMQGLEHPFLVNLWYSFQD-EEDMFMVVDLLLGGDLRYHL--QQNVHFKEE 115

Query: 365 LSWEVRYKIILSTAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF 421
               V+  I     E    L YL      RIIHRD+K  NILLDE     I DF +  + 
Sbjct: 116 ---TVKLFI----CELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAML 165

Query: 422 PEDITHISATLAGTLGYMAPEYVVRGKL---TEKADVYSFGVVVIEVVCRKR 470
           P +      T+AGT  YMAPE     K    +   D +S GV   E++  +R
Sbjct: 166 PRETQI--TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 88.6 bits (220), Expect = 3e-19
 Identities = 52/194 (26%), Positives = 80/194 (41%), Gaps = 23/194 (11%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD-HFFNEVNLISGINHKNLVKLLGCS 334
           +G G  G           E VAVK  +      +D +   E+     + H N+V+     
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVK--YIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDV-EPLSWEVRYKI--ILSTAEGLAYLHEESKLR 391
           +T     ++ E+     L + +       E    E R+    +LS   G++Y H    ++
Sbjct: 86  LTPTHLAIIMEYASGGELYERICNAGRFSED---EARFFFQQLLS---GVSYCH---SMQ 136

Query: 392 IIHRDIKLSNILLDEEFTA--KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
           I HRD+KL N LLD       KI DFG  +           +  GT  Y+APE V+  + 
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH--SQPKSTVGTPAYIAPE-VLLRQE 193

Query: 450 TE--KADVYSFGVV 461
            +   ADV+S GV 
Sbjct: 194 YDGKIADVWSCGVT 207

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 87.7 bits (218), Expect = 3e-19
 Identities = 55/207 (26%), Positives = 89/207 (42%), Gaps = 33/207 (15%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
           LG+G   +V       T       A+K L         + V +   E +++S ++H   V
Sbjct: 38  LGEGSFSTVVLARELAT---SREYAIKILEKRHIIKENK-VPYVTRERDVMSRLDHPFFV 93

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEV-R-YKIILSTAE---GLA 382
           KL        E L     +  N  LL  +   + +        R Y     TAE    L 
Sbjct: 94  KLYFTFQD-DEKLYFGLSYAKNGELLKYI---RKIGSFDETCTRFY-----TAEIVSALE 144

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA-TLAGTLGYMAP 441
           YLH      IIHRD+K  NILL+E+   +I DFG  ++   +     A +  GT  Y++P
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 201

Query: 442 EYVVRGKLTEKA-DVYSFGVVVIEVVC 467
           E ++  K   K+ D+++ G ++ ++V 
Sbjct: 202 E-LLTEKSACKSSDLWALGCIIYQLVA 227

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 88.3 bits (219), Expect = 6e-19
 Identities = 48/210 (22%), Positives = 86/210 (40%), Gaps = 33/210 (15%)

Query: 254 KSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKG---TLPGGEAVAVKRL----FYNTT 306
           K KL+   E +E    Y  E  K+G+G  G VYK         +  A+K++       + 
Sbjct: 8   KVKLSSERERVEDLFEY--EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA 65

Query: 307 QWVDHFFNEVNLISGINHKNLVKLLG-CSITGPESL-LVYEFVPN--QSLLDNLFVRQDV 362
                   E+ L+  + H N++ L           + L++++  +    ++      +  
Sbjct: 66  C------REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKAN 119

Query: 363 E---PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA----KIADF 415
           +    L   +   ++    +G+ YLH      ++HRD+K +NIL+  E       KIAD 
Sbjct: 120 KKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADM 176

Query: 416 GLVRLF---PEDITHISATLAGTLGYMAPE 442
           G  RLF    + +  +   +  T  Y APE
Sbjct: 177 GFARLFNSPLKPLADLDPVVV-TFWYRAPE 205

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 87.1 bits (216), Expect = 2e-18
 Identities = 53/208 (25%), Positives = 84/208 (40%), Gaps = 30/208 (14%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVK 329
           +G+G  G V     K      +  A+K L             F  E +++   + K +  
Sbjct: 82  IGRGAFGEVAVVKLKNA---DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITT 138

Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLH 385
           L   +     +L LV ++     LL  L   +D  P      Y      AE    +  +H
Sbjct: 139 LH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY-----LAEMVIAIDSVH 192

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
              +L  +HRDIK  NIL+D     ++ADFG      ED T  S+   GT  Y++PE ++
Sbjct: 193 ---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPE-IL 248

Query: 446 RGKLTEK------ADVYSFGVVVIEVVC 467
           +     K       D +S GV + E++ 
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLY 276

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 85.6 bits (212), Expect = 6e-18
 Identities = 59/207 (28%), Positives = 84/207 (40%), Gaps = 34/207 (16%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
           LG+G  G V     K T   G   A+K L          V H   E  ++    H  L  
Sbjct: 156 LGKGTFGKVILVKEKAT---GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212

Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE---GLA 382
           L     T  + L  V E+         LF       LS E  +    +    AE    L 
Sbjct: 213 LKYSFQT-HDRLCFVMEYANG----GELFFH-----LSRERVFSEDRARFYGAEIVSALD 262

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMA 440
           YLH  S+  +++RD+KL N++LD++   KI DFGL +  +          T  GT  Y+A
Sbjct: 263 YLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMK---TFCGTPEYLA 317

Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVC 467
           PE +         D +  GVV+ E++C
Sbjct: 318 PEVLEDNDYGRAVDWWGLGVVMYEMMC 344

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 59/207 (28%), Positives = 82/207 (39%), Gaps = 35/207 (16%)

Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
           LG+G  G V     K T   G   A+K L          V H   E  ++    H  L  
Sbjct: 13  LGKGTFGKVILVREKAT---GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTA 69

Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE---GLA 382
           L     T  + L  V E+         LF       LS E  +    +    AE    L 
Sbjct: 70  LKYAFQT-HDRLCFVMEYANG----GELFFH-----LSRERVFTEERARFYGAEIVSALE 119

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMA 440
           YLH      +++RDIKL N++LD++   KI DFGL +  +          T  GT  Y+A
Sbjct: 120 YLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK---TFCGTPEYLA 173

Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVC 467
           PE +         D +  GVV+ E++C
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMC 200

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 80.9 bits (200), Expect = 4e-17
 Identities = 22/192 (11%), Positives = 46/192 (23%), Gaps = 44/192 (22%)

Query: 276 KLGQGGSGSVYKGT---LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
             G       ++     L     VA+  +          +    +    +S I+   + +
Sbjct: 38  FHGGVPPLQFWQALDTAL--DRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVAR 95

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           +L    T    L+V E++   SL +           S     + + S A      H    
Sbjct: 96  VLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHRAG- 149

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
             +       S + +  +    +A                         M          
Sbjct: 150 --VALSIDHPSRVRVSIDGDVVLAYP---------------------ATMPDA------- 179

Query: 450 TEKADVYSFGVV 461
             + D+   G  
Sbjct: 180 NPQDDIRGIGAS 191

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 83.0 bits (205), Expect = 4e-17
 Identities = 63/234 (26%), Positives = 107/234 (45%), Gaps = 30/234 (12%)

Query: 253 NKSKLNFSYETLEKATNYFHESNK------LGQGGSGSVYKGT-LPGGEAVAVKRL---F 302
           +KSK++  + ++E   + F    +      +G G  G V           VA+K+L   F
Sbjct: 40  SKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF 99

Query: 303 YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDN 355
            N T      + E+ L+  +NHKN++ LL    T  ++L       LV E +   + L  
Sbjct: 100 QNQTH-AKRAYRELVLMKCVNHKNIISLLNV-FTPQKTLEEFQDVYLVMELM--DANLCQ 155

Query: 356 LFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF 415
           + ++ +++     + Y ++     G+ +LH      IIHRD+K SNI++  + T KI DF
Sbjct: 156 V-IQMELDHE--RMSY-LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDF 208

Query: 416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
           GL R        +      T  Y APE ++     E  D++S G ++ E+V  K
Sbjct: 209 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 82.0 bits (203), Expect = 4e-17
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 32/204 (15%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
           LG G  G V     K +   G   A+K L         Q ++H  NE  ++  +N   LV
Sbjct: 49  LGTGSFGRVMLVKHKES---GNHYAMKILDKQKVVKLKQ-IEHTLNEKRILQAVNFPFLV 104

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
           KL         +L +V E+V    +  +L   + +   S E   +     A+      YL
Sbjct: 105 KLEFSFKD-NSNLYMVMEYVAGGEMFSHL---RRIGRFS-EPHARFY--AAQIVLTFEYL 157

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
           H    L +I+RD+K  N+L+D++   ++ DFG  +   +  T    TL GT   +APE +
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTW---TLCGTPEALAPE-I 209

Query: 445 VRGKLTEKA-DVYSFGVVVIEVVC 467
           +  K   KA D ++ GV++ E+  
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAA 233

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 83.5 bits (206), Expect = 5e-17
 Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 30/205 (14%)

Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
           LG+G  G V     KGT    E  AVK L          V+    E   L        L 
Sbjct: 349 LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
           +L  C  T  + L  V E+V    L+ ++  +         V Y      AE   GL +L
Sbjct: 406 QLHSCFQT-MDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFY-----AAEIAIGLFFL 458

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPE 442
                  II+RD+KL N++LD E   KIADFG+ +  ++    T    T  GT  Y+APE
Sbjct: 459 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK---TFCGTPDYIAPE 512

Query: 443 YVVRGKLTEKADVYSFGVVVIEVVC 467
            +      +  D ++FGV++ E++ 
Sbjct: 513 IIAYQPYGKSVDWWAFGVLLYEMLA 537

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 81.0 bits (201), Expect = 6e-17
 Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 38/207 (18%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
           LG G  G V+    +     G   A+K L         Q V+H  +E  ++S + H  ++
Sbjct: 14  LGTGSFGRVHLIRSRHN---GRYYAMKVLKKEIVVRLKQ-VEHTNDERLMLSIVTHPFII 69

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE---GL 381
           ++ G      + + ++ +++    L    F       L    R+   ++    AE    L
Sbjct: 70  RMWGTFQD-AQQIFMIMDYIEGGEL----FSL-----LRKSQRFPNPVAKFYAAEVCLAL 119

Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
            YLH      II+RD+K  NILLD+    KI DFG  +  P D+T+   TL GT  Y+AP
Sbjct: 120 EYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-DVTY---TLCGTPDYIAP 172

Query: 442 EYVVRGKLTEKA-DVYSFGVVVIEVVC 467
           E VV  K   K+ D +SFG+++ E++ 
Sbjct: 173 E-VVSTKPYNKSIDWWSFGILIYEMLA 198

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 82.1 bits (203), Expect = 7e-17
 Identities = 51/209 (24%), Positives = 77/209 (36%), Gaps = 30/209 (14%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVK 329
           +G+G    V     K T   G+  A+K +          V  F  E +++   + + + +
Sbjct: 69  IGRGAFSEVAVVKMKQT---GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQ 125

Query: 330 LLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYLH 385
           L   +      L LV E+     LL  L    +  P      Y      AE    +  +H
Sbjct: 126 LH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY-----LAEIVMAIDSVH 179

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
              +L  +HRDIK  NILLD     ++ADFG       D T  S    GT  Y++PE + 
Sbjct: 180 ---RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

Query: 446 RGKLTEKADVY-------SFGVVVIEVVC 467
                     Y       + GV   E+  
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFY 265

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 81.2 bits (201), Expect = 9e-17
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 33/217 (15%)

Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
              +     +G G  GSV        GE VA+K+L   F +        + E+ L+  + 
Sbjct: 23  PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIF-AKRAYRELLLLKHMQ 81

Query: 324 HKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI-- 373
           H+N++ LL    T   SL       LV  F+  Q+ L  + +       S E ++Y +  
Sbjct: 82  HENVIGLLDV-FTPASSLRNFYDFYLVMPFM--QTDLQKI-MGL---KFSEEKIQYLVYQ 134

Query: 374 ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
           +L    GL Y+H      ++HRD+K  N+ ++E+   KI DFGL R    ++T    T  
Sbjct: 135 MLK---GLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW 188

Query: 434 GTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRK 469
               Y APE ++      +  D++S G ++ E++  K
Sbjct: 189 ----YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 81.2 bits (201), Expect = 9e-17
 Identities = 57/208 (27%), Positives = 97/208 (46%), Gaps = 32/208 (15%)

Query: 277 LGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLG 332
           +G G  G+V        G  VA+K+L   F +        + E+ L+  + H+N++ LL 
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF-AKRAYRELRLLKHMRHENVIGLLD 91

Query: 333 CSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLA 382
              T  E+L       LV  F+   + L  L   +    L  + +++ +  +L    GL 
Sbjct: 92  V-FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KLGEDRIQFLVYQMLK---GLR 142

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           Y+H      IIHRD+K  N+ ++E+   KI DFGL R    ++T    T      Y APE
Sbjct: 143 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----YRAPE 195

Query: 443 YVV-RGKLTEKADVYSFGVVVIEVVCRK 469
            ++   + T+  D++S G ++ E++  K
Sbjct: 196 VILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 58/240 (24%), Positives = 94/240 (39%), Gaps = 45/240 (18%)

Query: 260 SYETLEKATNYFHESNK------LGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDH 311
                +         +       +  G  G+V  G    G  VA+KR+F   +  + V+ 
Sbjct: 7   EAAMRDLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNI 66

Query: 312 FFN---------EVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDN 355
             +         E+ L++  +H N++ L    I             LV E +  ++ L  
Sbjct: 67  LSDSFLCKRVLREIRLLNHFHHPNILGLR--DIFVHFEEPAMHKLYLVTELM--RTDLAQ 122

Query: 356 LFVRQDVEPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
           + +      +S + ++Y +  IL    GL  LHE     ++HRD+   NILL +     I
Sbjct: 123 V-IHDQRIVISPQHIQYFMYHILL---GLHVLHEAG---VVHRDLHPGNILLADNNDITI 175

Query: 413 ADFGLVRLFPED--ITHISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRK 469
            DF L R    D   TH          Y APE V+     T+  D++S G V+ E+  RK
Sbjct: 176 CDFNLAREDTADANKTHYVTHRW----YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 80.9 bits (200), Expect = 1e-16
 Identities = 63/244 (25%), Positives = 104/244 (42%), Gaps = 38/244 (15%)

Query: 240 RERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAV 298
           R ++      V +  S     +  L++    +     +G G  G V           VA+
Sbjct: 4   RSKRDNNFYSVEIGDST----FTVLKR----YQNLKPIGSGAQGIVCAAYDAILERNVAI 55

Query: 299 KRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVP 348
           K+L   F N T      + E+ L+  +NHKN++ LL    T  +SL       +V E + 
Sbjct: 56  KKLSRPFQNQTH-AKRAYRELVLMKCVNHKNIIGLLNV-FTPQKSLEEFQDVYIVMELM- 112

Query: 349 NQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLD 405
             + L  + ++     L  E + Y +  +L    G+ +LH      IIHRD+K SNI++ 
Sbjct: 113 -DANLCQV-IQM---ELDHERMSYLLYQMLC---GIKHLHSAG---IIHRDLKPSNIVVK 161

Query: 406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
            + T KI DFGL R        +      T  Y APE ++     E  D++S G ++ E+
Sbjct: 162 SDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219

Query: 466 VCRK 469
           +   
Sbjct: 220 IKGG 223

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 32/206 (15%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
           +G+G    V     K T       A+K +     N  + +D    E +      NH  LV
Sbjct: 17  IGRGSYAKVLLVRLKKT---DRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 73

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
            L  C  T    L  V E+V    L+ ++  RQ   P      Y     +AE    L YL
Sbjct: 74  GLHSCFQT-ESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFY-----SAEISLALNYL 126

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPE 442
           HE     II+RD+KL N+LLD E   K+ D+G+ +  L P D T    T  GT  Y+APE
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPE 180

Query: 443 YVVRGKLTEKA-DVYSFGVVVIEVVC 467
            ++RG+    + D ++ GV++ E++ 
Sbjct: 181 -ILRGEDYGFSVDWWALGVLMFEMMA 205

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 79.1 bits (196), Expect = 3e-16
 Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 41/212 (19%)

Query: 277 LGQGGSGSVY-------KGTLPGGEAVAVK-----RLFYNTTQWVDHFFNEVNLISGINH 324
           LG+GG G V+         T   G+  A+K      +  N      H   E N++  + H
Sbjct: 25  LGKGGYGKVFQVRKVTGANT---GKIFAMKVLKKAMIVRNAKD-TAHTKAERNILEEVKH 80

Query: 325 KNLVKLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS---TAE- 379
             +V L+    T    L L+ E++        LF++     L  E  +    +    AE 
Sbjct: 81  PFIVDLIYAFQT-GGKLYLILEYLSG----GELFMQ-----LEREGIFMEDTACFYLAEI 130

Query: 380 --GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL--VRLFPEDITHISATLAGT 435
              L +LH+     II+RD+K  NI+L+ +   K+ DFGL    +    +TH   T  GT
Sbjct: 131 SMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH---TFCGT 184

Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
           + YMAPE ++R       D +S G ++ +++ 
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLT 216

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 79.6 bits (197), Expect = 3e-16
 Identities = 61/205 (29%), Positives = 88/205 (42%), Gaps = 30/205 (14%)

Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
           LG+G  G V     KGT    E  AVK L          V+    E   L        L 
Sbjct: 28  LGKGSFGKVMLSERKGT---DELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
           +L  C  T  + L  V E+V    L+ ++  +         V Y      AE   GL +L
Sbjct: 85  QLHSCFQT-MDRLYFVMEYVNGGDLMYHI-QQVGRFKEPHAVFY-----AAEIAIGLFFL 137

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPE 442
                  II+RD+KL N++LD E   KIADFG+ +  ++    T    T  GT  Y+APE
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK---TFCGTPDYIAPE 191

Query: 443 YVVRGKLTEKADVYSFGVVVIEVVC 467
            +      +  D ++FGV++ E++ 
Sbjct: 192 IIAYQPYGKSVDWWAFGVLLYEMLA 216

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 80.1 bits (198), Expect = 3e-16
 Identities = 63/206 (30%), Positives = 94/206 (45%), Gaps = 32/206 (15%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
           +G+G    V     K T       A++ +     N  + +D    E +      NH  LV
Sbjct: 60  IGRGSYAKVLLVRLKKT---DRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 116

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
            L  C  T    L  V E+V    L+ ++  RQ   P      Y     +AE    L YL
Sbjct: 117 GLHSCFQT-ESRLFFVIEYVNGGDLMFHMQ-RQRKLPEEHARFY-----SAEISLALNYL 169

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPE 442
           HE     II+RD+KL N+LLD E   K+ D+G+ +  L P D T    T  GT  Y+APE
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS---TFCGTPNYIAPE 223

Query: 443 YVVRGKLTEKA-DVYSFGVVVIEVVC 467
            ++RG+    + D ++ GV++ E++ 
Sbjct: 224 -ILRGEDYGFSVDWWALGVLMFEMMA 248

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 79.1 bits (196), Expect = 3e-16
 Identities = 41/96 (42%), Positives = 55/96 (57%), Gaps = 11/96 (11%)

Query: 377 TAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL--VRLFPEDITHISAT 431
            AE    L +LH    L II+RD+K  NILLDEE   K+ DFGL    +  E   +   +
Sbjct: 132 LAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAY---S 185

Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
             GT+ YMAPE V R   T+ AD +SFGV++ E++ 
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLT 221

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 57/208 (27%), Positives = 91/208 (43%), Gaps = 33/208 (15%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHKNLV 328
           +G+G  G V     K T    +  A+K L        +     F+ E ++++  N   +V
Sbjct: 77  IGRGAFGEVQLVRHKST---RKVYAMKLLSKFEMIKRSD-SAFFWEERDIMAFANSPWVV 132

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
           +L          L +V E++P   L+ NL    DV P  W   Y     TAE    L  +
Sbjct: 133 QLFYAFQD-DRYLYMVMEYMPGGDLV-NLMSNYDV-PEKWARFY-----TAEVVLALDAI 184

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV 444
           H    +  IHRD+K  N+LLD+    K+ADFG      ++      T  GT  Y++PE V
Sbjct: 185 H---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPE-V 240

Query: 445 VRGKLTEKA-----DVYSFGVVVIEVVC 467
           ++ +  +       D +S GV + E++ 
Sbjct: 241 LKSQGGDGYYGRECDWWSVGVFLYEMLV 268

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 79.4 bits (196), Expect = 4e-16
 Identities = 48/255 (18%), Positives = 97/255 (38%), Gaps = 66/255 (25%)

Query: 264 LEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFN-EVNLISG 321
           LE ++  +     LG G  G V +   +  G+  A+K++  +       + N E++++  
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKV 56

Query: 322 INHKNLVKLLGCSITGPESL--------------------------------------LV 343
           ++H N++KL+    T  +                                        ++
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 344 YEFVP---NQSLLDNLFVRQDVEPLSWEVRYKI--ILSTAEGLAYLHEESKLRIIHRDIK 398
            E+VP   ++ L   +   + +      +   I  +      + ++H    L I HRDIK
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMN--LISIYIYQLF---RAVGFIH---SLGICHRDIK 168

Query: 399 LSNILLDEE-FTAKIADFGLVRLFPEDITHIS--ATLAGTLGYMAPEYVVRGKL-TEKAD 454
             N+L++ +  T K+ DFG  +        ++   +      Y APE ++     T   D
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRF----YRAPELMLGATEYTPSID 224

Query: 455 VYSFGVVVIEVVCRK 469
           ++S G V  E++  K
Sbjct: 225 LWSIGCVFGELILGK 239

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 78.8 bits (195), Expect = 5e-16
 Identities = 61/205 (29%), Positives = 92/205 (44%), Gaps = 30/205 (14%)

Query: 277 LGQGGSGSV----YKGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
           LG+G  G V    +K T    +  A+K L          V+    E   L     H  L 
Sbjct: 25  LGKGSFGKVFLAEFKKT---NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 81

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
            +     T  E+L  V E++    L+ ++        LS    Y      AE   GL +L
Sbjct: 82  HMFCTFQT-KENLFFVMEYLNGGDLMYHIQ-SCHKFDLSRATFY-----AAEIILGLQFL 134

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMAPE 442
           H      I++RD+KL NILLD++   KIADFG+ +  +  +  T+   T  GT  Y+APE
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN---TFCGTPDYIAPE 188

Query: 443 YVVRGKLTEKADVYSFGVVVIEVVC 467
            ++  K     D +SFGV++ E++ 
Sbjct: 189 ILLGQKYNHSVDWWSFGVLLYEMLI 213

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 67/206 (32%), Positives = 94/206 (45%), Gaps = 32/206 (15%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
           LG+G  G V     K T   G+  AVK L          V+    E   L    NH  L 
Sbjct: 31  LGKGSFGKVMLARVKET---GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLT 87

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE---GLAYL 384
           +L  C  T P+ L  V EFV    L+ ++   Q       E R +     AE    L +L
Sbjct: 88  QLFCCFQT-PDRLFFVMEFVNGGDLMFHI---QKSRRFD-EARARFY--AAEIISALMFL 140

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGL--VRLFPEDITHISATLAGTLGYMAPE 442
           H+     II+RD+KL N+LLD E   K+ADFG+    +     T    T  GT  Y+APE
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA---TFCGTPDYIAPE 194

Query: 443 YVVRGKLTEKA-DVYSFGVVVIEVVC 467
            +++  L   A D ++ GV++ E++C
Sbjct: 195 -ILQEMLYGPAVDWWAMGVLLYEMLC 219

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 77.7 bits (191), Expect = 1e-15
 Identities = 34/94 (36%), Positives = 50/94 (53%), Gaps = 12/94 (12%)

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
           A+G+ +L   S+ + IHRD+   NILL E+   KI DFGL R    DI      +     
Sbjct: 203 AKGMEFL--ASR-KCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDYVRKGDA 255

Query: 438 -----YMAPEYVVRGKLTEKADVYSFGVVVIEVV 466
                +MAPE +     T ++DV+SFGV++ E+ 
Sbjct: 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 32/152 (21%), Positives = 56/152 (36%), Gaps = 19/152 (12%)

Query: 275 NKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGI-NHKN 326
             LG+G  G V +    G         VAVK L    T        +E+ ++  I +H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 327 LVKLLG-CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           +V LLG C+  G   +++ EF    +L   L             R + +    +G  +  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTKGARFRQ 137

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGL 417
            +  +  I  D+K     +    ++  + F  
Sbjct: 138 GKDYVGAIPVDLKRRLDSITSSQSSASSGFVE 169

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 38/97 (39%), Positives = 53/97 (54%), Gaps = 10/97 (10%)

Query: 377 TAE---GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLA 433
             E    L +LH+   L II+RDIKL NILLD      + DFGL + F  D T  +    
Sbjct: 165 VGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC 221

Query: 434 GTLGYMAPEYVVRGKL---TEKADVYSFGVVVIEVVC 467
           GT+ YMAP+ +VRG      +  D +S GV++ E++ 
Sbjct: 222 GTIEYMAPD-IVRGGDSGHDKAVDWWSLGVLMYELLT 257

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 77.3 bits (191), Expect = 2e-15
 Identities = 56/207 (27%), Positives = 82/207 (39%), Gaps = 34/207 (16%)

Query: 277 LGQGGSGSVY----KGTLPGGEAVAVKRL---FYNTTQWVDHFFNEVN-LISGINHKNLV 328
           +G+G  G V     K         AVK L        +   H  +E N L+  + H  LV
Sbjct: 46  IGKGSFGKVLLARHKAE---EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 329 KLLGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYK-----IILSTAEGLA 382
            L     T  + L  V +++    L  +L   Q       E R +     I       L 
Sbjct: 103 GLHFSFQT-ADKLYFVLDYINGGELFYHL---QRERCFL-EPRARFYAAEIAS----ALG 153

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR--LFPEDITHISATLAGTLGYMA 440
           YLH    L I++RD+K  NILLD +    + DFGL +  +     T    T  GT  Y+A
Sbjct: 154 YLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS---TFCGTPEYLA 207

Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVC 467
           PE + +       D +  G V+ E++ 
Sbjct: 208 PEVLHKQPYDRTVDWWCLGAVLYEMLY 234

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 55/219 (25%), Positives = 99/219 (45%), Gaps = 32/219 (14%)

Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNLISGINH 324
              +   + +G+G  G V           VA+K++  F + T        E+ ++    H
Sbjct: 26  GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTY-CQRTLREIKILLRFRH 84

Query: 325 KNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--I 374
           +N++ +    I    ++       +V + +  ++ L  L   Q    LS + + Y +  I
Sbjct: 85  ENIIGIN--DIIRAPTIEQMKDVYIVQDLM--ETDLYKLLKTQ---HLSNDHICYFLYQI 137

Query: 375 LSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAG 434
           L    GL Y+H  +   ++HRD+K SN+LL+     KI DFGL R+   D  H +  L  
Sbjct: 138 LR---GLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH-TGFLTE 190

Query: 435 ---TLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
              T  Y APE ++  K  T+  D++S G ++ E++  +
Sbjct: 191 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 47/193 (24%), Positives = 84/193 (43%), Gaps = 32/193 (16%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVD--HFFNEVNLISGINHKNLVK 329
            +G+G  G VY        + VA+K++   F +     D      E+ +++ +    +++
Sbjct: 33  LIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI---DCKRILREITILNRLKSDYIIR 89

Query: 330 LLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAE 379
           L    +  P+ L       +V E     S L  LF       L+ E ++  +  +L    
Sbjct: 90  LY--DLIIPDDLLKFDELYIVLEIA--DSDLKKLFKTPI--FLTEEHIKTILYNLLL--- 140

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR-LFPEDITHISATLAGTLGY 438
           G  ++HE     IIHRD+K +N LL+++ + K+ DFGL R +  E  T+I   L      
Sbjct: 141 GENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 439 MAPEYVVRGKLTE 451
                 ++ +LT 
Sbjct: 198 GPHNKNLKKQLTS 210

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 56/222 (25%), Positives = 105/222 (47%), Gaps = 29/222 (13%)

Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN 326
            + + +   LG GG+G V+        + VA+K++     Q V H   E+ +I  ++H N
Sbjct: 10  GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDN 69

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDV-----------EPLSWE-VRYKI- 373
           +VK+    I GP    + + V + + L+++++ Q+             PL  E  R  + 
Sbjct: 70  IVKVF--EILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARLFMY 127

Query: 374 -ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDITHISAT 431
            +L    GL Y+H  +   ++HRD+K +N+ ++ E    KI DFGL R+     +H    
Sbjct: 128 QLLR---GLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSH-KGH 180

Query: 432 LAG---TLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
           L+    T  Y +P  ++     T+  D+++ G +  E++  K
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 77.2 bits (190), Expect = 4e-15
 Identities = 42/198 (21%), Positives = 76/198 (38%), Gaps = 40/198 (20%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVD--HFFNEVNLISGINHKNLVKLLG 332
            +G G  G V +         VA+K++       +D      E+ +++ +NH ++VK+L 
Sbjct: 60  LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVL- 118

Query: 333 CSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEGLA 382
             I  P+ +       +V E     S    LF       L+   ++  +  +L    G+ 
Sbjct: 119 -DIVIPKDVEKFDELYVVLEIA--DSDFKKLFRTPV--YLTELHIKTLLYNLLV---GVK 170

Query: 383 YLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP- 441
           Y+H      I+HRD+K +N L++++ + K+ DFGL R         S             
Sbjct: 171 YVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227

Query: 442 --------------EYVV 445
                          +VV
Sbjct: 228 VTFPHTKNLKRQLTGHVV 245

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 75.8 bits (187), Expect = 5e-15
 Identities = 64/238 (26%), Positives = 107/238 (44%), Gaps = 38/238 (15%)

Query: 253 NKSKLNFSYETLEKATNYFHESNK------LGQGGSGSVYKGT-LPGGEAVAVKRL---F 302
           + S+   ++   E     +    +      +G G  GSV        G  VAVK+L   F
Sbjct: 7   HHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF 66

Query: 303 YNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDN 355
            +        + E+ L+  + H+N++ LL    T   SL       LV   +   + L+N
Sbjct: 67  QSIIH-AKRTYRELRLLKHMKHENVIGLLDV-FTPARSLEEFNDVYLVTHLM--GADLNN 122

Query: 356 LFVRQDVEPLSWE-VRYKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI 412
           +   Q    L+ + V++ I  IL    GL Y+H      IIHRD+K SN+ ++E+   KI
Sbjct: 123 IVKCQ---KLTDDHVQFLIYQILR---GLKYIHSAD---IIHRDLKPSNLAVNEDCELKI 173

Query: 413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRK 469
            DFGL R   +++T   AT      Y APE ++      +  D++S G ++ E++  +
Sbjct: 174 LDFGLARHTADEMTGYVATRW----YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 50/210 (23%), Positives = 96/210 (45%), Gaps = 36/210 (17%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDH--FFNEVNLISGI-NHKNLVKL 330
            KLG+G    V++   +   E V VK L     + V       E+ ++  +    N++ L
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRGGPNIITL 96

Query: 331 LGCSITGPES---LLVYEFVPNQSLLDNLFVRQDVEPLS-WEVRYKI--ILSTAEGLAYL 384
               +  P S    LV+E V N         +Q  + L+ +++R+ +  IL   + L Y 
Sbjct: 97  ADI-VKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYMYEIL---KALDYC 146

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTA-KIADFGLVRLF--PEDITHISATLAGTLGYMAP 441
           H  S   I+HRD+K  N+++D E    ++ D+GL   +   ++     A+      +  P
Sbjct: 147 H--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRY----FKGP 199

Query: 442 EYVVRGKLTEKA-DVYSFGVVVIEVVCRKR 470
           E +V  ++ + + D++S G ++  ++ RK 
Sbjct: 200 ELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 75.4 bits (186), Expect = 7e-15
 Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 41/233 (17%)

Query: 262 ETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL--FYNTTQWVDHFFNEVNL 318
             +   ++ F   + LG+G  G V   T  P GE VA+K++  F            E+ +
Sbjct: 4   RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLF-ALRTLREIKI 62

Query: 319 ISGINHKNLVKLLGCSITGPESL-------LVYEFVPNQSLLDNLFVRQDVEPLSWE-VR 370
           +    H+N++ +   +I  P+S        ++ E +  Q+ L  +   Q    LS + ++
Sbjct: 63  LKHFKHENIITIF--NIQRPDSFENFNEVYIIQELM--QTDLHRVISTQ---MLSDDHIQ 115

Query: 371 YKI--ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI 428
           Y I   L     +  LH  +   +IHRD+K SN+L++     K+ DFGL R+  E     
Sbjct: 116 YFIYQTLR---AVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAAD- 168

Query: 429 SATLAGTLGYMAPEYVV------------RGKLTEKADVYSFGVVVIEVVCRK 469
           ++   G    M  E+V               K +   DV+S G ++ E+  R+
Sbjct: 169 NSEPTGQQSGM-VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 44/202 (21%), Positives = 71/202 (35%), Gaps = 41/202 (20%)

Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKN 326
           +Y   S  LG G +G V +       E  A+K L     Q       EV          +
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 72

Query: 327 LVKLLGC---SITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           +V+++        G + L +V E +    L   +   +  +  +     +I+ S  E + 
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMKSIGEAIQ 131

Query: 383 YLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           YLH    + I HRD+K  N+L          K+ DFG                       
Sbjct: 132 YLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGF---------------------- 166

Query: 440 APEYVVRGKLTEKADVYSFGVV 461
           A E     K  +  D++S GV+
Sbjct: 167 AKE-TTGEKYDKSCDMWSLGVI 187

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 52/191 (27%), Positives = 89/191 (46%), Gaps = 30/191 (15%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVD--HFFNEVNLISGIN-HKNL 327
            KLG+G  G V+K      GE VAVK++   F N+T   D    F E+ +++ ++ H+N+
Sbjct: 15  KKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST---DAQRTFREIMILTELSGHENI 71

Query: 328 VKLLGCSITGPESL----LVYEFVPNQSLLDNLFVRQDVEPLSWE-VRYKI--ILSTAEG 380
           V LL  ++   ++     LV++++  ++ L  +        L     +Y +  ++     
Sbjct: 72  VNLL--NVLRADNDRDVYLVFDYM--ETDLHAVIRAN---ILEPVHKQYVVYQLIK---V 121

Query: 381 LAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMA 440
           + YLH      ++HRD+K SNILL+ E   K+ADFGL R F       +           
Sbjct: 122 IKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 441 PEYVVRGKLTE 451
                +  LT+
Sbjct: 179 NFDDDQPILTD 189

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 70.7 bits (172), Expect = 2e-13
 Identities = 44/304 (14%), Positives = 78/304 (25%), Gaps = 75/304 (24%)

Query: 267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVD--------HFFNEVNL 318
            T       K+G+G  G V++        VA+K +       V+            E+ +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTP-VAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 319 ---------ISGINHKNLVKLLGCSI---TGPESL------------------------- 341
                          +  + L        + P  L                         
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 342 --LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKL 399
             +V EF      L+ +  +      S      I+      LA       LR  HRD+  
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK----LSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHW 190

Query: 400 SNILLDEEFTAKIADFGLVRLF----------PEDITHISATLAGTLGYM---APEYVVR 446
            N+LL +    K+      +              D T       G + +      E +  
Sbjct: 191 GNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFT 250

Query: 447 GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF 506
           G    + D+Y           +K  N            +W  Y+  ++ + +      N 
Sbjct: 251 GDGDYQFDIYRL--------MKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNT 302

Query: 507 QEGK 510
              K
Sbjct: 303 PAMK 306

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 69.7 bits (171), Expect = 6e-13
 Identities = 52/225 (23%), Positives = 92/225 (40%), Gaps = 33/225 (14%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN----------- 323
           KLG G   +V+    +     VA+K +      + +   +E+ L+  +N           
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 324 HKNLVKLLGC-SITGPESL---LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
             +++KLL   +  GP  +   +V+E V  ++LL  L  + +   +      +I      
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLA-LIKKYEHRGIPLIYVKQISKQLLL 142

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEE------FTAKIADFGLVRLFPEDITHISATLA 433
           GL Y+H   +  IIH DIK  N+L++           KIAD G    + E  T       
Sbjct: 143 GLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT----NSI 196

Query: 434 GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS 478
            T  Y +PE ++       AD++S   ++ E++      LF  + 
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF--LFEPDE 239

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.9 bits (157), Expect = 5e-11
 Identities = 87/552 (15%), Positives = 167/552 (30%), Gaps = 174/552 (31%)

Query: 76  DDYDFFNESLSSQDRTVCGSKD--------FGGNNTVFGA---NAIELVRNLSVQAVKND 124
            +Y F    + ++ R                  +N VF     + ++    L  QA+   
Sbjct: 89  INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLR-QALLEL 147

Query: 125 GFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIASCTQKEEGRV--LNAGC 182
                       NV + G+        G   +  +   V        K + ++  LN   
Sbjct: 148 R--------PAKNVLIDGVLGS-----G---KTWVALDVCLSYKVQCKMDFKIFWLNLKN 191

Query: 183 YLRYST-----QRFYNNSGPD-----------PVPGNGGDNKLAVILATSA-VALLLVFS 225
                T     Q+      P+            +  +    +L  +L +      LLV  
Sbjct: 192 CNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLL 251

Query: 226 LV-------AFFVRRKLLQKRRERK---QLGAL---QVAVNKSKLNFSYETLEKATNYFH 272
            V       AF +  K+L   R ++    L A     ++++   +     T ++  +   
Sbjct: 252 NVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTL---TPDEVKSLL- 307

Query: 273 ESNKLGQGGSGSVYKGTLPGGEAV-----------AVKRLFYNTTQWVDHFFNEVNLISG 321
               L            LP  E +              R    T     H          
Sbjct: 308 -LKYLDCR------PQDLP-REVLTTNPRRLSIIAESIRDGLATWDNWKH---------- 349

Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFV-RQDVE-P---LS--WE--VRYK 372
           +N   L  ++  S+     L   E+   + + D L V       P   LS  W   ++  
Sbjct: 350 VNCDKLTTIIESSL---NVLEPAEY---RKMFDRLSVFPPSAHIPTILLSLIWFDVIKSD 403

Query: 373 IILSTAE----GLAYLH-EESKLRI--IHRDIKLSNILLDEEFT--AKIAD-FGLVRLF- 421
           +++   +     L     +ES + I  I+ ++K+    L+ E+     I D + + + F 
Sbjct: 404 VMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVK---LENEYALHRSIVDHYNIPKTFD 460

Query: 422 PEDIT----------HISATLAGTLGYMAPEYVVRGKLTEKADV-------YSFGVVVIE 464
            +D+           HI        G+    ++   +  E+  +       + F    +E
Sbjct: 461 SDDLIPPYLDQYFYSHI--------GH----HLKNIEHPERMTLFRMVFLDFRF----LE 504

Query: 465 VVCRKRINLFTQNSC--SILQTVWDL--YVK------GRLHEAVD------PALAGNFQE 508
              +K  +  T  +   SIL T+  L  Y         +    V+      P +  N   
Sbjct: 505 ---QKIRHDSTAWNASGSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLIC 561

Query: 509 GKPSRLLQIGLL 520
            K + LL+I L+
Sbjct: 562 SKYTDLLRIALM 573

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 63.0 bits (153), Expect = 8e-11
 Identities = 59/261 (22%), Positives = 93/261 (35%), Gaps = 73/261 (27%)

Query: 276 KLGQGGSGSVYKG-TLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--------NHKN 326
           KLG G   +V+    + G + VA+K +  +   + +   +E+ L+  +        N + 
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREM 102

Query: 327 LVKLLGC-SITGPESL---LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           +V+LL    I+G       +V+E V    LL    ++ + + L      KII    +GL 
Sbjct: 103 VVQLLDDFKISGVNGTHICMVFE-VLGHHLLK-WIIKSNYQGLPLPCVKKIIQQVLQGLD 160

Query: 383 YLHEESKLRIIHRDIKLSNILL-------------------------------------- 404
           YLH  +K RIIH DIK  NILL                                      
Sbjct: 161 YLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAG 218

Query: 405 -----------DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
                       E+   KIAD G      +  T        T  Y + E ++       A
Sbjct: 219 NFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTED----IQTRQYRSLEVLIGSGYNTPA 274

Query: 454 DVYSFGVVVIEVVCRKRINLF 474
           D++S   +  E+       LF
Sbjct: 275 DIWSTACMAFELATGDY--LF 293

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 52/235 (22%), Positives = 88/235 (37%), Gaps = 65/235 (27%)

Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFF 313
           + + YE L+           +G+G  G V K       + VA+K  R   N  ++     
Sbjct: 95  VAYRYEVLKV----------IGKGSFGQVVKAYDHKVHQHVALKMVR---NEKRFHRQAA 141

Query: 314 NEVNLISGINHK------NLVKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVR 359
            E+ ++  +  +      N++ +L         C      S+ +YE      +  N F  
Sbjct: 142 EEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYEL-----IKKNKFQ- 195

Query: 360 QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA--KIADFGL 417
                 S  +  K   S  + L  LH   K RIIH D+K  NILL ++  +  K+ DFG 
Sbjct: 196 ----GFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFG- 247

Query: 418 VRLFPEDITHISATLAG--------TLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
                      S+            +  Y APE ++  +     D++S G ++ E
Sbjct: 248 -----------SSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAE 291

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 51/227 (22%), Positives = 84/227 (37%), Gaps = 53/227 (23%)

Query: 265 EKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISG 321
           EK  + +   + +G+G  G V K       E VA+K  +   N   +++    EV L+  
Sbjct: 50  EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIK---NKKAFLNQAQIEVRLLEL 106

Query: 322 INH------KNLVKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSW 367
           +N         +V L          C +    S  +Y+      L +  F       +S 
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLYDL-----LRNTNFR-----GVSL 156

Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA--KIADFGLVRLFPEDI 425
            +  K        L +L    +L IIH D+K  NILL     +  KI DFG         
Sbjct: 157 NLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFG--------- 206

Query: 426 THISATLAG--------TLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
              S+   G        +  Y +PE ++        D++S G +++E
Sbjct: 207 ---SSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVE 250

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 55.5 bits (134), Expect = 2e-08
 Identities = 27/198 (13%), Positives = 60/198 (30%), Gaps = 43/198 (21%)

Query: 275 NKLGQGGSGSVYKGT---------LPGGEAVAVK-----------RLFYNTTQWVDHFFN 314
           +   +   G +Y+            P  +  ++K           + F+           
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 315 EVNLISGINHKNLVKLLGCSITGPE-SLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYK 372
              L        +   +G  +   +   LV   +  +   L +         LS     +
Sbjct: 108 WKKL-YSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS---LQSALDVSPKHVLSERSVLQ 163

Query: 373 I---ILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI--ADFGLVRLFPEDITH 427
           +   +L   E   +LHE      +H ++   NI +D E  +++  A +G    +     H
Sbjct: 164 VACRLLDALE---FLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217

Query: 428 I------SATLAGTLGYM 439
           +       +   G L ++
Sbjct: 218 VAYVEGSRSPHEGDLEFI 235

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 52.0 bits (125), Expect = 2e-07
 Identities = 43/186 (23%), Positives = 68/186 (36%), Gaps = 39/186 (20%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC 333
           K+G G  G +  G  L   E VA+K               E      + +   + ++   
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYF 73

Query: 334 SITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA--------YL 384
              G  + +V E + P+   L++LF   D             L T   +A        Y+
Sbjct: 74  GPCGKYNAMVLELLGPS---LEDLFDLCD---------RTFSLKTVLMIAIQLISRMEYV 121

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAK-----IADFGLVRLF--PEDITHI----SATLA 433
           H ++   +I+RD+K  N L+            I DF L + +  PE   HI      +L 
Sbjct: 122 HSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLT 178

Query: 434 GTLGYM 439
           GT  YM
Sbjct: 179 GTARYM 184

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 51.2 bits (123), Expect = 4e-07
 Identities = 40/182 (21%), Positives = 75/182 (41%), Gaps = 31/182 (17%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGC 333
           ++G+G  G +++GT L   + VA+K     +        +E      +     +  +   
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYF 74

Query: 334 SITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE----GLAYLHEES 388
              G  ++LV + + P+   L++L         S     K +   A+     +  +HE+S
Sbjct: 75  GQEGLHNVLVIDLLGPS---LEDLLDLCG-RKFS----VKTVAMAAKQMLARVQSIHEKS 126

Query: 389 KLRIIHRDIKLSNILLDEEFTAK-----IADFGLVRLF--PEDITHI----SATLAGTLG 437
              +++RDIK  N L+    +       + DFG+V+ +  P    HI       L+GT  
Sbjct: 127 ---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR 183

Query: 438 YM 439
           YM
Sbjct: 184 YM 185

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 32/190 (16%), Positives = 60/190 (31%), Gaps = 29/190 (15%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDH--FFNEVN----LISGINHKNLVK 329
            +GQGG G +Y   +   E+V          +  D+   F E+            +  ++
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 330 LLGCSITGPESLLVYEFVPNQSLLDNLFVRQ----DVEPLSWEVRYKIILSTAEGLA--- 382
                  G                    +      D++ +      +    T   L+   
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 383 -----YLHEESKLRIIHRDIKLSNILLDEEFTAKI--ADFGLVRLFPEDITHI------S 429
                Y+HE      +H DIK SN+LL+ +   ++   D+GL   +  +  H        
Sbjct: 162 LDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218

Query: 430 ATLAGTLGYM 439
               GT+ + 
Sbjct: 219 RCHDGTIEFT 228

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 25/178 (14%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNL---ISGINHKNLVKLL 331
           K+G G  G +Y GT +  GE VA+K     T         E  +   + G     +  + 
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG--IPTIR 71

Query: 332 GCSITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            C   G  +++V E + P+   L++LF     +  S +    +       + Y+H ++  
Sbjct: 72  WCGAEGDYNVMVMELLGPS---LEDLFNFCSRK-FSLKTVLLLADQMISRIEYIHSKN-- 125

Query: 391 RIIHRDIKLSNILL---DEEFTAKIADFGLVRLF--PEDITHI----SATLAGTLGYM 439
             IHRD+K  N L+    +     I DFGL + +       HI    +  L GT  Y 
Sbjct: 126 -FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYA 182

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 43/176 (24%), Positives = 70/176 (39%), Gaps = 21/176 (11%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV-KLLGC 333
           K+G G  G +Y GT +   E VA+K     T         E  +   +     +  +   
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWF 71

Query: 334 SITGPESLLVYEFV-PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRI 392
            + G  ++LV + + P+   L++LF       LS +    +       + ++H +S    
Sbjct: 72  GVEGDYNVLVMDLLGPS---LEDLFNFCS-RKLSLKTVLMLADQMINRVEFVHSKS---F 124

Query: 393 IHRDIKLSNILLDEEFTAK---IADFGLVRLF--PEDITHI----SATLAGTLGYM 439
           +HRDIK  N L+     A    I DFGL + +       HI    +  L GT  Y 
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYA 180

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 35/195 (17%), Positives = 58/195 (29%), Gaps = 42/195 (21%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK----------RLFYNTTQWVDHFFNEVNLISGINH 324
           K+G GG G +Y        E  A             LF         F+    +      
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSEL-----KFYQR--VAKKDCI 96

Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQ----DVEPLSWEVRYKIILSTAEG 380
           K  ++       G            +       V +    D++ +          ST   
Sbjct: 97  KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKI-SGQNGTFKKSTVLQ 155

Query: 381 LA--------YLHEESKLRIIHRDIKLSNILLDEEFTAKI--ADFGLVRLFPEDITHI-- 428
           L         Y+HE      +H DIK +N+LL  +   ++  AD+GL   +  +  H   
Sbjct: 156 LGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212

Query: 429 ----SATLAGTLGYM 439
                    GT+ + 
Sbjct: 213 QENPRKGHNGTIEFT 227

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 45.8 bits (109), Expect = 3e-05
 Identities = 48/234 (20%), Positives = 74/234 (31%), Gaps = 73/234 (31%)

Query: 276 KLGQGGSGSVYKG--TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHK------ 325
            LG+G  G V +      G   VA+K  R   N  ++ +    E+N++  I  K      
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLKKIKEKDKENKF 82

Query: 326 NLVKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
             V +          C          +EF     L +N F      P        +    
Sbjct: 83  LCVLMSDWFNFHGHMCIAFELLGKNTFEF-----LKENNFQ-----PYPLPHVRHMAYQL 132

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-------------------KIADFGLV 418
              L +LH   + ++ H D+K  NIL                          ++ADFG  
Sbjct: 133 CHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-- 187

Query: 419 RLFPEDITHISATLAG--------TLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
                     SAT           T  Y  PE ++     +  DV+S G ++ E
Sbjct: 188 ----------SATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 44.6 bits (106), Expect = 6e-05
 Identities = 50/234 (21%), Positives = 85/234 (36%), Gaps = 73/234 (31%)

Query: 276 KLGQGGSGSVYKG--TLPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHK------ 325
            LG+G  G V +      GG  VAVK  +   N  ++ +   +E+ ++  +N        
Sbjct: 21  TLGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTDPNSTF 77

Query: 326 NLVKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILST 377
             V++L         C +     L  Y+F     + +N F+     P   +   K+    
Sbjct: 78  RCVQMLEWFEHHGHICIVFELLGLSTYDF-----IKENGFL-----PFRLDHIRKMAYQI 127

Query: 378 AEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA-------------------KIADFGLV 418
            + + +LH     ++ H D+K  NIL  +                       K+ DFG  
Sbjct: 128 CKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-- 182

Query: 419 RLFPEDITHISATLAG--------TLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
                     SAT           T  Y APE ++    ++  DV+S G ++IE
Sbjct: 183 ----------SATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIE 226

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 50/226 (22%), Positives = 77/226 (34%), Gaps = 53/226 (23%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINH-----KNL 327
           K+G G  G V     +   +  AVK  R   N  ++      E +++  I +      N+
Sbjct: 42  KMGDGTFGRVLLCQHIDNKKYYAVKVVR---NIKKYTRSAKIEADILKKIQNDDINNNNI 98

Query: 328 VKLLG--------CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
           VK  G        C I  P    +YE      +  N +          E      +   +
Sbjct: 99  VKYHGKFMYYDHMCLIFEPLGPSLYEI-----ITRNNYN-----GFHIEDIKLYCIEILK 148

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI----------- 428
            L YL    K+ + H D+K  NILLD+ +  K           + I              
Sbjct: 149 ALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205

Query: 429 --SATLAG--------TLGYMAPEYVVRGKLTEKADVYSFGVVVIE 464
              AT           T  Y APE ++       +D++SFG V+ E
Sbjct: 206 FGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAE 251

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	573
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.81
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.8
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.8
3a2e_A	108	Ginkbilobin-2; domain 26 unknown function (DUF26),	99.8
2e79_A	108	Ginkbilobin-2; DUF26 fold, C-X8-C-X2-C motif, lect	99.79
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.68
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.32
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.15
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.03
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.93
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.63
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.59
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.41
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.34
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.28
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.26
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.97
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.89
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.84
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.68
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.54
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.4
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.26
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.23
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.15
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.11
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.08
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.01
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.92
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	96.63
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.56
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.34
3mes_A	424	Choline kinase; malaria, structural genomics, stru	95.16
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	92.67
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	92.61
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	91.93
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.87
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	86.07
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	83.06
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	82.31

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=5.7e-56  Score=442.87  Aligned_cols=257  Identities=24%  Similarity=0.370  Sum_probs=214.7

Q ss_pred             cCccccccccccCceeEEEEEcC------CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ++|...++||+|+||+||+|++.      +++.||||++.....+..++|.+|+++|++++|||||+++|++.+.+..+|
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l   92 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM   92 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            56888999999999999999864      477899999987777778899999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccC----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEE
Q 008239          343 VYEFVPNQSLLDNLFVRQ----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI  412 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl  412 (573)
                      |||||++|+|.++|....          ....++|..+++++.||+.||+|||+++   ||||||||+||||++++.+||
T Consensus        93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki  169 (299)
T 4asz_A           93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI  169 (299)
T ss_dssp             EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence            999999999999996532          3457999999999999999999999987   999999999999999999999


Q ss_pred             eecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhh
Q 008239          413 ADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYV  490 (573)
Q Consensus       413 ~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  490 (573)
                      +|||+++....... .......||+.|||||++.++.++.++|||||||+||||+| |+.|+..... ..+    .....
T Consensus       170 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~-~~~----~~~i~  244 (299)
T 4asz_A          170 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN-NEV----IECIT  244 (299)
T ss_dssp             CCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH-HHH----HHHHH
T ss_pred             CCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH-HHH----HHHHH
Confidence            99999986644322 23334578999999999999999999999999999999999 7877654321 122    22222


Q ss_pred             cCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          491 KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       491 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .+..         ...+...+.++.+|+.+||+.||++||||+||+++|+..
T Consensus       245 ~~~~---------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          245 QGRV---------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             HTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            2221         123456778899999999999999999999999999653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.5e-55  Score=445.89  Aligned_cols=257  Identities=25%  Similarity=0.341  Sum_probs=208.5

Q ss_pred             cCccccccccccCceeEEEEEcC------CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ++|...++||+|+||+||+|++.      +++.||||++.....+..++|.+|+++|++++|||||+++|+|.+....+|
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l  120 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM  120 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            56778899999999999999864      478899999987777778899999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccC------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcE
Q 008239          343 VYEFVPNQSLLDNLFVRQ------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA  410 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~  410 (573)
                      |||||++|+|.+++....            ...+++|.++++++.||+.||+|||+++   ||||||||+||||++++.+
T Consensus       121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~  197 (329)
T 4aoj_A          121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV  197 (329)
T ss_dssp             EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred             EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence            999999999999986532            1346999999999999999999999987   9999999999999999999


Q ss_pred             EEeecccccccCCCC-cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHH
Q 008239          411 KIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       411 kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  488 (573)
                      ||+|||+++...... ........||+.|||||++.+..++.++|||||||+||||+| |+.|+..... ..    +...
T Consensus       198 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~-~~----~~~~  272 (329)
T 4aoj_A          198 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN-TE----AIDC  272 (329)
T ss_dssp             EECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH-HH----HHHH
T ss_pred             EEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH-HH----HHHH
Confidence            999999998664332 233445679999999999999999999999999999999999 7887654321 11    2222


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ...+.         ....+...+.++.+|+.+||+.||++||||+||+++|+..
T Consensus       273 i~~g~---------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          273 ITQGR---------ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             HHHTC---------CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHcCC---------CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            22221         1123455678899999999999999999999999999654

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.8e-55  Score=441.07  Aligned_cols=257  Identities=23%  Similarity=0.338  Sum_probs=211.8

Q ss_pred             cCccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      .+++..++||+|+||+||+|++.      +++.||||++.... ....++|.+|+.+|++++|||||+++|+|.+.+..+
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~  105 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLS  105 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEE
Confidence            34667889999999999999863      46789999996543 344678999999999999999999999999999999


Q ss_pred             EEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC
Q 008239          342 LVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF  408 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~  408 (573)
                      ||||||++|+|.++|..+..             ...++|..+++++.|||.||+|||+++   ||||||||+||||++++
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~  182 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKL  182 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGG
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCC
Confidence            99999999999999965321             246899999999999999999999987   99999999999999999


Q ss_pred             cEEEeecccccccCCCC-cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHH
Q 008239          409 TAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVW  486 (573)
Q Consensus       409 ~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  486 (573)
                      .+||+|||+++...... ........||++|||||++.++.++.++|||||||+||||+| |+.|+.... ...+    .
T Consensus       183 ~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~-~~~~----~  257 (308)
T 4gt4_A          183 NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS-NQDV----V  257 (308)
T ss_dssp             CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC-HHHH----H
T ss_pred             CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC-HHHH----H
Confidence            99999999998654322 233445679999999999999999999999999999999999 677764322 1122    2


Q ss_pred             HHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          487 DLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       487 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .....+..         .+.+...+..+.+|+.+||+.||++||||+||+++|+..
T Consensus       258 ~~i~~~~~---------~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          258 EMIRNRQV---------LPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHcCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            22222221         233556788899999999999999999999999999643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-54  Score=431.70  Aligned_cols=258  Identities=28%  Similarity=0.420  Sum_probs=205.7

Q ss_pred             HhcCccccccccccCceeEEEEEcCCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ..++++..++||+|+||+||+|++.+  .||||+++..  ..+..+.|.+|+.+|++++|||||+++|++.+ +..+|||
T Consensus        34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVm  110 (307)
T 3omv_A           34 EASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVT  110 (307)
T ss_dssp             CTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             cHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEE
Confidence            34677889999999999999999863  5999998643  34556789999999999999999999998865 5689999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      |||++|+|.++|...  ...++|..+++++.||+.||+|||+++   ||||||||+||||++++.+||+|||+++.....
T Consensus       111 Ey~~gGsL~~~l~~~--~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~  185 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQ--ETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW  185 (307)
T ss_dssp             ECCSSCBHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred             EcCCCCCHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence            999999999998643  346999999999999999999999987   999999999999999999999999999876533


Q ss_pred             C-cccccccccCcCcCchhhhcc---CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          425 I-THISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       425 ~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      . ........||+.|||||++..   ++|+.++|||||||+||||+||+.|+.......    .+......+.    ..+
T Consensus       186 ~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~----~~~~~~~~~~----~~p  257 (307)
T 3omv_A          186 SGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD----QIIFMVGRGY----ASP  257 (307)
T ss_dssp             --------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH----HHHHHHHTTC----CCC
T ss_pred             CcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH----HHHHHHhcCC----CCC
Confidence            2 223446689999999999964   468999999999999999999999986443321    1122222221    111


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .+ ...+.+.+..+.+|+.+||+.+|++||||.||++.|+.
T Consensus       258 ~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~  297 (307)
T 3omv_A          258 DL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIEL  297 (307)
T ss_dssp             CS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHH
T ss_pred             Cc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11 12345667889999999999999999999999999854

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.8e-52  Score=423.57  Aligned_cols=250  Identities=18%  Similarity=0.291  Sum_probs=204.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|+.+++||+|+||+||+|+.. +|+.||||++...  .....+.+.+|+++|++|+|||||++++++.+++..+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            57999999999999999999974 6999999999654  34456789999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++|+|.+++... +...+++..++.++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++.+....
T Consensus       104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            99999999998543 3345789999999999999999999998   9999999999999999999999999998764321


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                       ......+||+.|||||++.+..|+.++|||||||+||||++|+.||.....    .+.+.. ...+..         ..
T Consensus       180 -~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~----~~~~~~-i~~~~~---------~~  244 (350)
T 4b9d_A          180 -ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM----KNLVLK-IISGSF---------PP  244 (350)
T ss_dssp             -HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHH-HHHTCC---------CC
T ss_pred             -ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHHHH-HHcCCC---------CC
Confidence             223456799999999999999999999999999999999999999864322    111111 222221         12


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .+...+.++.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          245 VSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            23445678999999999999999999999986

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=7.2e-53  Score=429.64  Aligned_cols=268  Identities=25%  Similarity=0.316  Sum_probs=219.2

Q ss_pred             ccChHHHHHHhcCccccccccccCceeEEEEEcCC------CCEEEEEEecccC-hhhHHHHHHHHHHHcCCCC-CCeee
Q 008239          258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGINH-KNLVK  329 (573)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~  329 (573)
                      .++...++...++|+..++||+|+||+||+|++..      ++.||||++.... ....+.|.+|+++|++++| ||||+
T Consensus        53 p~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~  132 (353)
T 4ase_A           53 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN  132 (353)
T ss_dssp             CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             CCCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEE
Confidence            35556777778899999999999999999998642      3579999997653 3445679999999999965 89999


Q ss_pred             eeeeeecC-CceeEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 008239          330 LLGCSITG-PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR  395 (573)
Q Consensus       330 l~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHr  395 (573)
                      ++|+|.+. ...++|||||++|+|.++|.....             ...++|..++.++.|||.||+|||+++   ||||
T Consensus       133 l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHR  209 (353)
T 4ase_A          133 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHR  209 (353)
T ss_dssp             EEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecC
Confidence            99998764 568999999999999999964321             345899999999999999999999988   9999


Q ss_pred             cCCCCCeeeCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 008239          396 DIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINL  473 (573)
Q Consensus       396 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~  473 (573)
                      ||||+|||+++++.+||+|||+++....+.. .......||+.|||||++.++.|+.++|||||||+||||+| |+.|+.
T Consensus       210 DLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~  289 (353)
T 4ase_A          210 DLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP  289 (353)
T ss_dssp             CCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             ccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCC
Confidence            9999999999999999999999997654433 23345678999999999999999999999999999999998 788875


Q ss_pred             CCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          474 FTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       474 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .......+    ......+.         +...+...+.++.+++.+||+.||++|||++||+++|+.
T Consensus       290 ~~~~~~~~----~~~i~~g~---------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          290 GVKIDEEF----CRRLKEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             TCCCSHHH----HHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCHHHHH----HHHHHcCC---------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            43332222    22222221         112344567789999999999999999999999999854

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.5e-52  Score=422.33  Aligned_cols=250  Identities=20%  Similarity=0.207  Sum_probs=205.7

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .+.|+..++||+|+||+||+|++. +|+.||||++.....     ..+|+.+|++++|||||++++++.+++..+|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            356888899999999999999975 689999999965432     24699999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-cEEEeecccccccCCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPEDI  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~~~  425 (573)
                      +++|+|.+++...   ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++ .+||+|||+++.+..+.
T Consensus       132 ~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          132 LEGGSLGQLIKQM---GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            9999999999543   46999999999999999999999988   99999999999999887 69999999999775432


Q ss_pred             cc----cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          426 TH----ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       426 ~~----~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ..    .....+||+.|||||++.+..|+.++|||||||+||||++|+.||....... +...+.    .+..      .
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~i~----~~~~------~  274 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP-LCLKIA----SEPP------P  274 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSC-CHHHHH----HSCC------G
T ss_pred             cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH-HHHHHH----cCCC------C
Confidence            21    1234679999999999999999999999999999999999999986544332 222221    1110      0


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      + ..++...+..+.+++.+||+.||++|||+.|+++.|.
T Consensus       275 ~-~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~  312 (336)
T 4g3f_A          275 I-REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVG  312 (336)
T ss_dssp             G-GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             c-hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHH
Confidence            0 1234556788999999999999999999999998874

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.9e-52  Score=421.44  Aligned_cols=249  Identities=27%  Similarity=0.392  Sum_probs=210.2

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      ..|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~  153 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL  153 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence            56899999999999999999975 69999999997665555667889999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++|+|.+++..    ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++.+..... 
T Consensus       154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-  225 (346)
T 4fih_A          154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  225 (346)
T ss_dssp             TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-
T ss_pred             CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCC-
Confidence            99999998853    35899999999999999999999998   99999999999999999999999999997654322 


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      .....+||+.|||||++.+..|+.++|||||||++|||++|+.||.....    .+. ......+.     .+.+  ...
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~-~~~i~~~~-----~~~~--~~~  293 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKA-MKMIRDNL-----PPRL--KNL  293 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHH-HHHHHHSS-----CCCC--SCG
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHH-HHHHHcCC-----CCCC--Ccc
Confidence            33467899999999999999999999999999999999999999864321    111 11112111     1111  112


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ...+.++.+|+.+||+.||++|||++|+++
T Consensus       294 ~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          294 HKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             GGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            345678899999999999999999999986

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4e-52  Score=417.54  Aligned_cols=263  Identities=26%  Similarity=0.320  Sum_probs=200.1

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC----ceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----ESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  344 (573)
                      ++|...++||+|+||+||+|++. |+.||||++.....+ ...+..|+..+.+++|||||+++|++.++.    ..+|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            45778899999999999999984 899999999654322 223345666778899999999999998654    478999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      |||++|+|.+++..    ..++|..+++++.|++.||+|||++     ..++||||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~  156 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             cCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence            99999999999954    3589999999999999999999987     23459999999999999999999999999998


Q ss_pred             ccCCCCcc---cccccccCcCcCchhhhccC------CCCcccchHhHHHHHHHHHcCCCCCCCCCCCc----------c
Q 008239          420 LFPEDITH---ISATLAGTLGYMAPEYVVRG------KLTEKADVYSFGVVVIEVVCRKRINLFTQNSC----------S  480 (573)
Q Consensus       420 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg~~p~~~~~~~~----------~  480 (573)
                      ........   ......||+.|||||++.+.      .++.++|||||||+||||+||+.|+.......          .
T Consensus       157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~  236 (303)
T 3hmm_A          157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccc
Confidence            76543322   22346799999999999764      36779999999999999999987754332211          1


Q ss_pred             hHHHHHHHhhcCccccccCccccCC-CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          481 ILQTVWDLYVKGRLHEAVDPALAGN-FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~d~~l~~~-~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...........+.    .++.+... .+.+.+..+.+|+.+||+.||++||||.||+++|+.
T Consensus       237 ~~~~~~~~~~~~~----~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~  294 (303)
T 3hmm_A          237 SVEEMRKVVCEQK----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHTTSC----CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhccc----CCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            1222222222222    12222111 123456788999999999999999999999999954

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.5e-52  Score=411.82  Aligned_cols=247  Identities=25%  Similarity=0.339  Sum_probs=200.0

Q ss_pred             ccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec----CCceeEE
Q 008239          271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESLLV  343 (573)
Q Consensus       271 ~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~lv  343 (573)
                      |+..++||+|+||+||+|.+. ++..||||++...  .....+.|.+|+++|++++|||||++++++.+    ....+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            466778999999999999975 5889999998643  34446789999999999999999999999865    3457899


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC-CCCcEEEeecccccccC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFP  422 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~~~  422 (573)
                      ||||++|+|.+++...   ..+++..+..++.||+.||+|||+++ ++||||||||+||||+ .++.+||+|||+|+...
T Consensus       108 mEy~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             EECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            9999999999999543   46899999999999999999999975 4699999999999998 47999999999998654


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ..   .....+||+.|||||++. +.|+.++|||||||+||||+||+.||......    ..+......+....      
T Consensus       184 ~~---~~~~~~GTp~YmAPE~~~-~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~----~~~~~~i~~~~~~~------  249 (290)
T 3fpq_A          184 AS---FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNA----AQIYRRVTSGVKPA------  249 (290)
T ss_dssp             TT---SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH----HHHHHHHTTTCCCG------
T ss_pred             CC---ccCCcccCccccCHHHcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH----HHHHHHHHcCCCCC------
Confidence            32   234568999999999886 56999999999999999999999998643332    12222222221111      


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus       250 --~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 --SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             --GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              112234467889999999999999999999986

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=8.8e-52  Score=411.80  Aligned_cols=247  Identities=20%  Similarity=0.255  Sum_probs=209.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..++||+|+||+||+++.. +|+.||||++...   .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            57999999999999999999874 6899999999653   2344678899999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++...   +.+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+...
T Consensus       112 Ey~~gG~L~~~i~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~  185 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  185 (311)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence            999999999999543   46999999999999999999999998   999999999999999999999999999977543


Q ss_pred             C-cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 I-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      . .......+||+.|||||++.+..|+.++||||+||+||||++|+.||.....     .........++.         
T Consensus       186 ~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~-----~~~~~~i~~~~~---------  251 (311)
T 4aw0_A          186 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----GLIFAKIIKLEY---------  251 (311)
T ss_dssp             TTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCC---------
T ss_pred             CCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCC---------
Confidence            2 2334567899999999999999999999999999999999999999864321     111222222221         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVV  536 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl  536 (573)
                       .++...+.++.+|+.+||+.||++|||++|++
T Consensus       252 -~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          252 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             -CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             -CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence             22344567889999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5e-51  Score=422.41  Aligned_cols=250  Identities=26%  Similarity=0.392  Sum_probs=211.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .+.|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..+|||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            367999999999999999999975 6999999999776655667789999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      |++|+|.+++..    ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||+++.+.... 
T Consensus       230 ~~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~-  301 (423)
T 4fie_A          230 LEGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-  301 (423)
T ss_dssp             CTTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSC-
T ss_pred             CCCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCC-
Confidence            999999998843    34899999999999999999999998   9999999999999999999999999999765432 


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......+||+.|||||++.+..|+.++|||||||++|||++|+.||.....    .+.. .....+.     .+.+  ..
T Consensus       302 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~----~~~~-~~i~~~~-----~~~~--~~  369 (423)
T 4fie_A          302 PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP----LKAM-KMIRDNL-----PPRL--KN  369 (423)
T ss_dssp             CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH-HHHHHSC-----CCCC--SC
T ss_pred             ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH----HHHH-HHHHcCC-----CCCC--cc
Confidence            233467899999999999999999999999999999999999999854321    1111 1112111     1111  11


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ....+..+.+|+.+||+.||++|||++|+++
T Consensus       370 ~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             TTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            2345678899999999999999999999987

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-50  Score=398.08  Aligned_cols=245  Identities=22%  Similarity=0.340  Sum_probs=192.9

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++...   .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            57999999999999999999975 6999999998653   2334567899999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+ +|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        93 Ey~-~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  165 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR---DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG  165 (275)
T ss_dssp             ECC-CEEHHHHHHHS---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             eCC-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence            999 68999988543   46999999999999999999999998   999999999999999999999999999865432


Q ss_pred             CcccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .  .....+||+.|||||++.+..+ +.++||||+||++|||++|+.||.....     .........+..         
T Consensus       166 ~--~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~-----~~~~~~i~~~~~---------  229 (275)
T 3hyh_A          166 N--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI-----PVLFKNISNGVY---------  229 (275)
T ss_dssp             -----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCC---------
T ss_pred             C--ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCC---------
Confidence            2  2345689999999999998876 5799999999999999999999854321     122222222221         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       .++...+.++.+|+.+||+.||++|||++|+++
T Consensus       230 -~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 -TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             123445678899999999999999999999997

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.1e-51  Score=404.43  Aligned_cols=247  Identities=26%  Similarity=0.263  Sum_probs=198.5

Q ss_pred             cCccccccccccCceeEEEEEcC----CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ++|+..+.||+|+||+||+|+..    .++.||||++....  ......+.+|+++|++++|||||++++++.+++..++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999852    47899999986532  2223467889999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       104 vmEy~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~  177 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI  177 (304)
T ss_dssp             EECCCTTCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence            99999999999998543   46999999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ... ......+||+.|||||++.+..|+.++|||||||+||||++|+.||...... .+    ......+..        
T Consensus       178 ~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~-~~----~~~i~~~~~--------  243 (304)
T 3ubd_A          178 DHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK-ET----MTMILKAKL--------  243 (304)
T ss_dssp             ----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH----HHHHHHCCC--------
T ss_pred             CCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH-HH----HHHHHcCCC--------
Confidence            322 2234578999999999999999999999999999999999999998643221 11    112222211        


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPS-----MSIVVK  537 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  537 (573)
                        .++...+.++.+|+.+||+.||++|||     ++|+++
T Consensus       244 --~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~  281 (304)
T 3ubd_A          244 --GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKR  281 (304)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHT
T ss_pred             --CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHc
Confidence              223456678999999999999999998     467764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.9e-50  Score=402.27  Aligned_cols=250  Identities=22%  Similarity=0.317  Sum_probs=190.6

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC--------
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--------  338 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--------  338 (573)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+++|++++|||||++++++.+.+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            46899999999999999999975 68999999986543 344567899999999999999999999987544        


Q ss_pred             ----ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEee
Q 008239          339 ----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD  414 (573)
Q Consensus       339 ----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  414 (573)
                          ..++||||+++|+|.+++.........++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence                36899999999999999976555556778889999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCcc-----------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHH
Q 008239          415 FGLVRLFPEDITH-----------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQ  483 (573)
Q Consensus       415 fgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~  483 (573)
                      ||+++.+......           .....+||+.|||||++.+..|+.++|||||||++|||++   |+....   ....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~---~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM---ERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH---HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc---HHHH
Confidence            9999876543221           1234579999999999999999999999999999999996   443211   1111


Q ss_pred             HHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          484 TVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       484 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .. ..........     .    .......+.+|+.+||+.||++|||+.|+++
T Consensus       236 ~~-~~~~~~~~p~-----~----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          236 TL-TDVRNLKFPP-----L----FTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             HH-HHHHTTCCCH-----H----HHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HH-HHHhcCCCCC-----C----CcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            11 1111111110     0    1122345678999999999999999999987

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.4e-46  Score=381.57  Aligned_cols=282  Identities=38%  Similarity=0.592  Sum_probs=241.4

Q ss_pred             ccChHHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC
Q 008239          258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG  337 (573)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  337 (573)
                      .+...++...+++|+..+.||+|+||+||+|++.+|+.||||++........+.+.+|+.+++.++||||+++++++...
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            44555666788999999999999999999999988999999999877666778899999999999999999999999999


Q ss_pred             CceeEEEEeccCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQD-VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                      ...++||||+++|+|.+++..... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999865432 246899999999999999999999988   9999999999999999999999999


Q ss_pred             cccccCCCC-cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--chHHHHHHHhhcCc
Q 008239          417 LVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--SILQTVWDLYVKGR  493 (573)
Q Consensus       417 la~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~  493 (573)
                      +++...... ........||+.|+|||.+.+..++.++||||||+++|||++|+.|+.......  ....+.......+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            998654322 222334568999999999999999999999999999999999999987554332  44455555556666


Q ss_pred             cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       494 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      +...+++.+........+..+.+++.+||+.||++|||++||++.|+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            7777777777677778889999999999999999999999999999654

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8e-47  Score=384.19  Aligned_cols=289  Identities=42%  Similarity=0.669  Sum_probs=246.2

Q ss_pred             CccccChHHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccCh-hhHHHHHHHHHHHcCCCCCCeeeeeee
Q 008239          255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT-QWVDHFFNEVNLISGINHKNLVKLLGC  333 (573)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~l~~~  333 (573)
                      ....++..++....++|+..++||+|+||.||+|+..+|+.||||++..... .....+.+|+.+++.++||||++++++
T Consensus        16 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   95 (326)
T 3uim_A           16 QLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGF   95 (326)
T ss_dssp             CCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEE
T ss_pred             ccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEE
Confidence            3456899999999999999999999999999999988899999999975432 223368899999999999999999999


Q ss_pred             eecCCceeEEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEE
Q 008239          334 SITGPESLLVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI  412 (573)
Q Consensus       334 ~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl  412 (573)
                      +......++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+...++|+||||||+|||++.++.+||
T Consensus        96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl  175 (326)
T 3uim_A           96 CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVV  175 (326)
T ss_dssp             ECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEE
T ss_pred             EecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEe
Confidence            999999999999999999999986543 3446999999999999999999999982223999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCC----CCCCcchHHHHHHH
Q 008239          413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF----TQNSCSILQTVWDL  488 (573)
Q Consensus       413 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~----~~~~~~~~~~~~~~  488 (573)
                      +|||++...............||+.|+|||.+.+..++.++||||||+++|||++|+.|+..    .........+....
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  255 (326)
T 3uim_A          176 GDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL  255 (326)
T ss_dssp             CCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTT
T ss_pred             ccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHH
Confidence            99999997765555555566799999999999999999999999999999999999999863    22223455555555


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      ..........+..+........+..+.+++.+||+.+|++|||++||+++|++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~  310 (326)
T 3uim_A          256 LKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDG  310 (326)
T ss_dssp             TSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSS
T ss_pred             hhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcc
Confidence            5666667777777777777888899999999999999999999999999997643

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.4e-46  Score=385.57  Aligned_cols=261  Identities=22%  Similarity=0.311  Sum_probs=201.4

Q ss_pred             HHhcCccccccccccCceeEEEEEcC----CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCce
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES  340 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  340 (573)
                      ...+.|++.++||+|+||+||+|+.+    .++.||||++.....  ..++.+|+++|+.+ +|||||++++++.+.+..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            45678999999999999999999753    467899999865432  35678999999988 699999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC-CcEEEeeccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVR  419 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~  419 (573)
                      ++||||+++|+|.+++      ..+++..+..++.||+.||+|||+++   |+||||||+|||++.+ +.+||+|||+|+
T Consensus        96 ~lvmE~~~g~~L~~~~------~~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~  166 (361)
T 4f9c_A           96 VIAMPYLEHESFLDIL------NSLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQ  166 (361)
T ss_dssp             EEEEECCCCCCHHHHH------TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             EEEEeCCCcccHHHHH------cCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCc
Confidence            9999999999999988      24899999999999999999999998   9999999999999876 799999999998


Q ss_pred             ccCCCCcc---------------------------cccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCC
Q 008239          420 LFPEDITH---------------------------ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRI  471 (573)
Q Consensus       420 ~~~~~~~~---------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p  471 (573)
                      ........                           .....+||+.|+|||++.+. .++.++||||+||+++||++|+.|
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~P  246 (361)
T 4f9c_A          167 GTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYP  246 (361)
T ss_dssp             ECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSS
T ss_pred             ccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCC
Confidence            65432111                           12245799999999999875 589999999999999999999999


Q ss_pred             CCCCCCCcchHHHHHHHhhc----------Cc------------cc---------cccCccc---------cCCCCCchH
Q 008239          472 NLFTQNSCSILQTVWDLYVK----------GR------------LH---------EAVDPAL---------AGNFQEGKP  511 (573)
Q Consensus       472 ~~~~~~~~~~~~~~~~~~~~----------~~------------~~---------~~~d~~l---------~~~~~~~~~  511 (573)
                      |....+....+..+......          +.            ..         ....+.+         ........+
T Consensus       247 f~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is  326 (361)
T 4f9c_A          247 FYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVP  326 (361)
T ss_dssp             SSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCC
T ss_pred             CCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCC
Confidence            87655433222221111000          00            00         0000000         001112345


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          512 SRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       512 ~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .++.+|+.+||+.||++|||++|+++
T Consensus       327 ~~a~DLl~~lL~~dP~~R~ta~eaL~  352 (361)
T 4f9c_A          327 DEAYDLLDKLLDLNPASRITAEEALL  352 (361)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             HHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            67889999999999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-46  Score=390.79  Aligned_cols=262  Identities=21%  Similarity=0.291  Sum_probs=201.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec------CCc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT------GPE  339 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  339 (573)
                      ++|+..++||+|+||+||+|++. +|+.||||++...  .....+.+.+|+.+|++++|||||++++++..      ...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999974 6999999999654  23445678899999999999999999998753      357


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .+||||||+ |+|.+++..   ...+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+++
T Consensus       134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~  206 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR  206 (398)
T ss_dssp             EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence            899999995 789888843   356999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCC---cccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc
Q 008239          420 LFPEDI---THISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH  495 (573)
Q Consensus       420 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  495 (573)
                      .+....   .......+||+.|||||++.+. .++.++||||+||++|||++|+.||...... ..+..+..........
T Consensus       207 ~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~-~~l~~I~~~~g~p~~~  285 (398)
T 4b99_A          207 GLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV-HQLQLIMMVLGTPSPA  285 (398)
T ss_dssp             CC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred             ecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhcCCCChH
Confidence            764322   2233467899999999998875 5699999999999999999999988643321 2222222211110000


Q ss_pred             cc--cC--------ccccCC-------CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          496 EA--VD--------PALAGN-------FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       496 ~~--~d--------~~l~~~-------~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..  +.        ..+...       .....+.++.+|+.+||+.||++|||++|+++.
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          286 VIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             GTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            00  00        000000       011235678899999999999999999999873

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.9e-45  Score=399.53  Aligned_cols=252  Identities=19%  Similarity=0.229  Sum_probs=210.6

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|++.+.||+|+||+||+++.. +|+.||||++........+.+.+|+.+|+.|+|||||++++++.+....+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~  235 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  235 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEee
Confidence            367999999999999999999875 6999999999876666677889999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC--CcEEEeecccccccCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE--FTAKIADFGLVRLFPED  424 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~--~~~kl~Dfgla~~~~~~  424 (573)
                      |++|+|.+++..  ....+++..+..++.||+.||.|||+++   |+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       236 ~~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          236 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             cCCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999998843  2346899999999999999999999998   9999999999999854  89999999999987543


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .  .....+||+.|||||++.+..|+.++|||||||++|||++|+.||......    +. .........      .+..
T Consensus       311 ~--~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~----~~-~~~i~~~~~------~~~~  377 (573)
T 3uto_A          311 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD----ET-LRNVKSCDW------NMDD  377 (573)
T ss_dssp             S--EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH----HH-HHHHHTTCC------CCCS
T ss_pred             C--ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH----HH-HHHHHhCCC------CCCc
Confidence            3  234568999999999999999999999999999999999999998643321    11 111122111      0111


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ......+..+.+|+.+||+.||++|||+.|+++
T Consensus       378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            112234667889999999999999999999997

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8e-45  Score=392.45  Aligned_cols=248  Identities=21%  Similarity=0.193  Sum_probs=202.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hh---hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQ---WVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~---~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ++|++.++||+|+||+||+++.. +|+.||||++.+..   .+   .......++.+++.++|||||++++++.+...++
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            67999999999999999999975 68999999995431   11   1223344577888999999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      |||||+++|+|.++|...   ..+++..+..++.||+.||+|||+++   ||||||||+||||+.+|.+||+|||+++.+
T Consensus       269 lVmEy~~GGdL~~~l~~~---~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence            999999999999999543   46999999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ....   ....+||+.|||||++.. ..|+.++|||||||+||||++|+.||....... .. .+........       
T Consensus       343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~-~~-~i~~~i~~~~-------  410 (689)
T 3v5w_A          343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KH-EIDRMTLTMA-------  410 (689)
T ss_dssp             SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCC-HH-HHHHHHHHCC-------
T ss_pred             CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HH-HHHHhhcCCC-------
Confidence            5432   345689999999999975 579999999999999999999999986543322 11 1111111111       


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPS-----MSIVVK  537 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  537 (573)
                         ..++...+.++.+|+.+||+.||++|++     ++||++
T Consensus       411 ---~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          411 ---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             ---CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence               1234456778999999999999999998     677765

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.4e-43  Score=357.01  Aligned_cols=282  Identities=36%  Similarity=0.580  Sum_probs=230.5

Q ss_pred             CccccChHHHHHHhcCcccc------ccccccCceeEEEEEcCCCCEEEEEEeccc----ChhhHHHHHHHHHHHcCCCC
Q 008239          255 SKLNFSYETLEKATNYFHES------NKLGQGGSGSVYKGTLPGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGINH  324 (573)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~------~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h  324 (573)
                      ....|++.++..++++|...      ++||+|+||.||+|.. +++.||||++...    ..+..+.+.+|+.++++++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            34568999999999999877      8999999999999997 5889999998643    23456788999999999999


Q ss_pred             CCeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee
Q 008239          325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL  404 (573)
Q Consensus       325 ~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll  404 (573)
                      |||+++++++......++||||+++++|.+++........+++..++.++.||+.||.|||+.+   |+||||||+||++
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999999865545567999999999999999999999988   9999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHH
Q 008239          405 DEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQ  483 (573)
Q Consensus       405 ~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~  483 (573)
                      +.++.+||+|||++......... ......||+.|+|||.+.+ .++.++||||||+++|||++|+.|+........+..
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            99999999999999866543222 2334578999999998764 588999999999999999999999876554433222


Q ss_pred             HHHHHhh-cCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          484 TVWDLYV-KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       484 ~~~~~~~-~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ....... ...+...+++.+ ...+...+..+.+++.+||+.+|.+|||+++|+++|+..
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          246 IKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             HHHHHHTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHhhhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            2222211 112333344433 234556778899999999999999999999999999653

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=362.81  Aligned_cols=258  Identities=27%  Similarity=0.385  Sum_probs=211.8

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|...++||+|+||+||++.+. +++.||+|++........+.+.+|++++++++||||+++++++.+....++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            357889999999999999999975 6899999999777777788999999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++...  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        89 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  163 (310)
T 3s95_A           89 IKGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKT  163 (310)
T ss_dssp             CTTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC----
T ss_pred             cCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccc
Confidence            9999999998543  345899999999999999999999998   99999999999999999999999999987643322


Q ss_pred             cc-------------ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc
Q 008239          427 HI-------------SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR  493 (573)
Q Consensus       427 ~~-------------~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  493 (573)
                      ..             .....||+.|+|||.+.+..++.++||||||+++|||++|..|+..........           
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----------  232 (310)
T 3s95_A          164 QPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----------  232 (310)
T ss_dssp             ----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----------
T ss_pred             cccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----------
Confidence            11             114578999999999999999999999999999999999998865433221000           


Q ss_pred             cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       494 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                       .......+....+...+..+.+++.+||+.||++|||+++++++|+..
T Consensus       233 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          233 -GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             -SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             000000001112334456788999999999999999999999999654

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=9.7e-45  Score=366.03  Aligned_cols=270  Identities=28%  Similarity=0.403  Sum_probs=207.7

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      .+....++|++.++||+|+||+||+++. +|+.||||++....  .+..+.+.+|+.++++++||||+++++++......
T Consensus        31 ~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           31 DMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             -CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            3334467899999999999999999987 48899999986543  34456889999999999999999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++|+|.+++........+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++.
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  188 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL  188 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence            999999999999999865433335899999999999999999999975 4599999999999999999999999999985


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ..... .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......    +..........       
T Consensus       189 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~----~~~~~~~~~~~-------  256 (309)
T 3p86_A          189 KASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA----QVVAAVGFKCK-------  256 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHH----HHHHHHHHSCC-------
T ss_pred             ccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHhcCC-------
Confidence            54322 2233457899999999999999999999999999999999999987543221    11111111110       


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCCCC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQP  548 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~~~p  548 (573)
                        ....+...+..+.+++.+||+.+|++|||++++++.|+.......|
T Consensus       257 --~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~p  302 (309)
T 3p86_A          257 --RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAVP  302 (309)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC----
T ss_pred             --CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCCC
Confidence              1123445667899999999999999999999999999765554333

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.6e-43  Score=366.14  Aligned_cols=258  Identities=25%  Similarity=0.329  Sum_probs=211.1

Q ss_pred             hcCccccccccccCceeEEEEEcC--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG  337 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  337 (573)
                      .++|+..+.||+|+||.||+|++.        ++..||||++... .....+.+.+|+.+++++ +||||+++++++...
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~  159 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD  159 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence            467899999999999999999852        3567999999765 334567899999999999 899999999999999


Q ss_pred             CceeEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL  404 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll  404 (573)
                      ...++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+++   |+||||||+|||+
T Consensus       160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll  236 (370)
T 2psq_A          160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV  236 (370)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence            999999999999999999865431             245899999999999999999999988   9999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchH
Q 008239          405 DEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSIL  482 (573)
Q Consensus       405 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~  482 (573)
                      +.++.+||+|||+++....... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.|+.... ...+.
T Consensus       237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~-~~~~~  315 (370)
T 2psq_A          237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-VEELF  315 (370)
T ss_dssp             CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHH
T ss_pred             CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC-HHHHH
Confidence            9999999999999986654322 22234567889999999999999999999999999999999 777764322 11221


Q ss_pred             HHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       483 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .    ....+.         ....+...+..+.+++.+||+.+|++||++.|+++.|+..
T Consensus       316 ~----~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          316 K----LLKEGH---------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             H----HHHTTC---------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----HHhcCC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1    112211         1123445677899999999999999999999999999653

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1.9e-43  Score=354.65  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=210.3

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|+..++||+|+||+||++.. .+|+.||||++........+.+.+|+.+++.++||||+++++++...+..++||||
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   98 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEEC
Confidence            46799999999999999999996 46899999999766555567889999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++|+|.+++...    .+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        99 ~~~~~L~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           99 LAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             CTTCBHHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             CCCCCHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            9999999988542    4899999999999999999999998   99999999999999999999999999987654332


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                       ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....    ..........+.. .       ...
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~~~~~~~~~~~-~-------~~~  238 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATNGTP-E-------LQN  238 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHHCSC-C-------CSC
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCC-C-------CCC
Confidence             23356789999999999999999999999999999999999999754322    1111122111111 0       112


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +...+..+.+++.+||+.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          239 PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            33456778999999999999999999999873

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=360.96  Aligned_cols=257  Identities=27%  Similarity=0.398  Sum_probs=208.0

Q ss_pred             hcCccccccccccCceeEEEEEcC----CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..++||+|+||+||+|++.    .+..||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  127 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI  127 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence            356888899999999999999974    3456999999764 44456789999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       128 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          128 VTEYMENGSLDTFLRTH--DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             EeeCCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            99999999999998533  346899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          423 EDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       423 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .....  ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... .    .......+       
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~-~----~~~~~~~~-------  270 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNR-D----VISSVEEG-------  270 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHH-H----HHHHHHTT-------
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHH-H----HHHHHHcC-------
Confidence            43222  2223446778999999999999999999999999999999 88776443211 1    11111111       


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                        .....+...+..+.+|+.+||+.+|++|||+.+|+++|+...
T Consensus       271 --~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          271 --YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              111234456778999999999999999999999999996543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-43  Score=350.22  Aligned_cols=255  Identities=26%  Similarity=0.364  Sum_probs=211.4

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .++|+..+.||+|+||+||++++.+++.||||++...... .+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   87 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   87 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeC
Confidence            3678899999999999999999988999999999765432 467899999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.........
T Consensus        88 ~~~~L~~~l~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           88 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             TTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHHhc--CcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            999999998543  346899999999999999999999988   999999999999999999999999999876544333


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......+|+.|+|||.+....++.++||||||+++|||++ |+.|+..... ...    ......+         .....
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~-~~~----~~~~~~~---------~~~~~  228 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEV----VEDISTG---------FRLYK  228 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHH----HHHHHTT---------CCCCC
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH-HHH----HHHHhcC---------ccCCC
Confidence            3445567888999999999999999999999999999999 7777643221 111    1111111         11122


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      +...+..+.+++.+||+.+|++||++++++++|+..
T Consensus       229 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          229 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            334567899999999999999999999999999653

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=3.6e-43  Score=352.07  Aligned_cols=262  Identities=24%  Similarity=0.343  Sum_probs=208.7

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..++||+|+||.||+++.. +++.||||++...   ..+..+.+.+|+.++++++||||+++++++......++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv   89 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV   89 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence            467999999999999999999864 6899999998543   334567889999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++...   ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        90 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  163 (294)
T 4eqm_A           90 MEYIEGPTLSEYIESH---GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE  163 (294)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred             EeCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence            9999999999998543   35899999999999999999999988   99999999999999999999999999987654


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ..........||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....    .......... ..     +...
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~----~~~~~~~~~~-~~-----~~~~  233 (294)
T 4eqm_A          164 TSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA----VSIAIKHIQD-SV-----PNVT  233 (294)
T ss_dssp             -----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH----HHHHHHHHSS-CC-----CCHH
T ss_pred             ccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhhc-cC-----CCcc
Confidence            443334456799999999999999999999999999999999999999754322    1111111111 11     1111


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCC-CHHHHHHHhccCCCC
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRP-SMSIVVKMLTGNHEI  545 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~~~~~  545 (573)
                      .......+..+.+++.+||+.+|++|| +++++.+.|......
T Consensus       234 ~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          234 TDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             HHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             hhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            122345667899999999999999998 899999999665443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1.5e-42  Score=351.89  Aligned_cols=262  Identities=26%  Similarity=0.347  Sum_probs=216.0

Q ss_pred             cccChHHHHHHhcC----------ccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCC
Q 008239          257 LNFSYETLEKATNY----------FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK  325 (573)
Q Consensus       257 ~~~~~~~~~~~~~~----------~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  325 (573)
                      ..+++++++.+++.          |+..++||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            34777787777754          677789999999999999976 7999999999776666677899999999999999


Q ss_pred             CeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC
Q 008239          326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD  405 (573)
Q Consensus       326 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~  405 (573)
                      ||+++++++......++||||+++++|.+++..    ..+++..++.++.||+.||.|||+.+   |+||||||+|||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~  175 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLT  175 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEC
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEC
Confidence            999999999999999999999999999998742    35899999999999999999999988   99999999999999


Q ss_pred             CCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH
Q 008239          406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV  485 (573)
Q Consensus       406 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~  485 (573)
                      .++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....    .+..
T Consensus       176 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~----~~~~  250 (321)
T 2c30_A          176 LDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSP----VQAM  250 (321)
T ss_dssp             TTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH
T ss_pred             CCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHH
Confidence            999999999999987654322 23356789999999999999999999999999999999999998764321    1111


Q ss_pred             HHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          486 WDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       486 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       .......     .+.+.  .....+..+.+++.+||+.||++|||++|+++.
T Consensus       251 -~~~~~~~-----~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          251 -KRLRDSP-----PPKLK--NSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -HHHHHSS-----CCCCT--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -HHHhcCC-----CCCcC--ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             1111111     11111  122345678999999999999999999999974

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.6e-43  Score=366.42  Aligned_cols=256  Identities=25%  Similarity=0.367  Sum_probs=198.5

Q ss_pred             hcCccccccccccCceeEEEEEcC----CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..+.||+|+||.||+|++.    ++..||||++... .....+.+.+|+.++++++||||+++++++.+....++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  123 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI  123 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence            357889999999999999999875    5778999999764 34456789999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~sL~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          124 VTEYMENGSLDSFLRKH--DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             EEECCTTCBHHHHHHTT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999998543  346899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCccc--ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          423 EDITHI--SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       423 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ......  .....+++.|+|||++....++.++||||||+++|||++ |+.|+..... ..    .......+       
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~-~~----~~~~i~~~-------  266 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN-QD----VIKAVDEG-------  266 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH-HH----HHHHHHTT-------
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHHHcC-------
Confidence            432221  112345778999999999999999999999999999998 8887654321 11    11111111       


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                        .....+...+..+.+++.+||+.+|++||++++|+++|+..
T Consensus       267 --~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          267 --YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             --EECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --CCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence              11222445678899999999999999999999999999543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=5.9e-44  Score=379.63  Aligned_cols=264  Identities=27%  Similarity=0.384  Sum_probs=215.8

Q ss_pred             hHHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       261 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      ...++...++|+..++||+|+||+||+|.+.++..||||++.... ...+.+.+|+.+|++++||||+++++++. .+..
T Consensus       180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~  257 (454)
T 1qcf_A          180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI  257 (454)
T ss_dssp             TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred             ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence            344556678899999999999999999999888999999997644 34678999999999999999999999986 5678


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus       258 ~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  333 (454)
T 1qcf_A          258 YIITEFMAKGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARV  333 (454)
T ss_dssp             EEEECCCTTCBHHHHHHSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGG
T ss_pred             EEEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceE
Confidence            99999999999999985432 124789999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .............+|..|+|||.+..+.++.++||||||++||||++ |+.|+..... ..+.    .....+.      
T Consensus       334 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~-~~~~----~~i~~~~------  402 (454)
T 1qcf_A          334 IEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN-PEVI----RALERGY------  402 (454)
T ss_dssp             BCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-HHHH----HHHHHTC------
T ss_pred             cCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH-HHHH----HHHHcCC------
Confidence            65433222334456789999999999999999999999999999999 8777643221 1111    1112111      


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE  544 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  544 (573)
                         ....+...+..+.+|+.+||+.+|++|||+++|+++|+....
T Consensus       403 ---~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          403 ---RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             ---CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence               112244567889999999999999999999999999976544

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4e-43  Score=356.38  Aligned_cols=262  Identities=29%  Similarity=0.348  Sum_probs=205.5

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc----eeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE----SLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----~~lv  343 (573)
                      .++|+..++||+|+||+||+|++. ++.||||++...... ...+..|+.++++++||||+++++++.....    .++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467999999999999999999886 789999999654332 3455679999999999999999999987543    6999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------CCCCeEEecCCCCCeeeCCCCcEEEe
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE----------SKLRIIHRDIKLSNILLDEEFTAKIA  413 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~----------~~~~iiHrDlk~~NIll~~~~~~kl~  413 (573)
                      |||+++|+|.+++..    ..+++..++.++.|++.||+|||+.          +   |+||||||+|||++.++.+||+
T Consensus       101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEEC
T ss_pred             EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEc
Confidence            999999999999854    2489999999999999999999997          6   9999999999999999999999


Q ss_pred             ecccccccCCCCcc-cccccccCcCcCchhhhccC-----CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcc-------
Q 008239          414 DFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRG-----KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS-------  480 (573)
Q Consensus       414 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~sDvwslGvil~elltg~~p~~~~~~~~~-------  480 (573)
                      |||+++........ ......||+.|+|||++.+.     .++.++||||||+++|||++|+.|+........       
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            99999876543322 23346789999999999763     456688999999999999999999865433211       


Q ss_pred             ----hHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          481 ----ILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       481 ----~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                          .................+....   .....+..+.+|+.+||+.||++|||++||++.|+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  315 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYW---QKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQ  315 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGG---GSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccc---cccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence                1111111111111111111111   123456779999999999999999999999999964

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.2e-43  Score=354.61  Aligned_cols=248  Identities=22%  Similarity=0.300  Sum_probs=208.4

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .++|+..+.||+|+||.||+|++ .+|+.||||++...  .....+.+.+|+++++.++||||+++++++......++||
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   93 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM   93 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            46799999999999999999997 57999999998654  3445677889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  167 (328)
T 3fe3_A           94 EYASGGEVFDYLVAH---GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG  167 (328)
T ss_dssp             CCCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred             ECCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence            999999999998543   35899999999999999999999998   999999999999999999999999999866443


Q ss_pred             CcccccccccCcCcCchhhhccCCCC-cccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLT-EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .  ......||+.|+|||.+.+..+. .++||||||+++|||++|+.|+.....     .........+..         
T Consensus       168 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~-----~~~~~~i~~~~~---------  231 (328)
T 3fe3_A          168 G--KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL-----KELRERVLRGKY---------  231 (328)
T ss_dssp             C--GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCC---------
T ss_pred             C--ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCC---------
Confidence            2  23456799999999999888775 799999999999999999999754321     112222222221         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       ..+...+..+.+++.+||+.||.+|||++|+++.
T Consensus       232 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 -RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             -CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             -CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             1233456788999999999999999999999874

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=7.5e-43  Score=350.48  Aligned_cols=260  Identities=26%  Similarity=0.366  Sum_probs=201.7

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcC--CCCCCeeeeeeeeec----CCcee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSIT----GPESL  341 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----~~~~~  341 (573)
                      .++|+..++||+|+||+||+|++ +|+.||||++....   .+.+..|.+++..  ++||||+++++++..    ....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46899999999999999999988 58999999986432   3445556666555  899999999998654    34578


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEecCCCCCeeeCCCCcEEEe
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH--------EESKLRIIHRDIKLSNILLDEEFTAKIA  413 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~iiHrDlk~~NIll~~~~~~kl~  413 (573)
                      +||||+++|+|.+++.    ...+++..++.++.||+.||+|||        +.+   |+||||||+|||++.++.+||+
T Consensus        83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred             EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence            9999999999999983    246899999999999999999999        666   9999999999999999999999


Q ss_pred             ecccccccCCCCccc---ccccccCcCcCchhhhccC------CCCcccchHhHHHHHHHHHcC----------CCCCCC
Q 008239          414 DFGLVRLFPEDITHI---SATLAGTLGYMAPEYVVRG------KLTEKADVYSFGVVVIEVVCR----------KRINLF  474 (573)
Q Consensus       414 Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~sDvwslGvil~elltg----------~~p~~~  474 (573)
                      |||+++.........   .....||+.|+|||.+.+.      .++.++||||||+++|||++|          +.|+..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            999998664433221   2244789999999999876      455799999999999999999          666654


Q ss_pred             CCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          475 TQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       475 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .......................+.+   ...+...+..+.+|+.+||+.||++|||++||+++|+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQRPNIPN---RWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCG---GGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCCCCCCh---hhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            43333333333333222111111111   11234567889999999999999999999999999964

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.2e-43  Score=346.39  Aligned_cols=256  Identities=26%  Similarity=0.335  Sum_probs=212.3

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .++|+..+.||+|+||.||++.+.++..||||++...... .+++.+|+.++++++||||+++++++......++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI   85 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence            4678999999999999999999998889999999754432 467899999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  160 (268)
T 3sxs_A           86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV  160 (268)
T ss_dssp             TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE
T ss_pred             CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhh
Confidence            999999998543  235899999999999999999999988   999999999999999999999999999876555444


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+......    .. ......+.         ....
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~----~~-~~~~~~~~---------~~~~  226 (268)
T 3sxs_A          161 SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNS----EV-VLKVSQGH---------RLYR  226 (268)
T ss_dssp             ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHH----HH-HHHHHTTC---------CCCC
T ss_pred             cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChH----HH-HHHHHcCC---------CCCC
Confidence            4445566788999999999899999999999999999999 88776443221    11 11111111         0111


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      +...+..+.+++.+||+.+|++|||+.|+++.|+...
T Consensus       227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~  263 (268)
T 3sxs_A          227 PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLR  263 (268)
T ss_dssp             CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGC
T ss_pred             CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            2334667899999999999999999999999997654

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.3e-43  Score=377.50  Aligned_cols=261  Identities=28%  Similarity=0.385  Sum_probs=215.8

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcCC-CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ++....+|+..++||+|+||.||+|++.. +..||||++..... ..+.|.+|+.+|++++||||+++++++......++
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            33445678899999999999999999864 88999999976543 36789999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       294 v~E~~~~g~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~  369 (495)
T 1opk_A          294 ITEFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMT  369 (495)
T ss_dssp             EEECCTTCBHHHHHHHSC-TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCT
T ss_pred             EEEccCCCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceecc
Confidence            999999999999986432 345899999999999999999999988   9999999999999999999999999999775


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ...........++..|+|||.+..+.++.++||||||++||||++ |..|+.... ...+...    ...         .
T Consensus       370 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~-~~~~~~~----~~~---------~  435 (495)
T 1opk_A          370 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYEL----LEK---------D  435 (495)
T ss_dssp             TCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHHHH----HHT---------T
T ss_pred             CCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC-HHHHHHH----HHc---------C
Confidence            544333334556789999999999999999999999999999999 666654322 2222211    111         1


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      .....+...+..+.+|+.+||+.+|++|||+.+|+++|+...
T Consensus       436 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          436 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            112234556788999999999999999999999999997653

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.3e-43  Score=368.02  Aligned_cols=257  Identities=25%  Similarity=0.355  Sum_probs=209.5

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ...++|+..++||+|+||.||+|++. +++.||||++.... .+..+.+.+|+++|++++||||+++++++......++|
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence            34568899999999999999999986 68999999987543 33445788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++|+|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       191 ~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~  265 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTE--GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD  265 (377)
T ss_dssp             EECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred             EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence            9999999999998543  235889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccc-cccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          424 DITHIS-ATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       424 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ...... ....+++.|+|||.+..+.++.++||||||+++|||++ |..|+.....     .........+.        
T Consensus       266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~-----~~~~~~~~~~~--------  332 (377)
T 3cbl_A          266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN-----QQTREFVEKGG--------  332 (377)
T ss_dssp             SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH-----HHHHHHHHTTC--------
T ss_pred             CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCC--------
Confidence            322111 12345778999999999999999999999999999998 7766543221     11112222211        


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                       ....+...+..+.+|+.+||+.+|++|||+++|++.|+.
T Consensus       333 -~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  371 (377)
T 3cbl_A          333 -RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQS  371 (377)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence             112344567789999999999999999999999999954

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.4e-43  Score=362.31  Aligned_cols=269  Identities=26%  Similarity=0.317  Sum_probs=217.4

Q ss_pred             cccChHHHHHHhcCccccccccccCceeEEEEEc------CCCCEEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCee
Q 008239          257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLV  328 (573)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv  328 (573)
                      ..+....++...++|+..++||+|+||.||+|++      .+++.||||++... .....+.+.+|++++.++ +||||+
T Consensus        10 ~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv   89 (359)
T 3vhe_A           10 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   89 (359)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCccee
Confidence            4466777778889999999999999999999973      34679999999764 334456789999999999 799999


Q ss_pred             eeeeeeecCCc-eeEEEEeccCCCccccccccCC----------------------------------------------
Q 008239          329 KLLGCSITGPE-SLLVYEFVPNQSLLDNLFVRQD----------------------------------------------  361 (573)
Q Consensus       329 ~l~~~~~~~~~-~~lv~e~~~~gsL~~~l~~~~~----------------------------------------------  361 (573)
                      ++++++.+... .++||||+++|+|.+++.....                                              
T Consensus        90 ~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (359)
T 3vhe_A           90 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVE  169 (359)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------
T ss_pred             eeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccc
Confidence            99999887654 8999999999999999865432                                              


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          362 -----------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       362 -----------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                                       ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  246 (359)
T 3vhe_A          170 EKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKD  246 (359)
T ss_dssp             --------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSC
T ss_pred             ccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeeccc
Confidence                             122899999999999999999999998   999999999999999999999999999866433


Q ss_pred             Cc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          425 IT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       425 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++ |+.|+........+    ......+..        
T Consensus       247 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~----~~~~~~~~~--------  314 (359)
T 3vhe_A          247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----CRRLKEGTR--------  314 (359)
T ss_dssp             TTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH----HHHHHHTCC--------
T ss_pred             ccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHH----HHHHHcCCC--------
Confidence            22 22335568899999999999999999999999999999998 88887544332222    122222111        


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                       ...+...+..+.+++.+||+.+|++|||++||+++|+.
T Consensus       315 -~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  352 (359)
T 3vhe_A          315 -MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  352 (359)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHH
Confidence             12234456789999999999999999999999999964

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.1e-43  Score=354.19  Aligned_cols=254  Identities=26%  Similarity=0.320  Sum_probs=205.0

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|+..++||+|+||+||+++.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   85 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEE
Confidence            367999999999999999999875 78999999986443 2334678899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++..   ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..+....
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  159 (323)
T 3tki_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (323)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCC
Confidence            9999999998843   345899999999999999999999988   9999999999999999999999999998654322


Q ss_pred             -cccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          426 -THISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       426 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                       ........||+.|+|||++.+..+ +.++||||||+++|||++|+.|+...........    .+.....        .
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~----~~~~~~~--------~  227 (323)
T 3tki_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS----DWKEKKT--------Y  227 (323)
T ss_dssp             EECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHH----HHHTTCT--------T
T ss_pred             cccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHH----HHhcccc--------c
Confidence             222335679999999999987765 7799999999999999999999865543322111    1111110        0


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      .......+..+.+|+.+||+.||++|||++|+++.-
T Consensus       228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~  263 (323)
T 3tki_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDR  263 (323)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCT
T ss_pred             CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhCh
Confidence            011133466788999999999999999999998753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=4.5e-43  Score=351.31  Aligned_cols=260  Identities=27%  Similarity=0.385  Sum_probs=206.9

Q ss_pred             hcCccccccccccCceeEEEEEc-----CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec--CCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~  340 (573)
                      .++|+..++||+|+||+||++++     .+++.||||++........+.+.+|+.++++++||||+++++++..  ....
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            46789999999999999999984     3588999999987777777889999999999999999999998864  3568


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++++|.+++....  ..+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~  163 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK--ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  163 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG--GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-
T ss_pred             EEEEEeCCCCCHHHHHHhcc--cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccccc
Confidence            99999999999999985432  35899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCc--ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCC-----------cchHHHHHH
Q 008239          421 FPEDIT--HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS-----------CSILQTVWD  487 (573)
Q Consensus       421 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~-----------~~~~~~~~~  487 (573)
                      ......  .......++..|+|||.+.+..++.++||||||+++|||++|..|+......           .........
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (295)
T 3ugc_A          164 LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  243 (295)
T ss_dssp             ------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHH
Confidence            654322  1223445677899999999999999999999999999999998876532110           000011111


Q ss_pred             HhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          488 LYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       488 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...         .......+...+..+.+++.+||+.+|++|||++|+++.|+.
T Consensus       244 ~~~---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~  288 (295)
T 3ugc_A          244 LLK---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  288 (295)
T ss_dssp             HHH---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             HHh---------ccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence            111         111123345667889999999999999999999999999954

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.4e-43  Score=348.49  Aligned_cols=256  Identities=23%  Similarity=0.345  Sum_probs=209.1

Q ss_pred             HHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ...++|+..++||+|+||+||++.+.++..||||++...... .+.+.+|++++++++||||+++++++.+....++|||
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence            345789999999999999999999998889999999765332 4678899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus       100 ~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A          100 YMANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             CCTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             ccCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            99999999998542  235899999999999999999999988   9999999999999999999999999998765443


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... .    .......+         ...
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~-~----~~~~~~~~---------~~~  240 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS-E----TAEHIAQG---------LRL  240 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHH-H----HHHHHHTT---------CCC
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChh-H----HHHHHhcc---------cCC
Confidence            333334556788999999999999999999999999999998 88776543211 1    11111111         111


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ..+...+..+.+++.+||+.+|++|||++++++.|.+
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~  277 (283)
T 3gen_A          241 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  277 (283)
T ss_dssp             CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            1233446789999999999999999999999999954

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.8e-42  Score=347.94  Aligned_cols=270  Identities=22%  Similarity=0.283  Sum_probs=215.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC--ceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  343 (573)
                      .++|+..++||+|+||+||+|+.. +|+.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            367899999999999999999976 58999999996543 334567889999999999999999999988665  67999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee----CCCCcEEEeeccccc
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVR  419 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll----~~~~~~kl~Dfgla~  419 (573)
                      |||+++++|.+++........+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~  164 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (319)
T ss_dssp             EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred             EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence            999999999999976555555999999999999999999999998   9999999999999    788889999999998


Q ss_pred             ccCCCCcccccccccCcCcCchhhhc--------cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVV--------RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      .......  .....||+.|+|||++.        +..++.++||||||+++|||++|+.|+...................
T Consensus       165 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (319)
T 4euu_A          165 ELEDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (319)
T ss_dssp             ECCTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHH
T ss_pred             ecCCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcC
Confidence            7654332  23456899999999986        5788999999999999999999999986544433323333222221


Q ss_pred             C---ccccc---cC------ccc--cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          492 G---RLHEA---VD------PAL--AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       492 ~---~~~~~---~d------~~l--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .   .+...   ..      +.+  ........+..+.+++.+||+.||++|||++|+++..++.
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            1   11100   00      011  1123456677889999999999999999999999999543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.9e-43  Score=372.93  Aligned_cols=263  Identities=27%  Similarity=0.380  Sum_probs=208.5

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++...++|+..++||+|+||.||+|.+.++..||||++..... ..+.|.+|+.+|++++||||+++++++.+ ...++
T Consensus       178 ~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i  255 (452)
T 1fmk_A          178 AWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI  255 (452)
T ss_dssp             CSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred             ccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence            34445678899999999999999999998888899999976443 35689999999999999999999999876 67899


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       256 v~e~~~~gsL~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~  331 (452)
T 1fmk_A          256 VTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIE  331 (452)
T ss_dssp             EECCCTTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred             EehhhcCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecC
Confidence            999999999999985321 235899999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ...........++..|+|||.+..+.++.++||||||+++|||++ |+.|+..... ..    .......+         
T Consensus       332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~-~~----~~~~i~~~---------  397 (452)
T 1fmk_A          332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-RE----VLDQVERG---------  397 (452)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HH----HHHHHHTT---------
T ss_pred             CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH-HH----HHHHHHcC---------
Confidence            433333334456889999999999999999999999999999999 7776643221 11    11111211         


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCC
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEI  545 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~  545 (573)
                      .....+...+..+.+|+.+||+.+|++|||+++|+++|+.....
T Consensus       398 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          398 YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence            11123445678899999999999999999999999999776544

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.3e-43  Score=369.24  Aligned_cols=264  Identities=19%  Similarity=0.169  Sum_probs=212.5

Q ss_pred             ChHHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeee
Q 008239          260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSI  335 (573)
Q Consensus       260 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  335 (573)
                      .+.++....++|+..++||+|+||+||++++. +++.||||++....   ....+.+.+|+.++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            45556667789999999999999999999986 47899999996432   122334788999999999999999999999


Q ss_pred             cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeec
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF  415 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  415 (573)
                      +....++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||||+.++.+||+||
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~--~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF  219 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF--EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF  219 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence            999999999999999999998542  346899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh
Q 008239          416 GLVRLFPEDITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV  490 (573)
Q Consensus       416 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  490 (573)
                      |+++..............||+.|+|||++.     .+.++.++|||||||++|||++|+.|+...... .....+   ..
T Consensus       220 Gla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~-~~~~~i---~~  295 (437)
T 4aw2_A          220 GSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV-ETYGKI---MN  295 (437)
T ss_dssp             TTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHH---HT
T ss_pred             hhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh-HHHHhh---hh
Confidence            999876555444445578999999999997     567899999999999999999999998643321 111111   11


Q ss_pred             cCccccccCccccCCCCCchHHHHHHHHHHccCCCCCC--CCCHHHHHHH
Q 008239          491 KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAEL--RPSMSIVVKM  538 (573)
Q Consensus       491 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~  538 (573)
                      . .. ...-    .......+..+.+|+.+||+.+|++  ||+++|+++.
T Consensus       296 ~-~~-~~~~----p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          296 H-KE-RFQF----PTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             H-HH-HCCC----CSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             c-cc-cccC----CcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            0 00 0000    1111235678899999999888888  9999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-42  Score=361.22  Aligned_cols=262  Identities=25%  Similarity=0.323  Sum_probs=213.7

Q ss_pred             HHhcCccccccccccCceeEEEEEcC--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeee
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI  335 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  335 (573)
                      ...++|...++||+|+||+||+|+..        .+..||||++... .....+.+.+|+++++++ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            34578999999999999999999852        2457999999764 344457889999999999 9999999999999


Q ss_pred             cCCceeEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCe
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI  402 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI  402 (573)
                      .....++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+.+   |+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence            99999999999999999999865431             245899999999999999999999988   99999999999


Q ss_pred             eeCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcc
Q 008239          403 LLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCS  480 (573)
Q Consensus       403 ll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~  480 (573)
                      |++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....    
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~----  298 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP----  298 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC----
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC----
Confidence            999999999999999986654322 22334567889999999999999999999999999999999 777764322    


Q ss_pred             hHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 008239          481 ILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE  544 (573)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  544 (573)
                       ..........+.         ....+...+..+.+++.+||+.+|++|||++||++.|+....
T Consensus       299 -~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  352 (382)
T 3tt0_A          299 -VEELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  352 (382)
T ss_dssp             -HHHHHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HHHHHHHHHcCC---------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence             112222222221         112234567789999999999999999999999999965543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=346.88  Aligned_cols=254  Identities=27%  Similarity=0.394  Sum_probs=200.2

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      ++|+..+.||+|+||+||++++. ++.||||++...  ...+.+.+|++++++++||||+++++++.+  ..++||||++
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~   82 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAE   82 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCT
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCC
Confidence            57888999999999999999986 788999998643  345788999999999999999999998874  4899999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc-EEEeecccccccCCCCcc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-AKIADFGLVRLFPEDITH  427 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~-~kl~Dfgla~~~~~~~~~  427 (573)
                      +++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||++.++. +||+|||++......   
T Consensus        83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~---  159 (307)
T 2eva_A           83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---  159 (307)
T ss_dssp             TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----------
T ss_pred             CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc---
Confidence            9999999976554456889999999999999999999943234999999999999988876 799999999765432   


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                       .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+......  .....+.... +..         ....
T Consensus       160 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~-~~~---------~~~~  226 (307)
T 2eva_A          160 -MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP--AFRIMWAVHN-GTR---------PPLI  226 (307)
T ss_dssp             ------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS--HHHHHHHHHT-TCC---------CCCB
T ss_pred             -cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc--HHHHHHHHhc-CCC---------CCcc
Confidence             22346899999999999999999999999999999999999997643322  1111222111 111         1122


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      ...+..+.+++.+||+.+|++|||+++++++|+...
T Consensus       227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  262 (307)
T 2eva_A          227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLM  262 (307)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHG
T ss_pred             cccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHH
Confidence            345678899999999999999999999999995543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.4e-42  Score=365.52  Aligned_cols=250  Identities=26%  Similarity=0.396  Sum_probs=206.2

Q ss_pred             HhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC-ceeEEEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP-ESLLVYE  345 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~lv~e  345 (573)
                      ..++|+..++||+|+||.||+|.+. |+.||||++....  ..+.|.+|+.+|++++||||+++++++.... ..++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467888999999999999999986 7899999997543  4578999999999999999999999987665 7899999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus       268 ~~~~g~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  343 (450)
T ss_dssp             CCTTCBHHHHHHHHC-TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             ecCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccc
Confidence            999999999996543 234789999999999999999999988   9999999999999999999999999998543221


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                          ....++..|+|||.+.+..++.++||||||+++|||++ |+.|+...... .....    ...+         ...
T Consensus       344 ----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~-~~~~~----i~~~---------~~~  405 (450)
T 1k9a_A          344 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPR----VEKG---------YKM  405 (450)
T ss_dssp             -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTT-THHHH----HHTT---------CCC
T ss_pred             ----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH-HHHHH----HHcC---------CCC
Confidence                22356889999999999999999999999999999998 88776543322 22221    1111         111


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ..+...+..+.+|+.+||+.+|++|||+.++++.|+.
T Consensus       406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~  442 (450)
T 1k9a_A          406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEH  442 (450)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            2345567889999999999999999999999999954

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=355.54  Aligned_cols=263  Identities=28%  Similarity=0.384  Sum_probs=213.7

Q ss_pred             HHHhcCccccccccccCceeEEEEEcC------CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG  337 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  337 (573)
                      ....++|+..+.||+|+||.||+++..      +++.||||++... .....+.+.+|+.++++++||||+++++++...
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~  122 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG  122 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC
Confidence            344678999999999999999999874      3478999999764 344467889999999999999999999999999


Q ss_pred             CceeEEEEeccCCCccccccccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEec
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQD---------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRD  396 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrD  396 (573)
                      ...++||||+++|+|.+++.....                     ...+++..++.++.||+.||.|||+++   |+|||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~D  199 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRD  199 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCC
Confidence            999999999999999999865321                     256899999999999999999999998   99999


Q ss_pred             CCCCCeeeCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCC
Q 008239          397 IKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLF  474 (573)
Q Consensus       397 lk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~  474 (573)
                      |||+|||++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+..
T Consensus       200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence            999999999999999999999986543221 22234567899999999999999999999999999999999 8777653


Q ss_pred             CCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 008239          475 TQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE  544 (573)
Q Consensus       475 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  544 (573)
                      ...     .........+..         ...+...+..+.+++.+||+.+|++||++.+|+++|+....
T Consensus       280 ~~~-----~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~  335 (343)
T 1luf_A          280 MAH-----EEVIYYVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE  335 (343)
T ss_dssp             SCH-----HHHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             CCh-----HHHHHHHhCCCc---------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHh
Confidence            221     112222222221         12234566789999999999999999999999999976543

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2.4e-42  Score=348.93  Aligned_cols=258  Identities=26%  Similarity=0.336  Sum_probs=211.5

Q ss_pred             HhcCccccccccccCceeEEEEEc------CCCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE  339 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  339 (573)
                      ..++|...+.||+|+||.||++..      .+++.||||++... .....+.+.+|+.++++++||||+++++++.....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~  100 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP  100 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence            457899999999999999999985      24578999999754 34456788999999999999999999999999999


Q ss_pred             eeEEEEeccCCCccccccccCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQD---------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK  398 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk  398 (573)
                      .++||||+++++|.+++.....                     ...+++..++.++.||+.||+|||+++   |+|||||
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik  177 (314)
T 2ivs_A          101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA  177 (314)
T ss_dssp             CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred             eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence            9999999999999999865432                     234889999999999999999999988   9999999


Q ss_pred             CCCeeeCCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCC
Q 008239          399 LSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ  476 (573)
Q Consensus       399 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~  476 (573)
                      |+|||++.++.+||+|||+++........ ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+....
T Consensus       178 p~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          178 ARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             GGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999876443322 2234457889999999999999999999999999999999 877765432


Q ss_pred             CCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          477 NSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      . ..+.    .....+.         ....+...+..+.+++.+||+.||++||++.|+++.|+.
T Consensus       258 ~-~~~~----~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~  308 (314)
T 2ivs_A          258 P-ERLF----NLLKTGH---------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEK  308 (314)
T ss_dssp             G-GGHH----HHHHTTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H-HHHH----HHhhcCC---------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            2 1221    1112111         112334567789999999999999999999999999964

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.9e-42  Score=346.03  Aligned_cols=263  Identities=22%  Similarity=0.285  Sum_probs=204.8

Q ss_pred             HhcCccccccccccCceeEEEEEcCCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ..++|+..++||+|+||+||+++..+|+.||||++....  ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            347899999999999999999999889999999986542  233567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++ +|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        99 e~~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  172 (311)
T 3niz_A           99 EFMEK-DLKKVLDEN--KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP  172 (311)
T ss_dssp             ECCSE-EHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC
T ss_pred             cCCCC-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC
Confidence            99984 787777432  345899999999999999999999988   999999999999999999999999999876433


Q ss_pred             CcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcc---ccc---
Q 008239          425 ITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL---HEA---  497 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~---  497 (573)
                      .. ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ....+.........   ...   
T Consensus       173 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~  250 (311)
T 3niz_A          173 VR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDD-QLPKIFSILGTPNPREWPQVQEL  250 (311)
T ss_dssp             CC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTT-HHHHHHHHHCCCCTTTSGGGTTS
T ss_pred             cc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHHCCCChHHhhhhhcc
Confidence            22 2234568999999999876 568999999999999999999999886544432 22222222211110   000   


Q ss_pred             ----------cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          498 ----------VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       498 ----------~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                                .+...........+.++.+++.+||+.||++|||++|+++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             HHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             chhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence                      0000000011234567889999999999999999999996

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.9e-42  Score=357.53  Aligned_cols=266  Identities=15%  Similarity=0.176  Sum_probs=208.4

Q ss_pred             HhcCccccccccccCceeEEEEEcCC------CCEEEEEEecccChhhH-----------HHHHHHHHHHcCCCCCCeee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWV-----------DHFFNEVNLISGINHKNLVK  329 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  329 (573)
                      ..++|+..++||+|+||+||+|.+.+      ++.||||++........           ..+..|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34689999999999999999998764      47899999866543211           23345677788899999999


Q ss_pred             eeeeeecC----CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC
Q 008239          330 LLGCSITG----PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD  405 (573)
Q Consensus       330 l~~~~~~~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~  405 (573)
                      +++++...    ...++||||+ +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~  186 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN--AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN  186 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence            99998765    3479999999 99999988543  346999999999999999999999998   99999999999999


Q ss_pred             --CCCcEEEeecccccccCCCCcc------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCC
Q 008239          406 --EEFTAKIADFGLVRLFPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN  477 (573)
Q Consensus       406 --~~~~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~  477 (573)
                        .++.+||+|||+++.+......      ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....
T Consensus       187 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~  266 (364)
T 3op5_A          187 YKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLK  266 (364)
T ss_dssp             SSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred             cCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccccc
Confidence              8899999999999866432211      11234599999999999999999999999999999999999999875444


Q ss_pred             CcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          478 SCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       478 ~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ............. ..+..++++.+.   ....+..+.+++..||+.+|++||++++|+++|+..
T Consensus       267 ~~~~~~~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          267 DPKYVRDSKIRYR-ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             CHHHHHHHHHHHH-HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhh-hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            3333222222221 123334444332   234567899999999999999999999999998543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.3e-42  Score=348.41  Aligned_cols=252  Identities=21%  Similarity=0.323  Sum_probs=201.3

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE------  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------  339 (573)
                      .++|+..++||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.++++++||||+++++++.+...      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            467899999999999999999986 78999999996543 3456789999999999999999999998865432      


Q ss_pred             ---------------------------------------------------eeEEEEeccCCCccccccccCCCCCCCHH
Q 008239          340 ---------------------------------------------------SLLVYEFVPNQSLLDNLFVRQDVEPLSWE  368 (573)
Q Consensus       340 ---------------------------------------------------~~lv~e~~~~gsL~~~l~~~~~~~~l~~~  368 (573)
                                                                         .++||||+++++|.+++.........++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                               78999999999999999776665667888


Q ss_pred             HHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc-----------ccccccccCcC
Q 008239          369 VRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-----------HISATLAGTLG  437 (573)
Q Consensus       369 ~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-----------~~~~~~~gt~~  437 (573)
                      .++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            89999999999999999988   99999999999999999999999999987654421           12234578999


Q ss_pred             cCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHH
Q 008239          438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQI  517 (573)
Q Consensus       438 y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l  517 (573)
                      |+|||.+.+..++.++||||||+++|||++|..|...       ...............         .....+..+.++
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-------~~~~~~~~~~~~~~~---------~~~~~~~~~~~l  305 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-------RVRIITDVRNLKFPL---------LFTQKYPQEHMM  305 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-------HHHHHHHHHTTCCCH---------HHHHHCHHHHHH
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-------HHHHHHHhhccCCCc---------ccccCChhHHHH
Confidence            9999999999999999999999999999998655211       011111111111100         012234567899


Q ss_pred             HHHccCCCCCCCCCHHHHHHH
Q 008239          518 GLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       518 ~~~cl~~~p~~RPt~~evl~~  538 (573)
                      +.+||+.||++|||++|+++.
T Consensus       306 i~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          306 VQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHccCCCCcCCCHHHHhhc
Confidence            999999999999999999973

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=5.7e-42  Score=349.48  Aligned_cols=249  Identities=24%  Similarity=0.274  Sum_probs=207.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..+.||+|+||+||+++.. +|+.||||++...   .....+.+.+|+.+|+.++||||+++++++......++|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            367899999999999999999975 6899999999653   233456788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  157 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             EECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             EeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhccc
Confidence            9999999999888543   35899999999999999999999988   99999999999999999999999999985432


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     .........+..         
T Consensus       158 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~~---------  222 (337)
T 1o6l_A          158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEEI---------  222 (337)
T ss_dssp             TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCC---------
T ss_pred             CC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCC---------
Confidence            22 223456799999999999999999999999999999999999999754321     111122222211         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                       .++...+..+.+++.+||+.||++||     +++|+++.
T Consensus       223 -~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          223 -RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence             12344567889999999999999999     89999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=9e-42  Score=341.43  Aligned_cols=262  Identities=22%  Similarity=0.290  Sum_probs=206.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|+..++||+|+||+||+|+.. +|+.||||++....  ....+.+.+|+.++++++||||+++++++.+....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            57899999999999999999975 68999999996543  3345778899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++ +|.+.+..  ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  155 (292)
T 3o0g_A           82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCC
T ss_pred             cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcc
Confidence            9975 55555533  2346999999999999999999999998   9999999999999999999999999998764332


Q ss_pred             cccccccccCcCcCchhhhccCC-CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc------cc
Q 008239          426 THISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE------AV  498 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~------~~  498 (573)
                      . ......||+.|+|||.+.+.. ++.++||||||+++|||++|+.|+............+...........      ..
T Consensus       156 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  234 (292)
T 3o0g_A          156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             c-cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccc
Confidence            2 233457899999999998765 899999999999999999999997665544333333333222111000      00


Q ss_pred             C---------ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          499 D---------PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       499 d---------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +         ...........+..+.+++.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            0         00001122345678899999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.5e-42  Score=341.32  Aligned_cols=253  Identities=28%  Similarity=0.417  Sum_probs=198.6

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccC----hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..++||+|+||.||++.+. |+.||||++....    .+..+.+.+|+++++.++||||+++++++...+..++|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLV   84 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEE
Confidence            367889999999999999999976 8899999986542    23356788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC--------CCcEEEeec
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--------EFTAKIADF  415 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~--------~~~~kl~Df  415 (573)
                      |||+++++|.+++.    ...+++..++.++.|++.||+|||+++..+|+||||||+|||++.        ++.+||+||
T Consensus        85 ~e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           85 MEFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999998883    246899999999999999999999987556999999999999986        678999999


Q ss_pred             ccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc
Q 008239          416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH  495 (573)
Q Consensus       416 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  495 (573)
                      |++........   ....||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....    .......... .  
T Consensus       161 g~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~~~~~~~~~-~--  230 (271)
T 3dtc_A          161 GLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG----LAVAYGVAMN-K--  230 (271)
T ss_dssp             CC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH----HHHHHHHHTS-C--
T ss_pred             Ccccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHHHHhhhcC-C--
Confidence            99986543322   245689999999999999999999999999999999999998754321    1111111111 1  


Q ss_pred             cccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       496 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                            .....+...+..+.+++.+||+.+|++|||+.|++++|+.
T Consensus       231 ------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          231 ------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             ------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             ------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                  1122344567789999999999999999999999999964

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.1e-42  Score=359.67  Aligned_cols=257  Identities=28%  Similarity=0.353  Sum_probs=207.5

Q ss_pred             hcCccccccccccCceeEEEEEcC------CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      .++|+..++||+|+||+||+|++.      +++.||||++... ..+....+.+|+.++++++||||+++++++......
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  149 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR  149 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence            467889999999999999999853      4678999999654 344556788999999999999999999999999999


Q ss_pred             eEEEEeccCCCccccccccC----CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC---cEEEe
Q 008239          341 LLVYEFVPNQSLLDNLFVRQ----DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIA  413 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl~  413 (573)
                      ++||||+++|+|.+++....    ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++   .+||+
T Consensus       150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999986543    2245899999999999999999999998   99999999999999554   59999


Q ss_pred             ecccccccCCC-CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhc
Q 008239          414 DFGLVRLFPED-ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       414 Dfgla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      |||+++..... .........+|+.|+|||.+.+..++.++||||||+++|||++ |..|+.....     .........
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~-----~~~~~~i~~  301 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEFVTS  301 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHHHHT
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHc
Confidence            99999854221 1222334567899999999999999999999999999999998 7777643221     111122222


Q ss_pred             CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       492 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      +.         ....+...+..+.+|+.+||+.+|++||++++|++.|+.
T Consensus       302 ~~---------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          302 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             TC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CC---------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11         112234556789999999999999999999999999944

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-42  Score=347.03  Aligned_cols=260  Identities=28%  Similarity=0.394  Sum_probs=215.6

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      +++...++|+..++||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.++++++||||+++++++.+....+
T Consensus         7 ~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   85 (288)
T 3kfa_A            7 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   85 (288)
T ss_dssp             TTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEE
T ss_pred             cccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEE
Confidence            33445678999999999999999999986 48899999997543 34678899999999999999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+++++|.+++... ....+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        86 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~  161 (288)
T 3kfa_A           86 IITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLM  161 (288)
T ss_dssp             EEEECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTS
T ss_pred             EEEEcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceec
Confidence            999999999999998543 3356899999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ............+|+.|+|||.+.+..++.++||||||+++|||++ |..|+.... ........    ...        
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~-~~~~~~~~----~~~--------  228 (288)
T 3kfa_A          162 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID-LSQVYELL----EKD--------  228 (288)
T ss_dssp             CSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHHHHH----HTT--------
T ss_pred             cCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC-HHHHHHHH----hcc--------
Confidence            6554444445667889999999999999999999999999999999 766654322 11221111    111        


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                       .....+...+..+.+++.+||+.+|++|||+++++++|+.
T Consensus       229 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~  268 (288)
T 3kfa_A          229 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFET  268 (288)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHH
Confidence             1112334566789999999999999999999999999854

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=6.4e-42  Score=352.30  Aligned_cols=251  Identities=22%  Similarity=0.267  Sum_probs=206.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChh------hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ------WVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      .+.|+..+.||+|+||+||+++.. +|+.||||++......      ..+.+.+|+.+|++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            467999999999999999999975 6899999999654321      346789999999999999999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC----cEEEeecc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG  416 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfg  416 (573)
                      ++||||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            999999999999999843   346999999999999999999999988   99999999999998776    79999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      ++.......  ......||+.|+|||++.+..++.++||||||+++|||++|..|+......     ........+..  
T Consensus       165 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~-----~~~~~i~~~~~--  235 (361)
T 2yab_A          165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANITAVSY--  235 (361)
T ss_dssp             SCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHTTCC--
T ss_pred             CceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhcCC--
Confidence            998765432  233567999999999999999999999999999999999999998643221     11111222111  


Q ss_pred             ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       497 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .+++..    ....+..+.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~----~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          236 DFDEEF----FSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             CCCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCchh----ccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            011111    1234567889999999999999999999985

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=6.1e-43  Score=355.78  Aligned_cols=263  Identities=26%  Similarity=0.341  Sum_probs=213.2

Q ss_pred             hcCccccccccccCceeEEEEEc-----CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeee--cCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI--TGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  340 (573)
                      .++|+..++||+|+||.||++++     .+++.||||++........+.+.+|++++++++||||+++++++.  +....
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  101 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSL  101 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceE
Confidence            36788999999999999999984     368899999998777777788999999999999999999999886  45568


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++++|.+++....  ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       102 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  176 (327)
T 3lxl_A          102 RLVMEYLPSGCLRDFLQRHR--ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKL  176 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHHG--GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred             EEEEeecCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccccee
Confidence            89999999999999985432  35899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCC----------cchHHHHHHH
Q 008239          421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNS----------CSILQTVWDL  488 (573)
Q Consensus       421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~----------~~~~~~~~~~  488 (573)
                      .......  ......+|..|+|||.+.+..++.++||||||+++|||++|+.|+......          ..........
T Consensus       177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (327)
T 3lxl_A          177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLEL  256 (327)
T ss_dssp             CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHH
T ss_pred             cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHH
Confidence            6543322  223456788899999999999999999999999999999999886542211          0011111111


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE  544 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  544 (573)
                               +........+...+..+.+|+.+||+.||++|||++|++++|+....
T Consensus       257 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          257 ---------LEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             ---------HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             ---------hhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence                     11112223345667889999999999999999999999999966543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.9e-42  Score=352.28  Aligned_cols=254  Identities=24%  Similarity=0.367  Sum_probs=200.1

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCC----EEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      .++|+..++||+|+||+||+|++. +++    +||+|.+... .....+.+.+|+.++++++||||+++++++... ..+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~   92 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ   92 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeE
Confidence            356889999999999999999964 444    4688887543 334567899999999999999999999999875 478


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +|+||+++|+|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~  167 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEc
Confidence            999999999999998653  345899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          422 PEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       422 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... .+..    ....+.      
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~~~----~~~~~~------  236 (327)
T 3poz_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS-EISS----ILEKGE------  236 (327)
T ss_dssp             TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG-GHHH----HHHTTC------
T ss_pred             cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH-HHHH----HHHcCC------
Confidence            543322 2224456889999999999999999999999999999999 88776543221 1111    111111      


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                         ....+...+..+.+++.+||+.+|++||++.|++++|+.
T Consensus       237 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~  275 (327)
T 3poz_A          237 ---RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  275 (327)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHH
Confidence               112244567789999999999999999999999999854

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.7e-42  Score=351.08  Aligned_cols=264  Identities=24%  Similarity=0.336  Sum_probs=211.6

Q ss_pred             HHHHhcCccccccccccCceeEEEEEc------CCCCEEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeee
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI  335 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  335 (573)
                      ++...++|+..+.||+|+||.||+|++      .++..||||++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            344567899999999999999999986      24568999999754 234457889999999999 8999999999999


Q ss_pred             cCCceeEEEEeccCCCccccccccCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEe
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQDV--------------------EPLSWEVRYKIILSTAEGLAYLHEESKLRIIHR  395 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHr  395 (573)
                      .....++||||+++|+|.+++......                    ..+++..++.++.||+.||+|||+++   |+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccC
Confidence            999999999999999999998654321                    34899999999999999999999988   9999


Q ss_pred             cCCCCCeeeCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCC
Q 008239          396 DIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINL  473 (573)
Q Consensus       396 Dlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~  473 (573)
                      ||||+|||++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999986643322 22334567889999999999999999999999999999998 887775


Q ss_pred             CCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          474 FTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       474 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      ........    ......+         .....+...+..+.+|+.+||+.||.+|||+.+++++|+...
T Consensus       277 ~~~~~~~~----~~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          277 GIPVDANF----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             TCCCSHHH----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cCCcHHHH----HHHHhcC---------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            54332221    1222211         111223445678999999999999999999999999996543

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.2e-42  Score=340.82  Aligned_cols=255  Identities=26%  Similarity=0.348  Sum_probs=210.3

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .++|+..+.||+|+||.||++...+++.||||++...... .+.+.+|+.++++++||||+++++++.+....++||||+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   85 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM   85 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCC
T ss_pred             hhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCC
Confidence            3678899999999999999999988899999999765432 467899999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.........
T Consensus        86 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           86 EHGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             TTCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCcHHHHHhhC--cccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            999999998543  245899999999999999999999998   999999999999999999999999999876443322


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......++..|+|||.+....++.++||||||+++|||++ |+.|+.....     .........+.         ....
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~i~~~~---------~~~~  226 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-----SEVVEDISTGF---------RLYK  226 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTC---------CCCC
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH-----HHHHHHHhcCC---------cCCC
Confidence            3334567789999999999999999999999999999999 6766543221     11111112111         1112


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      +...+..+.+++.+||+.+|++||++++++++|+..
T Consensus       227 ~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          227 PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            334567889999999999999999999999999643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-42  Score=353.31  Aligned_cols=254  Identities=26%  Similarity=0.372  Sum_probs=201.1

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCE----EEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEA----VAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ++|+..++||+|+||+||+|++. +++.    ||+|.+.... .+..+.+.+|+.++++++||||+++++++. ....++
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~   91 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL   91 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence            56889999999999999999864 4443    7888775432 333456778999999999999999999886 567889


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  166 (325)
T 3kex_A           92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP  166 (325)
T ss_dssp             EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred             EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence            99999999999988543  346888999999999999999999998   9999999999999999999999999999775


Q ss_pred             CCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          423 EDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       423 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ..... ......+|..|+|||.+.++.++.++||||||+++|||++ |+.|+...... ...    .....+..      
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~-~~~----~~~~~~~~------  235 (325)
T 3kex_A          167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA-EVP----DLLEKGER------  235 (325)
T ss_dssp             CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT-HHH----HHHHTTCB------
T ss_pred             cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH-HHH----HHHHcCCC------
Confidence            44322 2334567889999999999999999999999999999999 88887543322 111    11121111      


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                         ...+...+..+.+++.+||+.+|++||++.++++.|+..
T Consensus       236 ---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~  274 (325)
T 3kex_A          236 ---LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRM  274 (325)
T ss_dssp             ---CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHH
T ss_pred             ---CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               112233445678999999999999999999999999554

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.4e-41  Score=346.25  Aligned_cols=257  Identities=18%  Similarity=0.192  Sum_probs=206.3

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|+..++||+|+||+||+|+. .+|+.||||++.....  .+.+.+|+.+++++ +||||+++++++......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e   85 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLE   85 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEE
Confidence            46799999999999999999996 5789999999865432  34678999999999 99999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc-----EEEeecccccc
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-----AKIADFGLVRL  420 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~-----~kl~Dfgla~~  420 (573)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.     +||+|||+++.
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           86 LL-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             eC-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            99 99999988643  346999999999999999999999998   999999999999998887     99999999987


Q ss_pred             cCCCCcc------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcc
Q 008239          421 FPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL  494 (573)
Q Consensus       421 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  494 (573)
                      +......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+....... ........ .....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~-~~~~~~~i-~~~~~  237 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADT-LKERYQKI-GDTKR  237 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSS-HHHHHHHH-HHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccccc-HHHHHHHH-Hhhhc
Confidence            6443221      1235679999999999999999999999999999999999999986543322 21111111 11000


Q ss_pred             ccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       495 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      .. ....+    ....+ .+.+++..||+.+|.+||++++|++.|+
T Consensus       238 ~~-~~~~~----~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~  277 (330)
T 2izr_A          238 AT-PIEVL----CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFT  277 (330)
T ss_dssp             HS-CHHHH----TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHH
T ss_pred             cC-CHHHH----hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHH
Confidence            00 00001    12234 8999999999999999999999999884

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.2e-42  Score=342.66  Aligned_cols=255  Identities=22%  Similarity=0.307  Sum_probs=196.4

Q ss_pred             HhcCccccccccccCceeEEEEEcCC----CCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ..++|+..+.||+|+||.||+|....    +..||||++... .....+.+.+|+.++++++||||+++++++. .+..+
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   91 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   91 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccE
Confidence            35688999999999999999998743    457999998654 3445678899999999999999999999874 56789


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+++++|.+++...  ...+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             EEEecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            999999999999998543  245899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ............+|+.|+|||.+....++.++||||||+++|||++ |..|+..... ......+    ..+..      
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~-~~~~~~i----~~~~~------  235 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIGRI----ENGER------  235 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHHH----HTTCC------
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH-HHHHHHH----HcCCC------
Confidence            5443333334556789999999999999999999999999999997 7777654322 2222211    11111      


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                         ...+...+..+.+++.+||+.+|++|||+.|+++.|+.
T Consensus       236 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~  273 (281)
T 1mp8_A          236 ---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  273 (281)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence               12334567789999999999999999999999999954

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=342.04  Aligned_cols=249  Identities=23%  Similarity=0.298  Sum_probs=197.7

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh--------------------------hhHHHHHHHHHHHc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--------------------------QWVDHFFNEVNLIS  320 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l~  320 (573)
                      .++|+..+.||+|+||.||+|+.. +++.||||++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            367999999999999999999874 688999999865421                          12356889999999


Q ss_pred             CCCCCCeeeeeeeeec--CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q 008239          321 GINHKNLVKLLGCSIT--GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK  398 (573)
Q Consensus       321 ~l~h~niv~l~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk  398 (573)
                      +++||||+++++++.+  ....++||||+++++|.+++.    ...+++..++.++.||+.||+|||+++   |+|||||
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlk  164 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT----LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIK  164 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCC
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCC
Confidence            9999999999999886  567899999999999988652    346999999999999999999999998   9999999


Q ss_pred             CCCeeeCCCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccCC---CCcccchHhHHHHHHHHHcCCCCCCCC
Q 008239          399 LSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK---LTEKADVYSFGVVVIEVVCRKRINLFT  475 (573)
Q Consensus       399 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~  475 (573)
                      |+|||++.++.+||+|||+++....... ......||+.|+|||.+.+..   ++.++||||||+++|||++|+.|+...
T Consensus       165 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          165 PSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999987654322 223457899999999997665   378899999999999999999997543


Q ss_pred             CCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          476 QNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       476 ~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..    . ........+...        .......+..+.+++.+||+.||++|||++|+++
T Consensus       244 ~~----~-~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          244 RI----M-CLHSKIKSQALE--------FPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             SH----H-HHHHHHHHCCCC--------CCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             cH----H-HHHHHHhcccCC--------CCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            21    1 111111221110        0112345678999999999999999999999975

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-41  Score=344.43  Aligned_cols=274  Identities=26%  Similarity=0.355  Sum_probs=206.0

Q ss_pred             cChHHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCC--CCCCeeeeeeeeec
Q 008239          259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI--NHKNLVKLLGCSIT  336 (573)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~  336 (573)
                      ..........++|+..++||+|+||.||+|+.. |+.||||++....   ...+..|.+++..+  +||||+++++++..
T Consensus        27 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~  102 (337)
T 3mdy_A           27 LPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIK  102 (337)
T ss_dssp             SCHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             CCcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEcc
Confidence            334444555688999999999999999999986 8999999985432   23445566665554  99999999999887


Q ss_pred             C----CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCeEEecCCCCCeeeCCC
Q 008239          337 G----PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES-----KLRIIHRDIKLSNILLDEE  407 (573)
Q Consensus       337 ~----~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~-----~~~iiHrDlk~~NIll~~~  407 (573)
                      .    ...++||||+++|+|.+++..    ..+++..++.++.|++.||+|||++.     .++|+||||||+|||++.+
T Consensus       103 ~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          103 GTGSWTQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN  178 (337)
T ss_dssp             SCGGGCEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             CCCCCCceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence            7    678999999999999999843    25899999999999999999999871     1239999999999999999


Q ss_pred             CcEEEeecccccccCCCCccc---ccccccCcCcCchhhhccCCCCcc------cchHhHHHHHHHHHcC----------
Q 008239          408 FTAKIADFGLVRLFPEDITHI---SATLAGTLGYMAPEYVVRGKLTEK------ADVYSFGVVVIEVVCR----------  468 (573)
Q Consensus       408 ~~~kl~Dfgla~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------sDvwslGvil~elltg----------  468 (573)
                      +.+||+|||++..+.......   .....||+.|+|||.+.+.....+      +||||||+++|||++|          
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999999998664433221   124578999999999988776665      9999999999999999          


Q ss_pred             CCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          469 KRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       469 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      +.|+.........................+....   .....+..+.+|+.+||+.||++|||+.||++.|+...
T Consensus       259 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          259 QLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRW---SSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG---GGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccHhhhcCCCCchhhhHHHHhhhccCccccccc---hhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            4444433322222233323222222111111111   12357788999999999999999999999999996543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.5e-42  Score=375.92  Aligned_cols=265  Identities=27%  Similarity=0.377  Sum_probs=215.1

Q ss_pred             HHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       262 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ..++...++|+..++||+|+||.||+|.+.++..||||++..... ..+.|.+|+.+|++++||||+++++++.+ ...+
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            344455678899999999999999999998888899999976543 35689999999999999999999999876 6789


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+++|+|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       338 lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceec
Confidence            9999999999999985321 235899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ............++..|+|||.+..+.++.++||||||++||||++ |+.|+..... ..    +......+.       
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~-~~----~~~~i~~~~-------  481 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-RE----VLDQVERGY-------  481 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH-HH----HHHHHHTTC-------
T ss_pred             CCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH-HH----HHHHHHcCC-------
Confidence            5432222234456789999999999999999999999999999999 7766543221 11    111122211       


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEIL  546 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~~  546 (573)
                        ....+...+..+.+|+.+||+.+|++|||+++|+++|+......
T Consensus       482 --~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          482 --RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence              11224456778999999999999999999999999997765443

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6e-43  Score=354.46  Aligned_cols=268  Identities=26%  Similarity=0.394  Sum_probs=208.5

Q ss_pred             cCccccccccccCceeEEEEEcC-----CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--Cce
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-----GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PES  340 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-----~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~  340 (573)
                      ++|+..++||+|+||+||++.+.     +++.||||++.... .+..+.+.+|++++++++||||+++++++.+.  ...
T Consensus        31 r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  110 (318)
T 3lxp_A           31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASL  110 (318)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEE
T ss_pred             HHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceE
Confidence            34589999999999999988642     57899999997653 34467789999999999999999999999874  567


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++++|.+++...    .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       111 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  183 (318)
T 3lxp_A          111 QLVMEYVPLGSLRDYLPRH----SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKA  183 (318)
T ss_dssp             EEEECCCTTCBHHHHGGGS----CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEecccCCcHHHHHhhC----CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccc
Confidence            8999999999999998532    3899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCc--ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc-chHHHHHHHhhcCccccc
Q 008239          421 FPEDIT--HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC-SILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       421 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  497 (573)
                      ......  .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+....... ..............+.+.
T Consensus       184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (318)
T 3lxp_A          184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTEL  263 (318)
T ss_dssp             CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHH
T ss_pred             ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHH
Confidence            754332  12334567888999999999999999999999999999999998865422110 000000000000011111


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      +........+...+..+.+|+.+||+.+|++|||++|++++|+...
T Consensus       264 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  309 (318)
T 3lxp_A          264 LERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVH  309 (318)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHH
Confidence            2222222344566788999999999999999999999999996543

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2e-42  Score=343.61  Aligned_cols=259  Identities=29%  Similarity=0.412  Sum_probs=210.6

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++...++|+..+.||+|+||.||+|...+++.||||++..... ..+.+.+|++++++++||||+++++++. .+..++|
T Consensus         8 ~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v   85 (279)
T 1qpc_A            8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII   85 (279)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             cccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEE
Confidence            3344578999999999999999999998888999999965432 3567899999999999999999999886 4568999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++.... ...+++..++.++.|++.||+|||+++   |+||||||+||++++++.+||+|||++.....
T Consensus        86 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  161 (279)
T 1qpc_A           86 TEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIED  161 (279)
T ss_dssp             EECCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EecCCCCCHHHHHhcCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence            99999999999984321 125899999999999999999999988   99999999999999999999999999987765


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ..........++..|+|||.+.++.++.++||||||+++|||++ |+.|+..... ...    ......+.         
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~-~~~----~~~~~~~~---------  227 (279)
T 1qpc_A          162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEV----IQNLERGY---------  227 (279)
T ss_dssp             SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHH----HHHHHTTC---------
T ss_pred             cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH-HHH----HHHHhccc---------
Confidence            44333344567889999999998999999999999999999999 7766543221 111    11111111         


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ....+...+..+.+++.+||+.+|++|||++++++.|+..
T Consensus       228 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          228 RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence            1122344567899999999999999999999999999654

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-41  Score=346.54  Aligned_cols=252  Identities=23%  Similarity=0.254  Sum_probs=205.9

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChh------hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ------WVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      .++|+..+.||+|+||.||++... +|+.||||++......      ..+.+.+|+.+|++++||||+++++++......
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   89 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   89 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            356899999999999999999975 6899999998654321      356789999999999999999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC----cEEEeecc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG  416 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfg  416 (573)
                      ++||||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        90 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg  163 (326)
T 2y0a_A           90 ILILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  163 (326)
T ss_dssp             EEEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECC
Confidence            999999999999999843   346899999999999999999999988   99999999999999887    89999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      +++......  ......||+.|+|||++....++.++||||||+++|||++|+.|+...... ...    ........  
T Consensus       164 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~----~~~~~~~~--  234 (326)
T 2y0a_A          164 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-ETL----ANVSAVNY--  234 (326)
T ss_dssp             TCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-HHH----HHHHHTCC--
T ss_pred             CCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH-HHH----HHHHhcCC--
Confidence            998764332  223457899999999999999999999999999999999999987543221 111    11111111  


Q ss_pred             ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       497 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .....    .....+..+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          235 EFEDE----YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CCCHH----HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CcCcc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            00111    112345678899999999999999999999974

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=5e-42  Score=348.30  Aligned_cols=262  Identities=23%  Similarity=0.331  Sum_probs=195.4

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcCCC----CEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLPGG----EAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG  337 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  337 (573)
                      +....++|+..+.||+|+||+||+|++...    ..||||++...  .....+.+.+|+.++++++||||+++++++...
T Consensus        18 ~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           18 VLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             TBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             cccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            334457899999999999999999997643    27999998654  344567899999999999999999999999877


Q ss_pred             Cce------eEEEEeccCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC
Q 008239          338 PES------LLVYEFVPNQSLLDNLFVRQ---DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF  408 (573)
Q Consensus       338 ~~~------~lv~e~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~  408 (573)
                      ...      ++||||+++|+|.+++....   ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~  174 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDM  174 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTS
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCC
Confidence            655      89999999999999885432   2235899999999999999999999998   99999999999999999


Q ss_pred             cEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHH
Q 008239          409 TAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVW  486 (573)
Q Consensus       409 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~  486 (573)
                      .+||+|||+++....... .......+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..... ......  
T Consensus       175 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-~~~~~~--  251 (323)
T 3qup_A          175 TVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIEN-AEIYNY--  251 (323)
T ss_dssp             CEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHH--
T ss_pred             CEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccCh-HHHHHH--
Confidence            999999999986643322 22234456789999999999999999999999999999999 6766543322 122111  


Q ss_pred             HHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          487 DLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       487 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                        ...+.         ....+...+..+.+++.+||+.||++|||+.++++.|+..
T Consensus       252 --~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          252 --LIGGN---------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             --HHTTC---------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HhcCC---------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence              11111         1122345567899999999999999999999999999654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.3e-41  Score=339.82  Aligned_cols=260  Identities=30%  Similarity=0.466  Sum_probs=198.9

Q ss_pred             HHhcCccccccccccCceeEEEEEcCCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ...++|+..++||+|+||+||+|+..+  .||||++...  .....+.+.+|+.++++++||||++++++. .....++|
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            345789999999999999999998753  5999998654  344567899999999999999999999965 55678999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++...  ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        98 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  172 (289)
T 3og7_A           98 TQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR  172 (289)
T ss_dssp             EECCCEEEHHHHHTTC-----CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred             EEecCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence            9999999999988533  346899999999999999999999988   99999999999999999999999999986543


Q ss_pred             CC-cccccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          424 DI-THISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       424 ~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .. ........||+.|+|||.+.   ...++.++||||||+++|||++|+.|+........+    ......+....   
T Consensus       173 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~----~~~~~~~~~~~---  245 (289)
T 3og7_A          173 WSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI----IEMVGRGSLSP---  245 (289)
T ss_dssp             -----------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHH----HHHHHHTSCCC---
T ss_pred             ccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHH----HHHhcccccCc---
Confidence            22 22223457899999999986   567889999999999999999999998654432222    22222222211   


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                       .+ .......+..+.+++.+||+.+|++|||+++++++|+..
T Consensus       246 -~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          246 -DL-SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             -CT-TSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -ch-hhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence             11 122345678899999999999999999999999999654

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=9.5e-42  Score=344.40  Aligned_cols=261  Identities=26%  Similarity=0.365  Sum_probs=212.4

Q ss_pred             HHhcCccccccccccCceeEEEEEc------CCCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG  337 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  337 (573)
                      ...++|+..+.||+|+||.||+|++      .+++.||||++.... ....+.+.+|+.+++++ +||||+++++++...
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   99 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG   99 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC
Confidence            3457899999999999999999984      346799999997553 34457889999999999 999999999999999


Q ss_pred             CceeEEEEeccCCCccccccccCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCe
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQD---------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI  402 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI  402 (573)
                      ...++||||+++|+|.+++.....               ...+++..++.++.||+.||+|||+++   |+||||||+||
T Consensus       100 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Ni  176 (313)
T 1t46_A          100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNI  176 (313)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGE
T ss_pred             CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceE
Confidence            999999999999999999865432               225899999999999999999999988   99999999999


Q ss_pred             eeCCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcc
Q 008239          403 LLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCS  480 (573)
Q Consensus       403 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~  480 (573)
                      |++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+........
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~  256 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhH
Confidence            9999999999999999876544322 2234557889999999999999999999999999999999 7777654433222


Q ss_pred             hHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          481 ILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ..    .....+         .....+...+..+.+++.+||+.||.+|||+.|++++|+..
T Consensus       257 ~~----~~~~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          257 FY----KMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             HH----HHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HH----HHhccC---------CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            21    111111         11112334567899999999999999999999999999543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.5e-41  Score=353.99  Aligned_cols=267  Identities=18%  Similarity=0.238  Sum_probs=205.2

Q ss_pred             hcCcccccccccc--CceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQG--GSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G--~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..++||+|  +||+||+++.. +|+.||||++....  .+..+.+.+|+.+++.++|||||++++++.+....++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  103 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV  103 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence            4679999999999  99999999976 68999999996542  4456778899999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus       104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~  179 (389)
T 3gni_B          104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMI  179 (389)
T ss_dssp             EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred             EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence            99999999999998543 2345899999999999999999999998   9999999999999999999999999986442


Q ss_pred             CCC------cccccccccCcCcCchhhhcc--CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh----
Q 008239          423 EDI------THISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV----  490 (573)
Q Consensus       423 ~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----  490 (573)
                      ...      ........||+.|+|||++.+  ..++.++|||||||++|||++|+.|+........+.........    
T Consensus       180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  259 (389)
T 3gni_B          180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  259 (389)
T ss_dssp             ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC----------
T ss_pred             cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCcccc
Confidence            211      111223478999999999987  67999999999999999999999998654332221111100000    


Q ss_pred             -----cCc-------------cccccC---c------cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          491 -----KGR-------------LHEAVD---P------ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       491 -----~~~-------------~~~~~d---~------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                           ...             ..+.+.   +      ..........+..+.+|+.+||+.||++|||++|+++.
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~h  334 (389)
T 3gni_B          260 TSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  334 (389)
T ss_dssp             ----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcC
Confidence                 000             000000   0      00001233456778999999999999999999999965

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.2e-42  Score=347.93  Aligned_cols=253  Identities=23%  Similarity=0.352  Sum_probs=196.3

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce---
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES---  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~---  340 (573)
                      .++|+..++||+|+||.||+++. .+++.||||++...   .....+.+.+|+.++++++||||+++++++......   
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999996 56899999999654   334456788999999999999999999998765544   


Q ss_pred             -eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          341 -LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       341 -~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                       ++||||+++++|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~  164 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  164 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred             cEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence             9999999999999998543   35899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          420 LFPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       420 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      ........  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....    ....+........   
T Consensus       165 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~----~~~~~~~~~~~~~---  237 (311)
T 3ork_A          165 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----VSVAYQHVREDPI---  237 (311)
T ss_dssp             -----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHCCCC---
T ss_pred             cccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhcCCCC---
Confidence            66443221  22345689999999999999999999999999999999999998754322    1222222222111   


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       .+.   ......+..+.+++.+||+.||++||+..+++.
T Consensus       238 -~~~---~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~  273 (311)
T 3ork_A          238 -PPS---ARHEGLSADLDAVVLKALAKNPENRYQTAAEMR  273 (311)
T ss_dssp             -CHH---HHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHH
T ss_pred             -Ccc---cccCCCCHHHHHHHHHHHhcCHhhChhhHHHHH
Confidence             010   012235678899999999999999997766654

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.5e-41  Score=352.92  Aligned_cols=254  Identities=21%  Similarity=0.259  Sum_probs=205.4

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..++||+|+||+||+++.. +++.||||++....   .+..+.+.+|..++.++ +||||+++++++.+....++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            467999999999999999999976 57899999997542   23345678899999887 89999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus       131 V~E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~  204 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL  204 (396)
T ss_dssp             EEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEcCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecc
Confidence            99999999999888543   35899999999999999999999998   9999999999999999999999999998532


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc----chHHHHHHHhhcCcccccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC----SILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~  498 (573)
                      .. .......+||+.|+|||++.+..++.++|||||||++|||++|+.|+.......    ............+..    
T Consensus       205 ~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~----  279 (396)
T 4dc2_A          205 RP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI----  279 (396)
T ss_dssp             CT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCC----
T ss_pred             cC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhcccc----
Confidence            22 222345689999999999999999999999999999999999999986432211    112222222222221    


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSM------SIVVKM  538 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~------~evl~~  538 (573)
                            .++...+..+.+|+.+||+.||++||++      +||++.
T Consensus       280 ------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          280 ------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             ------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             ------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence                  2344566788999999999999999995      566553

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.9e-41  Score=350.54  Aligned_cols=253  Identities=21%  Similarity=0.238  Sum_probs=209.0

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|+..+.||+|+||.||+|... +|+.||+|++..........+.+|+.+|+.++||||+++++++.+....++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            467999999999999999999875 6889999999776655567889999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC--CCcEEEeecccccccCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--EFTAKIADFGLVRLFPED  424 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~  424 (573)
                      +++|+|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++.....
T Consensus       130 ~~gg~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          130 LSGGELFDRIAAE--DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             CCCCBHHHHTTCT--TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999999988532  345899999999999999999999988   999999999999974  578999999999876543


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      ..  .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.....    .... ........      .+..
T Consensus       205 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~----~~~~-~~i~~~~~------~~~~  271 (387)
T 1kob_A          205 EI--VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETL-QNVKRCDW------EFDE  271 (387)
T ss_dssp             SC--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHH-HHHHHCCC------CCCS
T ss_pred             cc--eeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH----HHHH-HHHHhCCC------CCCc
Confidence            22  2345789999999999999999999999999999999999999764322    1111 11111111      0111


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ......+..+.+++.+||+.||++|||++|+++.
T Consensus       272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            1223456789999999999999999999999975

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.9e-41  Score=338.38  Aligned_cols=261  Identities=25%  Similarity=0.356  Sum_probs=201.8

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..++||+|+||+||+++..+|+.||||++....  ....+.+.+|+.++++++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            4788999999999999999999889999999986543  22346788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++ +|.+++...  ...+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  155 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (288)
T ss_dssp             CSE-EHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             cCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccc
Confidence            975 888877532  346899999999999999999999988   99999999999999999999999999986643221


Q ss_pred             ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc---cc-----cc
Q 008239          427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR---LH-----EA  497 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~-----~~  497 (573)
                       ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .....+........   +.     ..
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T 1ob3_A          156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELPK  233 (288)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHHCCCChhhchhhhcccc
Confidence             2234568999999999976 46899999999999999999999887543321 12222222111110   00     00


Q ss_pred             cCcccc-------CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          498 VDPALA-------GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       498 ~d~~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .++.+.       .......+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            111110       1122345678899999999999999999999986

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=3.2e-41  Score=347.76  Aligned_cols=253  Identities=19%  Similarity=0.271  Sum_probs=207.3

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ..++|+..+.||+|+||.||++... +|+.||||++...  .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4567999999999999999999875 6899999999654  334456788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC---CcEEEeecccccc
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVRL  420 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~---~~~kl~Dfgla~~  420 (573)
                      |||+++|+|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.+   +.+||+|||++..
T Consensus       107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            999999999998843   346899999999999999999999998   9999999999999865   4599999999987


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      .....  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     ...+.....+.... .. 
T Consensus       181 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~-----~~~~~~i~~~~~~~-~~-  251 (362)
T 2bdw_A          181 VNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ-----HRLYAQIKAGAYDY-PS-  251 (362)
T ss_dssp             CTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCCC-CT-
T ss_pred             ecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHhCCCCC-Cc-
Confidence            65332  22346799999999999999999999999999999999999998754321     12222222222110 00 


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                          ......+..+.+++.+||+.||++||++.|+++.
T Consensus       252 ----~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          252 ----PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ----TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                1112346788999999999999999999999864

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=7e-42  Score=351.08  Aligned_cols=248  Identities=24%  Similarity=0.314  Sum_probs=202.1

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..++||+|+||+||+++.. +|+.||||++...   .....+.+.+|..++..+ +||||+++++++.+....++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            478999999999999999999975 5899999999653   233456788899999988 79999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       102 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKS---RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            99999999999988543   35899999999999999999999998   9999999999999999999999999998543


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      .. .......+||+.|+|||++.+..++.++|||||||++|||++|+.|+.....     .........+..        
T Consensus       176 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~~--------  241 (353)
T 3txo_A          176 CN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-----DDLFEAILNDEV--------  241 (353)
T ss_dssp             C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCC--------
T ss_pred             cC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCC--------
Confidence            22 2223456799999999999999999999999999999999999999864332     111222222211        


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCH------HHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSM------SIVVK  537 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~------~evl~  537 (573)
                        .++...+..+.+++.+||+.+|++||++      +|+++
T Consensus       242 --~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          242 --VYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             --CCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence              2234456778999999999999999998      77775

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.8e-41  Score=338.25  Aligned_cols=254  Identities=31%  Similarity=0.497  Sum_probs=204.1

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChh-------hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ-------WVDHFFNEVNLISGINHKNLVKLLGCSITGPE  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  339 (573)
                      .++|+..+.||+|+||+||+|++. +++.||||++......       ..+.+.+|+.++++++||||+++++++.+.. 
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-   96 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-   96 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-
T ss_pred             hccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-
Confidence            367899999999999999999974 6899999998653321       1267889999999999999999999986654 


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc-----EEEee
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-----AKIAD  414 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~-----~kl~D  414 (573)
                       ++||||+++++|.+++...  ...+++..++.++.|++.||+|||+++ ++|+||||||+|||++.++.     +||+|
T Consensus        97 -~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           97 -RMVMEFVPCGDLYHRLLDK--AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             -EEEEECCTTCBHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             -eEEEEecCCCCHHHHHhcc--cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence             7999999999998888543  346899999999999999999999975 34999999999999988776     99999


Q ss_pred             cccccccCCCCcccccccccCcCcCchhhh--ccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC
Q 008239          415 FGLVRLFPEDITHISATLAGTLGYMAPEYV--VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG  492 (573)
Q Consensus       415 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  492 (573)
                      ||+++.....    .....||+.|+|||.+  ....++.++||||||+++|||++|+.|+........  ...... ...
T Consensus       173 fg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~--~~~~~~-~~~  245 (287)
T 4f0f_A          173 FGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI--KFINMI-REE  245 (287)
T ss_dssp             CTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH--HHHHHH-HHS
T ss_pred             CCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH--HHHHHH-hcc
Confidence            9999854332    2345789999999998  345678999999999999999999999865433221  111111 111


Q ss_pred             ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       493 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .        .....+...+..+.+++.+||+.||++|||++|+++.|+.
T Consensus       246 ~--------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          246 G--------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             C--------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             C--------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence            1        1122344567789999999999999999999999999964

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-41  Score=343.19  Aligned_cols=253  Identities=17%  Similarity=0.195  Sum_probs=207.3

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|+..+.||+|+||+||+++.. +++.||+|.+.... ...+.+.+|+.+++.++||||+++++++.+....++||||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~   82 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence            467999999999999999999975 58899999986543 3356788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC--CCcEEEeecccccccCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--EFTAKIADFGLVRLFPED  424 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~  424 (573)
                      +++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.  ++.+||+|||++......
T Consensus        83 ~~g~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            9999999988432  346899999999999999999999998   999999999999987  789999999999876543


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .  ......||+.|+|||++.+..++.++||||||+++|||++|..|+......     ........+...  .+...  
T Consensus       158 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----~~~~~i~~~~~~--~~~~~--  226 (321)
T 1tki_A          158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMNAEYT--FDEEA--  226 (321)
T ss_dssp             C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCCC--CCHHH--
T ss_pred             C--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH-----HHHHHHHcCCCC--CChhh--
Confidence            2  223457899999999999888999999999999999999999998653321     111112221110  01100  


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                        ....+..+.+++.+||+.||++|||+.|+++.-
T Consensus       227 --~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          227 --FKEISIEAMDFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             --HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             --hccCCHHHHHHHHHHcCCChhHCcCHHHHhcCh
Confidence              123456789999999999999999999999743

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-41  Score=341.45  Aligned_cols=245  Identities=24%  Similarity=0.316  Sum_probs=206.2

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||+||+++.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            67899999999999999999975 68999999996542   234567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        86 e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~  159 (318)
T 1fot_A           86 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  159 (318)
T ss_dssp             CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCc
Confidence            999999999998543   45899999999999999999999988   999999999999999999999999999875432


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                          .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.....    ... ......+..          
T Consensus       160 ----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~----~~~-~~~i~~~~~----------  220 (318)
T 1fot_A          160 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----MKT-YEKILNAEL----------  220 (318)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----HHH-HHHHHHCCC----------
T ss_pred             ----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH----HHH-HHHHHhCCC----------
Confidence                2346799999999999999999999999999999999999999854321    111 111122211          


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      .++...+..+.+++.+||+.+|++||     +++|+++.
T Consensus       221 ~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          221 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            12344567889999999999999999     89999853

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.1e-42  Score=344.03  Aligned_cols=251  Identities=25%  Similarity=0.353  Sum_probs=206.5

Q ss_pred             hcCccccccccccCceeEEEEEcCC-C-------CEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG-G-------EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~-g-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  339 (573)
                      .++|+..+.||+|+||+||+|+... +       ..||+|++........+.+.+|+.++++++||||+++++++.....
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDE   86 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCC
Confidence            3678899999999999999998753 3       4799999977666777889999999999999999999999999999


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc--------EE
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--------AK  411 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~--------~k  411 (573)
                      .++||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.        +|
T Consensus        87 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~k  161 (289)
T 4fvq_A           87 NILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIK  161 (289)
T ss_dssp             CEEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred             CEEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceee
Confidence            99999999999999998543  234899999999999999999999998   999999999999998877        99


Q ss_pred             EeecccccccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh
Q 008239          412 IADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV  490 (573)
Q Consensus       412 l~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  490 (573)
                      |+|||++......     ....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...........    ...
T Consensus       162 l~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~----~~~  232 (289)
T 4fvq_A          162 LSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQ----FYE  232 (289)
T ss_dssp             ECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH----HHH
T ss_pred             eccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHH----Hhh
Confidence            9999998754322     23457889999999987 7799999999999999999998776654433211111    111


Q ss_pred             cCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          491 KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       491 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      ..           ...+...+..+.+++.+||+.||++|||++|+++.|+...
T Consensus       233 ~~-----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~  274 (289)
T 4fvq_A          233 DR-----------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLF  274 (289)
T ss_dssp             TT-----------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC
T ss_pred             cc-----------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            10           1112223456789999999999999999999999997654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.6e-41  Score=348.81  Aligned_cols=254  Identities=20%  Similarity=0.259  Sum_probs=205.4

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-----hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      .+.|+..+.||+|+||+||++... +|+.||||++....     ....+.+.+|+.+++.++||||+++++++.+....+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~  102 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY  102 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            357899999999999999999875 68999999985421     123577899999999999999999999999999999


Q ss_pred             EEEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc---EEEeeccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFGL  417 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~---~kl~Dfgl  417 (573)
                      +||||+++++|.+.+.... ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||+
T Consensus       103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            9999999999988775432 2345899999999999999999999988   999999999999986554   99999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      +........ ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....      .........+...  
T Consensus       180 a~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~i~~~~~~--  250 (351)
T 3c0i_A          180 AIQLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK------ERLFEGIIKGKYK--  250 (351)
T ss_dssp             CEECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH------HHHHHHHHHTCCC--
T ss_pred             eeEecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH------HHHHHHHHcCCCC--
Confidence            987654322 2334579999999999999999999999999999999999999986431      1122222222211  


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+..    ....+..+.+|+.+||+.||++|||+.|+++
T Consensus       251 ~~~~~----~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          251 MNPRQ----WSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             CCHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCccc----cccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            01111    1234567899999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.4e-42  Score=347.07  Aligned_cols=260  Identities=22%  Similarity=0.350  Sum_probs=207.2

Q ss_pred             hcCccccccccccCceeEEEEEc-----CCCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--Cc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PE  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~  339 (573)
                      .+.|+..++||+|+||.||++++     .+++.||||++... .....+.+.+|+.+++.++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            35688899999999999999983     36889999999754 334457889999999999999999999999876  66


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++||||+++++|.+++....  ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHHT--TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             EEEEEEeCCCCcHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccc
Confidence            899999999999999985432  45899999999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCc--ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCC----------CCcchHHHHHH
Q 008239          420 LFPEDIT--HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ----------NSCSILQTVWD  487 (573)
Q Consensus       420 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~----------~~~~~~~~~~~  487 (573)
                      .......  .......+|..|+|||.+.+..++.++||||||+++|||++|+.|+....          ...........
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVN  254 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHH
Confidence            7654432  22334567888999999999999999999999999999999998743211          00011111111


Q ss_pred             HhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          488 LYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       488 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ....         ......+...+..+.+|+.+||+.||++|||+++++++|+.
T Consensus       255 ~~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          255 TLKE---------GKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHT---------TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHhc---------cCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            1111         11122345567889999999999999999999999999964

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.7e-42  Score=351.45  Aligned_cols=269  Identities=27%  Similarity=0.404  Sum_probs=216.7

Q ss_pred             cChHHHHHHhcCccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeee
Q 008239          259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLL  331 (573)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~  331 (573)
                      +..++++...++|+..+.||+|+||.||+|++.      +++.||||++.... ......+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            445566677889999999999999999999864      36789999997543 34456788999999999999999999


Q ss_pred             eeeecCCceeEEEEeccCCCccccccccC-------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee
Q 008239          332 GCSITGPESLLVYEFVPNQSLLDNLFVRQ-------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL  404 (573)
Q Consensus       332 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll  404 (573)
                      +++.+....++||||+++|+|.+++....       ....+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus        95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli  171 (322)
T 1p4o_A           95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV  171 (322)
T ss_dssp             EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred             EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence            99999999999999999999999886421       2246799999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchH
Q 008239          405 DEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSIL  482 (573)
Q Consensus       405 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~  482 (573)
                      +.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.... .    
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~----  246 (322)
T 1p4o_A          172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-N----  246 (322)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC-H----
T ss_pred             cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCC-H----
Confidence            9999999999999986543221 12234456889999999999999999999999999999999 666654321 1    


Q ss_pred             HHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 008239          483 QTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE  544 (573)
Q Consensus       483 ~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  544 (573)
                      .........+..         ...+...+..+.+++.+||+.+|++|||+.|+++.|+....
T Consensus       247 ~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          247 EQVLRFVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             HHHHHHHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHHHcCCc---------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence            111222222211         12234566789999999999999999999999999976543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.3e-41  Score=335.91  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=206.1

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC--CceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG--PESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~lv  343 (573)
                      .++|+..++||+|+||+||+|++. ++.||||++...  .....+.+.+|+.++++++||||+++++++.+.  ...++|
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLI   87 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEee
Confidence            357889999999999999999986 889999999754  344456899999999999999999999999877  778999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++|+|.+++.... ...+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.++|+|||+......
T Consensus        88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~  165 (271)
T 3kmu_A           88 THWMPYGSLYNVLHEGT-NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS  165 (271)
T ss_dssp             EECCTTCBHHHHHHSCS-SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC
T ss_pred             ecccCCCcHHHHHhhcc-cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc
Confidence            99999999999996432 235899999999999999999999865 4599999999999999999999999988764322


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCc---ccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTE---KADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                            ....+|+.|+|||.+.+..++.   ++||||||+++|||++|+.|+.....    ..........+        
T Consensus       166 ------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~~~~~~~~~--------  227 (271)
T 3kmu_A          166 ------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN----MEIGMKVALEG--------  227 (271)
T ss_dssp             ------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH----HHHHHHHHHSC--------
T ss_pred             ------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh----HHHHHHHHhcC--------
Confidence                  2346799999999998765544   89999999999999999998754322    11111111111        


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                       .....+...+..+.+++.+||+.+|++|||++++++.|+..
T Consensus       228 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          228 -LRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence             11223445677899999999999999999999999999653

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.9e-42  Score=350.02  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=200.9

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCC--CCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINH--KNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv  343 (573)
                      .+.|+..++||+|+||.||++...+++.||||++...  ..+..+.+.+|+.+|.+++|  |||+++++++......++|
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv   87 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV   87 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence            4679999999999999999999988999999998654  34455788999999999986  9999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      || +.+++|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++ ++.+||+|||+++....
T Consensus        88 ~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~  159 (343)
T 3dbq_A           88 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  159 (343)
T ss_dssp             EC-CCSEEHHHHHHHS---CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred             Ee-CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence            99 5688999998543   46899999999999999999999988   99999999999997 57899999999987654


Q ss_pred             CCcc-cccccccCcCcCchhhhcc-----------CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc
Q 008239          424 DITH-ISATLAGTLGYMAPEYVVR-----------GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       424 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      .... ......||+.|+|||++.+           ..++.++||||||+++|||++|+.|+......   .....     
T Consensus       160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~---~~~~~-----  231 (343)
T 3dbq_A          160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLH-----  231 (343)
T ss_dssp             ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---HHHHH-----
T ss_pred             ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH---HHHHH-----
Confidence            3322 2335679999999999865           67899999999999999999999997543221   11111     


Q ss_pred             CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       492 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                          ..+++......+...+..+.+|+.+||+.||++|||+.|+++.-
T Consensus       232 ----~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          232 ----AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             ----HHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ----HHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCc
Confidence                11222222334445567889999999999999999999998653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.2e-42  Score=361.06  Aligned_cols=260  Identities=18%  Similarity=0.180  Sum_probs=210.5

Q ss_pred             HHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC
Q 008239          262 ETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITG  337 (573)
Q Consensus       262 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  337 (573)
                      .++....++|+..++||+|+||+||+++.. +++.||||++....   ....+.+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            345556788999999999999999999976 58899999986421   12234578899999999999999999999999


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ...++||||+++|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~  214 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGT  214 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccce
Confidence            999999999999999998853    24899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhccCC----CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVRGK----LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR  493 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  493 (573)
                      ++..............||+.|+|||++....    ++.++|||||||++|||++|+.|+...... .....+   . .+.
T Consensus       215 a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~-~~~~~i---~-~~~  289 (410)
T 3v8s_A          215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV-GTYSKI---M-NHK  289 (410)
T ss_dssp             CEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHH---H-THH
T ss_pred             eEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh-hHHHHH---H-hcc
Confidence            9877654443445678999999999998765    789999999999999999999998643221 111111   1 100


Q ss_pred             cccccCccccCCCCCchHHHHHHHHHHccCCCCCC--CCCHHHHHHHh
Q 008239          494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAEL--RPSMSIVVKML  539 (573)
Q Consensus       494 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~--RPt~~evl~~L  539 (573)
                      .      .+.-......+..+.+|+.+||+.+|++  ||+++||++.-
T Consensus       290 ~------~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp  331 (410)
T 3v8s_A          290 N------SLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  331 (410)
T ss_dssp             H------HCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSG
T ss_pred             c------cccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCc
Confidence            0      0000112245678899999999999988  99999999764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.6e-41  Score=345.80  Aligned_cols=246  Identities=21%  Similarity=0.284  Sum_probs=204.1

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|...+.||+|+||.||+|.+ .+|+.||||++....   .+..+.+.+|+.+++.++||||+++++++......++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5789999999999999999997 578999999986432   223457889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+ +|+|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus        89 E~~-~g~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           89 EYA-GGELFDYIVEK---KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             CCC-CEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             ECC-CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            999 78998888543   35899999999999999999999998   999999999999999999999999999866443


Q ss_pred             CcccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .  ......||+.|+|||.+.+..+ +.++||||||+++|||++|+.|+......              .+...+.... 
T Consensus       162 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--------------~~~~~i~~~~-  224 (336)
T 3h4j_B          162 N--FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIP--------------NLFKKVNSCV-  224 (336)
T ss_dssp             B--TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSST--------------TCBCCCCSSC-
T ss_pred             c--ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHH--------------HHHHHHHcCC-
Confidence            2  2345579999999999988776 78999999999999999999998643221              1111111111 


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...+...+..+.+++.+||+.||.+|||++|+++.
T Consensus       225 ~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          225 YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             CCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             CCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            12344456788999999999999999999999864

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.2e-42  Score=347.45  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=199.4

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCE----EEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEA----VAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~----vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      .++|+..++||+|+||+||+|.+. +++.    ||+|.+... .....+.+.+|+.++++++||||+++++++.... .+
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~   92 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ   92 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence            367999999999999999999964 4543    577777543 3445678999999999999999999999998754 88


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +|+||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~  167 (327)
T 3lzb_A           93 LITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  167 (327)
T ss_dssp             EEECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred             EEEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence            999999999999998643  345899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          422 PEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       422 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+..... ..+...    ...+.      
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~-~~~~~~----~~~~~------  236 (327)
T 3lzb_A          168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA-SEISSI----LEKGE------  236 (327)
T ss_dssp             ------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG-GGHHHH----HHTTC------
T ss_pred             cCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHH----HHcCC------
Confidence            433222 2223456788999999999999999999999999999999 8877654322 122111    11111      


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                         ....+...+..+.+++.+||+.+|++||++.|+++.|+...
T Consensus       237 ---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          237 ---RLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             ---CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence               11224456678999999999999999999999999996543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.2e-41  Score=354.02  Aligned_cols=255  Identities=18%  Similarity=0.238  Sum_probs=207.6

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ...++|+..++||+|+||+||++... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.+....++
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            34577999999999999999999864 68999999986543  3345678899999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC---CCCcEEEeeccccc
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVR  419 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~---~~~~~kl~Dfgla~  419 (573)
                      ||||+++|+|.+.+...   ..+++..+..++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||++.
T Consensus        88 v~E~~~gg~L~~~i~~~---~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~  161 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAI  161 (444)
T ss_dssp             EECCCBCCBHHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCB
T ss_pred             EEEeCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeE
Confidence            99999999999988543   45899999999999999999999998   99999999999998   56789999999998


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ....... ......||+.|+|||++.+..++.++||||||+++|||++|..|+.....     .........+... .  
T Consensus       162 ~~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~~-~--  232 (444)
T 3soa_A          162 EVEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ-----HRLYQQIKAGAYD-F--  232 (444)
T ss_dssp             CCCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTCCC-C--
T ss_pred             EecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH-----HHHHHHHHhCCCC-C--
Confidence            7654322 23356799999999999999999999999999999999999998754321     1222222222211 0  


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                         ........+..+.+++.+||+.||++|||+.|+++.
T Consensus       233 ---~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          233 ---PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             ---CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ---CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence               011123456788999999999999999999999974

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=2.7e-41  Score=345.85  Aligned_cols=253  Identities=21%  Similarity=0.260  Sum_probs=206.2

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++|+..+.||+|+||.||+++.. +++.||||++...   .....+.+.+|+.++.++ +||||+++++++.+....++|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            57899999999999999999975 5889999999654   334456788999999887 899999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        89 ~e~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~  162 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  162 (345)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCC
T ss_pred             EeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccC
Confidence            9999999999988543   35899999999999999999999998   99999999999999999999999999985432


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc----chHHHHHHHhhcCccccccC
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC----SILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~----~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .. .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.......    ............+..     
T Consensus       163 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~-----  236 (345)
T 3a8x_A          163 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI-----  236 (345)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCC-----
T ss_pred             CC-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCC-----
Confidence            21 22345689999999999999999999999999999999999999986432211    111222222222211     


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCH------HHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSM------SIVVKM  538 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~------~evl~~  538 (573)
                           .++...+..+.+++.+||+.||++||++      +|+++.
T Consensus       237 -----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          237 -----RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             -----CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             -----CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence                 2344556788999999999999999995      666643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.3e-41  Score=344.96  Aligned_cols=246  Identities=22%  Similarity=0.281  Sum_probs=207.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..+.||+|+||.||+++.. +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv  119 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV  119 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence            367999999999999999999975 68999999986532   23456788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       120 ~e~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             EECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             EcCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence            9999999999998543   35899999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .    .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     .........+..         
T Consensus       194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~~---------  255 (350)
T 1rdq_E          194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP-----IQIYEKIVSGKV---------  255 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCC---------
T ss_pred             C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH-----HHHHHHHHcCCC---------
Confidence            3    2346789999999999999999999999999999999999998764321     112222222221         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPS-----MSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~~  538 (573)
                       .++...+..+.+++.+||+.||++||+     ++||++.
T Consensus       256 -~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          256 -RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -CCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence             123445678999999999999999998     8888764

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=3.6e-42  Score=350.88  Aligned_cols=263  Identities=25%  Similarity=0.344  Sum_probs=211.1

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEcCC------CCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeee
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCS  334 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~  334 (573)
                      .++...++|+..+.||+|+||.||+|....      +..||||++.... ....+.+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            345556789999999999999999998642      2479999997543 34467789999999999 899999999999


Q ss_pred             ecCCceeEEEEeccCCCccccccccC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCee
Q 008239          335 ITGPESLLVYEFVPNQSLLDNLFVRQ-----------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNIL  403 (573)
Q Consensus       335 ~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIl  403 (573)
                      ......++||||+++|+|.+++....           ....+++..++.++.||+.||+|||+++   |+||||||+|||
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence            99999999999999999999886432           1345899999999999999999999988   999999999999


Q ss_pred             eCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcch
Q 008239          404 LDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSI  481 (573)
Q Consensus       404 l~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~  481 (573)
                      ++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|||++ |..|+.........
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~  276 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKF  276 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHH
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHH
Confidence            99999999999999986543322 22234557889999999999999999999999999999999 77676543322111


Q ss_pred             HHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          482 LQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       482 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                          ......+.         ....+...+..+.+++.+||+.+|.+|||+.||+++|+.
T Consensus       277 ----~~~~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  323 (333)
T 2i1m_A          277 ----YKLVKDGY---------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQE  323 (333)
T ss_dssp             ----HHHHHHTC---------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----HHHHhcCC---------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHH
Confidence                11111111         111233446788999999999999999999999999954

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-41  Score=346.25  Aligned_cols=261  Identities=25%  Similarity=0.322  Sum_probs=210.8

Q ss_pred             HHhcCccccccccccCceeEEEEEcC--------CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeee
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSI  335 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  335 (573)
                      ...++|+..+.||+|+||.||+|++.        ++..||||++... .....+.+.+|+.+++++ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            34578999999999999999999863        4678999999754 334567789999999999 8999999999999


Q ss_pred             cCCceeEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCe
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI  402 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI  402 (573)
                      .....++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+.+   |+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceE
Confidence            99999999999999999999865432             234899999999999999999999988   99999999999


Q ss_pred             eeCCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcc
Q 008239          403 LLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCS  480 (573)
Q Consensus       403 ll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~  480 (573)
                      |++.++.+||+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.... .  
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-~--  265 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-V--  265 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCC-H--
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCC-H--
Confidence            9999999999999999876543322 2234456889999999999999999999999999999999 777764322 1  


Q ss_pred             hHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          481 ILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                        .........+..         ...+...+..+.+++.+||+.+|.+||++.|+++.|+...
T Consensus       266 --~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~  317 (334)
T 2pvf_A          266 --EELFKLLKEGHR---------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  317 (334)
T ss_dssp             --HHHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --HHHHHHHhcCCC---------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              112222222211         1223455678999999999999999999999999996543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=3e-41  Score=345.99  Aligned_cols=264  Identities=17%  Similarity=0.174  Sum_probs=201.7

Q ss_pred             hcCccccccccccCceeEEEEEcC----CCCEEEEEEecccChh-----------hHHHHHHHHHHHcCCCCCCeeeeee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYNTTQ-----------WVDHFFNEVNLISGINHKNLVKLLG  332 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l~~  332 (573)
                      .++|+..++||+|+||+||+|...    ++..||||++......           ....+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            367999999999999999999975    5788999998765322           1224667889999999999999999


Q ss_pred             eeec----CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC
Q 008239          333 CSIT----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF  408 (573)
Q Consensus       333 ~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~  408 (573)
                      ++..    ....++||||+ +++|.+++....   .+++..++.++.||+.||+|||+.+   |+||||||+|||++.++
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~  188 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNG---TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKN  188 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGGG---BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSS
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCC
Confidence            9887    67889999999 999999985433   6899999999999999999999988   99999999999998877


Q ss_pred             --cEEEeecccccccCCCCc------ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcc
Q 008239          409 --TAKIADFGLVRLFPEDIT------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS  480 (573)
Q Consensus       409 --~~kl~Dfgla~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~  480 (573)
                        .+||+|||+++.+.....      .......||+.|+|||++.+..++.++||||||+++|||++|+.|+........
T Consensus       189 ~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~  268 (345)
T 2v62_A          189 PDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPV  268 (345)
T ss_dssp             TTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHH
T ss_pred             CCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccH
Confidence              999999999986643211      112345789999999999999999999999999999999999999864333322


Q ss_pred             hHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          481 ILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ............ +...+....   .....+..+.+++.+||+.+|++||++++|+++|+..
T Consensus       269 ~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  326 (345)
T 2v62_A          269 AVQTAKTNLLDE-LPQSVLKWA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPH  326 (345)
T ss_dssp             HHHHHHHHHHHT-TTHHHHHHS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTT
T ss_pred             HHHHHHHhhccc-ccHHHHhhc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhcc
Confidence            222222221111 111111100   0124567899999999999999999999999999654

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=4.5e-41  Score=340.54  Aligned_cols=264  Identities=25%  Similarity=0.370  Sum_probs=192.0

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|+..++||+|+||+||+|... +|+.||||++.... ....+.+.+|+.++++++||||+++++++......++|||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   83 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE   83 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence            357899999999999999999975 58999999986543 2334678899999999999999999999999999999999


Q ss_pred             eccCCCccccccccC---CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          346 FVPNQSLLDNLFVRQ---DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      |++ ++|.+++....   ....+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            998 69988875432   2245899999999999999999999988   9999999999999999999999999998764


Q ss_pred             CCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc---ccc--
Q 008239          423 EDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR---LHE--  496 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~--  496 (573)
                      .... ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .....+........   +..  
T Consensus       160 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 IPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDE-EQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             SCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCChhHhhhhh
Confidence            3322 2234568999999999976 46899999999999999999999987644322 22222222111000   000  


Q ss_pred             ---ccCcc------------ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          497 ---AVDPA------------LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       497 ---~~d~~------------l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                         ...+.            +........+..+.+++.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence               00000            011112235668999999999999999999999986

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.6e-41  Score=346.85  Aligned_cols=252  Identities=22%  Similarity=0.310  Sum_probs=192.6

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ..++|+..++||+|+||.||+|+.. +++.||||++....  ..+.+.+|+.++++++||||+++++++......++|||
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  128 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE  128 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence            4577999999999999999999986 57899999997543  24567889999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---CCcEEEeecccccccC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLVRLFP  422 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla~~~~  422 (573)
                      |+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||+++...
T Consensus       129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            9999999998843   345899999999999999999999988   999999999999975   8899999999998654


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ...  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+.........    ..........      .
T Consensus       203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~----~~~i~~~~~~------~  270 (349)
T 2w4o_A          203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFM----FRRILNCEYY------F  270 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHH----HHHHHTTCCC------C
T ss_pred             ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHH----HHHHHhCCCc------c
Confidence            322  223457899999999999999999999999999999999999998654332111    1122221110      1


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ........+..+.+++.+||+.||++|||+.|+++.
T Consensus       271 ~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          271 ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            111223456789999999999999999999999973

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.8e-41  Score=342.88  Aligned_cols=269  Identities=25%  Similarity=0.315  Sum_probs=216.3

Q ss_pred             cccChHHHHHHhcCccccccccccCceeEEEEEc------CCCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCee
Q 008239          257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLV  328 (573)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv  328 (573)
                      ..+....+....++|+..+.||+|+||+||++++      .+++.||||++.... ....+.+.+|+.++.++ +||||+
T Consensus        15 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv   94 (316)
T 2xir_A           15 LPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV   94 (316)
T ss_dssp             SCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             ccccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCee
Confidence            3456666667788999999999999999999974      356899999997643 34456789999999999 799999


Q ss_pred             eeeeeeecCC-ceeEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 008239          329 KLLGCSITGP-ESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH  394 (573)
Q Consensus       329 ~l~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH  394 (573)
                      ++++++.... ..++||||+++++|.+++.....             ...+++..++.++.||+.||.|||+.+   |+|
T Consensus        95 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H  171 (316)
T 2xir_A           95 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH  171 (316)
T ss_dssp             CEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             eEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccc
Confidence            9999987655 48999999999999999865432             123889999999999999999999988   999


Q ss_pred             ecCCCCCeeeCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCC
Q 008239          395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRIN  472 (573)
Q Consensus       395 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~  472 (573)
                      |||||+||+++.++.+||+|||+++....... .......+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+
T Consensus       172 ~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~  251 (316)
T 2xir_A          172 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  251 (316)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             ccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999986644322 22334567889999999999999999999999999999998 88776


Q ss_pred             CCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          473 LFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       473 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .........    ......+..         ...+...+..+.+++.+||+.+|.+|||+.|+++.|+.
T Consensus       252 ~~~~~~~~~----~~~~~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  307 (316)
T 2xir_A          252 PGVKIDEEF----CRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  307 (316)
T ss_dssp             TTCCCSHHH----HHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cccchhHHH----HHHhccCcc---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            544332222    122222211         11233456789999999999999999999999999954

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.4e-41  Score=348.88  Aligned_cols=248  Identities=23%  Similarity=0.262  Sum_probs=199.1

Q ss_pred             cccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccCC
Q 008239          272 HESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       272 ~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      ...+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++||||+++++++......++||||++++
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~  171 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG  171 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            34678999999999999874 68999999998776666788999999999999999999999999999999999999999


Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee--CCCCcEEEeecccccccCCCCccc
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll--~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||+  +.++.+||+|||+++.......  
T Consensus       172 ~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--  244 (373)
T 2x4f_A          172 ELFDRIIDE--SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--  244 (373)
T ss_dssp             EEHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--
T ss_pred             cHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--
Confidence            999888542  235899999999999999999999988   9999999999999  6778999999999987654322  


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE  508 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  508 (573)
                      .....||+.|+|||++....++.++||||||+++|||++|+.|+......    ...... ...... ...     ....
T Consensus       245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~----~~~~~i-~~~~~~-~~~-----~~~~  313 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA----ETLNNI-LACRWD-LED-----EEFQ  313 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH----HHHHHH-HHTCCC-SCS-----GGGT
T ss_pred             cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH-HhccCC-CCh-----hhhc
Confidence            23456899999999999999999999999999999999999987643321    111111 111110 000     1112


Q ss_pred             chHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          509 GKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       509 ~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+..+.+++.+||+.+|++|||++|+++
T Consensus       314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          314 DISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             TSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            34678899999999999999999999997

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.9e-41  Score=343.06  Aligned_cols=271  Identities=25%  Similarity=0.306  Sum_probs=211.2

Q ss_pred             ccChHHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcC--CCCCCeeeeeeeee
Q 008239          258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISG--INHKNLVKLLGCSI  335 (573)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~  335 (573)
                      ...........++|+..+.||+|+||.||+|+.. |+.||||++...   ..+.+.+|++++..  ++||||+++++++.
T Consensus        31 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~  106 (342)
T 1b6c_B           31 GLPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADN  106 (342)
T ss_dssp             SSCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEE
T ss_pred             CCceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeec
Confidence            3444455566788999999999999999999984 899999998543   34567788888876  79999999999998


Q ss_pred             cCC----ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH--------hcCCCCeEEecCCCCCee
Q 008239          336 TGP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH--------EESKLRIIHRDIKLSNIL  403 (573)
Q Consensus       336 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH--------~~~~~~iiHrDlk~~NIl  403 (573)
                      ...    ..++||||+++|+|.+++..    ..+++..++.++.|++.||+|||        +.+   |+||||||+|||
T Consensus       107 ~~~~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIl  179 (342)
T 1b6c_B          107 KDNGTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNIL  179 (342)
T ss_dssp             CCCSSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEE
T ss_pred             ccCCccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEE
Confidence            776    78999999999999999853    25899999999999999999999        665   999999999999


Q ss_pred             eCCCCcEEEeecccccccCCCCcc---cccccccCcCcCchhhhccCC------CCcccchHhHHHHHHHHHcC------
Q 008239          404 LDEEFTAKIADFGLVRLFPEDITH---ISATLAGTLGYMAPEYVVRGK------LTEKADVYSFGVVVIEVVCR------  468 (573)
Q Consensus       404 l~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslGvil~elltg------  468 (573)
                      ++.++.+||+|||++.........   ......||+.|+|||.+.+..      ++.++||||||+++|||++|      
T Consensus       180 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~  259 (342)
T 1b6c_B          180 VKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  259 (342)
T ss_dssp             ECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTB
T ss_pred             ECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCc
Confidence            999999999999999876543322   223457899999999997652      33689999999999999999      


Q ss_pred             ----CCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          469 ----KRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       469 ----~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                          +.|+...................+.....+....   .....+..+.+|+.+||+.+|++|||+.+|+++|+..
T Consensus       260 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          260 HEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence                5565443333222333333332222211111111   1345677899999999999999999999999999653

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=3.5e-42  Score=351.04  Aligned_cols=260  Identities=24%  Similarity=0.282  Sum_probs=192.8

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeeeeee------
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSI------  335 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~------  335 (573)
                      ++....+|+..++||+|+||.||++++. +|+.||||++........+.+.+|+.++.++. ||||+++++++.      
T Consensus        23 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~  102 (337)
T 3ll6_A           23 VELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES  102 (337)
T ss_dssp             EEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred             eeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence            3344568999999999999999999974 68999999997777677778999999999996 999999999884      


Q ss_pred             --cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEe
Q 008239          336 --TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA  413 (573)
Q Consensus       336 --~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~  413 (573)
                        .....++||||+. |+|.+++........+++..++.++.||+.||+|||+.+ ++|+||||||+|||++.++.+||+
T Consensus       103 ~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~  180 (337)
T 3ll6_A          103 DTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLC  180 (337)
T ss_dssp             TTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBC
T ss_pred             ccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEe
Confidence              3344789999995 799888865444557999999999999999999999875 459999999999999999999999


Q ss_pred             ecccccccCCCCcc-----------cccccccCcCcCchhhh---ccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc
Q 008239          414 DFGLVRLFPEDITH-----------ISATLAGTLGYMAPEYV---VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC  479 (573)
Q Consensus       414 Dfgla~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~  479 (573)
                      |||++.........           ......||+.|+|||.+   .+..++.++||||||+++|||++|+.|+...... 
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~-  259 (337)
T 3ll6_A          181 DFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL-  259 (337)
T ss_dssp             CCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred             cCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHH-
Confidence            99999876543221           11144589999999998   5667899999999999999999999987532211 


Q ss_pred             chHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                                      ..+............+..+.+|+.+||+.+|++|||++|+++.|...
T Consensus       260 ----------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          260 ----------------RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             ----------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------------HhhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                            01111111111233345678999999999999999999999999544

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.7e-41  Score=337.42  Aligned_cols=255  Identities=24%  Similarity=0.330  Sum_probs=204.0

Q ss_pred             HhcCccccccccccCceeEEEEEcCC----CCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ..++|+..+.||+|+||+||+|++.+    +..||||++... .....+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            35679999999999999999998642    346999998765 34456789999999999999999999999765 4578


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        89 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  163 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN--KNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI  163 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC
T ss_pred             EEEecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCccc
Confidence            999999999999998543  245899999999999999999999988   999999999999999999999999999876


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ............+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... .....    ...+..      
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~-~~~~~----~~~~~~------  232 (281)
T 3cc6_A          164 EDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENK-DVIGV----LEKGDR------  232 (281)
T ss_dssp             ---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGG-GHHHH----HHHTCC------
T ss_pred             ccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChH-HHHHH----HhcCCC------
Confidence            5443333344567889999999999999999999999999999998 88887543322 22211    111110      


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                         ...+...+..+.+++.+||+.+|++||++.|+++.|+.
T Consensus       233 ---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~  270 (281)
T 3cc6_A          233 ---LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSD  270 (281)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHH
Confidence               11233456789999999999999999999999999954

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.3e-41  Score=347.58  Aligned_cols=250  Identities=23%  Similarity=0.302  Sum_probs=206.3

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..+.||+|+||.||++... +++.||||++....   ....+.+.+|+.+|+.++||||+++++++.+....++|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            367999999999999999999875 58899999986432   23456788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++|+|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        94 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  167 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR  167 (384)
T ss_dssp             ECCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC
Confidence            999999999998853   345899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccCcCcCchhhhcc---CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          424 DITHISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ..  ......||+.|+|||++..   ..++.++|||||||++|||++|+.|+....... . ...........       
T Consensus       168 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~-~~~~~~~~~~~-------  236 (384)
T 4fr4_A          168 ET--QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTS-S-KEIVHTFETTV-------  236 (384)
T ss_dssp             TC--CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSC-H-HHHHHHHHHCC-------
T ss_pred             CC--ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCcc-H-HHHHHHHhhcc-------
Confidence            32  2345679999999999964   458999999999999999999999986543321 1 11111111111       


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCC-HHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPS-MSIVVK  537 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~  537 (573)
                         ..++...+..+.+|+.+||+.+|++||+ +++|++
T Consensus       237 ---~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          237 ---VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ---cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence               1234455678999999999999999999 777765

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.7e-41  Score=353.46  Aligned_cols=251  Identities=22%  Similarity=0.331  Sum_probs=200.7

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCC--CCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGIN--HKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..++||+|+||.||++...+++.||||++...  ..+..+.+.+|+.+|++++  ||||+++++++......++|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            3569999999999999999999888999999998654  3445678899999999996  59999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      || +.+++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||+++.+..
T Consensus       135 ~E-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EE-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             Ee-cCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            99 5688999988543   36889999999999999999999988   99999999999996 57999999999987654


Q ss_pred             CCcc-cccccccCcCcCchhhhcc-----------CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc
Q 008239          424 DITH-ISATLAGTLGYMAPEYVVR-----------GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       424 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      .... ......||+.|+|||++.+           ..++.++|||||||++|||++|+.|+......   ......    
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~~----  279 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---ISKLHA----  279 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH---HHHHHH----
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH---HHHHHH----
Confidence            3322 2345679999999999865           46899999999999999999999998543221   111111    


Q ss_pred             CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       492 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                           ++++......+...+..+.+|+.+||+.||++|||+.|+++.
T Consensus       280 -----~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          280 -----IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             -----HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----HhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence                 122222223344446788999999999999999999999865

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=5.6e-41  Score=336.53  Aligned_cols=256  Identities=29%  Similarity=0.391  Sum_probs=205.2

Q ss_pred             cCccccccccccCceeEEEEEcCC----CCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeee-cCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSI-TGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~l  342 (573)
                      ..|+..++||+|+||+||+|++.+    ...||||.+... .....+.+.+|+.++++++||||+++++++. .....++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  104 (298)
T 3f66_A           25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV  104 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred             eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence            568889999999999999998643    236899998754 3445678899999999999999999999865 4567899


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++..  ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~  179 (298)
T 3f66_A          105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY  179 (298)
T ss_dssp             EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred             EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence            9999999999999854  3345899999999999999999999998   9999999999999999999999999998664


Q ss_pred             CCCcc---cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          423 EDITH---ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       423 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .....   ......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+.............    ..+..     
T Consensus       180 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~----~~~~~-----  250 (298)
T 3f66_A          180 DKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGRR-----  250 (298)
T ss_dssp             CGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH----HTTCC-----
T ss_pred             ccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH----hcCCC-----
Confidence            43221   2234567889999999999999999999999999999999777665544433332221    11110     


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                          ...+...+..+.+++.+||+.+|++|||++|++++|+..
T Consensus       251 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          251 ----LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             ----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                111334567899999999999999999999999999654

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=343.83  Aligned_cols=245  Identities=26%  Similarity=0.353  Sum_probs=195.4

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..++||+|+||+||+|++. +|+.||||++....  ......+..|+..+.++ +||||+++++++.+....++|
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            367999999999999999999986 78999999986532  23334455566655555 999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+ +++|.+++....  ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       136 ~e~~-~~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWG--ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EECC-CCBHHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             Eecc-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            9999 679988875442  45999999999999999999999988   99999999999999999999999999886643


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ..  ......||+.|+|||++.+ .++.++||||||+++|||++|..++....        .+.....+..    .+.  
T Consensus       210 ~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~--------~~~~~~~~~~----~~~--  272 (311)
T 3p1a_A          210 AG--AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE--------GWQQLRQGYL----PPE--  272 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH--------HHHHHTTTCC----CHH--
T ss_pred             CC--CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc--------HHHHHhccCC----Ccc--
Confidence            32  2334568999999998875 79999999999999999999987654321        1222222211    111  


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        .....+..+.+++.+||+.||++|||++|+++
T Consensus       273 --~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          273 --FTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             --HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             --cccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence              12334678999999999999999999999996

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=3.7e-41  Score=337.59  Aligned_cols=259  Identities=17%  Similarity=0.212  Sum_probs=208.9

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++....  ..+.+.+|+.+++.+ +|+|++++++++......++|||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e   86 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   86 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence            46799999999999999999996 578999999986443  234678899999999 79999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc-----EEEeecccccc
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT-----AKIADFGLVRL  420 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~-----~kl~Dfgla~~  420 (573)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.     +||+|||+++.
T Consensus        87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~  160 (298)
T 1csn_A           87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  160 (298)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence            99 99999998543  235899999999999999999999988   999999999999987765     99999999987


Q ss_pred             cCCCCcc------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcc--hHHHHHHHhhcC
Q 008239          421 FPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS--ILQTVWDLYVKG  492 (573)
Q Consensus       421 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~--~~~~~~~~~~~~  492 (573)
                      .......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........  ....+.......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T 1csn_A          161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  240 (298)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc
Confidence            6543221      23356789999999999999999999999999999999999999876433221  111111111111


Q ss_pred             ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       493 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      ..     +.    .....+..+.+++.+||+.+|++||++++|++.|+...
T Consensus       241 ~~-----~~----~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~  282 (298)
T 1csn_A          241 PL-----RE----LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL  282 (298)
T ss_dssp             CH-----HH----HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred             cH-----HH----HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHH
Confidence            10     01    12245678999999999999999999999999996543

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-41  Score=350.27  Aligned_cols=256  Identities=29%  Similarity=0.402  Sum_probs=195.9

Q ss_pred             CccccccccccCceeEEEEEcC--CC--CEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec-CCceeEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP--GG--EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT-GPESLLV  343 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~lv  343 (573)
                      .|+..++||+|+||+||+|++.  ++  ..||||.+... .....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999864  22  36899998653 33556789999999999999999999998754 4578999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++|+|.+++..  ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~  244 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD  244 (373)
T ss_dssp             EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence            999999999999853  2345889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcc---cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          424 DITH---ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       424 ~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ....   ......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+.............    ..+..      
T Consensus       245 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~----~~~~~------  314 (373)
T 3c1x_A          245 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGRR------  314 (373)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH----HTTCC------
T ss_pred             cccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH----HcCCC------
Confidence            2211   1223457889999999999999999999999999999999666555444333332221    11111      


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                         ...+...+..+.+++.+||+.+|++||+++|+++.|+...
T Consensus       315 ---~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~  354 (373)
T 3c1x_A          315 ---LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF  354 (373)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence               1123345678999999999999999999999999996543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-41  Score=336.25  Aligned_cols=254  Identities=23%  Similarity=0.333  Sum_probs=206.8

Q ss_pred             cCccccc-cccccCceeEEEEEcC---CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          269 NYFHESN-KLGQGGSGSVYKGTLP---GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       269 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++|...+ .||+|+||.||+|.+.   ++..||||++... .....+.+.+|++++++++||||+++++++ ..+..++|
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv   87 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV   87 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence            4555665 9999999999999853   5778999999764 344567899999999999999999999998 55678999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++..  ....+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999998853  3346899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCccc--ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          424 DITHI--SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       424 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      .....  .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+...... ..    ......+.       
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~-~~----~~~i~~~~-------  230 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EV----MAFIEQGK-------  230 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH-HH----HHHHHTTC-------
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH-HH----HHHHhcCC-------
Confidence            33221  223456889999999998899999999999999999998 88887543321 11    11222221       


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                        ....+...+..+.+++.+||+.+|++||++.++++.|...
T Consensus       231 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          231 --RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             --CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              1123445678899999999999999999999999999543

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=343.57  Aligned_cols=262  Identities=21%  Similarity=0.251  Sum_probs=207.0

Q ss_pred             HhcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeee----cCCcee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI----TGPESL  341 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~  341 (573)
                      ..++|+..+.||+|+||.||+++. .+|+.||||++........+.+.+|+.+++.++||||+++++++.    .....+
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence            357899999999999999999997 578999999997776677788999999999999999999999987    334678


Q ss_pred             EEEEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          342 LVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      +||||+++++|.+++... .....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~  183 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQ  183 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence            999999999999988642 23456899999999999999999999998   99999999999999999999999999875


Q ss_pred             cCCCCcc--------cccccccCcCcCchhhhccCC---CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh
Q 008239          421 FPEDITH--------ISATLAGTLGYMAPEYVVRGK---LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY  489 (573)
Q Consensus       421 ~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  489 (573)
                      .......        ......||+.|+|||.+....   ++.++||||||+++|||++|+.|+............   ..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~---~~  260 (317)
T 2buj_A          184 ACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVAL---AV  260 (317)
T ss_dssp             SCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHH---HH
T ss_pred             cccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhH---Hh
Confidence            4321111        012345799999999987554   688999999999999999999987432111111111   00


Q ss_pred             hcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       490 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      ..         ..........+..+.+++.+||+.||.+||+++++++.|+...
T Consensus       261 ~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  305 (317)
T 2buj_A          261 QN---------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ  305 (317)
T ss_dssp             HC---------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTC
T ss_pred             hc---------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcC
Confidence            11         1111122345678999999999999999999999999997654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.9e-41  Score=346.35  Aligned_cols=253  Identities=21%  Similarity=0.222  Sum_probs=197.0

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|+..++||+|+||+||+++.. +++.||||++..... ..+.+.+|+.+++.++||||+++++++......++||||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   97 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA-IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY   97 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT-SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc-ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence            467999999999999999999976 689999999965432 246688999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc--EEEeecccccccCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--AKIADFGLVRLFPED  424 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~--~kl~Dfgla~~~~~~  424 (573)
                      +++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.  +||+|||+++.....
T Consensus        98 ~~~~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~  171 (361)
T 3uc3_A           98 ASGGELYERICNA---GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH  171 (361)
T ss_dssp             CCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred             CCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence            9999999988543   35899999999999999999999988   999999999999987765  999999998743222


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcc-cchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEK-ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~-sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                        .......||+.|+|||++.+..++.+ +||||||+++|||++|+.|+................... ..        .
T Consensus       172 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~-~~--------~  240 (361)
T 3uc3_A          172 --SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSV-KY--------S  240 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTT-CC--------C
T ss_pred             --CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcC-CC--------C
Confidence              12234568999999999988887766 899999999999999999987654433333322222211 11        1


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .......+..+.+|+.+||+.+|++|||+.|+++.
T Consensus       241 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          241 IPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            11122346788999999999999999999999974

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.1e-40  Score=340.30  Aligned_cols=249  Identities=22%  Similarity=0.278  Sum_probs=207.3

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|...+.||+|+||.||+++.. +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  119 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV  119 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence            467899999999999999999976 5789999998654   334567788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++.....
T Consensus       120 ~e~~~~~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          120 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             ECCCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            9999999999987543   45899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....    . ..+.....+..         
T Consensus       194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~----~-~~~~~~~~~~~---------  258 (335)
T 2owb_A          194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----K-ETYLRIKKNEY---------  258 (335)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----H-HHHHHHHHTCC---------
T ss_pred             Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCH----H-HHHHHHhcCCC---------
Confidence            222 22345789999999999999999999999999999999999998754321    1 11111222111         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       ..+...+..+.+++.+||+.||++||+++|+++.
T Consensus       259 -~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          259 -SIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             1233455678899999999999999999999973

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=371.54  Aligned_cols=251  Identities=23%  Similarity=0.339  Sum_probs=200.6

Q ss_pred             ccccc-cccccCceeEEEEEcC---CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          271 FHESN-KLGQGGSGSVYKGTLP---GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       271 ~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      +...+ +||+|+||.||+|.+.   ++..||||++.... ....+.+.+|+++|++++|||||++++++.. +..++|||
T Consensus       337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E  415 (613)
T 2ozo_A          337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVME  415 (613)
T ss_dssp             EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEE
T ss_pred             eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEE
Confidence            33344 7999999999999864   46689999997643 3456789999999999999999999999876 56899999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++|+|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++......
T Consensus       416 ~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          416 MAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             CCTTCBHHHHHTTC--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             eCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            99999999998533  356899999999999999999999988   9999999999999999999999999998764432


Q ss_pred             ccc--ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          426 THI--SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       426 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ...  .....+|+.|+|||++..+.++.++|||||||+||||++ |+.|+...... .+    ...+..+.         
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~-~~----~~~i~~~~---------  556 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP-EV----MAFIEQGK---------  556 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSH-HH----HHHHHTTC---------
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHH-HH----HHHHHcCC---------
Confidence            221  122345689999999999999999999999999999998 88887543321 11    12222221         


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ....+...+..+.+|+.+||+.+|++||++.+|++.|+.
T Consensus       557 ~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          557 RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            112345567889999999999999999999999999954

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.1e-41  Score=346.28  Aligned_cols=250  Identities=22%  Similarity=0.259  Sum_probs=205.4

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCce
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPES  340 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~  340 (573)
                      ...++|+..+.||+|+||.||+++.. +|+.||||++....   ....+.+..|..++..+ +||||+++++++.+....
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~   93 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL   93 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence            44578999999999999999999975 58899999996542   23456678899999876 999999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        94 ~lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~  167 (345)
T 1xjd_A           94 FFVMEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE  167 (345)
T ss_dssp             EEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhh
Confidence            9999999999999988543   35899999999999999999999998   99999999999999999999999999985


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ..... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     .........+.       
T Consensus       168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~-------  234 (345)
T 1xjd_A          168 NMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHSIRMDN-------  234 (345)
T ss_dssp             CCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCC-------
T ss_pred             cccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHhCC-------
Confidence            43222 123456899999999999999999999999999999999999998754321     11122222221       


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS-IVVK  537 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl~  537 (573)
                         ..++...+..+.+++.+||+.+|++||++. +|++
T Consensus       235 ---~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          235 ---PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             ---CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             ---CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHc
Confidence               122344567889999999999999999997 6653

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-41  Score=336.98  Aligned_cols=256  Identities=27%  Similarity=0.370  Sum_probs=207.2

Q ss_pred             CccccccccccCceeEEEEEcCC----CCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce-eEE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES-LLV  343 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-~lv  343 (573)
                      .|...++||+|+||+||+|++.+    +..||+|++... .....+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            45667899999999999998632    237999998754 334567889999999999999999999999876665 999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+.+++|.+++..  ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  176 (298)
T 3pls_A          102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD  176 (298)
T ss_dssp             ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred             EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence            999999999999854  2356899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCc---ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          424 DIT---HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       424 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ...   .......+|+.|+|||.+.+..++.++||||||+++|||++|+.|+.............    ..+.       
T Consensus       177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~----~~~~-------  245 (298)
T 3pls_A          177 REYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL----AQGR-------  245 (298)
T ss_dssp             GGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH----HTTC-------
T ss_pred             CcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh----hcCC-------
Confidence            221   12234567889999999999999999999999999999999888766554433332221    1111       


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                        ....+...+..+.+++.+||+.+|.+|||+++++++|+...
T Consensus       246 --~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~  286 (298)
T 3pls_A          246 --RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIV  286 (298)
T ss_dssp             --CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence              11223345678999999999999999999999999996543

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.4e-41  Score=340.89  Aligned_cols=249  Identities=23%  Similarity=0.289  Sum_probs=196.3

Q ss_pred             hcCccccccccccCceeEEEEEc----CCCCEEEEEEecccC----hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  339 (573)
                      .++|+..++||+|+||.||+++.    .+|+.||||++....    ......+.+|+.++++++||||+++++++.....
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            46799999999999999999986    468999999996542    2334567889999999999999999999999999


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~  169 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLERE---GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK  169 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-
T ss_pred             EEEEEeCCCCCcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccc
Confidence            99999999999999988543   35889999999999999999999998   9999999999999999999999999988


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ...... .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... ..   . .......      
T Consensus       170 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-~~---~-~~i~~~~------  237 (327)
T 3a62_A          170 ESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK-KT---I-DKILKCK------  237 (327)
T ss_dssp             ----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HH---H-HHHHHTC------
T ss_pred             ccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH-HH---H-HHHHhCC------
Confidence            543222 1233567899999999999999999999999999999999999987643221 11   1 1111111      


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                          ...+...+..+.+++.+||+.+|++||     +++|+++.
T Consensus       238 ----~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          238 ----LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             ----CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                122344567889999999999999999     77888764

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-41  Score=354.45  Aligned_cols=263  Identities=20%  Similarity=0.189  Sum_probs=210.0

Q ss_pred             ChHHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeee
Q 008239          260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSI  335 (573)
Q Consensus       260 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  335 (573)
                      .++++....++|+..++||+|+||+||+++.. +|+.||||++....   ....+.+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34455566789999999999999999999975 68999999996432   223445788999999999999999999999


Q ss_pred             cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeec
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF  415 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  415 (573)
                      +....++||||+++|+|.+++....  ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+||
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF  206 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKFG--ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF  206 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHS--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence            9999999999999999999985432  35899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCcCcCchhhhc-------cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH
Q 008239          416 GLVRLFPEDITHISATLAGTLGYMAPEYVV-------RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       416 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  488 (573)
                      |+++.............+||+.|+|||++.       ...++.++|||||||++|||++|+.|+...... .....+   
T Consensus       207 Gla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~-~~~~~i---  282 (412)
T 2vd5_A          207 GSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA-ETYGKI---  282 (412)
T ss_dssp             TTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH-HHHHHH---
T ss_pred             hhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH-HHHHHH---
Confidence            999877554443344568999999999997       357899999999999999999999998653321 111111   


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCC---CCHHHHHHH
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELR---PSMSIVVKM  538 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R---Pt~~evl~~  538 (573)
                      . .... ....+    ......+.++.+++.+||+ +|++|   |+++|+++.
T Consensus       283 ~-~~~~-~~~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          283 V-HYKE-HLSLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             H-THHH-HCCCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             H-hccc-CcCCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            1 1000 00001    1123456788999999999 99998   689999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.5e-41  Score=345.30  Aligned_cols=262  Identities=23%  Similarity=0.211  Sum_probs=203.5

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-----ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-----TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT  336 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  336 (573)
                      .+....++|+..++||+|+||+||++... +++.||||++...     .....+.+.+|+.++++++||||+++++++.+
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            45567788999999999999999999874 6889999998643     23456788999999999999999999999999


Q ss_pred             CCceeEEEEeccCCCccccccccC-------------------------------------CCCCCCHHHHHHHHHHHHH
Q 008239          337 GPESLLVYEFVPNQSLLDNLFVRQ-------------------------------------DVEPLSWEVRYKIILSTAE  379 (573)
Q Consensus       337 ~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------~~~~l~~~~~~~i~~~ia~  379 (573)
                      ....++||||+++|+|.+++....                                     ....+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            999999999999999999884210                                     0112357788899999999


Q ss_pred             HHHHHHhcCCCCeEEecCCCCCeeeCCCC--cEEEeecccccccCCCC---cccccccccCcCcCchhhhcc--CCCCcc
Q 008239          380 GLAYLHEESKLRIIHRDIKLSNILLDEEF--TAKIADFGLVRLFPEDI---THISATLAGTLGYMAPEYVVR--GKLTEK  452 (573)
Q Consensus       380 ~l~yLH~~~~~~iiHrDlk~~NIll~~~~--~~kl~Dfgla~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~~~~~  452 (573)
                      ||+|||+.+   |+||||||+|||++.++  .+||+|||++..+....   ........||+.|+|||.+..  ..++.+
T Consensus       180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  256 (345)
T 3hko_A          180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPK  256 (345)
T ss_dssp             HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTH
T ss_pred             HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcH
Confidence            999999998   99999999999998776  89999999998653321   112335678999999999975  688999


Q ss_pred             cchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCH
Q 008239          453 ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSM  532 (573)
Q Consensus       453 sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~  532 (573)
                      +||||||+++|||++|+.|+......    +........ .. ....+     .....+..+.+++.+||+.+|++||++
T Consensus       257 ~DiwslG~il~el~~g~~pf~~~~~~----~~~~~~~~~-~~-~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~  325 (345)
T 3hko_A          257 CDAWSAGVLLHLLLMGAVPFPGVNDA----DTISQVLNK-KL-CFENP-----NYNVLSPLARDLLSNLLNRNVDERFDA  325 (345)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHH----HHHHHHHHC-CC-CTTSG-----GGGGSCHHHHHHHHHHSCSCTTTSCCH
T ss_pred             HHHHHHHHHHHHHHHCCCCCCCCChH----HHHHHHHhc-cc-ccCCc-----ccccCCHHHHHHHHHHcCCChhHCCCH
Confidence            99999999999999999987543321    112222211 11 00011     112346788999999999999999999


Q ss_pred             HHHHHH
Q 008239          533 SIVVKM  538 (573)
Q Consensus       533 ~evl~~  538 (573)
                      .|+++.
T Consensus       326 ~~~l~h  331 (345)
T 3hko_A          326 MRALQH  331 (345)
T ss_dssp             HHHHHS
T ss_pred             HHHhcC
Confidence            999873

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.5e-41  Score=343.69  Aligned_cols=255  Identities=26%  Similarity=0.378  Sum_probs=200.9

Q ss_pred             cCccccccccccCceeEEEEEcCC-----CCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG-----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~-----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .+|...+.||+|+||+||+|.+..     +..||||++... .......+.+|+.++++++||||+++++++......++
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  123 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI  123 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence            567778999999999999998643     236999999754 33445678999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++++|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       124 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~  198 (333)
T 1mqb_A          124 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  198 (333)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEeCCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence            99999999999998543  346899999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          423 EDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       423 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .....  ......+|+.|+|||.+....++.++||||||+++|||++ |+.|+.....     .........+.      
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~~~~~~------  267 (333)
T 1mqb_A          199 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-----HEVMKAINDGF------  267 (333)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHHHTTC------
T ss_pred             cccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCH-----HHHHHHHHCCC------
Confidence            43221  1123345788999999999999999999999999999999 8887643321     11112222211      


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                         ....+...+..+.+++.+||+.+|++||++.+++++|+..
T Consensus       268 ---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          268 ---RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             ---CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               1122345677899999999999999999999999999553

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=9.3e-41  Score=339.72  Aligned_cols=266  Identities=20%  Similarity=0.265  Sum_probs=210.4

Q ss_pred             cccChHHHHHHhcCcccc-ccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCC-CCCCeeeee
Q 008239          257 LNFSYETLEKATNYFHES-NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGI-NHKNLVKLL  331 (573)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l-~h~niv~l~  331 (573)
                      .+..+...+...+.|... ++||+|+||.||++... +|+.||||++....  ......+.+|+.++..+ .||||++++
T Consensus        16 ~n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~   95 (327)
T 3lm5_A           16 ENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLH   95 (327)
T ss_dssp             CCCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEE
Confidence            345556666777778877 89999999999999875 68999999986542  33457888999999999 569999999


Q ss_pred             eeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---CC
Q 008239          332 GCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EF  408 (573)
Q Consensus       332 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~  408 (573)
                      +++......++||||+++|+|.+++... ....+++..++.++.||+.||+|||+.+   |+||||||+|||++.   ++
T Consensus        96 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~  171 (327)
T 3lm5_A           96 EVYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLG  171 (327)
T ss_dssp             EEEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBC
T ss_pred             EEEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCC
Confidence            9999999999999999999999988542 2356899999999999999999999998   999999999999997   78


Q ss_pred             cEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH
Q 008239          409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       409 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  488 (573)
                      .+||+|||+++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......    ... ..
T Consensus       172 ~~kL~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~----~~~-~~  244 (327)
T 3lm5_A          172 DIKIVDFGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQ----ETY-LN  244 (327)
T ss_dssp             CEEECCGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----HHH-HH
T ss_pred             cEEEeeCccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch----HHH-HH
Confidence            99999999998764332  223457899999999999999999999999999999999999987543321    111 11


Q ss_pred             hhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          489 YVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       489 ~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ......      ..........+..+.+++.+||+.+|++|||++++++.-
T Consensus       245 i~~~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~  289 (327)
T 3lm5_A          245 ISQVNV------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS  289 (327)
T ss_dssp             HHHTCC------CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCG
T ss_pred             HHhccc------ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCH
Confidence            111110      111122234567889999999999999999999999753

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=6.8e-41  Score=349.85  Aligned_cols=270  Identities=22%  Similarity=0.284  Sum_probs=213.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC--ceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~lv  343 (573)
                      .++|+..++||+|+||+||+|++. +|+.||||++.... ....+.+.+|++++++++||||+++++++....  ..++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            367899999999999999999976 58999999996543 334567889999999999999999999988665  67999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee----CCCCcEEEeeccccc
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIADFGLVR  419 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll----~~~~~~kl~Dfgla~  419 (573)
                      |||+++|+|.+++........+++..++.++.||+.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~  164 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR  164 (396)
T ss_dssp             ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred             EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence            999999999999966544455999999999999999999999998   9999999999999    778889999999998


Q ss_pred             ccCCCCcccccccccCcCcCchhhhcc--------CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVR--------GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      ......  ......||+.|+|||++..        ..++.++||||||+++|||++|+.|+...................
T Consensus       165 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~  242 (396)
T 4eut_A          165 ELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITG  242 (396)
T ss_dssp             ECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHS
T ss_pred             EccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcC
Confidence            764432  2234568999999999865        567889999999999999999999986544433223333332221


Q ss_pred             Cc---cccc---cC------ccc--cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          492 GR---LHEA---VD------PAL--AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       492 ~~---~~~~---~d------~~l--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ..   +...   .+      ..+  ........+..+.+++.+||+.||++||+++|+++.|...
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~i  307 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             CCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHH
Confidence            11   0000   00      001  1123355677889999999999999999999999888543

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-41  Score=349.38  Aligned_cols=255  Identities=24%  Similarity=0.265  Sum_probs=207.9

Q ss_pred             hcCccccccccccCceeEEEEEc----CCCCEEEEEEecccC----hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCC
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYNT----TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP  338 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  338 (573)
                      .++|+..++||+|+||.||+++.    .+|+.||||++....    ....+.+.+|+.+++++ +||||+++++++....
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            36799999999999999999987    368999999986432    23345677899999999 6999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++||||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a  206 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS  206 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eEEEEeecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCC
Confidence            999999999999999998643   35899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhcc--CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      +.+............||+.|+|||++.+  ..++.++||||||+++|||++|+.|+................. ...   
T Consensus       207 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~-~~~---  282 (355)
T 1vzo_A          207 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL-KSE---  282 (355)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH-HCC---
T ss_pred             eecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh-ccC---
Confidence            8765444444445679999999999985  3578999999999999999999999875443332222221111 111   


Q ss_pred             ccCccccCCCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHHh
Q 008239          497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKML  539 (573)
Q Consensus       497 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~L  539 (573)
                             ..++...+..+.+|+.+||+.||++||     +++|+++..
T Consensus       283 -------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          283 -------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             -------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             -------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence                   123445667889999999999999999     999999876

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.7e-41  Score=341.39  Aligned_cols=266  Identities=23%  Similarity=0.343  Sum_probs=201.0

Q ss_pred             ChHHHHHHhcCccccccccccCceeEEEEEcC----CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeee
Q 008239          260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLP----GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGC  333 (573)
Q Consensus       260 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~----~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~  333 (573)
                      ..+++....++|...+.||+|+||.||+|.+.    .++.||||++...  .....+.+.+|+.++++++||||++++++
T Consensus        25 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~  104 (313)
T 3brb_A           25 KLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGV  104 (313)
T ss_dssp             CTTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred             hHHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence            34445556678999999999999999999864    3458999998654  34446778999999999999999999999


Q ss_pred             eecCCc-----eeEEEEeccCCCcccccccc---CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC
Q 008239          334 SITGPE-----SLLVYEFVPNQSLLDNLFVR---QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD  405 (573)
Q Consensus       334 ~~~~~~-----~~lv~e~~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~  405 (573)
                      +.....     .++||||+++++|.+++...   .....+++..++.++.||+.||.|||+++   |+||||||+|||++
T Consensus       105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~  181 (313)
T 3brb_A          105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR  181 (313)
T ss_dssp             EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEEC
T ss_pred             EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEc
Confidence            887553     48999999999999988432   23456999999999999999999999988   99999999999999


Q ss_pred             CCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHH
Q 008239          406 EEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQ  483 (573)
Q Consensus       406 ~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~  483 (573)
                      .++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|||++ |..|+.... ......
T Consensus       182 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~-~~~~~~  260 (313)
T 3brb_A          182 DDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ-NHEMYD  260 (313)
T ss_dssp             TTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC-GGGHHH
T ss_pred             CCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCC-HHHHHH
Confidence            999999999999986643322 22234457889999999999999999999999999999999 665654322 222221


Q ss_pred             HHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          484 TVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       484 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .    ...+.         ....+...+..+.+++.+||+.+|++|||+++++++|+..
T Consensus       261 ~----~~~~~---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          261 Y----LLHGH---------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             H----HHTTC---------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             H----HHcCC---------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            1    11111         1122344567899999999999999999999999999653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.9e-40  Score=352.60  Aligned_cols=246  Identities=23%  Similarity=0.336  Sum_probs=206.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|...+.||+|+||.||+|+.. +|+.||||++....   .+..+.+.+|+.+++.++||||+++++++......++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            57889999999999999999975 79999999996532   233567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++..   ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~  169 (476)
T 2y94_A           96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  169 (476)
T ss_dssp             ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred             eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence            99999999999843   346899999999999999999999988   999999999999999999999999999876543


Q ss_pred             CcccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .  ......||+.|+|||++.+..+ +.++||||||+++|||++|+.|+...... .    .......+..         
T Consensus       170 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~-~----~~~~i~~~~~---------  233 (476)
T 2y94_A          170 E--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP-T----LFKKICDGIF---------  233 (476)
T ss_dssp             C--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH-H----HHHHHHTTCC---------
T ss_pred             c--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH-H----HHHHHhcCCc---------
Confidence            2  2335679999999999988765 68999999999999999999997643321 1    1111222211         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       ..+...+..+.+++.+||+.||++|||++|+++
T Consensus       234 -~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 -YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             -CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             -CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence             123345567899999999999999999999997

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.8e-41  Score=357.32  Aligned_cols=249  Identities=23%  Similarity=0.271  Sum_probs=197.0

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..++||+|+||.||+++.. +|+.||||++...   .......+.+|+.+++.++||||+++++++...+..++|
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv  226 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV  226 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence            367899999999999999999864 6899999999653   233456778899999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++.+||+|||+++...
T Consensus       227 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  300 (446)
T 4ejn_A          227 MEYANGGELFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI  300 (446)
T ss_dssp             ECCCSSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred             EeeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence            9999999999888543   358999999999999999999998 77   9999999999999999999999999998643


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     .........+..        
T Consensus       301 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~-----~~~~~~i~~~~~--------  366 (446)
T 4ejn_A          301 KDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----EKLFELILMEEI--------  366 (446)
T ss_dssp             C------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCC--------
T ss_pred             CCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH-----HHHHHHHHhCCC--------
Confidence            322 223456799999999999999999999999999999999999999754322     111111121111        


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                        .++...+..+.+|+.+||+.||++||     +++|+++.
T Consensus       367 --~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          367 --RFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --CCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence              12344567889999999999999999     99999863

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1e-40  Score=342.31  Aligned_cols=250  Identities=22%  Similarity=0.237  Sum_probs=205.7

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCcee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  341 (573)
                      ..++|+..+.||+|+||+||+++.. +|+.||||++....   ....+.+..|..++..+ +||||+++++++.+....+
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            3478999999999999999999986 47899999996542   23456788999999988 8999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+++|+|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++..
T Consensus        98 lv~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  171 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  171 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence            999999999999998543   35899999999999999999999998   999999999999999999999999999854


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      .... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     .........+..       
T Consensus       172 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~~-------  238 (353)
T 2i0e_A          172 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEHNV-------  238 (353)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCC-------
T ss_pred             ccCC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhCCC-------
Confidence            3221 223456799999999999999999999999999999999999999754321     111122222211       


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCC-----HHHHHHH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPS-----MSIVVKM  538 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~~  538 (573)
                         .++...+..+.+++.+||+.+|++||+     ++++++.
T Consensus       239 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          239 ---AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ---CCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ---CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence               223456678999999999999999995     4777654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.4e-41  Score=345.69  Aligned_cols=247  Identities=28%  Similarity=0.451  Sum_probs=202.1

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      +.|+..+.||+|+||+||+|+. .+|+.||||++....   ....+.+.+|++++++++||||+++++++......++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            4588899999999999999986 578999999986542   334567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||++ |+|.+++...  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus       134 e~~~-g~l~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          134 EYCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             ECCS-EEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             ecCC-CCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            9997 6887777432  246899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CcccccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          425 ITHISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                           ....||+.|+|||++.   .+.++.++||||||+++|||++|+.|+.....    ............      +.
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~----~~~~~~~~~~~~------~~  272 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQNES------PA  272 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHSCC------CC
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHHhcCC------CC
Confidence                 2457899999999985   56789999999999999999999998754322    122222222111      11


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      +   .....+..+.+++.+||+.+|++|||++++++..
T Consensus       273 ~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          273 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             C---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            1   1233467789999999999999999999998643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1.5e-40  Score=330.30  Aligned_cols=248  Identities=25%  Similarity=0.326  Sum_probs=202.9

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..+.||+|+||+||++... +++.||||++....   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            467999999999999999999875 57799999985432   23356788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++...   ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus        88 ~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             ECCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            9999999999988543   35899999999999999999999987   99999999999999999999999999865433


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ..   .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....     ...........          
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~----------  223 (279)
T 3fdn_A          162 SR---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISRVE----------  223 (279)
T ss_dssp             ---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHHTC----------
T ss_pred             cc---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH-----HHHHHHHHhCC----------
Confidence            22   2345789999999999999999999999999999999999998754321     11111111111          


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ...+...+..+.+++.+||+.+|++|||++|+++.-
T Consensus       224 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          224 FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCH
T ss_pred             CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            122344567889999999999999999999999753

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2e-40  Score=331.86  Aligned_cols=252  Identities=25%  Similarity=0.326  Sum_probs=202.6

Q ss_pred             CccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      .|....+||+|+||.||+|.. .+++.||||++........+.+.+|+.+++.++||||+++++++......++||||++
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  102 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVP  102 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCS
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCC
Confidence            344566899999999999996 4688999999987666667889999999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-CCcEEEeecccccccCCCCcc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      +++|.+++........+++..+..++.||+.||.|||+.+   |+||||||+||+++. ++.+||+|||++........ 
T Consensus       103 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-  178 (295)
T 2clq_A          103 GGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-  178 (295)
T ss_dssp             EEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred             CCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCC-
Confidence            9999999876544556789999999999999999999988   999999999999987 89999999999986643221 


Q ss_pred             cccccccCcCcCchhhhccCC--CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      ......||+.|+|||.+....  ++.++||||||+++|||++|+.|+........   .........         ....
T Consensus       179 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~~~~~---------~~~~  246 (295)
T 2clq_A          179 CTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGMFK---------VHPE  246 (295)
T ss_dssp             --CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH---HHHHHHHHC---------CCCC
T ss_pred             cccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH---HHHhhcccc---------cccc
Confidence            223456899999999997654  88999999999999999999998754322111   111110000         1112


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .+...+..+.+++.+||+.||++||+++++++
T Consensus       247 ~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 IPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             ccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            34456678999999999999999999999985

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=8.8e-41  Score=339.74  Aligned_cols=260  Identities=27%  Similarity=0.378  Sum_probs=209.4

Q ss_pred             hcCccccccccccCceeEEEEEc-----CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC--ce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-----PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP--ES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~  340 (573)
                      .++|+..++||+|+||.||++++     .+|+.||||++........+.+.+|+.++++++||||+++++++....  ..
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            45688999999999999999983     368899999998777677788999999999999999999999887654  67


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++++|.+++...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus       120 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~  194 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKV  194 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhh
Confidence            9999999999999998543  245899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCC---------C--cchHHHHHH
Q 008239          421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN---------S--CSILQTVWD  487 (573)
Q Consensus       421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~---------~--~~~~~~~~~  487 (573)
                      .......  ......++..|+|||.+.+..++.++||||||+++|||++|..|+.....         .  .........
T Consensus       195 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (326)
T 2w1i_A          195 LPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIE  274 (326)
T ss_dssp             CCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHH
T ss_pred             ccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHH
Confidence            6543321  12234567789999999998999999999999999999999887643210         0  000011111


Q ss_pred             HhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          488 LYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       488 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...         .......+...+..+.+++.+||+.+|++|||+.||++.|+.
T Consensus       275 ~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~  319 (326)
T 2w1i_A          275 LLK---------NNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQ  319 (326)
T ss_dssp             HHH---------TTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             Hhh---------cCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            111         111112344567889999999999999999999999999964

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.1e-40  Score=336.34  Aligned_cols=260  Identities=19%  Similarity=0.210  Sum_probs=201.1

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..++||+|+||.||+++.. +++.||||++...   .....+.+.+|+.++++++||||+++++++......++|
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv  112 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD  112 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence            478999999999999999999975 6889999998654   233457889999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++...   ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          113 MRLINGVDLAAMLRRQ---GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EECCCCEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEecCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            9999999999988543   35899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ..........|++.|+|||.+.+..++.++||||||+++|||++|+.|+.....     ......... ...   .+   
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~~~~-~~~---~~---  254 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQL-----SVMGAHINQ-AIP---RP---  254 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH-----HHHHHHHHS-CCC---CG---
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH-----HHHHHHhcc-CCC---Cc---
Confidence            433333455789999999999999999999999999999999999998754321     111111111 110   00   


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCC-CHHHHHHHhccCCCC
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRP-SMSIVVKMLTGNHEI  545 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~~~~~~  545 (573)
                      .......+..+.+++.+||+.||++|| +++++++.|+.....
T Consensus       255 ~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~  297 (309)
T 2h34_A          255 STVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALAT  297 (309)
T ss_dssp             GGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC-
T ss_pred             cccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHh
Confidence            112334566789999999999999999 999999999765444

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.9e-41  Score=341.35  Aligned_cols=261  Identities=26%  Similarity=0.379  Sum_probs=195.7

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHH--HHcCCCCCCeeeeeeeee-----cCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVN--LISGINHKNLVKLLGCSI-----TGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~--~l~~l~h~niv~l~~~~~-----~~~~~  340 (573)
                      .++|+..++||+|+||+||+|+. +++.||||++.....   +.+..|.+  .+..++||||+++++.+.     .....
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccch---hhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            46799999999999999999987 589999999864432   33444444  455689999999998543     23356


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc---------CCCCeEEecCCCCCeeeCCCCcEE
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE---------SKLRIIHRDIKLSNILLDEEFTAK  411 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~---------~~~~iiHrDlk~~NIll~~~~~~k  411 (573)
                      ++||||+++|+|.+++...    ..++..++.++.||+.||+|||+.         +   |+||||||+|||++.++.+|
T Consensus        88 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~k  160 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCV  160 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEE
T ss_pred             EEEEecCCCCcHHHHHhhc----ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEE
Confidence            8999999999999998432    358899999999999999999998         6   99999999999999999999


Q ss_pred             EeecccccccCCCC-------cccccccccCcCcCchhhhcc-------CCCCcccchHhHHHHHHHHHcCCCCCCCCCC
Q 008239          412 IADFGLVRLFPEDI-------THISATLAGTLGYMAPEYVVR-------GKLTEKADVYSFGVVVIEVVCRKRINLFTQN  477 (573)
Q Consensus       412 l~Dfgla~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGvil~elltg~~p~~~~~~  477 (573)
                      |+|||+++.+....       ........||+.|+|||++.+       ..++.++||||||+++|||++|+.|+.....
T Consensus       161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~  240 (336)
T 3g2f_A          161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGES  240 (336)
T ss_dssp             ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSC
T ss_pred             EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccc
Confidence            99999998764322       112224568999999999976       4566789999999999999999888765433


Q ss_pred             Ccch-------------HHHHHHHhhcCccccccCccccCC--CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          478 SCSI-------------LQTVWDLYVKGRLHEAVDPALAGN--FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       478 ~~~~-------------~~~~~~~~~~~~~~~~~d~~l~~~--~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ....             .............    .+.+...  .....+..+.+|+.+||+.||++|||++|+++.|+..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          241 VPEYQMAFQTEVGNHPTFEDMQVLVSREKQ----RPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCCCCTTHHHHCSSCCHHHHHHHHTTSCC----CCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhHHHHhhhcccCCCchHHHHHhhhccccc----CCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            2111             1111111111111    1111111  1223667899999999999999999999999999664


Q ss_pred             C
Q 008239          543 H  543 (573)
Q Consensus       543 ~  543 (573)
                      .
T Consensus       317 l  317 (336)
T 3g2f_A          317 M  317 (336)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-40  Score=342.60  Aligned_cols=272  Identities=22%  Similarity=0.244  Sum_probs=210.7

Q ss_pred             CccccChHHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCC-----CCCee
Q 008239          255 SKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----HKNLV  328 (573)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv  328 (573)
                      ....+++.+.....++|+..++||+|+||+||+++.. +++.||||++... ....+.+..|+.+++.++     ||||+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv   99 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIV   99 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBC
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCee
Confidence            3445666777777889999999999999999999974 6889999998643 344566778999998886     99999


Q ss_pred             eeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC--
Q 008239          329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--  406 (573)
Q Consensus       329 ~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~--  406 (573)
                      ++++++......++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.  
T Consensus       100 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~  174 (360)
T 3llt_A          100 KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN-YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPY  174 (360)
T ss_dssp             CEEEEEEETTEEEEEECCC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTT
T ss_pred             cccceeeECCeeEEEEcCC-CCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEcccc
Confidence            9999999999999999999 999999886433 345899999999999999999999988   999999999999975  


Q ss_pred             -----------------------CCcEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHH
Q 008239          407 -----------------------EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVI  463 (573)
Q Consensus       407 -----------------------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~  463 (573)
                                             ++.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~  250 (360)
T 3llt_A          175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLA  250 (360)
T ss_dssp             CCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred             ccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHH
Confidence                                   789999999999865432    23457899999999999999999999999999999


Q ss_pred             HHHcCCCCCCCCCCCcchHHHHHHHhh-----------cCccccccC-ccccCCCC--------------------CchH
Q 008239          464 EVVCRKRINLFTQNSCSILQTVWDLYV-----------KGRLHEAVD-PALAGNFQ--------------------EGKP  511 (573)
Q Consensus       464 elltg~~p~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~d-~~l~~~~~--------------------~~~~  511 (573)
                      ||++|+.|+...... .....+.....           .......++ ..+....+                    ....
T Consensus       251 ell~g~~pf~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (360)
T 3llt_A          251 ELYTGSLLFRTHEHM-EHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKH  329 (360)
T ss_dssp             HHHHSSCSCCCSSHH-HHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCC
T ss_pred             HHHHCCCCCCCCcHH-HHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchH
Confidence            999999988653321 11111111100           000000000 00000000                    0112


Q ss_pred             HHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          512 SRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       512 ~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+.+|+.+||+.||++|||++|+++
T Consensus       330 ~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          330 ELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            56789999999999999999999985

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.3e-40  Score=329.75  Aligned_cols=252  Identities=26%  Similarity=0.330  Sum_probs=206.3

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|+..+.||+|+||.||+++.. +++.||||++... .....+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            467899999999999999999975 6899999998643 33445788999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++..   ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            9999999998843   345899999999999999999999988   9999999999999999999999999998654322


Q ss_pred             c-ccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          426 T-HISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       426 ~-~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      . .......||+.|+|||.+.+..+ +.++||||||+++|||++|+.|+...........    .+......        
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~----~~~~~~~~--------  227 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS----DWKEKKTY--------  227 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHH----HHHTTCTT--------
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHH----Hhhhcccc--------
Confidence            1 22335678999999999987665 7799999999999999999999866543322111    11111100        


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .......+..+.+++.+||+.||++|||++|+++
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            0111234667889999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.6e-41  Score=340.78  Aligned_cols=255  Identities=25%  Similarity=0.334  Sum_probs=203.1

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCE--EEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEA--VAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~--vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++|+..+.||+|+||.||+++.. ++..  +|||++... .....+.+.+|+++++++ +||||+++++++.+....++|
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  104 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA  104 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence            67889999999999999999875 4554  499988653 333456788999999999 899999999999999999999


Q ss_pred             EEeccCCCccccccccC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcE
Q 008239          344 YEFVPNQSLLDNLFVRQ-------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA  410 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~  410 (573)
                      |||+++++|.+++....             ....+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+
T Consensus       105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~  181 (327)
T 1fvr_A          105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  181 (327)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence            99999999999986432             2346899999999999999999999988   9999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHh
Q 008239          411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLY  489 (573)
Q Consensus       411 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  489 (573)
                      ||+|||+++....  ........+++.|+|||.+....++.++||||||+++|||++ |+.|+.....     .......
T Consensus       182 kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~-----~~~~~~~  254 (327)
T 1fvr_A          182 KIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC-----AELYEKL  254 (327)
T ss_dssp             EECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCH-----HHHHHHG
T ss_pred             EEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcH-----HHHHHHh
Confidence            9999999874322  112223456889999999998899999999999999999998 8887644321     1111222


Q ss_pred             hcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       490 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ..+         .....+...+..+.+++.+||+.+|++|||++|+++.|+..
T Consensus       255 ~~~---------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          255 PQG---------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             GGT---------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcC---------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            211         11122345667899999999999999999999999998543

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.4e-40  Score=330.20  Aligned_cols=249  Identities=25%  Similarity=0.321  Sum_probs=185.2

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++....   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            35789999999999999999987 478999999986432   22346788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~  164 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM  164 (278)
T ss_dssp             EECCTTEEHHHHHHTC--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             EecCCCCcHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence            9999999999988532  356899999999999999999999988   99999999999999999999999999987643


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+........+             .......  
T Consensus       165 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------------~~~~~~~--  228 (278)
T 3cok_A          165 PHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------------NKVVLAD--  228 (278)
T ss_dssp             ----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------------CCSSC--
T ss_pred             CCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------------HHHhhcc--
Confidence            222 223456899999999999989999999999999999999999987654322110             0011111  


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ...+...+..+.+++.+||+.||++||+++++++
T Consensus       229 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          229 YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence            1123445678899999999999999999999986

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=8.5e-41  Score=341.04  Aligned_cols=243  Identities=23%  Similarity=0.277  Sum_probs=203.1

Q ss_pred             HhcCccccccccccCceeEEEEEc-CCCCEEEEEEecccCh--------hhHHHHHHHHHHHcCCCCCCeeeeeeeeecC
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT--------QWVDHFFNEVNLISGINHKNLVKLLGCSITG  337 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  337 (573)
                      ..++|+..++||+|+||+||+|+. .+++.||||++.....        ...+.+.+|+.++++++||||+++++++.+.
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999986 4688999999865421        1234567899999999999999999999999


Q ss_pred             CceeEEEEeccCC-CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          338 PESLLVYEFVPNQ-SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       338 ~~~~lv~e~~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                      ...++||||+..| +|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence            9999999999777 99888843   345899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH  495 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  495 (573)
                      ++........  .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.|+.....                  
T Consensus       176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------------------  235 (335)
T 3dls_A          176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------------------  235 (335)
T ss_dssp             TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------------------
T ss_pred             cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------------------
Confidence            9987654322  234578999999999988776 8899999999999999999998753211                  


Q ss_pred             cccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       496 ~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       ......  ..+...+..+.+++.+||+.+|++|||++++++.
T Consensus       236 -~~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          236 -TVEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             -GTTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             -HHhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             011111  1133356789999999999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=6.7e-40  Score=352.47  Aligned_cols=255  Identities=20%  Similarity=0.265  Sum_probs=209.6

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..++||+|+||.||+++.. +|+.||||++....   ....+.+.+|+.++++++||||+++++++......++|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            367889999999999999999975 68999999996532   23356788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          344 YEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      |||+++|+|.+++.... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            99999999999886533 2456999999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      .... ......||+.|+|||++.+..++.++|||||||++|||++|+.|+......... ..+......+.         
T Consensus       341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~-~~~~~~i~~~~---------  409 (543)
T 3c4z_A          341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQRVLEQA---------  409 (543)
T ss_dssp             TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH-HHHHHHHHHCC---------
T ss_pred             CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH-HHHHHHHhhcc---------
Confidence            4322 223458999999999999999999999999999999999999998765432222 12222222211         


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSM-----SIVVK  537 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~-----~evl~  537 (573)
                       ..++...+..+.+++.+||+.||++||++     ++|++
T Consensus       410 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~  448 (543)
T 3c4z_A          410 -VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRT  448 (543)
T ss_dssp             -CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHT
T ss_pred             -cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHc
Confidence             12344567788999999999999999975     66664

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=334.05  Aligned_cols=263  Identities=26%  Similarity=0.326  Sum_probs=200.2

Q ss_pred             HhcCccccccccccCceeEEEEEc-CCCCEEEEEEecccC-----hhhHHHHHHHHHHHcCCC---CCCeeeeeeeeecC
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT-----TQWVDHFFNEVNLISGIN---HKNLVKLLGCSITG  337 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~  337 (573)
                      ..++|+..++||+|+||+||+|+. .+|+.||||++....     ......+.+|+.++++++   ||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999997 468999999986432     122345667777777664   99999999998876


Q ss_pred             C-----ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEE
Q 008239          338 P-----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI  412 (573)
Q Consensus       338 ~-----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl  412 (573)
                      .     ..++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl  161 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAP-PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL  161 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence            5     4789999997 59998885433 234899999999999999999999998   999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC
Q 008239          413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG  492 (573)
Q Consensus       413 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  492 (573)
                      +|||+++......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... .....+.......
T Consensus       162 ~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~  238 (308)
T 3g33_A          162 ADFGLARIYSYQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA-DQLGKIFDLIGLP  238 (308)
T ss_dssp             CSCSCTTTSTTCC--CSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH-HHHHHHHHHHCCC
T ss_pred             eeCccccccCCCc--ccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCC
Confidence            9999998664332  234567899999999999999999999999999999999999987554322 2222222221111


Q ss_pred             c---cccc---cCcccc-------CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          493 R---LHEA---VDPALA-------GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       493 ~---~~~~---~d~~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .   +...   ....+.       .....+.+..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            0   0000   000000       0112345678899999999999999999999986

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.7e-40  Score=358.03  Aligned_cols=254  Identities=24%  Similarity=0.261  Sum_probs=210.1

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..++||+|+||.||+++.. +|+.||||++...   .......+.+|+.+|+.++||||+++++++.+....++|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            467999999999999999999975 6899999999653   223356788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++|+|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       263 mEy~~gg~L~~~l~~~~-~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMG-QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             ECCCCSCBHHHHHHSSS-SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEcCCCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            99999999999886433 345899999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ...  .....||+.|+|||++.+..++.++|||||||++|||++|+.|+......... ..+........          
T Consensus       339 ~~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~-~~i~~~i~~~~----------  405 (576)
T 2acx_A          339 GQT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR-EEVERLVKEVP----------  405 (576)
T ss_dssp             TCC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH-HHHHHHHHHCC----------
T ss_pred             Ccc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH-HHHHHHhhccc----------
Confidence            322  23457999999999999999999999999999999999999998754432211 12222222111          


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      ..++...+..+.+|+.+||+.||++||     +++||++.
T Consensus       406 ~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          406 EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            123345567899999999999999999     78888864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.3e-41  Score=338.17  Aligned_cols=262  Identities=22%  Similarity=0.330  Sum_probs=200.6

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ..+|+..+.||+|+||.||++.. .+|+.||||++...   .....+.+.+|+.++++++||||+++++++......++|
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv  110 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV  110 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence            45799999999999999999986 47899999998652   344567789999999999999999999999999999999


Q ss_pred             EEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          344 YEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      |||+++++|.+++... .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus       111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            9999999999988542 23456899999999999999999999988   9999999999999999999999999988654


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      .... ......+++.|+|||.+.+..++.++||||||+++|||++|+.|+......  ... ............      
T Consensus       188 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~-~~~~~~~~~~~~------  257 (310)
T 2wqm_A          188 SKTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN--LYS-LCKKIEQCDYPP------  257 (310)
T ss_dssp             ------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC--HHH-HHHHHHTTCSCC------
T ss_pred             CCCc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh--HHH-HHHHhhcccCCC------
Confidence            3322 223456899999999999999999999999999999999999987543221  111 111112211111      


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCC
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE  544 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~  544 (573)
                        ......+..+.+++.+||+.||++|||+++|+++|+...+
T Consensus       258 --~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          258 --LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             --CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence              1123456789999999999999999999999999966543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=2.4e-40  Score=334.81  Aligned_cols=258  Identities=21%  Similarity=0.237  Sum_probs=199.9

Q ss_pred             cCcccc-ccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHES-NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      +.|++. ++||+|+||+||+++.. +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus        12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   91 (316)
T 2ac3_A           12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE   91 (316)
T ss_dssp             TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence            567764 78999999999999964 6899999999776666677899999999885 79999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc---EEEeecccccccC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFGLVRLFP  422 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~---~kl~Dfgla~~~~  422 (573)
                      |+++++|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.   +||+|||++....
T Consensus        92 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           92 KMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             cCCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            99999999998643   35899999999999999999999998   999999999999998765   9999999988653


Q ss_pred             CCCc------ccccccccCcCcCchhhhcc-----CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcc----------h
Q 008239          423 EDIT------HISATLAGTLGYMAPEYVVR-----GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS----------I  481 (573)
Q Consensus       423 ~~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~----------~  481 (573)
                      ....      .......||+.|+|||.+..     ..++.++||||||+++|||++|+.|+........          .
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            2211      11224468999999999875     5688999999999999999999999865432210          0


Q ss_pred             HHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          482 LQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       482 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..........+... . ....    ....+..+.+++.+||+.||++|||++|+++.
T Consensus       246 ~~~~~~~i~~~~~~-~-~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          246 QNMLFESIQEGKYE-F-PDKD----WAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHHHHHCCCC-C-CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHhccCcc-c-Cchh----cccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence            11112222222110 0 0000    01245678999999999999999999999984

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.6e-40  Score=335.35  Aligned_cols=262  Identities=20%  Similarity=0.278  Sum_probs=199.6

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|+..++||+|+||+||+++.. +|+.||||++....  ....+.+.+|+.++++++||||+++++++......++|||
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            57899999999999999999975 58999999986543  3345678899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++..   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            9999999887743   345899999999999999999999998   9999999999999999999999999998765332


Q ss_pred             cccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH-----------HhhcCc
Q 008239          426 THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD-----------LYVKGR  493 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-----------~~~~~~  493 (573)
                      . ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+......... ..+..           .+....
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  234 (311)
T 4agu_A          157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL-YLIRKTLGDLIPRHQQVFSTNQ  234 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH-HHHHHHHCSCCHHHHHHHHTCG
T ss_pred             c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhccccccccccccccc
Confidence            2 2234568999999999976 67899999999999999999999887554322111 11111           111111


Q ss_pred             ccc---ccCccccC---CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          494 LHE---AVDPALAG---NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       494 ~~~---~~d~~l~~---~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...   ..++.-..   ......+..+.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          235 YFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000   00000000   0012346678999999999999999999999964

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.9e-41  Score=339.78  Aligned_cols=261  Identities=21%  Similarity=0.260  Sum_probs=195.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChh-hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..++||+|+||+||+|+.. +++.||||++...... ....+.+|+.+++.++||||+++++++......++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57889999999999999999975 6899999998654322 122455799999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      ++ |+|.+++...  ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  155 (324)
T 3mtl_A           82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK  155 (324)
T ss_dssp             CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-----
T ss_pred             cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcc
Confidence            97 5888887543  245899999999999999999999988   99999999999999999999999999986543222


Q ss_pred             ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC---ccccccCc--
Q 008239          427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG---RLHEAVDP--  500 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~d~--  500 (573)
                       ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .....+.......   .+......  
T Consensus       156 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (324)
T 3mtl_A          156 -TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE-EQLHFIFRILGTPTEETWPGILSNEE  233 (324)
T ss_dssp             --------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGCHH
T ss_pred             -ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCChHhchhhhcchh
Confidence             2234567999999999876 57899999999999999999999887553322 2222222221111   00000000  


Q ss_pred             -------ccc----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          501 -------ALA----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       501 -------~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                             ...    .......+..+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          234 FKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence                   000    0011234567889999999999999999999997

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-40  Score=331.45  Aligned_cols=248  Identities=26%  Similarity=0.375  Sum_probs=204.7

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec---------
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT---------  336 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---------  336 (573)
                      ...+|+..+.||+|+||.||+++.. +|+.||||++.....    .+.+|++++++++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            4567999999999999999999986 789999999976542    46689999999999999999998754         


Q ss_pred             -------CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc
Q 008239          337 -------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT  409 (573)
Q Consensus       337 -------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~  409 (573)
                             ....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~  160 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR-GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ  160 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG-GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence                   345789999999999999985432 346899999999999999999999988   999999999999999999


Q ss_pred             EEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh
Q 008239          410 AKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY  489 (573)
Q Consensus       410 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  489 (573)
                      +||+|||++........  .....+|+.|+|||.+.+..++.++||||||+++|||++|..|+...       ...+...
T Consensus       161 ~kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-------~~~~~~~  231 (284)
T 2a19_B          161 VKIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-------SKFFTDL  231 (284)
T ss_dssp             EEECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-------HHHHHHH
T ss_pred             EEECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-------HHHHHHh
Confidence            99999999987654322  23456899999999999999999999999999999999998775321       1111111


Q ss_pred             hcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       490 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      ..+.            .+...+..+.+++.+||+.||++|||+.|+++.|....
T Consensus       232 ~~~~------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          232 RDGI------------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HTTC------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             hccc------------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            1111            22334567889999999999999999999999996543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=4.4e-40  Score=326.40  Aligned_cols=251  Identities=20%  Similarity=0.258  Sum_probs=205.4

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ..++|+..++||+|+||+||+|... ++..||+|++........+.+.+|++++++++||||+++++++.+....++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            3467999999999999999999976 477999999977655667889999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee---CCCCcEEEeecccccccC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~~  422 (573)
                      |+++++|.+++...   ..+++..++.++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++....
T Consensus        87 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~  160 (277)
T 3f3z_A           87 LCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK  160 (277)
T ss_dssp             CCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             ccCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence            99999999888543   35899999999999999999999998   9999999999999   788999999999998765


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ...  ......||+.|+|||.+.+ .++.++||||||+++|||++|+.|+......     ........+....  ... 
T Consensus       161 ~~~--~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-----~~~~~~~~~~~~~--~~~-  229 (277)
T 3f3z_A          161 PGK--MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDS-----EVMLKIREGTFTF--PEK-  229 (277)
T ss_dssp             TTS--CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCCCC--CHH-
T ss_pred             Ccc--chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhCCCCC--Cch-
Confidence            432  2234568999999998865 4899999999999999999999987543321     1111122221100  000 


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                         .....+..+.+++.+||+.+|++|||+.++++
T Consensus       230 ---~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          230 ---DWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             ---HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ---hhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               00134568899999999999999999999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=9.3e-41  Score=332.60  Aligned_cols=247  Identities=24%  Similarity=0.322  Sum_probs=202.4

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~l  342 (573)
                      ..++|+..+.||+|+||+||+++.. +++.||||++...  .......+.+|+..+..+ +||||+++++++.+....++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            3467999999999999999999976 7899999998754  233456788999999999 99999999999999999999


Q ss_pred             EEEeccCCCccccccccCC-CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---------------
Q 008239          343 VYEFVPNQSLLDNLFVRQD-VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---------------  406 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---------------  406 (573)
                      ||||+++++|.+++..... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.               
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999864321 256899999999999999999999998   999999999999984               


Q ss_pred             ----CCcEEEeecccccccCCCCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcch
Q 008239          407 ----EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSI  481 (573)
Q Consensus       407 ----~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~  481 (573)
                          ...+||+|||++.......     ...||+.|+|||.+.+. .++.++||||||+++|||++|..++....     
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~-----  235 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD-----  235 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH-----
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh-----
Confidence                4479999999998765432     23589999999999776 66789999999999999999987653221     


Q ss_pred             HHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          482 LQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       482 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                         .+.....+..         ...+...+..+.+++.+||+.||++|||+.|+++.
T Consensus       236 ---~~~~~~~~~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          236 ---QWHEIRQGRL---------PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             ---HHHHHHTTCC---------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ---HHHHHHcCCC---------CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence               1112222221         12344566789999999999999999999999863

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.4e-40  Score=343.66  Aligned_cols=245  Identities=22%  Similarity=0.246  Sum_probs=193.9

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHH-HcCCCCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNL-ISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..+.||+|+||.||+++.. +++.||||++....   ......+.+|..+ ++.++||||+++++++.+....++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            367999999999999999999976 58899999996542   2234456677776 577899999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++...
T Consensus       117 v~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~  190 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI  190 (373)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred             EEeCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence            99999999999988543   35889999999999999999999988   9999999999999999999999999998643


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ... .......||+.|+|||++.+..++.++||||||+++|||++|+.|+.....     .........+..        
T Consensus       191 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~-----~~~~~~i~~~~~--------  256 (373)
T 2r5t_A          191 EHN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT-----AEMYDNILNKPL--------  256 (373)
T ss_dssp             CCC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH-----HHHHHHHHHSCC--------
T ss_pred             cCC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhccc--------
Confidence            222 223456899999999999999999999999999999999999999854321     111222222111        


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSI  534 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~e  534 (573)
                        .++...+..+.+|+.+||+.||++||++.+
T Consensus       257 --~~~~~~~~~~~~li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          257 --QLKPNITNSARHLLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             --CCCSSSCHHHHHHHHHHTCSSGGGSTTTTT
T ss_pred             --CCCCCCCHHHHHHHHHHcccCHHhCCCCCC
Confidence              123445678899999999999999999853

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.4e-40  Score=337.41  Aligned_cols=252  Identities=22%  Similarity=0.261  Sum_probs=206.3

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChh------hHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQ------WVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      .++|+..+.||+|+||.||+++.. +|+.||||++......      ..+.+.+|+.++++++||||+++++++.+....
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            467899999999999999999975 6899999998654321      356789999999999999999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC----cEEEeecc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG  416 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfg  416 (573)
                      ++||||+++++|.+++..   ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg  164 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (321)
T ss_dssp             EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred             EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence            999999999999999853   346899999999999999999999988   99999999999999887    79999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      ++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......     ...........  
T Consensus       165 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~i~~~~~--  235 (321)
T 2a2a_A          165 LAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ-----ETLANITSVSY--  235 (321)
T ss_dssp             TCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHH-----HHHHHHHTTCC--
T ss_pred             cceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHH-----HHHHHHHhccc--
Confidence            998765432  223456899999999999999999999999999999999999987543221     11111111111  


Q ss_pred             ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       497 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..++.+    ....+..+.+++.+||+.||++|||++|+++.
T Consensus       236 ~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          236 DFDEEF----FSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CCCHHH----HTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             ccChhh----hcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            011111    12345678999999999999999999999973

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-40  Score=330.09  Aligned_cols=252  Identities=20%  Similarity=0.285  Sum_probs=206.3

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .++|+..++||+|+||.||++... +|+.||+|++...  .....+.+.+|+.++++++||||+++++++......++||
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   84 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF   84 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence            478999999999999999999875 5899999998654  3344577889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc---EEEeeccccccc
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFGLVRLF  421 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~---~kl~Dfgla~~~  421 (573)
                      ||+++++|.+.+...   ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.   +||+|||++...
T Consensus        85 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           85 DLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             CCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            999999998888543   35899999999999999999999998   999999999999986655   999999999866


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      .....  .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+......     ........+....     
T Consensus       159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~-----~~~~~~~~~~~~~-----  226 (284)
T 3kk8_A          159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH-----RLYAQIKAGAYDY-----  226 (284)
T ss_dssp             CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHTCCCC-----
T ss_pred             ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchh-----HHHHHHHhccccC-----
Confidence            43322  23457899999999999999999999999999999999999997543221     1111222221110     


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       ........+..+.+++.+||+.+|++|||++|+++.
T Consensus       227 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          227 -PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             -CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -CchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence             011123456788999999999999999999999973

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=7.4e-41  Score=334.60  Aligned_cols=253  Identities=25%  Similarity=0.357  Sum_probs=203.6

Q ss_pred             hcCccccc-cccccCceeEEEEEc---CCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          268 TNYFHESN-KLGQGGSGSVYKGTL---PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       268 ~~~~~~~~-~lg~G~~g~Vy~~~~---~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      .++|...+ .||+|+||+||+|.+   .+++.||||++....  ....+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~   93 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM   93 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence            45677777 999999999999964   246889999996542  33467899999999999999999999998 567789


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+++++|.+++...   ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~  167 (291)
T 1xbb_A           94 LVMEMAELGPLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL  167 (291)
T ss_dssp             EEEECCTTEEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred             EEEEeCCCCCHHHHHHhC---cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence            999999999999998543   45899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCccc--ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          422 PEDITHI--SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       422 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      .......  .....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+.....     .........+..    
T Consensus       168 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~-----~~~~~~~~~~~~----  238 (291)
T 1xbb_A          168 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGER----  238 (291)
T ss_dssp             CTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTCC----
T ss_pred             ccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCC----
Confidence            5433221  223346788999999998899999999999999999999 8887654321     112222222211    


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                           ...+...+..+.+++.+||+.||++||++.++++.|+.
T Consensus       239 -----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  276 (291)
T 1xbb_A          239 -----MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  276 (291)
T ss_dssp             -----CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                 12344567789999999999999999999999999954

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=9.3e-41  Score=347.95  Aligned_cols=264  Identities=26%  Similarity=0.342  Sum_probs=192.9

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCC--c
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGP--E  339 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--~  339 (573)
                      ...++|+..++||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            34578999999999999999999864 6899999998543  3444567889999999997 999999999987544  6


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++||||++ ++|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~  157 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR  157 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence            899999997 688888743    35899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCC--------------------CcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCC
Q 008239          420 LFPED--------------------ITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNS  478 (573)
Q Consensus       420 ~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~  478 (573)
                      .+...                    .........||+.|+|||++.+ ..++.++|||||||++|||++|+.|+......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                    1112234579999999999976 67999999999999999999999887543321


Q ss_pred             cchHHHHHHHhhcCccccc---c------------------Ccccc------------CCCCCchHHHHHHHHHHccCCC
Q 008239          479 CSILQTVWDLYVKGRLHEA---V------------------DPALA------------GNFQEGKPSRLLQIGLLCVQAS  525 (573)
Q Consensus       479 ~~~~~~~~~~~~~~~~~~~---~------------------d~~l~------------~~~~~~~~~~l~~l~~~cl~~~  525 (573)
                       .....+...........+   .                  .....            .......+..+.+|+.+||+.|
T Consensus       238 -~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          238 -NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             -HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             -HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence             111111111100000000   0                  00000            0011234567899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 008239          526 AELRPSMSIVVKM  538 (573)
Q Consensus       526 p~~RPt~~evl~~  538 (573)
                      |++|||++|+++.
T Consensus       317 P~~R~t~~e~l~H  329 (388)
T 3oz6_A          317 PNKRISANDALKH  329 (388)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999975

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.7e-41  Score=370.27  Aligned_cols=246  Identities=26%  Similarity=0.365  Sum_probs=198.1

Q ss_pred             ccccccCceeEEEEEcC---CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ++||+|+||+||+|.+.   .++.||||++....  ....+++.+|+.+|++++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            47999999999999653   46789999997543  3446789999999999999999999999864 568899999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc--c
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT--H  427 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~--~  427 (573)
                      |+|.+++..   ...+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+.....  .
T Consensus       454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            999999853   245899999999999999999999988   99999999999999999999999999987654332  1


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......+|+.|+|||++....++.++||||||++||||++ |+.|+.....     ..+......+.         ....
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~-----~~~~~~i~~~~---------~~~~  593 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG-----SEVTAMLEKGE---------RMGC  593 (635)
T ss_dssp             -------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-----HHHHHHHHTTC---------CCCC
T ss_pred             cccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH-----HHHHHHHHcCC---------CCCC
Confidence            2233456789999999999999999999999999999998 8888754322     11222222221         1223


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      +...+..+.+|+.+||+.||++||++++|+++|+.
T Consensus       594 p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          594 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            45567889999999999999999999999999954

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.1e-40  Score=339.13  Aligned_cols=258  Identities=28%  Similarity=0.358  Sum_probs=204.2

Q ss_pred             HhcCccccccccccCceeEEEEEc------CCCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE  339 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  339 (573)
                      ..++|+..+.||+|+||.||+|++      .+++.||||++... .......+.+|+.++++++||||+++++++.....
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  107 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCC
Confidence            357899999999999999999984      24778999999654 34456678999999999999999999999999999


Q ss_pred             eeEEEEeccCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---CCcEEE
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKI  412 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl  412 (573)
                      .++||||+++++|.+++.....    ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   +..+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl  184 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  184 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEE
Confidence            9999999999999999865432    245899999999999999999999988   999999999999984   456999


Q ss_pred             eecccccccCCCC-cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhh
Q 008239          413 ADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYV  490 (573)
Q Consensus       413 ~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  490 (573)
                      +|||++....... ........+|+.|+|||.+.+..++.++||||||+++|||++ |+.|+.....     ........
T Consensus       185 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~-----~~~~~~~~  259 (327)
T 2yfx_A          185 GDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN-----QEVLEFVT  259 (327)
T ss_dssp             CCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH-----HHHHHHHH
T ss_pred             CccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH-----HHHHHHHh
Confidence            9999998543322 122334567899999999999999999999999999999998 7766543221     11112222


Q ss_pred             cCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          491 KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       491 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .+..         ...+...+..+.+++.+||+.+|.+||++.++++.|..
T Consensus       260 ~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          260 SGGR---------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             TTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCC---------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            2111         12234456789999999999999999999999999954

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=7.2e-41  Score=332.33  Aligned_cols=249  Identities=27%  Similarity=0.398  Sum_probs=197.3

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-CceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-PESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  346 (573)
                      .++|+..+.||+|+||+||+++.. |+.||||++....  ..+.+.+|+.++++++||||+++++++... ...++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            467899999999999999999875 8899999986543  456789999999999999999999987654 478999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++++|.+++.... ...+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++....... 
T Consensus        97 ~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-  171 (278)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             CCCCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccc-
Confidence            99999999885432 123789999999999999999999988   9999999999999999999999999988554321 


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                         ....+++.|+|||.+.+..++.++||||||+++|||++ |+.|+..... .....    ....+         ....
T Consensus       172 ---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~-~~~~~----~~~~~---------~~~~  234 (278)
T 1byg_A          172 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL-KDVVP----RVEKG---------YKMD  234 (278)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG-GGHHH----HHTTT---------CCCC
T ss_pred             ---cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH-HHHHH----HHhcC---------CCCC
Confidence               23356889999999999999999999999999999998 8777654322 12111    11111         1122


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .+...+..+.+++.+||+.+|++||++.|+++.|+.
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~  270 (278)
T 1byg_A          235 APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  270 (278)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHH
Confidence            344567789999999999999999999999999954

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.5e-40  Score=332.65  Aligned_cols=250  Identities=26%  Similarity=0.392  Sum_probs=207.6

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .+.|+..++||+|+||.||+|+.. +++.||||++.... ....+.+.+|+.+++.++||||+++++++......++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  100 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME  100 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence            356899999999999999999864 68999999986543 3446788999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++.    ...+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.......
T Consensus       101 ~~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  173 (303)
T 3a7i_A          101 YLGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  173 (303)
T ss_dssp             CCTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB
T ss_pred             eCCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc
Confidence            999999999883    246899999999999999999999998   9999999999999999999999999998765432


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      . ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....    .... .....+.         ...
T Consensus       174 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~-~~~~~~~---------~~~  238 (303)
T 3a7i_A          174 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHP----MKVL-FLIPKNN---------PPT  238 (303)
T ss_dssp             C-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH-HHHHHSC---------CCC
T ss_pred             c-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCH----HHHH-HHhhcCC---------CCC
Confidence            2 22345789999999999999999999999999999999999998754321    1111 1111111         112


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      .....+..+.+++.+||+.+|++|||++|+++..
T Consensus       239 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          239 LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             CccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            2344567899999999999999999999998743

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=8e-41  Score=339.80  Aligned_cols=249  Identities=22%  Similarity=0.261  Sum_probs=181.2

Q ss_pred             cccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeEEEEeccCCC
Q 008239          274 SNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQS  351 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  351 (573)
                      .++||+|+||+||+++.. +|+.||||++...   ....+.+|+.+++.+. ||||+++++++.+....++||||+++|+
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~   92 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE   92 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCc
Confidence            478999999999999975 6899999999543   3456778999999997 9999999999999999999999999999


Q ss_pred             ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC---cEEEeecccccccCCCCccc
Q 008239          352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---TAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       352 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~~kl~Dfgla~~~~~~~~~~  428 (573)
                      |.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++   .+||+|||+++....... .
T Consensus        93 L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~  165 (325)
T 3kn6_A           93 LFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-P  165 (325)
T ss_dssp             HHHHHHHC---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-c
Confidence            99998543   46899999999999999999999988   99999999999997665   899999999986544322 2


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--chHHHHHHHhhcCccccccCccccCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--SILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+.......  ............+...      +....
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~  239 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS------FEGEA  239 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC------CCSHH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC------CCccc
Confidence            334568999999999999999999999999999999999999986543221  1112222222222210      00000


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ....+..+.+|+.+||+.||++|||++|+++.
T Consensus       240 ~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             ccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            12346778999999999999999999999854

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.3e-40  Score=327.05  Aligned_cols=249  Identities=22%  Similarity=0.280  Sum_probs=207.1

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|...+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.+....++|
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv   93 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV   93 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence            467899999999999999999976 5789999998654   234567788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++...   ..+++..++.++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        94 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  167 (294)
T 2rku_A           94 LELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  167 (294)
T ss_dssp             EECCTTCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence            9999999999987543   35899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      ... ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....    .. .......+..         
T Consensus       168 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~----~~-~~~~~~~~~~---------  232 (294)
T 2rku_A          168 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL----KE-TYLRIKKNEY---------  232 (294)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH----HH-HHHHHHTTCC---------
T ss_pred             Ccc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HH-HHHHHhhccC---------
Confidence            222 22345689999999999998999999999999999999999998754321    11 1111111111         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       ..+...+..+.+++.+||+.+|++|||++|+++.
T Consensus       233 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 -SIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             -CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             -CCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence             1233456788999999999999999999999974

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=2.1e-40  Score=348.41  Aligned_cols=254  Identities=21%  Similarity=0.297  Sum_probs=195.3

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--------hhhHHHHHHHHHHHcCCCCCCeeeeeeeeec
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGINHKNLVKLLGCSIT  336 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~  336 (573)
                      ...++|...++||+|+||+||+|... +++.||||++....        ......+.+|+.+|++++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            45678999999999999999999875 58999999986532        112235789999999999999999999975 


Q ss_pred             CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC---CcEEEe
Q 008239          337 GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIA  413 (573)
Q Consensus       337 ~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~---~~~kl~  413 (573)
                      .+..++||||+++|+|.+++..   ...+++..++.++.||+.||+|||+++   |+||||||+|||++.+   +.+||+
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence            4558999999999999998843   346899999999999999999999988   9999999999999754   459999


Q ss_pred             ecccccccCCCCcccccccccCcCcCchhhhcc---CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh
Q 008239          414 DFGLVRLFPEDITHISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV  490 (573)
Q Consensus       414 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  490 (573)
                      |||+++.....  .......||+.|+|||++..   ..++.++||||||+++|||++|+.|+........+...+    .
T Consensus       285 DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i----~  358 (419)
T 3i6u_A          285 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----T  358 (419)
T ss_dssp             CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHH----H
T ss_pred             ecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHH----h
Confidence            99999876432  22345679999999999853   678889999999999999999999986544433332222    1


Q ss_pred             cCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          491 KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       491 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+....  .+..    ....+..+.+++.+||+.||++|||++|+++.
T Consensus       359 ~~~~~~--~~~~----~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          359 SGKYNF--IPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             TTCCCC--CHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cCCCCC--Cchh----hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            111100  0111    12345678999999999999999999999973

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=5.6e-41  Score=344.97  Aligned_cols=261  Identities=16%  Similarity=0.182  Sum_probs=204.9

Q ss_pred             hcCccccccccccCceeEEEEEcCC---------CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeee---------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG---------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK---------  329 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  329 (573)
                      .++|+..+.||+|+||.||+|+...         ++.||||++...     +.+.+|++++++++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3689999999999999999999763         789999998644     35788999999999999998         


Q ss_pred             ------eeeeeec-CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCe
Q 008239          330 ------LLGCSIT-GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI  402 (573)
Q Consensus       330 ------l~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI  402 (573)
                            +++++.. ....++||||+ +++|.+++... ....+++..++.++.||+.||.|||+++   |+||||||+||
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NI  190 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENI  190 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHE
Confidence                  5666665 67789999999 99999998643 1346999999999999999999999998   99999999999


Q ss_pred             eeCCCC--cEEEeecccccccCCCCcc------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCC
Q 008239          403 LLDEEF--TAKIADFGLVRLFPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLF  474 (573)
Q Consensus       403 ll~~~~--~~kl~Dfgla~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~  474 (573)
                      |++.++  .+||+|||+++.+......      ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+..
T Consensus       191 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  270 (352)
T 2jii_A          191 FVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTN  270 (352)
T ss_dssp             EEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred             EEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999998  9999999999866432211      12345789999999999999999999999999999999999999876


Q ss_pred             CCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          475 TQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       475 ~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ..............+.. ....+.+...   .....+..+.+++.+||+.||++||++++|+++|+..
T Consensus       271 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          271 CLPNTEDIMKQKQKFVD-KPGPFVGPCG---HWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             GTTCHHHHHHHHHHHHH-SCCCEECTTS---CEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             CCcCHHHHHHHHHhccC-Chhhhhhhcc---ccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            54332222222221111 1111111111   0123467899999999999999999999999999554

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5e-40  Score=328.95  Aligned_cols=259  Identities=20%  Similarity=0.262  Sum_probs=201.9

Q ss_pred             HhcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeee-ecCCceeEEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS-ITGPESLLVY  344 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~  344 (573)
                      ..++|+..+.||+|+||+||+|+. .+++.||||++.....  .+.+.+|+.+++.++|+|++..++.+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999996 5688999998754332  23578899999999988877777655 5667789999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee---CCCCcEEEeeccccccc
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLF  421 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~  421 (573)
                      ||+ +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++..
T Consensus        85 e~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             ECC-CCBHHHHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             Ecc-CCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence            999 99999988532  235899999999999999999999998   9999999999999   78899999999999876


Q ss_pred             CCCCc------ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--chHHHHHHHhhcCc
Q 008239          422 PEDIT------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--SILQTVWDLYVKGR  493 (573)
Q Consensus       422 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~  493 (573)
                      .....      .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.......  ..............
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch
Confidence            54332      12235678999999999999999999999999999999999999987543322  22222111111100


Q ss_pred             cccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          494 LHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       494 ~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .     +.    .....+..+.+++.+||+.+|++|||+++|+++|+..
T Consensus       239 ~-----~~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          239 I-----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             H-----HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             h-----hh----hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            0     00    1123457899999999999999999999999999543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=2e-40  Score=330.56  Aligned_cols=252  Identities=25%  Similarity=0.282  Sum_probs=198.6

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|...++||+|+||+||+++.. ++..||+|++.... ....+.+.+|++++++++||||+++++++.+....++|||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  100 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME  100 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence            357899999999999999999875 68899999986543 3345788999999999999999999999999999999999


Q ss_pred             eccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee---CCCCcEEEeeccccccc
Q 008239          346 FVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLF  421 (573)
Q Consensus       346 ~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~  421 (573)
                      |+++++|.+++... .....+++..++.++.||+.||+|||+.+   |+||||||+|||+   +.++.+||+|||++...
T Consensus       101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~  177 (285)
T 3is5_A          101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF  177 (285)
T ss_dssp             CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-
T ss_pred             eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceec
Confidence            99999999988543 22356899999999999999999999988   9999999999999   45688999999999865


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ....  ......||+.|+|||.+. +.++.++||||||+++|||++|+.|+......     ...........      .
T Consensus       178 ~~~~--~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~-----~~~~~~~~~~~------~  243 (285)
T 3is5_A          178 KSDE--HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLE-----EVQQKATYKEP------N  243 (285)
T ss_dssp             -----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-----HHHHHHHHCCC------C
T ss_pred             CCcc--cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHH-----HHHhhhccCCc------c
Confidence            4432  233556899999999875 57899999999999999999999987543211     11111111110      0


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .. ......+..+.+++.+||+.||++|||+.|+++
T Consensus       244 ~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          244 YA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             CC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00 011224567889999999999999999999985

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.5e-41  Score=350.84  Aligned_cols=243  Identities=16%  Similarity=0.156  Sum_probs=191.8

Q ss_pred             HhcCccccccccccCceeEEEEEc-CCCCEEEEEEeccc---ChhhHHHHHHHH---HHHcCCCCCCeeeee-------e
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEV---NLISGINHKNLVKLL-------G  332 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~---~~l~~l~h~niv~l~-------~  332 (573)
                      ..++|+..+.||+|+||+||+|+. .+|+.||||++...   .....+.+.+|+   .++++++|||||+++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            357789999999999999999997 46899999999642   344567889999   556666899999998       5


Q ss_pred             eeecCC-----------------ceeEEEEeccCCCccccccccCC----CCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 008239          333 CSITGP-----------------ESLLVYEFVPNQSLLDNLFVRQD----VEPLSWEVRYKIILSTAEGLAYLHEESKLR  391 (573)
Q Consensus       333 ~~~~~~-----------------~~~lv~e~~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  391 (573)
                      ++...+                 ..++||||+ +|+|.+++.....    ...+++..++.++.||+.||+|||+++   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  226 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  226 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence            555443                 278999999 6899999864321    123446888999999999999999998   


Q ss_pred             eEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccC-----------CCCcccchHhHHH
Q 008239          392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-----------KLTEKADVYSFGV  460 (573)
Q Consensus       392 iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~sDvwslGv  460 (573)
                      |+||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++||||||+
T Consensus       227 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~  301 (377)
T 3byv_A          227 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL  301 (377)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHH
T ss_pred             eecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHH
Confidence            99999999999999999999999999986432    2234567 999999999887           8999999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          461 VVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       461 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ++|||++|+.|+.......             ....+..      .....+..+.+|+.+||+.||++|||+.|+++
T Consensus       302 il~elltg~~Pf~~~~~~~-------------~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  359 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALG-------------GSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME  359 (377)
T ss_dssp             HHHHHHHSSCCC------C-------------CSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHT
T ss_pred             HHHHHHHCCCCCccccccc-------------chhhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhh
Confidence            9999999999875432211             1111111      11345678999999999999999999999986

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.5e-40  Score=338.71  Aligned_cols=264  Identities=23%  Similarity=0.355  Sum_probs=200.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .++|+..++||+|+||.||+++.. +|+.||||++....  ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            357889999999999999999976 58999999986543  334566789999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++..   ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||++......
T Consensus       104 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  177 (331)
T 4aaa_A          104 EFVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  177 (331)
T ss_dssp             ECCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             ecCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence            99999988877632   245899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH----------HHHhhcCc
Q 008239          425 ITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV----------WDLYVKGR  493 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~----------~~~~~~~~  493 (573)
                      .. ......||+.|+|||.+.+. .++.++||||||+++|||++|+.|+........+....          +..+....
T Consensus       178 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (331)
T 4aaa_A          178 GE-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNP  256 (331)
T ss_dssp             -------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCG
T ss_pred             cc-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcc
Confidence            22 22345689999999999875 78999999999999999999998876543221111111          11111110


Q ss_pred             c-ccccCccccCC-----CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          494 L-HEAVDPALAGN-----FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       494 ~-~~~~d~~l~~~-----~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      . .....+.+...     .....+..+.+|+.+||+.||++|||++|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            0 00011111100     112346789999999999999999999999863

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.8e-40  Score=328.11  Aligned_cols=258  Identities=20%  Similarity=0.270  Sum_probs=205.3

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeee-ecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS-ITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~lv~e  345 (573)
                      .++|+..+.||+|+||.||+|+. .+|+.||||++.....  .+.+.+|+.+++.++|++++..+..+ ......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46899999999999999999996 5789999999865432  24688999999999998877766655 56677799999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee---CCCCcEEEeecccccccC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~~  422 (573)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||++....
T Consensus        86 ~~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~  159 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC--SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             ec-CCCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence            99 99999988532  245899999999999999999999998   9999999999999   488899999999998765


Q ss_pred             CCCcc------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--chHHHHHHHhhcCcc
Q 008239          423 EDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--SILQTVWDLYVKGRL  494 (573)
Q Consensus       423 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~  494 (573)
                      .....      ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.......  .....+.........
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             ccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            43321      1235678999999999999999999999999999999999999987543221  222222111111000


Q ss_pred             ccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       495 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                           +.    .....+..+.+++.+||+.+|++|||+++|++.|+..
T Consensus       240 -----~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          240 -----EV----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             -----HH----HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             -----HH----HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence                 00    1133457899999999999999999999999999554

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.8e-40  Score=333.38  Aligned_cols=265  Identities=24%  Similarity=0.328  Sum_probs=189.6

Q ss_pred             HHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ....++|+..+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus        11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   90 (303)
T 2vwi_A           11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWL   90 (303)
T ss_dssp             --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEE
T ss_pred             ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEE
Confidence            344678999999999999999999874 68999999886542 3345678899999999999999999999999999999


Q ss_pred             EEEeccCCCcccccccc-----CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          343 VYEFVPNQSLLDNLFVR-----QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~-----~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ||||+++++|.+++...     .....+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        91 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           91 VMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             EehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccc
Confidence            99999999999988531     12456899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCc----ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC
Q 008239          418 VRLFPEDIT----HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG  492 (573)
Q Consensus       418 a~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  492 (573)
                      +........    .......||+.|+|||.+.. ..++.++||||||+++|||++|+.|+..........    .... +
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~----~~~~-~  242 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLM----LTLQ-N  242 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH----HHHT-S
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHH----HHhc-c
Confidence            886543211    11234568999999999876 578999999999999999999999976543321111    1111 1


Q ss_pred             ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       493 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..................+..+.+++.+||+.||++||++.|+++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          243 DPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             SCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            111111111111223445678999999999999999999999986

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.4e-41  Score=332.68  Aligned_cols=258  Identities=23%  Similarity=0.321  Sum_probs=206.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeee--cCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSI--TGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~l  342 (573)
                      .++|+..+.||+|+||.||+++.. +|+.||+|++...  .....+.+.+|+.++++++||||+++++++.  .....++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            467899999999999999999975 6899999999654  3345677899999999999999999999875  4567899


Q ss_pred             EEEeccCCCccccccccC-CCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          343 VYEFVPNQSLLDNLFVRQ-DVEPLSWEVRYKIILSTAEGLAYLHEES--KLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      ||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+  ..+|+||||||+|||++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            999999999999986432 2345899999999999999999999975  2349999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      ....... ......|++.|+|||.+.+..++.++||||||+++|||++|+.|+.....     .........+..     
T Consensus       165 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~~~~~-----  233 (279)
T 2w5a_A          165 ILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGKF-----  233 (279)
T ss_dssp             HC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCC-----
T ss_pred             eeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH-----HHHHHHHhhccc-----
Confidence            7644322 22345689999999999999999999999999999999999988754321     111222222221     


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                          ...+...+..+.+++.+||+.+|++||+++||++.+.
T Consensus       234 ----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~  270 (279)
T 2w5a_A          234 ----RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  270 (279)
T ss_dssp             ----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             ----ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChh
Confidence                1223445678999999999999999999999998773

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.2e-40  Score=328.87  Aligned_cols=249  Identities=25%  Similarity=0.344  Sum_probs=200.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec----CCcee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~  341 (573)
                      +.|...+.||+|+||+||+|... ++..||+|++...  .....+.+.+|+.++++++||||+++++++..    ....+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  105 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV  105 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEE
Confidence            45778889999999999999875 5789999998654  34456788999999999999999999998765    34578


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC-CCCcEEEeecccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRL  420 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~  420 (573)
                      +||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+ .+|+||||||+|||++ .++.+||+|||++..
T Consensus       106 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~  181 (290)
T 1t4h_A          106 LVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  181 (290)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEEEecCCCCHHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccc
Confidence            999999999999998543   45899999999999999999999975 3599999999999998 789999999999976


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      .....   .....||+.|+|||.+. +.++.++||||||+++|||++|+.|+........    .......+....    
T Consensus       182 ~~~~~---~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~----~~~~~~~~~~~~----  249 (290)
T 1t4h_A          182 KRASF---AKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTSGVKPA----  249 (290)
T ss_dssp             CCTTS---BEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHTTTCCCG----
T ss_pred             ccccc---cccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH----HHHHHhccCCcc----
Confidence            54332   23456899999999876 5699999999999999999999999865433211    112222211111    


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                          ..+...+..+.+++.+||+.+|++|||++|+++
T Consensus       250 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          250 ----SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ----GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ----ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                112233467899999999999999999999996

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=4.5e-40  Score=349.97  Aligned_cols=259  Identities=24%  Similarity=0.271  Sum_probs=194.3

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------  338 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  338 (573)
                      .++|+..++||+|+||+||++... +|+.||||++...  .....+.+.+|+.+|+.++||||+++++++....      
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            467999999999999999999865 6899999999654  3445678889999999999999999999987553      


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++||||++++ |.+.+.     ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a  211 (464)
T 3ttj_A          141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  211 (464)
T ss_dssp             EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred             eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence            469999999764 555552     23899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC------
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG------  492 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  492 (573)
                      +.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+.......      
T Consensus       212 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~-~~~~~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          212 RTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI-DQWNKVIEQLGTPCPEFMK  288 (464)
T ss_dssp             -----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCSCCHHHHT
T ss_pred             eecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHHH
Confidence            866432  2234567899999999999999999999999999999999999988543221 1111111110000      


Q ss_pred             cc-------------------ccccCccccCCC---CCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          493 RL-------------------HEAVDPALAGNF---QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       493 ~~-------------------~~~~d~~l~~~~---~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+                   ...+...+....   ....+..+.+|+.+||+.||++|||++|+++.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00                   000000000000   00125678999999999999999999999975

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=6e-40  Score=342.75  Aligned_cols=253  Identities=19%  Similarity=0.205  Sum_probs=192.4

Q ss_pred             cCcccc-ccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHH-cCCCCCCeeeeeeeeec----CCcee
Q 008239          269 NYFHES-NKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLI-SGINHKNLVKLLGCSIT----GPESL  341 (573)
Q Consensus       269 ~~~~~~-~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  341 (573)
                      ++|... ++||+|+||+||++... +|+.||||++...     ..+.+|+.++ +..+||||+++++++..    ....+
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456555 78999999999999875 6889999998532     3566788887 44589999999998865    56789


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---CCcEEEeecccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLV  418 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla  418 (573)
                      +||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence            9999999999999986432 345899999999999999999999988   999999999999997   789999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      +......  ......||+.|+|||++.+..++.++|||||||++|||++|+.|+......... .........+...   
T Consensus       212 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~-~~~~~~i~~~~~~---  285 (400)
T 1nxk_A          212 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-PGMKTRIRMGQYE---  285 (400)
T ss_dssp             EECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSC-CSHHHHHHHTCCC---
T ss_pred             cccCCCC--ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcccccc-HHHHHHHHcCccc---
Confidence            8654322  223567899999999999999999999999999999999999998654332110 0011111122110   


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                         +........+..+.+|+.+||+.||++|||++|+++.-
T Consensus       286 ---~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          286 ---FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             ---CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             ---CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence               00111134567899999999999999999999999753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.4e-40  Score=334.95  Aligned_cols=255  Identities=18%  Similarity=0.243  Sum_probs=201.7

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeec--CCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSIT--GPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  344 (573)
                      ++|+..++||+|+||+||+++. .+++.||||++....   .+.+.+|+.++++++ ||||+++++++..  ....++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence            6799999999999999999986 568999999986433   467889999999997 9999999999987  56789999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-cEEEeecccccccCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLFPE  423 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~~~  423 (573)
                      ||+++++|.+++.      .+++..++.++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++....
T Consensus       113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            9999999998873      3889999999999999999999998   99999999999999776 899999999987644


Q ss_pred             CCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh---------hcCc
Q 008239          424 DITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY---------VKGR  493 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~---------~~~~  493 (573)
                      ...  .....+|..|+|||.+.+ ..++.++||||||+++|||++|+.|+.................         ....
T Consensus       184 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          184 GQE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             TCC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CCc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            322  234578999999999977 6799999999999999999999999865544322221111111         1100


Q ss_pred             c--------------ccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          494 L--------------HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       494 ~--------------~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .              ................+..+.+++.+||+.||++|||++|+++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0              0000011111112235678999999999999999999999996

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.9e-40  Score=337.84  Aligned_cols=253  Identities=19%  Similarity=0.292  Sum_probs=203.7

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ..++|+..+.||+|+||.||++... +|+.||||++......    ..+|++++.++ +||||+++++++.+....++||
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            3567999999999999999999975 6889999999655332    34688888887 7999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC----CcEEEeecccccc
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRL  420 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~----~~~kl~Dfgla~~  420 (573)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||+.++    +.+||+|||++..
T Consensus        96 E~~~gg~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           96 ELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             CCCCSCBHHHHHHTC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             eCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999999999988543   45899999999999999999999998   9999999999998543    3599999999987


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ...... ......||+.|+|||++.+..++.++||||||+++|||++|..|+......  ....+......+...     
T Consensus       170 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~~~~~~i~~~~~~-----  241 (342)
T 2qr7_A          170 LRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD--TPEEILARIGSGKFS-----  241 (342)
T ss_dssp             CBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTS--CHHHHHHHHHHCCCC-----
T ss_pred             CcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcC--CHHHHHHHHccCCcc-----
Confidence            654322 233567899999999998888999999999999999999999998653221  122222333333221     


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       +........+..+.+|+.+||+.||++||++.++++.
T Consensus       242 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          242 -LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             -CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             -cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence             1112234456789999999999999999999999863

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=8.5e-40  Score=325.63  Aligned_cols=245  Identities=24%  Similarity=0.286  Sum_probs=204.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||.||+++.. +++.||||++....   ....+.+.+|++++++++||||+++++++.+....++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            67899999999999999999975 57899999986432   223467889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        94 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKH---GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL  167 (284)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS
T ss_pred             EeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc
Confidence            999999999988543   35899999999999999999999988   999999999999999999999999998765432


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .   .....|++.|+|||.+.+..++.++||||||+++|||++|+.|+......     ..........          .
T Consensus       168 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-----~~~~~~~~~~----------~  229 (284)
T 2vgo_A          168 R---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHT-----ETHRRIVNVD----------L  229 (284)
T ss_dssp             C---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHTTC----------C
T ss_pred             c---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHh-----HHHHHHhccc----------c
Confidence            2   23456899999999999999999999999999999999999987543211     1111111111          1


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .++...+..+.+++.+||+.+|.+||+++++++
T Consensus       230 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          230 KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            223445678899999999999999999999996

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.8e-40  Score=335.61  Aligned_cols=266  Identities=23%  Similarity=0.271  Sum_probs=198.7

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh-----hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-----QWVDHFFNEVNLISGINHKNLVKLLGCSITGPE  339 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  339 (573)
                      ...++|+..+.||+|+||.||+++.. +|+.||||++.....     ...+.+.+|+.+++.++||||+++++++.....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            34578999999999999999999985 589999999864322     123467899999999999999999999999999


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++||||+++ +|.+++..  ....+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus        87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~  160 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK  160 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred             eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence            9999999986 78777743  2345888999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc---cc
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR---LH  495 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~  495 (573)
                      .+.... .......+|+.|+|||.+.+. .++.++||||||+++|||++|..|+..... ......+........   +.
T Consensus       161 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          161 SFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             TTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSS
T ss_pred             eccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH-HHHHHHHHHHcCCCChhhhh
Confidence            764332 223345789999999999764 589999999999999999999877654322 122222222211110   00


Q ss_pred             cc---cCccccCC--------CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          496 EA---VDPALAGN--------FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       496 ~~---~d~~l~~~--------~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ..   .+......        .....+..+.+++.+||+.||++|||++|++++-
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             hhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence            00   00000000        0133457899999999999999999999999864

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.1e-39  Score=323.97  Aligned_cols=251  Identities=20%  Similarity=0.184  Sum_probs=200.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC----hhhHHHHHHHHHHHcCCCCCCeeeeeeeee--cCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT----TQWVDHFFNEVNLISGINHKNLVKLLGCSI--TGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~  340 (573)
                      .++|+..+.||+|+||.||++... +++.||||++....    ....+.+.+|+.++++++||||+++++++.  +....
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM   83 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence            468999999999999999999975 68899999996542    234578899999999999999999999884  45678


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||++++ |.+++... ....+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~  158 (305)
T 2wtk_C           84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA  158 (305)
T ss_dssp             EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence            9999999876 66666433 2356899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCC-cccccccccCcCcCchhhhccCC--CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          421 FPEDI-THISATLAGTLGYMAPEYVVRGK--LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       421 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      ..... ........||+.|+|||.+.+..  ++.++||||||+++|||++|+.|+.....     .........+..   
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~i~~~~~---  230 (305)
T 2wtk_C          159 LHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNI-----YKLFENIGKGSY---  230 (305)
T ss_dssp             CCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHCCC---
T ss_pred             cCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchH-----HHHHHHHhcCCC---
Confidence            64322 22233556899999999997644  37799999999999999999998754321     112222222211   


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                             ..+...+..+.+++.+||+.||++|||++|+++.
T Consensus       231 -------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          231 -------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             -------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             -------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                   2234566788999999999999999999999975

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.6e-40  Score=339.83  Aligned_cols=253  Identities=14%  Similarity=0.164  Sum_probs=203.3

Q ss_pred             HHHHhcCccccccccccCceeEEEEE------cCCCCEEEEEEecccChhhHHHHHHHHHHHcCCC---CCCeeeeeeee
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGT------LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN---HKNLVKLLGCS  334 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~------~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~  334 (573)
                      ++...++|...++||+|+||+||+|.      ..+++.||||++....   ..++..|+.++..++   |+||+++++++
T Consensus        60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~e~~~~~~l~~~~~~~iv~~~~~~  136 (365)
T 3e7e_A           60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN---PWEFYIGTQLMERLKPSMQHMFMKFYSAH  136 (365)
T ss_dssp             EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC---HHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred             EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC---hhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence            33445789999999999999999994      3468899999996544   345667777777775   99999999999


Q ss_pred             ecCCceeEEEEeccCCCccccccccC--CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC------
Q 008239          335 ITGPESLLVYEFVPNQSLLDNLFVRQ--DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE------  406 (573)
Q Consensus       335 ~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~------  406 (573)
                      ...+..++||||+++|+|.+++....  ....+++..++.++.||+.||+|||+.+   |+||||||+||||+.      
T Consensus       137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~  213 (365)
T 3e7e_A          137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD  213 (365)
T ss_dssp             ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred             ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence            99999999999999999999986422  3456999999999999999999999988   999999999999998      


Q ss_pred             -----CCcEEEeecccccccCC-CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcc
Q 008239          407 -----EFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS  480 (573)
Q Consensus       407 -----~~~~kl~Dfgla~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~  480 (573)
                           ++.+||+|||+++.... ..........||+.|+|||++.+..++.++||||||+++|||++|+.|+....... 
T Consensus       214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-  292 (365)
T 3e7e_A          214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-  292 (365)
T ss_dssp             -----CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-
T ss_pred             ccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-
Confidence                 89999999999975432 22223345679999999999999999999999999999999999999875433211 


Q ss_pred             hHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCC-CCHHHHHHHhcc
Q 008239          481 ILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELR-PSMSIVVKMLTG  541 (573)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~R-Pt~~evl~~L~~  541 (573)
                                     ..+...+. ..  ...+.+.+++..|++.+|.+| |+++++.+.|+.
T Consensus       293 ---------------~~~~~~~~-~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          293 ---------------CKPEGLFR-RL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             ---------------EEECSCCT-TC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             ---------------eeechhcc-cc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                           00111111 11  235677899999999999998 678888777754

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1e-40  Score=339.68  Aligned_cols=264  Identities=21%  Similarity=0.278  Sum_probs=193.7

Q ss_pred             HHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh--hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ....++|+..++||+|+||+||+++.. +++.||||++.....  ...+.+.+|+.++++++||||+++++++......+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            344578999999999999999999864 689999999965432  23456789999999999999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee-----CCCCcEEEeecc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL-----DEEFTAKIADFG  416 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll-----~~~~~~kl~Dfg  416 (573)
                      +||||++ |+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||+     +.++.+||+|||
T Consensus       110 lv~e~~~-~~L~~~~~~~---~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg  182 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG  182 (329)
T ss_dssp             EEEECCS-EEHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred             EEEecCC-CCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence            9999997 5998888543   35899999999999999999999998   9999999999999     455669999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc--
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR--  493 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--  493 (573)
                      +++....... ......+|+.|+|||++.+. .++.++||||||+++|||++|+.|+........ ...+........  
T Consensus       183 ~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          183 LARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ-LFKIFEVLGLPDDT  260 (329)
T ss_dssp             HHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHHHCCCCTT
T ss_pred             CccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH-HHHHHHHhCCCchh
Confidence            9987643322 22345679999999999874 589999999999999999999998765432211 111111111000  


Q ss_pred             -ccc-------------ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          494 -LHE-------------AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       494 -~~~-------------~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       +..             .....+........+..+.+|+.+||+.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence             000             00000000001124567889999999999999999999996

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=8.4e-40  Score=348.29  Aligned_cols=194  Identities=24%  Similarity=0.362  Sum_probs=154.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-----Cc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PE  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  339 (573)
                      .++|+..++||+|+||+||+|+.. +|+.||||++...  .....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            367999999999999999999875 6899999998653  334457889999999999999999999998533     56


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++||||+ +++|.+++..   ...+++..+..++.||+.||+|||+.+   |+||||||+||||+.++.+||+|||+++
T Consensus       132 ~~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~  204 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLAR  204 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred             EEEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccch
Confidence            89999998 5788888743   346899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCc--------------------------ccccccccCcCcCchhhh-ccCCCCcccchHhHHHHHHHHHcC
Q 008239          420 LFPEDIT--------------------------HISATLAGTLGYMAPEYV-VRGKLTEKADVYSFGVVVIEVVCR  468 (573)
Q Consensus       420 ~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg  468 (573)
                      .......                          .......||+.|+|||++ ....++.++|||||||+||||++|
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg  280 (458)
T 3rp9_A          205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNM  280 (458)
T ss_dssp             CTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTT
T ss_pred             hccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHh
Confidence            7642211                          122345789999999986 456799999999999999999995

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.4e-40  Score=328.18  Aligned_cols=251  Identities=22%  Similarity=0.254  Sum_probs=202.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh------hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      .++|+..+.||+|+||.||+++.. +|+.||||++.....      ...+.+.+|+.++++++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            356899999999999999999986 689999999865421      1357889999999999999999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC----cEEEeecc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG  416 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfg  416 (573)
                      ++||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++    .+||+|||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg  157 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFG  157 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEeecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecc
Confidence            9999999999999998542   35899999999999999999999988   99999999999998877    89999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      ++.......  ......+++.|+|||.+....++.++||||||+++|||++|+.|+.....     ............  
T Consensus       158 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--  228 (283)
T 3bhy_A          158 IAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK-----QETLTNISAVNY--  228 (283)
T ss_dssp             TCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTCC--
T ss_pred             cceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch-----HHHHHHhHhccc--
Confidence            998664332  12345689999999999999999999999999999999999998754321     111111111111  


Q ss_pred             ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       497 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ...+..    ....+..+.+++.+||+.+|++||++.|+++
T Consensus       229 ~~~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          229 DFDEEY----FSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             CCCHHH----HTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCcchh----cccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence            011111    1234567899999999999999999999997

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.7e-40  Score=330.31  Aligned_cols=251  Identities=22%  Similarity=0.323  Sum_probs=204.4

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|...+.||+|+||.||+++.. +|+.||||++........+.+.+|+.++++++||||+++++++.+....++||||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   87 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL   87 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence            467899999999999999999975 6899999999766554556788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee---CCCCcEEEeecccccccCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~~~  423 (573)
                      +++++|.+++...   ..+++..++.++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++.....
T Consensus        88 ~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           88 VSGGELFDRILER---GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             CCCccHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            9999999988543   35899999999999999999999988   9999999999999   7889999999999875433


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .   ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....     .........+...      ..
T Consensus       162 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----~~~~~~i~~~~~~------~~  227 (304)
T 2jam_A          162 G---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-----SKLFEKIKEGYYE------FE  227 (304)
T ss_dssp             B---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCH-----HHHHHHHHHCCCC------CC
T ss_pred             C---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH-----HHHHHHHHcCCCC------CC
Confidence            2   22345689999999999999999999999999999999999998754321     1112222222110      11


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .......+..+.+++.+||+.||++|||++|+++.
T Consensus       228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            12233456789999999999999999999999973

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.5e-40  Score=332.01  Aligned_cols=257  Identities=28%  Similarity=0.407  Sum_probs=197.6

Q ss_pred             hcCccccccccccCceeEEEEEcC--CCC--EEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP--GGE--AVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      .++|+..++||+|+||+||+|++.  +++  .||||++...   ..+..+.+.+|++++++++||||+++++++.... .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~   95 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-M   95 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-C
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-c
Confidence            467999999999999999999863  333  6899988654   3345678899999999999999999999988754 8


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++|+||+++++|.+++...  ...+++..++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++..
T Consensus        96 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~  170 (291)
T 1u46_A           96 KMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRA  170 (291)
T ss_dssp             EEEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEE
T ss_pred             eeeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccc
Confidence            8999999999999988643  245889999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          421 FPEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      .......  ......+|..|+|||.+.+..++.++||||||+++|||++ |+.|+.....    ... .........   
T Consensus       171 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~----~~~-~~~~~~~~~---  242 (291)
T 1u46_A          171 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG----SQI-LHKIDKEGE---  242 (291)
T ss_dssp             CCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH----HHH-HHHHHTSCC---
T ss_pred             ccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH----HHH-HHHHHccCC---
Confidence            6543322  2224467888999999998889999999999999999999 8877654321    111 111111110   


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                           ....+...+..+.+++.+||+.+|++|||+.+++++|....
T Consensus       243 -----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  283 (291)
T 1u46_A          243 -----RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  283 (291)
T ss_dssp             -----CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             -----CCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhC
Confidence                 11123456778999999999999999999999999996543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-39  Score=334.28  Aligned_cols=258  Identities=21%  Similarity=0.268  Sum_probs=206.4

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhh-----------------HHHHHHHHHHHcCCCCCCeeee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQW-----------------VDHFFNEVNLISGINHKNLVKL  330 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~l  330 (573)
                      .++|+..+.||+|+||.||++.. +|+.||||++.......                 .+.+.+|+.++++++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46899999999999999999999 89999999986432211                 1789999999999999999999


Q ss_pred             eeeeecCCceeEEEEeccCCCcccc------ccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCee
Q 008239          331 LGCSITGPESLLVYEFVPNQSLLDN------LFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNIL  403 (573)
Q Consensus       331 ~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NIl  403 (573)
                      ++++.+.+..++||||+++++|.++      +.. .....+++..++.++.||+.||.|||+ .+   |+||||||+||+
T Consensus       109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil  184 (348)
T 2pml_X          109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL  184 (348)
T ss_dssp             SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred             EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence            9999999999999999999999998      432 224679999999999999999999999 77   999999999999


Q ss_pred             eCCCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccC-CCCc-ccchHhHHHHHHHHHcCCCCCCCCCCCcch
Q 008239          404 LDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTE-KADVYSFGVVVIEVVCRKRINLFTQNSCSI  481 (573)
Q Consensus       404 l~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~sDvwslGvil~elltg~~p~~~~~~~~~~  481 (573)
                      ++.++.+||+|||++......   ......||..|+|||.+.+. .++. ++||||||+++|||++|+.|+.........
T Consensus       185 ~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          185 MDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             ECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             EcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            999999999999999876443   23355789999999999877 6666 999999999999999999998755432222


Q ss_pred             HHHHHHHhhcCccccccC------c---cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          482 LQTVWDLYVKGRLHEAVD------P---ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       482 ~~~~~~~~~~~~~~~~~d------~---~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                          ......+......+      +   ..........+..+.+++.+||+.||++|||++|+++
T Consensus       262 ----~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          262 ----FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ----HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ----HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence                22222222111000      0   0000111345678999999999999999999999997

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.1e-39  Score=347.35  Aligned_cols=259  Identities=21%  Similarity=0.292  Sum_probs=203.7

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCC-CCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|++.++||+|+||.||+|++ .+++.||||++.....  .+++.+|+++++.++| +++..+..++......++|||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46799999999999999999996 5689999998765432  2357889999999987 555566667777888899999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee---CCCCcEEEeecccccccC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~~~  422 (573)
                      |+ +++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+||||   +.++.+||+|||+++.+.
T Consensus        84 ~~-g~sL~~ll~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC--SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             CC-CCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            99 99999988532  245899999999999999999999998   9999999999999   588999999999998765


Q ss_pred             CCCcc------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          423 EDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       423 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      .....      ......||+.|+|||.+.+..++.++||||||++||||++|+.|+....... ..+.+... .......
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~-~~~~~~~i-~~~~~~~  235 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGT-KKQKYEKI-SEKKVAT  235 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSS-HHHHHHHH-HHHHHHS
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchh-HHHHHHHH-hhccccc
Confidence            43321      1225679999999999999999999999999999999999999986544322 11111111 1111111


Q ss_pred             ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       497 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .+. .+    ....+.++.+|+..||+.+|++||++++|+++|+.
T Consensus       236 ~~~-~l----~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~  275 (483)
T 3sv0_A          236 SIE-AL----CRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRD  275 (483)
T ss_dssp             CHH-HH----HTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cHH-HH----hcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence            111 11    12346789999999999999999999999998844

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=1.5e-39  Score=343.49  Aligned_cols=198  Identities=23%  Similarity=0.344  Sum_probs=166.0

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-----Cc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PE  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  339 (573)
                      .++|+..++||+|+||.||+|+.. +|+.||||++...  .....+.+.+|+.+|++++||||+++++++...     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            468999999999999999999875 5889999999653  334456889999999999999999999998766     56


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++||||+. ++|.+++..   ...+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus       105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~  177 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR  177 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence            899999986 599888843   345899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCc---------------------ccccccccCcCcCchhhh-ccCCCCcccchHhHHHHHHHHHcCCCCC
Q 008239          420 LFPEDIT---------------------HISATLAGTLGYMAPEYV-VRGKLTEKADVYSFGVVVIEVVCRKRIN  472 (573)
Q Consensus       420 ~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~sDvwslGvil~elltg~~p~  472 (573)
                      .......                     .......||+.|+|||++ ....++.++|||||||++|||++|..|+
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             EC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            7643321                     123456789999999986 5567999999999999999999864443

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.3e-40  Score=329.40  Aligned_cols=252  Identities=21%  Similarity=0.293  Sum_probs=189.0

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .++|+..++||+|+||+||+++. .+|+.||||++....  ....+.+.++...++.++||||+++++++.+....++||
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~   85 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM   85 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence            46899999999999999999997 478999999996542  222334455566688899999999999999999999999


Q ss_pred             EeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          345 EFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       345 e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||++ |+|.+++... .....+++..++.++.|++.||+|||++ +   |+||||||+|||++.++.+||+|||++....
T Consensus        86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            9997 5887776431 2345699999999999999999999997 7   9999999999999999999999999998664


Q ss_pred             CCCcccccccccCcCcCchhhh----ccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          423 EDITHISATLAGTLGYMAPEYV----VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      ....  .....||+.|+|||.+    ....++.++||||||+++|||++|+.|+......   .............    
T Consensus       162 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~----  232 (290)
T 3fme_A          162 DDVA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP---FQQLKQVVEEPSP----  232 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH---HHHHHHHHHSCCC----
T ss_pred             cccc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch---HHHHHHHhccCCC----
Confidence            4322  2234689999999996    4567899999999999999999999998643322   1112222221110    


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                           .......+..+.+++.+||+.+|++|||++|+++
T Consensus       233 -----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          233 -----QLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             -----CCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             -----CcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence                 1112345678899999999999999999999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=5.8e-40  Score=338.60  Aligned_cols=269  Identities=21%  Similarity=0.264  Sum_probs=200.9

Q ss_pred             hHHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccC-----------hhhHHHHHHHHHHHcCCCCCCeee
Q 008239          261 YETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT-----------TQWVDHFFNEVNLISGINHKNLVK  329 (573)
Q Consensus       261 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~niv~  329 (573)
                      ..++....++|+..+.||+|+||.||+|...+|+.||||++....           ....+.+.+|+.++++++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            566778889999999999999999999999889999999985432           122478899999999999999999


Q ss_pred             eeeeeec-----CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee
Q 008239          330 LLGCSIT-----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL  404 (573)
Q Consensus       330 l~~~~~~-----~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll  404 (573)
                      +++++..     ....++||||++ |+|.+++..  ....+++..++.++.||+.||.|||+++   |+||||||+|||+
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL  167 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence            9999854     335799999997 688887753  3346899999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHH
Q 008239          405 DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQ  483 (573)
Q Consensus       405 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~  483 (573)
                      +.++.+||+|||++.......  ......+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... ....
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~  244 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADA--NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY-NQLN  244 (362)
T ss_dssp             CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHH
T ss_pred             cCCCCEEEEecCccccccccc--ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHH-HHHH
Confidence            999999999999998543322  2234568999999999877 67999999999999999999999987643321 1111


Q ss_pred             HHHHHhhcCcc-----------ccccCcccc-------CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          484 TVWDLYVKGRL-----------HEAVDPALA-------GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       484 ~~~~~~~~~~~-----------~~~~d~~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .+.........           .+.+...+.       .......+..+.+|+.+||+.||++|||+.|+++.
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            11111111000           000000000       01122345678999999999999999999999974

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-39  Score=335.94  Aligned_cols=257  Identities=22%  Similarity=0.332  Sum_probs=196.6

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------  338 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  338 (573)
                      .++|+..+.||+|+||.||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            467999999999999999999974 6899999998543  3344567889999999999999999999987653      


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++||||+ +++|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a  175 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  175 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence            459999999 7899888843    35899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC-----
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG-----  492 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  492 (573)
                      +.....    .....+|+.|+|||++.+ ..++.++|||||||+++||++|+.|+...... .....+.......     
T Consensus       176 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~~~~~~~  250 (367)
T 1cm8_A          176 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHL-DQLKEIMKVTGTPPAEFV  250 (367)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHH-HHHHHHHHHHCCCCHHHH
T ss_pred             cccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCCHHHH
Confidence            875432    234578999999999887 68999999999999999999999987643321 1111111110000     


Q ss_pred             -------------ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          493 -------------RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       493 -------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                                   .+.......+ .......+..+.+|+.+||+.||++|||++|+++.
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          251 QRLQSDEAKNYMKGLPELEKKDF-ASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCG-GGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHhhhHHHHHHHHhCCCCCCCCH-HHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                         0000000111 11223456788999999999999999999999984

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.2e-39  Score=322.92  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=197.9

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..+.||+|+||.||+++.. +|+.||||++....   .+..+.+.+|+.+++.++||||+++++++......++|
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV   89 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence            367899999999999999999976 68999999986532   23456788999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++...   ..+++..++.++.||+.||.|||+++   |+|+||||+||+++.++.+||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~  163 (276)
T 2h6d_A           90 MEYVSGGELFDYICKH---GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD  163 (276)
T ss_dssp             EECCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred             EeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence            9999999999998543   35899999999999999999999998   99999999999999999999999999987644


Q ss_pred             CCcccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ..  ......+++.|+|||.+.+..+ +.++||||||+++|||++|+.|+.....     .........+..        
T Consensus       164 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~--------  228 (276)
T 2h6d_A          164 GE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHV-----PTLFKKIRGGVF--------  228 (276)
T ss_dssp             ---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCC--------
T ss_pred             Cc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcH-----HHHHHHhhcCcc--------
Confidence            32  2234568999999999987765 6899999999999999999988754321     112222222211        


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                        ..+...+..+.+++.+||+.||++|||++|+++.
T Consensus       229 --~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          229 --YIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             --CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --cCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence              1233456778999999999999999999999974

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=8.5e-40  Score=337.16  Aligned_cols=260  Identities=20%  Similarity=0.302  Sum_probs=204.1

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|+..++||+|+||+||++... +++.||+|++... .....+.+.+|+.++++++||||+++++++......++|||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  111 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME  111 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence            367899999999999999999976 6899999998765 34456788999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      |+++++|.+++...   ..+++..+..++.|++.||+|||+. +   |+||||||+|||++.++.+||+|||++......
T Consensus       112 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  185 (360)
T 3eqc_A          112 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  185 (360)
T ss_dssp             CCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             CCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence            99999999998543   3589999999999999999999985 6   999999999999999999999999998754221


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH-------------Hhh-
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD-------------LYV-  490 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-------------~~~-  490 (573)
                         ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.......  ......             ... 
T Consensus       186 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          186 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE--LELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             ---C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHH--HHHHHC-----------------
T ss_pred             ---cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccCCCCCCCcccC
Confidence               1234578999999999999999999999999999999999999986432111  000000             000 


Q ss_pred             -------------cCccccccCc----cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          491 -------------KGRLHEAVDP----ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       491 -------------~~~~~~~~d~----~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                                   .....+.++.    ..........+..+.+++.+||+.||++|||++|+++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                         0000000000    00001122346689999999999999999999999863

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.1e-39  Score=334.74  Aligned_cols=256  Identities=21%  Similarity=0.347  Sum_probs=206.2

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--------hhhHHHHHHHHHHHcCC-CCCCeeeeee
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGI-NHKNLVKLLG  332 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l-~h~niv~l~~  332 (573)
                      ......++|+..+.||+|+||.||+|++. +|+.||||++....        ....+.+.+|+.+++++ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34455678999999999999999999985 69999999986543        12245678999999999 7999999999


Q ss_pred             eeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEE
Q 008239          333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKI  412 (573)
Q Consensus       333 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl  412 (573)
                      ++......++||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||
T Consensus       168 ~~~~~~~~~lv~e~~~g~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          168 SYESSSFMFLVFDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEEBSSEEEEEECCCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEE
T ss_pred             EEeeCCEEEEEEEeCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999988543   35899999999999999999999988   999999999999999999999


Q ss_pred             eecccccccCCCCcccccccccCcCcCchhhhcc------CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHH
Q 008239          413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR------GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVW  486 (573)
Q Consensus       413 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~  486 (573)
                      +|||++.......  ......||+.|+|||++.+      ..++.++||||||+++|||++|+.|+.....    . ...
T Consensus       242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~----~-~~~  314 (365)
T 2y7j_A          242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ----I-LML  314 (365)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH----H-HHH
T ss_pred             EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCH----H-HHH
Confidence            9999998765432  2235678999999999864      3588899999999999999999998754321    1 111


Q ss_pred             HHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          487 DLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       487 ~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .....+... ...+.     ....+..+.+++.+||+.||++|||++|+++
T Consensus       315 ~~i~~~~~~-~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          315 RMIMEGQYQ-FSSPE-----WDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HHHHHTCCC-CCHHH-----HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhCCCC-CCCcc-----cccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            111222110 00000     1234567899999999999999999999987

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.9e-39  Score=359.84  Aligned_cols=249  Identities=22%  Similarity=0.234  Sum_probs=207.1

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCcee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~  341 (573)
                      ..++|+..++||+|+||.||+++.. +++.||||++...   .....+.+..|..++..+ +||||+++++++.+....+
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            4578999999999999999999975 5889999999653   233456788899999988 7999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus       419 lV~E~~~gg~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~  492 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV---GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN  492 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred             EEEeCcCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence            999999999999998643   35899999999999999999999998   999999999999999999999999999864


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      .... .......||+.|+|||++.+..++.++||||||++||||++|+.|+.....     .........+.        
T Consensus       493 ~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~-----~~~~~~i~~~~--------  558 (674)
T 3pfq_A          493 IWDG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-----DELFQSIMEHN--------  558 (674)
T ss_dssp             CCTT-CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHSSC--------
T ss_pred             ccCC-cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCH-----HHHHHHHHhCC--------
Confidence            3222 223457899999999999999999999999999999999999999864322     11122222221        


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCH-----HHHHH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSM-----SIVVK  537 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~-----~evl~  537 (573)
                        ..++...+.++.+|+.+||+.||++||++     +||++
T Consensus       559 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             --CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             --CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence              12344567789999999999999999998     77765

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.5e-40  Score=341.49  Aligned_cols=262  Identities=21%  Similarity=0.271  Sum_probs=197.1

Q ss_pred             HHHhcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC------
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------  337 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------  337 (573)
                      +...++|+..++||+|+||+||+|+. .+|+.||||++......    ..+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45567899999999999999999986 57899999998654322    23699999999999999999988543      


Q ss_pred             --------------------------------CceeEEEEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 008239          338 --------------------------------PESLLVYEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYL  384 (573)
Q Consensus       338 --------------------------------~~~~lv~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yL  384 (573)
                                                      ...++||||++ ++|.+.+... .....+++..++.++.||+.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                            23789999998 5877766431 2345689999999999999999999


Q ss_pred             HhcCCCCeEEecCCCCCeeeC-CCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHH
Q 008239          385 HEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVV  462 (573)
Q Consensus       385 H~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil  462 (573)
                      |+.+   |+||||||+|||++ .++.+||+|||+++.......  .....+|+.|+|||.+.+. .++.++||||||+++
T Consensus       158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            9988   99999999999997 688999999999987644322  2345679999999998775 589999999999999


Q ss_pred             HHHHcCCCCCCCCCCCcchHHHHHHHhhcC----------cccc-----ccCccccCCCCCchHHHHHHHHHHccCCCCC
Q 008239          463 IEVVCRKRINLFTQNSCSILQTVWDLYVKG----------RLHE-----AVDPALAGNFQEGKPSRLLQIGLLCVQASAE  527 (573)
Q Consensus       463 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~----------~~~~-----~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~  527 (573)
                      |||++|+.|+........+ ..+.......          ...+     .....+...++...+..+.+|+.+||+.+|+
T Consensus       233 ~ell~g~~pf~~~~~~~~~-~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  311 (383)
T 3eb0_A          233 GELILGKPLFSGETSIDQL-VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPD  311 (383)
T ss_dssp             HHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGG
T ss_pred             HHHHhCCCCCCCCChHHHH-HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChh
Confidence            9999999887654322111 1111111100          0000     0011111113344567899999999999999


Q ss_pred             CCCCHHHHHH
Q 008239          528 LRPSMSIVVK  537 (573)
Q Consensus       528 ~RPt~~evl~  537 (573)
                      +|||+.|+++
T Consensus       312 ~R~t~~e~l~  321 (383)
T 3eb0_A          312 LRINPYEAMA  321 (383)
T ss_dssp             GSCCHHHHHT
T ss_pred             hCCCHHHHhc
Confidence            9999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.5e-39  Score=334.16  Aligned_cols=264  Identities=21%  Similarity=0.288  Sum_probs=199.4

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG-------  337 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-------  337 (573)
                      .++|+..++||+|+||+||+++. .+|+.||||++....  ......+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            36799999999999999999997 478999999986543  23345778999999999999999999998863       


Q ss_pred             -CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          338 -PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       338 -~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                       ...++||||+++ +|.+.+...  ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  169 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG  169 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccch
Confidence             467899999975 776666432  345899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCC---cccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC
Q 008239          417 LVRLFPEDI---THISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG  492 (573)
Q Consensus       417 la~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  492 (573)
                      +++.+....   ........||+.|+|||++.+ ..++.++||||||+++|||++|+.|+...... .....+......-
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~  248 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ-HQLALISQLCGSI  248 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCC
Confidence            998764322   122234578999999999876 46899999999999999999999887653321 1222221111100


Q ss_pred             ---ccccccCccccCC------CCCc---------hHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          493 ---RLHEAVDPALAGN------FQEG---------KPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       493 ---~~~~~~d~~l~~~------~~~~---------~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                         .+....+..+...      ....         ....+.+|+.+||+.||++|||++|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence               0000000000000      0000         13457899999999999999999999974

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.5e-40  Score=342.54  Aligned_cols=261  Identities=19%  Similarity=0.265  Sum_probs=196.6

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc------ee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE------SL  341 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~------~~  341 (573)
                      ..+|+..++||+|+||+||++++..+..||+|++......    ..+|+.+++.++||||+++++++.....      .+
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3568999999999999999999987777999988654322    2369999999999999999999865433      78


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC-CCCcEEEeecccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRL  420 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~  420 (573)
                      +||||++++.+............+++..++.++.||+.||+|||+.+   |+||||||+|||++ .++.+||+|||+++.
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~  191 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKI  191 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCccc
Confidence            99999987544333322233456899999999999999999999998   99999999999999 799999999999987


Q ss_pred             cCCCCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc--------
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK--------  491 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~--------  491 (573)
                      ......  .....+|+.|+|||++.+. .++.++|||||||++|||++|+.|+........+ ..+......        
T Consensus       192 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l-~~i~~~~g~p~~~~~~~  268 (394)
T 4e7w_A          192 LIAGEP--NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQL-VEIIKVLGTPSREQIKT  268 (394)
T ss_dssp             CCTTCC--CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHHHH
T ss_pred             ccCCCC--CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHHhCCCCHHHHHh
Confidence            643322  2345689999999998765 5899999999999999999999987654322111 111111100        


Q ss_pred             -------CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          492 -------GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       492 -------~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                             ......-...+...+....+..+.+|+.+||+.||++|||+.|+++.
T Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          269 MNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                   00000000001111223356789999999999999999999999974

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=1.9e-39  Score=329.30  Aligned_cols=252  Identities=22%  Similarity=0.299  Sum_probs=199.0

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--------hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGINHKNLVKLLGCSITG  337 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  337 (573)
                      ..++|+..+.||+|+||.||+++.. +++.||||++....        ......+.+|+.++++++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            3467999999999999999999875 58899999986432        12234578999999999999999999998765


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc---EEEee
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIAD  414 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~---~kl~D  414 (573)
                      . .++||||+++++|.+++..   ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.   +||+|
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~D  160 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITD  160 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECC
T ss_pred             c-eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEcc
Confidence            4 8999999999999998843   346899999999999999999999988   999999999999987654   99999


Q ss_pred             cccccccCCCCcccccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc
Q 008239          415 FGLVRLFPEDITHISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       415 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      ||++.......  ......||+.|+|||++.   ...++.++||||||+++|||++|+.|+........+...+    ..
T Consensus       161 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----~~  234 (322)
T 2ycf_A          161 FGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI----TS  234 (322)
T ss_dssp             CTTCEECCCCH--HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH----HH
T ss_pred             Cccceeccccc--ccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH----Hh
Confidence            99998764332  223456899999999974   4678999999999999999999999986554433333222    11


Q ss_pred             CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       492 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +...  ..+..    ....+..+.+++.+||+.||++||+++++++
T Consensus       235 ~~~~--~~~~~----~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          235 GKYN--FIPEV----WAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             TCCC--CCHHH----HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             Cccc--cCchh----hhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            1110  01111    1234567899999999999999999999885

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5.3e-40  Score=340.16  Aligned_cols=253  Identities=10%  Similarity=0.023  Sum_probs=182.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh---hhHHHHHHHH---HHHcCCCCCCeeeee-------ee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT---QWVDHFFNEV---NLISGINHKNLVKLL-------GC  333 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~---~~~~~~~~E~---~~l~~l~h~niv~l~-------~~  333 (573)
                      ...|+..++||+|+||+||+|++. +|+.||||++.....   ...+.+.+|+   .+|+. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            456889999999999999999965 789999999976532   3455677784   55555 799988855       33


Q ss_pred             eecC-----------------CceeEEEEeccCCCccccccccCCCCCCCHHHH------HHHHHHHHHHHHHHHhcCCC
Q 008239          334 SITG-----------------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVR------YKIILSTAEGLAYLHEESKL  390 (573)
Q Consensus       334 ~~~~-----------------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~~l~yLH~~~~~  390 (573)
                      +...                 ...++||||++ |+|.+++.....  .+.+..+      +.++.||+.||+|||+++  
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--  214 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF--VYVFRGDEGILALHILTAQLIRLAANLQSKG--  214 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc--ccchhhhhhhhhHHHHHHHHHHHHHHHHHCC--
Confidence            3322                 23799999998 899999865322  2344455      778899999999999988  


Q ss_pred             CeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccCcCcCchhhhcc--CCCCcccchHhHHHHHHHHHcC
Q 008239          391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCR  468 (573)
Q Consensus       391 ~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg  468 (573)
                       |+||||||+|||++.++.+||+|||+++......    ....+|+.|+|||++.+  ..++.++||||||+++|||++|
T Consensus       215 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg  289 (371)
T 3q60_A          215 -LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTRG----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCL  289 (371)
T ss_dssp             -EEETTCSGGGEEECTTSCEEECCGGGEEETTCEE----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHS
T ss_pred             -CccCcCCHHHEEECCCCCEEEEecceeeecCCCc----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhC
Confidence             9999999999999999999999999998664321    13456799999999987  6899999999999999999999


Q ss_pred             CCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          469 KRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       469 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +.|+.........      .+............+........+..+.+|+.+||+.||++|||+.++++
T Consensus       290 ~~Pf~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          290 FLPFGLVTPGIKG------SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             SCSTTBCCTTCTT------CCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCCCCCcCccccc------chhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            9998654322100      00000001111111111222356788999999999999999999999974

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.8e-40  Score=333.99  Aligned_cols=262  Identities=21%  Similarity=0.333  Sum_probs=203.3

Q ss_pred             ccChHHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCC--CCCeeeeeee
Q 008239          258 NFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGIN--HKNLVKLLGC  333 (573)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~l~~~  333 (573)
                      ++.++.+....++|+..+.||+|+||.||++...+++.||||++...  .....+.+.+|+.++.+++  ||||++++++
T Consensus        17 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~   96 (313)
T 3cek_A           17 NLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDY   96 (313)
T ss_dssp             ---CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEE
T ss_pred             CCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEE
Confidence            34444555566889999999999999999999988999999998653  3445678899999999997  5999999999


Q ss_pred             eecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEe
Q 008239          334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA  413 (573)
Q Consensus       334 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~  413 (573)
                      +......++||| +.+++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+|||+++ +.+||+
T Consensus        97 ~~~~~~~~lv~e-~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~  168 (313)
T 3cek_A           97 EITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLI  168 (313)
T ss_dssp             EECSSEEEEEEC-CCSEEHHHHHHHC---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEEC
T ss_pred             eecCCEEEEEEe-cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEe
Confidence            999999999999 6688999998543   36899999999999999999999998   999999999999965 799999


Q ss_pred             ecccccccCCCCcc-cccccccCcCcCchhhhcc-----------CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcch
Q 008239          414 DFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVR-----------GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSI  481 (573)
Q Consensus       414 Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~  481 (573)
                      |||++......... ......||+.|+|||.+..           ..++.++||||||+++|||++|+.|+......   
T Consensus       169 Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~---  245 (313)
T 3cek_A          169 DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ---  245 (313)
T ss_dssp             CCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSH---
T ss_pred             eccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHH---
Confidence            99999876443222 2234568999999999875           47888999999999999999999987543221   


Q ss_pred             HHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHh
Q 008239          482 LQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML  539 (573)
Q Consensus       482 ~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L  539 (573)
                      ......         .+++......+...+..+.+++.+||+.+|++||+++|+++.-
T Consensus       246 ~~~~~~---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          246 ISKLHA---------IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             HHHHHH---------HHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             HHHHHH---------HHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            111111         1122222233444567899999999999999999999999643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.6e-40  Score=330.39  Aligned_cols=253  Identities=22%  Similarity=0.316  Sum_probs=199.9

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ..+.|+..+.||+|+||.||+|+.. +++.||+|++........+.+.+|+.+++.++||||+++++++......++|||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   96 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE   96 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence            3467999999999999999999986 588999999977666667889999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        97 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  170 (302)
T 2j7t_A           97 FCPGGAVDAIMLEL--DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT-  170 (302)
T ss_dssp             CCTTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred             eCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999887542  235899999999999999999999988   999999999999999999999999987643211 


Q ss_pred             cccccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          426 THISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ........||+.|+|||.+.     ...++.++||||||+++|||++|+.|+.....    ......... ......   
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~~~~~---  242 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP----MRVLLKIAK-SDPPTL---  242 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHH-SCCCCC---
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH----HHHHHHHhc-cCCccc---
Confidence            11122356899999999984     56789999999999999999999998754322    111111111 111110   


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                          ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus       243 ----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          243 ----LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             ----SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             ----CCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                112344678899999999999999999999986

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2e-39  Score=325.36  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=195.0

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec----------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----------  336 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----------  336 (573)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++... ....+.+.+|+.++++++||||+++++++.+          
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA   83 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence            467899999999999999999974 7899999998643 3446788999999999999999999998765          


Q ss_pred             ---CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEe
Q 008239          337 ---GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA  413 (573)
Q Consensus       337 ---~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~  413 (573)
                         ....++||||+++++|.+++...  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~  158 (303)
T 1zy4_A           84 VKKKSTLFIQMEYCENGTLYDLIHSE--NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG  158 (303)
T ss_dssp             --CEEEEEEEEECCCSCBHHHHHHHS--CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred             cccCCceEEEEecCCCCCHHHhhhcc--ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence               34678999999999999998643  235788999999999999999999998   9999999999999999999999


Q ss_pred             ecccccccCCCC-------------cccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCc
Q 008239          414 DFGLVRLFPEDI-------------THISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSC  479 (573)
Q Consensus       414 Dfgla~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~  479 (573)
                      |||++.......             ........||+.|+|||.+.+. .++.++||||||+++|||++   |+.....  
T Consensus       159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~--  233 (303)
T 1zy4_A          159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME--  233 (303)
T ss_dssp             CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH--
T ss_pred             eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh--
Confidence            999998654321             1122345689999999999764 78999999999999999998   3322111  


Q ss_pred             chHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                        ...........      ...+...++...+..+.+++.+||+.||++|||++++++.
T Consensus       234 --~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          234 --RVNILKKLRSV------SIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             --HHHHHHHHHST------TCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             --HHHHHHhcccc------ccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence              11111111111      1112223445567788999999999999999999999973

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.2e-39  Score=347.48  Aligned_cols=251  Identities=24%  Similarity=0.281  Sum_probs=205.4

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      .++|+..++||+|+||+||+++.. +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+....++|
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  104 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV  104 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            467999999999999999999975 78999999986432   34467889999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee---CCCCcEEEeecccccc
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---DEEFTAKIADFGLVRL  420 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll---~~~~~~kl~Dfgla~~  420 (573)
                      |||+++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||++..
T Consensus       105 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          105 GEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             ECCCCSCBHHHHHHTC---SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            9999999999988543   45899999999999999999999998   9999999999999   5678999999999987


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      +....  ......||+.|+|||++.+ .++.++||||||+++|||++|..|+...... .+    ......+.....   
T Consensus       179 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~----~~~i~~~~~~~~---  247 (484)
T 3nyv_A          179 FEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEY-DI----LKKVEKGKYTFE---  247 (484)
T ss_dssp             BCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH----HHHHHHCCCCCC---
T ss_pred             ccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHH-HH----HHHHHcCCCCCC---
Confidence            65432  2234578999999999865 7999999999999999999999997643221 11    122222221100   


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                         .......+..+.+++.+||+.+|++|||+.|+++.
T Consensus       248 ---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          248 ---LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             ---SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ---CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence               00112356788999999999999999999999963

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=8.3e-40  Score=344.05  Aligned_cols=259  Identities=22%  Similarity=0.295  Sum_probs=194.2

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC------Ccee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------PESL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~  341 (573)
                      .+|+..++||+|+||.||+|++. +|+.||||++.....    ...+|+++|++++|||||++++++...      ...+
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46889999999999999999985 589999999865432    234699999999999999999988532      1357


Q ss_pred             EEEEeccCCCccccccc-cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC-CcEEEeeccccc
Q 008239          342 LVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVR  419 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~  419 (573)
                      +||||+++ +|.+.+.. ......+++..++.++.||+.||+|||+++   |+||||||+||||+.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999975 55554432 123456999999999999999999999988   9999999999999955 678999999998


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh--------
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV--------  490 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~--------  490 (573)
                      .......  .....||+.|+|||++.+. .++.++|||||||++|||++|+.||........+.. +.....        
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~-i~~~lg~p~~~~~~  282 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE-IIKVLGTPTREQIR  282 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHHHCSCCHHHHH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH-HHHHhCCCCHHHHH
Confidence            7643322  2345789999999999764 799999999999999999999998765432222211 111110        


Q ss_pred             --cCccccccCcccc-----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          491 --KGRLHEAVDPALA-----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       491 --~~~~~~~~d~~l~-----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                        .....+...+.+.     ..+....+.++.+|+.+||+.||++|||+.|+++.
T Consensus       283 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          283 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence              0011111011110     01223456789999999999999999999999864

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.4e-39  Score=345.85  Aligned_cols=251  Identities=25%  Similarity=0.313  Sum_probs=199.9

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .+.|+..++||+|+||+||+++.. ++..||||++....  ......+.+|+.+++.++||||+++++++.+....++||
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  115 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM  115 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            457999999999999999999975 68899999986542  333567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---CCcEEEeeccccccc
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLVRLF  421 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla~~~  421 (573)
                      ||+++|+|.+.+...   ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.   ++.+||+|||++..+
T Consensus       116 e~~~~g~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          116 ECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             ECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999999888543   35899999999999999999999988   999999999999976   455999999999876


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ....  ......||+.|+|||++. +.++.++|||||||++|||++|..|+.....     .........+... ...+.
T Consensus       190 ~~~~--~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i~~~~~~-~~~~~  260 (494)
T 3lij_A          190 ENQK--KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTD-----QEILRKVEKGKYT-FDSPE  260 (494)
T ss_dssp             BTTB--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHTCCC-CCSGG
T ss_pred             CCCc--cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHhCCCC-CCchh
Confidence            5432  233467999999999876 5799999999999999999999998754322     1122222222211 00111


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                           ....+..+.+++.+||+.+|++|||+.|+++.
T Consensus       261 -----~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          261 -----WKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             -----GTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             -----cccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                 12345778999999999999999999999853

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.9e-39  Score=326.58  Aligned_cols=252  Identities=27%  Similarity=0.391  Sum_probs=200.9

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ...++|+..+.||+|+||.||+|... +|+.||||++....  ..+.+.+|+.+++.++||||+++++++......++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            44578999999999999999999876 58999999986543  3467889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++...  ...+++..++.++.||+.||.|||+.+   |+|+||||+||+++.++.+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRLR--NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHHH--TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence            999999999988532  346899999999999999999999988   999999999999999999999999999866443


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .. ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+.....    ......... ...     +.+  
T Consensus       179 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~~-~~~-----~~~--  245 (314)
T 3com_A          179 MA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP----MRAIFMIPT-NPP-----PTF--  245 (314)
T ss_dssp             BS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHH-SCC-----CCC--
T ss_pred             cc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh----HHHHHHHhc-CCC-----ccc--
Confidence            22 22345689999999999999999999999999999999999998754321    111111111 110     001  


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+...+..+.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          246 RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            112334678899999999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.4e-39  Score=346.02  Aligned_cols=252  Identities=26%  Similarity=0.356  Sum_probs=202.3

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh-------------hhHHHHHHHHHHHcCCCCCCeeeeee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-------------QWVDHFFNEVNLISGINHKNLVKLLG  332 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~l~~  332 (573)
                      ..++|...++||+|+||+||+++.. +++.||||++.....             ...+.+.+|+.+|++++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999975 578999999865321             33567889999999999999999999


Q ss_pred             eeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC---c
Q 008239          333 CSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF---T  409 (573)
Q Consensus       333 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~---~  409 (573)
                      ++.+....++||||+++|+|.+++...   ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++   .
T Consensus       114 ~~~~~~~~~lv~e~~~gg~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~  187 (504)
T 3q5i_A          114 VFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN  187 (504)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred             EEEcCCEEEEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence            999999999999999999999988543   35899999999999999999999988   99999999999998775   6


Q ss_pred             EEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh
Q 008239          410 AKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY  489 (573)
Q Consensus       410 ~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  489 (573)
                      +||+|||++.......  ......||+.|+|||++. +.++.++||||||+++|||++|..|+.....     .......
T Consensus       188 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-----~~~~~~i  259 (504)
T 3q5i_A          188 IKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQND-----QDIIKKV  259 (504)
T ss_dssp             EEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH
T ss_pred             EEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCH-----HHHHHHH
Confidence            9999999998765432  233457999999999886 5699999999999999999999998764322     1112222


Q ss_pred             hcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       490 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..+....  +...    ....+..+.+++.+||+.||.+|||++|+++.
T Consensus       260 ~~~~~~~--~~~~----~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          260 EKGKYYF--DFND----WKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             HHCCCCC--CHHH----HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HcCCCCC--Cccc----cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            2222110  0000    12345678999999999999999999999863

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.2e-39  Score=340.39  Aligned_cols=259  Identities=19%  Similarity=0.242  Sum_probs=200.0

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC------CCCCeeeeeeeeecCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI------NHKNLVKLLGCSITGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~~~~~~  340 (573)
                      ..+|+..++||+|+||+||+|... +++.||||++... ....+.+.+|+.+++.+      .|+||+++++++......
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~  174 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI  174 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence            467999999999999999999875 5889999999653 33345677788877766      577999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc--EEEeecccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT--AKIADFGLV  418 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~--~kl~Dfgla  418 (573)
                      ++||||+. ++|.+++.... ...+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.  +||+|||++
T Consensus       175 ~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          175 CMTFELLS-MNLYELIKKNK-FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEECCCC-CBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             EEEEeccC-CCHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence            99999996 68988885433 345899999999999999999999998   999999999999999887  999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC------
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG------  492 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  492 (573)
                      +.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.|+....... ....+.......      
T Consensus       250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~-~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD-QLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHH
T ss_pred             eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCHHHHH
Confidence            765432    234578999999999999999999999999999999999998875543221 111111111000      


Q ss_pred             ---ccccccCc---------------------------ccc---------CCCCCchHHHHHHHHHHccCCCCCCCCCHH
Q 008239          493 ---RLHEAVDP---------------------------ALA---------GNFQEGKPSRLLQIGLLCVQASAELRPSMS  533 (573)
Q Consensus       493 ---~~~~~~d~---------------------------~l~---------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~  533 (573)
                         +....++.                           .+.         ..........+.+|+.+||+.||++|||++
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence               00000000                           000         001112256789999999999999999999


Q ss_pred             HHHH
Q 008239          534 IVVK  537 (573)
Q Consensus       534 evl~  537 (573)
                      |+++
T Consensus       405 e~L~  408 (429)
T 3kvw_A          405 QALR  408 (429)
T ss_dssp             HHHT
T ss_pred             HHhC
Confidence            9997

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.6e-40  Score=333.60  Aligned_cols=260  Identities=24%  Similarity=0.332  Sum_probs=200.8

Q ss_pred             cChHHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeec
Q 008239          259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSIT  336 (573)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~  336 (573)
                      ++...+....++|+..+.||+|+||.||+|++. +|+.||||++..... ..+.+.+|+.+++++ +||||+++++++..
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   92 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIK   92 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEE
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEee
Confidence            444555567789999999999999999999974 689999999865433 346788999999998 89999999999876


Q ss_pred             ------CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcE
Q 008239          337 ------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA  410 (573)
Q Consensus       337 ------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~  410 (573)
                            ....++||||+++++|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           93 KNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             CC--CCCCEEEEEEECCTTEEHHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             ccCccccceEEEEEEcCCCCcHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence                  457899999999999999885432 346899999999999999999999998   9999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH
Q 008239          411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV  485 (573)
Q Consensus       411 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~  485 (573)
                      ||+|||++........ ......||+.|+|||.+.     ...++.++||||||+++|||++|+.|+.....    ....
T Consensus       169 kl~Dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~  243 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP----MRAL  243 (326)
T ss_dssp             EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH----HHHH
T ss_pred             EEeeCcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH----HHHH
Confidence            9999999886543221 223456899999999987     56789999999999999999999998754321    1111


Q ss_pred             HHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          486 WDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       486 ~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ...... ..     +.   ......+..+.+++.+||+.+|++||+++++++
T Consensus       244 ~~~~~~-~~-----~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          244 FLIPRN-PA-----PR---LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             HHHHHS-CC-----CC---CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHhhcC-cc-----cc---CCccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            111111 11     11   112345678999999999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=327.93  Aligned_cols=262  Identities=21%  Similarity=0.315  Sum_probs=195.6

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeee-----------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI-----------  335 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-----------  335 (573)
                      .++|+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.++++++||||+++++++.           
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            367899999999999999999986 48999999998777777788999999999999999999999874           


Q ss_pred             ---cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC-CCCcEE
Q 008239          336 ---TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAK  411 (573)
Q Consensus       336 ---~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~k  411 (573)
                         +....++||||++ |+|.+++.    ...+++..++.++.||+.||+|||+++   |+||||||+|||++ +++.+|
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             cccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence               3457789999997 69988883    245899999999999999999999988   99999999999997 677999


Q ss_pred             EeecccccccCCCCcc--cccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH
Q 008239          412 IADFGLVRLFPEDITH--ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL  488 (573)
Q Consensus       412 l~Dfgla~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~  488 (573)
                      |+|||+++........  ......+|..|+|||.+.. ..++.++||||||+++|||++|+.|+....... ....+...
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-~~~~~~~~  240 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELE-QMQLILES  240 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHH
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHh
Confidence            9999999876432221  1234467899999998875 689999999999999999999999876543211 11111110


Q ss_pred             hhc----------CccccccCcccc------CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          489 YVK----------GRLHEAVDPALA------GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       489 ~~~----------~~~~~~~d~~l~------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...          ..+...+.....      .......+..+.+++.+||+.||++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            000          000000000000      00112356789999999999999999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.8e-39  Score=345.74  Aligned_cols=252  Identities=24%  Similarity=0.299  Sum_probs=203.4

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ..++|+..++||+|+||+||+++.. +++.||||++...  .......+.+|+.++++++||||+++++++.+....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            3467999999999999999999975 6899999998543  223456789999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC---CCCcEEEeecccccc
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRL  420 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~---~~~~~kl~Dfgla~~  420 (573)
                      |||+++++|.+.+...   ..+++..++.++.||+.||.|||+++   |+||||||+|||++   .++.+||+|||+++.
T Consensus       100 ~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  173 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (486)
T ss_dssp             ECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTT
T ss_pred             EEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeE
Confidence            9999999999888543   35899999999999999999999998   99999999999995   456899999999987


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      +....  ......||+.|+|||++.+ .++.++||||||+++|||++|+.|+...... .+    ......+..... . 
T Consensus       174 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~----~~~i~~~~~~~~-~-  243 (486)
T 3mwu_A          174 FQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEY-DI----LKRVETGKYAFD-L-  243 (486)
T ss_dssp             BCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH-HH----HHHHHHTCCCSC-S-
T ss_pred             CCCCC--ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HH----HHHHHhCCCCCC-C-
Confidence            64432  2334578999999999865 6999999999999999999999997543221 11    112222221100 0 


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                          ......+..+.+++.+||+.+|++|||+.|+++.
T Consensus       244 ----~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          244 ----PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             ----GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             ----cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0112346778999999999999999999999974

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-39  Score=334.49  Aligned_cols=258  Identities=23%  Similarity=0.324  Sum_probs=184.3

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC------C
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------P  338 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~  338 (573)
                      .++|+..+.||+|+||.||+|.. .+|+.||||++...  .....+.+.+|+.+++.++||||+++++++...      .
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            47899999999999999999986 46899999998653  334456788999999999999999999998654      5


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++|+|++ +++|.+++..    ..+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a  179 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA  179 (367)
T ss_dssp             CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred             eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence            679999999 7899888742    45899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc---c
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR---L  494 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~  494 (573)
                      +.....    .....||+.|+|||++.+ ..++.++|||||||++|||++|+.|+...... .....+........   +
T Consensus       180 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-~~l~~i~~~~g~p~~~~~  254 (367)
T 2fst_X          180 RHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELL  254 (367)
T ss_dssp             ---------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCSCCHHHH
T ss_pred             cccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            865432    234578999999999877 68999999999999999999999987543321 11111111111000   0


Q ss_pred             ccccC-------cccc-------CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          495 HEAVD-------PALA-------GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       495 ~~~~d-------~~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..+..       ..+.       .......+..+.+|+.+||+.||++|||++|+++.
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          255 KKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             TTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            00000       0000       00012235678899999999999999999999974

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.5e-39  Score=357.87  Aligned_cols=258  Identities=22%  Similarity=0.298  Sum_probs=204.4

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcCC----CCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP  338 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~  338 (573)
                      .+...++|+..+.||+|+||+||+|.+..    +..||||++... .....+.+.+|+.++++++||||+++++++. .+
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            33445678889999999999999998742    457999998654 3344578899999999999999999999985 45


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++||||+++|+|.+++...  ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a  538 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR--KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLS  538 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT--TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCC
Confidence            689999999999999998543  235899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      +..............+|+.|+|||.+....++.++||||||+++|||++ |..|+..... .....    ....+..   
T Consensus       539 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~-~~~~~----~i~~~~~---  610 (656)
T 2j0j_A          539 RYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN-NDVIG----RIENGER---  610 (656)
T ss_dssp             CSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHH----HHHHTCC---
T ss_pred             eecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH-HHHHH----HHHcCCC---
Confidence            8765443333334567889999999999999999999999999999997 7766543221 11111    1122111   


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                            ...+...+..+.+++.+||+.||++|||+.+|++.|+.
T Consensus       611 ------~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~  648 (656)
T 2j0j_A          611 ------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  648 (656)
T ss_dssp             ------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ------CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                  12344567789999999999999999999999999954

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=7.6e-39  Score=320.87  Aligned_cols=252  Identities=21%  Similarity=0.291  Sum_probs=204.7

Q ss_pred             HhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---------hhhHHHHHHHHHHHcCCC-CCCeeeeeeeee
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---------TQWVDHFFNEVNLISGIN-HKNLVKLLGCSI  335 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~  335 (573)
                      ..++|+..+.||+|+||.||++... +|+.||||++....         ....+.+.+|+.+++++. ||||+++++++.
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   94 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   94 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence            4578999999999999999999975 68899999986542         123457789999999995 999999999999


Q ss_pred             cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeec
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF  415 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  415 (573)
                      .....++||||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.++.+||+||
T Consensus        95 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           95 TNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred             cCCeEEEEEeccCCCcHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence            999999999999999999998543   45899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCcCcCchhhhc------cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh
Q 008239          416 GLVRLFPEDITHISATLAGTLGYMAPEYVV------RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY  489 (573)
Q Consensus       416 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  489 (573)
                      |++.......  ......+++.|+|||.+.      ...++.++||||||+++|||++|+.|+.....     .......
T Consensus       169 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~  241 (298)
T 1phk_A          169 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLRMI  241 (298)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHH
T ss_pred             cchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccH-----HHHHHHH
Confidence            9998764332  223456899999999985      45688999999999999999999998754321     1111122


Q ss_pred             hcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       490 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+...      .........+..+.+++.+||+.||++|||+.|+++
T Consensus       242 ~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          242 MSGNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             HHTCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hcCCcc------cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            222111      001112345678999999999999999999999986

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2.7e-39  Score=333.25  Aligned_cols=270  Identities=20%  Similarity=0.222  Sum_probs=193.1

Q ss_pred             hHHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc
Q 008239          261 YETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE  339 (573)
Q Consensus       261 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~  339 (573)
                      .+......++|+..++||+|+||+||+|+.. +|+.||||++.... ...+.+.+|+..++.++||||+++++++.....
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           15 DERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             SHHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             hhhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            3455667789999999999999999999975 68999999986543 223456778888899999999999999875433


Q ss_pred             -------eeEEEEeccCCCccccccc-cCCCCCCCHHHHHHHHHHHHHHHHHHH--hcCCCCeEEecCCCCCeeeCC-CC
Q 008239          340 -------SLLVYEFVPNQSLLDNLFV-RQDVEPLSWEVRYKIILSTAEGLAYLH--EESKLRIIHRDIKLSNILLDE-EF  408 (573)
Q Consensus       340 -------~~lv~e~~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~~l~yLH--~~~~~~iiHrDlk~~NIll~~-~~  408 (573)
                             .++||||+++ +|...+.. ......+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~  169 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADG  169 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTT
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCC
Confidence                   7899999986 44443322 234556899999999999999999999  776   999999999999996 89


Q ss_pred             cEEEeecccccccCCCCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH
Q 008239          409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD  487 (573)
Q Consensus       409 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~  487 (573)
                      .+||+|||+++.......  .....||+.|+|||++.+. .++.++||||||+++|||++|+.|+........ ...+..
T Consensus       170 ~~kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~-~~~~~~  246 (360)
T 3e3p_A          170 TLKLCDFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQ-LHEIVR  246 (360)
T ss_dssp             EEEECCCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHH
T ss_pred             cEEEeeCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHH-HHHHHH
Confidence            999999999987654322  2345689999999998765 489999999999999999999998765432211 111111


Q ss_pred             Hhhc-----------Cc-cccccC------ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          488 LYVK-----------GR-LHEAVD------PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       488 ~~~~-----------~~-~~~~~d------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ....           .. .....+      ..+........+..+.+|+.+||+.||++|||+.|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            1100           00 000000      001112233467889999999999999999999999974

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=6.9e-39  Score=331.71  Aligned_cols=259  Identities=23%  Similarity=0.275  Sum_probs=191.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------  338 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  338 (573)
                      .++|+..+.||+|+||.||++... +++.||||++...  .....+.+.+|+.+++.++||||+++++++....      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            367999999999999999999865 6889999998653  3344567889999999999999999999987655      


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++||||++ ++|.+.+.     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  174 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA  174 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred             ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence            6799999997 47777763     24889999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH-----------
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD-----------  487 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~-----------  487 (573)
                      +......  ......||+.|+|||++.+..++.++||||||+++|||++|+.|+....... ....+..           
T Consensus       175 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~  251 (371)
T 2xrw_A          175 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEFMK  251 (371)
T ss_dssp             -----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHC-CCCCCHHHHT
T ss_pred             ccccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHHHHH
Confidence            8654321  2234578999999999999999999999999999999999999875432211 1111000           


Q ss_pred             --------HhhcC-c-----cccccCccccCC---CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          488 --------LYVKG-R-----LHEAVDPALAGN---FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       488 --------~~~~~-~-----~~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                              ..... .     +...+...+...   .....+..+.+|+.+||+.||++|||++|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             TSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence                    00000 0     000000000000   001125678999999999999999999999974

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.4e-40  Score=333.21  Aligned_cols=265  Identities=22%  Similarity=0.333  Sum_probs=203.7

Q ss_pred             ChHHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC
Q 008239          260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITG  337 (573)
Q Consensus       260 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~  337 (573)
                      ...+++...++|+..+.||+|+||.||+|+..+  .||||++....  ....+.+.+|+.++++++||||+++++++...
T Consensus        24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  101 (319)
T 2y4i_B           24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP  101 (319)
T ss_dssp             CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS
T ss_pred             ccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence            344555567889999999999999999998864  59999986532  23345677899999999999999999999999


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ...++||||+++++|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||++ ++.+||+|||+
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~  175 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGL  175 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTSS--CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSC
T ss_pred             CceEEEeecccCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCC
Confidence            9999999999999999998542  346899999999999999999999998   99999999999998 67999999999


Q ss_pred             ccccCCCC----cccccccccCcCcCchhhhcc---------CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHH
Q 008239          418 VRLFPEDI----THISATLAGTLGYMAPEYVVR---------GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQT  484 (573)
Q Consensus       418 a~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~  484 (573)
                      ++......    ........|++.|+|||.+..         ..++.++||||||+++|||++|+.|+.....    ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~----~~~  251 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA----EAI  251 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH----HHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH----HHH
Confidence            87543211    112224468999999999864         4578999999999999999999998754322    111


Q ss_pred             HHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCC
Q 008239          485 VWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEI  545 (573)
Q Consensus       485 ~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~  545 (573)
                      .+. ...+..     +.+   .....+..+.+++.+||+.+|++|||+++++++|+.....
T Consensus       252 ~~~-~~~~~~-----~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          252 IWQ-MGTGMK-----PNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HHH-HHTTCC-----CCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             HHH-hccCCC-----CCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            111 111111     111   1123455688999999999999999999999999765543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=4.2e-39  Score=336.06  Aligned_cols=260  Identities=22%  Similarity=0.290  Sum_probs=201.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCC--------CCCeeeeeeeee---
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN--------HKNLVKLLGCSI---  335 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~~---  335 (573)
                      .++|++.++||+|+||+||+++.. +++.||||++... ....+.+.+|+.+++.++        |+||+++++++.   
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence            467999999999999999999864 6889999999643 344567889999999885        788999999887   


Q ss_pred             -cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCC-----
Q 008239          336 -TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEF-----  408 (573)
Q Consensus       336 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~-----  408 (573)
                       .....++||||+ +++|.+.+... ....+++..++.++.||+.||+|||++ +   |+||||||+|||++.++     
T Consensus       115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHH
T ss_pred             CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhh
Confidence             556789999999 66777766443 234689999999999999999999998 7   99999999999999775     


Q ss_pred             --------------------------------------------cEEEeecccccccCCCCcccccccccCcCcCchhhh
Q 008239          409 --------------------------------------------TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV  444 (573)
Q Consensus       409 --------------------------------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~  444 (573)
                                                                  .+||+|||++......    .....||+.|+|||++
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~  265 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVL  265 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhh
Confidence                                                        7999999999876432    2345689999999999


Q ss_pred             ccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc-----chHHHHHHHhh--------cCccc-cccCc--cc------
Q 008239          445 VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC-----SILQTVWDLYV--------KGRLH-EAVDP--AL------  502 (573)
Q Consensus       445 ~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~-----~~~~~~~~~~~--------~~~~~-~~~d~--~l------  502 (573)
                      .+..++.++|||||||++|||++|+.|+.......     .....+.....        .+... ..+..  .+      
T Consensus       266 ~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (397)
T 1wak_A          266 IGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKL  345 (397)
T ss_dssp             HTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCC
T ss_pred             cCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccccc
Confidence            99999999999999999999999999987544322     11111111110        00000 00000  00      


Q ss_pred             -----------cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          503 -----------AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       503 -----------~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                                 ....+...+..+.+|+.+||+.||++|||++|+++
T Consensus       346 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          346 KPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                       00223456678999999999999999999999986

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=9.4e-39  Score=329.88  Aligned_cols=262  Identities=19%  Similarity=0.269  Sum_probs=201.8

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-----Cce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  340 (573)
                      .++|+..++||+|+||.||++... +++.||||++... .....+.+.+|+.++++++||||+++++++...     ...
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            467999999999999999999865 6889999999653 334457888999999999999999999998754     367


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+. ++|.+++..    ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus       106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~  177 (364)
T 3qyz_A          106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV  177 (364)
T ss_dssp             EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence            99999997 588888743    35899999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCCCcc--cccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc--
Q 008239          421 FPEDITH--ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH--  495 (573)
Q Consensus       421 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~--  495 (573)
                      .......  ......||+.|+|||++.+ ..++.++||||||+++|||++|+.|+....... ....+..........  
T Consensus       178 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  256 (364)
T 3qyz_A          178 ADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDL  256 (364)
T ss_dssp             CCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGG-HHHHHHHHHCSCCHHHH
T ss_pred             cCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHH-HHHHHHHHhCCCCHHHH
Confidence            6433221  1234578999999998765 458999999999999999999998875543322 222221111110000  


Q ss_pred             -c------------ccCcccc--CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          496 -E------------AVDPALA--GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       496 -~------------~~d~~l~--~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       .            ...+.-.  .......+..+.+|+.+||+.||++|||++|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          257 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0            0000000  00112345678999999999999999999999974

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-39  Score=340.10  Aligned_cols=264  Identities=20%  Similarity=0.299  Sum_probs=183.2

Q ss_pred             Cccc-cccccccCceeEEEEEcC---CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeee--cCCceeEE
Q 008239          270 YFHE-SNKLGQGGSGSVYKGTLP---GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSI--TGPESLLV  343 (573)
Q Consensus       270 ~~~~-~~~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~lv  343 (573)
                      .|+. .++||+|+||+||+|++.   +++.||||++.....  ...+.+|+.+|++++||||+++++++.  .....++|
T Consensus        21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv   98 (405)
T 3rgf_A           21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLL   98 (405)
T ss_dssp             HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEE
T ss_pred             hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEE
Confidence            3554 568999999999999965   578999999965432  346789999999999999999999995  46678999


Q ss_pred             EEeccCCCcccccccc------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee----CCCCcEEEe
Q 008239          344 YEFVPNQSLLDNLFVR------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL----DEEFTAKIA  413 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll----~~~~~~kl~  413 (573)
                      |||+. ++|.+++...      .....+++..++.++.||+.||+|||+.+   |+||||||+||||    +.++.+||+
T Consensus        99 ~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~  174 (405)
T 3rgf_A           99 FDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIA  174 (405)
T ss_dssp             EECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred             EeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEE
Confidence            99996 5777766421      12235899999999999999999999998   9999999999999    678899999


Q ss_pred             ecccccccCCCCc--ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--------chH
Q 008239          414 DFGLVRLFPEDIT--HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--------SIL  482 (573)
Q Consensus       414 Dfgla~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--------~~~  482 (573)
                      |||+++.+.....  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.|+.......        ..+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            9999987654322  22335678999999999987 458999999999999999999999986443210        111


Q ss_pred             HHHHHHhhcCc---cccc------------cCcccc---------CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          483 QTVWDLYVKGR---LHEA------------VDPALA---------GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       483 ~~~~~~~~~~~---~~~~------------~d~~l~---------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..+........   +..+            +.....         ..........+.+|+.+||+.||++|||++|+++.
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            22211111000   0000            000000         00111124578899999999999999999999974


Q ss_pred             h
Q 008239          539 L  539 (573)
Q Consensus       539 L  539 (573)
                      =
T Consensus       335 p  335 (405)
T 3rgf_A          335 P  335 (405)
T ss_dssp             G
T ss_pred             h
Confidence            3

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.6e-39  Score=326.14  Aligned_cols=263  Identities=25%  Similarity=0.333  Sum_probs=201.5

Q ss_pred             HhcCccccccccccCceeEEEEEc--CCCCEEEEEEecccCh--hhHHHHHHHHHHHcCC---CCCCeeeeeeeee----
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL--PGGEAVAVKRLFYNTT--QWVDHFFNEVNLISGI---NHKNLVKLLGCSI----  335 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~l~~~~~----  335 (573)
                      +.++|+..+.||+|+||.||+++.  .+|+.||||++.....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999997  4688999999864321  2223556677776665   8999999999987    


Q ss_pred             -cCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEee
Q 008239          336 -TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIAD  414 (573)
Q Consensus       336 -~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~D  414 (573)
                       .....++||||++ |+|.+++.... ...+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.+||+|
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP-EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC-TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence             5567899999998 69998885433 235899999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC--
Q 008239          415 FGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG--  492 (573)
Q Consensus       415 fgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~--  492 (573)
                      ||++......  .......||+.|+|||.+.+..++.++||||||+++|||++|+.|+...... .....+.......  
T Consensus       164 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~i~~~~~~~~~  240 (326)
T 1blx_A          164 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGE  240 (326)
T ss_dssp             CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCG
T ss_pred             CcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHHHHcCCCCc
Confidence            9999865432  2233457899999999999999999999999999999999999987644321 1222222211100  


Q ss_pred             -cccc-------ccC---ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          493 -RLHE-------AVD---PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       493 -~~~~-------~~d---~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       .+..       .+.   ...........+..+.+++.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence             0000       000   00001223456778899999999999999999999995

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1e-38  Score=324.62  Aligned_cols=255  Identities=24%  Similarity=0.345  Sum_probs=181.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHH-HHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVN-LISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .++|+..+.||+|+||.||++... +|+.||||++.... .....++..|+. +++.++||||+++++++...+..++||
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~  100 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM  100 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence            467899999999999999999975 68999999997643 333445666666 778889999999999999999999999


Q ss_pred             EeccCCCccccccc--cCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          345 EFVPNQSLLDNLFV--RQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       345 e~~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      ||+++ +|.+++..  ......+++..+..++.|++.||.|||+. +   |+||||||+|||++.++.+||+|||+++..
T Consensus       101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            99985 77776642  12245689999999999999999999998 7   999999999999999999999999999866


Q ss_pred             CCCCcccccccccCcCcCchhhh----ccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          422 PEDITHISATLAGTLGYMAPEYV----VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      .....  .....||+.|+|||.+    .+..++.++||||||+++|||++|+.|+.......   ...      ......
T Consensus       177 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---~~~------~~~~~~  245 (327)
T 3aln_A          177 VDSIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---DQL------TQVVKG  245 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC----------------CCCCCS
T ss_pred             ccccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---HHH------HHHhcC
Confidence            43321  2234689999999998    45678999999999999999999999875432110   000      011111


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..+.+........+..+.+++.+||+.||++||++.++++
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence            1111222223346778999999999999999999999976

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=9.1e-39  Score=328.37  Aligned_cols=262  Identities=22%  Similarity=0.306  Sum_probs=199.7

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-----Cce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~  340 (573)
                      .++|+..+.||+|+||.||+|+.. +|+.||||++... .......+.+|+.++++++||||+++++++...     ...
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            468999999999999999999975 6899999999653 334456788999999999999999999987654     678


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+. ++|.+++..    ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..
T Consensus        90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI  161 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence            99999997 688888743    35899999999999999999999988   99999999999999999999999999987


Q ss_pred             cCCCCcc---------cccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh
Q 008239          421 FPEDITH---------ISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV  490 (573)
Q Consensus       421 ~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  490 (573)
                      .......         ......||+.|+|||.+.. ..++.++||||||+++|||++|+.|+....... ....+.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~  240 (353)
T 2b9h_A          162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRH-QLLLIFGIIG  240 (353)
T ss_dssp             CC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHC
T ss_pred             cccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhC
Confidence            6432211         1123468999999998765 789999999999999999999999876433211 1111111111


Q ss_pred             cCc----cccccCc-------ccc-------CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          491 KGR----LHEAVDP-------ALA-------GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       491 ~~~----~~~~~d~-------~l~-------~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ...    ......+       .+.       .......+..+.+++.+||+.||++|||++|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          241 TPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            000    0000000       000       00112456778999999999999999999999973

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.5e-38  Score=315.63  Aligned_cols=252  Identities=24%  Similarity=0.312  Sum_probs=203.3

Q ss_pred             HHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ...++|+..++||+|+||.||+++.. +++.||||++....  ....+.+.+|+.++++++||||+++++++......++
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   98 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI   98 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence            34568999999999999999999975 68999999986532  3346788999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC---CcEEEeeccccc
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE---FTAKIADFGLVR  419 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~---~~~kl~Dfgla~  419 (573)
                      |+||+++++|.+++...   ..+++..++.++.||+.||.|||+.+   |+||||||+||+++.+   +.+||+|||++.
T Consensus        99 v~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~  172 (287)
T 2wei_A           99 VGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (287)
T ss_dssp             EECCCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred             EEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence            99999999999888543   35899999999999999999999988   9999999999999754   479999999998


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .......  .....+|+.|+|||.+.+ .++.++||||||+++|||++|+.|+.....     .........+..... .
T Consensus       173 ~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-----~~~~~~~~~~~~~~~-~  243 (287)
T 2wei_A          173 CFQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE-----YDILKRVETGKYAFD-L  243 (287)
T ss_dssp             TBCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCCCCC-S
T ss_pred             eecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCCCCC-c
Confidence            6644322  223457899999998865 589999999999999999999998754321     111222222221100 0


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +     .....+..+.+++.+||+.+|++|||+.|+++
T Consensus       244 ~-----~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          244 P-----QWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             G-----GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             h-----hhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            0     01234678899999999999999999999997

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.3e-38  Score=329.62  Aligned_cols=257  Identities=20%  Similarity=0.291  Sum_probs=196.7

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce----
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES----  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----  340 (573)
                      .++|...+.||+|+||+||+|... +|+.||||++...  .....+.+.+|+.+++.++||||+++++++......    
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467899999999999999999865 6899999999654  334467888999999999999999999999877655    


Q ss_pred             --eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          341 --LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       341 --~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                        ++||||+. ++|.+.+.     ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++
T Consensus       121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a  191 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  191 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred             eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence              99999997 67877662     23899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc--cc
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR--LH  495 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~  495 (573)
                      +.....    .....||+.|+|||.+.+ ..++.++||||||+++|||++|+.|+....... ....+........  ..
T Consensus       192 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~i~~~~~~~~~~~~  266 (371)
T 4exu_A          192 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGTEFV  266 (371)
T ss_dssp             ------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCHHHH
T ss_pred             cccccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCcHHHH
Confidence            865432    234568999999999987 789999999999999999999999886433211 1111111100000  00


Q ss_pred             cc------------cCcccc---CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          496 EA------------VDPALA---GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       496 ~~------------~d~~l~---~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..            +.....   .......+..+.+|+.+||+.||++|||++|+++.
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          267 QKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             TTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            00            000000   00112346788999999999999999999999974

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=4.6e-38  Score=323.35  Aligned_cols=256  Identities=21%  Similarity=0.301  Sum_probs=197.6

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc-----
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-----  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  339 (573)
                      .++|...+.||+|+||.||+|+.. +|+.||||++...  .....+.+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            467899999999999999999975 6899999999653  33445678899999999999999999999987654     


Q ss_pred             -eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          340 -SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       340 -~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                       .++||||+. ++|.+++.     ..+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~  173 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA  173 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred             eEEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccc
Confidence             499999997 68887762     24899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC-----
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG-----  492 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  492 (573)
                      +.....    .....+|+.|+|||.+.+ ..++.++||||||+++|||++|+.|+...... .....+.......     
T Consensus       174 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~-~~~~~i~~~~~~~~~~~~  248 (353)
T 3coi_A          174 RHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL-DQLTQILKVTGVPGTEFV  248 (353)
T ss_dssp             TC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHH-HHHHHHHHHHCBCCHHHH
T ss_pred             cCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHHHhCCCCHHHH
Confidence            865432    234568999999999877 68899999999999999999999987653321 1111111110000     


Q ss_pred             -------------ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          493 -------------RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       493 -------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                                   .+.....+.+ .......+..+.+++.+||+.||++|||++|+++.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          249 QKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             TTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                         0000000011 11223457789999999999999999999999964

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.3e-38  Score=321.73  Aligned_cols=259  Identities=21%  Similarity=0.266  Sum_probs=202.5

Q ss_pred             hcCccccccccccCceeEEEEEc--CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCC------eeeeeeeeecCCc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL--PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN------LVKLLGCSITGPE  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~--~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  339 (573)
                      .++|+..++||+|+||+||++..  .+++.||||++... ....+.+.+|+.+++.++|+|      ++++++++.....
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~   91 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH   91 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence            46899999999999999999986  36889999998643 344567888999998887654      9999999999999


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-------------
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-------------  406 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-------------  406 (573)
                      .++||||+ +++|.+++.... ...+++..++.++.||+.||+|||+++   |+||||||+|||++.             
T Consensus        92 ~~lv~e~~-~~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           92 ICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             EEEEEECC-CCBHHHHHHHTT-TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             EEEEEcCC-CCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence            99999999 889999885432 346899999999999999999999988   999999999999987             


Q ss_pred             ------CCcEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcc
Q 008239          407 ------EFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS  480 (573)
Q Consensus       407 ------~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~  480 (573)
                            ++.+||+|||++......    .....||+.|+|||.+.+..++.++||||||+++|||++|+.|+....... 
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  241 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKE-  241 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHH-
T ss_pred             ccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHH-
Confidence                  678999999999865432    234578999999999999999999999999999999999999886543211 


Q ss_pred             hHHHHHHHhhc--------Cccccc---------------------cCccc-cCCCCCchHHHHHHHHHHccCCCCCCCC
Q 008239          481 ILQTVWDLYVK--------GRLHEA---------------------VDPAL-AGNFQEGKPSRLLQIGLLCVQASAELRP  530 (573)
Q Consensus       481 ~~~~~~~~~~~--------~~~~~~---------------------~d~~l-~~~~~~~~~~~l~~l~~~cl~~~p~~RP  530 (573)
                      ....+......        ......                     ..+.. ........+..+.+++.+||+.||++||
T Consensus       242 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  321 (339)
T 1z57_A          242 HLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRI  321 (339)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccccc
Confidence            11111111000        000000                     00000 0112344578899999999999999999


Q ss_pred             CHHHHHH
Q 008239          531 SMSIVVK  537 (573)
Q Consensus       531 t~~evl~  537 (573)
                      |++|+++
T Consensus       322 t~~ell~  328 (339)
T 1z57_A          322 TLREALK  328 (339)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999985

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.6e-38  Score=326.33  Aligned_cols=261  Identities=20%  Similarity=0.265  Sum_probs=199.1

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-----------CCCeeeeeeeee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----------HKNLVKLLGCSI  335 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~  335 (573)
                      .++|+..++||+|+||+||+|+. .+++.||||++... ....+.+.+|+.++++++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            36799999999999999999996 46899999998643 334567888999998886           899999999987


Q ss_pred             cCC----ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeC-----
Q 008239          336 TGP----ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLD-----  405 (573)
Q Consensus       336 ~~~----~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~-----  405 (573)
                      ...    ..++||||+ +++|.+++.... ...+++..++.++.||+.||+|||++ +   |+||||||+|||++     
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE-HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh-ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCC
Confidence            644    678999999 889999885432 34589999999999999999999997 7   99999999999994     


Q ss_pred             -CCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc-----
Q 008239          406 -EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC-----  479 (573)
Q Consensus       406 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~-----  479 (573)
                       ..+.+||+|||++......    .....||+.|+|||++.+..++.++||||||+++|||++|+.|+.......     
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  247 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  247 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChH
Confidence             4458999999999866432    234578999999999999999999999999999999999999986543211     


Q ss_pred             chHHHHHHHhh--------cCcc----------ccccCc--------cc--cCCCCCchHHHHHHHHHHccCCCCCCCCC
Q 008239          480 SILQTVWDLYV--------KGRL----------HEAVDP--------AL--AGNFQEGKPSRLLQIGLLCVQASAELRPS  531 (573)
Q Consensus       480 ~~~~~~~~~~~--------~~~~----------~~~~d~--------~l--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt  531 (573)
                      .....+.....        .++.          ...+..        .+  ...++...+..+.+|+.+||+.||++|||
T Consensus       248 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  327 (373)
T 1q8y_A          248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  327 (373)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC
Confidence            11111111100        0000          000000        00  01234566788999999999999999999


Q ss_pred             HHHHHHH
Q 008239          532 MSIVVKM  538 (573)
Q Consensus       532 ~~evl~~  538 (573)
                      ++|+++.
T Consensus       328 ~~ell~h  334 (373)
T 1q8y_A          328 AGGLVNH  334 (373)
T ss_dssp             HHHHHTC
T ss_pred             HHHHhhC
Confidence            9999973

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.4e-38  Score=334.35  Aligned_cols=252  Identities=23%  Similarity=0.299  Sum_probs=185.9

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      +.|...++||+|+||+||.+...+|+.||||++...   ..+.+.+|+.++.++ +||||+++++++.+....++||||+
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~   91 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC   91 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecC
Confidence            345567889999999998776677999999998653   245678899999876 8999999999999999999999999


Q ss_pred             cCCCccccccccCCCC----CCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC-------------CcE
Q 008239          348 PNQSLLDNLFVRQDVE----PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-------------FTA  410 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~----~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~-------------~~~  410 (573)
                      . |+|.+++.......    ..++..++.++.||+.||+|||+++   |+||||||+|||++.+             +.+
T Consensus        92 ~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           92 N-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             S-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             C-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEE
Confidence            5 69999886433211    1133456789999999999999988   9999999999999653             589


Q ss_pred             EEeecccccccCCCCcc---cccccccCcCcCchhhhcc-------CCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCc
Q 008239          411 KIADFGLVRLFPEDITH---ISATLAGTLGYMAPEYVVR-------GKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSC  479 (573)
Q Consensus       411 kl~Dfgla~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~  479 (573)
                      ||+|||+++........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |+.|+.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            99999999977543322   1234579999999999975       678999999999999999999 777764322110


Q ss_pred             chHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                         .   .. ..+...   .+.+........+..+.+++.+||+.||++|||+.||++
T Consensus       248 ---~---~i-~~~~~~---~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ---S---NI-IRGIFS---LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ---H---HH-HHTCCC---CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---H---HH-hcCCCC---cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence               1   11 111110   001111112345678999999999999999999999986

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.2e-39  Score=326.47  Aligned_cols=244  Identities=24%  Similarity=0.360  Sum_probs=200.1

Q ss_pred             HHHhcCccccccccccCceeEEEEEc-CCCCEEEEEEecccCh------hhHHHHHHHHHHHcCCC--CCCeeeeeeeee
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT------QWVDHFFNEVNLISGIN--HKNLVKLLGCSI  335 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~  335 (573)
                      +...++|+..++||+|+||.||+|+. .+++.||||++.....      ...+.+.+|+.++++++  |+||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            34457899999999999999999986 4688999999865422      12245667999999996  599999999999


Q ss_pred             cCCceeEEEEeccC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC-CCCcEEEe
Q 008239          336 TGPESLLVYEFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIA  413 (573)
Q Consensus       336 ~~~~~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~kl~  413 (573)
                      .....++|+|++.+ ++|.+++...   ..+++..++.++.||+.||+|||+.+   |+||||||+|||++ +++.+||+
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999976 8999988543   45899999999999999999999988   99999999999999 78999999


Q ss_pred             ecccccccCCCCcccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC
Q 008239          414 DFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG  492 (573)
Q Consensus       414 Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  492 (573)
                      |||++.......   .....||+.|+|||.+.+..+ +.++||||||+++|||++|+.|+....       .   . ..+
T Consensus       193 Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-------~---~-~~~  258 (320)
T 3a99_A          193 DFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E---I-IRG  258 (320)
T ss_dssp             CCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H---H-HHC
T ss_pred             eCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-------h---h-hcc
Confidence            999998765432   234568999999999987765 678999999999999999999874321       0   0 111


Q ss_pred             ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       493 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ..          ..+...+..+.+++.+||+.+|++|||++|+++.
T Consensus       259 ~~----------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          259 QV----------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CC----------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cc----------cccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            10          1233456789999999999999999999999973

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=3.3e-38  Score=322.15  Aligned_cols=254  Identities=19%  Similarity=0.218  Sum_probs=174.3

Q ss_pred             HhcCccccc-cccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec----CCce
Q 008239          267 ATNYFHESN-KLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPES  340 (573)
Q Consensus       267 ~~~~~~~~~-~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~  340 (573)
                      ..++|...+ +||+|+||+||+++.. +|+.||||++.....    ........++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            346788754 6999999999999976 689999999865321    11223334566799999999999875    4457


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---CCcEEEeeccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGL  417 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgl  417 (573)
                      ++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+++   |+||||||+|||++.   ++.+||+|||+
T Consensus       102 ~lv~e~~~gg~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQERG-DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEeccCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEecccc
Confidence            89999999999999986432 346999999999999999999999998   999999999999976   45699999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      +.......   .....+|+.|+|||.+....++.++||||||+++|||++|+.|+........ ..........+.    
T Consensus       178 ~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~----  249 (336)
T 3fhr_A          178 AKETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI-SPGMKRRIRLGQ----  249 (336)
T ss_dssp             CEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------
T ss_pred             ceeccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhh-hhhHHHhhhccc----
Confidence            98654322   2345679999999999888899999999999999999999999754432211 000000000000    


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                        ..+........+..+.+++.+||+.||++|||++|+++.
T Consensus       250 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          250 --YGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             ---CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             --cccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence              011111123456789999999999999999999999983

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.4e-38  Score=324.53  Aligned_cols=206  Identities=24%  Similarity=0.279  Sum_probs=172.4

Q ss_pred             HHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CC-----Ceeeeeeee
Q 008239          262 ETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HK-----NLVKLLGCS  334 (573)
Q Consensus       262 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~  334 (573)
                      .......++|+..++||+|+||+||+|... +++.||||++... ....+++..|+.++..++ |+     +|+++++++
T Consensus        47 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~  125 (382)
T 2vx3_A           47 KNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHF  125 (382)
T ss_dssp             CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEE
T ss_pred             ecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeee
Confidence            334445688999999999999999999875 6889999999643 334567778888888774 44     499999999


Q ss_pred             ecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC--CCCcEEE
Q 008239          335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEFTAKI  412 (573)
Q Consensus       335 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~--~~~~~kl  412 (573)
                      ......++||||++ ++|.+++.... ...+++..+..++.||+.||.|||++. .+|+||||||+|||++  .++.+||
T Consensus       126 ~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~-~~ivHrDlkp~NIll~~~~~~~~kL  202 (382)
T 2vx3_A          126 MFRNHLCLVFEMLS-YNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENILLCNPKRSAIKI  202 (382)
T ss_dssp             EETTEEEEEEECCC-CBHHHHHHHTT-TSCCCHHHHHHHHHHHHHHHHHHTSTT-TCEECCCCSGGGEEESSTTSCCEEE
T ss_pred             ccCCceEEEEecCC-CCHHHHHhhcC-cCCCCHHHHHHHHHHHHHHHHHhccCC-CCEEcCCCCcccEEEecCCCCcEEE
Confidence            99999999999996 59999886432 245899999999999999999999531 2499999999999995  5788999


Q ss_pred             eecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCC
Q 008239          413 ADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFT  475 (573)
Q Consensus       413 ~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~  475 (573)
                      +|||+++.....    .....||+.|+|||++.+..++.++|||||||++|||++|+.|+...
T Consensus       203 ~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~  261 (382)
T 2vx3_A          203 VDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGA  261 (382)
T ss_dssp             CCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             EeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999876432    23457899999999999999999999999999999999999988654

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=319.60  Aligned_cols=245  Identities=25%  Similarity=0.334  Sum_probs=192.1

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh------hhHHHHHHHHHHHcCC----CCCCeeeeee
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT------QWVDHFFNEVNLISGI----NHKNLVKLLG  332 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l----~h~niv~l~~  332 (573)
                      .+...++|+..++||+|+||.||+|+.. +++.||||++.....      .....+.+|+.++.++    +||||+++++
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~  105 (312)
T 2iwi_A           26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD  105 (312)
T ss_dssp             -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred             hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence            4455678999999999999999999874 688999999965432      1223455788888888    8999999999


Q ss_pred             eeecCCceeEEEEe-ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC-CCCcE
Q 008239          333 CSITGPESLLVYEF-VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTA  410 (573)
Q Consensus       333 ~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~  410 (573)
                      ++...+..++|+|| +++++|.+++...   ..+++..++.++.||+.||.|||+++   |+||||||+||+++ .++.+
T Consensus       106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          106 WFETQEGFMLVLERPLPAQDLFDYITEK---GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EC-----CEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEE
T ss_pred             EEecCCeEEEEEEecCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeE
Confidence            99999999999999 7899999998543   35899999999999999999999998   99999999999999 88999


Q ss_pred             EEeecccccccCCCCcccccccccCcCcCchhhhccCCCC-cccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHh
Q 008239          411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT-EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLY  489 (573)
Q Consensus       411 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~  489 (573)
                      ||+|||++.......   .....|+..|+|||++.+..+. .++||||||+++|||++|+.|+....       ..    
T Consensus       180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-------~~----  245 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-------EI----  245 (312)
T ss_dssp             EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------HH----
T ss_pred             EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-------HH----
Confidence            999999998765432   2345689999999999877664 58999999999999999998874321       00    


Q ss_pred             hcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          490 VKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       490 ~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ....          ...+...+..+.+++.+||+.+|++|||++|+++.
T Consensus       246 ~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          246 LEAE----------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             HHTC----------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             hhhc----------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            1111          11234456788999999999999999999999984

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=8.1e-38  Score=316.30  Aligned_cols=252  Identities=23%  Similarity=0.354  Sum_probs=180.7

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh--hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT--QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .++|+..+.||+|+||.||+++.. +|+.||||++.....  ...+.+.++..+++.++||||+++++++......++||
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~  103 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM  103 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence            467889999999999999999985 689999999975432  22334445556788899999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      ||+ ++.+..+. .. ....+++..++.++.||+.||.|||++ +   |+||||||+|||++.++.+||+|||++.....
T Consensus       104 e~~-~~~~~~l~-~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  177 (318)
T 2dyl_A          104 ELM-GTCAEKLK-KR-MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD  177 (318)
T ss_dssp             CCC-SEEHHHHH-HH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred             ecc-CCcHHHHH-HH-hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence            999 44443333 22 134689999999999999999999985 7   99999999999999999999999999976543


Q ss_pred             CCcccccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          424 DITHISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      ..  ......+|+.|+|||.+.     ...++.++||||||+++|||++|+.|+...........   .. ..+..    
T Consensus       178 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~---~~-~~~~~----  247 (318)
T 2dyl_A          178 DK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLT---KV-LQEEP----  247 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHH---HH-HHSCC----
T ss_pred             Cc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHH---HH-hccCC----
Confidence            22  223456899999999994     56788999999999999999999988764332211111   11 11111    


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       +.+  ......+..+.+++.+||+.||.+||+++++++.
T Consensus       248 -~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          248 -PLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             -CCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             -CCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence             111  1122356789999999999999999999999863

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.4e-37  Score=319.29  Aligned_cols=259  Identities=19%  Similarity=0.224  Sum_probs=199.9

Q ss_pred             hcCccccccccccCceeEEEEEcC-CC-CEEEEEEecccChhhHHHHHHHHHHHcCCCCCC------eeeeeeeeecCCc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GG-EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN------LVKLLGCSITGPE  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~~~~~~  339 (573)
                      .++|+..+.||+|+||+||++... ++ +.||||++... ....+.+.+|+.++++++|+|      ++.+++++.....
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~   96 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH   96 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence            468999999999999999999874 34 68999998643 344567888999999987766      8999999999999


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee---------------
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL---------------  404 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll---------------  404 (573)
                      .++||||+ +++|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+|||+               
T Consensus        97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence            99999999 66777776543 2346899999999999999999999987   9999999999999               


Q ss_pred             ----CCCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcc
Q 008239          405 ----DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS  480 (573)
Q Consensus       405 ----~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~  480 (573)
                          +.++.+||+|||+++.....    .....||+.|+|||++.+..++.++||||||+++|||++|+.|+....... 
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-  246 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE-  246 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             cccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Confidence                56789999999999865432    234578999999999999999999999999999999999999986543221 


Q ss_pred             hHHHHHHHhhc--------Cccccc-cCc-------------------cc--cCCCCCchHHHHHHHHHHccCCCCCCCC
Q 008239          481 ILQTVWDLYVK--------GRLHEA-VDP-------------------AL--AGNFQEGKPSRLLQIGLLCVQASAELRP  530 (573)
Q Consensus       481 ~~~~~~~~~~~--------~~~~~~-~d~-------------------~l--~~~~~~~~~~~l~~l~~~cl~~~p~~RP  530 (573)
                      ....+......        ...... ...                   .+  ........+..+.+|+.+||+.||++||
T Consensus       247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp  326 (355)
T 2eu9_A          247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI  326 (355)
T ss_dssp             HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred             HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence            11111111100        000000 000                   00  0011234467899999999999999999


Q ss_pred             CHHHHHH
Q 008239          531 SMSIVVK  537 (573)
Q Consensus       531 t~~evl~  537 (573)
                      |++|+++
T Consensus       327 t~~e~l~  333 (355)
T 2eu9_A          327 TLAEALL  333 (355)
T ss_dssp             CHHHHTT
T ss_pred             CHHHHhc
Confidence            9999985

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9e-38  Score=329.22  Aligned_cols=250  Identities=22%  Similarity=0.268  Sum_probs=185.8

Q ss_pred             HhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEEEE
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ...+|...++||+|+||+|+.....+|+.||||++......   .+.+|+.+|+++ +|||||++++++.+....++|||
T Consensus        22 ~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E   98 (432)
T 3p23_A           22 GKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE   98 (432)
T ss_dssp             TTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence            34568889999999999976555567899999999654322   356799999999 79999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-----CCcEEEeecccccc
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRL  420 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-----~~~~kl~Dfgla~~  420 (573)
                      |++ |+|.+++....  ..+.+..++.++.||+.||.|||+.+   |+||||||+|||++.     ...+||+|||+++.
T Consensus        99 ~~~-g~L~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~  172 (432)
T 3p23_A           99 LCA-ATLQEYVEQKD--FAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK  172 (432)
T ss_dssp             CCS-EEHHHHHHSSS--CCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred             CCC-CCHHHHHHhcC--CCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence            996 69999885433  23444556789999999999999998   999999999999953     34688999999987


Q ss_pred             cCCCCc--ccccccccCcCcCchhhhc---cCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCcc
Q 008239          421 FPEDIT--HISATLAGTLGYMAPEYVV---RGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRL  494 (573)
Q Consensus       421 ~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  494 (573)
                      ......  .......||+.|+|||++.   ...++.++|||||||++|||++ |..|+.....     ............
T Consensus       173 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~-----~~~~~~~~~~~~  247 (432)
T 3p23_A          173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQ-----RQANILLGACSL  247 (432)
T ss_dssp             C------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTT-----HHHHHHTTCCCC
T ss_pred             ccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhH-----HHHHHHhccCCc
Confidence            653322  2233567999999999997   4577889999999999999999 6666533221     111111111110


Q ss_pred             ccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       495 ~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       ..      ..........+.+|+.+||+.||++|||++||++
T Consensus       248 -~~------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          248 -DC------LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             -TT------SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -cc------cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence             00      0112334566889999999999999999999984

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=3.6e-38  Score=343.20  Aligned_cols=259  Identities=24%  Similarity=0.292  Sum_probs=199.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec------CCc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT------GPE  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~~  339 (573)
                      .++|+..++||+|+||+||++... +|+.||||++... .....+.+.+|+.++++++||||+++++++..      ...
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            368999999999999999999874 6899999998654 44456788999999999999999999998765      667


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCc---EEEeecc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFT---AKIADFG  416 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~---~kl~Dfg  416 (573)
                      .++||||+++|+|.+++........+++..++.++.|++.||+|||+.+   |+||||||+|||++.++.   +||+|||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG  169 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLG  169 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccc
Confidence            8999999999999999976555556899999999999999999999988   999999999999997664   9999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc---
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR---  493 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---  493 (573)
                      ++.......  ......||+.|+|||.+.+..++.++||||||+++|||++|+.|+......   ..+.........   
T Consensus       170 ~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~---~~~~~~i~~~~~~~~  244 (676)
T 3qa8_A          170 YAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP---VQWHGKVREKSNEHI  244 (676)
T ss_dssp             CCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH---HHSSTTCC------C
T ss_pred             ccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch---hhhhhhhhcccchhh
Confidence            998764432  223467899999999999999999999999999999999999998653211   000000000000   


Q ss_pred             -ccccc------Cccc--cCCCCCchHHHHHHHHHHccCCCCCCCCCHHH
Q 008239          494 -LHEAV------DPAL--AGNFQEGKPSRLLQIGLLCVQASAELRPSMSI  534 (573)
Q Consensus       494 -~~~~~------d~~l--~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~e  534 (573)
                       ..+..      ...+  ........+..+.+++.+||+.||++|||+.|
T Consensus       245 ~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~e  294 (676)
T 3qa8_A          245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQ  294 (676)
T ss_dssp             CSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTT
T ss_pred             hhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHH
Confidence             00000      0000  11234457889999999999999999999965

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.7e-37  Score=340.81  Aligned_cols=236  Identities=21%  Similarity=0.255  Sum_probs=189.9

Q ss_pred             hcCccccccccccCceeEEEEEcC--CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc-----
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP--GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE-----  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~--~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-----  339 (573)
                      .++|++.++||+|+||+||++.+.  +|+.||||++... .....+.+.+|+.++++++||||+++++++.....     
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            367999999999999999999975  5899999998654 34556678899999999999999999999987665     


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++||||+++++|.+++..     .+++..++.++.||+.||.|||+++   |+||||||+|||++.+ .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccch
Confidence            6999999999999887632     5899999999999999999999998   9999999999999986 99999999998


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD  499 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d  499 (573)
                      .....     ....||+.|+|||++.++. +.++||||||+++|||++|..|+......              .+    .
T Consensus       230 ~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------------~~----~  285 (681)
T 2pzi_A          230 RINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD--------------GL----P  285 (681)
T ss_dssp             ETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS--------------SC----C
T ss_pred             hcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc--------------cc----c
Confidence            76443     3457899999999987664 89999999999999999997764321110              00    0


Q ss_pred             ccccCCCCCchHHHHHHHHHHccCCCCCCCCC-HHHHHHHh
Q 008239          500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPS-MSIVVKML  539 (573)
Q Consensus       500 ~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-~~evl~~L  539 (573)
                         ........+..+.+|+.+||+.||++||+ ++++.+.|
T Consensus       286 ---~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  323 (681)
T 2pzi_A          286 ---EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQL  323 (681)
T ss_dssp             ---TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             ---ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHH
Confidence               00000112357889999999999999996 55555554

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.6e-36  Score=302.39  Aligned_cols=227  Identities=12%  Similarity=0.062  Sum_probs=182.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+..+.||+|+||.||+|+.. +|+.||||++....   .+..+.+.+|+.++.+++||||+++++++...+..++||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            67999999999999999999986 48999999997542   344578899999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++++|.+++..    . .....+.+++.||+.||+|||+++   |+||||||+|||++.++.+||++++        
T Consensus       111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc--------
Confidence            99999999999832    1 355678899999999999999998   9999999999999999999998543        


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc-
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA-  503 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~-  503 (573)
                                   |++       .++.++||||||+++|||++|+.|+........+.          .....+..... 
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~----------~~~~~~~~~~~~  224 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLA----------PAERDTAGQPIE  224 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSE----------ECCBCTTSCBCC
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhH----------HHHHHhccCCCC
Confidence                         333       36889999999999999999999986543221000          00000000000 


Q ss_pred             -CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          504 -GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       504 -~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                       .......+..+.+|+.+||+.||++| |+.|+++.|...
T Consensus       225 ~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          225 PADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             HHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             hhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence             01123456789999999999999999 999999999553

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-37  Score=326.52  Aligned_cols=242  Identities=16%  Similarity=0.144  Sum_probs=179.9

Q ss_pred             HhcCccccccccccCceeEEEEEc-CCCCEEEEEEecccCh---hhHHHHHHHHHHHcCCCC-CCeeeee----------
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTT---QWVDHFFNEVNLISGINH-KNLVKLL----------  331 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~l~----------  331 (573)
                      .+..|...++||+|+||+||+|++ .+|+.||||++.....   ...+.+.+|+.+++.++| +|.....          
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCE
T ss_pred             CceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchh
Confidence            345688889999999999999995 5799999999874322   335788999999999987 3221111          


Q ss_pred             -----------eeeec-----CCceeEEEEeccCCCccccccc----cCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 008239          332 -----------GCSIT-----GPESLLVYEFVPNQSLLDNLFV----RQDVEPLSWEVRYKIILSTAEGLAYLHEESKLR  391 (573)
Q Consensus       332 -----------~~~~~-----~~~~~lv~e~~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~  391 (573)
                                 .+...     ....+++|+++ +++|.+++..    ......+++..++.++.||+.||+|||+++   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---  231 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---  231 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---
Confidence                       11111     12345666654 6889887731    122345788899999999999999999988   


Q ss_pred             eEEecCCCCCeeeCCCCcEEEeecccccccCCCCcccccccccCcCcCchhhh----------ccCCCCcccchHhHHHH
Q 008239          392 IIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYV----------VRGKLTEKADVYSFGVV  461 (573)
Q Consensus       392 iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~sDvwslGvi  461 (573)
                      |+||||||+||||+.++.+||+|||+++.....    .....| +.|+|||++          ....++.++|||||||+
T Consensus       232 iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvi  306 (413)
T 3dzo_A          232 LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLA  306 (413)
T ss_dssp             EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHH
T ss_pred             cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHH
Confidence            999999999999999999999999998865432    334567 999999999          55568889999999999


Q ss_pred             HHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHH
Q 008239          462 VIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVV  536 (573)
Q Consensus       462 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl  536 (573)
                      +|||++|+.|+.......                 ..+..+..  ....+..+.+|+.+||+.||++||++.+++
T Consensus       307 l~elltg~~Pf~~~~~~~-----------------~~~~~~~~--~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l  362 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALG-----------------GSEWIFRS--CKNIPQPVRALLEGFLRYPKEDRLLPLQAM  362 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGS-----------------CSGGGGSS--CCCCCHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             HHHHHHCCCCCCCcchhh-----------------hHHHHHhh--cccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence            999999999975432211                 11111111  123457899999999999999999976654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=2.6e-35  Score=295.54  Aligned_cols=227  Identities=19%  Similarity=0.234  Sum_probs=177.7

Q ss_pred             cCcccc-ccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHH-cCCCCCCeeeeeeeeec----CCcee
Q 008239          269 NYFHES-NKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLI-SGINHKNLVKLLGCSIT----GPESL  341 (573)
Q Consensus       269 ~~~~~~-~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~----~~~~~  341 (573)
                      ++|... +.||+|+||.||++.. .+++.||||++...     ..+.+|+.++ +.++||||+++++++..    ....+
T Consensus        17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            456666 7899999999999987 46899999998532     4567788887 66699999999999876    66789


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---CCcEEEeecccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLV  418 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla  418 (573)
                      +||||+++++|.+++.... ...+++..++.++.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRG-DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence            9999999999999986532 346899999999999999999999988   999999999999998   789999999998


Q ss_pred             cccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      ....                       +..++.++||||||+++|||++|+.|+........         . ......+
T Consensus       168 ~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---------~-~~~~~~~  214 (299)
T 3m2w_A          168 KETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---------S-PGMKTRI  214 (299)
T ss_dssp             EECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-----------------CCSCCSS
T ss_pred             cccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---------h-HHHHHHH
Confidence            7542                       13467799999999999999999999754322100         0 0000000


Q ss_pred             CccccCCCC----CchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          499 DPALAGNFQ----EGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       499 d~~l~~~~~----~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .... ...+    ...+..+.+++.+||+.||++|||++|+++.
T Consensus       215 ~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          215 RMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             CTTC-CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhcc-ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            0000 0011    2356789999999999999999999999974

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.3e-36  Score=308.40  Aligned_cols=242  Identities=16%  Similarity=0.139  Sum_probs=181.4

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccC--------hhhHHHHHHHHHHHcCCC---------CCCeeee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--------TQWVDHFFNEVNLISGIN---------HKNLVKL  330 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~l  330 (573)
                      .++|+..++||+|+||+||+|+. +|+.||||++....        ....+.+.+|+.+++.++         |||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            46788999999999999999998 68999999996542        223467888999988885         6666665


Q ss_pred             eee-----------------eec-------------CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHH
Q 008239          331 LGC-----------------SIT-------------GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEG  380 (573)
Q Consensus       331 ~~~-----------------~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~  380 (573)
                      .+.                 +.+             ....++||||+++|++.+.+..    ..+++..++.++.||+.|
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence            554                 333             6789999999999988777732    458999999999999999


Q ss_pred             HHHHH-hcCCCCeEEecCCCCCeeeCCCC--------------------cEEEeecccccccCCCCcccccccccCcCcC
Q 008239          381 LAYLH-EESKLRIIHRDIKLSNILLDEEF--------------------TAKIADFGLVRLFPEDITHISATLAGTLGYM  439 (573)
Q Consensus       381 l~yLH-~~~~~~iiHrDlk~~NIll~~~~--------------------~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~  439 (573)
                      |+||| +.+   |+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+
T Consensus       174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~  244 (336)
T 2vuw_A          174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSM  244 (336)
T ss_dssp             HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTT
T ss_pred             HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeeccc
Confidence            99999 888   99999999999999887                    8999999999876432      347899999


Q ss_pred             chhhhccCCCCcccchHhHHHH-HHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHH
Q 008239          440 APEYVVRGKLTEKADVYSFGVV-VIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIG  518 (573)
Q Consensus       440 aPE~~~~~~~~~~sDvwslGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~  518 (573)
                      |||++.+.. +.++|||||+++ .+++++|..|+....    ..............   .............+.++.+|+
T Consensus       245 aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~----~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~~~dli  316 (336)
T 2vuw_A          245 DEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL----WLHYLTDKMLKQMT---FKTKCNTPAMKQIKRKIQEFH  316 (336)
T ss_dssp             CSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH----HHHHHHHHHHHTCC---CSSCCCSHHHHHHHHHHHHHH
T ss_pred             ChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh----hhhHHHHhhhhhhc---cCcccchhhhhhcCHHHHHHH
Confidence            999998666 899999998777 777888877752100    00001111110000   000000111234678899999


Q ss_pred             HHccCCCCCCCCCHHHHH
Q 008239          519 LLCVQASAELRPSMSIVV  536 (573)
Q Consensus       519 ~~cl~~~p~~RPt~~evl  536 (573)
                      .+||+.+     |++|++
T Consensus       317 ~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          317 RTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHGGGSS-----SHHHHH
T ss_pred             HHHhccC-----CHHHHH
Confidence            9999976     899988

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=8.7e-30  Score=276.55  Aligned_cols=183  Identities=20%  Similarity=0.207  Sum_probs=129.0

Q ss_pred             cccccCceeEEEEEc-CCCCEEEEEEecccC----------hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEE
Q 008239          276 KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT----------TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       276 ~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~----------~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ..+.|++|.+..++. --|+.+++|.+....          ....++|.+|+++|+++ .|+||++++++++++...|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            345566665555432 248889999986531          23346799999999999 799999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||++|++|.+.|...   ++++..   +|+.||+.||+|||+++   ||||||||+||||++++.+||+|||+++....
T Consensus       321 MEyv~G~~L~d~i~~~---~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~  391 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG---EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ  391 (569)
T ss_dssp             EECCCSEEHHHHHHTT---CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred             EecCCCCcHHHHHHhC---CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence            9999999999999543   456654   58899999999999998   99999999999999999999999999997654


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCC
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK  469 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~  469 (573)
                      +.. .....+||+.|||||++.+ .+..++|+||+|++++++.++.
T Consensus       392 ~~~-~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          392 DCS-WPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             --C-CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred             CCc-cccCceechhhccHHHhCC-CCCCcccccccccchhhhcccc
Confidence            332 2345679999999998865 5677899999999998887654

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=5e-27  Score=253.48  Aligned_cols=183  Identities=15%  Similarity=0.159  Sum_probs=144.1

Q ss_pred             cccccccccCceeEEEEEcCCCCEEEEEEecccCh--------hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--------QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ...++||+|+||+||++... ++.+++|+......        ...+.+.+|++++++++||||+++..++......++|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            45678999999999999554 78899998643211        1234688999999999999999777667777888999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++++|.+++..           +..++.|+++||.|||+++   |+||||||+|||++.  .+||+|||+++....
T Consensus       418 mE~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          418 MSYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             EECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             EECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999999999999843           5689999999999999988   999999999999999  999999999998754


Q ss_pred             CCccc------ccccccCcCcCchhhhcc--CCCCcccchHhHHHHHHHHHcCCCC
Q 008239          424 DITHI------SATLAGTLGYMAPEYVVR--GKLTEKADVYSFGVVVIEVVCRKRI  471 (573)
Q Consensus       424 ~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~sDvwslGvil~elltg~~p  471 (573)
                      .....      .....||+.|||||++..  ..|+..+|+|+..+-.++-+.++.+
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~r  537 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRAR  537 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccc
Confidence            32221      235679999999999976  6688889999999988887766543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=7e-24  Score=210.06  Aligned_cols=151  Identities=17%  Similarity=0.109  Sum_probs=121.4

Q ss_pred             HHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccCh------------------hhHHHHHHHHHHHcCCCCC
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------------------QWVDHFFNEVNLISGINHK  325 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~  325 (573)
                      +......|...+.||+|+||.||+|...+|+.||||++.....                  .....+.+|+.++++++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3444556777899999999999999997799999999864321                  13456889999999999  


Q ss_pred             CeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC
Q 008239          326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD  405 (573)
Q Consensus       326 niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~  405 (573)
                      | +++.+++. .+..++||||+++++|.+ +..         .....++.||+.||.|||+.+   |+||||||+|||++
T Consensus       163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~  227 (282)
T 1zar_A          163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS  227 (282)
T ss_dssp             T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred             C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence            4 66666543 356799999999999988 411         124579999999999999988   99999999999999


Q ss_pred             CCCcEEEeecccccccCCCCcccccccccCcCcCchhhhcc
Q 008239          406 EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR  446 (573)
Q Consensus       406 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~  446 (573)
                       ++.+||+|||+++.              +..++|||++..
T Consensus       228 -~~~vkl~DFG~a~~--------------~~~~~a~e~l~r  253 (282)
T 1zar_A          228 -EEGIWIIDFPQSVE--------------VGEEGWREILER  253 (282)
T ss_dssp             -TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred             -CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence             99999999999873              345789998853

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.81  E-value=7.4e-20  Score=151.94  Aligned_cols=101  Identities=23%  Similarity=0.455  Sum_probs=84.9

Q ss_pred             cceeecCCCCCCCchhhhHHHHHHHHHHHHHhccC-CCceeeeecccCCCceEEEEeeeccCCCcchhhhHHHHHHhhcc
Q 008239           89 DRTVCGSKDFGGNNTVFGANAIELVRNLSVQAVKN-DGFFVGSVTFSKGNVSVHGLAQCWEFVNGSACENCLENAVSRIA  167 (573)
Q Consensus        89 ~~~~~~~~~~~~~~~~f~~~~~~ll~~l~~~a~~~-~~~~~~~~~~~~~~~~vy~l~qC~~dl~~~~C~~Cl~~~~~~~~  167 (573)
                      .+..|+..+++. ++.|+.+|+.||..|+..++.+ .+|+++..+. .++++||||+||++|+++.+|..||+.++.++.
T Consensus         6 v~~~Cn~~~~t~-~s~f~~nl~~ll~~L~~~a~~s~~~~~t~~~~~-~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~   83 (108)
T 3a2e_A            6 VSSACNTQKIPS-GSPFNRNLRAMLADLRQNTAFSGYDYKTSRAGS-GGAPTAYGRATCKQSISQSDCTACLSNLVNRIF   83 (108)
T ss_dssp             EEEEECSSBCCT-TCTHHHHHHHHHHHHHHHGGGTTSEEEEEECCS-TTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHH
T ss_pred             eeeecCCCccCC-CChHHHHHHHHHHHHHhhCccccCCceEeeccC-CCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHH
Confidence            355688766554 5789999999999999988764 4466655542 456899999999999999999999999999998


Q ss_pred             c-ccCCCCcEEeccceeeecccccc
Q 008239          168 S-CTQKEEGRVLNAGCYLRYSTQRF  191 (573)
Q Consensus       168 ~-c~~~~~g~v~~~~C~~ry~~~~f  191 (573)
                      . |..++||++++.+|++|||+++|
T Consensus        84 ~~C~~~~g~~i~~~~C~lRY~~~~F  108 (108)
T 3a2e_A           84 SICNNAIGARVQLVDCFIQYEQRSF  108 (108)
T ss_dssp             HHTTSBSSEEEEETTEEEEEESSCC
T ss_pred             HHCCCCceEEEECCCEEEEEeCCcC
Confidence            7 66688999999999999999887

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.80  E-value=4.4e-20  Score=180.42  Aligned_cols=137  Identities=17%  Similarity=0.152  Sum_probs=105.8

Q ss_pred             CccccccccccCceeEEEEEc-CCCCE--EEEEEecccChh------------------------hHHHHHHHHHHHcCC
Q 008239          270 YFHESNKLGQGGSGSVYKGTL-PGGEA--VAVKRLFYNTTQ------------------------WVDHFFNEVNLISGI  322 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l  322 (573)
                      .|+..+.||+|+||.||+|.. .+|+.  ||||++......                        ....+.+|+..|.++
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            366789999999999999998 67888  999987543111                        123678899999999


Q ss_pred             CCCCe--eeeeeeeecCCceeEEEEeccC-C----CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH-hcCCCCeEE
Q 008239          323 NHKNL--VKLLGCSITGPESLLVYEFVPN-Q----SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH-EESKLRIIH  394 (573)
Q Consensus       323 ~h~ni--v~l~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH-~~~~~~iiH  394 (573)
                      .|+++  ..+++.    ...+|||||+.+ |    +|.++...      .++..+..++.|++.+|.||| +.+   |+|
T Consensus       128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivH  194 (258)
T 1zth_A          128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVH  194 (258)
T ss_dssp             HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EEC
T ss_pred             HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEe
Confidence            88764  344432    367899999952 4    44443321      224457789999999999999 877   999


Q ss_pred             ecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          395 RDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       395 rDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      |||||.|||+++  .++|+|||++...
T Consensus       195 rDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          195 ADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCCHHHEEEcC--cEEEEECcccccC
Confidence            999999999998  9999999999754

>3a2e_A Ginkbilobin-2; domain 26 unknown function (DUF26), C-X8-C-X2-C motif, antifungal protein, embryo-abundant protein (EAP), plant protein; 2.38A {Ginkgo biloba}

Probab=99.80  E-value=4.1e-20  Score=153.45  Aligned_cols=76  Identities=21%  Similarity=0.478  Sum_probs=66.4

Q ss_pred             Cccccccccc--ccEEeeeC-CCCCcEEEEEecCCCCChhhhHHHHHHHHHHHHhhCCCCCCcccEEEEccceEEEecCC
Q 008239            2 DIVTPLIARQ--RYAAVVNG-TGTASVYAFGECMKDLSPNDCNLCFAQCKTQVLKCLPFQLATRGGRVFYDGCYLRYDDY   78 (573)
Q Consensus         2 ~~l~~~~~~~--~~~~~~~~-~~~~~vygl~~C~~d~~~~~C~~Cl~~~~~~~~~~c~~~~~~~~~~~~~~~C~~ry~~~   78 (573)
                      ++|+++++.+  +|+++..+ .++++||||+|||||+++++|+.||+.++..++++||++   +||+||+++|++|||++
T Consensus        30 ~~L~~~a~~s~~~~~t~~~~~~~~~~vygl~qC~~Dls~~~C~~Cl~~a~~~~~~~C~~~---~g~~i~~~~C~lRY~~~  106 (108)
T 3a2e_A           30 ADLRQNTAFSGYDYKTSRAGSGGAPTAYGRATCKQSISQSDCTACLSNLVNRIFSICNNA---IGARVQLVDCFIQYEQR  106 (108)
T ss_dssp             HHHHHHGGGTTSEEEEEECCSTTCCCEEEEEEECTTSCHHHHHHHHHHHHTTHHHHTTSB---SSEEEEETTEEEEEESS
T ss_pred             HHHHhhCccccCCceEeeccCCCCceEEEEEEEcCCCCHHHHHHHHHHHHHHHHHHCCCC---ceEEEECCCEEEEEeCC
Confidence            4566666654  46666654 567999999999999999999999999999999999987   99999999999999999


Q ss_pred             Cc
Q 008239           79 DF   80 (573)
Q Consensus        79 ~f   80 (573)
                      +|
T Consensus       107 ~F  108 (108)
T 3a2e_A          107 SF  108 (108)
T ss_dssp             CC
T ss_pred             cC
Confidence            98

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.68  E-value=2e-17  Score=168.19  Aligned_cols=139  Identities=15%  Similarity=0.110  Sum_probs=98.2

Q ss_pred             CccccccccccCceeEEEEEcCCCCEEEEEEecccCh--------------hhHHHHHHHHHHHcCCCCCCeeeeeeeee
Q 008239          270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT--------------QWVDHFFNEVNLISGINHKNLVKLLGCSI  335 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~--------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~  335 (573)
                      -|++.++||+|+||.||+|...+|+.||||+++....              ........++++.....|+|+++++....
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3888999999999999999999999999998753210              01112223333333333444444433221


Q ss_pred             cC------CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-
Q 008239          336 TG------PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-  408 (573)
Q Consensus       336 ~~------~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-  408 (573)
                      ..      ...+|||||+++++|..+...         .....++.||+.+|.|||+.+   ||||||||.|||+++++ 
T Consensus       176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             SCCCEEEEETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred             CCCeeeeccCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence            11      234799999999888665411         123567899999999999988   99999999999998776 


Q ss_pred             ---------cEEEeecccccc
Q 008239          409 ---------TAKIADFGLVRL  420 (573)
Q Consensus       409 ---------~~kl~Dfgla~~  420 (573)
                               .+.|+||+-+..
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence                     389999997654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.32  E-value=3.5e-12  Score=124.42  Aligned_cols=146  Identities=17%  Similarity=0.069  Sum_probs=112.9

Q ss_pred             HHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeEE
Q 008239          265 EKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       265 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv  343 (573)
                      ......|.....++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. |.++.++++++...+..++|
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv   88 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL   88 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence            334456877888888889999999865 6889999986532222345788999998884 67788999999888889999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE------------------------------------  387 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------------------------------------  387 (573)
                      |||+++.+|.+.+.        +......++.+++++|+.||+.                                    
T Consensus        89 ~e~i~G~~l~~~~~--------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (263)
T 3tm0_A           89 MSEADGVLCSEEYE--------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE  160 (263)
T ss_dssp             EECCSSEEHHHHCC--------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred             EEecCCeehhhccC--------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence            99999998876531        1122347788999999999981                                    


Q ss_pred             --------------------CCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          388 --------------------SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       388 --------------------~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                                          ....++|+|+++.|||++++..+.|+||+.+.
T Consensus       161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                11459999999999999876667799998765

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.15  E-value=5.1e-11  Score=115.68  Aligned_cols=137  Identities=18%  Similarity=0.213  Sum_probs=100.7

Q ss_pred             CccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCC--eeeeeeeeecCCceeEEEEec
Q 008239          270 YFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .+......+.|..+.||+....+|+.+++|+....   ....+.+|+.+++.+.+.+  +.+++++....+..++||||+
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i   97 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEV   97 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECC
T ss_pred             CCceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEec
Confidence            34433333456669999998877888999997543   2245678999998885444  456888888777889999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC---------------------------------------
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES---------------------------------------  388 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~---------------------------------------  388 (573)
                      ++.+|.  .. .     .+   ...++.++++.|..||+..                                       
T Consensus        98 ~G~~l~--~~-~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (264)
T 1nd4_A           98 PGQDLL--SS-H-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA  166 (264)
T ss_dssp             SSEETT--TS-C-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred             CCcccC--cC-c-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence            998884  21 1     11   2356778888888888743                                       


Q ss_pred             ----------------CCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          389 ----------------KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       389 ----------------~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                                      ...++|+|++|.|||++++..+.|+||+.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                            12399999999999998876677999998663

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.03  E-value=7.3e-10  Score=113.18  Aligned_cols=142  Identities=18%  Similarity=0.245  Sum_probs=107.2

Q ss_pred             ccccccccCceeEEEEEcCCCCEEEEEEec--ccC-hhhHHHHHHHHHHHcCCC--CCCeeeeeeeeecC---CceeEEE
Q 008239          273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNT-TQWVDHFFNEVNLISGIN--HKNLVKLLGCSITG---PESLLVY  344 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~~~lv~  344 (573)
                      ..+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+.+++.|.  +..+.+++.++.+.   +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            46789999999999998764 678888775  322 122346778999998886  45678888888766   3478999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES------------------------------------  388 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~------------------------------------  388 (573)
                      ||+++..+.+..     ...++...+..++.++++.|+.||+..                                    
T Consensus       121 e~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (359)
T 3dxp_A          121 EFVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP  195 (359)
T ss_dssp             ECCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred             EecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence            999998775422     134678888999999999999999831                                    


Q ss_pred             -------------------CCCeEEecCCCCCeeeCCCCc--EEEeecccccc
Q 008239          389 -------------------KLRIIHRDIKLSNILLDEEFT--AKIADFGLVRL  420 (573)
Q Consensus       389 -------------------~~~iiHrDlk~~NIll~~~~~--~kl~Dfgla~~  420 (573)
                                         ...++|+|+++.|||+++++.  +.|+||+.+..
T Consensus       196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                               256999999999999997753  68999998874

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.93  E-value=9.8e-10  Score=109.48  Aligned_cols=184  Identities=18%  Similarity=0.181  Sum_probs=121.3

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCC-CCCC--eeeeeeeeecCC---ceeEEEEec
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGI-NHKN--LVKLLGCSITGP---ESLLVYEFV  347 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~n--iv~l~~~~~~~~---~~~lv~e~~  347 (573)
                      .+.++.|.+..||+..    ..+++|+....  .....+.+|+++|+.+ .+..  +.+.+.......   ..++|||++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            5678999999999863    56889986432  3456788999999887 3332  344555443333   347899999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE----------------------------------------  387 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~----------------------------------------  387 (573)
                      ++.+|.+...     ..++..++..++.+++..|+.||+.                                        
T Consensus        99 ~G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  173 (304)
T 3sg8_A           99 KGVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV  173 (304)
T ss_dssp             CCEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred             CCeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence            9988865332     2367777888888888888888861                                        


Q ss_pred             ---------------CCCCeEEecCCCCCeeeCC--CCcEEEeecccccccCCCCccccccc--------------ccCc
Q 008239          388 ---------------SKLRIIHRDIKLSNILLDE--EFTAKIADFGLVRLFPEDITHISATL--------------AGTL  436 (573)
Q Consensus       388 ---------------~~~~iiHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~~~~~~~~~--------------~gt~  436 (573)
                                     ..+.++|+|+++.||++++  +..+.|+||+.+..-... .......              ....
T Consensus       174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~~~~~~~~~~~~~~~~~l~~Y  252 (304)
T 3sg8_A          174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFISLMEDDEEYGMEFVSKILNHY  252 (304)
T ss_dssp             HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHTTCCTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHHHHhhccccCHHHHHHHHHHc
Confidence                           1245899999999999998  556889999988753211 0000000              0000


Q ss_pred             CcCc-hhhhccCCCCcccchHhHHHHHHHHHcCCCC
Q 008239          437 GYMA-PEYVVRGKLTEKADVYSFGVVVIEVVCRKRI  471 (573)
Q Consensus       437 ~y~a-PE~~~~~~~~~~sDvwslGvil~elltg~~p  471 (573)
                      +... |+.....  ....+.|+++.++|++.+|..+
T Consensus       253 ~~~~~~~~~~r~--~~~~~~~~l~~~~~~~~~g~~~  286 (304)
T 3sg8_A          253 KHKDIPTVLEKY--RMKEKYWSFEKIIYGKEYGYMD  286 (304)
T ss_dssp             TCSCHHHHHHHH--HHHHHHHHHHHHHHHHHTTCHH
T ss_pred             CCCCcHHHHHHH--HHHHHHHHHHHHHHHHHcCCHH
Confidence            1112 2222111  1236899999999999999754

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.41  E-value=1.4e-06  Score=86.62  Aligned_cols=136  Identities=19%  Similarity=0.179  Sum_probs=95.1

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCC---Ceeeeeeeee-cCCceeEEEEeccC
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK---NLVKLLGCSI-TGPESLLVYEFVPN  349 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~lv~e~~~~  349 (573)
                      .+.++.|....||+.    |..+++|+..  .......+.+|+++|+.+.+.   .+.+.+.+.. ..+..++||||+++
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888988999988    5778889853  233456788999999998642   3556666664 44567899999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc------------------------------------------
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE------------------------------------------  387 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~------------------------------------------  387 (573)
                      .+|.+...     ..++......++.++++.|+.||+.                                          
T Consensus        98 ~~l~~~~~-----~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l  172 (306)
T 3tdw_A           98 QILGEDGM-----AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL  172 (306)
T ss_dssp             EECHHHHH-----TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred             eECchhhh-----hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence            88865321     1234445555555555555555542                                          


Q ss_pred             ---------------CCCCeEEecCCCCCeeeCC---CCc-EEEeecccccc
Q 008239          388 ---------------SKLRIIHRDIKLSNILLDE---EFT-AKIADFGLVRL  420 (573)
Q Consensus       388 ---------------~~~~iiHrDlk~~NIll~~---~~~-~kl~Dfgla~~  420 (573)
                                     ..+.++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                           2235799999999999987   455 48999998764

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.34  E-value=1.1e-06  Score=85.47  Aligned_cols=136  Identities=18%  Similarity=0.158  Sum_probs=95.4

Q ss_pred             ccccccCce-eEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeEEEEeccCCC
Q 008239          275 NKLGQGGSG-SVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVYEFVPNQS  351 (573)
Q Consensus       275 ~~lg~G~~g-~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~e~~~~gs  351 (573)
                      +.+..|..| .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+.++++++.+.+..++|||++++.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            345556665 68988765 4667899986432   3456778999888774 3346778888888889999999999987


Q ss_pred             ccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------
Q 008239          352 LLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--------------------------------------------  387 (573)
Q Consensus       352 L~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~--------------------------------------------  387 (573)
                      +.+....       .......+..+++..|+-||+.                                            
T Consensus       107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            7654321       1112234555666666666642                                            


Q ss_pred             -----------CCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          388 -----------SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       388 -----------~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                                 ..+.++|+|+.+.|||+++++.+-|+||+.+..
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                       112389999999999999887778999998763

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.28  E-value=1.1e-06  Score=89.34  Aligned_cols=81  Identities=10%  Similarity=0.014  Sum_probs=56.3

Q ss_pred             cccc-cccCceeEEEEEcC-------CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCC-C--CCeeeeeeeeecC--
Q 008239          274 SNKL-GQGGSGSVYKGTLP-------GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGIN-H--KNLVKLLGCSITG--  337 (573)
Q Consensus       274 ~~~l-g~G~~g~Vy~~~~~-------~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~--  337 (573)
                      .+.| +.|....+|+....       +++.+++|+.....   ......+.+|+.+++.|. +  -.+.+++.++.+.  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4667 88889999998764       26778898764332   001245678888888874 3  3566778776654  


Q ss_pred             -CceeEEEEeccCCCccc
Q 008239          338 -PESLLVYEFVPNQSLLD  354 (573)
Q Consensus       338 -~~~~lv~e~~~~gsL~~  354 (573)
                       ...++||||+++..+.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999877764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.97  E-value=1.3e-05  Score=82.60  Aligned_cols=75  Identities=12%  Similarity=0.096  Sum_probs=49.5

Q ss_pred             cccccccCceeEEEEEcC-CCCEEEEEEecccCh-------hhHHHHHHHHHHHcCCCC--CC-eeeeeeeeecCCceeE
Q 008239          274 SNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-------QWVDHFFNEVNLISGINH--KN-LVKLLGCSITGPESLL  342 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~l  342 (573)
                      .+.||.|.++.||++... +++.++||.......       ...+.+..|.++|+.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            567999999999999865 468899997643211       123456778888877632  33 3455543  3456789


Q ss_pred             EEEeccCC
Q 008239          343 VYEFVPNQ  350 (573)
Q Consensus       343 v~e~~~~g  350 (573)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.89  E-value=4.4e-05  Score=76.64  Aligned_cols=141  Identities=17%  Similarity=0.194  Sum_probs=79.8

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-----CCCeeeee-e--eeecCCceeEEEE
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----HKNLVKLL-G--CSITGPESLLVYE  345 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lv~e  345 (573)
                      .+.|+.|..+.||+....+| .+++|+.... .   ..+..|+.++..|.     .|.++... |  +....+..+++||
T Consensus        37 ~~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~  111 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD  111 (346)
T ss_dssp             EEECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred             eeeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence            44566677899999987655 4899988652 1   23334555554442     34444311 1  1124566789999


Q ss_pred             eccCCCccc--------------ccccc-CC---C-------CCCCHHHHH-----------------------------
Q 008239          346 FVPNQSLLD--------------NLFVR-QD---V-------EPLSWEVRY-----------------------------  371 (573)
Q Consensus       346 ~~~~gsL~~--------------~l~~~-~~---~-------~~l~~~~~~-----------------------------  371 (573)
                      |+++..+..              .++.. ..   .       ....|...+                             
T Consensus       112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  191 (346)
T 2q83_A          112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE  191 (346)
T ss_dssp             CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred             eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence            999866531              11110 00   0       011232211                             


Q ss_pred             --HHHHHHHHHHHHHHh----------cCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          372 --KIILSTAEGLAYLHE----------ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       372 --~i~~~ia~~l~yLH~----------~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                        .+...+..++.+|++          .....++|+|+++.|||++.++.+.|+||+.+.
T Consensus       192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence              111223445667763          123569999999999999888899999999765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.84  E-value=4.2e-05  Score=75.04  Aligned_cols=81  Identities=16%  Similarity=0.171  Sum_probs=59.1

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-C--CCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-H--KNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ......+.+|.|..+.||+.++.+|+.|.+|+...........|..|+..|+.|. .  --+.+.+++.    ..++|||
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             CCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            3456678899999999999999999999999876554444456788998888773 2  2344555442    3478999


Q ss_pred             eccCCCcc
Q 008239          346 FVPNQSLL  353 (573)
Q Consensus       346 ~~~~gsL~  353 (573)
                      |++.+...
T Consensus        91 ~l~~~~~~   98 (288)
T 3f7w_A           91 WVDERPPT   98 (288)
T ss_dssp             CCCCCCCC
T ss_pred             eecccCCC
Confidence            99876543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.68  E-value=0.0003  Score=69.64  Aligned_cols=139  Identities=17%  Similarity=0.140  Sum_probs=92.8

Q ss_pred             ccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCC---CCCeeeeeeeeecCCceeEEEEeccC
Q 008239          273 ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN---HKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ..+.|+.|.+..+|+.... +..+++|+....   ....+..|+..|+.|.   ...+.+++.+....+..++||||+++
T Consensus        40 ~~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             eeEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            4567999999999999864 678889987533   2456788988888873   35678888888777889999999998


Q ss_pred             CCccc-----------cccccCC---C----------------CCCCHHHHH---HHHH----------------HHHHH
Q 008239          350 QSLLD-----------NLFVRQD---V----------------EPLSWEVRY---KIIL----------------STAEG  380 (573)
Q Consensus       350 gsL~~-----------~l~~~~~---~----------------~~l~~~~~~---~i~~----------------~ia~~  380 (573)
                      ..+..           .|+....   .                -.-+|...+   ++..                .+..-
T Consensus       116 ~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~  195 (312)
T 3jr1_A          116 SKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQI  195 (312)
T ss_dssp             CCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHH
T ss_pred             CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHH
Confidence            76532           1111111   0                012454322   1111                11111


Q ss_pred             -HHHHHh-cCCCCeEEecCCCCCeeeCCCCcEEEeecc
Q 008239          381 -LAYLHE-ESKLRIIHRDIKLSNILLDEEFTAKIADFG  416 (573)
Q Consensus       381 -l~yLH~-~~~~~iiHrDlk~~NIll~~~~~~kl~Dfg  416 (573)
                       ...|.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       196 l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          196 VADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence             223432 2356799999999999999887 8899984

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.54  E-value=0.00017  Score=74.72  Aligned_cols=79  Identities=14%  Similarity=0.156  Sum_probs=47.9

Q ss_pred             CCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccccccc-ccCcCcCchhhhccC---CCCcccchHhHHHHHHH
Q 008239          389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL-AGTLGYMAPEYVVRG---KLTEKADVYSFGVVVIE  464 (573)
Q Consensus       389 ~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~sDvwslGvil~e  464 (573)
                      ...++|+|+++.|||++.++ ++|+||+.+..-+... ...... .-...|++|+.....   .-....++......+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            35699999999999999876 9999999877432110 000000 001345666554311   11123556688888888


Q ss_pred             HHcCC
Q 008239          465 VVCRK  469 (573)
Q Consensus       465 lltg~  469 (573)
                      .+.++
T Consensus       309 ~y~~~  313 (420)
T 2pyw_A          309 LFNKR  313 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            87653

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.40  E-value=0.00046  Score=68.58  Aligned_cols=158  Identities=12%  Similarity=0.131  Sum_probs=86.8

Q ss_pred             cChHHHHHHhcCccc-----cccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCC--eeeee
Q 008239          259 FSYETLEKATNYFHE-----SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN--LVKLL  331 (573)
Q Consensus       259 ~~~~~~~~~~~~~~~-----~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~  331 (573)
                      ++.+++...-..|..     .+.|+.|....+|+....+| .+++|+.....  ..+.+..|+.++..|...+  +.+++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            444555555555543     34577788899999987665 68899886521  1234456777776663222  23333


Q ss_pred             ee------eecCCceeEEEEeccCCCcccc--------------ccccC-C--CC---CC---CHHHHHHH---------
Q 008239          332 GC------SITGPESLLVYEFVPNQSLLDN--------------LFVRQ-D--VE---PL---SWEVRYKI---------  373 (573)
Q Consensus       332 ~~------~~~~~~~~lv~e~~~~gsL~~~--------------l~~~~-~--~~---~l---~~~~~~~i---------  373 (573)
                      ..      ....+..+++++|+++..+...              ++... .  ..   ..   .|...+.-         
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            21      1123456899999998665321              11100 0  00   01   13221110         


Q ss_pred             ---HHHHHHHHHHHHhc----CCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          374 ---ILSTAEGLAYLHEE----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       374 ---~~~ia~~l~yLH~~----~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                         ...+...++.++..    ....++|+|+.+.|||++++..+.|+||+.+.
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               01134455566532    13469999999999999987666899998765

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.26  E-value=0.00056  Score=67.32  Aligned_cols=71  Identities=11%  Similarity=0.120  Sum_probs=44.7

Q ss_pred             cccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCe-eeeeeeeecCCceeEEEEec-cCCC
Q 008239          274 SNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFV-PNQS  351 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~-~~gs  351 (573)
                      .+.|+.|....+|+.     +.+++|+........ ....+|+.+++.+...++ .++++.  +.+..++++||+ ++.+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~-~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEEY-INRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC----C-CCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccce-eCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            678999999999998     568889875432221 122457777766643233 355543  344568999999 6555


Q ss_pred             c
Q 008239          352 L  352 (573)
Q Consensus       352 L  352 (573)
                      |
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.23  E-value=0.00036  Score=72.47  Aligned_cols=74  Identities=19%  Similarity=0.268  Sum_probs=50.6

Q ss_pred             cccccccCceeEEEEEcCC--------CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCe-eeeeeeeecCCceeEEE
Q 008239          274 SNKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVY  344 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  344 (573)
                      .+.|+.|....+|+....+        ++.+++|+.....  ..+.+.+|+.+++.|...++ .++++.+.+    .+|+
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~  151 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--TESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  151 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--cHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEE
Confidence            5678888899999998753        5789999884321  11455679888888753333 566665542    3899


Q ss_pred             EeccCCCcc
Q 008239          345 EFVPNQSLL  353 (573)
Q Consensus       345 e~~~~gsL~  353 (573)
                      ||+++.+|.
T Consensus       152 e~l~G~~l~  160 (429)
T 1nw1_A          152 EYIPSRPLS  160 (429)
T ss_dssp             CCCCEEECC
T ss_pred             EEeCCcccC
Confidence            999865553

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.15  E-value=0.001  Score=69.48  Aligned_cols=75  Identities=13%  Similarity=0.012  Sum_probs=48.7

Q ss_pred             cccccccCceeEEEEEcCC-CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCe-eeeeeeeecCCceeEEEEeccCCC
Q 008239          274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVYEFVPNQS  351 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~e~~~~gs  351 (573)
                      .+.|+.|-...+|+....+ +..+++|+......... ...+|..++..|...++ .++++.+.  +  .+|+||+++.+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            5678888899999998865 57888988743322211 12578888888864444 46777663  2  35999998755


Q ss_pred             cc
Q 008239          352 LL  353 (573)
Q Consensus       352 L~  353 (573)
                      |.
T Consensus       188 l~  189 (458)
T 2qg7_A          188 LS  189 (458)
T ss_dssp             CC
T ss_pred             CC
Confidence            53

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.11  E-value=0.001  Score=67.65  Aligned_cols=142  Identities=18%  Similarity=0.181  Sum_probs=84.3

Q ss_pred             cccccccCceeEEEEEcC--------CCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCceeEEE
Q 008239          274 SNKLGQGGSGSVYKGTLP--------GGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~--------~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~lv~  344 (573)
                      .+.|..|-...+|+....        +++.+++|+.-.. ......+.+|.++++.|. +.-..++++.+.+    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            456777888999999875        2478999986322 223455668999988874 3223566666543    2999


Q ss_pred             EeccCCCcccc-c----------------cccC--CCCCCC--HHHHHHHHHHHHH-------------------HHHHH
Q 008239          345 EFVPNQSLLDN-L----------------FVRQ--DVEPLS--WEVRYKIILSTAE-------------------GLAYL  384 (573)
Q Consensus       345 e~~~~gsL~~~-l----------------~~~~--~~~~l~--~~~~~~i~~~ia~-------------------~l~yL  384 (573)
                      ||+++.+|..- +                +...  -.....  |.++.++..++..                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99998666421 1                0000  011122  4555555544321                   23333


Q ss_pred             H----hc-CCCCeEEecCCCCCeeeCCC----CcEEEeecccccc
Q 008239          385 H----EE-SKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRL  420 (573)
Q Consensus       385 H----~~-~~~~iiHrDlk~~NIll~~~----~~~kl~Dfgla~~  420 (573)
                      .    .. ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    22 23469999999999999876    7899999998763

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.08  E-value=0.0043  Score=61.63  Aligned_cols=158  Identities=15%  Similarity=0.080  Sum_probs=87.2

Q ss_pred             cChHHHHHHhcCcc-----ccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCC--Ceeeee
Q 008239          259 FSYETLEKATNYFH-----ESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHK--NLVKLL  331 (573)
Q Consensus       259 ~~~~~~~~~~~~~~-----~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~  331 (573)
                      .+.+.+...-..|.     ....|+ |....||+....+|+.+++|+...... ..+.+..|..++..|...  .+.+++
T Consensus        11 l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp~~~   88 (328)
T 1zyl_A           11 LHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVAAPV   88 (328)
T ss_dssp             CCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBCCCC
T ss_pred             CCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeeccee
Confidence            44444544444442     234566 888899998877787899999853211 234566677777766322  234444


Q ss_pred             ee-----eecCCceeEEEEeccCCCccc----c----------ccc--cC----CCCCCCHHHH----HHHH--------
Q 008239          332 GC-----SITGPESLLVYEFVPNQSLLD----N----------LFV--RQ----DVEPLSWEVR----YKII--------  374 (573)
Q Consensus       332 ~~-----~~~~~~~~lv~e~~~~gsL~~----~----------l~~--~~----~~~~l~~~~~----~~i~--------  374 (573)
                      ..     ....+..++++||+++..+..    .          ++.  ..    .....++...    ..++        
T Consensus        89 ~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  168 (328)
T 1zyl_A           89 AFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPS  168 (328)
T ss_dssp             CBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCT
T ss_pred             ecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCH
Confidence            33     112345578999998865431    0          110  00    0111222211    0010        


Q ss_pred             -------HHHHHHHHHHHhc----CCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          375 -------LSTAEGLAYLHEE----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       375 -------~~ia~~l~yLH~~----~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                             ..+...++.+...    ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       169 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          169 GLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             TTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                   0111223333221    234589999999999999 4 899999987653

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.01  E-value=0.0018  Score=64.63  Aligned_cols=143  Identities=16%  Similarity=0.117  Sum_probs=72.5

Q ss_pred             cccccccCcee-EEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCC--CCeeeeeeeeecCCceeEEEEeccCC
Q 008239          274 SNKLGQGGSGS-VYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH--KNLVKLLGCSITGPESLLVYEFVPNQ  350 (573)
Q Consensus       274 ~~~lg~G~~g~-Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~lv~e~~~~g  350 (573)
                      .+.|+.|.... +|+....+|+.+++|.......   +.+..|+.++..+..  -.+.+++.+...  ..+++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~--~g~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHA--RGLLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETT--TTEEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCC--CCEEEEeeCCCc
Confidence            45566665554 6777665467787776533221   223456666665532  234556655332  237899999776


Q ss_pred             Ccccccccc---------------------C--CCCCCCHHHHH-------H-------------HHHHHHHHHHHHHh-
Q 008239          351 SLLDNLFVR---------------------Q--DVEPLSWEVRY-------K-------------IILSTAEGLAYLHE-  386 (573)
Q Consensus       351 sL~~~l~~~---------------------~--~~~~l~~~~~~-------~-------------i~~~ia~~l~yLH~-  386 (573)
                      .+.+++...                     .  ....++.....       .             ....+...+..|.. 
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            654332110                     0  01112221110       0             00111122233311 


Q ss_pred             --cCCCCeEEecCCCCCeeeCCC----CcEEEeeccccccc
Q 008239          387 --ESKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRLF  421 (573)
Q Consensus       387 --~~~~~iiHrDlk~~NIll~~~----~~~kl~Dfgla~~~  421 (573)
                        .....++|+|+.+.|||++.+    ..+.|+||+.+..-
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence              123469999999999999874    68999999987743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.92  E-value=0.0013  Score=66.63  Aligned_cols=74  Identities=11%  Similarity=0.102  Sum_probs=44.9

Q ss_pred             cccccccCceeEEEEEcCC---------CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCC-eeeeeeeeecCCceeEE
Q 008239          274 SNKLGQGGSGSVYKGTLPG---------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-LVKLLGCSITGPESLLV  343 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~---------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv  343 (573)
                      .+.|+.|....+|+....+         ++.+++|+........ .....|..+++.+...+ ..++++..    ..++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~-~~~~~E~~~l~~L~~~g~~P~~~~~~----~~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDEL-YNTISEFEVYKTMSKYKIAPQLLNTF----NGGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGT-SCHHHHHHHHHHHHHTTSSCCEEEEE----TTEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccce-ecHHHHHHHHHHHHhcCCCCceEEec----CCcEE
Confidence            4567888889999998754         2678888875432221 12356888887774333 34566543    24789


Q ss_pred             EEeccCCCc
Q 008239          344 YEFVPNQSL  352 (573)
Q Consensus       344 ~e~~~~gsL  352 (573)
                      |||+++..+
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987554

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=96.63  E-value=0.0048  Score=56.66  Aligned_cols=102  Identities=16%  Similarity=0.107  Sum_probs=63.9

Q ss_pred             CccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccccc
Q 008239          351 SLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA  430 (573)
Q Consensus       351 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~~~  430 (573)
                      ||.+.|...  ..+++++++|.++.|.+..|.-+-....+  ..+=+.|..|++..+|.|.+.+ ..+.           
T Consensus        34 SL~eIL~~~--~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY--NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             cHHHHHHHc--CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc-----------
Confidence            667777443  45799999999999999988776221101  1223456889999999888764 1110           


Q ss_pred             ccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCC
Q 008239          431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRI  471 (573)
Q Consensus       431 ~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p  471 (573)
                        .....+.|||... ...+.+.=|||||++||.-+--+.|
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~  135 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK  135 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence              1123456888653 3456788999999999998855544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.56  E-value=0.018  Score=57.54  Aligned_cols=32  Identities=31%  Similarity=0.402  Sum_probs=28.0

Q ss_pred             CCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       389 ~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ...++|+|+.+.||++++++.+.|+||+.+..
T Consensus       205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             GCEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             CceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            34699999999999999888899999987664

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=95.16  E-value=0.069  Score=54.88  Aligned_cols=141  Identities=14%  Similarity=0.201  Sum_probs=84.6

Q ss_pred             cccccccCceeEEEEEcCC--------CCEEEEEEecccChhhHHHHHHHHHHHcCCCCCC-eeeeeeeeecCCceeEEE
Q 008239          274 SNKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-LVKLLGCSITGPESLLVY  344 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~lv~  344 (573)
                      .+.|..|-...+|+....+        ++.+++|+......... ...+|..+++.+...+ ..++++.+.    .++|+
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~i-dR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFY-DSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCC-CHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhc-CHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            4567778889999998763        57899998644332211 2356888887774222 345555332    37899


Q ss_pred             EeccCCCcccc-cc----------------c--------cC--CCCCCCHHHHHHHHHHH-------------------H
Q 008239          345 EFVPNQSLLDN-LF----------------V--------RQ--DVEPLSWEVRYKIILST-------------------A  378 (573)
Q Consensus       345 e~~~~gsL~~~-l~----------------~--------~~--~~~~l~~~~~~~i~~~i-------------------a  378 (573)
                      ||+++..|..- +.                .        ..  ...+.-|.++.++..++                   .
T Consensus       150 efI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~  229 (424)
T 3mes_A          150 EFIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKIL  229 (424)
T ss_dssp             ECCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHH
T ss_pred             EEeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHH
Confidence            99998665321 10                0        00  11112244444443322                   2


Q ss_pred             HHHHHHHh---------------------cCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          379 EGLAYLHE---------------------ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       379 ~~l~yLH~---------------------~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ..+.+|.+                     .....++|+|+.+.||+ +.++.+.|+||..+..
T Consensus       230 ~e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          230 EEIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             HHHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            22333321                     12346899999999999 7788999999998763

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=92.67  E-value=0.1  Score=34.20  Aligned_cols=16  Identities=19%  Similarity=0.328  Sum_probs=6.6

Q ss_pred             HHHHHHHHHHHHHHHH
Q 008239          219 ALLLVFSLVAFFVRRK  234 (573)
Q Consensus       219 ~~~~l~~~~~~~~~r~  234 (573)
                      +++++++++++++.||
T Consensus        22 ll~vi~~l~~~~~~RR   37 (44)
T 2jwa_A           22 LLVVVLGVVFGILIKR   37 (44)
T ss_dssp             HHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhheeh
Confidence            3334444444444443

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=92.61  E-value=0.11  Score=34.19  Aligned_cols=12  Identities=25%  Similarity=0.199  Sum_probs=4.8

Q ss_pred             HHHHHHHHHHHH
Q 008239          223 VFSLVAFFVRRK  234 (573)
Q Consensus       223 l~~~~~~~~~r~  234 (573)
                      +++++.++++||
T Consensus        26 ii~~~~~~~~RR   37 (44)
T 2ks1_B           26 VVALGIGLFMRR   37 (44)
T ss_dssp             HHHHHHHHHHHT
T ss_pred             HHHHHHHHHhhh
Confidence            333444444443

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=91.93  E-value=0.29  Score=49.87  Aligned_cols=30  Identities=30%  Similarity=0.386  Sum_probs=25.3

Q ss_pred             CeEEecCCCCCeee------CCCCcEEEeecccccc
Q 008239          391 RIIHRDIKLSNILL------DEEFTAKIADFGLVRL  420 (573)
Q Consensus       391 ~iiHrDlk~~NIll------~~~~~~kl~Dfgla~~  420 (573)
                      .++|+|+.+.|||+      +++..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4567899999998763

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.87  E-value=0.28  Score=32.18  Aligned_cols=26  Identities=12%  Similarity=0.160  Sum_probs=10.1

Q ss_pred             hhhhhhHHH-HHHHHHHHHHHHHHHHH
Q 008239          209 LAVILATSA-VALLLVFSLVAFFVRRK  234 (573)
Q Consensus       209 ~~ii~~~~~-~~~~~l~~~~~~~~~r~  234 (573)
                      ..|..+++. +++++++.++.++++||
T Consensus        10 ~aIA~gVVgGv~~v~ii~~~~~~~~RR   36 (44)
T 2l2t_A           10 PLIAAGVIGGLFILVIVGLTFAVYVRR   36 (44)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred             ceEEEeehHHHHHHHHHHHHHHHHhhh
Confidence            344444333 22333333444444443

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=86.07  E-value=0.1  Score=54.44  Aligned_cols=61  Identities=7%  Similarity=0.009  Sum_probs=18.5

Q ss_pred             cccccccccCceeEEEEEcCC-CCEEEE------EEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeee
Q 008239          272 HESNKLGQGGSGSVYKGTLPG-GEAVAV------KRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSI  335 (573)
Q Consensus       272 ~~~~~lg~G~~g~Vy~~~~~~-g~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  335 (573)
                      ...++||   ||.||+|.+.. ..+|||      |.....  ..+....+.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            3456777   99999999864 367888      766542  2233456888999999999999999988654

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=83.06  E-value=1.7  Score=39.75  Aligned_cols=84  Identities=6%  Similarity=0.036  Sum_probs=58.6

Q ss_pred             CCCCeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHH-HHHhcCCCCeEEecCCCCC
Q 008239          323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA-YLHEESKLRIIHRDIKLSN  401 (573)
Q Consensus       323 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~-yLH~~~~~~iiHrDlk~~N  401 (573)
                      .||++  -..+-.+.+...+.++.-+++.-...+      ..++...+++++.+|+.... +++.     -+|--|.|.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i------~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~N  114 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI------RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPEN  114 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH------HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH------HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCce
Confidence            57777  333345555566666654343222333      24778899999999887666 5554     6888999999


Q ss_pred             eeeCCCCcEEEeeccccc
Q 008239          402 ILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       402 Ill~~~~~~kl~Dfgla~  419 (573)
                      |+++.++.++|.-.|+-.
T Consensus       115 L~f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A          115 LMFNRALEPFFLHVGVKE  132 (219)
T ss_dssp             EEECTTCCEEESCCEETT
T ss_pred             EEEeCCCcEEEEEcCCcc
Confidence            999999999999888644

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=82.31  E-value=1.7  Score=39.74  Aligned_cols=115  Identities=7%  Similarity=0.024  Sum_probs=75.2

Q ss_pred             CCCCeeeeeeeeecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCe
Q 008239          323 NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNI  402 (573)
Q Consensus       323 ~h~niv~l~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NI  402 (573)
                      .||+++.. .+-.+.+...+.++.-  .+..++-    ....++...+++++.+|+....+++.     -+|--|.|.||
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~--~~~~~f~----~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDIN--DNHTPFD----NIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCC--TTSEEGG----GGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcC--cccCCHH----HHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceE
Confidence            57888765 3445555444444433  3333322    12347788999999999988866664     47889999999


Q ss_pred             eeCCCCcEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCC
Q 008239          403 LLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRIN  472 (573)
Q Consensus       403 ll~~~~~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~  472 (573)
                      +++.++.++|.-.|+-..++.                  .     ..+...=.-.+=+++..+++++..+
T Consensus       111 ~f~~~~~p~i~~RGik~~l~P------------------~-----~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVVDP------------------L-----PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             EECTTSCEEESCCEETTTBSC------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             EEcCCCCEEEEEccCccCCCC------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence            999999999988876443221                  1     1122222345677888888887654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	573
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-68
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-66
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-65
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-63
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	4e-62
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-62
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-61
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-60
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-58
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	3e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	4e-57
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-57
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-57
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-56
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-56
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-55
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-55
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-55
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	8e-55
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-53
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-52
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-52
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-51
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-50
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-47
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-44
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	4e-43
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	8e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-41
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-41
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	4e-41
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-40
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-40
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	5e-40
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-39
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	4e-39
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-38
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-38
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-38
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	6e-38
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-36
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-36
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	9e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-35
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	4e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-29
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-28
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	2e-26
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	5e-24
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-20

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (560), Expect = 3e-68
 Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 23/281 (8%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            ++G G  G+VYKG   G  AV +  +   T Q +  F NEV ++    H N++  +G S
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
            T P+  +V ++    SL  +L + +            I   TA+G+ YLH +S   IIH
Sbjct: 74  -TAPQLAIVTQWCEGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIH 127

Query: 395 RDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGTLGYMAPEYVV---RGKLT 450
           RD+K +NI L E+ T KI DFGL  +      +H    L+G++ +MAPE +    +   +
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYS 187

Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK 510
            ++DVY+FG+V+ E++  +       N   I+  V   Y+   L +          +   
Sbjct: 188 FQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK---------VRSNC 238

Query: 511 PSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
           P  + ++   C++   + RP    ++  +    E+L  + P
Sbjct: 239 PKAMKRLMAECLKKKRDERPLFPQILASI----ELLARSLP 275

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  215 bits (548), Expect = 1e-66
 Identities = 69/277 (24%), Positives = 122/277 (44%), Gaps = 22/277 (7%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
                ++G G  G V+ G     + VA+K +        + F  E  ++  ++H  LV+L
Sbjct: 7   LTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQL 65

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G  +      LV+EF+ +  L D  ++R      + E    + L   EG+AYL E    
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEA--- 120

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
            +IHRD+   N L+ E    K++DFG+ R   +D    S      + + +PE     + +
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180

Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK 510
            K+DV+SFGV++ EV    +I    +++  +++ +              P LA       
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------STGFRLYKPRLA------- 227

Query: 511 PSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ 547
            + + QI   C +   E RP+ S +++ L    EI +
Sbjct: 228 STHVYQIMNHCWKERPEDRPAFSRLLRQLA---EIAE 261

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (542), Expect = 2e-65
 Identities = 79/282 (28%), Positives = 127/282 (45%), Gaps = 22/282 (7%)

Query: 269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLV 328
                  +LG G  G V+ G   G   VAVK L   +    D F  E NL+  + H+ LV
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLV 71

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           +L       P   ++ E++ N SL+D L     +  L+      +    AEG+A++ E +
Sbjct: 72  RLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEERN 129

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
               IHRD++ +NIL+ +  + KIADFGL RL  ++           + + APE +  G 
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT 186

Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE 508
            T K+DV+SFG+++ E+V   RI      +  ++Q +   Y        V P       +
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------RMVRP-------D 233

Query: 509 GKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQ 550
             P  L Q+  LC +   E RP+   +  +L    +    T+
Sbjct: 234 NCPEELYQLMRLCWKERPEDRPTFDYLRSVL---EDFFTATE 272

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  213 bits (542), Expect = 2e-65
 Identities = 72/295 (24%), Positives = 125/295 (42%), Gaps = 22/295 (7%)

Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNL 318
            + +  E          KLGQG  G V+ GT  G   VA+K L    T   + F  E  +
Sbjct: 7   LAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQV 65

Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
           +  + H+ LV+L    ++     +V E++   SLLD     +  + L       +    A
Sbjct: 66  MKKLRHEKLVQLYAV-VSEEPIYIVTEYMSKGSLLD-FLKGETGKYLRLPQLVDMAAQIA 123

Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
            G+AY+    ++  +HRD++ +NIL+ E    K+ADFGL RL  ++           + +
Sbjct: 124 SGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180

Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV 498
            APE  + G+ T K+DV+SFG+++ E+  + R+      +  +L             + V
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL-------------DQV 227

Query: 499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPF 553
           +           P  L  +   C +   E RP+   +   L    +    T+P +
Sbjct: 228 ERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFL---EDYFTSTEPQY 279

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (526), Expect = 2e-63
 Identities = 56/269 (20%), Positives = 111/269 (41%), Gaps = 19/269 (7%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
                +LG G  G V  G   G   VA+K +    +   D F  E  ++  ++H+ LV+L
Sbjct: 6   LTFLKELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQL 64

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
            G         ++ E++ N  LL+ L   +       +   ++     E + YL  +   
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESK--- 119

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           + +HRD+   N L++++   K++DFGL R   +D    S      + +  PE ++  K +
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS 179

Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK 510
            K+D+++FGV++ E+    +               ++ +      E +   L        
Sbjct: 180 SKSDIWAFGVLMWEIYSLGK-------------MPYERFTNSETAEHIAQGLRLYRPHLA 226

Query: 511 PSRLLQIGLLCVQASAELRPSMSIVVKML 539
             ++  I   C    A+ RP+  I++  +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (520), Expect = 4e-62
 Identities = 77/292 (26%), Positives = 127/292 (43%), Gaps = 22/292 (7%)

Query: 260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNL 318
           +Y+  E         +KLG G  G VY+G        VAVK L  +T + V+ F  E  +
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAV 66

Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
           +  I H NLV+LLG     P   ++ EF+   +LLD L    + + +S  V   +    +
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLR-ECNRQEVSAVVLLYMATQIS 125

Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
             + YL    K   IHRD+   N L+ E    K+ADFGL RL   D     A     + +
Sbjct: 126 SAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKW 182

Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV 498
            APE +   K + K+DV++FGV++ E+                  + +      +++E +
Sbjct: 183 TAPESLAYNKFSIKSDVWAFGVLLWEIATYGM-------------SPYPGIDLSQVYELL 229

Query: 499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQ 550
           +        EG P ++ ++   C Q +   RPS + + +       + Q + 
Sbjct: 230 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF---ETMFQESS 278

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (519), Expect = 6e-62
 Identities = 75/317 (23%), Positives = 130/317 (41%), Gaps = 46/317 (14%)

Query: 259 FSYETLEKATNYFHES---------NKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNT 305
           F++E   +A   F +            +G G  G V  G L         VA+K L    
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 306 T-QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEP 364
           T +    F +E +++   +H N++ L G        +++ EF+ N SL    F+RQ+   
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124

Query: 365 LSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED 424
            +      ++   A G+ YL     +  +HRD+   NIL++     K++DFGL R   +D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181

Query: 425 ITHISATLA----GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCS 480
            +  + T A      + + APE +   K T  +DV+S+G+V+ EV+       +   +  
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD 241

Query: 481 ILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
           ++              A++           PS L Q+ L C Q     RP    +V  L 
Sbjct: 242 VI-------------NAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTL- 287

Query: 541 GNHEILQPTQPPFLNPN 557
              ++++       NPN
Sbjct: 288 --DKMIR-------NPN 295

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  202 bits (513), Expect = 6e-61
 Identities = 77/312 (24%), Positives = 121/312 (38%), Gaps = 45/312 (14%)

Query: 257 LNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQWV- 309
           LN    +LE   N       +G+G  G V++   PG         VAVK L    +  + 
Sbjct: 1   LNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ 60

Query: 310 DHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLF------------ 357
             F  E  L++  ++ N+VKLLG    G    L++E++    L + L             
Sbjct: 61  ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH 120

Query: 358 ---------VRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
                          PLS   +  I    A G+AYL E    + +HRD+   N L+ E  
Sbjct: 121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENM 177

Query: 409 TAKIADFGLVR-LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC 467
             KIADFGL R ++  D        A  + +M PE +   + T ++DV+++GVV+ E+  
Sbjct: 178 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 237

Query: 468 RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAE 527
                 +      ++  V      G +             E  P  L  +  LC      
Sbjct: 238 YGLQPYYGMAHEEVIYYV----RDGNILA---------CPENCPLELYNLMRLCWSKLPA 284

Query: 528 LRPSMSIVVKML 539
            RPS   + ++L
Sbjct: 285 DRPSFCSIHRIL 296

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 1e-60
 Identities = 54/235 (22%), Positives = 107/235 (45%), Gaps = 12/235 (5%)

Query: 264 LEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWV-DHFFNEVNLISG 321
           +E   + F + ++LG G  G V+K +  P G  +A K +       + +    E+ ++  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
            N   +V   G   +  E  +  E +   SL   L   +    +  ++  K+ ++  +GL
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGL 117

Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
            YL    K +I+HRD+K SNIL++     K+ DFG+     + + +   +  GT  YM+P
Sbjct: 118 TYLR--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN---SFVGTRSYMSP 172

Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE 496
           E +     + ++D++S G+ ++E+   +            L+ ++   V+G   E
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRY--PIPPPDAKELELMFGCQVEGDAAE 225

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (506), Expect = 2e-60
 Identities = 71/278 (25%), Positives = 118/278 (42%), Gaps = 27/278 (9%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL 330
                 +G+G  G V  G   G + VAVK +          F  E ++++ + H NLV+L
Sbjct: 9   LKLLQTIGKGEFGDVMLGDYRGNK-VAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQL 65

Query: 331 LGCSITGPESL-LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESK 389
           LG  +     L +V E++   SL+D L   +    L  +   K  L   E + YL     
Sbjct: 66  LGVIVEEKGGLYIVTEYMAKGSLVDYLR-SRGRSVLGGDCLLKFSLDVCEAMEYLEGN-- 122

Query: 390 LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKL 449
              +HRD+   N+L+ E+  AK++DFGL +           T    + + APE +   K 
Sbjct: 123 -NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD----TGKLPVKWTAPEALREKKF 177

Query: 450 TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEG 509
           + K+DV+SFG+++ E+    R+         ++  V     KG   +A D          
Sbjct: 178 STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKGYKMDAPDGC-------- 225

Query: 510 KPSRLLQIGLLCVQASAELRPSMSIVVKMLTG--NHEI 545
            P  + ++   C    A +RPS   + + L     HE+
Sbjct: 226 -PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHEL 262

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (492), Expect = 3e-58
 Identities = 68/293 (23%), Positives = 127/293 (43%), Gaps = 29/293 (9%)

Query: 263 TLEKATNYFHESNKLGQGGSGSVYKGTLPGGE-----AVAVKRLFYNTTQW-VDHFFNEV 316
           T E   +       +G G  G VYKG L          VA+K L    T+     F  E 
Sbjct: 1   TTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEA 60

Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
            ++   +H N+++L G        +++ E++ N +L    F+R+     S      ++  
Sbjct: 61  GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRG 118

Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI--THISATLAG 434
            A G+ YL     +  +HRD+   NIL++     K++DFGL R+  +D   T+ ++    
Sbjct: 119 IAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 435 TLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRL 494
            + + APE +   K T  +DV+SFG+V+ EV+       +  ++  ++            
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM------------ 223

Query: 495 HEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ 547
            +A++           PS + Q+ + C Q     RP  + +V +L    ++++
Sbjct: 224 -KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL---DKLIR 272

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 3e-58
 Identities = 75/291 (25%), Positives = 123/291 (42%), Gaps = 33/291 (11%)

Query: 276 KLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFF-NEVNLISGINHKNLVKLLGCS 334
            +G+G  G V++G   G E VAVK    ++ +    F   E+     + H+N++  +   
Sbjct: 10  SIGKGRFGEVWRGKWRG-EEVAVKIF--SSREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 335 I----TGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE--- 387
                T  +  LV ++  + SL D L    +   ++ E   K+ LSTA GLA+LH E   
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 388 --SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA---TLAGTLGYMAPE 442
              K  I HRD+K  NIL+ +  T  IAD GL          I        GT  YMAPE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 443 Y------VVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQN------SCSILQTVWDLYV 490
                  +   +  ++AD+Y+ G+V  E+  R  I    ++               +   
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 491 KGRLHEAVDPALAGNFQEGKPSRLL-QIGLLCVQASAELRPSMSIVVKMLT 540
           K    + + P +   +Q  +  R++ +I   C  A+   R +   + K L+
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 4e-57
 Identities = 66/274 (24%), Positives = 107/274 (39%), Gaps = 27/274 (9%)

Query: 273 ESNKLGQGGSGSVYKGTLPG---GEAVAVKRLFYNTTQ--WVDHFFNEVNLISGINHKNL 327
           E  +LG G  G+V KG        + VAVK L          D    E N++  +++  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           V+++G        +LV E      L   L   +    +  +   +++   + G+ YL E 
Sbjct: 71  VRMIGI-CEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLEES 126

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLGYMAPEYVV 445
                +HRD+   N+LL  +  AKI+DFGL +    D  +  A       + + APE + 
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 446 RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN 505
             K + K+DV+SFGV++ E     +              V  +  KG             
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----SEVTAMLEKGERMG--------- 230

Query: 506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
              G P  +  +  LC     E RP  + V   L
Sbjct: 231 CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 4e-57
 Identities = 79/280 (28%), Positives = 126/280 (45%), Gaps = 27/280 (9%)

Query: 270 YFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGINH 324
             H +  +G+G  G VY GTL          AVK L   T    V  F  E  ++   +H
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSH 87

Query: 325 KNLVKLLGCSITGPES-LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
            N++ LLG  +    S L+V  ++ +  L +  F+R +    + +      L  A+G+ +
Sbjct: 88  PNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE---DITHISATLAGTLGYMA 440
           L  +   + +HRD+   N +LDE+FT K+ADFGL R   +   D  H        + +MA
Sbjct: 146 LASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202

Query: 441 PEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP 500
            E +   K T K+DV+SFGV++ E++ R        N+  I   +            + P
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR------RLLQP 256

Query: 501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
                  E  P  L ++ L C    AE+RPS S +V  ++
Sbjct: 257 -------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  190 bits (485), Expect = 9e-57
 Identities = 70/292 (23%), Positives = 116/292 (39%), Gaps = 36/292 (12%)

Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
              F +  ++G G  G+VY    +   E VA+K++      + +       EV  +  + 
Sbjct: 14  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73

Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           H N ++  GC +    + LV E+    +       ++   PL       +     +GLAY
Sbjct: 74  HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAY 130

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEY 443
           LH      +IHRD+K  NILL E    K+ DFG   +     + +     GT  +MAPE 
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEV 182

Query: 444 VV---RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP 500
           ++    G+   K DV+S G+  IE+  RK   LF  N+ S L  +     +         
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPP-LFNMNAMSALYHI----AQNESPALQSG 237

Query: 501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPP 552
                               C+Q   + RP+  +++K     H  +   +PP
Sbjct: 238 HW--------SEYFRNFVDSCLQKIPQDRPTSEVLLK-----HRFVLRERPP 276

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 2e-56
 Identities = 63/280 (22%), Positives = 112/280 (40%), Gaps = 25/280 (8%)

Query: 266 KATNYFHESNKLGQGGSGSVYKGTL---PGGEAVAVKRLFYNTTQW-VDHFFNEVNLISG 321
           K  N      +LG G  GSV +G          VA+K L   T +   +    E  ++  
Sbjct: 6   KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65

Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
           +++  +V+L+G        +LV E      L    F+    E +      +++   + G+
Sbjct: 66  LDNPYIVRLIGV-CQAEALMLVMEMAGGGPLHK--FLVGKREEIPVSNVAELLHQVSMGM 122

Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA--TLAGTLGYM 439
            YL E++    +HRD+   N+LL     AKI+DFGL +    D ++ +A       L + 
Sbjct: 123 KYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD 499
           APE +   K + ++DV+S+GV + E +   +          ++  +     +G+  E   
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI----EQGKRME--- 232

Query: 500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                      P  L  +   C     E RP    V + +
Sbjct: 233 ------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-56
 Identities = 66/286 (23%), Positives = 112/286 (39%), Gaps = 33/286 (11%)

Query: 270 YFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKN 326
           +     ++G+G   +VYKG        VA   L     T      F  E  ++ G+ H N
Sbjct: 10  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69

Query: 327 LVKLLGCSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           +V+      +  +     +LV E + + +L   L   +    +  +V         +GL 
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQ 126

Query: 383 YLHEESKLRIIHRDIKLSNILL-DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
           +LH  +   IIHRD+K  NI +     + KI D GL  L           + GT  +MAP
Sbjct: 127 FLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAP 182

Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA 501
           E +   K  E  DVY+FG+ ++E+   +      QN+  I + V          +   P 
Sbjct: 183 E-MYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE 241

Query: 502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ 547
           +             +I   C++ + + R S+  ++     NH   Q
Sbjct: 242 VK------------EIIEGCIRQNKDERYSIKDLL-----NHAFFQ 270

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-56
 Identities = 70/319 (21%), Positives = 124/319 (38%), Gaps = 41/319 (12%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGG---EAVAVKRL-FYNTTQWVDHFFNEVNLISGI-NHK 325
               + +G+G  G V K  +         A+KR+  Y +      F  E+ ++  + +H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVE-------------PLSWEVRYK 372
           N++ LLG         L  E+ P+ +LLD L   + +E              LS +    
Sbjct: 72  NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131

Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATL 432
                A G+ YL +    + IHRD+   NIL+ E + AKIADFGL R     +       
Sbjct: 132 FAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR- 187

Query: 433 AGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG 492
              + +MA E +     T  +DV+S+GV++ E+V                 T +      
Sbjct: 188 -LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-------------TPYCGMTCA 233

Query: 493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPP 552
            L+E +               +  +   C +     RPS + ++  L   + +L+  +  
Sbjct: 234 ELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSL---NRMLEE-RKT 289

Query: 553 FLNPNGSE-ISSVGTPSTS 570
           ++N    E  +  G   ++
Sbjct: 290 YVNTTLYEKFTYAGIDCSA 308

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-55
 Identities = 70/308 (22%), Positives = 134/308 (43%), Gaps = 30/308 (9%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGE----AVAVKRLFYNTT-QWVDHFFNEVNLISGINH 324
           F +   LG G  G+VYKG  +P GE     VA+K L   T+ +      +E  +++ +++
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
            ++ +LLG  +T     L+ + +P   LLD +   +D   +  +      +  A+G+ YL
Sbjct: 71  PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKD--NIGSQYLLNWCVQIAKGMNYL 127

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEY 443
            +    R++HRD+   N+L+      KI DFGL +L   E+  + +      + +MA E 
Sbjct: 128 EDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 444 VVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA 503
           ++    T ++DV+S+GV V E++                   +D      +   ++    
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGS-------------KPYDGIPASEISSILEKGER 231

Query: 504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQPPFLNPNGSEISS 563
                     +  I + C    A+ RP    ++   +   ++ +  Q  +L   G E   
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFS---KMARDPQ-RYLVIQGDERMH 287

Query: 564 VGTPSTSN 571
           + +P+ SN
Sbjct: 288 LPSPTDSN 295

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 2e-55
 Identities = 62/293 (21%), Positives = 109/293 (37%), Gaps = 44/293 (15%)

Query: 276 KLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQ-WVDHFFNEVNLISGI-NHKNL 327
            LG G  G V   T  G         VAVK L         +   +E+ +++ + +H+N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVR--------------------QDVEPLSW 367
           V LLG         L++E+     LL+ L  +                    +D+  L++
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
           E         A+G+ +L  +     +HRD+   N+L+      KI DFGL R    D  +
Sbjct: 164 EDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 428 -ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVW 486
            +       + +MAPE +  G  T K+DV+S+G+++ E+                     
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV------------NPYP 268

Query: 487 DLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
            + V    ++ +      +        +  I   C    +  RPS   +   L
Sbjct: 269 GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 3e-55
 Identities = 74/314 (23%), Positives = 126/314 (40%), Gaps = 40/314 (12%)

Query: 250 VAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFY 303
           V ++ ++L + ++  E   N       LG G  G V + T  G         VAVK L  
Sbjct: 5   VYIDPTQLPYDHK-WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKP 63

Query: 304 NTTQW-VDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD 361
           +      +   +E+ ++S + NH N+V LLG    G  +L++ E+     LL+ L  ++D
Sbjct: 64  SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRD 123

Query: 362 VE---------------PLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE 406
                             L  E         A+G+A+L  +     IHRD+   NILL  
Sbjct: 124 SFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTH 180

Query: 407 EFTAKIADFGLVRLFPEDITHISATLA-GTLGYMAPEYVVRGKLTEKADVYSFGVVVIEV 465
               KI DFGL R    D  ++    A   + +MAPE +     T ++DV+S+G+ + E+
Sbjct: 181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWEL 240

Query: 466 VCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQAS 525
                                 + V  + ++ +         E  P+ +  I   C  A 
Sbjct: 241 FSLGS------------SPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDAD 288

Query: 526 AELRPSMSIVVKML 539
              RP+   +V+++
Sbjct: 289 PLKRPTFKQIVQLI 302

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 5e-55
 Identities = 69/278 (24%), Positives = 105/278 (37%), Gaps = 30/278 (10%)

Query: 271 FHESNKLGQGGSGSVYKGTLP-GGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
           F     LG+G  G+VY          +A+K L                EV + S + H N
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++L G         L+ E+ P  ++   L   Q +     +     I   A  L+Y H 
Sbjct: 68  ILRLYGYFHDATRVYLILEYAPLGTVYREL---QKLSKFDEQRTATYITELANALSYCHS 124

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
               R+IHRDIK  N+LL      KIADFG     P        TL GTL Y+ PE +  
Sbjct: 125 ---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT---TLCGTLDYLPPEMIEG 178

Query: 447 GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF 506
               EK D++S GV+  E +  K    F  N+    Q  +    +              F
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKP--PFEANT---YQETYKRISRVEF----------TF 223

Query: 507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKM--LTGN 542
            +        +    ++ +   RP +  V++   +T N
Sbjct: 224 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 261

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 8e-55
 Identities = 73/279 (26%), Positives = 110/279 (39%), Gaps = 27/279 (9%)

Query: 271 FHESNKLGQGGSGSVYKGTLPG----GEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
                KLG G  G V +G          +VAVK L     +  + +D F  EVN +  ++
Sbjct: 10  LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69

Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           H+NL++L G  +T P   +V E  P  SLLD L   Q           +  +  AEG+ Y
Sbjct: 70  HRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGY 126

Query: 384 LHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLGYMAP 441
           L  +   R IHRD+   N+LL      KI DFGL+R  P++  H            + AP
Sbjct: 127 LESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 442 EYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA 501
           E +     +  +D + FGV + E+    +      N   IL  +     +    E     
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC--- 240

Query: 502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT 540
                    P  +  + + C     E RP+   +   L 
Sbjct: 241 ---------PQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 1e-53
 Identities = 65/280 (23%), Positives = 111/280 (39%), Gaps = 24/280 (8%)

Query: 266 KATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGI 322
           +A +Y      +G G  G   K      G+ +  K L Y   T        +EVNL+  +
Sbjct: 2   RAEDY-EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLREL 60

Query: 323 NHKNLVKLLGCSITGPESLL--VYEFVPNQSLLDNLF-VRQDVEPLSWEVRYKIILSTAE 379
            H N+V+     I    + L  V E+     L   +    ++ + L  E   +++     
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 380 GLAYLHEESK--LRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLG 437
            L   H  S     ++HRD+K +N+ LD +   K+ DFGL R+   D T  +    GT  
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHD-TSFAKAFVGTPY 179

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA 497
           YM+PE + R    EK+D++S G ++ E+        FT  S    + +     +G+    
Sbjct: 180 YMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP--PFTAFS---QKELAGKIREGKFRR- 233

Query: 498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK 537
                           L +I    +      RPS+  +++
Sbjct: 234 --------IPYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 1e-53
 Identities = 69/309 (22%), Positives = 123/309 (39%), Gaps = 40/309 (12%)

Query: 261 YETLEKATN---YFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEV 316
           YE + +  N   ++    +LG G  G VYK          A K +   + + ++ +  E+
Sbjct: 1   YEHVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEI 60

Query: 317 NLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILS 376
           ++++  +H N+VKLL          ++ EF    ++   +   +   PL+      +   
Sbjct: 61  DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQIQVVCKQ 118

Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTL 436
           T + L YLH+    +IIHRD+K  NIL   +   K+ADFG+       I     +  GT 
Sbjct: 119 TLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD-SFIGTP 174

Query: 437 GYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK 491
            +MAPE V+           KADV+S G+ +IE+   +      + +      V     K
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP--PHHELN---PMRVLLKIAK 229

Query: 492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP 551
                   P           S        C++ + + R + S          ++L   Q 
Sbjct: 230 SEPPTLAQP-------SRWSSNFKDFLKKCLEKNVDARWTTS----------QLL---QH 269

Query: 552 PFLNPNGSE 560
           PF+  + ++
Sbjct: 270 PFVTVDSNK 278

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-52
 Identities = 62/280 (22%), Positives = 107/280 (38%), Gaps = 27/280 (9%)

Query: 276 KLGQGGSGSVYKGTLPG----GEAVAVKRLFYNTTQWV-DHFFNEVNLISGINHKNLVKL 330
            +G+G  G V++G          AVA+K     T+  V + F  E   +   +H ++VKL
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 331 LGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKL 390
           +G  IT     ++ E      L    F++     L            +  LAYL      
Sbjct: 74  IGV-ITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---K 127

Query: 391 RIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLT 450
           R +HRDI   N+L+      K+ DFGL R   +   + ++     + +MAPE +   + T
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187

Query: 451 EKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGK 510
             +DV+ FGV + E++           +  ++          R+       +  N     
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIG---------RIENGERLPMPPNC---- 234

Query: 511 PSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQ 550
           P  L  +   C       RP  + +   L+    IL+  +
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQLS---TILEEEK 271

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 5e-52
 Identities = 75/293 (25%), Positives = 130/293 (44%), Gaps = 34/293 (11%)

Query: 271 FHESNKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGIN 323
              S +LGQG  G VY+G   G         VA+K +    +      F NE +++   N
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 324 HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQD-------VEPLSWEVRYKIILS 376
             ++V+LLG    G  +L++ E +    L   L   +        + P S     ++   
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 377 TAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE-DITHISATLAGT 435
            A+G+AYL+     + +HRD+   N ++ E+FT KI DFG+ R   E D           
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH 495
           + +M+PE +  G  T  +DV+SFGVV+ E+           ++  +L+ V    ++G L 
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV----MEGGLL 254

Query: 496 EAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQP 548
           +  D           P  L ++  +C Q + ++RPS   ++  +    E ++P
Sbjct: 255 DKPDNC---------PDMLFELMRMCWQYNPKMRPSFLEIISSIK---EEMEP 295

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (446), Expect = 1e-51
 Identities = 67/271 (24%), Positives = 107/271 (39%), Gaps = 22/271 (8%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHKNLV 328
           +     LG+G  G V         EAVAVK +         ++   E+ +   +NH+N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           K  G    G    L  E+     L D +        +      +       G+ YLH   
Sbjct: 67  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG-- 121

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEYVVRG 447
            + I HRDIK  N+LLDE    KI+DFGL  +F   +   +   + GTL Y+APE + R 
Sbjct: 122 -IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRR 180

Query: 448 KL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF 506
           +   E  DV+S G+V+  ++  +       +SC       +        + +D A     
Sbjct: 181 EFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL--- 237

Query: 507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVK 537
                  LL      +  +   R ++  + K
Sbjct: 238 ------ALLH---KILVENPSARITIPDIKK 259

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 2e-50
 Identities = 68/284 (23%), Positives = 121/284 (42%), Gaps = 27/284 (9%)

Query: 275 NKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGC 333
            K+GQG SG+VY    +  G+ VA++++        +   NE+ ++    + N+V  L  
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
            + G E  +V E++   SL D +        +       +     + L +LH     ++I
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSN---QVI 138

Query: 394 HRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKA 453
           HRDIK  NILL  + + K+ DFG       + +  S T+ GT  +MAPE V R     K 
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS-TMVGTPYWMAPEVVTRKAYGPKV 197

Query: 454 DVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSR 513
           D++S G++ IE++  +    +   + + L+ ++ +   G         L         + 
Sbjct: 198 DIWSLGIMAIEMIEGEP--PYL--NENPLRALYLIATNGTPELQNPEKL--------SAI 245

Query: 514 LLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPTQP-PFLNP 556
                  C+    E R S   ++      H+ L+  +P   L P
Sbjct: 246 FRDFLNRCLDMDVEKRGSAKELL-----QHQFLKIAKPLSSLTP 284

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 1e-47
 Identities = 67/289 (23%), Positives = 114/289 (39%), Gaps = 40/289 (13%)

Query: 275 NKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGI-NH 324
             LG+G  G V      G           VAVK L  + T+  +    +E+ ++  I  H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR-------------QDVEPLSWEVRY 371
           KN++ LLG         ++ E+    +L + L  R                E LS +   
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SA 430
                 A G+ YL  +   + IHRD+   N+L+ E+   KIADFGL R       +  + 
Sbjct: 139 SCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 431 TLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV 490
                + +MAPE +     T ++DV+SFGV++ E+      + +       ++ ++ L  
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG-SPYPGVP---VEELFKLLK 251

Query: 491 KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
           +G   +               + L  +   C  A    RP+   +V+ L
Sbjct: 252 EGHRMD---------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-47
 Identities = 72/296 (24%), Positives = 112/296 (37%), Gaps = 41/296 (13%)

Query: 275 NKLGQGGSGSVYKGTLPG------GEAVAVKRLFYNTTQW-VDHFFNEVNLISGINHKNL 327
             LG+G  G V +    G         VAVK L    T        +E+ ++  I H   
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 328 VKLLG--CSITGPESLLVYEFVPNQSLLDNLFVRQDV-------------EPLSWEVRYK 372
           V  L   C+  G   +++ EF    +L   L  +++              + L+ E    
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 373 IILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI-SAT 431
                A+G+ +L      + IHRD+   NILL E+   KI DFGL R   +D  ++    
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 432 LAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK 491
               L +MAPE +     T ++DV+SFGV++ E+               I +       +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA---SPYPGVKIDEEFCRRLKE 252

Query: 492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQ 547
           G    A D              + Q  L C       RP+ S +V+ L     +LQ
Sbjct: 253 GTRMRAPDYT---------TPEMYQTMLDCWHGEPSQRPTFSELVEHLG---NLLQ 296

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  165 bits (418), Expect = 1e-46
 Identities = 54/282 (19%), Positives = 102/282 (36%), Gaps = 23/282 (8%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           +LG G  G V++ T    G   A K +        +    E+  +S + H  LV L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
               E +++YEF+    L + +    +   +S +   + +    +GL ++HE      +H
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHEN---NYVH 147

Query: 395 RDIKLSNILL--DEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
            D+K  NI+         K+ DFGL        +    T  GT  + APE      +   
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGYY 205

Query: 453 ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS 512
            D++S GV+   ++         +N    L+ V        + ++    +          
Sbjct: 206 TDMWSVGVLSYILLSGLSP-FGGENDDETLRNV--KSCDWNMDDSAFSGI--------SE 254

Query: 513 RLLQIGLLCVQASAELRPSMSIVVKM--LTGNHEILQPTQPP 552
                    + A    R ++   ++   LT  +   + +Q P
Sbjct: 255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 296

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 2e-46
 Identities = 48/205 (23%), Positives = 81/205 (39%), Gaps = 11/205 (5%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
           F     LG+G   +V     L      A+K L          V +   E +++S ++H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
            VKL        +      +  N  LL  +     +                  L YLH 
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF-PEDITHISATLAGTLGYMAPEYVV 445
                IIHRD+K  NILL+E+   +I DFG  ++  PE     + +  GT  Y++PE + 
Sbjct: 127 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 446 RGKLTEKADVYSFGVVVIEVVCRKR 470
                + +D+++ G ++ ++V    
Sbjct: 184 EKSACKSSDLWALGCIIYQLVAGLP 208

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  158 bits (401), Expect = 3e-44
 Identities = 57/282 (20%), Positives = 101/282 (35%), Gaps = 23/282 (8%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           +LG G  G V++      G     K +            NE+++++ ++H  L+ L    
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
               E +L+ EF+    L D   +  +   +S       +    EGL ++HE     I+H
Sbjct: 96  EDKYEMVLILEFLSGGELFD--RIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVH 150

Query: 395 RDIKLSNILLD--EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
            DIK  NI+ +  +  + KI DFGL      D   I      T  + APE V R  +   
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPD--EIVKVTTATAEFAAPEIVDREPVGFY 208

Query: 453 ADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPS 512
            D+++ GV+   ++       F            +     +  +  D     +       
Sbjct: 209 TDMWAIGVLGYVLLSGLS--PFAGED------DLETL---QNVKRCDWEFDEDAFSSVSP 257

Query: 513 RLLQIGLLCVQASAELRPSMSIVVKM--LTGNHEILQPTQPP 552
                    +Q     R ++   ++   L G+H  L    P 
Sbjct: 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPS 299

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  155 bits (393), Expect = 4e-43
 Identities = 65/326 (19%), Positives = 113/326 (34%), Gaps = 50/326 (15%)

Query: 269 NYFHESNKLGQGGSGSVYKGTLPG-GEAVAVKRL---FYNTTQWVDHFFNEVNLIS---G 321
           N F     +G+GG G VY       G+  A+K L        Q      NE  ++S    
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 322 INHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGL 381
            +   +V +     T  +   + + +    L  +L         S             GL
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL---SQHGVFSEADMRFYAAEIILGL 120

Query: 382 AYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAP 441
            ++H      +++RD+K +NILLDE    +I+D GL   F +   H S    GT GYMAP
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAP 174

Query: 442 EYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP 500
           E + +G      AD +S G ++ +++     + F Q+       +  + +   +      
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGH--SPFRQHKTKDKHEIDRMTLTMAVE----- 227

Query: 501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEIL-------------- 546
                  +     L  +    +Q     R        +  G  E+               
Sbjct: 228 -----LPDSFSPELRSLLEGLLQRDVNRRLGC-----LGRGAQEVKESPFFRSLDWQMVF 277

Query: 547 -QPTQPPFLNPNGSEISSVGTPSTSN 571
            Q   PP + P   E+++       +
Sbjct: 278 LQKYPPPLI-PPRGEVNAADAFDIGS 302

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  150 bits (380), Expect = 8e-42
 Identities = 53/298 (17%), Positives = 111/298 (37%), Gaps = 20/298 (6%)

Query: 261 YETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQW-VDHFFNEVNL 318
           ++  E   + +   + LG G    V         + VA+K +     +       NE+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTA 378
           +  I H N+V L     +G    L+ + V    L D +  +      +     ++I    
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVL 117

Query: 379 EGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGY 438
           + + YLH+   +    +   L    LDE+    I+DFGL ++  ED   + +T  GT GY
Sbjct: 118 DAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGY 175

Query: 439 MAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV 498
           +APE + +   ++  D +S GV+   ++C      F   +      +++  +K       
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP--PFYDEN---DAKLFEQILKA------ 224

Query: 499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM--LTGNHEILQPTQPPFL 554
           +      + +             ++   E R +    ++   + G+  + +       
Sbjct: 225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVS 282

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (380), Expect = 1e-41
 Identities = 50/204 (24%), Positives = 83/204 (40%), Gaps = 14/204 (6%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
           F     LG G  G V+       G   A+K L        + V+H  +E  ++S + H  
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           ++++ G      +  ++ +++    L   L   Q       +     +         L  
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC------LALEY 119

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
                II+RD+K  NILLD+    KI DFG  +  P+       TL GT  Y+APE V  
Sbjct: 120 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY----TLCGTPDYIAPEVVST 175

Query: 447 GKLTEKADVYSFGVVVIEVVCRKR 470
               +  D +SFG+++ E++    
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYT 199

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 3e-41
 Identities = 40/198 (20%), Positives = 75/198 (37%), Gaps = 11/198 (5%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
            LG+G  G V++       +    K +    T        E+++++   H+N++ L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70

Query: 335 ITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH 394
            +  E ++++EF+    + +   +      L+       +    E L +LH      I H
Sbjct: 71  ESMEELVMIFEFISGLDIFE--RINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGH 125

Query: 395 RDIKLSNILLD--EEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEK 452
            DI+  NI+       T KI +FG  R            L     Y APE      ++  
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

Query: 453 ADVYSFGVVVIEVVCRKR 470
            D++S G +V  ++    
Sbjct: 184 TDMWSLGTLVYVLLSGIN 201

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  147 bits (373), Expect = 4e-41
 Identities = 67/274 (24%), Positives = 114/274 (41%), Gaps = 27/274 (9%)

Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGIN 323
           ++ +     LG GG   V+    L     VAVK L         +   F  E    + +N
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 324 HKNLVKLLGCSIT----GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
           H  +V +          GP   +V E+V   +L D +       P++ +   ++I    +
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQ 122

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI--SATLAGTLG 437
            L + H+     IIHRD+K +NI++      K+ DFG+ R   +    +  +A + GT  
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179

Query: 438 YMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA 497
           Y++PE      +  ++DVYS G V+ EV+  +    FT +S     +V   +V+      
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP--PFTGDS---PVSVAYQHVRE----- 229

Query: 498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPS 531
            DP       EG  + L  + L  +  + E R  
Sbjct: 230 -DPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 262

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 1e-40
 Identities = 45/207 (21%), Positives = 87/207 (42%), Gaps = 8/207 (3%)

Query: 268 TNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL-FYNTTQWVDHFFNEVNLISGINHK 325
              +   + +G+G  G V           VA+K++  +    +      E+ ++    H+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
           N++ +           +   ++    +  +L+     + LS +     +     GL Y+H
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISA--TLAGTLGYMAPEY 443
                 ++HRD+K SN+LL+     KI DFGL R+   D  H         T  Y APE 
Sbjct: 127 SA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 183

Query: 444 VVRGKL-TEKADVYSFGVVVIEVVCRK 469
           ++  K  T+  D++S G ++ E++  +
Sbjct: 184 MLNSKGYTKSIDIWSVGCILAEMLSNR 210

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  147 bits (371), Expect = 1e-40
 Identities = 53/275 (19%), Positives = 92/275 (33%), Gaps = 26/275 (9%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLG-C 333
           K+G G  G +Y GT +  GE VA+K     T         E  +   +     +  +  C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
              G  +++V E +         F  +     S +    +       + Y+H       I
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSR---KFSLKTVLLLADQMISRIEYIHS---KNFI 125

Query: 394 HRDIKLSNIL---LDEEFTAKIADFGLVRLFPEDITHI------SATLAGTLGYMAPEYV 444
           HRD+K  N L     +     I DFGL + + +  TH       +  L GT  Y +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 445 VRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG 504
           +  + + + D+ S G V++                    T    Y +    +   P    
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSL-----PWQGLKAATKRQKYERISEKKMSTPIEV- 239

Query: 505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
              +G PS        C     + +P  S + ++ 
Sbjct: 240 -LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 5e-40
 Identities = 59/277 (21%), Positives = 114/277 (41%), Gaps = 18/277 (6%)

Query: 275 NKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVD-----HFFNEVNLISGINHKNLV 328
           + LG+G   +VYK       + VA+K++                  E+ L+  ++H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
            LL          LV++F+     +    ++ +   L+       +L T +GL YLH+  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH- 119

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
              I+HRD+K +N+LLDE    K+ADFGL + F       +     T  Y APE +   +
Sbjct: 120 --WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ-VVTRWYRAPELLFGAR 176

Query: 449 L-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ 507
           +     D+++ G ++ E++ R    L   +    L  +++        +  D     ++ 
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPF-LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE 544
             K    + +  +   A  +L     ++  +   N  
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLL---DLIQGLFLFNPC 269

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (365), Expect = 9e-40
 Identities = 51/215 (23%), Positives = 89/215 (41%), Gaps = 15/215 (6%)

Query: 266 KATNYFHESNKLGQGGSGSVYKGT--LPGGEAVAVKRLFYNTTQ--WVDHFFNEVNL--- 318
           +A   +    ++G+G  G V+K      GG  VA+KR+   T +         EV +   
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 319 ISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLL---DNLFVRQDVEPLSWEVRYKIIL 375
           +    H N+V+L                +  + +         +     +  E    ++ 
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 376 STAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGT 435
               GL +LH     R++HRD+K  NIL+      K+ADFGL R++   +     ++  T
Sbjct: 124 QLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALT--SVVVT 178

Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKR 470
           L Y APE +++       D++S G +  E+  RK 
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-39
 Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 10/204 (4%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVK--RLFYNTTQWVDHFFNEVNLISGINHKNL 327
           F +  K+G+G  G VYK      GE VA+K  RL   T         E++L+  +NH N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           VKLL    T  +  LV+EF+     L        +  +   +    +    +GLA+ H  
Sbjct: 64  VKLLDVIHTENKLYLVFEFLHQD--LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
              R++HRD+K  N+L++ E   K+ADFGL R F   +   +     TL Y APE ++  
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT-HEVVTLWYRAPEILLGC 177

Query: 448 K-LTEKADVYSFGVVVIEVVCRKR 470
           K  +   D++S G +  E+V R+ 
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRA 201

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  142 bits (359), Expect = 4e-39
 Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 25/216 (11%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTT---------QWVDHFFNEVNLIS 320
           +     LG+G S  V +    P  +  AVK +              +  +    EV+++ 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 321 GIN-HKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
            ++ H N+++L     T     LV++ +    L D L    +   LS +   KI+ +  E
Sbjct: 65  KVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRALLE 121

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
            +  LH+   L I+HRD+K  NILLD++   K+ DFG               + GT  Y+
Sbjct: 122 VICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCGTPSYL 176

Query: 440 APEYV------VRGKLTEKADVYSFGVVVIEVVCRK 469
           APE +            ++ D++S GV++  ++   
Sbjct: 177 APEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  141 bits (355), Expect = 2e-38
 Identities = 41/277 (14%), Positives = 91/277 (32%), Gaps = 28/277 (10%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGC 333
           ++G+G  G +++GT L   + VA+K              +E      +     +  +   
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRII 393
              G  ++LV + +          +       S +            +  +HE     ++
Sbjct: 70  GQEGLHNVLVIDLLGP---SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123

Query: 394 HRDIKLSNILLDEEFT-----AKIADFGLVRLFPEDITHI------SATLAGTLGYMAPE 442
           +RDIK  N L+    +       + DFG+V+ + + +T           L+GT  YM+  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 443 YVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL 502
             +  + + + D+ + G V +  +    +      + +  Q         R+ E      
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRG-SLPWQGLKAATNKQKYE------RIGEKKQSTP 236

Query: 503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKML 539
                 G P    +        + +  P    +  + 
Sbjct: 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (356), Expect = 2e-38
 Identities = 53/205 (25%), Positives = 84/205 (40%), Gaps = 12/205 (5%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLIS-GINHK 325
           F     LG+G  G V+        +  A+K L          V+    E  ++S    H 
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
            L  +     T      V E++    L+ ++   Q                   GL +LH
Sbjct: 64  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHI---QSCHKFDLSRATFYAAEIILGLQFLH 120

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                 I++RD+KL NILLD++   KIADFG+ +         + T  GT  Y+APE ++
Sbjct: 121 ---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-TFCGTPDYIAPEILL 176

Query: 446 RGKLTEKADVYSFGVVVIEVVCRKR 470
             K     D +SFGV++ E++  + 
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQS 201

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  139 bits (351), Expect = 5e-38
 Identities = 64/281 (22%), Positives = 105/281 (37%), Gaps = 26/281 (9%)

Query: 271 FHESNKLGQGGSGSVYKGTLPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNLV 328
           +H   K+G+G  G VYK     GE  A+K++               E++++  + H N+V
Sbjct: 4   YHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 329 KLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES 388
           KL     T    +LV+E +                 L        +L    G+AY H+  
Sbjct: 64  KLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHD-- 118

Query: 389 KLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGK 448
             R++HRD+K  N+L++ E   KIADFGL R F   +   +  +           +   K
Sbjct: 119 -RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK 177

Query: 449 LTEKADVYSFGVVVIEVVCRKRINLFTQNSCS-----ILQTVWDLYVKGRLHEAVDPALA 503
            +   D++S G +  E+V      LF   S +     I + +     K   +    P   
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTP--LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235

Query: 504 GNFQEGKPSRLLQ---------IGLL--CVQASAELRPSMS 533
            NF   +P              I LL   ++     R +  
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (355), Expect = 6e-38
 Identities = 70/318 (22%), Positives = 124/318 (38%), Gaps = 29/318 (9%)

Query: 271 FHESNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVK 329
           + ++  +G G  G VY+  L   GE VA+K++     Q       E+ ++  ++H N+V+
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77

Query: 330 LLGCSITGPES------LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAY 383
           L     +  E        LV ++VP           +  + L        +      LAY
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137

Query: 384 LHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGTLGYMAPE 442
           +H      I HRDIK  N+LLD +    K+ DFG  +       ++  +   +  Y APE
Sbjct: 138 IHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--SYICSRYYRAPE 192

Query: 443 YVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA 501
            +      T   DV+S G V+ E++  +   +F  +S  + Q V  + V G         
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQP--IFPGDS-GVDQLVEIIKVLGTPTREQIRE 249

Query: 502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHE----ILQPTQPPFL--- 554
           +  N+ E K  ++       V        ++++  ++L          L+     F    
Sbjct: 250 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL 309

Query: 555 -NPNGSEISSVGTPSTSN 571
            +PN    +   TP+  N
Sbjct: 310 RDPNVKLPNGRDTPALFN 327

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-36
 Identities = 56/274 (20%), Positives = 102/274 (37%), Gaps = 27/274 (9%)

Query: 269 NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVN-LISGINHKN 326
           +Y   S  LG G +G V +       E  A+K L     Q       EV          +
Sbjct: 12  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 66

Query: 327 LVKLLGCSITGPES----LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLA 382
           +V+++             L+V E +    L       +  +  +     +I+ S  E + 
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFS-RIQDRGDQAFTEREASEIMKSIGEAIQ 125

Query: 383 YLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPEDITHISATLAGTLGYM 439
           YLH    + I HRD+K  N+L          K+ DFG  +      +    T   T  Y+
Sbjct: 126 YLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT--TPCYTPYYV 180

Query: 440 APEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD 499
           APE +   K  +  D++S GV++  ++C      F  N    +       ++   +E  +
Sbjct: 181 APEVLGPEKYDKSCDMWSLGVIMYILLCGYP--PFYSNHGLAISPGMKTRIRMGQYEFPN 238

Query: 500 PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMS 533
           P  +   +E K   L++     ++     R +++
Sbjct: 239 PEWSEVSEEVK--MLIR---NLLKTEPTQRMTIT 267

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 4e-36
 Identities = 61/295 (20%), Positives = 108/295 (36%), Gaps = 49/295 (16%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLF------YNTTQWVDHFFNEVNLISGIN--HKN 326
            LG GG GSVY G  +     VA+K +       +           EV L+  ++     
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           +++LL         +L+ E       L +    +    L  E+         E + + H 
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHN 128

Query: 387 ESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
                ++HRDIK  NIL+D      K+ DFG   L  + +        GT  Y  PE++ 
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT---DFDGTRVYSPPEWIR 182

Query: 446 RGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG 504
             +     A V+S G+++ ++VC      F  +   I         +G++          
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDI--PFEHDEEII---------RGQVF--------- 222

Query: 505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH----EILQPTQPPFLN 555
            F++   S    +   C+      RP+   +      NH    ++L P +   ++
Sbjct: 223 -FRQRVSSECQHLIRWCLALRPSDRPTFEEIQ-----NHPWMQDVLLPQETAEIH 271

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 9e-36
 Identities = 55/222 (24%), Positives = 90/222 (40%), Gaps = 22/222 (9%)

Query: 259 FSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL------FYNTTQWVDH 311
           F  E ++   +Y+    +LG G    V K      G   A K +              + 
Sbjct: 3   FRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 59

Query: 312 FFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRY 371
              EV+++  I H N++ L        + +L+ E V    L D L  ++    L+ E   
Sbjct: 60  IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEAT 116

Query: 372 KIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE----FTAKIADFGLVRLFPEDITH 427
           + +     G+ YLH    L+I H D+K  NI+L +        KI DFGL         +
Sbjct: 117 EFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--N 171

Query: 428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
               + GT  ++APE V    L  +AD++S GV+   ++   
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (337), Expect = 1e-35
 Identities = 54/204 (26%), Positives = 76/204 (37%), Gaps = 11/204 (5%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKN 326
           F     LG+G  G V        G   A+K L          V H   E  ++    H  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 327 LVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE 386
           L  L     T      V E+     L  +L         + E            L YLH 
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYLHS 123

Query: 387 ESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVR 446
                +++RDIKL N++LD++   KI DFGL +    D      T  GT  Y+APE +  
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLED 179

Query: 447 GKLTEKADVYSFGVVVIEVVCRKR 470
                  D +  GVV+ E++C + 
Sbjct: 180 NDYGRAVDWWGLGVVMYEMMCGRL 203

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 2e-35
 Identities = 53/278 (19%), Positives = 106/278 (38%), Gaps = 13/278 (4%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFY--NTTQWVDHFFNEVNLISGINHKNL 327
           + +  K+G+G  G+V+K       E VA+KR+    +          E+ L+  + HKN+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           V+L     +  +  LV+EF              D++    E+    +    +GL + H  
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCHSR 120

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
               ++HRD+K  N+L++     K+A+FGL R F   +   SA +               
Sbjct: 121 ---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 448 KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ 507
             +   D++S G +  E+    R      +    L+ ++ L       +        +++
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 508 EGKPSRLLQ-IGLLCVQASAELRPSMSIVVKMLTGNHE 544
                     +  +  + +A  R    ++  +L  N  
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGR---DLLQNLLKCNPV 272

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  133 bits (336), Expect = 3e-35
 Identities = 52/242 (21%), Positives = 93/242 (38%), Gaps = 25/242 (10%)

Query: 233 RKLLQKRRERKQLGALQVAVNKSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LP 291
           ++ L K +E         + N ++L+  ++ ++           LG G  G V       
Sbjct: 16  KEFLAKAKEDFLKKWETPSQNTAQLD-QFDRIKT----------LGTGSFGRVMLVKHKE 64

Query: 292 GGEAVAVKRL---FYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP 348
            G   A+K L        + ++H  NE  ++  +N   LVKL           +V E+V 
Sbjct: 65  SGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVA 124

Query: 349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF 408
              +  +L         S                YLH    L +I+RD+K  N+L+D++ 
Sbjct: 125 GGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQG 178

Query: 409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCR 468
             ++ DFG  +           TL GT   +APE ++     +  D ++ GV++ E+   
Sbjct: 179 YIQVTDFGFAKRVKGRTW----TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

Query: 469 KR 470
             
Sbjct: 235 YP 236

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 9e-34
 Identities = 50/223 (22%), Positives = 93/223 (41%), Gaps = 23/223 (10%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNL 327
           + +  K+GQG  G V+K      G+ VA+K++        +      E+ ++  + H+N+
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 328 VKLLGCSITGPES--------LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAE 379
           V L+    T             LV++F  +        V       +     +++     
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLN 128

Query: 380 GLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF---PEDITHISATLAGTL 436
           GL Y+H     +I+HRD+K +N+L+  +   K+ADFGL R F        +       TL
Sbjct: 129 GLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 437 GYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNS 478
            Y  PE ++  +      D++  G ++ E+  R    +   N+
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP--IMQGNT 226

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 4e-33
 Identities = 51/223 (22%), Positives = 96/223 (43%), Gaps = 16/223 (7%)

Query: 256 KLNFSYETLEKAT----NYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQW 308
           +  F  + + K        + +   +G G  G+V        G  VA+K+L+  + +  +
Sbjct: 1   RSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELF 60

Query: 309 VDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVR-QDVEPLSW 367
               + E+ L+  + H+N++ LL             +F      +     +    E L  
Sbjct: 61  AKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE 120

Query: 368 EVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH 427
           +    ++    +GL Y+H      IIHRD+K  N+ ++E+   KI DFGL R    ++T 
Sbjct: 121 DRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT- 176

Query: 428 ISATLAGTLGYMAPEYVV-RGKLTEKADVYSFGVVVIEVVCRK 469
                  T  Y APE ++   + T+  D++S G ++ E++  K
Sbjct: 177 ---GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 1e-29
 Identities = 56/207 (27%), Positives = 86/207 (41%), Gaps = 17/207 (8%)

Query: 275 NKLGQGGSGSVYKGTLPG----GEAVAVKRL----FYNTTQWVDHFFNEVNLISGINHK- 325
             LG G  G V+          G+  A+K L         +  +H   E  ++  I    
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 326 NLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLH 385
            LV L     T  +  L+ +++    L  +L  R+     +       +      L +LH
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLH 146

Query: 386 EESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVV 445
           +   L II+RDIKL NILLD      + DFGL + F  D T  +    GT+ YMAP+ V 
Sbjct: 147 K---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR 203

Query: 446 RGK--LTEKADVYSFGVVVIEVVCRKR 470
            G     +  D +S GV++ E++    
Sbjct: 204 GGDSGHDKAVDWWSLGVLMYELLTGAS 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (287), Expect = 1e-28
 Identities = 56/246 (22%), Positives = 90/246 (36%), Gaps = 8/246 (3%)

Query: 271 FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVDHFFNEVNLISGINHKNL 327
           +     +G G  G V           VA+K+L   +         + E+ L+  +NHKN+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 328 VKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE 387
           + LL             +      L+D    +     L  E    ++     G+ +LH  
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA 138

Query: 388 SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRG 447
               IIHRD+K SNI++  + T KI DFGL R               T  Y APE ++  
Sbjct: 139 ---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRYYRAPEVILGM 193

Query: 448 KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ 507
              E  D++S G ++ E+V  K +           + +  L                N+ 
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 253

Query: 508 EGKPSR 513
           E +P  
Sbjct: 254 ENRPKY 259

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  109 bits (272), Expect = 7e-27
 Identities = 44/231 (19%), Positives = 87/231 (37%), Gaps = 23/231 (9%)

Query: 249 QVAVNKSKLNFSYETLEKATNY---FHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLFYN 304
            V  ++ +  + YE+          +    KLG+G    V++   +   E V VK L   
Sbjct: 12  DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL--- 68

Query: 305 TTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPESL--LVYEFVPNQSLLDNLFVRQD 361
                     E+ ++  +    N++ L             LV+E V N            
Sbjct: 69  KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY----- 123

Query: 362 VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRL 420
            + L+       +    + L Y H    + I+HRD+K  N+++D E    ++ D+GL   
Sbjct: 124 -QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179

Query: 421 FPEDITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKR 470
           +     +       +  +  PE +V  ++     D++S G ++  ++ RK 
Sbjct: 180 YHPGQEYN--VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 2e-26
 Identities = 54/225 (24%), Positives = 100/225 (44%), Gaps = 23/225 (10%)

Query: 254 KSKLNFSYETLEKATNYFHESNKLGQGGSGSVYKGT-LPGGEAVAVKRLF--YNTTQWVD 310
           + +LN   +T+ +    +   + +G G  GSV        G  VAVK+L   + +     
Sbjct: 6   RQELN---KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK 62

Query: 311 HFFNEVNLISGINHKNLVKLLGC-----SITGPESLLVYEFVPNQSLLDNLFVRQDVEPL 365
             + E+ L+  + H+N++ LL       S+     + +   +    L +        + L
Sbjct: 63  RTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNN----IVKCQKL 118

Query: 366 SWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI 425
           + +    +I     GL Y+H      IIHRD+K SN+ ++E+   KI DFGL R   +++
Sbjct: 119 TDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 175

Query: 426 THISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRK 469
           T        T  Y APE ++      +  D++S G ++ E++  +
Sbjct: 176 T----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  101 bits (252), Expect = 5e-24
 Identities = 43/214 (20%), Positives = 77/214 (35%), Gaps = 27/214 (12%)

Query: 276 KLGQGGSGSVYKGT-LPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCS 334
           KLG G   +V+    +     VA+K +      + +   +E+ L+  +N  +  K     
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 335 ITGPESLLVYEFVPNQSLL-------------DNLFVRQDVEPLSWEVRYKIILSTAEGL 381
                 LL +      + +               L  + +   +      +I      GL
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 382 AYLHEESKLRIIHRDIKLSNILLDEE------FTAKIADFGLVRLFPEDITHISATLAGT 435
            Y+H      IIH DIK  N+L++           KIAD G    + E  T+       T
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI----QT 192

Query: 436 LGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRK 469
             Y +PE ++       AD++S   ++ E++   
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGD 226

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 87.1 bits (215), Expect = 2e-20
 Identities = 31/202 (15%), Positives = 65/202 (32%), Gaps = 28/202 (13%)

Query: 275 NKLGQGGSGSVYKGTLPGGEAVAVKRL------FYNTTQWVD----HFFNEVNLISGINH 324
             +G+G   +V+           VK        F    +  D    HF       +    
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 325 KNLVKLLGCSITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYL 384
           + L KL G ++  P+            +L  L   +++  +  E   +++    E +A  
Sbjct: 66  RALQKLQGLAV--PKVYAWEGNA----VLMELIDAKELYRVRVENPDEVLDMILEEVAKF 119

Query: 385 HEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHISAT--LAGTLGYMAPE 442
           +      I+H D+   N+L+  E    I DF        ++        L   +  +   
Sbjct: 120 YHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSV----EVGEEGWREILERDVRNIITY 171

Query: 443 YVVRGKLTEKADVYSFGVVVIE 464
           +        + D+ S    +++
Sbjct: 172 F--SRTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	573
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.89
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.53
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.01
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.46
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.61
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.47
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.66

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=415.84  Aligned_cols=255  Identities=25%  Similarity=0.376  Sum_probs=204.0

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      ++|+..++||+|+||+||+|++.+++.||||++.... ...++|.+|++++++++|||||+++|++...+..++||||++
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~   83 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME   83 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence            5788899999999999999999888999999997543 335689999999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +|+|.+++...  ...+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++.........
T Consensus        84 ~g~L~~~l~~~--~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          84 HGCLSDYLRTQ--RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             TCBHHHHHHTT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             CCcHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            99999988543  346899999999999999999999988   9999999999999999999999999998776554444


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQE  508 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~  508 (573)
                      .....||+.|+|||++.++.++.++|||||||++|||+|++.|+........+...    ...+.         ....+.
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~----i~~~~---------~~~~p~  225 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED----ISTGF---------RLYKPR  225 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH----HHHTC---------CCCCCT
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH----HHhcC---------CCCCcc
Confidence            44567899999999999999999999999999999999987776554432222222    22221         112234


Q ss_pred             chHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          509 GKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       509 ~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ..+.++.+|+.+||+.||++||||+||+++|++.
T Consensus       226 ~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i  259 (263)
T d1sm2a_         226 LASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEI  259 (263)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            4567899999999999999999999999999653

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-53  Score=418.31  Aligned_cols=257  Identities=29%  Similarity=0.445  Sum_probs=214.9

Q ss_pred             HHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          266 KATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       266 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ...++|+..++||+|+||+||+|++++++.||||++..... ..+.|.+|+.+|++++|||||+++|++.+ +..++|||
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E   87 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE   87 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence            34578899999999999999999999889999999975433 35679999999999999999999998754 56799999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++|+|.+++.... ...+++..+++++.||++||.|||+++   |+||||||+||||++++.+||+|||+++......
T Consensus        88 y~~~g~L~~~~~~~~-~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~  163 (272)
T d1qpca_          88 YMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (272)
T ss_dssp             CCTTCBHHHHTTSHH-HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             eCCCCcHHHHHhhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence            999999998775432 235899999999999999999999987   9999999999999999999999999999876655


Q ss_pred             cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGN  505 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~  505 (573)
                      ........||+.|+|||++..+.++.++|||||||++|||+||+.|+........+...    ...+.         ...
T Consensus       164 ~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~----i~~~~---------~~~  230 (272)
T d1qpca_         164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN----LERGY---------RMV  230 (272)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTTC---------CCC
T ss_pred             cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH----HHhcC---------CCC
Confidence            55555677899999999999999999999999999999999988776654433222222    22211         112


Q ss_pred             CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          506 FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       506 ~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      .+...+.++.+|+.+||+.+|++||||+||+++|++
T Consensus       231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            244567789999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-53  Score=420.78  Aligned_cols=263  Identities=29%  Similarity=0.404  Sum_probs=221.7

Q ss_pred             HHHHHHhcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          262 ETLEKATNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       262 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      ++++...++|+..++||+|+||+||+|++. +|+.||||++..+.. ..++|.+|+.+|++++|||||++++++.+++..
T Consensus        10 ~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (287)
T d1opja_          10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   88 (287)
T ss_dssp             CTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred             cccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc-hHHHHHHHHHHHHhCCCCCEecCCccEeeCCee
Confidence            344455678999999999999999999975 588999999876543 356899999999999999999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ++||||+++|+|.+++... ....+++..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.
T Consensus        89 ~iv~E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~  164 (287)
T d1opja_          89 YIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRL  164 (287)
T ss_dssp             EEEEECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTT
T ss_pred             EEEeecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceee
Confidence            9999999999999998643 3356899999999999999999999988   99999999999999999999999999998


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ...+.........|++.|+|||++.++.++.++|||||||++|||++|+.|+........    +......+        
T Consensus       165 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~----~~~~i~~~--------  232 (287)
T d1opja_         165 MTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELLEKD--------  232 (287)
T ss_dssp             CCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----HHHHHHTT--------
T ss_pred             cCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH----HHHHHhcC--------
Confidence            766555545556789999999999999999999999999999999998888765443222    22222221        


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                       .....+...+.++.+|+.+||+.||++|||++||+++|+..
T Consensus       233 -~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~  273 (287)
T d1opja_         233 -YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  273 (287)
T ss_dssp             -CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             -CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence             12233455678899999999999999999999999999654

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=411.93  Aligned_cols=257  Identities=30%  Similarity=0.463  Sum_probs=204.7

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|+..++||+|+||+||+|++++  .||||++...  ..+..+.|.+|+.+|++++|||||++++++.+ +..++|||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E   83 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ   83 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEECC--EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence            5678999999999999999998753  5999998643  44557789999999999999999999998754 56899999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+++|+|.+++...  ...+++..++.++.||++||+|||+++   ||||||||+||||+.++.+||+|||+++......
T Consensus        84 y~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~  158 (276)
T d1uwha_          84 WCEGSSLYHHLHII--ETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS  158 (276)
T ss_dssp             CCCEEEHHHHHHTS--CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred             cCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence            99999999998543  345999999999999999999999987   9999999999999999999999999998765432


Q ss_pred             c-ccccccccCcCcCchhhhcc---CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          426 T-HISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       426 ~-~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      . .......||+.|||||++..   +.++.++|||||||+||||+||+.|+........+    ......+..    .+.
T Consensus       159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~----~~~~~~~~~----~p~  230 (276)
T d1uwha_         159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI----IFMVGRGYL----SPD  230 (276)
T ss_dssp             -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH----HHHHHHTSC----CCC
T ss_pred             CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH----HHHHhcCCC----CCc
Confidence            2 23345679999999999864   45899999999999999999999997644332222    222222211    111


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      + ...+...++.+.+|+.+||+.||++|||++||+++|+.
T Consensus       231 ~-~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~  269 (276)
T d1uwha_         231 L-SKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIEL  269 (276)
T ss_dssp             G-GGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             c-hhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            1 12344567889999999999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=402.31  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=213.5

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEecc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVP  348 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~  348 (573)
                      ++|+..++||+|+||+||+|++++++.||||++..... ..++|.+|+.++++++|||||+++|++.+....++||||++
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~   82 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA   82 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence            67899999999999999999998888999999976543 35689999999999999999999999999999999999999


Q ss_pred             CCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCccc
Q 008239          349 NQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITHI  428 (573)
Q Consensus       349 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~~  428 (573)
                      +|+|.+++...  ...+++..+++++.||++||+|||+.+   |+||||||+|||+++++.+||+|||+++.........
T Consensus        83 ~g~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          83 NGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             TEEHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             CCcHHHhhhcc--ccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            99999887543  345889999999999999999999987   9999999999999999999999999998776554444


Q ss_pred             ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          429 SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       429 ~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      .....+|+.|+|||.+....++.++||||||+++|||+| |+.|+..... ..+.    .....+.         ....+
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~-~~~~----~~i~~~~---------~~~~p  223 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN-SETA----EHIAQGL---------RLYRP  223 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCH-HHHH----HHHHTTC---------CCCCC
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCH-HHHH----HHHHhCC---------CCCCc
Confidence            445678999999999999999999999999999999998 5666543321 1221    1222211         11234


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...+..+.+++.+||+.||++|||++||++.|.+
T Consensus       224 ~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         224 HLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             ccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            4566789999999999999999999999999854

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-52  Score=413.46  Aligned_cols=254  Identities=26%  Similarity=0.379  Sum_probs=196.7

Q ss_pred             cCccccccccccCceeEEEEEcCC-CC---EEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG-GE---AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~---~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++|+..++||+|+||+||+|++.. |+   .||||++... ..+..+.|.+|+.+|++++|||||+++|++......++|
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv  105 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII  105 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEE
Confidence            345667899999999999999753 32   5899988654 445567899999999999999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++|+|.+++..  ....++|..++.++.||++||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus       106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  180 (299)
T d1jpaa_         106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED  180 (299)
T ss_dssp             EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccC
Confidence            999999999998753  3346899999999999999999999987   99999999999999999999999999987654


Q ss_pred             CCccc----ccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          424 DITHI----SATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       424 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      .....    .....||+.|||||.+.++.++.++|||||||+||||+| |+.|+.... ...+.    .....+      
T Consensus       181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~-~~~~~----~~i~~~------  249 (299)
T d1jpaa_         181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT-NQDVI----NAIEQD------  249 (299)
T ss_dssp             ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC-HHHHH----HHHHTT------
T ss_pred             CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCC-HHHHH----HHHHcC------
Confidence            33221    123457899999999999999999999999999999998 676654322 11221    112221      


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                         .....+.+.+..+.+|+.+||+.||++|||++||++.|+.
T Consensus       250 ---~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~  289 (299)
T d1jpaa_         250 ---YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDK  289 (299)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             ---CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               1122345567889999999999999999999999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=408.30  Aligned_cols=263  Identities=27%  Similarity=0.405  Sum_probs=211.7

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      .++|++.+.||+|+||+||+|++++++.||||++.... ...+.|.+|+.++++++|||||+++|++.+ +..++||||+
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~   93 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM   93 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEec
Confidence            46799999999999999999999888899999996543 335789999999999999999999999854 5689999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++|+|.+++.... ...++|..++.++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++........
T Consensus        94 ~~g~l~~~~~~~~-~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~  169 (285)
T d1fmka3          94 SKGSLLDFLKGET-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  169 (285)
T ss_dssp             TTCBHHHHHSHHH-HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             CCCchhhhhhhcc-cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCce
Confidence            9999998875432 235899999999999999999999988   999999999999999999999999999877555444


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      ......||+.|+|||++..+.++.++||||||+++|||++|+.|+........+...    +..+         .....+
T Consensus       170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~----i~~~---------~~~~~~  236 (285)
T d1fmka3         170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ----VERG---------YRMPCP  236 (285)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH----HHTT---------CCCCCC
T ss_pred             eeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH----HHhc---------CCCCCC
Confidence            445567899999999999999999999999999999999988887665543333222    2221         112234


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCCCCCCCC
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNHEILQPT  549 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~~~~~p~  549 (573)
                      ...+.++.+++.+||+.||++||+|++|+++|+.......|.
T Consensus       237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence            556778999999999999999999999999997766554443

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-51  Score=404.44  Aligned_cols=251  Identities=26%  Similarity=0.336  Sum_probs=205.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..++||+|+||+||+|++. +|+.||||++.... .+..+.+.+|+.+|++++|||||++++++.+++..++||||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy   84 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY   84 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence            57999999999999999999975 68999999986543 33456788999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC-
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI-  425 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-  425 (573)
                      +++|+|.+++..   ...+++..++.++.||+.||+|||+++   |+||||||+|||+++++.+||+|||+++...... 
T Consensus        85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            999999999843   346999999999999999999999988   9999999999999999999999999999764332 


Q ss_pred             cccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          426 THISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      ........||+.|||||++.+..+ +.++|||||||++|||++|+.|+............    ......        ..
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~----~~~~~~--------~~  226 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSD----WKEKKT--------YL  226 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHH----HHTTCT--------TS
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHH----HhcCCC--------CC
Confidence            233446789999999999988776 57899999999999999999998665443222111    111110        01


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ......+.++.+|+.+||+.||++|||++|+++
T Consensus       227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         227 NPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            112234577889999999999999999999975

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-51  Score=403.15  Aligned_cols=256  Identities=25%  Similarity=0.385  Sum_probs=204.8

Q ss_pred             cCccccccccccCceeEEEEEcCCC-----CEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGG-----EAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      ..|+..++||+|+||+||+|.+.+.     ..||||++... .....++|.+|+.+|++++|||||+++|++.+....++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~   86 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI   86 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence            4688899999999999999987532     37999999654 33445678999999999999999999999999999999


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+.++++.+++...  ...+++..+++++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             EEEecccCcchhhhhcc--cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence            99999999998877433  346999999999999999999999988   9999999999999999999999999998765


Q ss_pred             CCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          423 EDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       423 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      .....  ......||+.|||||++.++.++.++|||||||++|||++++.|+........+.    .....+        
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~----~~i~~~--------  229 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVM----KAINDG--------  229 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHHHTT--------
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHH----HHHhcc--------
Confidence            43322  2234568999999999999999999999999999999999887776544332222    222222        


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                       .....+...+..+.+|+.+||+.+|++||||.||+++|+..
T Consensus       230 -~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         230 -FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             -CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence             12234455678899999999999999999999999999653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-51  Score=402.51  Aligned_cols=249  Identities=26%  Similarity=0.385  Sum_probs=210.0

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      ++|+..++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+.+..++||||+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~   99 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL   99 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence            47999999999999999999974 69999999997665555678999999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..... 
T Consensus       100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-  171 (293)
T d1yhwa1         100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  171 (293)
T ss_dssp             TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred             CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccccc-
Confidence            99999987743    35899999999999999999999998   99999999999999999999999999997654332 


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQ  507 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~  507 (573)
                      ......||+.|+|||++.++.++.++|||||||++|||++|+.||.....    ..........+..      .+  ..+
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~~~~~~~~~~~~------~~--~~~  239 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP----LRALYLIATNGTP------EL--QNP  239 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHHCSC------CC--SSG
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH----HHHHHHHHhCCCC------CC--CCc
Confidence            23456799999999999999999999999999999999999999754322    2222222222211      01  123


Q ss_pred             CchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          508 EGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       508 ~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ...+..+.+++.+||+.||++|||++|+++
T Consensus       240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             GGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            345678999999999999999999999985

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-51  Score=396.34  Aligned_cols=245  Identities=26%  Similarity=0.350  Sum_probs=207.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++...   .....+.+.+|+.++++++|||||++++++.++...++||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            46899999999999999999975 6889999998643   2334567889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus        86 Ey~~~g~L~~~l~~~---~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~  159 (263)
T d2j4za1          86 EYAPLGTVYRELQKL---SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  159 (263)
T ss_dssp             ECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred             eecCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence            999999999998543   45899999999999999999999988   999999999999999999999999999865433


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .   .....||+.|||||++.+..++.++|||||||+||||++|+.|+.....     ..........+.          
T Consensus       160 ~---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-----~~~~~~i~~~~~----------  221 (263)
T d2j4za1         160 R---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY-----QETYKRISRVEF----------  221 (263)
T ss_dssp             C---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH-----HHHHHHHHTTCC----------
T ss_pred             c---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCH-----HHHHHHHHcCCC----------
Confidence            2   2356799999999999999999999999999999999999999754321     112222222211          


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .++...++++.+|+.+||+.||++|||++|+++
T Consensus       222 ~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 TFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence            223445678899999999999999999999986

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9e-51  Score=398.08  Aligned_cols=254  Identities=23%  Similarity=0.331  Sum_probs=197.4

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec--CCceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--GPESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~lv  343 (573)
                      ++|+..+.||+|+||+||+|+.. +|+.||||++...  .....+.+.+|+++|++++|||||++++++.+  ....++|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            67999999999999999999874 6899999998654  34446678999999999999999999998865  4567899


Q ss_pred             EEeccCCCcccccccc-CCCCCCCHHHHHHHHHHHHHHHHHHHhcC--CCCeEEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          344 YEFVPNQSLLDNLFVR-QDVEPLSWEVRYKIILSTAEGLAYLHEES--KLRIIHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      |||+++|+|.+++... .....+++..++.++.||+.||+|||+++  ..+|+||||||+||||+.++.+||+|||+++.
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999988542 23456999999999999999999999865  23599999999999999999999999999997


Q ss_pred             cCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          421 FPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       421 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      +..... ......||+.|||||++.+..++.++|||||||++|||++|+.|+.....     .........+...     
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~-----~~~~~~i~~~~~~-----  232 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ-----KELAGKIREGKFR-----  232 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHHTCCC-----
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH-----HHHHHHHHcCCCC-----
Confidence            654322 23456899999999999999999999999999999999999998754321     1222222333221     


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                          ..+...++++.+|+.+||+.||++|||++|+++
T Consensus       233 ----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         233 ----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                223445678999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-51  Score=401.39  Aligned_cols=253  Identities=23%  Similarity=0.331  Sum_probs=206.9

Q ss_pred             cCccccc-cccccCceeEEEEEcC---CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEE
Q 008239          269 NYFHESN-KLGQGGSGSVYKGTLP---GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       269 ~~~~~~~-~lg~G~~g~Vy~~~~~---~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++|...+ +||+|+||+||+|.+.   ++..||||++.... ....++|.+|+++|++++|||||+++|++.. +..++|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv   86 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV   86 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence            4566666 4999999999999864   35579999997543 4456789999999999999999999999865 568999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++|+|.+++..  ....+++..+++++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++....
T Consensus        87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~  161 (285)
T d1u59a_          87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  161 (285)
T ss_dssp             EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence            999999999998743  2346999999999999999999999988   99999999999999999999999999997754


Q ss_pred             CCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          424 DITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       424 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ....  ......||+.|+|||++..+.++.++|||||||++|||+| |+.|+..... ..+    ......+..      
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~-~~~----~~~i~~~~~------  230 (285)
T d1u59a_         162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG-PEV----MAFIEQGKR------  230 (285)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT-HHH----HHHHHTTCC------
T ss_pred             cccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH-HHH----HHHHHcCCC------
Confidence            4332  2234568999999999999999999999999999999998 7877654322 122    222222221      


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                         ...+...+.++.+|+.+||+.+|++||||.+|++.|+.
T Consensus       231 ---~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~  268 (285)
T d1u59a_         231 ---MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  268 (285)
T ss_dssp             ---CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence               23345567889999999999999999999999998853

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-51  Score=409.58  Aligned_cols=258  Identities=24%  Similarity=0.363  Sum_probs=208.4

Q ss_pred             HhcCccccccccccCceeEEEEEcCC-C-----CEEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCC
Q 008239          267 ATNYFHESNKLGQGGSGSVYKGTLPG-G-----EAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGP  338 (573)
Q Consensus       267 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-g-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~  338 (573)
                      ..++|+..++||+|+||+||+|++.. +     ..||||++... .....+.+.+|+.+|.++ +|||||++++++.+.+
T Consensus        35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~  114 (325)
T d1rjba_          35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  114 (325)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence            44689999999999999999998643 2     36999998654 334456789999999998 8999999999999999


Q ss_pred             ceeEEEEeccCCCccccccccCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCC
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQD--------------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIK  398 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk  398 (573)
                      ..++||||+++|+|.+++.....                    ...+++..++.++.||+.||+|||+++   |||||||
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlK  191 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLA  191 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCS
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCc
Confidence            99999999999999999865432                    235899999999999999999999988   9999999


Q ss_pred             CCCeeeCCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCC
Q 008239          399 LSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQ  476 (573)
Q Consensus       399 ~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~  476 (573)
                      |+|||++.++.+||+|||+++........ ......||+.|||||++.++.++.++|||||||++|||+| |+.|+....
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            99999999999999999999866443322 2335678999999999999999999999999999999998 777765433


Q ss_pred             CCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhc
Q 008239          477 NSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLT  540 (573)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~  540 (573)
                      ....+    ......+         ...+.+...+.++.+|+.+||+.||++|||++||+++|.
T Consensus       272 ~~~~~----~~~~~~~---------~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         272 VDANF----YKLIQNG---------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CSHHH----HHHHHTT---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHH----HHHHhcC---------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            32222    2222221         112334556788999999999999999999999999984

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-50  Score=398.85  Aligned_cols=246  Identities=26%  Similarity=0.360  Sum_probs=198.7

Q ss_pred             ccccccCceeEEEEEcCC---CCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEeccC
Q 008239          275 NKLGQGGSGSVYKGTLPG---GEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFVPN  349 (573)
Q Consensus       275 ~~lg~G~~g~Vy~~~~~~---g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~~~  349 (573)
                      ++||+|+||+||+|.+.+   ++.||||++...  .....++|.+|+++|++++|||||+++|++.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            479999999999998643   468999998653  33445789999999999999999999999865 567899999999


Q ss_pred             CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc--
Q 008239          350 QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH--  427 (573)
Q Consensus       350 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~--  427 (573)
                      |+|.+++..   ...+++..+++++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.+......  
T Consensus        92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~  165 (277)
T d1xbba_          92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  165 (277)
T ss_dssp             EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred             CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccc
Confidence            999998854   345899999999999999999999987   999999999999999999999999999876544332  


Q ss_pred             cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          428 ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                      ......||+.|||||.+.++.++.++|||||||++|||++ |+.|+.... .    ..+......+.         ....
T Consensus       166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~-~----~~~~~~i~~~~---------~~~~  231 (277)
T d1xbba_         166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK-G----SEVTAMLEKGE---------RMGC  231 (277)
T ss_dssp             C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCC-H----HHHHHHHHTTC---------CCCC
T ss_pred             cccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCC-H----HHHHHHHHcCC---------CCCC
Confidence            2234578999999999999999999999999999999998 677764322 1    11222222221         1233


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      +...+.++.+|+.+||+.||++|||+++|+++|+.
T Consensus       232 p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         232 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence            45567889999999999999999999999988853

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-50  Score=403.67  Aligned_cols=264  Identities=27%  Similarity=0.394  Sum_probs=216.1

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEcC------CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeee
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSI  335 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  335 (573)
                      +++...++|+..++||+|+||+||+|++.      +++.||||++.... .+..++|.+|+.+|++++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            44456788999999999999999999863      35789999997543 344667999999999999999999999999


Q ss_pred             cCCceeEEEEeccCCCccccccccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEE
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQ---------------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIH  394 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiH  394 (573)
                      .....++||||+++|+|.+++....                     ....+++..++.++.||+.||+|||+++   |||
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence            9999999999999999999886432                     1235899999999999999999999988   999


Q ss_pred             ecCCCCCeeeCCCCcEEEeecccccccCCCC-cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCC
Q 008239          395 RDIKLSNILLDEEFTAKIADFGLVRLFPEDI-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINL  473 (573)
Q Consensus       395 rDlk~~NIll~~~~~~kl~Dfgla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~  473 (573)
                      |||||+||||+.++.+||+|||+++...... ........+|+.|+|||.+.+..++.++|||||||++|||++|..|+.
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            9999999999999999999999998664332 223345678999999999999999999999999999999999987655


Q ss_pred             CCCCCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          474 FTQNSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       474 ~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .......+..    ....+..         ...+...+.++.+|+.+||+.+|++||||.||+++|+..
T Consensus       244 ~~~~~~e~~~----~v~~~~~---------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         244 YGMAHEEVIY----YVRDGNI---------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTSCHHHHHH----HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCHHHHHH----HHHcCCC---------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            4443322222    2233322         123445677899999999999999999999999999764

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-50  Score=393.69  Aligned_cols=248  Identities=25%  Similarity=0.347  Sum_probs=199.6

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec----CCceeE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT----GPESLL  342 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~~l  342 (573)
                      .|+..++||+|+||+||+|++. +++.||+|++...  .....+.+.+|+++|++++|||||++++++.+    ....++
T Consensus        10 y~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          10 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            3466778999999999999975 6889999998654  34456678999999999999999999999864    345789


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC-CCCcEEEeeccccccc
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD-EEFTAKIADFGLVRLF  421 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~-~~~~~kl~Dfgla~~~  421 (573)
                      ||||+++|+|.+++...   ..+++..++.++.||+.||+|||+++ ++|+||||||+||||+ +++.+||+|||+++..
T Consensus        90 vmE~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~  165 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  165 (270)
T ss_dssp             EEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEeCCCCCcHHHHHhcc---ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceec
Confidence            99999999999998543   45899999999999999999999975 4599999999999996 5789999999999865


Q ss_pred             CCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ...   ......||+.|||||++.+ .++.++|||||||++|||++|+.|+........    .......+....     
T Consensus       166 ~~~---~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~----~~~~i~~~~~~~-----  232 (270)
T d1t4ha_         166 RAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ----IYRRVTSGVKPA-----  232 (270)
T ss_dssp             CTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH----HHHHHTTTCCCG-----
T ss_pred             cCC---ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH----HHHHHHcCCCCc-----
Confidence            432   2335689999999998864 699999999999999999999999864333212    222222221111     


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                         ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus       233 ---~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         233 ---SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ---GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ---ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence               112234567889999999999999999999986

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=399.19  Aligned_cols=251  Identities=25%  Similarity=0.352  Sum_probs=207.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEec
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEFV  347 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~~  347 (573)
                      +.|+..++||+|+||+||+|++. +|+.||||++.....+..+.+.+|+++|++++|||||++++++.+.+..++||||+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~   91 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   91 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence            46899999999999999999975 68999999998776666788999999999999999999999999999999999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++|+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++...... .
T Consensus        92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~  165 (288)
T d2jfla1          92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q  165 (288)
T ss_dssp             TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred             CCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence            999999987543  245999999999999999999999998   9999999999999999999999999997553221 1


Q ss_pred             cccccccCcCcCchhhhc-----cCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          428 ISATLAGTLGYMAPEYVV-----RGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       428 ~~~~~~gt~~y~aPE~~~-----~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ......||+.|+|||++.     ...++.++|||||||++|||++|+.|+...... .....   . ..+....     +
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~-~~~~~---i-~~~~~~~-----~  235 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM-RVLLK---I-AKSEPPT-----L  235 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG-GHHHH---H-HHSCCCC-----C
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH-HHHHH---H-HcCCCCC-----C
Confidence            233567999999999984     456899999999999999999999987544322 22111   1 1111111     1


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ..+...+.++.+|+.+||+.||++|||++|+++
T Consensus       236 --~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         236 --AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             --SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              112345678899999999999999999999986

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-50  Score=403.67  Aligned_cols=261  Identities=20%  Similarity=0.295  Sum_probs=205.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|+..++||+|+||+||+|+.. +|+.||||++... .....+.+.+|+.+|++++|||||++++++.+....++|||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE   84 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME   84 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            578999999999999999999974 6899999998754 34445788999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      |+++|+|.+++...   ..+++..+..++.|++.||.|||++ +   |+||||||+||||+.++.+||+|||+|+.+...
T Consensus        85 y~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          85 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             CCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             cCCCCcHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            99999999998543   3589999999999999999999974 6   999999999999999999999999999865322


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh-----------c--
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV-----------K--  491 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~-----------~--  491 (573)
                         .....+||+.|+|||++.+..++.++|||||||++|||++|+.||..................           .  
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence               223568999999999999999999999999999999999999998654332110000000000           0  


Q ss_pred             ------------CccccccCcccc---CCC-CCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          492 ------------GRLHEAVDPALA---GNF-QEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       492 ------------~~~~~~~d~~l~---~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                                  ....+..+....   ... ....+.++.+++.+||+.||++|||++|+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence                        000000000000   001 1123567899999999999999999999987

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-50  Score=394.29  Aligned_cols=248  Identities=20%  Similarity=0.253  Sum_probs=205.1

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|++.+.||+|+||+||+|+.. +|+.||||++...   .....+.+.+|+++|++++|||||++++++.+.+..++||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            57999999999999999999974 6899999998643   2334567899999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++...   ..+++..++.++.|++.||+|||+++   |+||||||+|||+++++.+||+|||+++.+...
T Consensus        88 Ey~~gg~L~~~~~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~  161 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI---GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE  161 (288)
T ss_dssp             CCCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EccCCCCHHHhhhcc---CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence            999999999988543   45899999999999999999999998   999999999999999999999999999977543


Q ss_pred             C-cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          425 I-THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       425 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      . ........||+.|+|||++.+..++.++|||||||++|||++|+.||.....     .........++.         
T Consensus       162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i~~~~~---------  227 (288)
T d1uu3a_         162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE-----YLIFQKIIKLEY---------  227 (288)
T ss_dssp             --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHTTCC---------
T ss_pred             CcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH-----HHHHHHHHcCCC---------
Confidence            2 2233456799999999999999999999999999999999999999864321     111122222211         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       .++...+.++.+|+.+||+.||++|||++|+++
T Consensus       228 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         228 -DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             -CCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             -CCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence             223445678899999999999999999998753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-49  Score=396.88  Aligned_cols=245  Identities=27%  Similarity=0.431  Sum_probs=202.2

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ..|+..++||+|+||+||+|+.. +|+.||||++....   ....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            45899999999999999999864 68899999986543   334567899999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|..++..   ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++.... 
T Consensus        95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-  167 (309)
T d1u5ra_          95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (309)
T ss_dssp             ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred             EecCCCchHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-
Confidence            99999998765533   246899999999999999999999998   99999999999999999999999999986543 


Q ss_pred             CcccccccccCcCcCchhhhcc---CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          425 ITHISATLAGTLGYMAPEYVVR---GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~---~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                          .....||+.|||||++.+   +.|+.++|||||||++|||++|+.|+.....    .+........ ..     +.
T Consensus       168 ----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~----~~~~~~i~~~-~~-----~~  233 (309)
T d1u5ra_         168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA----MSALYHIAQN-ES-----PA  233 (309)
T ss_dssp             ----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH----HHHHHHHHHS-CC-----CC
T ss_pred             ----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH----HHHHHHHHhC-CC-----CC
Confidence                234579999999999864   4689999999999999999999998754321    1222222221 11     11


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +   .+...++.+.+|+.+||+.||++|||++|+++
T Consensus       234 ~---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         234 L---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             C---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             C---CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            1   12334678999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-49  Score=384.99  Aligned_cols=250  Identities=27%  Similarity=0.416  Sum_probs=199.3

Q ss_pred             hcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-CceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-PESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~  346 (573)
                      .++|+..++||+|+||.||+|+++ |+.||||++..+  ...+.+.+|++++++++||||++++|++.+. ...++||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            356888999999999999999985 789999999654  3357799999999999999999999998654 567999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +++|+|.+++..+. ...++|..+++++.||+.||.|||+.+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        83 ~~~g~L~~~l~~~~-~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--  156 (262)
T d1byga_          83 MAKGSLVDYLRSRG-RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  156 (262)
T ss_dssp             CTTEEHHHHHHHHH-HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred             cCCCCHHHHHHhcC-CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCC--
Confidence            99999999986432 235899999999999999999999987   999999999999999999999999999865432  


Q ss_pred             ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccCCC
Q 008239          427 HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAGNF  506 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~  506 (573)
                        .....+|..|+|||++.++.++.++||||||+++|||+|++.|+........+...+    .++         ...+.
T Consensus       157 --~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i----~~~---------~~~~~  221 (262)
T d1byga_         157 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV----EKG---------YKMDA  221 (262)
T ss_dssp             -------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH----TTT---------CCCCC
T ss_pred             --CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcC---------CCCCC
Confidence              223457889999999999999999999999999999999655544433333333222    211         12234


Q ss_pred             CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          507 QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       507 ~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      +...+.++.+|+.+||+.||++||||.+|+++|+.
T Consensus       222 ~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         222 PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            45566789999999999999999999999999954

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.6e-49  Score=392.05  Aligned_cols=252  Identities=21%  Similarity=0.310  Sum_probs=193.0

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC-hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT-TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .+.|+..+.||+|+||+||+|+.. +|+.||||++.... ....+.+.+|+.+|++++|||||++++++.++...++|||
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            466999999999999999999975 68999999986543 2334567899999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC---CCCcEEEeecccccccC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFP  422 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~---~~~~~kl~Dfgla~~~~  422 (573)
                      |+++|+|.+++..   ...+++..+..++.||+.||+|||+++   |+||||||+|||+.   +++.+||+|||+++...
T Consensus        88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            9999999999853   346999999999999999999999988   99999999999994   57899999999998664


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPAL  502 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l  502 (573)
                      ...  ......||+.|||||++.++.++.++|||||||++|||++|+.|+.....     .........+..      .+
T Consensus       162 ~~~--~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----~~~~~~i~~~~~------~~  228 (307)
T d1a06a_         162 PGS--VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND-----AKLFEQILKAEY------EF  228 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-----HHHHHHHHTTCC------CC
T ss_pred             CCC--eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHhccCC------CC
Confidence            332  23456799999999999999999999999999999999999999754321     112222222221      11


Q ss_pred             cCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          503 AGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       503 ~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ........+..+.+|+.+||+.||++|||++|+++.
T Consensus       229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            112234556789999999999999999999999983

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-49  Score=389.13  Aligned_cols=254  Identities=22%  Similarity=0.302  Sum_probs=196.4

Q ss_pred             hcCccccccccccCceeEEEEEcCC----CCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG----GEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~----g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .++|+..+.||+|+||+||+|++..    +..||||++... .....+.+.+|+.+|++++|||||+++|++. .+..++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i   84 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI   84 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence            4679999999999999999998743    346899988654 3444677999999999999999999999986 467899


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ||||+++|+|.+++...  ...+++..++.++.||++||.|||+++   |+||||||+||+++.++.+||+|||+++...
T Consensus        85 v~E~~~~g~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~  159 (273)
T d1mp8a_          85 IMELCTLGELRSFLQVR--KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  159 (273)
T ss_dssp             EEECCTTEEHHHHHHHT--TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred             EEEeccCCcHHhhhhcc--CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence            99999999999877533  346899999999999999999999988   9999999999999999999999999999776


Q ss_pred             CCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          423 EDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       423 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ...........||+.|+|||.+..+.++.++|||||||++|||++ |..|+.. .....+...+    ..+..       
T Consensus       160 ~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~-~~~~~~~~~i----~~~~~-------  227 (273)
T d1mp8a_         160 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQG-VKNNDVIGRI----ENGER-------  227 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTT-CCGGGHHHHH----HTTCC-------
T ss_pred             CCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCC-CCHHHHHHHH----HcCCC-------
Confidence            554444556678999999999999999999999999999999998 5555543 3322332222    22211       


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                        ...+...+..+.+|+.+||+.||++|||++||++.|+.
T Consensus       228 --~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         228 --LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             --CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence              12345567889999999999999999999999998854

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.8e-48  Score=395.94  Aligned_cols=253  Identities=21%  Similarity=0.250  Sum_probs=210.9

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|++.++||+|+||+||+|+. .+|+.||||++........+.+.+|+.+|++++|||||++++++.++...++||||
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  107 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  107 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            35799999999999999999997 46999999999776655567888999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC--CCCcEEEeecccccccCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~--~~~~~kl~Dfgla~~~~~~  424 (573)
                      +++|+|.+++..  ....+++..++.++.||+.||+|||+++   |+||||||+||||+  .++.+||+|||+++.+...
T Consensus       108 ~~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         108 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999887743  2346999999999999999999999988   99999999999998  6789999999999977543


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .  ......||+.|+|||++.+..++.++|||||||++|||++|+.||.....    .... .....+..      .+..
T Consensus       183 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~-~~i~~~~~------~~~~  249 (352)
T d1koba_         183 E--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD----LETL-QNVKRCDW------EFDE  249 (352)
T ss_dssp             S--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH----HHHH-HHHHHCCC------CCCS
T ss_pred             C--ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHH-HHHHhCCC------CCCc
Confidence            2  23456789999999999999999999999999999999999999854322    1111 11122111      1111


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ......+.++.+|+.+||+.||++|||++|+++.
T Consensus       250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2233456788999999999999999999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.7e-48  Score=395.84  Aligned_cols=253  Identities=19%  Similarity=0.224  Sum_probs=210.2

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      -++|++.++||+|+||+||+|+.. +|+.||||++........+.+.+|+.+|++++|||||++++++.+....++||||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~  104 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF  104 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            357999999999999999999974 6899999999877666677899999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC--CCCcEEEeecccccccCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD--EEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~--~~~~~kl~Dfgla~~~~~~  424 (573)
                      +++|+|.+++...  ...+++..+..++.||+.||.|||+++   |+||||||+|||++  .++.+||+|||+++.+...
T Consensus       105 ~~gg~L~~~l~~~--~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         105 MSGGELFEKVADE--HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CCSCBHHHHHTCT--TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCCHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            9999999988432  346999999999999999999999998   99999999999996  4678999999999976543


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .  ......||+.|||||++.+..++.++|||||||++|||++|+.|+..... ....    .........  +..    
T Consensus       180 ~--~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~-~~~~----~~i~~~~~~--~~~----  246 (350)
T d1koaa2         180 Q--SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND-DETL----RNVKSCDWN--MDD----  246 (350)
T ss_dssp             S--CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHH----HHHHHTCCC--SCC----
T ss_pred             c--ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCH-HHHH----HHHHhCCCC--CCc----
Confidence            3  23456789999999999999999999999999999999999999754321 1111    111222110  011    


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      ......+..+.+|+.+||+.||++|||++|+++.
T Consensus       247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1112345678999999999999999999999984

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-49  Score=393.41  Aligned_cols=267  Identities=25%  Similarity=0.304  Sum_probs=204.0

Q ss_pred             ChHHHHHHhcCccccccccccCceeEEEEEcC------CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeee
Q 008239          260 SYETLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLL  331 (573)
Q Consensus       260 ~~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~  331 (573)
                      +...++...++|+..++||+|+||+||+|++.      +++.||||++... .....+.+.+|...+.++ +|+|||+++
T Consensus         4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~   83 (299)
T d1ywna1           4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   83 (299)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence            33445455678999999999999999999853      3468999998654 334456788888888777 689999999


Q ss_pred             eeeecC-CceeEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecC
Q 008239          332 GCSITG-PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDI  397 (573)
Q Consensus       332 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDl  397 (573)
                      +++... ...++||||+++|+|.+++.....             ...+++..++.++.||+.||+|||+++   |+||||
T Consensus        84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl  160 (299)
T d1ywna1          84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL  160 (299)
T ss_dssp             EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred             eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcC
Confidence            987764 468999999999999999864321             245899999999999999999999988   999999


Q ss_pred             CCCCeeeCCCCcEEEeecccccccCCCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCC
Q 008239          398 KLSNILLDEEFTAKIADFGLVRLFPEDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQ  476 (573)
Q Consensus       398 k~~NIll~~~~~~kl~Dfgla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~  476 (573)
                      ||+||||++++.+||+|||+++........ ......||+.|+|||.+.++.++.++|||||||++|||+++..++....
T Consensus       161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~  240 (299)
T d1ywna1         161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  240 (299)
T ss_dssp             CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             CccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999866443322 3345679999999999999999999999999999999999876544332


Q ss_pred             CCcchHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          477 NSCSILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       477 ~~~~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...   ..+......+..         ...+...+.++.+++.+||+.||++|||++||+++|+.
T Consensus       241 ~~~---~~~~~~~~~~~~---------~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         241 KID---EEFCRRLKEGTR---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             CCS---HHHHHHHHHTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHH---HHHHHHHhcCCC---------CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            221   122222222221         12344556789999999999999999999999999964

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=390.31  Aligned_cols=254  Identities=24%  Similarity=0.357  Sum_probs=201.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCC----EEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGE----AVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLL  342 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~l  342 (573)
                      .+|+..++||+|+||+||+|++. +|+    +||||++... ..+..++|.+|+.++++++|||||+++|++.+ +..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence            46999999999999999999874 444    6899988653 34556789999999999999999999999986 45778


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccC
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFP  422 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~  422 (573)
                      ++||+.+|+|.+++...  ...+++..+++++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++...
T Consensus        88 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEECCTTCBHHHHHHHT--SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             EEEeccCCccccccccc--ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            89999999999887543  356899999999999999999999987   9999999999999999999999999999775


Q ss_pred             CCCcc-cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcc
Q 008239          423 EDITH-ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPA  501 (573)
Q Consensus       423 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  501 (573)
                      ..... ......||+.|+|||++.++.++.++|||||||++|||+|++.++........+...    ...+.        
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~----i~~~~--------  230 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI----LEKGE--------  230 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHH----HHHTC--------
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHH----HHcCC--------
Confidence            44332 233456899999999999999999999999999999999954444333332222222    22221        


Q ss_pred             ccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          502 LAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       502 l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                       ....+...+..+.+|+.+||+.+|++|||+.||++.|+.
T Consensus       231 -~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~  269 (317)
T d1xkka_         231 -RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK  269 (317)
T ss_dssp             -CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHH
Confidence             122345567889999999999999999999999998744

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-49  Score=385.99  Aligned_cols=254  Identities=28%  Similarity=0.428  Sum_probs=197.1

Q ss_pred             cCccccccccccCceeEEEEEcC--CC--CEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP--GG--EAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~--~g--~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ++|+..+.||+|+||+||+|++.  ++  ..||||++...   ..+..+.|.+|+.+|++++|||||+++|++.+ +..+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            56899999999999999999863  23  37899988653   34456789999999999999999999999976 4678


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+++|+|.+.+..+  ...+++..++.++.||+.||.|||+++   |+||||||+||||+.++.+||+|||+++..
T Consensus        87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~  161 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  161 (273)
T ss_dssp             EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             eeeeeecCcchhhhhhcc--cCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence            999999999999887543  245899999999999999999999987   999999999999999999999999999977


Q ss_pred             CCCCcc--cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHc-CCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          422 PEDITH--ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVC-RKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       422 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      ......  ......+|..|+|||.+.+..++.++||||||+++|||+| |+.|+... ..   .+........+      
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~-~~---~~~~~~i~~~~------  231 (273)
T d1u46a_         162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL-NG---SQILHKIDKEG------  231 (273)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC-CH---HHHHHHHHTSC------
T ss_pred             ccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc-CH---HHHHHHHHhCC------
Confidence            544322  2334567889999999999999999999999999999998 67775432 21   11222222221      


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                         ...+.+...+..+.+|+.+||+.||++|||++||+++|.+
T Consensus       232 ---~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         232 ---ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             ---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence               1112344566789999999999999999999999999954

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-48  Score=386.36  Aligned_cols=251  Identities=29%  Similarity=0.406  Sum_probs=203.4

Q ss_pred             cccccccCceeEEEEEcCCC----CEEEEEEecc-cChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-CceeEEEEec
Q 008239          274 SNKLGQGGSGSVYKGTLPGG----EAVAVKRLFY-NTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-PESLLVYEFV  347 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~~~lv~e~~  347 (573)
                      .++||+|+||+||+|++.++    ..||||++.. ......++|.+|+++|++++|||||+++|++... ...++||||+
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            57899999999999997542    2689999864 3455567899999999999999999999998754 5789999999


Q ss_pred             cCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCcc
Q 008239          348 PNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDITH  427 (573)
Q Consensus       348 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~~  427 (573)
                      ++|+|.+++..  ....+++..+++++.|++.||.|||+.+   |+||||||+||||++++.+||+|||+++........
T Consensus       112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~  186 (311)
T d1r0pa_         112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD  186 (311)
T ss_dssp             TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred             ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccccc
Confidence            99999998854  3345788999999999999999999987   999999999999999999999999999876543222


Q ss_pred             ---cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          428 ---ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       428 ---~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                         ......||+.|+|||.+..+.++.++||||||+++|||++|+.|+........+...+    ..+..         .
T Consensus       187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i----~~g~~---------~  253 (311)
T d1r0pa_         187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL----LQGRR---------L  253 (311)
T ss_dssp             CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHH----HTTCC---------C
T ss_pred             cceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHH----HcCCC---------C
Confidence               2234568999999999999999999999999999999999998876654433332222    22211         1


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ..+...+..+.+|+.+||+.||++||+|.||+++|+..
T Consensus       254 ~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         254 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            12344567899999999999999999999999999654

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=390.30  Aligned_cols=257  Identities=25%  Similarity=0.336  Sum_probs=207.0

Q ss_pred             cCccccccccccCceeEEEEEcCC-CC--EEEEEEeccc-ChhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecCCceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPG-GE--AVAVKRLFYN-TTQWVDHFFNEVNLISGI-NHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~-g~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++|+..++||+|+||+||+|++.+ |.  .||||++... ..+..+.|.+|+++|+++ +|||||+++|++.+.+..++|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            678889999999999999999864 43  5788887543 344566899999999999 799999999999999999999


Q ss_pred             EEeccCCCcccccccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcE
Q 008239          344 YEFVPNQSLLDNLFVR-------------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTA  410 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~  410 (573)
                      |||+++|+|.++++..             .....+++..+++++.||+.||.|||+++   |+||||||+|||++.++.+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~  166 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA  166 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence            9999999999998643             23457999999999999999999999987   9999999999999999999


Q ss_pred             EEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhh
Q 008239          411 KIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYV  490 (573)
Q Consensus       411 kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  490 (573)
                      ||+|||+++......  ......||..|+|||.+..+.++.++|||||||++|||++|..|+........+.    ....
T Consensus       167 kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~----~~i~  240 (309)
T d1fvra_         167 KIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY----EKLP  240 (309)
T ss_dssp             EECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH----HHGG
T ss_pred             EEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH----HHHH
Confidence            999999998653221  2234568999999999999999999999999999999999887655443322222    2222


Q ss_pred             cCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccCC
Q 008239          491 KGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGNH  543 (573)
Q Consensus       491 ~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~~  543 (573)
                      .+.         ....+...+.++.+|+.+||+.||++||||+||++.|+...
T Consensus       241 ~~~---------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         241 QGY---------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             GTC---------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcC---------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            221         12334556788999999999999999999999999986544

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=390.31  Aligned_cols=263  Identities=27%  Similarity=0.369  Sum_probs=215.7

Q ss_pred             HHHHhcCccccccccccCceeEEEEEc------CCCCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeee
Q 008239          264 LEKATNYFHESNKLGQGGSGSVYKGTL------PGGEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSI  335 (573)
Q Consensus       264 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~------~~g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~  335 (573)
                      ++...++|+..++||+|+||.||+|++      .+++.||||++.... ......+.+|+.+++++ +|||||+++|++.
T Consensus        18 ~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          18 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            334457889999999999999999985      246789999997643 34456789999999999 6999999999999


Q ss_pred             cCCceeEEEEeccCCCccccccccC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCC
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVRQ---------------DVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLS  400 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~  400 (573)
                      +....++||||+++|+|.+++....               ....+++..++.++.||+.||+|||+++   |+||||||+
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~  174 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccc
Confidence            9999999999999999999986543               2336899999999999999999999998   999999999


Q ss_pred             CeeeCCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc
Q 008239          401 NILLDEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC  479 (573)
Q Consensus       401 NIll~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~  479 (573)
                      |||++.++.+||+|||+++....... .......||+.|+|||.+..+.++.++||||||+++|||+|++.|+.......
T Consensus       175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~  254 (311)
T d1t46a_         175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (311)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999997654433 33345678999999999999999999999999999999999777665544432


Q ss_pred             chHHHHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          480 SILQTVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       480 ~~~~~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...   +.....+         .....+...+..+.+|+.+||+.||++||||+||+++|+.
T Consensus       255 ~~~---~~~i~~~---------~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~  304 (311)
T d1t46a_         255 SKF---YKMIKEG---------FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (311)
T ss_dssp             HHH---HHHHHHT---------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHH---HHHHhcC---------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            222   2222222         1122334456789999999999999999999999999964

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-48  Score=389.17  Aligned_cols=264  Identities=27%  Similarity=0.403  Sum_probs=216.5

Q ss_pred             HHHHHhcCccccccccccCceeEEEEEcC------CCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeee
Q 008239          263 TLEKATNYFHESNKLGQGGSGSVYKGTLP------GGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSI  335 (573)
Q Consensus       263 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~------~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~  335 (573)
                      +++...++|+..++||+|+||+||+|.+.      +++.||||++... ..+....|.+|+.++++++|||||+++|++.
T Consensus        14 ~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          14 EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             TTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             ceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            44455678999999999999999999863      3578999999754 3344567899999999999999999999999


Q ss_pred             cCCceeEEEEeccCCCcccccccc-------CCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC
Q 008239          336 TGPESLLVYEFVPNQSLLDNLFVR-------QDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF  408 (573)
Q Consensus       336 ~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~  408 (573)
                      .....++||||+++|+|.+++...       .....+++..+.+++.|+++||.|||+++   |+||||||+|||++.++
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~  170 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDF  170 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTC
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCc
Confidence            999999999999999999988542       22345799999999999999999999987   99999999999999999


Q ss_pred             cEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH
Q 008239          409 TAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD  487 (573)
Q Consensus       409 ~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~  487 (573)
                      ++||+|||+++....... .......+|+.|+|||.+.++.++.++||||||+++|||+||+.++..........    .
T Consensus       171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~----~  246 (308)
T d1p4oa_         171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL----R  246 (308)
T ss_dssp             CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH----H
T ss_pred             eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH----H
Confidence            999999999986644322 22334568999999999999999999999999999999999976655443322222    2


Q ss_pred             HhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          488 LYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       488 ~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      ....+..         .+.+...+..+.+|+.+||+.+|++||||++|+++|++.
T Consensus       247 ~i~~~~~---------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         247 FVMEGGL---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             HHHTTCC---------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             HHHhCCC---------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            2222221         122345667899999999999999999999999999665

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-48  Score=385.16  Aligned_cols=251  Identities=22%  Similarity=0.252  Sum_probs=206.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccC------hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCce
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT------TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPES  340 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~  340 (573)
                      .++|+..+.||+|+||+||+|+.. +|+.||||++....      ....+.+.+|+.+|++++|||||++++++.+....
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999974 68999999986432      12357899999999999999999999999999999


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC----cEEEeecc
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF----TAKIADFG  416 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~----~~kl~Dfg  416 (573)
                      ++||||+++|+|.+++...   ..+++..++.++.||+.||+|||+.+   |+||||||+|||++.++    .+||+|||
T Consensus        89 ~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG  162 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG  162 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred             EEEEEcCCCccccchhccc---cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchh
Confidence            9999999999999998543   35999999999999999999999998   99999999999998776    59999999


Q ss_pred             cccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          417 LVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       417 la~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      ++.......  ......||+.|+|||++.+..++.++|||||||++|||++|+.|+......    + .......+... 
T Consensus       163 ~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~----~-~~~~i~~~~~~-  234 (293)
T d1jksa_         163 LAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ----E-TLANVSAVNYE-  234 (293)
T ss_dssp             TCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH----H-HHHHHHTTCCC-
T ss_pred             hhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH----H-HHHHHHhcCCC-
Confidence            998764432  234567899999999999999999999999999999999999998643221    1 11112221110 


Q ss_pred             ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       497 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                       ..+    ......+..+.+|+.+||+.||++|||++|+++
T Consensus       235 -~~~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         235 -FED----EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -CCH----HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCc----hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             011    111234567889999999999999999999987

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-47  Score=386.11  Aligned_cols=247  Identities=24%  Similarity=0.280  Sum_probs=208.2

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|++++.||+|+||+||+++. .+|+.||||++.+.   .....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999997 47999999999653   2334577889999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ey~~gg~L~~~~~~~---~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~  158 (337)
T d1o6la_          85 EYANGGELFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD  158 (337)
T ss_dssp             ECCTTCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred             eccCCCchhhhhhcc---cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence            999999999988543   35899999999999999999999998   999999999999999999999999999865432


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|+.|+.....     .........+.+          
T Consensus       159 ~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~-----~~~~~~i~~~~~----------  222 (337)
T d1o6la_         159 G-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH-----ERLFELILMEEI----------  222 (337)
T ss_dssp             T-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCC----------
T ss_pred             C-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCH-----HHHHHHHhcCCC----------
Confidence            2 233457899999999999999999999999999999999999988765432     112222222221          


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPS-----MSIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  537 (573)
                      .++...+.++.+|+.+||+.||++||+     ++|+++
T Consensus       223 ~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         223 RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            234456678899999999999999995     788876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.1e-47  Score=381.50  Aligned_cols=245  Identities=23%  Similarity=0.311  Sum_probs=206.3

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|++.++||+|+||+||+|+.. +|+.||||++...   .....+.+.+|+.+|++++|||||++++++.+....++||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            56899999999999999999974 6899999998643   2334678899999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+++|+|..++...   ..+++..+..++.||+.||+|||+++   |+||||||+||||+.++.+||+|||+++.....
T Consensus        84 E~~~gg~l~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~  157 (316)
T d1fota_          84 DYIEGGELFSLLRKS---QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV  157 (316)
T ss_dssp             CCCCSCBHHHHHHHT---SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred             eecCCcccccccccc---ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence            999999998887543   35788999999999999999999988   999999999999999999999999999976543


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                          .....||+.|||||++.+..++.++|||||||+||||++|+.|+.....    . ........+..          
T Consensus       158 ----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~----~-~~~~~i~~~~~----------  218 (316)
T d1fota_         158 ----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT----M-KTYEKILNAEL----------  218 (316)
T ss_dssp             ----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH----H-HHHHHHHHCCC----------
T ss_pred             ----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH----H-HHHHHHHcCCC----------
Confidence                2356899999999999999999999999999999999999999864321    1 11112222211          


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVKM  538 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~~  538 (573)
                      .++...+.++.+++.+||+.||++||     |++++++.
T Consensus       219 ~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         219 RFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             CCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence            22344567889999999999999996     89999863

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=382.22  Aligned_cols=259  Identities=25%  Similarity=0.335  Sum_probs=207.3

Q ss_pred             hcCccccccccccCceeEEEEEcCC--------CCEEEEEEecccC-hhhHHHHHHHHHHHcCC-CCCCeeeeeeeeecC
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLPG--------GEAVAVKRLFYNT-TQWVDHFFNEVNLISGI-NHKNLVKLLGCSITG  337 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------g~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~  337 (573)
                      .++|+..+.||+|+||.||+|+...        +..||||++.... .....++.+|+..+.++ +|||||++++++.++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~   91 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD   91 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence            4678899999999999999998532        3479999997654 34457888999999888 899999999999999


Q ss_pred             CceeEEEEeccCCCccccccccCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeee
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQD-------------VEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILL  404 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll  404 (573)
                      ...++||||+++|+|.+++..+..             ...+++..++.++.||+.||+|||+.+   ||||||||+|||+
T Consensus        92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl  168 (299)
T d1fgka_          92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV  168 (299)
T ss_dssp             SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred             CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence            999999999999999999965432             246899999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEeecccccccCCCCc-ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHH
Q 008239          405 DEEFTAKIADFGLVRLFPEDIT-HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQ  483 (573)
Q Consensus       405 ~~~~~~kl~Dfgla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~  483 (573)
                      +.++.+||+|||+++....... .......+|+.|+|||.+.++.++.++||||||+++|||++++.++......    .
T Consensus       169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~----~  244 (299)
T d1fgka_         169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----E  244 (299)
T ss_dssp             CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH----H
T ss_pred             cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH----H
Confidence            9999999999999987644322 2334567899999999999999999999999999999999965444333222    2


Q ss_pred             HHHHHhhcCccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhccC
Q 008239          484 TVWDLYVKGRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTGN  542 (573)
Q Consensus       484 ~~~~~~~~~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~~  542 (573)
                      .++..+..+.         ....+...+.++.+|+.+||+.||++|||+.||+++|+..
T Consensus       245 ~~~~~i~~~~---------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         245 ELFKLLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHHHHHHTTC---------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCC---------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            2333333322         1223445677899999999999999999999999999653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-47  Score=381.34  Aligned_cols=263  Identities=27%  Similarity=0.326  Sum_probs=199.3

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC----ceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----ESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~lv~  344 (573)
                      ++|...++||+|+||+||+|++ +|+.||||++.....+ ...+..|+..+.+++|||||++++++.+..    ..++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            5677889999999999999997 4889999998644322 222334556667889999999999998654    468999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEE-----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~-----~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      ||+++|+|.+++..    ..++|..+++++.|++.||+|||+.     +.++|+||||||+||||+.++.+||+|||+++
T Consensus        81 Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~  156 (303)
T d1vjya_          81 DYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  156 (303)
T ss_dssp             ECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             ecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence            99999999999954    2489999999999999999999974     12459999999999999999999999999998


Q ss_pred             ccCCCCcc---cccccccCcCcCchhhhccCC------CCcccchHhHHHHHHHHHcCCCCCCCCCCCc----------c
Q 008239          420 LFPEDITH---ISATLAGTLGYMAPEYVVRGK------LTEKADVYSFGVVVIEVVCRKRINLFTQNSC----------S  480 (573)
Q Consensus       420 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~sDvwslGvil~elltg~~p~~~~~~~~----------~  480 (573)
                      ........   ......||+.|+|||++....      ++.++|||||||+||||+||..|+.......          .
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T d1vjya_         157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  236 (303)
T ss_dssp             EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccc
Confidence            76543322   223567999999999987643      5678999999999999999987764432211          1


Q ss_pred             hHHHHHHHhhcCccccccCccccCCC-CCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          481 ILQTVWDLYVKGRLHEAVDPALAGNF-QEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       481 ~~~~~~~~~~~~~~~~~~d~~l~~~~-~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ...........+..    ++.+.... +.+.+..+.+|+.+||+.||++|||+.||+++|+.
T Consensus       237 ~~~~~~~~~~~~~~----~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~  294 (303)
T d1vjya_         237 SVEEMRKVVCEQKL----RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQ  294 (303)
T ss_dssp             CHHHHHHHHTTSCC----CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHHHHHhcccc----CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            22333333322222    22221111 23456679999999999999999999999999954

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-46  Score=380.27  Aligned_cols=244  Identities=23%  Similarity=0.301  Sum_probs=206.4

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~  344 (573)
                      ++|+.+++||+|+||+||+|++. +|+.||||++...   .....+.+.+|+.+|+.++|||||++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            57999999999999999999975 6999999998643   2234567899999999999999999999999999999999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPED  424 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~  424 (573)
                      ||+.+|+|.+++...   ..+++..++.++.||+.||.|||+++   ||||||||+||||+.++.+||+|||+++.....
T Consensus       121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~  194 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR  194 (350)
T ss_dssp             ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             ccccccchhhhHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence            999999999988543   35899999999999999999999998   999999999999999999999999999976543


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                          .....||+.|||||++.+..++.++|||||||++|||++|+.|+.....    .. .......+..          
T Consensus       195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~----~~-~~~~i~~~~~----------  255 (350)
T d1rdqe_         195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP----IQ-IYEKIVSGKV----------  255 (350)
T ss_dssp             ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH----HH-HHHHHHHCCC----------
T ss_pred             ----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH----HH-HHHHHhcCCC----------
Confidence                2346799999999999999999999999999999999999999854321    11 1111122211          


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCC-----CCHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELR-----PSMSIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~R-----Pt~~evl~  537 (573)
                      ..+...+.++.+++.+||+.||.+|     ||++|+++
T Consensus       256 ~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         256 RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            1234456788999999999999999     48999986

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=4e-47  Score=374.76  Aligned_cols=256  Identities=23%  Similarity=0.335  Sum_probs=201.5

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEeccc---ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCc----
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN---TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPE----  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----  339 (573)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++...   ..+..+.+.+|+.+|+.++|||||++++++.....    
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999986 47899999999654   33445678999999999999999999998876543    


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++||||+++++|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.++|+|||.+.
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~  159 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE---GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR  159 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred             EEEEEECCCCCEehhhhccc---CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence            78999999999999887543   45899999999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCC--cccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          420 LFPEDI--THISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       420 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      ......  ........||+.|+|||++.+..++.++|||||||++|||+||+.|+.....    .+........+...  
T Consensus       160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~----~~~~~~~~~~~~~~--  233 (277)
T d1o6ya_         160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP----VSVAYQHVREDPIP--  233 (277)
T ss_dssp             ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH----HHHHHHHHHCCCCC--
T ss_pred             hhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCH----HHHHHHHHhcCCCC--
Confidence            653322  2233456799999999999999999999999999999999999999754321    22222222222110  


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCC-CHHHHHHHhc
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRP-SMSIVVKMLT  540 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-t~~evl~~L~  540 (573)
                        +   .......+..+.+++.+||+.||++|| |++++++.|.
T Consensus       234 --~---~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         234 --P---SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             --G---GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             --C---chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence              1   112344567899999999999999999 8999988774

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-46  Score=370.15  Aligned_cols=250  Identities=21%  Similarity=0.307  Sum_probs=206.1

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEecccC---------hhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecC
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT---------TQWVDHFFNEVNLISGIN-HKNLVKLLGCSITG  337 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~  337 (573)
                      ++|+..+.||+|+||+||+++. .+|+.||||++....         ....+.+.+|+.++++++ |||||++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            6799999999999999999997 478999999986542         122346889999999997 99999999999999


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ...++||||+++|+|.+++..+   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             cceEEEEEcCCCchHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence            9999999999999999999543   46899999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhcc------CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVR------GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK  491 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  491 (573)
                      ++......  ......||+.|+|||.+.+      ..++.++||||+||+++||++|+.|+.....     .........
T Consensus       157 a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~-----~~~~~~i~~  229 (277)
T d1phka_         157 SCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ-----MLMLRMIMS  229 (277)
T ss_dssp             CEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHH
T ss_pred             eeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCH-----HHHHHHHHh
Confidence            99775432  2345679999999999863      3568899999999999999999999864321     112222222


Q ss_pred             CccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          492 GRLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       492 ~~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ++..      .........++++.+++.+||+.+|++|||++||++
T Consensus       230 ~~~~------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         230 GNYQ------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             TCCC------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCC------CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            2221      111122345678999999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3e-46  Score=381.48  Aligned_cols=248  Identities=22%  Similarity=0.193  Sum_probs=201.1

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccC---hhhHHHH---HHHHHHHcCCCCCCeeeeeeeeecCCcee
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNT---TQWVDHF---FNEVNLISGINHKNLVKLLGCSITGPESL  341 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~l~~~~~~~~~~~  341 (573)
                      ++|++.++||+|+||+||+|+.. +|+.||||++....   .+....+   ..|+.+++.++|||||++++++.+.+..+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            57999999999999999999975 68999999985421   1112223   34578888999999999999999999999


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      +||||+++|+|.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.+
T Consensus        84 ivmE~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~  157 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH---GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF  157 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence            999999999999998543   45789999999999999999999998   999999999999999999999999999976


Q ss_pred             CCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCc
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDP  500 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  500 (573)
                      ....   .....||+.|+|||++.. ..++.++|||||||+||||++|+.||....... .. .+.......        
T Consensus       158 ~~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~-~~~~~~~~~--------  224 (364)
T d1omwa3         158 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-KH-EIDRMTLTM--------  224 (364)
T ss_dssp             SSSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSC-HH-HHHHHSSSC--------
T ss_pred             CCCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHH-HH-HHHHhcccC--------
Confidence            5432   335679999999999975 568999999999999999999999986543321 11 111111110        


Q ss_pred             cccCCCCCchHHHHHHHHHHccCCCCCCCCC-----HHHHHH
Q 008239          501 ALAGNFQEGKPSRLLQIGLLCVQASAELRPS-----MSIVVK  537 (573)
Q Consensus       501 ~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt-----~~evl~  537 (573)
                        ....+...+.++.+|+.+||+.||++|||     ++|+++
T Consensus       225 --~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         225 --AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             --CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             --CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence              11234456778999999999999999999     688875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-46  Score=377.72  Aligned_cols=247  Identities=22%  Similarity=0.270  Sum_probs=204.5

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc---ChhhHHHHHHHHHHHc-CCCCCCeeeeeeeeecCCceeEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN---TTQWVDHFFNEVNLIS-GINHKNLVKLLGCSITGPESLLV  343 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~lv  343 (573)
                      ++|+..++||+|+||+||+|+.. +|+.||||++...   ..+..+.+..|..++. .++|||||++++++.++...++|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            57899999999999999999975 6899999999653   2333556677777665 68999999999999999999999


Q ss_pred             EEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCC
Q 008239          344 YEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       344 ~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~  423 (573)
                      |||+++|+|.+++...   ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++....
T Consensus        82 mEy~~~g~L~~~i~~~---~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~  155 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC---HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML  155 (320)
T ss_dssp             EECCTTCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EeecCCCcHHHHhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence            9999999999998543   35889999999999999999999998   99999999999999999999999999986543


Q ss_pred             CCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCcccc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALA  503 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~  503 (573)
                      .. .......||+.|+|||++.+..++.++|||||||++|||++|+.|+.....     ..++.....+..         
T Consensus       156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~-----~~~~~~i~~~~~---------  220 (320)
T d1xjda_         156 GD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE-----EELFHSIRMDNP---------  220 (320)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH-----HHHHHHHHHCCC---------
T ss_pred             cc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCH-----HHHHHHHHcCCC---------
Confidence            32 233456799999999999999999999999999999999999999864322     122222222221         


Q ss_pred             CCCCCchHHHHHHHHHHccCCCCCCCCCHH-HHHH
Q 008239          504 GNFQEGKPSRLLQIGLLCVQASAELRPSMS-IVVK  537 (573)
Q Consensus       504 ~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~-evl~  537 (573)
                       .++...+.++.+|+.+||+.||++||++. ++++
T Consensus       221 -~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 -FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             -CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             -CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence             22344567899999999999999999995 6764

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-46  Score=370.09  Aligned_cols=257  Identities=23%  Similarity=0.262  Sum_probs=196.2

Q ss_pred             ccccccccCceeEEEEEcC-CCCEEEEEEecccCh-----hhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          273 ESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT-----QWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       273 ~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .+++||+|+||+||+|+.. +|+.||||++.....     ...+.+.+|+.+|++++|||||++++++..++..++||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            4678999999999999975 689999999865322     1234688999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +.++++..+.   .....+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.......
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             hcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            9988776555   23456888999999999999999999988   99999999999999999999999999987654332


Q ss_pred             ccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccC------
Q 008239          427 HISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVD------  499 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d------  499 (573)
                       ......||+.|+|||++... .++.++|||||||++|||++|+.|+..... .+....+.............+      
T Consensus       156 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~-~~~l~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         156 -AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             -CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH-HHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             -cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH-HHHHHHHHHhcCCCChhhccchhccch
Confidence             22345789999999998754 679999999999999999999877654322 222222222211111000000      


Q ss_pred             ccccCC--------CCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          500 PALAGN--------FQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       500 ~~l~~~--------~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ......        .....+..+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            000000        01234567899999999999999999999997

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-46  Score=372.57  Aligned_cols=251  Identities=18%  Similarity=0.213  Sum_probs=205.8

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      .++|++.+.||+|+||+||+|... +|+.||||++.....+ ...+.+|+++|++++|||||++++++.+....++||||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~   82 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF   82 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEec
Confidence            467999999999999999999975 6889999999765433 45688999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC--CCcEEEeecccccccCCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE--EFTAKIADFGLVRLFPED  424 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~--~~~~kl~Dfgla~~~~~~  424 (573)
                      +++|+|.+++...  ...+++.+++.++.||+.||+|||+++   |+||||||+|||++.  ...+||+|||+++.....
T Consensus        83 ~~gg~L~~~i~~~--~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~  157 (321)
T d1tkia_          83 ISGLDIFERINTS--AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCBHHHHHTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             CCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence            9999999988432  236899999999999999999999988   999999999999985  458999999999876443


Q ss_pred             CcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccccCccccC
Q 008239          425 ITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAVDPALAG  504 (573)
Q Consensus       425 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~l~~  504 (573)
                      .  ......+|+.|+|||.+.+..++.++|||||||++|||++|+.||......     ........+...  ++...  
T Consensus       158 ~--~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~-----~~~~~i~~~~~~--~~~~~--  226 (321)
T d1tkia_         158 D--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ-----QIIENIMNAEYT--FDEEA--  226 (321)
T ss_dssp             C--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH-----HHHHHHHHTCCC--CCHHH--
T ss_pred             C--cccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH-----HHHHHHHhCCCC--CChhh--
Confidence            2  233457899999999999999999999999999999999999997654321     111112222110  11111  


Q ss_pred             CCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          505 NFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       505 ~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                        ....+.++.+++.+||+.||++|||++|+++
T Consensus       227 --~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         227 --FKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             --HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             --ccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              1124567889999999999999999999997

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=367.14  Aligned_cols=263  Identities=25%  Similarity=0.341  Sum_probs=200.7

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|+..++||+|+||+||+|+. .+|+.||||++....  ....+.+.+|+++|++++|||||++++++.+....++|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999997 568999999996543  2345788999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      |+.++ +.+++.. .....+++..+..++.||+.||+|||+++   ||||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~-~~~~~~~-~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~  156 (298)
T d1gz8a_          82 FLHQD-LKKFMDA-SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  156 (298)
T ss_dssp             CCSEE-HHHHHHH-TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred             ecCCc-hhhhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCc
Confidence            99754 4444432 23456999999999999999999999988   9999999999999999999999999998765433


Q ss_pred             cccccccccCcCcCchhhhccCC-CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCc---ccccc-Cc
Q 008239          426 THISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGR---LHEAV-DP  500 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~-d~  500 (573)
                      . ......||+.|+|||.+.... ++.++|||||||++|||++|+.|+...... ..............   ..... .+
T Consensus       157 ~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~  234 (298)
T d1gz8a_         157 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI-DQLFRIFRTLGTPDEVVWPGVTSMP  234 (298)
T ss_dssp             B-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             c-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHH-HHHHHHHHhcCCCchhhcccccccc
Confidence            2 334557899999999887765 578999999999999999999998643321 11111111111100   00000 00


Q ss_pred             cccCC-----------CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          501 ALAGN-----------FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       501 ~l~~~-----------~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                      .....           .....+.++.+++.+||+.||++|||++|+++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         235 DYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            00000           011334678899999999999999999999974

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.3e-45  Score=365.73  Aligned_cols=261  Identities=23%  Similarity=0.318  Sum_probs=202.0

Q ss_pred             cCccccccccccCceeEEEEEcCCCCEEEEEEecccC--hhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNT--TQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e~  346 (573)
                      ++|+..++||+|+||+||+|++++|+.||||++....  ....+.+.+|+.+|++++|||||++++++...+..++++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            5799999999999999999999999999999996543  33357899999999999999999999999999999999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCCc
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDIT  426 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~~  426 (573)
                      +.++.+..+.   .....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus        82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~  155 (286)
T d1ob3a_          82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR  155 (286)
T ss_dssp             CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred             ehhhhHHHHH---hhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCcc
Confidence            9877666554   23456999999999999999999999987   99999999999999999999999999987654322


Q ss_pred             ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc------cc--
Q 008239          427 HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH------EA--  497 (573)
Q Consensus       427 ~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~--  497 (573)
                       ......+++.|+|||.+.+ ..++.++|||||||++|||++|+.|+...... +....+..........      ..  
T Consensus       156 -~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         156 -KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEA-DQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             -ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCChhhccchhhhhh
Confidence             2234468999999999876 45799999999999999999999987543321 2222222111110000      00  


Q ss_pred             -------cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          498 -------VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       498 -------~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                             ..+.-........+..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   0000001122344678899999999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-46  Score=374.51  Aligned_cols=252  Identities=20%  Similarity=0.213  Sum_probs=197.1

Q ss_pred             cCccccc-cccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcC-CCCCCeeeeeeeeec----CCcee
Q 008239          269 NYFHESN-KLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISG-INHKNLVKLLGCSIT----GPESL  341 (573)
Q Consensus       269 ~~~~~~~-~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~----~~~~~  341 (573)
                      ++|++.. .||+|+||+||+|+. .+|+.||||++..     ...+.+|+.++.+ ++|||||++++++.+    ....+
T Consensus        11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1          11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            5788765 599999999999986 5689999999853     2456789988655 589999999998865    45679


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC---CCcEEEeecccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE---EFTAKIADFGLV  418 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~---~~~~kl~Dfgla  418 (573)
                      +|||||++|+|.+++..+ ....+++..++.++.||+.||+|||+++   |+||||||+|||++.   ++.+||+|||++
T Consensus        86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a  161 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA  161 (335)
T ss_dssp             EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred             EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence            999999999999998643 2346999999999999999999999998   999999999999985   567999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccccc
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEAV  498 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  498 (573)
                      +......  ......||+.|||||++.+..++.++|||||||+||||++|+.||....... ...........+..    
T Consensus       162 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~-~~~~~~~~i~~~~~----  234 (335)
T d2ozaa1         162 KETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA-ISPGMKTRIRMGQY----  234 (335)
T ss_dssp             EECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC---------CCCSCSS----
T ss_pred             eeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH-HHHHHHHHHhcCCC----
Confidence            8765433  2345679999999999999999999999999999999999999986543221 11111111111110    


Q ss_pred             CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          499 DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       499 d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                        .+........+.++.+|+.+||+.||++|||++|+++.
T Consensus       235 --~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         235 --EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             --SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              00000112345678999999999999999999999983

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-45  Score=362.14  Aligned_cols=239  Identities=24%  Similarity=0.354  Sum_probs=195.8

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEecccCh------hhHHHHHHHHHHHcCCC--CCCeeeeeeeeecCCc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTT------QWVDHFFNEVNLISGIN--HKNLVKLLGCSITGPE  339 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~  339 (573)
                      ++|++.++||+|+||+||+|+.. +|+.||||++.....      ....++.+|+.+|++++  |||||++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            57999999999999999999974 689999999864321      11234668999999986  9999999999999999


Q ss_pred             eeEEEEeccC-CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-CCcEEEeeccc
Q 008239          340 SLLVYEFVPN-QSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-EFTAKIADFGL  417 (573)
Q Consensus       340 ~~lv~e~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-~~~~kl~Dfgl  417 (573)
                      .++||||+.+ +++.+++...   ..+++..++.++.||+.||+|||+++   |+||||||+|||++. ++.+||+|||+
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             EEEEEEeccCcchHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence            9999999976 5666666432   45899999999999999999999988   999999999999985 57999999999


Q ss_pred             ccccCCCCcccccccccCcCcCchhhhccCCC-CcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc
Q 008239          418 VRLFPEDITHISATLAGTLGYMAPEYVVRGKL-TEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE  496 (573)
Q Consensus       418 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  496 (573)
                      ++.....   ......||+.|+|||++.+..+ +.++|||||||++|||++|+.|+....       .    ...+..  
T Consensus       158 a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-------~----i~~~~~--  221 (273)
T d1xwsa_         158 GALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-------E----IIRGQV--  221 (273)
T ss_dssp             CEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-------H----HHHCCC--
T ss_pred             ceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-------H----Hhhccc--
Confidence            9865432   2335679999999999987765 567899999999999999999975321       1    111111  


Q ss_pred             ccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          497 AVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       497 ~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                              .++...+.++.+++.+||+.||++|||++|+++
T Consensus       222 --------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         222 --------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --------CCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence                    123345678999999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-45  Score=363.01  Aligned_cols=262  Identities=23%  Similarity=0.301  Sum_probs=197.5

Q ss_pred             hcCccccccccccCceeEEEEEcC-C-CCEEEEEEecccC--hhhHHHHHHHHHHHcCC---CCCCeeeeeeeeec----
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-G-GEAVAVKRLFYNT--TQWVDHFFNEVNLISGI---NHKNLVKLLGCSIT----  336 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~----  336 (573)
                      .++|+++++||+|+||+||+|++. + ++.||||++....  ......+.+|+.+|+.|   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            468999999999999999999863 4 6679999986532  22233456777776665   79999999998853    


Q ss_pred             -CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeec
Q 008239          337 -GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADF  415 (573)
Q Consensus       337 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Df  415 (573)
                       ....+++|||++++++.....  .....+++..+..++.||+.||+|||+++   |+||||||+|||+++++.+||+||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence             346789999998877654332  33456899999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc
Q 008239          416 GLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH  495 (573)
Q Consensus       416 gla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  495 (573)
                      |+++.....  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+..........
T Consensus       161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~-~~~~~i~~~~~~~~~~  237 (305)
T d1blxa_         161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV-DQLGKILDVIGLPGEE  237 (305)
T ss_dssp             CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCGG
T ss_pred             hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHH-HHHHHHHHhhCCCchh
Confidence            998865332  2344668999999999999999999999999999999999999998644322 2222221111100000


Q ss_pred             c----------cc---CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          496 E----------AV---DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       496 ~----------~~---d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .          ..   ............++.+.+|+.+||+.||++|||++|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            0          00   000001123345677889999999999999999999986

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-44  Score=363.43  Aligned_cols=259  Identities=21%  Similarity=0.279  Sum_probs=195.3

Q ss_pred             CccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC------CceeE
Q 008239          270 YFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------PESLL  342 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~~~l  342 (573)
                      +|+..++||+|+||+||+|++. +|+.||||++......    +.+|+++|++++||||+++++++...      ...++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            5888999999999999999975 6899999999654322    24699999999999999999988543      24689


Q ss_pred             EEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCC-cEEEeeccccccc
Q 008239          343 VYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEF-TAKIADFGLVRLF  421 (573)
Q Consensus       343 v~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~-~~kl~Dfgla~~~  421 (573)
                      ||||++++.+..+.........+++..+..++.||+.||+|||+++   |+||||||+|||++.++ .+||+|||+++..
T Consensus        97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~  173 (350)
T d1q5ka_          97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL  173 (350)
T ss_dssp             EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred             EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence            9999987654444333334557999999999999999999999988   99999999999999765 8999999999876


Q ss_pred             CCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHH----------HHHhh
Q 008239          422 PEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTV----------WDLYV  490 (573)
Q Consensus       422 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~----------~~~~~  490 (573)
                      .....  .....||+.|+|||.+.+ ..++.++|||||||++|||++|+.||........+....          +....
T Consensus       174 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  251 (350)
T d1q5ka_         174 VRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN  251 (350)
T ss_dssp             CTTSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred             cCCcc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhc
Confidence            54332  234578999999998875 578999999999999999999998886543221111111          11111


Q ss_pred             cC----ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          491 KG----RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       491 ~~----~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      ..    ..................+.++.+|+.+||+.||++|||+.|+++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             C---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00    000000011111122345677899999999999999999999996

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=349.49  Aligned_cols=262  Identities=21%  Similarity=0.269  Sum_probs=207.7

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCCceeEEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~lv~e  345 (573)
                      ++|+.+++||+|+||+||+|++ .+|+.||||++...  .....+++.+|+.+|+.++||||+++++++......++|+|
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5799999999999999999997 47899999998654  33456788999999999999999999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccccccCCCC
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLFPEDI  425 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~~~~~  425 (573)
                      ++.+++|..++.   ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++......
T Consensus        82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~  155 (292)
T d1unla_          82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV  155 (292)
T ss_dssp             CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred             eccccccccccc---cccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC
Confidence            999988877664   3356889999999999999999999988   9999999999999999999999999998765433


Q ss_pred             cccccccccCcCcCchhhhccCC-CCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccc------ccc
Q 008239          426 THISATLAGTLGYMAPEYVVRGK-LTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLH------EAV  498 (573)
Q Consensus       426 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~  498 (573)
                      . ......+++.|+|||.+.... ++.++|||||||++|||++|+.|+....+.......+..........      ...
T Consensus       156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (292)
T d1unla_         156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLP  234 (292)
T ss_dssp             S-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGST
T ss_pred             c-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcc
Confidence            2 223445778899999987664 68999999999999999999999866554333333333222211000      000


Q ss_pred             C---------ccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          499 D---------PALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       499 d---------~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      +         ..-...........+.+|+.+||+.||++|||++|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         235 DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             cccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0         00001122344567889999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-43  Score=358.27  Aligned_cols=260  Identities=22%  Similarity=0.327  Sum_probs=195.0

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC------
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP------  338 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~------  338 (573)
                      .++|+.+++||+|+||+||+|... +|+.||||++...  .....+.+.+|+.+|++++|||||++++++...+      
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            468999999999999999999964 6999999999653  3344668899999999999999999999987654      


Q ss_pred             ceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeecccc
Q 008239          339 ESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLV  418 (573)
Q Consensus       339 ~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla  418 (573)
                      ..++||||+ +.+|..++.    ...+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a  168 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA  168 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence            468999999 456665552    235999999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCcccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhc------
Q 008239          419 RLFPEDITHISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVK------  491 (573)
Q Consensus       419 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~------  491 (573)
                      +.....    .....||+.|+|||.+.+ ..++.++||||+||++|||++|+.|+........+ .........      
T Consensus       169 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~  243 (346)
T d1cm8a_         169 RQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL-KEIMKVTGTPPAEFV  243 (346)
T ss_dssp             EECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH-HHHHHHHCCCCHHHH
T ss_pred             eccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH-HHHHhccCCCcHHHH
Confidence            876443    234678999999999876 45789999999999999999999987654321111 111110000      


Q ss_pred             --C----------ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH--hcc
Q 008239          492 --G----------RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM--LTG  541 (573)
Q Consensus       492 --~----------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~--L~~  541 (573)
                        .          ...+.....+. .........+.+|+.+||+.||++|||++|+++.  +..
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         244 QRLQSDEAKNYMKGLPELEKKDFA-SILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             HTCSCHHHHHHHHHSCCCCCCCGG-GTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             hhhcchhhhhhhccCCcccccchH-HhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence              0          00000000111 1123345678899999999999999999999974  543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=353.76  Aligned_cols=263  Identities=21%  Similarity=0.268  Sum_probs=194.8

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeec--------C
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSIT--------G  337 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--------~  337 (573)
                      ++|++.++||+|+||+||+|++ .+|+.||||++...  .....+.+.+|+.+|++++||||+++++++..        .
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~   89 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK   89 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence            6899999999999999999997 47999999998543  33345678899999999999999999998765        3


Q ss_pred             CceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccc
Q 008239          338 PESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGL  417 (573)
Q Consensus       338 ~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgl  417 (573)
                      ...++||||+.++.+....   .....+++..+..++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+
T Consensus        90 ~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~  163 (318)
T d3blha1          90 GSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  163 (318)
T ss_dssp             -CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred             ceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence            4578999999887665444   23446889999999999999999999988   99999999999999999999999999


Q ss_pred             ccccCCCCcc---cccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC-
Q 008239          418 VRLFPEDITH---ISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG-  492 (573)
Q Consensus       418 a~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~-  492 (573)
                      ++.+......   ......||+.|+|||.+.+. .++.++|||||||++|||++|+.|+..... ......+....... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~-~~~~~~i~~~~~~~~  242 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE-QHQLALISQLCGSIT  242 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH-HHHHHHHHHHHCCCC
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCH-HHHHHHHHHhcCCCC
Confidence            9876533221   22245799999999998765 689999999999999999999988754322 11122221211110 


Q ss_pred             -cc-ccccCcccc------CCCCC---------chHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          493 -RL-HEAVDPALA------GNFQE---------GKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       493 -~~-~~~~d~~l~------~~~~~---------~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                       .. .........      .....         .....+.+|+.+||+.||++|||++|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         243 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence             00 000000000      00000         013356789999999999999999999963

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-43  Score=356.70  Aligned_cols=252  Identities=23%  Similarity=0.267  Sum_probs=206.1

Q ss_pred             cCccccccccccCceeEEEEEc----CCCCEEEEEEeccc----ChhhHHHHHHHHHHHcCCCC-CCeeeeeeeeecCCc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL----PGGEAVAVKRLFYN----TTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPE  339 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~----~~g~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~  339 (573)
                      ++|+..++||+|+||+||+|+.    .+|+.||||++...    .....+.+.+|+++|++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            6799999999999999999985    24789999998543    22335678899999999976 899999999999999


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .+++|||+.+|+|.+++....   .+++.....++.||+.||.|||+++   |+||||||+|||++.++.+||+|||+++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~  177 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK  177 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             eeeeeecccccHHHHHHHhcc---cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence            999999999999999885443   4678899999999999999999988   9999999999999999999999999998


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccC--CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRG--KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      .+............|++.|++||.+...  .++.++|||||||+||||++|+.||......... ..+........    
T Consensus       178 ~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~-~~i~~~~~~~~----  252 (322)
T d1vzoa_         178 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ-AEISRRILKSE----  252 (322)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH-HHHHHHHHHCC----
T ss_pred             hhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHHhcccCC----
Confidence            7765555555567899999999999764  4688999999999999999999998665443322 22222221111    


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCC-----CHHHHHH
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRP-----SMSIVVK  537 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RP-----t~~evl~  537 (573)
                            ..++...+.++.+++.+||+.||++||     |++|+++
T Consensus       253 ------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         253 ------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             ------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence                  123445678899999999999999999     4789986

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-42  Score=351.20  Aligned_cols=255  Identities=18%  Similarity=0.242  Sum_probs=198.0

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeec--CCceeEEE
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSIT--GPESLLVY  344 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~~~lv~  344 (573)
                      ++|+++++||+|+||+||+|+. .+|+.||||++....   .+++.+|+.+|++++ ||||+++++++..  ....++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999997 468999999986433   457889999999995 9999999999874  35688999


Q ss_pred             EeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCC-CcEEEeecccccccCC
Q 008239          345 EFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEE-FTAKIADFGLVRLFPE  423 (573)
Q Consensus       345 e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~-~~~kl~Dfgla~~~~~  423 (573)
                      ||+++++|..+.      ..+++..+..++.||+.||+|||+++   |+||||||+|||++.+ ..+||+|||+++....
T Consensus       112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~  182 (328)
T d3bqca1         112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  182 (328)
T ss_dssp             ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred             eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence            999999997754      35899999999999999999999998   9999999999999865 4699999999987654


Q ss_pred             CCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHH---------HhhcCc
Q 008239          424 DITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWD---------LYVKGR  493 (573)
Q Consensus       424 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~---------~~~~~~  493 (573)
                      ..  ......+|+.|+|||.+.+. .++.++||||+|++++||++|+.|+............+..         ......
T Consensus       183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         183 GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             TC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             CC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence            32  23455789999999998765 5799999999999999999999998765443211111111         000000


Q ss_pred             c------cccc--------CccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH
Q 008239          494 L------HEAV--------DPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK  537 (573)
Q Consensus       494 ~------~~~~--------d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~  537 (573)
                      .      ....        ............+.++.+|+.+||+.||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0      0000        000111112234567899999999999999999999986

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-43  Score=357.21  Aligned_cols=263  Identities=19%  Similarity=0.260  Sum_probs=196.7

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEeccc-ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecCC----cee
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN-TTQWVDHFFNEVNLISGINHKNLVKLLGCSITGP----ESL  341 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~~  341 (573)
                      +.+|+.+++||+|+||+||+|+. .+|+.||||++... .....+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            35699999999999999999986 57999999999654 3445678899999999999999999999987653    335


Q ss_pred             EEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccccc
Q 008239          342 LVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVRLF  421 (573)
Q Consensus       342 lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~~~  421 (573)
                      ++++|+.+|+|.+++..    ..+++..+..++.||+.||+|||+++   ||||||||+||||+.++.+||+|||++...
T Consensus        87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~  159 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  159 (345)
T ss_dssp             EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeec
Confidence            66677889999999843    25899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCCc--ccccccccCcCcCchhhhcc-CCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCcccc--
Q 008239          422 PEDIT--HISATLAGTLGYMAPEYVVR-GKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHE--  496 (573)
Q Consensus       422 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  496 (573)
                      .....  .......||+.|+|||++.. ..++.++||||+||+++||++|+.|+....... ................  
T Consensus       160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  238 (345)
T d1pmea_         160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD-QLNHILGILGSPSQEDLN  238 (345)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCSCCHHHHH
T ss_pred             cCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHH-HHHHHhhhccCCChhhhh
Confidence            43222  12345678999999999854 567899999999999999999999875433211 1111111000000000  


Q ss_pred             -----------ccCcccc----CCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          497 -----------AVDPALA----GNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       497 -----------~~d~~l~----~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                                 ...+...    .........++.+++.+||+.||++|||++|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         239 CIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                       0000000    00011234578899999999999999999999974

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.3e-43  Score=347.39  Aligned_cols=258  Identities=21%  Similarity=0.261  Sum_probs=195.9

Q ss_pred             cCccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCeeee-eeeeecCCceeEEEEe
Q 008239          269 NYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNLVKL-LGCSITGPESLLVYEF  346 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l-~~~~~~~~~~~lv~e~  346 (573)
                      ++|++.++||+|+||+||+|++ .+|+.||||++.....  .+++..|+++++.++|+|++.. .++..+....++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5699999999999999999987 4689999998865433  2457889999999987765555 5556777788999999


Q ss_pred             ccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeC---CCCcEEEeecccccccCC
Q 008239          347 VPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLD---EEFTAKIADFGLVRLFPE  423 (573)
Q Consensus       347 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~---~~~~~kl~Dfgla~~~~~  423 (573)
                      + +++|.+.+..  ....+++..+..++.|++.||+|||+++   |+||||||+|||++   .+..+||+|||+++.+..
T Consensus        85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9 5566655533  2346899999999999999999999998   99999999999986   456799999999997654


Q ss_pred             CCc------ccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcCccccc
Q 008239          424 DIT------HISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKGRLHEA  497 (573)
Q Consensus       424 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  497 (573)
                      ...      .......||+.|||||.+.+..++.++|||||||++|||++|+.|+............ ..... .... .
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~-~~~~~-~~~~-~  235 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY-ERISE-KKMS-T  235 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H-HHHHH-HHHH-S
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH-HHhhc-ccCC-C
Confidence            322      1233567999999999999999999999999999999999999998654433211111 00000 0000 0


Q ss_pred             cCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          498 VDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       498 ~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ..+.+    ....+.++.+++..||+.+|++||+++++.+.|+.
T Consensus       236 ~~~~~----~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         236 PIEVL----CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             CHHHH----TTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             ChhHh----ccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            00111    23456788999999999999999999998887743

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=2.3e-42  Score=343.05  Aligned_cols=257  Identities=17%  Similarity=0.226  Sum_probs=203.7

Q ss_pred             hcCccccccccccCceeEEEEEcC-CCCEEEEEEecccChhhHHHHHHHHHHHcCCCC-CCeeeeeeeeecCCceeEEEE
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYNTTQWVDHFFNEVNLISGINH-KNLVKLLGCSITGPESLLVYE  345 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~lv~e  345 (573)
                      .++|++.++||+|+||+||+|++. +|+.||||++.....  .+.+.+|++.++.++| +|++.+++++......++|||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme   81 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID   81 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEE
Confidence            367999999999999999999965 689999998855432  2356788999999965 899999999999999999999


Q ss_pred             eccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCC-----CCcEEEeecccccc
Q 008239          346 FVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDE-----EFTAKIADFGLVRL  420 (573)
Q Consensus       346 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~-----~~~~kl~Dfgla~~  420 (573)
                      |+ +++|.+++....  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.     ++.+||+|||+++.
T Consensus        82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             ec-CCCHHHHHHhhc--cchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            98 689988875432  35899999999999999999999998   999999999999964     57899999999997


Q ss_pred             cCCCCcc------cccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchH--HHHHHHhhcC
Q 008239          421 FPEDITH------ISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSIL--QTVWDLYVKG  492 (573)
Q Consensus       421 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~--~~~~~~~~~~  492 (573)
                      +......      ......||+.|||||.+.+..++.++||||||+++|||++|+.|+..........  ..+.......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST  235 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCC
Confidence            6533211      2235679999999999999999999999999999999999999986544332211  1111111110


Q ss_pred             ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHHHhcc
Q 008239          493 RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVKMLTG  541 (573)
Q Consensus       493 ~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~L~~  541 (573)
                      ..     +.+    ....++++.+++..|++.+|++||+++.+.+.|++
T Consensus       236 ~~-----~~l----~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         236 PL-----REL----CAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             CH-----HHH----TTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             Ch-----HHh----cCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            00     111    23345778999999999999999999988887744

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-42  Score=349.41  Aligned_cols=258  Identities=24%  Similarity=0.274  Sum_probs=188.7

Q ss_pred             cCccccccccccCceeEEEEEcC-CCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC------Cc
Q 008239          269 NYFHESNKLGQGGSGSVYKGTLP-GGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG------PE  339 (573)
Q Consensus       269 ~~~~~~~~lg~G~~g~Vy~~~~~-~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~~  339 (573)
                      ++|++.++||+|+||+||+|++. +|+.||||++...  .....+++.+|+.+|++++|||||++++++...      ..
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            57999999999999999999975 6999999999654  344456788999999999999999999998643      57


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .++||||+.++.+ +.+.     ..+++..++.++.||+.||+|||+++   |+||||||+|||++.++.+|++|||+++
T Consensus        97 ~~iv~Ey~~~~l~-~~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1          97 VYLVMELMDANLC-QVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EEEEEECCSEEHH-HHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             eEEEEeccchHHH-Hhhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence            7999999976544 4442     34899999999999999999999998   9999999999999999999999999988


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHH--------h--
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDL--------Y--  489 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~--------~--  489 (573)
                      .....  .......+|+.|+|||++.+..++.++||||+||+++||++|+.||....... ....+...        +  
T Consensus       168 ~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~-~~~~i~~~~~~~~~~~~~~  244 (355)
T d2b1pa1         168 TAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID-QWNKVIEQLGTPCPEFMKK  244 (355)
T ss_dssp             ---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHHHTT
T ss_pred             ccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHH-HHHHHHHhccCCCHHHHHH
Confidence            65432  23345578999999999999999999999999999999999998875432111 11111000        0  


Q ss_pred             --------hcCcc-------ccccCccccCC---CCCchHHHHHHHHHHccCCCCCCCCCHHHHHHH
Q 008239          490 --------VKGRL-------HEAVDPALAGN---FQEGKPSRLLQIGLLCVQASAELRPSMSIVVKM  538 (573)
Q Consensus       490 --------~~~~~-------~~~~d~~l~~~---~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~~  538 (573)
                              ..+..       ...+.......   .....+..+.+|+.+||+.||++|||++|+++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                    00000       00111111100   012245678999999999999999999999864

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-41  Score=345.68  Aligned_cols=261  Identities=22%  Similarity=0.295  Sum_probs=197.0

Q ss_pred             hcCccccccccccCceeEEEEEc-CCCCEEEEEEeccc--ChhhHHHHHHHHHHHcCCCCCCeeeeeeeeecC-----Cc
Q 008239          268 TNYFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYN--TTQWVDHFFNEVNLISGINHKNLVKLLGCSITG-----PE  339 (573)
Q Consensus       268 ~~~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~  339 (573)
                      .++|+..++||+|+||+||+|+. .+|+.||||++...  .....+++.+|+.+|++++|||||++++++...     ..
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            56799999999999999999996 47999999999654  334456788999999999999999999988643     34


Q ss_pred             eeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          340 SLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       340 ~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      .+++++|+.+|+|.+++..    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+|++|||++.
T Consensus        97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~  169 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  169 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred             eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence            5778888999999998842    35999999999999999999999998   9999999999999999999999999987


Q ss_pred             ccCCCCcccccccccCcCcCchhhhccC-CCCcccchHhHHHHHHHHHcCCCCCCCCCCCcchHHHHHHHhhcC------
Q 008239          420 LFPEDITHISATLAGTLGYMAPEYVVRG-KLTEKADVYSFGVVVIEVVCRKRINLFTQNSCSILQTVWDLYVKG------  492 (573)
Q Consensus       420 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~sDvwslGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  492 (573)
                      ....    ......||+.|+|||.+.+. .++.++|||||||++|||++|+.||...... .....+.......      
T Consensus       170 ~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~-~~~~~i~~~~~~~~~~~~~  244 (348)
T d2gfsa1         170 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHI-DQLKLILRLVGTPGAELLK  244 (348)
T ss_dssp             CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH-HHHHHHHHHHCCCCHHHHT
T ss_pred             ccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHH-HHHHHHHHhcCCCChHHhh
Confidence            5432    23346789999999987765 5688999999999999999999987543221 1111111110000      


Q ss_pred             ------------ccccccCccccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHHHH--Hhcc
Q 008239          493 ------------RLHEAVDPALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIVVK--MLTG  541 (573)
Q Consensus       493 ------------~~~~~~d~~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~evl~--~L~~  541 (573)
                                  .........+. ......+..+.+|+.+||+.||++|||++|+++  .+.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~  306 (348)
T d2gfsa1         245 KISSESARNYIQSLTQMPKMNFA-NVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ  306 (348)
T ss_dssp             TCCCHHHHHHHTTSCCCCCCCHH-HHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             hccchhhhhhhhhcccCCCcchh-hhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCC
Confidence                        00000000000 001234567889999999999999999999997  4543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.9e-37  Score=315.98  Aligned_cols=261  Identities=20%  Similarity=0.221  Sum_probs=192.3

Q ss_pred             CccccccccccCceeEEEEEc-CCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-----------CCCeeeeeeeeec-
Q 008239          270 YFHESNKLGQGGSGSVYKGTL-PGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-----------HKNLVKLLGCSIT-  336 (573)
Q Consensus       270 ~~~~~~~lg~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~~~~-  336 (573)
                      +|+++++||+|+||+||+|+. .+|+.||||++.... ...+.+.+|+.+++.++           |+||+++++++.. 
T Consensus        14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            489999999999999999997 479999999996543 23467788998888775           5789999988764 


Q ss_pred             -CCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh-cCCCCeEEecCCCCCeeeCCCC------
Q 008239          337 -GPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE-ESKLRIIHRDIKLSNILLDEEF------  408 (573)
Q Consensus       337 -~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~-~~~~~iiHrDlk~~NIll~~~~------  408 (573)
                       ....+++++++..+..............+++..+..++.||+.||+|||+ .+   |+||||||+||||+.++      
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~  169 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI  169 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence             34567788877666554444444556678999999999999999999998 55   99999999999998654      


Q ss_pred             cEEEeecccccccCCCCcccccccccCcCcCchhhhccCCCCcccchHhHHHHHHHHHcCCCCCCCCCCCc--c---hHH
Q 008239          409 TAKIADFGLVRLFPEDITHISATLAGTLGYMAPEYVVRGKLTEKADVYSFGVVVIEVVCRKRINLFTQNSC--S---ILQ  483 (573)
Q Consensus       409 ~~kl~Dfgla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~sDvwslGvil~elltg~~p~~~~~~~~--~---~~~  483 (573)
                      .++++|||.+......    .....||+.|+|||.+....++.++||||+||+++||++|+.||.......  .   ...
T Consensus       170 ~~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         170 QIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             eeeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence            4999999999865432    235678999999999999999999999999999999999999976433211  0   011


Q ss_pred             HHHHHhh--------cCc----------cccccCc----------cccCCCCCchHHHHHHHHHHccCCCCCCCCCHHHH
Q 008239          484 TVWDLYV--------KGR----------LHEAVDP----------ALAGNFQEGKPSRLLQIGLLCVQASAELRPSMSIV  535 (573)
Q Consensus       484 ~~~~~~~--------~~~----------~~~~~d~----------~l~~~~~~~~~~~l~~l~~~cl~~~p~~RPt~~ev  535 (573)
                      .......        ...          ....+..          ..........+..+.+|+.+||+.||++|||++|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            1000000        000          0000000          00112234567789999999999999999999999


Q ss_pred             HHH
Q 008239          536 VKM  538 (573)
Q Consensus       536 l~~  538 (573)
                      ++.
T Consensus       326 L~H  328 (362)
T d1q8ya_         326 VNH  328 (362)
T ss_dssp             HTC
T ss_pred             hcC
Confidence            974

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.89  E-value=7.1e-24  Score=195.44  Aligned_cols=164  Identities=17%  Similarity=0.155  Sum_probs=121.6

Q ss_pred             cccccccccCceeEEEEEcCCCCEEEEEEecccCh------------------hhHHHHHHHHHHHcCCCCCCeeeeeee
Q 008239          272 HESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTT------------------QWVDHFFNEVNLISGINHKNLVKLLGC  333 (573)
Q Consensus       272 ~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~l~~~  333 (573)
                      .+.++||+|+||+||+|+..+|+.||||+++....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            45789999999999999998999999998743210                  112344568889999999999998865


Q ss_pred             eecCCceeEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcCCCCeEEecCCCCCeeeCCCCcEEEe
Q 008239          334 SITGPESLLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEESKLRIIHRDIKLSNILLDEEFTAKIA  413 (573)
Q Consensus       334 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~~~~iiHrDlk~~NIll~~~~~~kl~  413 (573)
                      .    ..+++|||+++..+.+          +++.....++.|++.+|+|||+.+   |+||||||+|||++++ .++|+
T Consensus        83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred             c----CCEEEEEeeccccccc----------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence            3    3479999998765543          223345678999999999999988   9999999999999976 58999


Q ss_pred             ecccccccCCCCcccccccccCcCcCc------hhhhccCCCCcccchHhHHHHHH
Q 008239          414 DFGLVRLFPEDITHISATLAGTLGYMA------PEYVVRGKLTEKADVYSFGVVVI  463 (573)
Q Consensus       414 Dfgla~~~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~sDvwslGvil~  463 (573)
                      |||++.........         .|..      .|. ..+.|+.++|+||..--++
T Consensus       145 DFG~a~~~~~~~~~---------~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~~  190 (191)
T d1zara2         145 DFPQSVEVGEEGWR---------EILERDVRNIITY-FSRTYRTEKDINSAIDRIL  190 (191)
T ss_dssp             CCTTCEETTSTTHH---------HHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHHH
T ss_pred             ECCCcccCCCCCcH---------HHHHHHHHHHHHH-HcCCCCCcccHHHHHHHHh
Confidence            99999765432211         1111      111 2356788999999865544

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.53  E-value=1.4e-07  Score=89.01  Aligned_cols=149  Identities=17%  Similarity=0.079  Sum_probs=99.7

Q ss_pred             HHHHHHhcCccccccccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCC-CCCeeeeeeeeecCCce
Q 008239          262 ETLEKATNYFHESNKLGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN-HKNLVKLLGCSITGPES  340 (573)
Q Consensus       262 ~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~  340 (573)
                      .++......|+..+..+-++.+.||+.... ++.++||+...........+.+|...+..+. +--+.+++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            344555566666655444445789998754 5667888886554444445677888877663 43456777777788888


Q ss_pred             eEEEEeccCCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------
Q 008239          341 LLVYEFVPNQSLLDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHEES--------------------------------  388 (573)
Q Consensus       341 ~lv~e~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~~~--------------------------------  388 (573)
                      ++||+++++.++.+.....        .....++.++++.++.||+..                                
T Consensus        86 ~lv~~~l~G~~~~~~~~~~--------~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE--------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCEN  157 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC--------SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGG
T ss_pred             EEEEEeccccccccccccc--------ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhc
Confidence            9999999998775543111        112234555555666666421                                


Q ss_pred             ------------------------CCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          389 ------------------------KLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       389 ------------------------~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                                              ...++|+|+.|.|||++++..+-|+||+.+.
T Consensus       158 ~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         158 WEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                    1238999999999999987667799998766

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.01  E-value=1.1e-05  Score=75.06  Aligned_cols=130  Identities=21%  Similarity=0.246  Sum_probs=86.0

Q ss_pred             cccccCc-eeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCC--CCCeeeeeeeeecCCceeEEEEeccCCCc
Q 008239          276 KLGQGGS-GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGIN--HKNLVKLLGCSITGPESLLVYEFVPNQSL  352 (573)
Q Consensus       276 ~lg~G~~-g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~lv~e~~~~gsL  352 (573)
                      .+..|.. ..||+....++..+++|.......   ..+..|+..++.+.  .-.+.+++.+..+++..++||+++++.++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4555654 678999988888899998654432   24566777776663  23356778887888888999999988666


Q ss_pred             cccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 008239          353 LDNLFVRQDVEPLSWEVRYKIILSTAEGLAYLHE----------------------------------------------  386 (573)
Q Consensus       353 ~~~l~~~~~~~~l~~~~~~~i~~~ia~~l~yLH~----------------------------------------------  386 (573)
                      .+..        ...   ..++.+++..|+-||+                                              
T Consensus        94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (255)
T d1nd4a_          94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  162 (255)
T ss_dssp             TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence            4421        111   1112223333333332                                              


Q ss_pred             -----c----CCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          387 -----E----SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       387 -----~----~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                           .    ..+.++|+|+.|.|||++++..+-|+||+.+.
T Consensus       163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                 1    12238999999999999988667899998765

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.46  E-value=0.00013  Score=72.34  Aligned_cols=77  Identities=13%  Similarity=0.102  Sum_probs=49.2

Q ss_pred             cccccccCceeEEEEEcCC-CCEEEEEEeccc-------ChhhHHHHHHHHHHHcCCC-C--CCeeeeeeeeecCCceeE
Q 008239          274 SNKLGQGGSGSVYKGTLPG-GEAVAVKRLFYN-------TTQWVDHFFNEVNLISGIN-H--KNLVKLLGCSITGPESLL  342 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~-g~~vavK~~~~~-------~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~l  342 (573)
                      .+.||.|....||+....+ ++.++||.-...       .....++...|.+.|+.+. +  ..+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4568999999999998764 678999965321       1112344556877776652 2  345556544  4556789


Q ss_pred             EEEeccCCCc
Q 008239          343 VYEFVPNQSL  352 (573)
Q Consensus       343 v~e~~~~gsL  352 (573)
                      |||++++..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.61  E-value=0.0029  Score=60.52  Aligned_cols=135  Identities=15%  Similarity=0.122  Sum_probs=76.1

Q ss_pred             eeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCCe-----eeeee--eeecCCceeEEEEeccCCCcccc
Q 008239          283 GSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-----VKLLG--CSITGPESLLVYEFVPNQSLLDN  355 (573)
Q Consensus       283 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l~~--~~~~~~~~~lv~e~~~~gsL~~~  355 (573)
                      -.||+....+|+.+++|+.... ....+++..|...+..|...++     +..-+  ........+.+++++++..+...
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~  114 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD  114 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred             ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence            5799999999999999987543 2234567778888877642222     22111  22345567889999987444210


Q ss_pred             ----cc----------c----c--CCCCCCCHH-------------------HHHHHHHHHHHHHHHHHh----cCCCCe
Q 008239          356 ----LF----------V----R--QDVEPLSWE-------------------VRYKIILSTAEGLAYLHE----ESKLRI  392 (573)
Q Consensus       356 ----l~----------~----~--~~~~~l~~~-------------------~~~~i~~~ia~~l~yLH~----~~~~~i  392 (573)
                          +.          .    .  .....+++.                   ....+...+...++.+..    .....+
T Consensus       115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l  194 (325)
T d1zyla1         115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR  194 (325)
T ss_dssp             CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred             CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence                00          0    0  001111211                   111111122223333322    223468


Q ss_pred             EEecCCCCCeeeCCCCcEEEeecccccc
Q 008239          393 IHRDIKLSNILLDEEFTAKIADFGLVRL  420 (573)
Q Consensus       393 iHrDlk~~NIll~~~~~~kl~Dfgla~~  420 (573)
                      ||+|+.+.|||++++  ..++||+-+..
T Consensus       195 iHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         195 LHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ecCCCCcccEEEeCC--ceEEechhccc
Confidence            999999999999754  45899997763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.47  E-value=0.0028  Score=62.45  Aligned_cols=74  Identities=20%  Similarity=0.304  Sum_probs=49.7

Q ss_pred             cccccccCceeEEEEEcCCC--------CEEEEEEecccChhhHHHHHHHHHHHcCCCCCCe-eeeeeeeecCCceeEEE
Q 008239          274 SNKLGQGGSGSVYKGTLPGG--------EAVAVKRLFYNTTQWVDHFFNEVNLISGINHKNL-VKLLGCSITGPESLLVY  344 (573)
Q Consensus       274 ~~~lg~G~~g~Vy~~~~~~g--------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~lv~  344 (573)
                      ++.|+.|-.-.+|+...+++        +.|.+++.- .... .....+|..+++.+.-.++ .++++++.+    .+|+
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~  120 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE  120 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-Ccch-hhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEE
Confidence            46788888899999986543        456666654 3222 3345678888888853344 467777643    6899


Q ss_pred             EeccCCCcc
Q 008239          345 EFVPNQSLL  353 (573)
Q Consensus       345 e~~~~gsL~  353 (573)
                      ||+++..|.
T Consensus       121 efi~g~~l~  129 (395)
T d1nw1a_         121 EYIPSRPLS  129 (395)
T ss_dssp             CCCCEEECC
T ss_pred             EEeccccCC
Confidence            999875553

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.66  E-value=0.071  Score=49.95  Aligned_cols=158  Identities=11%  Similarity=0.043  Sum_probs=81.4

Q ss_pred             cChHHHHHHhcCcccccc-----ccccCceeEEEEEcCCCCEEEEEEecccChhhHHHHHHHHHHHcCCCCCC-----ee
Q 008239          259 FSYETLEKATNYFHESNK-----LGQGGSGSVYKGTLPGGEAVAVKRLFYNTTQWVDHFFNEVNLISGINHKN-----LV  328 (573)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~-----lg~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-----iv  328 (573)
                      .+.++++....+|...+.     |..|---+.|+.+..+|+ +++|+.....  ..+++..|++++..|...+     .+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence            456677777777766443     446666788999877664 8999885432  1234455666666663222     22


Q ss_pred             eeee---eeecCCceeEEEEeccCCCcccccc--------------c--c----CCCCCCCH------------------
Q 008239          329 KLLG---CSITGPESLLVYEFVPNQSLLDNLF--------------V--R----QDVEPLSW------------------  367 (573)
Q Consensus       329 ~l~~---~~~~~~~~~lv~e~~~~gsL~~~l~--------------~--~----~~~~~l~~------------------  367 (573)
                      ...+   +.........++.++.+......-.              .  .    ........                  
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            2111   1122344556666666543321110              0  0    00000000                  


Q ss_pred             HHHHHHHHHHHHHHHHHHhc-CCCCeEEecCCCCCeeeCCCCcEEEeeccccc
Q 008239          368 EVRYKIILSTAEGLAYLHEE-SKLRIIHRDIKLSNILLDEEFTAKIADFGLVR  419 (573)
Q Consensus       368 ~~~~~i~~~ia~~l~yLH~~-~~~~iiHrDlk~~NIll~~~~~~kl~Dfgla~  419 (573)
                      ......+..+...+.-.+.. -..++||+|+.+.||+++.+...-|.||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            01111222222222222221 13359999999999999988777899999876